<SEC-DOCUMENT>0001022079-21-000029.txt : 20210222
<SEC-HEADER>0001022079-21-000029.hdr.sgml : 20210222
<ACCEPTANCE-DATETIME>20210222161453
ACCESSION NUMBER:		0001022079-21-000029
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		121
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210222
DATE AS OF CHANGE:		20210222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		21660381

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>dgx-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:a87d206f-e33b-4d9f-a34a-b74e8733b14f,g:639ddba6-f3fe-4831-960f-76615a38edd9,d:17586f5c1918467f84e9d79a5a08b3e4--><html xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dgx="http://questdiagnostics.com/20201231" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dgx-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF80L2ZyYWc6NGI4NzQxYTVkMjU5NDRkNGE4YWUxZmQ1ZThmY2Q3MzkvdGFibGU6Njk2MjMwNjYwNGYzNDk1YWJhMGY0ZDhkMTY2NTc3NmIvdGFibGVyYW5nZTo2OTYyMzA2NjA0ZjM0OTVhYmEwZjRkOGQxNjY1Nzc2Yl8yLTEtMS0xLTA_0ac17609-b5ae-4fa5-aaa4-2f28a37e52c1">0001022079</ix:nonNumeric><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF80L2ZyYWc6NGI4NzQxYTVkMjU5NDRkNGE4YWUxZmQ1ZThmY2Q3MzkvdGFibGU6Njk2MjMwNjYwNGYzNDk1YWJhMGY0ZDhkMTY2NTc3NmIvdGFibGVyYW5nZTo2OTYyMzA2NjA0ZjM0OTVhYmEwZjRkOGQxNjY1Nzc2Yl80LTEtMS0xLTA_b147d0cb-abfb-4a4e-86a4-59c3530360e3">2020</ix:nonNumeric><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF80L2ZyYWc6NGI4NzQxYTVkMjU5NDRkNGE4YWUxZmQ1ZThmY2Q3MzkvdGFibGU6Njk2MjMwNjYwNGYzNDk1YWJhMGY0ZDhkMTY2NTc3NmIvdGFibGVyYW5nZTo2OTYyMzA2NjA0ZjM0OTVhYmEwZjRkOGQxNjY1Nzc2Yl81LTEtMS0xLTA_6393fe01-6958-41af-a1dd-2d6e87e478c7">FY</ix:nonNumeric><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF80L2ZyYWc6NGI4NzQxYTVkMjU5NDRkNGE4YWUxZmQ1ZThmY2Q3MzkvdGFibGU6Njk2MjMwNjYwNGYzNDk1YWJhMGY0ZDhkMTY2NTc3NmIvdGFibGVyYW5nZTo2OTYyMzA2NjA0ZjM0OTVhYmEwZjRkOGQxNjY1Nzc2Yl82LTEtMS0xLTA_63449a29-f9a7-4207-b7d3-b98dce2d2ecb">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i949923f39e104d6ea10b55d03b6467c2_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDgy_7012da4d-00be-4056-8e53-6cc514ee15da">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i7c9815de6056498884fbf7ad9eb40a7a_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njky_056ade57-4241-451a-a1e9-095ca78772c6">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="ib4e9bac07fa34fa6ac58f793d4697067_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQx_017f65e9-fcca-4642-991b-5a831db9e67f">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i225797e622964ed59d73033ade33c396_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzIvZnJhZzo2MWViMDJiNDYxYjI0ZjdkOTViMDVjZjk4NDlkYzgwOS90YWJsZToyN2FhMjliNzU0MTA0YmJmYmUzZTMzM2IzN2ZlMTdhNC90YWJsZXJhbmdlOjI3YWEyOWI3NTQxMDRiYmZiZTNlMzMzYjM3ZmUxN2E0XzktMS0xLTEtMA_cfee06a9-0540-4b87-b686-9167cb01695e">31.5</ix:nonNumeric><ix:nonNumeric contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" name="dgx:DerivativeGainAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1NzI_56514d22-493f-4c97-86ad-19ef10f8afd8">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" name="dgx:DerivativeGainAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1OTE_2bbebbdb-352e-417a-8de8-f6de9db537f1">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="iceca971098f048bb87e4938a5c193612_D20160901-20160930" name="dgx:AgreementtoOutsourceBillingandCollectionFunction" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzMzUzMTg_a020698b-1549-440e-9434-fef192bf4df1">P10Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dgx-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7d73fad95bda4e53aeeeb1bedb9f3590_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i27e80e3d49854295b01b300430151eb4_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2db1a35d1945348b1a626840f7580c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11ae4adedea143f39461ad0909150885_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79da04d8282d4c8291850645193b2909_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2adde92f1a5461aba05c280fca9d09c_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if187f4fa5af24cc385cdcc159b5ef5cf_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ba55df515514c52893c724f25d5e5b2_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14e2c4e502f24416aea41251e9a7a514_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i930baaff13c549eabbf5ad24d956f10a_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icab245fbfc314588851b15e6a8b204c7_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib94226cbc95e4f099933504fa1529358_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieda80e73180744408f6bbd3ae90626ce_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc23a2ce07eb4cab9ac46e9996f1a9da_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b3e31d6d274c90b794939c176a7b77_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6c6477bf68d434b85bfce824998f2ee_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67fd5ab592cb4dd3942ac4292d19633a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f0ce225b8594c6a86f10f4f1abe8e39_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i555d3026ca444d259517b679c5239f46_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f4f32dc2af94a159626591aaf9de348_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe7163fcb9b04409a8a0d9696060f250_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie567c107fbeb4e04816dbbef6a7bffb2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i115773febea64e13b53405dd26daabf7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dd09031318c470d8f39dd4c76ee0f42_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7cb1556ee64aad934a266328c5feb8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5538d27d3cf4309be1e10b072ade004_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41a7f39f717a41848294a65ad208374f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1868c09b2e774ccf815153a8ec738276_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b7931aebebd467eab54c73e0a052b8b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75af2f2e63234a768a4f963e010f642a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f9ff7ef1303400184e1457d527c79ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa95b24c6da4e29ba0be0001d98ee6f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2981e27108c24f95953c617cc7270437_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92ba93e0278a4f689344c35f78cc1de4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71632adeaf9840789ac22fcbe1d4ab41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd49c909bbf34ee8ac8ef91267017389_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c1b65002784549a102581ed4f9ec6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37b30b92632f4bb7b032b7a33f542c34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if93dc28be267444d8934097d07d281a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i4536b39c8fa64a308c3b9a68dc9e82ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bf2fc1a93c943d987e412080b37ceb5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bc00e25bfc644b48820a7fd5b03ba76_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd9a84f00e01401a9a6b093b0dc83ae7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac9f8df65254c228ccb0893cb2bcae7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i581470f6c29c4d3bbb553be7ce613857_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief7b1c30e21b4abe80d55c1558999325_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id931c5900d5344649f91ba0b0016de0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb24d45e71f14152b0beee33dd6fe7b8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i949923f39e104d6ea10b55d03b6467c2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentAndFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fa47ff8680e47e186c2a067dad4395c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentAndFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c9815de6056498884fbf7ad9eb40a7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76c1d7dadde4494c96e7166dd2fa23a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4e9bac07fa34fa6ac58f793d4697067_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff8b5e5555da40068d37c37923c31be5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe9d4b35706146759a8e29e92296d796_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic81a1f6e1fcc43198cf6c34688f73ef0_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b9a18afbf954307bc8e506be81cbe70_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i225797e622964ed59d73033ade33c396_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c671e617c045bcb06b53c554e033e0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9de3b9dd0a624ae68544d4880991cf82_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if585a3710daf402a97611004eea949c1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eea2c55b034437ba80ba06e3965157c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c9bd2166d847329c826595afad408b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b01ba3ff27b4ed39eb31b8ed8e1b653_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4b549cd3a3d4d348d914417e72845c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4019a241c0854daab20a021259e4c9f9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb29cd72cb14152805c1b85799d4c7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8b8bafd84534ecfa78e8dc260538826_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ccba44e5f4a40efb5fa7b5d55920320_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if014b0d6144e489c86cc32ab7f88bc09_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i348dfcaea5c4487f8852b9106d40158f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia52723062e0945b0b050cdad8b6e84ca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b77dcd1e3264ddbbfc39c8cb976394a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id46ed269b0314d81abc231a84b687522_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ba00c793ebf4cd4aef56d2438bd0c77_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49c3be8da8bb40cfada15e955553b6f3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3716ed1635444a1db24339ff3c1ee6b4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb5aef155d741e9acbdddbaa368b0a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0e0d2b48b134218ab9fe6ae972ccc18_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifae49365342b454dadab2010496cdb33_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a36f7ed0c74323a2fa29fbf45031a6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7c506d404ea4b66a4fc8535a8907e45_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba4d37f590c64c0da8af33c3f247ce79_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fb51ebe236448f590ad554101a9b9c6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea687d8906104369b661d038cde542bd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice4829526306498db68da2230ad3f3ff_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5734074de09c4b53a530f4b9f89b68ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45b1a79458e1445fa42674f9f2d678ab_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ca59367e3f94c41a84556b97c86bdbb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id83f485f0e424cc0b613c7b977010fa5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d87850a80eb4b4babfe02021d7d3c4d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09aa4abe117b4d52b3a8808dab5026d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c2eebecc91f4f99994187f91e6cf8ef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic85598bd2b86456e91558360409ce887_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8246072e29d64600b0af97728d423a90_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfc7590e98964831a39bf2babda2f26c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9773cd12324249bdad8bba77790feceb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice2731fc599e44eebad216d560288aa5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76cf32401c784f6282df17d6217338a3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50637c6aa27f4b9f88abbcb41129c619_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9e3619ec877416abb976607a2ecb8a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d5052a7f794e77a5d8ecd713c12c6c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c69355f4e54414844cb3cf76a843b9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib030f85555694c49b8643f2d91b9693a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72f4ed9e9a914e47a81066fd180c145e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b9ca495276140aebb8a6db9bff67956_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac7825e2fb043728473edf6a486a568_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3955951503f44fe3acd85937ac7a0bc4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f306c25282f4e34bc09d94f5699bb70_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d8ddb3ab9d49528f059c8a9bca7418_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8b59ca556114cfdb36009a1e4663f57_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58ee8ae71172430080535b5a0dd4856b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280c67ee68804035b46f2faa9dce6680_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a6ab703d4d84efbb36e4f1d64e0fadc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27711a12139e4ecc82c168186cb5ebe9_D20200121-20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-21</xbrli:startDate><xbrli:endDate>2020-01-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bacdce196024c839a813e482b5f95f0_I20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb09fcb6511f47edabcbc8b6c3de97e7_D20200121-20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-21</xbrli:startDate><xbrli:endDate>2020-01-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba3f50b191484f5a975775bb5bcd79c0_D20200121-20200121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-21</xbrli:startDate><xbrli:endDate>2020-01-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c610e7bc66145a9a5c3d919c604c9d1_D20200406-20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-06</xbrli:startDate><xbrli:endDate>2020-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2a967045abe4853ac22eaf7f12d73ce_I20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc58d2181184b70abf43e0a7797a61f_I20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09ff1a062aca4dd091930d26abdc94aa_D20200406-20200406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-06</xbrli:startDate><xbrli:endDate>2020-04-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ce66de126184e10bbe6987c714abe61_D20200801-20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b7731ca50f644dbae4378dcde7faab9_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae2b0a12d36246ed98b91815583efc9d_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb19efad8ebc48d8bf627a6c143d9f22_D20200801-20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10cf574e9c2e4d21a2695ebf75df7d6c_D20200801-20200801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice7bbcc9e8ed4ad2ade3ad58246561b0_D20190211-20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-11</xbrli:startDate><xbrli:endDate>2019-02-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61272b36e8f248a490bc5be2a3a5cbeb_I20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i131dd7c4ae56411b91d4494e08f2395b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2baa36a831dc45c59aff0f947d0f6d27_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6895b862b93d4f9db033b2c8960868fe_I20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7b3a596687e4a388e56161f877b4099_I20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcbcfd24bcb54356a9bf41706902f795_D20190211-20190211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-11</xbrli:startDate><xbrli:endDate>2019-02-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3dead11eb114dcbb814658459773ee1_D20180201-20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05fafb7616b247759bbe4a101ccfe88d_I20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c9edd27d62d479f8d54c3850fa9b9c2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42b26f40687b440793ed6325db576f39_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7836c791c01346a1b0c5012b1f08c16a_I20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib74c4c78b12e4840809c22866c04924d_D20180201-20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a716478a2894a559df1f5cf678bcbd6_D20180618-20180618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:CapeCodHealthcareInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-18</xbrli:startDate><xbrli:endDate>2018-06-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac4c7f439bc4a25a8b35842cf0ba6ef_D20180919-20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:ReproSourceInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-19</xbrli:startDate><xbrli:endDate>2018-09-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9436426b22c4886a5e98f743908762e_I20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:ReproSourceInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8da51f5c2e9c490f94945ecf8ac5e9bc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:ReproSourceInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3df733d55ebf4d58bee1631d8ddc6f98_D20181106-20181106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-06</xbrli:startDate><xbrli:endDate>2018-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0e89fc0040e4c588548eaca76b8e386_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e7f845975ee4548acd03e1afe47b0df_I20181106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a260c8c6a244ff0897322a198ac6525_D20181106-20181106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-06</xbrli:startDate><xbrli:endDate>2018-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a6c9ae6653b48b099eac07be30520ad_D20181106-20181106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:ContractRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-06</xbrli:startDate><xbrli:endDate>2018-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5b80ecba80a4ec3be7640854bdf798a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da74a1c6cec43718954e17544e09dab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fc1f28fcd3344fda11bc60c50575b60_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b53551e765e48ada91ce1b2213af833_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic086df6338f745a683de6c79a9de2fcb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id77fd8acee3c4413b86f9d17207eabab_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ae8426bd53a496485b1b374770b199e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5925d31cf3ff45fc9047d3197966b069_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d1e7f19b404c199e04abc162106cc4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b50bcaa47814ec28040b26b7160a5ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ca595e5eb740889d328b33d7ef80c9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib49a85f69283488d9da436dc5543b52e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92ef5f3f75a64fcea2e40d3c9b3ba138_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2ea36aabe78463eb75346dd3ac096a6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac45b37ce14e464c83d493dbb68d08ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i819ba4179ff04a9c8d4de164c0081dc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48245c8eab5c4b8091bfa77ef50e467e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1e6d68bf2d9484a8f112f2794388931_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02060ac5ffa04417a6b16a9bd1912233_I20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4202ba5a9d04407d83cd7e068541a1d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabd266dd7d024345af367a828d3a1650_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08f2967b216f47cdbe6de707915af4a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57203f1941a34c238bfee31665aa7843_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b179f5a47024b169176a67fc04394a0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98373f0ec7ac4501bf3c20e192a85ab3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b35a4725d3b4fe88bfb392d476d30ea_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i488c3759446b424087ce0ba119b76f4b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79e00f2d39ae4504bdf0f0d04a7db8be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17d8a0586d3241db9286ef290dada58c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963111a2b7bb47c19ef1cb3341f61107_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc60f47f344746ebae9a4d823259060a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460ce5e8869e4c7ebfa1175c77836f6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b113ac98aea45cf8f7bd27c96d34ba6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb8ced261d56482fb9e20fcf2b809143_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b3427db7dba497ca4f76498d69ffb7b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7baf33e596b473a946a41c842d5c491_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08feb83acb194d67a15c42b397b1d300_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide27b07e394e4a51961018b52520f0c9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28c19a374b654a3fa8f26f4bf1cada1b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i621c9dbaf928427c8d032db6c9363c81_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20fc99f28f194d7c887e0338830b8cb3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f467983b7f945f691b9a39b57df9e3f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if767f2717d3143c6901d055819025e8a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1e2caa4565945f894ecf42eb41689f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c7dfe44b07a4d7e846ac1bbb305e60e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4534f39f0409446090ba1928a95e44ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8718641f12744c54b79e3f030931340e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if578b84393414e85a55b974226b6eb09_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i610d712018cd496aa9a406ed51db8e20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic84b16b1ff6c4b6e9b65c95661c327fb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia97c59e5c69e47a6a83178a589df2ac9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e856d54e7714c97aec096fbeec1b506_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide2b357f410944b7bde3dde25e5e073f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f0d7b7e3f6c492db815036cc5c1c97e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7572c2a2924de4b2ef502d5bbbfa0c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenFivePercentSeniorNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9887f5d1e7ec47d794ad4b9c520d77f0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenFivePercentSeniorNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i492a760c40d7442ca1a7e0f8594d36e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieace3baae6f84b0e9354cf88139ef2c2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0dd309e22f4493e85b52fb6f70911e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie56f70613c89455ab45a405199ac352e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eb23b0916d24877a17f2212f4fbd7da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourpointtwofivepercentSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i253f26b0c58e4670a7e5d21e7ed55f38_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourpointtwofivepercentSeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68618e5aa89c4194adf23217f32a8b41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79c28753e6234d99a6b6e5ecd71a6645_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e04c7b3917042c0be08e09c6ee19d74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFourFivePercentSeniorNotesdueJune2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i979e993f5cad468e9c420fcb8e10baae_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFourFivePercentSeniorNotesdueJune2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64c30d8d93c246b9a9045e239918d12b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa89a373573f435bad75aa9ad414d5cf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3374f07e84740c1b2a1181c5c8ed5fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointNineFivePercentSeniorNotesdueJune2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id253b3ca50134883a39411cabb3236df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointNineFivePercentSeniorNotesdueJune2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a816a93885d4ca989a2e52f8edcd268_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia92ac89bc9464dc4a5bf688a1dc0f2e1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica3b9d8c23ad48a888fd41a9f78b692e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:SixPointNineFivePercentSeniorNotesDue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dc40d79750043f0a0c76f967a147ab5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:SixPointNineFivePercentSeniorNotesDue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c0a568fbbe54b32a4d65037b02187d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FivePointSevenFivePercentSeniorNotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie27dd42f03aa4d7da20e94071af99bcc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FivePointSevenFivePercentSeniorNotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f38dc71c4a4401ba20c8d9d84fd23b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44196df9463840cc83124dd513dea909_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i545c653723ac4b35958b7b601878135c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FinanceLeaseObligationsandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfbc63685ff840fb973900d155c530e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FinanceLeaseObligationsandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecaf492a9ad94a36b60612ba765970e6_I20201022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb648f82ea194e07a192722e1bf31021_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibce6a4a1e68c4e53a145b95c9e367803_I20201022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoancommitmentmaturingOctober2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f191ea10c984af4842750df37661e22_I20201022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i462cfe8638814f0f8481f3716a2592c3_I20201022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i524294a4d8b3418da3d3f916d41a20d1_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c91c94f07a044d2aa17c4da4b4cf161_D20201231-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-31</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i904ef886693341f7b599802cc0a219e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie586bfbfd98b4802b4c74457620ebe91_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b45d450024c47499fbde295edb34e7e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b81aaa9acb42f1810e4c076150e924_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f895fdee4b5481087569c16292b9b26_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4e79e85b7c548d0b0dc680c03e2b9e5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d93b15cf2364f2f9c77170f1dcdc9cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ee13471497b4108b33ff83c309a7a45_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80dc0f5cd5f241689a10b1242a112b9a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88d8839878a14fa79907f288bf110c47_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11c5ad757a094b24a5c73f68379fa8f9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6362246725c44d7844b750f652f23d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0847ec854f1041b091d07bb199a6faaf_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87fb802f159d45308c5722aab7a51e3f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i752e64558c134adab9652fe39589f9ca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66ce45540c0b49579be5f2a665d77e65_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dgx:ForwardStartingInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7827a00a60bc4aef8604397387c5b8e9_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dgx:InterestRateLockAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i837da46f467741f1a47e6456ab80934a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d52e8506b964853934619358132e916_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127dea9d515d4af9aad64832390b1702_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dgx:FixedtovariableinterestrateswapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifacb1c5c6dad45498481604994cc9c9b_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dgx:FixedtovariableinterestrateswapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id141c98d5c21416f95dd9ad86532d5f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb6a84f2be8142b7ad7ceae3cd3f42a7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb495ec24a01435fbd27a38907a75fca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff2d731644784878a01ffd609e67911a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if16ba469706349e7a5dda9f237173286_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia67a4a0ff8b1447e93f556e763ad297c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7186eb7282e4103827c4b7ee0d01c74_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3219d74c46bf4c0297cf3d070a80cc44_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73cb452a6ac74285af4a4f642559ad6f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34c51c66cc164d1da2582f9c600d44f1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69c7eeb1cf454f3087a541bf615ec3e1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50dd445f21194164a30af100f410f3e2_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1945a14f9f4ce2921e9bbaaa6b9124_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdffbc0183ce49ee8d6307cd711c32da_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41c2b4effc544078806b615118dd9278_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5448ffcdebdf4d7ea0f8ffee8b0b8f9b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff2b554598b47c6aec52cefb4f6bb51_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d31347983ac43948ce0a443c75f4aa8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dab0f39fda445528890429f9f021ab9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib698a53cb2f8426cbe61b6e19fb1a281_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bd46f02dc1f4473b397c6a576d3bc85_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id24dcfded8274220894b4ec84f289be9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35228c4a5cbe4bf9a0b8ad2de1992783_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73cf70b9879644efb91f2116611446a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0eb38fdc3746ec8e44fcd4afa6a3fe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i192e1f30a76a48d1a4fccda9268bcefa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fec735f32d545668c9011b3d1ba778b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e0cd2bf0ce400291395c2d343ce00b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67231146b7644c899681fc68de1cc785_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bc1b38e887c4144b5780eca80bd204b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifebaca822eff4cc387f98c008d09c38e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ef455113ed841c7b82fbb4ace9b85be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d73f4e924f4a10a8f521b757db5eb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7731e39a610040f98b51c6b6e8764070_D20180101-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63870adfaa434891bafa374146f885cb_D20180701-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i696a70381cba476b8c6f79dd4b77fe5b_D20180401-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie62d0efe4ae34fd6b32670577a82ac3f_D20181001-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1582bc80466c4a0a99308fa830a6db42_I20210204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32de60c551da40599315cbb1e6c3f5ca_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62130c12d0ec4b10b6bb1bea0f6d8ab3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b5c67810b5d48758c30b695b04494b1_I20210222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36c642409ac64921826ebf21bd9b07f1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie95d4b8fec93446cb65b51f7e24e8460_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i163121a462fb460dac48b33c7084fd77_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e33a74d2374686abe9f0c57a67eaa5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:EmployeeLongTermIncentivePlanEltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceca37b233814fac990bb0d43b3d1f18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:EmployeeLongTermIncentivePlanEltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i117f623b34944a4aa09ba43fe0f2b647_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b61e94e7f074f5ab9c3930b140386b5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib33f609e90994e12b073cfeb7263634a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b818bf8df5f410eb2045ec27d80953b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie98b52a6c1794c20a26d3553828e4078_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i727f4b6eb33e4f3c8265b0e2dc2dbd40_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d1ed33ea86c4c04ba5ce3c4c14d4697_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ff65eb76ff475b8f7a4009c8376341_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33ff90645a634391b6fdea36985a329f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec25aa9d406c44b6ade6d810256599b6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec3b8abba2144858babf9798d912c8a_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea41724e5f1a4bff83d7d555a0c98b95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32d8eea035f740d88c4e34d32ac07b50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia85a7d30ffe046e3afb073a1149514cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i362c812a405d45709cb7b160258b8ed1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifec7bf006deb455588ac5eef858ed849_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43c9eaea209849029715a8175ab5a38f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefd7e996ee1d4652be0e3370eb259fdb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba88a90ce070465d896214b27be236f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85260b1da0934bb69e54b6bb7d6ca068_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c5e3bd1735944849b8b66228d6f266b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5e7b1b65014971a56d11421ae554a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b09f22a0749457e8f3d51b1f9549c3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib706a5ff02034443bde21ac1c37511c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i739e5869c8ba4c87a0e6a0a88a17f0e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceca971098f048bb87e4938a5c193612_D20160901-20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-01</xbrli:startDate><xbrli:endDate>2016-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dgx:claim</xbrli:measure></xbrli:unit><xbrli:context id="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b19e4e8df441dd9a3a047864af82a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bfcea6d4a6f42a28ae201c9acd9e681_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i728b5f186c284cccb74701cceaa73177_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9491ec5cfff349bebd4c36dea5408c17_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i738f18abd516453e9c1b7fdf805a03d8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18079f917bab424fa56b9c2ca26f0aef_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c9b10d54f56453ab58e231cabe11e4e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i532b66c76cad4095bab3b1e800197403_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f0ce923b9cb4071b89bf2e5cf956d70_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a1e4a3f0744196ae6e420b749b6626_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib82b870198214f2fa9c11cf73b7c2285_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16009b81f04442439e6d1273e8b3e3d5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8de7c8519348419985b65110c0808877_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i375a264a2ebe483fbbbf773457d0b2fe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c6fa4c884c0473a8de98fccdb136f8e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c2eef5ed33d472db8175faea063b824_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i447b9c6561a048c985f4ab898c1121e8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a7391181b8741db9a1686e9c9b083dc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i944f676d67324e0ba91482f72d96b22c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f3f0dbfc5d747b19835bfdf96c93b85_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic42f8e90bb9742fda4370a7c80d21289_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c4439a4821541da95311cd6e7ab8e84_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0114534d1d8d4e39aa9cc6b5a35609ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibec3fcd21ae6474f999b20d69d69bd44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b9920e1039a4bbc96cddc20848124d0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35915c99296f48f3bf58b06369abc86d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceeca8e729a74e688a40d2720017ccf7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4cf653852bc4efabf147c2ab56dcdcf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c465a22a3f4e7e8356afdae38c480f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i720a47095d174e48af4858648c214a5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i448e43197d9648fdae5be5f882e40fe0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e9708bf7a3f4fe9bf78754bc3d52636_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:NidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b4de4e5f21041db87556bf0e720459f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d7dd6fe1eec401f8fa3bbc7218f34d9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bbe7f359fb441618dff6db8b09e9693_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i188d6941e8fa42beafe10767321c5eb9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice1470357afb4f228be84a3f77de9bb4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5034ddf618274bbab61b97eef0228bd8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia853061a347a4f67a24c62ecefdcf9e4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ac794c54fea41c082189f0a8fed1dd9_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb70b878994a44d0a2cea507d2ead6a6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib14b8a10b66a4c97a54f968b44161d88_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaf490fefc914c45b4456f72c9bdf613_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f50c4e8562542bc9cb4c710b1f0ce64_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b9e1c6b12a542709fad464b97f3772e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i299506ac090e48338ffdc86d6e316b6d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iada86b56f45a48b397d3c96f067a7475_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3c43507276845e68498c4ff71c1ccff_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1db356aed7c84b408e826cf4a5378149_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ff501c262847c0851ba168e5b293ff_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c24be469f644a7d9e205e4e693a21e4_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e8ef2ddd684f5c8ee33b7a03675400_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69b0cda2873944f69a703c9bcbb95cf5_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia72b92b0f0be40e89a72bc54bd0361fc_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3c02f9911b34985a9c3b2cd7600534c_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30b20cba82d2410f8d16e73bbaba47ad_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f3e38b6a2b49a1a515bcbb581fd02d_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f2e0858b3b740c9ad4cbd585da3c971_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e06c5cb90a9430688ffd3e687ac8d51_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8f06c22a7fb411ea90bc48b15e6234c_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iface07505ab342789068244bb97b89df_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic13cec6030c243db9ed599ac34410b5f_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97d3ffa754e846359243673a76a4dd3d_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb0fe8ee698545d98f72f17ee9b32a59_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0778872492304f04a882ac24394af772_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59a64dfb2bb34d24abf433537d03cfb6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbe11049deab4e0695a9136216555273_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb52dade7a1942a4a87b386331e3c5fd_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88fc2768290f406e90452310cc0cc35e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d23165dad6f4a7c9753adca8283f930_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:NidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4935382cf51a42e5ac2c7f7b75f377d1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id133d541098b460c855ee9ebba789ee6_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2cb4ca2313e45f5a150880b15665d99_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0177fd8fa149409d932b66e085fff082_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0567e595477470982b2e5e34d02c2b2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia64109811371447e8f58f600a7e213ec_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2549acbace4796a9c86fd435062b92_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9aa3e5c40ac445299ed6a675092e9ba_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e0b27f6e56e4d51946d35cdcfce7aa2_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebc62645fa31471fbe90700f9465c88a_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4cdaf18428f4a29ac09bbda7601b898_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94e290893fe1450ea0b89d2e52ba32cb_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ef0d848be64de88a06475f05c8fc23_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id92fdac500c449b68f3d7a77c241c32a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37650e5ac3af455b982266e74362e4f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5bea947c9da4d009c5112e1fb35819b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02d0b9ff9814b8c8b499379f5994f66_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9415c8123544c9387ed93ba012a625f_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0bc1c3cf41a470d861c0f391ba08410_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_1"></div><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODEz_157c68c2-0b12-4798-a22c-59c3e727ea35">10-K</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">           </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODE0_fef09847-3f70-49cd-abb7-2c819f6f196e">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the Fiscal Year Ended <ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV80OTQ3ODAyMzI4NzU3_7e784d6f-9d1a-4469-9bd6-c06a1988c5e0"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV80OTQ3ODAyMzI4NzU3_c8362d53-e13b-4397-8240-20c716e51d67">December 31</ix:nonNumeric>, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Or</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">           </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODA4_cbe2ff35-2ed0-40ee-a2a0-0ff8e54c81d7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from __________ to __________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODE1_9ba7d139-8fe2-4c07-9a80-37028e1c8eac">001-12215</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODA5_62be1eec-60f3-4f35-a96c-297c0397576a">Quest Diagnostics Inc</ix:nonNumeric>orporated</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8wLTAtMS0xLTA_7fc5652b-bdc2-428b-a941-aed62b04236b">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8wLTUtMS0xLTA_77c88851-0758-4dd1-9105-0889cebd8bcf">16-1387862</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(State of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8yLTAtMS0xLTA_99d3414a-2e3e-49eb-a1a0-f5eaf89017f7">500 Plaza Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8zLTAtMS0xLTA_43a98610-3c46-4f9b-b40e-32df8f5fdd31">Secaucus,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8zLTEtMS0xLTA_aff98956-e4dd-481e-8aba-c69c57cbb769">NJ</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8zLTItMS0xLTA_2cdeefd1-2446-4d0b-b4bb-48fc6609a12d">07094</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl80LTAtMS0xLTA_7e9dfeae-4b91-4b92-a2be-04ab9cfb8cfe">(973)</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl80LTEtMS0xLTA_d8c2d32c-3ca5-46f1-8339-81e6c296e497">520-2700</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6M2MyNDcwMDY0OGMzNDc0NjhmMjJkMGY2NTkyMjBhNGEvdGFibGVyYW5nZTozYzI0NzAwNjQ4YzM0NzQ2OGYyMmQwZjY1OTIyMGE0YV8yLTAtMS0xLTA_052d766d-cd91-4aa5-bc22-d668e0e655a1">Common Stock, $.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6M2MyNDcwMDY0OGMzNDc0NjhmMjJkMGY2NTkyMjBhNGEvdGFibGVyYW5nZTozYzI0NzAwNjQ4YzM0NzQ2OGYyMmQwZjY1OTIyMGE0YV8yLTEtMS0xLTA_99620331-133b-4ac8-9e9a-bb248bdfeede">DGX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6M2MyNDcwMDY0OGMzNDc0NjhmMjJkMGY2NTkyMjBhNGEvdGFibGVyYW5nZTozYzI0NzAwNjQ4YzM0NzQ2OGYyMmQwZjY1OTIyMGE0YV8yLTItMS0xLTA_ea48772a-45bc-46a2-860f-eb5ceeb2b11c">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:11pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:49.734%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(g) of the Act:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">None</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODEw_091464a0-ec58-4fa5-a8c7-b3734425a26f">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODA3_ca61c1c9-59f0-40ef-8c52-b07f90796a9f">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODEx_7508b3ad-7850-4e52-b93a-7c8ce5632618">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODEy_f4358011-47e0-42c7-bd25-88009679490c">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%"><tr><td style="width:1.0%"></td><td style="width:42.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6OTE1MjBiNTJhZDU0NDg0ODg1M2YxM2NlNDU2ZmY2NzMvdGFibGVyYW5nZTo5MTUyMGI1MmFkNTQ0ODQ4ODUzZjEzY2U0NTZmZjY3M18wLTAtMS0xLTA_950df878-8d19-4fb7-9876-b34fdb6bbe70">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6OTE1MjBiNTJhZDU0NDg0ODg1M2YxM2NlNDU2ZmY2NzMvdGFibGVyYW5nZTo5MTUyMGI1MmFkNTQ0ODQ4ODUzZjEzY2U0NTZmZjY3M18xLTMtMS0xLTA_5a47b25f-c467-4010-8cf8-d8ca40e069ce">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6OTE1MjBiNTJhZDU0NDg0ODg1M2YxM2NlNDU2ZmY2NzMvdGFibGVyYW5nZTo5MTUyMGI1MmFkNTQ0ODQ4ODUzZjEzY2U0NTZmZjY3M18yLTMtMS0xLTA_22a56e4f-61df-4125-93ac-5ca93852ac6b">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [&#9744; ]</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  [<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV80OTQ3ODAyMzI4Nzgy_8bd40f27-cfb2-4f5d-a299-6c6cb752db12">&#9746;</ix:nonNumeric>]</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes <ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV80OTQ3ODAyMzI4ODEx_2efb1ffa-0efa-4ae7-aea5-0e72ec57a5fb">&#9744;</ix:nonNumeric>    No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;X&#160;&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 30, 2020, the aggregate market value of the approximately 134&#160;million shares of voting and non-voting common equity held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i7d73fad95bda4e53aeeeb1bedb9f3590_I20200630" decimals="-8" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yMTk5MDIzMjU4NDQ4_03f6638e-b3fa-4e9e-b2f6-cef9fbd76d03">15.2</ix:nonFraction> billion, based on the closing price on such date of the registrant's Common Stock on the New York Stock Exchange.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of January&#160;31, 2021, there were outstanding <ix:nonFraction unitRef="shares" contextRef="i27e80e3d49854295b01b300430151eb4_I20210131" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yNTcy_af3726d8-0b8a-48ed-96b7-d19e049e41a8">133,454,761</ix:nonFraction> shares of the registrant&#8217;s common stock, $.01 par value.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.298%"><tr><td style="width:1.0%"></td><td style="width:78.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.366%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Documents Incorporated by Reference</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Part of Form 10-K into</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">which incorporated</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6ZDIxYjQ2ZTAyZDJjNDRlMzlhMmM4YzA0ODQ2YmE0MGMvdGFibGVyYW5nZTpkMjFiNDZlMDJkMmM0NGUzOWEyYzhjMDQ4NDZiYTQwY18yLTAtMS0xLTA_e8f594e3-e910-49e7-95d7-2f64b862fc4b" escape="true">Portions of the registrant's Proxy Statement to be filed by April&#160;30, 2021</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part III</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Such Proxy Statement, except for the portions thereof which have been specifically incorporated by reference, shall not be deemed &#8220;filed&#8221; as part of this report on Form 10-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> TABLE OF CONTENTS</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.883%"><tr><td style="width:1.0%"></td><td style="width:10.764%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.014%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.922%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">&#160;Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_16">Introduction</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_19">Our Strategy</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_22">Our Strengths</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_22">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_25">Business Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_25">11</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_28">The Clinical Testing Industry</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_28">14</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_31">General</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_31">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_34">Regulation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_34">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_37">Available Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_37">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_40">Information about Our Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_40">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_43">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_43">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_46">Cautionary Factors That May Affect Future Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_46">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_49">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_49">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_52">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_52">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_55">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_55">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_58">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_58">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_64">Market for Registrant's Common Stock, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_64">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_67">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_67">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_70">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_70">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_73">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_73">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_76">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_79">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_79">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_82">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_82">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_85">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_85">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_91">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_91">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_94">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_94">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_97">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders' Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_97">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_100">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_100">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_103">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_103">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_109">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_109">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_112">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_112">55</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_118">Selected Historical Financial Data of Our Company</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_118">58</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_121">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_121">63</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_136">Report of Management on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_136">83</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_139">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_139">1</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_142">Consolidated Financial Statements and Related Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_142">3</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_253">Supplementary Data: Quarterly Operating Results (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_253">49</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_256">Schedule II - Valuation Accounts and Reserves</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_256">52</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_13"></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The discussion in Item 1 below includes several defined terms:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACA - Affordable Care Act </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACO - Accountable Care Organization</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAP - The College of American Pathologists</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CARES Act - Coronavirus Aid, Relief and Economic Security Act </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLIA - Clinical Laboratory Improvement Act</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS - Centers for Medicare and Medicaid Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DCE - Direct Contract Entity</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA - U.S. Food and Drug Administration</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FQHC - Federally Qualified Health Center</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HHS - U. S. Department of Health and Human Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IDN - Independent Delivery Network (including hospital health systems)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPA - Independent Physician Association</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LAB Act - Laboratory Access for Beneficiaries Act</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LDT - Laboratory-Developed Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAMA - The Protecting Access to Medicare Act of 2014</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The discussion also includes several tables, indexed in the following guide.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:81.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.200%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#828282;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #828282;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guide to Tables</span></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;border-top:1pt solid #828282;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services Portfolio </span></td><td colspan="3" style="background-color:#cccccc;border-top:1pt solid #828282;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 1</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;border-top:1pt solid #828282;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Approaches to Accelerate Growth</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 2</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key Professional Laboratory Services Offerings</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 3</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Franchises</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 4</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer-Centric Initiatives</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 5</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major Themes to Drive Operational Excellence</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 6</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our Strengths </span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 7</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets and Capabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 8</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Net Revenues</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 9</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Testing Industry</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 10</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key Trends</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 11</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reducing Healthcare Costs and Improving Care</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 12</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customers</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 13</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Potential Factors Considered When Selecting a Diagnostics Information Services Provider</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 14</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Medicare and Medicaid Revenues as % of Consolidated Net Revenues                                                                                                                                                                                                                                                                                          </span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 15</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key Regulatory Schemes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 16</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cccccc;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Available at Our Corporate Governance Webpage</span></td><td colspan="3" style="background-color:#cccccc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 17</span></td><td colspan="3" style="background-color:#cccccc;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Officers</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Table 18</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1. Business</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTRODUCTION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated is the world's leading provider of diagnostic information services.  We play a crucial role in the healthcare ecosystem, empowering people to take action to improve health outcomes.  Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  In the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics was incorporated in Delaware in 1990; its predecessor companies date back to 1967.  We conduct business through our headquarters in Secaucus, New Jersey, and our laboratories, patient service centers, offices and other facilities around the United States and in selected locations outside the United States.  Unless the context otherwise requires, the terms &#8220;Quest Diagnostics,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; and &#8220;our&#8221; mean Quest Diagnostics Incorporated and its consolidated subsidiaries.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The patients we serve comprise approximately one-third of the adult population of the United States annually, and approximately one-half of the adult population in the United States over a three-year period.  We estimate that annually we serve approximately half of the physicians and half of the hospitals in the United States. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2020, we generated net revenues of $9.4 billion.  Additional financial information concerning Quest Diagnostics for each of the years ended December&#160;31, 2020, 2019 and 2018 is included in the consolidated financial statements and notes thereto in &#8220;Financial Statements and Supplementary Data&#8221; in Part II, Item 8.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our vision, aspirational goals and values are set forth below.&#160;&#160;&#160;&#160;</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span><br/></span></div><div style="text-align:center"><img src="dgx-20201231_g1.jpg" alt="dgx-20201231_g1.jpg" style="height:476px;margin-bottom:5pt;vertical-align:text-bottom;width:277px"/></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our vision, aspirational goals and strategy align very well with, and our strong value proposition supports, the triple aim of healthcare: improving medical quality and the patient experience while reducing the cost of care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In 2020, Quest Diagnostics was at the forefront of the response to the COVID-19 pandemic, playing a pivotal role to broaden access to laboratory insights to help people lead healthier and safer lives.  We provided both molecular diagnostic and antibody serology tests to aid in the diagnosis of COVID-19 and the detection of immune response to the virus, and performed over 30 million of these tests.  Beginning in March 2020, we worked closely with federal, state and local governments, healthcare organizations, payers, suppliers, retailers, trade associations and other laboratories in the effort to bring as much COVID-19 testing as possible to the American people.  We also provided data on COVID-19 testing that we conducted to federal, state and local public health authorities, including the federal Centers for Disease Control and Prevention, and participated in studies with government and private institutions, aiding COVID-19 public health response and research.  All of our employees, including our dedicated laboratory professionals, phlebotomists, air fleet team, and couriers take tremendous pride in the role we played and worked tirelessly to help patients and communities access quality COVID-19 testing.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2020, we also saw how underserved communities were disproportionately impacted by COVID-19 with tragic consequences.  With the Quest Diagnostics Foundation, we launched Quest for Health Equity, a $100 million-plus initiative to reduce health disparities in underserved communities.  This multi-year initiative, which will focus on people of color, elderly and homeless populations in locations throughout the United States, will provide a combination of testing services, education programs, alliances and financial support to efforts seeking to find new ways to address health disparities.     </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our approach to fighting the pandemic has been rooted in our vision of empowering better health through diagnostic insights.  We believe that the challenges we are facing from the COVID-19 pandemic have brought us together, made us a stronger company and will help us capture the substantial opportunities in front of us.  </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR STRATEGY </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have a two-point business strategy, reviewed by our Board of Directors, to achieve our vision and our goals.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="dgx-20201231_g2.jpg" alt="dgx-20201231_g2.jpg" style="height:261px;margin-bottom:5pt;vertical-align:text-bottom;width:440px"/></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accelerate Growth</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our strategy to accelerate revenue growth is based on the Company&#8217;s portfolio of services.</span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="12" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Services Portfolio (Table 1)</span></td></tr><tr><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Activity</span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Key Characteristics</span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">At A Glance</span></td><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #acacac;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Quest Value Proposition</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Diagnostics</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Testing services generating strong cash flows and steady growth </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Routine and non-routine testing services</span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Largest revenue stream</span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Essential portion of healthcare delivery</span></div></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Scale<br/>&#8226; Operational excellence<br/>&#8226; Access and convenience<br/></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #d8d8d8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Diagnostics</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-top:1pt solid #d8d8d8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Testing services targeting faster growth through innovation testing model</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-top:1pt solid #d8d8d8;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Genetic and advanced molecular testing services </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; An important part of precision medicine</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Innovation-based competitors</span></div></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #d8d8d8;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Rich clinical, scientific and medical innovation expertise<br/>&#8226; Quality and reliability of new assays<br/>&#8226; Ability to manage potential new regulatory requirements</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Services</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and data-related healthcare opportunities targeting faster growth</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Enables partners to deliver healthcare more efficiently (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, risk assessment; Professional Laboratory Services; Employer Population Health)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Services to support population health (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, data analytics; extended care services)</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Extensive diagnostic capability<br/>&#8226; Large and growing database and analytics expertise<br/>&#8226; Partnerships with industry leaders across healthcare landscape</span></td></tr></table></div><div style="margin-bottom:7pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have identified the following five approaches to accelerate growth.</span></div></td></tr><tr><td colspan="3" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approaches to Accelerate Growth (Table 2)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. Delivering a compound annual revenue growth rate of more than 2% through accretive, strategic acquisitions</span></div></td></tr><tr><td colspan="3" style="background-color:#d8d8d8;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plus organic growth through:</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2. Partnering with health plans, IDNs and other risk bearing entities</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3. Offering the broadest access to diagnostic innovation</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4. Being recognized as the consumer-friendly provider of choice of diagnostic information services </span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5. Supporting population health with data analytics and extended care services</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1. Growing through acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We have maintained a strategy since November 2018 to grow revenue each year by more than 2% compound annual growth rate through accretive, strategic acquisitions.  Although the merger and acquisition environment significantly slowed in 2020 due to the COVID-19 pandemic, we were able to consummate important acquisitions during 2020.  Our approach to acquisitions is discussed below under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deliver disciplined capital deployment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2. Partnering with health plans, IDNs and other risk bearing entities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  To help accelerate growth, we focus on large opportunities to partner with outside entities.  We strengthen our relationships with health plans and increase the volume of our services for their members by driving value with employers and providing strong value propositions for members and clinicians. This includes building an information platform to help health plans manage utilization and population health, and enhancing processes to help health plans keep laboratory testing in network.  For example, in 2020 we established a strategic relationship with Anthem to collaborate on a variety of outcomes-based programs designed to create an improved healthcare </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">experience for consumers and healthcare providers, and we advanced our position with UnitedHealthcare in its Preferred Lab Network.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the growing market challenges faced by IDNs, including continued price transparency, cost and utilization pressure, evolving healthcare payment models, capital needs, changing technology and limited resources, provides us with an opportunity to more effectively partner with them as they consider their laboratory testing strategy and will drive demand for our expertise.   We have deployed a dedicated health systems team to strengthen our relationships with IDNs, including with respect to their reference testing.  We provide reference testing for approximately half of the hospitals in the U.S., and are the leading provider of this testing in the country.  In 2020, we logged a record amount of new Professional Laboratory Services business, representing larger and longer term agreements than in the past, and implemented new relationships with, among others, Memorial Hermann Health System, Hackensack Meridian Health, Montefiore Nyack Hospital and Goshen Hospital.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Our industry-leading Professional Laboratory Services suite of solutions help IDNs build and execute their laboratory strategy, improve quality, reduce the cost of care and focus on core competencies.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Professional Laboratory Services Offerings (Table 3)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab management outsourcing</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced data solutions</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reference testing, including advanced diagnostics</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outreach acquisition</span></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supply chain management and purchasing</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Test menu optimization and spend consolidation</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood utilization management</span></td></tr></table></div><div style="padding-left:54pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering the broadest access to diagnostic innovation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Our diagnostic solutions deliver high clinical value to the medical community nationwide.  We create value through scientific and product innovation and solution delivery for major clinical opportunities.  Starting with a clinical focus on a specific disease state or clinical problem, we take advantage of advanced technology for more precise, comprehensive and actionable information, and deliver the information to the medical community in a meaningful way.  We make innovative diagnostic solutions available to community physicians through our connectivity solutions, operational footprint and by making complex results actionable.  We plan to expand our innovative diagnostic solutions through research and development, as well as partnerships with academic institutions, other technology and healthcare leaders and public health agencies.  In 2020, our approach delivered numerous innovations, including those discussed below under the headings "Innovation" (page 9), "Collaboration" (page 10), "Medical and Scientific Expertise" (page 10) and "Health Information Technology Solutions and Information Assets" (page 10).  </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:45.674%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our clinical franchises enable us to perform like a boutique while maintaining our scale advantages, and work with our research and development and commercial organizations to identify/deliver new and improved solutions.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clinical Franchises (Table 4)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular, Metabolic and Endocrinology</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer Diagnostics</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General Health and Wellness</span></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drug Monitoring and Toxicology</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infectious Diseases and Immunology</span></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sports Science and Human Performance</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurology</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Women&#8217;s and Reproductive Health</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The performance in 2020 of our Infectious Disease and Immunology franchise, which was leading our COVID-19 pandemic response, is an example of the power of our franchises.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Being recognized as the consumer-friendly provider of choice of diagnostic information services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We are focused on the consumer.   The Company has a long history of focusing on consumer interests, and continues to focus on improving the consumer experience, including through improved digitization and other enhancements of our operations.   Examples of our strong consumer focus during 2020 include the strong growth in our QuestDirect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consumer-initiated testing and establishing special hours at our patient service centers for non-COVID-19 testing to accommodate the needs of older and highly vulnerable patients.  Our industry-leading Net Promoter Scores reflect our consumer focus.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increasing consumer expectations inform our design for our consumer experience. </span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consumer-Centric Initiatives (Table 5)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer reminders</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Consumers whose physicians have ordered a test for them electronically can receive email reminders to complete the test.<br/><br/>&#8226; Consumers who have made appointments can receive appointment reminders via text messaging.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enhanced consumer experience</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Electronic check-in at patient service centers.<br/><br/>&#8226; Improved on-line pre-registration and appointment scheduling.<br/><br/>&#8226; Real-time payment determination for payers.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convenient access </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Partnerships with Walmart and Safeway to expand convenient access to testing services at select Walmart and Safeway locations across the United States (&gt;200 locations at year end).</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer-initiated testing </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; QuestDirect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, our consumer-initiated testing service, is available in nearly all states. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Consumers can choose from test packages (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, general health, men's and women's health, digestive health, heart health, infectious disease, sexually transmitted disease), which expanded in 2020 to include testing for COVID-19 with at-home specimen collection.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer connectivity and access to information</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; &gt;14.5 million registered users in our MyQuest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> health portal and mobile connectivity solution.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; During 2020, partnered with The Commons Project to make Quest lab results available for Android users through the CommonHealth app.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; MyQuest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> supports Health Records using the Apple Health app.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Using MyQuest,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">consumers can manage healthcare for a group of individuals. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expanded access to basic healthcare services</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Partnership with Walmart to expand access to basic healthcare services.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Self-collection technology</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Proprietary, consumer-friendly self-collection technology offered to consumers at home. </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumer satisfaction</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; We are measuring consumer satisfaction, including Net Promoter Score based on experience at our patient service centers. </span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supporting population health with data analytics and extended care services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We support population health by offering services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., home-based health risk assessments and related services) designed to identify gaps in care in a population, provide clinical solutions to close the gaps and foster consumer engagement with a solution.  Our services help healthcare providers, health plans, sponsors and IDNs deliver better care to their patient populations by identifying and filling gaps in care for their patient populations and by enabling them to deliver the most effective healthcare to the right populations and individuals.  Our offerings leverage the power of our assets and capabilities (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., call centers; patient service centers; and mobile workforce, including professionals) and integrate our extensive clinical data, and include data analytics and extended care services.  For example, Quest Lab Stewardship</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> employs machine learning to help optimize laboratory test utilization.  </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Drive operational excellence</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We strive to enhance operational excellence and improve our quality and efficiency across every portion of our value chain and operations, from the time that we interact with a potential customer until the time we receive payment.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Major Themes to Drive Operational Excellence (Table 6)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduce denials and patient concessions </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standardize and automate</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digitize the customer experience</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optimize</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Improving our operations will yield many benefits, including: enhancing customer experience; improving our quality and competitiveness; strengthening our foundation for growth; and increasing employee engagement and shareholder value.  We are building a superior experience, at lower cost, for all of our customers, including consumers, health plans, IDNs and clinicians.  We endeavor to improve our processes and effectiveness at the same time.  We are guided by a service dashboard that focuses throughout our operations on quality for consumers, healthcare providers and employees, including medical quality, on-time delivery, competitive costs and employee safety. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2020, our focus on and strength in operational excellence enabled us to rapidly scale up COVID-19 testing capacity without sacrificing our other test offerings.  We also made</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> strong progress on our improvement initiatives.  For example, we  continued (i) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidating and simplifying our immunoassay platforms, moving to a single supplier to provide greater throughput, autonomy and a more efficient footprint and (ii) optimizing our lab network through investments in our new 250,000 square foot flagship laboratory in Clifton, New Jersey, which we opened early in 2021 and will provide greater capacity, increased throughput and improved productivity.    </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our cost excellence program, Invigorate, includes structured plans to drive savings and improve performance across the value chain, including in such areas as revenue services, information technology and procurement.  We currently aim annually to save approximately 3% of our costs.  In 2020, we achieved our goal; our Invigorate program delivered approximately $200 million of cost savings.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_22"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR STRENGTHS</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We offer high value diagnostic information services and diagnostic solutions that are attractive to our customers.  </span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Our Strengths (Table 7)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Strong Operating Principles</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets and Capabilities to Deliver Value </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Information Technology Solutions and <br/>Information Assets</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Innovation</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical and Scientific Expertise</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #acacac;border-right:1pt solid #000000;border-top:1pt solid #acacac;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Focus</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our goal is to provide every patient with services and products of superior quality.  We strive to accomplish that through commitment, leadership, and establishing rigorous processes which we measure and continually seek to improve, and by using the Quest Management System, which provides best-in-class business performance tools to create and implement effective and sustainable quality processes.  The Quest Diagnostics Quality Program includes policies and procedures to document, measure and monitor the effectiveness of our laboratory operations in providing and improving quality and meeting applicable regulatory requirements.  The Quality Program is designed so that the quality of laboratory services is monitored objectively and evaluated systematically to deliver superior quality care, identify opportunities to improve patient care and resolve identified problems.  To help achieve our goal of becoming recognized as the undisputed quality leader in the diagnostics information services industry, we have implemented our Quality System Framework, which serves as a reference </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guide for our employees and describes our Quality System Elements, which provide the structure for each laboratory to achieve and maintain quality processes.   We also have a robust Supplier Quality Program designed to ensure we have a high quality supplier network and to raise the bar of quality expectations across that network.  Being chosen by UnitedHealthcare as a participant in the UnitedHealthcare Preferred Lab Network reflects the strength of our quality.  For additional information about our commitment to quality, see "General - Quality Assurance" on page 24.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strong operating principles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have a foundation of three strong operating principles: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthen organizational capabilities; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">remain focused on diagnostic information services; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">deliver disciplined capital deployment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strengthen organizational capabilities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We continuously strive to strengthen our organizational capabilities to support our two-point strategy, enable growth and productivity, better focus on our customers, speed decision-making and empower employees.  Highlights include:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Align for Growth, Execution and Efficiency</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Our organization is designed to align around future growth opportunities, coordinate business units for seamless execution and leverage our company-wide infrastructure to gain more capability, value and efficiency. We relied on this organizational design to allow us to develop a  coordinated and sustained strategy to respond to the unprecedented challenges we face responding to the COVID-19 pandemic.  The value creation side of our business includes product and commercial marketing and is organized by clinical franchise and focuses on customer solutions for the marketplace, including new test development and diagnostic insights.  The value delivery side includes sales, laboratory operations, field operations, logistics and client services.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Quest Management System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This system provides a foundation for day-to-day management, and includes best-in-class business performance tools to help develop new capabilities to improve our Company.  The system enables us to run the Company with a common language, approach and philosophy, and supports our efforts as we build a high-performance culture, with employees focused on behaviors to make us more agile, transparent, customer-focused, collaborative and performance oriented.  </span></div><div style="padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remain focused on diagnostic information services.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We maintain a sharp focus on providing diagnostic information services.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deliver disciplined capital deployment.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disciplined capital deployment framework includes investment in our business, dividends and share repurchases.  The framework is grounded in maintaining an investment grade credit rating.  We expect to return a majority of our free cash flow to investors through a combination of dividends and share repurchases.  Consistent with that expectation, in February 2021 we announced that we increased our quarterly common stock cash dividend by approximately 11%, from $0.56 per common share to $0.62 per common share.  This represents our tenth increase in the dividend since 2011.  For many years, we have maintained a common stock repurchase program.  Since the beginning of 2013, we have returned approximately $3.4 billion to stockholders through repurchases of our common stock.  Our share repurchases, dividends and capital expenditures in each of the last three years are presented in our consolidated financial statements (Part II, Item&#160;8 of this Report).  For most of 2020, we suspended our share repurchase program due to the challenges and uncertainty associated with the COVID-19 pandemic.</span></div><div style="padding-left:54pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's strategy includes generating growth through value-creating, strategically-aligned acquisitions using disciplined investment criteria.  We screen potential acquisitions using guidelines that assess strategic fit and financial considerations, including value creation, return on invested capital and impact on our earnings.  In 2020, we consummated the acquisition of Blueprint Genetics, acquired substantially all the operations of Memorial Hermann Diagnostics Laboratories, the outreach laboratory division of Memorial Hermann Health System, and acquired from our joint venture partners the remaining 56% interest in Mid America Clinical Laboratories, LLC.  Our material acquisitions in each of the last three years are further discussed in Note 6 to the audited consolidated financial statements (Part II, Item&#160;8 of this Report).</span></div><div style="padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We will continue to invest in our business in a disciplined manner, including focusing on enhancing our solid foundation of strategic assets and capabilities, accelerating growth and driving operational excellence.  Our near-term investments in growth are likely to focus on the strategies to accelerate growth set forth in table 2 above.  Our near-term </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investments to drive operational excellence are likely to focus on improving the customer experience and gaining efficiency, systems standardization, digital enablement of our processes and footprint optimization. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets and capabilities to deliver value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We use our unmatched size, scale and capabilities to deliver a very attractive value proposition to our customers.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets and Capabilities (Table 8)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Connectivity </span></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;border-top:1pt solid #606060;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Provide healthcare connectivity solutions to &gt;406,000 clinician and hospital accounts and interface with approximately 760 electronic health records systems</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Data  </span></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   The largest private database of de-identifiable laboratory test results: &gt;56 billion patient data points </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Logistics  </span></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Strong logistics capabilities </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    make approximately 72,000 stops daily</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    approximately 4,000 courier vehicles</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   24 aircraft serving the U.S.</span></div><div style="padding-left:9pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Medical and Scientific Staff </span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    One of the largest medical and scientific staffs in the industry to provide interpretive consultation </span></div><div style="padding-left:31.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    &gt;600 M.D.s and Ph.Ds, many of whom are recognized leaders in their field </span></div><div style="padding-left:13.5pt;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Genetic counselors</span></div><div style="padding-left:9pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Healthcare Professionals  </span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Approximately 23,000 phlebotomists, paramedics, nurses and other health and wellness professionals</span></div><div style="padding-left:9pt;text-indent:-13.5pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Consumer Access </span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   &gt;6,850 patient access points, including phlebotomists in physician offices and the most extensive patient service center network in the U.S. with &gt;2,200 locations </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Health Plan Participation</span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Access to approximately 90% of U.S. insured lives</span></div><div style="padding-left:9pt;text-indent:-13.5pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Processing Volume</span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Processed approximately 187 million test requisitions in 2020</span></div><div style="padding-left:9pt;text-indent:-13.5pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Range of Testing  </span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Industry-leading test menu across clinical sub-specialty areas and diagnostic technologies </span></div><div style="padding-left:9pt;text-indent:-13.5pt"><span><br/></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Patents</span></div></td><td colspan="3" style="border-left:1pt solid #d8d8d8;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9679;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Own or control approximately 1,100 issued and 450 pending patents worldwide in 2020</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Innovation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are a leading innovator in diagnostic information services.  We develop and introduce new tests, including many with a focus on personalized and targeted medicine, and new services.  Our capabilities include discovery, technology development and clinical validation of diagnostic tests.  We also partner with other developers of new technologies, services and tests to transfer their innovations to the marketplace, using our in-house expertise (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, strength in assay development and commercialization of testing services).  These developers include large commercial manufacturers, the academic community, pharmaceutical and biotechnology firms, emerging medical technology companies and others that develop and commercialize novel diagnostics, pharmaceutical and device technologies.  We maintain relationships with advisers and consultants who are leaders in key fields of science and medicine.  As the industry leader with the largest and broadest U.S. network, we believe we are the distribution channel of choice for developers of new solutions.       </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We seek innovations and solutions that help healthcare providers care for their patients through better testing for predisposition, screening, monitoring, diagnosis, prognosis and treatment choices, and that will reduce the overall cost of healthcare.  We seek to develop innovations and solutions that help to determine a patient's genotype or gene expression profile relative to a particular disease and its potential therapies, because they can help healthcare providers to determine a patient's susceptibility to disease or to tailor medical care to an individual's needs.  This would include determining if a medication might be an optimum choice for a particular person, or tailoring the right dosage once the proper medicine is prescribed.  We endeavor to improve test processes, including through increased automation.  In addition, we aim to develop holistic solutions responsive to challenges that healthcare providers and patients face, by developing solutions of tests, information and services focused on specific clinical challenges, and taking advantage of the latest informatics capabilities.  We also look for innovations and solutions that are less invasive than currently available options, to increase the choices that healthcare providers and patients have for the collection of diagnostic samples.  We additionally seek innovation in the ways we bring solutions to customers, and in the customer experience, including enhanced services and end-to-end solutions for convenience and support.  Further, we </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">seek innovative solutions to other challenges related to diagnostics information services faced by IDNs, health plans and other healthcare market participants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In 2020, we secured Emergency Use Authorization from the FDA for pooled specimen testing in connection with molecular diagnostic COVID-19 testing.  We also developed and launched new test offerings to educational institutions, such as colleges and universities, to help facilitate the return to classrooms.  In addition, we launched automated next generation genetic sequencing, which will enable genetic screening faster and at much lower cost.  With government and private sector partners, we developed and built  "pop-up" COVID-19 testing sites that offered a new, efficient model for consumer access to testing.  These initiatives, along with other 2020 developments highlighted below under the headings "Collaboration," Medical and Scientific Expertise," and "Healthcare Information Technology Solutions and Information Assets," demonstrated our strength in innovation during 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that strategic relationships, including with healthcare providers, public health authorities, consumer-focused entities and others, can position us for growth at the center of healthcare and that healthcare companies that can partner effectively with others will be successful in the long term.  We collaborate with partners that can help us to achieve our vision of empowering better health through diagnostic insights and have relationships across the spectrum of healthcare, including with world class healthcare and consumer-focused leaders, to foster important advances in healthcare, including in precision medicine and healthcare delivery.  We plan to continue to pursue strategic relationships to help accelerate growth and drive operational excellence.  Our collaborations with CVS Health, Walmart and other partners regarding expanding access to COVID-19 testing during 2020 demonstrate this strength.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medical and Scientific Expertise</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have strong medical and scientific expertise and aspire to be a trusted authority in diagnostic medicine, provide insights and tools to support public and personal health, lead and facilitate scientific discussion and inspire innovation.  Our medical and scientific experts regularly provide presentations, symposia and webinars regarding diagnostic testing and participate on scientific committees determining guidelines for diagnostic usage.  They also publish research that demonstrates the clinical value and importance of diagnostic testing, including in connection with our research and development efforts, in peer-reviewed journals, textbooks and other publications.  For over 30 years, the Company has published the Quest Diagnostics Drug Testing Index,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a series of reports on national workplace drug positivity trends based on the Company's employer workplace drug testing data, that is widely cited by employers, the federal government and the media to help identify and quantify drug abuse among the nation's workforce.  The Company also publishes Quest Diagnostics Health Trends,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a series of scientific reports that provide insights into health topics, based on analysis of objective clinical laboratory data, to empower better patient care, population health management and public health policy.   Our role at the forefront of the response to the COVID-19 pandemic demonstrated this strength.  We secured numerous Emergency Use Authorizations from the FDA for innovations in connection with COVID-19 testing and specimen collection, including regarding unobserved nasal specimen self-collection, combined COVID-19 and respiratory virus tests, COVID-19 testing ordered by consumers, and methods to increase testing capacity and expand the testing supply base.  We also published over ten Health Trends reports on COVID-19 during 2020, including reports addressing the "hidden pandemic": reduced hemoglobin A1c diabetes monitoring as a consequence of the COVID-19 pandemic; a 46% decrease in newly identified cancer patients during the COVID-19 pandemic; and drug testing decreased by as much as 70%, while drug positivity rates increased (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., 35% increase for non-prescribed fentanyl; 44% increase for heroin), during the COVID-19 pandemic. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Information Technology Solutions and Information Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have a history of providing leading information technology for diagnostic information services, including for patients, clinicians and healthcare organizations.   We were the first national diagnostic information services provider to offer online patient appointment scheduling and a patient connectivity solution.  Our MyQuest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patient healthcare portal, with over 14.5 million registered users at year-end 2020, enables patients to manage healthcare and medical information for themselves and a circle of others and, among other things, use their smartphone or computer to order a test, find a Quest Diagnostics location, schedule appointments, receive appointment reminders, and receive and archive their test resul</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ts.  During 2020, we collaborated with CLEAR to integrate CLEAR's safe and secure "Health Pass" technology with the Company's advanced COVID-19 testing capabilities to foster safer public environments and help reduce public health risk.  We also are a founding member of the Synaptic Healthcare Alliance, which is working to create a platform, powered by blockchain technology, that enables a culture of innovation, removes friction and solves shared challenges impacting constituents across healthcare today.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also have significant information assets and offer a robust portfolio of powerful analytics that inspire action and deliver value to an array of customers.  We offer an array of Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> solutions based on data insights, including retrospective analytics solutions for healthcare professionals and practices, health plans, IDNs, pharmaceutical companies and public health.  We believe that solutions can tap the potential of large amounts of clinical information to: enhance the customer experience; deliver more precise, comprehensive solutions and actionable information; provide increased and interactive insights and analytics; foster greater adherence to clinical and reimbursement guidelines; and advance the development of precision medicine.  We believe that the breadth and depth of our data, combined with our powerful analytics capabilities, enables us to take advantage of important data-based opportunities in diagnostics, and provides us a competitive advantage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Focus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our brand -- Action from Insight</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-- reflects our commitment to a superior customer experience.  The customer is at the center of everything we do; we strive to give them reason to put their trust in us.&#160; We use customer insights in developing our approach, listening to the voice of customers to identify and implement solutions and processes that will result in a superior customer experience.&#160; We also maintain our Everyday Excellence program, which includes guiding principles to support a superior customer experience, inspiring our employees to be their best every day, with every person and with every customer interaction. </span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_25"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BUSINESS OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is made up of two businesses:  Diagnostic Information Services and Diagnostic Solutions.  Our Diagnostic Information Services business develops and delivers diagnostic information services, providing insights that empower and enable a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  Our Diagnostic Solutions group includes our risk assessment services business, which offers solutions for insurers, and our healthcare information technology businesses, which offers solutions for healthcare providers.  Our services primarily are provided under the Quest Diagnostics brand, but we also provide services under other brands, including AmeriPath,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dermpath Diagnostics,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ExamOne,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Quanum.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are the leading provider in the United States, where we conduct substantially all of our business, of clinical laboratory and anatomic pathology testing, and related services.  We see opportunities to bring our experience and expertise in diagnostic information services to markets outside the United States, including leveraging existing facilities to serve new markets.  We have laboratory facilities in Mexico and Puerto Rico.  We are a founding member, with other leading diagnostic laboratories outside the United States, of the Global Diagnostics Network,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a strategic working group of diagnostic laboratories committed to unleashing and sharing local innovation to increase global access to diagnostic science, information and services and generating enhanced diagnostic insights to improve the delivery of global healthcare.  During 2020, COVID-19 was a key focus area for the Global Diagnostics Network, as members shared experiences and best practices regarding COVID-19 testing.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="dgx-20201231_g3.jpg" alt="dgx-20201231_g3.jpg" style="height:238px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Information Services&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background - clinical testing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   Clinical testing is an essential element in the delivery of healthcare services.  Clinicians use clinical testing for predisposition, screening, monitoring, diagnosis, prognosis and treatment choices of diseases and other medical conditions.  Clinical testing is generally categorized as clinical laboratory testing and anatomic pathology services.   Anatomic pathology involves the diagnosis of cancer and other diseases and medical conditions through examination of tissue and cell samples taken from patients. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;Clinical laboratory testing, which can be characterized as routine, non-routine or advanced, generally is performed on whole blood, serum, plasma and other body fluids, such as urine, and specimens such as microbiology samples.  Clinical laboratory tests which can be performed by most clinical laboratories are considered routine.  Routine testing measures various important bodily health parameters such as the functions of the kidney, heart, liver, thyroid and other organs.  Commonly ordered routine tests include blood chemistries, urinalysis, allergy tests and complete blood cell counts.  Non-routine tests may require professional &#8220;hands-on&#8221; attention from highly-skilled technical personnel, generally require more sophisticated informatics, technology, equipment or materials, may be performed less frequently than routine tests and may be reimbursed at higher levels than routine tests.  It may not be practical, from a cost-effectiveness or infrastructure perspective, for many hospitals, IDNs, ACOs, DCEs, commercial laboratories or physician office laboratories to develop and perform a broad menu of non-routine tests, or to perform low-volume non-routine testing in-house.  Such tests generally are outsourced to a clinical testing laboratory which can perform these non-routine tests.  Some non-routine tests are advanced.  Advanced tests include procedures in the areas of molecular diagnostics (including next-generation sequencing), oncology, neurology, companion diagnostics and non-invasive pre-natal and other germline genetic testing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our services. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the world's leading provider of diagnostic information services.  We provide information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We have strong testing capabilities, including services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases, and offer advanced tests in many fields, including endocrinology, immunology, neurology and oncology.  Increasingly, we are focused on providing solutions and insights to our customers, based on the testing that we perform, the data that we gather and our extensive medical, information and connectivity assets.  We believe that offering services, solutions and insights based on a full range of tests, information assets and other capabilities strengthens our market offering, market position and reputation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer the broadest access in the United States to clinical testing.  We maintain a nationwide network of laboratories, including advanced laboratories (such as our world-renowned Quest Diagnostics Nichols Institute</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) as well as rapid response laboratories (smaller facilities where we can quickly perform an abbreviated menu of routine tests for customers that require rapid turnaround times).  We operate 24 hours a day, 365 days a year.  Our nationwide network also includes patient service centers, phlebotomists in physician offices, and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  Our large in-house staff of medical and scientific experts, including medical directors, scientific directors, genetic counselors and board certified geneticists, provide medical and scientific consultation to healthcare providers and patients regarding our tests and test results, and help them best utilize our services to improve outcomes and enhance satisfaction.   We also provide testing (including anatomic pathology) services and medical director services at hospital laboratories.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  We are a leading provider of diagnostic information services for infectious disease, such as COVID-19 (including molecular diagnostic and serology antibody offerings), tuberculosis (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our T.SPOT.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Quantiferon offerings) and tick-borne disease (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our Accutix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offering).  We strive to be the first to provide diagnostic solutions for emerging infectious diseases  (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., our offerings for Zika, West Nile Virus, SARS and Influenza A H1N1).  We have leading positions in  drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., our CardioIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Cleveland HeartLab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offerings), and in cancer diagnostics (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., our QuestVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Med Fusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offerings).  We are a leader in providing testing for the detection of employee use of drugs of abuse, offering a full range of solutions, including urine, hair, blood and oral fluid tests.  We are the largest workplace drug testing provider certified by the U.S. Department of Health and Human Services to perform drug testing using electronic custody and control forms for federally-mandated, safety-sensitive workers.   </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are a leading provider of employer population health services, including biometric screenings, flu shots and related preventative services that leverage clinical data to improve population health outcomes and reduce healthcare spend.  Our solutions enable employers to leverage screening insights to identify chronic disease risks, connect employees to needed in-network care, and empower better health.  Our offerings include connecting participants to the right care at the right time, such as (i) a program designed to prevent diabetes and other chronic conditions, (ii) a program that enables participants to engage with a board-certified physician about their results and to be guided about actions based on those results and (iii) a mental health assessment program that links participants to virtual support.  These services are sold directly to employers and through reseller partnerships with health plans.  During 2020, in response to the COVID-19 pandemic, we developed and offered to employers COVID-19 Return to Work services, to assist organizations develop plans for safer workplaces.  We also collaborated with Catapult Health, the leading national provider of employer-sponsored preventative checkups, to help organizations facilitate virtual telehealth access to clinical services for their employees and adult dependents, with emphasis on reducing risks related to preventable chronic diseases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">health information technology solutions, including our products and national healthcare provider network, to help healthcare organizations and clinicians empower better health by leveraging the power of our significant information assets, including many years of test result data, and our technology prowess, including our history of providing leading information technology for diagnostic information services.  Our portfolio of offerings is designed to address analytic, clinical and financial needs.  The solutions help healthcare organizations and clinicians analyze and put in context data, and enable them to connect across the healthcare system and engage with their stakeholders.  They can enter, share and access clinical information without costly information technology implementation or significant workflow disruption.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer an array of population health solutions.  Our services build on the power of our information assets and data capabilities and help clinicians, health plans, sponsors and IDNs deliver better care to their patient populations by identifying gaps in care in a population, providing clinical solutions to close the gaps and fostering consumer engagement with a solution.  Our extended care services, including home-based health risk assessments and related services, leverage our assets and capabilities (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., call centers, patient service centers and mobile workforce, including professionals) and focus on extending the reach of clinician offices beyond their traditional four walls to assess the health of their populations, and doing so when and where it is convenient for consumers.  Once gaps are identified, we engage patients in our retail sites, in home or by telephone, including through our call centers and our mobile base capabilities, including highly-trained healthcare professionals.  We also offer services such as diabetic retinopathy and bone density examinations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer services to pharmaceutical companies, including clinical trials testing.  We have expertise in developing laboratory tests for FDA submission as companion diagnostics and laboratory developed tests for complementary diagnostics, and offer an array of assets and services to support the development of companion diagnostics, including our robust data set and patient services network. We also offer Quest Clinical Trials Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to help accelerate clinical trials (and thus the speed of drugs to market) through better patient recruitment, involvement and management, and improved physician outreach. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also offer sports teams, including at the professional and collegiate levels, our BluePrint for Athletes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> performance tools, based on biomarker testing, designed to optimize high-level athletic performance through actionable insights.  This  service provides the context for athletes to consider performance variables holistically, including nutritional education and intervention, maximum fitness, injury assessment and training load monitoring as well as sophisticated biometric analysis.  During 2020 we also expanded our test offerings for athletes to include COVID-19 testing, to foster the country's return to athletic fields.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Solutions </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust health information technology solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Assessment Services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ExamOne</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the largest provider of risk assessment services to the life insurance industry in North America.  Our risk assessment services comprise underwriting support services, including data gathering, paramedical examinations and clinical laboratory testing and analytics, designed to assist life insurance companies objectively to evaluate the mortality risks of applicants.  Most specimen collections and paramedical examinations are performed by our network of paramedical examiners at the applicant's home or workplace, but they also are offered at hundreds of Company patient service centers and hundreds of additional North American locations. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Information Technology. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our healthcare information technology offerings, including Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Practice Solutions, our Electronic Health Record, Practice Management and Revenue Cycle Management Solutions for healthcare providers, and our award-winning Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Enterprise Content Solutions for hospitals and IDNs, connect data to decision-making and help clinicians advance clinical and operational strategies.  Healthcare organizations have contracted for the use of Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Enterprise Content Solutions at over 375 sites in North America.  Our Quanum</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Electronic Health Record is a cloud-based, mobile-accessible offering that enables clinicians to generate a complete record of a clinical patient encounter, automates and streamlines the clinician's workflow, provides clinical decision support tools, captures patient encounter notes and lab and radiology results and enables secure communication with patients and other clinicians. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> our joint venture with IQVIA Holdings Inc., is the second largest central laboratory services company in the world and provides services to customers across all segments of the biopharmaceutical industry.  Central laboratory testing services are critical to advances in genomics, precision medicine and drug development.  We own a minority interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions, which has helped develop many of the oncology precision medicine drugs approved by the FDA in recent years. </span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_28"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE CLINICAL TESTING INDUSTRY</span></div><div style="text-align:center"><img src="dgx-20201231_g4.jpg" alt="dgx-20201231_g4.jpg" style="height:351px;margin-bottom:5pt;vertical-align:text-bottom;width:634px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our estimate in table 10 does not include the impact of COVID-19 testing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The healthcare system in the United States is evolving; significant change is taking place in the system.   We expect that the evolution of the healthcare industry, including impacts of the COVID-19 pandemic, which include the increased adoption of telemedicine, will continue, and that industry change is likely to be extensive.  There are a number of key trends that are having, and that we expect will continue to have, a significant impact on the diagnostic information services business in the United States and on our business.  These trends, discussed in the table below, present both opportunities and risks.  We believe that several of the trends, including consolidation, price transparency and consumerization, are favorable to our business.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Because diagnostic information services is an essential healthcare service and because of the key trends discussed below, we believe that the industry will continue to grow over the long term.  In addition, we believe that the clinical testing market continued with fundamental changes in 2020.  First, we believe that PAMA-driven reimbursement pressure is negatively impacting access to care and hurting the clinical testing industry, and remains a catalyst for structural change in the market.  Second, we believe that health plans increasingly are focusing on driving better value in laboratory testing services.  Third, we believe that ongoing consumerization in healthcare, with increased cost being borne by consumers, is sharpening focus on price disparities.  We believe that these changing market fundamentals will benefit low-cost, high-value providers like Quest and that we are well positioned to grow from the changing market conditions and benefit from the long-term growth expected in the industry.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Trends (Table 11)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PAMA-driven reimbursement pressure</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to PAMA, reimbursement rates for many clinical laboratory tests provided under Medicare were reduced in 2018, 2019 and 2020.  PAMA calls for further revision of the Medicare Clinical Laboratory Fee Schedule for years after 2020, based on future surveys of market rates; reimbursement rate reduction from 2022-24 is capped by PAMA at 15% annually. <br/><br/>The LAB Act provided an opportunity for reforms to PAMA by delaying PAMA's next data collection and reporting period until January 1, 2021 and by ordering a study to determine ways to improve future collection of more representative market rate data under PAMA.  The CARES Act, adopted in early 2020 in response to the COVID-19 pandemic, suspended the PAMA reimbursement rate cuts that had been scheduled for 2021 and delayed PAMA's next data collection and reporting period until January 1, 2022.<br/><br/>The American Clinical Laboratory Association, of which the Company is a member, initiated a lawsuit charging that in implementing PAMA, CMS failed to follow a Congressional directive to implement a market-based laboratory payment system.  The lawsuit is pending. <br/><br/>We believe that PAMA is negatively impacting participants in the laboratory testing industry generally, including hospitals as well as independent clinical laboratories.  <br/></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Health plans driving value in lab spending</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospitals, which provide outreach testing and may encourage clinicians to send their outreach testing volume to the hospital's laboratory, historically were able to negotiate higher reimbursement rates with health plans than commercial clinical laboratories for comparable services.   In addition, health plans generally reimburse non-participating laboratory testing providers at higher out-of-network rates.  We are finding increased interest among health plans in driving better value in spending for laboratory testing.  Health plans increasingly are taking steps to encourage the movement of testing volume to high value, low cost providers like our Company, including by identifying preferred provider partners, plan design changes (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., zero-dollar out-of-pocket costs for members using preferred providers) and better aligning reimbursement rates for hospital-based providers and independent commercial laboratories.  The UnitedHealthcare Preferred Lab Network, in which we were chosen to participate, is a recent example of a health plan taking these steps.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health plans also are increasingly adopting policies, practices and procedures based on requirements imposed by government payers such as Medicare and Medicaid.  These policies, practices and procedures are subject to change, and may be changed without notice to us.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Consumerization</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumers are our customers.  Increasingly, consumers are engaged in their own healthcare, being empowered to understand and manage their healthcare.  Consumers are taking increased interest in and responsibility for their healthcare, their expectations of healthcare providers are increasing and they are becoming more sophisticated regarding healthcare.  Some patients are interested in selecting their own diagnostics tests, rather than relying upon a healthcare professional to select the tests.  In addition, consumers often are bearing increased financial responsibility for their healthcare (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., high deductible health plans; rising deductibles).  In our experience, consumers are more focused on transparency, ease of doing business and understanding diagnostics information services than they have been in the past.  Consumers increasingly are demanding convenience; a superior and personalized experience relevant to their needs; and to be empowered to make their own healthcare decisions.  During the COVID-19 pandemic, we saw consumers increase their use of telemedicine capabilities, increase their responsibility for their own healthcare (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, increased consumer-initiated testing; increased specimen self-collection) and increase their openness to new delivery channels (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., retail; convenient "pop-up" test centers).  In addition, consumers are seeking prompt, direct access to their test results.  Increasingly, consumers are motivated to find high quality service providers with strong digital experience delivery engines, accessible customer service and low prices, like our Company.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Prevention and wellness</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We believe that the value of detection, prevention, wellness and personalized care is well recognized. Consumers, employers, ACOs, IDNs, health plans and government agencies increasingly focus on helping the healthy stay healthy, detecting symptoms among those at risk and providing preventive insight and care that helps avoid disease. </span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Medical innovation</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical advances allow for more accurate and earlier diagnosis and treatment of diseases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing advances in genomics and proteomics are expected to yield new, more sophisticated and specialized diagnostic tests. These advances also are spurring interest in and demand for precision medicine, which relies on diagnostic and prognostic testing and in which data information services and strategies are used to deliver the most effective healthcare to the right populations and individuals. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacogenomic testing increasingly is used as a parameter to help speed drug approval processes and to better focus therapy based on patient and tumor-specific genetic markers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Demand also is growing toward comprehensive care management solutions that serve patients, payers and healthcare providers by improving clinical decision support and access to patient data, and by increasing patient participation in care management and population health management.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Innovation also includes making healthcare services, including laboratory testing services, more convenient for populations and consumers to access, including at home (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., telehealth) or in retail settings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is increasing focus on access to patient data and data-driven insights.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Healthcare industry evolution</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinicians, health plans, IDNs, ACOs, employers and others, have been consolidating, converging and diversifying. For example, a number of hospital systems are considering establishing or have established health insurance plans, and health insurance plans are considering providing or are providing healthcare services.   In recent years, a leading provider of retail medical clinics and pharmacy benefits management services has acquired a leading health insurance provider, a leading health insurance provider has acquired a leading pharmacy benefits manager, and the corporate parent of a leading health insurance company provides a wide array of healthcare services through its non-insurance company subsidiaries.   Health plans are entering agreements with other providers of healthcare services, including laboratory testing services providers, to partner on value-based approaches to delivering healthcare to populations.  DCEs have been established.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidation is increasing pricing transparency and bargaining power, and may encourage internalization of clinical testing.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Physicians frequently now are employed by hospital systems, IDNs, ACOs, DCEs or large group practices integrated with healthcare systems, instead of organizing physician-owned practices, which is impacting the dynamics for whether clinical testing is performed in or outside of a hospital.  Physicians and other clinicians also increasingly are being employed by health plans or their affiliates.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value-based reimbursement is contributing to changes in the healthcare system.  ACOs and patient-centered medical homes have grown as a means to deliver patient care.  Healthcare services increasingly are being provided by non-traditional providers (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, physician assistants), in non-traditional venues (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., retail medical clinics, urgent care centers) and using new technologies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, telemedicine, digital pathology).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition the ACA continues to result in changes in the way that some healthcare services are purchased and delivered in the United States.  Hospitals and IDNs are under significant pressure, and are evolving.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pricing transparency</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There has been a trend toward greater pricing transparency in healthcare, including in the laboratory testing marketplace.  Several states have taken action to foster greater pricing transparency in healthcare.  For example, Massachusetts launched a website to help consumers understand the wide variation in healthcare costs.  In addition, the federal government requires providers of COVID-19 testing to post on their websites information regarding test pricing, and has adopted new legislation and issued new regulations designed to increase transparency regarding pricing and quality in healthcare, including requiring providers, group health plans and insurers to disclose cost information to consumers in advance of care being provided.<br/><br/>Increased price transparency, combined with increased patient financial responsibility for medical care, is enhancing purchasing sophistication and fostering changes in behavior in the healthcare marketplace.  We believe that increased price transparency should benefit low cost, high value providers like our Company.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Competition</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The diagnostic information services industry remains fragmented, is highly competitive and is subject to new competition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition is emerging from new technologies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., digital pathology) and growing from non-traditional competitors (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., a government agency or employer establishing its own clinical laboratory for testing).  Increased hospital acquisitions of physician practices may enhance clinician ties to hospital-affiliated laboratories and may strengthen their competitive position.  However, in light of other trends, including continued reimbursement pressure, hospitals may change their approach to providing clinical testing services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New industry entrants with extensive resources may make acquisitions or expand into our traditional areas of operations.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Healthcare utilization<br/></span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare utilization in the United States has fluctuated based on a number of factors.  These factors include, without limitation, the economy, healthcare benefits design, patients delaying medical care (e.g., due to the COVID-19 pandemic), and increased consumer financial responsibility for, interest in and control of their healthcare.  <br/><br/>The ACA contained provisions eliminating patient cost-sharing for preventative services, and additional provisions that we believe increased the number of patients that have health insurance, including Medicaid, and thus better access to diagnostic testing.<br/></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reimbursement pressure; affordability</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There is a strong focus in the United States on controlling the overall cost of healthcare. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare market participants, including governments, are focused on controlling costs. Examples of cost control approaches include reducing reimbursement for healthcare services, changing reimbursement for healthcare services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., shift from fee for service to capitation), changing medical coverage policies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., healthcare benefits design), denying coverage for services, requiring preauthorization of laboratory testing, requiring co-pays, introducing laboratory spend management utilities and payment and patient care innovations such as ACOs, DCEs and patient-centered medical homes.  CMS has set goals for value-based reimbursement to be achieved in Medicare.  There is increased market activity regarding alternative payment models, including bundled payment models.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Health Transformation Alliance, a group of over 50 major U.S. companies, was formed to improve and reform the healthcare system in the United States.  The rising cost of healthcare in the United States was a key driver for the formation of this alliance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In 2018, a trio of high profile U.S. corporations, citing rising healthcare costs, announced plans to reduce their workers' healthcare costs by forming a non-profit venture that would provide simplified, high-quality healthcare for their workers.  Although the venture announced in early 2021 that it was disbanding, we believe that there will be other initiatives to transform healthcare.    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">While pressure to control healthcare costs poses a risk to our Company, it also creates opportunities, such as an opportunity for increased proper utilization of testing as an efficient means to manage the total cost of healthcare.  We believe that it also creates greater opportunities for consolidation and gaining share for high value, low-cost providers, like our Company, as compared to other providers.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Legislative, regulatory and policy environment</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government oversight of and attention to the healthcare industry in the United States is significant and increasing; healthcare payment reform and cost transparency are significant issues.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legislation introduced in Congress would enable the FDA to regulate LDTs, in vitro diagnostics, software and other items used in the diagnosis of disease.  If the legislation becomes law, the FDA could regulate diagnostic tests and components and platforms used as part of these tests.  The FDA and HHS also have expressed views regarding the regulation of LDTs. Either new law or a revised approach to regulation of LDTs could have a significant impact on the clinical laboratory testing industry, including regulating LDTs in new ways, while creating avenues of opportunity and competition regarding clinical laboratory testing.  New competitors may enter the industry, and competition may come in new forms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The ACA has created significant uncertainty as healthcare markets react to changes.  For example, more than half of the states have opted in to Medicaid expansion and employers may discontinue offering group health insurance to their employees, shifting more people to exchange products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain aspects of the ACA have been repealed, delayed or modified (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., the medical device excise tax).  The scope and timing of any further legislation to repeal, amend, replace, or reform the rest of the ACA is uncertain, but if such legislation were to become law, it could have a significant impact on the U.S. healthcare system.  In addition, uncertainty regarding the status of the ACA prior to any such repeal, amendment, replacement or reform could create uncertainty generally in the healthcare market.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Several federal courts have recently issued determinations that portions of the ACA are unconstitutional; those rulings are not yet final, with appeals pending at the U.S. Supreme Court.  </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Informatics; technology; privacy concerns</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The increased availability of healthcare data, including data made available as a result of next generation DNA sequencing, and the increased ability to effectively analyze that data at population and patient levels, is impacting healthcare practices.  It is anticipated that the increased use of data in healthcare, coupled with mobile healthcare IT solutions for doctors and patients, will help to improve patient outcomes and reduce overall healthcare costs.  In 2020, we launched automated next generation genetic sequencing, which will enable genetic screening faster and at much lower cost.<br/><br/>Informatics, including integrated diagnostic and decision support solutions, predictive analytics, use of population data and healthcare information technology, is spurring advances in precision medicine, including medical decision making and value, for populations and individuals.  The increased focus on data and its use is increasing focus on maintaining the privacy of patient data.<br/><br/>There is a need for technology solutions to harness these opportunities.  In addition, new technology, social media and mobile technology are changing the way that healthcare markets interact with each other, and the expectations that they have about how services are provided, what services are provided, and other capabilities of healthcare market participants.  These developments are creating new opportunities and new challenges and disrupting the healthcare environment. For example, during 2020, telemedicine practices became more commonly used; digital pathology is an emerging technology that may change the practice of pathology.  Information technology that includes self-learning or "artificial intelligence" features is growing and may impact the healthcare industry. <br/><br/>Healthcare market participants, including pharmaceutical companies, health plans, clinicians, ACOs and IDNs, are striving to leverage interoperability, informatics and analytics to positively influence the health of patient populations while maintaining patient privacy.<br/></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chronic diseases and conditions; gaps in care</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We believe that the cost and challenges of identifying, treating and controlling chronic diseases and conditions such as diabetes and heart disease are now well recognized.  The COVID-19 pandemic called attention to gaps in care in underserved populations.  <br/><br/>As a result of multiple factors, including increased focus on population health management and pressure to reduce the systemic costs associated with such diseases and conditions, there is increased focus on better identifying and attempting to reduce or eliminate the gaps in care historically associated with these diseases and conditions.  Healthcare market participants are developing new approaches for this purpose.  We believe that there also is increased focus on reducing or eliminating gaps in care in underserved populations.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Healthcare services delivery </span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare delivery is moving out of hospitals, doctor offices and other traditional locations in which it had been provided.  Care is increasingly being provided in new settings, such as outpatient, consumer-focused and home settings.  In response to the COVID-19 pandemic, telemedicine practices became more commonly used during 2020.  In addition, see the discussion of Emerging Retail Healthcare Providers in table 13.  This dynamic offers new opportunities and challenges for healthcare providers and reflects not only efforts to take advantage of new technologies, but also the trends of consumerization and affordability, each of which are discussed above in this table.</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Value of Diagnostic Information Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As noted in table 11, there is an increased focus on the affordability of healthcare.  There also is increased focus on a disease-oriented approach to diagnostics, treatment and management. Healthcare providers, consumers and payers increasingly recognize the value of diagnostic information services as a means to improve health and reduce the overall cost of healthcare through early detection, prevention and treatment.  Healthcare providers increasingly rely on diagnostic information services to help identify risk for a disease, to detect the symptoms of disease earlier, to aid in the choice of therapeutic regimen, to monitor patient compliance and to evaluate treatment results.  Table 12 highlights how diagnostic information services contribute to improving care and reducing healthcare costs. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reducing Healthcare Costs and Improving Care (Table 12)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Identifying patients at risk for disease before they require urgent care, hospital treatment or expensive therapies</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Helping clinicians to target the right medicines for the right patients at the right time</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Identifying treatment-related side effects</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Early assessment of the efficacy of a therapy, enabling changes or discontinuation of ineffective therapies</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Enabling population health management by utilizing diagnostic information, identifying gaps in care and delivering targeted solutions to individuals who need care</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Identification and proactive management of individuals at risk for developing chronic diseases, to decrease progression and associated costs and morbidity</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; Providing telemedicine services along with laboratory testing to help individuals interpret and obtain appropriate advice and referrals into needed care</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We provide diagnostic information services to a broad range of customers, including those discussed below.  As discussed in table 11 above, customers are consolidating, converging and diversifying.  In many cases, the customer that orders our services is not responsible for paying for these services. Depending on the billing arrangement and applicable law, the payer may be the patient or a third party, such as a health plan, Medicare or a Medicaid program.  Increasingly, patients are bearing greater responsibility for some portion of the payment for the services we provide to them, even if a third party is primarily responsible for payment.  In addition, patients are more frequently taking advantage of offerings like the Company's QuestDirect offering, and requesting and paying for tests themselves.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Customers (Table 13)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Health plans including managed care organizations and other health insurance providers</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">These customers typically reimburse us as a contracted (or out-of-network) provider on behalf of their members.  In certain locations, health plans may delegate to IPAs or other alternative delivery systems (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., physician hospital organizations, ACOs, patient-centered medical homes) the ability to negotiate for diagnostic information services on behalf of certain members.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health plans and IPAs often require that diagnostic information services providers accept discounted fee structures or assume all or a portion of the financial risk associated with providing such services through capitated payment arrangements. Under capitated payment arrangements, we provide services at a predetermined monthly reimbursement rate for each covered member, generally regardless of the number or cost of services provided by us.  Under some capitated programs, we may provide certain services on a negotiated fee-for-service basis.  Reimbursement under programs that do not provide for capitated payments is typically negotiated on a fee-for-service basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursement from our five largest health plans totaled approximately 20%, and no one health plan accounted for 10%, of our consolidated net revenues in 2020.  Health plans typically negotiate directly or indirectly with a number of diagnostic information services providers, and represent approximately one-half of our total clinical testing volume and approximately 40% of our net revenues from diagnostic information services.  There has been a trend of consolidation among health plans.  Some health plans also have narrowed their provider networks.  In addition, some health plans have established "preferred provider" networks within their broader networks, in effect distinguishing among contracted providers.   </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are also sometimes a member of a &#8220;complementary network.&#8221; A complementary network generally is a set of contractual arrangements that a third party will maintain with various providers that provide discounted fees for the benefit of its customers. A member of a health plan may choose to access a non-contracted provider that is a member of a complementary network; if so, the provider will be reimbursed at a rate negotiated by the complementary network.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We offer to health plans services and programs that leverage our Company's expertise and resources, including our superior access, extensive test menu, medical staff, data, information technology solutions, and wellness and population health management capabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Since the beginning of 2019, the Company has had access to a very high percentage of the insured lives in the U.S., including very strong access in key high-population states.  This is the best access to health plan members that we have had in over a decade.  We believe that this strong access increases our attractiveness to other customer groups, including clinicians, patients and employers.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Clinicians</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinicians, including primary care physicians, specialists and physician assistants, requiring diagnostic information services for patients are the primary referral source for our services when patients choose their diagnostic information services provider. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In recent years, there has been a marked increase in the number of physician practices owned by IDNs and hospital systems.  There also has been a notable increase in some branches of medicine of the establishment of very large "rolled-up" specialty physician practice groups.   Hospitals that own physician practices may encourage or require the practices to refer outreach testing to the hospital's affiliated laboratory.  Large specialty physician groups may encourage their members to refer testing to other members of the group.  In each case, referrals to independent diagnostic services providers may be reduced.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinicians determine which laboratory to recommend or use based on a variety of factors, including those set forth in table 14.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Hospitals</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We believe that we are the industry's leader in servicing hospitals.  We provide services to hospitals throughout the United States, including advanced testing services, in some cases helping manage their laboratories and serving as the medical directors of the hospital's histology or clinical laboratory, including through our Professional Laboratory Services offerings (our industry-leading Professional Lab Services offering is discussed in table 3 above).  Hospitals generally maintain an on-site laboratory to perform the significant majority of clinical testing for their patients (inpatients and outpatients) and refer certain testing to outside service providers, which typically charge the hospitals on a negotiated fee-for-service basis. Fee schedules for hospital reference testing services often are negotiated on behalf of hospitals by group purchasing organizations. <br/><br/>We also have joint venture arrangements with leading hospitals or IDNs in several metropolitan areas.  These joint venture arrangements, which provide diagnostic information services for affiliated hospitals as well as for unaffiliated clinicians and other local healthcare providers, serve as our principal facilities in their service areas.  Typically, we have either a majority ownership interest in, or day-to-day management responsibilities for, our joint venture relationships. <br/><br/>In light of continued pressure to reduce systemic healthcare costs, hospitals may change their approach to providing clinical testing services, including by insourcing tests, seeking ways to improve profitability or to better utilize their laboratory capacity.  We believe that our combination of services positions us to be an attractive partner for hospitals, offering a full range of strategic relationships.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;ACOs, DCEs and IDNs</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">An ACO is a network of providers and facilities that share financial risk in providing or arranging for the provision of healthcare.   A DCE is a healthcare provider that agrees to assume some level of financial risk for providing Medicare services.  An IDN is a network of providers and facilities working together in providing or arranging for the provision of healthcare.  ACOs, DCEs and IDNs have increased in number; their impact on the provision of healthcare services to date has varied. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACOs, DCEs and IDNs may exercise operational and financial control over providers across the continuum of care, and may function as a payer.  Thus, they may be able to manage the health of a population group within a defined geography, and also may be able to influence the cost and quality of healthcare delivery, for example through owned entities and through ancillary services.  They  may be encouraged to consider exclusive arrangements with healthcare providers, or to limit service providers.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are actively engaging with ACOs, DCEs and IDNs to demonstrate the value of our services.  </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Employers</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employers use tests for drugs of abuse to determine an individual's employability and his or her &#8220;fitness for duty.&#8221;  Companies with high levels of employee hiring, safety conscious environments or regulatory testing requirements provide the highest volumes of testing. Factors such as the general economy, the job market and changes in the legal environment (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., marijuana decriminalization) can impact the utilization of drugs-of-abuse testing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employers also are investing in population health services.  We meet their needs by providing nationwide access to our customizable services (discussed above at page 13), directly and through health plan and health improvement providers.  These services help employers, employees and others manage healthcare costs, capitalize on trends in personalized health and improve health outcomes.  In response to the COVID-19 pandemic, we expanded our offerings to employers to assist their pandemic response to create safer workplaces (discussed above at page 13). </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We seek to grow our employer business through offering new and innovative programs to help them with their goals of (1) maintaining a safe and productive workplace, (2) improving healthcare for employees and (3) lowering healthcare costs for employees and employers. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Consumers </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are well positioned to provide information and insights to patients to help them take actions to improve their healthcare.  The changing expectations of patients about their healthcare and their healthcare transactions are influencing our services and the way we provide them.  See the discussions of our consumer strategy at page 5 and consumerization above in table 11.  </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">FQHCs</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federally Qualified Health Centers offer a broad array of healthcare services, including to historically underserved populations.  We strive to offer an attractive array of services to FQHCs to demonstrate the value of our services.  </span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Emerging Retail Healthcare Providers</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In recent years, as the healthcare sector changes, retail providers of healthcare services have emerged and are growing.  These providers include "big-box" retailers, pharmacy chains, supermarkets, urgent care centers and Internet-based service providers.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are taking advantage of opportunities to work with these providers, not only to offer new access points for our services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., our collaboration with Safeway), but also to grow our business by expanding our service offerings (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">., our joint venture with Walmart).  See the discussion of our consumer strategy at page 5.</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;Government Agencies</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We provide services on a fee-for-service basis to federal, state and local governmental agencies.<br/>Historically, most Medicare and Medicaid beneficiaries were covered under the traditional Medicare and Medicaid programs administered by the federal government.  Over the last several years, the federal government has expanded its contracts with private health insurance plans for Medicare beneficiaries and has encouraged such beneficiaries to switch from the traditional programs to the private programs, called &#8220;Medicare Advantage&#8221; programs.  There has been growth of health insurance providers offering Medicare Advantage programs and of beneficiary enrollment in these programs.  States also have mandated that Medicaid beneficiaries enroll in private managed care arrangements.  During 2020, we provided additional services to and in conjunction with government agencies across the United States in connection with the COVID-19 pandemic. </span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pharmaceutical companies</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have expertise with laboratory developed tests for companion and complementary diagnostics, and offer an array of assets and services to support the development of companion diagnostics, including our robust data set and patient services network. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We also offer Quest Clinical Trials Connect,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to help accelerate clinical trials (and thus the speed of drugs to market) through better patient recruitment, involvement and management, and improved physician outreach.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Laboratories</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We provide services on a fee-for-service basis to other commercial clinical laboratories.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> While there has been consolidation in the diagnostic information services industry in recent years, our industry remains fragmented and highly competitive.  We primarily compete with three types of clinical testing providers: commercial clinical laboratories, hospital-affiliated laboratories and physician-office laboratories.  Our largest commercial clinical laboratory competitor is Laboratory Corporation of America Holdings, Inc.  In addition, we compete with many smaller regional and local commercial clinical laboratories and specialized advanced laboratories.  In anatomic pathology, we compete with anatomic pathology practices, including those in academic institutions and large physician group practices, and providers of emerging digital pathology solutions.  There also has been a trend among specialty physician practices to establish their own histology laboratory capabilities and/or bring pathologists into their practices, thereby reducing referrals from these practices and increasing the competitive position of these practices.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.673%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare providers consider a number of factors when selecting a diagnostic information services provider.</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Potential Factors Considered When Selecting a Diagnostic Information Services Provider (Table 14)</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Service capability and quality</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Reputation in the medical community</span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Accuracy, timeliness and consistency in reporting test results</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Healthcare information technology solutions, including connectivity options</span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Access to medical/scientific thought leaders for consultation</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Patient access, including the number, convenience and geographic coverage of patient service centers</span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Patient insurance coverage and experience</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Ability to develop new and useful tests and services</span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Number and type of tests performed</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Qualifications of its staff</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Pricing and overall value</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Provider office workflow </span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Real time payment determination</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Capabilities to support population health initiatives </span></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</span></td></tr></table></div><div style="padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that providing the most attractive service offering in the industry, including the most comprehensive test menu, innovative test offerings, a positive customer experience, a staff including medical and scientific experts, strong quality, unparalleled access and distribution, and data-powered integrated information technology solutions provide us with a competitive advantage.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that large diagnostic information services providers have a competitive advantage due to their large networks and lower cost structures, including as a result of PAMA.  These advantages should enable larger providers to more effectively serve customers.  In addition, we believe that consolidation in the diagnostic information services industry will continue.  However, a significant portion of clinical testing is likely to continue to be performed by hospitals, which generally have affiliations with community clinicians and may have more, or more convenient, locations in a market.  As a result, we compete against hospital-affiliated laboratories primarily on the basis of service capability, quality and pricing.  In addition, market activity may increase the competitive environment.  For example, hospital ownership of physician practices may enhance the ties of the clinicians to hospital-affiliated laboratories, enhancing the competitive position of hospital-affiliated laboratories.  ACOs, DCEs and IDNs, and their approach to contracts with healthcare providers, in addition to the impact of informatics, also may impact competition to provide diagnostic information services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The diagnostic information services industry is faced with changing technology, new product introductions and new service offerings. Competitors may compete using advanced technology, including technology that enables more convenient or cost-effective testing.  Digital pathology, still in an emerging state, is an example of this.  Competitors also may compete on the basis of new service offerings.  Competitors also may offer testing to be performed outside of a commercial clinical laboratory, such as (1) point-of-care testing that can be performed by physicians in their offices; (2) testing that can be performed by hospitals in their own laboratories; and (3) home testing that can be carried out without requiring the services of outside providers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The risk assessment and healthcare information technology industries are highly competitive.  We have many competitors, some of which have much more extensive experience in these industries and some of which have greater resources.  We compete in the risk assessment business by seeking to provide a wider array of quality, integrated services than our competitors, faster services completion and a superior applicant experience.  We compete in the healthcare information technology industry by offering solutions that foster better patient care and improve performance for healthcare providers, including smaller and medium sized physician practices.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_31"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Creating an inspiring workplace is one of our three corporate goals, and this goal drives our approach to human capital management.  Effectively managing our human capital resources is a priority with key components that include culture, safety and well-being programs, employee engagement, and development and succession planning.  Our Board of Directors actively engages in oversight of our human capital management, including by receiving management reports on key areas, strategies and initiatives.  Additional information about our human capital management strategies and initiatives is available in our annual corporate responsibility report. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of January 4, 2021, we have approximately 49,000 employees, of whom approximately 40,000 are full-time and the remainder are part-time or on-call.   Our employee population is more diverse than the U.S. workforce, taken as a whole.  Approximately 72% of our employees globally are women; approximately 51% of our U.S. employees are people of color.  A majority of our employees work directly with our customers or in our laboratories.  We believe that our overall relations with our employees are good.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Culture</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We strive to foster a strong culture, built on our Code of Ethics, which reinforces our commitment to integrity and aligns with our vision, values, goals and brand.  We are focused on building and maintaining a culture in which all employees are empowered to raise and discuss difficult issues and valued for their strengths, experience and unique perspectives.   We encourage our employees to actively participate in their communities, and support their participation, including offering incentives for participation.  Our Everyday Excellence program includes guiding principles for our entire organization to support a superior customer experience and inspire employees to be their best every day, with every person and with every customer interaction; the program is integrated into performance assessments and frontline employee behavioral standards.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Safety and Well-Being</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The health and safety of our employees is of paramount concern.  We use a systematic, risk-based approach to develop tailored incident prevention and response programs designed to keep our employees safe in each of our diverse functional areas, and use data insights and a detailed audit program to foster the effectiveness of our programs. We have a comprehensive curriculum of annual safety training, as well as training for new employees.  In 2020, our cross-functional Safely Working Together Steering Committee designed and implemented tactics, techniques and procedures to enable our colleagues to continue to work safely during the COVID-19 pandemic.  As part of our comprehensive and competitive compensation and benefits program, we also offer innovative initiatives to support the well-being of our employees and their families through our HealthyQuest program.  The cornerstone of our HealthyQuest program is our Blueprint for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Wellness program, which empowers our employees and their dependents with health insights based on lab and biometric data and invites them each year to take the initiative to improve their physical and mental health.  We also offer other programs designed to engage employees in managing their health, including access to medical expertise and support programs tailored to their individual needs, helping them to adopt healthier behaviors and access better care at lower costs.  These include customized programs for conditions such as type 2 diabetes management, chronic kidney disease, cardiovascular disease, zero-cost lab testing and specialty drugs, advocacy for mental health concerns and special support for orthopedic surgery and for cancer and other serious diagnoses.   In 2020, The Health Project named Quest Diagnostics the sole winner of the prestigious C. Everett Koop National Health Award, which is given to health programs that deliver significant health improvements and business results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inclusion and Diversity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We understand the need to create an environment where employees can bring their whole selves to work.  We aim to harness the unique mix of capabilities, talents, cultures, beliefs and experience of our employees and create a workforce that is demographically diverse at all levels of the organization.  In 2020, in light of societal issues raised around us, our leadership and employees engaged squarely on the issue of racial equality in our country and the workplace. Several hundred leaders participated in a session on the topic, received a toolkit to help simulate thinking and action and how to address these issues and held dozens of meetings and panels with their teams to talk about racial inequities.  We also launched, with the Quest Diagnostics Foundation, Quest for Health Equity, a multi-year, $100 million-plus initiative to help reduce health disparities in underserved communities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engagement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Since 1997, we have sought to foster the engagement and enablement of our employees, and have regularly surveyed our employees to gauge their engagement.  Employee engagement has been a metric in the annual incentive plan for our executive officers since 2013.  During 2020, we increased our engagement efforts, including by shifting to an approach of surveying employees more frequently and, during the COVID-19 pandemic, holding near-weekly meetings among hundreds of company leaders to foster increased communication across the company regarding topics of concern to employees.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Development and Succession Planning</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We provide training on a wide array of topics to our employees.  We also offer a number of development opportunities for our employees, such as training, mentoring and education programs, including a higher education tuition reimbursement program.  In addition, we offer leadership training programs for employees at different levels, including programs designed to strengthen our more senior employee leaders to create a high-performance culture and sharpen the capabilities needed to lead our organization.  We regularly engage in succession planning for our talent, including at the most senior levels.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Sales and Marketing.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Our Diagnostic Information Services business has a unified commercial organization focused on the sale of most of our services.  It coordinates closely with our clinical franchises (discussed above under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and marketing organization.  The commercial organization is centrally led, and is organized regionally, in conjunction with our operations organization, to focus on local customer needs and to ensure aligned delivery for our customers.  Our commercial organization employs world-class processes and tools and strong management discipline.  We provide industry-leading training and development, focus on opportunities with IDNs and specialty physicians, and foster a customer-focused, performance-driven culture.   We also maintain distinct sales and marketing organizations for our offerings in Diagnostic Solutions and our employer drugs-of-abuse testing services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Information Technology.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We use information systems extensively in virtually all aspects of our business, including clinical testing, test ordering and reporting, billing, customer service, logistics and management of medical data.  We endeavor to establish systems that create value and efficiencies for our Company and customers.  The successful delivery of our services depends, in part, on the continued and uninterrupted performance of our information technology systems.  We take precautionary measures to prevent problems that could affect our information technology systems.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some of our historic growth has come through acquisitions and, as a result, we continue to use multiple information systems.  We have made significant progress implementing common systems in our regional laboratories, and we continue to standardize laboratory information and billing systems across our operations.  We expect that our standardization efforts will take several more years to complete, and will result in significantly more centralized systems, improved operating efficiency, more positive customer experiences and enhanced control over our operational environment.  Even after we complete our efforts to standardize our historic systems, we will need to focus on standardizing systems in connection with future business acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Quality Assurance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  As discussed further under the heading </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quality </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on page 7, our goal is to provide every patient with services and products of superior quality, and to meet that goal we have adopted the Quest Diagnostics Quality Program System.  Employing root cause analysis, process improvements and rigorous tracking and measuring, we continuously seek to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enhance quality, reduce defects, further increase the efficacy and efficiency of our operations and processes, eliminate waste and help standardize operations across our Company.&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our laboratory operations, our quality assurance efforts focus on pre-analytic, analytic and post-analytic processes, including positive patient identification of specimens, appropriate specimen transport, analysis and report accuracy, proficiency testing, reference range relevance, process audits, statistical process control and personnel training for all of our laboratories and patient service centers.  As part of our quality assurance program, we utilize internal and external proficiency testing, comprehensive quality control and rigorous process audits.  We monitor test results to identify trends, biases or imprecision in our analytical processes.  We also focus on the licensing, credentialing, training and competence of our professional and technical staff.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, we have accreditation or licenses for our clinical laboratory operations from various regulatory agencies or accrediting organizations, such as CMS, CAP and certain states.  All of our laboratories participate in external quality surveillance programs, including proficiency testing programs administered by CAP and several state agencies. CAP is an independent, nongovernmental organization of board-certified pathologists approved by CMS to inspect clinical laboratories to determine compliance with the standards required by CLIA.  CAP offers an accreditation program to which clinical laboratories may voluntarily subscribe. All of our major laboratories, including our laboratories outside the U.S., and a number of our rapid response laboratories, are accredited by CAP.  Accreditation includes on-site inspections and participation in the CAP (or equivalent) proficiency testing program.  Also, our cytotechnologists and pathologists participate in an internal peer-review evaluation and one or more external individual proficiency testing programs.  In addition, some of our laboratories also have International Organization for Standardization certification for their quality management systems. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For additional information about our commitment to quality, see "Our Strengths - Quality " on page 7.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property Rights.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We own significant intellectual property, including patents, patent applications, technology, trade secrets, know-how, copyrights and trademarks in the United States and other countries.  From time to time, we also license patents, patent applications, technology, trade secrets, know-how, copyrights or trademarks owned by others; we also may license our intellectual property to others. In the aggregate, our intellectual property assets and licenses are of material importance to our business.  We believe, however, that no single patent, technology, trademark, intellectual property asset or license is material to our business as a whole.  Our approach is to manage our intellectual property assets, to safeguard them and to maximize their value to our enterprise.  We actively defend our important intellectual property assets and pursue protection of our products, processes and other intellectual property where possible.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enterprise Risk Management Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  We maintain an enterprise risk management program designed to promote a culture of risk awareness throughout the Company's key business, operations and support functions.  Our program, which is integrated with the Company&#8217;s governance, performance management and internal control frameworks, entails a formal continuous process that identifies, assesses, mitigates and manages the risks from both internal and external conditions that could significantly impact the Company and influence its business strategy and performance.  The program is based on the most recent framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, which focuses on the following risk types:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operational risk - risks arising from systems, processes, people and external events that affect the Company&#8217;s operational objectives or fundamental reason for its existence, including: product life-cycle and execution; service quality and performance; information management and data protection and security, including cybersecurity; supply chain and business disruption; and other risks, including human capital and reputation.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Financial risk - risks arising from the Company&#8217;s ability to meet its financial obligations pursuant to its strategic and operational objectives, including exposure to broad market and more specific industry risk that could impact liquidity, interest rate, credit, pricing and reimbursement, and also to internal and external financial reporting.   </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Legal and compliance risk - risks arising from the regulatory and enforcement environment, legal proceedings and adherence to ethics and compliance policies and procedures.   </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strategic risk - risks that will impede the Company&#8217;s plan to achieve its mission and vision and apply its core values, including changes in the broad market and Company's industry, business development and restructuring activities, competitive threats and practices, technology and product innovation, and public policy.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As part of our program, we routinely assess our enterprise level risks, emerging risks, overall Company-level risk tolerance and the effectiveness of risk management, and monitor the progress of and resources applied to risk mitigation; our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Board of Directors actively oversees our program.  Our primary risk factors are discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> beginning on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_43">32</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Billing; Government Reimbursement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We generally bill for diagnostic information services on a fee-for-service basis under one of two types of fee schedules; fees may be negotiated or discounted.  The types of fee schedules are:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Client&#8221; fees charged to physicians, hospitals and institutions for which services are performed on a wholesale basis and which are billed on a monthly basis.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Patient&#8221; fees charged to individual patients and certain third-party payers on a claim-by-claim basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Billing for diagnostic information services is very complicated.  Patients, insurance companies, Medicare, Medicaid, physicians, hospitals, IDNs, ACOs, DCEs and employer groups all have different billing requirements. Some billing arrangements require us to bill multiple payers, and there are several other factors that complicate billing (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., disparity in coverage and information requirements among payers; incomplete or inaccurate billing information provided by ordering clinicians; and lack of access to patients before testing).  We maintain compliance policies and procedures for our billing practices, and we audit our practices for compliance with applicable laws and regulations and internal policies and procedures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With regard to the clinical testing services performed on behalf of Medicare beneficiaries, we generally must bill Medicare directly and must accept the Medicare carrier's fee schedule amount for covered services as payment in full.  In addition, state Medicaid programs are prohibited from paying more (and in most instances, pay significantly less) than Medicare.  Currently, Medicare does not require the beneficiary to pay a co-payment for diagnostic testing services reimbursed under the Clinical Laboratory Fee Schedule, but generally does require a patient deductible and co-insurance for anatomic pathology services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Part B of the Medicare program contains fee schedule payment methodologies for clinical testing services performed for covered patients, including a national ceiling on the amount that carriers could pay under their local Medicare clinical testing fee schedules.  Historically, the Medicare Clinical Laboratory Fee Schedule and the Medicare Physician Fee Schedule established under that program have been subject to change, including each year.  Pursuant to PAMA, reimbursement rates for many clinical laboratory tests provided under Medicare were reduced in 2018, 2019 and 2020.  PAMA calls for further revision of the Medicare Clinical Laboratory Fee Schedule for years after 2020, based on future surveys of market rates; reimbursement reduction from 2022-24 is capped by PAMA at 15% annually.  The LAB Act provided an opportunity for reforms to PAMA by delaying PAMA's next data collection and reporting period until January 1, 2021 and by ordering a study to determine ways to improve future collection of more representative market rate data under PAMA. The CARES Act, adopted in early 2020 in response to the COVID-19 pandemic, suspended the PAMA price cuts that had been scheduled for 2021 and delayed PAMA's next data collection and reporting period until January 1, 2022. </span></div><div><span><br/></span></div><div style="text-align:center"><img src="dgx-20201231_g5.jpg" alt="dgx-20201231_g5.jpg" style="height:281px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our net revenues reimbursed under Medicare and Medicaid in 2020 were lower as a percentage of our consolidated net revenues than in recent years as a result of revenues attributable to COVID-19 testing.  Excluding revenues attributable to COVID-19 testing, our net revenues reimbursed under Medicare and Medicaid in 2020 were comparable, as a percentage of our consolidated net revenues, to recent years.  &#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_34"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGULATION </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to extensive and frequently changing laws and regulations in the United States (at both the federal and state levels) and other jurisdictions in which we conduct business, and to government inspections and audits. </span></div><div style="text-align:center"><span><br/></span></div></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Regulatory Schemes (Table 16)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">CLIA and State Clinical Laboratory Licensing</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CLIA regulates the operations of virtually all clinical laboratories, requiring that they be certified by the federal government and that they comply with various technical, operational, personnel and quality requirements intended to ensure that the services provided are accurate, reliable and timely.  </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State laws may require additional personnel qualifications or licenses, quality control, record maintenance, proficiency testing or detailed review of our scientific method validations and technical procedures for certain tests. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Medicare and Medicaid; Fraud and Abuse</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic testing services provided under Medicare and Medicaid programs are subject to complex, evolving, stringent and frequently ambiguous federal and state laws and regulations, including those relating to billing, coverage and reimbursement.  <br/><br/>Anti-kickback laws and regulations prohibit making payments or furnishing other benefits to influence the referral of tests billed to Medicare, Medicaid or certain other federal or state healthcare programs.  <br/><br/>In addition, federal and state anti-self-referral laws generally prohibit Medicare and Medicaid payments for clinical tests referred by physicians who have an ownership or investment interest in, or a compensation arrangement with, the testing laboratory, unless specific exceptions are met.<br/><br/>Federal substance abuse legislation enacted in 2018 contains anti-kickback provisions that are, by their terms, applicable to laboratory testing paid for by all payers.  We are attempting to clarify the application of that legislation.<br/><br/>Some states have similar laws that are not limited in applicability to only Medicare and Medicaid referrals and could also affect tests that are paid for by health plans and other non-governmental payers. <br/><br/>Violations of these laws and regulations may result in monetary fines, criminal and civil penalties and/or suspension or exclusion from participation in Medicare, Medicaid and other federal or state healthcare programs. </span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The FDA has regulatory responsibility over, among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the United States.  The FDA also regulates drugs-of-abuse testing for employers and insurers, testing for blood bank purposes and testing of donors of human cells for purposes such as in vitro fertilization. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A number of advanced tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the 21st Century Cures Act, the FDA issued final guidance regarding its position on the regulation of clinical decision software, which may be used in connection with LDTs. The guidance attempts to address uncertainty regarding whether FDA approval of certain software is required.  It has been used by the FDA, in part, to assert authority over the annotation software aspects of pharmacogenetic testing services.  In addition, the FDA continued during 2020 to work on a pre-certification program to help software developers have a speedier and less restrictive path to clearance or approval of their software. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legislation introduced in Congress would enable the FDA to regulate LDTs, in vitro diagnostics, software and other items used in the diagnosis of disease. The FDA and the U. S. Department of Health and Human Services also have expressed views regarding the regulation of LDTs. Either new law or a revised approach to regulation of LDTs could have a significant impact on the clinical laboratory testing industry, including regulating LDTs in new ways, while creating avenues of opportunity and competition regarding clinical laboratory testing.  New competitors may enter the industry, and competition may come in new forms. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Environmental, Health and Safety</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to laws and regulations related to the protection of the environment, the health and safety of employees and the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For example, the U.S. Occupational Safety and Health Administration has established extensive requirements relating specifically to workplace safety for healthcare employers in the U.S.  This includes requirements to develop and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including preventing or minimizing any exposure through needle stick injuries. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of transportation, some biological materials and laboratory supplies are classified as hazardous materials and are subject to regulation by one or more of the following agencies: the U.S. Department of Transportation, the U.S. Public Health Service, the U.S. Postal Service and the International Air Transport Association. </span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Physicians</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Our pathologists are required to hold a valid license to practice medicine in the jurisdiction in which they practice.  <br/><br/>Several jurisdictions in which our businesses are located prohibit business corporations from engaging in the practice of medicine. In certain jurisdictions, business corporations are prohibited from employing licensed healthcare professionals to provide services on behalf of the corporation; these laws vary.  In some jurisdictions, anatomic pathology services are delivered through physician-owned entities that employ the practicing pathologists.  The manner in which licensed physicians can be organized to perform medical services may be governed by the laws of the jurisdictions in which medical services are provided and by the medical boards or other entities authorized by these jurisdictions to oversee the practice of medicine. </span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Privacy and Security of Health and Personal Information</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We are subject to laws and regulations regarding protecting the security and privacy of certain healthcare and personal information, including: (a) the federal Health Insurance Portability and Accountability Act and the regulations thereunder, which establish (i) a complex regulatory framework including requirements for safeguarding protected health information and (ii) comprehensive federal standards regarding the uses and disclosures of protected health information; (b) state laws, including the California Consumer Privacy Act; and (c) laws outside the U.S., including the European Union's General Data Protection Regulation. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A healthcare provider may be subject to penalties for non-compliance and may be required to notify individuals or state, federal or county governments if the provider discovers certain breaches of personal information or protected health information.  </span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Drug Testing; Controlled Substances</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All U.S. laboratories that perform drug testing for certain public sector employees and employees of certain federally regulated businesses are required to be certified as meeting the detailed performance and quality standards of the Substance Abuse and Mental Health Services Administration. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">To obtain access to controlled substances used to perform drugs-of-abuse testing in the United States, laboratories must be licensed by the Drug Enforcement Administration. </span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Compliance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We strive to conduct our business in compliance with all applicable laws and regulations.  We license and maintain appropriate accreditations for all of our laboratories and, where applicable, patient service centers, as required by the appropriate federal and state agencies.  We have a long-standing and well-established compliance program.  The Quality, Safety and Compliance Committee of our Board of Directors oversees, and receives periodic management reports regarding, our compliance program.  Our program includes detailed policies and procedures and training programs intended to ensure the implementation and observance of all applicable laws and regulations (including regarding billing and reimbursement, and privacy of protected health information and personally identifiable information) and Company policies.  Further, we conduct in-depth reviews of procedures and facilities to assure regulatory compliance throughout our operations.  We conduct annual training of our employees on these compliance policies and procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As an integral part of our billing compliance program, we investigate reported or suspected failures to comply with federal and state healthcare reimbursement requirements.  Any Medicare or Medicaid overpayments resulting from non-compliance are refunded by us.  As a result of these efforts, we have periodically identified and reported overpayments, refunded the payers for overpayments and taken appropriate corrective action. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_37"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Securities and Exchange Commission (the &#8220;SEC&#8221;) maintains an internet site, www.sec.gov, that contains annual, quarterly and current reports, proxy and information statements and other information that issuers file electronically with the SEC.  We file reports, proxy statements and other information with the SEC; they are publicly available at the SEC's internet site.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our internet address is www.QuestDiagnostics.com.  You can access our Investor Relations webpage at www.QuestDiagnostics.com/investor.  The information on our website is not incorporated by reference into this Report.  We make available free of charge, on or through our Investor Relations webpage, our proxy statements, Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), as soon as reasonably practical after such material is filed with, or furnished to, the SEC. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:57.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">www.QuestDiagnostics.com/investor provides information about our corporate governance.</span></td></tr><tr><td colspan="6" style="background-color:#606060;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information Available at Our Corporate Governance Webpage (Table 17)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors</span></div></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Governance Guidelines</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Composition of the committees of our Board of Directors</span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Code of Ethics</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior management</span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Incorporation</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charters for the standing committees of our Board of Directors</span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bylaws</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information about our corporate political contributions </span></div></td><td colspan="3" style="border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Values </span></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statements of beneficial ownership of our equity securities filed by our directors, officers and others under Section 16 of the Exchange Act</span></div></td></tr></table></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_40"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION ABOUT OUR EXECUTIVE OFFICERS </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:32.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#828282;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Officers (Table 18)</span></td></tr><tr><td colspan="3" style="background-color:#dddddd;border-left:1pt solid #acacac;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name, Age, Title</span></td><td colspan="3" style="background-color:#dddddd;border-left:1pt solid #acacac;border-right:1pt solid #acacac;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Background</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stephen H. Rusckowski (63) <br/>Chairman of the Board, Chief Executive Officer and President </span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Rusckowski joined the Company in May 2012 as Chief Executive Officer and President and became Chairman of the Board on January 1, 2017.  From October 2006 until he joined the Company, he was Chief Executive Officer of Philips Healthcare, the largest unit of Royal Philips Electronics, and a member of the Board of Management of Royal Philips Electronics and its Executive Committee.  Previously, he was CEO of the Imaging Systems business of Royal Phillips Electronics. <br/><br/>Before joining Philips in 2001, Mr. Rusckowski held numerous management positions with the healthcare division of Hewlett-Packard/Agilent Technologies. <br/><br/>Mr. Rusckowski has been a director of the Company since May 2012.  He was a director of Xerox Corporation from February 2015 to 2018, and a director of Covidien plc from December 2013 to January 2015.  Mr. Rusckowski served as Chairman of the American Clinical Laboratory Association from 2014 to 2017.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">James E. Davis (58) <br/>Executive Vice President, General Diagnostics</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In January 2017, Mr. Davis became Executive Vice President, General Diagnostics; previously he was Senior Vice President and Group Executive - Regional Businesses.  In January 2015, he assumed responsibility for the general management of the Company's regional Diagnostic Information Services business.  Mr. Davis was responsible for our products business from February 2014 until 2016.  From February 2014 to January 2015, he was responsible for operations for the Company's Diagnostic Information Services business. &#160;He joined Quest Diagnostics in April 2013 as Senior Vice President, Diagnostics Solutions, with responsibility for the healthcare information technology, risk assessment, clinical trials, diagnostic products and employer solutions businesses.&#160; <br/><br/>Prior to joining Quest Diagnostics, from March 2012 to April 2013, Mr. Davis served as Lead Director, and then as Chief Executive Officer, of InSightec, Inc., a medical device company that designs and develops ultrasound ablation devices that are guided by magnetic resonance imaging systems.  <br/><br/>Previously, Mr. Davis held a number of senior positions in General Electric&#8217;s healthcare business, including from 2007 to 2012 as Vice President and General Manager of GE Healthcare&#8217;s magnetic resonance imaging business.  Prior to joining GE Healthcare, Mr. Davis held leadership positions in GE&#8217;s aviation business and led the development of strategic and operational improvement initiatives for clients of McKinsey &amp; Company, Inc.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:32.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Catherine T. Doherty (58) <br/>Senior Vice President and Group Executive - Clinical Franchise Solutions and Marketing</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Since January 2013, Ms. Doherty has been responsible for overseeing the development of clinical franchise solutions in the areas of general health and wellness, cardiovascular, metabolic and endocrinology, infectious disease and immunology, and prescription drug monitoring and toxicology, as well as enterprise-wide marketing.  Ms. Doherty is also responsible for the employer solutions and risk assessment businesses, and since February 2020, our sports diagnostics franchise.  Additionally, in October 2018, QuestDirect, our consumer initiated testing platform was launched under her leadership.  She also was responsible for clinical franchise solutions in the areas of neurology and women's health from January 2013 to January 2017 and for the healthcare information technology business from February 2014 to January 2017.<br/><br/>Prior to January 2013, Ms. Doherty held a variety of positions of increasing responsibility since joining the Company in 1990, including Senior Vice President, Physician Services; Vice President, Hospital Services; Vice President, Office of the Chairman; Vice President, Finance and Administration for the Hospital business; Vice President, Communications and Investor Relations; and Chief Accounting Officer.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Carrie Eglinton Manner (46)<br/>Senior Vice President, Advanced Diagnostics</span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ms. Eglinton Manner joined the Company in January 2017.  She is responsible for the Company's advanced testing activities, including overseeing the development of clinical franchise solutions in the areas of neurology, oncology, pathology and women's health, as well as the Company's global business and pharmaceutical/diagnostic development services.   Ms. Eglinton Manner has served as a director of Repligen Corporation since June 2020.<br/><br/>Previously, Ms. Eglinton Manner spent over 20 years in various leadership roles in healthcare businesses at General Electric. From 2015 to 2016, she served as President and CEO of the Detection and Guidance Solutions business, delivering advanced x-ray technologies spanning the continuum of healthcare.  From 2013 to 2015, Ms. Eglinton Manner served as President and CEO of OEC Surgical Mobile C-arm systems.  She was President and CEO of General Electric's diagnostic pathology laboratory services business from 2012 to 2013, and President of the Maternal Infant Care Business from 2009 to 2012.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Mark J. Guinan (59) <br/>Executive Vice President and Chief Financial Officer<br/></span></td><td colspan="3" style="border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Guinan joined the Company in July 2013.  From 2010 until joining Quest Diagnostics in 2013, he served as Chief Financial Officer for Hill-Rom Holdings Inc., a manufacturer and provider of medical technologies and related services for the healthcare industry.  Mr. Guinan has served as a director of Myovant Sciences, Ltd. since July 2018.<br/><br/>Previously, he had served in a number of finance and operations roles in a long career at Johnson &amp; Johnson including 2009 to 2010 as Vice President, Chief Procurement Officer, and 2005 to 2009 as Vice President, Group Finance Pharmaceuticals.  Before joining Johnson &amp; Johnson in 1997, he held a number of financial roles at Procter &amp; Gamble.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Manuel O. Mendez (53)<br/>Senior Vice President, Chief Commercial Officer</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Mendez is responsible for the commercial organization for the Company's Diagnostic Information Services business.  <br/><br/>Prior to joining the Company in October 2019, Mr. M&#233;ndez was Senior Vice President, Global Commercial Operations at QIAGEN, a worldwide provider of molecular sample and assay technologies, where he helped accelerate growth and led a global commercial team.  From 2010-2014, Mr. Mendez served as Executive Vice President Americas for bioM&#233;rieux.  Previously,  he held a variety of sales, marketing and general management roles with Abbott Laboratories, Thermo Fisher Scientific and OraSure Technologies - with leadership positions in the United States, Latin America, Europe and Asian markets.<br/></span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:32.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:65.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Michael E. Prevoznik (59) <br/>Senior Vice President and General Counsel</span></td><td colspan="3" style="border-bottom:1pt solid #acacac;border-left:1pt solid #acacac;border-right:1pt solid #ffffff;border-top:1pt solid #acacac;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr. Prevoznik joined the Company as Vice President and General Counsel in August 1999.  In 2003, he assumed responsibility for governmental affairs.  From 1999 until April 2009, Mr. Prevoznik also had responsibility for the Company's Compliance Department.  <br/><br/>In addition, from April 2011 to January 2017, he had management responsibility for the Company's diagnostic information services activities outside the U.S., and from April 2011 to January 2013, he had management responsibility for the Company's clinical trials business.  <br/><br/>Prior to joining the Company, Mr. Prevoznik served in positions of increasing responsibility within the compliance organization at SmithKline Beecham, most recently as Vice President, Compliance, with responsibility for coordinating all SmithKline Beecham compliance activities worldwide.</span></td></tr></table></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1A. Risk Factors </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;You should carefully consider all of the information set forth in this Report, including the following risk factors, before deciding to invest in any of our securities.  The risks below are not the only ones that we face. Additional risks not presently known to us, or that we presently deem immaterial, may also negatively impact us.  Our business, consolidated financial condition, revenues, results of operations, profitability, reputation or cash flows could be materially impacted by any of these factors.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Report also includes forward-looking statements that involve risks or uncertainties.  Our results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks we face described below and elsewhere.  See &#8220;Cautionary Factors that May Affect Future Results&#8221; on page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_46">42</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.252%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_2222"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR BUSINESS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The U.S. healthcare system is evolving and medical laboratory testing market fundamentals are changing, and our business could be adversely impacted if we fail to adapt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The U.S. healthcare system is evolving, in part in response to the ACA. The ACA established the Center for Medicare and Medicaid Innovation to examine alternative payment methodologies and conduct demonstration programs. The ACA provided for extensive health insurance reforms, including the elimination of pre-existing condition exclusions and other limitations on coverage, fixed percentages on medical loss ratios, expansion in Medicaid and other programs, employer mandates, individual mandates, creation of state and regional health insurance exchanges, and tax subsidies for individuals to help cover the cost of individual insurance coverage. The ACA also permits the establishment of ACOs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain aspects of the ACA have been repealed, delayed or modified.  The scope and timing of any further legislation to repeal, amend, replace, or reform the rest of the ACA is uncertain, but if such legislation were to become law, it could have a significant impact on the U.S. healthcare system.  In addition, uncertainty regarding the status of the ACA prior to any such repeal, amendment, replacement or reform could create uncertainty generally in the healthcare market.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Several federal courts have issued determinations that portions of the ACA are unconstitutional; those rulings are net yet final.   </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Significant change is taking place in the healthcare system, including as discussed above under the heading The Clinical Testing Industry, beginning on page 14.  For example, value-based reimbursement is increasing (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, UnitedHealthcare's Preferred Lab Network); CMS has set goals for value-based reimbursement to be achieved.  Patients are encouraged to take increased interest in and responsibility for, and often are bearing increased responsibility for payment for, their healthcare.  Healthcare industry participants are evolving and consolidating.  Healthcare services increasingly are being provided by non-traditional providers (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., physician assistants), in non-traditional venues (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., retail medical clinics, urgent care centers) and using new technologies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., telemedicine, digital pathology).  Utilization of the healthcare system is being influenced by several factors and may result in a decline in the demand for diagnostic information services.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, we believe that clinical testing market fundamentals are changing.  We believe that PAMA-driven reimbursement pressure is negatively impacting access to care and hurting the clinical testing industry, and remains a catalyst for structural change in the market.  We also believe that health plans increasingly are focusing on driving better value in laboratory testing services.  We also believe that ongoing consumerization in healthcare, with increased cost being borne by consumers, is sharpening focus on price disparities.  We expect that the evolution of the healthcare industry will continue, and that industry change is likely to be extensive. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The clinical testing business is highly competitive, and if we fail to provide an appropriately priced level of service or otherwise fail to compete effectively it could have a material adverse effect on our revenues and profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The clinical testing business remains a fragmented and highly competitive industry.  We primarily compete with three types of clinical testing providers: other commercial clinical laboratories, hospital-affiliated laboratories and physician-office laboratories. We also compete with other providers, including anatomic pathology practices and large physician group practices. Hospitals generally maintain on-site laboratories to perform testing on their patients (inpatient or outpatient). In addition, many hospitals compete with commercial clinical laboratories for outreach (non-hospital patients) testing.  Hospitals may seek to leverage their relationships with community clinicians and encourage the clinicians to send their outreach testing to the hospital's laboratory.  As a result of this affiliation between hospitals and community clinicians, we compete against hospital-affiliated laboratories primarily based on quality and scope of service as well as pricing. In addition, hospitals that own physician practices may encourage or require the practices to refer testing to the hospital's laboratory. In recent years, there has been a trend of hospitals acquiring physician practices, increasing the percentage of physician practices owned by hospitals.  Increased hospital ownership of physician practices may enhance clinician ties to hospital-affiliated laboratories and may strengthen their competitive position.  The formation of ACOs, DCEs and IDNs, and their approach to contracts with healthcare providers, in addition to the impact of informatics, also may increase competition to provide diagnostic information services.  In addition, new players have recently started to provide clinical lab testing services (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., employers; government agencies).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The diagnostic information services industry also is faced with changing technology and new product introductions. Competitors may compete using advanced technology, including technology that enables more convenient or cost-effective testing.  Digital pathology, still in an emerging state, is an example of this.  Competitors also may compete on the basis of new service offerings.  Competitors also may offer testing to be performed outside of a commercial clinical laboratory, such as (1) point-of-care testing that can be performed by physicians in their offices; (2) advanced testing that can be performed by hospitals in their own laboratories; and (3) home testing that can be carried out without requiring the services of outside providers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government payers, such as Medicare and Medicaid, have taken steps to reduce the utilization and reimbursement of healthcare services, including clinical testing services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We face efforts by government payers to reduce utilization of and reimbursement for diagnostic information services.   One example of this is increased use of prior authorization requirements.  We expect efforts to reduce reimbursements, to impose more stringent cost controls and to reduce utilization of clinical test services will continue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to PAMA, reimbursement rates for many clinical laboratory tests provided under Medicare were reduced in 2018,  2019 and 2020.  PAMA calls for further revision of the Medicare Clinical Laboratory Fee Schedule for years after 2020, based on future surveys of market rates; reimbursement rate reduction from 2022-24 is capped by PAMA at 15% annually.  The LAB Act provides an opportunity for reforms to PAMA by delaying PAMA's next data collection and reporting period until January 1, 2021 and by ordering a study to determine ways to improve future collection of more representative market rate data under PAMA.  The CARES Act, adopted in early 2020 in response to the COVID-19 pandemic, suspended the PAMA price cuts that had been scheduled for 2021 and delayed PAMA's next data collection and reporting period until January 1, 2022.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, CMS has adopted policies limiting or excluding coverage for clinical tests that we perform. We also provide physician services that are reimbursed by Medicare under a physician fee schedule, which is subject to adjustment on an annual basis.  Medicaid reimbursement varies by state and is subject to administrative and billing requirements and budget pressures. The ACA includes further provisions that are designed to control utilization and payment levels. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, over the last several years, the federal government has expanded its contracts with private health insurance plans for Medicare beneficiaries, called &#8220;Medicare Advantage&#8221; programs, and has encouraged such beneficiaries to switch from the traditional programs to the private programs.  There has been growth of health insurance plans offering Medicare Advantage programs, and of beneficiary enrollment in these programs.  States have mandated that Medicaid beneficiaries enroll in private managed care arrangements.  In addition, state budget pressures have encouraged states to consider several courses of action that may impact our business, such as delaying payments, reducing reimbursement, restricting coverage eligibility, denying claims and service coverage restrictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the federal government has considered whether competitive bidding could be used to provide clinical testing services for Medicare beneficiaries at attractive rates while maintaining quality and access to care.  Congress periodically considers cost-saving initiatives.  These initiatives have included coinsurance for clinical testing services, co-payments for clinical testing and further laboratory fee schedule reductions.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health plans and other third parties have taken steps to reduce the utilization and reimbursement of health services, including clinical testing services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We face efforts by non-governmental third-party payers, including health plans, to reduce utilization of and reimbursement for clinical testing services. Examples include increased use of prior authorization requirements and increased denial of coverage for services. Since the passage of ACA, there is increased market activity regarding alternative payment models, including bundled payment models. We expect continuing efforts by third-party payers, including in their rules, practices and policies, to reduce reimbursements, to impose more stringent cost controls and to reduce utilization of clinical testing services. ACOs, DCEs and IDNs also may undertake efforts to reduce utilization of, or reimbursement for, diagnostic information services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The healthcare industry has experienced a trend of consolidation among health insurance plans, resulting in fewer but larger insurance plans with significant bargaining power to negotiate fee arrangements with healthcare providers, including clinical testing providers. These health plans, and independent physician associations, may demand that clinical testing providers accept discounted fee structures or assume all or a portion of the financial risk associated with providing testing services to their members through capitated payment arrangements. Some health plans also are reviewing test coding, evaluating coverage decisions and requiring preauthorization of certain testing. There are also an increasing number of patients enrolling in consumer driven products and high deductible plans that involve greater patient cost-sharing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The increased consolidation among health plans also has increased pricing transparency and bargaining power and the potential adverse impact of ceasing to be a contracted provider with any such insurer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government payers and third parties, including health plans, may establish reimbursement levels that do not properly recognize the value of new and innovative solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Government payers and third parties, including health plans, are taking steps to reduce utilization of, and reimbursement for, some new and innovative healthcare solutions, including new tests and other solutions that we may offer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In response to requests from payers to have a strategy to report a single or at most a few codes to describe procedures used to perform molecular and toxicology testing, the American Medical Association CPT&#174; Editorial Panel has established and replaced billing codes used to report those procedures.  The adoption of these revised codes has resulted in limited coverage decisions on certain occasions, new requirements for documentation to facilitate payment from certain payers and increased payment denials.  While some payers have adopted the new payment methods, others have not yet modified their systems and ask that laboratories continue to report their services using the previous reporting strategies, when those codes still exist. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;These steps may discourage innovation and access to innovative solutions that we may offer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to develop, or acquire licenses for, new tests, technology and services could negatively impact our testing volume and revenues.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The diagnostic information services industry is faced with changing technology and new product introductions. Other companies or individuals, including our competitors, may obtain patents or other property rights that would prevent, limit or interfere with our ability to develop, perform or sell our solutions or operate our business or increase our costs. In addition, they could introduce new tests, technologies or services that may result in a decrease in the demand for our services or cause us to reduce the prices of our services. Our success in continuing to introduce new solutions, technology and services will depend, in part, on our ability to license new and improved technologies on favorable terms. We may be unable to develop or introduce new solutions or services. Other companies or individuals, including our competitors, may obtain patents or other property rights on tests or processes that we may be performing, that could prevent, limit or interfere with our ability to develop, perform or sell our tests or operate our business.  We also may be unable to continue to negotiate acceptable licensing arrangements, and arrangements that we do conclude may not yield commercially successful clinical tests. If we are unable to license these testing methods at competitive rates, our research and development costs may increase as a result. In addition, if we are unable to develop and introduce, or license, new solutions, technology and services to expand our advanced testing capabilities, our services may become outdated when compared with our competition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to establish, and perform to, appropriate quality standards to assure that the appropriate standard of quality is observed in the performance of our diagnostic information services could adversely affect the results of our operations and adversely impact our reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The provision of diagnostic information services involves certain inherent risks. The services that we provide are intended to provide information for healthcare providers in providing patient care. Therefore, users of our services may have a greater sensitivity to errors than the users of services or products that are intended for other purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Negligence in performing our services can lead to injury or other adverse events. We may be sued under physician liability or other liability law for acts or omissions by our pathologists, laboratory personnel and hospital employees who are under the supervision of our hospital-based pathologists. We are subject to the attendant risk of substantial damages awards and risk to our reputation.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_2217"></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO CHANGE IN PUBLIC POLICY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND THE REGULATORY AND LEGAL ENVIRONMENT</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to numerous legal and regulatory requirements governing our activities, and we may face substantial fines and penalties, and our business activities may be impacted, if we fail to comply.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our business is subject to or impacted by extensive and frequently changing laws and regulations in the United States (including at both the federal and state levels) and the other jurisdictions in which we engage in business. While we seek to conduct our business in compliance with all applicable laws, many of the laws and regulations applicable to us are vague or indefinite and have not been interpreted by the courts, including many of those relating to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">billing and reimbursement of clinical testing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certification or licensure of clinical laboratories;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anti-self-referral and anti-kickback laws and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the laws and regulations administered by the FDA;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the corporate practice of medicine;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operational, personnel and quality requirements intended to ensure that clinical testing services are accurate, reliable and timely;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physician fee splitting;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">relationships with physicians and hospitals;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safety and health of laboratory employees; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These laws and regulations may be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that could require us to make changes in our operations, including our pricing and/or billing practices. We may not be able to maintain, renew or secure required permits, licenses or any other regulatory approvals needed to operate our business or commercialize our services. If we fail to comply with applicable laws and regulations, or if we fail to maintain, renew or obtain necessary permits, licenses and approvals, we could suffer civil and criminal penalties, fines, exclusion from participation in governmental healthcare programs and the loss of various licenses, certificates and authorizations necessary to operate our business, as well as incur additional liabilities from third-party claims. If any of the foregoing were to occur, our reputation could be damaged and important business relationships with third parties could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We regularly receive requests for information, and occasionally subpoenas, from governmental authorities. We also are subject from time to time to qui tam claims brought by former employees or other &#8220;whistleblowers.&#8221; The federal and state governments continue aggressive enforcement efforts against perceived healthcare fraud.  Legislative provisions relating to healthcare fraud and abuse provide government enforcement personnel substantial funding, powers, penalties and remedies to pursue suspected cases of fraud and abuse.  In addition, the government has substantial leverage in negotiating settlements since the amount of potential damages far exceeds the rates at which we are reimbursed for our services, and the government has the remedy of excluding a non-compliant provider from participation in the Medicare and Medicaid programs. Regardless of merit or eventual outcome, these types of investigations and related litigation can result in:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management time and attention;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenditure of large amounts of cash on legal fees, costs and payment of damages;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases to our administrative, billing or other operating costs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limitations on our ability to continue some of our operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enforcement actions, fines and penalties or the assertion of private litigation claims and damages;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases to the amount of reimbursement related to diagnostic information services performed;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse affects to important business relationships with third parties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased demand for our services; and/or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injury to our reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Changes in applicable laws and regulations may result in existing practices becoming more restricted, or subject our existing or proposed services to additional costs, delay, modification, withdrawal or reconsideration. Such changes also could require us to modify our business objectives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be adversely impacted by the FDA's approach to regulation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The FDA has regulatory responsibility over, among other areas, instruments, software, test kits, reagents and other devices used by clinical laboratories to perform diagnostic testing in the U.S.  A number of tests we develop internally are offered as LDTs. The FDA has claimed regulatory authority over all LDTs, but has stated that it exercised enforcement discretion with regard to most LDTs performed by high complexity CLIA-certified laboratories. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As the FDA moves to regulate more clinical laboratory testing, its approach to regulation is impacting industry practices and participants, new competitors may enter the industry, and competition may come in new forms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Legislation introduced in Congress would enable the FDA to regulate LDTs, in vitro diagnostics, software and other items used in the diagnosis of disease. The FDA and the U. S. Department of Health and Human Services also have expressed views regarding the regulation of LDTs. Either new law or a revised approach to regulation of LDTs could have a significant impact on the clinical laboratory testing industry, including regulating LDTs in new ways, while creating avenues of opportunity and competition regarding clinical laboratory testing.  New competitors may enter the industry, and competition may come in new forms. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the 21st Century Cures Act, the FDA issued final guidance regarding its position on the regulation of clinical decision software, which may be used in connection with LDTs. The guidance attempts to clarify whether FDA approval of certain software is required.  It has been used by the FDA, in part, to assert authority over the annotation software aspects of pharmacogenetic testing services.  In addition, the FDA continued during 2020 to work on a pre-certification program to help software developers have a speedier and less restrictive path to clearance or approval of their software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to accurately bill for our services, or to comply with applicable laws relating to government healthcare programs, could have a material adverse effect on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Billing for diagnostic information services is complex and subject to extensive and non-uniform rules and administrative requirements. Depending on the billing arrangement and applicable law, we bill various payers, such as patients, insurance companies, Medicare, Medicaid, clinicians, hospitals and employer groups.  The majority of billing and related operations for our Company are being provided by a third party under the Company's oversight.  Failure to accurately bill for our services could have a material adverse effect on our business.  In addition, failure to comply with applicable laws relating to billing government healthcare programs may result in various consequences, including: civil and criminal fines and penalties, exclusion from participation in governmental healthcare programs and the loss of various licenses, certificates and authorizations necessary to operate our business, as well as incur additional liabilities from third-party claims, all of which could have a material adverse effect on our business.  Certain violations of these laws may also provide the basis for a civil remedy under the federal False Claims Act, including fines and damages of up to three times the amount claimed.  The qui tam provisions of the federal False Claims Act and similar provisions in certain state false claims acts allow private individuals to bring lawsuits against healthcare companies on behalf of government payers, private payers and/or patients alleging inappropriate billing practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although we believe that we are in compliance, in all material respects, with applicable laws and regulations, there can be no assurance that a regulatory agency or tribunal would not reach a different conclusion.  The federal or state government may bring claims based on our current practices, which we believe are lawful.  The federal and state governments have substantial leverage in negotiating settlements since the amount of potential damages and fines far exceeds the rates at which we are reimbursed, and the government has the remedy of excluding a non-compliant provider from participation in the Medicare and Medicaid programs.  We believe that federal and state governments continue aggressive enforcement efforts against perceived healthcare fraud.  Legislative provisions relating to healthcare fraud and abuse provide government enforcement personnel with substantial funding, powers, penalties and remedies to pursue suspected cases of fraud and abuse. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to numerous political, legal, operational and other risks as a result of our international operations which could impact our business in many ways.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our international operations increase our exposure to risks inherent in doing business in non-U.S. markets, which may vary by market and include: intellectual property legal protections and remedies; weak legal systems which may affect our ability to enforce contractual rights; trade regulations and procedures and actions affecting approval, production, pricing, reimbursement and marketing of services; and challenges based on differing languages and cultures.  International operations also require us to devote management resources to implement our controls and systems in new markets, and to comply with the U.S. Foreign Corrupt Practices Act and similar anti-corruption laws in non-U.S. jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be unable to obtain, maintain or enforce our intellectual property rights and may be subject to intellectual property litigation that could adversely impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We may be unable to obtain or maintain adequate patent or other proprietary rights for our solutions or services or to successfully enforce our proprietary rights. In addition, we may be subject to intellectual property litigation and we may be found to infringe on the proprietary rights of others, which could force us to do one or more of the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cease developing, performing or selling solutions or services that incorporate the challenged intellectual property;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain and pay for licenses from the holder of the infringed intellectual property right;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">redesign or re-engineer our tests;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">change our business processes; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay substantial damages, court costs and attorneys' fees, including potentially increased damages for any infringement held to be willful.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adverse results in material litigation could have an adverse financial impact and an adverse impact on our client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are involved in various legal proceedings arising in the ordinary course of business including, among other things, disputes as to intellectual property, professional liability and employee-related matters, as well as inquiries from governmental agencies and Medicare or Medicaid carriers. Some proceedings against us involve claims that are substantial in amount and could divert management's attention from operations. These proceedings also may result in substantial monetary damages.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_2212"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR INDEBTEDNESS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our outstanding debt may impair our financial and operating flexibility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December 31, 2020, we had approximately $4.0 billion of debt outstanding.  Other than credit facilities in the normal course of business, we do not have any off-balance sheet financing arrangements in place or available. Our debt agreements contain various restrictive covenants. These restrictions could limit our ability to use operating cash flow in other areas of our business because we must use a portion of these funds to make principal and interest payments on our debt. We have obtained ratings on our public debt from Standard and Poor's, Moody's Investor Services and Fitch Ratings. There can be no assurance that any rating so assigned will remain for any given period of time or that a rating will not be lowered or withdrawn entirely by a rating agency if in that rating agency's judgment future circumstances relating to the basis of the rating, such as adverse changes in our Company or our industry, so warrant. If such ratings are lowered, our borrowing costs could increase. Changes in our credit ratings, however, do not require repayment or acceleration of any of our debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We or our subsidiaries may incur additional indebtedness in the future. Our ability to make principal and interest payments will depend on our ability to generate cash in the future. If we incur additional debt, a greater portion of our cash flows may be needed to satisfy our debt service obligations and if we do not generate sufficient cash to meet our debt service requirements, we may need to seek additional financing. In that case, it may be more difficult, or we may be unable, to obtain financing on terms that are acceptable to us. As a result, we would be more vulnerable to general adverse economic, industry and capital markets conditions as well as the other risks associated with indebtedness.</span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_2206"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR OPERATIONS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The development of new technologies (including artificial intelligence technologies) may impact the healthcare industry, and the development of new, more cost-effective solutions that can be performed by our customers or by patients, and the continued internalization of testing by hospitals or clinicians, could negatively impact our testing volume and revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The diagnostic information services industry is faced with changing technology and new product introductions, including technology that enables more convenient or cost-effective testing.  For example, digital pathology is an emerging technology that may change the practice of pathology.  Information technology that includes self-learning or "artificial intelligence" features is growing and may impact the healthcare industry.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Competitors also may offer testing to be performed outside of a commercial clinical laboratory, such as (1) point-of-care testing that can be performed by clinicians in their offices; (2) complex testing that can be performed by hospitals in their own laboratories; and (3) home testing that can be carried out without requiring the services of outside providers.  Advances in technology also may lead to the need for less frequent testing.  Further, diagnostic tests approved or cleared by the FDA for home use are automatically deemed to be &#8220;waived&#8221; tests under CLIA and may be performed by patients in their homes; test kit manufacturers could seek to increase sales to patients of such test kits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some traditional customers for anatomic pathology services, including specialty physicians that generate biopsies through surgical procedures, such as dermatologists, gastroenterologists, urologists and oncologists, are consolidating, have added in-office histology labs or have retained pathologists to read cases on site.  Hospitals also are internalizing clinical laboratory testing, including some non-routine and advanced testing.  Internalization of testing may reduce demand for services previously referred to outside service providers, such as the Company. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hardware and software failures or delays in our information technology systems, including failures resulting from our systems conversions or otherwise, could disrupt our operations and cause the loss of confidential information, customers and business opportunities or otherwise adversely impact our business.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;IT systems are used extensively in virtually all aspects of our business, including clinical testing, test reporting, billing, customer service, logistics and management of medical data. Our success depends, in part, on the continued and uninterrupted performance of our IT systems.  A failure or delay in our IT systems could impede our ability to serve our customers and patients and protect their confidential data.  Despite redundancy and backup measures and precautions that we have implemented, our IT systems may be vulnerable to damage, disruptions and shutdown from a variety of sources, including telecommunications or network failures, system conversion or standardization initiatives, human acts and natural disasters.  These issues can also arise as a result of failures by third parties with whom we do business and over which we have limited control.  Any disruption or failure of our IT systems could have a material impact on our ability to serve our customers and patients, including negatively affecting our reputation in the marketplace.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be negatively affected if we are unable to continue to strengthen our efficiency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;It is important that we continue to strengthen our efficiency to promote our competitive position and to enable us to mitigate the impact on our profitability of steps taken by government payers and health insurers to reduce the utilization and reimbursement of healthcare services, including diagnostic information services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business operations and reputation may be materially impaired if we do not comply with privacy laws or information security policies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our business, we collect, generate, process or maintain sensitive information, such as patient data and other personal information. If we do use or not adequately safeguard that information in compliance with applicable requirements under federal, state and international laws, or if it were disclosed to persons or entities that should not have access to it, our business could be materially impaired, our reputation could suffer and we could be subject to fines, penalties and litigation.  In the event of a data security breach, we may be subject to notification obligations, litigation and governmental investigation or sanctions, and may suffer reputational damage, which could have an adverse impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are subject to laws and regulations regarding protecting the security and privacy of certain healthcare and personal information, including: (a) the federal Health Insurance Portability and Accountability Act and the regulations thereunder, which establish (i) a complex regulatory framework including requirements for safeguarding protected health information and (ii) comprehensive federal standards regarding the uses and disclosures of protected health information; (b) state laws, including the California Consumer Privacy Act; and (c) laws outside the U.S., including the European Union's General Data Protection Regulation.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The IT systems that we rely on may be subject to unauthorized tampering, cyberattack or other security breach.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our IT systems have been and are subject to potential cyberattacks, tampering or other security breaches.  These attacks, if successful, could result in shutdowns or significant disruptions of our IT systems and/or in unauthorized persons misappropriating intellectual property and other confidential information, including patient data that we obtain, transmit and store on and through our IT systems. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;External actors may develop and deploy viruses and other malicious software programs, including those that target our employees, designed to attack our IT systems or otherwise exploit security vulnerabilities, such as electronic spamming, phishing, spear phishing or similar tactics.  As a result of the difficulty in detecting many of these attacks, intrusions and breaches, failures or losses may be repeated or compounded before they are discovered or rectified, which could further increase these costs and consequences. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, our IT systems have experienced other attacks, viruses, attempted intrusions or similar problems, but each was mitigated.  None materially disrupted, interrupted, damaged or shutdown the company's IT systems, materially disrupted the Company's performance of its business or, to the Company's knowledge, resulted in material unauthorized access to data.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain third parties to whom we outsource certain of our services or functions, or with whom we interface, store or process our confidential patient data or other confidential information, as well as those third parties&#8217; providers, are also subject to the risks outlined above. A breach or attack affecting these third parties could also harm our business, results of operations and reputation and subject us to liability.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;), informed the Company and Optum360 LLC, which provides revenue management services to the Company, about a data security incident involving AMCA (the &#8220;AMCA Data Security Incident&#8221;). AMCA (which provided debt collection services for Optum360) informed the Company and Optum360 that AMCA had learned that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019. AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019. AMCA&#8217;s affected system included financial information (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., credit card numbers and bank account information), medical information and other personal information (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., social security numbers). Test results were not included. Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident.  AMCA also informed us that information pertaining to other laboratories&#8217; customers was also affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although the Company has robust security measures implemented, which are monitored and routinely tested both by internal resources and external parties, cyber threats against us or our third party providers continue to evolve and are often not recognized until such attacks are launched against a potential target.  There can be no assurance that the Company or its third party providers can anticipate all such evolving future attacks, viruses or intrusions, implement adequate preventative measures, nor remediate any security vulnerabilities.  Such breaches could expose our or our third party providers' IT systems to attack, which could result in major disruption of our business, and compromise our customer&#8217;s confidential information, result in litigation and potential liability for the Company, government investigation, significant damage to our reputation or otherwise adversely affect our business.  Any mitigation or remediation efforts that we undertake may require expenditures of significant resources and the diversion of the attention of management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have taken, and continue to take, precautionary measures to reduce the risk of, and detect and respond to, future cyber threats, and prevent or minimize vulnerabilities in our IT systems, including the loss or theft of intellectual property, patient data or other confidential information that we obtain and store on our systems. We also have taken, and will continue to take, measures to assess the cybersecurity protections used by our third-party providers.   In addition, we collaborate with government agencies regarding potential cyber threats and have worked with firms that have cyber security expertise to evaluate and strengthen our systems.  There can be no assurances that our precautionary measures or measures used by our third-party providers will prevent, contain or successfully defend against cyber or information security threats that could have a significant impact on our business, results of operations and reputation and subject us to liability.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to attract and retain qualified employees is critical to the success of our business and the failure to do so may materially adversely affect our performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our people are a critical resource. The supply of qualified personnel may be limited and competition for qualified employees is strong.  We may lose, or fail to attract and retain, key management personnel, or qualified skilled technical or professional employees (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., pathologists). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Business development activities are inherently risky and integrating our operations with businesses we acquire may be difficult.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We plan selectively to enhance our business from time to time through business development activities, such as acquisitions, licensing arrangements, investments and alliances. However, these plans are subject to the availability of appropriate opportunities and competition from other companies seeking similar opportunities. Moreover, the success of any such effort may be affected by a number of factors, including our ability to properly assess and value the potential business opportunity, and to integrate it into our business. The success of our strategic alliances depends not only on our contributions and capabilities, but also on the property, resources, efforts and skills contributed by our strategic partners. Further, disputes may arise with strategic partners, due to conflicting priorities or conflicts of interests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Acquisitions are not all the same (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., asset acquisitions differ from acquisitions of equity interests); different acquisitions offer different risks.  Acquisitions may involve the integration of a separate company that has different systems, processes, policies and cultures. Integration of acquisitions involves a number of risks including the diversion of management's attention to the assimilation of the operations of assets or businesses we have acquired, difficulties in the integration of operations and systems and the realization of potential operating synergies, the assimilation and retention of the personnel of the acquired businesses, challenges in retaining the customers of the combined businesses, and potential adverse effects on operating results. The process of combining acquisitions may be disruptive to our businesses and may cause an interruption of, or a loss of momentum in, such businesses as a result of the following difficulties, among others:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of key customers or employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in standardizing information and other systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty in consolidating facilities and infrastructure;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to maintain the quality or timeliness of services that our Company has historically provided;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management's attention from the day-to-day business of our Company as a result of the need to deal with the foregoing disruptions and difficulties; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the added costs of dealing with such disruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If we are unable successfully to integrate strategic acquisitions in a timely manner, our business and our growth strategies could be negatively affected. Even if we are able to successfully complete the integration of the operations of other assets or businesses we may acquire in the future, we may not be able to realize all or any of the benefits that we expect to result from such integration, either in monetary terms or in a timely manner. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our operations may be adversely impacted by the effects of natural disasters such as hurricanes and earthquakes, public health emergencies and health pandemics, hostilities or acts of terrorism and other criminal activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our operations may be adversely impacted by the effects of natural disasters such as hurricanes and earthquakes, public health emergencies and health pandemics, hostilities or acts of terrorism or other criminal activities. Such events may result in a decline in the number of patients who seek clinical testing services or in our employees' ability to perform their job duties. In addition, such events may interrupt our ability to transport specimens, to receive materials from our suppliers or otherwise to provide our services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The COVID-19 pandemic has significantly affected our consolidated results of operations, financial position and cash flows, and may continue to do so.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A pandemic caused by a novel strain of coronavirus (COVID-19) continues to severely impact the economy of the United States and other countries around the world. Federal, state and local governmental authorities in the United States have implemented numerous policies and initiatives to try and reduce the transmission of COVID-19, such as travel bans and restrictions, quarantines, shelter-in-place orders, and business shutdowns. These policies and initiatives have resulted in, among other things, a significant reduction in physician office visits, the cancellation of elective medical procedures, customers closing or severely curtailing their operations (voluntarily or in response to government orders), increased unemployment and loss of healthcare insurance, and the adoption of work-from-home policies, all of which have had, and we believe will continue to have, an impact on our consolidated results of operations, financial position and cash flows. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Due to the COVID-19 pandemic, we have experienced significant volatility, including periods of material decline compared to prior year periods, in testing volume in our base business (which excludes COVID-19 molecular and antibody testing) and this volatility, including periods of material decline, could continue. Although we also have experienced heavy demand for COVID-19 molecular testing as a result of the COVID-19 pandemic, which has had a positive impact on our overall testing volume, the duration and level of the demand for, and reimbursement for, COVID-19 molecular testing is uncertain.  We may also experience an adverse impact on cash collections and supply chain disruptions, including shortages, delays and price increases in testing equipment and supplies, as a result of the impact of the COVID-19 pandemic. Any of these events could have an adverse impact on our business, consolidated results of operation, financial position and cash flows. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe the COVID-19 pandemic&#8217;s adverse impact on our consolidated results of operations, financial position and cash flows will be primarily driven by: the severity and duration of the COVID-19 pandemic; the COVID-19 pandemic&#8217;s impact on the U.S. healthcare system and the U.S. economy; the timing, scope and effectiveness of federal, state and local governmental responses; and the ability to effectively and comprehensively administer COVID-19 vaccines across the U.S.  These primary drivers are beyond our knowledge and control and will change over time, and as a result, at this time we cannot reasonably estimate the adverse impact the COVID-19 pandemic will have on our businesses, consolidated results of operations, financial position and cash flows, and the adverse impact may be material. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our business also may be impacted by changes in the severity of the COVID-19 pandemic at different times in the various cities and regions where we operate and offer services, and by challenges faced in implementing nationwide COVID-19 vaccinations. Even after the COVID-19 pandemic has moderated and the business and social distancing restrictions have eased, we may continue to experience similar adverse effects to our businesses, consolidated results of operations, financial position and cash flows resulting from a recessionary economic environment that may persist. The impact that the COVID-19 pandemic will have on our businesses, consolidated results of operations, financial position and cash flows could exacerbate other risks identified in this Report.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some statements and disclosures in this document are forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan&#8221; or &#8220;continue.&#8221; These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking statements. Investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this document. The following important factors could cause our actual financial results to differ materially from those projected, forecasted or estimated by us in forward-looking statements:</span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Heightened competition from commercial clinical testing companies, hospitals, physicians and others.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Increased pricing pressure from customers, including payers and patients.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;A decline in economic conditions.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Impact of changes in payment mix, including increased patient financial responsibility and any shift from fee-for-service to discounted, capitated or bundled fee arrangements.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Adverse actions by government or other third-party payers, including healthcare reform that focuses on reducing healthcare costs but does not recognize the value and importance to healthcare of clinical testing or innovative solutions, unilateral reduction of fee schedules payable to us, unilateral recoupment of amounts allegedly owed and competitive bidding.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;The impact upon our testing volume and collected revenue or general or administrative expenses resulting from compliance with policies and requirements imposed by Medicare, Medicaid  and other third-party payers. These include:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the requirements of government and other payers to provide diagnosis codes and other information for many tests;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;inability to obtain from patients a valid advance consent form for tests that cannot be billed without prior receipt of the form; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the impact of additional or expanded limited coverage policies and limits on the allowable number of test units or ordering frequency of same; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;the impact of increased prior authorization programs.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Adverse results from pending or future government investigations, lawsuits or private actions. These include, in particular, monetary damages, loss or suspension of licenses, and/or suspension or exclusion from the Medicare and Medicaid programs and/or criminal penalties.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Failure to efficiently integrate acquired businesses and to manage the costs related to any such integration, or to retain key technical, professional or management personnel.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Denial, suspension or revocation of CLIA certification or other licenses for any of our clinical laboratories under the CLIA standards, revocation or suspension of the right to bill the Medicare and Medicaid programs or other adverse regulatory actions by federal, state and local agencies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Changes in and complexity of federal, state or local laws or regulations, including changes that result in new or increased federal or state regulation of commercial clinical laboratories, tests developed by commercial clinical laboratories or other products or services that we offer or activities in which we are engaged, including regulation by the FDA.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Inability to achieve expected benefits from our acquisitions of other businesses.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;Inability to achieve additional benefits from our business performance tools and efficiency initiatives.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;Adverse publicity and news coverage about the diagnostic information services industry or us.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;Failure of the Company to maintain, defend and secure its financial, accounting, technology, customer data and other operational systems from cyberattacks, IT system outages, telecommunications failures, malicious human acts and failure of the systems of third parties upon which the Company relies.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;Development of technologies that substantially alter the practice of clinical testing, including technology changes that lead to the development of more convenient or cost-effective testing, or testing to be performed outside of a commercial clinical laboratory, such as (1) point-of-care testing that can be performed by physicians in their offices, (2) advanced testing that can be performed by hospitals in their own laboratories or (3) home testing that can be carried out without requiring the services of clinical laboratories.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;Negative developments regarding intellectual property and other property rights that could prevent, limit or interfere with our ability to develop, perform or sell our tests or operate our business. These include:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;issuance of patents or other property rights to our competitors or others; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;inability to obtain or maintain adequate patent or other proprietary rights for our products and services or to successfully enforce our proprietary rights.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;Development of tests by our competitors or others which we may not be able to license, or usage (or theft) of our technology or similar technologies or our trade secrets or other intellectual property by competitors, any of which could negatively affect our competitive position.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;Regulatory delay or inability to commercialize newly developed or licensed tests or technologies or to obtain appropriate reimbursements for such tests.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;The complexity of billing and revenue recognition for clinical laboratory testing.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;Increases in interest rates and negative changes in our credit ratings from Standard &amp; Poor's, Moody's Investor Services or Fitch Ratings causing an unfavorable impact on our cost of or access to capital.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;Inability to hire or retain qualified or key senior management personnel.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Terrorist and other criminal activities, hurricanes, earthquakes or other natural disasters, and public health emergencies and health pandemics, which could affect our customers or suppliers, transportation or systems, or our facilities, and for which insurance may not adequately reimburse us.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;Difficulties and uncertainties in the discovery, development, regulatory environment and/or marketing of new services or solutions or new uses of existing tests.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;Failure to adapt to changes in the healthcare system (including the medical laboratory testing market) and healthcare delivery, including those stemming from the ACA (or its repeal, amendment or replacement), PAMA, trends in utilization of the healthcare system and increased patient financial responsibility for services.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(y) &#160;&#160;&#160;&#160;Results and consequences of governmental inquiries.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(z)   Difficulty in implementing, or lack of success with, our strategic plan.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(aa) The impact of informatics on our industry and the ability of our Company to adapt to that impact.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(bb) Failure to adequately operationalize appropriate controls around use of our data, including risk of non-compliance with privacy law requirements.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cc) The COVID-19 pandemic.  </span></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1B. Unresolved Staff Comments</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no unresolved SEC comments that require disclosure.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 2. Properties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our executive offices are located at 500 Plaza Drive, Secaucus, New Jersey.  We maintain clinical testing laboratories throughout the continental United States; in several instances a joint venture of which we are a partner maintains the laboratory.  We also maintain offices, data centers, call centers, distribution centers and patient service centers at locations throughout the United States.  In addition, we maintain offices, patient service centers and clinical laboratories in locations outside the United States, including in Puerto Rico and Mexico.  Our properties that are not owned are leased on terms and for durations that are reflective of commercial standards in the communities where these properties are located. We believe that, in general, our facilities are suitable and adequate for our current and anticipated future levels of operation and are adequately maintained.  We believe that if we were unable to renew a lease on any of our facilities, we could find alternative space at competitive market rates and relocate our operations to such new location without material disruption to our business.  Several of our principal facilities are highlighted below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:77.639%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Leased or Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3600 Northgate Blvd., Sacramento, California  95834  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8401 Fallbrook Avenue, West Hills, California  91304 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33608 Ortega Hwy., San Juan Capistrano, California 92675 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4151C East Fowler Avenue, Tampa, Florida  33617 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1777 Montreal Circle, Tucker, Georgia 30084-6802  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">506 E State Parkway, Schaumburg, Illinois 60173 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1355 Mittle Blvd., Wood Dale, Illinois 60191 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">200 Forest Street, Marlborough, Massachusetts  01752  (laboratories)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1715 Twin Springs Road, Baltimore, Maryland  21227  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">One Malcolm Avenue, Teterboro, New Jersey  07608  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">800 Business Center Drive, Horsham, Pennsylvania 19044  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4770 Regent Blvd., Irving, Texas  75063 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14225 Newbrook Drive, Chantilly, Virginia 22021  (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10101 Renner Blvd., Lenexa, Kansas  66219 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4380 Federal Drive, Greensboro, North Carolina  27410 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2501 South State Hwy 121, Lewisville, Texas 75067 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6700 Euclid Avenue, Cleveland, Ohio 44103 (laboratory)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr></table></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 3. Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 18 to the Consolidated Financial Statements (Part II, Item</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;8 of th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is Report) for information regarding legal proceedings in which we are involved.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 4. Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our common stock is listed and traded on the New York Stock Exchange under the symbol &#8220;DGX.&#8221; As of February 1, 2021, we had approximately 2,500 record holders of our common stock; we believe that the number of beneficial holders of our common stock exceeds the number of record holders. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the fourth quarter of 2020. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.587%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yet Be Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Under the Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">or Programs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2020 &#8211; October 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167,138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,871&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2020 &#8211; November 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2020 &#8211; December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,678&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,605,678&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028,979&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,238&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.12pt">Since the share repurchase program's inception in May 2003, our Board of Directors has authorized $9 billion of share repurchases of our common stock through December&#160;31, 2020.  The share repurchase authority has no set expiration or termination date.  On February 4, 2021, the Company announced that our Board of Directors had increased the size of its repurchase program by $1 billion.  </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.68pt">Includes: (1) shares delivered or attested to in satisfaction of the exercise price and/or tax withholding obligations by holders of stock options (granted under the Company's Amended and Restated Employee Long-Term Incentive Plan) who exercised options; and (2) shares withheld (under the terms of grants under the Amended and Restated Employee Long-Term Incentive Plan) to offset tax withholding obligations that occur upon the delivery of outstanding common shares underlying restricted share units and performance share units.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Set forth below is a line graph comparing the cumulative total shareholder return on Quest Diagnostics' common stock since December&#160;31, 2015 based on the market price of the Company's common stock and assuming reinvestment of dividends, with the cumulative total shareholder return of companies on the Standard &amp; Poor's 500 Stock Index and the S&amp;P 500 Healthcare Equipment &amp; Services Index. </span></div><div><span><br/></span></div><div style="text-align:center"><img src="dgx-20201231_g6.jpg" alt="dgx-20201231_g6.jpg" style="height:480px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:18.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.676%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Closing DGX Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholder Return</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Graph Values</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DGX</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500 H.C.&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">DGX</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500 H.C.&#160;</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2016</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.90&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.89&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.69)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.89&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2017</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/30/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.84)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/29/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 6. Selected Financial Data</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_118">58</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr></table></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_121">63</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Management's Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 8. Financial Statements and Supplementary Data</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Item 15(a)1 and Item 15(a)2.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 9A. Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conclusion Regarding Effectiveness of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).  Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Management on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;See page </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_136">83</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the fourth quarter of 2020, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 9B. Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our Code of Ethics applies to all employees, executive officers and directors, including our Chief Executive Officer, Chief Financial Officer and Corporate Controller.  You can find our Code of Ethics on our corporate governance website, www.QuestDiagnostics.com/investor.  We will post any amendments to the Code of Ethics, and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange, on our website.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information regarding the Company's executive officers is contained in Part I, Item 1 of this Report under &#8220;Information about our Executive Officers.&#8221;  Information regarding the directors and executive off</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">icers of the Company appearing in our Proxy Statement to be filed by April&#160;30, 2021 (&#8220;Proxy Statement&#8221;) under the captions &#8220;Proposal No. 1 - Election of Directors,&#8221; &#8220;Director Independence,&#8221; &#8220;Board Committees&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and "Delinquent Section 16(a) Reports" is incorporated by reference herein.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 11. Executive Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information appearing in our Proxy Statement under the captions</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;2020 Director Compensation Table,&#8221; &#8220;Compensation Discussion and Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;Information Regarding Executive Compensation&#8221; and &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation Committee Report&#8221; is incorporated by reference herein.  </span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders' Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information regarding security ownership of certain beneficial owners and management appearing in our Proxy Statement under the captions </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Stock Ownership Information&#8221; and "Equity Compensation Plan Information" is incorporated by reference herein. </span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information regarding certain relationships and related transactions appearing in our Proxy Statement under the captions</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Related Person Transactions&#8221; and &#8220;Director Independence&#8221; is incorporated by reference herein. </span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 14. Principal Accounting Fees and Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Information regarding principal accountant fees and services appearing in our Proxy Statement under the caption </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Audit" (excluding the information under the subheading &#8220;Audit and Finance Committee Report&#8221;) is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incorporated by reference herein. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_109"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 15. Exhibits, Financial Statement Schedules</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Documents filed as part of this Report.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Index to financial statements and supplementary data filed as part of this Report.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:85.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_139">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_139">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_145">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_145">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_151">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_151">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_154">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_154">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_157">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_157">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_160">Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_160">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_163">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_163">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_253">Supplementary Data: Quarterly Operating Results (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_253">49</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statement Schedule.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:85.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_256">Schedule II - Valuation Accounts and Reserves</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F- <a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_256">52</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Exhibits</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207918000180/dgx09302018ex31.htm">Restated Certificate of Incorporation (filed as an Exhibit to the Company's current report on Form 10-Q for the quarter ended September 30, 2018 (Date of Report: October 24, 2018)  and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000144/dgx051319ex31.htm">Amended and Restated By-Laws of the Company (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: May 17, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex10-1.htm">Form of 6.95% Senior Note due 2037 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041309005747/c59372_ex1-1.htm">Form of 5.750% Senior Note due 2040 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0101.htm">Form of 4.250% Senior Note due 2024 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0101.htm">Form of 3.500% Senior Note due 2025 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0101.htm">Form of 4.700% Senior Note due 2045 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787116001220/ss1485098_ex0101.htm">Form of 3.450% Senior Note due 2026 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0101.htm">Form of 4.200% Senior Note due 2029 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 7, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000957/ss159854_ex0101.htm">Form of 2.950% Senior Note due 2030 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: December 9, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000458/ss173511_ex0101.htm">Form of 2.800% Senior Note due 2031 (filed as an Exhibit to the Company&#8217;s current re</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000458/ss173511_ex0101.htm">port on Form 8-K (Date of Report: May 11, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-3_062801.txt">Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and the Trustee (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-4_062801.txt">First Supplemental Indenture, dated as of June 27, 2001, among the Company, the Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787101501115/ex4-1_112601.txt">Second Supplemental Indenture, dated as of November 26, 2001, among the Company, the Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 26, 2001) and incorporated herein by reference) (Commission File Number 001-12215)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787102000692/ex4-1_040902.txt">Third Supplemental Indenture, dated as of April 4, 2002, among the Company, the Additional Subsidiary Guarantors, and The Bank of New York (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: April 1, 2002) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011703001797/ex10-1.txt">Fourth Supplemental Indenture dated as of March 19, 2003, among Unilab Corporation (f/k/a Quest Diagnostics Newco Incorporated), the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2003 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011704001657/ex10-1.txt">Fifth Supplemental Indenture dated as of April 16, 2004, among Unilab Acquisition Corporation (d/b/a FNA Clinics of America), the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's quarterly report on Form 10-Q for the quarter ended March 31, 2004 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011705004157/ex4-7.htm">Sixth Supplemental Indenture dated as of October 31, 2005, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: October 31, 2005) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.17</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011705004480/ex4-1.htm">Seventh Supplemental Indenture dated as of November 21, 2005, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 21, 2005) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.18</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011706003285/ex4-1.htm">Eighth Supplemental Indenture dated as of July 31, 2006, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: July 31, 2006) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000095011706004130/ex4-1.htm">Ninth Supplemental Indenture dated as of September 30, 2006, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: September 30, 2006) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-11.htm">Tenth Supplemental Indenture dated as of June 22, 2007, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-14.htm">Eleventh Supplemental Indenture dated as of June 22, 2007, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.22</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041307005477/c49146_ex4-15.htm">Twelfth Supplemental Indenture dated as of June 25, 2007, among the Company, The Bank of New York, and the Additional Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: June 19, 2007) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.23</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041309005838/c59427_ex4-14.htm">Thirteenth Supplemental Indenture dated as of November 17, 2009, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 17, 2009) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.24</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041311002247/c64911_ex4-15.htm">Fourteenth Supplemental Indenture dated as of March 24, 2011, among the Company, The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 21, 2011) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041312000949/c68209_ex4-24.htm">Fifteenth Supplemental Indenture dated as of November 30, 2011, among the Company, The Bank of New York Mellon Trust Company, N.A., as successor trustee to The Bank of New York, and the Subsidiary Guarantors (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.26</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0417.htm">Sixteenth Supplemental Indenture dated as of March 17, 2014, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0417.htm">b</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0417.htm">etween</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787114000160/ss206544_ex0417.htm"> the Company, The Bank of New York Mellon Trust Company, N.A., (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: March 12, 2014) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.27</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0418.htm">Seventeenth Supplemental Indenture dated as of March 10, 2015, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0418.htm">between</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787115000168/ss419933_ex0418.htm"> the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 5, 2015) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787116001220/ss1485098_ex0419.htm">Eighteenth Supplemental Indenture dated as of May 26, 2016, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787116001220/ss1485098_ex0419.htm">between</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787116001220/ss1485098_ex0419.htm"> the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 23, 2016) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.29</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0402.htm">Nineteenth Supplemental Indenture dated as of March 12 2019, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0402.htm">b</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0402.htm">etween</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000202/ss128814_ex0402.htm"> the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: March 7, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000973/ss160605_ex0402.htm">Twentieth Supplemental Indenture dated as of December 16, 2019, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000973/ss160605_ex0402.htm">between</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787119000973/ss160605_ex0402.htm"> the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: December 16, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000458/ss173511_ex0402.htm">Twenty-First Supplemental Indenture dated as of May 13, 2020, between the Company and The Bank of New York Mellon (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 11, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207920000017/dgx12312019ex431.htm">Description of Securities (filed as an Exhibit to the Company&#8217;s 2019 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000118/dgx03312019ex101.htm">Amended and Restated Employee Stock Purchase Plan, as amended, effective February 18, 2019 (filed as an Exhibit to the Company's quarterly report on form 10-Q for the quarter ended March 31, 2019 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000166/dgx063019ex101.htm">Amended and Restated Quest Diagnostics Incorporated Employee Long-Term Incentive Plan as amended May 14, 2019 (filed as an Exhibit to the Company's 2019 quarterly report on Form 10-Q for the quarter ended June 30, 2019 and incorporated herein by reference) (Commission file number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207918000106/dgx033118ex101.htm">Form of Equity Award Agreement dated as of February 19, 2018 (filed as an Exhibit to the Company&#8217;s 2018 quarterly report on Form 10-Q for the quarter ended March 31, 2018 and incorporated herein by reference) (Commission file number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#8225;*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex104.htm">Quest Diagnostics Supplemental Deferred Compensation Plan (Post 2004) amended and restated as of January 15, 2020 </a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#8225;*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex105.htm">Quest Diagnostics Supplemental Deferred Compensation Plan (Pre-2005) amended and restated January 15, 2020</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000118/dgx03312019ex102.htm">Quest Diagnostics Incorporated Senior Management Incentive Plan, as amended and restated February 18, 2019 (filed as an Exhibit to the Company's 2019 quarterly report on Form 10-Q for the quarter ended March 31, 2019 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000189/dgx111919ex101.htm">Amended and Restated Quest Diagnostics Incorporated Executive Officer Severance Plan as amended November 19, 2019 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: November 19, 2019) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207916000195/dgx12312015ex1011.htm">The Profit Sharing Plan of Quest Diagnostics Incorporated (Amendment and Restatement, effective as of January 1, 2016) (filed as an Exhibit to the Company&#8217;s 2015 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207918000038/dgx123117ex109.htm">Amendment No. 1 to The Profit Sharing Plan of Quest Diagnostics Incorporated, effective as of January 1, 2018 (filed as an Exhibit to the Company's 2017 annual report on Form 10-K and incorporated herein by reference) (Commission file number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000030/dgx12312018ex1011.htm">Amendment No. 2 to The Profit Sharing Plan of Quest Diagnostics Incorporated, as amended December 20, 2018 (filed as an Exhibit to the Company's 2018 annual report on Form 10-K and incorporated herein by reference)(Commission file number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207920000017/dgx12312019ex1011.htm">Amendment No. 3 to The Profit Sharing Plan of Quest Diagnostics Incorporated effective January 1, 2020 (filed as an Exhibit to the Company&#8217;s 2019 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207920000107/dgx03312020ex101.htm">Amendment No. 4 to The Profit Sharing Plan of Quest Diagnostics Incorporated effective March 1, 2020 (filed as an Exhibit to the Company&#8217;s 2020 quarterly report on Form 10-Q for the quarter ended March 31, 2020 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207920000107/dgx03312020ex102.htm">Amendment No. 5 to The Profit Sharing Plan of Quest Diagnostics Incorporated effective January 1, 2020 (filed as an Exhibit to the Company&#8217;s 2020 quarterly report on Form 10-Q for the quarter ended March 31, 2020 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207920000185/dgx09302020ex101.htm">Amendment No. 6 to The Profit Sharing Plan of Quest Diagnostics Incorporated effective January 1, 2021 (filed as an Exhibit to the Company&#8217;s 2020 quarterly report on Form 10-Q for the quarter ended September 30, 2020 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15&#8225;*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="dgx12312020exh1015.htm">Amendment No. 7 to The Profit Sharing Plan of Quest Diagnostics Incorporated effective January 1, 2021 </a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207920000017/dgx12312019ex1012.htm">Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan For Directors as amended effective February 18, 2020 (filed as an Exhibit to the Company&#8217;s 2019 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17&#8225;*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex1017.htm">Amended and Restated Quest Diagnostics Incorporated Long-Term Incentive Plan for Non-Employee Directors, as amended and restated as of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex1017.htm">November</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex1017.htm"> 18, 2020</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041312000949/c68209_ex10-40.htm">Form of Non-Employee Director Equity Award Agreement (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207916000195/dgx12312015ex1015.htm">Form of Non-Employee Director Equity Award Agreement dated May 15, 2015 (filed as an Exhibit to the Company&#8217;s 2015 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000093041312000949/c68209_ex10-41.htm">Form of Non-Employee Director Elective Option Award Agreement (filed as an Exhibit to the Company's 2011 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787112000371/ss142217_ex1001.htm">Employment Agreement between Stephen H. Rusckowski and Quest Diagnostics Incorporated, dated April 3, 2012 (filed as an Exhibit to the Company's current report on Form 8-K (Date of Report: April 9, 2012) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207915000099/ex101061115.htm">Amendment to Employment Agreement between Stephen H. Rusckowski and Quest Diagnostics Incorporated, dated June 11, 2015 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: June 11, 2015) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207914000013/dgx12312013ex1030.htm">Aircraft Timesharing Agreement dated as of December 17, 2013 between Quest Diagnostics Incorporated and Stephen H. Rusckowski (filed as an Exhibit to the Company&#8217;s 2013 annual report on Form 10-K and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000102207919000166/dgx063019ex102.htm">Assignment and Amendment No. 1 to Aircraft Timesharing Agreement dated as of May 29, 2019 between Quest Diagnostics Incorporated and Stephen H. Rusckowski (filed as an Exhibit to the Company&#8217;s 2019 quarterly report on Form 10-Q for the quarter ended June 30, 2019 and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex211.htm">Subsidiaries of Quest Diagnostics Incorporated</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex231.htm">Consent of PricewaterhouseCoopers LLP</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_115">Power of Attorney (included on signature page)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex311.htm">Rule 13a-14(a) Certification of Chief Executive Officer</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex312.htm">Rule 13a-14(a) Certification of Chief Financial Officer</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex321.htm">Section 1350 Certification of Chief Executive Officer</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex322.htm">Section 1350 Certification of Chief Financial Officer</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9901.htm">Fourth </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9901.htm">Amended and Restated Receivables Sales Agreement, dated as of October 28, 2015, between Quest Diagnostics Incorporated and the subsidiaries identified therein, as Sellers, and Quest Diagnostics Receivables Inc., as Buyer (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9902.htm">Amendment No. 1 to Fourth Amended and Restated Receivables Sales Agreement, dated October 25, 2019 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.3&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9903.htm">Sixth Amended and Restated Credit and Security Agreement, dated as of October 27, 2017 among Quest Diagnostics Receivables Inc., Quest Diagnostics Incorporated, as Initial Servicer, MUFG Bank, LTD., as Administrative Agent, the Lenders party thereto, the financial institutions party thereto as agents for the conduit lenders (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.4&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9904.htm">Amendment No. 1 to Sixth Amended and Restated Credit and Security Agreement, dated as of October 26, 2018 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.5&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9905.htm">Amendment No. 2 to Sixth Amended and Restated Credit and Security Agreement, dated as of June 14, 2019 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.6&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9906.htm">Amendment No. 3 to Sixth Amended and Restated Credit and Security Agreement, dated as of October 25, 2019 (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.7&#8225;*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx12312020ex997.htm">Amendment No. 4 to Sixth Amended and Restated Credit and Security Agreement, dated as of October 22, 2020</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.8&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1022079/000094787120000426/ss171981_ex9907.htm">Amendment No. 1, dated as of April 30, 2020, relating to the Second Amended and Restated Credit Agreement, dated as of March 22, 2018, among Quest Diagnostics Incorporated, as Borrower, the lenders identified therein, JPMorgan Chase Bank, N.A., as Administrative Agent, and other agents party thereto and which includes, as Exhibit A, the Second Restated Credit Agreement marked to show the amended text (filed as an Exhibit to the Company&#8217;s current report on Form 8-K (Date of Report: May 4, 2020) and incorporated herein by reference) (Commission File Number 001-12215)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document  - dgx-20201231.xsd</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20201231_cal.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20201231_def.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20201231_lab.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20201231_pre.xml</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from this annual report on Form 10-K, formatted in Inline XBRL.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#8225;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or compensatory plan or arrangement required to be filed as an Exhibit to this Form 10-K pursuant to Item 15(b) of Form 10-K.</span></td></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits filed as part of this Report.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The exhibit index in (a) above is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 16. Form 10-K Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_115"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February&#160;22, 2021.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:53.459%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QUEST DIAGNOSTICS INCORPORATED</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board, Chief Executive Officer and President </span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each individual whose signature appears below constitutes and appoints Michael E. Prevoznik and William J. O'Shaughnessy, Jr., and each of them singly, his or her true and lawful attorneys-in-fact and agents with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K filed with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all the said attorneys-in-fact and agents or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February&#160;22, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:357.75pt"><tr><td style="width:1.0pt"></td><td style="width:175.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:154.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Capacity</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Stephen H. Rusckowski</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board, Chief Executive Officer and President<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Mark J. Guinan</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Michael J. Deppe</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. Deppe</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Corporate Controller and Chief Accounting Officer<br/>(Principal Accounting Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Vicky B. Gregg</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vicky B. Gregg</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Wright L. Lassiter, III</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wright L. Lassiter, III</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Timothy L. Main</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy L. Main</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Denise M. Morrison</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denise M. Morrison</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Gary M. Pfeiffer</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary M. Pfeiffer</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Timothy M. Ring</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy M. Ring</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Daniel C. Stanzione</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel C. Stanzione</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/>Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Helen I. Torley </span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/>Director</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/Gail R. Wilensky</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gail R. Wilensky</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SELECTED HISTORICAL FINANCIAL DATA OF OUR COMPANY</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes selected historical financial data of our Company and our subsidiaries at the dates and for each of the periods presented.  The selected historical financial data is only a summary and should be read together with the audited consolidated financial statements and related notes of our Company and management's discussion and analysis of financial condition and results of operations included elsewhere in this Annual Report on Form 10-K. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operations Data:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b) (c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (d) (e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (f) (g)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;(a) (h) (i)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (j) (k)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less:  Net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics' common stockholders:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - basic:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.39&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.63&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.51&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends per common share</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Data (at end of year):</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (b) (c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (d) (e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (f) (g)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;(a) (h) (i)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) (j) (k)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,026&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,843&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,003&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,503&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,966&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,748&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,728&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,784&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(411)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(801)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(830)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(127)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,267)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(401)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(738)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">On January 1, 2019, we adopted a new lease accounting standard, which required us to recognize an asset and a liability for most operating leases on our balance sheet.  As of December 31, 2019, operating lease right-of-use assets and operating lease liabilities totaled $518 million and $558 million, respectively.  Periods prior to 2019 have not been restated.  During the third quarter of 2006, we completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary, which was reported as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  During 2020, our results were materially impacted by the COVID-19 pandemic including a decline in testing volume in our base business (which excludes COVID-19 molecular and antibody testing) which was more than offset by COVID-19 molecular and antibody testing.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On January 21, 2020, we completed the acquisition of Blueprint Genetics Oy ("Blueprint Genetics").  On April 6, 2020, we completed the acquisition of select assets which constitute substantially all of the operations of Memorial Hermann Diagnostics Laboratories, the outreach laboratory division of Memorial Hermann Health System ("Memorial Hermann").  On August 1, 2020, we completed the acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC ("MACL") from our joint venture partners.  Consolidated operating results for 2020 included the results of operations of Blueprint Genetics, Memorial Hermann and MACL subsequent to the closing of these acquisitions.  Prior to the acquisition, we accounted for our 44% interest in MACL as an equity method investment.  For further details regarding our acquisitions, see Note 6 to the audited consolidated financial statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During January 2020, we redeemed in full the outstanding indebtedness under our senior notes due January 2020 and  senior notes due March 2020 using the net proceeds from the issuance, in December 2019, of the 2.95% senior notes due June 2030, along with cash on hand.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">During May 2020, we completed a senior notes offering, consisting of $550 million aggregate principal amount of 2.80% senior notes due June 2031 (the "2031 Senior Notes").  During November 2020, the net proceeds from the 2031 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under our senior notes due April 2021. </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Operating income included (for 2020): </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $103 million;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $76 million, representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19, incremental costs incurred primarily to protect the health and safety of our employees and customers, and certain asset impairment charges; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $58 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $2&#160;million, associated with Quest for Health Equity (our recently announced initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities).</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the items included in operating income, income from continuing operations included:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain of $70 million recognized upon the acquisition of the remaining 56% interest in MACL as a result of the remeasurement of our previously held equity interest to fair value;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax amortization expense of $11&#160;million included in equity in earnings of equity method investees, net of taxes;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">a net pre-tax gain of $4&#160;million principally related to a gain recognized by an equity method investee to adjust certain of its investments to fair value, partially offset by a loss on the retirement of debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;padding-left:14.68pt">a pre-tax gain of $4 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in equity in earnings of equity method investees, net of taxes, representing the impact of certain items resulting from the COVID-19 pandemic; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $23 million.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities included $40&#160;million of proceeds received from the termination of interest rate swap agreements.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On February 11, 2019, we completed the acquisition of certain assets of the clinical laboratory services business of Boyce &amp; Bynum Pathology Laboratories, P.C. ("Boyce &amp; Bynum"). Consolidated operating results for 2019 included the results of operations of Boyce &amp; Bynum subsequent to the closing of the acquisition. For further details regarding our acquisitions, see Note 6 to the audited consolidated financial statements.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, we completed a senior notes offering, consisting of $800 million aggregate principal amount of 2.95% senior notes due June 2030.  </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Operating income included (for 2019):</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $96 million;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $78 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $89 million, primarily due to a gain associated with the sale and leaseback of a property, a gain associated with the decrease in the fair value of the contingent consideration accruals associated with previous acquisitions, and a gain associated with proceeds from an insurance claim for hurricane related losses, partially offset by costs incurred related to a data security incident and non-cash asset impairment charges.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the items included in operating income, income from continuing operations included:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $15 million included in equity in earnings of equity method investees, net of taxes; and </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $13 million.</span></div><div style="padding-left:54pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">On February 1, 2018, we completed the acquisition of Mobile Medical Examination Services, LLC. ("MedXM").  On June 18, 2018, we completed the acquisition of the outreach laboratory services business of Cape Cod Healthcare, Inc.  On September 19, 2018, we completed the acquisition of ReproSource, Inc. ("ReproSource").  On November 6, 2018, we completed the acquisition of the U.S. laboratory services business of Oxford Immunotec, Inc. ("Oxford").  Consolidated operating results for 2018 include the results of operations of MedXM, the outreach laboratory services business of Cape Cod Healthcare, Inc., ReproSource and Oxford subsequent to the closing of the applicable acquisition.  For further details regarding our acquisitions, see Note 6 to the audited consolidated financial statements.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Operating income included (for 2018): </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $122 million, primarily associated with workforce reductions, systems conversions and integration incurred in connection with further restructuring and integrating our business;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $90 million; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $2 million, primarily associated with costs incurred related to certain legal matters and a loss on the sale of a foreign subsidiary, partially offset by a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition and proceeds from an insurance claim for hurricane related losses.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the items included in operating income, income from continuing operations included:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $17 million included in equity in earnings of equity method investees, net of taxes;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $18 million; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an income tax benefit of $14 million primarily associated with a change in a tax return accounting method that enabled us to accelerate the deduction of certain expenses on our 2017 tax return at the federal corporate statutory income tax rate in effect during 2017, partially offset by an income tax expense associated with finalizing the impact of the enactment of the Tax Cuts and Jobs Act ("TCJA").</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the TCJA, among other changes to U.S. corporate income tax laws, the federal corporate statutory income tax rate was reduced from 35% to 21% effective for 2018.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On May 1, 2017, we completed the acquisition of the outreach laboratory services business of PeaceHealth Laboratories ("PHL"). On July 14, 2017, we completed the acquisition of Med Fusion, LLC and Clearpoint Diagnostic Laboratories, LLC ("Med Fusion"). On September 28, 2017, we completed the acquisition of the outreach laboratory services businesses of two hospitals of Hartford HealthCare Corporation ("HHC"), The William W. Backus Hospital and The Hospital of Central Connecticut.  On December 1, 2017, we completed the acquisition of Cleveland HeartLab, Inc. ("CHL").  On December 7, 2017, we completed the acquisition of certain assets of the clinical and anatomic pathology laboratory business of Shiel Holdings, LLC ("Shiel"). Consolidated operating results for 2017 include the results of operations of PHL, Med Fusion, the outreach laboratory services businesses of The William W. Backus Hospital and The Hospital of Central Connecticut, CHL and Shiel subsequent to the closing of the applicable acquisition.  For further details regarding our acquisitions, see Note 5 to the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2017.  </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Operating income included (for 2017):</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $105 million, primarily associated with systems conversions, integration and workforce reductions incurred in connection with further restructuring and integrating our business;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $74 million; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $12 million, primarily a result of non-cash asset impairment charges, incremental costs incurred as a result of hurricanes and costs incurred related to certain legal matters.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the items included in operating income, income from continuing operations included:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $16 million included in equity in earnings of equity method investees, net of taxes;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $2 million, primarily a result of a gain on the sale of an interest in an equity method investment, partially offset by non-cash asset impairment charges associated with an investment; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$1 million of pre-tax restructuring and integration charges associated with our Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions joint venture; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a provisional estimated income tax benefit of $106 million associated with the TCJA, including a deferred income tax benefit of $115 million primarily due to the remeasurement of our net deferred tax liabilities and reserves at the new combined federal and state statutory income tax rate, partially offset by $9 million of current income tax expense primarily due to the mandatory repatriation toll charge on undistributed foreign earnings and profits; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $37 million; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">income tax expense of $3 million primarily a result of recording a valuation allowance against certain net operating loss carryforwards in a geography impacted by hurricanes.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities benefited from a decrease in tax payments associated with the realization of a $62 million deferred tax benefit.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">On February 29, 2016, we completed the acquisition of the outreach laboratory services business of Clinical Laboratory Partners, LLC ("CLP"), a wholly-owned subsidiary of&#160;HHC.  Consolidated operating results for 2016 include the results of operations of CLP subsequent to the closing of the acquisition.  For further details regarding acquisitions, see Note 5 to the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016.  On May 13, 2016, we completed the sale of our Focus Diagnostics products business ("Focus Sale").  Our Focus Diagnostics products business was not classified as a discontinued operation.  For further details regarding dispositions, see Note 6 to the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2016.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Operating income included (for 2016):</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain of $118 million associated with the Focus Sale;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $72 million;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $78 million, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $7 million, primarily a result of a non-taxable gain on an escrow recovery associated with an acquisition, partially offset by costs associated with winding down subsidiaries, non-cash asset impairment charges and costs incurred related to certain legal matters.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the items included in operating income, income from continuing operations included:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $16 million included in equity in earnings of equity method investees, net of taxes;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">income tax expense of $84 million associated with the Focus Sale, consisting of $91 million of current income tax expense and a deferred income tax benefit of $7 million;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$48 million of pre-tax charges on the retirement of debt and the related income tax benefit of $18 million;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">non-cash pre-tax asset impairment charges of $7 million associated with certain investments; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$4 million of pre-tax restructuring and integration charges associated with our Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions joint venture; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $9 million.</span></div><div style="padding-left:54pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities included:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $17 million cash tax benefit on the retirement of debt;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$54 million of proceeds received from the termination of interest rate swap agreements; and </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$91 million of income taxes paid in connection with the Focus Sale.</span></div><div style="padding-left:54pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities included proceeds from the sale of businesses of $295 million, principally related to the Focus Sale.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities included $43 million of pre-tax cash charges on the retirement of debt, principally comprised of premiums paid to retire the debt.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Information Services</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics empowers people to take action to improve health outcomes.  We use our extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  Our diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We provide services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  We offer the broadest access in the United States to diagnostic information services through our nationwide network of laboratories, patient service centers and phlebotomists in physician offices and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  We are the world's leading provider of diagnostic information services.  We provide interpretive consultation with one of the largest medical and scientific staffs in the industry.  Our DIS business makes up greater than 95% of our consolidated net revenues.  During 2020, we processed approximately 187 million test requisitions through our extensive laboratory network. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The clinical testing that we perform is an essential element in the delivery of healthcare services.  Clinicians use clinical testing for predisposition, screening, monitoring, diagnosis, prognosis and treatment choices of diseases and other medical conditions.  The United States clinical testing industry consists of two segments.  One segment, which we believe makes up approximately 36% of the total industry, includes hospital inpatient and outpatient testing.  The second segment, which we believe makes up approximately 64% of the total industry, includes testing of persons who are not hospital patients, including testing done in commercial clinical laboratories, physician-office laboratories and other locations, as well as hospital outreach (non-hospital patients) testing.  We believe that hospital-affiliated laboratories account for approximately 36% of the second segment, commercial clinical laboratories approximately 53% and physician-office laboratories and other locations account for the balance.  Our estimates of the clinical laboratories industry do not include the impact of COVID-19 testing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The clinical testing industry is subject to seasonal fluctuations in operating results and cash flows.  Typically, testing volume declines during vacation and major holiday periods, reducing net revenues and operating cash flows below annual averages.  Testing volume is also subject to declines due to severe weather or other events (such as public health emergencies and health pandemics), which can deter patients from having testing performed and which can vary in duration and severity from year to year.  Additionally, orders for clinical testing generated from clinician offices, hospitals and employers can be affected by factors such as changes in the United States economy and regulatory environment, which affect the number of unemployed and uninsured, and design changes in healthcare plans, which affect utilization as well as patient responsibility for healthcare costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our revenue performance for the DIS business based upon, among other factors, volume (measured by test requisitions) and revenue per requisition.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each requisition accompanies patient specimens, indicating the test(s) to be performed and the party to be billed for the test(s). </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue per requisition is impacted by various factors, including, among other items, the impact of fee schedule changes (i.e. unit price), test mix, payer mix, and the number of tests per requisition.  Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix. Therefore, we believe that information related to changes in these metrics from period to period are useful information for investors as it allows them to assess the performance of the business.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A summary of our revenue performance over the past three years is as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.467%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,437</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,726</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,531</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,139</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,405</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,204</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per requisition change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16.2%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.6%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.5%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact that the COVID-19 pandemic had on our DIS revenues, including requisition volume and revenue per requisition are discussed further below under "2020 Highlights" and "Impact of COVID-19".</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Diagnostic Solutions ("DS") businesses, which represent the balance of our consolidated net revenues, we offer a variety of solutions for life insurers and healthcare organizations and clinicians.  We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2020 Highlights</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our total net revenues of $9.4 billion were up 22.1% from the prior year.   </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In DIS: </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Revenues of $9.1 billion increased by 23.4% compared to the prior year, driven by demand for COVID-19 molecular and antibody testing, and, to a lesser extent, the impact of recent acquisitions, partially offset by a decline in testing volume in our base business (which excludes COVID-19 molecular and antibody testing).</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Volume, measured by the number of requisitions, increased by 6.6% compared to the prior year, with organic growth (which excludes the impact of recent acquisitions) and acquisitions contributing approximately 4.5% and 2.1%, respectively.  Organic volume growth was driven by demand for COVID-19 molecular testing, partially offset by declines in testing volume in the base business. Testing volume in the base business were negatively impacted by the COVID-19 pandemic and declined by 11.4% compared to the prior year.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Revenue per requisition increased by 16.2% compared to the prior year driven, in large part, by COVID-19 molecular testing.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DS revenues of $298 million decreased by 7.0% compared to the prior year and were negatively impacted by the COVID-19 pandemic.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income from continuing operations attributable to Quest Diagnostics' stockholders was $1,431 million, or $10.47 per diluted share, in 2020, compared to $838 million, or $6.13 per diluted share, in 2019.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities was approximately $2.0 billion in 2020, compared to $1.2 billion in 2019.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID - 19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a novel strain of coronavirus (COVID-19) continues to spread and severely impact the economy of the United States and other countries around the world, we are committed to being a part of the coordinated public and private sector response to this unprecedented challenge. We have made substantial investments to expand the amount of COVID-19 testing available to the country and are currently capable of performing approximately 225,000 COVID-19 molecular diagnostic tests per day to aid in the diagnosis of COVID-19 and approximately 200,000 COVID-19 antibody tests per day to aid in the detection of immune response. We have been effectively managing challenges in the global supply chain; and, at this point, we have sufficient supplies to conduct our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2020, our testing volume and revenues were materially impacted by the COVID-19 pandemic including a decline in testing volume in our base business (which excludes COVID-19 molecular and antibody testing) which was more than offset by COVID-19 molecular and antibody testing.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During January and February 2020, we experienced growth in DIS revenues and volume compared to the prior year period. However, in March and April 2020, we experienced a material decline in testing volume due to the COVID-19 pandemic.  During May and June 2020, we began to experience a recovery in base testing volume, which continued in the second half of 2020. Volume in our base business (which includes the impact of recent acquisitions) for the second, third and fourth quarters of 2020 decreased approximately 34%, 5% and 2%, respectively, compared to the prior year periods.  However, at the end of November and into December 2020, the trend of recovery in our base business volume was impacted somewhat due to the increase in COVID-19 infections across the country.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in base testing volume was driven by federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19, a significant reduction in physician office visits, the cancellation of elective medical procedures, customers closing or severely curtailing their operations (voluntarily or in response to government orders), and the adoption of work-from-home policies, all of which have had, and we believe will continue to have, an impact on our operating results, financial position and cash flows, including base testing volume. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning during the second quarter of 2020, we experienced growing demand for COVID-19 testing services, which partially offset the decrease in base testing volume during that period.  During the second half of 2020, as we have expanded our capacity in order to satisfy such demand, the impact of COVID-19 testing more than offset the decrease in base testing volume.  Additionally, the impact of COVID-19 molecular testing drove an increase in revenue per requisition compared to the prior year. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020 the Centers for Medicare and Medicaid Services ("CMS") announced that it would increase the reimbursement for certain COVID-19 molecular tests making use of high-throughput technologies developed by the private sector that allow for increased testing capacity, faster results, and more effective means of combating the spread of the virus to $100 per test, effective April 14, 2020. Beginning January 1, 2021, Medicare changed the base reimbursement rate for COVID-19 diagnostic tests run on high-throughput technologies to $75 per test with an additional payment of $25 per test if the laboratory (1) completes the test in two calendar days or less and (2) completes the majority of its COVID-19 tests that use high throughput technology in two calendar days or less for all of its patients in the previous month.  Certain healthcare insurers have now moved to a similar reimbursement model for COVID-19 molecular tests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the COVID-19 pandemic&#8217;s impact on our consolidated results of operations, financial position and cash flows will be primarily driven by: the severity and duration of the COVID-19 pandemic; healthcare insurer, government, and client payer reimbursement rates for COVID-19 molecular testing; the COVID-19 pandemic&#8217;s impact on the U.S. healthcare system and the U.S. economy; and the timing, scope and effectiveness of federal, state and local governmental responses to the COVID-19 pandemic. We may also be impacted by changes in the severity of the COVID-19 pandemic at different times in the various cities and regions where we operate and offer services. Even after the COVID-19 pandemic has moderated and the business and social distancing restrictions have eased, we may continue to experience similar effects to our businesses, consolidated results of operations, financial position and cash flows resulting from a recessionary economic environment that may persist. In the longer term, given the many challenges that hospitals will face, we may have more opportunities to partner with hospitals to help achieve their laboratory strategies, and the COVID-19 pandemic may also be a further catalyst for consolidation in the laboratory testing industry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act (CARES Act)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, in response to the COVID-19 pandemic, the CARES Act was signed into law. The CARES Act provides numerous tax provisions and other stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social Security taxes, technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property, and the creation of certain payroll tax credits associated with the retention of employees. Beginning in the second quarter of 2020, we started taking advantage of the temporary suspension of payment requirements for the employer portion of Social Security taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also includes a number of benefits that are applicable to us and other healthcare providers including, but not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing coverage for COVID-19 testing at no out-of-pocket cost to nearly all patients;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing clinical laboratories a one-year reprieve from the reporting requirements under the Protecting Access to Medicare Act ("PAMA") as well as a one-year delay of reimbursement rate reductions for clinical laboratory services provided under Medicare that were scheduled to take place in 2021. Further revisions of the Medicare Clinical </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Fee Schedule for years after 2022 will be based on future surveys of market rates. Reimbursement reduction from 2022-2024 is capped by PAMA at 15% annually;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriating $100 billion to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic. In April 2020 and August 2020, we received approximately $65 million and $73 million, respectively, of funds that were distributed to healthcare providers for related expenses or lost revenues that are attributable to the COVID-19 pandemic under the CARES Act.  During the fourth quarter of 2020, we returned the entire $138 million of funds; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspending Medicare sequestration from May 2020 to December 2020. In December 2020, the suspension of the Medicare sequestration, which has resulted in a small benefit to us in the form of higher reimbursement rates for diagnostic testing services performed on behalf of Medicare beneficiaries, was extended through March 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes Offerings and Retirement of Debt</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During January 2020, we redeemed in full the outstanding indebtedness under our senior notes due January 2020 and senior notes due March 2020 using the net proceeds from the issuance, in December 2019, of $800&#160;million aggregate principal amount of 2.95% senior notes due June 2030 (the "2030 Senior Notes"), along with cash on hand.  For the year ended December&#160;31, 2020, we recorded a loss on retirement of debt in connection with the transaction, principally comprised of premiums paid, of $1&#160;million in other income (expense), net.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During May 2020, we completed a senior notes offering, consisting of $550&#160;million aggregate principal amount of 2.80% senior notes due June 2031 (the &#8220;2031 Senior Notes&#8221;), which were issued at an original issue discount of $1&#160;million.  During November 2020, the net proceeds from the 2031 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under our senior notes due April 2021.  For the year ended December&#160;31, 2020, we recorded a loss on retirement of debt in connection with the transaction, principally comprised of premiums paid, of $8&#160;million in other income (expense), net.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details regarding our debt, see Note 13 to the audited consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Two Point Strategy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our two point strategy is described in detail in "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business: Our Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">."  We continued to execute our strategy during 2020 as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Acquisition of Blueprint Genetics Oy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 21, 2020, we completed the acquisition of Blueprint Genetics Oy ("Blueprint Genetics"), in an all cash transaction for $108 million, net of $3 million cash acquired. Blueprint Genetics is a leading specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing and proprietary bioinformatics. Through the acquisition, we acquired all of Blueprint Genetics' operations. The acquired business is included in our DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Acquisition of the Outreach Laboratory Services Business of Memorial Hermann Health System</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, we completed the acquisition of select assets which constitute substantially all of the operations of Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System ("Memorial Hermann") in an all cash transaction for $120 million. Memorial Hermann is a not-for-profit health system in Southeast Texas. The acquired business is included in our DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Acquisition of the Remaining 56% Interest in Mid America Clinical Laboratories, LLC</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2020, we completed the acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC ("MACL") from our joint venture partners in an all cash transaction for $93 million, net of $18 million cash acquired. MACL is the largest independent clinical laboratory provider in Indiana. Prior to the acquisition, we accounted for our 44% interest in MACL as an equity method investment, which was remeasured to its fair value of $87 million on the acquisition date, resulting in a gain of $70&#160;million that was recognized in other income (expense), net in the consolidated statements of operations. As a result of the acquisition, MACL became our wholly owned subsidiary. The acquired business is included in our DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details regarding our acquisitions, see Note 6 to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Invigorate Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are engaged in a multi-year program called Invigorate, which is designed to reduce our cost structure and improve our performance.  We currently aim annually to save approximately 3% of our costs, and in 2020 we achieved that goal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invigorate has consisted of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, we have identified key themes to change how we operate including reducing denials and patient price concessions; further digitizing our business; standardization and automation; and optimization initiatives in our lab network and patient service center network.  We believe that our efforts to standardize our information technology systems, equipment and data also foster our efforts to strengthen our foundation for growth and support the value creation initiatives of our clinical franchises by enhancing our operational flexibility, empowering and enhancing the customer experience, facilitating the delivery of actionable insights and bolstering our large data platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, we incurred $42&#160;million of pre-tax charges under our Invigorate program primarily consisting of systems conversion and integration costs, all of which result in cash expenditures. Additional restructuring charges may be incurred in future periods as we identify additional opportunities to achieve further cost savings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details of the Invigorate program and associated costs, see Note 5 to the audited consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outlook and Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The healthcare system in the United States is evolving; significant change is taking place in the system.   We expect that the evolution of the healthcare industry, including impacts of the COVID-19 pandemic, such as increased adoption of telemedicine, will continue, and that industry change is likely to be extensive.  There are a number of key trends that are having, and that we expect will continue to have, a significant impact on the diagnostic information services business in the United States and on our business.  We believe that several of the trends, including consolidation, price transparency and consumerization, are favorable to our business.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Healthcare market participants, including governments, are focusing on controlling costs, including potentially by reducing reimbursement for healthcare services, changing reimbursement for healthcare services (including but not limited to a shift from fee-for-service to capitation), changing medical coverage policies (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., healthcare benefits design), denying coverage for services, requiring preauthorization of laboratory testing, requiring co-pays, introducing laboratory spend management utilities and payment and patient care innovations such as ACOs, DCEs and patient-centered medical homes.  The ongoing trend of rising patient responsibility and increasing payer denials has resulted in an increase in our reserves for patient price concessions.  As health plans and government programs require greater levels of patient cost-sharing, our patient price concessions may continue to be negatively impacted and adversely impact our results of operations.  As previously mentioned, there could be a shift to capitation arrangements where we agree to a predetermined monthly reimbursement rate for each member enrolled in a restricted plan, generally regardless of the number or cost of services provided by us.  In both 2020 and 2019, we derived approximately 3% of our consolidated net revenues from capitated payment arrangements.  In 2020 and 2019, we derived approximately 8% and 10%, respectively, of our testing volume from capitated payment arrangements.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Medicare Clinical Laboratory Fee Schedule ("CLFS") and the Medicare Physician Fee Schedule established under Part B of the Medicare program have been subject to change, including each year.  Pursuant to PAMA, the Centers for Medicare and Medicaid Services ("CMS") promulgated revised reimbursement schedules for 2018-2020 for clinical laboratory testing services provided under Medicare. Under the revised Medicare Clinical Laboratory Fee Schedule (in 2020 CLFS revenues comprised 8% of our consolidated net revenues), reimbursement rates for clinical laboratory testing were </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reduced in 2018, 2019 and 2020.   PAMA calls for further revision of the CLFS for years after 2020, based on future surveys of market rates; reimbursement reduction from 2022-24 is capped by PAMA at 15%.  In late 2019, the Laboratory Access for Beneficiaries Act (the &#8220;LAB Act&#8221;) was signed into law.  The LAB Act delayed PAMA's next data collection and reporting period until January 1, 2021 and ordered a study to determine ways to improve future collection of more representative market rate data under PAMA.  In 2020, the CARES Act provided clinical laboratories with a one-year reprieve from the reporting requirements under PAMA as well as a one-year delay of reimbursement rate reductions that were scheduled to take place in 2021.  Overall, we expect total reimbursement rate pressure for 2021 from all payers on a combined basis to be approximately 1%.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the trend of consolidating, converging and diversifying among our customers, payers and other healthcare industry participants has continued and may result in increased price transparency and bargaining power, and may encourage internalization of clinical testing.  We also believe that PAMA may be a further catalyst for consolidation as diagnostic information services providers realize lower Medicare reimbursement rates and large diagnostic information services providers may be able to increase their share of the overall diagnostic information services industry due to their large networks and lower cost structures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For a discussion of the impact of the COVID-19 pandemic on our business, see "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19" </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our key trends, which present both opportunities and risks, see "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 1. Business: The Clinical Testing Industry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">." </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions and select accounting policies that affect our reported financial results and the disclosure of contingent assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our revenues are primarily comprised of a high volume of relatively low-dollar transactions, and about one-half of our total costs and expenses consist of employee compensation and benefits.  Due to the nature of our business, several of our accounting policies involve significant estimates and judgments: </span></div><div><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">revenues and accounts receivable associated with DIS; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reserves for general and professional liability claims; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reserves for other legal proceedings; and</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accounting for and recoverability of goodwill.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Revenues and accounts receivable associated with DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The process for estimating revenues and the ultimate collection of receivables associated with our DIS business involves significant assumptions and judgments.  We recognize as revenue the amount of consideration to which we expect to be entitled primarily upon completion of the testing process (when results are reported) or when services have been rendered.  We estimate the amount of consideration we expect to be entitled to receive from customer groups in exchange for providing services using the portfolio approach.  These estimates include the impact of contractual allowances (including payer denials), and patient price concessions, as discussed below.  The portfolios determined using the portfolio approach consist of the following customers:  </span></div><div><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Healthcare Insurers</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Government Payers</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Client Payers</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have a standardized approach to estimate the amount of consideration that we expect to be entitled to, including the impact of contractual allowances (including payer denials), and patient price concessions.  Historical collection and payer reimbursement experience (along with the period the receivables have been outstanding) is an integral part of the estimation process related to revenues and receivables.  Adjustments to our estimated contractual allowances and implicit patient price concessions are recorded in the current period as changes in estimates. Further adjustments to the allowances, based on actual receipts, may be recorded upon settlement.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We regularly assess the state of our billing operations in order to identify issues which may impact the collectability of receivables or revenue estimates. We believe that the collectability of our receivables is directly linked to the quality of our billing processes, most notably those related to obtaining the correct information in order to bill effectively for the services we provide. As such, we continue to implement &#8220;best practices&#8221; and endeavor to increase the use of electronic ordering to reduce the number of requisitions that we receive from healthcare providers with missing or incorrect billing information. We believe that our collection and revenue estimation processes, along with our close monitoring of our billing operations, help to reduce the risk associated with material adjustments to reserve estimates.  However, changes to our estimate of the impact of contractual allowances (including payer denials) and patient price concessions could have a material impact on our results of operations and financial condition in the period that the estimates are adjusted.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table shows the approximate percentage of our total requisition volume and net revenues associated with our DIS business during 2020 applicable to each customer group: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.982%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Volume</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenues</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients *</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97%</span></td></tr></table></div><div style="padding-left:9pt;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Patients revenue includes coinsurance and deductible responsibilities but volume associated with such revenue is reported under Healthcare insurers.</span></div><div style="padding-left:9pt;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table shows net accounts receivable as of December&#160;31, 2020 applicable to each customer group:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:83.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Accounts</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Receivable</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Healthcare insurers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from healthcare insurers are based on fee-for-service schedules and on capitated payment rates.  Under fee-for-service arrangements, healthcare insurers are billed at our list price.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration we expect to receive from such payers, which considers historical denial and collection experience and the terms of our contractual arrangements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Substantially all of the accounts receivable due from healthcare insurers represent amounts billed under fee-for-service arrangements.  Collection of our net revenues from healthcare insurers is normally a function of providing complete and correct billing information to the healthcare insurers within the various filing deadlines and generally occurs within 30 to 60 days of billing.  Provided we have billed healthcare insurers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, we determine if the amounts in question will likely go past the filing deadline, and if so, we will reserve accordingly for the billing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under capitated arrangements with healthcare insurers, we recognize revenue based on a predetermined monthly reimbursement rate for each member of an insurer's health plan regardless of the number or cost of services provided by us.  Under capitated payment arrangements, the healthcare insurers typically reimburse us in the same month services are performed, essentially giving rise to no outstanding accounts receivable at the end of a reporting period.  If any capitated </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments are not received on a timely basis, we determine the cause and make a separate determination as to whether or not the collection of the amount from the healthcare insurer is at risk and, if so, would reserve accordingly.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Government payers</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from government payers are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration we expect to receive from such payers, which considers historical denial and collection experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of our net revenues from government payers is normally a function of providing the complete and correct billing information within the various filing deadlines.  Collection generally occurs within 30 days of billing.  Provided we have billed government payers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, we determine if the amounts in question will likely go past the filing deadline, and, if so, we will reserve for the billing accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Client payers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Client payers include physicians, hospitals, ACOs, DCEs, IDNs, employers, other commercial laboratories and institutions for which services are performed on a wholesale basis, and are billed based on a negotiated fee schedule.  Credit risk and ability to pay are more of a consideration for these payers than healthcare insurers and government payers.  Collection of consideration we expect to receive generally occurs within 60 to 90 days of billing.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We principally estimate the allowance for credit losses for client payers based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding. To the extent that any individual client payers are identified that have deteriorated in credit quality, we establish allowances based on the individual risk characteristics of such customers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Patients</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients.  Insured patients (includes coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers.  Collection of billings from patients is subject to credit risk and ability of the patients to pay.  Net revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with our policies and implicit price concessions.  Implicit price concessions represent differences between amounts billed and the estimated consideration we expect to receive from patients, which considers historical collection experience (along with the period the receivables have been outstanding) and other factors including current market conditions.  Patient billings are generally fully reserved for when the related billing reaches 210 days outstanding.  Balances are automatically written off when they are sent to collection agencies.  Allowances are further adjusted for estimated recoveries of amounts sent to collection agencies based on historical collection experience, which is regularly monitored.  Collection of consideration we expect to receive generally occurs within 30 to 60 days of billing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Although we believe that our estimates for contractual allowances and patient price concessions, as well as our allowance for credit losses, are appropriate, it is possible that we will experience an impact on cash collections as a result of the impact of the COVID-19 pandemic.  For further details on revenue and receivables, see Note 3 to the audited consolidated financial statements.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Reserves for general and professional liability claims</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a general matter, providers of diagnostic information services may be subject to lawsuits alleging negligence or other similar claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on our client base and reputation.  We maintain various liability insurance coverages for claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  Our insurance coverage limits our maximum exposure on individual claims; however, we are essentially self-insured for a significant portion of these claims.  While the basis for claims reserves is actuarially determined losses based upon our historical and projected loss experience, the process of analyzing, assessing and establishing reserve estimates relative to these types of claims involves a high degree of judgment.  Although we believe that our present reserves and insurance coverage are sufficient to cover currently estimated exposures, it is possible that we may incur liabilities in excess of our recorded reserves or insurance coverage.  Changes in the facts and circumstances associated with claims could have a material </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact on our results of operations (principally costs of services), cash flows and financial condition in the period that reserve estimates are adjusted or paid.  See Note 18 to the audited consolidated financial statements for a discussion of our reserves for general and professional liability claims. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Reserves for other legal proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our businesses are subject to or impacted by extensive and frequently changing laws and regulations, including inspections and audits by governmental agencies, in the United States (at both the federal and state levels) and the other jurisdictions in which we conduct business.  Although we believe that we are in compliance, in all material respects, with applicable laws and regulations, there can be no assurance that a regulatory agency would not reach a different conclusion.  Any noncompliance by us with applicable laws and regulations could have a material adverse effect on our results of operations.  In addition, these laws and regulations may be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that could require us to make changes in our operations, including our pricing and/or billing practices.  We have, in the past, entered into several settlement agreements with various government and private payers relating to industry-wide billing and marketing practices that had been substantially discontinued.  The federal or state governments may bring claims based on our current practices, which we believe are lawful.  In addition, certain federal and state statutes, including the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of federal and state false claims acts, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers alleging inappropriate billing practices.  We are aware of certain pending lawsuits including class action lawsuits, and have received subpoenas related to billing practices.  See Note 18 to the audited consolidated financial statements for a discussion of the various legal proceedings that we are involved in. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The process of analyzing, assessing and establishing reserve estimates relative to legal proceedings involves a high degree of judgment.  Management has established reserves for legal proceedings in accordance with generally accepted accounting principles.  Changes in facts and circumstances related to such proceedings could lead to significant adjustments to reserve estimates for such matters and could have a material impact on our results of operations, cash flows and financial condition in the period that reserve estimates are adjusted or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Accounting for and recoverability of goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not amortize goodwill, but evaluate the recoverability and measure the potential impairment of our goodwill annually, or more frequently, in the case of other events that indicate a potential impairment.  We have identified the following reporting units for goodwill impairment testing in 2020:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS business;</span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk assessment services business, which is part of our DS businesses</span></div><div style="padding-left:63pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The DIS reporting unit components have been aggregated into a single reporting unit because they have similar economic characteristics, including similarities in financial performance, nature of products or services, nature of production processes and types of customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On a quarterly basis, we perform a review of our business to determine if events or changes in circumstances have occurred which could have a material adverse effect on our fair value and our goodwill.  If such events or changes in circumstances were deemed to have occurred, we would perform an impairment test of goodwill and record any noted impairment loss.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative analysis may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  In evaluating whether it is more likely than not that the fair value of a reporting unit is less than its carrying value, we assess relevant events and circumstances, such as: (a) macroeconomic conditions; (b) industry and market considerations; (c) cost factors; (d) overall financial performance; (e) other relevant entity-specific events; (f) events affecting a reporting unit; and (g) a sustained decrease in share price.  If, after assessing the totality of events or circumstances, we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then we are required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, our policy is to update the fair value calculation of our reporting units and perform the quantitative goodwill impairment test on a periodic basis.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  If the carrying value is greater than our estimate of fair value, an impairment loss will be recognized in the amount of the excess.   We calculate the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amounts into a single discounted present value amount or (ii) a market approach.  We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation.  The discounted cash flows analysis includes several unobservable inputs related to our own assumptions.  The assumptions and estimates used in the discounted cash flows model are based upon the best available information in the circumstances and include a forecast of expected future cash flows, long-term growth rates, discount rates that are commensurate with economic risks, assumed income tax rates and estimates of capital expenditures and working capital.  The fair values of the reporting units could be different if, for example, forecasted revenue growth rates, economic conditions, government regulations or actions by payers to control utilization of or reimbursement for healthcare services, turn out to be different than our assumptions or estimates.  Changes in the assumed discount rates due to changes in interest rates could also affect the estimated fair values of the reporting units.  We use a discount rate that considers a weighted average cost of capital plus an appropriate risk premium based upon the reporting unit being valued.  Our analysis also considers publicly available information regarding our market capitalization, as well as (i) the financial projections and future prospects of our business, including its growth opportunities and likely operational improvements, and (ii) comparable sales prices, if available.  We believe our estimation methods are reasonable and reflect common valuation practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We perform our annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2020, in accordance with our policy to perform the quantitative test on a periodic basis, we updated the fair value calculation of  our reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.  As a sensitivity, if the estimated fair values of each of our reporting units decreased by 10%, we would have concluded that our goodwill was not impaired.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For the discussions on the year-over-year changes for the year ended December 31, 2019 compared to December 31, 2018 and the results of operations for the year ended December 31, 2018, see Item 7 - Management's Discussion and Analysis of Financial Condition and Result of Operations of our Annual Report on Form 10-K for the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our DIS business currently represents our one reportable business segment.  The DIS business for the years ended December&#160;31, 2020 and 2019 accounted for greater than 95% of our consolidated net revenues.  Our other operating segments consist of our DS businesses.  For further details regarding our business segment information, see Note 19 to the audited consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table sets forth certain results of operations data for the periods presented:&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:57.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,804&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,466&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,495&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:57.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics' common stockholders</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share from continuing operations attributable to Quest Diagnostics&#8217; common stockholders</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NM - Not Meaningful</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table sets forth certain results of operations data as a percentage of net revenues for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:78.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Operating Results</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the year ended December&#160;31, 2020 were affected by certain items that on a net basis decreased diluted earnings per share from continuing operations by $0.71 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $114 million ($103 million in amortization of intangible assets and $11 million in equity in earnings of equity method investees, net of taxes) or $0.63 per diluted share; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">net pre-tax charges of $72 million ($57 million of charges in cost of services, $10 million of charges in selling, general and administrative expenses and $9 million of charges in other operating expense (income), net, partially offset by a $4 million gain in equity in earnings of equity method investees, net of taxes), or $0.39 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19, incremental costs incurred primarily to protect the health and safety of our employees and customers, and certain asset impairment charges; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $58 million ($27 million in cost of services and $31 million in selling, general and administrative expenses), or $0.32 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax gain of $70 million, or $0.46 per diluted share, recognized in other income (expense), net upon the acquisition of the remaining 56% interest in MACL as a result of the remeasurement of our previously held equity interest to fair value; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $23 million, or $0.17 per diluted share, recorded in income tax expense; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $2 million (a $14 million gain in equity in earnings of equity method investees, net of taxes, partially offset by a $10 million loss in other income (expense), net and $2 million of charges in selling, general and administrative expenses) primarily due to a gain recognized by an equity method investee to adjust certain of its investments to fair value, a loss on retirement of debt, and, to a lesser extent, costs associated with Quest for Health Equity, our recently announced initiative with the Quest Diagnostics Foundation to reduce health disparities in underserved communities.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the year ended December&#160;31, 2019 were affected by certain items that on a net basis reduced diluted earnings per share from continuing operations by $0.43 as follows:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $111 million ($96 million in amortization of intangible assets and $15 million in equity in earnings of equity method investees, net of taxes) or $0.61 per diluted share; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $78 million ($35 million in cost of services and $43 million in selling, general and administrative expenses), or $0.42 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a net pre-tax gain of $89 million (a $95 million gain in other operating expense (income), net offset by a $6 million charge in selling, general and administrative expenses), or $0.50 per diluted share, primarily due to a gain associated with the sale and leaseback of a property, a gain associated with the decrease in the fair value of the contingent consideration accruals associated with previous acquisitions, and a gain associated with proceeds from an insurance claim for hurricane related losses, partially offset by costs incurred related to a data security incident, and non-cash asset impairment charges; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $13 million, or $0.10 per diluted share, recorded in income tax expense.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenues </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the year ended December&#160;31, 2020 increased by 22.1% compared to the prior year. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the year ended December&#160;31, 2020 increased by 23.4% compared to the prior year driven by demand for COVID-19 molecular and antibody testing, and, to a lesser extent, the impact of recent acquisitions, partially offset by a decline in testing volume in our base business (which excludes COVID-19 molecular and antibody testing).  </span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Organic revenue and acquisitions contributed approximately 21.6% and 1.8%, respectively, to DIS revenue growth.  </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume increased by 6.6%, with organic growth and acquisitions contributing approximately 4.5% and 2.1%, respectively. Organic volume growth was driven by demand for COVID-19 molecular testing, partially offset by declines in testing volume in the base business.  Testing volume in the base business was negatively impacted by the COVID-19 pandemic and declined by 11.4% compared to the prior year.           </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition increased by 16.2% compared to the prior year primarily due to favorable mix, driven in large part by COVID-19 molecular testing, partially offset by reimbursement pressure, including unit price reductions associated with PAMA and all other sources, of approximately 1.7%.</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Cost of Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services consists principally of costs for obtaining, transporting and testing specimens as well as facility costs used for the delivery of our services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services increased by $767 million for the year ended December&#160;31, 2020 compared to the prior year.  The increase was primarily driven by higher variable expenses related to increased testing volume as well as test mix and a higher supply cost associated with COVID-19 testing, additional operating costs associated with our acquisitions, higher performance-based compensation, and incremental costs incurred related to the COVID-19 pandemic including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19 and costs incurred to protect the health and safety of our employees and customers. These increases were partially offset by lower compensation and benefit costs as a result of a series of temporary actions implemented to manage our workforce costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In order to mitigate the impact that the COVID-19 pandemic had on our business, we implemented a series of temporary actions in April 2020 to manage our workforce costs and preserve cash including temporary salary reductions; suspension of certain benefits; reduced hours for employees whose work had significantly declined; and approved furloughs for employees with diminished work requirements who expressed an interest. As our testing volume started to recover, we recalled the vast majority of employees from furlough and reinstated full working hours for almost all employees who were asked to work reduced hours. By the end of the third quarter of 2020, salaries were restored for all exempt employees that had temporary salary reductions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses ("SG&amp;A")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A consists principally of the costs associated with our sales and marketing efforts, billing operations, credit loss expense and general management and administrative support as well as administrative facility costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $93 million for the year ended December&#160;31, 2020, compared to the prior year, primarily driven by higher performance-based compensation and additional operating costs associated with our acquisitions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The $7 million increase in amortization of intangible assets for the year ended December&#160;31, 2020 compared to the prior year was a result of recent acquisitions.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Operating Expense (Income), Net</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other operating expense (income), net includes miscellaneous income and expense items and other charges related to operating activities.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, other operating expense (income), net primarily represents impairment charges due to the impact of the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, other operating expense (income), net included a $73 million gain associated with the sale and leaseback of a property, a $12 million gain associated with proceeds from an insurance claim for hurricane related losses and a $12 million gain associated with the decrease in the fair value of the contingent consideration accruals associated with previous acquisitions, partially offset by non-cash asset impairment charges of $2 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net decreased by $12 million for the year ended December&#160;31, 2020 compared to the prior year, primarily driven by lower interest rates associated with our variable rate indebtedness, partially offset by higher average outstanding indebtedness.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other income, net represents miscellaneous income and expense items related to non-operating activities, such as gains and losses associated with investments and other non-operating assets.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, other income, net included a $70 million gain recognized as a result of the remeasurement of our previously held equity interest in MACL to fair value (see Note 6 to the audited consolidated financial statements) and gains associated with investments in our deferred compensation plans, partially offset by a $9&#160;million loss on the retirement of debt, principally due to premiums paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, other income, net included $19 million of gains associated with investments in our deferred compensation plans.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the years ended December&#160;31, 2020 and 2019 was $460 million and $247 million, respectively.  The increase in income tax expense compared to the prior year was primarily driven by an increase in income from continuing operations before income taxes and equity in earnings of equity method investees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective income tax rate for the years ended December&#160;31, 2020 and 2019 was 24.5% and 23.0%, respectively.  The effective income tax rate for the year ended December&#160;31, 2020 benefited from a lower effective income tax rate (11.8%) associated with a $70 million gain recognized as a result of the remeasurement of our previously held equity interest in MACL to fair value due to a permanent difference in the financial reporting and tax basis of goodwill, and $23 million of excess tax benefits associated with stock-based compensation arrangements.  The effective income tax rate for the year ended December&#160;31, 2019 benefited from a $12 million release of valuation allowances associated with net operating loss carryforwards, and $13 million of excess tax benefits associated with stock-based compensation arrangements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Equity Method Investees, Net of Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, there was an $18 million increase in equity in earnings of equity method investees, net of taxes, compared to the prior year primarily due to a $14 million gain recognized by an equity method investee to adjust certain of its investments to fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Discontinued Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the third quarter of 2006, we completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary, which was classified as discontinued operations for the year ended December 31, 2019.  Income from discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete income tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We address our exposure to market risks, principally the risk of changes in interest rates, through a controlled program of risk management that includes the use of derivative financial instruments.  We do not hold or issue derivative financial instruments for speculative purposes.  We seek to mitigate the variability in cash outflows that result from changes in interest rates by maintaining a balanced mix of fixed-rate and variable-rate debt obligations.  In order to achieve this objective, we have historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements are recognized as an adjustment to interest expense, net.  We believe that our exposures to foreign exchange impacts and changes in commodity prices are not material to our consolidated results of operations, financial position or cash flows.  For further details regarding our significant accounting policies on interest rate risk and foreign currency, see Note 2 to the audited consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020 and 2019, the fair value of our debt was estimated at approximately $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xMjcvZnJhZzpkYmJjZTVkYzRlMWY0NjllYmQwN2I4M2VjNTM1N2ZmNi90ZXh0cmVnaW9uOmRiYmNlNWRjNGUxZjQ2OWViZDA3YjgzZWM1MzU3ZmY2XzIxOTkwMjMyNzE3NzU_99d6bff2-30c7-4b47-8046-a2a6190df74a">4.6</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xMjcvZnJhZzpkYmJjZTVkYzRlMWY0NjllYmQwN2I4M2VjNTM1N2ZmNi90ZXh0cmVnaW9uOmRiYmNlNWRjNGUxZjQ2OWViZDA3YjgzZWM1MzU3ZmY2XzIxOTkwMjMyNzE3OTQ_e38628b6-05de-420f-962f-630317d0c154">5.1</ix:nonFraction> billion, respectively, principally using quoted prices in active markets and yields for the same or similar types of borrowings, taking into account the underlying terms of the debt instruments.  As of December&#160;31, 2020 and 2019, the estimated fair value exceeded the carrying value of the debt by $597&#160;million and $313&#160;million, respectively.  A hypothetical 10% increase in interest rates (representing 17 basis points as of December&#160;31, 2020 and 28 basis points as of December&#160;31, 2019) would potentially reduce the estimated fair value of our debt by approximately $82&#160;million and $100&#160;million as of December&#160;31, 2020 and 2019, respectively.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our secured receivables credit facility and our senior unsecured revolving credit facility are subject to variable interest rates. Interest on our secured receivables credit facility is based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread. As of December&#160;31, 2020, interest on our senior unsecured revolving credit facility is based on certain published rates plus an applicable margin based on changes in our public debt ratings and our leverage ratio. As such, our borrowing cost under this credit arrangement is subject to fluctuations in interest rates, our leverage ratio and changes in our public debt ratings.  As of December&#160;31, 2020, the borrowing rates under these debt instruments were: for our secured receivables credit facility, commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.825% to 0.95%; and for our senior unsecured revolving credit facility, LIBOR plus 1.125%.  As of December&#160;31, 2020, there were no borrowings outstanding under either our $600&#160;million secured receivables credit facility or our $750&#160;million senior unsecured revolving credit facility.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2020, we terminated our existing fixed-to-variable interest rate swap agreements. Based on our remaining net exposure to interest rate changes, a hypothetical 10% change to the variable rate component of our variable rate indebtedness would not materially change annual interest expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During March 2020, we entered into a forward-starting interest rate swap agreement with a financial institution for a total notional amount of $25 million. Additionally, during May 2020, we entered into interest rate lock agreements with several financial institutions for a total notional amount of $275 million. The forward-starting interest rate swap agreement and the interest rate lock agreements were entered into in order to hedge a portion of our interest rate exposure associated with variability in future cash flows attributable to changes in interest rates over a ten-year period related to an anticipated issuance of debt and were accounted for as cash flow hedges. In connection with the issuance of the 2031 Senior Notes, these agreements were settled and we received net proceeds of $1 million. The net gain is deferred in stockholders' equity, net of taxes, as a component of accumulated other comprehensive loss, and is being amortized as an adjustment to interest expense, net over a ten-year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our outstanding debt and our financial instruments and hedging activities, see Notes 13 and 15, respectively, to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Associated with Investment Portfolio</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investment portfolio primarily includes equity investments comprised mostly of strategic holdings in privately and publicly held companies.  These securities are exposed to price fluctuations and are generally concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value with changes in fair value recognized in net income. Equity investments that do not have readily determinable fair values are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  We regularly evaluate these equity investments to determine if there are any indicators that the investment is impaired.  The carrying value of our equity investments that do not have readily determinable fair values was $25&#160;million as of December&#160;31, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not hedge our equity price risk.  The impact of an adverse movement in equity prices on our holdings in privately held companies cannot be easily quantified, as our ability to realize returns on investments depends on, among other things, the enterprises&#8217; ability to raise additional capital or derive cash inflows from continuing operations or through liquidity events such as initial public offerings, mergers or private sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our audited consolidated financial statements for the year ended December&#160;31, 2020, we considered whether the carrying values of our investments were impaired and concluded that no impairment existed.  However, should the impact of the COVID-19 pandemic be worse than currently expected, it is possible that we could incur impairment charges in the future.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,243&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,267)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,492)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,091)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents consist of cash and highly-liquid short-term investments.  Cash and cash equivalents as of December&#160;31, 2020 and 2019 totaled $1,158 million and $1,192 million, respectively.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, approximately 4% of our $1,158 million of consolidated cash and cash equivalents were held outside of the United States.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by operating activities for the year ended December&#160;31, 2020 was $2,005 million, and increased $762 million compared to the prior year primarily as a result of:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher operating income in 2020 as compared to 2019; and, to a lesser extent</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $100 million increase due to the temporary suspension in 2020 of certain payment requirements for the employer portion of Social Security taxes; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$40&#160;million of proceeds received in 2020 from the termination of interest rate swap agreements; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $158 million increase in income tax payments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher performance-based compensation payments in 2020 compared to 2019; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $28 million refund received in the prior year period from the taxing authorities associated with the favorable resolution of certain tax contingencies related to a discontinued operation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Days sales outstanding, a measure of billing and collection efficiency, was 46 days as of December&#160;31, 2020 and 54 days as of December&#160;31, 2019.  The decrease in DSO is partially due to recent fluctuations in our monthly revenue due to the impact of the COVID-19 pandemic. Although we believe that our current revenue reserves and allowance for credit losses are appropriate, it is possible that we will experience an impact on cash collections as a result of the impact of the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in investing activities for the year ended December&#160;31, 2020 was $772 million, compared to $411 million for the year ended December&#160;31, 2019.  This $361 million increase in cash used in investing activities was primarily a result of:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $272 million increase in net cash paid for business acquisitions; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an $88 million decrease in proceeds from disposition of property, plant and equipment, primarily due to proceeds in the prior year period associated with the sale and leaseback of a property.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in financing activities for the year ended December&#160;31, 2020 was $1,267 million, compared to net cash provided by financing activities of $225 million for the year ended December&#160;31, 2019.  This $1,492 million change in cash flows from financing activities was primarily a result of:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$805 million of net debt repayments (repayments of debt less proceeds from borrowings) in 2020 compared to $832 million of net borrowings in 2019; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $76 million increase in overdrafts, which are generally settled in cash the following day; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $70 million increase in proceeds from the exercise of stock options, which was a result of an increase in the volume of stock options exercised and the average exercise price compared to the prior year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During January 2020, we redeemed in full the outstanding indebtedness under our senior notes due January 2020 and senior notes due March 2020 using net proceeds from the issuance, in December 2019, of the 2030 Senior Notes, along with cash on hand.  During May 2020, we completed the issuance of the 2031 Senior Notes, the net proceeds from which were used during November 2020, along with cash on hand, to redeem in full the outstanding indebtedness under our senior notes due April 2021.  Additionally, during the year ended December&#160;31, 2020, we borrowed $100&#160;million under our secured receivables credit facility and $100&#160;million under our senior unsecured revolving credit facility, both of which were repaid prior to December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During March 2019, we completed the issuance of the $500 million aggregate principal amount of 4.20% senior notes due June 2029 and repaid in full, at maturity, our senior notes due April 2019.  In December 2019, we completed the issuance of the 2030 Senior Notes.  In addition, during the year ended December 31, 2019 we borrowed a total of $985 million under our secured receivables credit facility to fund periodic working capital requirements, as well as our 2019 acquisition, and repaid $1,145 million under our secured receivables credit facility.  During the year ended December 31, 2019, there were no borrowings or repayments under our senior unsecured revolving credit facility.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For details regarding our debt and related transactions, see Note 13 to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the four quarters of 2020, our Board of Directors declared a quarterly cash dividend of $0.56 per common share.  During each of the four quarters of 2019, our Board of Directors declared a quarterly cash dividend of $0.53 per common share.  On February 4, 2021, we announced that our Board of Directors authorized a 10.7% increase in our quarterly cash dividend from $0.56 to $0.62 per share, or $2.48 per share annually, commencing with the dividend payable in April 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of December&#160;31, 2020, $0.9 billion remained available under our share repurchase authorization.  In February 2021, our Board of Directors authorized us to repurchase an additional $1 billion of our common stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, we repurchased 2.7 million shares of our common stock for $325 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December 31, 2019, we repurchased 3.5 million shares of our common stock for $350 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our share repurchases, see Note 16 to the audited consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes certain of our contractual obligations as of December&#160;31, 2020 (dollars in millions):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less than <br/>1 year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1-3 years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4-5 years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5 years</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding debt</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,976&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments on outstanding debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">910&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contractual obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,764&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,414&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest payments on our outstanding debt include interest associated with finance lease obligations and have been calculated using the interest rates as of December&#160;31, 2020 applied to the December&#160;31, 2020 balances, which are assumed to remain outstanding through their maturity dates.  A description of the terms of our indebtedness and related debt service requirements is contained in Note 13 to the audited consolidated financial statement</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Operating lease obligations include variable charges (primarily maintenance fees and utilities associated with our real estate leases) in effect as of December&#160;31, 2020.  A discussion and analysis regarding our operating lease obligations is contained in Note 14 to the audited consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Purchase obligations include our noncancellable commitments to purchase products or services as described in Note 18 to the audited consolidated financial statements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, our total liabilities associated with unrecognized tax benefits were approximately $93 million, which were excluded from the table above.  We expect that these liabilities may decrease by less than $15 million within the next twelve months, primarily as a result of payments, settlements, expiration of statutes of limitations and/or the conclusion of tax examinations on certain tax positions.  For the remainder, we cannot make reasonably reliable estimates of the timing of the future payments of these liabilities.  See Note 8 to the audited consolidated financial statements for information regarding our contingent tax liability reserves.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass"), we granted UMass the right to require us to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of December&#160;31, 2020, the fair value of the redeemable noncontrolling interest on the audited consolidated balance sheet was $82 million, which was excluded from the table above.  Since the redemption of the noncontrolling interest is outside of our control, we cannot make a reasonably reliable estimate of the timing of the future payment, if any, of the redeemable noncontrolling interest.  For further details regarding the redeemable noncontrolling interest, see Note 16 to the audited consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investees</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our equity method investees primarily consist of our clinical trials central laboratory services joint venture, our diagnostic information services joint venture, and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry. Such investees are accounted for under the equity method of accounting.  Our investment in equity method investees is less than 5% of our consolidated total assets.  Our proportionate share of income before income taxes associated with our equity method investees is less than 5% of our consolidated income from continuing operations before income taxes and equity in earnings of equity method investees.  We partially guarantee a lease obligation of one of our equity method investees; payment under such guarantee is not likely at this time and we have no other material unconditional obligations or guarantees to, or in support of, our equity method investees and their operations.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our audited consolidated financial statements for the year ended December&#160;31, 2020, we considered whether the carrying values of our equity method investments were impaired and concluded that no such impairment existed.  However, should the impact of the COVID-19 pandemic be worse than currently expected, it is possible that we could incur impairment charges in the future. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding related party transactions with our equity method investees, see Note 20 to the audited consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We estimate that we will invest approximately $350 million to $400 million during 2021 for capital expenditures, to support and grow our existing operations, principally related to investments in information technology; laboratory equipment and facilities, including COVID testing equipment and completion of our new multi-year laboratory construction in New Jersey; and investments in our advanced diagnostics and consumer growth strategies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Together with the Quest Diagnostics Foundation, we launched a multi-year initiative to reduce health disparities in underserved communities, including those impacted by the COVID-19 pandemic. As part of this initiative, we plan to offer testing services and fund a range of initiatives estimated to total more than $100 million aimed at improving access to testing and awareness of the value of diagnostic insights in managing overall health, a significant portion of which will occur in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, $1.3 billion of borrowing capacity was available under our existing credit facilities consisting of $530 million available under our secured receivables credit facility and $750 million available under our senior unsecured revolving credit facility.  There were no borrowings under these credit facilities as of December&#160;31, 2020.  In support of our risk management program, to ensure our performance or payment to third parties, $70 million in letters of credit under the secured receivables credit facility were outstanding as of December&#160;31, 2020.  The secured receivables credit facility includes a $250 million loan commitment which matures October 2021, and a $250 million loan commitment and a $100 million letter of credit facility which mature October 2022.  The senior unsecured revolving credit facility matures in March 2023.  For further details regarding the credit facilities, see Note 13 to the audited consolidated financial statements.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our secured receivables credit facility is subject to customary affirmative and negative covenants, and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility. Our senior unsecured revolving credit facility is also subject to certain financial covenants and limitations on indebtedness. As of December&#160;31, 2020, we were in compliance with all such applicable financial covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In 2020, due to the impact of the COVID-19 pandemic, we took certain actions to preserve liquidity including temporarily suspending share repurchases under our existing share repurchase authorization (which suspension was lifted in November 2020) and implementing a series of temporary actions to manage our workforce costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, we took certain steps to ensure adequate access to liquidity. In April 2020, we entered into an amendment to our senior unsecured revolving credit facility in order to provide for increased flexibility. Pursuant to the amendment, the leverage ratio covenant was increased as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.046%"><tr><td style="width:1.0%"></td><td style="width:36.259%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Covenant:</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 6.5 times EBITDA</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 6.25 times EBITDA</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 4.5 times EBITDA</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Thereafter, the leverage ratio covenant reverts to no more than 3.5 times EBITDA.  During the period that the increased covenant applies, which period may be terminated early by us provided that we are in compliance with the historical 3.5 times EBITDA leverage ratio, the amended credit agreement contains certain additional limitations and restrictions including, but not limited to, repurchases of our common stock, the amount of funds that can be used on business acquisitions, the incurrence of secured indebtedness and the payment of dividends.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, in May 2020, we completed the issuance of the 2031 Senior Notes.  In November 2020, we redeemed in full the outstanding indebtedness under our senior notes due April 2021 using the net proceeds from the issuance of the 2031 Senior Notes, along with cash on hand.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our cash and cash equivalents and cash from operations, together with our borrowing capacity under our credit facilities, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares, share repurchases and additional growth opportunities for the foreseeable future.  However, should it become necessary, we believe that our credit </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that inflation generally does not have a material adverse effect on our results of operations or financial condition.</span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The adoption of new accounting standards is discussed in Note 2 to the audited consolidated financial statements.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The impacts of recent accounting pronouncements not yet effective on our audited consolidated financial statements are discussed in Note 2 to the audited consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF MANAGEMENT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The management of the Company, including its Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended.  Management assessed the effectiveness of the Company's internal control over financial reporting as of December&#160;31, 2020 based on criteria for effective internal control over financial reporting described in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Internal Control - Integrated Framework (2013)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission.  Based on this assessment, management has determined that the Company's internal control over financial reporting as of December&#160;31, 2020 is effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.  Internal control over financial reporting includes policies and procedures that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorization of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;PricewaterhouseCoopers LLP, the independent registered public accounting firm that audited the financial statements included in this annual report, audited the Company's internal control over financial reporting as of December&#160;31, 2020 and issued their audit report on the Company's internal control over financial reporting included herein. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of Quest Diagnostics Incorporated</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Quest Diagnostics Incorporated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and its subsidiaries</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the &#8220;Company&#8221;) as of December 31,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2019,</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the related consolidated statements of operations, comprehensive income, stockholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2020, including the related notes and financial statement schedule</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of valuation accounts and reserves for each of the three years in the period ended December 31, 2020 listed in the index appearing under Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013)</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the consolidated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2019</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the results of its</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operations and its</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash flows for each of the three years in the period ended December 31, 2020</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2013)</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Accounting Principle</span></div><div style="padding-left:36pt"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note&#160;2 to the&#160;consolidated&#160;financial statements, the Company changed the manner in which it accounts for leases in 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Report of Management on Internal Control Over Financial Reporting. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits of the consolidated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements included performing procedures to assess the risks of material misstatement of the consolidated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Diagnostic Information Services (DIS) Business Accounts Receivable - Contractual Allowances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 3 to the consolidated financial statements, management estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials) and patient price concessions. The portfolio approach includes the following groups of customers: healthcare insurers, government payers, client payers and patients (34%, 6%, 46% and 11% of consolidated net accounts receivable as of December 31, 2020, respectively, as disclosed by management). The DIS business accounted for 97% of consolidated net accounts receivable ($1,520 million) as of December 31, 2020. Net revenues and accounts receivable recognized from healthcare insurers and government payers consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and, additionally for healthcare insurers, the terms of the Company&#8217;s contractual arrangements. As disclosed by management, the process for estimating revenues and the ultimate collection of receivables associated with the DIS business involves significant assumptions and judgments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal considerations for our determination that performing procedures relating to the valuation of DIS business accounts receivable - contractual allowances is a critical audit matter are the estimate of net collectible accounts receivable, specifically contractual allowances, involves significant judgment and estimation on the part of management; this in turn led to significant auditor judgment, subjectivity and effort in performing procedures to evaluate the audit evidence related to the contractual allowances. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the valuation of DIS business accounts receivable, which included controls over management&#8217;s methodology and data used to estimate contractual allowances. These procedures also included, among others, testing management's process for developing the estimate for contractual allowances, including (i) evaluating the appropriateness of the methodology, (ii) testing the completeness and accuracy of the historical contractual allowance and collection data from the Company&#8217;s billing system, which is an input to the methodology, and (iii) evaluating the reasonableness of management&#8217;s assumptions used to estimate contractual allowances by comparing actual cash collected to the prior year estimate (net accounts receivable). </span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:32.602%"><tr><td style="width:1.0%"></td><td style="width:9.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.587%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PricewaterhouseCoopers LLP</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florham Park, New Jersey</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2021</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1995.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DECEMBER&#160;31, 2020 AND 2019 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_145"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMtMS0xLTEtMA_afd142fa-916b-49d7-b636-b5b1dc0a9ad5">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMtMy0xLTEtMA_86a8b9c1-8401-4f46-988d-e08c060ec081">1,192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjUxN2VlMzM4YTYxOTQwZmY4NzU0MGYyOGQ5YWQ5ZjJiXzQ5NDc4MDIzMjUxMDQ_aabfb559-45ce-40bf-83e4-031c4c0ad7ac">28</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjUxN2VlMzM4YTYxOTQwZmY4NzU0MGYyOGQ5YWQ5ZjJiXzIxOTkwMjMyNTU3MDE_2173ec70-efd5-45bd-964c-da819187da80">15</ix:nonFraction> as of December&#160;31, 2020 and 2019, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQtMS0xLTEtMA_ded46d82-e6ac-491f-a592-5356664ac154">1,520</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQtMy0xLTEtMA_bf849dfa-2ca2-4d0a-9616-90ce08f09ee8">1,063</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzUtMS0xLTEtMA_a04e4ee7-86a9-4d1d-92d3-4f1f39ec024b">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzUtMy0xLTEtMA_15f9071b-550c-435b-9c58-4fd5aaf130e9">123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzYtMS0xLTEtMA_e042caed-9e8c-4579-91e5-ebfea0e42562">157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzYtMy0xLTEtMA_388ae5e8-58cd-473c-90f3-0533ff6dd806">112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzgtMS0xLTEtMA_89badb56-43e9-4484-86f6-58d0fd860a27">3,058</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzgtMy0xLTEtMA_c56d78a2-bc03-4ca7-82c7-ad3ecfd67fa4">2,490</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzktMS0xLTEtMA_bf3f3669-8d4f-4e4c-8ef7-3004f4ae6aba">1,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzktMy0xLTEtMA_164ee54f-4d5c-452e-92dd-13dc8eda53b9">1,453</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEwLTEtMS0xLTA_2ef82887-36e2-4ce3-9e23-2ac94956baf0">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEwLTMtMS0xLTA_6d6b0de9-7f18-4057-90c6-2dc363f1f232">518</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzExLTEtMS0xLTA_4f89b626-e10a-4b57-9ed8-cf7e0a34ca98">6,873</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzExLTMtMS0xLTA_2267c8d0-9912-476b-a168-7b75354fcfeb">6,619</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEyLTEtMS0xLTA_e60e1775-bb48-4959-aa9d-15c9e814c23a">1,167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEyLTMtMS0xLTA_8f6797cd-c158-4f62-a224-73b2f8fdaa5d">1,121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments in equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEzLTEtMS0xLTA_ff4e56c3-3f5e-4663-a4bc-e8c4432280a8">521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEzLTMtMS0xLTA_2a0b73f9-63fc-4e87-a5a0-1f377efea30f">482</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzE0LTEtMS0xLTA_3bef38a0-2ae2-456e-a538-53d0277cf4d8">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzE0LTMtMS0xLTA_5ac4bc0d-5449-435b-8330-e546331bae1a">160</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzE2LTEtMS0xLTA_72ec415b-4da2-4fd7-8086-f9bf8d3f8d94">14,026</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzE2LTMtMS0xLTA_3d3ac8cb-c744-4538-9f87-977b32aa3424">12,843</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIwLTEtMS0xLTA_3e2fbd51-2488-4804-a2bd-5e0b6149ad34">1,633</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIwLTMtMS0xLTA_d28a69a7-9c61-43cf-8238-6a561ac96d49">1,041</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIxLTEtMS0xLTA_11b78c57-04bb-49b8-a6de-57c43303b80b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIxLTMtMS0xLTA_05674031-5734-400f-886c-9f1b7caab27a">804</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIyLTEtMS0xLTA_49e4e2a5-d0f9-429c-b286-22475d084e1b">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIyLTMtMS0xLTA_12f06bc0-dc9c-4042-a742-3aa896bc60f3">145</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIzLTEtMS0xLTA_2a2ec9e7-5277-444a-b905-c0365b072839">1,776</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIzLTMtMS0xLTA_ffdc56d4-78dc-4889-ae99-f5f3d2593d39">1,990</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI0LTEtMS0xLTA_be0a796b-65a1-4d6c-a651-34523f85454e">4,013</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI0LTMtMS0xLTA_0f3ead66-d656-4a71-9ddd-9fa607a58cd9">3,966</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI1LTEtMS0xLTA_2524ba60-969b-485a-a364-1fa3aa53e1c7">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI1LTMtMS0xLTA_0b2c7611-037a-407c-b967-6c0fc5281286">413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI2LTEtMS0xLTA_71b8c142-38d0-495e-8d27-3f50f1cda574">847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI2LTMtMS0xLTA_ec5db944-f175-48a5-bee5-d69807c15052">711</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI4LTEtMS0xLTA_9c19e824-fa33-4841-bd5a-e173ecedff38"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI4LTMtMS0xLTA_47b99332-1278-47f8-9881-02062b9cd25c"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI5LTEtMS0xLTA_2b47e4f5-a896-4816-9c38-e7a9817fc719">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI5LTMtMS0xLTA_4e7a890e-fda6-4464-a26e-e79c3e56be9e">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTYx_82049554-7d71-464e-809c-2340b28dda15"><ix:nonFraction unitRef="usdPerShare" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTYx_89e88483-c50c-4e67-a97d-fab7eecefea9">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTY3_a6b93a48-5ce1-4ad8-b11c-af2c40a94845"><ix:nonFraction unitRef="shares" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTY3_e497b864-d796-4bda-baa1-4ed79d2bfe5d">600</ix:nonFraction></ix:nonFraction> shares authorized as of both December 31, 2020 and 2019; <ix:nonFraction unitRef="shares" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTcz_63ed7796-aa19-4832-b7eb-5ac026362cb9"><ix:nonFraction unitRef="shares" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTcz_c8ab7540-6755-4670-89d6-b55ed482f153">217</ix:nonFraction></ix:nonFraction> shares issued as of both December 31, 2020 and 2019</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTEtMS0xLTA_3785e19b-5edb-493c-a308-f578667c2aad">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTMtMS0xLTA_f92e5646-3a56-4f9d-9e33-6e66db713a8f">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMzLTEtMS0xLTA_1f47e9ce-4d93-4d01-bdf6-026140741570">2,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMzLTMtMS0xLTA_877c97ff-c4e1-42e3-81d2-61a46c21fddf">2,722</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM0LTEtMS0xLTA_434806f4-5f61-468a-9176-dcf1eafad93a">9,303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM0LTMtMS0xLTA_b1e0db34-a043-48df-83c2-a9f73ba6d945">8,174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM1LTEtMS0xLTA_666ec43a-dc57-4899-80bb-200a25685e1a">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM1LTMtMS0xLTA_445bc6ae-fba5-443b-a089-9bc9c7b2d74f">39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjpjODQwMjU2NmI2YWE0OGVlOTIzODNmMzEyMjQ5MGRiNV80OTQ3ODAyMzI1MTA3_34312f6b-358f-4db0-ac4e-db911672bcdf"><ix:nonFraction unitRef="shares" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjpjODQwMjU2NmI2YWE0OGVlOTIzODNmMzEyMjQ5MGRiNV80OTQ3ODAyMzI1MTA3_6a6c718a-4611-4baa-9d6b-99d79c10b6f3">84</ix:nonFraction></ix:nonFraction> shares as of both December 31, 2020 and 2019</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM2LTEtMS0xLTA_91a0c93f-9f7f-462e-ac5c-40f641ff5d39">5,366</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM2LTMtMS0xLTA_6b493d86-cdb3-4e90-8f54-0a1c42ca4d45">5,218</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Quest Diagnostics stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM3LTEtMS0xLTA_2f37225e-fbe4-4619-971b-e8b90fd2183d">6,759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM3LTMtMS0xLTA_9059de83-354d-43bd-9f9d-f9b90c2490a2">5,641</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM4LTEtMS0xLTA_5db4a5c9-4d83-4af3-b5a1-860ad94d72da">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM4LTMtMS0xLTA_88725d12-eb9d-4221-a583-b5108c2d52ea">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM5LTEtMS0xLTA_ada9ec69-cf94-4bae-a24c-21fa77e19c30">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM5LTMtMS0xLTA_08212a82-b8eb-4806-9e5b-c7c9e56acd44">5,687</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQwLTEtMS0xLTA_5a42dbc9-7abe-4cae-981f-bb21342473d1">14,026</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQwLTMtMS0xLTA_0852f1a5-7dfd-4438-b05d-c1a8fb02fd25">12,843</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2020, 2019 AND 2018 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.615%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzItMS0xLTEtMA_17b58273-e5cf-47be-86e8-8733b485968b">9,437</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzItMy0xLTEtMA_ae5a0d77-75d5-41bc-b9d3-de49b4dcc828">7,726</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzItNS0xLTEtMA_75e13333-caaa-43df-b226-69deccff8fd6">7,531</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating expense (income):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzUtMS0xLTEtMA_5e6940a1-40e4-4a02-bf14-f980e55f2924">5,804</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzUtMy0xLTEtMA_632eee2c-3e90-41ff-9363-308b0755501b">5,037</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzUtNS0xLTEtMA_9eab9018-7681-4a64-bf23-4220044951ee">4,926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzYtMS0xLTEtMA_2f55fd39-03a4-4402-8230-bcd4def8ade7">1,550</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzYtMy0xLTEtMA_3576de12-ced3-416e-bfe8-370138a945ec">1,457</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzYtNS0xLTEtMA_8f56ea1d-7a92-470b-9539-e0567607efb9">1,424</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzctMS0xLTEtMA_9526eb1c-359a-4145-ad03-c701bcf20ea8">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzctMy0xLTEtMA_4c09944e-24c9-469c-a07c-93d490698eb2">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzctNS0xLTEtMA_92aa61ec-2dd5-4681-a52b-4a45d2e2974c">90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense (income), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzgtMS0xLTEtMA_8ad97635-c8b1-47b8-a25d-eaf863382cc0">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzgtMy0xLTEtMA_1f16af8d-06c6-41e5-a14c-6539dfee1b35">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzgtNS0xLTEtMA_93db7d2b-f1ab-4856-a25a-e53f166004da">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzktMS0xLTEtMA_481f2ca6-ab70-48e4-bd8e-ee321e666f0c">7,466</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzktMy0xLTEtMA_09d408a1-f920-4bf0-89bd-31def512af47">6,495</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzktNS0xLTEtMA_99c0befe-9b8c-420d-9728-5887b11df009">6,430</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzExLTEtMS0xLTA_a7940ae4-d780-49e5-9e9c-677d5a6acda2">1,971</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzExLTMtMS0xLTA_081d0a0c-7803-45bb-adaf-32ed1812b5b8">1,231</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzExLTUtMS0xLTA_cdacca3a-fc15-4b9c-9e7c-300ef513b4bd">1,101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE0LTEtMS0xLTA_f110f342-95ad-4037-878a-d5177a114644">163</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE0LTMtMS0xLTA_4dd771aa-7068-4a04-970e-0014be1352d5">175</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE0LTUtMS0xLTA_9c395ed6-c6a9-4359-96b2-37d54c0e6841">167</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE1LTEtMS0xLTA_abfaf569-779b-4024-91ee-e1b7e9216558">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE1LTMtMS0xLTA_af25f0d2-462b-4e48-85cd-08530918ee23">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE1LTUtMS0xLTA_2d411edb-5909-446f-b75e-2973c9911c85">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating expense, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE2LTEtMS0xLTA_a95ac519-ff60-4acc-940f-0ce5cc46bb3f">87</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE2LTMtMS0xLTA_870441c3-4a23-4c1e-8f0d-99c7ba0527a2">155</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE2LTUtMS0xLTA_f9e1a4fe-8b63-4f22-bccd-03a22033de93">175</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations before income taxes and equity in earnings of equity method investees</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE4LTEtMS0xLTA_5057422d-d1ea-4000-a46b-131585f05df6">1,884</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE4LTMtMS0xLTA_a855f93a-9b8c-4b11-a9d4-2b52a1f3dbdc">1,076</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE4LTUtMS0xLTA_127b344e-5b39-477e-8733-eb70d5104738">926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE5LTEtMS0xLTA_e6421230-801d-4f27-bf9d-c1603a704e2d">460</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE5LTMtMS0xLTA_bc6a7fef-8403-4f56-b0a5-4bd023092122">247</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE5LTUtMS0xLTA_27a81fcf-faa3-4e47-9908-3b5952187867">182</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIwLTEtMS0xLTA_ef964fdc-6824-4705-90aa-256aaad90cbe">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIwLTMtMS0xLTA_2175e198-2f0e-4a25-b5f6-92b6d3bf34ea">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIwLTUtMS0xLTA_666a9882-f151-47c8-adec-b6a10871bb1e">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIzLTEtMS0xLTA_302cc3a4-a2b6-43ac-acbd-9ece36acb7ca">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIzLTMtMS0xLTA_fdca214b-4015-410a-bdd7-e3a43e9d19d4">886</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIzLTUtMS0xLTA_c5893705-9122-4525-ac55-1ed04bcc123b">788</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI0LTEtMS0xLTA_858a69d1-cc53-4643-b018-f89a0d838053">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI0LTMtMS0xLTA_e8731773-ff6f-4cea-839c-1e935aa399df">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI0LTUtMS0xLTA_4785f10c-8d56-4c98-bbc7-f500dcc801b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI1LTEtMS0xLTA_998d71d0-1a86-4e93-98a3-339542e11575">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI1LTMtMS0xLTA_314a0b24-be33-4c2f-a77f-2cc23966da3c">906</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI1LTUtMS0xLTA_daf06ade-71dd-4349-a035-dbafad88baa6">788</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI2LTEtMS0xLTA_2d816f2e-2f37-40d0-b46d-46c8f89ab645">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI2LTMtMS0xLTA_0fc05eb5-4f17-400a-9bfa-ae4fea75cbcc">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI2LTUtMS0xLTA_de4382f3-5f9c-4c5e-9629-df46920bfcc6">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI3LTEtMS0xLTA_2188af7f-9e66-4bac-90d2-f5f3f1f06c6a">1,431</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI3LTMtMS0xLTA_7800c693-cbd0-4c36-abaf-7543e0adfc65">858</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI3LTUtMS0xLTA_9903cd66-93ba-4e10-a29e-1a17496ae0d0">736</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMwLTEtMS0xLTA_78bb0a6b-d1a3-4340-a314-c33e0e91188d">1,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMwLTMtMS0xLTA_b2cac41a-7e94-4cd9-bab6-c656618535e5">838</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMwLTUtMS0xLTA_73ce7356-148d-41fa-8a7d-16c6f2859411">736</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMxLTEtMS0xLTA_8676d368-dfb5-4ed1-bc50-617482a864ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMxLTMtMS0xLTA_6055e6bf-4ae3-4f88-b755-45b9666c0757">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMxLTUtMS0xLTA_c2e2777c-1381-4b01-b52e-4f295e12594e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMyLTEtMS0xLTA_d711e33d-d87f-479b-af45-1c16670ec69e">1,431</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMyLTMtMS0xLTA_d42307b6-f384-4ed8-9da1-6abf9c4b23bb">858</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMyLTUtMS0xLTA_b35e3d38-4665-4362-9fa1-22355a9d0c26">736</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM1LTEtMS0xLTA_510a3b88-693a-4cce-970f-cc1a6b7d7f25">10.62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM1LTMtMS0xLTA_1b006825-1829-464c-9cfe-d56907b0b26c">6.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM1LTUtMS0xLTA_ac12fce7-6a7f-422b-966d-c0311d79a99e">5.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM2LTEtMS0xLTA_dd9d63a2-ef66-4df4-acd9-5d05200d3483">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM2LTMtMS0xLTA_7b2a5afb-76e5-43f5-b78a-23e33fdb232a">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM2LTUtMS0xLTA_396e7290-400e-4e35-a749-42a53abda969">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM3LTEtMS0xLTA_6266b02f-bf6a-4fa5-aaa7-7fe6d785b08f">10.62</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM3LTMtMS0xLTA_447732e2-1a62-4ccf-916e-c400fc4df42e">6.36</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM3LTUtMS0xLTA_8b48f3d4-2258-4a33-96f7-02fa64333d87">5.39</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQwLTEtMS0xLTA_b44dbd75-f30f-4df2-a63a-6e08df055cd0">10.47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQwLTMtMS0xLTA_70e99fdb-039e-4caa-ae1c-8cf56cfe551d">6.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQwLTUtMS0xLTA_e890b404-0f64-48e9-8724-3a13d59115a6">5.29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQxLTEtMS0xLTA_11a1cfae-7622-4d8b-89eb-a744299cc677">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQxLTMtMS0xLTA_b4ea33fd-4fb7-462a-84ca-d2ad6b817d60">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQxLTUtMS0xLTA_2f5f781c-24f1-4476-a39c-b2791a00e22b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQyLTEtMS0xLTA_0d311596-1020-4084-b3fc-8c051901742c">10.47</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQyLTMtMS0xLTA_19d4d753-c152-40a6-a56e-2c75b32eca87">6.28</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQyLTUtMS0xLTA_11bec738-f58a-406f-bd88-c0470e9b5f60">5.29</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2020, 2019 AND 2018 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzItMS0xLTEtMA_7e99bcd3-1eb5-42a7-a236-e4ac9877b7f1">1,499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzItMy0xLTEtMA_525a0ca2-eaf8-4048-9f39-5e131f2325f6">906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzItNS0xLTEtMA_c39fc405-ec71-4f4c-885d-721ef9105e25">788</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzUtMS0xLTEtMA_8ea84989-ee2e-4486-abf1-a0eef095e956">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzUtMy0xLTEtMA_7f11f3dc-1e66-4c8e-a288-3f70348b7e40">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzUtNS0xLTEtMA_d74e4e27-ee3f-4786-9cdd-f6e2a3abc2ce">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in available-for-sale debt securities, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzYtMS0xLTEtMA_09e1500a-2385-4fd6-baba-fa1241c38603">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzYtMy0xLTEtMA_11582426-b312-4380-b2d3-c5880db2859c">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzYtNS0xLTEtMA_ab7ee995-bcb9-415c-af64-7b657a9fc176">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred gain on cash flow hedges, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzctMS0xLTEtMA_b864ccbd-2fff-469e-8ede-9c362d312e77">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzctMy0xLTEtMA_ccd88a0c-4c2b-45d8-ad0b-b8c54b63744a">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzctNS0xLTEtMA_7fec155c-2c69-4791-ae10-cf4f36a55ff9">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzktMS0xLTEtMA_a630264c-254d-4d4d-a1fa-9e2eeceba626">18</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzktMy0xLTEtMA_8f1c198c-3b3e-45b7-a9fc-870bc137199d">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzktNS0xLTEtMA_116c0bb9-00c0-4ff4-a034-d38597f14f34">9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzExLTEtMS0xLTA_44b3aded-b134-4f38-b6c4-ff66194a7abb">1,517</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzExLTMtMS0xLTA_3da53301-e30b-4c0f-85e7-8e28a46d02c3">926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzExLTUtMS0xLTA_1db0e0ac-d0b8-448c-8cfe-82cca1030c50">779</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEyLTEtMS0xLTA_39eb6ff3-fc7d-4bda-b950-7d252bd8a4c8">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEyLTMtMS0xLTA_b1f0fee2-8c86-4209-9f53-7291afdb1c69">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEyLTUtMS0xLTA_38ec6eac-c588-41ba-9a9d-5582bf94ce56">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEzLTEtMS0xLTA_d1863028-5ff0-49e1-a64c-24342c147671">1,449</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEzLTMtMS0xLTA_db996a79-ffec-4ad3-b7a3-73dc038c8165">878</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEzLTUtMS0xLTA_3569cd25-1acd-41a6-9001-425d285b7b06">727</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2020, 2019 AND 2018 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzItMS0xLTEtMA_808abf34-1531-4467-bbcc-c8d2b917da60">1,499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzItMy0xLTEtMA_ac0ad8eb-7b38-4134-b62c-f0cabaf39979">906</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzItNS0xLTEtMA_01e29f80-4d7f-43d2-8a65-c6ab44d41b9f">788</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQtMS0xLTEtMA_1de15a3e-0466-42c4-8ef2-bc1bcdf25e50">361</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQtMy0xLTEtMA_2cb01542-d144-49e6-911b-c134e73affbf">329</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQtNS0xLTEtMA_c5b50a0a-37db-41db-93fd-ade4670812e7">309</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUtMS0xLTEtMA_cfcf4264-958d-4044-a5e4-2cd92ec9d37c">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUtMy0xLTEtMA_b52839cc-e643-492b-9cc2-d14990bb0afc">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUtNS0xLTEtMA_dc0f76d3-4128-46a8-bed2-6f5d34e17845">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzYtMS0xLTEtMA_f9671ed6-ceac-4a47-8a55-1e87384ff359">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzYtMy0xLTEtMA_0faaeb2d-dea4-40dc-a3e1-a5cb4740063b">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzYtNS0xLTEtMA_e2226443-5a8c-4d37-b06b-344ee7da0d51">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzctMS0xLTEtMA_499d0c3e-0d12-4344-88bb-7650a8348d0c">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzctMy0xLTEtMA_2a458287-364f-42f5-9008-20a737b7940b">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzctNS0xLTEtMA_9a99ff7d-3e14-47c5-8bcb-7b1ce3538312">61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses (gains) on sale of property, plant and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzEzLTEtMS0xLTA_fce79422-605c-46a5-b13c-0c844d669e93">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzEzLTMtMS0xLTA_7ba16759-dc38-4898-9733-fe35c8da3472">70</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzEzLTUtMS0xLTA_0e574cfc-9629-4ba0-93e4-b0b385c744d7">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE0LTEtMS0xLTA_9ada0ed8-5149-4aac-8506-5e3fd8fceb79">81</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE0LTMtMS0xLTA_be5725d6-0bd8-4d76-b0e9-cfa5c16142c0">39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE0LTUtMS0xLTA_dac0f975-13e7-4e8f-870b-a5808b112951">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE2LTEtMS0xLTA_bc9ec78e-1a87-4947-b9c5-c8409ac453d0">455</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE2LTMtMS0xLTA_11b857e4-4d75-49a1-a1c1-38849ff7bf79">63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE2LTUtMS0xLTA_1fef0408-149a-47d2-baaf-72ef9626632a">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE3LTEtMS0xLTA_d65c6623-c40f-44e6-8303-27fc85db2742">452</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE3LTMtMS0xLTA_99d2225a-785e-45d9-8323-66b6445edae4">73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE3LTUtMS0xLTA_2e71ecbe-d1e1-406a-90d6-db2c14dc86f8">19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE5LTEtMS0xLTA_a3866d35-f5ab-489a-ac5b-aad020f35147">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE5LTMtMS0xLTA_89d45fe8-6b70-447a-a817-fbd4fcb092dc">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE5LTUtMS0xLTA_b82d1f5d-2d86-4387-8588-2fac1854bfe2">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Termination of interest rate swap agreements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="dgx:TerminationOfInterestRateSwapAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIwLTEtMS0xLTA_e4f67e62-63e9-4345-8fec-9dd6457d4baf">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="dgx:TerminationOfInterestRateSwapAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIwLTMtMS0xLTA_5a61ad74-d5bb-4535-81f0-fb081675b2b9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="dgx:TerminationOfInterestRateSwapAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIwLTUtMS0xLTA_d8434bff-84f6-4acd-920e-ed1d4c93f18b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIxLTEtMS0xLTA_84740c80-0caa-4d4a-87cd-0d5d8a27907d">37</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIxLTMtMS0xLTA_cf104e71-075b-47d8-b7bd-7a31884ee9fe">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIxLTUtMS0xLTA_08cf1b5a-7115-4acd-b1e9-37cd926586bc">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIyLTEtMS0xLTA_c5397371-ba1e-43b9-9494-4dae3b09d2cb">2,005</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIyLTMtMS0xLTA_a8500b4e-c3e2-443b-b2ed-94847474faa6">1,243</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIyLTUtMS0xLTA_7b54a957-3a6c-4779-9e13-47235a5661c0">1,200</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI1LTEtMS0xLTA_c293751b-00a3-49be-875a-4f3b8bf7e1c5">330</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI1LTMtMS0xLTA_28b81394-d6b6-4378-87c5-7b81a1079c55">58</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI1LTUtMS0xLTA_0f448c16-f8ae-4876-b19a-b072ca518d8e">421</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from disposition of property, plant, and equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI4LTEtMS0xLTA_b79421ab-58aa-4a4a-907b-9cb4a4cafb8e">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI4LTMtMS0xLTA_f5983133-aedf-4c4e-9001-bbfaffd1f390">91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI4LTUtMS0xLTA_f7f049c2-f433-40f0-89af-c006c1d47e06">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI5LTEtMS0xLTA_27d15b09-b962-407e-b02a-f1a370fd1aa9">418</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI5LTMtMS0xLTA_5a1cc752-1801-4681-aa47-0ebdbcdb6123">400</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI5LTUtMS0xLTA_1b6df91b-e7db-47af-b584-e595f568a94d">383</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Increase) decrease in investments and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMxLTEtMS0xLTA_fc9ec712-24ad-41e0-bd7f-c56833a02729">27</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMxLTMtMS0xLTA_f76ec52f-09cf-46c6-b9f4-2e587ac29e38">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMxLTUtMS0xLTA_8bd690d5-a7d1-4051-a266-914af831399b">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMyLTEtMS0xLTA_c3399eb8-9013-4fdf-ba60-c8e80f0c14d4">772</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMyLTMtMS0xLTA_db06c409-4c9f-4f91-9703-e08d93453664">411</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMyLTUtMS0xLTA_ae6bff72-56ee-4546-8010-00f17e754466">801</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM1LTEtMS0xLTA_82416094-79c2-40bb-8241-2c5f214471f1">749</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM1LTMtMS0xLTA_85cde062-28f9-42b5-9a8f-edb0d10532ae">2,281</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM1LTUtMS0xLTA_3bdb348e-ee1c-4f69-bb1b-3104d9ff17f7">2,090</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM2LTEtMS0xLTA_955fb804-5523-4c94-a10a-7b51e8c7972f">1,554</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM2LTMtMS0xLTA_61333944-4f64-429f-aa9b-62177c132bd1">1,449</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM2LTUtMS0xLTA_2264b46e-1a25-43c9-bd7c-5d85c085a6ef">1,966</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM3LTEtMS0xLTA_5f890008-4685-46c8-8cc6-f111f0df7bcb">325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM3LTMtMS0xLTA_05e97e4b-bdea-4907-9c67-6aad47c6962c">353</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM3LTUtMS0xLTA_c1c880b7-9813-4b8c-a9cd-1c6ab0d889b3">322</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM4LTEtMS0xLTA_8ae59104-bfdd-41fb-88d2-464e6f31c8ff">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM4LTMtMS0xLTA_270bc971-853d-488e-9421-ac6d2cdaa76a">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM4LTUtMS0xLTA_63cb7524-ad46-4725-b2d6-6e88d6de6c16">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM5LTEtMS0xLTA_7ad3fe6b-8811-4fca-a7c7-99b2f80a8696">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM5LTMtMS0xLTA_6c66d8e2-0be3-413a-95c3-dbf78e7507ed">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM5LTUtMS0xLTA_8f2d3d25-f970-4c87-857f-85353091ad69">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQwLTEtMS0xLTA_e2301604-141d-4445-9239-2604fee72fd0">297</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQwLTMtMS0xLTA_b8eaabbc-4351-4ce0-a546-5c30477edf58">286</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQwLTUtMS0xLTA_d43c47fb-1a5d-402c-8351-c80cfa65c92e">266</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQxLTEtMS0xLTA_5192df6f-4961-4a47-bd39-4ecb3ca94676">58</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQxLTMtMS0xLTA_15d89fc0-9d26-41a6-abd1-be3ce54a9f21">54</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQxLTUtMS0xLTA_f3fbab91-9575-4159-8dcf-f846bce0ffb9">54</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQzLTEtMS0xLTA_1865d019-d3ef-4270-b886-6f2089cd4075">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQzLTMtMS0xLTA_6d8b3329-68cc-4410-845b-a4adf07fca80">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQzLTUtMS0xLTA_debe9314-6487-47ec-87ae-c50477a1a1d6">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ1LTEtMS0xLTA_5beed050-64b3-4b43-a2fd-526bc269b010">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ1LTMtMS0xLTA_0a93a6d0-6f96-41d8-9540-619d18bece7e">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ1LTUtMS0xLTA_2ccf7bd5-6afb-447e-8f62-6109147b1dcd">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ2LTEtMS0xLTA_c8723eac-3a4a-41e3-8814-abd30ab11ba8">1,267</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ2LTMtMS0xLTA_4a847de7-9a50-49a8-84af-03b9d72292b2">225</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ2LTUtMS0xLTA_ebf876a3-4a20-4da8-9b48-3382335e51ae">401</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ4LTEtMS0xLTA_1719e6a1-e653-40d3-b601-4c3f4d5dafc7">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ4LTMtMS0xLTA_73dacfc6-57b0-4e69-8285-c3ca90087598">1,057</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ4LTUtMS0xLTA_4c611aab-74bd-4d2e-873a-08657ef66635">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUwLTEtMS0xLTA_f4783652-88ee-42eb-82dc-352610badbdb">1,192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUwLTMtMS0xLTA_9852658f-f832-47da-9dac-69899ffe7028">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79da04d8282d4c8291850645193b2909_I20171231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUwLTUtMS0xLTA_00daca45-e3e6-4275-9a53-e64c707792d7">137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, end of year</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUxLTEtMS0xLTA_d3e88463-0ab3-4e7d-b848-6445fb200804">1,158</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUxLTMtMS0xLTA_ef611611-45fa-40db-86ad-65672cea9d9c">1,192</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUxLTUtMS0xLTA_a7c1f65e-d7af-47ea-a844-cfa6d3df5ea3">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER&#160;31, 2020, 2019 AND 2018 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.187%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.436%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Shares of<br/>Common<br/>Stock Out-<br/>standing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/> Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Total Stock-holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2017</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2adde92f1a5461aba05c280fca9d09c_I20171231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItMS0xLTEtMA_1f8a7596-3e65-4005-8717-58d47f7adab1">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2adde92f1a5461aba05c280fca9d09c_I20171231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItMi0xLTEtMA_6ae3a82e-60fb-4a29-bba9-4fd10ab2786d">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if187f4fa5af24cc385cdcc159b5ef5cf_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItMy0xLTEtMA_753eab87-5776-4f30-9271-c0b1809884df">2,612</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ba55df515514c52893c724f25d5e5b2_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItNC0xLTEtMA_54023391-7476-4405-9b87-b76837128fd9">7,138</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14e2c4e502f24416aea41251e9a7a514_I20171231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItNS0xLTEtMA_776fc3f8-c72c-4436-86a8-80ed826378f4">48</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i930baaff13c549eabbf5ad24d956f10a_I20171231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItNi0xLTEtMA_85b23638-8876-45fc-a353-374fee869d7e">4,783</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab245fbfc314588851b15e6a8b204c7_I20171231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItNy0xLTEtMA_0932a732-3e16-46e6-83fd-b008a44f6061">34</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79da04d8282d4c8291850645193b2909_I20171231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItOC0xLTEtMA_30ed5997-037a-4135-b4dd-5b8382fbce9c">4,955</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79da04d8282d4c8291850645193b2909_I20171231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItMTEtMS0xLTA_720d3688-a6eb-4a30-a5e0-21cc3d49e2a8">80</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94226cbc95e4f099933504fa1529358_D20180101-20181231" decimals="-6" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMtNC0xLTEtMA_8d0786c3-2ecf-4f94-b99f-3aa91ac85865">736</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda80e73180744408f6bbd3ae90626ce_D20180101-20181231" decimals="-6" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMtNy0xLTEtMA_609d3b96-333f-4973-9831-61cf9f06f445">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMtOC0xLTEtMA_98ae7de7-e3ab-4ecc-997d-2df72dfd4e02">781</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMtMTEtMS0xLTA_c8c2a344-649a-4d8b-b342-253fb1ed9609">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQtNS0xLTEtMA_ce0fa630-f0b0-4eae-9e3c-d50dfec97617">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQtOC0xLTEtMA_d50b6029-0348-4621-80b1-86cf12ebb7e3">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib94226cbc95e4f099933504fa1529358_D20180101-20181231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzUtNC0xLTEtMA_07d820eb-fd3a-4e7e-90a7-b0e54ccd1b5f">274</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzUtOC0xLTEtMA_ba2da02f-1581-4c38-be78-42cce949cdee">274</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieda80e73180744408f6bbd3ae90626ce_D20180101-20181231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzYtNy0xLTEtMA_45ad4a7f-f57e-46f4-9aeb-28810227932f">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzYtOC0xLTEtMA_e54c4ee7-12a4-46be-89a3-20b28c874a49">44</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzYtMTEtMS0xLTA_ae318129-c5b9-4730-933c-cfb3db3c5085">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzctMy0xLTEtMA_ec0cb450-a74f-4fe3-b1ca-b8b135132366">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzctNi0xLTEtMA_4591ef3a-242d-4c80-b09a-dd48891e0e69">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzctOC0xLTEtMA_78c94679-a699-4dfa-9b38-c24c2666f2e9">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzgtMy0xLTEtMA_576d02ef-e7f4-4859-a4bc-bbe3d7e80ed7">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzgtNi0xLTEtMA_d13148d1-3935-4cfb-a133-e6d5407850b8">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzgtOC0xLTEtMA_fd180d66-40e8-470e-a776-d71b24fd297a">61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc23a2ce07eb4cab9ac46e9996f1a9da_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzktMS0xLTEtMA_bc061d55-d6b5-4596-a629-e40f49d7fe8d">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzktMy0xLTEtMA_134affa4-10ad-4d74-9923-fee39914d5dd">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzktNi0xLTEtMA_43c0f15d-b923-4835-8d7b-07b15053ede3">93</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzktOC0xLTEtMA_363f6dad-da56-4a73-94f9-76db237fe061">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEwLTMtMS0xLTA_cfac07fa-141c-4a0c-9524-320f6c0b9028">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEwLTgtMS0xLTA_526c9080-942d-442a-b6c8-d6d4ad7b867b">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idc23a2ce07eb4cab9ac46e9996f1a9da_D20180101-20181231" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEyLTEtMS0xLTA_fae1ac77-2ee8-45e6-a0c1-3e72b4138e17">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEyLTYtMS0xLTA_d386ecaa-d26a-44cb-b49d-d0826dee35ec">325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEyLTgtMS0xLTA_1698dbcc-e8e5-4b43-bc91-5f047dd8b1f6">325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Contributions from noncontrolling interest partners</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieda80e73180744408f6bbd3ae90626ce_D20180101-20181231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEzLTctMS0xLTA_36af24b6-f880-4f39-8be0-08f18601fb94">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEzLTgtMS0xLTA_575ae474-4fae-4e81-884c-b5a775020089">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Reclassification of stranded tax  effects resulting from enactment of the Tax Cuts and Jobs Act</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94226cbc95e4f099933504fa1529358_D20180101-20181231" decimals="-6" name="dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE1LTQtMS0xLTA_f050b597-cc8f-4dd6-9c84-01fb35691e80">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231" decimals="-6" sign="-" name="dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE1LTUtMS0xLTA_6ae681fb-f470-4edf-a552-432a19bf7545">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE1LTgtMS0xLTA_7e41c3c2-e8e7-4535-875e-a2a34f25403e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2018</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3b3e31d6d274c90b794939c176a7b77_I20181231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTEtMS0xLTA_767d1fbe-e86e-41fa-ae6c-d7093b7b6247">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b3e31d6d274c90b794939c176a7b77_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTItMS0xLTA_ffeda07e-0c96-4af1-afde-a67906197d80">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c6477bf68d434b85bfce824998f2ee_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTMtMS0xLTA_509198f8-4c18-44b4-977e-9a0ee4b697d4">2,667</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67fd5ab592cb4dd3942ac4292d19633a_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTQtMS0xLTA_d0e30270-005a-45c8-906a-66935a2a6617">7,602</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0ce225b8594c6a86f10f4f1abe8e39_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTUtMS0xLTA_4e14170a-aa6b-4a7d-879b-abdc848fa616">59</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i555d3026ca444d259517b679c5239f46_I20181231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTYtMS0xLTA_6d7308ec-858d-4890-b9a4-af34c7bb3e51">4,996</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f4f32dc2af94a159626591aaf9de348_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTctMS0xLTA_7bfef0e3-8b18-497d-8d8e-3bd340d44dd2">51</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTgtMS0xLTA_5002fbe4-4dcd-4324-8225-a5963cb9d437">5,267</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTExLTEtMS0w_a4af0758-63fd-4047-97b6-2e7aaea227f9">77</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7163fcb9b04409a8a0d9696060f250_D20190101-20191231" decimals="-6" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE3LTQtMS0xLTA_b2b9f4b2-a229-49b2-ae8c-adc8d0087d32">858</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie567c107fbeb4e04816dbbef6a7bffb2_D20190101-20191231" decimals="-6" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE3LTctMS0xLTA_71bc41cc-980d-41ff-8c30-2ed3a2f48010">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE3LTgtMS0xLTA_9703439a-a86c-472c-bed1-09333973d5a8">900</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE3LTExLTEtMS0w_2df388ec-c214-4363-8c53-4e6e623bbec9">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE4LTUtMS0xLTA_c39290ba-1196-4018-a2eb-6b1355916389">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE4LTgtMS0xLTA_349702f4-d5c4-43b6-a5c3-90124b593d02">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe7163fcb9b04409a8a0d9696060f250_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE5LTQtMS0xLTA_51286497-4ae5-4dff-9959-acaf502740e6">286</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE5LTgtMS0xLTA_4c5fa144-b56a-4d1d-8f5c-e017a05a3202">286</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie567c107fbeb4e04816dbbef6a7bffb2_D20190101-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIwLTctMS0xLTA_490385df-1f9b-4e00-a099-1312df3761b5">47</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIwLTgtMS0xLTA_ff77d526-0d32-4c7b-8390-236e11ee9bf5">47</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIwLTExLTEtMS0w_ecea7580-6613-459d-866a-876a4e31ca31">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIxLTMtMS0xLTA_0777af38-36ba-44c8-91f6-a2d2008cd4b4">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIxLTYtMS0xLTA_1c44dff7-af3b-4a4b-b839-c576c7fbbd16">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIxLTgtMS0xLTA_48a08c61-4be5-4a5f-a081-ba34f359742c">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIyLTMtMS0xLTA_8d9ec04f-0237-4420-b216-f43d9efc3117">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIyLTYtMS0xLTA_0f28d24d-3e17-4980-a53b-62b0fe823763">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIyLTgtMS0xLTA_303d1e90-6dd4-477e-a27a-52d0260d6523">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i115773febea64e13b53405dd26daabf7_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIzLTEtMS0xLTA_7753977e-20cb-44f2-9137-3876553478bf">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIzLTMtMS0xLTA_72fa66b9-a3f8-49b9-b78c-1bd3ec648e30">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIzLTYtMS0xLTA_fd538f30-68f0-4909-b005-c905e466995a">112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIzLTgtMS0xLTA_bf3c3293-1dd1-4840-af05-1f3f0a56fe5a">119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI0LTMtMS0xLTA_00ffba34-c621-4638-8b21-bb9f9d1abc89">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI0LTgtMS0xLTA_af85f59f-b739-4507-bdb4-db192bb23473">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i115773febea64e13b53405dd26daabf7_D20190101-20191231" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI2LTEtMS0xLTA_6aaf6975-213f-46e1-94cd-d9d72652dce0">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI2LTYtMS0xLTA_4d83792f-b4af-4cd7-86c7-861f71dccc7e">350</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI2LTgtMS0xLTA_0dfd4c89-cf6b-48d0-af62-184b8791cfda">350</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1dd09031318c470d8f39dd4c76ee0f42_I20191231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTEtMS0xLTA_e380a6e4-d63f-44c8-90dc-062cf44f8764">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd09031318c470d8f39dd4c76ee0f42_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTItMS0xLTA_aebe07a2-e3ab-48e2-8b3a-65f96cb0d0a7">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7cb1556ee64aad934a266328c5feb8_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTMtMS0xLTA_590bc3dc-b0f0-4551-a1d6-adf5317457a5">2,722</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5538d27d3cf4309be1e10b072ade004_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTQtMS0xLTA_27259ecc-0561-4f2c-a189-a9e67dac11df">8,174</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a7f39f717a41848294a65ad208374f_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTUtMS0xLTA_0919b3fb-4867-4443-a9c3-d1ddee8316de">39</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1868c09b2e774ccf815153a8ec738276_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTYtMS0xLTA_0dee0a04-f9ee-42c5-b710-7154f3298265">5,218</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b7931aebebd467eab54c73e0a052b8b_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTctMS0xLTA_8460e29b-e696-48e3-bc8b-87d35752c41f">46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTgtMS0xLTA_da718308-6d2b-4eaf-bdbb-1a80c8d3157c">5,687</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTExLTEtMS0w_1f7cb5ba-7524-487b-8a99-abe4939b3cef">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75af2f2e63234a768a4f963e010f642a_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMxLTQtMS0xLTA_25d7b739-1890-4902-87f4-868bf18fa4b3">1,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f9ff7ef1303400184e1457d527c79ba_D20200101-20201231" decimals="-6" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMxLTctMS0xLTA_d7bf2d03-760f-4afe-87e7-7cb255886922">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMxLTgtMS0xLTA_ed580bec-0e9c-48c4-8b41-1fd646d91ff2">1,484</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMxLTExLTEtMS0w_ddc41542-5a48-4c64-bdd1-762beb0450f1">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMyLTUtMS0xLTA_7f33f288-75c7-4e73-a06b-9562eebea78b">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMyLTgtMS0xLTA_cdcc7646-0e99-4ffa-809c-a273fb71f605">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Dividends declared</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75af2f2e63234a768a4f963e010f642a_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMzLTQtMS0xLTA_ead438de-bc1e-4c32-b2ac-fe10cc743300">302</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMzLTgtMS0xLTA_eb6d3ade-a9e2-4ff9-981c-16527eee213e">302</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f9ff7ef1303400184e1457d527c79ba_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM0LTctMS0xLTA_1b4c120d-9cea-458c-87fc-3f33540c97ba">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM0LTgtMS0xLTA_6aed6852-66b7-4d4a-aba0-553c6d28d7cc">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM0LTExLTEtMS0w_407873fd-cd5e-4024-9674-be417336c15b">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3aa95b24c6da4e29ba0be0001d98ee6f_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM1LTEtMS0xLTA_330335d4-afb1-496c-82ec-862b20c62beb">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2981e27108c24f95953c617cc7270437_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM1LTMtMS0xLTA_7a64fc8b-579b-400e-93bd-e212a4af2b05">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM1LTYtMS0xLTA_f0c295dd-8e71-4da4-95ca-add1073f337d">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM1LTgtMS0xLTA_a072b228-7683-4d2f-8720-68d825c96884">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2981e27108c24f95953c617cc7270437_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM2LTMtMS0xLTA_a5a42aeb-c0ad-46e3-a6e5-2dad2b104eab">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM2LTgtMS0xLTA_79571370-7a3e-4f0a-8dac-edd924e9e2be">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3aa95b24c6da4e29ba0be0001d98ee6f_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM3LTEtMS0xLTA_e005c163-ded4-453c-9655-3f0ce5707aa6">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2981e27108c24f95953c617cc7270437_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM3LTMtMS0xLTA_57f30262-2e63-4acc-b688-86fd6bba7877">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM3LTYtMS0xLTA_fd6e5635-765c-4a1d-a8ad-09bb9359a07a">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM3LTgtMS0xLTA_35165c82-65e5-47a2-abc5-cd5f42f6e42c">189</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2981e27108c24f95953c617cc7270437_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM4LTMtMS0xLTA_6e4f218d-d5da-45b2-909f-b5ad5875e369">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM4LTgtMS0xLTA_d7e71f6b-984e-4ea0-b9dc-ea1103c1ffda">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3aa95b24c6da4e29ba0be0001d98ee6f_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM5LTEtMS0xLTA_ed497a5f-26c5-4597-a331-6d0983ca8d42">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM5LTYtMS0xLTA_8ffac86d-1221-4345-8506-b29dc95e4615">325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM5LTgtMS0xLTA_6c694a15-9681-44ab-a076-a68958317446">325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92ba93e0278a4f689344c35f78cc1de4_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTEtMS0xLTA_f44ce5b0-961c-49d5-8ce9-4c475b3fe2c8">133</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ba93e0278a4f689344c35f78cc1de4_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTItMS0xLTA_ae9b3dd3-5e11-40ea-8027-f20f7144f582">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71632adeaf9840789ac22fcbe1d4ab41_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTMtMS0xLTA_14bcc337-9b6e-44c4-9f0e-da32960e453f">2,841</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd49c909bbf34ee8ac8ef91267017389_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTQtMS0xLTA_84d24b7a-e7b6-4d13-853d-07d3981f2f22">9,303</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15c1b65002784549a102581ed4f9ec6b_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTUtMS0xLTA_2312cf29-2f18-4645-be47-811be6ba70c1">21</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37b30b92632f4bb7b032b7a33f542c34_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTYtMS0xLTA_593298fa-d5ab-48c8-a2c8-e31ad06cb590">5,366</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if93dc28be267444d8934097d07d281a0_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTctMS0xLTA_e94b45e8-aa51-45ed-8dcf-b535f4bba91b">50</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTgtMS0xLTA_94751198-8ec3-4f9a-b27e-23bb47491583">6,809</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTExLTEtMS0w_c1fd01b0-cd88-4212-97d7-0fb8047dacd7">82</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_163"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div style="text-align:center"><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_166"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjYvZnJhZzoyZjI3NjBjYjkzMmY0MzA0Yjg3NTI0ZjZmYmU2OTkyYy90ZXh0cmVnaW9uOjJmMjc2MGNiOTMyZjQzMDRiODc1MjRmNmZiZTY5OTJjXzE3NTA_f7ede858-994e-4242-9ff8-ce559fe42cd5" continuedAt="i7128f9e08aeb41e5a2485cdec441ffca" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i7128f9e08aeb41e5a2485cdec441ffca"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</span></div></ix:continuation><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_169"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjk0_c08a70af-42f9-47bd-8477-97daa946fc93" continuedAt="i43de87f7b7574882aaf1b1e57104c7c2" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i43de87f7b7574882aaf1b1e57104c7c2" continuedAt="id44a6278d0a74ee8bbb6998b81e09d7a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjY0_467ca85a-ba80-44df-b067-487a2c7dd7e7" continuedAt="i3d183a649b7a4c4e92703c6f92e03daa" escape="true">The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#8220;VIEs&#8221;) in which the Company has a variable interest and for which the Company is the &#8220;primary beneficiary&#8221; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3d183a649b7a4c4e92703c6f92e03daa">&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjIw_2f9899c8-77e8-4349-9034-55240fed6587" escape="true">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 21 for a further discussion of discontinued operations.</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Reclassifications</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjU5_39438c9f-ef92-4080-9cda-5b923aa93bb4" escape="true">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements.</ix:nonNumeric> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="id44a6278d0a74ee8bbb6998b81e09d7a" continuedAt="ifdbc929b8cbc408b9308c128e36340b7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjk2_b252adbd-e5fd-48e6-9d2c-0c7e4e4ecc58" escape="true">Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between <ix:nonFraction unitRef="number" contextRef="i4536b39c8fa64a308c3b9a68dc9e82ab_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE5OTk_510bbae9-72e4-4e54-affe-66f458ede54e">20</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3bf2fc1a93c943d987e412080b37ceb5_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIwMDY_405360ae-9e12-4993-9918-8dd0215996f4">49</ix:nonFraction>%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</ix:nonNumeric>&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjIx_ecbbba1c-eaa5-4e17-85d5-8466913de997" escape="true">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</ix:nonNumeric>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjcy_f185eaaf-d03d-404b-a835-7e266cca383b" escape="true">The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately <ix:nonFraction unitRef="number" contextRef="i9bc00e25bfc644b48820a7fd5b03ba76_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzM1MDA_651646f4-4756-418c-ab54-1dedbedb2571">11</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ibd9a84f00e01401a9a6b093b0dc83ae7_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzM1MDQ_24a01ab2-e642-41c9-b565-521ec092dfbd">15</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3ac9f8df65254c228ccb0893cb2bcae7_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzM1MTE_d12a7109-d11f-4661-baa2-7d8ae03a68a1">16</ix:nonFraction>% of the Company's consolidated net revenues for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes on Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjMx_a8fdb5e8-8a60-4bf1-b84c-df3b631d25dd" escape="true">The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position.</ix:nonNumeric> </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjM2_a0ed27e6-c8e1-4850-97b5-32ad6c80e312" escape="true">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#8220;ELTIP&#8221;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#8220;DLTIP&#8221;).  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="ifdbc929b8cbc408b9308c128e36340b7" continuedAt="ib3e69f51a9394b109ac90bb69cec9cba"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjI2_e34f9139-f836-43ac-847d-2d1160e09b8e" continuedAt="i609ea0389b37486fa4dcde22c9c8f102" escape="true">The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost</ix:nonNumeric></span><ix:continuation id="i609ea0389b37486fa4dcde22c9c8f102"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.</span></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNTk5_2f837f8c-a59e-43f8-bd33-278c6a300d9f" continuedAt="i13477ff569e04d20b40a1c452b4025d0" escape="true">The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i13477ff569e04d20b40a1c452b4025d0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 1: Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjEz_7c36b4b3-0142-41f2-add6-947e01b72fd4" escape="true">The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating expense (income), net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjc4_6e6f2c03-15d8-40ff-af93-8e87019794a6" escape="true">Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="ib3e69f51a9394b109ac90bb69cec9cba" continuedAt="i97062c0e90914c6ebff075a28ee0a7e3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjA4_e9018092-76a4-47c7-9201-377bd3ac866f" escape="true">Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and is limited to certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of December&#160;31, 2020 and 2019, receivables due from government payers under the Medicare and Medicaid programs represented approximately <ix:nonFraction unitRef="number" contextRef="i581470f6c29c4d3bbb553be7ce613857_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzExNDA4_fea49c38-8c74-4323-b36d-1f3d3a13341c">6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ief7b1c30e21b4abe80d55c1558999325_I20191231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzExNDE1_72bdb8ad-4f01-46d9-82a3-645e6a2f2c1a">11</ix:nonFraction>%, respectively, of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2020 and 2019, receivables due from patients represented approximately <ix:nonFraction unitRef="number" contextRef="id931c5900d5344649f91ba0b0016de0c_I20201231" decimals="2" name="dgx:PercentageofReceivablesDueFromPatients" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzEwNDQ1MzYwNTE5ODM2_2c4c6b64-1bad-43ad-96e0-d5fcd47bfa33">11</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ifb24d45e71f14152b0beee33dd6fe7b8_I20191231" decimals="3" name="dgx:PercentageofReceivablesDueFromPatients" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzExNjgx_9e147ec7-ae24-43b1-ae8a-e1ee17473bcc">20</ix:nonFraction>%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dgx:AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjU1_9383d8b6-6b41-48f8-956b-16d834178424" continuedAt="iff86ec9ae5684bd683e5407e014cd501" escape="true">Accounts receivable are reported net of allowances for credit losses.  </ix:nonNumeric></span></div><ix:continuation id="iff86ec9ae5684bd683e5407e014cd501"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNzIy_5b4671db-47f7-48a7-8566-4bc3e437eebb" escape="true">Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.</ix:nonNumeric>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjM5_9b070949-87d2-4518-b334-1e55839f2959" continuedAt="id8f6bb33a0fd48d2b07250ee63cb3d78" escape="true">Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2020 as follows: </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id8f6bb33a0fd48d2b07250ee63cb3d78"><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">buildings and improvements, ranging up to thirty-one and a half years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory equipment and furniture and fixtures, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDgy_7012da4d-00be-4056-8e53-6cc514ee15da">five</span> to <ix:nonNumeric contextRef="i4fa47ff8680e47e186c2a067dad4395c_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDg4_da7548cf-74cc-4eb9-b09e-d6d3c69ea3b1">twelve years</ix:nonNumeric>; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computer software developed or obtained for internal use, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njky_056ade57-4241-451a-a1e9-095ca78772c6">five</span> to <ix:nonNumeric contextRef="i76c1d7dadde4494c96e7166dd2fa23a9_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njk4_8bce2674-8995-4194-bdaa-e77e09477b04">ten years</ix:nonNumeric>.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i97062c0e90914c6ebff075a28ee0a7e3" continuedAt="ice9b0e75df68490b93b8b67534a8c8e5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjA5_849b7ae8-c35a-4187-8930-108ec9782fc7" continuedAt="i2f6c23ea2ff94d26b9653d6b428a1fcd" escape="true">Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2f6c23ea2ff94d26b9653d6b428a1fcd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.  For the year ended December&#160;31, 2019, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjAz_b26f8f45-0c30-4058-a8c8-fd03e7ea44f3" continuedAt="i3cdf4dd5b6e946ddab5b1ad81506453d" escape="true">Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQx_017f65e9-fcca-4642-991b-5a831db9e67f">five</span> to <ix:nonNumeric contextRef="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQ3_6128722f-d0b9-4a96-9939-0b1dbe3fd8ab">twenty years</ix:nonNumeric>.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="ice9b0e75df68490b93b8b67534a8c8e5" continuedAt="ib6bb6453759347b2bf0cc20e47f7c171"><ix:continuation id="i3cdf4dd5b6e946ddab5b1ad81506453d"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Based upon the Company&#8217;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2020 and 2019, the Company concluded that indefinite-lived intangible assets were not impaired.</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNTg3_afcd6c1d-3747-414e-a587-5eb6f9c63f01" continuedAt="i7c586c3e06df4b05b616c18eee4e5d40" escape="true">The Company's investments (except for those accounted for under the equity method of accounting), are included in other assets in the consolidated balance sheet and include:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7c586c3e06df4b05b616c18eee4e5d40"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments with readily determinable fair values which are comprised of participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income (expense), net in the consolidated statements of operations.  For the years ended December&#160;31, 2020, 2019 and 2018, gains and (losses) from these equity securities totaled $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzEwNDQ1MzYwNTE4NTY0_cdff4d87-0159-424d-bb82-1ce53a9b7f3e">8</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIwNjQ4_1c8e395f-78f6-40bb-bd95-735cbb92b443">10</ix:nonFraction> million, and $(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIwNjU2_6351eda7-1e73-4739-9d80-9aa2221b2f65">2</ix:nonFraction>) million, respectively.  The carrying value of these investments were $<ix:nonFraction unitRef="usd" contextRef="iff8b5e5555da40068d37c37923c31be5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TradingSecuritiesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzEwNDQ1MzYwNTE4NTQw_08bebd6a-793e-447a-8628-2344b5de966b">67</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ibe9d4b35706146759a8e29e92296d796_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TradingSecuritiesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIwNzI3_03f6b434-dbf6-4acc-809d-14e2367a8e6f">59</ix:nonFraction> million at December&#160;31, 2020 and 2019, respectively.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; <ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="0" format="ixt-sec:numwordsen" name="dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMTc3_8c5abe28-a689-4e8d-9858-59d1f677dcc8"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="0" format="ixt-sec:numwordsen" name="dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMTc3_c9b0b7fe-5837-41ec-b5f1-c1b684441e89"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="0" format="ixt-sec:numwordsen" name="dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMTc3_e7845de4-a06c-4c64-bbdd-71148090a293">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment charges were recognized related to these investments for the years ended December&#160;31, 2020, 2019, and 2018.  The carrying value of these investments was $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMzMz_6aea7c13-362b-4307-814c-e64a84e482b9"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMzMz_dbb51803-8344-48f8-ae69-0449dc75d941">25</ix:nonFraction></ix:nonFraction> million at both December&#160;31, 2020 and 2019.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxNjAx_15490825-c620-4b88-9f52-dae68182cab3"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxNjAx_b708b957-3fa3-44ac-bfb4-60b1ba43093f">12</ix:nonFraction></ix:nonFraction> million at both December&#160;31, 2020 and 2019.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjQ5_65f8017a-b8a6-4a12-bb42-22a2dc863023" continuedAt="ie847c0de045540239d81d1ca8de49a46" escape="true">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="ib6bb6453759347b2bf0cc20e47f7c171" continuedAt="icb47ee61f07d4bb2b5935d8e69733211"><ix:continuation id="ie847c0de045540239d81d1ca8de49a46" continuedAt="idc931c2f3bee4530a5948ca788e41109"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idc931c2f3bee4530a5948ca788e41109">&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income (expense), net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:StockholdersEquityPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNzI0_ee3358f6-cff3-46fd-82b9-dd8bc906cc97" continuedAt="if4be7998c34e4cd6929fc81d33c18976" escape="true">Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if4be7998c34e4cd6929fc81d33c18976" continuedAt="ie43ff995223745e6ada0fdc6c3dad30a"><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities; and </span></div></ix:continuation><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie43ff995223745e6ada0fdc6c3dad30a" continuedAt="i319815f910ff4613be0f670a7ab709df">&#8226;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:continuation id="i319815f910ff4613be0f670a7ab709df">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16).</ix:continuation>  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjg1_1183369c-743a-4091-8ef8-4f21b32ab771" continuedAt="ifcc9c4a211e84be9b75ed088f25e7e2f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="ifcc9c4a211e84be9b75ed088f25e7e2f" continuedAt="i18965b059d824c5da4cc5dc980ccc87c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the Financial Accounting Standards Board ("FASB") which aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.  The adoption of this standard, which the Company elected to do on a prospective basis, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the FASB that changes the impairment model for most financial instruments, including trade receivables, from an incurred loss method to a new forward </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="icb47ee61f07d4bb2b5935d8e69733211" continuedAt="ia60daa4f35f44e31a2202f2749c6b61e"><ix:continuation id="i18965b059d824c5da4cc5dc980ccc87c" continuedAt="ic16b09f587114f7cbb35ef6195e903af"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">looking approach, based on expected losses.  The estimate of expected credit losses requires entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts.  The adoption of this new standard, which was done using a modified retrospective transition approach, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.  See "Accounts Receivable and Allowance for Credit Losses" in this footnote for further details on the Company's allowance for credit losses policy.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2019, the Company adopted a new accounting standard issued by the FASB on accounting for leases using the modified retrospective method. This new accounting standard requires a lessee to recognize on its balance sheet an asset and liability for most leases. The Company elected the optional transition method that allowed for a cumulative-effect adjustment to the opening balance of retained earnings recorded on January 1, 2019 and did not restate previously reported results in the comparative periods.  The Company also elected the package of practical expedients, which among other things, allowed it to carry forward its historical lease classification. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a result of adoption of the new standard, the Company recorded operating lease assets and lease liabilities of approximately $<ix:nonFraction unitRef="usd" contextRef="ic81a1f6e1fcc43198cf6c34688f73ef0_I20190101" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxOTkwMjMzMTgwNTg_8ad4c698-721c-40a5-a533-bfa67e0a7f39">500</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic81a1f6e1fcc43198cf6c34688f73ef0_I20190101" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxOTkwMjMzMTgwODY_634fb3b1-4918-457b-8d94-0a20354c8e10">550</ix:nonFraction>&#160;million, respectively as of January 1, 2019.  The operating lease liability was determined based on the present value of the remaining minimum rental payments and the operating lease asset was determined based on the value of the lease liability, adjusted for the deferred rent balances of approximately $<ix:nonFraction unitRef="usd" contextRef="i1b9a18afbf954307bc8e506be81cbe70_I20190101" decimals="-6" format="ixt:numdotdecimal" name="dgx:DeferredRentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxOTkwMjMzMTgxMTM_043204ee-1c4f-4680-9e78-b3b8de2c8b97">50</ix:nonFraction>&#160;million, which were previously included in accounts payable and accrued expenses as well as other liabilities in the consolidated balance sheet.  Accounting for the Company's finance leases remained substantially unchanged.  The adoption of the new standard did not materially impact the Company's consolidated results of operations or cash flows.</span></div><div style="text-indent:38.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the adoption of this new accounting standard resulted in increased qualitative and quantitative disclosures regarding the amount, timing, and uncertainty of cash flows arising from leases. For further details, see Note 14.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards To Be Adopted</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="ia60daa4f35f44e31a2202f2749c6b61e" continuedAt="i2b1c68af56c04aeb8413b9a294d42670"><ix:continuation id="ic16b09f587114f7cbb35ef6195e903af" continuedAt="i285e92dc4880463586cc1974c3ff1aae">&#160;&#160;&#160;&#160;</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2b1c68af56c04aeb8413b9a294d42670"><ix:continuation id="i285e92dc4880463586cc1974c3ff1aae">In March 2020, the FASB issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</ix:continuation></ix:continuation>&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_175"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzc3NDc_39b9175c-13dd-4cc7-b6a9-2b6225125426" continuedAt="i9745f72e148a44eba02a5853f6fd6e9b" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9745f72e148a44eba02a5853f6fd6e9b" continuedAt="i5df8c60dc4e844ebb2a7d65721454c4f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i29c671e617c045bcb06b53c554e033e0_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzEwNA_2a80342c-6593-4f01-9eb7-b27e9cea3064"><ix:nonFraction unitRef="number" contextRef="i9de3b9dd0a624ae68544d4880991cf82_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzEwNA_789f5cd0-709b-4831-a748-eb10be631f11"><ix:nonFraction unitRef="number" contextRef="if585a3710daf402a97611004eea949c1_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzEwNA_84f3135a-23c8-4c55-8f55-1946a3e9752e">95</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total net revenues for the years ended December&#160;31, 2020, 2019 and 2018 and are primarily comprised of a high volume of relatively low-dollar transactions.  The DIS business, which provides clinical testing services and other services, satisfies its performance obligation and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions, as discussed below. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers, client payers and patients.  Contracts with customers in the DIS business do not contain significant financing components based on the typical period of time between performance of services and collection of consideration.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The process for estimating revenues and the ultimate collection of accounts receivable involves significant judgment and estimation.  The Company follows a standard process, which considers historical denial and collection experience and other factors (including the period the receivables have been outstanding), to estimate contractual allowances and implicit price concessions, recording adjustments in the current period as changes in estimates.  Further adjustments to the allowances, based on actual receipts, may be recorded upon settlement.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i5df8c60dc4e844ebb2a7d65721454c4f" continuedAt="i3a91bad1f1774d0c918e78deaabff95f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following are descriptions of the DIS business&#8217; portfolios:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Insurers </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from healthcare insurers are based on negotiated fee-for-service schedules and on capitated payment rates.  Under fee-for-service arrangements, healthcare insurers are billed at the Company's list price.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and the terms of the Company&#8217;s contractual arrangements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of the Company's net revenues from healthcare insurers is normally a function of providing complete and correct billing information to the healthcare insurers within the various filing deadlines and generally occurs within <ix:nonNumeric contextRef="i6eea2c55b034437ba80ba06e3965157c_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzI4Mzg_5bad0566-53d3-49ec-8a15-2fad8b5f645d">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i77c9bd2166d847329c826595afad408b_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzI4NDQ_0b761d37-752b-478e-bbba-1f1e39920070">60</ix:nonNumeric> days of billing.  Provided the Company has billed healthcare insurers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and if so, it will reserve accordingly for the billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under capitated arrangements with healthcare insurers, the Company recognizes revenue based on a predetermined monthly reimbursement rate for each member of an insurer's health plan regardless of the number or cost of services provided by the Company.  Healthcare insurers typically reimburse the Company under capitated arrangements in the same month services are performed, essentially giving rise to no outstanding accounts receivable at the end of a reporting period.  If any capitated payments are not received on a timely basis, the Company determines the cause and makes a separate determination as to whether or not the collection of the amount from the healthcare insurer is at risk and, if so, would reserve accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Payers</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from government payers are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and other factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of the Company's net revenues from government payers is normally a function of providing the complete and correct billing information within the various filing deadlines and generally occurs within <ix:nonNumeric contextRef="i0b01ba3ff27b4ed39eb31b8ed8e1b653_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzQ2MzU_baf38a1a-2686-483c-a794-b7f280df9465">30</ix:nonNumeric> days of billing.  Provided the Company has billed government payers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and, if so, it will reserve for the billing accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Client Payers </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Client payers include physicians, hospitals, ACOs, DCEs, IDNs, employers, other commercial laboratories and institutions for which services are performed on a wholesale basis, and are billed based on negotiated fee schedules.  Credit risk and ability to pay are more of a consideration for these payers than healthcare insurers and government payers.  Collection of consideration the Company expects to receive generally occurs within <ix:nonNumeric contextRef="ic4b549cd3a3d4d348d914417e72845c3_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzU0NzI_3c640902-d7c4-4dd8-b0f0-d441c81a69ef">60</ix:nonNumeric> to <ix:nonNumeric contextRef="i4019a241c0854daab20a021259e4c9f9_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzU0Nzg_7c6c45c1-cd8b-4a89-a9fd-c4d105092d42">90</ix:nonNumeric> days of billing.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company principally estimates the allowance for credit losses for client payers based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding. To the extent that any individual client payers are identified that have deteriorated in credit quality, the Company establishes allowances based on the individual risk characteristics of such customers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patients</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i3a91bad1f1774d0c918e78deaabff95f" continuedAt="i52607d22b4174d759072c199885d7c51"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients.  Insured patients (includes coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers.  Collection of billings from patients is subject to credit risk and ability of the patients to pay.  Net revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with the Company&#8217;s policies and implicit price concessions.  Implicit price concessions represent differences between amounts billed and the estimated consideration the Company expects to receive from patients, which considers historical collection experience (including the period the receivables have been outstanding) and other factors including current market conditions. Patient billings are generally fully reserved for when the related billing reaches <ix:nonNumeric contextRef="ifcb29cd72cb14152805c1b85799d4c7a_D20200101-20201231" format="ixt-sec:durday" name="dgx:PeriodofBillingFullyReserve" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzY3NjI_0bbb5214-e2af-40ed-95d0-f3e735f50553">210</ix:nonNumeric> days outstanding.  Balances are automatically written off when they are sent to collection agencies.  Allowances are further adjusted for estimated recoveries of amounts sent to collection agencies based on historical collection experience, which is regularly monitored.  Collection of consideration the Company expects to receive generally occurs within <ix:nonNumeric contextRef="ie8b8bafd84534ecfa78e8dc260538826_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzcxMjA_8bbadd57-2212-4df2-8d25-58828366245d">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i2ccba44e5f4a40efb5fa7b5d55920320_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzcxMjY_90736009-b6d8-42d9-8c26-4cd1c5a733d5">60</ix:nonNumeric> days of billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered.  Collection of consideration the Company expects to receive generally occurs within <ix:nonNumeric contextRef="if014b0d6144e489c86cc32ab7f88bc09_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzczOTM_21acb058-5af3-45b5-96d5-0d97eb26b53e">30</ix:nonNumeric> to <ix:nonNumeric contextRef="i348dfcaea5c4487f8852b9106d40158f_D20200101-20201231" format="ixt-sec:durday" name="dgx:RevenueCollectionofConsiderationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzczOTk_d2df5e37-a2f3-4163-a684-f8a6e3aa7a4b">60</ix:nonNumeric> days of billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzc3NTA_a4c913b3-d4a8-4656-984b-9674d5b547e7" continuedAt="i0faac7fe528e4c5181b2cf16e5d7af4e" escape="true">The approximate percentage of net revenue by type of customer was as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i0faac7fe528e4c5181b2cf16e5d7af4e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:62.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.702%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia52723062e0945b0b050cdad8b6e84ca_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzMtMS0xLTEtMA_84b13c9d-7b70-4e95-acf0-1a6f1848d178">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b77dcd1e3264ddbbfc39c8cb976394a_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzMtMy0xLTEtMA_d6b36cbe-5f95-4878-8a16-23e7e569c8af">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id46ed269b0314d81abc231a84b687522_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzMtNS0xLTEtMA_bab7f71c-837b-4bc0-a9d8-8c8585ce2590">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1ba00c793ebf4cd4aef56d2438bd0c77_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzQtMS0xLTEtMA_339327a0-2922-490a-b893-ed040df961c0">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49c3be8da8bb40cfada15e955553b6f3_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzQtMy0xLTEtMA_f73071d1-148b-48df-97d1-3f3d5cbec218">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3716ed1635444a1db24339ff3c1ee6b4_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzQtNS0xLTEtMA_46f24fe6-87a3-4033-aaf7-186b627e0a8e">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iacb5aef155d741e9acbdddbaa368b0a8_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzUtMS0xLTEtMA_08004e2c-00a1-4fcc-90fb-26a205fb96b6">37</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0e0d2b48b134218ab9fe6ae972ccc18_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzUtMy0xLTEtMA_abc4fde7-8bd6-414a-a14f-d1e4d576481c">36</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifae49365342b454dadab2010496cdb33_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzUtNS0xLTEtMA_fbb7735b-e8ad-499c-9a8e-ecf98373c648">35</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9bc00e25bfc644b48820a7fd5b03ba76_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzYtMS0xLTEtMA_651646f4-4756-418c-ab54-1dedbedb2571">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibd9a84f00e01401a9a6b093b0dc83ae7_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzYtMy0xLTEtMA_24a01ab2-e642-41c9-b565-521ec092dfbd">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ac9f8df65254c228ccb0893cb2bcae7_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzYtNS0xLTEtMA_d12a7109-d11f-4661-baa2-7d8ae03a68a1">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24a36f7ed0c74323a2fa29fbf45031a6_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzctMS0xLTEtMA_792ebe09-23c0-4db7-a2b6-38a95a7cb8d7">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7c506d404ea4b66a4fc8535a8907e45_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzctMy0xLTEtMA_9fd9aaeb-151a-4933-82e7-79afd69684d3">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba4d37f590c64c0da8af33c3f247ce79_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzctNS0xLTEtMA_cc4530b6-59f8-4b15-9bf7-1f147e233005">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifcb29cd72cb14152805c1b85799d4c7a_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzgtMS0xLTEtMA_12e307e2-2fd7-48d2-b161-ab8c5f0bbcab">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9fb51ebe236448f590ad554101a9b9c6_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzgtMy0xLTEtMA_10fdb7d0-7ecd-4233-9fd3-35e46b1e47ae">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea687d8906104369b661d038cde542bd_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzgtNS0xLTEtMA_9e47ba58-def0-4f29-a1b4-13aab814a9e4">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzktMS0xLTEtMA_c4294434-1ef3-4a24-a0e5-6d5541dd97aa">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzktMy0xLTEtMA_7cffcb0d-2b21-4e98-8bb0-3fcf599a063e">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzktNS0xLTEtMA_4d88babd-4e4b-4626-adc1-baf94b661358">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5734074de09c4b53a530f4b9f89b68ad_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzEwLTEtMS0xLTA_1af7a47f-03dc-41ae-aa4b-466bc05de8cb">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45b1a79458e1445fa42674f9f2d678ab_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzEwLTMtMS0xLTA_7eb0b0b3-e705-4d29-ae19-52eae9d24651">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ca59367e3f94c41a84556b97c86bdbb_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzEwLTUtMS0xLTA_c16b8928-5eff-4873-9971-15ad671b7c3f">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzExLTEtMS0xLTA_2dfae373-a026-4b40-a928-bfaecf70ce46">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzExLTMtMS0xLTA_2f860d48-b467-4969-b897-c50407fb4667">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzExLTUtMS0xLTA_c8cc2af6-6b43-4b5b-bb8a-1cbb4a0a2e6f">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, substantially all of the Company&#8217;s services were provided within the United States, see Note 19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dgx:AccountsReceivableDisaggregationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzc3NTE_58259dc3-2599-4e9a-8c3c-f57c6f70457a" continuedAt="i3781e14987bb4a4c9f7e1cfe592b345c" escape="true">The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2020 and 2019 was as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i3781e14987bb4a4c9f7e1cfe592b345c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:74.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id83f485f0e424cc0b613c7b977010fa5_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzItMS0xLTEtMA_cbe8e01a-49d7-4fe0-bab5-699c697d6178">34</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d87850a80eb4b4babfe02021d7d3c4d_I20191231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzItMy0xLTEtMA_b0e9b5ee-f686-42e5-937e-daac94d32580">22</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i581470f6c29c4d3bbb553be7ce613857_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzMtMS0xLTEtMA_fea49c38-8c74-4323-b36d-1f3d3a13341c">6</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief7b1c30e21b4abe80d55c1558999325_I20191231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzMtMy0xLTEtMA_72bdb8ad-4f01-46d9-82a3-645e6a2f2c1a">11</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i09aa4abe117b4d52b3a8808dab5026d6_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzQtMS0xLTEtMA_f210a37e-32cc-4a93-8ca1-4640855bcf7c">46</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c2eebecc91f4f99994187f91e6cf8ef_I20191231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzQtMy0xLTEtMA_56a4da26-41ea-4e4a-9a57-16cf87ea87fc">42</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id931c5900d5344649f91ba0b0016de0c_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzUtMS0xLTEtMA_97c5549c-c5ab-4e10-9ba4-6d34702b9a7e">11</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb24d45e71f14152b0beee33dd6fe7b8_I20191231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzUtMy0xLTEtMA_4970b3ae-d8ab-4c11-b0e7-de7032cf448a">20</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic85598bd2b86456e91558360409ce887_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzYtMS0xLTEtMA_e51c96be-0f07-454b-9dba-8995759465b4">97</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8246072e29d64600b0af97728d423a90_I20191231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzYtMy0xLTEtMA_7f35aa87-4857-4983-94ab-f78cbee23427">95</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icfc7590e98964831a39bf2babda2f26c_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzctMS0xLTEtMA_61ef8021-5435-4590-9ebb-f877fb7e6adf">3</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9773cd12324249bdad8bba77790feceb_I20191231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzctMy0xLTEtMA_34f835f6-aa2b-45e4-b6aa-c1002bdc1a77">5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzgtMS0xLTEtMA_8d7d9149-2abc-42c5-8723-14923794a269">100</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzgtMy0xLTEtMA_cd785a47-0c58-45d7-8e9d-e11f1a48acbb">100</ix:nonFraction>%</span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i52607d22b4174d759072c199885d7c51"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzQ5NDc4MDIzMzU4MDA_24ba442b-2c07-4bd0-bfa5-73406e44f198" continuedAt="i5c75b029f2ab4d33915be4d635e7356e" escape="true">The following table summarizes the activity for the Company's allowance for credit losses during the year ended December&#160;31, 2020, which principally relates to client payers:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i5c75b029f2ab4d33915be4d635e7356e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Credit Losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTplYjc3MGU4ZjdhN2Y0NjQwYTAxNzY5MjgxYWJhOTIzZS90YWJsZXJhbmdlOmViNzcwZThmN2E3ZjQ2NDBhMDE3NjkyODFhYmE5MjNlXzItMS0xLTEtMTY5NA_8e9ad984-875e-40fb-951f-f5c925b321d4">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTplYjc3MGU4ZjdhN2Y0NjQwYTAxNzY5MjgxYWJhOTIzZS90YWJsZXJhbmdlOmViNzcwZThmN2E3ZjQ2NDBhMDE3NjkyODFhYmE5MjNlXzMtMS0xLTEtMTY5NA_f2bb301a-69a5-4a3b-b9d9-b6fc56172b7c">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTplYjc3MGU4ZjdhN2Y0NjQwYTAxNzY5MjgxYWJhOTIzZS90YWJsZXJhbmdlOmViNzcwZThmN2E3ZjQ2NDBhMDE3NjkyODFhYmE5MjNlXzQtMS0xLTEtMTY5NA_30f5f5f8-343b-4fe3-837d-7a6098f7207a">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2020</span></div></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTplYjc3MGU4ZjdhN2Y0NjQwYTAxNzY5MjgxYWJhOTIzZS90YWJsZXJhbmdlOmViNzcwZThmN2E3ZjQ2NDBhMDE3NjkyODFhYmE5MjNlXzUtMS0xLTEtMTY5NA_a453af5d-25ab-4772-ba8c-5e786c1fd8da">28</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_181"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90ZXh0cmVnaW9uOjVlNWZmN2FmZjQ4MjQzNDY4ZDQ1ODQzNzlmZjdiMjNjXzI5NQ_3a47bee3-b00f-4404-98b4-c78fd80305a8" continuedAt="ifd8add18ac0b446991daba94bda7040e" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifd8add18ac0b446991daba94bda7040e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90ZXh0cmVnaW9uOjVlNWZmN2FmZjQ4MjQzNDY4ZDQ1ODQzNzlmZjdiMjNjXzI5Mw_880c4288-8d59-4f08-8699-bfdec060bfe3" continuedAt="ifbfefcc2c1e0431096f65ad6096d1992" escape="true">The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ifbfefcc2c1e0431096f65ad6096d1992"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzItMS0xLTEtMA_78bb0a6b-d1a3-4340-a314-c33e0e91188d">1,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzItMy0xLTEtMA_b2cac41a-7e94-4cd9-bab6-c656618535e5">838</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzItNS0xLTEtMA_73ce7356-148d-41fa-8a7d-16c6f2859411">736</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzMtMS0xLTEtMA_8676d368-dfb5-4ed1-bc50-617482a864ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzMtMy0xLTEtMA_6055e6bf-4ae3-4f88-b755-45b9666c0757">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzMtNS0xLTEtMA_c2e2777c-1381-4b01-b52e-4f295e12594e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics' common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzQtMS0xLTEtMA_d711e33d-d87f-479b-af45-1c16670ec69e">1,431</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzQtMy0xLTEtMA_d42307b6-f384-4ed8-9da1-6abf9c4b23bb">858</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzQtNS0xLTEtMA_b35e3d38-4665-4362-9fa1-22355a9d0c26">736</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzYtMS0xLTEtMA_b954860e-d87b-4fec-b553-88670e0d701f">1,431</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzYtMy0xLTEtMA_39ff06ce-e322-4c04-9774-63260942f90e">838</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzYtNS0xLTEtMA_f24b7e7d-6e3e-478b-8ab0-229e0a768a41">736</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzctMS0xLTEtMA_2ed778be-f599-4acf-bba7-9a3157a4d411">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzctMy0xLTEtMA_71a8af9d-0066-45af-ba8d-1fb860f13fa0">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzctNS0xLTEtMA_7aa248a6-5d6c-493b-9bac-5b4a21caa81d">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzgtMS0xLTEtMA_bf0a3916-bd42-44dd-82b7-add5e0763499">1,425</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzgtMy0xLTEtMA_3741ef99-f6d0-44bd-bdeb-4a43ca1e1405">835</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzgtNS0xLTEtMA_7f87776d-fd88-47c5-9283-c034ca83ae98">733</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEwLTEtMS0xLTA_fcdd2d33-759f-4e52-8141-927825c05261">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEwLTMtMS0xLTA_a3be71c8-a83a-4315-80c2-d0515a1e6807">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEwLTUtMS0xLTA_2ee02bd8-f493-41e1-a3b3-011991fde25d">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEyLTEtMS0xLTA_4ad9dfd0-b7dd-4651-bc67-22159cb01c80">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEyLTMtMS0xLTA_bc22b039-362c-4c52-b337-f0652619530c">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEyLTUtMS0xLTA_20a7c574-7cc9-4824-8f37-d051568fa746">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEzLTEtMS0xLTA_126236f8-2634-411e-ab93-80819696cbba">136</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEzLTMtMS0xLTA_e38fd575-2897-4f38-b364-5751536f62e4">136</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEzLTUtMS0xLTA_51d4cb7a-0a7a-4aa9-bf23-381471f20ba4">139</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE2LTEtMS0xLTA_510a3b88-693a-4cce-970f-cc1a6b7d7f25">10.62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE2LTMtMS0xLTA_1b006825-1829-464c-9cfe-d56907b0b26c">6.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE2LTUtMS0xLTA_ac12fce7-6a7f-422b-966d-c0311d79a99e">5.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE3LTEtMS0xLTA_dd9d63a2-ef66-4df4-acd9-5d05200d3483">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE3LTMtMS0xLTA_7b2a5afb-76e5-43f5-b78a-23e33fdb232a">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE3LTUtMS0xLTA_396e7290-400e-4e35-a749-42a53abda969">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE4LTEtMS0xLTA_6266b02f-bf6a-4fa5-aaa7-7fe6d785b08f">10.62</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE4LTMtMS0xLTA_447732e2-1a62-4ccf-916e-c400fc4df42e">6.36</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE4LTUtMS0xLTA_8b48f3d4-2258-4a33-96f7-02fa64333d87">5.39</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIxLTEtMS0xLTA_b44dbd75-f30f-4df2-a63a-6e08df055cd0">10.47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIxLTMtMS0xLTA_70e99fdb-039e-4caa-ae1c-8cf56cfe551d">6.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIxLTUtMS0xLTA_e890b404-0f64-48e9-8724-3a13d59115a6">5.29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIyLTEtMS0xLTA_11a1cfae-7622-4d8b-89eb-a744299cc677">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIyLTMtMS0xLTA_b4ea33fd-4fb7-462a-84ca-d2ad6b817d60">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIyLTUtMS0xLTA_2f5f781c-24f1-4476-a39c-b2791a00e22b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIzLTEtMS0xLTA_0d311596-1020-4084-b3fc-8c051901742c">10.47</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIzLTMtMS0xLTA_19d4d753-c152-40a6-a56e-2c75b32eca87">6.28</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIzLTUtMS0xLTA_11bec738-f58a-406f-bd88-c0470e9b5f60">5.29</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90ZXh0cmVnaW9uOjVlNWZmN2FmZjQ4MjQzNDY4ZDQ1ODQzNzlmZjdiMjNjXzI4MQ_6870fbf4-1a26-4473-9050-f165f1def7ec" continuedAt="ia57d7aa9db6b42ee96d4979de3bae377" escape="true">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ia57d7aa9db6b42ee96d4979de3bae377"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZTo3NmEzMmJhY2NhNTY0YzQ5OGJiMzU2MmZjMWE0ZTYxZC90YWJsZXJhbmdlOjc2YTMyYmFjY2E1NjRjNDk4YmIzNTYyZmMxYTRlNjFkXzItMS0xLTEtMA_ecdf90bf-42df-4096-a2c0-87fa6848bbd2">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZTo3NmEzMmJhY2NhNTY0YzQ5OGJiMzU2MmZjMWE0ZTYxZC90YWJsZXJhbmdlOjc2YTMyYmFjY2E1NjRjNDk4YmIzNTYyZmMxYTRlNjFkXzItMy0xLTEtMA_c54afd39-f520-45aa-b3a8-455c5902a770">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZTo3NmEzMmJhY2NhNTY0YzQ5OGJiMzU2MmZjMWE0ZTYxZC90YWJsZXJhbmdlOjc2YTMyYmFjY2E1NjRjNDk4YmIzNTYyZmMxYTRlNjFkXzItNS0xLTEtMA_ae25da21-6537-4830-9fcd-60ce4ec4f034">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_184"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzI3MTk_92d52f8e-0557-4a09-afb0-d9ed8ddee3de" continuedAt="i1534d26a6a9444a8b79759572534b4c3" escape="true">RESTRUCTURING ACTIVITIES</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i1534d26a6a9444a8b79759572534b4c3" continuedAt="ia7051456fdee4d29a5e6b51c30a8d97f"> </ix:continuation></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="ia7051456fdee4d29a5e6b51c30a8d97f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Invigorate Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is committed to a program called Invigorate which is designed to reduce its cost structure and improve performance.  Invigorate consists of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; service excellence; lab excellence; and revenue services excellence.  In addition to these programs, the Company identified key themes to change how it operates including reducing denials and patient price concessions; further digitizing the business; standardization and automation; and optimization initiatives in the areas of lab network and patient service center network. The Invigorate program is intended to partially offset reimbursement pressures and labor and benefit cost increases; free up additional resources to invest in science, innovation and other growth initiatives; and enable the Company to improve service quality and operating profitability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Restructuring Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzI3MjA_a04de1b1-6e2b-4979-a54b-de698cdb7157" continuedAt="i4b6f3b9743dd4da0b406bab64252c732" escape="true">The following table provides a summary of the Company's pre-tax restructuring charges for the years ended December&#160;31, 2020, 2019 and 2018: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i4b6f3b9743dd4da0b406bab64252c732"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee separation costs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzItMS0xLTEtMA_541d4f5f-ff46-4a03-bb7c-d81b731c5195">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2731fc599e44eebad216d560288aa5_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzItMy0xLTEtMA_4e709950-0192-4b36-ad59-548d940e7373">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf32401c784f6282df17d6217338a3_D20180101-20181231" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzItNS0xLTEtMA_88690b53-0c10-403d-9e40-5d9ed17a8f7f">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility-related costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzMtMS0xLTEtMA_2045d0f1-1026-4c3a-9b09-6c99d98e894d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2731fc599e44eebad216d560288aa5_D20190101-20191231" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzMtMy0xLTEtMA_8bda9060-9cb8-42ad-b02a-0049c3ec48ed">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf32401c784f6282df17d6217338a3_D20180101-20181231" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzMtNS0xLTEtMA_ced7b285-ac7e-47b8-8a37-38896be9de70">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charges</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzQtMS0xLTEtMA_145a3e51-7664-48c3-88a1-0cb0da4cb332">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2731fc599e44eebad216d560288aa5_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzQtMy0xLTEtMA_36130173-e53a-4c7d-8179-4a8e2fe53991">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf32401c784f6282df17d6217338a3_D20180101-20181231" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzQtNS0xLTEtMA_064690e4-4aa7-41e4-99f4-53ae3c38df2a">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzYtMS0xLTEtMA_15e71c11-e1eb-4bd4-ac83-b9e916ce25dd">14</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2731fc599e44eebad216d560288aa5_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzYtMy0xLTEtMA_a2097660-d508-49c1-b6a8-b8a4169c306b">2</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cf32401c784f6282df17d6217338a3_D20180101-20181231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzYtNS0xLTEtMA_8252feea-527a-46f0-9552-0df90a904c1f">51</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The restructuring charges incurred for the year ended December&#160;31, 2020 and 2018 were primarily associated with various workforce reduction initiatives as the Company continued to simplify and restructure its organization.  The restructuring activity incurred for the year ended December&#160;31, 2019 primarily represents a release of the liability relating to restructuring charges recorded in prior periods, which were determined to no longer be required.  Of the total restructuring charges incurred during the year ended December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i50637c6aa27f4b9f88abbcb41129c619_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzE2OTk_5718f44e-44aa-4184-afcd-a089cef72665">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie9e3619ec877416abb976607a2ecb8a4_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzIxOTkwMjMyNTg5NjE_e2c2014c-3544-404f-b482-19190f807e6f">5</ix:nonFraction>&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.  The $(<ix:nonFraction unitRef="usd" contextRef="ic7d5052a7f794e77a5d8ecd713c12c6c_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzE4OTc_02da20fa-7ba5-46d2-9aa0-bbcac91b5846">2</ix:nonFraction>) million of restructuring charges recognized during the year ended December&#160;31, 2019 were recorded in selling, general and administrative expenses.  Of the total restructuring charges incurred during the year ended December&#160;31, 2018, $<ix:nonFraction unitRef="usd" contextRef="ib4c69355f4e54414844cb3cf76a843b9_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzIwNzY_e610cd82-a6c3-4463-8031-d29839702327">22</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib030f85555694c49b8643f2d91b9693a_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzIwODM_6eb65a21-a9c7-48f0-a379-dbd02e173478">29</ix:nonFraction> million were recorded in cost of services and selling, general and administrative expenses, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Charges for all periods presented were primarily recorded in the Company's DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzI3MTU_cba2dc88-b52a-4a92-9fc9-4aac4e817878" continuedAt="i9f398490aead44339ff8ce17aeab1e9c" escape="true">The following table summarizes the activity of the restructuring liability during 2020 and 2019, which is included in accrued expenses in Note 12:  </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i9f398490aead44339ff8ce17aeab1e9c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:62.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Separation Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Facility-Related Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2018</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f4ed9e9a914e47a81066fd180c145e_I20181231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzItMS0xLTEtMA_96aeac33-f034-47c6-a346-173fcb570f56">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9ca495276140aebb8a6db9bff67956_I20181231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzItMy0xLTEtMA_fb51fa7a-c8e2-42af-9a21-2ffcc2ead3eb">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzItNS0xLTEtMA_f4acfdbf-6b54-4596-8a75-84b6057d64d2">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac7825e2fb043728473edf6a486a568_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzMtMS0xLTEtMA_b8760546-34a2-40d8-bb16-fde393f3a63d">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3955951503f44fe3acd85937ac7a0bc4_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzMtMy0xLTEtMA_d54cbc9d-0d94-4208-97b3-ac23b8e792f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzMtNS0xLTEtMA_198fb523-8040-4f1a-bca1-d3c56134caf9">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac7825e2fb043728473edf6a486a568_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzQtMS0xLTEtMA_7ad9ee78-d9a7-4c58-b255-330b29e2c508">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3955951503f44fe3acd85937ac7a0bc4_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzQtMy0xLTEtMA_95ce0820-e946-4e99-ae5e-e1517b3bcf61">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzQtNS0xLTEtMA_fdadf355-91e7-4ba2-a904-6390b840d26e">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac7825e2fb043728473edf6a486a568_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReservePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzUtMS0xLTEtMzM5Mw_7967d9b6-8053-42fa-833f-9065b22f6bc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3955951503f44fe3acd85937ac7a0bc4_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:RestructuringReservePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzUtMy0xLTEtMzM5Ng_75a5430e-a562-4cc7-829b-53ff47262359">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:RestructuringReservePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzUtNS0xLTEtMzM5OQ_a8244495-cd73-4448-ac41-478727080460">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2019</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f306c25282f4e34bc09d94f5699bb70_I20191231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzYtMS0xLTEtMA_625b8338-563f-47a9-a170-68b8985685d1">9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d8ddb3ab9d49528f059c8a9bca7418_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzYtMy0xLTEtMA_038e1ba1-88b3-4436-bcbf-6c815b021746">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzYtNS0xLTEtMA_fba8fd09-9292-4698-b5df-66f9f0900de6">9</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b59ca556114cfdb36009a1e4663f57_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzctMS0xLTEtMA_b4f623f2-4232-43ba-bff8-41381b93d24c">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ee8ae71172430080535b5a0dd4856b_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzctMy0xLTEtMA_bca41e18-4049-4e4a-aea0-8cc88a257576">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzctNS0xLTEtMA_ac6f33ae-5662-47fb-901b-e0b6db3bdb6d">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8b59ca556114cfdb36009a1e4663f57_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzgtMS0xLTEtMA_1beb8aa3-dde1-49ae-91ee-a9f06c08f58a">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58ee8ae71172430080535b5a0dd4856b_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzgtMy0xLTEtMA_25d21b74-d844-4866-a5d7-5d0cbfdd3a75">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzgtNS0xLTEtMA_3d85ff55-3420-4832-9aa6-5db7993f6886">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2020</span></div></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i280c67ee68804035b46f2faa9dce6680_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzEwLTEtMS0xLTA_ff86b2c7-1fb8-4d21-af98-f9247ee446ee">7</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a6ab703d4d84efbb36e4f1d64e0fadc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzEwLTMtMS0xLTA_d2c77ef6-c685-4eae-a477-bb880374001b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzEwLTUtMS0xLTA_75f1c9cf-d8fc-4732-825c-095b211c6f65">7</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_187"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEwOTA4_983f7df4-c20a-4ba1-9890-241f4ee28c0b" continuedAt="iea191979e9404578b93d39e25bd983c1" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="iea191979e9404578b93d39e25bd983c1" continuedAt="i967712b12273491b9d5b0f953038539b">&#160;&#160;&#160;&#160;2020 Acquisitions</ix:continuation></span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i967712b12273491b9d5b0f953038539b" continuedAt="i93eff9efc4a34dfb9a8dfa0dd2a1c52f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company completed acquisitions for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDg1Njg_70e2fc6a-8046-4e64-a692-492a81cf66f3">330</ix:nonFraction>&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2020 acquisitions resulted in goodwill of $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDg1ODI_ac357e90-319a-497f-95d2-8ec28bb76d3f">247</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDk1MTY_b7e2bc67-db51-4292-a167-fd4a0662032e">210</ix:nonFraction>&#160;million is deductible for tax purposes.  These acquisitions also resulted in $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDg2MTA_5b01b530-3c86-41b5-b804-457e0a5cae14">146</ix:nonFraction>&#160;million of intangible assets, principally comprised of customer-related and technology intangible assets.  Net revenues attributable to the 2020 acquisitions were $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessAcquisitionPostacquisitionRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDg2MjQ_872b2471-25a4-4115-8d32-74b11cbe1843">127</ix:nonFraction>&#160;million for the year ended December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Blueprint Genetics Oy</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 21, 2020, the Company completed its acquisition of Blueprint Genetics Oy ("Blueprint Genetics"), in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i27711a12139e4ecc82c168186cb5ebe9_D20200121-20200121" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI2OTI_14599628-b8a1-4484-b93b-6276b3b2db55">108</ix:nonFraction>&#160;million, net of $<ix:nonFraction unitRef="usd" contextRef="i27711a12139e4ecc82c168186cb5ebe9_D20200121-20200121" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3MDY_a61da349-74b5-4fa7-8ebc-5190ee4b37d6">3</ix:nonFraction>&#160;million cash acquired.  Blueprint Genetics is a leading specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing and proprietary bioinformatics.  Through the acquisition, the Company acquired all of Blueprint Genetics' operations.  In the fourth quarter of 2020, the Company made an election to treat the acquisition as a taxable business combination for income tax purposes, which resulted in an adjustment to the preliminary purchase price allocation to reverse the previously recorded $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzcyMjk_fa8b59b6-1f8f-4714-a83a-f091f88432e8">11</ix:nonFraction>&#160;million deferred tax liability, with a corresponding decrease to goodwill. Based on the final purchase price allocation, the assets acquired and liabilities assumed primarily consist of $<ix:nonFraction unitRef="usd" contextRef="i9bacdce196024c839a813e482b5f95f0_I20200121" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3MTg_019ed159-f77c-404f-989e-7bacaba27261"><ix:nonFraction unitRef="usd" contextRef="i9bacdce196024c839a813e482b5f95f0_I20200121" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3MTg_36d35e48-1f32-4867-8609-4331d9e80def">66</ix:nonFraction></ix:nonFraction>&#160;million of tax-deductible goodwill, $<ix:nonFraction unitRef="usd" contextRef="i9bacdce196024c839a813e482b5f95f0_I20200121" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3MzE_1f8d4ea4-3464-46cb-9f82-3cdfac9f0259">43</ix:nonFraction>&#160;million of intangible assets, and $<ix:nonFraction unitRef="usd" contextRef="i9bacdce196024c839a813e482b5f95f0_I20200121" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3NTc_152fc8ea-e967-49cf-befd-00648f6191b2">2</ix:nonFraction>&#160;million of property, plant and equipment and working capital.  The intangible assets primarily consist of technology and customer-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="idb09fcb6511f47edabcbc8b6c3de97e7_D20200121-20200121" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3Njg_cabd66b9-6de7-498b-9aed-ccb6ee5a9c33">10</ix:nonNumeric> years and<ix:nonNumeric contextRef="iba3f50b191484f5a975775bb5bcd79c0_D20200121-20200121" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3Njk_44e3ff0f-760f-4666-8e2b-4a50f5bdeae9">15</ix:nonNumeric> years, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Outreach Laboratory Services Business of Memorial Hermann Health System</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company completed its acquisition of select assets which constitute substantially all of the operations of Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System ("Memorial Hermann"), in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i9c610e7bc66145a9a5c3d919c604c9d1_D20200406-20200406" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3NzE_ad5acf99-9171-4eb9-b09e-27b1c8d36c93">120</ix:nonFraction>&#160;million.  Memorial Hermann is a not-for-profit health system in Southeast Texas.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $<ix:nonFraction unitRef="usd" contextRef="if2a967045abe4853ac22eaf7f12d73ce_I20200406" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3ODU_5694cf95-29a0-4c81-bbce-399a4d971ec3">27</ix:nonFraction>&#160;million of customer-related intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i5bc58d2181184b70abf43e0a7797a61f_I20200406" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3OTg_6d18e059-6615-409e-8793-d0226b860140"><ix:nonFraction unitRef="usd" contextRef="i5bc58d2181184b70abf43e0a7797a61f_I20200406" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3OTg_776032f1-1ce4-48d6-82ea-a536106f297c">93</ix:nonFraction></ix:nonFraction>&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of <ix:nonNumeric contextRef="i09ff1a062aca4dd091930d26abdc94aa_D20200406-20200406" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4MTI_60a66a3f-968a-4ca7-a078-c1f8b4373c14">15</ix:nonNumeric> years.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Remaining <ix:nonFraction unitRef="number" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4MTQ_0b8466b4-1f24-4d1a-8ff5-042d907f901d">56</ix:nonFraction>% Interest in Mid America Clinical Laboratories, LLC</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On August 1, 2020, the Company completed its acquisition of the remaining <ix:nonFraction unitRef="number" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4MTk_3c933b0a-7436-4df0-ac81-31aa8aaf369c">56</ix:nonFraction>% interest in Mid America Clinical Laboratories, LLC ("MACL") from its joint venture partners in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i0ce66de126184e10bbe6987c714abe61_D20200801-20200801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4MjQ_21879a28-f9f7-44b9-b020-b1ac20d4c9f7">93</ix:nonFraction>&#160;million, net of $<ix:nonFraction unitRef="usd" contextRef="i0ce66de126184e10bbe6987c714abe61_D20200801-20200801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4Mzc_c8d517b5-c0bc-4138-9887-fa446b684975">18</ix:nonFraction>&#160;million cash acquired.  MACL is the largest independent clinical laboratory provider in Indiana.  Prior to the acquisition, the Company accounted for its <ix:nonFraction unitRef="number" contextRef="i4b7731ca50f644dbae4378dcde7faab9_I20200731" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI5NDU_b34c5082-cd17-46c8-97ea-6a25df90f911">44</ix:nonFraction>% interest in MACL as an equity method investment, which was remeasured to its fair value of $<ix:nonFraction unitRef="usd" contextRef="iae2b0a12d36246ed98b91815583efc9d_D20200731-20200731" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI5NTA_298901b7-fb01-449e-a739-93628e9ad27e">87</ix:nonFraction>&#160;million on the acquisition date, resulting in a gain of $<ix:nonFraction unitRef="usd" contextRef="ibb19efad8ebc48d8bf627a6c143d9f22_D20200801-20200801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI5NjQ_95fc7c2f-e180-4852-85fc-6e2267208b5f">70</ix:nonFraction>&#160;million that was recognized in other income (expense), net in the consolidated statements of operations.  The fair value of the previously held equity interest was determined using a discounted cash flow analysis that takes into account, among other items, MACL's expected future cash flows, long-term growth rate (<ix:nonFraction unitRef="number" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="3" name="dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwMzY_361bb109-5756-4827-a7d5-e08d2471aa73">1.5</ix:nonFraction>%), and a discount rate commensurate with economic risk (<ix:nonFraction unitRef="number" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="3" name="dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwNDI_a0329c95-4329-4086-b9d7-ef61153c7655">7.5</ix:nonFraction>%).  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $<ix:nonFraction unitRef="usd" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwNDg_dbcef9dd-98ae-4745-ace8-d0e20f276786">84</ix:nonFraction>&#160;million of goodwill (of which $<ix:nonFraction unitRef="usd" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwNjE_0bf3e87b-bf12-452b-8afd-f57e9edd6236">47</ix:nonFraction>&#160;million is tax-deductible), $<ix:nonFraction unitRef="usd" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwNzQ_9e7e7f5b-a9dd-4f38-9116-82997f59689d">74</ix:nonFraction>&#160;million of intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwODc_b9ce39d3-f09a-4b71-9da0-31e5ee42da15">11</ix:nonFraction>&#160;million of working capital and $<ix:nonFraction unitRef="usd" contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMxMDA_28643f18-3121-4293-8d46-56e9b63de69e">11</ix:nonFraction>&#160;million of property, plant and equipment.  The intangible assets consist of customer-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="i10cf574e9c2e4d21a2695ebf75df7d6c_D20200801-20200801" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMxMTI_02593768-fabd-4095-839e-06f82641154c">15</ix:nonNumeric> years.  As a result of the acquisition, MACL became a wholly owned subsidiary of the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2019 Acquisitions</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2019, the Company completed acquisitions for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEzNA_47b754e5-4eb9-4c9f-94b9-e8a54e4e0520">63</ix:nonFraction> million, including the acquisition discussed below.  The 2019 acquisitions resulted in goodwill of $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIyOA_36b88cba-8ee8-40e9-80ae-71bb778543e3">43</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzI0MQ_1e950936-11af-4581-81a7-852d1e2adaf8">36</ix:nonFraction> million is deductible for tax purposes.  These acquisitions also resulted in $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMxMw_81f0afc5-fbd0-46bc-ae75-6de57a593dc7">21</ix:nonFraction> million of intangible assets, principally comprised of customer-related intangibles. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Clinical Laboratory Services Business of Boyce &amp; Bynum Pathology Laboratories, P.C.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i93eff9efc4a34dfb9a8dfa0dd2a1c52f" continuedAt="ibace591f22394f96b309f30097c0c04c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 11, 2019, the Company completed its acquisition of certain assets of the clinical laboratory services business of Boyce &amp; Bynum Pathology Laboratories, P.C. ("Boyce &amp; Bynum") in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="ice7bbcc9e8ed4ad2ade3ad58246561b0_D20190211-20190211" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzcxOQ_e270bdbf-2dcd-4d28-83f3-c4d6e6fb68ed">61</ix:nonFraction> million, which consisted of cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ice7bbcc9e8ed4ad2ade3ad58246561b0_D20190211-20190211" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzc2NA_13959056-eaef-494e-a25f-3be67e3eb044">55</ix:nonFraction> million and contingent consideration initially estimated at $<ix:nonFraction unitRef="usd" contextRef="i61272b36e8f248a490bc5be2a3a5cbeb_I20190211" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzgxOQ_ad3a2fc1-8bbd-426c-b2e0-46f5a6fdb062">6</ix:nonFraction> million.  The contingent consideration arrangement was dependent upon the achievement of certain testing volume benchmarks.  During 2019, the liability was reduced to $<ix:nonFraction unitRef="usd" contextRef="i131dd7c4ae56411b91d4494e08f2395b_I20191231" decimals="INF" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzk4MA_dffc7e85-91ae-4f63-8a0b-354daea0f841">0</ix:nonFraction> as a result of updated testing volume forecasts for the earn-out period compared to the testing volume target included in the contingent consideration arrangement, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i2baa36a831dc45c59aff0f947d0f6d27_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzExNjI_5395ca58-2df1-4c37-a875-683e263ea756">6</ix:nonFraction> million gain recorded in other operating expense (income), net.  Based on the purchase price allocation, the assets acquired principally consist of $<ix:nonFraction unitRef="usd" contextRef="i6895b862b93d4f9db033b2c8960868fe_I20190211" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEzMDU_06a7f334-4ccb-4516-bfcb-a3a8df09533b">41</ix:nonFraction> million of goodwill (of which $<ix:nonFraction unitRef="usd" contextRef="i6895b862b93d4f9db033b2c8960868fe_I20190211" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEzMzA_ab4583c4-8623-495b-85a2-7789264cdff0">35</ix:nonFraction> million is tax deductible) and $<ix:nonFraction unitRef="usd" contextRef="id7b3a596687e4a388e56161f877b4099_I20190211" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEzNTY_74b7bdf4-da71-46f4-8113-67c3b6bfd2f4">20</ix:nonFraction> million of customer-related intangible assets.  The intangible assets are being amortized over a useful life of <ix:nonNumeric contextRef="ibcbcfd24bcb54356a9bf41706902f795_D20190211-20190211" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE0NjE_0e6351f7-22ba-45c3-a1bc-899363309b40">15</ix:nonNumeric> years.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2018 Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2018, the Company completed acquisitions for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE2NjE_51d63beb-9abc-47e4-96ff-8d24c22e3116">440</ix:nonFraction> million, net of cash acquired, including the acquisitions discussed below.  The 2018 acquisitions resulted in goodwill of $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="dgx:GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE3Nzg_816b7266-921f-4e7b-9a64-dee36f9917a3">241</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE3OTE_2c1562de-1c40-4dfe-bf21-79d010d62d37">205</ix:nonFraction> million is deductible for tax purposes.  These acquisitions also resulted in $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE4NjM_f18f8500-820f-4ea4-b88f-e02c88962e9f">167</ix:nonFraction> million of intangible assets, principally comprised of customer-related intangibles.  Net revenues attributable to the 2018 acquisitions were $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessAcquisitionPostacquisitionRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIwMDA_3f56ebbb-fa57-40d7-9fcf-f30e5dab420c">84</ix:nonFraction> million for the year ended December 31, 2018.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Mobile Medical Examination Services, LLC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2018, the Company completed its acquisition of Mobile Medical Examination Services, LLC. ("MedXM"), a leading national provider of home-based health risk assessments and related services, in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="if3dead11eb114dcbb814658459773ee1_D20180201-20180201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIyNDc_f298c2d8-2063-4fbc-b39a-21aeb3bd4bb0">142</ix:nonFraction> million, net of $<ix:nonFraction unitRef="usd" contextRef="if3dead11eb114dcbb814658459773ee1_D20180201-20180201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIyNTg_8d86e9c2-bd80-4fd5-8a41-c93ac1525eea">5</ix:nonFraction> million cash acquired, which consisted of cash consideration of $<ix:nonFraction unitRef="usd" contextRef="if3dead11eb114dcbb814658459773ee1_D20180201-20180201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIzMTc_497c09a2-be2e-454c-a541-bff9890c25d7">130</ix:nonFraction> million and contingent consideration initially estimated at $<ix:nonFraction unitRef="usd" contextRef="i05fafb7616b247759bbe4a101ccfe88d_I20180201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIzNjI_9fe72d2a-dc17-451c-b8a5-58c974b078fa">12</ix:nonFraction> million.  The contingent consideration arrangement was dependent upon the achievement of certain revenue targets.  Subsequent to the acquisition, the estimated fair value of the contingent consideration was reduced to $<ix:nonFraction unitRef="usd" contextRef="i7c9edd27d62d479f8d54c3850fa9b9c2_I20181231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzI1NzQ_14f32e83-6aa5-4a2e-8456-5a37fb1aea5b">0</ix:nonFraction> as a result of updated revenue forecasts for 2018 compared to the earn-out revenue target included in the contingent consideration arrangement, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i42b26f40687b440793ed6325db576f39_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzI3MzY_e6e8f424-4478-4c93-9c35-e00f720cae6f">12</ix:nonFraction> million net gain recorded in other operating expense (income), net.  Through the acquisition, the Company acquired all of MedXM's operations.  The assets acquired and liabilities assumed consist of $<ix:nonFraction unitRef="usd" contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMwMjY_906670bb-59e9-4c5e-b430-b1fd1e979e84">77</ix:nonFraction> million of intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMwNTE_8a5f7d35-3dd8-437b-8d71-25752c3e666b">57</ix:nonFraction> million of goodwill (of which $<ix:nonFraction unitRef="usd" contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMwNzY_0c48103f-26da-4d92-906b-1457070ab468">45</ix:nonFraction> million is tax deductible), $<ix:nonFraction unitRef="usd" contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMwOTk_94d7d909-25a0-4bbb-a25f-03ed5f090e83">7</ix:nonFraction> million of working capital and $<ix:nonFraction unitRef="usd" contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMxMjU_8b6c05b1-61ed-4f82-9cd3-355198fac0fd">1</ix:nonFraction> million of property, plant and equipment. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="ib74c4c78b12e4840809c22866c04924d_D20180201-20180201" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMyNzc_74e2926f-f135-4476-a4e0-5579c4992539">15</ix:nonNumeric> years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Outreach Laboratory Services Business of Cape Cod Healthcare, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 18, 2018, the Company completed the acquisition of the outreach laboratory services business of Cape Cod Healthcare, Inc., in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i2a716478a2894a559df1f5cf678bcbd6_D20180618-20180618" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzM1MzM_910b96f7-7d0b-4144-a82d-e54086dde5f5">35</ix:nonFraction> million.  The assets acquired principally consist of tax deductible goodwill and customer-related intangible assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of ReproSource, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On September 19, 2018, the Company completed the acquisition of ReproSource, Inc. ("ReproSource"), in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="ifac4c7f439bc4a25a8b35842cf0ba6ef_D20180919-20180919" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzM4MTI_a9c4f299-560b-466f-8ccd-f5ef0ce0ab2b">35</ix:nonFraction> million, which consisted of cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ifac4c7f439bc4a25a8b35842cf0ba6ef_D20180919-20180919" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzM4NTc_b5234818-527d-44eb-8c38-956774374506">30</ix:nonFraction> million and contingent consideration initially estimated at $<ix:nonFraction unitRef="usd" contextRef="ie9436426b22c4886a5e98f743908762e_I20180919" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzM5MDI_1acda90a-5d68-42a8-8250-42ac5388cc65">5</ix:nonFraction> million.  The contingent consideration arrangement was dependent upon the achievement of certain revenue targets.  During 2019, the liability was reduced to $<ix:nonFraction unitRef="usd" contextRef="i8da51f5c2e9c490f94945ecf8ac5e9bc_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQwNTM_cb3523bb-f629-4008-9358-f67c001cf914">0</ix:nonFraction> as a result of updated revenue forecasts for 2019 compared to the earn-out revenue target included in the contingent consideration arrangement, resulting in a net gain recorded in other operating expense (income), net. ReproSource is a national leader in specialty fertility diagnostic services.  Through the acquisition, the Company acquired all of ReproSource's operations.  The assets acquired principally consist of goodwill, technology-related intangible assets and customer-related intangible assets.  </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the U.S. Laboratory Services Business of Oxford Immunotec, Inc.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On November 6, 2018, the Company completed the acquisition of all of the operations of the U.S. laboratory services business of Oxford Immunotec, Inc. ("Oxford"), in an all cash transaction for $<ix:nonFraction unitRef="usd" contextRef="i3df733d55ebf4d58bee1631d8ddc6f98_D20181106-20181106" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5MzA_43c88c9b-1e5e-4bd5-9304-b9b13805621b">170</ix:nonFraction> million, net of $<ix:nonFraction unitRef="usd" contextRef="i3df733d55ebf4d58bee1631d8ddc6f98_D20181106-20181106" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDE_84b4970a-c956-4a9c-93ff-5d1185dc11c0">1</ix:nonFraction> million cash acquired.  The acquisition included laboratories in Tennessee and Massachusetts that provide tuberculosis and tick-borne disease testing services.  As part of the transaction, Oxford will sell test kits and related accessories to the Company under a long-term supply agreement.  In September 2019, the Company finalized its purchase price allocation and recorded a $<ix:nonFraction unitRef="usd" contextRef="ie0e89fc0040e4c588548eaca76b8e386_D20190901-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzUzMTQ_25353fac-0e4e-47f8-a197-ca8bc0aecc6b">13</ix:nonFraction> million increase to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="ibace591f22394f96b309f30097c0c04c" continuedAt="i4f555a18e8e64646b31dbb457757624f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goodwill, an $<ix:nonFraction unitRef="usd" contextRef="ie0e89fc0040e4c588548eaca76b8e386_D20190901-20190930" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzUzNDI_d20166f3-f4e0-41ac-a9ed-4b2d9aa270f0">11</ix:nonFraction> million decrease to intangible assets and a $<ix:nonFraction unitRef="usd" contextRef="ie0e89fc0040e4c588548eaca76b8e386_D20190901-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzUzODE_fa761643-53c9-4f23-9756-5742d96db53a">2</ix:nonFraction> million adjustment to other assets and liabilities.  These adjustments did not have a material impact on the Company's consolidated results of operations.  Based on the final purchase price allocation, the assets acquired and liabilities assumed primarily consist of $<ix:nonFraction unitRef="usd" contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU2NDM_fa6d54f7-8fb3-4997-afc3-872eca468b70">43</ix:nonFraction> million of intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU2Njg_bfce9a2b-a2e5-4c80-add4-83e4065d188b"><ix:nonFraction unitRef="usd" contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU2Njg_ef188313-caa1-4172-b5b0-2ac16544a41f">112</ix:nonFraction></ix:nonFraction> million of tax deductible goodwill, $<ix:nonFraction unitRef="usd" contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106" decimals="-6" format="ixt:numdotdecimal" name="dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU2OTk_38b3c62f-d2ac-4ae6-abcf-c43fd130d7b2">13</ix:nonFraction> million of working capital and $<ix:nonFraction unitRef="usd" contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU3MjU_0329661b-73ab-4608-8c7c-e3476782760c">6</ix:nonFraction> million of property, plant and equipment.  The intangible assets consist primarily of customer-related and contract-related assets which are being amortized over a useful life of <ix:nonNumeric contextRef="i0a260c8c6a244ff0897322a198ac6525_D20181106-20181106" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU4OTk_dcb841d0-0c05-4b8d-8799-a5c2b87ec076">15</ix:nonNumeric> years and <ix:nonNumeric contextRef="i6a6c9ae6653b48b099eac07be30520ad_D20181106-20181106" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU5MTI_445d482f-05c4-41fe-8d3f-5ab9e6839fc3">5</ix:nonNumeric> years, respectively. </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Information</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4f555a18e8e64646b31dbb457757624f">&#160;&#160;&#160;&#160;The acquisitions described above were accounted for under the acquisition method of accounting.  As such, the assets acquired and liabilities assumed are recorded based on their estimated fair values as of the closing date.  Supplemental pro forma combined financial information has not been presented as the impact of the acquisitions is not material to the Company's consolidated financial statements.  The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entities with those of the Company and the value associated with an&#160;assembled workforce and other intangible assets that do not qualify for separate recognition.  All of the goodwill acquired in connection with these acquisitions has been allocated to the Company's DIS business.  For further details regarding business segment information, see Note 19.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_190"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzU2MzQ_9c7211f3-4f80-4e85-ac26-73c2b11693f3" continuedAt="i53bbff4ea8ba45ada82195e02e287cc9" escape="true">FAIR VALUE MEASUREMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i53bbff4ea8ba45ada82195e02e287cc9" continuedAt="i1582d464e33c43a19578d2c9343cc249"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzU2MTU_d6200a72-5549-432e-9cfd-cf606788e650" continuedAt="i5b03e770ffef48f89ec4c75535bb7e50" escape="true">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i5b03e770ffef48f89ec4c75535bb7e50"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzUtMS0xLTEtMA_15fe5404-2190-4f08-8534-30cc2337781d">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzUtMy0xLTEtMA_5309c50d-cfb0-4490-a5a4-23af1a4012da">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzUtNS0xLTEtMA_ea5d993d-e9c2-402e-acb9-840446c2270c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzUtNy0xLTEtMA_962e6cad-a9a9-430f-b707-f450163399b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzYtMS0xLTEtMA_b3220fd0-bed3-406e-9af3-b184699b619e">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzYtMy0xLTEtMA_03935d1d-d054-4960-80a5-87974db6e1c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzYtNS0xLTEtMA_5a68da56-f841-407b-8bcf-3e711cd28ee2">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzYtNy0xLTEtMA_d716a2f4-86cb-43a2-9818-b78d781b45e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzgtMS0xLTEtMA_9e747164-be81-42ae-b03f-170497b3a797">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzgtMy0xLTEtMA_0cc04922-e199-4551-a7f6-02e6993c511e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzgtNS0xLTEtMA_1ad3c9ea-b753-4e86-b688-6c44b6ca0a52">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzgtNy0xLTEtMA_d2c97643-9ff4-44b8-80fd-763cae930433">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzExLTEtMS0xLTA_ffbe9aa1-a081-4f45-998d-9243081abee0">129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzExLTMtMS0xLTA_73cd8b1f-67fb-4721-a863-3323c166910c">67</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzExLTUtMS0xLTA_09c6a0b1-82ad-48a2-8417-65327cde4070">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzExLTctMS0xLTA_df4231e3-2155-441d-a1d9-e0047c675477">12</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzE0LTEtMS0xLTA_7132b5ac-e9a0-437f-8823-c27b94148494">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzE0LTMtMS0xLTA_5ec0f6b2-abc8-4757-a28b-93f3fb278fd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzE0LTUtMS0xLTA_2f7d9ef2-bbf9-4d08-911d-bc91854aa746">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzE0LTctMS0xLTA_db86661c-71af-470e-8f67-ca841e3a2f3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzIxLTEtMS0xLTA_fc5ec872-a3ac-4919-aa42-4de08d6a179c">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzIxLTMtMS0xLTA_a0523fb9-8ff0-4189-ac9b-795b8c2f005a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzIxLTctMS0xLTA_3c13adeb-02e1-45ed-b854-f7a7799e4150">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI1LTEtMS0xLTA_f3b10071-56f7-4e2b-a431-359eb3721583">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI1LTMtMS0xLTA_2e75eaf1-4af5-41d3-be96-c8af080cc232">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI1LTUtMS0xLTA_789810f0-b497-42dc-807a-7ac9a031ff3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI1LTctMS0xLTA_7bb3d987-3319-4830-b4de-0cb43a68dc78">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI2LTEtMS0xLTA_00cca368-2ef0-4c1c-a975-36a9b9dac2e2">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI2LTMtMS0xLTA_5eff49a1-8513-4481-b5f8-5079c952eb5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI2LTUtMS0xLTA_6f409cef-bbed-4356-8b78-6447cbb4331f">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI2LTctMS0xLTA_4f0add9d-a7d5-47e9-90d1-c15dda0605e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI5LTEtMS0xLTA_92530e57-3966-4d36-bdfe-722e664c0404">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI5LTMtMS0xLTA_3cd243b6-e4fb-4c3b-ad39-1e5e9cc0abcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI5LTUtMS0xLTA_02be5f29-7551-40b8-81a7-724d7cd6aa45">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI5LTctMS0xLTA_9d7929cb-2d29-488e-99de-a8d764b0e4d7">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzMxLTEtMS0xLTA_6551c3d2-b04f-42de-84b0-e7a6eb3b289a">114</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzMxLTMtMS0xLTA_8687b9be-810d-40a7-b6a0-7a2567d6ed8b">59</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzMxLTUtMS0xLTA_072c9449-1711-4c6b-b5f3-2bf8cd7a9649">43</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzMxLTctMS0xLTA_120de064-9001-43ed-8484-eb493029f1fe">12</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM0LTEtMS0xLTA_ea7f6199-5b08-41f9-8d00-b06ca5e6c4b8">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM0LTMtMS0xLTA_a97fb906-99c7-45e7-b25e-719da68d3136">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM0LTUtMS0xLTA_8ee4695b-86c0-4347-910d-bd3662baec64">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM0LTctMS0xLTA_e07ac723-76e7-4af2-9ac2-c205405e3016">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-to-variable interest rate swaps</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5925d31cf3ff45fc9047d3197966b069_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM1LTEtMS0xLTA_2e52bfd7-8c89-4820-943d-79f95a120637">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d1e7f19b404c199e04abc162106cc4_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM1LTMtMS0xLTA_21f1e154-141f-4034-97d9-e08b3ba4f727">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b50bcaa47814ec28040b26b7160a5ba_I20191231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM1LTUtMS0xLTA_75807f04-f291-41b7-9cf7-74c6517af855">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ca595e5eb740889d328b33d7ef80c9_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM1LTctMS0xLTA_80c67c23-b508-47e1-acb6-deefca21db44">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM2LTEtMS0xLTA_e0a2fd0a-3f64-4c85-b164-18182ec7add2">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM2LTMtMS0xLTA_40eaa75c-b00f-47c3-bfb2-a7fa59a5caad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM2LTUtMS0xLTA_48ca8d0f-486b-43dd-b7f8-5852e8b52985">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM2LTctMS0xLTA_ec580388-f262-4237-a0ea-f3dcae76ec85">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM5LTEtMS0xLTA_4636f762-3998-4faa-9100-2d6ed198d90d">145</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM5LTMtMS0xLTA_091d2d40-97a4-4292-ad09-e8d350b98ff7">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM5LTUtMS0xLTA_043a56e7-38cb-455d-ac08-20b929ce5337">138</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM5LTctMS0xLTA_1579530f-7f80-4427-b62d-cfb0515b15ea">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzQxLTEtMS0xLTA_b46db1d0-760a-47c5-811b-b3c0b3deca25">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzQxLTMtMS0xLTA_19f52077-7e90-4cf5-be26-bf77e14e94a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzQxLTctMS0xLTA_734c908c-5ef8-42cc-9bd7-92814d45d94a">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i1582d464e33c43a19578d2c9343cc249"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value measurements of the Company's fixed-to-variable interest rate swaps, which were terminated during April 2020 (see Note 15), were classified within Level 2 of the fair value hierarchy, and were model-derived valuations as of a given date in which all significant inputs were observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with previous business acquisitions, the Company had contingent consideration obligations that were to be paid based on the achievement of certain testing volume or revenue benchmarks.  As of December&#160;31, 2020, <ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzEwNDQ1MzYwNDcwMTI0_8ab00fac-c92f-4834-9df3-c8bca25e6e2f">no</ix:nonFraction> contingent consideration obligations were outstanding.  Contingent consideration liabilities are measured at fair value using an option-pricing method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#8217;s estimate of volume or revenue and other market inputs including comparable company revenue volatility and a discount rate.    </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzU2MTg_d72f6a6e-b326-400b-b45e-70ffa669445f" continuedAt="i7adc0161be4243918d1355c76c3e04e5" escape="true">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i7adc0161be4243918d1355c76c3e04e5"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.912%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib49a85f69283488d9da436dc5543b52e_I20181231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzItMS0xLTEtMA_def432e1-c233-433d-ad10-bb51008d6bd9">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ef5f3f75a64fcea2e40d3c9b3ba138_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzMtMS0xLTEtMA_932461f2-8dd3-4193-9efe-f7635396782e">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92ef5f3f75a64fcea2e40d3c9b3ba138_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzQtMS0xLTEtMA_e6a40415-2d34-4332-8525-ba4ad95a3d29">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (gains)/losses included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92ef5f3f75a64fcea2e40d3c9b3ba138_D20190101-20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzUtMS0xLTEtMA_02279bfb-c0e2-4781-a2a9-066df17f61cc">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2ea36aabe78463eb75346dd3ac096a6_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzktMS0xLTEtMA_b53d9e7c-78c1-4035-ae9b-9e0302efa11e">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac45b37ce14e464c83d493dbb68d08ee_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzExLTEtMS0xLTA_fd6b8879-23e1-4b4b-8601-83b163acc747">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (gains)/losses included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac45b37ce14e464c83d493dbb68d08ee_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzEyLTEtMS0xLTA_4a805ab8-6587-4ccb-b0fa-c1ea21c6da93">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819ba4179ff04a9c8d4de164c0081dc2_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzEzLTEtMS0xLTA_db61d9ed-3e96-46b3-a081-d64198dfb83d">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The $<ix:nonFraction unitRef="usd" contextRef="i48245c8eab5c4b8091bfa77ef50e467e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzQwMzc_d41e9d30-1092-4a92-a637-3450601c7111">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if1e6d68bf2d9484a8f112f2794388931_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzIxOTkwMjMyNjEyOTQ_2b0b4800-b6c1-41d9-b4c1-6fec39f9f31f">12</ix:nonFraction> million net gains included in earnings associated with the changes in the fair value of contingent consideration for the years ended December&#160;31, 2020 and 2019, respectively, are reported in other operating expense (income), net.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i02060ac5ffa04417a6b16a9bd1912233_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzQyOTA_c2c286b3-d4d6-46b4-ae05-e33b604079db">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long-term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of December&#160;31, 2020 and 2019, the fair value of the Company&#8217;s debt was estimated at $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzIxOTkwMjMyNjE3MTA_99d6bff2-30c7-4b47-8046-a2a6190df74a">4.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzUyNTc_e38628b6-05de-420f-962f-630317d0c154">5.1</ix:nonFraction> billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_193"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzcwMDA_7fe45a8f-e465-413d-8038-8755a4b60ff9" continuedAt="i5bc900a7a99642a581760f434fd7527f" escape="true">TAXES ON INCOME</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5bc900a7a99642a581760f434fd7527f" continuedAt="i147e9fd8688942e1b2fd89c597ca3dcc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's pre-tax income from continuing operations before equity in earnings of equity method investees consisted of approximately $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-8" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzE2Mg_8d15582d-31c1-45d2-a4d6-ad0f43ded8c7">1.9</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzE2Ng_aa4c5b55-e5e2-4899-9963-a4cd5c78cc47">1.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzE3Mw_1cfa4d47-1fb2-4c71-a21e-0f7bedce2239">0.9</ix:nonFraction> billion from U.S. operations and pre-tax (loss) income of $(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzIyNg_4814b3d6-175c-4e7b-b0ed-40c12a0e7e7a">7</ix:nonFraction>) million, $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzIzMA_e49c1c58-56c3-4691-a84b-3dce8f091d80">15</ix:nonFraction> million and $(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzIzNw_3b96c965-98e4-4363-b3cd-b0f914dd03d2">1</ix:nonFraction>) million from foreign operations for the years ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a result of the Tax Cuts and Jobs Act, the Company changed its assertion that it intends to indefinitely reinvest undistributed earnings from certain non-U.S. subsidiaries outside the U.S.  The Company is indefinitely reinvested in the remaining basis difference and it is not practicable to determine the associated amount of unrecognized deferred tax liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzY5ODY_0ca6bbd1-f412-494a-979f-94ae5fb3a32c" continuedAt="i28d6377940754c4a8e130216a50426c8" escape="true">The components of income tax expense (benefit) for 2020, 2019 and 2018 were as follows: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i28d6377940754c4a8e130216a50426c8"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzItMS0xLTEtMA_de21fea9-5103-4ea0-9178-188c0d85391e">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzItMy0xLTEtMA_a89c5764-f891-4dcd-b24b-d263d4419858">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzItNS0xLTEtMA_28e9e60a-e8f7-43c6-8e7c-1060e932d343">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzMtMS0xLTEtMA_def4c64a-eaf4-4aeb-bcf6-310171930f80">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzMtMy0xLTEtMA_df854f92-2b34-4ecd-ba55-db5666755a56">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzMtNS0xLTEtMA_e12f9966-fd97-4417-81d1-73b25037ce7e">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzQtMS0xLTEtMA_3f594ff6-4138-4687-aa08-34614624b734">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzQtMy0xLTEtMA_c3a3561f-2875-435c-bddb-ec3dd192402a">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzQtNS0xLTEtMA_59e6a292-1f7f-4a74-8a2f-144df6a3f49d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzYtMS0xLTEtMA_93a014e4-34cb-48e0-8efa-b6ff4a45dd99">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzYtMy0xLTEtMA_9baffb4f-87d4-488f-93fd-116093adf761">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzYtNS0xLTEtMA_90bbb4fd-e05b-416f-9960-abc6fbadfe64">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzctMS0xLTEtMA_5e8956d7-2fec-41ac-bd30-37499adf9d86">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzctMy0xLTEtMA_f90047cc-230f-4338-a448-544c731805e0">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzctNS0xLTEtMA_473f2710-37bf-4253-9dd4-f7103adfb3ce">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzgtMS0xLTEtMA_4f0e696e-d614-4a71-9c5e-bf9b30ad9bed">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzgtMy0xLTEtMA_c4529cb6-ebc6-40ed-8bec-d9e925192323">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzgtNS0xLTEtMA_d26c865f-4428-4246-b6d3-71d641c4e389">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzktMS0xLTEtMA_76faf29b-6bee-4540-92ec-a9fad3946073">460</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzktMy0xLTEtMA_4e986900-50c0-421c-a4ae-a20ca842de71">247</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzktNS0xLTEtMA_c36bc224-ef83-48d1-aa9a-b604c870dae3">182</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:42.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzY5OTM_acb73859-3db8-41e6-a02b-4bdd181494f6" continuedAt="i120c9e5811184bb4a37b428584521109" escape="true">A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2020, 2019 and 2018 was as follows: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i120c9e5811184bb4a37b428584521109"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at statutory rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzItMS0xLTEtMA_6d473874-d29e-44a0-84e6-859b6f2d373d">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzItMy0xLTEtMA_9d40b31a-ad4d-45d8-958c-25564d105e58">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzItNS0xLTEtMA_52582a26-01f1-4f1a-8414-270707d7ee51">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzMtMS0xLTEtMA_399bf1db-e971-49d3-b49d-86e3f49da8c6">4.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzMtMy0xLTEtMA_790b268e-d74f-4b21-8bfa-7a639fe69ddc">4.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzMtNS0xLTEtMA_e3ec88eb-4867-4dbd-978c-7679648e1116">4.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzgtMS0xLTEtMA_1906b25f-2e86-4547-b85a-3b1d9fd8bf42">0.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzgtMy0xLTEtMA_907cdd97-9c99-47e5-b04d-5871f325ef3c">1.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzgtNS0xLTEtMA_f79eeea6-8deb-47bb-a959-924a89eb87e3">1.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on stock-based compensation arrangements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEwLTEtMS0xLTA_99c3eb60-2fb1-446f-9c71-fe7e66e667b3">1.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEwLTMtMS0xLTA_a0327f11-85c6-46e6-bfe5-56da681ede07">1.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEwLTUtMS0xLTA_a992cc96-f6ab-4638-8038-4ce279e2357f">1.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision true-ups </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzExLTEtMS0xLTA_e7a8132f-472a-460e-883d-5ac991aa74c3">0.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzExLTMtMS0xLTA_72240645-72da-4ab9-8aa9-e9e67af694aa">1.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzExLTUtMS0xLTA_b817dbca-42aa-427c-a659-741f203ef867">1.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accounting method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" format="ixt:zerodash" name="dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEzLTEtMS0xLTA_a701cd1d-f815-4e6f-bdd5-b3749b3b2036">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" format="ixt:zerodash" name="dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEzLTMtMS0xLTA_f44c7940-e6b6-4dd6-a2a6-a98fbdaaed2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" sign="-" name="dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEzLTUtMS0xLTA_aed611a1-5473-48ea-af8c-d6494c248ebf">1.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of equity earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE0LTEtMS0xLTA_b21025f2-5b64-4e9b-bbb2-44337d95a13b">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE0LTMtMS0xLTA_84576556-1608-471b-988e-198e93d4fa33">1.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE0LTUtMS0xLTA_2a8a0eed-d043-48d1-a6fa-a1dc0d8aaab8">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in reserves for uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE1LTEtMS0xLTA_bfeda372-ac62-47fa-b17d-16c7780acdcf">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" name="dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE1LTMtMS0xLTA_3564819f-e197-4f70-9418-079e51e11919">1.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" sign="-" name="dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE1LTUtMS0xLTA_a3ff9fde-1ce2-435c-98e6-4a26d9bfc0f1">0.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances associated with certain net operating losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE2LTEtMS0xLTA_72b86a6e-4f05-4d08-9a60-d6259ca9a9ea">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE2LTMtMS0xLTA_2bce7748-da88-4498-8e9f-77ef72399d71">1.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE2LTUtMS0xLTA_abba658d-39ee-4257-9ff6-9d71615ebda2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE3LTEtMS0xLTA_92337f51-8382-49dd-b121-6153f89b5e70">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE3LTMtMS0xLTA_0bb546f2-69fa-48e7-ab0b-ae739f6b299e">0.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE3LTUtMS0xLTA_513c808b-3355-4190-887a-61461504ab25">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE4LTEtMS0xLTA_c1994351-1089-4077-ba6c-69c2347b8580">24.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE4LTMtMS0xLTA_f03484f7-396e-49a9-8309-f777e579b1f8">23.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE4LTUtMS0xLTA_e9586b42-2aee-4693-8d4d-91a37a76742c">19.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzIyNjU_9c286fa0-7ffc-4187-9627-c81c10d10b9f">12</ix:nonFraction> million net income tax benefit due to the release of valuation allowances associated with certain net operating loss carryforwards.   In 2018, the Company filed for a tax return accounting method change, effective for the tax year ending December 31, 2017, to accelerate the deduction of certain expenses on its 2017 tax return at the higher 2017 federal corporate statutory income tax rate, resulting in a $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="dgx:IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzI2NjM_c7fddc0d-534f-44e5-a67f-0a5f9a06c101">15</ix:nonFraction> million income tax benefit.  The net income tax benefit associated with changes in reserves for uncertain tax positions in 2018 was primarily related to the expiration of the statute of limitations for certain income tax returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzY5OTk_b3b9024c-d933-4ea0-a6d4-da5f0837f100" continuedAt="if3209696a02244f28f2a4427df504f0f" escape="true">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2020 and 2019 were as follows: </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i147e9fd8688942e1b2fd89c597ca3dcc" continuedAt="ia99b6eb23b6f4cc6bb57591b76e1958f"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="if3209696a02244f28f2a4427df504f0f"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzItMS0xLTEtMA_ef183d0e-4dbd-4cb3-8fbf-f3bd804846dc">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzItMy0xLTEtMA_ca4e3903-065d-49f9-83dc-ced079f5e63f">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities not currently deductible</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzMtMS0xLTEtMA_7f6c5f0b-b82d-4682-b79e-c0d159547b9b">146</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzMtMy0xLTEtMA_b5935326-883e-4824-a941-0a8b3840fcfd">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzQtMS0xLTEtMA_736ae082-0841-4e87-bba8-dd33f81c14bd">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzQtMy0xLTEtMA_549b7817-3764-4f1b-ba9d-4e43a7548ce9">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis differences in investments, joint ventures and subsidiaries </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzYtMS0xLTEtMA_7939bef5-e616-430c-aa68-7db5aa7e425a">81</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzYtMy0xLTEtMA_cdb0f28e-9c56-48b9-b23e-a7f97a731d15">80</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards, net of valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzctMS0xLTEtMA_3766151a-0ff2-4e20-81f2-93706496ce4d">61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzctMy0xLTEtMA_c383896f-315d-4629-b372-aea9285e1593">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzgtMS0xLTEtMTI1MTE_aa8ac901-9aa1-4ccb-b118-49435300c26a">151</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzgtMy0xLTEtMTI1MDc_cfe25100-ebcd-4cc5-87f0-4bdd2effab7f">129</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzktMS0xLTEtMTMyMjg_08d11297-b0dc-45a3-8273-59a373ea8502">161</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzktMy0xLTEtMTMyMzE_ed9a0ff7-c0ab-42c1-8d3f-ddbbe8a47d47">139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzgtMS0xLTEtMA_39a8f021-7a96-49b4-8de1-e8a31f98585b">604</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzgtMy0xLTEtMA_81893612-96bd-4f25-ab54-66ccec3054b0">494</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current deferred tax liabilities, net</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzktMS0xLTEtMA_d1c352dd-67dd-4fa2-9d42-9d1084ee33fc">350</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzktMy0xLTEtMA_634f572e-d28e-4fa8-a3c6-79e4ca423025">264</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The non-current deferred tax assets (liabilities) disclosure at December 31, 2019 has been adjusted to separately state the gross deferred tax right-of-use asset and related gross deferred tax lease liability recognized in accordance with the new accounting standard for leases adopted on January 1, 2019.  As of December&#160;31, 2020 and 2019, non-current deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzMxMDc_1475740d-8129-4cf6-8182-5281acbedcca">350</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzMxMTQ_531d8750-2ac3-494c-b6bd-3f8828188412">264</ix:nonFraction> million, respectively, are included in other liabilities in the consolidated balance sheet. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, the Company had estimated net operating loss carryforwards for federal and state income tax purposes of $<ix:nonFraction unitRef="usd" contextRef="i4202ba5a9d04407d83cd7e068541a1d7_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzMyODU_48360907-d285-42dc-a6f6-c35a89c425e6">60</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iabd266dd7d024345af367a828d3a1650_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzMyOTI_60646de9-d180-4a6e-9ba4-07c5992ce826">1.0</ix:nonFraction> billion, respectively, which expire at various dates through 2040.  Estimated net operating loss carryforwards for foreign income tax purposes are $<ix:nonFraction unitRef="usd" contextRef="i08f2967b216f47cdbe6de707915af4a3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM0MzI_3a942002-54f3-4da5-8999-47994b6f0b6c">76</ix:nonFraction> million as of December&#160;31, 2020, some of which can be carried forward indefinitely while others expire at various dates through 2040.  As of December&#160;31, 2020 and 2019, deferred tax assets associated with net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM2MzQ_db5668c6-3f99-4d57-8e01-689f36fd88c1">94</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM2NDE_f74c15d5-9812-4b76-a885-9a1b3a096fac">101</ix:nonFraction> million, respectively, have each been reduced by valuation allowances of $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM3MDk_a02f2a7e-e495-4931-8485-bec27abe9d03">33</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM3MTY_7092d308-0c35-48e9-8e6d-00b13e4b0107">26</ix:nonFraction> million, respectively.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income taxes payable, including those classified as long-term in other liabilities in the consolidated balance sheet as of December&#160;31, 2020 and 2019, were $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM4NDQ_58650287-cee5-46d4-89cc-ad8011904ee4">135</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM4NTE_ae824d63-2485-48c3-8926-2346af55471c">113</ix:nonFraction> million, respectively.  Prepaid income taxes were $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM4OTY_b211029f-90b9-4d79-9d10-346d4a25a8dd">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM5MDM_5de8d78e-0c72-453b-84c7-13b5f6b88d75">3</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively, and were recorded in prepaid expenses and other current assets in the consolidated balance sheet. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzY5OTU_3cdc469e-6a42-40a6-8638-0c5b65135e4f" continuedAt="i98f4b17c873e474dac3c51968b97f2a9" escape="true">The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2020, 2019 and 2018 consisted of the following:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i98f4b17c873e474dac3c51968b97f2a9"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzItMS0xLTEtMA_af9c3ba1-9ab3-47d0-a5af-974dfe5cefde">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzItMy0xLTEtMA_e5b5dac3-5c8a-48d1-88ce-e74d80233565">107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79da04d8282d4c8291850645193b2909_I20171231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzItNS0xLTEtMA_276ca4c4-e094-4152-b4c2-cc76d44d9a67">115</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzQtMS0xLTEtMA_5e7ccd16-f92a-46e1-80b8-b8d6c6a06b25">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzQtMy0xLTEtMA_7306f632-1bdb-4f14-a6ca-a081ec40e4ca">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzQtNS0xLTEtMA_5ae3aff7-3210-4bc4-86d2-e7b72aa5fa24">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzUtMS0xLTEtMA_23e997de-48ee-4c96-b46a-34bafe0d18ce">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzUtMy0xLTEtMA_6db5f37b-98b5-44a1-b8e1-9c3a09d0288c">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzUtNS0xLTEtMA_a4030442-9d50-4da7-9785-ebe5ac71a74d">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in judgment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="dgx:ReductionsForChangesInJudgment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzctMS0xLTEtMA_e1138bcd-1808-4d01-b643-4244820487cb">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="dgx:ReductionsForChangesInJudgment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzctMy0xLTEtMA_c21757b9-1ed3-4d04-b90e-0eb6236c2f2d">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="dgx:ReductionsForChangesInJudgment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzctNS0xLTEtMA_30020c2e-9479-4235-844a-c7beed869124">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expirations of statutes of limitations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzgtMS0xLTEtMA_2144e430-0478-410a-82ea-eddec77731d8">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzgtMy0xLTEtMA_06d23d5d-8c43-46e1-88e8-f9d991311a6b">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzgtNS0xLTEtMA_8193fa91-f86a-4d71-ba4e-cc36b5592a3c">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzktMS0xLTEtMA_495c4558-e2c7-4ed2-a0e4-4e2dfa6c7b0a">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzktMy0xLTEtMA_b3063928-699f-4711-933b-7e845a05f4ce">32</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzktNS0xLTEtMA_0ad4e3d0-5db4-4e83-b8ef-9e20964d0ee7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzEwLTEtMS0xLTA_93b4ac17-2fe0-425b-85b7-82b8d06ce06b">93</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzEwLTMtMS0xLTA_99f26cbe-9805-4900-b3b6-3babcfa5d2f2">88</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzEwLTUtMS0xLTA_c5359e9d-153c-48c9-ad0a-42eebd4cdb83">107</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The contingent liabilities for tax positions primarily relate to uncertainties associated with the realization of tax benefits derived from the allocation of income and expense among state jurisdictions, the characterization and timing of certain tax deductions associated with business combinations, certain tax credits and the deductibility of certain expenses and settlement payments.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of December&#160;31, 2020, that, if recognized, would affect the effective income tax rate is $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzQ3MTA_e7df478b-83ff-46d7-a40f-ce98bcf2b6ba">75</ix:nonFraction> million.  Based upon the expiration of statutes of limitations, settlements and/or the conclusion of tax examinations, the Company believes it is reasonably possible that the total amount of unrecognized tax benefits may decrease by up to $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzQ5NDQ_48d35ace-43b3-461e-990a-ee1cd2ce30e8">15</ix:nonFraction> million within the next twelve months.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ia99b6eb23b6f4cc6bb57591b76e1958f" continuedAt="i3ba50f8fcb95440ea9e58ae4fecbc97b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accruals for interest expense on contingent tax liabilities are classified in income tax expense in the consolidated statements of operations.  Accruals for penalties have historically been immaterial.  Interest expense included in income tax expense in each of the years ended December&#160;31, 2020, 2019 and 2018 was approximately $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUyOTA_5ce56185-73af-444a-80f8-10c635bbc42c">6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUyOTQ_ae7d3ae1-c9dd-4108-82b0-0af1615cc247">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUzMDE_c0fe53f5-4bde-4d71-b6a4-bf10ff38ef19">1</ix:nonFraction> million, respectively.  As of December&#160;31, 2020 and 2019, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUzNjc_f7e5e107-f66f-4bff-a5d1-3940069047ac">21</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUzNzQ_d655503a-43a6-4a5f-9d16-db68dee51118">17</ix:nonFraction> million, respectively, accrued, net of the benefit of a federal and state deduction, for the payment of interest on uncertain tax positions.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The recognition and measurement of certain tax benefits includes estimates and judgment by management and inherently involves subjectivity.  Changes in estimates may create volatility in the Company's effective tax rate in future periods and may be due to settlements with various tax authorities (either favorable or unfavorable), the expiration of the statute of limitations on certain tax positions and obtaining new information about particular tax positions that may cause management to change its estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the regular course of business, various federal, state, local and foreign tax authorities conduct examinations of the Company's income tax filings and the Company generally remains subject to examination until the statute of limitations expires for the respective jurisdiction.  The Internal Revenue Service has either completed its examinations of the Company's consolidated federal income tax returns or the statute of limitations has expired up through and including the 2016 tax year.  At this time, the Company does not believe that there will be any material additional payments beyond its recorded contingent liability reserves that may be required as a result of these tax audits.  As of December&#160;31, 2020, a summary of the tax years that remain subject to examination, awaiting approval, are under appeal, or are otherwise unresolved for the Company's major jurisdictions are:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;United States - federal&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2017 -  2020 </span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3ba50f8fcb95440ea9e58ae4fecbc97b">&#160;&#160;&#160;&#160;United States - various states&#160;&#160;&#160;&#160;2002 - 2020</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_196"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90ZXh0cmVnaW9uOjY4ZWMxOWViMzJiNDQ5MDhhOTE2Y2EwNzZjNTZiOWYzXzQ2Mw_e9e7e38e-abff-4794-89a2-24965cfc3db2" continuedAt="ic4fd11b6a6a94335b8923a22f8162378" escape="true">SUPPLEMENTAL CASH FLOW AND OTHER DATA </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic4fd11b6a6a94335b8923a22f8162378"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90ZXh0cmVnaW9uOjY4ZWMxOWViMzJiNDQ5MDhhOTE2Y2EwNzZjNTZiOWYzXzQ3MQ_f2fd21e8-c64a-4a71-b422-067efd294ffc" continuedAt="i489d05669da84bd69c6b39d49ed45b1a" escape="true">Supplemental cash flow and other data for the years ended December&#160;31, 2020, 2019 and 2018 was as follows:</ix:nonNumeric></span></div><ix:continuation id="i489d05669da84bd69c6b39d49ed45b1a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzItMS0xLTEtMA_5c49c620-90b8-4511-b021-4c086304cba7">258</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzItMy0xLTEtMA_d1630bed-44de-4168-997c-8301cd4197a7">233</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzItNS0xLTEtMA_cc5960ac-aef4-485d-b967-ba5c023cae87">219</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzMtMS0xLTEtMA_77b84477-9e17-4374-9f63-2a4cf97b5f79">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzMtMy0xLTEtMA_ccc5fd09-82ba-4475-8c5e-00dddd5fdf8a">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzMtNS0xLTEtMA_3cb3a249-12ae-4d58-92ec-183f6453dc8f">90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzQtMS0xLTEtMA_398e9ce1-a3b8-4ae0-92a7-486d533b345a">361</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzQtMy0xLTEtMA_e2587a0e-e944-45e8-855e-e090cbb9a6ea">329</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzQtNS0xLTEtMA_3ebf6dff-7ae5-43f3-84be-a8051c4cf8ce">309</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzYtMS0xLTEtMA_7028ccf7-52b6-4106-bb09-9d941839873e">166</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzYtMy0xLTEtMA_1a695da0-f131-46d0-a2d8-ea20192c07f5">180</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzYtNS0xLTEtMA_e2553e69-2467-4e2e-87c6-d31cfcf8d908">169</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzctMS0xLTEtMA_0f44b289-df25-49c3-9197-710d4551ce06">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzctMy0xLTEtMA_1659b50f-ab1e-48fd-85b4-0a7895016138">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzctNS0xLTEtMA_eee61bb4-c357-448a-b44d-584f7413fe0d">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzgtMS0xLTEtMA_6e476557-eb0d-43b4-a647-21a2d8f359cb">163</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzgtMy0xLTEtMA_a7cf9331-fe71-491b-8b93-6469360b174c">175</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzgtNS0xLTEtMA_d37a99c1-3c4f-4606-81b6-9e628a165700">167</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEwLTEtMS0xLTA_028b1849-ccbd-4a87-bf89-a159c0773975">201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEwLTMtMS0xLTA_3419c0fb-e26e-486d-b1ea-4e06058429fd">192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEwLTUtMS0xLTA_0de95b57-1f85-4934-a0e1-1dc0953f7915">174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzExLTEtMS0xLTA_b4690eb6-a659-496e-bb85-cf99befda780">360</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzExLTMtMS0xLTA_bd93fb22-4bb8-493b-a8df-74a4d18932ac">202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzExLTUtMS0xLTA_9fbcf859-03fd-4f54-9799-98018422b298">84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEzLTEtMS0xLTA_71109283-1d20-448b-a78c-5f80a9d6ffca">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEzLTMtMS0xLTA_838d9044-e460-4710-99eb-2657cfdd5dcb">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEzLTUtMS0xLTA_55a75b4f-5c31-4976-8a6b-eecc02e727f0">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:zerodash" name="dgx:TreasuryStockPurchasedbutNotyetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE0LTEtMS0xLTA_06ca68fc-3e8e-449c-9133-5e1c929f7938">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:zerodash" name="dgx:TreasuryStockPurchasedbutNotyetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE0LTMtMS0xLTA_592219d7-a68e-4f6c-91ba-9640b0cfd045">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" name="dgx:TreasuryStockPurchasedbutNotyetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE0LTUtMS0xLTA_1d891494-a63d-457c-83a5-9ab3d1dd4b4b">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE1LTEtMS0xLTA_a3aab0f3-4ce9-44ac-ae61-2603a032b50d">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE1LTMtMS0xLTA_fc1fc353-5fcf-49bc-bb1b-2dfe03266165">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE1LTUtMS0xLTA_312e9737-1828-4da1-9dc5-4223b31df4bc">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE4LTEtMS0xLTA_373c5b9d-b212-49c5-bde9-de929c3cacd1">368</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE4LTMtMS0xLTA_72dcf34a-128a-4e85-9446-d093fc4e9047">63</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE4LTUtMS0xLTA_e45e9820-89d2-45a2-a283-9d5b7204a29d">453</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE5LTEtMS0xLTA_e0e62063-4bb0-4aeb-93cf-8632abc16d44">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE5LTMtMS0xLTA_343afc82-2a20-48d6-bfed-507406b55eed">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE5LTUtMS0xLTA_57647e06-3ba7-4a6b-87ae-132ca279f508">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIwLTEtMS0xLTA_49d7c2bf-b1a1-4dcf-8e35-3e7a7aa9a27a">351</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIwLTMtMS0xLTA_cff4aad4-f39f-4e73-ab95-dbd92813ece0">63</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIwLTUtMS0xLTA_ddda369c-bc8b-498c-9ba6-8b6a6e2e3506">446</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIxLTEtMS0xLTA_01e28aee-fac4-43b1-8597-46633213b620">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIxLTMtMS0xLTA_5b648f25-d9d9-4710-914e-8328757a45b8">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="dgx:Mergerconsiderationpaidpayablenet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIxLTUtMS0xLTA_2a2aae37-1ce6-49da-bb94-5e4d7a0ac47c">19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIyLTEtMS0xLTA_aded9d62-1f57-46cf-96f0-48519601f1b4">351</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIyLTMtMS0xLTA_9f22dfd5-3c56-40c8-8f12-96c3545c24ed">58</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIyLTUtMS0xLTA_79e19909-3e59-4289-96bd-1852caaf2be8">427</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIzLTEtMS0xLTA_49c29cf3-78a2-4b4c-978a-f3a3331c3618">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIzLTMtMS0xLTA_30029a77-31c7-4591-967d-1340492119e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIzLTUtMS0xLTA_c74bfc6d-ba6c-4116-ac37-1d054e08ae47">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzI0LTEtMS0xLTA_11ad259c-da25-48fd-97c2-30a205a5de2b">330</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzI0LTMtMS0xLTA_af398d72-c7f8-4f4f-bb39-df4bd9cbff1b">58</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzI0LTUtMS0xLTA_9e6bd023-ff89-41c4-821e-6f739da0644b">421</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzMtNC0xLTEtMA_2c3ecd48-1278-414e-9251-b0573172110b">185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzMtNi0xLTEtMjI4_03fc32f0-1bb9-44cd-aa92-bab69954cdbe">180</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzQtNC0xLTEtMA_9051ec6a-8369-46d5-b0f2-1c07de17aaeb">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzQtNi0xLTEtMjM1_c6b53361-48d5-47bf-8962-3ac5706d0050">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzUtNC0xLTEtMA_7591a2a6-6266-45cf-8984-2c6a4f307684">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzUtNi0xLTEtMjM4_c7167e3a-4970-4490-8dcb-8d92417feaeb">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzYtNC0xLTEtMA_5dd32fea-38a7-44cc-ae1b-de7aee999f90">219</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzYtNi0xLTEtMjQx_a143db4e-d991-45f0-a95b-7eac76c106a5">164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities (a)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzctNC0xLTEtMA_bb2c045a-24c3-404f-ad1c-b3cefc042a89">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzctNi0xLTEtMA_9a45a0d4-71f0-4601-8e05-fc1a0f8aacc1">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:CapitalLeaseObligationsIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzctOC0xLTEtMA_f4a89a85-cfb9-4bdb-86fc-dc1784209a06">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) For the year ended December 31, 2018, leased assets obtained in exchange for new finance lease liabilities reflects information prior to the adoption of the new accounting standard for leases on January 1, 2019.  See Note 14 for further discussion of the Company's accounting for leases.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_199"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90ZXh0cmVnaW9uOjEyOGU0ZjFjMjJlYTQ5Njk5NGZjNTA3ZjMwNzdlM2Q5XzI2OA_e0589dbf-fb69-4a76-add9-e6dcd5e15e94" continuedAt="i8b79915d7a054c0d9ef8588635f6b004" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8b79915d7a054c0d9ef8588635f6b004"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90ZXh0cmVnaW9uOjEyOGU0ZjFjMjJlYTQ5Njk5NGZjNTA3ZjMwNzdlM2Q5XzI3MA_c4db2997-250d-4653-a822-89bfa7c7a77c" continuedAt="i5f961ff001c14df69ee4bed72c3b54a8" escape="true">Property, plant and equipment as of December&#160;31, 2020 and 2019 consisted of the following: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i5f961ff001c14df69ee4bed72c3b54a8"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57203f1941a34c238bfee31665aa7843_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzItMS0xLTEtMA_0c4f04ad-da6d-4b3e-9e84-e45a6814e38b">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b179f5a47024b169176a67fc04394a0_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzItMy0xLTEtMA_4354494d-a11b-464f-8665-3d2b2314553b">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98373f0ec7ac4501bf3c20e192a85ab3_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzMtMS0xLTEtMA_d02d4135-a381-4344-a56a-34feb3609c3c">526</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b35a4725d3b4fe88bfb392d476d30ea_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzMtMy0xLTEtMA_c0d14c77-ebaa-4b70-b54e-cdc3cebbd6ed">341</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment and furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i488c3759446b424087ce0ba119b76f4b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzQtMS0xLTEtMA_c4a1378f-348e-462d-a7e5-454deee935f7">1,974</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79e00f2d39ae4504bdf0f0d04a7db8be_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzQtMy0xLTEtMA_35b72cbd-0ce8-4128-aa77-9539673c81d9">1,788</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d8a0586d3241db9286ef290dada58c_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzUtMS0xLTEtMA_e8c15f9e-f083-4460-9ddb-707c38760020">666</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963111a2b7bb47c19ef1cb3341f61107_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzUtMy0xLTEtMA_fa84ab80-ea70-44f0-a8b6-1f2b68275554">639</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software developed or obtained for internal use</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc60f47f344746ebae9a4d823259060a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzYtMS0xLTEtMA_d81bb237-31e1-469b-9950-c434f211ce30">1,209</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460ce5e8869e4c7ebfa1175c77836f6a_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzYtMy0xLTEtMA_f5478741-649f-4a1f-8256-3b25c62ce894">1,106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b113ac98aea45cf8f7bd27c96d34ba6_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzctMS0xLTEtMA_8d18eccb-a049-4e58-9b09-a8ec6715108d">202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb8ced261d56482fb9e20fcf2b809143_I20191231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzctMy0xLTEtMA_aea0196c-a20f-4c7c-9af5-3669fb606ed8">330</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzgtMS0xLTEtMA_b93250fd-c639-49ff-b589-b2d0ac071618">4,619</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzgtMy0xLTEtMA_9dd0fd1d-0c8f-48c2-bd73-871b288c8cb0">4,229</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzktMS0xLTEtMA_37f04981-ffd0-47cc-aeec-2497f658e42c">2,992</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzktMy0xLTEtMA_7e3638ba-63a2-48f5-bbad-b08a4d9f438e">2,776</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzEwLTEtMS0xLTA_beb5c776-baa6-46b7-b8bd-1c1be88ff998">1,627</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzEwLTMtMS0xLTA_af0e928b-ee99-4073-b3b0-24fc17d6999f">1,453</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company recognized a $<ix:nonFraction unitRef="usd" contextRef="i6b3427db7dba497ca4f76498d69ffb7b_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90ZXh0cmVnaW9uOjEyOGU0ZjFjMjJlYTQ5Njk5NGZjNTA3ZjMwNzdlM2Q5XzE3MA_4b9a4149-32c0-459f-bfdf-38ce0e6ea003">73</ix:nonFraction> million gain in other operating expense (income), net on the sale and leaseback of a property.</span></div></ix:continuation><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_202"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90ZXh0cmVnaW9uOjBlYjUwZTAxMmUyZDRmMWVhNGY0NWYyYjczOTk1NmJmXzk2MA_febf017e-3506-4a89-a56d-cc0127d8fcb9" continuedAt="if5439dff0f0448dcacfe09c60e9f39b0" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if5439dff0f0448dcacfe09c60e9f39b0" continuedAt="i553dd2fe2571445590af52ba37a1c3fd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90ZXh0cmVnaW9uOjBlYjUwZTAxMmUyZDRmMWVhNGY0NWYyYjczOTk1NmJmXzk0OQ_f91d421d-3c99-4d68-a4f7-8d06594944f8" continuedAt="ifd959a28cead4cc7b0080a8d1b0dce97" escape="true">The changes in goodwill for the years ended December&#160;31, 2020 and 2019 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ifd959a28cead4cc7b0080a8d1b0dce97"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzItMS0xLTEtMA_8703e271-7c00-40b9-977a-64ea62b88573">6,619</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzItMy0xLTEtMA_e19d8440-cee9-4567-b69d-28333ffe2e5b">6,563</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzMtMS0xLTEtMA_f523a6f2-957e-46d1-a12d-e318e17d64d6">247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzMtMy0xLTEtMA_c91c71b3-ef70-4b21-800f-e8e6ebdabfbf">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzQtMS0xLTEtMA_62e19ed5-7588-4452-80d3-a8115feaebfa">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzQtMy0xLTEtMA_3fe98de7-8c38-47b1-92b3-9043cd713eb7">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzUtMS0xLTEtMA_ac864493-059c-4e69-8179-32cb2a0970fe">6,873</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzUtMy0xLTEtMA_2729e581-16c6-41db-a70b-dd5f55e3cd71">6,619</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of December&#160;31, 2020 and 2019 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, goodwill acquired during the period was principally associated with the acquisitions of Blueprint Genetics, Memorial Hermann and MACL (see Note 6). For the year ended December&#160;31, 2020, adjustments to goodwill related to foreign currency translation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, goodwill acquired during the period was principally associated with the acquisition of certain assets of the clinical laboratory services business of Boyce &amp; Bynum and adjustments to goodwill primarily related to the finalization of the purchase price allocation for Oxford (see Note 6).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90ZXh0cmVnaW9uOjBlYjUwZTAxMmUyZDRmMWVhNGY0NWYyYjczOTk1NmJmXzk0Ng_0e3252cc-25d3-4b92-a46c-47624b0063fe" continuedAt="i4e074122daef441b80b98c964454eb5b" escape="true">Intangible assets as of December&#160;31, 2020 and 2019 consisted of the following:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i553dd2fe2571445590af52ba37a1c3fd"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i4e074122daef441b80b98c964454eb5b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.436%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7baf33e596b473a946a41c842d5c491_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtMS0xLTEtMA_ee45e313-c97d-482f-ba51-e245c81999cd">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08feb83acb194d67a15c42b397b1d300_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtMy0xLTEtMA_26353400-a782-4c58-9478-ee71ae504b23">1,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08feb83acb194d67a15c42b397b1d300_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtNS0xLTEtMA_14e6981c-5cc7-41f9-a491-dbc096f9cd37">638</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08feb83acb194d67a15c42b397b1d300_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtNy0xLTEtMA_84272d7b-f2e8-4fb6-922b-6e5d958934f6">841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide27b07e394e4a51961018b52520f0c9_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtOS0xLTEtMA_45f9bb6d-3ce9-4c58-98f9-7b22a51228ba">1,367</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide27b07e394e4a51961018b52520f0c9_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtMTEtMS0xLTA_0b7d9db4-34a4-4de9-a54c-675ee4eef55c">556</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide27b07e394e4a51961018b52520f0c9_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtMTMtMS0xLTA_2d828fee-0c5d-4e53-a0f4-23cdf7842480">811</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i28c19a374b654a3fa8f26f4bf1cada1b_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtMS0xLTEtMA_846d05d6-b6d5-4022-8e67-b6f66f6bc88b">9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621c9dbaf928427c8d032db6c9363c81_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtMy0xLTEtMA_3c067f72-94b5-4d86-9706-13c263d88e83">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i621c9dbaf928427c8d032db6c9363c81_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtNS0xLTEtMA_5931ff80-9c70-4352-90c1-31340ba17489">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i621c9dbaf928427c8d032db6c9363c81_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtNy0xLTEtMA_08f2438e-1102-4265-ad8c-82c3b65bb944">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20fc99f28f194d7c887e0338830b8cb3_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtOS0xLTEtMA_204f36fe-0965-48a7-9f74-c12b095ce403">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20fc99f28f194d7c887e0338830b8cb3_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtMTEtMS0xLTA_a67a34d1-e987-4115-b1a2-787662141270">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20fc99f28f194d7c887e0338830b8cb3_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtMTMtMS0xLTA_50b24553-26a8-4c4a-9785-30ad91bc9e79">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f467983b7f945f691b9a39b57df9e3f_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtMS0xLTEtMA_24ee5070-d0ef-4b16-b03e-704bf20aadcb">15</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767f2717d3143c6901d055819025e8a_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtMy0xLTEtMA_f36df7aa-5b7e-48d4-b5dd-8a0f07199b8d">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if767f2717d3143c6901d055819025e8a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtNS0xLTEtMA_c8257609-8774-41a2-85bd-e264b7f9af74">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767f2717d3143c6901d055819025e8a_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtNy0xLTEtMA_c305320d-dccb-4b1e-afb6-74ea8cffc500">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e2caa4565945f894ecf42eb41689f8_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtOS0xLTEtMA_50a6c931-ff7d-4452-a3fd-2752d100d7f1">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e2caa4565945f894ecf42eb41689f8_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtMTEtMS0xLTA_9b071515-6fab-46b9-bfea-0a8e9921e66f">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e2caa4565945f894ecf42eb41689f8_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtMTMtMS0xLTA_bf12a469-c69c-4eb4-aa8d-b5c8e99c1d78">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7c7dfe44b07a4d7e846ac1bbb305e60e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtMS0xLTEtMA_da36dfb2-aa12-40d0-8024-4b317f02b6ec">9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4534f39f0409446090ba1928a95e44ed_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtMy0xLTEtMA_bbda1cc2-a814-46c1-87a2-f6fdb3fd9b57">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4534f39f0409446090ba1928a95e44ed_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtNS0xLTEtMA_122e3183-ffaf-416f-8d1d-43951a8302f9">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4534f39f0409446090ba1928a95e44ed_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtNy0xLTEtMA_442e8d14-a8bd-4f03-823c-02eb94dcdb6b">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8718641f12744c54b79e3f030931340e_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtOS0xLTEtMA_0fb5b1e1-73d5-446e-b8d9-d5e0f9d6d5a2">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8718641f12744c54b79e3f030931340e_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtMTEtMS0xLTA_de06b70f-d69b-4222-84c4-2f5feb3e2540">85</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8718641f12744c54b79e3f030931340e_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtMTMtMS0xLTA_8dc8a9a4-cedc-4721-a473-a640aacd59d3">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if578b84393414e85a55b974226b6eb09_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctMS0xLTEtMA_b8d06ff6-60c7-4f1b-98cf-927621417713">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i610d712018cd496aa9a406ed51db8e20_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctMy0xLTEtMA_4bace7d0-3d6c-4e05-afe6-7c2edfe8de68">1,731</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i610d712018cd496aa9a406ed51db8e20_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctNS0xLTEtMA_46d4e50a-9165-430b-a916-d4eeba02205f">800</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i610d712018cd496aa9a406ed51db8e20_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctNy0xLTEtMA_ad975155-69ef-4e58-b90c-25c8606139bf">931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b16b1ff6c4b6e9b65c95661c327fb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctOS0xLTEtMA_0d5dee0d-b50f-44fa-bc73-b625ee5fab4f">1,584</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic84b16b1ff6c4b6e9b65c95661c327fb_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctMTEtMS0xLTA_29ea064f-6025-4359-83bf-37dba6abf98e">699</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b16b1ff6c4b6e9b65c95661c327fb_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctMTMtMS0xLTA_dccdc906-47fe-4f90-89c4-50581b484622">885</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97c59e5c69e47a6a83178a589df2ac9_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEwLTMtMS0xLTA_8b64f34b-260e-4a57-8c57-ba57f387a121">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97c59e5c69e47a6a83178a589df2ac9_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEwLTctMS0xLTA_49496316-16bf-43b5-8c06-9f360878be0d">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e856d54e7714c97aec096fbeec1b506_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEwLTktMS0xLTA_79c416f2-9066-4299-8f6b-fc44d38c4591">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e856d54e7714c97aec096fbeec1b506_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEwLTEzLTEtMS0w_6b97b568-380f-4930-9d49-54003faa58ac">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide2b357f410944b7bde3dde25e5e073f_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzExLTMtMS0xLTA_c081b2f5-2413-4c86-a04d-09f31ecb108b">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide2b357f410944b7bde3dde25e5e073f_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzExLTctMS0xLTA_522d506c-d475-4b91-8f33-a0f41a17b74d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0d7b7e3f6c492db815036cc5c1c97e_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzExLTktMS0xLTA_db32d125-9f86-4e38-9ad9-755010ef0c62">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0d7b7e3f6c492db815036cc5c1c97e_I20191231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzExLTEzLTEtMS0w_4a4b48e1-73f2-4a96-b8b3-9be91089d081">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTMtMS0xLTA_5f19cecf-2b5a-4adb-9115-67132a89f30c">1,967</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTUtMS0xLTA_26a655a7-474b-4ae6-a238-e72fb1110981">800</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTctMS0xLTA_59f2f233-f687-42db-8421-dab268a28195">1,167</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTktMS0xLTA_7612673f-cd24-4467-8be0-75d3951eb28b">1,820</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTExLTEtMS0w_2e4e249b-c1b0-441d-9b7e-2eb396c65e42">699</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTEzLTEtMS0w_7e4261aa-cea1-437c-8ae0-2abde0d82499">1,121</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90ZXh0cmVnaW9uOjBlYjUwZTAxMmUyZDRmMWVhNGY0NWYyYjczOTk1NmJmXzk1OA_29ddfbe3-0843-4bbd-bf00-b40a2e9ca928" continuedAt="i2cfc0ef54c094522acd45b4c75bc42a9" escape="true">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2020 is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i2cfc0ef54c094522acd45b4c75bc42a9"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:41.959%"><tr><td style="width:1.0%"></td><td style="width:71.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzEtMS0xLTEtMA_508f48bd-205b-4587-8edc-1ff093b473f2">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzItMS0xLTEtMA_d23fcd95-1450-4ae4-9f76-aaa51ea0422f">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzMtMS0xLTEtMA_113f6985-6a95-4ced-8347-f8db6766910b">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzQtMS0xLTEtMA_8c4b5462-d43f-4c05-a327-75afb9bf8146">93</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzUtMS0xLTEtMA_3495a451-f177-4a38-8d0a-a2d9632e9a72">92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzYtMS0xLTEtMA_1216b118-b88b-487d-a242-2acac875f677">451</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzctMS0xLTEtMA_3ef2ba19-e96e-46c8-a3fd-d8af531deab5">931</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_205"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90ZXh0cmVnaW9uOjhkNTlkYjk4MTZlMDQ3ZWZiN2Q0OTU3ZWYyYWYxYjUyXzE0Mg_9908ae7d-c6dc-49ef-b8d1-c3e27fbc8a29" continuedAt="i0a4a494147524c1d93b2cc42f87dcc90" escape="true">ACCOUNTS PAYABLE AND ACCRUED EXPENSES </ix:nonNumeric></span></div><ix:continuation id="i0a4a494147524c1d93b2cc42f87dcc90"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90ZXh0cmVnaW9uOjhkNTlkYjk4MTZlMDQ3ZWZiN2Q0OTU3ZWYyYWYxYjUyXzEzNw_d3ac48b4-3f8f-4581-8172-95e7db107d90" continuedAt="ic5f9cd8b1da04b859b5f762924fc2491" escape="true">Accounts payable and accrued expenses as of December&#160;31, 2020 and 2019 consisted of the following: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ic5f9cd8b1da04b859b5f762924fc2491"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:74.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages and benefits (including incentive compensation)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzItMS0xLTEtMA_c7cd56de-db0a-4ba2-b4a1-4f684d5c0001">502</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzItMy0xLTEtMA_aa91fe83-2554-4b59-a0f6-49e2beef6d48">287</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzMtMS0xLTEtODg5Mw_efa37e13-6f84-4fea-bff2-efb37badb4c5">446</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzMtMy0xLTEtODg5Ng_c60c1ddd-0918-4aff-a018-a32a66151723">263</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzMtMS0xLTEtMA_2d0feb87-5cd9-4ddc-b031-309db611fdaa">356</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzMtMy0xLTEtMA_23f84a66-345f-43be-afa2-45ebf2ee0e1a">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overdrafts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:BankOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzUtMS0xLTEtMA_3e416ffa-2804-4869-a538-10ae0d417d40">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:BankOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzUtMy0xLTEtMA_cda62320-44f8-44df-9a54-2191dccafd30">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzYtMS0xLTEtMA_6c607ce6-7f25-499a-a7da-09b417547e47">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzYtMy0xLTEtMA_984a6136-2223-45b6-bf33-cccfbee53af1">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzgtMS0xLTEtOTc1OA_3b09f4e3-9da4-42b1-82d9-bd6ee3a6baa0">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzgtMy0xLTEtOTc1OA_4678b057-2ad4-4221-8416-a5c45cecf84e">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:AccruedInsuranceCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzktMS0xLTEtODkwOQ_0cf9bb1c-be46-4df6-99e8-2dd61e46cef7">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:AccruedInsuranceCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzktMy0xLTEtODkwOQ_71e33d15-19b2-4f51-81cf-1fe65b88ceea">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzctMS0xLTEtMA_24696ec4-2a8d-40b2-bcb7-f10662974767">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:InterestPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzctMy0xLTEtMA_0870a114-4203-4bab-9ba9-5ae1e9cadf69">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:zerodash" name="dgx:MergerConsiderationPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzEwLTEtMS0xLTA_ce577a49-8c73-40d8-b414-9a85602addb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="dgx:MergerConsiderationPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzEwLTMtMS0xLTA_e463ad69-5eed-4e6d-9519-acaf6faaae95">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzExLTEtMS0xLTA_4a7fb0b3-1de3-427b-960b-6d0d31e13f1f">1,633</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzExLTMtMS0xLTA_47be40f1-ef87-4d50-babe-92775c27bbea">1,041</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_208"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5ODk_1e2d3ae6-b597-4714-a681-c80f4e7cb08a" continuedAt="iadb04a9373e04d1fb2aafebb6f19105b" escape="true">DEBT</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iadb04a9373e04d1fb2aafebb6f19105b" continuedAt="i60602632a38c4d86a86b3e475fa7197f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5ODU_4033013b-f948-4b8b-be01-1b4c53547c9e" continuedAt="i9610c2aea2df4dd9b4666061cfac65cc" escape="true">Long-term debt (including finance lease obligations) as of December&#160;31, 2020 and 2019 consisted of the following: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i9610c2aea2df4dd9b4666061cfac65cc"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:77.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifc7572c2a2924de4b2ef502d5bbbfa0c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzQtMC0xLTEtMC90ZXh0cmVnaW9uOjc3YTlkNWI2NmIzNzRkNjg5ZWNjOTk4NTQ3OTJhMDc2XzQ5NDc4MDIzMjUwMzY_cae24bf9-b4f8-4e89-9791-ac1a8ac91830">4.75</ix:nonFraction>% Senior Notes due January 2020</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7572c2a2924de4b2ef502d5bbbfa0c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzQtMS0xLTEtMA_88da109a-6c1a-4dd1-82e1-2d3664e4d2d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9887f5d1e7ec47d794ad4b9c520d77f0_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzQtMy0xLTEtMA_07d2757d-68a9-4b0a-b9aa-8f1353f46707">500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i492a760c40d7442ca1a7e0f8594d36e4_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjBjYjdiMDE4M2JhYjQ3ODk4NWY3MjM5MWRmOTUwMmNjXzQ5NDc4MDIzMjUwMzQ_24f00cc8-325a-487c-8811-f8a3d1dc53a3">2.50</ix:nonFraction>% Senior Notes due March 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i492a760c40d7442ca1a7e0f8594d36e4_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzUtMS0xLTEtMA_7e2c7ec4-742d-4773-adda-6d8f6dd0b375">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieace3baae6f84b0e9354cf88139ef2c2_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzUtMy0xLTEtMA_45df75aa-5ef4-4400-8929-27b288d3b7be">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia0dd309e22f4493e85b52fb6f70911e3_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk3ODNmNTBkYTg1ZjRlZDI4Mjc4OWMxZmZjNDdkYTAwXzQ5NDc4MDIzMjUwMzQ_d69351db-0b6a-468c-8849-70e3dd840f68">4.70</ix:nonFraction>% Senior Notes due April 2021</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0dd309e22f4493e85b52fb6f70911e3_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzYtMS0xLTEtMA_0a273497-ebe3-4870-a4db-ada06ab68a02">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56f70613c89455ab45a405199ac352e_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzYtMy0xLTEtMA_f4744f5a-63b3-4516-9c05-3aeb5ef1b070">554</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8eb23b0916d24877a17f2212f4fbd7da_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzctMC0xLTEtMC90ZXh0cmVnaW9uOmZiZGU5NDdhZmQ3YzQwMzk5MTYyNTM0OGFjOWVlNjc4XzQ5NDc4MDIzMjUwMzQ_74c5a6a0-c6e3-4c1e-a652-e2ddf0f29f37">4.25</ix:nonFraction>% Senior Notes due April 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eb23b0916d24877a17f2212f4fbd7da_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzctMS0xLTEtMA_0585e997-93e0-4b54-ac77-a82926a7c911">316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253f26b0c58e4670a7e5d21e7ed55f38_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzctMy0xLTEtMA_e78df8df-06dc-4783-baeb-76b2c4063a3b">308</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i68618e5aa89c4194adf23217f32a8b41_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzgtMC0xLTEtMC90ZXh0cmVnaW9uOjlhYjA2MzU3MTNmZTQ1ZWU4MDIzZjFiYmUzMmY3MThmXzQ5NDc4MDIzMjUwMzQ_1dd4733f-7f4e-4d97-aecc-8ecd6f7f9784">3.50</ix:nonFraction>% Senior Notes due March 2025</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68618e5aa89c4194adf23217f32a8b41_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzgtMS0xLTEtMA_9d18cb9b-c0a5-42de-a724-b36d3f79e40e">622</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c28753e6234d99a6b6e5ecd71a6645_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzgtMy0xLTEtMA_24d4815d-5847-4c04-bd05-273674e20b69">593</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5e04c7b3917042c0be08e09c6ee19d74_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzktMC0xLTEtMC90ZXh0cmVnaW9uOmRlYzYxMDU5NDQ0MDRjZDk5MmViMDY2YjNlMTc0NjJhXzQ5NDc4MDIzMjUwMzM_c465d921-716a-4da5-92ac-011140433035">3.45</ix:nonFraction>% Senior Notes due June 2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e04c7b3917042c0be08e09c6ee19d74_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzktMS0xLTEtMA_de592948-c5d9-4353-bf51-7b85ffcde83c">512</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979e993f5cad468e9c420fcb8e10baae_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzktMy0xLTEtMA_6622847f-e8fa-4538-afb3-8841cebe17fc">490</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64c30d8d93c246b9a9045e239918d12b_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjpkYWQ2YTJmNGZjMzE0Mjk0OTQwMjU3ZGZjYzBkNWFkN180OTQ3ODAyMzI1MDMz_381c6dcf-cf8d-4937-8760-a7b707664812">4.20</ix:nonFraction>% Senior Notes due June 2029</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c30d8d93c246b9a9045e239918d12b_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEwLTEtMS0xLTA_46faadc0-e38a-4826-97a3-da75e2e5497c">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa89a373573f435bad75aa9ad414d5cf_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEwLTMtMS0xLTA_55ec2672-3a73-4298-b97a-b33e5255e8ef">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id3374f07e84740c1b2a1181c5c8ed5fe_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MDFkMDA3MjQxODk0ZjE4OTUxZGM2ODZiN2IxYTQ3Ml80OTQ3ODAyMzI1MDMz_4b922892-dd28-4522-ae17-e6caabd2d596">2.95</ix:nonFraction>% Senior Notes due June 2030</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3374f07e84740c1b2a1181c5c8ed5fe_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzExLTEtMS0xLTA_664943e0-b817-4f50-98f6-a216ec4c249c">798</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id253b3ca50134883a39411cabb3236df_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzExLTMtMS0xLTA_c100eea6-49d6-46ec-a58d-ffd0b94e9f59">798</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a816a93885d4ca989a2e52f8edcd268_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTAtMS0xLTI0NzMvdGV4dHJlZ2lvbjo5NjRiMWUxZjVmYmQ0ZjBiYWZjYzQ2YjczNzA4YjlhOV80OTQ3ODAyMzI1MDMx_fb9a7635-e33d-49a4-8ff6-5cee21190649">2.80</ix:nonFraction>% Senior Notes due June 2031</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a816a93885d4ca989a2e52f8edcd268_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTEtMS0xLTI2OQ_75d9e357-039e-4d9f-b596-c31471ee944e">549</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia92ac89bc9464dc4a5bf688a1dc0f2e1_I20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTMtMS0xLTI3Mg_159b926e-d615-432b-8a24-594eba3da05a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica3b9d8c23ad48a888fd41a9f78b692e_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjowOGUwZjhjNTZkMTA0ZWRkODgwMjQ2NjA4NTA0NjBhZl80OTQ3ODAyMzI1MDMz_b9d83d8d-6ed8-456b-bb03-efec08a49b55">6.95</ix:nonFraction>% Senior Notes due July 2037</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3b9d8c23ad48a888fd41a9f78b692e_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTEtMS0xLTA_db062e76-ed3f-420a-b41c-54cfce7b8e5c">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc40d79750043f0a0c76f967a147ab5_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTMtMS0xLTA_d0858768-dbc0-4a9b-9fe1-c9d83c83dfa8">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c0a568fbbe54b32a4d65037b02187d7_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEzLTAtMS0xLTAvdGV4dHJlZ2lvbjpkYjY0OGRkMmJkYmY0ZTMxOGMyMjRjMWYwZTMxN2EzNF80OTQ3ODAyMzI1MDM2_6f54be49-d214-46fb-8ce3-e5f8582005f2">5.75</ix:nonFraction>% Senior Notes due January 2040</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c0a568fbbe54b32a4d65037b02187d7_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEzLTEtMS0xLTA_0a7aebdb-57d4-4774-ae76-789e8cced141">245</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie27dd42f03aa4d7da20e94071af99bcc_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEzLTMtMS0xLTA_d6589cb1-4bd7-45b7-9148-405d197164c8">245</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4f38dc71c4a4401ba20c8d9d84fd23b7_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5YzhkMGNkOTkwN2E0ODkzODBkMzEzZjEzZDE5ZjRmOF80OTQ3ODAyMzI1MDM0_77159338-a0fd-43ea-88b2-c17ab935fca7">4.70</ix:nonFraction>% Senior Notes due March 2045</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f38dc71c4a4401ba20c8d9d84fd23b7_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE0LTEtMS0xLTA_1433163a-428b-4bc6-bb4f-21f6db48c7db">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44196df9463840cc83124dd513dea909_I20191231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE0LTMtMS0xLTA_4fb11838-dc23-4779-8c86-cfbf6455e6ea">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545c653723ac4b35958b7b601878135c_I20201231" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE1LTEtMS0xLTA_a3104a3a-1ca8-40d4-8230-5851c873b3f8">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfbc63685ff840fb973900d155c530e7_I20191231" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE1LTMtMS0xLTA_f30f0919-0acb-4823-8e70-3657fa19caa0">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE2LTEtMS0xLTA_749ce109-58f4-4904-ae99-0d0b01e94e32">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE2LTMtMS0xLTA_0c766802-b8ed-4426-b6a5-5624b09d83e5">26</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE3LTEtMS0xLTA_8970a93d-6ae5-413c-aecd-e984909079c5">4,015</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE3LTMtMS0xLTA_4ee97d0b-97d7-4dda-b9f7-aae734d39f89">4,770</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE4LTEtMS0xLTA_11b78c57-04bb-49b8-a6de-57c43303b80b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE4LTMtMS0xLTA_517cf2d9-fc63-4c05-99d6-066e21067c2c">804</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE5LTEtMS0xLTA_b51cd464-143c-4f9f-aacc-a43c008ca853">4,013</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE5LTMtMS0xLTA_5d1699b7-7d2d-49c4-88f1-fd81ef2df52b">3,966</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Secured Receivables Credit Facility </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On October 22, 2020, the Company amended the agreement for its $<ix:nonFraction unitRef="usd" contextRef="iecaf492a9ad94a36b60612ba765970e6_I20201022" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MDIx_ebd64165-0fc5-4eb3-8fb2-7d6f2741958f">600</ix:nonFraction>&#160;million secured receivables credit facility (the &#8220;Secured Receivables Credit Facility&#8221;), previously amended in October 2019, to extend the maturity dates for each underlying commitment by <ix:nonNumeric contextRef="ifb648f82ea194e07a192722e1bf31021_D20201001-20201031" format="ixt-sec:durwordsen" name="dgx:DebtInstrumentExtensionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5NDc4MDIzNTU4NTE_0dadb1ec-97d8-4c6c-a069-253026c9738c">one year</ix:nonNumeric>, while maintaining the borrowing capacity under the facility at $<ix:nonFraction unitRef="usd" contextRef="iecaf492a9ad94a36b60612ba765970e6_I20201022" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MDQ4_f5e5d4a3-855f-4cb8-95c0-e39220f5d51b">600</ix:nonFraction>&#160;million.  Under the Secured Receivables Credit Facility, the Company can borrow against a $<ix:nonFraction unitRef="usd" contextRef="ibce6a4a1e68c4e53a145b95c9e367803_I20201022" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MDc1_da2ab0fd-70a0-42e8-9c0a-2bc91e00e99f">250</ix:nonFraction>&#160;million loan commitment maturing October 2021 and a $<ix:nonFraction unitRef="usd" contextRef="i6f191ea10c984af4842750df37661e22_I20201022" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MTE4_fead43d9-363f-4889-b0ea-0a01caf5ef0c">250</ix:nonFraction>&#160;million loan commitment maturing October 2022, and can issue up to $<ix:nonFraction unitRef="usd" contextRef="i462cfe8638814f0f8481f3716a2592c3_I20201022" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MTU5_0be67e22-9dc8-48af-80c0-f6005600dedf">100</ix:nonFraction>&#160;million of letters of credit (see Note 18) through October 2022.  Borrowings under the Secured Receivables Credit Facility are collateralized by certain domestic receivables.  As of December&#160;31, 2020, interest on the borrowings under the Secured Receivables Credit Facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of <ix:nonFraction unitRef="number" contextRef="i524294a4d8b3418da3d3f916d41a20d1_D20201231-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MjI1_42be64ec-08cc-4018-8db8-9a793425eb35">0.825</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i6c91c94f07a044d2aa17c4da4b4cf161_D20201231-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MjE4_5f185c35-58eb-4108-be6e-d0344211c36c">0.95</ix:nonFraction>%.  The Secured Receivables Credit Facility is subject to customary affirmative and negative covenants and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility.  As of both December&#160;31, 2020 and 2019, there were <ix:nonFraction unitRef="usd" contextRef="i904ef886693341f7b599802cc0a219e7_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0MzIz_3bff1f9f-3cef-412a-a994-6ca3cef7df5a"><ix:nonFraction unitRef="usd" contextRef="ie586bfbfd98b4802b4c74457620ebe91_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0MzIz_50c27213-0309-4a77-8143-94230683060d">no</ix:nonFraction></ix:nonFraction> outstanding borrowings under the Secured Receivables Credit Facility. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i60602632a38c4d86a86b3e475fa7197f" continuedAt="i749e01ffbbf54b92b305bbe58b493e1c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Unsecured Revolving Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is party to a $<ix:nonFraction unitRef="usd" contextRef="i1b45d450024c47499fbde295edb34e7e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkxOTgy_400bfc35-2ebb-44bc-8c00-25debf421751">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility (the &#8220;Credit Facility&#8221; or "Senior Unsecured Revolving Credit Facility") which matures in March 2023.  Under the Credit Facility, the Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="i95b81aaa9acb42f1810e4c076150e924_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkxNzI5_b3471076-4c1d-4d7e-9c66-9585d649c8f4">150</ix:nonFraction>&#160;million (see Note 18).  Issued letters of credit reduce the available borrowing capacity under the Credit Facility.  Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings and its leverage ratio.  At the option of the Company, it may elect to lock into LIBOR-based interest rates for periods up to six months.  Interest on any outstanding amounts not covered under LIBOR-based interest rate contracts is based on an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted LIBOR rate.  As of both December&#160;31, 2020 and 2019, the Company's borrowing rate for LIBOR-based loans under the Credit Facility was LIBOR plus <ix:nonFraction unitRef="number" contextRef="i2f895fdee4b5481087569c16292b9b26_D20190101-20191231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0MzM0_84a856cd-024b-4d27-b933-683cb0e64866"><ix:nonFraction unitRef="number" contextRef="ic4e79e85b7c548d0b0dc680c03e2b9e5_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0MzM0_9577715f-93bd-4bd3-b1ab-fdda6d9d1fc6">1.125</ix:nonFraction></ix:nonFraction>%.  The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness.  In April 2020, the Company amended the Credit Facility to provide increased covenant flexibility.  <ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dgx:ScheduleOfLeverageRatioCovenantsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5NDc4MDIzNTU4NjY_e0ff7034-2c5f-4cbd-9792-b784397ddfdb" continuedAt="i5403899980e04ceebc84ee494f23bc71" escape="true">As amended, the leverage ratio covenant (as defined in the Credit Facility) was increased as follows:</ix:nonNumeric></span></div><ix:continuation id="i5403899980e04ceebc84ee494f23bc71"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.046%"><tr><td style="width:1.0%"></td><td style="width:36.259%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Covenant:</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than <ix:nonFraction unitRef="number" contextRef="i6d93b15cf2364f2f9c77170f1dcdc9cc_I20201231" decimals="INF" name="dgx:DebtInstrumentLeverageRatioRequirement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyMmUyYjdjMWZiMDY0ZjVmOGNiOTFkMTJlMTg3MDJhMi90YWJsZXJhbmdlOjIyZTJiN2MxZmIwNjRmNWY4Y2I5MWQxMmUxODcwMmEyXzItMi0xLTEtNTQ3MC90ZXh0cmVnaW9uOjUyZjdkMjU2YmFlOTQyNzQ5Y2NiZjgyZGQ0MzczMWYxXzIxOTkwMjMyNTU1ODQ_3463ed49-ecd0-4106-a371-57f0586722cc">6.5</ix:nonFraction> times EBITDA</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than <ix:nonFraction unitRef="number" contextRef="i9ee13471497b4108b33ff83c309a7a45_I20210331" decimals="INF" name="dgx:DebtInstrumentLeverageRatioRequirement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyMmUyYjdjMWZiMDY0ZjVmOGNiOTFkMTJlMTg3MDJhMi90YWJsZXJhbmdlOjIyZTJiN2MxZmIwNjRmNWY4Y2I5MWQxMmUxODcwMmEyXzMtMi0xLTEtNTQ3MC90ZXh0cmVnaW9uOjI5MzFlNWJjNTVjYTQ3ZjBhYTFmYTczZmJmMWMzNjlhXzIxOTkwMjMyNTU1ODQ_883bb550-d0d6-48ce-a8ed-8c1f4e4d975f">6.25</ix:nonFraction> times EBITDA</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than <ix:nonFraction unitRef="number" contextRef="i80dc0f5cd5f241689a10b1242a112b9a_I20210630" decimals="INF" name="dgx:DebtInstrumentLeverageRatioRequirement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyMmUyYjdjMWZiMDY0ZjVmOGNiOTFkMTJlMTg3MDJhMi90YWJsZXJhbmdlOjIyZTJiN2MxZmIwNjRmNWY4Y2I5MWQxMmUxODcwMmEyXzQtMi0xLTEtNTQ3MC90ZXh0cmVnaW9uOmJiNjI5M2VkYmFmMDRjM2FiNTQ0N2Q2ZTMwYjg1NDNlXzIxOTkwMjMyNTU1ODQ_c780f2e4-c32b-44e7-a5e0-9ea37aa48047">4.5</ix:nonFraction> times EBITDA</span></div></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                     </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Thereafter, the leverage ratio covenant reverts to no more than <ix:nonFraction unitRef="number" contextRef="i88d8839878a14fa79907f288bf110c47_I20210930" decimals="INF" name="dgx:DebtInstrumentLeverageRatioRequirement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyODcwNjc_8e93bd9e-cb57-4c31-9395-ee5028a2fc45">3.5</ix:nonFraction> times EBITDA.  During the period that the increased covenant applies, which period may be terminated early by the Company provided that the Company is in compliance with the historical <ix:nonFraction unitRef="number" contextRef="i88d8839878a14fa79907f288bf110c47_I20210930" decimals="INF" name="dgx:DebtInstrumentLeverageRatioRequirement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyODcwNzc_0329153e-4006-480b-b0e2-9b6c92bc69ca">3.5</ix:nonFraction> times EBITDA leverage ratio, the amended Credit Facility contains certain additional limitations and restrictions including, but not limited to, repurchases of the Company's common stock, the amount of funds that can be used on business acquisitions, the incurrence of secured indebtedness and the payment of dividends.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of both December&#160;31, 2020 and 2019, there were <ix:nonFraction unitRef="usd" contextRef="i1b45d450024c47499fbde295edb34e7e_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkyMjU1_507f6010-fcd6-4aab-9a1f-2c85e59493f9"><ix:nonFraction unitRef="usd" contextRef="i11c5ad757a094b24a5c73f68379fa8f9_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkyMjU1_930eadfd-edb1-42bf-8102-8cc9ea39032e">no</ix:nonFraction></ix:nonFraction> outstanding borrowings under the Senior Unsecured Revolving Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December 31, 2020, the Company was in compliance with all covenants for its credit facilities.  As of December 31, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkyNjY0_51c51049-0663-46c0-81ed-ff14cfc050c9">1.3</ix:nonFraction>&#160;billion of borrowing capacity available under the facilities, including $<ix:nonFraction unitRef="usd" contextRef="ie6362246725c44d7844b750f652f23d9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0NTk2_223b9f3e-ed9d-462a-a956-ec68eb9d765c">530</ix:nonFraction>&#160;million available under the Secured Receivables Credit Facility and $<ix:nonFraction unitRef="usd" contextRef="i1b45d450024c47499fbde295edb34e7e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkyNzAx_5c0a3384-ba73-4f16-9233-18d85522dc30">750</ix:nonFraction>&#160;million available under the Senior Unsecured Revolving Credit Facility. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i749e01ffbbf54b92b305bbe58b493e1c" continuedAt="id55cd4ba04d54fd4a5204fd89e69c339"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes Offerings</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company completed a senior notes offering, consisting of $<ix:nonFraction unitRef="usd" contextRef="i0847ec854f1041b091d07bb199a6faaf_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyNjEwNzY_f0d412d8-3281-4566-9729-4d5773a8d7a1">550</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i0847ec854f1041b091d07bb199a6faaf_I20200531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyNjExMTA_e61545fd-481a-4ba1-87a3-73e4a15832b3">2.80</ix:nonFraction>% senior notes due June 2031 (the &#8220;2031 Senior Notes&#8221;), which were issued at an original issue discount of $<ix:nonFraction unitRef="usd" contextRef="i0847ec854f1041b091d07bb199a6faaf_I20200531" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyNjEyMTM_76410c3a-e5dd-4fca-93ac-ce014a58c0e1">1</ix:nonFraction>&#160;million.  The Company incurred $<ix:nonFraction unitRef="usd" contextRef="i0847ec854f1041b091d07bb199a6faaf_I20200531" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDc4NDgy_a2eda081-01fa-40b4-b02b-94f2c51d8408">5</ix:nonFraction>&#160;million of debt issuance costs associated with the 2031 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During November 2020, the net proceeds from the 2031 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due April 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;In December 2019, the Company completed a senior notes offering, consisting of $<ix:nonFraction unitRef="usd" contextRef="id253b3ca50134883a39411cabb3236df_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTQx_6aa2d7c7-21dd-4805-8ba0-e5f2ae577f70">800</ix:nonFraction>&#160;million&#160;aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="id253b3ca50134883a39411cabb3236df_I20191231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTU1_fb2fddd9-c94d-42b6-9f5a-19117b8fa0bf">2.95</ix:nonFraction>% senior notes due June 2030 (the "2030 Senior Notes"), which were issued at an original issue discount of&#160;$<ix:nonFraction unitRef="usd" contextRef="id253b3ca50134883a39411cabb3236df_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTYy_5e955cbc-8748-48f0-8f6d-4564f84b3ff1">2</ix:nonFraction>&#160;million.  The Company incurred $<ix:nonFraction unitRef="usd" contextRef="id253b3ca50134883a39411cabb3236df_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTc0_79ab940c-75c8-4dc0-bd9c-2b51c312cfe0">7</ix:nonFraction>&#160;million&#160;of debt issuance costs associated with the 2030 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During January 2020, the net proceeds from the 2030 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due January 2020 and senior notes due March 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2019, the Company completed a senior notes offering, consisting of $<ix:nonFraction unitRef="usd" contextRef="i87fb802f159d45308c5722aab7a51e3f_I20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTg2_ed762867-8905-4877-bb38-5e4ce4964811">500</ix:nonFraction>&#160;million&#160;aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i87fb802f159d45308c5722aab7a51e3f_I20190331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNjAw_e7110d1e-3c35-4a6e-a13c-1b7680c4fe98">4.20</ix:nonFraction>% senior notes due June 2029 (the "2029 Senior Notes"), which were issued at an original issue discount of&#160;$<ix:nonFraction unitRef="usd" contextRef="i87fb802f159d45308c5722aab7a51e3f_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNjQx_f23e7b2a-b3b7-453c-820f-2f26bb316db3">1</ix:nonFraction>&#160;million.  The Company incurred&#160;$<ix:nonFraction unitRef="usd" contextRef="i87fb802f159d45308c5722aab7a51e3f_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNjI5_a3a2276b-c3a2-4705-9b1d-3b1d435c0772">5</ix:nonFraction>&#160;million&#160;of debt issuance costs associated with the 2029 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The net proceeds from the 2029 Senior Notes were used to repay in full the outstanding indebtedness under the Company's senior notes due April 2019, to repay outstanding indebtedness under the Secured Receivables Credit Facility and for general corporate purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, the Company recorded a loss on retirement of debt, principally comprised of premiums paid, of $<ix:nonFraction unitRef="usd" contextRef="i752e64558c134adab9652fe39589f9ca_D20200101-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDc4OTc3_7ad05f87-4f68-4737-9910-e63e9d352db6">9</ix:nonFraction>&#160;million in other income (expense), net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All of the senior notes are unsecured obligations of the Company and rank equally with the Company's other senior unsecured obligations.  None of the Company's senior notes have a sinking fund requirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may redeem its outstanding senior notes prior to scheduled maturity, as a whole or in part, at a redemption price equal to the present value of the remaining scheduled payments of principal and interest, except for certain notes for which the Company also has an option to redeem such instruments at par value on or after dates specified in the indentures governing the notes ("the par value redemption option"). &#160;For notes with the par value redemption option, if such notes are redeemed prior to the specified dates, the redemption price calculations exclude any interest that would have been due after such dates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="id55cd4ba04d54fd4a5204fd89e69c339"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturities of Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5ODM_e8ae1d56-593d-478d-bc8e-9a161e831f65" continuedAt="i4b45c48002bf4ad3b43446c191d7a9b1" escape="true">As of December&#160;31, 2020, long-term debt matures as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i4b45c48002bf4ad3b43446c191d7a9b1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:297.00pt"><tr><td style="width:1.0pt"></td><td style="width:235.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzEtMS0xLTEtMA_28826ee6-79d9-4cf3-8066-64ae2f73eee8">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzItMS0xLTEtMA_85548f2c-1b75-4ca7-9d90-c26ed10db745">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzMtMS0xLTEtMA_d234d61e-0a54-4101-854b-320ff318e687">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzQtMS0xLTEtMA_073ee1c3-9e4f-48f5-89ee-b2adb3a6beec">302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzUtMS0xLTEtMA_e9543b0b-a6f4-4f9c-9063-ce775acac5fb">602</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzYtMS0xLTEtMA_2184b35a-c841-42df-a9c7-f60fe844b8bb">3,095</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities of long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:LongTermDebtMaturitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzctMS0xLTEtMA_15e999f5-0e08-405a-8599-39e2098e2f0d">4,003</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzgtMS0xLTEtMA_ef6ef3b9-1001-4931-9726-9553fbbf8c61">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzktMS0xLTEtMA_749ce109-58f4-4904-ae99-0d0b01e94e32">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value basis adjustments attributable to hedged debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" sign="-" name="dgx:DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzEwLTEtMS0xLTA_80c5510c-1b32-4e63-a7c1-9c1b25b71744">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzExLTEtMS0xLTA_306f8355-8217-42c2-b517-f7beaa58cce9">4,015</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzEyLTEtMS0xLTA_f73061eb-045e-4aca-bc25-15586a336ca3">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzEzLTEtMS0xLTA_2c09bc24-6421-44e5-a9b4-20c316037148">4,013</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_214"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTU_d61045ba-e813-4a48-ae0d-3763deaeb09b" continuedAt="i4c846916c7af4e39808a7a26b6d9cf2e" escape="true"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTY_8152b5c2-ea04-4457-b291-1b9ed33e2d84" continuedAt="i7164fdfaa84b4aeeb06279d8b8ac32ec" escape="true">LEASES</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i4c846916c7af4e39808a7a26b6d9cf2e" continuedAt="i5b5206c970d943efb1df79c79996491f"><ix:continuation id="i7164fdfaa84b4aeeb06279d8b8ac32ec" continuedAt="i2a7f41a0238241f4890f7c2041973613"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTc_7c6b6a70-935c-469f-ac2f-801e47872ef8" escape="true">The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A right-of-use asset, representing the underlying asset during the lease term, and a lease liability, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.</ix:nonNumeric>  For the year ended December&#160;31, 2020 and 2019, lease expense associated with short-term leases was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#8217;s leases based on tenor.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than <ix:nonNumeric contextRef="ib4e9bac07fa34fa6ac58f793d4697067_D20200101-20201231" format="ixt-sec:duryear" name="dgx:LeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzE5NTA_088c5ac2-92fd-4218-bd0c-32add704a1c1">1</ix:nonNumeric> year to <ix:nonNumeric contextRef="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231" format="ixt-sec:duryear" name="dgx:LeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzQ5NDc4MDIzMjk3MTE_8b5456dc-c9d6-4c80-8e78-5e5041055656">16</ix:nonNumeric> years, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231" format="ixt-sec:duryear" name="dgx:LeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzIwMjE_935796d6-aa1b-4a33-8c68-b56cd81d0073">15</ix:nonNumeric> years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dgx:ScheduleOfLeaseByAssetTypeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTg_38f73790-910c-46c5-9fd9-c8990e8109b0" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's assets and liabilities for its lease agreements as of December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:21.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.672%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.573%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzItNC0xLTEtMA_2ef82887-36e2-4ce3-9e23-2ac94956baf0">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzItNi0xLTEtMTEwNzI_06548e47-2913-4d91-888f-47dd329d86ff">518</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzMtNC0xLTEtMA_921f5e89-1cd9-4bd6-9b8f-108c1a4b2b18">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzMtNi0xLTEtMTEwNzI_740ba795-89df-44d8-a093-c822362180c3">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LeaseRightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzQtNC0xLTEtMA_74e86ae5-28d0-4cfd-aa55-fda7aae4c925">626</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="dgx:LeaseRightofUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzQtNi0xLTEtMTEwNzI_d7e6325a-b7cb-45a4-9d60-0e9979eccd64">553</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzgtNC0xLTEtMA_49e4e2a5-d0f9-429c-b286-22475d084e1b">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzgtNi0xLTEtMzg5NQ_12f06bc0-dc9c-4042-a742-3aa896bc60f3">145</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzktNC0xLTEtMA_ff3075e8-5653-4e40-8b29-2416f581e7e1">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzktNi0xLTEtMzg5OA_d8229587-7ac6-461d-b593-542357926294">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzExLTQtMS0xLTA_2524ba60-969b-485a-a364-1fa3aa53e1c7">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzExLTYtMS0xLTM5MDE_0b2c7611-037a-407c-b967-6c0fc5281286">413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzEyLTQtMS0xLTA_1526b691-717d-4048-80c5-ad0be9df0726">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzEyLTYtMS0xLTM5MDM_8c9f31ad-3b8e-4351-9884-1ebc1f1ebeb9">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzEzLTQtMS0xLTA_d747e486-41bc-4f59-a7e4-f091948018c7">667</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" name="dgx:LeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzEzLTYtMS0xLTExMDcy_05c0e5d9-517f-4a47-a9d1-06d718a1b39a">591</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Finance lease assets as of December 31, 2020 and 2019 were recorded net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzEwNDQ1MzYwNDY4NjE5_9f5b76a2-f9e3-4191-a56b-ef7a1eca5ea0">14</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzEwNDQ1MzYwNDY4MDIw_c6756c87-967f-4c43-b980-d666558f6f9b">24</ix:nonFraction>&#160;million, respectively.</span></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i5b5206c970d943efb1df79c79996491f"><ix:continuation id="i2a7f41a0238241f4890f7c2041973613"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTM_71858773-6b3a-4e3c-a67a-026c4520293c" continuedAt="icad8eda57de24359876c2b8b42f7d4ce" escape="true">Components of lease cost for the years ended December&#160;31, 2020 and 2019 were as follows:</ix:nonNumeric></span></div><ix:continuation id="icad8eda57de24359876c2b8b42f7d4ce"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:364.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="dgx:OperatingLeaseFixedAndVariableCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzItNC0xLTEtMA_e91492bd-9fa9-44b0-a962-29a7f40e8b86">300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="dgx:OperatingLeaseFixedAndVariableCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzItNC0xLTEtMzk0Mw_b9de2764-2f8c-47e7-83c8-98c4b3b66040">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzUtNC0xLTEtMA_6abee039-0b95-4fc8-b1a4-48d95b0b1400">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzUtNC0xLTEtMzk0Ng_2de83519-1445-4cd6-9112-a8468be2d723">7</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzYtNC0xLTEtMA_0bc5572d-cff2-46e2-ad29-5ee8b3e47516">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzYtNC0xLTEtMzk0Ng_38f2c484-1f68-41f8-9933-99092a018b87">3</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzctNC0xLTEtMA_ffcdeb05-538f-43a9-86f2-a655d8952bdd">309</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzctNC0xLTEtMTEwNzU_6534aadd-8cb8-45de-b829-23aaaf83da90">304</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:ShorttermLeaseandVariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzEwNDQ1MzYwNDY4MTk0_1c03bcb9-c1a0-443d-93e7-11d75e427178"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:ShorttermLeaseandVariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzEwNDQ1MzYwNDY4MTk0_6b476990-0be2-4899-b0f3-c261ca7e7e75">120</ix:nonFraction></ix:nonFraction>&#160;million for each of the years ended December&#160;31, 2020 and 2019.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Rental expense for real estate, laboratory equipment and vehicles under operating leases amounted to $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LeaseAndRentalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzI5MjI_1cfd0047-fb6f-46b4-b0f0-b9b4ba1fcdd6">220</ix:nonFraction> million for the year ended December&#160;31, 2018.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTQ_bbbb42dd-3c00-4cc2-ac2f-41a624f356e6" continuedAt="i46ee90157aa84f45b5dc538d911e3336" escape="true"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTk_5b18ad91-dfa8-44f2-8f16-8911619dbce5" continuedAt="i9234fa7ffa9b4069a38e276be104d3ad" escape="true">The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i46ee90157aa84f45b5dc538d911e3336"><ix:continuation id="i9234fa7ffa9b4069a38e276be104d3ad"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"><tr><td style="width:1.0pt"></td><td style="width:163.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzEtMi0xLTEtMA_a99958db-4035-4e93-974c-6e965be2c202">160</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzEtNC0xLTEtMA_19ebd94d-8522-4ded-b980-cd3a153f2fc5">4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzEtNi0xLTEtMA_67089878-cfab-4096-b087-8907e215f0e5">164</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzItMi0xLTEtMA_8f9d7242-3d83-4cf2-9a40-75e3fd3518c7">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzItNC0xLTEtMA_6078762b-454a-4bdd-8d0f-e34b5b66a487">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzItNi0xLTEtMA_ba521cdb-6ef0-47ed-9724-50b1fb6ddc53">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzMtMi0xLTEtMA_91c35c31-c0b6-47fc-9ceb-3dca326f9c46">122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzMtNC0xLTEtMA_19dbd158-5a25-4b23-91aa-f49cbdd9d03e">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzMtNi0xLTEtMA_e296a7c9-ac94-4fe1-be5f-25b10d5835b3">125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzQtMi0xLTEtMA_ac2644ea-1bd6-497f-a0d7-a7be607a3751">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzQtNC0xLTEtMA_cb027041-202f-4540-9129-f01be68ca5b9">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzQtNi0xLTEtMA_bb91a2fe-9e7e-470d-a782-8a31bd4e5cd6">90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzUtMi0xLTEtMA_5088a129-3e98-4d9d-bc93-b84e6b047e16">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzUtNC0xLTEtMA_4f155a69-7149-4c2a-b7e2-9b03fc64a513">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzUtNi0xLTEtMA_7a7ccec3-c390-4bdc-964b-a1ea0375b0ea">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzYtMi0xLTEtMA_46d3a2bc-d6a3-4265-b8de-079cd7e61b97">153</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzYtNC0xLTEtMA_8ad110de-f884-4111-a5b9-4bd253f390b0">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzYtNi0xLTEtMA_c9088951-629b-4933-8b96-c07bc06ccfbf">181</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzctMi0xLTEtMA_3c0492c4-47b8-47b2-b525-0d7eab4c57d4">719</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzctNC0xLTEtMA_614126bf-8b8b-4b2f-835b-74bb08aaf60b">44</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzctNi0xLTEtMA_eb9696fb-3a9e-4a81-a806-ea6bfc969fb2">763</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzgtMi0xLTEtMA_f93b4304-a9f7-43ac-8361-b0790f88d315">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzgtNC0xLTEtMA_607768c1-f2f4-4ff3-90d3-3d3abd708ac7">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzgtNi0xLTEtMA_3299ae6b-0637-4017-9d94-36ceaa344626">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzktMi0xLTEtMA_d171a4d5-b0f4-4a2b-a339-d99b75eea479">640</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzktNC0xLTEtMA_633a7bb1-6511-4249-80ee-d542c047fe04">27</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" name="dgx:OperatingandFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzktNi0xLTEtMA_e2e0def9-4317-4d7a-831d-ea33a55b447f">667</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dgx:ScheduleofLeaseTermandDiscountRateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NjE_83a81c73-02aa-463e-946b-5cbe7b5a168d" continuedAt="i829f6517bbce47a69f50dc4edfc96e46" escape="true">Lease term and discount rate as of December&#160;31, 2020 and 2019 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i829f6517bbce47a69f50dc4edfc96e46"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:363.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzItMS0xLTEtMA_6c5fdd56-6c44-4d18-ac9f-a1c6b4796800">6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i11ae4adedea143f39461ad0909150885_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzItMi0xLTEtMTEwNzg_ac2540a4-37c4-42ec-b69c-fe2dc6e5cafc">5</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzMtMS0xLTEtMA_a921889d-8d15-48ac-94cd-e31eef136788">13</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i11ae4adedea143f39461ad0909150885_I20191231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzMtMi0xLTEtMTEwNzg_db598de3-8e47-4d09-a7df-25d1f8feaef8">12</ix:nonNumeric></span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzYtMS0xLTEtMA_4b85ef48-447e-4492-9ee1-593b4cedfdab">3.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzYtMi0xLTEtMTEwNzg_c715ce06-ebbb-4fab-97e8-1eb62f3f4367">3.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzctMS0xLTEtMA_fad27c89-43ef-4901-b0d8-937ce515cbca">8.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzctMi0xLTEtMTEwNzg_45812a43-e998-4fd1-8e80-1974fef1b17f">8.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2020 and 2019.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_217"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzM0NjQ_1c2268f8-a4eb-4bd4-be60-11d29e64a29e" continuedAt="icf5464d23867430198cef6495edbb5bd" escape="true">FINANCIAL INSTRUMENTS </ix:nonNumeric></span></div><ix:continuation id="icf5464d23867430198cef6495edbb5bd" continuedAt="id35b916682644ddc9673e646ba0cccc6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During March 2020, the Company entered into a forward-starting interest rate swap agreement with a financial institution for a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i66ce45540c0b49579be5f2a665d77e65_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzIxOTkwMjMyNjA2MTc_8e3a5e59-fa2d-4aab-8698-902b61ab95d0">25</ix:nonFraction>&#160;million.  Additionally, during May 2020, the Company entered into interest rate lock agreements with several financial institutions for a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="i7827a00a60bc4aef8604397387c5b8e9_I20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzIxOTkwMjMyNjA2MzA_73b9aba1-48c6-4a16-a8cf-5b1a333a37ae">275</ix:nonFraction>&#160;million.  The forward-starting interest rate swap agreement and the interest rate lock agreements were entered into in order to hedge a portion of the Company's interest rate exposure associated with variability in future cash flows attributable to changes in interest rates over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1NzI_56514d22-493f-4c97-86ad-19ef10f8afd8">ten</span>-year period related to an anticipated issuance of debt and were accounted for as cash flow hedges.  In connection with the issuance of the 2031 Senior Notes (see Note 13), these agreements were settled and the Company received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzIxOTkwMjMyNjA2NDg_0376236e-1280-4e1f-9eb9-cd50e48c0efd">1</ix:nonFraction>&#160;million. The net gain is deferred in stockholders' equity, net of taxes, as a component of accumulated other comprehensive loss, and is being amortized as an adjustment to interest expense, net over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1OTE_2bbebbdb-352e-417a-8de8-f6de9db537f1">ten</span>-year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $<ix:nonFraction unitRef="usd" contextRef="i837da46f467741f1a47e6456ab80934a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzEwNDQ1MzYwNDcyNDAy_4091f2d3-0898-4bf0-8128-390388a4ef93">1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4d52e8506b964853934619358132e916_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM2MjQ_c829c3ec-28b3-4707-9bab-d22f23dd61ef">4</ix:nonFraction>&#160;million as of December&#160;31, 2020 and 2019, respectively.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzEwNDQ1MzYwNDcyNDMy_d102286c-f818-44de-85fe-c3eb2a455bcd">1</ix:nonFraction>&#160;million.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2019, the Company had various fixed-to-variable interest rate swap agreements outstanding with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i127dea9d515d4af9aad64832390b1702_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzEwNDQ1MzYwNDcyMDg5_eb911ad6-000b-4ca7-a9cd-b3ab15d78ff6">1.2</ix:nonFraction>&#160;billion, which were entered into in order to convert a portion of the Company's long-term debt into variable interest rate debt.  In April 2020, the Company terminated these existing fixed-to-variable interest rate swap agreements and received proceeds of $<ix:nonFraction unitRef="usd" contextRef="ifacb1c5c6dad45498481604994cc9c9b_D20200401-20200430" decimals="-6" format="ixt:numdotdecimal" name="dgx:ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzIxOTkwMjMyNjMzNTI_59fce5ac-d065-4259-b829-35ffe6df3b92">40</ix:nonFraction>&#160;million.  Such amount was reflected as a basis adjustment to the hedged debt instruments and is being amortized as a reduction of interest expense, net over their remaining terms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzM0OTA_8d61e199-6c2d-43bc-9b61-bdaf2820a830" continuedAt="i6c1b0fd791034286b9a154281ebbbaaa" escape="true">As of December&#160;31, 2020 and 2019, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</ix:nonNumeric></span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i6c1b0fd791034286b9a154281ebbbaaa" continuedAt="i148c4aae18fc4143a454e64550e4d0ad"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.380%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id141c98d5c21416f95dd9ad86532d5f8_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo0MDQ2YmM1NmZhZmM0NGZiOTBkNTliYmY4Mjk5YjgyOC90YWJsZXJhbmdlOjQwNDZiYzU2ZmFmYzQ0ZmI5MGQ1OWJiZjgyOTliODI4XzItMy0xLTEtMA_6254ff48-1eea-4172-8025-dc5d84c3bca8">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id141c98d5c21416f95dd9ad86532d5f8_I20201231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo0MDQ2YmM1NmZhZmM0NGZiOTBkNTliYmY4Mjk5YjgyOC90YWJsZXJhbmdlOjQwNDZiYzU2ZmFmYzQ0ZmI5MGQ1OWJiZjgyOTliODI4XzItNS0xLTEtMA_35c40673-24c1-4447-b9a3-17bd72e07cb4">51</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6a84f2be8142b7ad7ceae3cd3f42a7_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HedgedLiabilityFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo0MDQ2YmM1NmZhZmM0NGZiOTBkNTliYmY4Mjk5YjgyOC90YWJsZXJhbmdlOjQwNDZiYzU2ZmFmYzQ0ZmI5MGQ1OWJiZjgyOTliODI4XzItNy0xLTEtMA_1a266eb5-346d-45ce-8826-4b9e025eb37f">1,186</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb6a84f2be8142b7ad7ceae3cd3f42a7_I20191231" decimals="-6" sign="-" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo0MDQ2YmM1NmZhZmM0NGZiOTBkNTliYmY4Mjk5YjgyOC90YWJsZXJhbmdlOjQwNDZiYzU2ZmFmYzQ0ZmI5MGQ1OWJiZjgyOTliODI4XzItOS0xLTEtMA_31e55f45-9969-43e8-a14b-6c0fa65b06a9">3</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i148c4aae18fc4143a454e64550e4d0ad">(a) As of December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships.  As of December&#160;31, 2019, the balance includes $<ix:nonFraction unitRef="usd" contextRef="ifb6a84f2be8142b7ad7ceae3cd3f42a7_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredGainLossOnDiscontinuationOfFairValueHedge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzMwNjQ_7027f797-3769-417d-81b5-fddf43c9146e">25</ix:nonFraction> million of remaining unamortized hedging adjustments on discontinued relationships.</ix:continuation> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="id35b916682644ddc9673e646ba0cccc6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dgx:ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzM0ODg_4dde65fb-e760-460f-a9bf-f06be4d1ac6d" continuedAt="ib7e3572ddd36476a88db6f372e840bcf" escape="true">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2020, 2019 and 2018, respectively:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ib7e3572ddd36476a88db6f372e840bcf"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.949%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.246%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzMtMy0xLTEtMA_abfaf569-779b-4024-91ee-e1b7e9216558">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzMtNS0xLTEtMA_af25f0d2-462b-4e48-85cd-08530918ee23">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzMtNy0xLTEtMA_2d411edb-5909-446f-b75e-2973c9911c85">8</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb495ec24a01435fbd27a38907a75fca_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzYtMy0xLTEtMA_40b04cf3-f2e8-476c-b89f-75729dafe03d">68</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff2d731644784878a01ffd609e67911a_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzYtNS0xLTEtMA_13651b75-59de-46a9-bd69-5b74736cbbf2">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16ba469706349e7a5dda9f237173286_D20180101-20181231" decimals="-6" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzYtNy0xLTEtMA_c8651f4a-0d63-4339-b8e2-202a7e3e2756">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia67a4a0ff8b1447e93f556e763ad297c_D20200101-20201231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzctMy0xLTEtMA_57610537-b3af-4140-b0ce-5eecf9e17e50">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7186eb7282e4103827c4b7ee0d01c74_D20190101-20191231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzctNS0xLTEtMA_8350ad2b-2587-40ca-93b0-1d258f53f9c1">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3219d74c46bf4c0297cf3d070a80cc44_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzctNy0xLTEtMA_cf151baf-76cb-4500-a22d-15b2042c38c6">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzM0NzE_efce06a7-1dcc-4a22-8ef5-6cadbc12a3a5" continuedAt="id71abe2dff5c43a6ab83f9cd0f7ea5d2" escape="true">A summary of the fair values of derivative instruments in the consolidated balance sheet was as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="id71abe2dff5c43a6ab83f9cd0f7ea5d2"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.590%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-to-variable interest rate swap agreements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb452a6ac74285af4a4f642559ad6f_I20191231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo4M2NkNGYwZDU0ZmE0ZDU1OGQzYWM2NWY0NzUyYjIzYy90YWJsZXJhbmdlOjgzY2Q0ZjBkNTRmYTRkNTU4ZDNhYzY1ZjQ3NTJiMjNjXzgtNy0xLTEtMA_ae94fef2-92e1-4cf1-a0d6-35e5d13f442b">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_223"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzc0ODg_ec7f1c84-983d-4dfc-9546-46943ec2c16d" continuedAt="i3865b20c0e824a929fca8fef9ec76619" escape="true">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><ix:continuation id="i3865b20c0e824a929fca8fef9ec76619" continuedAt="ibdfaca8bdf7c49ff82e76a375b3a66a9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Series Preferred Stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i3bf2fc1a93c943d987e412080b37ceb5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzE2OQ_ed522712-8b0a-4167-9a36-3fbeaabf64c7">10</ix:nonFraction> million shares of Series Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxNg_ba5424ce-110d-4bea-bb44-bdd3340e7cad">1.00</ix:nonFraction> per share.  The Company's Board of Directors has the authority to issue such shares without stockholder approval and to determine the designations, preferences, rights and restrictions of such shares.  <ix:nonFraction unitRef="shares" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQyMQ_7116e5bb-7a64-44d8-a0be-71025d44cc64">No</ix:nonFraction> shares are currently outstanding.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the Company's Restated Certificate of Incorporation the number of authorized shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzYyOQ_848c3d87-ea89-4db3-80dc-a50ce11b1f07">0.01</ix:nonFraction> per share, is <ix:nonFraction unitRef="shares" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzY2MQ_05fcecb6-af5d-405e-a82c-898945901a50">600</ix:nonFraction> million shares.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Changes in Accumulated Other Comprehensive Loss by Component</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Comprehensive income (loss) includes:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 15).  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019, and 2018, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="ibdfaca8bdf7c49ff82e76a375b3a66a9" continuedAt="if7395268e2324c46866e858a9153ecd2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzUyNTY_d103eb45-5473-4f96-b82c-804afbf9ee9a" continuedAt="i14632236bbdd489c83baa603b9723410" escape="true">The changes in accumulated other comprehensive loss by component for 2020, 2019 and 2018 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i14632236bbdd489c83baa603b9723410"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Changes in Available-for-Sale Debt Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Losses on Cash Flow Hedges, net of tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2017</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34c51c66cc164d1da2582f9c600d44f1_I20171231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItMS0xLTEtMA_151c8ddc-bc73-4276-9a76-972dfca4b0d9">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c7eeb1cf454f3087a541bf615ec3e1_I20171231" decimals="-6" format="ixt:zerodash" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItMy0xLTEtMA_04000e07-6bd6-4654-a128-24be7373f180">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50dd445f21194164a30af100f410f3e2_I20171231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItNS0xLTEtMA_9cb26596-db34-4164-a02a-790bc5589831">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d1945a14f9f4ce2921e9bbaaa6b9124_I20171231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItNy0xLTEtMA_27d9a73d-9fa9-435f-84d6-41aca3249a8d">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14e2c4e502f24416aea41251e9a7a514_I20171231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItOS0xLTEtMA_c0262c2c-4229-4e3d-b370-0fe6ae539022">48</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtMS0xLTEtMA_6ef5ca75-c326-4711-839b-27f2b54342a2">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtMy0xLTEtMA_edde9105-da83-4dc6-8955-1468f88acf99">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtNS0xLTEtMA_1d8f9f7e-0178-4855-a2a7-a3d153b6e4df">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtNy0xLTEtMA_dd97796a-0844-46dd-a5b5-d9b39e7e779f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtOS0xLTEtMA_39ba3fae-dcf7-4c71-a7bc-31b63ad8e24c">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtMS0xLTEtMA_e946f36d-1840-4695-bbd2-3bfbd2d9ae2f">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtMy0xLTEtMA_612dcb44-fffa-412c-b6db-822ef3a7db5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtNS0xLTEtMA_56d099df-3863-451f-b8df-2d0d3f6c8523">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtNy0xLTEtMA_4e389fb2-cda2-4432-8d35-63049f801ffc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtOS0xLTEtMA_eb0938ef-3a97-479f-bde3-678eddfb4a72">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtMS0xLTEtMA_b68ecad6-41b9-4282-a9e8-7b7bc3437845">11</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtMy0xLTEtMA_50198f78-7128-494f-acd7-dcbf61feea84">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtNS0xLTEtMA_9b569bbc-142f-4d2a-99a8-0dab2bf99f34">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtNy0xLTEtMA_c312f30b-f516-40e7-95b1-6174d5392e0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtOS0xLTEtMA_5f161074-b636-49d5-98b8-ce90b6ae3c3a">9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtMS0xLTEtNDE5NQ_d0d607ae-f7f2-42c6-b565-5ea5048b6359">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtMy0xLTEtNDE5OQ_6e6913e3-df61-4f27-a9eb-0ba6c4ac6c18">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231" decimals="-6" sign="-" name="dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtNS0xLTEtNDE4NQ_8a75e5e7-bba5-406d-91e6-08cee2e1df7e">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtNy0xLTEtNDIwMg_fb2427fc-14a5-4211-a349-f04f55c13d02">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231" decimals="-6" sign="-" name="dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtOS0xLTEtNDE4OQ_4a654fe1-c42a-4cc3-81d6-91dca25078b0">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdffbc0183ce49ee8d6307cd711c32da_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtMS0xLTEtMA_a43b4b3b-c04a-41cf-9618-e8341ae96c98">49</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c2b4effc544078806b615118dd9278_I20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtMy0xLTEtMA_3b3592f0-1588-4651-9437-bfe1abbdb767">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5448ffcdebdf4d7ea0f8ffee8b0b8f9b_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtNS0xLTEtMA_33a6702a-535f-4023-a1da-759889dedfb0">9</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ff2b554598b47c6aec52cefb4f6bb51_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtNy0xLTEtMA_3d2fba2b-faa5-4a3e-a820-467b751bfcc1">1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f0ce225b8594c6a86f10f4f1abe8e39_I20181231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtOS0xLTEtMA_28ebbf89-ecb8-45b2-a581-a0a5742cab20">59</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d31347983ac43948ce0a443c75f4aa8_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctMS0xLTEtMA_5bb8e4c8-e1f8-42d5-be0f-cfd5922823a1">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dab0f39fda445528890429f9f021ab9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctMy0xLTEtMA_80f03945-24b0-49eb-a36a-98c8a55ece85">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib698a53cb2f8426cbe61b6e19fb1a281_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctNS0xLTEtMA_a003f81b-aa59-40f9-b80b-c47e8cba6cb3">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd46f02dc1f4473b397c6a576d3bc85_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctNy0xLTEtMA_20ae1032-933d-4cd0-b2d1-48129dc9ed24">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctOS0xLTEtMA_e38ecf9d-d83f-4d2c-b53d-7dac7fd14d10">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d31347983ac43948ce0a443c75f4aa8_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtMS0xLTEtMA_2bbf292a-1819-4e4e-a1ae-97d11cf4ad08">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dab0f39fda445528890429f9f021ab9_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtMy0xLTEtMA_96bfb436-46e6-4f42-b10f-72ed75415e48">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib698a53cb2f8426cbe61b6e19fb1a281_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtNS0xLTEtMA_ac69a9ee-dd53-48dd-a67b-1ed5c75c27dd">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd46f02dc1f4473b397c6a576d3bc85_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtNy0xLTEtMA_fc7d870a-2ce3-4584-9c0a-dafbb61c5ab6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtOS0xLTEtMA_b25c788c-6752-418e-ab20-ae682e5f2378">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d31347983ac43948ce0a443c75f4aa8_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktMS0xLTEtMA_49a29021-4a18-4ab5-b4f0-1d7f755b30ee">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dab0f39fda445528890429f9f021ab9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktMy0xLTEtMA_bc7f4c35-fab8-4aa6-a7d2-292f7b274564">8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib698a53cb2f8426cbe61b6e19fb1a281_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktNS0xLTEtMA_a785163b-53c3-4e23-b8ec-7ae7fa2d79f6">5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bd46f02dc1f4473b397c6a576d3bc85_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktNy0xLTEtMA_a725595c-deb1-4da0-afb1-6f36269e1989">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktOS0xLTEtMA_6d57d8d7-fedf-4989-8f46-82839632af2b">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id24dcfded8274220894b4ec84f289be9_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTEtMS0xLTA_08575764-7762-46d6-827f-ad7a19ea2365">42</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35228c4a5cbe4bf9a0b8ad2de1992783_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTMtMS0xLTA_d18c063d-8924-4ada-bd58-cd57340cd97b">8</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cf70b9879644efb91f2116611446a5_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTUtMS0xLTA_eb94b09c-762e-409e-a9ed-695669f7069d">4</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e0eb38fdc3746ec8e44fcd4afa6a3fe_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTctMS0xLTA_d69c20de-e336-4b66-832f-a067761c91a9">1</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41a7f39f717a41848294a65ad208374f_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTktMS0xLTA_220b66f5-2700-4f03-b424-e3aa13c53a2c">39</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192e1f30a76a48d1a4fccda9268bcefa_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTEtMS0xLTA_3879ff9a-fd15-46ef-95ba-42a8f8e26478">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fec735f32d545668c9011b3d1ba778b_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTMtMS0xLTA_04f1c77d-f42a-4244-ae35-f5d6da27c561">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e0cd2bf0ce400291395c2d343ce00b_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTUtMS0xLTA_1e379ce6-83e3-444f-badc-fa8766b75bd0">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67231146b7644c899681fc68de1cc785_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTctMS0xLTA_8e831620-44cd-41fe-aeb0-bc0061f01dc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTktMS0xLTA_7c9aab18-c983-4e0f-a5a4-234a39199ab3">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192e1f30a76a48d1a4fccda9268bcefa_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTEtMS0xLTA_212a4350-70ad-464c-8a85-43019c11c3d2">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fec735f32d545668c9011b3d1ba778b_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTMtMS0xLTA_87f0f1e6-a454-424a-b333-7a07b1b65a87">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e0cd2bf0ce400291395c2d343ce00b_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTUtMS0xLTA_0e807b93-ae8a-4c71-8891-fb29022a387f">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67231146b7644c899681fc68de1cc785_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTctMS0xLTA_d8d4dbe2-8038-412e-a999-e6062e1da865">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTktMS0xLTA_21c26f9e-b9e6-41c4-87da-8ffdb3760739">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192e1f30a76a48d1a4fccda9268bcefa_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTEtMS0xLTA_5f90bf9c-d86f-4289-8b61-955f102253c6">15</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fec735f32d545668c9011b3d1ba778b_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTMtMS0xLTA_37a4c3cf-0487-412b-acdf-1157bb363159">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e0cd2bf0ce400291395c2d343ce00b_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTUtMS0xLTA_d97ace2c-0c53-424d-8cc1-9b0c095d4cb8">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67231146b7644c899681fc68de1cc785_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTctMS0xLTA_84117998-585d-4a68-b899-cba8a1063575">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTktMS0xLTA_179d89ec-b5bb-46fe-8a66-d2586e31e6bf">18</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc1b38e887c4144b5780eca80bd204b_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTEtMS0xLTA_63d25b3a-780d-405e-a876-a9b0ff6cbf70">27</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifebaca822eff4cc387f98c008d09c38e_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTMtMS0xLTA_1939258f-a694-4afa-b2ab-1aa8fc740a02">8</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ef455113ed841c7b82fbb4ace9b85be_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTUtMS0xLTA_7ac4eddf-6f95-4bb1-b042-2e3d4e32056f">1</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24d73f4e924f4a10a8f521b757db5eb7_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTctMS0xLTA_a91e7740-afe6-4d5d-a366-935d1c9a79c5">1</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15c1b65002784549a102581ed4f9ec6b_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTktMS0xLTA_c000cd81-1b33-41b2-9a7a-341648cfad3b">21</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, the gross deferred losses on cash flow hedges were reclassified from accumulated other comprehensive loss to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December 31, 2020 and 2018, foreign currency translation adjustment amounts were reclassified from accumulated other comprehensive loss to other operating expense (income), net as a result of the sale of foreign subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjIxNzA_47a53e2b-6ee6-4629-88be-be37eb894475"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjIxNzA_7e00b099-5a1b-43bc-a122-89960df62da2"><ix:nonFraction unitRef="usdPerShare" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjIxNzA_a4918063-83d5-4d3e-a00a-2919766486b9"><ix:nonFraction unitRef="usdPerShare" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjIxNzA_e6bc7c7a-1728-43de-b580-197252e6a965">0.56</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share.  During each of the four quarters of 2019, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI3MDE_06d901c9-0c60-42cc-b266-ae067355e87c"><ix:nonFraction unitRef="usdPerShare" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI3MDE_55c6006a-ecff-4215-af53-f4a7b8ae2d6b"><ix:nonFraction unitRef="usdPerShare" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI3MDE_707158b6-567b-4599-a8e9-47c184cf31b6"><ix:nonFraction unitRef="usdPerShare" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI3MDE_ab90ed37-506e-425d-be63-fc8895b2c659">0.53</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share.  During each of the first three quarters of 2018, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7731e39a610040f98b51c6b6e8764070_D20180101-20180331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI4NDM_213e1e76-e351-4f9d-8572-b51de3ecf87c"><ix:nonFraction unitRef="usdPerShare" contextRef="i63870adfaa434891bafa374146f885cb_D20180701-20180930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI4NDM_43324c5d-6a86-4761-bb9e-22f2c1b640b9"><ix:nonFraction unitRef="usdPerShare" contextRef="i696a70381cba476b8c6f79dd4b77fe5b_D20180401-20180630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI4NDM_88639851-6314-4b35-9a8f-9e8e19c9eeca">0.50</ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share.  During the fourth quarter of 2018, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie62d0efe4ae34fd6b32670577a82ac3f_D20181001-20181231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI5NzE_59a30f65-0c52-4cd4-be65-4b1cb6246c45">0.53</ix:nonFraction> per common share.  On February 4, 2021, the Company announced that its Board of Directors authorized a <ix:nonFraction unitRef="number" contextRef="i1582bc80466c4a0a99308fa830a6db42_I20210204" decimals="3" name="dgx:IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzczNzQ_accabc12-5f8f-4840-9676-eddac5849dac">10.7</ix:nonFraction>% increase in its quarterly cash dividend from $<ix:nonFraction unitRef="usdPerShare" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzczODE_f986a4a1-8188-4ca7-a96e-82fc2c95c2c7">0.56</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="i32de60c551da40599315cbb1e6c3f5ca_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzczODg_f571924f-162e-48b6-9bb3-888f6e63ebba">0.62</ix:nonFraction> per share, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i62130c12d0ec4b10b6bb1bea0f6d8ab3_D20210101-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzczOTU_6fac60b7-bf42-4405-98da-7f6394c775ab">2.48</ix:nonFraction> per share annually, commencing with the dividend payable in April 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="if7395268e2324c46866e858a9153ecd2" continuedAt="i007cbabc2ca243ba810dd96b69fcda2c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzM1MzY_cc93ce54-5b94-4f18-ad34-1c05c59b8709">0.9</ix:nonFraction> billion remained available under the Company&#8217;s share repurchase authorization.  In February 2021, the Company's Board of Directors authorized the Company to repurchase an additional $<ix:nonFraction unitRef="usd" contextRef="i0b5c67810b5d48758c30b695b04494b1_I20210222" decimals="INF" format="ixt:numdotdecimal" name="dgx:StockRepurchaseProgramAdditionalAuthorizedAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjg0MjM_a7897f24-b648-4e19-b969-0b0e32c00a36">1</ix:nonFraction>&#160;billion of the Company's common stock.  The share repurchase authorization has no set expiration or termination date.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjQ1NzI_a0774e84-142d-4c8e-816e-cf6184083659">2.7</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjQ1OTY_925cf464-4c50-43ae-b502-9a55a324ed41">325</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzM4NTA_42cd550c-2270-4959-9567-3107b28ffec2">3.5</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzM4ODQ_24808727-b1f6-4c3e-8676-e92f6f75d478">350</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2018, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQxMTg_35b385a8-c35d-44a3-b431-f1e78b49a0f0">3.4</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQxNTI_c51e1c4c-23ef-4706-99a4-f172f89bd06b">325</ix:nonFraction> million, which included an accrual of $<ix:nonFraction unitRef="usd" contextRef="i36c642409ac64921826ebf21bd9b07f1_I20181231" decimals="-6" format="ixt:numdotdecimal" name="dgx:TreasuryStockValueAcquiredCostMethod1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjE1NTU_193de7eb-da26-4602-a769-68582a4b6114">3</ix:nonFraction>&#160;million recorded in accounts payable and accrued expenses in the consolidated balance sheet for share repurchases not settled until after December 31, 2018.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Shares Reissued from Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018 the Company reissued <ix:nonFraction unitRef="shares" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQyNTQ_0d124fa0-edcd-45bd-9741-e8aa52e9a276">3</ix:nonFraction> million shares, <ix:nonFraction unitRef="shares" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjQ2MDc_adbc5d5c-e255-41c9-aba5-1b0947ab0f80">2</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjQ2MTA_3d3fa107-dfd9-4573-b1e7-85e7800cf105">3</ix:nonFraction> million shares, respectively, from treasury stock for shares issued under the Employee Stock Purchase Plan ("ESPP") and stock option plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interest</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i007cbabc2ca243ba810dd96b69fcda2c">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="i02060ac5ffa04417a6b16a9bd1912233_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ0ODc_5e91afa1-3041-4ad4-8c10-1660d972ed5a">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  The Company records changes in the fair value of the noncontrolling interest immediately as they occur.  As of December&#160;31, 2020 and 2019, the redeemable noncontrolling interest was $<ix:nonFraction unitRef="usd" contextRef="ie95d4b8fec93446cb65b51f7e24e8460_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzUxODY_dbb39962-b35e-43a9-9b08-f1a387ed144b">82</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i163121a462fb460dac48b33c7084fd77_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzUxOTM_9b4571b2-0b16-4d8a-b725-97b30b6da02c">76</ix:nonFraction> million, respectively, and was presented at its fair value.</ix:continuation> </span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_229"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkzNjI_f54866ff-3ca6-44cd-a562-8fef0e868ce1" continuedAt="i5907fb3a904c464390b247f608408747" escape="true">STOCK OWNERSHIP AND COMPENSATION PLANS</ix:nonNumeric></span></div><ix:continuation id="i5907fb3a904c464390b247f608408747" continuedAt="i3d35b93b44f54a0eb04dc4f3695416f3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee and Non-employee Directors Stock Ownership Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The ELTIP provides for three types of awards: (a) stock options, (b) stock appreciation rights and (c) stock awards.  The ELTIP provides for the grant to eligible employees of either non-qualified or incentive stock options, or both, to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Grants of stock appreciation rights allow eligible employees to receive a payment based on the appreciation of Company common stock in cash, shares of Company common stock or a combination thereof.  The stock appreciation rights are granted at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Stock options and stock appreciation rights granted under the ELTIP expire on the date designated by the Board of Directors but in no event more than <ix:nonNumeric contextRef="i98e33a74d2374686abe9f0c57a67eaa5_D20200101-20201231" format="ixt-sec:durwordsen" name="dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzEwODI_de083032-e4e4-492e-a361-690be1c43003">ten years</ix:nonNumeric> from date of grant.  No stock appreciation rights have been granted under the ELTIP.  Under the ELTIP, awards are subject to forfeiture if employment terminates prior to the end of the vesting period prescribed by the Board of Directors.  For all award types, the vesting period is generally over <ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzEzODc_a230eaec-f87b-4918-9ed6-ace755afbc07">three years</ix:nonNumeric> from the date of grant.  For performance share units, the actual amount of shares earned is based on the achievement of the performance goals specified in the awards.  The performance goals for awards granted for 2018 and 2019 were based on the financial performance of the Company.  The performance goals for awards granted in 2020 were based on the financial performance of the Company as well as relative TSR.  The maximum number of shares of Company common stock in respect of which awards may be granted under the ELTIP is approximately <ix:nonFraction unitRef="shares" contextRef="iceca37b233814fac990bb0d43b3d1f18_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzE2ODI_855af881-0e52-49ff-b5bc-f3cfeee6941b">79</ix:nonFraction> million shares.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The DLTIP provides for the grant to non-employee directors of non-qualified stock options to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  The DLTIP also permits awards of restricted stock and restricted stock units to non-employee directors.  Stock options </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i3d35b93b44f54a0eb04dc4f3695416f3" continuedAt="i47ce700835394c1085b0bdfeabde61b0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">granted under the DLTIP expire on the date designated by the Board of Directors but in no event more than <ix:nonNumeric contextRef="i117f623b34944a4aa09ba43fe0f2b647_D20200101-20201231" format="ixt-sec:durwordsen" name="dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzIyNDU_83638a05-d698-4f07-9497-579c6af56209">ten years</ix:nonNumeric> from date of grant.  For all award types, the vesting period is generally over <ix:nonNumeric contextRef="i9b61e94e7f074f5ab9c3930b140386b5_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzIzMjc_8ca5ff10-7d00-457a-9526-3c29569c6eaa">three years</ix:nonNumeric> from the date of grant, regardless of whether the award recipient remains a director of the Company.  The maximum number of shares that may be issued under the DLTIP is <ix:nonFraction unitRef="shares" contextRef="ib33f609e90994e12b073cfeb7263634a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzI0OTk_d390cf30-4b83-451d-892a-cc6b8389f774">2.4</ix:nonFraction> million shares.  For the years ended December&#160;31, 2020, 2019 and 2018, grants under the DLTIP totaled <ix:nonFraction unitRef="shares" contextRef="i9b61e94e7f074f5ab9c3930b140386b5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzI1Nzc_0938cbac-709b-4091-89d9-6c5f92eb2c2e">14</ix:nonFraction> thousand shares, <ix:nonFraction unitRef="shares" contextRef="i8b818bf8df5f410eb2045ec27d80953b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzI1ODg_f1b005c4-79fb-4c21-b5bc-7cd3ffc7fe6b">14</ix:nonFraction> thousand shares and <ix:nonFraction unitRef="shares" contextRef="ie98b52a6c1794c20a26d3553828e4078_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzI2MDI_511077b8-b4f5-47b0-9e91-cd7fa35bf5e2">15</ix:nonFraction> thousand shares, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  See Note 16 for further information regarding the Company's share repurchase program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; The fair value of each stock option award granted was estimated on the date of grant using a Black-Scholes option-valuation model.  The expected volatility under the Black-Scholes option-valuation model was based on historical volatilities of the Company's common stock.  The dividend yield was based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the expected holding period of the related award.  The expected holding period was estimated using the historical stock option exercise behavior of employees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkzNTg_75f4277d-5441-4ff4-a587-f4c0840514cc" continuedAt="ie9ca6ba7f5114505acb39d28aaa8e501" escape="true">The weighted average assumptions used in valuing stock options granted in the periods presented were:  </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ie9ca6ba7f5114505acb39d28aaa8e501"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:61.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.219%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzItMS0xLTEtMA_d4ef4403-6de3-47ec-b840-ab3b04ec7e2b">17.25</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzItMy0xLTEtMA_898c1bdd-5cbe-40c7-9118-1ad112b096b0">14.30</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzItNS0xLTEtMA_4aeaf2c0-8713-41bd-9c63-776248a7d3a1">18.14</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzMtMS0xLTEtMA_343d5748-0bbb-42f1-b8a2-4ef0f678ca2d">20.3</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzMtMy0xLTEtMA_65ecba1c-e787-4a52-b60a-062176024587">20.4</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzMtNS0xLTEtMA_29dd81da-fa78-46f4-8cab-16a82a32c720">19.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzQtMS0xLTEtMA_3ca6d70b-e5d9-4cb9-a31d-f9f04cc43bf9">2.0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzQtMy0xLTEtMA_3b60e929-c96d-4a5b-9145-4c77eee0e896">2.4</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzQtNS0xLTEtMA_403a29d9-dff2-47d0-a975-181689794c90">1.9</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzUtMS0xLTEtMA_f26248a0-5de8-4cc8-bc94-961886355773">1.5</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzUtMy0xLTEtMA_43ab6e03-2940-4928-87c0-6bddf007e887">2.5</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzUtNS0xLTEtMA_a9893ee8-8060-41bd-bbb0-d4dbb8ed1f68">2.8</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected holding period, in years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzYtMS0xLTEtMA_6685b8bc-d488-4cfb-bc68-bbf8b896d520">5.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzYtMy0xLTEtMA_60e0003e-4fc0-43bf-b8c0-6ad46f7149dc">5.2</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzYtNS0xLTEtMA_70034805-ff04-45d5-b09b-e9eb8536e90c">5.3</ix:nonNumeric></span></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkzNjU_47a600fa-3a46-4dc1-90a0-bdc52c4c59a8" continuedAt="ia114037f958749b697345b5b9a2aedd0" escape="true">The following summarizes the activity relative to stock option awards for 2020: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ia114037f958749b697345b5b9a2aedd0"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:54.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i727f4b6eb33e4f3c8265b0e2dc2dbd40_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzItMS0xLTEtMA_7882cdbb-77b2-4085-83ce-b37b97e7e8e7">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i727f4b6eb33e4f3c8265b0e2dc2dbd40_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzItMy0xLTEtMA_9b809d2a-00ad-4e84-b88d-763c579c2edb">81.67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzMtMS0xLTEtMA_056bbb2c-b269-453b-89d4-855c58aac964">1.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzMtMy0xLTEtMA_e1ff07fb-ed88-4f23-a7e5-33835572cb3d">112.23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzQtMS0xLTEtMA_102d0f7e-2ec1-4c42-adbc-ca39a06365af">2.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzQtMy0xLTEtMA_bc2bdd09-09d0-4452-baee-b4fd94027985">72.57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, end of year</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzYtMS0xLTEtMA_3535e5d2-1c54-4049-a43e-af26967da0ed">6.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzYtMy0xLTEtMA_b9e52976-194c-4435-9b06-6b37e923f2fb">90.32</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzYtNS0xLTEtMA_de946d47-7ff6-4dd5-b1ed-6d36c86a2bed">6.7</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzYtNy0xLTEtMA_1da16758-cf38-4721-bd5f-53590a984333">187</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzgtMS0xLTEtMA_6dcd46e0-3b16-476d-ae6b-7f7938f6342b">3.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzgtMy0xLTEtMA_49921dee-8bb2-4bb5-93c5-0dac0584e4fa">83.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzgtNS0xLTEtMA_4c2b3bef-b6cc-469a-9d10-67283ef60db0">5.6</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzgtNy0xLTEtMA_0cdf33ae-c9ba-4cc5-8a5e-46e833a6af2e">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzktMS0xLTEtMA_a6fe346e-c901-46ac-b237-0829f4b4b72d">6.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzktMy0xLTEtMA_2acf6a01-3b11-4944-8eb7-e2cd1eaea312">90.14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzktNS0xLTEtMA_e80d060d-9a2a-4ceb-9342-51743c78ee5b">6.7</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzktNy0xLTEtMA_10cf2e4b-6768-4111-a284-b4d00cf04482">185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company's closing common stock price on the last trading day of 2020 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2020.  This amount changes based on the fair market value of the Company's common stock.  Total intrinsic value of options exercised in 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ1MzA_f8baa16f-8026-4d9a-a0c2-1bb46b3a44d4">113</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6d1ed33ea86c4c04ba5ce3c4c14d4697_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ1MzQ_b2fa1dea-848e-412e-8232-6f234f216506">62</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id1ff65eb76ff475b8f7a4009c8376341_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ1NDE_a3ec5149-c037-4c21-81d9-7679c2e4e579">67</ix:nonFraction> million, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ1ODM_0357d4eb-b637-4ec0-a4fd-ce83ca34538b">9</ix:nonFraction> million of unrecognized stock-based compensation cost related to nonvested stock options which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ3MzY_67c74504-9879-4d4f-9844-2a06ef0bb0e0">1.6</ix:nonNumeric> years.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i47ce700835394c1085b0bdfeabde61b0" continuedAt="i56cf9a83be19449ba306b8e9e27770df"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of restricted stock awards and restricted stock units is the average market price of the Company's common stock at the date of grant.  For performance share units with a goal based on the financial performance of the Company, the fair value is based on the average market price of the Company's common stock at the date of grant, adjusted for the present value of dividends expected to be paid on the Company's common stock during the vesting period.  For performance share units with a market-based relative TSR goal, the fair value is estimated on the date of grant using a Monte Carlo valuation model.  The expected volatility under the Monte Carlo valuation model is based on the historical volatility of the common stock of the Company and the common stock of the companies in the peer index.  The dividend yield is based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the performance period of the related award. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="dgx:ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ5NDc4MDIzMzg4OTg_d6b4e6aa-8d93-4e56-91f9-7535e7618366" continuedAt="i2123b70819624c298cae24e3dda78fe3" escape="true">The weighted average assumptions used in valuing performance share units in 2020 with a market-based relative TSR goal were:</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:continuation id="i2123b70819624c298cae24e3dda78fe3" continuedAt="i3c3a75c1b22441cfbd7674fb761a332b">  </ix:continuation></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="i3c3a75c1b22441cfbd7674fb761a332b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i33ff90645a634391b6fdea36985a329f_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo0YzIwYWQ4NjViNjQ0NjE4YTdjMTRkYTE3YmJhMDYwZC90YWJsZXJhbmdlOjRjMjBhZDg2NWI2NDQ2MThhN2MxNGRhMTdiYmEwNjBkXzAtMS0xLTEtOTI1MQ_a8e17628-e016-4f48-804d-a286f257cf94">144.03</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33ff90645a634391b6fdea36985a329f_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo0YzIwYWQ4NjViNjQ0NjE4YTdjMTRkYTE3YmJhMDYwZC90YWJsZXJhbmdlOjRjMjBhZDg2NWI2NDQ2MThhN2MxNGRhMTdiYmEwNjBkXzEtMS0xLTEtOTI1MQ_b260b574-e085-45fd-a166-b0f5e816a74a">20.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33ff90645a634391b6fdea36985a329f_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo0YzIwYWQ4NjViNjQ0NjE4YTdjMTRkYTE3YmJhMDYwZC90YWJsZXJhbmdlOjRjMjBhZDg2NWI2NDQ2MThhN2MxNGRhMTdiYmEwNjBkXzItMS0xLTEtOTI1MQ_dc3298c1-b631-4b70-9375-ccca1faf2bb7">2.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33ff90645a634391b6fdea36985a329f_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo0YzIwYWQ4NjViNjQ0NjE4YTdjMTRkYTE3YmJhMDYwZC90YWJsZXJhbmdlOjRjMjBhZDg2NWI2NDQ2MThhN2MxNGRhMTdiYmEwNjBkXzMtMS0xLTEtOTI1MQ_ac4cebb8-2560-4aa7-b020-f973d1e844a3">1.4</ix:nonFraction>%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkzNjA_7304a737-757c-4469-8b69-dc585cfc80f6" continuedAt="iaddbab76e5f947759bae0ae11efb1a01" escape="true">The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2020, 2019 and 2018: </ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="iaddbab76e5f947759bae0ae11efb1a01"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.472%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec25aa9d406c44b6ade6d810256599b6_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtMS0xLTEtMA_e078b1cb-fcdc-404b-b332-d1de99ed3cfd">1.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec25aa9d406c44b6ade6d810256599b6_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtMy0xLTEtMA_bb6330b0-2ced-4303-8350-3051e02198e5">93.30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtNS0xLTEtMA_9b4cf4de-d670-4611-af46-bb28fbb07a43">1.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtNy0xLTEtMA_b2114d03-a034-4791-8aef-62d74a1bf696">88.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ec3b8abba2144858babf9798d912c8a_I20171231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtOS0xLTEtMA_0e4622d8-4e31-48f5-bb4a-81aafd8316b5">1.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1ec3b8abba2144858babf9798d912c8a_I20171231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtMTEtMS0xLTA_1e0079f7-bb65-4ca2-bdad-df811b8a78aa">77.90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtMS0xLTEtMA_97d3d714-a61d-4b61-85ae-1fe416e2a221">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtMy0xLTEtMA_d7bca079-4180-4106-b39b-1d344fd0e5c8">112.43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtNS0xLTEtMA_7afb61aa-bb3d-47e0-8ccc-de92605a474d">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtNy0xLTEtMA_9748f7fc-7697-41b6-bcb0-0b216cdfc5e5">86.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtOS0xLTEtMA_d6d09e6b-0d75-4831-964d-454c34f33786">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtMTEtMS0xLTA_c6d9b3ef-5254-47f6-ac95-b7b8594101fc">103.51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtMS0xLTEtMA_82ae25c4-6150-4bf7-b59f-7a009458d0c3">0.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtMy0xLTEtMA_7aebe5ac-161a-4946-a29a-5086d48a983d">96.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtNS0xLTEtMA_e8e86571-2021-491e-9e7b-42fd8d5e010f">0.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtNy0xLTEtMA_9be428a1-1614-4212-ab3a-0cab0975c605">75.58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtOS0xLTEtMA_703f9c4a-2798-48a8-a55e-229f6f3d2e1b">0.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtMTEtMS0xLTA_ada3bfbf-4dcf-4acf-a3da-ee0fe239d97c">74.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtMS0xLTEtMA_52376257-bc55-4981-ba44-bf65cb133880">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtMy0xLTEtMA_0c0f8ada-ae6a-4033-8e09-d343b40801af">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtNS0xLTEtMA_84be915b-4f2f-4f43-9ad8-618ea9f467d2">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtNy0xLTEtMA_4d247dfb-e0ff-4a1d-83b9-6e39224dec34">94.09</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtOS0xLTEtMA_4b59ea7c-9fbe-4ba9-bc85-d8efd453be41">0.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtMTEtMS0xLTA_03e97e06-d6a3-46d6-92f6-b6018cc9cca7">90.16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of year</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea41724e5f1a4bff83d7d555a0c98b95_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtMS0xLTEtMA_1bdaa2e0-165d-4bec-92c6-9128efe6fe16">1.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iea41724e5f1a4bff83d7d555a0c98b95_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtMy0xLTEtMA_67339409-9708-496f-97cb-866bc5daf705">100.12</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec25aa9d406c44b6ade6d810256599b6_I20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtNS0xLTEtMA_557d5890-64b9-48ab-a8b1-a6c3c25a3570">1.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec25aa9d406c44b6ade6d810256599b6_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtNy0xLTEtMA_a7b0ae3b-740c-41fb-9eb8-95d0c181a325">93.30</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtOS0xLTEtMA_d123ed02-4ba6-48bd-a90c-73de247b1cbb">1.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtMTEtMS0xLTA_9db15dc1-6323-4c03-92f4-6076d978da87">88.13</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="iea41724e5f1a4bff83d7d555a0c98b95_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ5MjE_3bea357b-5fa8-40e3-baf9-a92211597f8d">29</ix:nonFraction> million of unrecognized stock-based compensation cost related to nonvested stock awards, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzUwNzQ_407dc260-0987-45e0-8585-c28b41ce574a">1.5</ix:nonNumeric> years.  Total fair value of shares vested was $<ix:nonFraction unitRef="usd" contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzUxMjM_98a13e55-765f-4732-8202-b5b612a1c84b">37</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzUxMjc_b5d5e3e0-4706-44e6-9b20-c4105eee85c1">40</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzUxMzQ_36eaefe7-ec39-4785-a4b8-45bd4ca97585">54</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.  For performance share units with a goal based on financial performance of the Company, the amount of unrecognized stock-based compensation cost is subject to change based on changes, if any, to management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned at the end of the performance periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, stock-based compensation expense totaled $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU1NjM_32c937fa-6178-47d3-8744-9bcfbd5c75ca">97</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU1Njc_6771f7e9-76a0-4ec5-adc6-18a5bb7c61e4">56</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU1NzQ_508cf21c-6a70-48b6-9037-aee047e32412">61</ix:nonFraction> million, respectively.  Income tax benefits recognized in the consolidated statements of operations related to stock-based compensation expense totaled $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU3MjE_e237b9a1-a759-44e8-9ef3-0c52e4964cd7">39</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU3MjU_8c8cb011-51f5-4b57-8cad-b320e689e3ca">27</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU3MzI_2edc2cad-4b2a-451f-983a-e6cfc14343aa">33</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively, which includes excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU4NzY_4b17f3f0-d5b7-4e43-9a30-13fa325a4116">23</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU4ODA_07a6ce3c-348c-4a5c-bbc5-c53297fd85ae">13</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU4ODc_05a633b1-7351-4c97-b0bf-4cd1a724056d">18</ix:nonFraction> million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i56cf9a83be19449ba306b8e9e27770df"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the Company's ESPP, substantially all employees can elect to have up to <ix:nonFraction unitRef="number" contextRef="i32d8eea035f740d88c4e34d32ac07b50_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzYwNTE_ac7aeafc-07a2-4fb1-8eb3-afba481061f0">10</ix:nonFraction>% of their annual wages withheld to purchase Quest Diagnostics common stock.  The purchase price of the stock is <ix:nonFraction unitRef="number" contextRef="ia85a7d30ffe046e3afb073a1149514cb_D20200101-20201231" decimals="INF" name="dgx:MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzYxNjU_11c6c7ee-2e27-4bb5-9f7e-68a51e6d6f7e">95</ix:nonFraction>% of the market price of the Company's common stock on the last business day of each calendar month.  Under the ESPP, the maximum number of shares of Quest Diagnostics common stock which may be purchased by eligible employees is <ix:nonFraction unitRef="shares" contextRef="i32d8eea035f740d88c4e34d32ac07b50_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzYzOTU_e25f73eb-8d99-4240-bf02-33268bbab4cb">9</ix:nonFraction> million.  Approximately <ix:nonFraction unitRef="shares" contextRef="ia85a7d30ffe046e3afb073a1149514cb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY0MTQ_5b56561a-aa57-4651-b624-3641484b020f">225</ix:nonFraction> thousand shares, <ix:nonFraction unitRef="shares" contextRef="i362c812a405d45709cb7b160258b8ed1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY0MTg_fb47e3b6-0304-421b-8e6b-5abf65e98266">269</ix:nonFraction> thousand shares and <ix:nonFraction unitRef="shares" contextRef="ifec7bf006deb455588ac5eef858ed849_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY0MjU_3edd5648-6936-487c-9e59-f818d8f335b9">326</ix:nonFraction> thousand shares of common stock were purchased by eligible employees in 2020, 2019 and 2018, respectively.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company maintains qualified defined contribution plans covering substantially all of its employees.  The maximum Company matching contribution is <ix:nonFraction unitRef="number" contextRef="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY3MDQ_0689be2a-ffa9-4600-b62e-4cab32b65ec9">5</ix:nonFraction>% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions for certain qualified defined contribution plans; matching contributions were reinstated in the third quarter of 2020.  The Company's expense for contributions to its defined contribution plans aggregated $<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY4Mjg_19e42934-15d8-4d23-95e6-fc63a247d1f6">64</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY4MzI_0e30d364-fc27-4f18-8551-f42e9566b26a">84</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY4Mzk_d118c49f-9544-40af-8ff7-85ad4ad047e2">78</ix:nonFraction> million for 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Deferred Compensation Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has a supplemental deferred compensation plan that is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to <ix:nonFraction unitRef="number" contextRef="i43c9eaea209849029715a8175ab5a38f_D20200101-20201231" decimals="2" name="dgx:SupplementalDeferredCompensationPlanSalaryDeferral" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzcxMDQ_7f6723dc-1ac5-4649-850a-3d032ed911d5">50</ix:nonFraction>% of their salary in excess of their defined contribution plan limits and for certain eligible employees, up to <ix:nonFraction unitRef="number" contextRef="i43c9eaea209849029715a8175ab5a38f_D20200101-20201231" decimals="2" name="dgx:SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzcyMTc_50904546-08e5-4448-bfaf-e4278928ffe9">95</ix:nonFraction>% of their variable incentive compensation.  The maximum Company matching contribution is <ix:nonFraction unitRef="number" contextRef="iefd7e996ee1d4652be0e3370eb259fdb_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzczMDg_fcde0896-17be-4433-87a0-20386a08a7e2">5</ix:nonFraction>% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions; matching contributions were reinstated in the third quarter of 2020.  The compensation deferred under this plan, together with Company matching amounts, are credited with earnings or losses measured by the mirrored rate of return on investments elected by plan participants.  Each plan participant is fully vested in all deferred compensation, Company match and earnings credited to their account.  The amounts accrued under the Company's deferred compensation plans were $<ix:nonFraction unitRef="usd" contextRef="iba88a90ce070465d896214b27be236f6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzc3NDk_305fdcd2-0072-45ec-ad4d-362d7d861c6a">67</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i85260b1da0934bb69e54b6bb7d6ca068_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzc3NTY_423d0f86-9350-40be-b6ac-38886aa47983">59</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively.  Although the Company is currently contributing all participant deferrals and matching amounts to a trust, the funds in this trust, totaling $<ix:nonFraction unitRef="usd" contextRef="iba88a90ce070465d896214b27be236f6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzc5MzI_9b9f06ff-2e31-4c62-8331-e731740d9754">67</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i85260b1da0934bb69e54b6bb7d6ca068_I20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzc5Mzk_93b96757-1238-4f29-8386-706526b5bc35">59</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively, are general assets of the Company and are subject to any claims of the Company's creditors. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company also offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  The Company matches employee contributions equal to <ix:nonFraction unitRef="number" contextRef="i1c5e3bd1735944849b8b66228d6f266b_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzgzMzI_eb1013d9-0e29-4f21-aee2-670c401d30ef">25</ix:nonFraction>%, up to a maximum of $<ix:nonFraction unitRef="usd" contextRef="i6f5e7b1b65014971a56d11421ae554a8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzgzNTU_472fb5a1-c7bf-4a50-98c5-d367c076ba84">5</ix:nonFraction> thousand per plan year.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  Each participant is fully vested in their deferred compensation and vests in Company matching contributions over a period of <ix:nonNumeric contextRef="i1c5e3bd1735944849b8b66228d6f266b_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzg2OTc_47954f92-e947-43cc-8719-30216dda9f38">four years</ix:nonNumeric> at <ix:nonFraction unitRef="number" contextRef="i1c5e3bd1735944849b8b66228d6f266b_D20200101-20201231" decimals="2" name="dgx:SdcpIiGradedVestingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzg3MDM_1198deec-fa13-49c5-bd10-ab8e08e6998a">25</ix:nonFraction>% per year.  This plan was amended effective January 1, 2018 so that future deferrals under the plan may only be made by participants who made deferrals under the plan in 2017.  The amounts accrued under this plan were $<ix:nonFraction unitRef="usd" contextRef="i6b09f22a0749457e8f3d51b1f9549c3c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzg5MjM_6676d330-f9e4-45c7-a00d-995c74087678">59</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib706a5ff02034443bde21ac1c37511c0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzg5MzA_4f161eef-4dc7-49fb-84da-9d0debb39d29">51</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  The cash surrender value of such life insurance policies was $<ix:nonFraction unitRef="usd" contextRef="i6b09f22a0749457e8f3d51b1f9549c3c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkxODE_358e9556-ea32-4278-8e37-060939255c43">50</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib706a5ff02034443bde21ac1c37511c0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkxODg_bbd55639-4e9c-4cf6-a56f-524b04b58566">43</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  For each of the years ended December&#160;31, 2020, 2019 and 2018, the Company's expense for matching contributions to these plans was not material.</span></div></ix:continuation><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_232"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzEwMzE4_db36039d-7bca-4bb0-9956-df1759eafc19" continuedAt="ifc8c619713ee4742a384f5a4e9a9006a" escape="true">COMMITMENTS AND CONTINGENCIES </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifc8c619713ee4742a384f5a4e9a9006a" continuedAt="i7101cf58bc84410393d83dfbbcbdc562"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit and Contractual Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit under its Secured Receivables Credit Facility and Senior Unsecured Revolving Credit Facility (see Note 13).  In support of its risk management program, to ensure the Company&#8217;s performance or payment to third parties, $<ix:nonFraction unitRef="usd" contextRef="i739e5869c8ba4c87a0e6a0a88a17f0e2_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzM0OQ_dc9033d6-b26f-49c8-9962-33c5ecc38879">70</ix:nonFraction> million in letters of credit under the Secured Receivables Credit Facility were outstanding as of December&#160;31, 2020.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div></ix:continuation><div style="padding-right:13.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i7101cf58bc84410393d83dfbbcbdc562" continuedAt="i94c6d23606b24baea32b313950a1d886"><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has certain noncancelable commitments, primarily under take-or-pay arrangements, to purchase products or services from various suppliers, mainly for consulting and other service agreements, and standing orders to purchase reagents and other laboratory supplies.  As of December&#160;31, 2020, the approximate total future purchase commitments are $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzkyNg_24a14f96-f194-46f4-b351-f63d1fe9ea50">334</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzkzOQ_a1e5a552-3f51-424c-9f67-dd7ac57468e5">106</ix:nonFraction> million are expected to be incurred in 2021, $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzk3Nw_652de087-0cd2-4084-8ce3-87b7c4955a91">103</ix:nonFraction> million are expected to be incurred in 2022 through 2023 and the balance thereafter. </span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Billing and Collection Agreement</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In September 2016, the Company entered into a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzMzUzMTg_a020698b-1549-440e-9434-fef192bf4df1">ten</span>-year agreement with a third party to outsource its billing and  related operations for the majority of the Company&#8217;s revenues.  Services under the agreement commenced during the fourth quarter of 2016.  The agreement includes an annual fee, which is subject to adjustment based on certain changes in the Company's requisition volume and the achievement of various performance metrics.</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including real estate leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  While over the course of many years, the title to certain properties and interest in the subject leases have been transferred to third parties and the subject leases have been amended several times by such third parties, the lessors have not formally released the subsidiary predecessor companies from their original obligations under the leases and therefore remain contingently liable in the event of default.  The remaining terms of the lease obligations and the Company's corresponding indemnifications range up to <ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" format="ixt-sec:duryear" name="dgx:RemainingTermsofContingentLeaseObligationsMaximum" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzNDc2ODQ_82cfc234-f409-49ea-897b-cbb886eee09d">27</ix:nonNumeric> years.  The lease payments under certain leases are subject to market value adjustments and contingent rental payments and therefore, the total contingent obligations under the leases cannot be precisely determined but are likely to total several hundred million dollars.  A claim against the Company would be made only upon the current lessee's default and, in certain cases, after a series of claims and corresponding defaults by third parties that precede the Company in the order of liability.  The Company also has certain indemnification rights from other parties to recover losses in the event of default on the lease obligations.  The Company believes that the likelihood of its performance under these contingent obligations is remote and no liability has been recorded for any potential payments under the contingent lease obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, <ix:nonFraction unitRef="claim" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzNTg0MjQ_583b82a4-558e-4279-850f-eb2e4edc85c9">two</ix:nonFraction> putative class action lawsuits were filed in the U.S. District Court for the District of New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzNTg0MzI_5f0363be-f5fb-43c2-a4e9-d12cce97592b">two</ix:nonFraction> lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  The Company plans to vigorously defend this matter and has filed a motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div></ix:continuation><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i94c6d23606b24baea32b313950a1d886" continuedAt="i8a0a28251dab4c098f6057df7e89362b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i8a0a28251dab4c098f6057df7e89362b" continuedAt="i916f7418588f4967a9d97ba0fee1a4d0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of December&#160;31, 2020, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzkwMzQ_633d6e6d-7c98-41b9-9074-1e04b3858bbb"><ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzkwMzQ_d5a86d21-6d59-49b6-a4b4-578d9590d7ef">1</ix:nonFraction></ix:nonFraction> million as of both December&#160;31, 2020 and December&#160;31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i916f7418588f4967a9d97ba0fee1a4d0">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $<ix:nonFraction unitRef="usd" contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzEwMTM3_6322cc9f-b38f-4616-b4ce-6aebbca7a420">138</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i11ae4adedea143f39461ad0909150885_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzEwMTQ0_fc01c5f9-fc81-4cf5-b016-c790a94cd706">132</ix:nonFraction> million as of December&#160;31, 2020 and December&#160;31, 2019, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</ix:continuation> </span></div><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_238"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzI0NDQ_f8fbe877-32e5-44bb-b543-fd77c1081af5" continuedAt="i81b874e008544b2c84bf2a49f94f66f6" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i81b874e008544b2c84bf2a49f94f66f6" continuedAt="i170cbca38b004368a39772be251297c3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs, and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i29c671e617c045bcb06b53c554e033e0_D20180101-20181231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzgwMQ_2a80342c-6593-4f01-9eb7-b27e9cea3064"><ix:nonFraction unitRef="number" contextRef="i9de3b9dd0a624ae68544d4880991cf82_D20200101-20201231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzgwMQ_789f5cd0-709b-4831-a748-eb10be631f11"><ix:nonFraction unitRef="number" contextRef="if585a3710daf402a97611004eea949c1_D20190101-20191231" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzgwMQ_84f3135a-23c8-4c55-8f55-1946a3e9752e">95</ix:nonFraction></ix:nonFraction></ix:nonFraction>% of net revenues in 2020, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i170cbca38b004368a39772be251297c3" continuedAt="i5144af8d8b8346d3a9a9979084dcaa46"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzI0Mzc_45bcb542-aea8-463f-bfc5-da042464b1c9" continuedAt="i63f2427bba334e3f8e7c81c123cd17ae" escape="true">The following table is a summary of segment information for the years ended December&#160;31, 2020, 2019 and 2018. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.</ix:nonNumeric></span></div><ix:continuation id="i63f2427bba334e3f8e7c81c123cd17ae" continuedAt="iab97a33fb25640048d72835627116bc7"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzItMS0xLTEtMA_b578c28c-3d40-49ff-beca-ff8d4be9a4f7">9,139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzItMy0xLTEtMA_8e6fdeaf-7748-4f54-a4c5-0856cc94ec46">7,405</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzItNS0xLTEtMA_c14fa188-38d4-4e75-b64d-efd30b12c9d1">7,204</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzMtMS0xLTEtMA_03a7940c-d8c9-4e98-b1da-d9b5877a7110">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzMtMy0xLTEtMA_b623d87e-a582-40e5-805a-2e803f057fe0">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzMtNS0xLTEtMA_3304ca38-157b-4e30-825a-17cb19655610">327</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzQtMS0xLTEtMA_43fff1b5-751e-4e2e-b3f3-761e6cd48805">9,437</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzQtMy0xLTEtMA_6a823d93-0c6a-45a5-aef4-28e49519ce9d">7,726</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzQtNS0xLTEtMA_e036227e-1238-4c9c-a8f6-626a5e5a0a3a">7,531</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzctMS0xLTEtMA_8cae6930-c965-4e24-a30b-816b3dc2509d">2,201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzctMy0xLTEtMA_2509aa6a-b224-45b2-b1a6-35932fcf24bc">1,298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzctNS0xLTEtMA_a1cefed7-cc3e-44e7-9e29-13ddcb7065c5">1,235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzgtMS0xLTEtMA_bb493708-6beb-4078-9387-efd25538ece9">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzgtMy0xLTEtMA_3b068d4c-5193-4552-b724-9ba382e326b2">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzgtNS0xLTEtMA_86830cd1-a4d4-45b2-aacd-73baef429be3">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0b19e4e8df441dd9a3a047864af82a9_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzktMS0xLTEtMA_e76eb7cf-8290-4043-8c89-ff09c6bb1fb6">269</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bfcea6d4a6f42a28ae201c9acd9e681_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzktMy0xLTEtMA_ebda9ad5-274b-4ac8-bbf0-293275d5949e">109</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728b5f186c284cccb74701cceaa73177_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzktNS0xLTEtMA_5d296a61-33db-45c2-af91-0325b5e73ff7">181</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEwLTEtMS0xLTA_4fc84431-825c-486c-9978-d137ad65783e">1,971</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEwLTMtMS0xLTA_51ed480b-9d80-465f-b1ff-9e29760d0a93">1,231</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEwLTUtMS0xLTA_0b288e83-7c36-4748-8f91-3f61c7b403cf">1,101</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expenses, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzExLTEtMS0xLTA_a95ac519-ff60-4acc-940f-0ce5cc46bb3f">87</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzExLTMtMS0xLTA_870441c3-4a23-4c1e-8f0d-99c7ba0527a2">155</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzExLTUtMS0xLTA_f9e1a4fe-8b63-4f22-bccd-03a22033de93">175</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations before income taxes and equity in earnings of equity method investees</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEyLTEtMS0xLTA_5057422d-d1ea-4000-a46b-131585f05df6">1,884</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEyLTMtMS0xLTA_a855f93a-9b8c-4b11-a9d4-2b52a1f3dbdc">1,076</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEyLTUtMS0xLTA_127b344e-5b39-477e-8733-eb70d5104738">926</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEzLTEtMS0xLTA_e6421230-801d-4f27-bf9d-c1603a704e2d">460</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEzLTMtMS0xLTA_bc6a7fef-8403-4f56-b0a5-4bd023092122">247</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEzLTUtMS0xLTA_27a81fcf-faa3-4e47-9908-3b5952187867">182</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE0LTEtMS0xLTA_ef964fdc-6824-4705-90aa-256aaad90cbe">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE0LTMtMS0xLTA_2175e198-2f0e-4a25-b5f6-92b6d3bf34ea">57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE0LTUtMS0xLTA_666a9882-f151-47c8-adec-b6a10871bb1e">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE1LTEtMS0xLTA_302cc3a4-a2b6-43ac-acbd-9ece36acb7ca">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE1LTMtMS0xLTA_fdca214b-4015-410a-bdd7-e3a43e9d19d4">886</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE1LTUtMS0xLTA_c5893705-9122-4525-ac55-1ed04bcc123b">788</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE2LTEtMS0xLTA_858a69d1-cc53-4643-b018-f89a0d838053">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE2LTMtMS0xLTA_e8731773-ff6f-4cea-839c-1e935aa399df">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE2LTUtMS0xLTA_4785f10c-8d56-4c98-bbc7-f500dcc801b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE3LTEtMS0xLTA_998d71d0-1a86-4e93-98a3-339542e11575">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE3LTMtMS0xLTA_314a0b24-be33-4c2f-a77f-2cc23966da3c">906</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE3LTUtMS0xLTA_daf06ade-71dd-4349-a035-dbafad88baa6">788</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE4LTEtMS0xLTA_2d816f2e-2f37-40d0-b46d-46c8f89ab645">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE4LTMtMS0xLTA_0fc05eb5-4f17-400a-9bfa-ae4fea75cbcc">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE4LTUtMS0xLTA_de4382f3-5f9c-4c5e-9629-df46920bfcc6">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE5LTEtMS0xLTA_2188af7f-9e66-4bac-90d2-f5f3f1f06c6a">1,431</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE5LTMtMS0xLTA_7800c693-cbd0-4c36-abaf-7543e0adfc65">858</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE5LTUtMS0xLTA_9903cd66-93ba-4e10-a29e-1a17496ae0d0">736</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzItMS0xLTEtMA_f1e96ffe-74bb-4fde-a81e-62eb9236e425">249</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzItMy0xLTEtMA_a0d7d2f2-f6b7-4180-8013-c4a826e6a682">226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzItNS0xLTEtMA_c5c6f915-18d3-4cb0-9de3-6400283a8db0">213</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzMtMS0xLTEtMA_708de140-87e2-41b7-a30e-1850e67f83a5">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzMtMy0xLTEtMA_b97a6b5f-c8f6-4da5-a82a-7777349ba68f">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzMtNS0xLTEtMA_6a52dc4d-16a3-4d23-8cc1-4c42785c2757">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b19e4e8df441dd9a3a047864af82a9_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzQtMS0xLTEtMA_259132c9-da68-48dc-a3aa-ba43d2a4fbc2">104</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bfcea6d4a6f42a28ae201c9acd9e681_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzQtMy0xLTEtMA_40b2ae16-f75b-4e8d-bb33-5fe32bbc40c1">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728b5f186c284cccb74701cceaa73177_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzQtNS0xLTEtMA_26f622f5-1a07-4dbb-8908-d6322a5f6341">90</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzgtMS0xLTEtMA_a097d522-1a09-4a75-a04a-2922764cbefa">361</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzgtMy0xLTEtMA_863e21d5-bb36-4b79-9e25-7cee0abd5502">329</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzgtNS0xLTEtMA_4dae0a30-7ee6-40d6-94c5-88f86b2a6f40">309</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions unless otherwise indicated)</span></div><div><span><br/></span></div></div><ix:continuation id="i5144af8d8b8346d3a9a9979084dcaa46"><ix:continuation id="iab97a33fb25640048d72835627116bc7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzItMS0xLTEtMA_315bd358-1a3e-433f-8d94-bde6e6115254">394</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzItMy0xLTEtMA_4f5863d7-2092-4512-a8d8-3491fcb618a1">373</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzItNS0xLTEtMA_f4944f8b-0111-4a65-ba87-57b5b59b4ec6">330</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzMtMS0xLTEtMA_8817ef94-bf69-4efb-8840-60327623cb3c">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzMtMy0xLTEtMA_3a33b8a1-1bf2-4f1c-b2ab-761b5d544ba8">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzMtNS0xLTEtMA_7dd9474a-3a6b-4770-9628-31f2703e31c0">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b19e4e8df441dd9a3a047864af82a9_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzQtMS0xLTEtMA_f628fba6-9c1a-4540-bb9b-9481a85c3602">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bfcea6d4a6f42a28ae201c9acd9e681_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzQtMy0xLTEtMA_e75d31c8-1c98-4989-adf3-0bad7a7d9a9a">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728b5f186c284cccb74701cceaa73177_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzQtNS0xLTEtMA_931cbcf5-2886-4943-af00-8db2f70161b9">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzgtMS0xLTEtMA_9473d4f4-69ce-427f-b1b9-77d8e56c3b87">418</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzgtMy0xLTEtMA_203bff9d-4f4c-441d-9922-063bd46ea40c">400</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzgtNS0xLTEtMA_bf01df69-f484-4696-8dc4-90e13d576a29">383</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2020, 2019 and 2018 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9491ec5cfff349bebd4c36dea5408c17_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzItMS0xLTEtMA_ac1b203d-a6ba-4aa3-b52a-96bc55e3a7f5">3,836</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i738f18abd516453e9c1b7fdf805a03d8_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzItMy0xLTEtMA_a73ce273-bee6-4941-b0f0-a9e412c9e804">4,206</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18079f917bab424fa56b9c2ca26f0aef_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzItNS0xLTEtMA_1855e68c-fbde-455c-ad73-16dd007c0148">4,217</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9b10d54f56453ab58e231cabe11e4e_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtMS0xLTEtMTMzNTA_f7cea9f5-06b5-42b0-9f37-436fc2b849cb">2,723</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i532b66c76cad4095bab3b1e800197403_D20190101-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtMy0xLTEtMTMzNTA_d319b68a-8db9-4e8f-b678-1f165a021235">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0ce923b9cb4071b89bf2e5cf956d70_D20180101-20181231" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtNS0xLTEtMTMzNTA_95dcd562-1877-478d-b2b6-8df27264af4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a1e4a3f0744196ae6e420b749b6626_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtMS0xLTEtMA_615dd073-3f1e-464f-91b5-8131fce42e99">2,098</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82b870198214f2fa9c11cf73b7c2285_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtMy0xLTEtMA_f276d5f1-4f13-496d-bc91-419ec4617337">2,620</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16009b81f04442439e6d1273e8b3e3d5_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtNS0xLTEtMA_8ee34fb3-9af0-475b-9c2c-ef8b903b2667">2,409</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de7c8519348419985b65110c0808877_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzQtMS0xLTEtMA_6f1bbbee-fc02-4c12-b128-cf4d9c0bd9dc">482</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i375a264a2ebe483fbbbf773457d0b2fe_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzQtMy0xLTEtMA_d674e5b3-2f21-462d-97bc-23ab05c96433">579</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c6fa4c884c0473a8de98fccdb136f8e_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzQtNS0xLTEtMA_ac9c90ca-d3ab-4daf-8ef3-7c0ce45bf22e">578</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c2eef5ed33d472db8175faea063b824_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzUtMS0xLTEtMA_21a88fb2-b292-4e98-9a7e-db612d056ae0">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i447b9c6561a048c985f4ab898c1121e8_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzUtMy0xLTEtMA_1f083400-3f85-4943-b1a0-81485dd8f5c1">321</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7391181b8741db9a1686e9c9b083dc_D20180101-20181231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzUtNS0xLTEtMA_96613f99-a47d-4234-afac-c4b8c5cd277b">327</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzYtMS0xLTEtMA_b42c563e-62df-4a66-a333-8842354eda90">9,437</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzYtMy0xLTEtMA_a65759c4-aa2d-4867-a995-cf2e23565523">7,726</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzYtNS0xLTEtMA_7fa598a6-ad40-48fb-978c-e18785c67b8a">7,531</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_244"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE5MDM_9a453c36-9394-4560-9f12-0a15ca5219fb" continuedAt="i1469d0bacd194485986ba208f843720e" escape="true">RELATED PARTIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1469d0bacd194485986ba208f843720e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's equity method investees primarily consist of its clinical trials central laboratory services joint venture and its diagnostic information services joint ventures, which are accounted for under the equity method of accounting.  During the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized net revenues of $<ix:nonFraction unitRef="usd" contextRef="i944f676d67324e0ba91482f72d96b22c_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzM0NQ_a01e5b9b-07ad-4197-8e2c-107644a582ff">34</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0f3f0dbfc5d747b19835bfdf96c93b85_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzM0OQ_fdef9506-0eb7-400c-954e-18005e8ae4f2">35</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic42f8e90bb9742fda4370a7c80d21289_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzM1Nw_25c72376-17f1-4985-94cc-670fa098ce60">36</ix:nonFraction> million, respectively, associated with diagnostic information services provided to its equity method investees.  As of December&#160;31, 2020 and 2019, there was $<ix:nonFraction unitRef="usd" contextRef="i6c4439a4821541da95311cd6e7ab8e84_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzQ5Mg_8bed2bfd-a375-42ad-bbd8-2bd5d13e629a">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0114534d1d8d4e39aa9cc6b5a35609ba_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzQ5OQ_453b2673-9514-4952-a9f5-9da89edfa1a3">4</ix:nonFraction> million, respectively, of accounts receivable from equity method investees related to such services.  During the years ended December&#160;31, 2020 and 2019, the Company recognized net revenues of $<ix:nonFraction unitRef="usd" contextRef="ibec3fcd21ae6474f999b20d69d69bd44_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzY2MA_4edc418f-987d-4e40-981d-d2fa66a2e80a">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b9920e1039a4bbc96cddc20848124d0_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzIxOTkwMjMyNTc0NzI_accc62e1-0d39-4ecd-b437-865480980f58">8</ix:nonFraction> million, respectively, associated with diagnostic information services provided to a noncontrolling interest partner in a joint venture.  As of December&#160;31, 2019, there was $<ix:nonFraction unitRef="usd" contextRef="i35915c99296f48f3bf58b06369abc86d_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzIxOTkwMjMyNTc1MDY_949945bb-cb4f-413a-9f03-4067006af858">4</ix:nonFraction> million of receivables from the noncontrolling interest partner included in accounts receivable and other assets in the consolidated balance sheet related to such services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized income of $<ix:nonFraction unitRef="usd" contextRef="iceeca8e729a74e688a40d2720017ccf7_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEwMTE_7d6846be-bf94-4939-a39d-5ac1ba321020">16</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic4cf653852bc4efabf147c2ab56dcdcf_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEwMTU_d1e25025-1dc2-41f1-aada-7ec6b0753c9a">15</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9c465a22a3f4e7e8356afdae38c480f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEwMjI_bdb81520-7fa5-43ec-b930-844db822d4f0">15</ix:nonFraction> million, respectively, associated with the performance of certain corporate services, including transition services, for its equity method investees, classified within selling, general and administrative expenses.  As of December&#160;31, 2020 and 2019, there was $<ix:nonFraction unitRef="usd" contextRef="i720a47095d174e48af4858648c214a5c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:OtherAccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEyNTk_7ce6867f-e149-4ce4-8fbd-8832d5934d2c">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i448e43197d9648fdae5be5f882e40fe0_I20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:OtherAccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEyNjY_4a75737d-082e-40fa-bf8c-313a3d836d17">1</ix:nonFraction> million, respectively, of other receivables from equity method investees included in prepaid expenses and other current assets in the consolidated balance sheet related to these service agreements and other transition related items.  In addition, accounts payable and accrued expenses in the consolidated balance sheet as of December&#160;31, 2020 and 2019 included $<ix:nonFraction unitRef="usd" contextRef="i6c4439a4821541da95311cd6e7ab8e84_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE1Mzc_ca7c79e9-00d1-4e66-a578-19562f9a097a">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0114534d1d8d4e39aa9cc6b5a35609ba_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE1NDQ_a8afd42f-943f-4800-b648-97137fbe2205">2</ix:nonFraction> million, respectively, due to equity method investees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the years ended December&#160;31, 2020, 2019 and 2018, the Company received dividends from its equity method investees of $<ix:nonFraction unitRef="usd" contextRef="i944f676d67324e0ba91482f72d96b22c_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE3MDE_89f6abcb-4a47-48bb-b7bc-d240b9a13135">54</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0f3f0dbfc5d747b19835bfdf96c93b85_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE3MDU_a0767c16-a919-4891-9c4a-64f0e41a314f">48</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ic42f8e90bb9742fda4370a7c80d21289_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE3MTM_656a86d4-7d27-4153-b1d5-84a0787c7167">74</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December 31, 2018, the Company contributed $<ix:nonFraction unitRef="usd" contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE3OTg_240726d5-4164-464c-9a3a-4cd36e4658c4">10</ix:nonFraction> million to an equity method investee to fund its share of an acquisition made by the equity method investee.</span></div></ix:continuation><div><span><br/></span></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_247"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDcvZnJhZzo4ZmI3YzZkMWI5ODQ0ZTk4OWMzOTNjMjc4YzdmNzA5OC90ZXh0cmVnaW9uOjhmYjdjNmQxYjk4NDRlOTg5YzM5M2MyNzhjN2Y3MDk4XzQ1Ng_c7b577b4-4d39-4060-b98a-87837881557e" continuedAt="ia20acdd208e04960b83e436cb04617cc" escape="true">DISCONTINUED OPERATIONS</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia20acdd208e04960b83e436cb04617cc">&#160;&#160;&#160;&#160;Discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i3e9708bf7a3f4fe9bf78754bc3d52636_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDcvZnJhZzo4ZmI3YzZkMWI5ODQ0ZTk4OWMzOTNjMjc4YzdmNzA5OC90ZXh0cmVnaW9uOjhmYjdjNmQxYjk4NDRlOTg5YzM5M2MyNzhjN2Y3MDk4XzE0Ng_6ba2dea4-dd38-43ff-bdeb-45721b031d75">20</ix:nonFraction> million associated with the favorable resolution of certain tax contingencies related to NID.  In addition, net cash provided by operating activities in the consolidated statement of cash flows for the year ended December 31, 2019 included a $<ix:nonFraction unitRef="usd" contextRef="i3e9708bf7a3f4fe9bf78754bc3d52636_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDcvZnJhZzo4ZmI3YzZkMWI5ODQ0ZTk4OWMzOTNjMjc4YzdmNzA5OC90ZXh0cmVnaW9uOjhmYjdjNmQxYjk4NDRlOTg5YzM5M2MyNzhjN2Y3MDk4XzM4Mw_901dbb9d-5285-47c5-8218-98f67ea1b9f1">28</ix:nonFraction> million refund from the taxing authorities related to discontinued operations.</ix:continuation></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_253"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Operating Results (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4Xzc1MDU_7112d759-9103-4444-89dd-ea7c2c03128f" continuedAt="i37a2e0483b92450f83db415dd263e95e" escape="true"><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4Xzc1MTI_cc1c425d-80e1-4bac-a0a0-9ca7389fd746" continuedAt="i8e252d4edde84c2c93d7bf6bb2edf98b" escape="true"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.899%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">2020 (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItMS0xLTEtMA_1ce4812f-508c-4cb6-a862-5fc447e9677d">1,822</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItMy0xLTEtMA_57fe195a-3362-47b3-8478-9544d3e0e164">1,827</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItNS0xLTEtMA_aef4980c-f998-49e1-9054-05e87094c664">2,786</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItNy0xLTEtMA_542d7acc-e795-436a-85a7-679b94afe63e">3,002</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItOS0xLTEtMA_bfada645-1ab9-439d-b60e-00c884f93249">9,437</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtMS0xLTEtMA_3fcff5de-f0da-416b-8f92-06d1891f74aa">552</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtMy0xLTEtMA_3739884d-40c3-4e8e-8812-1fb50dcdd7d5">606</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtNS0xLTEtMA_af988360-4553-4290-aa03-1eff2b9fc229">1,206</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtNy0xLTEtMA_7b4a0018-5363-45dd-9536-c0b209d4c4fb">1,269</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtOS0xLTEtMA_0b943bcf-c2f8-47f1-88ac-fb72d513436d">3,633</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctMS0xLTEtMA_3e1344af-0a6a-4d4c-ab3d-e2c79ffcef1f">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctMy0xLTEtMA_fe6a61b1-1243-4c06-a6dd-640b59aad665">193</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctNS0xLTEtMA_6cb4234c-2ee9-4a9a-a464-ad28ca0762d0">591</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctNy0xLTEtMA_718f3a3f-9961-4040-b6c2-d5b771f651bf">609</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctOS0xLTEtMA_65774fce-7296-48af-9e8d-0c00b47fc055">1,499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtMS0xLTEtMA_2062727a-208d-4a12-93a5-8b21cf500780">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtMy0xLTEtMA_2897b411-bc8a-4852-8ffd-ee4772f6c4c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtNS0xLTEtMA_0eacf1fb-2538-46e5-a633-cdefac03d505">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtNy0xLTEtMA_fa856f71-90b8-44dd-be6f-a394fcd6b7f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtOS0xLTEtMA_b5498410-552f-4255-8c59-ac87b231bdc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktMS0xLTEtMA_22023a57-beab-46b4-8946-4ec4c576c7bb">106</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktMy0xLTEtMA_0e87e980-3f00-45f7-80de-d156beca9d4b">193</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktNS0xLTEtMA_0f575a7a-7a0d-4a91-a5ac-bcf28768cb1d">591</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktNy0xLTEtMA_0a201576-ce1c-47a4-affc-9a78d3bb41af">609</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktOS0xLTEtMA_060c1832-1729-49e5-b9e6-b0428fdc2d9c">1,499</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTEtMS0xLTA_2d21c281-e6c9-4173-9c88-b769ee0e64c4">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTMtMS0xLTA_c2cebacd-75a9-4881-838c-4650a5bad430">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTUtMS0xLTA_97313cae-9f80-48fe-a72b-5cbe4bd87b8a">23</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTctMS0xLTA_4207a196-f4db-4a7a-a8ad-183bc05657e1">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTktMS0xLTA_1fe4eace-2de1-4a1f-a5c9-1117e01eebaa">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTEtMS0xLTA_fb6f555c-5a27-4421-98c3-1c9262f8fac6">99</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTMtMS0xLTA_4a46be66-afc6-422c-951b-32ed623cdb8e">185</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTUtMS0xLTA_456d30c8-9364-4a04-a862-c1f12815e750">568</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTctMS0xLTA_85b99ee5-f032-47c2-a95a-42fc06d2d31b">579</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTktMS0xLTA_96a27172-b4a7-4ed4-a5a3-b2897d842b9c">1,431</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - basic:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTEtMS0xLTA_41b7539f-beed-4725-af10-9b621f7fb426">0.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTMtMS0xLTA_512b4e06-4dab-4e5b-8cff-8a66b7c070ab">1.38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTUtMS0xLTA_0cf394a3-1b57-463d-8db2-73a3826f21de">4.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTctMS0xLTA_e112244e-8561-4c59-92c2-5d6410d57ea2">4.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTktMS0xLTA_80a499e9-3797-4642-9bd5-a9e1e1d3ea9b">10.62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTEtMS0xLTA_9ea8e145-d960-4802-8550-8b1f703e2667">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTMtMS0xLTA_4769571b-ef55-4cb5-aa02-f25861d96328">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTUtMS0xLTA_11a5a6ba-f9be-40a6-b73c-b32cce7582b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTctMS0xLTA_7af412a6-e51c-48c6-9671-c3f2faaacd3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTktMS0xLTA_4397a373-8278-4525-831d-392eefd218ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTEtMS0xLTA_6f4696f0-4460-4699-b885-ce8096194b87">0.74</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTMtMS0xLTA_693d597f-61ee-4f1e-af9a-ef77c36b4525">1.38</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTUtMS0xLTA_4c6ebec7-9f64-458d-8e72-680b3431265b">4.20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTctMS0xLTA_3df7b7ce-70d6-45bf-9480-e2dc18883840">4.28</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTktMS0xLTA_11d7a953-8dd4-4a8d-85a7-3d489fc852a0">10.62</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTEtMS0xLTA_d8a98ed9-a588-4c01-93c0-b601144f27cf">0.73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTMtMS0xLTA_9abc0660-d43e-43f8-a9f4-fb64a225c71b">1.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTUtMS0xLTA_889d2f37-4777-42bf-b57a-10fc241433f3">4.14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTctMS0xLTA_ebe79d32-0469-4a3e-9c04-ab3c8e47b943">4.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTktMS0xLTA_6cc59292-92ca-4cdd-82a2-adbadc6064e1">10.47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTEtMS0xLTA_3e460e20-fc15-448b-9bdd-87f39db8f5f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTMtMS0xLTA_9fa538c3-b343-40aa-a50a-d4825a3eb37a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTUtMS0xLTA_0d646a71-d3a7-419e-90db-5e389653950a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTctMS0xLTA_4a7fe9c4-b81f-419c-bd8a-97df0b7a37d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTktMS0xLTA_32585858-7305-49b4-bedc-9ccbf32d533e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTEtMS0xLTA_8c973c32-cf93-4ccc-be7f-9efbdf3f9d03">0.73</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTMtMS0xLTA_c9f68505-41a7-4b34-a4ac-1c23ccf82539">1.36</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTUtMS0xLTA_ba241ec9-e87e-43cd-9ac7-41044a03e1cd">4.14</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTctMS0xLTA_33104191-72bc-425a-bbab-25ba07c72c3e">4.21</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTktMS0xLTA_eddcf1d5-f850-4919-9a66-3b411757baf1">10.47</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.899%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">2019 (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(j)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItMS0xLTEtMA_730d95e9-7ce1-4795-bcd3-39c1c458a829">1,891</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItMy0xLTEtMA_6bef34f0-c26c-496a-8519-8aa94f5c3b28">1,953</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItNS0xLTEtMA_6bccac8d-6f4b-49f7-8dec-af7e4f8155b2">1,956</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItNy0xLTEtMA_3edd25a6-0bf5-45e8-8b7e-9dfa11f0e774">1,926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItOS0xLTEtMA_c2b0b57a-9ff1-4bdb-b9e1-18c5274a191a">7,726</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtMS0xLTEtMA_0dbddf03-1101-4316-916f-7731212eb344">647</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtMy0xLTEtMA_cb81c27c-08ff-4e68-b1f1-d889875fa4e2">688</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtNS0xLTEtMA_5cec8a48-a365-4a71-8a2a-719b98977bf8">692</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtNy0xLTEtMA_65905cf2-c3c7-477f-9f11-57998ac5d1cc">662</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtOS0xLTEtMA_96d73235-18ae-4e27-9df6-4441ab3cec40">2,689</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtMS0xLTEtMA_0b8cc3dc-5839-4770-b858-091d23ebd6bf">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtMy0xLTEtMA_86f6d886-3b2c-49f9-8c67-103cfcdf689d">219</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtNS0xLTEtMA_14173663-86dc-456a-ab88-db3d29be36f3">226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtNy0xLTEtMA_27b7d675-0dd8-401c-ad78-4d792cac325b">265</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtOS0xLTEtMA_2dab2da1-f770-4ee8-b79e-21c9ad14079a">886</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtMS0xLTEtMA_98f1a202-d6fd-4ebd-9d57-96ce90cf4876">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtMy0xLTEtMA_c2471b05-a76c-4b19-9fc0-e31296040271">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtNS0xLTEtMA_a84c4bdb-c456-4f95-a704-8b0ac3ed3482">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtNy0xLTEtMA_a4a2af41-90b4-4f9f-a90a-1c9bc4d0141a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtOS0xLTEtMA_a797e6d1-a03e-4283-94a1-2eb23657ebb2">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctMS0xLTEtMA_0ffb4e7c-1295-4ffd-9f31-41643d70d2a4">176</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctMy0xLTEtMA_5e05a3f6-8d73-482d-98c6-ccf0d0b738c5">239</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctNS0xLTEtMA_4807472e-7dde-4506-adf0-c20f8664f057">226</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctNy0xLTEtMA_0337e582-8947-44f3-b0d9-5b0ca9bdb2f1">265</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctOS0xLTEtMA_c437b924-0481-4938-869b-16ddb4946be2">906</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtMS0xLTEtMA_d198447b-34f5-4cac-a8eb-5e4b600a2ef5">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtMy0xLTEtMA_aa9a254a-3945-4407-a575-3899d35abb62">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtNS0xLTEtMA_d60c8b10-d33a-4493-bbba-c8a10fe4ab4e">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtNy0xLTEtMA_05a5ee92-9028-468a-8652-ef87348e24e3">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtOS0xLTEtMA_a767ffa1-950b-4328-aa04-78fa159a9391">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktMS0xLTEtMA_58d2afc4-3b91-459e-8993-19e80d7a126f">164</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktMy0xLTEtMA_5351ccb2-fd6e-44a8-85ca-d33db45b8e32">226</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktNS0xLTEtMA_41221634-5c93-417a-8431-27c474f286f7">215</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktNy0xLTEtMA_559f2f69-908a-4f38-9cb4-0c1c91995213">253</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktOS0xLTEtMA_5605537f-524f-495f-a40e-0aea8b64f694">858</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - basic:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTEtMS0xLTA_046caf44-ac49-46bf-ab15-a80f244969b8">1.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTMtMS0xLTA_7e28b23a-baf2-449a-92f9-aa02d71b1a98">1.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTUtMS0xLTA_a8c6f41e-f235-4b66-843c-43885252e9dc">1.59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTctMS0xLTA_db27425d-7357-42f8-bf34-ba74b24b7eb0">1.88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTktMS0xLTA_97988008-5517-4821-ae87-07d579724536">6.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTEtMS0xLTA_4b00515d-fcea-4037-a93b-8c93cd9239b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTMtMS0xLTA_22c00a83-3332-4ee7-93f9-884fa6e13f13">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTUtMS0xLTA_3178b1d3-84b0-4bbc-96b0-1a7d81bac8ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTctMS0xLTA_c07a2410-bf84-40c0-8f73-f6ffd80e163f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTktMS0xLTA_b449c224-5035-4b91-a0b8-a231aac2e9c0">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTEtMS0xLTA_6e7db102-e477-492b-acf3-4ee7aa515d65">1.22</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTMtMS0xLTA_469e0409-e45a-4c51-a8e3-300634105712">1.67</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTUtMS0xLTA_83f81f60-83da-4ee3-bb7a-df169dcb23c5">1.59</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTctMS0xLTA_3f447451-2da6-4ba9-beda-1f453f2b642d">1.88</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTktMS0xLTA_0b54c0da-8fb4-4b18-8eb8-b36116249e17">6.36</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTEtMS0xLTA_58b7407b-65e0-4fb9-b0d2-b79cf7bbbc5a">1.20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTMtMS0xLTA_06bb68ac-999c-4079-868b-783c530fbba0">1.51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTUtMS0xLTA_9d442382-ba72-4aab-89e5-5f3a1ae683ec">1.56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTctMS0xLTA_d6f604e5-d01b-483b-ae6a-fddf89536b48">1.86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTktMS0xLTA_31358097-58a3-430b-a2cc-fb037ae1ef3c">6.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTEtMS0xLTA_7fe6570f-3de2-4d6d-a00d-65ed99662e2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTMtMS0xLTA_c82747d2-1deb-4611-bfb2-84bf15155325">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTUtMS0xLTA_0e5adff7-6e52-4f45-864e-bdbf3e352bf1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTctMS0xLTA_d986693f-24ae-49df-9385-1390a7a34767">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTktMS0xLTA_587a8a96-40f4-45b0-ba44-e42210043c5b">0.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTEtMS0xLTA_f6295321-1914-4c3b-9f42-6657a3334d93">1.20</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTMtMS0xLTA_3ffea6aa-2929-4e94-a763-3fc3bac56364">1.66</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTUtMS0xLTA_76d2aa6a-cdde-4852-a5a6-c0a37af9b100">1.56</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTctMS0xLTA_b55aec3c-19bc-4fcc-9030-d44c8c0ef9c2">1.86</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTktMS0xLTA_dd70ff6b-cad3-4bf0-8fee-fe800709c328">6.28</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Operating Results (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><ix:continuation id="i37a2e0483b92450f83db415dd263e95e" continuedAt="i8256add51a174d6f87c43afa98ce35ee"><ix:continuation id="i8e252d4edde84c2c93d7bf6bb2edf98b" continuedAt="i9039d273cb8f4c36bd240f9b5216c913"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  As a result, NID was classified as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved (see Note 21 to the audited consolidated financial statements).</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i1b4de4e5f21041db87556bf0e720459f_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwMjg_f4162294-9e0a-488b-8855-2aaca31ed2ce">28</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwNDE_79931170-4759-4380-b97b-78bee7b48e99">25</ix:nonFraction>&#160;million in amortization of intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i5d7dd6fe1eec401f8fa3bbc7218f34d9_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwNzk_c1d8c661-5cf6-46cc-9627-6bda12230f0c">3</ix:nonFraction>&#160;million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwNTQ_79b1044d-3c7d-4323-9826-37993b691817">16</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i0bbe7f359fb441618dff6db8b09e9693_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwNjc_e97dc3a7-5bbe-4630-a1ac-66ccfacc2886">7</ix:nonFraction>&#160;million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="i188d6941e8fa42beafe10767321c5eb9_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwOTE_170c90f0-31b8-4f8f-bb4b-f809366e6291">9</ix:nonFraction>&#160;million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; and pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxMjc_b4c1c7f2-ab46-489e-ba6b-041d247eca13">9</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i0bbe7f359fb441618dff6db8b09e9693_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxMDM_97cef5f1-4bdf-471a-a40e-67aec543159e">1</ix:nonFraction>&#160;million in cost of services, $<ix:nonFraction unitRef="usd" contextRef="i188d6941e8fa42beafe10767321c5eb9_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxMTU_eafc7f7f-1a68-4d18-a9d0-544207590128">3</ix:nonFraction>&#160;million in selling, general and administrative expenses and $<ix:nonFraction unitRef="usd" contextRef="ice1470357afb4f228be84a3f77de9bb4_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxMzk_d775a0fa-4e94-411b-be2d-87a4e27df5c5">5</ix:nonFraction>&#160;million in other operating expense (income), net), associated with certain costs incurred as a result of the COVID-19 pandemic and resulting impact on the economy including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and to transition certain employees to a remote work environment, and certain asset impairment charges; partially offset by excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjg0OTE_d86a1f2e-1fe8-4355-9aae-2fd4638b3dfb">8</ix:nonFraction> million recorded in income tax expense.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included pre-tax amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i5034ddf618274bbab61b97eef0228bd8_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxNTE_86c04a90-d0e7-4a98-8295-f53fa6beea42">28</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxNjQ_588ff642-36ea-4c36-92f2-81942474c3c3">25</ix:nonFraction>&#160;million in amortization of intangible assets and $<ix:nonFraction unitRef="usd" contextRef="ia853061a347a4f67a24c62ecefdcf9e4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxNzc_2a838e1d-0448-4d95-bb27-5740982ba5c0">3</ix:nonFraction>&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxODk_e878ffa3-c75c-470f-8aec-c9735890da91">9</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i5ac794c54fea41c082189f0a8fed1dd9_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyMDE_010758eb-cc0c-4ef3-a618-61b35726f237">3</ix:nonFraction>&#160;million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="ieb70b878994a44d0a2cea507d2ead6a6_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNTAxNzc_39fcfadb-61e7-4ca8-8f06-0698970ec527">6</ix:nonFraction>&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:PreTaxGainLossDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyMTM_52ee3ed2-6b22-4efd-9c63-f4b3800dac43">26</ix:nonFraction>&#160;million (charges of $<ix:nonFraction unitRef="usd" contextRef="i5ac794c54fea41c082189f0a8fed1dd9_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:PreTaxGainLossDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwMDQ0_e47b1b35-320d-447f-a6cc-a4ee987717cb">34</ix:nonFraction>&#160;million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="ieb70b878994a44d0a2cea507d2ead6a6_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:PreTaxGainLossDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwMDMy_8afe7685-283a-4dc5-9353-302dbc5f6369">5</ix:nonFraction>&#160;million in selling, general and administrative expenses, offset by a $<ix:nonFraction unitRef="usd" contextRef="ib14b8a10b66a4c97a54f968b44161d88_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="dgx:PreTaxGainLossDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyMjY_0e6e709c-269b-4bfe-808d-ec8340a2f7a5">62</ix:nonFraction>&#160;million gain in other operating expense (income), net, and a $<ix:nonFraction unitRef="usd" contextRef="ia853061a347a4f67a24c62ecefdcf9e4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="dgx:PreTaxGainLossDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyNTI_6de7fc22-4698-4c7d-9c87-65dfd43b9457">3</ix:nonFraction>&#160;million gain in equity in earnings of equity method investees, net of taxes), representing certain items resulting from the COVID-19 pandemic, including expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19, incremental costs incurred primarily to protect the health and safety of the Company's employees and customers, and certain impairment charges, which were more than offset by $<ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyNzY_a05e9944-b4f9-4d0c-85ce-a89ad5ea409e">65</ix:nonFraction>&#160;million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"); and excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNzAyNDM_49f24dcc-e259-4357-bcf1-a66451fca89b">4</ix:nonFraction> million recorded in income tax expense.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included net pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyODk_955af0f6-2389-4b50-b653-d3f3bf833f17">69</ix:nonFraction>&#160;million (charges of $<ix:nonFraction unitRef="usd" contextRef="idaf490fefc914c45b4456f72c9bdf613_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwMTA2_5ff5fb36-0278-4e26-b491-02a575e6c52e">3</ix:nonFraction>&#160;million in cost of services, $<ix:nonFraction unitRef="usd" contextRef="i0f50c4e8562542bc9cb4c710b1f0ce64_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzMDI_196c417f-0321-4575-8112-a271befd0003">65</ix:nonFraction>&#160;million in other operating expense (income), net, and $<ix:nonFraction unitRef="usd" contextRef="i8b9e1c6b12a542709fad464b97f3772e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNTAxNjU_0118f457-6992-4876-b9ab-8baa7cb9f57f">1</ix:nonFraction>&#160;million in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and the reversal of $<ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzMjc_204a165a-0e37-4c87-8fcf-f56b128ae317">65</ix:nonFraction>&#160;million of income previously recognized during the second quarter of 2020 attributable to the receipt of funds from the government that were appropriated to healthcare providers under the CARES Act; pre-tax amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i299506ac090e48338ffdc86d6e316b6d_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzNzg_71a5591e-51c7-42e0-9b85-38f31c9297cd">30</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzOTE_9fbfdee6-d198-41de-96bb-f1be1e003939">27</ix:nonFraction>&#160;million in amortization of intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i8b9e1c6b12a542709fad464b97f3772e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzNjY_b7bc4194-9bd2-47b7-bda5-52e9beb1b6ca">3</ix:nonFraction>&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzNDA_ab612703-b3fc-4039-b810-ce30320a303f">18</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="iada86b56f45a48b397d3c96f067a7475_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzNTM_0a1aaf27-71e2-48ae-99e4-6c826f392216">11</ix:nonFraction>&#160;million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="ib3c43507276845e68498c4ff71c1ccff_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDg0MDQ_5ffc86e7-2bae-44cd-84de-7df8eee14ace">7</ix:nonFraction>&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i1db356aed7c84b408e826cf4a5378149_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDg0MTY_2317c3a0-fc94-48c3-8979-f38587cda689">70</ix:nonFraction>&#160;million recognized in other income (expense), net upon the acquisition of the remaining <ix:nonFraction unitRef="number" contextRef="i55ff501c262847c0851ba168e5b293ff_I20200930" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNTM4MDg_a0d5aa94-40b9-4203-a016-7a49fe46e440">56</ix:nonFraction>% interest in Mid America Clinical Laboratories, LLC as a result of the remeasurement of the Company's previously held equity interest to fair value; and excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNzE5ODc_a3f6f777-7229-43a6-a337-8b4af97ce526">3</ix:nonFraction> million recorded in income tax expense.    </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included pre-tax amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i8c24be469f644a7d9e205e4e693a21e4_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTI5Mjc_b93b3aa4-b867-4666-8604-f6b13d8389f9">28</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTI5MzM_e0f18b58-deb3-41c1-be3c-2ec44d5f892a">26</ix:nonFraction> million in amortization of intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i36e8ef2ddd684f5c8ee33b7a03675400_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTI5ODQ_23f021d3-3af7-458e-a2d6-fdc77e3f6ffc">2</ix:nonFraction> million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMxNjg_78591ea4-7d52-442f-85ad-7129e3848365">20</ix:nonFraction> million (charges of $<ix:nonFraction unitRef="usd" contextRef="i69b0cda2873944f69a703c9bcbb95cf5_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMwMjE_1c6f7a3a-3dfe-4e69-8bbc-cc57884dd37e">19</ix:nonFraction> million in cost of services, $<ix:nonFraction unitRef="usd" contextRef="ia72b92b0f0be40e89a72bc54bd0361fc_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMwMjQ_232574c0-46e4-4daa-a156-8d88c592f932">2</ix:nonFraction> million in selling, general and administrative expenses and $<ix:nonFraction unitRef="usd" contextRef="ia3c02f9911b34985a9c3b2cd7600534c_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMwMjc_7f356054-0542-4d4d-8f72-baa54f78703d">1</ix:nonFraction> million in other operating expense (income), net, partially offset by a $<ix:nonFraction unitRef="usd" contextRef="i36e8ef2ddd684f5c8ee33b7a03675400_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:ChargesDueToCOVID19" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMwMzM_e7e52f71-22e2-4715-971f-3ae972bce603">2</ix:nonFraction> million gain in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19 and incremental costs incurred primarily to protect the health and safety of the Company's employees and customers; and pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMyMzM_002a40e0-5a05-4a87-84a8-dae29e8dfbed">15</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i30b20cba82d2410f8d16e73bbaba47ad_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMyNjE_92fac182-671e-48b1-a55d-236871146c6d">6</ix:nonFraction> million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="i92f3e38b6a2b49a1a515bcbb581fd02d_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMyODk_6c91e47b-06a2-4d99-982e-15ccfc10728d">9</ix:nonFraction> million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDg5MDg3_74464857-5ca4-4eda-a04f-48b979769939">2</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i92f3e38b6a2b49a1a515bcbb581fd02d_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDg5NjY4_b328c69a-6bff-49a4-af5d-5ca580186dc1">2</ix:nonFraction>&#160;million of charges in selling, general and administrative expenses and a $<ix:nonFraction unitRef="usd" contextRef="i3f2e0858b3b740c9ad4cbd585da3c971_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDg5Njkz_0dd00390-35cd-488a-a5d0-91c3b2484626">10</ix:nonFraction>&#160;million loss in other income (expense), net, offset by a $<ix:nonFraction unitRef="usd" contextRef="i36e8ef2ddd684f5c8ee33b7a03675400_D20201001-20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDg5Njgw_83a1c627-e888-4478-93bd-d32060bde207">14</ix:nonFraction>&#160;million gain in equity in earnings of equity method investees, net of taxes) related to costs associated with Quest for Health Equity (the Company's recently announced initiative with the Quest </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents </a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quarterly Operating Results (unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i8256add51a174d6f87c43afa98ce35ee"><ix:continuation id="i9039d273cb8f4c36bd240f9b5216c913"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics Foundation to reduce health disparities in underserved communities) and a loss on retirement of debt, which were more than offset by a gain recognized by an equity method investee to adjust certain of its investments to fair value; and excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTM5MDM_f1f61cf4-57a1-4f28-bc88-e5389558acf3">8</ix:nonFraction> million recorded in income tax expense.  In the fourth quarter of 2020, the Company returned the funds received from the government that were appropriated to healthcare providers under the CARES Act.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the four quarters of 2020 did not equal the totals for the year ended December 31, 2020 due to quarterly fluctuations in the Company's earnings and weighted average common shares outstanding throughout the period primarily due to the impact of the COVID-19 pandemic on the Company's results and the temporary suspension of repurchases under the Company's share repurchase program.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i7e06c5cb90a9430688ffd3e687ac8d51_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4Xzk1NQ_1cf7a733-b986-400d-9b52-f6f845aba4e0">29</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4Xzk1OQ_a1781b6e-fc21-4fab-8a27-621a861bc1ba">24</ix:nonFraction> million in amortization of intangible assets and $<ix:nonFraction unitRef="usd" contextRef="if8f06c22a7fb411ea90bc48b15e6234c_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwMDM_426e2e0d-421b-4081-8c63-52a319070395">5</ix:nonFraction> million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwOTA_e1a487a5-591d-4996-9e7f-76e4f29aa6f6">22</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="iface07505ab342789068244bb97b89df_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwNjMw_9b9e8981-dbf0-4f68-8801-732c5d75bc07">11</ix:nonFraction>&#160;million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="ic13cec6030c243db9ed599ac34410b5f_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwNjQz_36eb7340-421a-4c39-ace0-9966db70cf45">11</ix:nonFraction>&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEzMzY_a94647e3-430b-4c4c-b852-ae6b65f4def8">8</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i97d3ffa754e846359243673a76a4dd3d_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwNjY4_9b809d6d-eca4-4680-a518-e42f15dbdf50">1</ix:nonFraction>&#160;million charge in selling, general and administrative expenses offset by a $<ix:nonFraction unitRef="usd" contextRef="ieb0fe8ee698545d98f72f17ee9b32a59_D20190101-20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwNjU2_d58d9f19-7ed3-490c-8db1-1b16664c555f">9</ix:nonFraction>&#160;million gain in other operating expense (income), net), due to non-cash asset impairment charges, which were more than offset by a gain associated with proceeds from an insurance claim for hurricane related losses; and excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjY4OTM_52550710-ba0c-4326-9a3e-73bda2a3449d">3</ix:nonFraction> million recorded in income tax expense.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i0778872492304f04a882ac24394af772_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzE3NjI_51eddd54-1f96-4597-a261-2fceb2b1c232">30</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzE3NjY_a5ec0b98-d4a5-4521-ba03-82a834946a52">25</ix:nonFraction> million in amortization of intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i59a64dfb2bb34d24abf433537d03cfb6_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzE4MTA_b288692e-a4de-4331-8ef0-9717c277c596">5</ix:nonFraction> million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzE4OTc_85939bfa-5e09-4d43-9cfa-fdbc2e507b1f">26</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="icbe11049deab4e0695a9136216555273_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzg2_c6daffb7-6b44-4803-a456-bd9e62c63978">11</ix:nonFraction>&#160;million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="ifb52dade7a1942a4a87b386331e3c5fd_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwODYw_c3f258e0-63c7-419a-ba8d-0a1034e54837">15</ix:nonFraction>&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="i88fc2768290f406e90452310cc0cc35e_D20190401-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxNDI_a704939f-9f64-46c7-b450-853224692a17">6</ix:nonFraction> million in other operating expense (income), net, primarily due to a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjY4OTk_0b2d5f0b-71a2-4ad4-9e5e-4dee3db5c947">5</ix:nonFraction> million recorded in income tax expense.  Income from discontinued operations, net of taxes includes discrete tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i5d23165dad6f4a7c9753adca8283f930_D20190401-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI1Mzk_f28612f5-2d7e-409c-8eac-d2200db7bfcc">20</ix:nonFraction> million associated with the favorable resolution of certain tax contingencies related to NID.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Included pre-tax amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i4935382cf51a42e5ac2c7f7b75f377d1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI2NzA_f79eda90-08a1-4688-8040-cdcc44081852">25</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI2NzQ_cdc76b4e-78f6-473d-a9b8-2d3893881687">23</ix:nonFraction> million in amortization of intangible assets and $<ix:nonFraction unitRef="usd" contextRef="id133d541098b460c855ee9ebba789ee6_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3MTg_9944a42a-4690-4026-b7ba-567a259e5714">2</ix:nonFraction> million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI4MDU_e8b937a6-87b9-4d90-b72f-679d9110b5aa">16</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="ie2cb4ca2313e45f5a150880b15665d99_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzc0_c884efd7-6bfe-45d4-9db1-f1d9a4e18df3">7</ix:nonFraction>&#160;million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="i0177fd8fa149409d932b66e085fff082_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzYy_55b87a96-529c-4b70-9d9c-05123ab811d6">9</ix:nonFraction>&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzMwNTE_1612595b-d9a7-419b-9d85-3fe39e0d83d3">3</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="if0567e595477470982b2e5e34d02c2b2_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxOTQ2_51964f1d-4f40-4723-a795-5e770f1ff918">4</ix:nonFraction>&#160;million charge in selling, general and administrative expenses, offset by a $<ix:nonFraction unitRef="usd" contextRef="ia64109811371447e8f58f600a7e213ec_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzUw_5383633a-8d14-4781-acc6-43a04e86534f">7</ix:nonFraction>&#160;million gain in other operating expense (income), net), consisting of costs incurred related to the AMCA Data Security Incident, which were more than offset by a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjY5MDU_dee1ccf4-76a2-44aa-8d87-8429ccd3411a">3</ix:nonFraction> million recorded in income tax expense.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Includes a pre-tax gain of $<ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM1NTU_54731377-859c-4f6e-b0f6-a7d3d7a0bc39">72</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="ifb2549acbace4796a9c86fd435062b92_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkyMTA4_9d27540c-7a62-45a7-bf75-8a4ec9e6e645">1</ix:nonFraction>&#160;million charge in selling, general and administrative expenses, offset by a $<ix:nonFraction unitRef="usd" contextRef="ib9aa3e5c40ac445299ed6a675092e9ba_D20191001-20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzEz_8766e196-36df-452f-84d5-5cc19b255b4b">73</ix:nonFraction>&#160;million gain in other operating expense (income), net), primarily associated with the sale and leaseback of a property; pre-tax amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i2e0b27f6e56e4d51946d35cdcfce7aa2_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM3Nzg_56f111c0-99b0-4a45-b435-912946b604d1">27</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM3ODI_d46f723a-e8a7-4f89-9f67-dd07c35b91ba">24</ix:nonFraction> million in amortization of intangible assets and $<ix:nonFraction unitRef="usd" contextRef="iebc62645fa31471fbe90700f9465c88a_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM4MjY_76e7f403-7c65-4c32-9727-09cb47b55571">3</ix:nonFraction> million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM5MTM_bb995f62-1025-43bd-8487-424432b60c91">14</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="id4cdaf18428f4a29ac09bbda7601b898_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNjg5_5484e5eb-8817-465a-818d-9e43515c7338">6</ix:nonFraction>&#160;million in cost of services and $<ix:nonFraction unitRef="usd" contextRef="i94e290893fe1450ea0b89d2e52ba32cb_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:RestructuringIntegrationCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzAx_09078ebc-5e62-472e-9cd5-d3be3205bcc8">8</ix:nonFraction>&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; and excess tax benefits associated with stock-based compensation arrangements of $<ix:nonFraction unitRef="usd" contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="dgx:Sharebasedcompensationexcesstaxbenefitamount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjY5MTE_08d7d3cb-af50-4e2d-848e-12003d073797">2</ix:nonFraction> million recorded in income tax expense.</span></div></ix:continuation></ix:continuation><div style="padding-left:18pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-51</span></div></div></div><div id="i17586f5c1918467f84e9d79a5a08b3e4_256"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i17586f5c1918467f84e9d79a5a08b3e4_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div></div><ix:nonNumeric contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90ZXh0cmVnaW9uOjMwNTI4ZTZmM2JmMDQ4NmJhMTFjMjRkOWJiODAwYWU5XzIwMQ_93445b47-c167-44dd-a5f9-1302be5309f3" continuedAt="iaf1d4aabe1544d7f9b3e0853cc2ed19e" escape="true"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II - VALUATION ACCOUNTS AND RESERVES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:51.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision for Credit Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deductions<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>End of Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ef0d848be64de88a06475f05c8fc23_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzItMS0xLTEtMA_f9f796b3-443e-404b-8653-290bcc3bcfdb">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92fdac500c449b68f3d7a77c241c32a_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzItMy0xLTEtMA_0b3d9e2e-de2f-4626-9729-e71450ff08ae">19</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id92fdac500c449b68f3d7a77c241c32a_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzItNS0xLTEtMA_ab7af159-05c0-4dfe-b986-9ea222476451">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37650e5ac3af455b982266e74362e4f3_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzItNy0xLTEtMA_911f46b0-d1f7-476c-89d5-3624dd4b3d08">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts and allowances</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5bea947c9da4d009c5112e1fb35819b_I20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzUtMS0xLTEtMA_d5a13437-6c06-4dfb-9af8-1bd2e147531e">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02d0b9ff9814b8c8b499379f5994f66_D20190101-20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzUtMy0xLTEtMA_52796007-1e2a-4804-9356-317847c83b0b">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02d0b9ff9814b8c8b499379f5994f66_D20190101-20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzUtNS0xLTEtMA_586ce88c-2724-4bd4-9e23-7dd4554b4321">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ef0d848be64de88a06475f05c8fc23_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzUtNy0xLTEtMA_020b32e1-a3a6-429b-a136-679e9f3e436d">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts and allowances</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9415c8123544c9387ed93ba012a625f_I20171231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzgtMS0xLTEtMA_a391076b-1a07-4be2-a0e2-d240099fbe3a">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bc1c3cf41a470d861c0f391ba08410_D20180101-20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzgtMy0xLTEtMA_05a32cef-3124-4698-9b8a-d0f43dea8c3f">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bc1c3cf41a470d861c0f391ba08410_D20180101-20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzgtNS0xLTEtMA_d215cc58-d63e-4798-9df7-d2ad1fe4a16a">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5bea947c9da4d009c5112e1fb35819b_I20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzgtNy0xLTEtMA_b3845e77-f8e7-4aa4-802e-488a4a7d2442">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaf1d4aabe1544d7f9b3e0853cc2ed19e" continuedAt="i5f82b23c54e844e2b15cc7f9af6045cf">(a)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"><ix:continuation id="i5f82b23c54e844e2b15cc7f9af6045cf">Primarily represents the write-off of accounts receivable, net of recoveries.</ix:continuation> </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-52</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>2
<FILENAME>dgx12312020ex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia92cc9daf27947ad892210368f38408f_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL DEFERRED COMPENSATION PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(POST &#8211; 2004)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED January 15, 2020</font></div><div><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ia92cc9daf27947ad892210368f38408f_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PREAMBLE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Effective as of January&#160;1, 1999, Quest Diagnostics adopted the Quest Diagnostics Supplemental Deferred Compensation Plan for the benefit of certain of its Employees.  As a result of the enactment in 2004 of Section 409A of the Internal Revenue Code of 1986, as amended, Quest Diagnostics has adopted this document, the Quest Diagnostics Supplemental Deferred Compensation Plan (Post &#8211; 2004), to reflect the terms that will govern amounts that are deferred (within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) under the Plan in taxable years beginning on and after January 1, 2005.  The terms of the Plan as in effect on October 3, 2004 will continue to govern amounts under the Plan that were deferred (within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) during taxable years beginning prior to January 1, 2005.  For these purposes, an amount is considered deferred before January 1, 2005, if before such date, the Participant had a legally binding right to be paid the amount (within the meaning of Treas. Reg. &#167;1.409A-1(b)(1)), and the right to the amount was earned and vested (within the meaning of Treas. Reg. &#167;1.409A-6(a)).  The purpose of the Plan is to provide supplemental retirement income and to permit eligible Employees the option to defer receipt of Compensation, pursuant to the terms of the Plan.  The Plan is intended to be an unfunded deferred compensation plan maintained for the benefit of a select group of management or highly compensated employees under Sections&#160;201(2), 301(a)(3) and 401(a)(1) of ERISA and therefore to be exempt from Parts 2, 3 and 4 of Subtitle B of Title I of ERISA to the maximum extent permissible under the provisions thereof.  </font></div><div style="text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ia92cc9daf27947ad892210368f38408f_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.314%"><tr><td style="width:1.0%"></td><td style="width:17.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 1.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DEFINITIONS.....................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Definitions.............................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 2.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PARTICIPATION................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Commencement of Participation...........................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Resumption of Participation Following Reemployment.......................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Change in Employment Status..............................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 3.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONTRIBUTIONS.............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deferral Contributions...........................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participating Employer Contributions...................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Transfer of Funds...................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 4.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PARTICIPANTS' ACCOUNTS..........................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Individual Accounts...............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Accounting for Payments......................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 5.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INVESTMENT OF CONTRIBUTIONS...........................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Manner of Investment............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Investment Decisions.............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 6.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PAYMENT OF ACCOUNT.................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment on Specified Date....................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Distribution of Vested Account upon Termination of Employment......</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Distribution upon Death&#59; Beneficiaries.................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment Due to an Unforeseen Emergency..........................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adjustment for Investment Experience During Installment Plan..........</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 409A and Payment Dates..........................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment in the Event of Taxation..........................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Valuations..............................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Spendthrift Provision.............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facility of Payment................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Discharge of Obligations.......................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.12</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Taxes......................................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 7.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDMENT AND TERMINATION............................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amendment by Quest Diagnostics........................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.314%"><tr><td style="width:1.0%"></td><td style="width:17.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Retroactive Amendments.......................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Plan Termination....................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment upon Termination of the Plan.................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 8.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THE TRUST.........................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Establishment of Trust...........................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 9.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MISCELLANEOUS............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Limitation of Rights...............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Furnishing Information..........................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Information between the Administrator and Trustee.............................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notices...................................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Writings and Electronic Communications.............................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Governing Law......................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Construction...........................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 409A Compliance.....................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Recovery of Overpayment.....................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Right of Reimbursement........................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.11</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Clawback...............................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 10.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLAN ADMINISTRATION...............................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Powers and Responsibilities of the Administrator.................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Claims and Review Procedures.............................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Plan's Administrative Costs...................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><div id="ia92cc9daf27947ad892210368f38408f_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.23pt">Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Pronouns used in the Plan are in the masculine gender but include the feminine gender unless the context clearly indicates otherwise.  Wherever used herein, the following terms have the meanings set forth below, unless a different meaning is clearly required by the context&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Account&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an account established on the books of a Participant&#8217;s Employer for the purpose of recording Deferral Contributions, Employer Contributions and Supplemental Contributions credited on behalf of a Participant in respect of compensation for services to such Employer and any notional income, expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 10.3), gains or losses related thereto.  For purposes of this Plan document, &#8220;Account&#8221; shall include only amounts that are deferred within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) during taxable years beginning on and after January 1, 2005.  The Administrator may establish such subaccounts as it deems appropriate for the administration of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Administrator&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Quest Diagnostics acting through its officers and employees.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Appeals Committee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Appeals Committee, which is designated from time to time by the Administrator to administer the claims and review procedures specified in Section 10.2. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Beneficiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the person or persons entitled under Section&#160;6.3 to receive benefits under the Plan upon the death of a Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Bonus&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the cash bonus that is payable each March (if not deferred pursuant to Section&#160;3.1) under the Senior Management Incentive Plan, the Quest Diagnostics Incorporated Annual Incentive Plan .</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Internal Revenue Code of 1986, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Compensation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall have the meaning ascribed to the term &#8220;Deferral Compensation&#8221; by the Profit Sharing Plan&#59; provided that any exclusion attributable to (i) deferred compensation deferred pursuant to this Plan or (ii) limits imposed by Code Section 401(a)(17) shall not apply. </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the preceding, with respect to an Eligible Employee whose primary place of employment is outside the United States, Compensation shall exclude such items as housing allowances, educational expenses, trips back and forth to the United States, tax gross-ups and such other similar items of remuneration as may be determined by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Deferral Contributions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means those amounts credited to a Participant&#8217;s Account pursuant to Section&#160;3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Eligible Employee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an Employee of an Employer who is determined by the Administrator to be among a select group of management or highly compensated Employees and who is designated by the Administrator as an Eligible Employee for purposes of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employee of an Employer.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Quest Diagnostics and any successors and assigns unless otherwise provided herein, and shall include any Related Employer or other affiliated employer adopting this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employer Contributions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means amounts credited to a Participant&#8217;s Account pursuant to Section&#160;3.2.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employer Stock&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any class of common stock of Quest Diagnostics or the preferred stock of Quest Diagnostics that is convertible into common stock.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;ERISA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Employee Retirement Income Security Act of 1974, as from time to time amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Intentionally omitted&#93; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Participant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any Eligible Employee who has filed in accordance with Article&#160;2 an election to defer Compensation pursuant to Section&#160;3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Supplemental Deferred Compensation Plan as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Plan Year&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the calendar year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Profit Sharing Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Profit Sharing Plan of Quest Diagnostics Incorporated, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Quest Diagnostics&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Quest Diagnostics Incorporated.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Quest Diagnostics Incorporated Annual Incentive Plan&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Quest Diagnostics Incorporated Annual Incentive Plan, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Related Employer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employer other than Quest Diagnostics, if Quest Diagnostics and such other employer are members of a controlled group of corporations (as defined in Section&#160;414(b) of the Code) or an affiliated service group (as defined in Code Section&#160;414(m)), or are trades or businesses (whether or not incorporated) which are under common control (as defined in Code Section&#160;414(c)), or such other employer is required to be aggregated with Quest Diagnostics pursuant to regulations issued under Code Section&#160;414(o).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Section&#160;401(a)(17) Limit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the maximum amount of annual compensation that can be taken into account by the Profit Sharing Plan pursuant to Code Section&#160;401(a)(17).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Section 409A Regulations&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the regulations and other administrative guidance issued under Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Senior Management Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Incorporated Senior Management Incentive Plan, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Signing Bonus&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means a bonus that is negotiated with an Employee prior to the commencement of his employment and that is designated a &#8220;signing bonus&#8221;.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SMIP Bonus Subaccount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the portion of a Participant&#8217;s Account that may be established and maintained by the Administrator on behalf of each Participant who elects to defer a portion of his Bonus payable under the Senior Management Incentive Plan and any other plan intended to pay performance-based compensation within the meaning of Code Section 162(m)(4)(c).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(bb)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Supplemental Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an additional discretionary Employer Contribution credited to a Participant&#8217;s Account pursuant to Section&#160;3.2.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(cc)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Trust&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the trust fund established pursuant to the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(dd)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Trust Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the agreement by and among the Trustee and each Employer establishing the Trust.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ee)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Trustee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the corporation or individuals named in the Trust Agreement and such successor and&#47;or additional trustees as may be named in accordance with the Trust Agreement.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Participation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Commencement of Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Eligible Employee who has an election in effect to defer Compensation in accordance with Section&#160;3.1 or has an Account is a Participant in this Plan.  Each other Eligible Employee shall become a Participant in this Plan after he has timely filed an election to defer Compensation pursuant to Section&#160;3.1 that has become irrevocable or has a Supplemental Contribution credited to his Account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Resumption of Participation Following Reemployment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be an Employee and thereafter returns to the employ of an Employer, he may again become a Participant following his reemployment, provided he is an Eligible Employee and has timely filed an election to defer Compensation pursuant to Section&#160;3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Change in Employment Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any Participant continues in the employ of an Employer but ceases to be an Eligible Employee, he shall continue to be a Participant until the entire amount of the value of his Account is paid&#59; provided, however, he shall not be entitled to make Deferral Contributions or receive an allocation of Employer Contributions or Supplemental Contributions after the end of the Plan Year in which he ceases to be an Eligible Employee and during the remainder of the period that he is not an Eligible Employee.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contributions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Deferral Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Participant deferral elections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Participant may elect to defer (1) up to fifty (50) percent (in whole percentages) of his regular salary to the extent his Compensation that is taken into account under the Profit Sharing Plan for the Plan Year in which his regular salary is earned exceeds the Section&#160;401(a)(17) Limit (no portion of any bonus payment, including the Bonus, shall be eligible for deferral under this provision), (2) up to ninety-five (95) percent (in whole percentages) of his Bonus to the extent his Compensation that is taken into account under the Profit Sharing Plan for the Plan Year in which the Bonus is paid exceeds the Section 401(a)(17) </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Limit and (3)  up to one hundred (100) percent (in whole percentages) of his Signing Bonus, regardless of whether his Compensation is in excess of the Section 401(a)(17) Limit.              </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Timing of deferral elections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.     </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In general</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An election to defer Compensation will be timely if it is filed in accordance with procedures established by the Administrator which shall require elections to be filed no later than December 31 of the Plan Year prior to the Plan Year to which the deferral election applies. </font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">First year of eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If an individual is designated by the Administrator as an Eligible Employee during the Plan Year, such Employee may file an election to defer Compensation within 30&#160;days following the date of such designation&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such Employee is not already participating in another elective nonqualified deferred compensation plan that would be aggregated with this Plan under the Section 409A Regulations, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such election shall apply only to Compensation earned for periods after the election is made in accordance with the Section 409A Regulations.</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effectiveness of deferral election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An election made in accordance with Section 3.1(b)(1), shall become effective on the first day of the Plan Year following the Plan Year in which the deferral election is made. It will apply only to Compensation earned and payable with respect to services rendered after such date.  Thus, for example, an election that becomes irrevocable on December 31, 2009 will apply to defer any salary to be earned in 2010 or a Bonus that will be earned in 2010 and paid in early 2011. An election made in accordance with Section 3.1(b)(2) will apply on the first day of the first payroll period that follows receipt by the Administrator of such election and shall apply to defer Compensation relating to all services performed from the date that it becomes effective through the balance of the Plan Year (unless such election expressly extends beyond such time).  Once an election becomes irrevocable, it will apply to all covered Compensation for services performed through the end of the Plan Year (except as provided in Section 3.1(f)).       </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement of deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:42.75pt;text-align:justify;text-indent:-40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Deferrals made pursuant to Sections 3.1(a)(1) and 3.1(a)(2).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  For a Participant who has  a deferral election solely under 3.1(a)(1), deferrals shall commence as of the payroll period next following the payroll period in which the Participant&#8217;s Compensation exceeds the Section&#160;401(a)(17) Limit.  If a Participant&#8217;s Compensation for a Plan Year exceeds the Section&#160;401(a)(17) Limit on account of payment of Bonus and the Participant has made a deferral election pursuant to Section 3.1(a)(2), then deferrals shall commence as of the payroll period coincident with the payroll period in which the Bonus is paid.    </font></div><div style="margin-bottom:12pt;padding-left:42.75pt;text-align:justify;text-indent:-40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Deferrals made pursuant to Sections 3.1(a)(3).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Deferrals of Signing Bonus pursuant to Sections 3.1(a)(3) shall be made in the payroll period in which the Signing Bonus otherwise would have been paid.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Crediting to Account</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Employer shall credit to the Account maintained on behalf of a Participant the amount of Compensation deferred pursuant to such Participant&#8217;s election under Section 3.1(a).  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#91;Intentionally omitted&#93; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Election forms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All Participant elections pursuant to this Section 3.1 shall be on forms prescribed by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Deferral Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant shall be fully vested in the Deferral Contributions credited to his Account.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Participating Employer Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Employer shall credit an Employer Contribution to the Account maintained on behalf of each Participant who had Deferral Contributions credited to his Account for a payroll period&#59; provided, that such Employer Contributions shall only be credited on Compensation that is in excess of the Section 401(a)(17) Limit.  Notwithstanding the preceding sentence, no Employer Contribution shall be credited to the Account of a Participant who is also a participant in the Quest Diagnostics Transferee Pension Plan for former Corning Incorporated employees.  The amount of the Employer Contribution to be credited on behalf of a Participant shall be equal to the applicable percentage that is specified from time to time in Section&#160;3.2 of the Profit Sharing Plan of the Deferral Contributions made on behalf of the Participant.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Supplemental Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant&#8217;s Employer may, from time to time in its sole discretion, credit a Supplemental Contribution to a Participant&#8217;s Account in an amount determined by such Employer in its sole discretion and without regard to any Deferral Contribution elected by such Participant.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Employer Contributions and Supplemental Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall be fully vested in the Employer Contributions credited to his Account.  Unless otherwise specified by the Employer at the time the Supplemental Contribution is made, a Participant shall be fully vested in the Supplemental Contributions credited to his Account.  Any portion of the value of a Participant&#8217;s Account attributable to a Supplemental Contribution that is not fully vested at the time he terminates employment shall be forfeited.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Transfer of Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator shall provide the Trustee with information on the amount to be credited to each Participant&#8217;s Account.  Each Employer may, as soon as administratively practicable after each payroll period, make a transfer of assets to the Trustee.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Participants&#8217; Accounts.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Individual Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator will establish and maintain an Account for each Participant which will reflect Deferral Contributions, Employer Contributions and Supplemental Contributions credited to the Account and any notional earnings, expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 10.3), gains and losses credited thereto attributable to the investments in which the </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participant&#8217;s Account is treated as invested. The Administrator will establish and maintain such other accounts and records as it decides in its discretion to be reasonably required or appropriate.  Participants will be furnished statements of their Account value at least once each Plan Year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Accounting for Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A payment to the Participant or to the Participant&#8217;s Beneficiary(ies) shall be charged to the Participant&#8217;s Account as of the date of such payment.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investment of Contributions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Manner of Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All amounts credited to the Accounts of Participants shall be treated as though invested in eligible investments offered by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Investment Decisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Investments in which the Accounts of Participants shall be treated as invested shall be directed by the Employer, each Participant, or both, as specified pursuant to procedures established by the Administrator from time to time.  No portion of the Employer Contributions or Deferrals Contributions credited to a Participant&#8217;s Account may be treated as though invested in Employer Stock.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment of Account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment on Specified Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Concurrently with a Participant&#8217;s election to defer Compensation pursuant to Section&#160;3.1 for any Plan Year, the Administrator shall permit a Participant to designate a specific date on which 100% of the value of his Account attributable to such election  shall be paid in a lump sum&#59; provided that in the event of such Participant&#8217;s termination of employment or death before the specified date, his Account shall be paid in accordance with Section&#160;6.2 or 6.3, as the case may be, and his election under this Section 6.1 shall no longer be effective.  Once an election is made pursuant to this Section 6.1, it shall be irrevocable. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Distribution of Vested Account upon Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In general</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Upon a Participant&#8217;s termination of employment other than by reason of death, the vested portion of the Participant&#8217;s Account shall be paid in a lump sum or, if permitted by the Administrator and specified in the Participant&#8217;s election to defer Compensation under Section 3.1, under an installment plan not exceeding 10&#160;years.  Unless otherwise required pursuant to Section 6.6, payments shall be made or begin within ninety (90) days of the Participant&#8217;s employment termination. The unvested portion, if any, of the Participant&#8217;s Account shall be immediately forfeited.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Installments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Distributions under an installment plan must be made in substantially equal annual installments, over a period certain which does not exceed 10&#160;years.  Each installment shall be based on the value of the Participant&#8217;s Account, as determined prior to the payment of the relevant installment, divided by the remaining number of installments.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Distribution upon Death&#59; Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Distributions upon death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon a Participant&#8217;s death prior to the commencement of benefit payments pursuant to Section 6.2, the vested portion of the Participant&#8217;s Account shall be paid in a lump sum to the Participant&#8217;s Beneficiary or Beneficiaries.  Payment shall be made as soon as practicable during the remainder of the calendar year in which the Participant died. The unvested portion, if any, of the </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Participant&#8217;s Account shall be immediately forfeited. Upon a Participant&#8217;s death after distributions have begun under an installment plan, no further installments shall be paid and, instead, payment shall be made of the balance of the Participant&#8217;s Account as soon as practicable during the remainder of the calendar year in which the Participant died.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Beneficiary designations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant may designate a Beneficiary or Beneficiaries, or change any prior designation of Beneficiary or Beneficiaries, by giving notice to the Administrator on a form designated by the Administrator.  A Participant&#8217;s spouse must consent to his designation of a Beneficiary other than his spouse.  If more than one person is designated as the Beneficiary, their respective interests shall be indicated on the designation form.  Prior to distribution pursuant to Section 6.3, a copy of the death notice or other sufficient documentation must be filed with and approved by the Administrator.  If upon the death of the Participant there is, in the opinion of the Administrator, no designated Beneficiary for part or all of the value of the Participant&#8217;s Account, such amount will be paid to his surviving spouse or, if none, to his estate (such spouse or estate shall be deemed to be the Beneficiary for purposes of the Plan).  If a Beneficiary dies after payment to such Beneficiary has commenced, but before the full value of the Participant&#8217;s Account has been paid, and, in the opinion of the Administrator, no person has been designated to receive such remaining balance, then such balance shall be paid to the deceased Beneficiary&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment Due to an Unforeseen Emergency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:51.75pt;padding-right:6.75pt;text-align:justify"><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:121%">   </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:121%">A </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">Participant shall not be permitted to withdraw any portion of the value of his Account prior to termination of employment or any date specified pursuant to Section 6.1 (whichever occurs first), except that a Participant may apply to the Administrator, in accordance with procedures specified by the Administrator, to withdraw some or all of the value of his Account if such withdrawal is required on account of a financial hardship resulting from an unforeseen emergency. The Administrator shall establish criteria to determine what constitutes financial hardship that are consistent with the Section 409A Regulations. Withdrawals made on account of financial hardship shall be made in a lump sum, and may include such additional amount as necessary to pay any federal, state, local or foreign income taxes reasonably anticipated to result from the distribution.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Adjustment for Investment Experience During Installment Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the total value of a Participant&#8217;s Account is not paid in a single sum, the amount remaining in the Account after the first payment will continue to be treated as invested in accordance with Article 5 and will be subject to adjustment until paid to reflect the income, gains and losses on such deemed investment, as well as any expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 10.3).  Unless otherwise permitted by the Administrator, each installment payment shall reduce each investment of the Participant&#8217;s Account on a pro-rata basis.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 409A and Payment Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless otherwise permitted under the Section 409A Regulations, all payments shall be made or commence no later than the end of the calendar year in which the applicable payment date occurs or, if later, by the 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of the third calendar month following the applicable payment date.   If a Participant is determined to be a &#8220;Specified </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee&#8221; within the meaning of Code Section 409A(a)(2)(B)(i) (pursuant to procedures developed by the Administrator consistent with the Section 409A Regulations), then to the extent required in order to comply with Code Section 409A and the Section 409A Regulations, payments under the Plan to such Participant pursuant to Section 6.2 shall be made or commence after the day following the six month anniversary of the Participant&#8217;s termination of employment, subject to earlier payment upon the Participant&#8217;s death.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment in the Event of Taxation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If, for any reason, all or any portion of the value of a Participant&#8217;s Account under this Plan becomes taxable to the Participant prior to receipt, a Participant may petition the Administrator for a payment of that portion of the value of his Account that has become taxable.  Upon the grant of such a petition, a payment shall immediately be made to a Participant in an amount equal to the taxable portion of the value of his Account (which amount shall not exceed the remaining balance of a Participant&#8217;s Account).  If the petition is granted, the tax liability payment shall be made as soon as practicable after the Participant&#8217;s petition is granted in accordance with Treasury Regulation Sections 1.409A-3(j)(4)(vii) and 1.49A-3(j)(4)(xi).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Valuations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For purposes of this Article 6, the valuation of a Participant&#8217;s Account shall be determined as of such valuation dates preceding the payment date as may be determined from time to time by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Spendthrift Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant&#8217;s or Beneficiary&#8217;s right to payment under the Plan is not subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, judgment, seizure, alimony or separate maintenance owed by Participant or his Beneficiary or garnishment by creditors of the Participant or his Beneficiary, either voluntarily, involuntarily by operation of law or as a result of property settlement, and any attempt to cause such right to payment to be so subjected will not be recognized, except to such extent as shall be required by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Facility of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event the Administrator determines, on the basis of medical reports or other evidence satisfactory to the Administrator, that the recipient of any benefit payments under the Plan is incapable of handling his affairs by reason of minority, illness, infirmity or other incapacity, the Administrator may make such payments to a person or institution designated by a court which has jurisdiction over such recipient or a person or institution otherwise having the legal authority under State law for the care and control of such recipient.  The receipt by such person or institution of any such payments therefore, and any such payment to the extent thereof, shall discharge the liability of the Employers and the Trust for the payment of benefits hereunder to such recipient.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Discharge of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Payment of the value of an Account under the Plan to a person believed in good faith by the Administrator to be a valid Beneficiary shall fully and completely discharge the Employers from all further obligations under this Plan with respect to the Participant.  Neither the Administrator nor Quest Diagnostics shall be obliged to search for any Participant or Beneficiary beyond the sending of a registered letter to the Participant&#8217;s or Beneficiary&#8217;s last known address.  If the Administrator notifies any Participant or Beneficiary that he is entitled to an amount under the Plan and the Participant or Beneficiary fails to claim such amount or make his location known to the Administrator within one year thereafter, then, </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">except as otherwise required by law, if the location of one or more of the next of kin of the Participant is known to the Administrator, the Administrator may direct payment of such amount to any one or more or all of such next of kin, and in such proportions as the Administrator determines.  If the location of none of the foregoing persons can be determined, the Administrator shall have the right to direct that the amount payable shall be deemed to be forfeited and retained by the Employers, except that the dollar amount of the forfeiture, unadjusted for deemed earnings, gains or losses in the interim, may be paid in full satisfaction of the Employers&#8217; obligations under this Plan in the sole discretion of the Administrator if a claim for payment subsequently is made by the Participant or the Beneficiary to whom it was payable.  If any benefit payable to a Participant or Beneficiary who has not been located is subject to escheat pursuant to applicable state law, neither the Administrator nor Quest Diagnostics shall be liable to any person for any payment made in accordance with such law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.    There shall be deducted from each payment made under the Plan to the Participant (or Beneficiary) all taxes that Quest Diagnostics determines are required to be withheld or deducted by Quest Diagnostics in respect to such payment or the Plan.  Quest Diagnostics shall have the right to reduce any payment by the amount of cash sufficient to provide the amount of such taxes.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amendment and Termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Amendment by Quest Diagnostics</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Compensation Committee of the Board of Directors of Quest Diagnostics shall have the authority to approve amendments to the Plan at any time and from time to time.  Such amendments may amend the Plan in whole or in part.  In addition, the Chief Executive Officer and Senior Vice President, Chief Human Resources Officer, of Quest Diagnostics, acting jointly (the &#8220;Authorizing Officers&#8221;), are hereby authorized, without action by the Board of Directors or any committee thereof, to approve any amendment to the Plan (in whole or in part) at any time and from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that such amendment (x) has been recommended to the Authorizing Officers by Quest Diagnostic&#8217;s Benefits Committee and (y) does not increase the benefits under the Plan or otherwise materially increase Quest Diagnostic&#8217;s costs with respect to the Plan.  The Authorizing Officers promptly shall report to the Compensation Committee of the Board of Directors any amendment approved by the Authorizing Officers pursuant to this Section 7.1.  Notwithstanding the foregoing, no amendment of the Plan may reduce the value of any Participant&#8217;s Account determined as though the Participant terminated his employment as of the date of such amendment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Retroactive Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An amendment made by Quest Diagnostics in accordance with Section&#160;7.1 may be made effective on a date prior to the first day of the Plan Year in which it is adopted.  Any retroactive amendment by the Employer shall be subject to the provisions of Section&#160;7.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Plan Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither Quest Diagnostics nor any other Employer has any obligation or liability whatsoever to maintain the Plan for any length of time and may discontinue deferrals under the Plan or terminate the Plan at any time without any liability hereunder for any such discontinuance or termination.</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Any termination of the Plan shall be accomplished in accordance with Section 409A of the Code and the Section 409A Regulations.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment upon Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon termination of the Plan, no further Deferral Contributions, Employer Contributions or Supplemental Contributions shall be made under the Plan, but Accounts of Participants maintained under the Plan at the time of termination shall continue to be governed by the terms of the Plan until paid out in accordance with the terms of the Plan.  In its discretion, and notwithstanding any prior election made by the Participant, Quest Diagnostics may, upon Plan termination or at any time thereafter, cause each Participant to be paid in a single lump sum the value of the Participant&#8217;s Account in full satisfaction of all obligations to the Participant under the Plan if such payment would be consistent with the requirements of Code Section 409A.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Trust</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Establishment of Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Quest Diagnostics has established the Trust between each Employer and the Trustee, in accordance with the terms and conditions as set forth in a separate agreement, under which assets are held, administered and managed, subject to the claims of an Employer&#8217;s creditors in the event of such Employer&#8217;s insolvency, until paid to Participants and their Beneficiaries as specified in the Plan.  The Trust is intended to be treated as a grantor trust under the Code, and the establishment of the Trust is not intended to cause Participants to realize current income on amounts contributed thereto or earnings on the Trust&#8217;s assets.  Notwithstanding the establishment of the Trust, a Participant&#8217;s rights under the Plan shall be solely those of a general unsecured creditor of Quest Diagnostics and the Employers.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Miscellaneous.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Limitation of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  None of the establishment of the Plan or the Trust, or any amendment thereof, or the creation of any fund or Account, or the payment of any benefits, will be construed as giving to any Participant or other person any legal or equitable right against an Employer, the Administrator or the Trustee, except as provided herein, and in no event will the terms of employment or service of any Participant be modified or in any way affected hereby.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Furnishing Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant or his Beneficiary will cooperate with the Administrator by furnishing any and all information requested by the Administrator and take such other actions as may be requested in order to facilitate the administration of the Plan and the payments of amounts hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Information between the Administrator and Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator agrees to furnish the Trustee, and the Trustee agrees to furnish the Administrator, with such information relating to the Plan and Trust as may be required by the other in order to carry out their respective duties hereunder, including without limitation information required under the Code or ERISA and any regulations issued or forms adopted thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any notice or other communication in connection with this Plan shall be deemed delivered in writing if addressed as provided below and if either actually delivered at said address or, in the case of a letter, three business&#160;days shall have elapsed after the same shall have been deposited in the United States mails, first-class postage prepaid and registered or certified&#58;</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If it is sent to Quest Diagnostics, an Employer or the Administrator, it will be at the address specified by Quest Diagnostics, such Employer or the Administrator, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If it is sent to the Trustee, it will be sent to the address set forth in the Trust Agreement, or, in each case, at such other address as the addressee shall have specified by written notice delivered in accordance with the foregoing to the addressee&#8217;s then-effective notice address.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Writings and Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All elections, notices and other communication with respect to the Plan, including signatures relating to such documentation, may be executed and stored on paper, electronically or in another medium.  Any documentation executed or stored electronically shall comply with the Electronic Signatures Act. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Plan will be construed, administered and enforced according to ERISA, and to the extent not preempted thereby, the laws of the State of New Jersey.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that it is determined that a Participant or group of Participants does not qualify as a select group of management or highly compensated employees as determined in accordance with Sections&#160;201(2), 301(a)(3) and 401(a)(1) of ERISA, the Administrator shall have the right, in its sole discretion, to prevent the Participant from making future elections to defer Compensation.  Following such determination the Plan shall constitute two plans, one covering such non-qualifying Participants and one covering the remaining Participants up to the maximum number of participants permissible for an unfunded deferred compensation plan maintained for the benefit of a select group of management or highly compensated employees under such sections of ERISA. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  It is the intent of the Employers that this Plan be considered and interpreted in all respects as a nonqualified deferred compensation plan satisfying the requirements of Code Section 409A and deferring the recognition of income by Participants in respect of Deferrals until amounts are actually paid to them pursuant to Article 6.   For purposes of this Plan, a &#8220;termination of employment&#8221; shall be deemed to have occurred when the Participant has a &#8220;separation from service&#8221; from all Employers as defined in section 1.409A-1(h) of the Section 409A Regulations.  Prior to January 1, 2009, the Company operated the Plan in good faith compliance with Section 409A and certain Internal Revenue Service transitional rules then in effect.  Written deferral and distribution elections made during, or with respect to, Plan Years 2005-2008 shall remain in effect hereunder, even to the extent that the specific election choices offered for such years may not be available under the terms of this Plan document and&#47;or specific election choices available under this Plan document may not have been offered, provided that subsequent actions with respect to such elections (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, changes thereto, forms of distribution) shall be governed by the terms of this Plan document.  The distribution provisions in Article 6 of this Plan document shall apply to the distribution of amounts deferred (within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) on and after January 1, 2005 that commence on or after January 1, 2009.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Recovery of Overpayment.</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If there is an overpayment under the Plan, Quest Diagnostics has the right at any time, as elected by Quest Diagnostics, to&#58;</font></div><div style="margin-top:6pt;padding-left:162pt;padding-right:6.75pt;text-indent:-33.75pt"><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.45pt">recover that overpayment from the person to whom it was made&#59;</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;padding-left:162pt;padding-right:6.75pt;text-indent:-33.75pt"><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.77pt">offset   the   amount   of that overpayment from a future payment&#59; or</font></div><div style="margin-top:6pt;padding-left:162pt;text-indent:-33.75pt"><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.45pt">a combination of both.</font></div><div style="margin-top:6pt;padding-left:162pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#070707;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Quest Diagnostics shall be considered to have established an equitable lien by agreement with the person to whom such overpayment was made. Such payee shall, upon request, execute and deliver such instruments and papers as may be required, and shall do whatever else is necessary, to secure such rights of recovery to Quest Diagnostics. Quest Diagnostics also may determine to compromise its right to a full recovery in order to facilitate a partial recovery that, in its sole discretion, it deems acceptable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Right of Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Payments to  be  made  under  the  terms  of the Plan may be used to reimburse the Employer, in accordance with procedures established by the Administrator, any amount the Participant owes an Employer at the time payment under the Plan is required to be made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  that  no such reimbursement  will be made to the extent that in the reasonable  judgment of the Administrator it would cause the Participant to recognize income for United States federal income tax purposes before the payment is made or to incur additional tax or interest pursuant to Code Section 409A or the Section 409A Regulations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">9.11 Clawback.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All amounts credited to a Participant's Account under the Plan shall be subject to cancellation and recoupment by Quest Diagnostics, and shall be repaid by the Participant to Quest Diagnostics, to the extent required by law, regulation, listing requirement or as determined in accordance with any Quest Diagnostics policy, in each case, as in effect from time to time&#59; </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such cancellation or recoupment will be made to the extent that in the reasonable judgment of the Administrator it would cause the Participant to recognize income for United States federal income tax purposes before the payment is made or to incur additional tax or interest pursuant to Code Section 409A or the Section 409A Regulations.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Plan Administration.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Powers and Responsibilities of the Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator has the full power and the full responsibility to administer the Plan in all of its details, subject, however, to the applicable requirements of ERISA.  The Administrator&#8217;s powers and responsibilities include, but are not limited to, the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To make and enforce such rules and regulations as it deems necessary or proper for the efficient administration of the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To interpret the Plan, its interpretation thereof in good faith to be final, conclusive and binding on all persons claiming payment under the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To decide all questions concerning the Plan and the eligibility of any person to participate in the Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To compute the amount of benefits which will be payable to any Participant, former Participant or Beneficiary in accordance with the provisions of the Plan&#59;</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To determine the person or persons to whom such benefits will be paid&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To authorize the payment of benefits&#59;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To comply with applicable requirements of Part&#160;1 of Subtitle&#160;B of Title&#160;I of ERISA&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To appoint such agents, counsel, accountants, and consultants as may be required to assist in administering the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Claims and Review Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any person believes he is being denied any rights or benefits under the Plan, such person may file a claim in writing with the Administrator.  </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All claims under the Plan must be submitted within one (1) year after the date on which a communication from the Plan, the Employer or the Administrator (or one of their delegates or agents) contains the information contested or challenged by the claim.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any such claim is wholly or partially denied, the Administrator will notify such person of its decision in writing.  Such notification will contain (i)&#160;specific reasons for the denial, (ii)&#160;specific reference to pertinent Plan provisions, (iii)&#160;a description of any additional material or information necessary for such person to perfect such claim and an explanation of why such material or information is necessary, and (iv)&#160;information as to the steps to be taken if the person wishes to submit a request for review.  Such notification will be given within 90&#160;days after the claim is received by the Administrator (or within 180&#160;days, if special circumstances require an extension of time for processing the claim, and if written notice of such extension and circumstances is given to such person within the initial 90-day period).  If such notification is not given within such period, the claim will be considered denied as of the last day of such period and such person may request a review of his claim.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Review Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Within 60&#160;days after the date on which a person receives written notice of a denied claim (or, if applicable, within 60&#160;days after the date on which such denial is considered to have occurred), such person (or his duly authorized representative) may (i)&#160;file a written request with the Appeals Committee for a review of his denied claim and of pertinent documents and (ii)&#160;submit issues and comments to the Appeals Committee.  The Appeals Committee will notify such person of its decision in writing.  Such notification will be written in a manner calculated to be understood by such person and will contain specific reasons for the decision as well as specific references to pertinent Plan provisions.  The decision on review will be made within 60&#160;days after the request for review is received by the Appeals Committee (or within 120&#160;days, if special circumstances require an extension of time for processing the request, such as an election by the Appeals Committee to hold a hearing, and if written notice of such extension and circumstances is given to such person within the initial 60-day period).  If the decision on review is not made within such period, the claim will be considered denied.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">LIMITATIONS ON ACTIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  NO ACTION (WHETHER AT LAW, IN EQUITY OR OTHERWISE) SHALL BE BROUGHT BY OR ON BEHALF OF ANY PARTICIPANT OR BENEFICIARY FOR OR WITH RESPECT TO PAYMENT DUE UNDER THIS PLAN UNLESS THE PERSON BRINGING SUCH ACTION HAS TIMELY EXHAUSTED THE PLAN&#8217;S CLAIM REVIEW PROCEDURE.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ANY ACTION (WHETHER AT LAW, IN EQUITY OR OTHERWISE) MUST BE COMMENCED WITHIN ONE YEAR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  THIS </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ONE-YEAR PERIOD SHALL BE COMPUTED FROM THE EARLIER OF (I)&#160;THE DATE A FINAL DETERMINATION DENYING SUCH BENEFIT, IN WHOLE OR IN PART, IS ISSUED UNDER THE PLAN&#8217;S CLAIM REVIEW PROCEDURE AND (II)&#160;THE DATE SUCH INDIVIDUAL&#8217;S CAUSE OF ACTION FIRST ACCRUED (AS DETERMINED UNDER THE LAWS OF THE STATE OF NEW JERSEY WITHOUT REGARD TO PRINCIPLES OF CHOICE OF LAWS).</font></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:-2.25pt"><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">(d) All action(s) or litigation arising out of or relating to this Plan shall be commenced and prosecuted in the federal district court whose jurisdiction includes Morris County, New Jersey. Each Employee, claimant or other person consents and submits, as a condition to continued participation in the Plan, to the personal jurisdiction over him of the federal district court whose jurisdiction includes Morris County, New Jersey in respect of any such action(s) or litigation. Each Employee, claimant or other person also consents to service of process upon him with respect to any such action(s) or litigation by registered mail, return receipt requested, and by any other means permitted by rule or law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Plan&#8217;s Administrative Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Employers may pay the reasonable costs and expenses (including legal, accounting, and employee communication fees) incurred by the Administrator and the Trustee in administering the Plan and Trust.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything in Section 10.3(a) to the contrary, the Administrator may determine that each Participant in one or more classes of Participants (as designated by the Administrator) shall be responsible for an amount equal to the reasonable costs and expenses incurred by the Administrator and the Trustee in administering the Plan and the Trust divided by the total number of Participants in (x) the Plan to the extent the costs and expenses apply to all Participants in the Plan or (y) the class or classes designated by the Administrator pursuant to this Section 10.3(b) to the extent the costs and expenses apply solely to the Participants in such class or classes. </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Quest Diagnostics has caused this Plan document to be executed by its duly authorized officer, effective as of January 15, 2020.   </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.929%"><tr><td style="width:1.0%"></td><td style="width:6.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUEST DIAGNOSTICS INCORPORATED</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Cecilia K. McKenney      </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cecilia K. McKenney<br>Senior Vice President, Chief Human Resources Officer<br>January 15, 2020<br></font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:69.551%"><tr><td style="width:1.0%"></td><td style="width:7.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.634%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Stephen H. Rusckowski      </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Stephen H. Rusckowski<br>Chairman, Chief Executive Officer and President<br>January 15, 2020<br></font></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><div id="ia92cc9daf27947ad892210368f38408f_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt;padding-left:209.25pt"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX A</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:6.75pt;text-align:justify"><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">This Appendix A describes special provisions applicable to accounts under the Celera Corporation Non-Qualified Savings and Deferral Plan (the &#34;Celera Plan&#34;) which was established effective as of July 1, 2008 and which was merged into this Plan effective as of June 25, 2012. Contributions under the Celera Plan ceased, and no new participants were admitted, effective as of December 31, 2011.</font></div><div style="padding-left:15.75pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">1.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%;padding-left:11.25pt;text-decoration:underline">Annual Deferral Amounts.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%"> The Celera Plan provided for an &#34;Annual Deferral Amount&#34; to record a participant's deferred salary and bonus for the calendar year in question and any employer contributions with respect to that year, as well as earnings or losses thereon. The Plan will continue to maintain such Annual Deferral Amounts for recordkeeping purposes.</font></div><div style="margin-bottom:12pt;margin-top:1pt;text-align:justify"><font><br></font></div><div style="padding-left:15.75pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">2.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%;padding-left:11.25pt;text-decoration:underline">Vesting.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%"> A Celera Plan participant's deferred salary and bonus were 100% vested. The Celera Plan applied (and the Plan will continue to apply) a 4-year graded vesting schedule to employer contributions, provided that a participant will become 100% vested if he or she dies or becomes disabled while employed by Celera and its affiliates. For these purposes&#58;</font></div><div style="margin-top:6pt;padding-left:15.75pt;padding-right:6.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">years of service are measured using the &#34;elapsed time&#34; method and include service with Applera Corporation and Berkeley HeartLab, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;padding-right:6.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:121%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:121%">&#160;&#160;&#160;&#160;</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">service with Quest Diagnostics and its affiliates on or after May 17, 2011 is considered service with Celera and its affiliates&#59;</font></div><div style="margin-top:6pt;padding-left:87.75pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;Retirement Age&#34; means the later of age 65 or five years of service&#59; and</font></div><div style="margin-top:6pt;padding-left:15.75pt;padding-right:6.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:121%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:121%">&#160;&#160;&#160;&#160;</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">a participant shall be considered &#34;disabled&#34; once he or she is, by reason of any medically determinable physical or mental impairment that can be expected to  result in death or to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of Celera or its affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="padding-left:15.75pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">3.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%;padding-left:11.25pt;text-decoration:underline">Time of Distribution.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%"> The time of distribution of Annual Deferral Amounts shall be the same as under the Celera Plan. Under the Celera Plan,  with  respect  to each Annual Deferral Amount, a participant was permitted to elect either a &#34;specified date payout&#34; or a payout upon separation from service&#59; the specified  payout  date had to be at least one year after the close of the year to which the specification applied, e.g., the earliest permitted specified payout date with respect to the Annual Deferral Amount for 2010 was January 1, 2012. Those elections were (and continue to be) irrevocable unless changed in accordance with paragraph 5 below. However, if a participant dies, his or her vested Annual Payment Amounts will be distributed in a lump sum notwithstanding any election he or she may have made. Payments of Annual Payment Amounts will commence (or will be made) on the 15th day of the month following the month in which the triggering event occurs.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:11pt;padding-left:15.75pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">4.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%;padding-left:11.25pt;text-decoration:underline">Method of Distribution.</font><font style="color:#050505;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%"> The method of distribution of Annual Deferral Amounts and distribution elections shall be the same as under the Celera Plan. Further, </font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">installments are not considered a series of separate payments for purposes of Section 409A. Those distributions elections will remain in effect unless changed in accordance with paragraph 5 below.</font></div><div style="margin-bottom:12pt;margin-top:1pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Change in Method of Distribution.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> A participant in the Celera Plan may elect to change the method of payment of, but not the time of payment of, an Annual Deferral Amount&#59; provided, however, that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;padding-right:6.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any such change must be made at least 12 months before the first day of the calendar year in which the specified payout date would have occurred (but for the requirements of (2) below applicable to a change of election)&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;padding-right:6.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:121%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:121%">&#160;&#160;&#160;&#160;</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">the payment with respect to such changed election must be deferred for a period of not less than 5 years from the date such payment would otherwise originally have been made (or commenced to be made)&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the change will not become effective for at least 12 months after the election&#59; and</font></div><div style="margin-top:6pt;padding-left:126pt;text-indent:-33.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">only one such change is permitted.</font></div><div style="margin-top:6pt;padding-left:18pt;padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">6.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%;padding-left:9pt;text-decoration:underline">Lump Sum Distribution of Small Benefit Payments.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%"> Notwithstanding anything contained herein to the contrary, if the Administrator determines that a participant's vested balance under the Celera Plan, taking into account all plans that would be aggregated with the Celera Plan under Section 409A of the Code, is $17,000 (as adjusted under Section 402(g)(1)(8) of the Code) or less, the Administrator may pay such vested balance in a lump sum on the 15th day of the month following the month in which the Administrator makes a written decision to make such payment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="padding-left:15.75pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.25pt;text-decoration:underline">Designations of Beneficiaries</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Beneficiary designations made under the Celera Plan shall not continue to apply to amounts arising under the Celera Plan. Instead, participants in the Celera Plan must file new beneficiary designations in accordance with the procedures established under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">8.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%;padding-left:9pt;text-decoration:underline">Trust.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%"> Effective June 25, 2012, the grantor trust established under the Celera Plan shall be considered as merged into, and superseded by, the grantor trust established under the Plan.</font></div><div style="margin-top:6pt;padding-left:15.75pt;padding-right:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%">9.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%;padding-left:11.25pt;text-decoration:underline">Applera Provisions.</font><font style="color:#080808;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:121%"> The following provisions relate to amounts under the Celera Plan attributable to the Applera Corporation Supplemental Executive Retirement Plan&#58; the election (made not later than December 31, 2008) by Kathy Ordonez with respect to her benefits under the Applera Corporation Supplemental Executive Retirement Plan shall be applied as if such benefits were a single Annual Deferral Amount under the Celera Plan.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>3
<FILENAME>dgx12312020ex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia71613d839724d93b5f08d7ae5697b30_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <br> <br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL DEFERRED COMPENSATION PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(PRE &#8211; 2005)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED DECEMBER 1, 2020</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ia71613d839724d93b5f08d7ae5697b30_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PREAMBLE </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Effective as of January 1, 1999, Quest Diagnostics adopted this Quest Diagnostics Supplemental Deferred Compensation Plan for the benefit of certain of its Employees.  As a result of the enactment in 2004 of Section 409A of the Internal Revenue Code of 1986, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Quest Diagnostics adopted the Quest Diagnostics Supplemental Deferred Compensation Plan (Post-2004) document to reflect the terms that will govern amounts that were deferred (within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) under the Plan in taxable years beginning on and after January 1, 2005. Quest Diagnostics hereby desires to amend the Plan document to evidence the intention that, with limited exceptions, amounts that were deferred (within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) under the Plan in taxable years beginning before January 1, 2005 will be governed by the terms of the Plan as in effect as of October 3, 2004 and that Section 409A will not be applicable to such amounts (including any earnings thereon) and adopts this document, the Quest Diagnostics Supplemental Deferred Compensation Plan (Pre &#8211; 2005) for that purpose.  Unless otherwise expressly determined by Quest Diagnostics, it is the intent that no amendment to this document be considered a &#8220;material modification&#8221; within the meaning of Treas. Reg. 1.409A-6(a)(4).  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For these purposes, an amount is considered deferred before January 1, 2005, if before such date, the employee had a legally binding right to be paid the amount (within the meaning of Treas. Reg. &#167;1.409A-1(b)(1)), and the right to the amount was earned and vested (within the meaning of Treas. Reg. &#167;1.409A-6(a)).  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The purpose of the Plan is to provide supplemental retirement income and to permit eligible Employees the option to defer receipt of Compensation, pursuant to the terms of the Plan.  The Plan is intended to be an unfunded deferred compensation plan maintained for the benefit of a select group of management or highly compensated employees under sections 201(2), 301(a)(3) and 401(a)(1) of ERISA and therefore to be exempt from Parts 2, 3 and 4 of Subtitle B of Title I of ERISA to the maximum extent permissible under the provisions thereof.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Effective December 1, 2020, the sponsor of the Plan is Quest Diagnostics Clinical Laboratories, Inc.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="ia71613d839724d93b5f08d7ae5697b30_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.5</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.314%"><tr><td style="width:1.0%"></td><td style="width:17.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 1.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DEFINITIONS.....................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Definitions.............................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 2.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PARTICIPATION................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participation..........................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Resumption of Participation Following Reemployment.......................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Change in Employment Status..............................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 3.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONTRIBUTIONS.............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Deferral Contributions...........................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participating Employer Contributions...................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Transfer of Funds...................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 4.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PARTICIPANTS' ACCOUNTS..........................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Individual Accounts...............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Accounting for Payments......................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 5.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INVESTMENT OF CONTRIBUTIONS...........................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Manner of Investment............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Investment Decisions.............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 6.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RIGHT TO BENEFITS......................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Termination of Employment..................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Death......................................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment of a Designated Future Date...................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment Due to an Unforeseen Emergency..........................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adjustment for Investment Experience.................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Forfeiture of Unvested Amounts...........................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Taxes......................................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 7.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PAYMENT OF BENEFITES</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;padding-right:18pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment of Benefits to Participants and Beneficiaries....................</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;padding-right:18pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Determination of Method of Payment.............................................</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;padding-right:18pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Right of Offset...............................................................................</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;padding-right:18pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment in the Event of Taxation....................................................</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.314%"><tr><td style="width:1.0%"></td><td style="width:17.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.631%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 8.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;margin-top:12pt;padding-left:83.25pt;padding-right:24.75pt;text-indent:-81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AMENDMENT AND TERMINATION</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;padding-right:18pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Plan Amendment......................................................................</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;padding-right:18pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Retroactive Amendments.........................................................</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;padding-right:18pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Plan Termination......................................................................</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;padding-right:18pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment upon Termination of the Plan....................................</font></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 9.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THE TRUST.........................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Establishment of Trust...........................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 10.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MISCELLANEOUS............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Limitation of Rights...............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Spendthrift Provision............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Facility of Payment...............................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.4</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Discharge of Obligation........................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.5</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Furnishing Information..........................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.6</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Information between the Administrator and Trustee.............................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.7</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notices...................................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.8</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Writings and Electronic Communications.............................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.9</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Governing Law......................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.10</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Construction...........................................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE 11.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLAN ADMINISTRATION...............................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.1</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Powers and Responsibilities of the Administrator.................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.2</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Claims and Review Procedures.............................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.3</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Plan's Administrative Costs...................................................................</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><div id="ia71613d839724d93b5f08d7ae5697b30_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:11.23pt">Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Pronouns used in the Plan are in the masculine gender but include the feminine gender unless the context clearly indicates otherwise.  Wherever used herein, the following terms have the meanings set forth below, unless a different meaning is clearly required by the context&#58; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Account&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an account established on the books of a Participant&#8217;s Employer for the purpose of recording Deferral Contributions and Employer Contributions credited on behalf of a Participant in respect of compensation for services to such Employer and any notional income, expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 11.3), gains or losses related thereto.  For each Participant who was a participant in the MetPath Inc. Deferred Compensation Plan, a MetPath Plan Subaccount was established as part of the Participant&#8217;s Account.  For purposes of this Plan document, &#8220;Account&#8221; shall include only amounts that are deferred within the meaning of Treas. Reg. &#167;1.409A-6(a)(1)) during taxable years before January 1, 2005. An amount is considered deferred before January 1, 2005, if before such date, the Participant had a legally binding right to be paid the amount (within the meaning of Treas. Reg. &#167;1.409A-1(b)(1)), and the right to the amount was earned and vested (within the meaning of Treas. Reg. &#167;1.409A-6(a)).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Administrator&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Benefits Administration Committee and any person or service provider to whom the Benefits Administration Committee has delegated authority. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Appeals Committee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Appeals Committee. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Beneficiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the person or persons entitled under Section 6.2 to receive benefits under the Plan upon the death of a Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Bonus&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the cash bonus that is payable each March (if not deferred pursuant to Section 3.1) under the Senior Management Incentive Plan or the Quest Diagnostics Incorporated Annual Incentive Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Internal Revenue Code of 1986, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Compensation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall have the meaning ascribed to the term &#8220;Deferral Compensation&#8221; by the Profit Sharing Plan&#59; provided that any exclusion attributable to (i) deferred compensation deferred pursuant to this Plan or (ii) limits imposed by Code Section 401(a)(17) shall not apply.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Deferral Contributions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means those amounts credited to a Participant&#8217;s Account pursuant to Section 3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Eligible Employee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an Employee of an Employer who is determined by the Administrator to be among a select group of management or highly compensated Employees and who is designated by the Administrator as an Eligible Employee for purposes of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employee of an Employer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Quest Diagnostics and any successors and assigns unless otherwise provided herein, and shall include any Related Employer or other affiliated employer adopting this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employer Contributions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means amounts credited to a Participant&#8217;s Account pursuant to Section 3.2.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employer Stock&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any class of common stock of Quest Diagnostics Incorporated or the preferred stock of Quest Diagnostics Incorporated that is convertible into common stock.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;ERISA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Employee Retirement Income Security Act of 1974, as from time to time amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#34;Investment Committee&#34; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Quest Diagnostics Investment Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;MetPath Plan Subaccount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the subaccount established and maintained by the Administrator pursuant to Section 4.1 on behalf of each Participant who was a participant in the MetPath Inc. Deferred Compensation Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(q)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Participant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any Eligible Employee who has filed in accordance with Article 2 an election to defer Compensation pursuant to Section 3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(r)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means this Quest Diagnostics Supplemental Deferred Compensation Plan as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(s)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Plan Year&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the calendar year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(t)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Profit Sharing Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Profit Sharing Plan of Quest Diagnostics, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(u)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Quest Diagnostics&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means Quest Diagnostics Clinical Laboratories, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Related Employer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means any employer other than Quest Diagnostics, if Quest Diagnostics and such other employer are members of a controlled group of corporations (as defined in Section 414(b) of the Code) or an affiliated service group (as defined in Code Section 414(m)), or are trades or businesses (whether or not incorporated) which are under common control (as defined in Section&#160;414(c)), or such other employer is required to be aggregated with Quest Diagnostics pursuant to regulations issued under Code Section 414(o).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(w)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> &#8220;Section 16 Executive&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an Eligible Employee who is designated as such by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Section 401(a)(17) Limit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the maximum amount of annual compensation that can be taken into account by the Profit Sharing Plan pursuant to Code Section 401(a)(17).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(y)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Senior Executive&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an Eligible Employee who is designated as such by the Administrator.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(z)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Senior Management Incentive Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the Quest Diagnostics Incorporated Senior Management Incentive Plan, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(aa)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;SMIP Bonus Subaccount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the portion of a Participant&#8217;s Account established and maintained by the Administrator on behalf of each Participant who elects to defer a portion of his Bonus payable under the Senior Management Incentive Plan and any other plan intended to pay performance-based compensation within the meaning of Code Section 162(m)(4)(c).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(bb)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Supplemental Contribution&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means an additional discretionary Employer Contribution credited to a Participant&#8217;s Account pursuant to Section 3.2.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(cc)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Trust&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the trust fund established pursuant to the terms of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(dd)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Trust Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the agreement establishing the Trust.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ee)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Trustee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> means the corporation or individuals named in the agreement establishing the Trust and such successor and&#47;or additional trustees as may be named in accordance with the Trust Agreement.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Participation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Eligible Employee who has an Account is a Participant covered under this Plan document.  No other Eligible Employee shall become a Participant covered under this Plan document after December 31, 2004.  An election to defer Compensation will be timely if it is filed in accordance with procedures established by the Administrator which shall require elections to be filed no later than January 1 of the Plan Year to which the deferral election applies or, if an individual is designated by the Administrator as an Eligible Employee during the Plan Year, within 30 days following the date of such designation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Resumption of Participation Following Reemployment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant ceases to be an Employee and thereafter returns to the employ of an Employer before December 31, 2004, he may again become a Participant following his reemployment, provided he is an Eligible Employee and has timely filed an election to defer Compensation pursuant to Section 3.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Change in Employment Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any Participant continues in the employ of an Employer but ceases to be an Eligible Employee, he shall continue to be a Participant until the entire amount of the value of his Account is paid.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contributions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Deferral Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Participant deferral elections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Participant who is not a Senior Executive may elect to defer up to fifty (50) percent (in whole percentages) of his future Compensation in excess of the Section 401(a)(17) Limit.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Executive deferral elections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Participant who is a Senior Executive may elect to defer (1) up to fifty (50) percent (in whole percentages) of his future Compensation (excluding any Bonus deferred pursuant to Section 3.1(b)(2)) in excess of the Section 401(a)(17) Limit&#59; and (2) up to ninety-five (95) percent (in whole percentages) of his future Compensation which constitutes Bonus.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effectiveness of deferral election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A deferral election shall become effective on the first day of the Plan Year (or for an individual who is designated as an Eligible Employee during the Plan Year and timely files a deferral election, the first day of the first payroll period that follows receipt by the Administrator of such election).  The election will be effective to defer Compensation relating to all services performed in the Plan Year subsequent to the time such election becomes effective.  Any subsequent election will be effective as of the first day of the following Plan Year and will apply only to Compensation payable with respect to services rendered after such date.  Amounts credited to a Participant&#8217;s Account prior to the effective date of any subsequent election will not be affected by such subsequent election.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commencement of deferrals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Deferrals made pursuant to Section 3.1(a) and 3.1(b)(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant&#8217;s Compensation for a Plan Year exceeds the Section 401(a)(17) Limit on account of payment of Compensation (excluding any Bonus), then deferrals pursuant to his election under Section 3.1(a) or 3.1(b)(1) shall commence as of the payroll period coincident with or next following the payroll period in which the Participant&#8217;s Compensation exceeds the Section 401(a)(17) Limit (but deferrals shall be made only on Compensation in excess of the Section 401(a)(17) Limit).  If a Participant&#8217;s Compensation for a Plan Year exceeds the Section 401(a)(17) Limit on account of payment of Bonus, then deferrals pursuant to his election shall commence as of the payroll period in which the Participant&#8217;s Compensation exceeds the Section 401(a)(17) Limit (but deferrals shall be made only on Compensation in excess of the Section 401(a)(17) Limit).  (ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Deferrals made pursuant to Section 3.1(b)(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Deferrals of Bonus pursuant to Section 3.1(b)(2) shall be made in the payroll period in which the Bonus would otherwise be paid.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Election irrevocable except as required pursuant to Profit Sharing Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Employer shall credit to the Account maintained on behalf of a Participant the amount of Compensation deferred pursuant to such Participant&#8217;s election.  Under no circumstances may an election to defer Compensation be adopted or effective retroactively.  A Participant may not revoke or change an election to defer Compensation for a Plan Year during that year&#59; provided, however, that a Participant who has made a hardship withdrawal under the Profit Sharing Plan may not defer Compensation under this Plan for a period of six months from the date of the withdrawal, unless otherwise determined by the Administrator.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SMIP Bonus Subaccount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant&#8217;s Employer shall credit to the Participant&#8217;s SMIP Bonus Subaccount an amount corresponding to the amount of Bonus payable under the Senior Management Incentive Plan deferred pursuant to Section 3.1(b)(2).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vested Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the claims of the Employer&#8217;s creditors in the event of the Employer&#8217;s insolvency, a Participant shall have a nonforfeitable right to the value of Deferral Contributions credited to his Account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Deferral Contributions after 2004</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All Deferral Contributions made after 2004 and attributable to periods after 2004 shall be governed by the terms of the Quest Diagnostics Supplemental Deferred Compensation Plan (Post &#8211; 2004).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Participating Employer Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employer Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(i) Matching Contribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An Employer shall credit an Employer Contribution to the Account maintained on behalf of each Participant who had Deferral Contributions credited to his Account for a payroll period.  Notwithstanding the preceding sentence, no Employer Contribution shall be credited to the Account of a Participant who is also a participant in the Quest Diagnostics Transferee Pension Plan for former Corning Incorporated employees.  The amount of the Employer Contribution to be credited on behalf of a Participant shall be equal to the applicable percentage specified from time to time in Section 3.2 of the Profit Sharing Plan of the Deferral Contributions made on behalf of the Participant with respect to such payroll period.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(ii) Vested Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the claims of the Employer&#8217;s creditors in the event of the Employer&#8217;s insolvency, a Participant shall have a nonforfeitable right to the value of Employer Contributions credited to his Account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Supplemental Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In addition, a Participant&#8217;s Employer may, from time to time in its sole discretion, credit a Supplemental Contribution to a Participant&#8217;s Account in an amount determined by such Employer in its sole discretion and without regard to any Deferral Contribution elected by such Participant.  Unless otherwise specified by the Employer at the time the Supplemental Contribution is made, a Participant shall have a nonforfeitable right to the value of such Supplemental Contribution credited to his Account, subject to the claims of such Employer&#8217;s creditors in the event of such Employer&#8217;s insolvency.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Employer Contributions after 2004</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All Employer Contributions made after 2004 and attributable to periods after 2004 shall be governed by the terms of the Quest Diagnostics Supplemental Deferred Compensation Plan (Post &#8211; 2004).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Transfer of Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each Employer will, as soon as administratively practicable after each payroll period, make a transfer of assets to the Trustee.  The Employers shall provide the Trustee with information on the amount credited to each Participant&#8217;s Account.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Participants&#8217; Accounts.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Individual Accounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator will establish and maintain an Account for each Participant which will reflect Deferral Contributions, Employer Contributions and Supplemental Contributions credited to the Account and any notional earnings, expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 11.3), gains and losses credited thereto, attributable to the investments in which the Participant&#8217;s Account is treated as invested.  For each Participant who was a participant in the MetPath Inc. Deferred Compensation Plan, the Administrator will establish and maintain, as part of such Participant&#8217;s Account, a subaccount (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;MetPath Plan Subaccount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) to reflect his participation in the MetPath Inc. Deferred Compensation Plan.  The MetPath Plan Subaccount had an opening balance equal to the balance of the Participant&#8217;s account under the MetPath Inc. Deferred Compensation Plan on the date the Participant&#8217;s balance under the MetPath Inc. Deferred Compensation Plan was transferred to this Plan (with interest credited, pursuant to the terms of the MetPath Inc. Deferred Compensation Plan, from December 31, 1998 to the transfer date).  The Administrator will establish and maintain such other accounts and records as it decides in its discretion to be reasonably required or appropriate in order to discharge its duties under the Plan.  Participants will be furnished statements of their Account value at least once each Plan Year.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Accounting for Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A payment to the Participant or to the Participant&#8217;s Beneficiary(ies) shall be charged to the Participant&#8217;s Account as of the date of such payment.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Investment of Contributions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Manner of Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All amounts credited to the Accounts of Participants shall be treated as though invested and reinvested only in eligible investments selected by the Investment Committee.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Investment Decisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Investments in which the Accounts of Participants shall be treated as invested and reinvested shall be directed by the Employer, each Participant, or both, as specified pursuant to procedures established by the Administrator from time to time.  No portion of the Employer Contributions credited to a Participant&#8217;s Account on or after January 1, 2003 or Deferral Contributions credited to a Participant&#8217;s Account on or after April 1, 2004 may be treated as though invested in Employer Stock, but the portion of the Employer Contributions credited to a Participant&#8217;s Account before January 1, 2003 that was treated as though invested in Employer Stock shall continue, on and after January 1, 2003, to be treated as though invested in Employer Stock.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the preceding provisions of this Section 5.2, in no event may a Section 16 Executive direct that Deferral Contributions made by him on or after January 1, 2000 be treated as though invested in Employer Stock.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Right to Benefits.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant terminates his employment for any reason, the value of the Participant&#8217;s Account will be paid in accordance with Article 7.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Participant dies before payment of the value of his Account has commenced, or before such payment has been completed, his designated Beneficiary or Beneficiaries will be entitled to receive the remaining balance of his Account.  Payment to the Beneficiary or Beneficiaries will be made in accordance with Article 7.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A Participant may designate a Beneficiary or Beneficiaries, or change any prior designation of Beneficiary or Beneficiaries by giving notice to the Administrator on a form designated by the Administrator.  With respect to any Beneficiary designations filed with the Administrator, after December 31, 2003, a Participant&#8217;s spouse must consent to his designation of a Beneficiary other than his spouse.  If more than one person is designated as the Beneficiary, their respective interests shall be indicated on the designation form.  A copy of the death notice or other sufficient documentation must be filed with and approved by the Administrator.  If upon the death of the Participant there is, in the opinion of the Administrator, no designated Beneficiary for part or all of the value of the Participant&#8217;s Account, such amount will be paid to his surviving spouse or, if none, to his estate (such spouse or estate shall be deemed to be the Beneficiary for purposes of the Plan).  If a Beneficiary dies after payment to such Beneficiary has commenced, but before the full value of the Participant&#8217;s Account has been paid, and, in the opinion of the Administrator, no person has been designated to receive such remaining balance, then such balance shall be paid to the deceased Beneficiary&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment on a Designated Future Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Concurrently with a Participant&#8217;s election to defer Compensation pursuant to Section 3.1 for any Plan Year (or the making of a Supplemental Contribution by an Employer), the Administrator may permit a Participant to designate a specific date on which a specified amount of the value of his Account attributable to such election (or a Supplemental Contribution that is nonforfeitable) shall be paid in accordance with Article 7&#59; provided that in the event of such Participant&#8217;s earlier termination of employment or death, his Account shall be paid in accordance with Section 6.1 or 6.2, as the case may be.  Unless otherwise permitted under procedures specified by the Administrator, such election shall be irrevocable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment Due to an Unforeseen Emergency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant shall not be permitted to withdraw any portion of the value of his Account prior to termination of employment or any date specified pursuant to Section 6.3 (whichever occurs first), except a Participant may apply to the Administrator, in accordance with procedures specified by the Administrator, to withdraw some or all of the value of his Account if such withdrawal is required on account of a financial hardship resulting from an unforeseen emergency.  The Administrator shall establish criteria to determine what constitutes financial hardship.  Withdrawals made on account of financial hardship shall be made in a lump sum payment in accordance with Article 7.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Adjustment for Investment Experience</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the total value of a Participant&#8217;s Account is not paid in a single sum after the Participant terminates employment, the amount remaining in the Account after the first payment will continue to be treated as invested in an interest-bearing money market account and will be subject to adjustment until paid to reflect the income, gains </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and losses on such deemed investment, as well as any expenses (including administrative costs of the Plan borne by the applicable Participant pursuant to Section 11.3).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Forfeiture of Unvested Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any portion of the value of a Participant&#8217;s Account attributable to a Supplemental Contribution that is not fully vested at the time he terminates employment shall be forfeited.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.    There shall be deducted from each payment made under the Plan to the Participant (or Beneficiary) all taxes that the Administrator determines are required to be withheld or deducted by the Employer in respect to such payment or the Plan.  The Administrator shall have the right to reduce any payment by the amount of cash sufficient to provide the amount of such taxes.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment of Benefits.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment of Benefits to Participants and Beneficiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  (a)&#160;Payments under the Plan to a Participant or to the Beneficiary of the Participant shall be made in a lump sum in cash or, if permitted by the Administrator and specified in the Participant&#8217;s election to defer Compensation, under a systematic withdrawal plan (installment(s)) not exceeding 5 years, upon termination of employment or death.  Notwithstanding the preceding sentence, amounts attributable to that portion of the Employer Contribution credited to a Participant&#8217;s Account treated as though invested in Employer Stock pursuant to Section 5.2 shall be paid in Employer Stock following termination of employment, and any amounts attributable to Deferral Contributions credited to a Participant&#8217;s Account treated as though invested in Employer Stock shall be paid in cash or Employer Stock, as elected by the Participant.  Payments under the Plan shall be made first from the value of the Participant&#8217;s SMIP Bonus Subaccount and then from the remaining value of the Participant&#8217;s Account.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Payments under a systematic withdrawal plan must be made in substantially equal annual installments, in cash, over a period certain which does not exceed 5 years.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Determination of Method of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Participant will determine the method of payment of benefits to himself and the method of payment to his Beneficiary.  Unless such determination was made at least one (1) year prior to the date on which a payment is to be made pursuant to Section 6.1, 6.2 or 6.3, the Participant&#8217;s prior determination shall govern such payment.  If the Participant does not determine the method of payment to him or his Beneficiary within the time frame set forth in the preceding sentence, the method shall be a lump sum.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Right of Offset</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The value of a Participant&#8217;s Account to be paid under the Plan may be reduced in accordance with procedures established by the Administrator by any amount the Participant owes his Employer at the time payment is made.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment in the Event of Taxation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If, for any reason, all or any portion of the value of a Participant&#8217;s Account under this Plan becomes taxable to the Participant prior to receipt, a Participant may petition the Administrator for a payment of that portion of the value of his Account that has become taxable.  Upon the grant of such a petition, a payment shall immediately be made to a Participant in an amount equal to the taxable portion of the value of his Account (which amount shall not exceed the remaining balance of a Participant&#8217;s Account).  If the petition is granted, the tax liability payment shall be made as soon as practicable after the Participant&#8217;s petition is granted.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amendment and Termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Plan Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Board of Directors of Quest Diagnostics shall have the authority to approve amendments to the Plan at any time and from time to time&#59; such amendments may amend the Plan in whole or in part.  Notwithstanding the foregoing, no amendment of the Plan may reduce the value of any Participant&#8217;s Account determined as though the Participant terminated his employment as of the date of such amendment </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Retroactive Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  An amendment made in accordance with Section 8.1 may be made effective on a date prior to the first day of the Plan Year in which it is adopted.  Any retroactive amendment shall be subject to the provisions of Section 8.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Plan Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Neither Quest Diagnostics nor any other Employer has any obligation or liability whatsoever to maintain the Plan for any length of time and may discontinue deferrals under the Plan or terminate the Plan at any time without any liability hereunder for any such discontinuance or termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Payment upon Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Upon termination of the Plan, no further Deferral Contributions or Employer Contributions shall be made under the Plan, but Accounts of Participants maintained under the Plan at the time of termination shall continue to be governed by the terms of the Plan until paid out in accordance with the terms of the Plan.  In its discretion, and notwithstanding any prior election made by the Participant, the Administrator may, upon Plan termination or at any time thereafter, cause each Participant to be paid in a single lump sum the value of the Participant&#8217;s Account in full satisfaction of all obligations to the Participant under the Plan.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Trust </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Establishment of Trust</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Trust has been established in accordance with the terms and conditions as set forth in a separate agreement, under which assets are held, administered and managed, subject to the claims of creditors in the event of insolvency, until paid to Participants and their Beneficiaries as specified in the Plan.  The Trust is intended to be treated as a grantor trust under the Code, and the establishment of the Trust is not intended to cause Participants to realize current income on amounts contributed thereto or earnings on the Trust&#8217;s assets.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Miscellaneous.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Limitation of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  None of the establishment of the Plan or the Trust, or any amendment thereof, or the creation of any fund or Account, or the payment of any benefits, will be construed as giving to any Participant or other person any legal or equitable right against an Employer, the Administrator or the Trustee, except as provided herein, and in no event will the terms of employment or service of any Participant be modified or in any way affected hereby.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Spendthrift Provision</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant&#8217;s or Beneficiary&#8217;s right to payment under the Plan is not subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, judgment, seizure, alimony or separate maintenance owed by Participant or his Beneficiary or garnishment by creditors of the Participant or his Beneficiary, either voluntarily, involuntarily by operation of law or as a result of property settlement, and any attempt to cause such right to payment to be so subjected will not be recognized, except to such extent as shall be required by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Facility of Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event the Administrator determines, on the basis of medical reports or other evidence satisfactory to the Administrator, that the recipient of any benefit payments under the Plan is incapable of handling his affairs by reason of minority, illness, infirmity or other incapacity, the Administrator may make such payments to a person or institution designated by a court which has jurisdiction over such recipient or a person or institution otherwise having the legal authority under State law for the care and control of such recipient.  The receipt by such person or institution of any such payments therefore, and any such payment to the extent thereof, shall discharge the liability of the Employers and the Trust for the payment of benefits hereunder to such recipient.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Discharge of Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Payment of the value of an Account under the Plan to a person believed in good faith by the Administrator to be a valid Beneficiary shall fully and completely discharge the Employers from all further obligations under this Plan with respect to the Participant.  Neither the Administrator nor Quest Diagnostics shall be obliged to search for any Participant or Beneficiary beyond the sending of a registered letter to the Participant&#8217;s or Beneficiary&#8217;s last known address.  If the Administrator notifies any Participant or Beneficiary that he is entitled to an amount under the Plan and the Participant or Beneficiary fails to claim such amount or make his location known to the Administrator within one year thereafter, then, except as otherwise required by law, if the location of one or more of the next of kin of the Participant is known to the Administrator, the Administrator may direct payment of such amount to any one or more or all of such next of kin, and in such proportions as the Administrator determines.  If the location of none of the foregoing persons can be determined, the Administrator shall have the right to direct that the amount payable shall be deemed to be forfeited and retained by the Employers, except that the dollar amount of the forfeiture, unadjusted for deemed earnings, gains or losses in the interim, may be paid in full satisfaction of the Employers&#8217; obligations under this Plan in the sole discretion of the Administrator if a claim for payment subsequently is made by the Participant or the Beneficiary to whom it was payable.  If any benefit payable to a Participant or Beneficiary who has not been located is subject to escheat pursuant to applicable state law, neither the Administrator nor Quest Diagnostics shall be liable to any person for any payment made in accordance with such law.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Furnishing Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  A Participant or his Beneficiary will cooperate with the Administrator by furnishing any and all information requested by the Administrator and take such other actions as may be requested in order to facilitate the administration of the Plan and the payments of amounts hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Information between the Administrator and Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator agrees to furnish the Trustee, and the Trustee agrees to furnish the Administrator, with such information relating to the Plan and Trust as may be required by the other in order to carry out their respective duties hereunder, including without limitation information required under the Code or ERISA and any regulations issued or forms adopted thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any notice or other communication in connection with this Plan shall be deemed delivered in writing if addressed as provided below and if either actually delivered at said address or, in the case of a letter, three business days shall have elapsed after the same shall have been deposited in the United States mails, first-class postage prepaid and registered or certified&#58; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If it is sent to Quest Diagnostics, an Employer or the Administrator, it will be at the address specified by Quest Diagnostics, such Employer or the Administrator, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If it is sent to the Trustee, it will be sent to the address set forth in the Trust Agreement&#59; or, in each case at such other address as the addressee shall have specified by written notice delivered in accordance with the foregoing to the addressee&#8217;s then effective notice address.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Writings and Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All elections, notices and other communication with respect to the Plan, including signatures relating to such documentation, may be executed and stored on paper, electronically or in another medium.  Any documentation executed or stored electronically shall comply with the Electronic Signatures Act.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Plan will be construed, administered and enforced according to ERISA, and to the extent not preempted thereby, the laws of the State of New Jersey.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event that it is determined that a Participant or group of Participants does not qualify as a select group of management or highly compensated employees as determined in accordance with Sections 201(2), 301(a)(3) and 401(a)(1) of ERISA, the Administrator shall have the right, in its sole discretion, to (i) terminate any election to defer Compensation made by each such Participant pursuant to Section 3.1 for the remainder of the Plan Year in which the Participant&#8217;s status changes, (ii) prevent the Participant from making future elections to defer Compensation and&#47;or (iii) immediately pay the value of the Participant&#8217;s Account and terminate the Participant&#8217;s participation in the Plan.  In any event, following such determination the Plan shall constitute two plans, one covering such non-qualifying Participants and one covering the remaining Participants up to the maximum number of participants permissible for an unfunded deferred compensation plan maintained for the benefit of a select group of management or highly compensated employees under such sections of ERISA.</font></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:60.75pt;text-align:justify;text-indent:-58.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Plan Administration.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Powers and Responsibilities of the Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Administrator has the full power and the full responsibility to administer the Plan in all of its details, subject, however, to the applicable requirements of ERISA.  The Administrator&#8217;s powers and responsibilities include, but are not limited to, the following&#58; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;To make and enforce such rules and regulations as it deems necessary or proper for the efficient administration of the Plan&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;To interpret the Plan, its interpretation thereof in good faith to be final, conclusive and binding on all persons claiming payment under the Plan&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;To decide all questions concerning the Plan and the eligibility of any person to participate in the Plan&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;To compute the amount of benefits which will be payable to any Participant, former Participant or Beneficiary in accordance with the provisions of the Plan&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;To determine the person or persons to whom such benefits will be paid&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;To authorize the payment of benefits&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;To comply with applicable requirements of Part 1 of Subtitle B of Title I of ERISA&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;To appoint such agents, counsel, accountants, and consultants as may be required to assist in administering the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Claims and Review Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Claims Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any person believes he is being denied any rights or benefits under the Plan, such person may file a claim in writing with the Administrator.  If any such claim is wholly or partially denied, the Administrator will notify such person of its decision in writing.  Such notification will contain (i) specific reasons for the denial, (ii) specific reference to pertinent Plan provisions, (iii) a description of any additional material or information necessary for such person to perfect such claim and an explanation of why such material or information is necessary, and (iv) information as to the steps to be taken if the person wishes to submit a request for review.  Such notification will be given within 90 days after the claim is received by the Administrator (or within 180 days, if special circumstances require an extension of time for processing the claim, and if written notice of such extension and circumstances is given to such person within the initial 90-day period).  If such notification is not given within such period, the claim will be considered denied as of the last day of such period and such person may request a review of his claim.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Review Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Within 60 days after the date on which a person receives written notice of a denied claim (or, if applicable, within 60 days after the date on which such denial is considered to have occurred), such person (or his duly authorized representative) may (i) file a written request with the Appeals Committee for a review of his denied claim and of pertinent documents and (ii) submit issues and comments to the Appeals Committee.  The Appeals </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Committee will notify such person of its decision in writing.  Such notification will be written in a manner calculated to be understood by such person and will contain specific reasons for the decision as well as specific references to pertinent Plan provisions.  The decision on review will be made within 60 days after the request for review is received by the Appeals Committee (or within 120 days, if special circumstances require an extension of time for processing the request, such as an election by the Appeals Committee to hold a hearing, and if written notice of such extension and circumstances is given to such person within the initial 60-day period).  If the decision on review is not made within such period, the claim will be considered denied.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">LIMITATIONS ON ACTIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  NO ACTION (WHETHER AT LAW, IN EQUITY OR OTHERWISE) SHALL BE BROUGHT BY OR ON BEHALF OF ANY PARTICIPANT OR BENEFICIARY FOR OR WITH RESPECT TO PAYMENT DUE UNDER THIS PLAN UNLESS THE PERSON BRINGING SUCH ACTION HAS TIMELY EXHAUSTED THE PLAN&#8217;S CLAIM REVIEW PROCEDURE.  ANY ACTION (WHETHER AT LAW, IN EQUITY OR OTHERWISE) MUST BE COMMENCED WITHIN ONE YEAR.  THIS ONE-YEAR PERIOD SHALL BE COMPUTED FROM THE EARLIER OF (I) THE DATE A FINAL DETERMINATION DENYING SUCH BENEFIT, IN WHOLE OR IN PART, IS ISSUED UNDER THE PLAN&#8217;S CLAIM REVIEW PROCEDURE AND (II) THE DATE SUCH INDIVIDUAL&#8217;S CAUSE OF ACTION FIRST ACCRUED (AS DETERMINED UNDER THE LAWS OF THE STATE OF NEW JERSEY WITHOUT REGARD TO PRINCIPLES OF CHOICE OF LAWS).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Plan&#8217;s Administrative Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Employers may pay the reasonable costs and expenses (including legal, accounting, and employee communication fees) incurred by the Administrator and the Trustee in administering the Plan and Trust.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding anything in Section 11.3(a) to the contrary, the Administrator may determine that each Participant in one or more classes of Participants (as designated by the Administrator) shall be responsible for an amount equal to the reasonable costs and expenses incurred by the Administrator and the Trustee in administering the Plan and the Trust divided by the total number of Participants in (x) the Plan to the extent the costs and expenses apply to all Participants in the Plan or (y) the class or classes designated by the Administrator pursuant to this Section 11.3(b) to the extent the costs and expenses apply solely to the Participants in such class or classes</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Quest Diagnostics has caused this Plan document to be executed by its duly authorized officer.   </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:53.044%"><tr><td style="width:1.0%"></td><td style="width:9.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUEST DIAGNOSTICS CLINICAL LABORATORIES, INC.</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Cecilia K. McKenney      </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cecilia K. McKenney<br>Senior Vice President, Chief Human Resources Officer  </font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:53.044%"><tr><td style="width:1.0%"></td><td style="width:9.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.024%"></td><td style="width:0.1%"></td></tr><tr style="height:51pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>4
<FILENAME>dgx12312020exh1015.htm
<DESCRIPTION>EX-10.15
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3780469c3c0c4661b380d78a6d1b03c1_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt"><font><br></font></div><div style="margin-bottom:0.12pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.15</font></div><div style="margin-bottom:0.12pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AMENDMENT NO. 7 TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE PROFIT SHARING PLAN OF</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED</font></div><div style="margin-bottom:0.12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Profit Sharing Plan of Quest Diagnostics Incorporated, as presently maintained under an amendment and restatement effective as of January 1, 2016 (the &#8220;Plan&#8221;), is hereby amended in the following respects, effective as of January 1, 2021&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Appendix A to the Plan is amended and restated in the form appended to this Amendment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;A new Appendix H is added to the Plan, in the form appended to this Amendment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As evidence of its adoption of this Amendment, Quest Diagnostics Incorporated has caused this Amendment to be executed by its Senior Vice President and Chief Human Resources Officer on </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">___</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">December 28, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">__.</font></div><div style="margin-bottom:18pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Cecilia K. McKenney</font></div><div style="margin-bottom:0.12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cecilia K. McKenney</font></div><div style="margin-bottom:0.12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SVP and Chief Human Resources Officer</font></div><div style="margin-bottom:6pt;padding-left:108pt;padding-right:108pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:108pt;padding-right:108pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">APPENDIX A</font></div><div style="margin-bottom:0.12pt;padding-left:108pt;padding-right:108pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PARTICIPATING EMPLOYERS</font></div><div style="margin-bottom:0.12pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:232%">The Plan allows Employers other than the Company to adopt its provisions.  The names (and jurisdictions of organization) of Quest Diagnostics and the other Employers, as of January&#160;1, 2021, in the Plan are&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:48.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.798%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">MEMBERS OF THE QUEST CONTROLLED GROUP</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">American Medical Laboratories, Incorporated (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Athena Diagnostics, Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Blueprint Genetics Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Diagnostic Reference Services, Inc. (MD)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ExamOne LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ExamOne World Wide, Inc. (PA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ExamOne World Wide of NJ, Inc. (NJ)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LabOne, LLC (MO)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LabOne of Ohio, Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mid America Clinical Laboratories, LLC (IN)Quest* HealthConnect, LLC (CA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nomad Massachusetts, Inc. (MA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pathology Building Partnership (MD)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PhenoPath Laboratories, PLLC (WA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Clinical Laboratories, Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Domestic Holder LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Holdings Incorporated (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated (MD)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated (NV)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Infectious Disease, Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics International LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Investments LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics LLC (CT)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics LLC (IL)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics LLC (MA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Massachusetts LLC (MA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Nichols Institute (CA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Nichols Institute, Inc. (VA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics of Pennsylvania Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Receivables Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics TB, LLC (DE)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Terracotta LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Ventures, LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reprosource Fertility Diagnostics, Inc. (MA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Specialty Laboratories, Inc. (CA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Quest Diagnostics Health &#38; Wellness, LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unilab Corporation (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Cincinnati, Inc. (OH)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Cleveland, Inc. (OH)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Consolidated Labs, Inc. (FL)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Florida, LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Hospital Services Florida, LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath, Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Indianapolis, P.C. (IN)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Kentucky, Inc. (KY)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Lubbock 5.01(a) Corporation (TX)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath New York, LLC (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Texas Inc. (TX)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AmeriPath Tucson, Inc. (AZ)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Clearpoint Diagnostic Laboratories, LLC (TX)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cleveland Heartlab, Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Colorado Pathology Consultants, P.C. (CO)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consolidated DermPath, Inc. (DE)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dermatopathology of Wisconsin, S.C. (WI)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DFW 5.01(a) Corporation (TX)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Diagnostic Pathology Services, Inc. (OK)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Institute for Dermatopathology, P.C. (PA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Kailash B. Sharma, M.D., Inc. (GA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Kilpatrick Pathology, P.A. (NC)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Med Fusion, LLC (TX)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nuclear Medicine and Pathology Associates (GA)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ocmulgee Medical Pathology Association, Inc. (GA)</font></div><div style="margin-bottom:0.12pt"><font><br></font></div></td></tr><tr style="height:135pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt"><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:48.002%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.798%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">EMPLOYERS THAT ARE NOT MEMBERS OF THE QUEST CONTROLLED GROUP</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Desert Pathology Medical Group, Inc. (CA)</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Associated Pathologists, Chartered (NV)</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Diagnostic Laboratory of Oklahoma LLC (OK)</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">DGXWMT JV, LLC (DE)</font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Quest Diagnostics Venture LLC (PA)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">*  &#160;&#160;&#160;&#160;The vesting service as of January 1, 2021, of a Participant who was a participant in the Mid America Clinical Laboratories Retirement Savings Plan on January 1, 2021, shall be equal to the total period of time commencing on the date in respect of the Participant communicated to the Company by Mid America Clinical Laboratories, LLC, which amount shall be final and conclusive as to the number of years of vesting service to which such Participant was entitled as of January 1, 2021.</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt"><font><br></font></div></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">APPENDIX H</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PARTICIPANTS TRANSFERRED FROM</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> HACKENSACK MERIDIAN HEALTH SYSTEM</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The provisions of this Appendix H shall apply to certain Participants who were formerly employees of Hackensack Meridian Health, Inc., a New Jersey not-for-profit corporation (&#8220;HMH&#8221;).  Pursuant to the terms of the Laboratory Management Agreement, dated as of July 2, 2020, and as amended from time to time (the &#8220;LMA&#8221;), between Quest Diagnostic Incorporated (&#8220;QDI&#8221;) and HMH, QDI has agreed to offer to employ each person employed by HMH at one of the Laboratories listed in Exhibit A to the LMA who (i) is not subject to an active performance improvement plan, not on a final written warning , and not subject to disciplinary action for a Level 2 Gross Infraction (as defined in HMH&#8217;s policies) which had been initiated within 12 months prior to January 1, 2021, (ii) satisfies all applicable federal and state laws and regulations, including but not limited to requirements of the Clinical Laboratory Improvement Amendments of 1988, as amended, and related regulations, regarding his or her job duties, (iii) is ready, willing and able to perform the essential functions of his&#47;her job with or without reasonable accommodation as specified in Exhibit I to the LMA&#59; and (iv) satisfactorily completes QDI&#8217;s pre-employment screens and requirements applicable to all QDI employees in the relevant function or having similar job responsibilities. Any such person who accepts an Employer&#8217;s offer of employment, reports for duty, and begins active employment with an Employer either on January 1, 2021, or such later date as may be specified in the LMA, is herein referred to as a &#8220;Transferred Employee.&#8221;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Each Transferred Employee shall be immediately eligible to participate in the Plan upon his or her date of hire by an Employer (the &#8220;Commencement Date&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The vesting service of each Transferred Employee shall equal the number of years of vesting service to which he or she is entitled under the terms of the retirement plan sponsored by HMH in which he or she is participating immediately prior to the Commencement Date (collectively the &#8220;HMH Plans&#8221;) as of the Commencement Date, plus the period of vesting service to which he or she is entitled pursuant to the terms of the Plan commencing on the Commencement Date.  For purposes of the immediately preceding sentence, the number of years of vesting service communicated to QDI by HMH pursuant to Exhibit O to the LMA shall be final and conclusive as to the number of years of vesting service to which the Transferred Employee is entitled under the HMH Plans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Each Transferred Employee shall be entitled to transfer to the Plan all or any portion of his or her account in the HMH Plan if and only if the amount transferred satisfies the requirements of the Plan for a Rollover Contribution. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;QDI shall make (or cause the applicable Employer to make) additional Employer Contributions (&#8220;Transition Credits&#8221;) to the Accounts of certain Transferred Employees, in amounts equal to the percentage of each such Transferred Employee&#8217;s Deferral Compensation specified in the following table, for the periods described in paragraph (a) below&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.12pt"><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.346%"><tr><td style="width:1.0%"></td><td style="width:71.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.269%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Transferred Employees</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Percentage of Deferral Compensation</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Active participants continuing to accrue a benefit under the PMC Active Pension Plan (including union participants) or the HUMC Active Pension Plan as of December 31, 2020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Participants in the Carrier Defined Contribution Plan who had an accrued benefit for 2020</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Former Meridian Cash Balance Plan participants eligible to receive transition credits under the HMH 401(k) Plan as of December 31, 2020</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3%</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Such Transition Credits shall be subject to the following provisions&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Transition Credits shall be contributed </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;as soon as practical following December 31, 2021, to all Transferred Employees who are employed on  December 31, 2021, based on each such Transferred Employee&#8217;s Deferral Compensation paid by an Employer during the period commencing on the Transferred Employee&#8217;s Commencement Date and ending on  December 31, 2021&#59; and </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;as soon as practical following June 30, 2022, to all eligible Transferred Employees who are employed on  June 30, 2022, based on each such Transferred Employee&#8217;s Deferral Compensation paid by an Employer during the period commencing on January 1, 2022 and ending on  June 30, 2022.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;A Transferred Employee who is on approved leave of absence in accordance with QDI policy on December 31, 2021, or June 30, 2022, shall be entitled to the Transition Credit payable as of such date, but for avoidance of doubt, a Transferred Employee who has incurred a termination of employment for any reason, including without limitation death, disability, or voluntary or involuntary termination, prior to either of such dates shall not be entitled to any portion of the Transition Credit payable as of such date.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Transition Credits shall be fully vested.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;Any person who is hired by an Employer and who does not qualify as a Transferred Employee shall be treated as a newly hired employee, and his or her prior service with HMH shall not be taken into account for any purpose.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>5
<FILENAME>dgx12312020ex1017.htm
<DESCRIPTION>EX-10.17
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i50ba1b3337004316afb0784f14ad1348_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.17</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">AMENDED AND RESTATED   <br>QUEST DIAGNOSTICS INCORPORATED   <br>LONG-TERM INCENTIVE PLAN FOR   <br>NON-EMPLOYEE DIRECTORS</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:144%">(As amended November 18, 2020)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;padding-left:24.03pt;text-decoration:underline">Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The purpose of the Amended and Restated Quest Diagnostics Incorporated Long&#8209;Term Incentive Plan for Non-Employee Directors is to secure for the Corporation and its stockholders the benefits of the incentive inherent in increased common stock ownership by the members of the Board of Directors who are not employees of the Corporation or any of its subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  When used herein, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Administrator&#8221; means the Board, or a committee of the Board, duly appointed to administer the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Board&#8221; means the Board of Directors of the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Common Stock&#8221; means ($.01 par&#160;value) common stock of the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Corporation&#8221; means Quest Diagnostics Incorporated, a Delaware corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Exercise Price&#8221; means the price per share specified in the Option agreement at which the Participant may purchase Common Stock through the exercise of his&#47;her Option, as the same may be adjusted in accordance with Section&#160;9.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Fair Market Value&#8221; means, unless the Administrator determines otherwise, the mean of the high and low selling prices of a share of Common Stock on the New York Stock Exchange Composite list (or such other stock exchange as shall be the principal public trading market for the Common Stock) on the relevant date of determination, or if the Common Stock is not traded on such date, the mean of the high and low selling prices on the New York Stock Exchange Composite list (or such other stock exchange as shall be the principal public trading market for the Common Stock) on the next preceding day on which the Common Stock was traded.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Option&#8221; means a right granted under the Plan to a Participant to purchase shares of Common Stock.  All Options shall be &#8220;nonqualified stock options&#8221; which are not intended to qualify as Incentive Stock Options under Section&#160;422 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Option Period&#8221; means the period within which the Option may be exercised pursuant to the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Participant&#8221; means a member of the Board who is not an employee of the Corporation or any subsidiary thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Plan&#8221; means the Amended and Restated Quest Diagnostics Incorporated Long&#8209;Term Incentive Plan for Non-Employee Directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">&#8220;Stock Awards&#8221; means a grant under the Plan to a Participant of shares of Common Stock or of a right to receive shares of Common Stock (or their cash equivalent or a combination of both) in the future.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Plan shall be administered by the Administrator who shall establish from time to time regulations for the administration of the Plan, interpret the Plan, delegate in writing administrative matters to committees of the Board or to other persons, and make such other determinations and take such other action as it deems necessary or advisable for the administration of the Plan.  All decisions, actions and interpretations of the Administrator shall be final, conclusive and binding upon all parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  All non-employee directors shall automatically be Participants in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Shares Subject to the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The maximum number of shares of Common Stock that may be delivered in conjunction with grants of Options and Stock Awards shall be 2,575,000, and 2,575,000 shares of Common Stock shall be reserved for this purpose under the Plan (subject to adjustment as provided in Section&#160;9).  The shares issued upon the grant of Stock Awards or exercise of Options may be authorized and unissued shares or shares held in the treasury of the Corporation including shares purchased on the open market by the Corporation (at such time or times and in such manner as it may determine).  The Corporation shall be under no obligation to acquire Common Stock for distribution to Participants before payment in shares of Common Stock is due. To the extent that  any Stock Award or Option shall be canceled or expire, new Stock Awards or Options may thereafter be granted covering the </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">number of shares that had been subject to the forfeited portion of the relevant Stock Award or Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Grants of Options and Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(a)&#160;&#160;&#160;&#160;On the date of the Annual Meeting of Stockholders of each year commencing on January&#160;1, 2006, the Administrator may grant to each Participant an Option and&#47;or a Stock Award, in such proportions as the Administrator may determine, covering shares of Common Stock having a value on the date of grant not exceeding $500,000.  In the event that a Participant is elected as a director of the Corporation other than on the date of the Annual Meeting of Stockholders, the Administrator may grant to such director, on his&#47;her election, an Option and&#47;or a Stock Award, in such proportions as the Administrator may determine, covering shares of Common Stock (not to exceed $500,000 in value) that is proportional, based on the fraction of a year remaining until the next Annual Meeting of Stockholders, to the value of the most recent annual equity awards made to the Corporation&#8217;s non-employee directors.  In addition, the Administrator may, at any time, grant to any Participant an Option and&#47;or a Stock Award covering shares of Common Stock for any special service of the Participant as a director (e.g., service on a specific purpose committee), as determined by the Administrator in its discretion, provided that the grant date value of such awards granted to an individual Participant in any calendar year shall not exceed the grant date value of the annual Option and&#47;or Stock Award granted to each Participant at the most recent Annual Meeting of Stockholders pursuant to the first sentence of this Section 6(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(b)&#160;&#160;&#160;&#160;As may be permitted from time to time by the Administrator, each Participant may elect to receive a Stock Award in lieu of all or a portion of the cash compensation payable to such director in any year.  The number of shares of Common Stock underlying the Stock Award issued to such director upon such election shall be computed using the same valuation methodology as is then used for reporting compensation expense in the Corporation&#8217;s financial statements so as to achieve a value equal to the cash compensation that would otherwise have been paid.  Any such election shall be irrevocable and shall be made by December&#160;31, effective for the fees payable during the following year and with a Stock Award being granted on each day on which the fees would otherwise have been payable (generally expected to be the first day of each calendar quarter).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Terms and Conditions of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  Each Option shall be evidenced by a written agreement, in form approved by the Administrator, which shall be subject to the following express terms and conditions and to such other terms and conditions as the Administrator may deem appropriate.  Options may be granted singularly or in combination with a Stock Award.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Option Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  Each Option agreement shall specify that the Option granted thereunder is granted for a period, which period is no longer than ten (10) years from the date of grant, and shall provide that the Option shall have an expiration date, which expiration date shall be no later than ten (10) years from the date of grant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Exercise Price per share shall be the Fair Market Value on the date the Option is granted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Exercise of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  Subject to Section 7(f) and unless the Administrator shall determine otherwise, Options shall become exercisable in three equal annual installments beginning on the first anniversary of the date of grant.  The exercisability of Options, and the ability of a Participant to sell or otherwise transfer shares of Common Stock acquired upon exercise of Options, may be limited by restrictions on exercise included in the Corporation&#8217;s securities trading policies or the Corporation&#8217;s non-employee director stock ownership guidelines, each as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Payment of Exercise Price Upon Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Exercise Price of the shares as to which an Option shall be exercised shall be paid to the Corporation at such time as is determined by the Administrator (but in no event later than the date on which any shares are issued on exercise of an Option).  The Administrator may authorize in its sole discretion, the payment of the Exercise Price by (i)&#160;cash, (ii) delivering Common Stock of the Corporation already owned by the Participant and having a total Fair Market Value on the date of such delivery equal to the Exercise Price, (iii)&#160;delivering a combination of cash and Common Stock of the Corporation having a total Fair Market Value on the date of such delivery equal to the Exercise Price, or (iv)&#160;  a net share settlement procedure or through withholding of shares of Common Stock subject to the Option valued using the Fair Market Value on the date of exercise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">No Repricing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  Except as provided for in Section 9, the Exercise Price of an Option may not be decreased after the date of grant, and an Option may not be surrendered as consideration in exchange for cash, the grant of a new option with a lower Exercise Price or the grant of a Stock Award, without stockholder approval.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Termination of Service on the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  In the event a Participant terminates service on the Board for any reason, all Options previously granted to such Participant may be exercised by the Participant (or, if the Participant is deceased, by his&#47;her representative) at any time, or from time to time, for the remaining term of the Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Transferability of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  No Option and no right arising under any Option shall be transferable, whether voluntarily or involuntarily, other than by will or by the laws of descent and distribution&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">, that the Administrator may permit transfers </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">as gifts to family members or to trusts or other entities for the benefit of one or more family members on such terms and conditions as it shall determine.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Participants to Have No Rights as Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  No Participant shall have any rights as a stockholder with respect to any shares subject to his or her Option prior to the date on which the Participant (or if the shares are held in &#8220;street name,&#8221; the broker designated by the Participant) is recorded as the holder of such shares on the records of the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Other Option Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The form of Option agreement may contain such other provisions as the Administrator may, from time to time, determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Terms and Conditions of Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  Each Stock Award shall be evidenced by a written agreement, in form approved by the Administrator which shall be subject to the following express terms and conditions and to such other terms and conditions as the Administrator may deem appropriate.  Stock Awards may be granted singularly or in combination with an Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Dividends and Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  A grant of Stock Awards may include the right to receive dividends or dividend equivalent payments which may be paid either currently or credited to a Participant&#8217;s account.  Any such crediting of dividends or dividend equivalents may be subject to such conditions, restrictions and contingencies as the Administrator shall establish, including the reinvestment of such credited amounts in Common Stock equivalents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  Stock Awards may be settled through cash payments, the delivery of shares of Common Stock or a combination thereof as the Administrator shall determine.  Any Stock Award settlement, including payment deferrals, may be subject to such conditions, restrictions and contingencies as the Administrator shall determine.  The Administrator may permit or require the deferral of any award payment, subject to such rules and procedures as it may establish, which may include provisions for the payment or crediting of interest, or dividend equivalents, including converting such credits into deferred share equivalents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Settlement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">  Subject to Section 8(d) and unless the Administrator shall determine otherwise, Stock Awards granted under Section&#160;6(a) hereof consisting of a right to receive shares of Common Stock (or their cash equivalent or a combination of both) in the future shall be settled in three equal annual installments beginning on the first anniversary of the date of grant.    Stock Awards granted under Section&#160;6(b) vest and become available for settlement immediately on the date of grant.  Settlement of the Stock Awards, and the ability of a Participant to sell or otherwise transfer shares of Common Stock acquired upon settlement of </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Stock Awards, may be limited by restrictions included in the Corporation&#8217;s securities trading policies or the Corporation&#8217;s non-employee director stock ownership guidelines, each as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Termination of Service on the Board.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">  In the event a Participant terminates service on the Board for any reason, each Stock Award previously granted to such Participant will be settled in accordance with its terms, subject to any payment deferral made pursuant to Section 8(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Transferability of Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  No Stock Award and no right arising under any Stock Award shall be transferable, whether voluntarily or involuntarily, other than by will or by the laws of descent and distribution&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">, that the Administrator may permit transfers as gifts to family members or to trusts or other entities for the benefit of one or more family members on such terms and conditions as it shall determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Participants to Have No Rights as Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  No Participant shall have any rights as a stockholder with respect to any shares subject to his or her Stock Award prior to the date on which the Participant (or if the shares are held in &#8220;street name,&#8221; the broker designated by the Participant) is recorded as the holder of such shares on the records of the Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Other Stock Award Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The form of Stock Award agreement authorized by the Plan may contain such other provisions as the Administrator may, from time to time, determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Adjustments in Event of Change in Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  In the event of any stock split, reverse stock split, stock dividend recapitalization, reorganization, merger, demerger, consolidation, split-up, spin-off, combination or exchange of shares, or of any similar change affecting the Common Stock, or in the event the Corporation pays an extraordinary cash dividend, (i) the number and kind of shares which thereafter may be optioned, awarded and sold under the Plan, (ii) the number and kind of shares subject to Stock Awards under outstanding Stock Award agreements or subject to Options under outstanding Option agreements, and (iii) the Exercise Price per share of such Options shall be appropriately adjusted consistent with such change in such manner as the Administrator may deem equitable to prevent substantial dilution or enlargement of the right granted to, or available for, Participants in the Plan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">, that no such adjustment shall be required if the Administrator determines that such action could cause an Option or Stock Award to fail to satisfy the conditions of an applicable exception from the requirements of Section&#160;409A (as defined below) or otherwise could subject a Participant to any interest or additional tax imposed under Section&#160;409A in respect of an outstanding award.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Listing and Qualification of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Plan, the grant of Stock Awards, the grant and exercise of Options thereunder, and the obligation of the Corporation to sell and deliver shares under such Stock Awards and Options, shall be subject to all applicable federal and state laws, rules and regulations and to such approvals by any government or regulatory agency as may be required.  The Corporation, in its discretion, may postpone the issuance or delivery of shares upon any grant of a Stock Award or exercise of an Option until completion of any stock exchange listing, or other qualification of such shares under any state or federal law, rule or regulation as the Corporation may consider appropriate, and may require any Participant, beneficiary or legal representative to make such representations and furnish such information as it may consider appropriate in connection with the issuance or delivery of the shares in compliance with applicable laws, rules and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(a)   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Corporation may make such provisions and take such steps as it may deem necessary or appropriate for the withholding of all federal, state, local and other taxes required by law to be withheld with respect to Options and Stock Awards including, but not limited to (a)&#160;reducing the number of shares of Common Stock otherwise deliverable to permit deduction of the amount of any such withholding taxes from the amount otherwise payable under the Plan, (b)&#160;deducting the amount of any such withholding taxes from any other amount then or thereafter payable to a Participant (but only to the extent that such deduction would not subject the Participant to any interest or additional tax imposed under Section 409A), or (c)&#160;requiring a Participant, beneficiary or legal representative to pay in cash to the Corporation the amount required to be withheld or to execute such documents as the Corporation deems necessary or desirable to enable it to satisfy its withholding obligations as a condition of releasing the Common Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Plan is intended and shall be construed to comply with Section 409A of the Code, including any amendments or successor provisions to that Section and any regulations and other administrative guidance thereunder, in each case as they, from time to time, may be amended or interpreted through further administrative guidance (collectively, &#8220;Section 409A&#8221;).  In this regard, and without limiting the previous sentence, any election made with respect to Section 8(b) shall be conformed to the requirements of Section 409A to the extent applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">No Liability of Board Members</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  No member of the Board shall be personally liable by reason of any contract or other instrument executed by such member or on his&#47;her behalf in his&#47;her capacity as a member of the Board or the Administrator nor for any mistake of judgment made in good faith, and the Corporation shall indemnify and hold harmless </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">to the fullest extent permitted by the Corporation&#8217;s Restated Certificate of Incorporation and By&#8209;Laws and Delaware General Corporation Law, each employee, officer or director of the Corporation to whom any duty or power relating to the administration or interpretation of the Plan may be allocated or delegated, against any cost or expense (including counsel fees) or liability (including any sum paid in settlement of a claim with the approval of the Board) arising out of any act or omission to act in connection with the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Board may, with prospective or retroactive effect, amend the Plan and the Administrator may amend any outstanding award in such manner as it deems necessary and appropriate to better achieve the Plan&#8217;s purpose&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">, that no amendment of the Plan shall deprive any Participant of any right with respect to any Stock Award or Option without his&#47;her written consent&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:144%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">further, that unless duly approved by the holders of stock entitled to vote thereon at a meeting (which may be the annual meeting) duly called and held for such purpose, except as provided in Section&#160;9, no amendment or change shall be made in the Plan (i)&#160;increasing the total number of shares which may be issued or transferred under the Plan&#59; (ii)&#160;changing the exercise price specified for the shares subject to Options&#59; (iii)&#160;changing the maximum period during which Options may be exercised&#59; or (iv)&#160; expanding the class of individuals eligible to receive Stock Awards or Options under the Plan.  Notwithstanding the foregoing, the consent of a Participant shall not be required for any action taken by the Administrator (x) to settle or adjust an outstanding award pursuant to Section 9 or (y) to modify an outstanding award to avoid, in the reasonable, good faith judgment of the Corporation, the imposition on the Participant of any interest or additional tax under Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Board may suspend or terminate this Plan at any time. No such suspension or termination of the Plan shall deprive any Participant of any right with respect to any outstanding Stock Award or Option without his&#47;her written consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The captions preceding the sections of the Plan have been inserted solely as a matter of convenience and shall not in any manner define or limit the scope or intent of any provisions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  The Plan and all rights thereunder shall be governed by and construed in accordance with the laws of the State of New Jersey applicable to contracts made and to be performed entirely within such State (without reference to its principles of conflicts of law).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">Section 17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%;text-decoration:underline">No Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:144%">.  No fractional shares shall be issued or delivered pursuant to the Plan or any Option or Stock Award, and the Administrator shall determine whether any fractional share shall be rounded up or rounded down to the nearest whole share, whether cash shall be paid or transferred in lieu of any fractional shares, or whether such fractional shares or any rights thereto shall be cancelled.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>dgx12312020ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if4686b3f2ea54eb5b259f4dd320cf0b2_49"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quest Diagnostics Incorporated (DE)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Incorporated on December 12, 1990 in Delaware&#59; EIN&#58; 16-1387862)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiaries, Joint Ventures and Affiliates</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.687%"><tr><td style="width:1.0%"></td><td style="width:4.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.270%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:4.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="30" style="background-color:#00b0f0;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company</font></td><td colspan="3" style="background-color:#00b0f0;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registered Alternate name</font></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Quest Diagnostics Holdings Incorporated (DE)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Quest Diagnostics International Holdings Limited (UK)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="24" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Holdings Ltd. (UK)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  ExamOne Canada, Inc. (New Brunswick)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Brasil Holdings Ltd. (UK)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.9%  Quest Diagnostics HTAS India Private Limited (India) (0.1% Quest Diagnostics International Holdings Limited (UK)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics of Puerto Rico, Inc. (PR)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Ireland Limited (Ireland)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics (Shanghai) Co., Ltd. (China)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="12" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Subsidiary Holdings Ltd. (UK)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40% Q Squared Solutions Holdings Limited (UK)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Clinical Laboratories, Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Toxicology Network</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smithkline Beecham Clinical      </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Laboratories</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solstas Lab Partners Group</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solstas Lab Partners</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Lab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LLC (MO)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LabOne, LLC of Kansas</font></div></td></tr><tr><td colspan="24" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Exam</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> World Wide, Inc. (PA)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% ExamOne LLC (DE)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% ExamOne World Wide of NJ, Inc. (NJ)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51%  DGXWMT JV, LLC (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Health Check by Quest Diagnostics</font></td></tr><tr><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Quest HealthConnect, LLC (CA)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%  Quest Diagnostics Health &#38; Wellness, LLC (DE)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="24" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Lab</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of Ohio, Inc. (DE)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LabOne</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51% Diagnostic Laboratory of Oklahoma LLC (OK)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Mid America Clinical Laboratories, LLC (IN)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49% Sonora Quest Laboratories LLC (AZ)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%  Quest Diagnostics Domestic Holder LLC (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40%  Q Squared Solutions Holdings, LLC (DE)</font></div><div><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics do Brasil Ltda. (Brazil)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Incorporated (MD)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Diagnostic Reference Services Inc. (MD)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Pathology Building Partnership (MD) (gen. ptnrshp.)</font></div><div><font><br></font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Registered Alternate Name&#58; QDI Delaware Incorporated</font></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1                                                                                                                    Revised&#58; January 1, 2021</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79104.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.687%"><tr><td style="width:1.0%"></td><td style="width:4.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.270%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:4.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.599%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%  Quest Diagnostics India Private Limited (India)</font></div><div><font><br></font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%   Quest Diagnostics Infectious Disease, Inc. (DE)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30%)&#160; Quest Diagnostics Domestic Holder LLC (DE)</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%  Quest Diagnostics International LLC (DE)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100% Quest Diagnostics Investments LLC  (DE)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics LLC (IL)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics LLC</font></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics LLC (MA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics LLC</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Quest Diagnostics of Connecticut LLC</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81.1% Quest Diagnostics Massachusetts LLC (MA)  </font></div><div><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics LLC (CT)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="33" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Mexico Holding Company Trust (Mexico)</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics Mexico, S de RL de CV (Mexico)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="30" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%  Quest Diagnostics Terracotta LLC (DE)</font></div></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Nichols Institute (CA)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nichols Institute</font></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics of Pennsylvania Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51% Quest Diagnostics Venture LLC (PA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.5% Associated Clinical Laboratories of Pennsylvania, L.L.C. (PA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1% Associated Clinical Laboratories, L.P. (PA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52.97% Associated Clinical Laboratories, L.P. (PA)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Quest Diagnostics Receivables Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Quest Diagnostics TB, LLC (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 % Quest Diagnostics Ventures LLC (DE)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Athena Diagnostics, Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  American Medical Laboratories, Incorporated (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%   Quest Diagnostics Nichols Institute, Inc. (VA)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nichols Institute</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%   Quest Diagnostics Incorporated (NV)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated of Nevada</font></div><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics</font></div></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Blueprint Genetics Oy (Finland)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Blueprint Genetics FZ-LLC (UAE)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                    Revised&#58; January 1, 2021</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79104.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.687%"><tr><td style="width:1.0%"></td><td style="width:4.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.270%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:4.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Blueprint Genetics Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%  Clearpoint Diagnostic Laboratories, LLC (TX)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Cleveland HeartLab, Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cleveland Heartlab Services, Inc.</font></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%   Isabella Street Urban Renewal, LLC (NJ)</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Med Fusion, LLC (TX)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">med fusion</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">med fusion clin-trials</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">med fusion clin-labs</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Nomad Massachusetts, Inc. (MA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Laboratorio de Analisis Biomedicos, S.A. (Mexico)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100% Reprosource Fertility Diagnostics, Inc. (MA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="30" style="background-color:#92d050;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Unilab Corporation (DE)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics</font></td></tr><tr style="height:15pt"><td colspan="33" style="background-color:#92d050;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath, Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Cincinnati, Inc. (OH)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richfield Laboratory of Dermatopathology</font></div><div style="padding-left:8.1pt;text-indent:-8.1pt"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Cleveland, Inc. (OH)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath GI Institute</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Consolidated Labs, Inc. (FL)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Florida, LLC (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Central Florida </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Northeast Florida</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Southwest Florida</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bay Area Dermatopathology</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics Bay Area</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Institute for Immunofluorescence</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Institute for Podiatric Pathology</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Hospital Services Florida, LLC (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Kentucky, Inc. (KY)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                    Revised&#58; January 1, 2021</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79104.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.687%"><tr><td style="width:1.0%"></td><td style="width:4.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.984%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.616%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.270%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.163%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:4.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.965%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Lubbock 5.01(A) Corporation (TX)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arlington Pathology Associates</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics Texas</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">North Arlington Pathology </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Associates</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pathology Associates of Texas</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath New York, LLC (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath East</font></div><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Gastrointestinal Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Northeast</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;NE-Braintree</font></div><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ackerman Academy of Dermatopathology</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics New York</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Texas Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  AmeriPath Tucson, Inc. (AZ)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriPath Arizona</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Consolidated DermPath, Inc. (DE)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  DFW 5.01(a) Corporation (TX)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath North Texas</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Dallas</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath DFW 5.01(a) </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Corporation</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Diagnostic Pathology Services, Inc. (OK)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriPath Oklahoma</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Kailash B. Sharma, M.D., Inc. (GA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Nuclear Medicine and Pathology Associates (GA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Institute for Dermatopathology, Inc. (PA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Mid Atlantic</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dermatopathology </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Laboratory</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Ocmulgee Medical Pathology Association, Inc. (GA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.1pt;text-indent:-8.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Georgia Gastrointestinal Diagnostics</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="27" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%  Specialty Laboratories, Inc. (CA)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Nichols </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Institute of Valencia, Inc.</font></div></td></tr><tr><td colspan="30" style="background-color:#00b0f0;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional Entities Consolidated for Accounting Purposes</font></td><td colspan="3" style="background-color:#00b0f0;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.6pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Indianapolis, PC (IN)&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Indianapolis, PSC</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado Pathology Consultants, P.C. (CO)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Colorado</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dermpath Diagnostics</font></div></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dermatopathology of Wisconsin, S.C. (WI)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AmeriPath Great Lakes</font></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hoffman, M.D., Associated Pathologists, Chartered (NV)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Associated Pathologists, </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;Chartered</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AmeriPath Nevada</font></div></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kilpatrick Pathology, P.A. (NC)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PhenoPath Laboratories, PLLC (WA)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                    Revised&#58; January 1, 2021</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79104.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                    Revised&#58; January 1, 2021</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">79104.1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>dgx12312020ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iec9c617564da409e9dfe65f84547c23d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-232138) and Form S-8 (Nos. 333-184580, 333-182863, 333-143889, 333-136196, 333-60758, 333-60477, 333-157447, 333-162710, 333-162711, 333-207746, 333-214215, 333-221076 and 333-234328) of Quest Diagnostics Incorporated of our report dated February&#160;22, 2021 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:32.163%"><tr><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PricewaterhouseCoopers LLP</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PricewaterhouseCoopers LLP</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florham Park, New Jersey</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2021</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>dgx12312020ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i506eec7d5a804216996869bd3e6d7c3b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen H. Rusckowski, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;22, 2021 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:36.988%"><tr><td style="width:1.0%"></td><td style="width:11.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>dgx12312020ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i27b5497794274ef38a49832ab1869587_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark J. Guinan, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;22, 2021 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:29.239%"><tr><td style="width:1.0%"></td><td style="width:15.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>dgx12312020ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9ea3dede650d46feb01a2447e1fd169b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Annual Report on Form 10-K for the period ended December&#160;31, 2020 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Office and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>dgx12312020ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2bd7954b0eca4eb9a646c680baa09b22_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Annual Report on Form 10-K for the period ended December&#160;31, 2020 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 22, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>12
<FILENAME>dgx12312020ex997.htm
<DESCRIPTION>EX-99.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia51c26d35af74f1985b49475152859c4_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.7</font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AMENDMENT NO. 4 TO SIXTH AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Amendment No. 4 to Sixth Amended and Restated Credit and Security Agreement (this </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Amendment&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) is entered into as of October 22, 2020 (the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), by and among&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(1) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">QUEST DIAGNOSTICS RECEIVABLES INC., a Delaware corporation (together with its successors and permitted assigns, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(2) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">QUEST DIAGNOSTICS INCORPORATED, a Delaware corporation, as initial servicer (in such capacity, together with any successor servicer or sub-servicer, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Servicer&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(3) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PNC BANK, NATIONAL ASSOCIATION, in its individual capacity as a Lender (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PNC&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PNC Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and as issuer of the Letters of Credit,</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(4) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gotham Funding Corporation, a Delaware corporation (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Gotham&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), in its capacity as a Liquidity Bank to Gotham (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;MUFG&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, together with Gotham, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Gotham Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">),</font></div><div style="padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">(5)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> ATLANTIC ASSET SECURITIZATION LLC, a Delaware limited liability company (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:115%">&#8220;Atlantic&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">), and CR&#201;DIT AGRICOLE CORPORATE AND INVESTMENT BANK, in its capacity as a Liquidity Bank to Atlantic (together with its successors, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:115%">&#8220;CACIB&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> and, together with Atlantic, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:115%">&#8220;Atlantic Group&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">),</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">(6) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">PNC BANK, NATIONAL ASSOCIATION, in its capacity as agent for the PNC Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:115%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">), </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">CR&#201;DIT </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">AGRICOLE CORPORATE AND INVESTMENT BANK, in its capacity as agent for the Atlantic Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:115%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">), and MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), in its capacity as agent for the Gotham Group (together with its successors in such capacity, a </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:115%">&#8220;Co-Agent&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:115%">), </font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(7) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PNC BANK, NATIONAL ASSOCIATION, in its capacity as Letter of Credit issuer (together with its successors in such capacity, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;LC Issuer&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(8) </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), as administrative agent for the Atlantic Group, the PNC Group, the Gotham Group and the Co-Agents (in such capacity, together with any successors thereto in such capacity, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Agent&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and together with each of the Co-Agents, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agents&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">RECITALS&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A.&#160;&#160;&#160;&#160;The Borrower, the Servicer, the PNC Group, the Gotham Group, the Atlantic Group and the Agents are parties to that certain Sixth Amended and Restated Credit and Security Agreement, dated as of October 27, 2017 (as amended, restated or otherwise modified from time to time, the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit and Security Agreement&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; capitalized terms used and not otherwise defined herein are used with the meanings attributed thereto in the Credit and Security Agreement).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;Each of the parties hereto desires to amend the Credit and Security Agreement as hereinafter set forth.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">NOW, THEREFORE,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in consideration of the premises, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows&#58;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 1. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Amendments to the Credit and Security Agreement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Effective as of the Effective Date&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1.&#160;&#160;&#160;&#160;The definition in Annex A to the Credit and Security Agreement of each of the capitalized terms set forth below is hereby amended and restated in its entirety to read, respectively, as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:108pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;A-Commitment Expiry Date&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means October 22, 2021.</font></div><div style="margin-bottom:6pt;padding-left:108pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Biennial Commitment Expiry Date&#8221;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means October 21, 2022.</font></div><div style="margin-bottom:6pt;padding-left:108pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Material Adverse Effect&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means an event, circumstance, occurrence, or condition which has caused as of any date of determination any of (a) a material adverse effect, or any condition or event that has resulted in a material adverse effect, on the business, operations, financial condition or assets of (i) the Originators taken as a whole (after taking into account indemnification obligations by third parties that are Solvent to the extent that such third party has not disputed (after notice of claim in accordance with the applicable agreement therefor) liability to make such indemnification payment), (ii) the Servicer, or (iii) the Borrower, (b) a material adverse effect on the ability of the Originators, the Servicer or the Borrower to perform when and as due any of their material obligations under any Transaction Document to which they are parties, (c) a material adverse effect on the legality, binding effect or enforceability of any Transaction Document or any of the material rights and remedies of any of the Agents or Lenders thereunder or the legality, priority, or enforceability of the Lien on a material portion of the Collateral, or (d) a material adverse effect upon the validity, enforceability or collectability of a material portion of the Receivables&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">provided, however, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that during the period beginning with the declaration on March 13, 2020 of the national emergency relating to COVID-19  and ending on April 30, 2021 or such later date, not to extend beyond October 22, 2021, as agreed to by the Administrative Agent (with the consent of the Lenders) and the Borrower, no event, circumstance, development, change, occurrence or effect (as is reasonably identifiable and factually supportable)&#160;related to the COVID-19 pandemic and the resulting work-at-home orders, travel restrictions and quarantine orders that ensued, shall be deemed to constitute, or shall be taken into account in determining whether there has been, a Material Adverse Effect of the type described in the preceding clause (a).</font></div><div style="margin-bottom:6pt;padding-left:108pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Monthly Reporting Date&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means the 22nd day of each calendar month&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">provided, however,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if any such day is not a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:108pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Business Day, then the Monthly Reporting Date shall occur on the next succeeding Business Day.</font></div><div style="margin-bottom:6pt;padding-left:108pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Scheduled Termination Date&#8221; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">means October 21, 2022.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.2.&#160;&#160;&#160;&#160;Section 10.1(d) is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:63pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)(i) The Borrower shall (A) fail to pay any principal or interest, regardless of amount, due in respect of any Indebtedness of which the aggregate unpaid principal amount is in excess of $16,750 (as such amount may be adjusted under Section 104 of the Bankruptcy Code), when and as the same shall become due and payable (after expiration of any applicable grace period) or (B) fail to observe or perform any other term, covenant, condition or agreement (after expiration of any applicable grace period) contained in any agreement or instrument evidencing or governing any such Indebtedness if the effect of any failure referred to in this clause (B) is to cause, or permit the holder or holders of such Indebtedness or a trustee on its or their behalf (with or without the giving of notice, the lapse of time or both) to cause, such Indebtedness to become due prior to its stated maturity&#59; or </font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:63pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii) any of the Originators (A) shall fail to pay any principal or interest, regardless of amount, due in respect of any Indebtedness of which the aggregate unpaid principal amount is in excess of the lesser of (1) $200,000,000 or (2) the amount that is currently set forth in the comparable provision of the Credit Agreement, in each case, when and as the same shall become due and payable (after expiration of any applicable grace period) or (B) shall fail to observe or perform any other term, covenant, condition or agreement (after expiration of any applicable grace period) contained in any agreement or instrument evidencing or governing any Indebtedness of the Originators in excess of the lesser of (1) $200,000,000, or (2) the amount currently set forth in the comparable provision of the Credit Agreement in aggregate principal amount, in each case, if, as a result of such failure, the holder or holders of the Indebtedness outstanding thereunder cause (or an agent or a trustee on their behalf cause) such Indebtedness to become due prior to its stated maturity.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.3.&#160;&#160;&#160;&#160;Section 10.1(o)(ii) is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:72pt;padding-right:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(o)(i) A final judgment or judgments for the payment of money in excess of $16,750 (as such amount may be adjusted under Section 104 of the Bankruptcy Code) in the aggregate (exclusive of judgment amounts to the extent covered by insurance or indemnity payments) shall be rendered by one or more courts, administrative tribunals or other bodies having jurisdiction against the Borrower and the same shall not be discharged (or provision which results in a stay of execution shall not be made for such discharge), vacated or bonded pending appeal, or a stay of execution thereof shall not be procured, within 60 days from the date of entry thereof and the Borrower shall not, within said period </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt;padding-left:72pt;padding-right:72pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of 60 days, or such longer period during which execution of the same shall have been stayed, appeal therefrom and cause the execution thereof to be stayed during such appeal&#59; or (ii) a final judgment or judgments for the payment of money in excess of the lesser of (A) $200,000,000 or (B) the amount currently set forth in the comparable provision of the Credit Agreement in the aggregate (exclusive of judgment amounts to the extent covered by insurance or indemnity payments) shall be rendered by one or more courts, administrative tribunals or other bodies having jurisdiction against any Originator and the same shall not be discharged (or provision which results in a stay of execution shall not be made for such discharge), vacated or bonded pending appeal, or a stay of execution thereof shall not be procured, within 60 days from the date of entry thereof and such Originator shall not, within said period of 60 days, or such longer period during which execution of the same shall have been stayed, appeal therefrom and cause the execution thereof to be stayed during such appeal.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.4.&#160;&#160;&#160;&#160;Section 10.1(q) is hereby amended and restated in its entirety to read as follows&#58;  </font></div><div style="margin-bottom:6pt;padding-left:72pt;padding-right:63pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(q) Quest Diagnostics shall fail to comply with any of the financial covenants set forth in Sections 7.2 (or analogous successor provisions) of the Credit Agreement&#59; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">provided, however, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that if (i) all of the Agents under this Agreement are also parties to the Credit Agreement and waive compliance with one or both of such provisions </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (ii) the requisite number of lenders (including the Agents) party to the Credit Agreement waive compliance with such provision or provisions under the Credit Agreement, then, upon receipt of notice to such effect from Quest Diagnostics, the applicable provision or provisions shall also be deemed waived for purposes of this Agreement without the need for further vote or documentation under this Agreement.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.5.&#160;&#160;&#160;&#160;Section 10.1(s) is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(s) &#91;Reserved&#93;.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall become effective as of the Effective Date provided that each of the following conditions precedent is satisfied&#58;  (a) The Administrative Agent shall have received counterparts of this Amendment (whether by facsimile or otherwise) duly executed by each of the parties hereto&#59; (b)(i) the Administrative Agent shall have received counterparts of the Fee Letter of even date herewith (whether by facsimile or otherwise) duly executed by each of the parties thereto, and (ii) each of the Co-Agents shall have received payment of its Amendment Structuring Fee specified therein&#59; and (c) each of the representations and warranties set forth in Section 3 of this Amendment is true and correct as of the Effective Date. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Borrower hereby represents and warrants to the Agents and the Lenders as of the Effective Date as follows</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#58;</font></div><div style="margin-bottom:6pt;padding-left:148.5pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The representations and warranties contained in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Article VI</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Credit and Security Agreement are true and correct as of the date hereof (unless stated to relate solely to an earlier date, in which case such representations or warranties were true and correct as of such earlier date).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:153pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Enforceability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The execution and delivery by each of the Borrower and the Servicer of this Amendment, and the performance of each of its obligations under this Amendment and the Credit and Security Agreement, as amended hereby, are within each of its organizational powers and have been duly authorized by all necessary action on each of its parts.  This Amendment and the Credit and Security Agreement, as amended hereby, are each of the Borrower&#8217;s and the Servicer&#8217;s valid and legally binding obligations, enforceable in accordance with its terms.</font></div><div style="margin-bottom:6pt;padding-left:153pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Immediately after giving effect to this Amendment and the transactions contemplated hereby, no Event of Default or Unmatured Default exists or shall exist.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 4. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Legal Fees and Disbursements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Borrower hereby acknowledges and agrees that this Amendment constitutes a Transaction Document and that the provisions of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 14.5(a)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of the Credit and Security Agreement apply hereto.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to any otherwise applicable conflicts of law principles (other than Sections 5-1401 and 5-1402 of the New York General Obligations Law which shall apply hereto).</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Effect of Amendment&#59; Ratification</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Except as specifically amended hereby, the Credit and Security Agreement is hereby ratified and confirmed in all respects, and all of its provisions shall remain in full force and effect.  After this Amendment becomes effective, all references in the Credit and Security Agreement (or in any other Transaction Document) to &#8220;the Credit and Security Agreement&#8221;, &#8220;this Agreement&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221;, or words of similar effect, in each case referring to the Credit and Security Agreement, shall be deemed to be references to the Credit and Security Agreement as amended hereby.  This Amendment shall not be deemed to expressly or impliedly waive, amend, or supplement any provision of the Credit and Security Agreement other than as specifically set forth herein.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 7. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, and each counterpart shall be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.  To the fullest extent permitted by applicable law, delivery of an executed counterpart of a signature page of this Amendment by telefacsimile or electronic image scan transmission (such as a &#8220;pdf&#8221; file) will be effective to the same extent as delivery of a manually executed original counterpart of this Amendment.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Section Headings</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The various headings of this Amendment are inserted for convenience only and shall not affect the meaning or interpretation of this Amendment or the Credit and Security Agreement or any provision hereof or thereof.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 9. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.91pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Amendment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 10. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.34pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If any one or more of the provisions or terms of this Amendment shall for any reason whatsoever be held invalid or unenforceable, then such agreements, provisions or terms shall be deemed severable from the remaining agreements, provisions and terms of this Amendment and shall in no way affect the validity or enforceability of the provisions of this Amendment or the Credit and Security Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#60;Balance of page intentionally left blank&#62;</font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div id="ia51c26d35af74f1985b49475152859c4_4"></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">IN WITNESS WHEREOF,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the parties have executed this Amendment as of the date first written above.</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">QUEST DIAGNOSTICS RECEIVABLES INC.</font></div><div style="padding-left:2.02pt;text-indent:-0.01pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Sandip R. Patel                    </font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Sandip R. Patel</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President and Treasurer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">QUEST DIAGNOSTICS INCORPORATED, as Servicer</font></div><div style="padding-left:2.02pt;text-indent:-0.01pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Sandip R. Patel                    </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:202.5pt;text-indent:13.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Sandip R. Patel</font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President and Treasurer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:203.05pt;text-indent:-1.45pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Atlantic Asset Securitization LLC, as a Conduit</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Konstantina Kourmpetis      </font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Konstantina Kourmpetis</font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;   Managing Director</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">__&#47;s&#47; Roger Klepper______________</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Roger Klepper</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director</font></div><div style="padding-left:418.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cr&#233;dit Agricole Corporate and Investment Bank, individually as a Liquidity Bank for Atlantic and as Atlantic Group Agent</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Konstantina Kourmpetis      </font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Konstantina Kourmpetis</font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;   Managing Director  </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">__&#47;s&#47; Roger Klepper______________</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Roger Klepper</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director  </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PNC BANK, NATIONAL ASSOCIATION,</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">individually as a Lender, as PNC Group Agent and as LC Issuer</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47;Michael Brown                       </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Michael Brown</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gotham Funding Corporation, as a Conduit</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> &#47;s&#47; Kevin J. Corrigan         </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Kevin J. Corrigan</font></div><div style="padding-left:216pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Vice President</font></div><div style="padding-left:108pt;padding-right:108pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), individually as a Liquidity Bank for Gotham</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;  __</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;Erik Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________                                   </font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Erik Williams</font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director         </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), as Gotham Agent</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;  __</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;Erik Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_______                                  </font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Erik Williams</font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director        </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MUFG BANK, LTD. (F&#47;K&#47;A THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.), as Administrative Agent</font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;  __</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;Erik Williams</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_______                                   </font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Erik Williams</font></div><div style="padding-left:220.5pt;text-indent:-1.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Managing Director </font></div><div style="padding-left:202.5pt;text-indent:-1.25pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quest Amendment No. 4 to 6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> A&#38;R CSA</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>dgx-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a87d206f-e33b-4d9f-a34a-b74e8733b14f,g:639ddba6-f3fe-4831-960f-76615a38edd9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dgx="http://questdiagnostics.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://questdiagnostics.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://questdiagnostics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1">
        <link:definition>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITION" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION">
        <link:definition>2105103 - Disclosure - REVENUE RECOGNITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONTables" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables">
        <link:definition>2306301 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONDetails" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails">
        <link:definition>2407402 - Disclosure - REVENUE RECOGNITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE">
        <link:definition>2108104 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSLOSSPERSHARETables" roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables">
        <link:definition>2309302 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSLOSSPERSHAREDetails" roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails">
        <link:definition>2410403 - Disclosure - EARNINGS (LOSS) PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIES" roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES">
        <link:definition>2111105 - Disclosure - RESTRUCTURING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESTables" roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables">
        <link:definition>2312303 - Disclosure - RESTRUCTURING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESNarrativeDetails" roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails">
        <link:definition>2413404 - Disclosure - RESTRUCTURING ACTIVITIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails" roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails">
        <link:definition>2414405 - Disclosure - RESTRUCTURING ACTIVITIES (Pre-Tax Restructuring charges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails" roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails">
        <link:definition>2415406 - Disclosure - RESTRUCTURING ACTIVITIES (Activities of Restructuring Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS">
        <link:definition>2116106 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>2417407 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2118107 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2319304 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2420408 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2421409 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails">
        <link:definition>2422410 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOME" roleURI="http://questdiagnostics.com/role/TAXESONINCOME">
        <link:definition>2123108 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMETables" roleURI="http://questdiagnostics.com/role/TAXESONINCOMETables">
        <link:definition>2324305 - Disclosure - TAXES ON INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TAXESONINCOMEDetails" roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails">
        <link:definition>2425411 - Disclosure - TAXES ON INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWANDOTHERDATA" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA">
        <link:definition>2126109 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWANDOTHERDATATables" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables">
        <link:definition>2327306 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWANDOTHERDATADetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails">
        <link:definition>2428412 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENT" roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT">
        <link:definition>2129110 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>2330307 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
        <link:definition>2431413 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2132111 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2333308 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
        <link:definition>2434414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSES" roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES">
        <link:definition>2135112 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables">
        <link:definition>2336309 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails">
        <link:definition>2437415 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://questdiagnostics.com/role/DEBT">
        <link:definition>2138113 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://questdiagnostics.com/role/DEBTTables">
        <link:definition>2339310 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTLongTermDebtDetails" roleURI="http://questdiagnostics.com/role/DEBTLongTermDebtDetails">
        <link:definition>2440416 - Disclosure - DEBT (Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSecuredReceivablesCreditFacilityNarrativeDetails" roleURI="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails">
        <link:definition>2441417 - Disclosure - DEBT (Secured Receivables Credit Facility) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" roleURI="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails">
        <link:definition>2442418 - Disclosure - DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSeniorNotesOfferingDetails" roleURI="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails">
        <link:definition>2443419 - Disclosure - DEBT (Senior Notes Offering) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaturitiesofLongTermDebtDetails" roleURI="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails">
        <link:definition>2444420 - Disclosure - DEBT (Maturities of Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://questdiagnostics.com/role/LEASES">
        <link:definition>2145114 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://questdiagnostics.com/role/LEASESTables">
        <link:definition>2346311 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://questdiagnostics.com/role/LEASESNarrativeDetails">
        <link:definition>2447421 - Disclosure - LEASES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLiabilitiesDetails" roleURI="http://questdiagnostics.com/role/LEASESLiabilitiesDetails">
        <link:definition>2448422 - Disclosure - LEASES (Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESCostsDetails" roleURI="http://questdiagnostics.com/role/LEASESCostsDetails">
        <link:definition>2449423 - Disclosure - LEASES (Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturityDetails" roleURI="http://questdiagnostics.com/role/LEASESMaturityDetails">
        <link:definition>2450424 - Disclosure - LEASES (Maturity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTermandRateDetails" roleURI="http://questdiagnostics.com/role/LEASESTermandRateDetails">
        <link:definition>2451425 - Disclosure - LEASES (Term and Rate) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2152115 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2353312 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>2454426 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSBalanceSheetsDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails">
        <link:definition>2455427 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSIncomeStatementDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails">
        <link:definition>2456428 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSFairValueofDerivativesDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails">
        <link:definition>2457429 - Disclosure - FINANCIAL INSTRUMENTS (Fair Value of Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>2158116 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables">
        <link:definition>2359313 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails">
        <link:definition>2460430 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails">
        <link:definition>2461431 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANS" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS">
        <link:definition>2162117 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables">
        <link:definition>2363314 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails">
        <link:definition>2464432 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails">
        <link:definition>2465433 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails">
        <link:definition>2466434 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails">
        <link:definition>2467435 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails">
        <link:definition>2468436 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails">
        <link:definition>2469437 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2170118 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2471438 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>2172119 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>2373315 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>2474439 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTIES" roleURI="http://questdiagnostics.com/role/RELATEDPARTIES">
        <link:definition>2175120 - Disclosure - RELATED PARTIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTIESDetails" roleURI="http://questdiagnostics.com/role/RELATEDPARTIESDetails">
        <link:definition>2476440 - Disclosure - RELATED PARTIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISCONTINUEDOPERATIONS" roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS">
        <link:definition>2177121 - Disclosure - DISCONTINUED OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DISCONTINUEDOPERATIONSDetails" roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails">
        <link:definition>2478441 - Disclosure - DISCONTINUED OPERATIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyOperatingResultsunaudited" roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited">
        <link:definition>2179122 - Disclosure - Quarterly Operating Results (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyOperatingResultsunauditedTables" roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables">
        <link:definition>2380316 - Disclosure - Quarterly Operating Results (unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyOperatingResultsunauditedScheduleDetails" roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails">
        <link:definition>2481442 - Disclosure - Quarterly Operating Results (unaudited) (Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyOperatingResultsunauditedNarrativeDetails" roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails">
        <link:definition>2482443 - Disclosure - Quarterly Operating Results (unaudited) (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationAccountsandReserves" roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves">
        <link:definition>2183123 - Disclosure - Schedule II - Valuation Accounts and Reserves</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationAccountsandReservesDetails" roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails">
        <link:definition>2484444 - Disclosure - Schedule II - Valuation Accounts and Reserves (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" abstract="false" name="FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DeferredRentAdjustments" abstract="false" name="DeferredRentAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_QuarterlyFinancialDataLineItems" abstract="true" name="QuarterlyFinancialDataLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock" abstract="false" name="ScheduleOfLeverageRatioCovenantsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" abstract="false" name="ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" abstract="false" name="IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PeriodofBillingFullyReserve" abstract="false" name="PeriodofBillingFullyReserve" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_OxfordImmunotecInc.Member" abstract="true" name="OxfordImmunotecInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_DerivativeGainAmortizationPeriod" abstract="false" name="DerivativeGainAmortizationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_RevenueCollectionofConsiderationPeriod" abstract="false" name="RevenueCollectionofConsiderationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" abstract="false" name="NetOperatingLossCarryfowardsNetOfValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PercentageofNetAccountsReceivable" abstract="false" name="PercentageofNetAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_Sharebasedcompensationexcesstaxbenefitamount" abstract="false" name="Sharebasedcompensationexcesstaxbenefitamount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_HealthcareInsurersMember" abstract="true" name="HealthcareInsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_UMassJointVentureMember" abstract="true" name="UMassJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" abstract="false" name="BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" abstract="false" name="Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ForwardStartingInterestRateSwapsMember" abstract="true" name="ForwardStartingInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_DebtInstrumentExtensionPeriod" abstract="false" name="DebtInstrumentExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" abstract="false" name="DiscontinuedOperationGainonSettlingUncertainTaxBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AgreementtoOutsourceBillingandCollectionFunction" abstract="false" name="AgreementtoOutsourceBillingandCollectionFunction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_AmortizationofIntangibleAssetsMember" abstract="true" name="AmortizationofIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_PreTaxGainLossDueToCOVID19" abstract="false" name="PreTaxGainLossDueToCOVID19" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FeeforserviceMember" abstract="true" name="FeeforserviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" abstract="false" name="ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LeaseRenewalTerm" abstract="false" name="LeaseRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" abstract="true" name="FivePointSevenFivePercentSeniorNotesDue2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_RemainingTermsofContingentLeaseObligationsMaximum" abstract="false" name="RemainingTermsofContingentLeaseObligationsMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" abstract="false" name="InvestmentwithoutReadilyDeterminableFairValueImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_CapeCodHealthcareInc.Member" abstract="true" name="CapeCodHealthcareInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" abstract="false" name="TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" abstract="true" name="MidAmericaClinicalLaboratoriesLLCMACLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" abstract="false" name="DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LaboratoryEquipmentFurnitureAndFixturesMember" abstract="true" name="LaboratoryEquipmentFurnitureAndFixturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" abstract="false" name="IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_AccountsReceivableDisaggregationTableTextBlock" abstract="false" name="AccountsReceivableDisaggregationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_FixedtovariableinterestrateswapMember" abstract="true" name="FixedtovariableinterestrateswapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SdcpIiGradedVestingPercentage" abstract="false" name="SdcpIiGradedVestingPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_StockAwardsMember" abstract="true" name="StockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" abstract="false" name="GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" abstract="true" name="FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_StockRepurchaseProgramAdditionalAuthorizedAmount" abstract="false" name="StockRepurchaseProgramAdditionalAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_COVID19TestingServicesMember" abstract="true" name="COVID19TestingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_NidMember" abstract="true" name="NidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" abstract="false" name="LaboratoryEquipmentAndFurnitureAndFixturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_InterestRateLockAgreementsMember" abstract="true" name="InterestRateLockAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" abstract="false" name="ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_SixPointNineFivePercentSeniorNotesDue2037Member" abstract="true" name="SixPointNineFivePercentSeniorNotesDue2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ChargesDueToCOVID19" abstract="false" name="ChargesDueToCOVID19" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ReproSourceInc.Member" abstract="true" name="ReproSourceInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" abstract="false" name="MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_LeaseRightofUseAsset" abstract="false" name="LeaseRightofUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ClientPayersMember" abstract="true" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_GovernmentPayersMember" abstract="true" name="GovernmentPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_BlueprintGeneticsOyMember" abstract="true" name="BlueprintGeneticsOyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ScheduleOfQuarterlyFinancialDataTable" abstract="true" name="ScheduleOfQuarterlyFinancialDataTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" abstract="false" name="IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_MergerConsiderationPayableCurrent" abstract="false" name="MergerConsiderationPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FinanceLeaseObligationsandOtherMember" abstract="true" name="FinanceLeaseObligationsandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" abstract="false" name="SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_ShorttermLeaseandVariableLeaseCost" abstract="false" name="ShorttermLeaseandVariableLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" abstract="false" name="IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FourpointtwofivepercentSeniorNotesDue2024Member" abstract="true" name="FourpointtwofivepercentSeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_OtherAccountsReceivableRelatedParties" abstract="false" name="OtherAccountsReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_CapitatedMember" abstract="true" name="CapitatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" abstract="false" name="Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_EmployeeLongTermIncentivePlanEltipMember" abstract="true" name="EmployeeLongTermIncentivePlanEltipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member" abstract="true" name="TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" abstract="true" name="BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_OperatingandFinanceLeaseLiability" abstract="false" name="OperatingandFinanceLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AnatomicpathologytestingservicesMember" abstract="true" name="AnatomicpathologytestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_GenebasedandesoterictestingservicesMember" abstract="true" name="GenebasedandesoterictestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_InvigorateProgramMember" abstract="true" name="InvigorateProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_TreasuryStockPurchasedbutNotyetPaid" abstract="false" name="TreasuryStockPurchasedbutNotyetPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" abstract="true" name="PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SdcpIiMember" abstract="true" name="SdcpIiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ContractRelatedMember" abstract="true" name="ContractRelatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_TotalAmortizingIntangibleAssetsMember" abstract="true" name="TotalAmortizingIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SeniorunsecuredrevolvingcreditfacilityMember" abstract="true" name="SeniorunsecuredrevolvingcreditfacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_OtherIncomeExpenseMember" abstract="true" name="OtherIncomeExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_RoutineclinicaltestingservicesMember" abstract="true" name="RoutineclinicaltestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_DiagnosticInformationServicesBusinessMember" abstract="true" name="DiagnosticInformationServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_PercentageofReceivablesDueFromPatients" abstract="false" name="PercentageofReceivablesDueFromPatients" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_LoancommitmentmaturingOctober2021Member" abstract="true" name="LoancommitmentmaturingOctober2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" abstract="true" name="ThreePointFourFivePercentSeniorNotesdueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember" abstract="true" name="RestatedDirectorLongTermIncentivePlanDltipAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" abstract="false" name="DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_OtherEquityComponentsMember" abstract="true" name="OtherEquityComponentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SupplementalDeferredCompensationPlanMember" abstract="true" name="SupplementalDeferredCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" abstract="false" name="FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" abstract="true" name="TwoPointEightZeroPercentSeniorNotesDueJune2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_DSBusinessesMember" abstract="true" name="DSBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" abstract="false" name="BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_PercentageofNetRevenues" abstract="false" name="PercentageofNetRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" abstract="false" name="ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" abstract="false" name="UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_RestructuringIntegrationCharges" abstract="false" name="RestructuringIntegrationCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ScheduleOfShareholdersEquityLineItems" abstract="true" name="ScheduleOfShareholdersEquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TerminationOfInterestRateSwapAgreements" abstract="false" name="TerminationOfInterestRateSwapAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LongTermDebtMaturitiesGross" abstract="false" name="LongTermDebtMaturitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" abstract="false" name="LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FairValueOfNetAssetsAcquired" abstract="false" name="FairValueOfNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_RestatedDirectorLongTermIncentivePlanDltipMember" abstract="true" name="RestatedDirectorLongTermIncentivePlanDltipMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ReductionsForChangesInJudgment" abstract="false" name="ReductionsForChangesInJudgment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" abstract="false" name="ScheduleofLeaseTermandDiscountRateTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" abstract="false" name="GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" abstract="true" name="FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" abstract="true" name="TwoPointNineFivePercentSeniorNotesdueJune2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SupplementalDeferredCompensationPlanSalaryDeferral" abstract="false" name="SupplementalDeferredCompensationPlanSalaryDeferral" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_Mergerconsiderationpaidpayablenet" abstract="false" name="Mergerconsiderationpaidpayablenet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_TreasuryStockValueAcquiredCostMethod1" abstract="false" name="TreasuryStockValueAcquiredCostMethod1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_BusinessAcquisitionPostacquisitionRevenue" abstract="false" name="BusinessAcquisitionPostacquisitionRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" abstract="false" name="AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" abstract="true" name="CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_MobileMedicalExaminationServicesInc.MedXMMember" abstract="true" name="MobileMedicalExaminationServicesInc.MedXMMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_LoanCommitmentMaturingOctober2022Member" abstract="true" name="LoanCommitmentMaturingOctober2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_FourPointSevenFivePercentSeniorNotesDue2020Member" abstract="true" name="FourPointSevenFivePercentSeniorNotesDue2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" abstract="true" name="ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_AllotherservicesMember" abstract="true" name="AllotherservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ScheduleOfShareholdersEquityTable" abstract="true" name="ScheduleOfShareholdersEquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataTable" abstract="true" name="SupplementalCashFlowAndOtherDataTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" abstract="false" name="ScheduleOfLeaseByAssetTypeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member" abstract="true" name="FourPointSevenZeroPercentSeniorNotesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" abstract="true" name="FourPointTwoZeroPercentSeniorNotesdueJune2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_PatientMember" abstract="true" name="PatientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SupplementalCashFlowAndOtherDataLineItems" abstract="true" name="SupplementalCashFlowAndOtherDataLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_LeaseRemainingLeaseTerm" abstract="false" name="LeaseRemainingLeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dgx_MemorialHermannMember" abstract="true" name="MemorialHermannMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" abstract="false" name="ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_OperatingLeaseFixedAndVariableCost" abstract="false" name="OperatingLeaseFixedAndVariableCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DebtInstrumentLeverageRatioRequirement" abstract="false" name="DebtInstrumentLeverageRatioRequirement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_EquityinEarningsofEquityMethodInvesteesMember" abstract="true" name="EquityinEarningsofEquityMethodInvesteesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>dgx-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a87d206f-e33b-4d9f-a34a-b74e8733b14f,g:639ddba6-f3fe-4831-960f-76615a38edd9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_96503966-3c05-4e0d-8c4e-c35887fb9eec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9500acf5-2873-44d0-bf77-b9048a8bfca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_96503966-3c05-4e0d-8c4e-c35887fb9eec" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9500acf5-2873-44d0-bf77-b9048a8bfca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_fca5c361-0293-4de8-bde9-ba76a9f64dab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_96503966-3c05-4e0d-8c4e-c35887fb9eec" xlink:to="loc_us-gaap_LongTermDebtCurrent_fca5c361-0293-4de8-bde9-ba76a9f64dab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d23076b2-f282-41ce-b97f-2ecf097220aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_96503966-3c05-4e0d-8c4e-c35887fb9eec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d23076b2-f282-41ce-b97f-2ecf097220aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5ba13452-c552-47a5-8c38-158d63f9c682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b6f7a11c-b2b5-4c95-ab3b-1dccf550ed63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5ba13452-c552-47a5-8c38-158d63f9c682" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b6f7a11c-b2b5-4c95-ab3b-1dccf550ed63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_90925e1a-4cdd-45bb-8b28-6d8213b5d719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5ba13452-c552-47a5-8c38-158d63f9c682" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_90925e1a-4cdd-45bb-8b28-6d8213b5d719" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_09173493-5c37-465c-8411-6572af631217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5ba13452-c552-47a5-8c38-158d63f9c682" xlink:to="loc_us-gaap_InventoryNet_09173493-5c37-465c-8411-6572af631217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db1d33f8-94aa-43ef-8f85-4b010fadd72a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5ba13452-c552-47a5-8c38-158d63f9c682" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db1d33f8-94aa-43ef-8f85-4b010fadd72a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1febd981-ca26-47a5-a81c-6efae88037b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2ae7a6b9-cce4-44ad-8a31-a35df8690b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1febd981-ca26-47a5-a81c-6efae88037b8" xlink:to="loc_us-gaap_CommonStockValue_2ae7a6b9-cce4-44ad-8a31-a35df8690b1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5556b4d4-1730-4fa9-a422-ed55da2e4a31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1febd981-ca26-47a5-a81c-6efae88037b8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5556b4d4-1730-4fa9-a422-ed55da2e4a31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29c83c19-37f6-4074-8dec-d29af510fe71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1febd981-ca26-47a5-a81c-6efae88037b8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_29c83c19-37f6-4074-8dec-d29af510fe71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e27007f-1e2d-4d15-a3e3-70198ad67bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1febd981-ca26-47a5-a81c-6efae88037b8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e27007f-1e2d-4d15-a3e3-70198ad67bef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_45704dad-ef73-4955-9164-e161028b9339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1febd981-ca26-47a5-a81c-6efae88037b8" xlink:to="loc_us-gaap_TreasuryStockValue_45704dad-ef73-4955-9164-e161028b9339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fc45696a-3582-4851-86ef-e66e0d11a640" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c96de5fa-08b7-48c7-913e-9baeb86e2c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc45696a-3582-4851-86ef-e66e0d11a640" xlink:to="loc_us-gaap_AssetsCurrent_c96de5fa-08b7-48c7-913e-9baeb86e2c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_583a7a07-1dc3-49c6-9ebc-0b50e4ecade6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc45696a-3582-4851-86ef-e66e0d11a640" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_583a7a07-1dc3-49c6-9ebc-0b50e4ecade6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4516b4e2-972d-4767-b54b-2b6d82ebd204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc45696a-3582-4851-86ef-e66e0d11a640" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4516b4e2-972d-4767-b54b-2b6d82ebd204" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_460c95ce-f97e-4161-a1ba-431675962a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc45696a-3582-4851-86ef-e66e0d11a640" xlink:to="loc_us-gaap_Goodwill_460c95ce-f97e-4161-a1ba-431675962a8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_273cbb8f-f7ea-4ad3-8f2f-16eb0be20be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc45696a-3582-4851-86ef-e66e0d11a640" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_273cbb8f-f7ea-4ad3-8f2f-16eb0be20be0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_39ffb421-9314-44d3-a7de-cc98f46a962c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc45696a-3582-4851-86ef-e66e0d11a640" xlink:to="loc_us-gaap_EquityMethodInvestments_39ffb421-9314-44d3-a7de-cc98f46a962c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_214f89e2-e90e-4c31-b97b-216a1830c7b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_fc45696a-3582-4851-86ef-e66e0d11a640" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_214f89e2-e90e-4c31-b97b-216a1830c7b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_18b6d265-c826-448a-859c-939274ff849d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0223a0fd-1821-49c8-b031-46b7098d569e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_18b6d265-c826-448a-859c-939274ff849d" xlink:to="loc_us-gaap_StockholdersEquity_0223a0fd-1821-49c8-b031-46b7098d569e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d09f4b6b-a304-47ad-928a-16c0ea248b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_18b6d265-c826-448a-859c-939274ff849d" xlink:to="loc_us-gaap_MinorityInterest_d09f4b6b-a304-47ad-928a-16c0ea248b7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5cab972b-e28a-4bc3-9a25-335b2b9a3c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b353f169-6c81-4aef-ba3b-85ba43f2b151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5cab972b-e28a-4bc3-9a25-335b2b9a3c1a" xlink:to="loc_us-gaap_LiabilitiesCurrent_b353f169-6c81-4aef-ba3b-85ba43f2b151" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1c4fb060-0452-45c4-80af-9fd6cf01f326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5cab972b-e28a-4bc3-9a25-335b2b9a3c1a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_1c4fb060-0452-45c4-80af-9fd6cf01f326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e26923e6-7fd3-4d59-9ff0-0ea2ac4a51fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5cab972b-e28a-4bc3-9a25-335b2b9a3c1a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e26923e6-7fd3-4d59-9ff0-0ea2ac4a51fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_902fe283-06b7-4b2f-96bf-67e02a72d785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5cab972b-e28a-4bc3-9a25-335b2b9a3c1a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_902fe283-06b7-4b2f-96bf-67e02a72d785" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_62dc3742-21c0-4ee5-8241-adc7e343ee8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5cab972b-e28a-4bc3-9a25-335b2b9a3c1a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_62dc3742-21c0-4ee5-8241-adc7e343ee8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e737896d-6bd5-409d-97e9-5131c2d70c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5cab972b-e28a-4bc3-9a25-335b2b9a3c1a" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e737896d-6bd5-409d-97e9-5131c2d70c7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f94b4c59-f4a9-45da-9db7-798d90805430" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_5cab972b-e28a-4bc3-9a25-335b2b9a3c1a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f94b4c59-f4a9-45da-9db7-798d90805430" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7c59002d-b3c3-49e0-9bb0-fe39064aa6a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8b313187-864e-4337-866a-775c5bbf0fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7c59002d-b3c3-49e0-9bb0-fe39064aa6a8" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8b313187-864e-4337-866a-775c5bbf0fbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ac6ef7d9-321d-4d77-b318-bb8ac1436273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7c59002d-b3c3-49e0-9bb0-fe39064aa6a8" xlink:to="loc_us-gaap_CostOfRevenue_ac6ef7d9-321d-4d77-b318-bb8ac1436273" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_e83e2cc1-1364-4555-926f-2f397e68ade7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7c59002d-b3c3-49e0-9bb0-fe39064aa6a8" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_e83e2cc1-1364-4555-926f-2f397e68ade7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_04a293f1-9673-4db5-aa5c-d6f11c41408d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7c59002d-b3c3-49e0-9bb0-fe39064aa6a8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_04a293f1-9673-4db5-aa5c-d6f11c41408d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4e393cc8-c719-4de4-892e-18f575708a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6c2777ce-5a45-48bd-8a26-7a3c334fcc73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4e393cc8-c719-4de4-892e-18f575708a0a" xlink:to="loc_us-gaap_ProfitLoss_6c2777ce-5a45-48bd-8a26-7a3c334fcc73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2cc2fe8c-676c-4f52-b76f-b0b6a1816022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4e393cc8-c719-4de4-892e-18f575708a0a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2cc2fe8c-676c-4f52-b76f-b0b6a1816022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ce7b7431-fff3-47fc-aad6-a9edef824518" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a30807f7-e5e2-42e2-94f0-15d3f21ff037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_ce7b7431-fff3-47fc-aad6-a9edef824518" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a30807f7-e5e2-42e2-94f0-15d3f21ff037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_9bb91472-7307-48e1-9d02-eed24c1aebe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_ce7b7431-fff3-47fc-aad6-a9edef824518" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_9bb91472-7307-48e1-9d02-eed24c1aebe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_890fded8-c2e4-4409-97fd-3649a1fddec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_54a0102d-c6e0-4471-a914-c343db6c4fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_890fded8-c2e4-4409-97fd-3649a1fddec4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_54a0102d-c6e0-4471-a914-c343db6c4fb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_fdf1c5bb-1a0f-4643-83d5-7d72ea9e4e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_890fded8-c2e4-4409-97fd-3649a1fddec4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_fdf1c5bb-1a0f-4643-83d5-7d72ea9e4e34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5058cde1-065c-4a73-bb24-c1ce111b3627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e54792ac-7dfc-48e0-9d11-0c73ee726b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_5058cde1-065c-4a73-bb24-c1ce111b3627" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e54792ac-7dfc-48e0-9d11-0c73ee726b5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6b28f088-003a-43f4-9641-757203d71a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_5058cde1-065c-4a73-bb24-c1ce111b3627" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_6b28f088-003a-43f4-9641-757203d71a5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_61b382b3-8735-4a7d-9a20-ddd31000bb98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_3722fefa-49b2-4fa3-ba89-91c22cc6938f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_61b382b3-8735-4a7d-9a20-ddd31000bb98" xlink:to="loc_us-gaap_CostsAndExpenses_3722fefa-49b2-4fa3-ba89-91c22cc6938f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6682efbc-c8a7-4200-95a1-7e51efd5cc78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_61b382b3-8735-4a7d-9a20-ddd31000bb98" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6682efbc-c8a7-4200-95a1-7e51efd5cc78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_373d1317-0a07-4a4a-bc2e-841ca66a89a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_641ff327-5a34-44ef-a8d6-17164ab5e4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_373d1317-0a07-4a4a-bc2e-841ca66a89a2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_641ff327-5a34-44ef-a8d6-17164ab5e4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5dfeb0c2-d4ee-45b8-979e-28cfb8e667e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_373d1317-0a07-4a4a-bc2e-841ca66a89a2" xlink:to="loc_us-gaap_OperatingIncomeLoss_5dfeb0c2-d4ee-45b8-979e-28cfb8e667e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ec292f63-9385-479e-baa1-c966df564b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_65c2bfdf-62f5-4d55-be40-e0f5a4d32c45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ec292f63-9385-479e-baa1-c966df564b8e" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_65c2bfdf-62f5-4d55-be40-e0f5a4d32c45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ee7f00c6-5dae-43eb-b39a-637abeb397cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_ec292f63-9385-479e-baa1-c966df564b8e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ee7f00c6-5dae-43eb-b39a-637abeb397cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_28e258c2-6cb0-47c0-be38-f580a3d861c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e3714dd2-6328-49b5-9499-54c17d5f5986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_28e258c2-6cb0-47c0-be38-f580a3d861c6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e3714dd2-6328-49b5-9499-54c17d5f5986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cb3ad317-742f-44fb-a256-aca0a4b2b90e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_28e258c2-6cb0-47c0-be38-f580a3d861c6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cb3ad317-742f-44fb-a256-aca0a4b2b90e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_357ef8f6-c9a1-4e15-a18c-635235b69a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_28e258c2-6cb0-47c0-be38-f580a3d861c6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_357ef8f6-c9a1-4e15-a18c-635235b69a42" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS_1"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a9c4b18e-719d-4322-8f7f-858d1c54b2bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_bb4f89a8-964f-4d83-a716-ebc1752edf61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a9c4b18e-719d-4322-8f7f-858d1c54b2bd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_bb4f89a8-964f-4d83-a716-ebc1752edf61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_b02a0e3e-3acc-454b-aa1c-a434056327f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a9c4b18e-719d-4322-8f7f-858d1c54b2bd" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_b02a0e3e-3acc-454b-aa1c-a434056327f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0d010ccc-ffd2-4c8f-acec-c58a321e8faa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0c6b6aab-68e3-40fa-bf42-91496c0de1b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0d010ccc-ffd2-4c8f-acec-c58a321e8faa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0c6b6aab-68e3-40fa-bf42-91496c0de1b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_53ffc293-0fe0-4643-bdec-995bdcdb7c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0d010ccc-ffd2-4c8f-acec-c58a321e8faa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_53ffc293-0fe0-4643-bdec-995bdcdb7c3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_2ce2656c-20c8-43d8-b6f0-65ef1618d2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0d010ccc-ffd2-4c8f-acec-c58a321e8faa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_2ce2656c-20c8-43d8-b6f0-65ef1618d2ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6a79b6fc-f3fc-4550-8f57-db40ccf1f754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5a7dddd9-dce7-4288-b509-0b66e2c7fa03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6a79b6fc-f3fc-4550-8f57-db40ccf1f754" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5a7dddd9-dce7-4288-b509-0b66e2c7fa03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a6d09674-9edd-4e15-b24e-4164cc0236be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6a79b6fc-f3fc-4550-8f57-db40ccf1f754" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a6d09674-9edd-4e15-b24e-4164cc0236be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_23607b23-765b-43b2-8756-18b07bc3521c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6adbb7f-43db-4fec-b95b-32cf69306843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_23607b23-765b-43b2-8756-18b07bc3521c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6adbb7f-43db-4fec-b95b-32cf69306843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_574c9dd5-0d60-4837-a2ec-67d1c95487fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_23607b23-765b-43b2-8756-18b07bc3521c" xlink:to="loc_us-gaap_ProfitLoss_574c9dd5-0d60-4837-a2ec-67d1c95487fc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_dfa8eb59-6706-4b44-8970-765294a8d538" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_ProfitLoss_dfa8eb59-6706-4b44-8970-765294a8d538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0e9f369e-76a1-49a8-82a7-52b0c41fa767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0e9f369e-76a1-49a8-82a7-52b0c41fa767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_93f82713-d2f8-4498-9354-84ef29017b4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_93f82713-d2f8-4498-9354-84ef29017b4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_29ad3f9e-19b3-424f-bd0d-751e56e16574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_29ad3f9e-19b3-424f-bd0d-751e56e16574" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e6b6df36-c8ad-4ca4-9d66-1ce4fa340db0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_ShareBasedCompensation_e6b6df36-c8ad-4ca4-9d66-1ce4fa340db0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_faae5d61-a9ae-4882-b273-77af3bff5d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_faae5d61-a9ae-4882-b273-77af3bff5d3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23d8aff3-03ac-489f-97a5-c37b98b34492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_23d8aff3-03ac-489f-97a5-c37b98b34492" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_52ee467e-6c8b-4ce7-b337-121bb1f2a23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_52ee467e-6c8b-4ce7-b337-121bb1f2a23b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements_5ebcfa4e-ffb4-4769-8c8b-1dc5566a194a" xlink:href="dgx-20201231.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_dgx_TerminationOfInterestRateSwapAgreements_5ebcfa4e-ffb4-4769-8c8b-1dc5566a194a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_22de6a46-8662-450a-a395-ac0d7e1a33d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_22de6a46-8662-450a-a395-ac0d7e1a33d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_067de3ce-e211-4294-8868-7fd44e7ab9a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_067de3ce-e211-4294-8868-7fd44e7ab9a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_35876009-3f44-4607-9743-329d16eb5caa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a90f231-774b-4f0c-b5e7-fa7cf2dd6522" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_35876009-3f44-4607-9743-329d16eb5caa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_50569519-7662-46de-bf51-7a28d39faec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_50569519-7662-46de-bf51-7a28d39faec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_355e066e-f82e-4f90-9b15-9bd946685787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_355e066e-f82e-4f90-9b15-9bd946685787" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_0adcd83f-9613-41b9-85b3-599e608c5b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_0adcd83f-9613-41b9-85b3-599e608c5b2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f79d0a6b-d740-43f7-9829-c83387f6df8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f79d0a6b-d740-43f7-9829-c83387f6df8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_c9ffc7dd-42ab-4649-804a-3bc3fb017bb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_c9ffc7dd-42ab-4649-804a-3bc3fb017bb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_add06192-6f6b-4ec5-aae2-cfcc8a6d9e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_add06192-6f6b-4ec5-aae2-cfcc8a6d9e9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_759239ae-cb15-4ec9-9a52-62721e561804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_759239ae-cb15-4ec9-9a52-62721e561804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_6698a05e-0565-48b7-8f51-2a01307873f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_RepaymentsOfDebt_6698a05e-0565-48b7-8f51-2a01307873f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_9ba0d448-61d4-49a6-9547-6f61e7468ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c01d417c-fa5e-4d3f-818d-55a1e1f8fd00" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_9ba0d448-61d4-49a6-9547-6f61e7468ddb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b7f172f-7a6f-46a0-94b3-11b7ffddee77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9f2b9f4d-f384-4e27-96ba-8f0f605cf010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b7f172f-7a6f-46a0-94b3-11b7ffddee77" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9f2b9f4d-f384-4e27-96ba-8f0f605cf010" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b485a608-f43f-4729-93bb-5aa77c244722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b7f172f-7a6f-46a0-94b3-11b7ffddee77" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b485a608-f43f-4729-93bb-5aa77c244722" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_48c39a36-fb8d-4d06-8fe9-0f740ef3c627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b7f172f-7a6f-46a0-94b3-11b7ffddee77" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_48c39a36-fb8d-4d06-8fe9-0f740ef3c627" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3f7121cb-1a4b-4196-891b-e8cfd64edb84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3b7f172f-7a6f-46a0-94b3-11b7ffddee77" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3f7121cb-1a4b-4196-891b-e8cfd64edb84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_84e49b36-f302-4134-8b20-f36de13ef6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a19c63ce-8acc-4cd9-8d40-9355df21c6e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_84e49b36-f302-4134-8b20-f36de13ef6cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a19c63ce-8acc-4cd9-8d40-9355df21c6e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1533c99e-a870-4ac3-b2ab-58f3af81439c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_84e49b36-f302-4134-8b20-f36de13ef6cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1533c99e-a870-4ac3-b2ab-58f3af81439c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2ea7d057-7c6b-4ba1-8de6-ee82e1a23570" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_84e49b36-f302-4134-8b20-f36de13ef6cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2ea7d057-7c6b-4ba1-8de6-ee82e1a23570" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20201231.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITION"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITIONTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITIONDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSPERSHARE"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSLOSSPERSHARETables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSLOSSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7c4ff24-6ba4-4a85-8034-a290b0344537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a13de83-8278-488b-a645-125e37a8981e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7c4ff24-6ba4-4a85-8034-a290b0344537" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6a13de83-8278-488b-a645-125e37a8981e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c638d9c0-c81c-4f7e-8a08-39c7f0496c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c7c4ff24-6ba4-4a85-8034-a290b0344537" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c638d9c0-c81c-4f7e-8a08-39c7f0496c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_9fa6ac2e-d941-4092-b7e8-f80a8c434411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_40658236-6353-43b9-ae28-ee2ede4983d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_9fa6ac2e-d941-4092-b7e8-f80a8c434411" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_40658236-6353-43b9-ae28-ee2ede4983d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_217b78b3-ec24-4157-80dd-962afdf87411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_9fa6ac2e-d941-4092-b7e8-f80a8c434411" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_217b78b3-ec24-4157-80dd-962afdf87411" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8d0347f0-64c1-4caf-9160-d93ea258737e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_5b66777a-e7da-4751-b46a-407988ef0243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_8d0347f0-64c1-4caf-9160-d93ea258737e" xlink:to="loc_us-gaap_SeveranceCosts1_5b66777a-e7da-4751-b46a-407988ef0243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_1a17d98d-0945-453b-ab91-81d0da992d51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_8d0347f0-64c1-4caf-9160-d93ea258737e" xlink:to="loc_us-gaap_OtherRestructuringCosts_1a17d98d-0945-453b-ab91-81d0da992d51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_9f03ba0e-f039-4503-ba0c-ade4a9fb4a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_8d0347f0-64c1-4caf-9160-d93ea258737e" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_9f03ba0e-f039-4503-ba0c-ade4a9fb4a16" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSACQUISITIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_85f06f9b-3327-4494-8615-3c2861cc8931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_b761e5d4-cded-486f-8457-d0254e8e3d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_85f06f9b-3327-4494-8615-3c2861cc8931" xlink:to="loc_us-gaap_TradingSecurities_b761e5d4-cded-486f-8457-d0254e8e3d7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_169ab133-4920-4c6b-8edd-09419e4d73ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_85f06f9b-3327-4494-8615-3c2861cc8931" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_169ab133-4920-4c6b-8edd-09419e4d73ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2d057735-3e38-4bb0-a3fe-09c0abddd4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_85f06f9b-3327-4494-8615-3c2861cc8931" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2d057735-3e38-4bb0-a3fe-09c0abddd4f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_e9d61c87-67ca-42b7-8e7c-380ab0cb5b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1e7401dd-32f1-4c9d-87a4-9f5daecc8063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e9d61c87-67ca-42b7-8e7c-380ab0cb5b73" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_1e7401dd-32f1-4c9d-87a4-9f5daecc8063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_02ff47e0-6e44-4dda-939f-8d13e1fc654c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e9d61c87-67ca-42b7-8e7c-380ab0cb5b73" xlink:to="loc_us-gaap_DerivativeLiabilities_02ff47e0-6e44-4dda-939f-8d13e1fc654c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3aec572b-270c-41e4-8f89-9a4a09b610a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e9d61c87-67ca-42b7-8e7c-380ab0cb5b73" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3aec572b-270c-41e4-8f89-9a4a09b610a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOME"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMETables" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOMETables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOMEDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_86ec5af0-6af7-43d6-b4d6-415513b71a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2b6a2bd4-f884-4583-91fd-2177210060a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_86ec5af0-6af7-43d6-b4d6-415513b71a66" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_2b6a2bd4-f884-4583-91fd-2177210060a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b2af785e-cf2a-4a15-a796-92f2edc9381a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_86ec5af0-6af7-43d6-b4d6-415513b71a66" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_b2af785e-cf2a-4a15-a796-92f2edc9381a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e7b8c12e-38ed-4f4d-a1d7-1e0fa86218ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_86ec5af0-6af7-43d6-b4d6-415513b71a66" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e7b8c12e-38ed-4f4d-a1d7-1e0fa86218ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fce1ccf2-b9d4-42ca-a549-b34a03849ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_86ec5af0-6af7-43d6-b4d6-415513b71a66" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_fce1ccf2-b9d4-42ca-a549-b34a03849ed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d37a43d3-56a1-4a82-acfb-5def3524adc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_86ec5af0-6af7-43d6-b4d6-415513b71a66" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_d37a43d3-56a1-4a82-acfb-5def3524adc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d6966074-1538-40e4-bb81-f5758c5e1295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_86ec5af0-6af7-43d6-b4d6-415513b71a66" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d6966074-1538-40e4-bb81-f5758c5e1295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_775f223b-08b0-499e-8277-8ebcc4802bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_775f223b-08b0-499e-8277-8ebcc4802bd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8c60905b-fd4e-442b-87c2-a4e9b7adfff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_8c60905b-fd4e-442b-87c2-a4e9b7adfff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_ba89b0f6-e523-485e-8180-b0cdb75683f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_ba89b0f6-e523-485e-8180-b0cdb75683f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a535a12c-036a-4582-8663-8df140c83d64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a535a12c-036a-4582-8663-8df140c83d64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_54dfe887-fbb3-4d61-ad79-9fa6838eb106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_54dfe887-fbb3-4d61-ad79-9fa6838eb106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_29142d0d-c945-4afa-91f1-29b5bd0f421a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_29142d0d-c945-4afa-91f1-29b5bd0f421a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_630eb46d-03d6-4ded-ba8d-95541c71887d" xlink:href="dgx-20201231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_630eb46d-03d6-4ded-ba8d-95541c71887d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_52a8e2c2-fb81-4afc-9755-ab1ff97c2138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_52a8e2c2-fb81-4afc-9755-ab1ff97c2138" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_9b5003e6-639c-4b2f-85ad-be6472371604" xlink:href="dgx-20201231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_9b5003e6-639c-4b2f-85ad-be6472371604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d3030602-ae5d-46c3-bb22-2130d0bd7622" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b88e0b22-f882-4146-9162-56d9fe9ccf66" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_d3030602-ae5d-46c3-bb22-2130d0bd7622" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATA"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATATables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATADetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_bf3e6566-9121-435b-be66-cad406cf0235" xlink:href="dgx-20201231.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_383d6d82-6ccf-4c4f-abca-61e6a95deef6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_bf3e6566-9121-435b-be66-cad406cf0235" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_383d6d82-6ccf-4c4f-abca-61e6a95deef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_14f42ef9-4e8c-468a-b4ec-ac51504eba5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_bf3e6566-9121-435b-be66-cad406cf0235" xlink:to="loc_us-gaap_LiabilitiesAssumed1_14f42ef9-4e8c-468a-b4ec-ac51504eba5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_5f2ff04a-e97f-4250-b3ad-f4de87fcbcba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_842b7a72-62dc-4013-89a8-3dba08021a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_5f2ff04a-e97f-4250-b3ad-f4de87fcbcba" xlink:to="loc_us-gaap_InterestExpense_842b7a72-62dc-4013-89a8-3dba08021a49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_eb37dc14-57ba-49be-9700-b0bed60001c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_5f2ff04a-e97f-4250-b3ad-f4de87fcbcba" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_eb37dc14-57ba-49be-9700-b0bed60001c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bf0e5232-606e-4509-a5a1-32005132ef1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a92c8e8c-8355-4c17-949b-6d834023ebe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bf0e5232-606e-4509-a5a1-32005132ef1c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a92c8e8c-8355-4c17-949b-6d834023ebe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_e185e63c-7307-43c0-aedf-393b89d92061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bf0e5232-606e-4509-a5a1-32005132ef1c" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_e185e63c-7307-43c0-aedf-393b89d92061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8eb4d8c2-11b1-4eeb-8867-85306c8dcb94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c9ca81db-44ff-4a31-b587-71326c150a7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_8eb4d8c2-11b1-4eeb-8867-85306c8dcb94" xlink:to="loc_us-gaap_Depreciation_c9ca81db-44ff-4a31-b587-71326c150a7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_18bcc5af-3829-42e1-96dd-d6bf07c90f49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_8eb4d8c2-11b1-4eeb-8867-85306c8dcb94" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_18bcc5af-3829-42e1-96dd-d6bf07c90f49" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_89bf88bd-1963-4055-8132-51cda568da90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_7df2a5eb-b487-4dbd-a818-70266b777800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_89bf88bd-1963-4055-8132-51cda568da90" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_7df2a5eb-b487-4dbd-a818-70266b777800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_efee7bb9-32d2-4d20-8c1e-29d90471d806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_89bf88bd-1963-4055-8132-51cda568da90" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_efee7bb9-32d2-4d20-8c1e-29d90471d806" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_d634905d-8ec2-4e2a-8010-7d0f82c658e9" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6fe0e1a8-f800-475d-8503-3659b7b5a093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_d634905d-8ec2-4e2a-8010-7d0f82c658e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6fe0e1a8-f800-475d-8503-3659b7b5a093" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_52b50827-ce2c-42a7-9750-110b7bf926ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_d634905d-8ec2-4e2a-8010-7d0f82c658e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_52b50827-ce2c-42a7-9750-110b7bf926ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_95dec9e8-9953-4fec-a8bd-75fe359fc4a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_d634905d-8ec2-4e2a-8010-7d0f82c658e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_95dec9e8-9953-4fec-a8bd-75fe359fc4a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cda2acdc-563c-4052-b956-38c48a29519c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_d634905d-8ec2-4e2a-8010-7d0f82c658e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cda2acdc-563c-4052-b956-38c48a29519c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1c17dae5-b15e-4788-bbb8-5a88db9b205d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_d634905d-8ec2-4e2a-8010-7d0f82c658e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1c17dae5-b15e-4788-bbb8-5a88db9b205d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_62676433-49cb-4dbf-b7ea-de82f0d124b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_d634905d-8ec2-4e2a-8010-7d0f82c658e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_62676433-49cb-4dbf-b7ea-de82f0d124b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_d197a4c0-2b05-418c-9dc9-71b096b43c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_d197a4c0-2b05-418c-9dc9-71b096b43c00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0a1497aa-b9ef-4630-ac2e-8ea24ed8eb23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0a1497aa-b9ef-4630-ac2e-8ea24ed8eb23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_c0c9944e-9f29-4c06-b8d3-a2fc09c01d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_c0c9944e-9f29-4c06-b8d3-a2fc09c01d48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_4854e9e1-8ecc-4446-a6fc-5616c3747c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_us-gaap_InterestPayableCurrent_4854e9e1-8ecc-4446-a6fc-5616c3747c95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7c345fef-f80e-4ba3-9bd8-de9a32873b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7c345fef-f80e-4ba3-9bd8-de9a32873b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MergerConsiderationPayableCurrent_909626a3-d2fa-4ea7-900c-b7f109b255e2" xlink:href="dgx-20201231.xsd#dgx_MergerConsiderationPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_dgx_MergerConsiderationPayableCurrent_909626a3-d2fa-4ea7-900c-b7f109b255e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_b90aa00f-649f-400b-8df3-2524cfe5d6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_us-gaap_DividendsPayableCurrent_b90aa00f-649f-400b-8df3-2524cfe5d6e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_f6f29820-ff79-4a48-8a29-e0b799a2b55a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_f6f29820-ff79-4a48-8a29-e0b799a2b55a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankOverdrafts_6d599d29-7adc-4094-b200-4541647bf0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankOverdrafts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_332c1db7-6959-4f84-b723-d7b44777f60c" xlink:to="loc_us-gaap_BankOverdrafts_6d599d29-7adc-4094-b200-4541647bf0f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBT" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBT"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBT" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b2f12384-c8a9-41e8-b2d6-4730de53d2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_dfc0efcd-515e-43dc-aa3f-c14c4e4653f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b2f12384-c8a9-41e8-b2d6-4730de53d2bb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_dfc0efcd-515e-43dc-aa3f-c14c4e4653f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_37759194-7abb-4e72-8d2a-8dcc010711af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b2f12384-c8a9-41e8-b2d6-4730de53d2bb" xlink:to="loc_us-gaap_LongTermDebtCurrent_37759194-7abb-4e72-8d2a-8dcc010711af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSecuredReceivablesCreditFacilityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSeniorNotesOfferingDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c8e32e9b-9d58-4169-8d52-43728f481559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LongTermDebtMaturitiesGross_b05a0626-67eb-45a5-861f-e314f508f728" xlink:href="dgx-20201231.xsd#dgx_LongTermDebtMaturitiesGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c8e32e9b-9d58-4169-8d52-43728f481559" xlink:to="loc_dgx_LongTermDebtMaturitiesGross_b05a0626-67eb-45a5-861f-e314f508f728" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_da427843-c3cb-44f4-8185-afcbef65b7b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c8e32e9b-9d58-4169-8d52-43728f481559" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_da427843-c3cb-44f4-8185-afcbef65b7b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_2e5746df-501e-478a-96fb-992ca3412021" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c8e32e9b-9d58-4169-8d52-43728f481559" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_2e5746df-501e-478a-96fb-992ca3412021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_8d7bf9ce-5481-4dca-b443-7f5f15450588" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c8e32e9b-9d58-4169-8d52-43728f481559" xlink:to="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_8d7bf9ce-5481-4dca-b443-7f5f15450588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LongTermDebtMaturitiesGross_3dcc9690-0ddd-4ebe-b38c-9e24bd2884b9" xlink:href="dgx-20201231.xsd#dgx_LongTermDebtMaturitiesGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_cc302a3a-90eb-4fc5-a223-ea00c5d5ec1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_3dcc9690-0ddd-4ebe-b38c-9e24bd2884b9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_cc302a3a-90eb-4fc5-a223-ea00c5d5ec1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_dc0785a6-b41f-487b-9020-e27c7faabb6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_3dcc9690-0ddd-4ebe-b38c-9e24bd2884b9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_dc0785a6-b41f-487b-9020-e27c7faabb6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e70903fc-9955-461f-be97-59d6e0c46e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_3dcc9690-0ddd-4ebe-b38c-9e24bd2884b9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e70903fc-9955-461f-be97-59d6e0c46e14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_75e1d876-ffb7-4939-aef1-177025132f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_3dcc9690-0ddd-4ebe-b38c-9e24bd2884b9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_75e1d876-ffb7-4939-aef1-177025132f86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_85350a54-255e-4907-ab56-6c9ebe298958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_3dcc9690-0ddd-4ebe-b38c-9e24bd2884b9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_85350a54-255e-4907-ab56-6c9ebe298958" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_caf527d0-70e2-40ba-9536-f7528f8a5b9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LongTermDebtMaturitiesGross_3dcc9690-0ddd-4ebe-b38c-9e24bd2884b9" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_caf527d0-70e2-40ba-9536-f7528f8a5b9c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASES" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRightofUseAsset_1eaf236b-8500-48f7-bb68-cc5c00ad6186" xlink:href="dgx-20201231.xsd#dgx_LeaseRightofUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8e479d17-4b00-4daf-aa02-bcb153490b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseRightofUseAsset_1eaf236b-8500-48f7-bb68-cc5c00ad6186" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8e479d17-4b00-4daf-aa02-bcb153490b85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_a245b670-2b18-46f9-8cb1-9c95c9e71198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseRightofUseAsset_1eaf236b-8500-48f7-bb68-cc5c00ad6186" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_a245b670-2b18-46f9-8cb1-9c95c9e71198" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseLiability_73ccf8f0-2f1c-43dd-b963-da25d1607ff1" xlink:href="dgx-20201231.xsd#dgx_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a4a484b5-273a-483b-8603-70f7486d82ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseLiability_73ccf8f0-2f1c-43dd-b963-da25d1607ff1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a4a484b5-273a-483b-8603-70f7486d82ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d8530ab8-ba58-411d-8e83-e38a4fe23a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseLiability_73ccf8f0-2f1c-43dd-b963-da25d1607ff1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d8530ab8-ba58-411d-8e83-e38a4fe23a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3125a44f-5ba9-4160-a367-cef73da1490d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseLiability_73ccf8f0-2f1c-43dd-b963-da25d1607ff1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3125a44f-5ba9-4160-a367-cef73da1490d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3193e42f-21de-4f0c-ba58-ceb22a2cb138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LeaseLiability_73ccf8f0-2f1c-43dd-b963-da25d1607ff1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3193e42f-21de-4f0c-ba58-ceb22a2cb138" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESCostsDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_b96fc3f6-6df7-4982-8879-efe87955174f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3bdbecd5-cf40-4771-ac21-6d6d658f24b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b96fc3f6-6df7-4982-8879-efe87955174f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3bdbecd5-cf40-4771-ac21-6d6d658f24b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingLeaseFixedAndVariableCost_68dc4128-0a2e-4038-ad0a-9b04aaac9701" xlink:href="dgx-20201231.xsd#dgx_OperatingLeaseFixedAndVariableCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b96fc3f6-6df7-4982-8879-efe87955174f" xlink:to="loc_dgx_OperatingLeaseFixedAndVariableCost_68dc4128-0a2e-4038-ad0a-9b04aaac9701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_b864d0d2-6887-4d22-845f-8320aacd1726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b96fc3f6-6df7-4982-8879-efe87955174f" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_b864d0d2-6887-4d22-845f-8320aacd1726" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESMaturityDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ebe59401-2cb1-428e-9cf7-4d5758e1b2d3" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b9676f61-4a68-4de9-9cab-2cc6f1219e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ebe59401-2cb1-428e-9cf7-4d5758e1b2d3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b9676f61-4a68-4de9-9cab-2cc6f1219e40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d89987df-7f4b-46c3-aaf1-6350889c3c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ebe59401-2cb1-428e-9cf7-4d5758e1b2d3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d89987df-7f4b-46c3-aaf1-6350889c3c8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_d968ff97-f85f-4fea-b9c9-9c300528b61a" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f1b9c5d6-8114-44cd-b0b4-9b4e5ce031eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_d968ff97-f85f-4fea-b9c9-9c300528b61a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f1b9c5d6-8114-44cd-b0b4-9b4e5ce031eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1488fbf2-6b90-4646-98d4-5fc4e6f7a7f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_d968ff97-f85f-4fea-b9c9-9c300528b61a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1488fbf2-6b90-4646-98d4-5fc4e6f7a7f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_3795a103-0921-4dc0-a62c-08d404f3768d" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8a09f17f-209b-4928-840b-ab5b09d729a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_3795a103-0921-4dc0-a62c-08d404f3768d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8a09f17f-209b-4928-840b-ab5b09d729a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_53424e35-2455-4e97-9261-71c617270938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_3795a103-0921-4dc0-a62c-08d404f3768d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_53424e35-2455-4e97-9261-71c617270938" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingandFinanceLeaseLiability_4326ec2d-3780-48da-8b6e-b671c2992fa9" xlink:href="dgx-20201231.xsd#dgx_OperatingandFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f4d83495-b315-4954-8072-8bdb49bfcdad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_OperatingandFinanceLeaseLiability_4326ec2d-3780-48da-8b6e-b671c2992fa9" xlink:to="loc_us-gaap_OperatingLeaseLiability_f4d83495-b315-4954-8072-8bdb49bfcdad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_f5d9d23c-af24-452c-a7d2-6f0194a1c60e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_OperatingandFinanceLeaseLiability_4326ec2d-3780-48da-8b6e-b671c2992fa9" xlink:to="loc_us-gaap_FinanceLeaseLiability_f5d9d23c-af24-452c-a7d2-6f0194a1c60e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_587cceb0-f79c-4798-9784-3b8f51d3e1fb" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f9706044-6efd-4eff-8fd7-4fa9f2634d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_587cceb0-f79c-4798-9784-3b8f51d3e1fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f9706044-6efd-4eff-8fd7-4fa9f2634d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_214dfd77-3b71-46da-ae83-1181eee4db02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_587cceb0-f79c-4798-9784-3b8f51d3e1fb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_214dfd77-3b71-46da-ae83-1181eee4db02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d0f12968-c53a-4ab1-92bd-87442e3ccfaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6ff971d5-00f5-4385-8334-6a56043bef40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d0f12968-c53a-4ab1-92bd-87442e3ccfaf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_6ff971d5-00f5-4385-8334-6a56043bef40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1dbad745-5a54-4a12-9093-08d095f0c575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d0f12968-c53a-4ab1-92bd-87442e3ccfaf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1dbad745-5a54-4a12-9093-08d095f0c575" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa792930-f02a-4ab2-9d8c-3dfb9fc4aa74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d0f12968-c53a-4ab1-92bd-87442e3ccfaf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fa792930-f02a-4ab2-9d8c-3dfb9fc4aa74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2b6d97e4-fad1-4c67-97f8-68236050fd19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d0f12968-c53a-4ab1-92bd-87442e3ccfaf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2b6d97e4-fad1-4c67-97f8-68236050fd19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3014e8de-a8e8-4569-94c9-f6a935eb8f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d0f12968-c53a-4ab1-92bd-87442e3ccfaf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3014e8de-a8e8-4569-94c9-f6a935eb8f36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_37b96704-dea3-4fa8-baf2-d4967d61aa9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d0f12968-c53a-4ab1-92bd-87442e3ccfaf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_37b96704-dea3-4fa8-baf2-d4967d61aa9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_0c7cdbed-51bb-4bfa-a439-13fd51664af1" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9ac0a570-caed-4dcf-8c3d-52220334ab01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_0c7cdbed-51bb-4bfa-a439-13fd51664af1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9ac0a570-caed-4dcf-8c3d-52220334ab01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_8c525aa1-2ebd-48ae-89cd-5f402702e951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_0c7cdbed-51bb-4bfa-a439-13fd51664af1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_8c525aa1-2ebd-48ae-89cd-5f402702e951" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7a78e4f-d7fc-4ade-af0d-ae3b3729cae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c68c82c5-e184-40ec-beaf-202d4d0a782d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7a78e4f-d7fc-4ade-af0d-ae3b3729cae2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c68c82c5-e184-40ec-beaf-202d4d0a782d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_44ae72e8-d80a-4301-ad53-73268eaf07a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7a78e4f-d7fc-4ade-af0d-ae3b3729cae2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_44ae72e8-d80a-4301-ad53-73268eaf07a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_14c8ec99-d9f0-4129-a1ad-cf18288bd2cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7a78e4f-d7fc-4ade-af0d-ae3b3729cae2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_14c8ec99-d9f0-4129-a1ad-cf18288bd2cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_8a69f6c9-81fb-4ced-bb83-c279cbb44031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7a78e4f-d7fc-4ade-af0d-ae3b3729cae2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_8a69f6c9-81fb-4ced-bb83-c279cbb44031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_7c476b6a-cb18-4d7e-90b6-5b3c74f29065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7a78e4f-d7fc-4ade-af0d-ae3b3729cae2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_7c476b6a-cb18-4d7e-90b6-5b3c74f29065" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_147ceb84-f7aa-4dba-8f77-56963f593131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d7a78e4f-d7fc-4ade-af0d-ae3b3729cae2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_147ceb84-f7aa-4dba-8f77-56963f593131" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_84ee60f1-8542-4dc9-8bf2-f20c6da1ea64" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cc309090-124b-4777-b4d4-59fff25cda8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_84ee60f1-8542-4dc9-8bf2-f20c6da1ea64" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cc309090-124b-4777-b4d4-59fff25cda8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_87c895ad-7f5c-47ed-8dd6-23a5eb78025f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_84ee60f1-8542-4dc9-8bf2-f20c6da1ea64" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_87c895ad-7f5c-47ed-8dd6-23a5eb78025f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_5c0f4f02-92a2-476d-a2e6-e675551e53a7" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3d9ee137-ccbe-4fd8-8899-d1fa540f1096" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_5c0f4f02-92a2-476d-a2e6-e675551e53a7" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3d9ee137-ccbe-4fd8-8899-d1fa540f1096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_aa030b8b-7e7a-4606-97c2-4c9b8defc24f" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_5c0f4f02-92a2-476d-a2e6-e675551e53a7" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_aa030b8b-7e7a-4606-97c2-4c9b8defc24f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_66502356-9137-48e0-9a1c-973a00a42eb8" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_5c0f4f02-92a2-476d-a2e6-e675551e53a7" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_66502356-9137-48e0-9a1c-973a00a42eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_c855b5ba-8f83-4a71-9d43-9c783c862b61" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_5c0f4f02-92a2-476d-a2e6-e675551e53a7" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_c855b5ba-8f83-4a71-9d43-9c783c862b61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_c222793a-c88d-4338-aa8f-90e916435e38" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_5c0f4f02-92a2-476d-a2e6-e675551e53a7" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_c222793a-c88d-4338-aa8f-90e916435e38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_bcd036bf-b2fb-4af0-b309-a972f2b6dc62" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_5c0f4f02-92a2-476d-a2e6-e675551e53a7" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_bcd036bf-b2fb-4af0-b309-a972f2b6dc62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_501af834-e294-436c-95eb-e7b6d0cacade" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_bb1ded2a-816c-48aa-93bd-3365d8aa8e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_501af834-e294-436c-95eb-e7b6d0cacade" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_bb1ded2a-816c-48aa-93bd-3365d8aa8e78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b32e4936-48f2-4c18-a6e6-242639e0cf57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_501af834-e294-436c-95eb-e7b6d0cacade" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_b32e4936-48f2-4c18-a6e6-242639e0cf57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESTermandRateDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESTermandRateDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/LEASESTermandRateDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSFairValueofDerivativesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#RELATEDPARTIES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RELATEDPARTIESDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#DISCONTINUEDOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DISCONTINUEDOPERATIONSDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunaudited"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedScheduleDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves" xlink:type="simple" xlink:href="dgx-20201231.xsd#ScheduleIIValuationAccountsandReserves"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#ScheduleIIValuationAccountsandReservesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>dgx-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a87d206f-e33b-4d9f-a34a-b74e8733b14f,g:639ddba6-f3fe-4831-960f-76615a38edd9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended" id="i6321077bc99440219c60a6516f657c1b_CoverPage"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i90e1e1ceaa2c4d1184939a7849405a50_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i7454d27cb2fc4b669a559f5732a1c052_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i0275313fd9f841478f812778b05e30a3_CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended" id="ideb21308b6ee4574ac72aa158d5e647e_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i322e8f7390fd4445bc5191f84965330e_CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i3e5b5d50cb344cfdbcbfcc4daa812e92_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f4191cea-55e0-43fe-ad7a-8cc0a9cdf21f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4191cea-55e0-43fe-ad7a-8cc0a9cdf21f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_154ab640-4083-4a20-a5e6-e84e15aaffb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_154ab640-4083-4a20-a5e6-e84e15aaffb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d2b66550-6015-487c-9c2e-33fff582d130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d2b66550-6015-487c-9c2e-33fff582d130" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_94711faf-0977-4d67-b2b0-32003320fd69" xlink:href="dgx-20201231.xsd#dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_94711faf-0977-4d67-b2b0-32003320fd69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6af38a9-b318-4d1f-847f-b2bf71bf2dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6af38a9-b318-4d1f-847f-b2bf71bf2dc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_8c56a5bc-1f71-426b-bcbe-e8487a5329a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_DividendsCommonStockCash_8c56a5bc-1f71-426b-bcbe-e8487a5329a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e49c0327-33e3-4ae0-85e9-861643da65c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e49c0327-33e3-4ae0-85e9-861643da65c2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e06896df-bc55-4f63-8677-d3fa590e0277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e06896df-bc55-4f63-8677-d3fa590e0277" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8ea3ea2a-679b-4fb3-9fb8-e7b706ddd821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8ea3ea2a-679b-4fb3-9fb8-e7b706ddd821" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_257727ef-439a-4265-b724-3a33899c5a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_257727ef-439a-4265-b724-3a33899c5a7f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_01102594-5146-4153-90cd-85cf641a31ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_01102594-5146-4153-90cd-85cf641a31ea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_81c00e49-1904-4b7f-bb85-ec7f6b675b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_81c00e49-1904-4b7f-bb85-ec7f6b675b66" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f637d0b5-db10-4048-b257-9049d6b2e8d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f637d0b5-db10-4048-b257-9049d6b2e8d8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_eeb364c9-5c9c-4a88-8e9d-c532d8f1190a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_eeb364c9-5c9c-4a88-8e9d-c532d8f1190a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d46a4c36-02b8-4cfd-a33d-88d7ed90bc83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d46a4c36-02b8-4cfd-a33d-88d7ed90bc83" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_26f74b5b-57c2-4cc7-86c2-3942bcecdba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_26f74b5b-57c2-4cc7-86c2-3942bcecdba8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_244dd59b-a5b2-4c70-94ba-e4fd2831f9d2" xlink:href="dgx-20201231.xsd#dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_244dd59b-a5b2-4c70-94ba-e4fd2831f9d2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62181890-74bb-4fa9-b2fd-ff49fe70835b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_91ff38b1-269a-47db-8202-f198621eaf0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4191cea-55e0-43fe-ad7a-8cc0a9cdf21f" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6e77bb83-e0d0-49c3-8e97-3e54ac07fa01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6e77bb83-e0d0-49c3-8e97-3e54ac07fa01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_6e0edbc1-a03b-4d06-a061-7a251ac1b50d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_6e0edbc1-a03b-4d06-a061-7a251ac1b50d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_bf924610-1988-4812-bea9-c0786c41585d" xlink:href="dgx-20201231.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_bf924610-1988-4812-bea9-c0786c41585d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4a52d721-8a97-48bf-b481-75a17103a491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cabf6934-2d1a-4ae3-889f-e8f061581dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f4191cea-55e0-43fe-ad7a-8cc0a9cdf21f" xlink:to="loc_us-gaap_StatementTable_cabf6934-2d1a-4ae3-889f-e8f061581dad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7bd63a78-a7ba-4eb3-9c2e-7a3169414251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cabf6934-2d1a-4ae3-889f-e8f061581dad" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7bd63a78-a7ba-4eb3-9c2e-7a3169414251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7bd63a78-a7ba-4eb3-9c2e-7a3169414251_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7bd63a78-a7ba-4eb3-9c2e-7a3169414251" xlink:to="loc_us-gaap_EquityComponentDomain_7bd63a78-a7ba-4eb3-9c2e-7a3169414251_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7bd63a78-a7ba-4eb3-9c2e-7a3169414251" xlink:to="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5a5add46-2bf9-488f-8426-75eda138e5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_CommonStockMember_5a5add46-2bf9-488f-8426-75eda138e5ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_54bde1cf-2b49-45f2-b391-cf042d2e6a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_54bde1cf-2b49-45f2-b391-cf042d2e6a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_449270c2-3a17-4ac0-b264-d8a96808df05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_RetainedEarningsMember_449270c2-3a17-4ac0-b264-d8a96808df05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f587ef36-23eb-4fcb-b7cb-1eaa6d22b2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f587ef36-23eb-4fcb-b7cb-1eaa6d22b2ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_39979e2c-1847-4f53-b400-8c1d9b8554b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_TreasuryStockMember_39979e2c-1847-4f53-b400-8c1d9b8554b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_8942de8b-65c3-4f51-b185-209a4db76e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_NoncontrollingInterestMember_8942de8b-65c3-4f51-b185-209a4db76e54" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20201231.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended" id="i24fb5c4afa594928992ab694618841ef_DESCRIPTIONOFBUSINESS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="i3b69a0b5aaf8488bba4077dc06f274ac_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="icb1054e287464192be55a130c7dae895_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended" id="iebf167c84729498f9b38488ccb15f4c5_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:href="dgx-20201231.xsd#dgx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d469a274-8cd0-4751-8d22-7feef28d7a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d469a274-8cd0-4751-8d22-7feef28d7a4e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_88304135-31d5-4666-b281-172ca7b7df2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_EquityMethodInvestments_88304135-31d5-4666-b281-172ca7b7df2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_b3f0d0fb-18b3-4204-b8a6-dd143b854f13" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_PercentageofNetRevenues_b3f0d0fb-18b3-4204-b8a6-dd143b854f13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7973a43c-e279-4146-925a-0d1ae9fdb3b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7973a43c-e279-4146-925a-0d1ae9fdb3b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_e6789717-2b8d-480c-95ba-610be38e533f" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_e6789717-2b8d-480c-95ba-610be38e533f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofReceivablesDueFromPatients_13f2ddfb-bd30-4f8c-bc80-13ea9995b8a6" xlink:href="dgx-20201231.xsd#dgx_PercentageofReceivablesDueFromPatients"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_PercentageofReceivablesDueFromPatients_13f2ddfb-bd30-4f8c-bc80-13ea9995b8a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1fa3773-ff19-4ce4-b8eb-d753aa9cda88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1fa3773-ff19-4ce4-b8eb-d753aa9cda88" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e555a0a6-9906-4071-9152-336aca4d306c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e555a0a6-9906-4071-9152-336aca4d306c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_13f82472-089d-4434-87bf-33e5d738766d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_OperatingIncomeLoss_13f82472-089d-4434-87bf-33e5d738766d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0ebe4864-f72f-4157-9f16-db5de6647433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_ProfitLoss_0ebe4864-f72f-4157-9f16-db5de6647433" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0e85043f-c025-42d5-b46d-9a45b7a71072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0e85043f-c025-42d5-b46d-9a45b7a71072" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesEquity_ec54dd49-5234-40fe-ad7b-166a6261fc50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_TradingSecuritiesEquity_ec54dd49-5234-40fe-ad7b-166a6261fc50" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_958f7ab5-b399-4d46-905d-6e12e2c562d3" xlink:href="dgx-20201231.xsd#dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_958f7ab5-b399-4d46-905d-6e12e2c562d3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_9a020819-9a15-401a-8401-c577274a74f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_9a020819-9a15-401a-8401-c577274a74f8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d20a902e-ac7e-43ef-ba08-62b2c5c72742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d20a902e-ac7e-43ef-ba08-62b2c5c72742" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_34c2302a-67a7-4818-9943-b7118e6f0eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_34c2302a-67a7-4818-9943-b7118e6f0eca" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_25064f5e-2af0-4a2f-a9cf-f7fe02ed66a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_OperatingLeaseLiability_25064f5e-2af0-4a2f-a9cf-f7fe02ed66a8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredRentAdjustments_7f3d6320-4dd2-4768-af63-4b7f5a0d8ec9" xlink:href="dgx-20201231.xsd#dgx_DeferredRentAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_DeferredRentAdjustments_7f3d6320-4dd2-4768-af63-4b7f5a0d8ec9" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:href="dgx-20201231.xsd#dgx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_srt_RangeAxis_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b" xlink:to="loc_srt_RangeMember_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7697037-9fd3-4adb-ac37-54b80373a5b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b" xlink:to="loc_srt_RangeMember_c7697037-9fd3-4adb-ac37-54b80373a5b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e1902732-2b05-4061-85a9-fc53924db54b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c7697037-9fd3-4adb-ac37-54b80373a5b7" xlink:to="loc_srt_MinimumMember_e1902732-2b05-4061-85a9-fc53924db54b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_238fea35-6f75-4297-990f-e787749c4f2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c7697037-9fd3-4adb-ac37-54b80373a5b7" xlink:to="loc_srt_MaximumMember_238fea35-6f75-4297-990f-e787749c4f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c" xlink:to="loc_us-gaap_SegmentDomain_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_497d9c5a-56a9-4499-a6dd-648109a322f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c" xlink:to="loc_us-gaap_SegmentDomain_497d9c5a-56a9-4499-a6dd-648109a322f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_1737e4d4-26a8-4549-9a17-8d3159bdbb3b" xlink:href="dgx-20201231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_497d9c5a-56a9-4499-a6dd-648109a322f8" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_1737e4d4-26a8-4549-9a17-8d3159bdbb3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_b4746f91-e010-46b0-b99e-68164016156b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_SubsegmentsAxis_b4746f91-e010-46b0-b99e-68164016156b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_b4746f91-e010-46b0-b99e-68164016156b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_b4746f91-e010-46b0-b99e-68164016156b" xlink:to="loc_us-gaap_SubsegmentsDomain_b4746f91-e010-46b0-b99e-68164016156b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_5751c1db-a902-44db-8078-0ced780fdcf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_b4746f91-e010-46b0-b99e-68164016156b" xlink:to="loc_us-gaap_SubsegmentsDomain_5751c1db-a902-44db-8078-0ced780fdcf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_0c168701-47ce-4c9b-b9bc-78324e017a07" xlink:href="dgx-20201231.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_5751c1db-a902-44db-8078-0ced780fdcf0" xlink:to="loc_dgx_GovernmentPayersMember_0c168701-47ce-4c9b-b9bc-78324e017a07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember_90d2a33b-7053-41b7-9a1d-6a255a2e022e" xlink:href="dgx-20201231.xsd#dgx_PatientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_5751c1db-a902-44db-8078-0ced780fdcf0" xlink:to="loc_dgx_PatientMember_90d2a33b-7053-41b7-9a1d-6a255a2e022e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abb6ee46-14c0-4ed3-ac87-bfae898c0856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abb6ee46-14c0-4ed3-ac87-bfae898c0856" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_abb6ee46-14c0-4ed3-ac87-bfae898c0856_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abb6ee46-14c0-4ed3-ac87-bfae898c0856" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_abb6ee46-14c0-4ed3-ac87-bfae898c0856_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abb6ee46-14c0-4ed3-ac87-bfae898c0856" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_5c13e5ff-3194-410a-9833-ebdba2c5dd85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_5c13e5ff-3194-410a-9833-ebdba2c5dd85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_59a8abe6-6900-4780-b1d4-1f56c92dd336" xlink:href="dgx-20201231.xsd#dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:to="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_59a8abe6-6900-4780-b1d4-1f56c92dd336" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ef9d7f6e-023e-4210-be37-dbb5607255f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ef9d7f6e-023e-4210-be37-dbb5607255f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_515d562f-03e3-4f6a-8805-5bbe11d49b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_515d562f-03e3-4f6a-8805-5bbe11d49b7e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_515d562f-03e3-4f6a-8805-5bbe11d49b7e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_515d562f-03e3-4f6a-8805-5bbe11d49b7e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_515d562f-03e3-4f6a-8805-5bbe11d49b7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6bd5d9b5-5840-4c5f-af8d-834344670700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_515d562f-03e3-4f6a-8805-5bbe11d49b7e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6bd5d9b5-5840-4c5f-af8d-834344670700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1f1e54f6-a6e1-4cb2-a35b-c99b696020eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6bd5d9b5-5840-4c5f-af8d-834344670700" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1f1e54f6-a6e1-4cb2-a35b-c99b696020eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bec650f4-d997-4c2b-b715-5d95eba0982e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bec650f4-d997-4c2b-b715-5d95eba0982e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_bec650f4-d997-4c2b-b715-5d95eba0982e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bec650f4-d997-4c2b-b715-5d95eba0982e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_bec650f4-d997-4c2b-b715-5d95eba0982e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d2f86121-10cc-4270-9bc8-36fa5fa80de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bec650f4-d997-4c2b-b715-5d95eba0982e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d2f86121-10cc-4270-9bc8-36fa5fa80de2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4dd0c783-33b6-4185-8145-91de5c3fc0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2f86121-10cc-4270-9bc8-36fa5fa80de2" xlink:to="loc_us-gaap_OtherAssetsMember_4dd0c783-33b6-4185-8145-91de5c3fc0ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f1836d24-6122-4657-9a0b-871a850d1676" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_srt_StatementScenarioAxis_f1836d24-6122-4657-9a0b-871a850d1676" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f1836d24-6122-4657-9a0b-871a850d1676_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_f1836d24-6122-4657-9a0b-871a850d1676" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f1836d24-6122-4657-9a0b-871a850d1676_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5d8436f3-7090-4c3c-bb12-33eec189f9af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_f1836d24-6122-4657-9a0b-871a850d1676" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5d8436f3-7090-4c3c-bb12-33eec189f9af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_bd44e310-2b4a-4b7d-8bd5-a4ea1f1f8a94" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5d8436f3-7090-4c3c-bb12-33eec189f9af" xlink:to="loc_srt_ScenarioForecastMember_bd44e310-2b4a-4b7d-8bd5-a4ea1f1f8a94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f9c5d442-388d-4398-9e6e-aa4a28d53281" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f9c5d442-388d-4398-9e6e-aa4a28d53281" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f9c5d442-388d-4398-9e6e-aa4a28d53281_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f9c5d442-388d-4398-9e6e-aa4a28d53281" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f9c5d442-388d-4398-9e6e-aa4a28d53281_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4ba817a2-dcec-4450-8845-848223bae9c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f9c5d442-388d-4398-9e6e-aa4a28d53281" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4ba817a2-dcec-4450-8845-848223bae9c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4233b95d-51bd-4b11-ba77-64797fc246cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4ba817a2-dcec-4450-8845-848223bae9c5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4233b95d-51bd-4b11-ba77-64797fc246cd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITION"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended" id="i8a3ad56a65624aef8c3cc4158a8f29d1_REVENUERECOGNITION"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITIONTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended" id="icdb0bf1f6b954056ba560ea6cb0ff7cd_REVENUERECOGNITIONTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended" id="i4b3a743ea70141b6ba74036633b061db_REVENUERECOGNITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_e8bf06f5-0e1e-4b1f-8852-e508fd9224ba" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_dgx_PercentageofNetRevenues_e8bf06f5-0e1e-4b1f-8852-e508fd9224ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueCollectionofConsiderationPeriod_1d6ed5da-c027-41cb-8933-c1c5d635bf71" xlink:href="dgx-20201231.xsd#dgx_RevenueCollectionofConsiderationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_dgx_RevenueCollectionofConsiderationPeriod_1d6ed5da-c027-41cb-8933-c1c5d635bf71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PeriodofBillingFullyReserve_4f117c48-47c1-49d3-95d5-4de0c1404801" xlink:href="dgx-20201231.xsd#dgx_PeriodofBillingFullyReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_dgx_PeriodofBillingFullyReserve_4f117c48-47c1-49d3-95d5-4de0c1404801" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_b7f6fbc4-e73a-422e-bf48-f7d5c7a9032e" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_b7f6fbc4-e73a-422e-bf48-f7d5c7a9032e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4053cf54-593d-4284-8528-00ffc406b7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4053cf54-593d-4284-8528-00ffc406b7dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_8097d53c-3b23-49ce-b62d-b7970dbf9a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_8097d53c-3b23-49ce-b62d-b7970dbf9a9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_93037c53-16a9-4ecb-8abc-c53a72635ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_93037c53-16a9-4ecb-8abc-c53a72635ec9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1989d623-faee-49d3-bc8b-12cc0e3fe17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f2affda1-02a3-4d20-ac19-de48fce530ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f2affda1-02a3-4d20-ac19-de48fce530ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f2affda1-02a3-4d20-ac19-de48fce530ed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f2affda1-02a3-4d20-ac19-de48fce530ed" xlink:to="loc_us-gaap_SegmentDomain_f2affda1-02a3-4d20-ac19-de48fce530ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d28092c5-fb47-44d9-b914-c34206aec171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f2affda1-02a3-4d20-ac19-de48fce530ed" xlink:to="loc_us-gaap_SegmentDomain_d28092c5-fb47-44d9-b914-c34206aec171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_934f4d87-c026-43ae-86f6-b61152f5a275" xlink:href="dgx-20201231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d28092c5-fb47-44d9-b914-c34206aec171" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_934f4d87-c026-43ae-86f6-b61152f5a275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_cf6d6d65-e414-4ef4-b7e7-7351c9cc1d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d28092c5-fb47-44d9-b914-c34206aec171" xlink:to="loc_us-gaap_AllOtherSegmentsMember_cf6d6d65-e414-4ef4-b7e7-7351c9cc1d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_c0746ddc-34d8-4476-a545-bd35c48eb753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_us-gaap_SubsegmentsAxis_c0746ddc-34d8-4476-a545-bd35c48eb753" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_c0746ddc-34d8-4476-a545-bd35c48eb753_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_c0746ddc-34d8-4476-a545-bd35c48eb753" xlink:to="loc_us-gaap_SubsegmentsDomain_c0746ddc-34d8-4476-a545-bd35c48eb753_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_c0746ddc-34d8-4476-a545-bd35c48eb753" xlink:to="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_34b9b0cf-f450-48a1-b957-b70b609658f6" xlink:href="dgx-20201231.xsd#dgx_HealthcareInsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_HealthcareInsurersMember_34b9b0cf-f450-48a1-b957-b70b609658f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_02fd91c9-c952-4beb-8f54-83c9c85b4b14" xlink:href="dgx-20201231.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_GovernmentPayersMember_02fd91c9-c952-4beb-8f54-83c9c85b4b14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_b9d1145f-32d5-470a-827c-744c538dd4c4" xlink:href="dgx-20201231.xsd#dgx_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_ClientPayersMember_b9d1145f-32d5-470a-827c-744c538dd4c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember_2941a7c3-a9cf-49ed-9f76-c1205fd7cba4" xlink:href="dgx-20201231.xsd#dgx_PatientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_PatientMember_2941a7c3-a9cf-49ed-9f76-c1205fd7cba4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_e388976d-4390-4c45-a274-c6a839e54eab" xlink:href="dgx-20201231.xsd#dgx_DSBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_DSBusinessesMember_e388976d-4390-4c45-a274-c6a839e54eab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b7a7d5a9-47f8-4b9e-b749-59dcea267d39" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_srt_ProductOrServiceAxis_b7a7d5a9-47f8-4b9e-b749-59dcea267d39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b7a7d5a9-47f8-4b9e-b749-59dcea267d39_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b7a7d5a9-47f8-4b9e-b749-59dcea267d39" xlink:to="loc_srt_ProductsAndServicesDomain_b7a7d5a9-47f8-4b9e-b749-59dcea267d39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_05a25dd9-d6e8-45ab-b369-f5b16ce9f3f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b7a7d5a9-47f8-4b9e-b749-59dcea267d39" xlink:to="loc_srt_ProductsAndServicesDomain_05a25dd9-d6e8-45ab-b369-f5b16ce9f3f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_1002deb2-9cad-4541-ab1a-96dfd0466b31" xlink:href="dgx-20201231.xsd#dgx_FeeforserviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_05a25dd9-d6e8-45ab-b369-f5b16ce9f3f1" xlink:to="loc_dgx_FeeforserviceMember_1002deb2-9cad-4541-ab1a-96dfd0466b31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_de4fbb8e-fdc5-4b81-afb0-3464d313adfc" xlink:href="dgx-20201231.xsd#dgx_CapitatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_05a25dd9-d6e8-45ab-b369-f5b16ce9f3f1" xlink:to="loc_dgx_CapitatedMember_de4fbb8e-fdc5-4b81-afb0-3464d313adfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7b98af07-3c9c-4a59-a54a-1a9b3895c341" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_srt_RangeAxis_7b98af07-3c9c-4a59-a54a-1a9b3895c341" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b98af07-3c9c-4a59-a54a-1a9b3895c341_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7b98af07-3c9c-4a59-a54a-1a9b3895c341" xlink:to="loc_srt_RangeMember_7b98af07-3c9c-4a59-a54a-1a9b3895c341_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3fed11a1-cbdf-4c7f-84d6-894802e7540f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7b98af07-3c9c-4a59-a54a-1a9b3895c341" xlink:to="loc_srt_RangeMember_3fed11a1-cbdf-4c7f-84d6-894802e7540f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d5ff7fa0-984e-4ae1-965b-9f801f220fc2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3fed11a1-cbdf-4c7f-84d6-894802e7540f" xlink:to="loc_srt_MinimumMember_d5ff7fa0-984e-4ae1-965b-9f801f220fc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2cea682d-b375-46e1-8853-5b266b07948e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3fed11a1-cbdf-4c7f-84d6-894802e7540f" xlink:to="loc_srt_MaximumMember_2cea682d-b375-46e1-8853-5b266b07948e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSPERSHARE"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended" id="ib93fdcddf9ce44ffa06f15a78f1c8c07_EARNINGSPERSHARE"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSLOSSPERSHARETables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables" xlink:type="extended" id="ie86a52016108479f8230909232dae906_EARNINGSLOSSPERSHARETables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSLOSSPERSHAREDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="extended" id="i0ba0728b601449ada51a6cac08afb7f3_EARNINGSLOSSPERSHAREDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES" xlink:type="extended" id="if4a44f96d0fe4e2d81f1134879e53bc9_RESTRUCTURINGACTIVITIES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables" xlink:type="extended" id="ia0e982139d434982ad9ce8b55af4693a_RESTRUCTURINGACTIVITIESTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails" xlink:type="extended" id="icdb5dd256176442688eba1060848c66f_RESTRUCTURINGACTIVITIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_49bddaff-958c-42b9-80e5-dfddd5943e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5613bb45-560b-4939-9288-490bcacd35e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_49bddaff-958c-42b9-80e5-dfddd5943e31" xlink:to="loc_us-gaap_RestructuringCharges_5613bb45-560b-4939-9288-490bcacd35e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_49bddaff-958c-42b9-80e5-dfddd5943e31" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e3665934-ef3b-40fc-aca8-5e997ebb2ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:to="loc_us-gaap_RestructuringPlanAxis_e3665934-ef3b-40fc-aca8-5e997ebb2ae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_e3665934-ef3b-40fc-aca8-5e997ebb2ae6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_e3665934-ef3b-40fc-aca8-5e997ebb2ae6" xlink:to="loc_us-gaap_RestructuringPlanDomain_e3665934-ef3b-40fc-aca8-5e997ebb2ae6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1806722f-749f-47c8-af12-359c9f99590e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_e3665934-ef3b-40fc-aca8-5e997ebb2ae6" xlink:to="loc_us-gaap_RestructuringPlanDomain_1806722f-749f-47c8-af12-359c9f99590e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvigorateProgramMember_938c1048-3ad0-4d83-ba74-6620efe14237" xlink:href="dgx-20201231.xsd#dgx_InvigorateProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1806722f-749f-47c8-af12-359c9f99590e" xlink:to="loc_dgx_InvigorateProgramMember_938c1048-3ad0-4d83-ba74-6620efe14237" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_cfa692cc-0aa1-4f35-a535-028e0205c730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_cfa692cc-0aa1-4f35-a535-028e0205c730" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_cfa692cc-0aa1-4f35-a535-028e0205c730_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cfa692cc-0aa1-4f35-a535-028e0205c730" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_cfa692cc-0aa1-4f35-a535-028e0205c730_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6fb99f26-f950-4240-a614-0a31af2d8164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cfa692cc-0aa1-4f35-a535-028e0205c730" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6fb99f26-f950-4240-a614-0a31af2d8164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9d844d92-491c-409d-840f-f8274b36e5ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6fb99f26-f950-4240-a614-0a31af2d8164" xlink:to="loc_us-gaap_CostOfSalesMember_9d844d92-491c-409d-840f-f8274b36e5ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_67810eb5-3255-40ce-83bb-f73054ace989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6fb99f26-f950-4240-a614-0a31af2d8164" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_67810eb5-3255-40ce-83bb-f73054ace989" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails" xlink:type="extended" id="ibf7d9f2c3b1441f08a0ca611112ac1ea_RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_461195a0-9b44-4b38-a98d-8eaba5a46a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_SeveranceCosts1_461195a0-9b44-4b38-a98d-8eaba5a46a40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_5d90eafe-8726-457b-b2bc-afe9eb5f9b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_OtherRestructuringCosts_5d90eafe-8726-457b-b2bc-afe9eb5f9b9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_040490ad-1a00-4ca5-bf3e-333094d5f5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_040490ad-1a00-4ca5-bf3e-333094d5f5db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_816c95e8-0e9e-451e-b7b8-138623a8eb96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_RestructuringCharges_816c95e8-0e9e-451e-b7b8-138623a8eb96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c227d590-830c-407c-b260-05cf8d7fa4da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c227d590-830c-407c-b260-05cf8d7fa4da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_db56b8d5-4646-481b-91c6-9d6382b13208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c227d590-830c-407c-b260-05cf8d7fa4da" xlink:to="loc_us-gaap_RestructuringPlanAxis_db56b8d5-4646-481b-91c6-9d6382b13208" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_db56b8d5-4646-481b-91c6-9d6382b13208_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_db56b8d5-4646-481b-91c6-9d6382b13208" xlink:to="loc_us-gaap_RestructuringPlanDomain_db56b8d5-4646-481b-91c6-9d6382b13208_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0dbed157-e9f4-462c-90aa-f01e6c0228c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_db56b8d5-4646-481b-91c6-9d6382b13208" xlink:to="loc_us-gaap_RestructuringPlanDomain_0dbed157-e9f4-462c-90aa-f01e6c0228c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvigorateProgramMember_95bd9266-659f-43f3-bbd0-5b2048c6e24d" xlink:href="dgx-20201231.xsd#dgx_InvigorateProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0dbed157-e9f4-462c-90aa-f01e6c0228c0" xlink:to="loc_dgx_InvigorateProgramMember_95bd9266-659f-43f3-bbd0-5b2048c6e24d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails" xlink:type="extended" id="iffd2a2ac56f644eca72eac8ac716d3ca_RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_bca97851-82c4-4302-8cb0-c327c6b12279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bca97851-82c4-4302-8cb0-c327c6b12279" xlink:to="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_571ca0b4-cc0b-4994-829c-6920192d245d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_RestructuringReserve_571ca0b4-cc0b-4994-829c-6920192d245d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cd6a02e5-1b71-420b-8306-1130553accc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_RestructuringCharges_cd6a02e5-1b71-420b-8306-1130553accc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_165f2500-7b28-44f1-b650-efb073926920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_PaymentsForRestructuring_165f2500-7b28-44f1-b650-efb073926920" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_89d18d21-8a93-491d-8063-dcf2a7692664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_89d18d21-8a93-491d-8063-dcf2a7692664" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b92ab4de-e11e-4dba-a3a6-aba5a1957327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0a9e824-dcad-4560-b5ca-557be775b542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bca97851-82c4-4302-8cb0-c327c6b12279" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0a9e824-dcad-4560-b5ca-557be775b542" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_524411d8-2a21-429d-9939-54d8fc5573d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0a9e824-dcad-4560-b5ca-557be775b542" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_524411d8-2a21-429d-9939-54d8fc5573d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_524411d8-2a21-429d-9939-54d8fc5573d5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_524411d8-2a21-429d-9939-54d8fc5573d5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_524411d8-2a21-429d-9939-54d8fc5573d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c9ff81ed-ba7b-45d2-95a5-795cb45a892f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_524411d8-2a21-429d-9939-54d8fc5573d5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c9ff81ed-ba7b-45d2-95a5-795cb45a892f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_87dd4117-b13b-40a1-91e8-cc152fbd7433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c9ff81ed-ba7b-45d2-95a5-795cb45a892f" xlink:to="loc_us-gaap_EmployeeSeveranceMember_87dd4117-b13b-40a1-91e8-cc152fbd7433" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_4f0e462a-b5e4-4649-b106-b91965cee0c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c9ff81ed-ba7b-45d2-95a5-795cb45a892f" xlink:to="loc_us-gaap_FacilityClosingMember_4f0e462a-b5e4-4649-b106-b91965cee0c9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSACQUISITIONS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended" id="ida02a0ebb29543e08b2188f02b49586a_BUSINESSACQUISITIONS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="i088ad26e15314730ad7c34020ae10d74_BUSINESSACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_37d3f3dc-4057-4cf8-837a-6a70cc3e9303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_37d3f3dc-4057-4cf8-837a-6a70cc3e9303" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a201e8d7-215c-43cf-bd41-6015bfb78462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a201e8d7-215c-43cf-bd41-6015bfb78462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_407820fa-2d97-49fc-85d9-66376909bd81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_407820fa-2d97-49fc-85d9-66376909bd81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_3af59375-97fa-4e2a-8176-d790f2d1d8b9" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_3af59375-97fa-4e2a-8176-d790f2d1d8b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessAcquisitionPostacquisitionRevenue_1013becf-7c04-470b-a857-dfe68818d17c" xlink:href="dgx-20201231.xsd#dgx_BusinessAcquisitionPostacquisitionRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessAcquisitionPostacquisitionRevenue_1013becf-7c04-470b-a857-dfe68818d17c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_1cb00118-5942-41b4-af19-a41b498bc5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_1cb00118-5942-41b4-af19-a41b498bc5f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes_33501d3d-5a72-4029-88a6-68c74a79df6a" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes_33501d3d-5a72-4029-88a6-68c74a79df6a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fbd99f61-0a9a-49cf-9bdf-46b817738823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_Goodwill_fbd99f61-0a9a-49cf-9bdf-46b817738823" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_67fb85ad-59c7-43be-8aed-8b6f95ed7bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_67fb85ad-59c7-43be-8aed-8b6f95ed7bb0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_6b0315d4-5c5a-47e6-837d-ba45a36d186a" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_6b0315d4-5c5a-47e6-837d-ba45a36d186a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55d5b5ba-2042-45a5-8c34-903d1c5da057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55d5b5ba-2042-45a5-8c34-903d1c5da057" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2365f661-9f12-4726-a0c6-41d30103bc7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2365f661-9f12-4726-a0c6-41d30103bc7d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_ad476ec7-6adb-4099-82a4-cce71f181404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_ad476ec7-6adb-4099-82a4-cce71f181404" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_3095d1b3-e5ca-43ed-90c1-e84281fda606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_3095d1b3-e5ca-43ed-90c1-e84281fda606" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c55b6ac9-57e6-4a28-92cf-1fdfd8e46340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c55b6ac9-57e6-4a28-92cf-1fdfd8e46340" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_8952c323-0d2a-41f2-b811-7ed6416235c4" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_8952c323-0d2a-41f2-b811-7ed6416235c4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_6e427f40-a936-48ac-91c1-a294c6666092" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_6e427f40-a936-48ac-91c1-a294c6666092" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_df4158fd-a0af-402d-8df8-f8aef776d98f" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_df4158fd-a0af-402d-8df8-f8aef776d98f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9ac8de18-2c93-4479-9deb-9d09551b7778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9ac8de18-2c93-4479-9deb-9d09551b7778" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e313b354-3bae-48c7-b07a-132323f776a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e313b354-3bae-48c7-b07a-132323f776a1" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_12538cad-f330-4fc8-b563-d198579bf426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_12538cad-f330-4fc8-b563-d198579bf426" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9bff77b0-71ca-4609-8b76-5b489179b98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9bff77b0-71ca-4609-8b76-5b489179b98b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods_e5f41a87-8f1e-409b-b155-49167fce11c3" xlink:href="dgx-20201231.xsd#dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods_e5f41a87-8f1e-409b-b155-49167fce11c3" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_606143b3-d63f-49a2-b5b6-4f404a090e0b" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_606143b3-d63f-49a2-b5b6-4f404a090e0b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_36c2c39a-760e-4379-a5f7-ef118495fb3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_36c2c39a-760e-4379-a5f7-ef118495fb3f" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities_141680c5-06f2-4a4d-829b-a77b8d4ad8e0" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities_141680c5-06f2-4a4d-829b-a77b8d4ad8e0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bee437d4-2f7f-4142-a36b-3967f6cbbc1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bee437d4-2f7f-4142-a36b-3967f6cbbc1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bee437d4-2f7f-4142-a36b-3967f6cbbc1d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bee437d4-2f7f-4142-a36b-3967f6cbbc1d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bee437d4-2f7f-4142-a36b-3967f6cbbc1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bee437d4-2f7f-4142-a36b-3967f6cbbc1d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BlueprintGeneticsOyMember_625e1ed5-e16f-4dd5-baa0-364db9dfc1be" xlink:href="dgx-20201231.xsd#dgx_BlueprintGeneticsOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_BlueprintGeneticsOyMember_625e1ed5-e16f-4dd5-baa0-364db9dfc1be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MemorialHermannMember_6d524587-8926-4f4a-9eb3-81ce36175cdd" xlink:href="dgx-20201231.xsd#dgx_MemorialHermannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_MemorialHermannMember_6d524587-8926-4f4a-9eb3-81ce36175cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_e603d49b-b493-404f-a553-4535ece673a7" xlink:href="dgx-20201231.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_e603d49b-b493-404f-a553-4535ece673a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_ef49841d-c8fc-4d8b-ada2-3c17cd4dfef5" xlink:href="dgx-20201231.xsd#dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_ef49841d-c8fc-4d8b-ada2-3c17cd4dfef5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MobileMedicalExaminationServicesInc.MedXMMember_734e2c9a-a1d6-4540-afd4-49fe3677c055" xlink:href="dgx-20201231.xsd#dgx_MobileMedicalExaminationServicesInc.MedXMMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_MobileMedicalExaminationServicesInc.MedXMMember_734e2c9a-a1d6-4540-afd4-49fe3677c055" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapeCodHealthcareInc.Member_1b7e91fb-7d7a-46f3-8216-a8ea0ec76259" xlink:href="dgx-20201231.xsd#dgx_CapeCodHealthcareInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_CapeCodHealthcareInc.Member_1b7e91fb-7d7a-46f3-8216-a8ea0ec76259" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReproSourceInc.Member_19d55955-2e1d-4b35-892d-6441132cf06d" xlink:href="dgx-20201231.xsd#dgx_ReproSourceInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_ReproSourceInc.Member_19d55955-2e1d-4b35-892d-6441132cf06d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OxfordImmunotecInc.Member_0c7b812d-e364-41f5-b0ad-d64c8394d5ad" xlink:href="dgx-20201231.xsd#dgx_OxfordImmunotecInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_OxfordImmunotecInc.Member_0c7b812d-e364-41f5-b0ad-d64c8394d5ad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6091d5e0-f368-4dd3-8698-3e8a4e54119b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6091d5e0-f368-4dd3-8698-3e8a4e54119b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6091d5e0-f368-4dd3-8698-3e8a4e54119b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6091d5e0-f368-4dd3-8698-3e8a4e54119b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6091d5e0-f368-4dd3-8698-3e8a4e54119b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6091d5e0-f368-4dd3-8698-3e8a4e54119b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_452e874c-bbd6-4185-a7f9-8b654d070a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_452e874c-bbd6-4185-a7f9-8b654d070a60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7fa7da18-38bc-492f-950c-f35b90412887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7fa7da18-38bc-492f-950c-f35b90412887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractRelatedMember_f7c40aa4-d555-45a2-8134-8331d65ff31b" xlink:href="dgx-20201231.xsd#dgx_ContractRelatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:to="loc_dgx_ContractRelatedMember_f7c40aa4-d555-45a2-8134-8331d65ff31b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5d18fe3f-954f-419a-a28a-1babd9279b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5d18fe3f-954f-419a-a28a-1babd9279b96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5d18fe3f-954f-419a-a28a-1babd9279b96_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5d18fe3f-954f-419a-a28a-1babd9279b96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5d18fe3f-954f-419a-a28a-1babd9279b96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6a2875eb-8e3e-431d-8793-3459392c3732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5d18fe3f-954f-419a-a28a-1babd9279b96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6a2875eb-8e3e-431d-8793-3459392c3732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_092ed17b-5738-44ab-819c-8119cdcaa79b" xlink:href="dgx-20201231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6a2875eb-8e3e-431d-8793-3459392c3732" xlink:to="loc_dgx_OtherIncomeExpenseMember_092ed17b-5738-44ab-819c-8119cdcaa79b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_4549c1d8-737c-4e17-a9a2-1d918836b4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6a2875eb-8e3e-431d-8793-3459392c3732" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_4549c1d8-737c-4e17-a9a2-1d918836b4d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c83f50e9-cc2f-482b-88f8-4546f64bb9e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c83f50e9-cc2f-482b-88f8-4546f64bb9e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c83f50e9-cc2f-482b-88f8-4546f64bb9e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c83f50e9-cc2f-482b-88f8-4546f64bb9e1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c83f50e9-cc2f-482b-88f8-4546f64bb9e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40babcc2-f1af-4369-b5b0-0e1a4c97e5b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c83f50e9-cc2f-482b-88f8-4546f64bb9e1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40babcc2-f1af-4369-b5b0-0e1a4c97e5b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ec3988eb-fbbe-4e64-8fbd-e7cebfcc4b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40babcc2-f1af-4369-b5b0-0e1a4c97e5b3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ec3988eb-fbbe-4e64-8fbd-e7cebfcc4b1b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended" id="ia875e304acbf417fa89d8e3e979341cb_FAIRVALUEMEASUREMENTS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended" id="i50eb027e7b9848adb9f895d530a01958_FAIRVALUEMEASUREMENTSTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="ic9781fc35d2442e9b60a2a81cd35c116_FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_6b2945c7-8a00-489a-80c4-7956c2c92bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_TradingSecurities_6b2945c7-8a00-489a-80c4-7956c2c92bb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_82db5d0f-79c8-4f32-8924-6ee7e36f558c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_82db5d0f-79c8-4f32-8924-6ee7e36f558c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_181e6be6-5efd-4427-9844-3057d53f8794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_181e6be6-5efd-4427-9844-3057d53f8794" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_34174be5-63c9-4450-8a9b-44aac7e915cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_34174be5-63c9-4450-8a9b-44aac7e915cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_70f6f61a-234f-48c7-a053-0ee21b064a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_70f6f61a-234f-48c7-a053-0ee21b064a68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_fd68555c-7997-4f60-9dca-4ba1da584de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_DerivativeLiabilities_fd68555c-7997-4f60-9dca-4ba1da584de6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b92ab666-2e8c-457c-9756-d70ddcdc5b67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b92ab666-2e8c-457c-9756-d70ddcdc5b67" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6ea78823-ab32-446e-8daf-cb0bc240ac73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6ea78823-ab32-446e-8daf-cb0bc240ac73" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_cd4d1f25-c99d-4c29-95ed-48cdad40595b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_cd4d1f25-c99d-4c29-95ed-48cdad40595b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59b21da9-c61f-474b-863c-c0ed0a6a57df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59b21da9-c61f-474b-863c-c0ed0a6a57df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_59b21da9-c61f-474b-863c-c0ed0a6a57df_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59b21da9-c61f-474b-863c-c0ed0a6a57df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_59b21da9-c61f-474b-863c-c0ed0a6a57df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2d29b030-5deb-4780-9c54-9eca3ea9202a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59b21da9-c61f-474b-863c-c0ed0a6a57df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2d29b030-5deb-4780-9c54-9eca3ea9202a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e39f5288-29c1-4702-86d7-bf0c703a4957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2d29b030-5deb-4780-9c54-9eca3ea9202a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e39f5288-29c1-4702-86d7-bf0c703a4957" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9441eb43-ecc7-4d83-b671-6d88b191913c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9441eb43-ecc7-4d83-b671-6d88b191913c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9441eb43-ecc7-4d83-b671-6d88b191913c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9441eb43-ecc7-4d83-b671-6d88b191913c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9441eb43-ecc7-4d83-b671-6d88b191913c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9441eb43-ecc7-4d83-b671-6d88b191913c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a902472b-cd57-4bd5-afd2-1e140f38d67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a902472b-cd57-4bd5-afd2-1e140f38d67b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8ba3f3eb-15a8-49b5-af4c-bc477891fc3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8ba3f3eb-15a8-49b5-af4c-bc477891fc3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7990803b-7f0b-4282-8a12-27053590ffb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7990803b-7f0b-4282-8a12-27053590ffb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ec6143df-e244-4896-8276-975a916f1840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ec6143df-e244-4896-8276-975a916f1840" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ec6143df-e244-4896-8276-975a916f1840_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec6143df-e244-4896-8276-975a916f1840" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ec6143df-e244-4896-8276-975a916f1840_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b29b66a1-e9b2-478e-a586-38af38a08989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec6143df-e244-4896-8276-975a916f1840" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b29b66a1-e9b2-478e-a586-38af38a08989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d4c45148-34fc-4ffa-b52e-4e084f95a5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b29b66a1-e9b2-478e-a586-38af38a08989" xlink:to="loc_us-gaap_InterestRateSwapMember_d4c45148-34fc-4ffa-b52e-4e084f95a5bf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="icb6f5edfd1b24d03920364d886b01718_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bd0303f4-b498-40a4-8ab2-944780822729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bd0303f4-b498-40a4-8ab2-944780822729" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_eda75055-c906-4f59-9141-1726a4c1f53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_eda75055-c906-4f59-9141-1726a4c1f53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_894e2814-a1ef-4d09-885e-0202b1370cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_894e2814-a1ef-4d09-885e-0202b1370cb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d6e38db4-cacb-4472-86b6-7f1fe159d02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d6e38db4-cacb-4472-86b6-7f1fe159d02d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cdd751b8-3339-486e-8983-024fe754621e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cdd751b8-3339-486e-8983-024fe754621e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cdd751b8-3339-486e-8983-024fe754621e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cdd751b8-3339-486e-8983-024fe754621e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cdd751b8-3339-486e-8983-024fe754621e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_09632371-75f7-4472-a06f-1492aabd13c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cdd751b8-3339-486e-8983-024fe754621e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_09632371-75f7-4472-a06f-1492aabd13c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_14eed956-dade-4386-b81a-2561ea270c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_09632371-75f7-4472-a06f-1492aabd13c0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_14eed956-dade-4386-b81a-2561ea270c82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_22868197-04da-41f9-88b5-474a4b3e2642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_22868197-04da-41f9-88b5-474a4b3e2642" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_22868197-04da-41f9-88b5-474a4b3e2642_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_22868197-04da-41f9-88b5-474a4b3e2642" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_22868197-04da-41f9-88b5-474a4b3e2642_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db32c05f-1782-4ce9-9ce0-58f6ac0011e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_22868197-04da-41f9-88b5-474a4b3e2642" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db32c05f-1782-4ce9-9ce0-58f6ac0011e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_7d5e4cab-7795-4952-ba10-a880e4a2c9c4" xlink:href="dgx-20201231.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db32c05f-1782-4ce9-9ce0-58f6ac0011e2" xlink:to="loc_dgx_ContingentConsiderationMember_7d5e4cab-7795-4952-ba10-a880e4a2c9c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_31ded74a-cc2f-4f80-b267-cd5f89b17484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_31ded74a-cc2f-4f80-b267-cd5f89b17484" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_31ded74a-cc2f-4f80-b267-cd5f89b17484_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_31ded74a-cc2f-4f80-b267-cd5f89b17484" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_31ded74a-cc2f-4f80-b267-cd5f89b17484_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_12676a7b-bfce-4248-992b-75a02d6aed12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_31ded74a-cc2f-4f80-b267-cd5f89b17484" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_12676a7b-bfce-4248-992b-75a02d6aed12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_1be22bd0-2a3e-4409-a168-810cd319b96c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12676a7b-bfce-4248-992b-75a02d6aed12" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_1be22bd0-2a3e-4409-a168-810cd319b96c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_srt_OwnershipAxis_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35" xlink:to="loc_srt_OwnershipDomain_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e715815f-6961-4d98-833b-47b14b97e284" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35" xlink:to="loc_srt_OwnershipDomain_e715815f-6961-4d98-833b-47b14b97e284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_62a841ea-c87d-416f-9a89-fd36998d7591" xlink:href="dgx-20201231.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_e715815f-6961-4d98-833b-47b14b97e284" xlink:to="loc_dgx_UMassJointVentureMember_62a841ea-c87d-416f-9a89-fd36998d7591" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="extended" id="i839e79e5ed97457c922aafe000852792_FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_95839cd8-1fc5-4c8b-bdba-905855a7a23c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_95839cd8-1fc5-4c8b-bdba-905855a7a23c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c5cbbed0-57d9-4d29-a2a6-6f4ea4f1982e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c5cbbed0-57d9-4d29-a2a6-6f4ea4f1982e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_f40d328b-cfd3-4eeb-a469-7d8b935b5b11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_f40d328b-cfd3-4eeb-a469-7d8b935b5b11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4cd48e29-4cd1-4f68-8836-ddc780208c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4cd48e29-4cd1-4f68-8836-ddc780208c34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_458ae5c4-7a69-48cb-9cd7-ad1ea42b58a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_458ae5c4-7a69-48cb-9cd7-ad1ea42b58a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a606bc9a-fcf6-4674-827e-5b4f1aa86cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_95839cd8-1fc5-4c8b-bdba-905855a7a23c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_24eaa897-6481-4937-a0e6-0504bc93d63f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_24eaa897-6481-4937-a0e6-0504bc93d63f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_24eaa897-6481-4937-a0e6-0504bc93d63f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_24eaa897-6481-4937-a0e6-0504bc93d63f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_24eaa897-6481-4937-a0e6-0504bc93d63f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ca4d274-e22d-4461-b085-a01dde2a9cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_24eaa897-6481-4937-a0e6-0504bc93d63f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ca4d274-e22d-4461-b085-a01dde2a9cb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c2f7547f-736c-4cf4-8b50-d97af4852e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ca4d274-e22d-4461-b085-a01dde2a9cb4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c2f7547f-736c-4cf4-8b50-d97af4852e84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_532da7fb-f606-4ac5-b97b-ae253a468b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_532da7fb-f606-4ac5-b97b-ae253a468b26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_532da7fb-f606-4ac5-b97b-ae253a468b26_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_532da7fb-f606-4ac5-b97b-ae253a468b26" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_532da7fb-f606-4ac5-b97b-ae253a468b26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87cb593e-8bbc-4c1e-82e3-7e03e3039ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_532da7fb-f606-4ac5-b97b-ae253a468b26" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87cb593e-8bbc-4c1e-82e3-7e03e3039ce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_6c76a964-3883-4f7f-a1e8-75ff213081dc" xlink:href="dgx-20201231.xsd#dgx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87cb593e-8bbc-4c1e-82e3-7e03e3039ce7" xlink:to="loc_dgx_ContingentConsiderationMember_6c76a964-3883-4f7f-a1e8-75ff213081dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOME"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="extended" id="iecd808ec15a54c6f8af034d7bbf0e43d_TAXESONINCOME"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMETables" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOMETables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMETables" xlink:type="extended" id="i827335a13be04d2f9b143aaf45636627_TAXESONINCOMETables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOMEDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended" id="i07ec82dda92a41a1b48da6d50dc1e83a_TAXESONINCOMEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6da42150-7586-464e-beb7-559f623dbf83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6da42150-7586-464e-beb7-559f623dbf83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b352f6a5-77cc-4c61-94e7-df62120fcc7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b352f6a5-77cc-4c61-94e7-df62120fcc7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e71e118b-05b1-4eba-8aeb-831fec944da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e71e118b-05b1-4eba-8aeb-831fec944da9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_231ae825-29bc-4587-bfd5-d348b10801cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_231ae825-29bc-4587-bfd5-d348b10801cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_480e4817-765a-41ed-b299-e869db237777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_480e4817-765a-41ed-b299-e869db237777" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c58a8a39-9e4a-42d7-a342-7dc7e1ed957d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c58a8a39-9e4a-42d7-a342-7dc7e1ed957d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_23033317-6542-4084-815d-e06c551d128a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_23033317-6542-4084-815d-e06c551d128a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0ae5a029-0f45-492a-b40e-9e66965d7e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0ae5a029-0f45-492a-b40e-9e66965d7e3a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9527f0c1-0f6f-445a-9dd4-fb6520524888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9527f0c1-0f6f-445a-9dd4-fb6520524888" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d2d53896-e972-4c5a-b310-00a401e06246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d2d53896-e972-4c5a-b310-00a401e06246" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9e9fbf4f-5572-41be-b005-7050a47e38e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9e9fbf4f-5572-41be-b005-7050a47e38e5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1bc30af1-00e7-461b-8248-721607be336f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1bc30af1-00e7-461b-8248-721607be336f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_62ee95dc-236b-47de-933e-193c86abfe18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_62ee95dc-236b-47de-933e-193c86abfe18" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_f33435ba-e62e-4971-8ced-da98ef1cbf61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_f33435ba-e62e-4971-8ced-da98ef1cbf61" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a026f1e8-1eca-4936-bc30-19080e9715a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a026f1e8-1eca-4936-bc30-19080e9715a7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_72d5522c-d0d7-4702-858b-6c5948250637" xlink:href="dgx-20201231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_72d5522c-d0d7-4702-858b-6c5948250637" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c357535a-40c1-4d12-8fe8-891bab8e4c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c357535a-40c1-4d12-8fe8-891bab8e4c7c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_28022871-1da1-4d01-8d12-84990734cce3" xlink:href="dgx-20201231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_28022871-1da1-4d01-8d12-84990734cce3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_0492d2d8-02f0-48bd-9fe8-d8202d00429d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_0492d2d8-02f0-48bd-9fe8-d8202d00429d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_406191b5-a560-4aad-acd2-df7a6165a689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_406191b5-a560-4aad-acd2-df7a6165a689" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_19453a57-18e3-47d6-9b6d-b676e3e85ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_19453a57-18e3-47d6-9b6d-b676e3e85ec4" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod_d8097f0b-3817-44db-b0e8-bbc63050d73b" xlink:href="dgx-20201231.xsd#dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod_d8097f0b-3817-44db-b0e8-bbc63050d73b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_cda13aeb-e5ae-4645-8149-46743dabe2ae" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_cda13aeb-e5ae-4645-8149-46743dabe2ae" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_05b83e92-1bb3-4c86-b78f-547ee0576323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_05b83e92-1bb3-4c86-b78f-547ee0576323" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0f74e46b-ca4d-4755-ae1c-f59d5bb50af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0f74e46b-ca4d-4755-ae1c-f59d5bb50af6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_624ab7eb-4d17-4277-a293-0001a9bef2c0" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_624ab7eb-4d17-4277-a293-0001a9bef2c0" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_d7f684fc-94ea-4b92-8ac9-e22a56ee90fd" xlink:href="dgx-20201231.xsd#dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_d7f684fc-94ea-4b92-8ac9-e22a56ee90fd" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f766d63d-ddb1-42d3-a594-cb79b9e091eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f766d63d-ddb1-42d3-a594-cb79b9e091eb" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_cb40c077-9229-4942-b411-89ef69f70eb9" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_cb40c077-9229-4942-b411-89ef69f70eb9" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a886d366-b3a7-406a-a4f7-143f9f06b295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a886d366-b3a7-406a-a4f7-143f9f06b295" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_4e2bfb2f-29b3-45ab-bc70-f6c5b3add6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxLiabilities_4e2bfb2f-29b3-45ab-bc70-f6c5b3add6e6" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_8e39897a-8419-4eef-a00b-3fb8a7a94503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_8e39897a-8419-4eef-a00b-3fb8a7a94503" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e22cb768-8925-4590-81c5-de91ad209843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e22cb768-8925-4590-81c5-de91ad209843" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d70588a-25b1-4450-ae4a-41cbcf2e2dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d70588a-25b1-4450-ae4a-41cbcf2e2dc7" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_b0968e7a-38dc-4dc0-b4b1-9db6a506b507" xlink:href="dgx-20201231.xsd#dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_b0968e7a-38dc-4dc0-b4b1-9db6a506b507" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_9a477278-3874-4d7c-b6ca-8de78cf616b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_AccruedIncomeTaxes_9a477278-3874-4d7c-b6ca-8de78cf616b6" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_3b694bca-7cb4-4a5d-a0f1-06185e89f68d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_PrepaidTaxes_3b694bca-7cb4-4a5d-a0f1-06185e89f68d" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_69536b3b-7efb-4fe6-adb1-f4483cc5c7d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_69536b3b-7efb-4fe6-adb1-f4483cc5c7d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_494e232e-a328-4f79-960b-5f545dca38d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_494e232e-a328-4f79-960b-5f545dca38d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_291be510-bd94-4a07-a375-7a6b5016102a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_291be510-bd94-4a07-a375-7a6b5016102a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReductionsForChangesInJudgment_12a7fc51-91ed-4f4e-a1af-72308a8b3442" xlink:href="dgx-20201231.xsd#dgx_ReductionsForChangesInJudgment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_dgx_ReductionsForChangesInJudgment_12a7fc51-91ed-4f4e-a1af-72308a8b3442" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fe3ca0cf-768d-4475-9bc8-a82b447ee43e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fe3ca0cf-768d-4475-9bc8-a82b447ee43e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_093f7cb2-eb0c-462b-ba4f-d5de9438f73a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_093f7cb2-eb0c-462b-ba4f-d5de9438f73a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6d7d6766-07ee-4bf7-9dcb-6cb84528af21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_d7cf903d-94f5-4aef-a3a6-9e34457fe88f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_d7cf903d-94f5-4aef-a3a6-9e34457fe88f" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_57f252d3-a2e2-49f6-a63d-fe2134c5c99a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_57f252d3-a2e2-49f6-a63d-fe2134c5c99a" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_36bb3400-7188-4b2c-a217-954293534dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_36bb3400-7188-4b2c-a217-954293534dc9" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_97418a2a-52cf-49aa-96d9-c94ed044aa3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_97418a2a-52cf-49aa-96d9-c94ed044aa3f" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_3135c62e-09a2-45aa-a167-5dec502ef09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_3135c62e-09a2-45aa-a167-5dec502ef09f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_37abbf48-c5ad-4b49-a77f-769f545a85a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_3135c62e-09a2-45aa-a167-5dec502ef09f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_37abbf48-c5ad-4b49-a77f-769f545a85a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_37abbf48-c5ad-4b49-a77f-769f545a85a9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_37abbf48-c5ad-4b49-a77f-769f545a85a9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_37abbf48-c5ad-4b49-a77f-769f545a85a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_37abbf48-c5ad-4b49-a77f-769f545a85a9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e43e52be-bceb-404b-aed2-85f52a65b1b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:to="loc_us-gaap_DomesticCountryMember_e43e52be-bceb-404b-aed2-85f52a65b1b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_c8ed953c-eece-4639-babb-5378b9dfd93c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_c8ed953c-eece-4639-babb-5378b9dfd93c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_60ba2baf-34a2-496d-8b48-9c6c00e45b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:to="loc_us-gaap_ForeignCountryMember_60ba2baf-34a2-496d-8b48-9c6c00e45b7f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATA"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA" xlink:type="extended" id="ib6d0fbb9fe5741a8a1b26857fb413a0f_SUPPLEMENTALCASHFLOWANDOTHERDATA"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATATables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables" xlink:type="extended" id="iedebe27665fb4b46822a2d02e9238ca1_SUPPLEMENTALCASHFLOWANDOTHERDATATables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATADetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="extended" id="i110e8275329042a49ebbba1d90ed5f60_SUPPLEMENTALCASHFLOWANDOTHERDATADetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_6d3a8521-c725-440c-9c02-5d2d61ca902d" xlink:href="dgx-20201231.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d895f15a-b272-40a9-82e8-d8721937181c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_6d3a8521-c725-440c-9c02-5d2d61ca902d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d895f15a-b272-40a9-82e8-d8721937181c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_588ae7f0-ec25-4d52-afab-f6317db34008" xlink:href="dgx-20201231.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_6d3a8521-c725-440c-9c02-5d2d61ca902d" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_588ae7f0-ec25-4d52-afab-f6317db34008" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_c49a12de-968b-40f5-ac19-aeccd58085b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_588ae7f0-ec25-4d52-afab-f6317db34008" xlink:to="loc_us-gaap_NatureOfExpenseAxis_c49a12de-968b-40f5-ac19-aeccd58085b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_c49a12de-968b-40f5-ac19-aeccd58085b8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c49a12de-968b-40f5-ac19-aeccd58085b8" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_c49a12de-968b-40f5-ac19-aeccd58085b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8868b558-e60d-4c50-905f-13ab7efc817c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c49a12de-968b-40f5-ac19-aeccd58085b8" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8868b558-e60d-4c50-905f-13ab7efc817c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmortizationofIntangibleAssetsMember_10ab9b99-ff21-4581-89b5-9f06fc6166f3" xlink:href="dgx-20201231.xsd#dgx_AmortizationofIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8868b558-e60d-4c50-905f-13ab7efc817c" xlink:to="loc_dgx_AmortizationofIntangibleAssetsMember_10ab9b99-ff21-4581-89b5-9f06fc6166f3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended" id="i48678178f7f1448f877f6e8a4d60dd70_PROPERTYPLANTANDEQUIPMENT"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended" id="i2a21d050a468459da0b9286a3fb8748c_PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended" id="i38745c28c81344af8c21d21bbc841b04_PROPERTYPLANTANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_cafa0dc5-e42b-4071-b8da-91ccfd1b1993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_cafa0dc5-e42b-4071-b8da-91ccfd1b1993" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ac6c8b2e-927a-4163-8b20-19b9cc8a7fe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ac6c8b2e-927a-4163-8b20-19b9cc8a7fe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_72e37505-4124-4dd5-9a63-34bc83916d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_72e37505-4124-4dd5-9a63-34bc83916d0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_890cde95-f66f-49af-84a6-7b110f640422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_890cde95-f66f-49af-84a6-7b110f640422" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_57f25992-4b3b-48f7-a4c2-ea39d4c240d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_57f25992-4b3b-48f7-a4c2-ea39d4c240d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_57f25992-4b3b-48f7-a4c2-ea39d4c240d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_57f25992-4b3b-48f7-a4c2-ea39d4c240d9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_57f25992-4b3b-48f7-a4c2-ea39d4c240d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_57f25992-4b3b-48f7-a4c2-ea39d4c240d9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_51bb9a8e-954a-4665-9563-3aa597c935b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_LandMember_51bb9a8e-954a-4665-9563-3aa597c935b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_677ab311-cc30-4966-afb2-8cacc0e66b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_677ab311-cc30-4966-afb2-8cacc0e66b26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_5cd68385-b949-4c7c-b92b-f7a60bf2f7b0" xlink:href="dgx-20201231.xsd#dgx_LaboratoryEquipmentFurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_5cd68385-b949-4c7c-b92b-f7a60bf2f7b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_1e6607a1-238f-4b2d-a277-400d6a94d471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_1e6607a1-238f-4b2d-a277-400d6a94d471" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_114b20eb-117a-4640-9c3f-f2716c8e7ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_114b20eb-117a-4640-9c3f-f2716c8e7ecf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_f1d0db34-df78-4b20-a3a1-ae11733d4ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_ConstructionInProgressMember_f1d0db34-df78-4b20-a3a1-ae11733d4ba6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98edfdf4-0e09-4283-85fb-d17a098a78bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98edfdf4-0e09-4283-85fb-d17a098a78bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_98edfdf4-0e09-4283-85fb-d17a098a78bf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98edfdf4-0e09-4283-85fb-d17a098a78bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_98edfdf4-0e09-4283-85fb-d17a098a78bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f00ff2f8-0b24-45d4-a679-e6adcec0e744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98edfdf4-0e09-4283-85fb-d17a098a78bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f00ff2f8-0b24-45d4-a679-e6adcec0e744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_fd53cdc9-3d5a-4d1c-8bd8-2f429734c039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f00ff2f8-0b24-45d4-a679-e6adcec0e744" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_fd53cdc9-3d5a-4d1c-8bd8-2f429734c039" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended" id="id07d7f8cf6d341628fba4f4d3992b4d5_GOODWILLANDINTANGIBLEASSETS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended" id="i944bd4e21fb0446bae6d0641f09c54d6_GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended" id="if1c9fd5d1c054079b4b57bfa7eb262d7_GOODWILLANDINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b5a80b41-2a05-430e-8685-bcfb4fbc8fac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b5a80b41-2a05-430e-8685-bcfb4fbc8fac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2eaa1cf8-955b-43f6-8221-e6eb05590037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2eaa1cf8-955b-43f6-8221-e6eb05590037" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a9880811-019b-45bd-8713-cc6627525aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a9880811-019b-45bd-8713-cc6627525aa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dc34a1c3-8637-48de-9b8b-26f36ea62051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dc34a1c3-8637-48de-9b8b-26f36ea62051" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1d4a439f-7a03-4a7e-9ebd-2c41c4946416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1d4a439f-7a03-4a7e-9ebd-2c41c4946416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_32ebf9b7-87a5-45f4-8220-4f947b2e0213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_32ebf9b7-87a5-45f4-8220-4f947b2e0213" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d156870a-94f9-412c-9a44-7d5efa602e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d156870a-94f9-412c-9a44-7d5efa602e4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c0095471-235e-4ea5-adfa-563a6af4bcc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c0095471-235e-4ea5-adfa-563a6af4bcc0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc9f998d-5f29-4b92-8353-f7daa1ed051a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc9f998d-5f29-4b92-8353-f7daa1ed051a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9e5b217a-ca32-49d2-b08e-09219e9801c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9e5b217a-ca32-49d2-b08e-09219e9801c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_e67a6240-7aee-4ba0-ab7a-ae816b57c300" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_e67a6240-7aee-4ba0-ab7a-ae816b57c300" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29120da4-5b40-4976-a3c1-970ac52d1ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29120da4-5b40-4976-a3c1-970ac52d1ce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_29120da4-5b40-4976-a3c1-970ac52d1ce8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29120da4-5b40-4976-a3c1-970ac52d1ce8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_29120da4-5b40-4976-a3c1-970ac52d1ce8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29120da4-5b40-4976-a3c1-970ac52d1ce8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9697a02b-8299-4658-af7f-fa7b2ba27a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9697a02b-8299-4658-af7f-fa7b2ba27a2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_fd549589-72c1-42dc-836b-a137841a16ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_fd549589-72c1-42dc-836b-a137841a16ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_3cff6446-3229-4dd8-b53e-1fcd6a7b8a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_3cff6446-3229-4dd8-b53e-1fcd6a7b8a41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_35002253-deb8-4358-a1ab-bc9105253eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_35002253-deb8-4358-a1ab-bc9105253eef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_0cbe13ca-7818-45f7-bf3f-cc8911117de6" xlink:href="dgx-20201231.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_0cbe13ca-7818-45f7-bf3f-cc8911117de6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dd7a872b-f99c-423d-8786-e3d0261ff2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dd7a872b-f99c-423d-8786-e3d0261ff2a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_dd7a872b-f99c-423d-8786-e3d0261ff2a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dd7a872b-f99c-423d-8786-e3d0261ff2a3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_dd7a872b-f99c-423d-8786-e3d0261ff2a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89bd0756-a812-40ab-ba70-ce92e76ed28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dd7a872b-f99c-423d-8786-e3d0261ff2a3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89bd0756-a812-40ab-ba70-ce92e76ed28a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_059c0f1a-9832-4ddc-bfbc-06084ce47645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89bd0756-a812-40ab-ba70-ce92e76ed28a" xlink:to="loc_us-gaap_TradeNamesMember_059c0f1a-9832-4ddc-bfbc-06084ce47645" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_de2c974d-c374-4e78-ba63-5adf99d93281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89bd0756-a812-40ab-ba70-ce92e76ed28a" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_de2c974d-c374-4e78-ba63-5adf99d93281" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="extended" id="i72dbc53b6c23460991a8170b9e85fd12_ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="extended" id="i265d0afbfb684c56aa669d39f60a1fe1_ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended" id="i13bf01d0ac524bf398611ef33c3ed3f2_ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBT" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBT"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBT" xlink:type="extended" id="ia00b30e5041a4126944fe2e228a3700c_DEBT"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTTables" xlink:type="extended" id="if683cdee869c4ff48f6872ddd87f9b9d_DEBTTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="extended" id="icb170979d5494feaafb303a4d52a317c_DEBTLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_121f4e77-c11e-49b9-abaf-4a887210aee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_LongTermDebt_121f4e77-c11e-49b9-abaf-4a887210aee2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_b0116ef6-dd22-4057-a60a-f35b4bfdc60b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_OtherLongTermDebt_b0116ef6-dd22-4057-a60a-f35b4bfdc60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_aafabd96-299e-4654-8311-49583d472667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_aafabd96-299e-4654-8311-49583d472667" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b3b1a4b8-4696-4f62-89a1-530e4e717979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_LongTermDebtCurrent_b3b1a4b8-4696-4f62-89a1-530e4e717979" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_21d038bb-6eaa-4358-9681-0cb741f82bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_21d038bb-6eaa-4358-9681-0cb741f82bc9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1e26d15-f9b6-4b3a-b43f-171f9b20b9a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1e26d15-f9b6-4b3a-b43f-171f9b20b9a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ee9f11fb-e711-401d-a659-a556bf4d84a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ee9f11fb-e711-401d-a659-a556bf4d84a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ee9f11fb-e711-401d-a659-a556bf4d84a9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ee9f11fb-e711-401d-a659-a556bf4d84a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ee9f11fb-e711-401d-a659-a556bf4d84a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72a186e0-cd3f-41ca-938a-ac309e3a6f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ee9f11fb-e711-401d-a659-a556bf4d84a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72a186e0-cd3f-41ca-938a-ac309e3a6f44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_78540ce7-443a-4ec5-aa56-e663f011752a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72a186e0-cd3f-41ca-938a-ac309e3a6f44" xlink:to="loc_us-gaap_SeniorNotesMember_78540ce7-443a-4ec5-aa56-e663f011752a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:to="loc_us-gaap_DebtInstrumentAxis_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member_4d16755f-46ce-4713-943a-05881a2ee193" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenFivePercentSeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member_4d16755f-46ce-4713-943a-05881a2ee193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member_1229fd58-884f-42a4-b1b3-a1d1246b24d1" xlink:href="dgx-20201231.xsd#dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member_1229fd58-884f-42a4-b1b3-a1d1246b24d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member_85c2f546-b24f-4475-9d7b-e40ed3a56094" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member_85c2f546-b24f-4475-9d7b-e40ed3a56094" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_4a2f1e39-61fb-48cb-a40d-f2dea03cefb4" xlink:href="dgx-20201231.xsd#dgx_FourpointtwofivepercentSeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_4a2f1e39-61fb-48cb-a40d-f2dea03cefb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_789cf00f-f9ed-41be-8a68-3386460b3d1e" xlink:href="dgx-20201231.xsd#dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_789cf00f-f9ed-41be-8a68-3386460b3d1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_c3c0d136-6b0d-4958-8995-87af980eda2e" xlink:href="dgx-20201231.xsd#dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_c3c0d136-6b0d-4958-8995-87af980eda2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_8962ac13-c304-4f2b-9092-181dac6ff78a" xlink:href="dgx-20201231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_8962ac13-c304-4f2b-9092-181dac6ff78a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_8f274e10-f645-4c72-8fda-eb929a096943" xlink:href="dgx-20201231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_8f274e10-f645-4c72-8fda-eb929a096943" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_0c312962-a4e1-47ec-a425-ec78cd9ff266" xlink:href="dgx-20201231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_0c312962-a4e1-47ec-a425-ec78cd9ff266" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_1d3c3201-648a-4701-8209-fd6969c651a2" xlink:href="dgx-20201231.xsd#dgx_SixPointNineFivePercentSeniorNotesDue2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_1d3c3201-648a-4701-8209-fd6969c651a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_f0fcc686-974d-4e2c-a8d1-d4c9483e23ea" xlink:href="dgx-20201231.xsd#dgx_FivePointSevenFivePercentSeniorNotesDue2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_f0fcc686-974d-4e2c-a8d1-d4c9483e23ea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_f4e7cfb8-35cf-4a90-bda4-0f0c07480fa7" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_f4e7cfb8-35cf-4a90-bda4-0f0c07480fa7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceLeaseObligationsandOtherMember_6e8c4b5c-0a99-44ee-84c4-f94124cc5714" xlink:href="dgx-20201231.xsd#dgx_FinanceLeaseObligationsandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FinanceLeaseObligationsandOtherMember_6e8c4b5c-0a99-44ee-84c4-f94124cc5714" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSecuredReceivablesCreditFacilityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="extended" id="ieecf1c52dc6a40a69fcfd884c5077c97_DEBTSecuredReceivablesCreditFacilityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f805ff33-74f9-4b28-ab73-e689df6f3bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f805ff33-74f9-4b28-ab73-e689df6f3bc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod_19114941-c2c2-419e-a510-4afcf5ac5721" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_dgx_DebtInstrumentExtensionPeriod_19114941-c2c2-419e-a510-4afcf5ac5721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e2e1e78b-a108-432d-a979-d4e8fcc4c46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e2e1e78b-a108-432d-a979-d4e8fcc4c46c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b2c89bb5-b7b6-451d-851d-ca5fb71522e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b2c89bb5-b7b6-451d-851d-ca5fb71522e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_435c5ece-3cb4-495d-9f15-50ea90eb7a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_435c5ece-3cb4-495d-9f15-50ea90eb7a25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_435c5ece-3cb4-495d-9f15-50ea90eb7a25_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_435c5ece-3cb4-495d-9f15-50ea90eb7a25" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_435c5ece-3cb4-495d-9f15-50ea90eb7a25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_444970fc-447c-4086-acf6-915ff032079d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_435c5ece-3cb4-495d-9f15-50ea90eb7a25" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_444970fc-447c-4086-acf6-915ff032079d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e3180781-de2c-4bdb-8e52-b85fc1585574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_444970fc-447c-4086-acf6-915ff032079d" xlink:to="loc_us-gaap_SecuredDebtMember_e3180781-de2c-4bdb-8e52-b85fc1585574" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_18b8c07a-35d1-4553-8fb5-0bba561d7e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_DebtInstrumentAxis_18b8c07a-35d1-4553-8fb5-0bba561d7e44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18b8c07a-35d1-4553-8fb5-0bba561d7e44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_18b8c07a-35d1-4553-8fb5-0bba561d7e44" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18b8c07a-35d1-4553-8fb5-0bba561d7e44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f897b883-8b25-4016-8b64-b08e236a75c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_18b8c07a-35d1-4553-8fb5-0bba561d7e44" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f897b883-8b25-4016-8b64-b08e236a75c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoancommitmentmaturingOctober2021Member_85be2f01-d59e-40de-af6b-059d737d509b" xlink:href="dgx-20201231.xsd#dgx_LoancommitmentmaturingOctober2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f897b883-8b25-4016-8b64-b08e236a75c0" xlink:to="loc_dgx_LoancommitmentmaturingOctober2021Member_85be2f01-d59e-40de-af6b-059d737d509b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member_2e53c3a1-c9e4-417a-9aa3-22546ea8725a" xlink:href="dgx-20201231.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f897b883-8b25-4016-8b64-b08e236a75c0" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2022Member_2e53c3a1-c9e4-417a-9aa3-22546ea8725a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ae384489-2674-4287-a3e1-db155fbc0acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_CreditFacilityAxis_ae384489-2674-4287-a3e1-db155fbc0acf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ae384489-2674-4287-a3e1-db155fbc0acf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ae384489-2674-4287-a3e1-db155fbc0acf" xlink:to="loc_us-gaap_CreditFacilityDomain_ae384489-2674-4287-a3e1-db155fbc0acf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7a2edb06-cb07-4ddf-832d-dcb277cb958c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ae384489-2674-4287-a3e1-db155fbc0acf" xlink:to="loc_us-gaap_CreditFacilityDomain_7a2edb06-cb07-4ddf-832d-dcb277cb958c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_dd21aff7-7de8-443d-b75f-ff14cdef256c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7a2edb06-cb07-4ddf-832d-dcb277cb958c" xlink:to="loc_us-gaap_LetterOfCreditMember_dd21aff7-7de8-443d-b75f-ff14cdef256c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_78d40cf9-ab0d-4714-9009-5ba2d1c4876b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7a2edb06-cb07-4ddf-832d-dcb277cb958c" xlink:to="loc_us-gaap_LineOfCreditMember_78d40cf9-ab0d-4714-9009-5ba2d1c4876b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_45ae44dd-6cd8-4722-bc2f-b9385ff3938c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_VariableRateAxis_45ae44dd-6cd8-4722-bc2f-b9385ff3938c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_45ae44dd-6cd8-4722-bc2f-b9385ff3938c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_45ae44dd-6cd8-4722-bc2f-b9385ff3938c" xlink:to="loc_us-gaap_VariableRateDomain_45ae44dd-6cd8-4722-bc2f-b9385ff3938c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_af1008ba-29c0-43c9-aea6-22a25b1450f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_45ae44dd-6cd8-4722-bc2f-b9385ff3938c" xlink:to="loc_us-gaap_VariableRateDomain_af1008ba-29c0-43c9-aea6-22a25b1450f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_1adf6e5f-7872-4ce6-b104-460a4f7dc27e" xlink:href="dgx-20201231.xsd#dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_af1008ba-29c0-43c9-aea6-22a25b1450f8" xlink:to="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_1adf6e5f-7872-4ce6-b104-460a4f7dc27e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a014b6d7-326f-47b9-a6b5-640fc2a26b76" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_srt_RangeAxis_a014b6d7-326f-47b9-a6b5-640fc2a26b76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a014b6d7-326f-47b9-a6b5-640fc2a26b76_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a014b6d7-326f-47b9-a6b5-640fc2a26b76" xlink:to="loc_srt_RangeMember_a014b6d7-326f-47b9-a6b5-640fc2a26b76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1e64d1ea-20ab-4704-a59f-53b2a1988a7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a014b6d7-326f-47b9-a6b5-640fc2a26b76" xlink:to="loc_srt_RangeMember_1e64d1ea-20ab-4704-a59f-53b2a1988a7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1bd39944-12f8-44f8-a14d-e9827e83e9bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1e64d1ea-20ab-4704-a59f-53b2a1988a7b" xlink:to="loc_srt_MinimumMember_1bd39944-12f8-44f8-a14d-e9827e83e9bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f24c638-43e0-4f7f-9eb2-131b7d7b287a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1e64d1ea-20ab-4704-a59f-53b2a1988a7b" xlink:to="loc_srt_MaximumMember_1f24c638-43e0-4f7f-9eb2-131b7d7b287a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="extended" id="ib449d55d078845a288bb3a04c7183e50_DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a703501b-3cb4-470f-83ed-89cbe12dfb9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a703501b-3cb4-470f-83ed-89cbe12dfb9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0fbee9a6-ff5f-4a6a-a7dd-64c0a26ef0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0fbee9a6-ff5f-4a6a-a7dd-64c0a26ef0c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentLeverageRatioRequirement_7b59d084-dc5f-4653-b475-6718eb98b10e" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentLeverageRatioRequirement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_dgx_DebtInstrumentLeverageRatioRequirement_7b59d084-dc5f-4653-b475-6718eb98b10e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d15626f2-a84e-4096-a049-b461a95f03af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d15626f2-a84e-4096-a049-b461a95f03af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fc9877e9-f798-4800-8b31-b4873813dfe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fc9877e9-f798-4800-8b31-b4873813dfe6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_522949d7-dcb7-4fec-b6f0-5795273673fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_522949d7-dcb7-4fec-b6f0-5795273673fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_cdd48985-a9ae-4df4-b14c-d108f25010fe" xlink:href="dgx-20201231.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_522949d7-dcb7-4fec-b6f0-5795273673fe" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_cdd48985-a9ae-4df4-b14c-d108f25010fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_ea7ace46-2a80-4d30-8eb7-d623fd38aca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_522949d7-dcb7-4fec-b6f0-5795273673fe" xlink:to="loc_us-gaap_SecuredDebtMember_ea7ace46-2a80-4d30-8eb7-d623fd38aca5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e8bf4db3-7bcb-4dde-8d48-192147de159d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_us-gaap_CreditFacilityAxis_e8bf4db3-7bcb-4dde-8d48-192147de159d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e8bf4db3-7bcb-4dde-8d48-192147de159d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e8bf4db3-7bcb-4dde-8d48-192147de159d" xlink:to="loc_us-gaap_CreditFacilityDomain_e8bf4db3-7bcb-4dde-8d48-192147de159d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5233dda0-58d9-47c4-a468-23b848fe956e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e8bf4db3-7bcb-4dde-8d48-192147de159d" xlink:to="loc_us-gaap_CreditFacilityDomain_5233dda0-58d9-47c4-a468-23b848fe956e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ee890430-75c2-4ea1-b5a8-f115bda5bff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5233dda0-58d9-47c4-a468-23b848fe956e" xlink:to="loc_us-gaap_LetterOfCreditMember_ee890430-75c2-4ea1-b5a8-f115bda5bff4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_30675654-178b-4555-8401-78d74a3241e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_us-gaap_VariableRateAxis_30675654-178b-4555-8401-78d74a3241e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_30675654-178b-4555-8401-78d74a3241e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_30675654-178b-4555-8401-78d74a3241e1" xlink:to="loc_us-gaap_VariableRateDomain_30675654-178b-4555-8401-78d74a3241e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_51848653-035e-4b04-b1af-573567b75b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_30675654-178b-4555-8401-78d74a3241e1" xlink:to="loc_us-gaap_VariableRateDomain_51848653-035e-4b04-b1af-573567b75b73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8c4f86a1-c58b-4ab8-992f-1bae41da512d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_51848653-035e-4b04-b1af-573567b75b73" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8c4f86a1-c58b-4ab8-992f-1bae41da512d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_de98fcb1-3ee5-432a-acc1-8877652cb3ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_srt_RangeAxis_de98fcb1-3ee5-432a-acc1-8877652cb3ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de98fcb1-3ee5-432a-acc1-8877652cb3ac_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_de98fcb1-3ee5-432a-acc1-8877652cb3ac" xlink:to="loc_srt_RangeMember_de98fcb1-3ee5-432a-acc1-8877652cb3ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1398df59-b4c6-4d16-9b09-67bdf53868b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_de98fcb1-3ee5-432a-acc1-8877652cb3ac" xlink:to="loc_srt_RangeMember_1398df59-b4c6-4d16-9b09-67bdf53868b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e17db0a4-b68d-4b0b-a7ce-c964efa3c58a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1398df59-b4c6-4d16-9b09-67bdf53868b2" xlink:to="loc_srt_MaximumMember_e17db0a4-b68d-4b0b-a7ce-c964efa3c58a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_45cd095c-4890-4b35-b218-a909bdf891c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_srt_StatementScenarioAxis_45cd095c-4890-4b35-b218-a909bdf891c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_45cd095c-4890-4b35-b218-a909bdf891c2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_45cd095c-4890-4b35-b218-a909bdf891c2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_45cd095c-4890-4b35-b218-a909bdf891c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_84a780cf-285c-4d01-aec4-12f5c9ce1efa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_45cd095c-4890-4b35-b218-a909bdf891c2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_84a780cf-285c-4d01-aec4-12f5c9ce1efa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_a1c57fda-1f14-4e29-bae9-b7bf151f2fe5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_84a780cf-285c-4d01-aec4-12f5c9ce1efa" xlink:to="loc_srt_ScenarioForecastMember_a1c57fda-1f14-4e29-bae9-b7bf151f2fe5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSeniorNotesOfferingDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="extended" id="icc1fe7a181474702beb27ceef5754bfc_DEBTSeniorNotesOfferingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e6d6d64e-b04f-40e1-be36-a685f47891bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e6d6d64e-b04f-40e1-be36-a685f47891bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5996ff1d-9712-45be-8452-bc7b22cfd747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5996ff1d-9712-45be-8452-bc7b22cfd747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5f756005-dedb-4f04-bfe8-c5aebd1af9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5f756005-dedb-4f04-bfe8-c5aebd1af9e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_4e6f9ec0-06e9-4e19-9679-623b0732f4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_4e6f9ec0-06e9-4e19-9679-623b0732f4f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bf17964a-aa98-4e9b-8094-c3444f5e539a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bf17964a-aa98-4e9b-8094-c3444f5e539a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_82492fdf-eb4d-49b8-bd9b-907797baa948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_82492fdf-eb4d-49b8-bd9b-907797baa948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_91e0842c-7854-4499-9be6-d7587de4ccae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_82492fdf-eb4d-49b8-bd9b-907797baa948" xlink:to="loc_us-gaap_SeniorNotesMember_91e0842c-7854-4499-9be6-d7587de4ccae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9db33d2d-4768-492b-82e2-7d4c8205758b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_9db33d2d-4768-492b-82e2-7d4c8205758b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9db33d2d-4768-492b-82e2-7d4c8205758b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9db33d2d-4768-492b-82e2-7d4c8205758b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9db33d2d-4768-492b-82e2-7d4c8205758b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9db33d2d-4768-492b-82e2-7d4c8205758b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_4c5d0ebe-21d8-44c0-becb-0872f705d29a" xlink:href="dgx-20201231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:to="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_4c5d0ebe-21d8-44c0-becb-0872f705d29a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_7169caf7-c547-45df-af6e-de1edbb2702c" xlink:href="dgx-20201231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:to="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_7169caf7-c547-45df-af6e-de1edbb2702c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_95a35a4f-2a4f-4a40-9f5e-ad536b8a49c0" xlink:href="dgx-20201231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:to="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_95a35a4f-2a4f-4a40-9f5e-ad536b8a49c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e0512496-199e-4485-bfc8-f5a2be6bc4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e0512496-199e-4485-bfc8-f5a2be6bc4ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e0512496-199e-4485-bfc8-f5a2be6bc4ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e0512496-199e-4485-bfc8-f5a2be6bc4ee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e0512496-199e-4485-bfc8-f5a2be6bc4ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c9eb89a2-9c3c-49c1-ad30-44548da38b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e0512496-199e-4485-bfc8-f5a2be6bc4ee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c9eb89a2-9c3c-49c1-ad30-44548da38b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_ce3807ab-1b5b-40fc-9bc9-b127f8078161" xlink:href="dgx-20201231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c9eb89a2-9c3c-49c1-ad30-44548da38b32" xlink:to="loc_dgx_OtherIncomeExpenseMember_ce3807ab-1b5b-40fc-9bc9-b127f8078161" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTMaturitiesofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="extended" id="iabfde8c666e045b9bbd060499bb84dc9_DEBTMaturitiesofLongTermDebtDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASES" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/LEASES" xlink:type="extended" id="ica609a3502da49ab8f45e83f2f38f107_LEASES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/LEASESTables" xlink:type="extended" id="i7b7e204a36624744b3091898b29ace52_LEASESTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="extended" id="id3717552b0ff48d28de56b991c16b54d_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f24b287-454f-4644-adde-3ef74394a7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRemainingLeaseTerm_8813f3f9-b4df-46d7-b49e-b1ad8b503f17" xlink:href="dgx-20201231.xsd#dgx_LeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f24b287-454f-4644-adde-3ef74394a7dc" xlink:to="loc_dgx_LeaseRemainingLeaseTerm_8813f3f9-b4df-46d7-b49e-b1ad8b503f17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRenewalTerm_f16b99ea-4659-4686-a238-f1649066befc" xlink:href="dgx-20201231.xsd#dgx_LeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f24b287-454f-4644-adde-3ef74394a7dc" xlink:to="loc_dgx_LeaseRenewalTerm_f16b99ea-4659-4686-a238-f1649066befc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2acdd736-422f-47a3-b950-4fef2277f8c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f24b287-454f-4644-adde-3ef74394a7dc" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2acdd736-422f-47a3-b950-4fef2277f8c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2acdd736-422f-47a3-b950-4fef2277f8c2" xlink:to="loc_srt_RangeAxis_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e" xlink:to="loc_srt_RangeMember_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1eb355d0-8027-4cb2-a9b6-da3bda1dc0cc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e" xlink:to="loc_srt_RangeMember_1eb355d0-8027-4cb2-a9b6-da3bda1dc0cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c34ecaf4-6094-4da7-8558-74c535c90994" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1eb355d0-8027-4cb2-a9b6-da3bda1dc0cc" xlink:to="loc_srt_MinimumMember_c34ecaf4-6094-4da7-8558-74c535c90994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4ce9efc0-79f1-4c29-8b8d-a5ca271e148d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1eb355d0-8027-4cb2-a9b6-da3bda1dc0cc" xlink:to="loc_srt_MaximumMember_4ce9efc0-79f1-4c29-8b8d-a5ca271e148d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="extended" id="i6285c1e0367f4981ace0838578dbac5a_LEASESLiabilitiesDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESCostsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="extended" id="i0c7ccbd520524673a4f307eba6929674_LEASESCostsDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESMaturityDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="extended" id="i5b81c37eda3442ccac44a9177fad351a_LEASESMaturityDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESTermandRateDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESTermandRateDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/LEASESTermandRateDetails" xlink:type="extended" id="i373e5d3d97d84f4e81c84bdb38bbb62a_LEASESTermandRateDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended" id="i82f33af8cd8741beadfcae5da199c967_FINANCIALINSTRUMENTS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended" id="iff1b72b1094f4c52b343b061a2954d28_FINANCIALINSTRUMENTSTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended" id="i4f3761bc01974d98b8b0ba6cfc614dab_FINANCIALINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_056c588d-7d47-47dc-a87b-f24c277a5392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_DerivativeNotionalAmount_056c588d-7d47-47dc-a87b-f24c277a5392" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DerivativeGainAmortizationPeriod_75e7b5c1-a142-4932-887f-31214bf3111a" xlink:href="dgx-20201231.xsd#dgx_DerivativeGainAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_dgx_DerivativeGainAmortizationPeriod_75e7b5c1-a142-4932-887f-31214bf3111a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_f8fe0574-6237-4217-8284-44d6a16cc579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_f8fe0574-6237-4217-8284-44d6a16cc579" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf4fa415-da03-4453-8c0f-7fbebaf1a31a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf4fa415-da03-4453-8c0f-7fbebaf1a31a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b251a0b6-3381-4353-b16d-9f9e1546fa5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b251a0b6-3381-4353-b16d-9f9e1546fa5d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge_d722ad6f-d8cb-43fc-8831-398dce19b087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge_d722ad6f-d8cb-43fc-8831-398dce19b087" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities_4d1975df-397e-497e-8d7a-c68aa7d9ed39" xlink:href="dgx-20201231.xsd#dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities_4d1975df-397e-497e-8d7a-c68aa7d9ed39" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_85b1765b-1627-4250-b57d-f43e1c22777a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_85b1765b-1627-4250-b57d-f43e1c22777a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_85b1765b-1627-4250-b57d-f43e1c22777a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_85b1765b-1627-4250-b57d-f43e1c22777a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_85b1765b-1627-4250-b57d-f43e1c22777a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c5e6f09c-2385-4610-8bdc-b05b7b374551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_85b1765b-1627-4250-b57d-f43e1c22777a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c5e6f09c-2385-4610-8bdc-b05b7b374551" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_f20f0c1e-56fd-499c-939f-2e31938470f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c5e6f09c-2385-4610-8bdc-b05b7b374551" xlink:to="loc_us-gaap_CashFlowHedgingMember_f20f0c1e-56fd-499c-939f-2e31938470f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_7b4384ca-4fef-4872-9237-82a9ef82b823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c5e6f09c-2385-4610-8bdc-b05b7b374551" xlink:to="loc_us-gaap_FairValueHedgingMember_7b4384ca-4fef-4872-9237-82a9ef82b823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForwardStartingInterestRateSwapsMember_b142ea9a-4ee0-497c-a779-bde587084a4d" xlink:href="dgx-20201231.xsd#dgx_ForwardStartingInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:to="loc_dgx_ForwardStartingInterestRateSwapsMember_b142ea9a-4ee0-497c-a779-bde587084a4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InterestRateLockAgreementsMember_4a8ca2f2-2146-4426-8e49-9de5bb6cf60b" xlink:href="dgx-20201231.xsd#dgx_InterestRateLockAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:to="loc_dgx_InterestRateLockAgreementsMember_4a8ca2f2-2146-4426-8e49-9de5bb6cf60b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FixedtovariableinterestrateswapMember_58a4541f-d2cc-4d50-b670-c9f8043849cd" xlink:href="dgx-20201231.xsd#dgx_FixedtovariableinterestrateswapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:to="loc_dgx_FixedtovariableinterestrateswapMember_58a4541f-d2cc-4d50-b670-c9f8043849cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7cfc83e2-2cae-4d5f-91f3-ce31126e951e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_srt_StatementScenarioAxis_7cfc83e2-2cae-4d5f-91f3-ce31126e951e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7cfc83e2-2cae-4d5f-91f3-ce31126e951e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7cfc83e2-2cae-4d5f-91f3-ce31126e951e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7cfc83e2-2cae-4d5f-91f3-ce31126e951e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b422d264-3e44-4c3b-962e-6830089b52d7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7cfc83e2-2cae-4d5f-91f3-ce31126e951e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b422d264-3e44-4c3b-962e-6830089b52d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_19c0fee8-1704-4eff-b506-87a46817638c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b422d264-3e44-4c3b-962e-6830089b52d7" xlink:to="loc_srt_ScenarioForecastMember_19c0fee8-1704-4eff-b506-87a46817638c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_3ccb5293-fe28-497b-bf63-b636945d457b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_VariableRateAxis_3ccb5293-fe28-497b-bf63-b636945d457b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3ccb5293-fe28-497b-bf63-b636945d457b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_3ccb5293-fe28-497b-bf63-b636945d457b" xlink:to="loc_us-gaap_VariableRateDomain_3ccb5293-fe28-497b-bf63-b636945d457b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_72845606-eccb-46ee-b4ad-90b0b940467b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_3ccb5293-fe28-497b-bf63-b636945d457b" xlink:to="loc_us-gaap_VariableRateDomain_72845606-eccb-46ee-b4ad-90b0b940467b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_dc4ab9eb-f16d-487d-a7ef-d7f2f09c5141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_72845606-eccb-46ee-b4ad-90b0b940467b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_dc4ab9eb-f16d-487d-a7ef-d7f2f09c5141" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_42f028a0-1d54-4ff7-a18c-223a10c94040" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_srt_RangeAxis_42f028a0-1d54-4ff7-a18c-223a10c94040" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_42f028a0-1d54-4ff7-a18c-223a10c94040_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_42f028a0-1d54-4ff7-a18c-223a10c94040" xlink:to="loc_srt_RangeMember_42f028a0-1d54-4ff7-a18c-223a10c94040_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdebca8a-08b9-41f3-acf3-57a1320a172d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_42f028a0-1d54-4ff7-a18c-223a10c94040" xlink:to="loc_srt_RangeMember_cdebca8a-08b9-41f3-acf3-57a1320a172d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ddb64061-fa68-472b-b21b-18b1a7850695" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdebca8a-08b9-41f3-acf3-57a1320a172d" xlink:to="loc_srt_MinimumMember_ddb64061-fa68-472b-b21b-18b1a7850695" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c3cb9de2-7271-46e5-8f99-8f9df449e1a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_cdebca8a-08b9-41f3-acf3-57a1320a172d" xlink:to="loc_srt_MaximumMember_c3cb9de2-7271-46e5-8f99-8f9df449e1a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_97ab634d-dc55-496f-88f3-290d93871ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_97ab634d-dc55-496f-88f3-290d93871ace" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_97ab634d-dc55-496f-88f3-290d93871ace_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_97ab634d-dc55-496f-88f3-290d93871ace" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_97ab634d-dc55-496f-88f3-290d93871ace_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8438fcab-f0b5-4c2c-a36e-65ff977de02c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_97ab634d-dc55-496f-88f3-290d93871ace" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8438fcab-f0b5-4c2c-a36e-65ff977de02c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_4562f2f8-d4a4-4caf-9fce-cb4dba83c671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8438fcab-f0b5-4c2c-a36e-65ff977de02c" xlink:to="loc_us-gaap_LongTermDebtMember_4562f2f8-d4a4-4caf-9fce-cb4dba83c671" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended" id="i337d3274de244547ab264337ac74e4c4_FINANCIALINSTRUMENTSBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_653de219-93fa-4a92-b1f7-88eb26269fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_0b7f36b6-a6c7-4d70-a51f-796410059683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_653de219-93fa-4a92-b1f7-88eb26269fd1" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_0b7f36b6-a6c7-4d70-a51f-796410059683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_7231cfa4-30cd-435e-a11d-9d8bca4f0f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_653de219-93fa-4a92-b1f7-88eb26269fd1" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_7231cfa4-30cd-435e-a11d-9d8bca4f0f0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_653de219-93fa-4a92-b1f7-88eb26269fd1" xlink:to="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_493c5a98-14ab-4baa-a495-5c549d41c67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_493c5a98-14ab-4baa-a495-5c549d41c67b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_493c5a98-14ab-4baa-a495-5c549d41c67b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_493c5a98-14ab-4baa-a495-5c549d41c67b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_493c5a98-14ab-4baa-a495-5c549d41c67b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0b162bff-d0de-42db-a925-0f663bb07b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_493c5a98-14ab-4baa-a495-5c549d41c67b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0b162bff-d0de-42db-a925-0f663bb07b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_ce8f7d13-da5a-4079-8544-9e9699be5d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0b162bff-d0de-42db-a925-0f663bb07b35" xlink:to="loc_us-gaap_LongTermDebtMember_ce8f7d13-da5a-4079-8544-9e9699be5d1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0290b789-1e7e-496b-b89b-783259372498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0290b789-1e7e-496b-b89b-783259372498" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_0290b789-1e7e-496b-b89b-783259372498_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0290b789-1e7e-496b-b89b-783259372498" xlink:to="loc_us-gaap_HedgingRelationshipDomain_0290b789-1e7e-496b-b89b-783259372498_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_250ad1f3-0cd6-4061-9cec-fa267f6dfaf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0290b789-1e7e-496b-b89b-783259372498" xlink:to="loc_us-gaap_HedgingRelationshipDomain_250ad1f3-0cd6-4061-9cec-fa267f6dfaf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_cd6882f5-74b9-4463-bb35-8749dc7673b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_250ad1f3-0cd6-4061-9cec-fa267f6dfaf7" xlink:to="loc_us-gaap_FairValueHedgingMember_cd6882f5-74b9-4463-bb35-8749dc7673b5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended" id="ia652c0b4d0674e8abb623958e402e508_FINANCIALINSTRUMENTSIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7dc1b5ed-e82b-4535-94f7-b46939d7872a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7dc1b5ed-e82b-4535-94f7-b46939d7872a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_bfb1ae71-b08c-4c68-a76e-7e99bdfec0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_bfb1ae71-b08c-4c68-a76e-7e99bdfec0c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0b6221e0-e927-4bf9-b1bd-8e72edbecb77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0b6221e0-e927-4bf9-b1bd-8e72edbecb77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:to="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d3aa41e3-6936-4a4c-8e76-1336700b62e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d3aa41e3-6936-4a4c-8e76-1336700b62e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d3aa41e3-6936-4a4c-8e76-1336700b62e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d3aa41e3-6936-4a4c-8e76-1336700b62e1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d3aa41e3-6936-4a4c-8e76-1336700b62e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a552c7ea-5170-4d5c-af3d-56c26cc98a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d3aa41e3-6936-4a4c-8e76-1336700b62e1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a552c7ea-5170-4d5c-af3d-56c26cc98a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_aea1b08d-bde3-4ea7-9d6b-51326dfb6553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a552c7ea-5170-4d5c-af3d-56c26cc98a01" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_aea1b08d-bde3-4ea7-9d6b-51326dfb6553" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_90badbaa-ef47-437f-a284-341bf542db6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_90badbaa-ef47-437f-a284-341bf542db6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_90badbaa-ef47-437f-a284-341bf542db6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_90badbaa-ef47-437f-a284-341bf542db6f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_90badbaa-ef47-437f-a284-341bf542db6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c5d20f43-43d3-468f-9258-33b1ebb4e4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_90badbaa-ef47-437f-a284-341bf542db6f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c5d20f43-43d3-468f-9258-33b1ebb4e4e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_210be646-3a14-454d-9647-3ebe5e5b7d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c5d20f43-43d3-468f-9258-33b1ebb4e4e9" xlink:to="loc_us-gaap_FairValueHedgingMember_210be646-3a14-454d-9647-3ebe5e5b7d92" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSFairValueofDerivativesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails" xlink:type="extended" id="i1bdd135dda3e4d74827d2a4e271d1e10_FINANCIALINSTRUMENTSFairValueofDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_2c00dec2-3bf3-44e2-9328-80bc104d5973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8bb0d63d-7516-42a3-9277-3d17fa0338c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2c00dec2-3bf3-44e2-9328-80bc104d5973" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8bb0d63d-7516-42a3-9277-3d17fa0338c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2c00dec2-3bf3-44e2-9328-80bc104d5973" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_bd814a74-3b68-46e9-8b7c-e37bbec98116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:to="loc_us-gaap_HedgingDesignationAxis_bd814a74-3b68-46e9-8b7c-e37bbec98116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_bd814a74-3b68-46e9-8b7c-e37bbec98116_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_bd814a74-3b68-46e9-8b7c-e37bbec98116" xlink:to="loc_us-gaap_HedgingDesignationDomain_bd814a74-3b68-46e9-8b7c-e37bbec98116_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4576b824-694b-411e-9f8a-75afdf7132a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_bd814a74-3b68-46e9-8b7c-e37bbec98116" xlink:to="loc_us-gaap_HedgingDesignationDomain_4576b824-694b-411e-9f8a-75afdf7132a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1ea6bcb6-8e40-4ae9-8158-81dffdd42938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4576b824-694b-411e-9f8a-75afdf7132a3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1ea6bcb6-8e40-4ae9-8158-81dffdd42938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f8c5a392-2a29-4392-9f42-6d51ac310e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f8c5a392-2a29-4392-9f42-6d51ac310e64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f8c5a392-2a29-4392-9f42-6d51ac310e64_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8c5a392-2a29-4392-9f42-6d51ac310e64" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f8c5a392-2a29-4392-9f42-6d51ac310e64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b1663e99-1778-41c2-bc32-bdd3ba92f65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8c5a392-2a29-4392-9f42-6d51ac310e64" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b1663e99-1778-41c2-bc32-bdd3ba92f65d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8db479b0-5446-47e9-8daf-5a4cce65d296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b1663e99-1778-41c2-bc32-bdd3ba92f65d" xlink:to="loc_us-gaap_InterestRateSwapMember_8db479b0-5446-47e9-8daf-5a4cce65d296" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7c61f6f9-8c66-4963-9a90-d4a901ec57e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7c61f6f9-8c66-4963-9a90-d4a901ec57e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7c61f6f9-8c66-4963-9a90-d4a901ec57e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7c61f6f9-8c66-4963-9a90-d4a901ec57e2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7c61f6f9-8c66-4963-9a90-d4a901ec57e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a0fd4f08-ba57-4b81-8f6b-9fd298a142d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7c61f6f9-8c66-4963-9a90-d4a901ec57e2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a0fd4f08-ba57-4b81-8f6b-9fd298a142d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_901f2dcc-37f8-47b1-9669-0109f5f2660b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a0fd4f08-ba57-4b81-8f6b-9fd298a142d7" xlink:to="loc_us-gaap_OtherLiabilitiesMember_901f2dcc-37f8-47b1-9669-0109f5f2660b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended" id="id46e430491bf4b8e85369c7deead8cb7_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="extended" id="i653d3680f3ea420bb379d9ad196ae099_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="extended" id="i77037389ff16422d9dbc8f033d086024_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2b39b25a-7655-458a-8e91-cc0faebf0168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2b39b25a-7655-458a-8e91-cc0faebf0168" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5d1ce16a-51ca-488f-8b62-330195f66625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5d1ce16a-51ca-488f-8b62-330195f66625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7cdf78ae-2728-4ef9-8ed4-df093249efad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7cdf78ae-2728-4ef9-8ed4-df093249efad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_633781e2-7d87-4d54-a6a8-27cd990e8f78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_633781e2-7d87-4d54-a6a8-27cd990e8f78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a98c0d0e-ff50-4ac8-9bc1-b1d5fcb6a8b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a98c0d0e-ff50-4ac8-9bc1-b1d5fcb6a8b8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_5489aab8-971b-4566-946c-79ee17e47d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_5489aab8-971b-4566-946c-79ee17e47d33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_ca99e519-1f96-410c-ba37-f0abd56a2da1" xlink:href="dgx-20201231.xsd#dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_ca99e519-1f96-410c-ba37-f0abd56a2da1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount_7dcaa592-9e2b-458b-a69c-8013c2d3d0fe" xlink:href="dgx-20201231.xsd#dgx_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount_7dcaa592-9e2b-458b-a69c-8013c2d3d0fe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0452e0ee-21bb-4ed0-9de5-6a3a92b3bde6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0452e0ee-21bb-4ed0-9de5-6a3a92b3bde6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_649e42f7-5605-481b-9d69-28fa379d1290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_649e42f7-5605-481b-9d69-28fa379d1290" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e85be5b5-c752-4fa6-8517-6b802cc2b171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e85be5b5-c752-4fa6-8517-6b802cc2b171" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockValueAcquiredCostMethod1_8d2a3dcf-f43a-483a-b8f9-537a901660ea" xlink:href="dgx-20201231.xsd#dgx_TreasuryStockValueAcquiredCostMethod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_dgx_TreasuryStockValueAcquiredCostMethod1_8d2a3dcf-f43a-483a-b8f9-537a901660ea" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_28d885e0-d449-43ed-b85a-cbbd586dfd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_28d885e0-d449-43ed-b85a-cbbd586dfd20" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_bc192f02-362e-48c4-b69c-445e3fd3bcb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_bc192f02-362e-48c4-b69c-445e3fd3bcb1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_4cb24742-2763-4b3f-a242-533f6aec5989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_4cb24742-2763-4b3f-a242-533f6aec5989" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e5c13f3c-c2f5-42ef-a19a-cf904dfd8b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e5c13f3c-c2f5-42ef-a19a-cf904dfd8b7a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_630ad11d-916e-44a7-aed7-1ea5bcf5a301" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_srt_RangeAxis_630ad11d-916e-44a7-aed7-1ea5bcf5a301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_630ad11d-916e-44a7-aed7-1ea5bcf5a301_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_630ad11d-916e-44a7-aed7-1ea5bcf5a301" xlink:to="loc_srt_RangeMember_630ad11d-916e-44a7-aed7-1ea5bcf5a301_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e27a6018-7a30-47da-9319-01762586d992" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_630ad11d-916e-44a7-aed7-1ea5bcf5a301" xlink:to="loc_srt_RangeMember_e27a6018-7a30-47da-9319-01762586d992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7905e83f-5c7a-4c6e-99a9-80f9af13e0e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e27a6018-7a30-47da-9319-01762586d992" xlink:to="loc_srt_MaximumMember_7905e83f-5c7a-4c6e-99a9-80f9af13e0e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5491a930-d6e9-489f-99ea-125cf7eb08b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5491a930-d6e9-489f-99ea-125cf7eb08b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5491a930-d6e9-489f-99ea-125cf7eb08b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5491a930-d6e9-489f-99ea-125cf7eb08b9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5491a930-d6e9-489f-99ea-125cf7eb08b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ae345ae0-3367-49e1-9c68-78446db6185a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5491a930-d6e9-489f-99ea-125cf7eb08b9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ae345ae0-3367-49e1-9c68-78446db6185a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_85602cf8-096c-46ef-a1c7-baa990d2d45a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ae345ae0-3367-49e1-9c68-78446db6185a" xlink:to="loc_us-gaap_SubsequentEventMember_85602cf8-096c-46ef-a1c7-baa990d2d45a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6442eae1-9d22-4eb5-accd-79c9d91d99df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_srt_StatementScenarioAxis_6442eae1-9d22-4eb5-accd-79c9d91d99df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6442eae1-9d22-4eb5-accd-79c9d91d99df_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_6442eae1-9d22-4eb5-accd-79c9d91d99df" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6442eae1-9d22-4eb5-accd-79c9d91d99df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ddf96881-a211-4654-a3bb-03edaac09f7e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_6442eae1-9d22-4eb5-accd-79c9d91d99df" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ddf96881-a211-4654-a3bb-03edaac09f7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c02f24c7-2aed-421a-8f73-a6ab31b78c9a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_ddf96881-a211-4654-a3bb-03edaac09f7e" xlink:to="loc_srt_ScenarioForecastMember_c02f24c7-2aed-421a-8f73-a6ab31b78c9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_66eafc89-50d8-4135-b4d8-ebc803afac89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_66eafc89-50d8-4135-b4d8-ebc803afac89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_66eafc89-50d8-4135-b4d8-ebc803afac89_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66eafc89-50d8-4135-b4d8-ebc803afac89" xlink:to="loc_us-gaap_EquityComponentDomain_66eafc89-50d8-4135-b4d8-ebc803afac89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ce0db203-ed69-448d-bdd8-be57817d711e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66eafc89-50d8-4135-b4d8-ebc803afac89" xlink:to="loc_us-gaap_EquityComponentDomain_ce0db203-ed69-448d-bdd8-be57817d711e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_d4c2f8e9-4e94-4686-b374-5d9f78d130b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ce0db203-ed69-448d-bdd8-be57817d711e" xlink:to="loc_us-gaap_TreasuryStockMember_d4c2f8e9-4e94-4686-b374-5d9f78d130b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_13339164-cc0d-4a07-a2c2-deaca194debd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_13339164-cc0d-4a07-a2c2-deaca194debd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_b42c01ec-3be6-4598-acb5-acd1907a474c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_13339164-cc0d-4a07-a2c2-deaca194debd" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_b42c01ec-3be6-4598-acb5-acd1907a474c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_srt_OwnershipAxis_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f" xlink:to="loc_srt_OwnershipDomain_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_62afd6f4-2572-42db-a15e-1f837eb5c3e3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f" xlink:to="loc_srt_OwnershipDomain_62afd6f4-2572-42db-a15e-1f837eb5c3e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_969f388c-7944-41d9-afea-3089b164a138" xlink:href="dgx-20201231.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_62afd6f4-2572-42db-a15e-1f837eb5c3e3" xlink:to="loc_dgx_UMassJointVentureMember_969f388c-7944-41d9-afea-3089b164a138" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended" id="i926abcaedf7f4fd7b518daef60d7869d_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_42278d75-bb1e-4549-bd2b-62372148ea46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_42278d75-bb1e-4549-bd2b-62372148ea46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9aac26ab-b768-4712-b0dd-254622cb555a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9aac26ab-b768-4712-b0dd-254622cb555a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_fc43ef9e-b94d-400c-89db-ffc3f8b37245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_fc43ef9e-b94d-400c-89db-ffc3f8b37245" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_473f6939-da6d-4dbf-90bd-e196bf629e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_473f6939-da6d-4dbf-90bd-e196bf629e45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_50a4257c-d4b0-4399-9581-50f2168a7a99" xlink:href="dgx-20201231.xsd#dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_50a4257c-d4b0-4399-9581-50f2168a7a99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4e828d60-57e2-46a7-abdd-4969a52ae8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable_9beef88f-1aef-4b8f-8c22-59835b09f470" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_dgx_ScheduleOfShareholdersEquityTable_9beef88f-1aef-4b8f-8c22-59835b09f470" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_889c9bea-aa8b-4d67-b3d4-adf3e293d332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_9beef88f-1aef-4b8f-8c22-59835b09f470" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_889c9bea-aa8b-4d67-b3d4-adf3e293d332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_889c9bea-aa8b-4d67-b3d4-adf3e293d332_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_889c9bea-aa8b-4d67-b3d4-adf3e293d332" xlink:to="loc_us-gaap_EquityComponentDomain_889c9bea-aa8b-4d67-b3d4-adf3e293d332_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_889c9bea-aa8b-4d67-b3d4-adf3e293d332" xlink:to="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b67ed2b4-3e3a-489b-be8e-2b13cb97ffb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b67ed2b4-3e3a-489b-be8e-2b13cb97ffb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0a48f42f-92b8-4b82-9c1d-4db1c656a42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0a48f42f-92b8-4b82-9c1d-4db1c656a42a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_50180a46-bed5-4f6f-9706-ec9c3c0aa18d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_50180a46-bed5-4f6f-9706-ec9c3c0aa18d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherEquityComponentsMember_e28e5a8b-72dc-4434-86c8-92020564a00b" xlink:href="dgx-20201231.xsd#dgx_OtherEquityComponentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_dgx_OtherEquityComponentsMember_e28e5a8b-72dc-4434-86c8-92020564a00b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af61772f-17d1-4987-a550-fce5a5f1eb72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af61772f-17d1-4987-a550-fce5a5f1eb72" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS" xlink:type="extended" id="idbde61d25e814e5480e0aace5d3a15eb_STOCKOWNERSHIPANDCOMPENSATIONPLANS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" xlink:type="extended" id="i00775a29799a40519cc0256bf895d399_STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="extended" id="icd4159130d3b4c69b8ad928767755584_STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_7d9d826b-a841-42ac-b2e7-b9b813220059" xlink:href="dgx-20201231.xsd#dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_7d9d826b-a841-42ac-b2e7-b9b813220059" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5c9d64e0-652f-4cf3-93fe-02b7522d4c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5c9d64e0-652f-4cf3-93fe-02b7522d4c1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_72208728-2794-4dc8-a6da-1dc1efe9a99b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_72208728-2794-4dc8-a6da-1dc1efe9a99b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7272cc66-18d5-47d4-9730-7fced0407257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7272cc66-18d5-47d4-9730-7fced0407257" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0ef6e17-e2d2-4893-b095-a92eebe0f125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0ef6e17-e2d2-4893-b095-a92eebe0f125" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6b73afb7-f3b9-47f0-8929-d0c1121ed04d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0ef6e17-e2d2-4893-b095-a92eebe0f125" xlink:to="loc_us-gaap_AwardTypeAxis_6b73afb7-f3b9-47f0-8929-d0c1121ed04d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b73afb7-f3b9-47f0-8929-d0c1121ed04d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6b73afb7-f3b9-47f0-8929-d0c1121ed04d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b73afb7-f3b9-47f0-8929-d0c1121ed04d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6b73afb7-f3b9-47f0-8929-d0c1121ed04d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EmployeeLongTermIncentivePlanEltipMember_033243f4-f63c-4aa1-8db0-12d09182f7b7" xlink:href="dgx-20201231.xsd#dgx_EmployeeLongTermIncentivePlanEltipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:to="loc_dgx_EmployeeLongTermIncentivePlanEltipMember_033243f4-f63c-4aa1-8db0-12d09182f7b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember_2783552d-61f0-4b85-b210-d64ee3fbb8e3" xlink:href="dgx-20201231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:to="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember_2783552d-61f0-4b85-b210-d64ee3fbb8e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_acedea87-507a-43dd-8875-10e4086e6ab7" xlink:href="dgx-20201231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:to="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_acedea87-507a-43dd-8875-10e4086e6ab7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_14369b4b-5023-4594-8ec8-1ac82602692e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:to="loc_us-gaap_StockOptionMember_14369b4b-5023-4594-8ec8-1ac82602692e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="extended" id="i3a5be4d05b9c443e92c79e6476e423ed_STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42ca94ac-7f40-4cd5-9524-76cbc725290c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42ca94ac-7f40-4cd5-9524-76cbc725290c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69c98013-217b-4e7a-beff-3907fa103d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69c98013-217b-4e7a-beff-3907fa103d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_04227ba7-cdc0-4b1d-bb04-396c9c3d18b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_04227ba7-cdc0-4b1d-bb04-396c9c3d18b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9eb911b0-6343-4c4f-8f66-fe2d41520b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9eb911b0-6343-4c4f-8f66-fe2d41520b6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2a9c3dd2-7e64-47ef-9c85-ffdc15b8e6c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2a9c3dd2-7e64-47ef-9c85-ffdc15b8e6c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9f8a1536-2b44-4fe3-8ce4-676672e55352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9f8a1536-2b44-4fe3-8ce4-676672e55352" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2f91982a-a230-42cd-b176-12997121e0ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:to="loc_us-gaap_AwardTypeAxis_2f91982a-a230-42cd-b176-12997121e0ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f91982a-a230-42cd-b176-12997121e0ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2f91982a-a230-42cd-b176-12997121e0ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f91982a-a230-42cd-b176-12997121e0ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cefa9dda-f530-4831-8768-13eb561caa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2f91982a-a230-42cd-b176-12997121e0ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cefa9dda-f530-4831-8768-13eb561caa89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_6fdd4b47-2a39-4b9a-b947-b5f007c33acd" xlink:href="dgx-20201231.xsd#dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cefa9dda-f530-4831-8768-13eb561caa89" xlink:to="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_6fdd4b47-2a39-4b9a-b947-b5f007c33acd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_76fdc169-337b-4e2f-8e6e-c15d13b819f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:to="loc_srt_RangeAxis_76fdc169-337b-4e2f-8e6e-c15d13b819f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_76fdc169-337b-4e2f-8e6e-c15d13b819f0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_76fdc169-337b-4e2f-8e6e-c15d13b819f0" xlink:to="loc_srt_RangeMember_76fdc169-337b-4e2f-8e6e-c15d13b819f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5153dae7-a794-422a-a162-0f19cf6425aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_76fdc169-337b-4e2f-8e6e-c15d13b819f0" xlink:to="loc_srt_RangeMember_5153dae7-a794-422a-a162-0f19cf6425aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_efd5737c-f8a1-4141-9446-4342d82fde23" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5153dae7-a794-422a-a162-0f19cf6425aa" xlink:to="loc_srt_MinimumMember_efd5737c-f8a1-4141-9446-4342d82fde23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cd0442d5-4412-4c6b-ad1b-9d30bfdad900" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5153dae7-a794-422a-a162-0f19cf6425aa" xlink:to="loc_srt_MaximumMember_cd0442d5-4412-4c6b-ad1b-9d30bfdad900" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="extended" id="i165dee1be69e48e1afee9322c25545e2_STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ec37527c-8810-4cf0-89be-dc246dbc6cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ec37527c-8810-4cf0-89be-dc246dbc6cbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_accd85b1-51e7-43ac-b114-c67ad5445363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_accd85b1-51e7-43ac-b114-c67ad5445363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bd32e617-fd5a-45cb-95ad-5038826f613a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bd32e617-fd5a-45cb-95ad-5038826f613a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_83d2c585-6095-4997-81b1-8d568cfa4fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_852b8512-c1ef-4a9b-a3ef-58728b637cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_852b8512-c1ef-4a9b-a3ef-58728b637cfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_09f428f7-38f8-48bc-bc6c-0e919c32fbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_09f428f7-38f8-48bc-bc6c-0e919c32fbed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3c1e200d-7962-478d-b9fe-07dd2c69ac60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3c1e200d-7962-478d-b9fe-07dd2c69ac60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7096fb0f-d520-4646-bd54-fb2d98e86ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dfae6665-c5ab-49ea-b9f2-e03eec782481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dfae6665-c5ab-49ea-b9f2-e03eec782481" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bc050257-6fe0-40f0-935b-75a30772efe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bc050257-6fe0-40f0-935b-75a30772efe5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6407199b-7dd6-4f63-b427-fc882239f9ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6407199b-7dd6-4f63-b427-fc882239f9ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d9524d2d-99d6-48c5-a97a-404e2171758a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d9524d2d-99d6-48c5-a97a-404e2171758a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f9d83b5e-6eae-4799-9ce5-640d1d6e337a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f9d83b5e-6eae-4799-9ce5-640d1d6e337a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_876b5b94-0c7a-4c69-8254-af19c761c958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_876b5b94-0c7a-4c69-8254-af19c761c958" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3088f6d3-939e-42af-9a8a-1760e2d4de5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3088f6d3-939e-42af-9a8a-1760e2d4de5b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e298cb15-6398-4eaf-91b0-bce040344006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e298cb15-6398-4eaf-91b0-bce040344006" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_9ff81c2a-8988-4bc9-8337-b758a18c4ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_9ff81c2a-8988-4bc9-8337-b758a18c4ff8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_710d37e3-c294-4756-9d3a-9f188017cfaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_710d37e3-c294-4756-9d3a-9f188017cfaa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b357d8ab-149b-483c-a6f4-03f659c4efb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b357d8ab-149b-483c-a6f4-03f659c4efb2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8ba41c83-447b-4025-9294-cff39d66d2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8ba41c83-447b-4025-9294-cff39d66d2de" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ff159f0e-3beb-4703-b601-d831e0deef2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ff159f0e-3beb-4703-b601-d831e0deef2c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c637c8ef-2649-4737-9ebe-6081dc049d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c637c8ef-2649-4737-9ebe-6081dc049d21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6ce7832c-4645-448e-8015-068de0b5c984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c637c8ef-2649-4737-9ebe-6081dc049d21" xlink:to="loc_us-gaap_AwardTypeAxis_6ce7832c-4645-448e-8015-068de0b5c984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ce7832c-4645-448e-8015-068de0b5c984_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6ce7832c-4645-448e-8015-068de0b5c984" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ce7832c-4645-448e-8015-068de0b5c984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4df1e223-e699-49bf-a10e-348a42d029fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6ce7832c-4645-448e-8015-068de0b5c984" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4df1e223-e699-49bf-a10e-348a42d029fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_d0d59769-ba76-4997-8987-1ecd6c8dff45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4df1e223-e699-49bf-a10e-348a42d029fe" xlink:to="loc_us-gaap_StockOptionMember_d0d59769-ba76-4997-8987-1ecd6c8dff45" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="extended" id="i8e45441330564e43b3aefae9ba812454_STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bded95b1-fd5b-47f7-97bd-f423b106fefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bded95b1-fd5b-47f7-97bd-f423b106fefd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_294f8f59-a7b5-47cd-96e8-439b34354775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_294f8f59-a7b5-47cd-96e8-439b34354775" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a3d1efac-dc56-468d-a926-2c57010a376c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a3d1efac-dc56-468d-a926-2c57010a376c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8b5d70db-bbaa-4b1f-85bb-4bea845adf69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8b5d70db-bbaa-4b1f-85bb-4bea845adf69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b114da53-1ea2-46cc-805b-85b53e19c1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ca8081bc-e288-44cb-a242-62210f53ed23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ca8081bc-e288-44cb-a242-62210f53ed23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9bbf6d2e-3e9c-40d7-b9e6-45054c05c995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9bbf6d2e-3e9c-40d7-b9e6-45054c05c995" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ba0b2b05-f82d-43cb-8bf8-f54cde404216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ba0b2b05-f82d-43cb-8bf8-f54cde404216" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d02f1c26-90dc-41ba-921e-0457bfddaa4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d02f1c26-90dc-41ba-921e-0457bfddaa4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_42cc852c-bcf0-482d-9162-251c37582a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7e8f7bff-e129-4137-84a4-82fdb868abfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7e8f7bff-e129-4137-84a4-82fdb868abfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c7adb272-bbe5-4d0c-bbc9-9d182b2fa761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c7adb272-bbe5-4d0c-bbc9-9d182b2fa761" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_bf6f96e4-fe49-4afa-bdff-57d137f7adcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_bf6f96e4-fe49-4afa-bdff-57d137f7adcb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f209d709-93d5-4b34-9001-3b4148336419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ShareBasedCompensation_f209d709-93d5-4b34-9001-3b4148336419" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_5cd15354-6f12-4a0a-8140-6a74ad501311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_5cd15354-6f12-4a0a-8140-6a74ad501311" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_041752e7-c688-450b-8298-eb9f49177991" xlink:href="dgx-20201231.xsd#dgx_Sharebasedcompensationexcesstaxbenefitamount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_041752e7-c688-450b-8298-eb9f49177991" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bb28baa7-a5e2-415b-97b4-d02e2003a0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bb28baa7-a5e2-415b-97b4-d02e2003a0a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8a2304ab-fc23-4260-9714-7032bddf56cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bb28baa7-a5e2-415b-97b4-d02e2003a0a4" xlink:to="loc_us-gaap_AwardTypeAxis_8a2304ab-fc23-4260-9714-7032bddf56cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a2304ab-fc23-4260-9714-7032bddf56cd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8a2304ab-fc23-4260-9714-7032bddf56cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a2304ab-fc23-4260-9714-7032bddf56cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b00f93e-d7bf-485a-b9c3-78e24ab883d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8a2304ab-fc23-4260-9714-7032bddf56cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b00f93e-d7bf-485a-b9c3-78e24ab883d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockAwardsMember_7dd51e51-8692-43f2-ab6b-c0ae9863acc7" xlink:href="dgx-20201231.xsd#dgx_StockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b00f93e-d7bf-485a-b9c3-78e24ab883d4" xlink:to="loc_dgx_StockAwardsMember_7dd51e51-8692-43f2-ab6b-c0ae9863acc7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="extended" id="if222385f106c475bb852ea77527fdd35_STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_4bb50bf9-e6a4-40fc-893b-5effe8726cad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_4bb50bf9-e6a4-40fc-893b-5effe8726cad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_8e912da1-d2e9-45e7-8384-f1e4dd7aee2a" xlink:href="dgx-20201231.xsd#dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_8e912da1-d2e9-45e7-8384-f1e4dd7aee2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_82def2c2-3598-47a1-95d6-20b22b1ff91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_82def2c2-3598-47a1-95d6-20b22b1ff91b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9f6a8b4e-ce83-4d9d-a540-79077d978dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9f6a8b4e-ce83-4d9d-a540-79077d978dcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2f46e289-0c7c-4437-97e8-09f763301814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2f46e289-0c7c-4437-97e8-09f763301814" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_5c50ad46-ef8d-4e4d-bb80-9cc54549d692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_5c50ad46-ef8d-4e4d-bb80-9cc54549d692" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dbc93e8a-a2cf-400f-bc3f-26e77797515b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:to="loc_us-gaap_AwardTypeAxis_dbc93e8a-a2cf-400f-bc3f-26e77797515b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbc93e8a-a2cf-400f-bc3f-26e77797515b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_dbc93e8a-a2cf-400f-bc3f-26e77797515b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbc93e8a-a2cf-400f-bc3f-26e77797515b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be562d0e-712f-4bee-a0e4-d1565916f3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_dbc93e8a-a2cf-400f-bc3f-26e77797515b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be562d0e-712f-4bee-a0e4-d1565916f3ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_cffa04ac-0768-438c-b137-2cf6dd1dc69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be562d0e-712f-4bee-a0e4-d1565916f3ec" xlink:to="loc_us-gaap_EmployeeStockMember_cffa04ac-0768-438c-b137-2cf6dd1dc69e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_52ae7940-1fa8-40f2-8ecb-f13da7643651" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:to="loc_srt_RangeAxis_52ae7940-1fa8-40f2-8ecb-f13da7643651" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_52ae7940-1fa8-40f2-8ecb-f13da7643651_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_52ae7940-1fa8-40f2-8ecb-f13da7643651" xlink:to="loc_srt_RangeMember_52ae7940-1fa8-40f2-8ecb-f13da7643651_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f400e3f5-9a6d-4db8-96cc-3ce2773933e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_52ae7940-1fa8-40f2-8ecb-f13da7643651" xlink:to="loc_srt_RangeMember_f400e3f5-9a6d-4db8-96cc-3ce2773933e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_47f8e93a-ed90-4813-bac0-2cc23e0eefd0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f400e3f5-9a6d-4db8-96cc-3ce2773933e1" xlink:to="loc_srt_MaximumMember_47f8e93a-ed90-4813-bac0-2cc23e0eefd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="extended" id="ic581c96cfb7b4d3ca30c1b33b7951d35_STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_2d7395b1-0e8a-42b5-8042-7b8424a2b4fa" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanSalaryDeferral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_2d7395b1-0e8a-42b5-8042-7b8424a2b4fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_23e79a23-1425-4c4e-b02c-c706eb0d436b" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_23e79a23-1425-4c4e-b02c-c706eb0d436b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_f414eb1d-105e-4a56-bd88-d68f2d4cd530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_f414eb1d-105e-4a56-bd88-d68f2d4cd530" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_5e293c5f-cf1e-48fc-8450-aee680a62505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_5e293c5f-cf1e-48fc-8450-aee680a62505" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_e95e4d14-1919-4124-8de3-f7c229d5395e" xlink:href="dgx-20201231.xsd#dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_e95e4d14-1919-4124-8de3-f7c229d5395e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_3806966f-ea31-4a24-b2fb-cd21a0b6a1de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_3806966f-ea31-4a24-b2fb-cd21a0b6a1de" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_11e3c0e3-2bca-4220-9ac2-dcde28406a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_11e3c0e3-2bca-4220-9ac2-dcde28406a74" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiGradedVestingPercentage_459b89b2-9e16-46f8-93fd-4d96fa2bf7af" xlink:href="dgx-20201231.xsd#dgx_SdcpIiGradedVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_dgx_SdcpIiGradedVestingPercentage_459b89b2-9e16-46f8-93fd-4d96fa2bf7af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_1003ccf0-89ed-428a-9fa7-01f4027f46bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_1003ccf0-89ed-428a-9fa7-01f4027f46bd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7" xlink:to="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_7751ede0-4f45-47da-89f2-e816e256dc83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7" xlink:to="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_7751ede0-4f45-47da-89f2-e816e256dc83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanMember_541bb2ef-64ac-4635-90bf-e5a16008fba1" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_7751ede0-4f45-47da-89f2-e816e256dc83" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanMember_541bb2ef-64ac-4635-90bf-e5a16008fba1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiMember_353d099f-3e13-4f62-b382-d5b9f12d5ca5" xlink:href="dgx-20201231.xsd#dgx_SdcpIiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_7751ede0-4f45-47da-89f2-e816e256dc83" xlink:to="loc_dgx_SdcpIiMember_353d099f-3e13-4f62-b382-d5b9f12d5ca5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:to="loc_srt_RangeAxis_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab" xlink:to="loc_srt_RangeMember_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e13a9bb4-a00e-49ac-bd00-3063fd6c053e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab" xlink:to="loc_srt_RangeMember_e13a9bb4-a00e-49ac-bd00-3063fd6c053e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08a960c3-895b-4e86-b7bd-67ae02faea50" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e13a9bb4-a00e-49ac-bd00-3063fd6c053e" xlink:to="loc_srt_MaximumMember_08a960c3-895b-4e86-b7bd-67ae02faea50" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended" id="i45583bfb76c34ca0aafb881e926b1bcd_COMMITMENTSANDCONTINGENCIES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ibd641a977de643b3924c17bfc48bec72_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41e7f5b3-98cf-4747-852a-d1836d29c422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41e7f5b3-98cf-4747-852a-d1836d29c422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_651d7aa7-5c5b-40d7-b5cd-554d7a3722dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_651d7aa7-5c5b-40d7-b5cd-554d7a3722dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_e83007d2-179c-4f25-a061-a6bfbde38d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_e83007d2-179c-4f25-a061-a6bfbde38d2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_3d4f7041-0095-4018-af43-7e673b619025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_3d4f7041-0095-4018-af43-7e673b619025" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_d6289ed6-4ec0-4081-8f27-fad7adc0f76f" xlink:href="dgx-20201231.xsd#dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_d6289ed6-4ec0-4081-8f27-fad7adc0f76f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction_afdce706-0843-491e-9159-6d4e53d6db75" xlink:href="dgx-20201231.xsd#dgx_AgreementtoOutsourceBillingandCollectionFunction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction_afdce706-0843-491e-9159-6d4e53d6db75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum_1c0e96bc-d66a-4079-9b6f-0603022b7567" xlink:href="dgx-20201231.xsd#dgx_RemainingTermsofContingentLeaseObligationsMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum_1c0e96bc-d66a-4079-9b6f-0603022b7567" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_56e60330-8a01-4fc6-bb46-d0ca8381196e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_56e60330-8a01-4fc6-bb46-d0ca8381196e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_401d0072-ba0d-401a-8df7-0d144c7a1260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_LitigationReserve_401d0072-ba0d-401a-8df7-0d144c7a1260" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_b1bafea0-4980-4436-b87c-ec5d1912ebc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_b1bafea0-4980-4436-b87c-ec5d1912ebc1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ad229736-5846-46fc-89ea-1cf7614ac8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ad229736-5846-46fc-89ea-1cf7614ac8e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ad229736-5846-46fc-89ea-1cf7614ac8e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad229736-5846-46fc-89ea-1cf7614ac8e5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ad229736-5846-46fc-89ea-1cf7614ac8e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b91fb481-7f61-4af2-8a94-fd1f59b09e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad229736-5846-46fc-89ea-1cf7614ac8e5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b91fb481-7f61-4af2-8a94-fd1f59b09e8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_2ffad462-889f-4a70-83f9-55995409706c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b91fb481-7f61-4af2-8a94-fd1f59b09e8d" xlink:to="loc_us-gaap_SecuredDebtMember_2ffad462-889f-4a70-83f9-55995409706c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a434fba5-8efa-4528-a897-ffd9daab7e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:to="loc_us-gaap_CreditFacilityAxis_a434fba5-8efa-4528-a897-ffd9daab7e22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a434fba5-8efa-4528-a897-ffd9daab7e22_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a434fba5-8efa-4528-a897-ffd9daab7e22" xlink:to="loc_us-gaap_CreditFacilityDomain_a434fba5-8efa-4528-a897-ffd9daab7e22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_03c4583d-7de2-40b3-a541-51584898ea9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a434fba5-8efa-4528-a897-ffd9daab7e22" xlink:to="loc_us-gaap_CreditFacilityDomain_03c4583d-7de2-40b3-a541-51584898ea9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_c817311d-13e7-443a-add5-f04ab861bbae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_03c4583d-7de2-40b3-a541-51584898ea9a" xlink:to="loc_us-gaap_LetterOfCreditMember_c817311d-13e7-443a-add5-f04ab861bbae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:to="loc_us-gaap_DebtInstrumentAxis_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_93607c29-da18-416c-ad18-f75c6feb566b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_93607c29-da18-416c-ad18-f75c6feb566b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d81362bd-c459-43d8-b937-a00305b8675c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93607c29-da18-416c-ad18-f75c6feb566b" xlink:to="loc_us-gaap_LetterOfCreditMember_d81362bd-c459-43d8-b937-a00305b8675c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended" id="i99a97a329f594e07a15090982d1cba68_BUSINESSSEGMENTINFORMATION"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended" id="if5c8cf9104a04b40a2156d0f6ed3a9e7_BUSINESSSEGMENTINFORMATIONTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="if0f9bc4b7d104b388e7e44299f5d4d06_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_eec01598-78c9-46d3-8be7-e90530ed54f5" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_dgx_PercentageofNetRevenues_eec01598-78c9-46d3-8be7-e90530ed54f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bb3abe27-556d-4d1a-8e3c-60326dace391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bb3abe27-556d-4d1a-8e3c-60326dace391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c3fe097d-6e0f-4f09-afc9-6c22a66b4916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_OperatingIncomeLoss_c3fe097d-6e0f-4f09-afc9-6c22a66b4916" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f3bcab35-13ff-4726-90db-b4a6f358404c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f3bcab35-13ff-4726-90db-b4a6f358404c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7ca31df8-71fa-4bed-b0c8-faa01e5c1ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7ca31df8-71fa-4bed-b0c8-faa01e5c1ac5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_06e707c1-e583-44ce-a290-f7971ae94eea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_06e707c1-e583-44ce-a290-f7971ae94eea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5b25f11e-92a4-4240-abe3-fa0710810001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5b25f11e-92a4-4240-abe3-fa0710810001" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_eadecec5-b295-4afa-b227-f2afc65256d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_eadecec5-b295-4afa-b227-f2afc65256d6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_9b8eaf2f-8961-4c3c-b2a5-4d5d8b4f17f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_9b8eaf2f-8961-4c3c-b2a5-4d5d8b4f17f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_405ededa-4634-41da-9d6f-742e3a8edd40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_ProfitLoss_405ededa-4634-41da-9d6f-742e3a8edd40" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c74f326e-25fb-462f-9dd2-246234b4d79e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c74f326e-25fb-462f-9dd2-246234b4d79e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_62928c8d-62a0-45b1-a138-93aab81e8f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_NetIncomeLoss_62928c8d-62a0-45b1-a138-93aab81e8f68" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_52ace38b-9a83-4881-bceb-31ff8cd0b50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_52ace38b-9a83-4881-bceb-31ff8cd0b50f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2bc5d847-37eb-401a-95d2-42af108d49fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2bc5d847-37eb-401a-95d2-42af108d49fa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_df0d8dd8-a79e-4305-9595-bdcc0ecf689d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:to="loc_srt_RangeAxis_df0d8dd8-a79e-4305-9595-bdcc0ecf689d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_df0d8dd8-a79e-4305-9595-bdcc0ecf689d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_df0d8dd8-a79e-4305-9595-bdcc0ecf689d" xlink:to="loc_srt_RangeMember_df0d8dd8-a79e-4305-9595-bdcc0ecf689d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ff077c09-3803-4dd1-ab95-ab40d8d320a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_df0d8dd8-a79e-4305-9595-bdcc0ecf689d" xlink:to="loc_srt_RangeMember_ff077c09-3803-4dd1-ab95-ab40d8d320a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1fd67cec-e907-495b-b755-5f14baac59a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ff077c09-3803-4dd1-ab95-ab40d8d320a3" xlink:to="loc_srt_MinimumMember_1fd67cec-e907-495b-b755-5f14baac59a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb" xlink:to="loc_us-gaap_SegmentDomain_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb" xlink:to="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_6cdf2a42-ef93-4f97-adb4-3d896fe401c7" xlink:href="dgx-20201231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_6cdf2a42-ef93-4f97-adb4-3d896fe401c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_917ad02f-71e2-4ff5-86cd-b2f263d5eb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_917ad02f-71e2-4ff5-86cd-b2f263d5eb04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_c4268ca4-6ee0-4c1c-a2a6-bf488f9343e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:to="loc_us-gaap_CorporateMember_c4268ca4-6ee0-4c1c-a2a6-bf488f9343e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_03a7a181-de91-40b5-9026-449ef0b940e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:to="loc_srt_ProductOrServiceAxis_03a7a181-de91-40b5-9026-449ef0b940e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_03a7a181-de91-40b5-9026-449ef0b940e6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_03a7a181-de91-40b5-9026-449ef0b940e6" xlink:to="loc_srt_ProductsAndServicesDomain_03a7a181-de91-40b5-9026-449ef0b940e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_03a7a181-de91-40b5-9026-449ef0b940e6" xlink:to="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_4aaf4d52-e39c-4fbe-be33-acec0e691533" xlink:href="dgx-20201231.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_4aaf4d52-e39c-4fbe-be33-acec0e691533" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_d5a2e809-6475-42e9-9a5c-16d93482c162" xlink:href="dgx-20201231.xsd#dgx_COVID19TestingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_COVID19TestingServicesMember_d5a2e809-6475-42e9-9a5c-16d93482c162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_16b34308-8ea9-4c9e-8ed9-07d2addede17" xlink:href="dgx-20201231.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_16b34308-8ea9-4c9e-8ed9-07d2addede17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_e747cd72-98aa-4f68-8f01-744c2fbc8d65" xlink:href="dgx-20201231.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_e747cd72-98aa-4f68-8f01-744c2fbc8d65" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_326361a8-59d2-4ea2-a42d-66db29751303" xlink:href="dgx-20201231.xsd#dgx_AllotherservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_AllotherservicesMember_326361a8-59d2-4ea2-a42d-66db29751303" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#RELATEDPARTIES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="extended" id="ia75793a7c5ca459993cc5e294747c090_RELATEDPARTIES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RELATEDPARTIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="extended" id="i987f47368e3f4128bd63cab053964493_RELATEDPARTIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_fc7813eb-367c-427e-bc04-2ccd77350168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_RevenueFromRelatedParties_fc7813eb-367c-427e-bc04-2ccd77350168" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_252b14c3-0db1-467a-9448-28f4a4f3fb9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_252b14c3-0db1-467a-9448-28f4a4f3fb9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_a093722b-29ee-42f7-8703-35a8841e7b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_a093722b-29ee-42f7-8703-35a8841e7b69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherAccountsReceivableRelatedParties_8127daca-06c7-4945-b996-34fbd4f7fa05" xlink:href="dgx-20201231.xsd#dgx_OtherAccountsReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_dgx_OtherAccountsReceivableRelatedParties_8127daca-06c7-4945-b996-34fbd4f7fa05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_1a40a1b0-e977-4aac-9534-7ec7e0d350ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_1a40a1b0-e977-4aac-9534-7ec7e0d350ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_2984b8af-bda7-4b23-b050-37018be880d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_2984b8af-bda7-4b23-b050-37018be880d9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a647bfe1-acb2-4666-a352-89d799996427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a647bfe1-acb2-4666-a352-89d799996427" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8aaa5ff8-45e8-433b-8814-0be41acc01e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8aaa5ff8-45e8-433b-8814-0be41acc01e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8aaa5ff8-45e8-433b-8814-0be41acc01e7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8aaa5ff8-45e8-433b-8814-0be41acc01e7" xlink:to="loc_us-gaap_RelatedPartyDomain_8aaa5ff8-45e8-433b-8814-0be41acc01e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_81beff05-9274-4baa-b66b-f86ea7070ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8aaa5ff8-45e8-433b-8814-0be41acc01e7" xlink:to="loc_us-gaap_RelatedPartyDomain_81beff05-9274-4baa-b66b-f86ea7070ac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_64106da3-0cba-4eab-9fa9-dee80949e7d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_81beff05-9274-4baa-b66b-f86ea7070ac8" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_64106da3-0cba-4eab-9fa9-dee80949e7d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_904d9f05-a210-48fc-ad81-239e2ef02527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_81beff05-9274-4baa-b66b-f86ea7070ac8" xlink:to="loc_us-gaap_CorporateJointVentureMember_904d9f05-a210-48fc-ad81-239e2ef02527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d45ff101-942b-40e0-85d3-1c7da686283f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d45ff101-942b-40e0-85d3-1c7da686283f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d45ff101-942b-40e0-85d3-1c7da686283f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d45ff101-942b-40e0-85d3-1c7da686283f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d45ff101-942b-40e0-85d3-1c7da686283f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f7866393-13c3-4bb2-aef2-2e9788bd9ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d45ff101-942b-40e0-85d3-1c7da686283f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f7866393-13c3-4bb2-aef2-2e9788bd9ec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a34101d2-20d3-4d0c-965f-fdd54d282e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f7866393-13c3-4bb2-aef2-2e9788bd9ec8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a34101d2-20d3-4d0c-965f-fdd54d282e26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb69af66-af53-465e-bec8-a23a9c1f0417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb69af66-af53-465e-bec8-a23a9c1f0417" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fb69af66-af53-465e-bec8-a23a9c1f0417_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb69af66-af53-465e-bec8-a23a9c1f0417" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fb69af66-af53-465e-bec8-a23a9c1f0417_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b23c0860-29ef-4dd2-9c35-5b3df09b3fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb69af66-af53-465e-bec8-a23a9c1f0417" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b23c0860-29ef-4dd2-9c35-5b3df09b3fec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_c8de60d7-4386-4de9-8406-8390507bedd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b23c0860-29ef-4dd2-9c35-5b3df09b3fec" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_c8de60d7-4386-4de9-8406-8390507bedd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8f8ca388-21da-4907-a222-6a2bcb381a05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b23c0860-29ef-4dd2-9c35-5b3df09b3fec" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8f8ca388-21da-4907-a222-6a2bcb381a05" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#DISCONTINUEDOPERATIONS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS" xlink:type="extended" id="i8173a5faa82646ddacb9e76d941090b9_DISCONTINUEDOPERATIONS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DISCONTINUEDOPERATIONSDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="extended" id="i645f18d7ccaf4763a74e6190ba08690a_DISCONTINUEDOPERATIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3695b616-6caa-47e2-b3ba-1c73caf4041b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_617a2e6b-15a0-49e0-bf58-b409eb15ca8a" xlink:href="dgx-20201231.xsd#dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3695b616-6caa-47e2-b3ba-1c73caf4041b" xlink:to="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_617a2e6b-15a0-49e0-bf58-b409eb15ca8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3d665d69-de3c-46af-bdf5-f233bd12adc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3695b616-6caa-47e2-b3ba-1c73caf4041b" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3d665d69-de3c-46af-bdf5-f233bd12adc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f48bafbc-114c-4d68-9add-26482acbe095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3695b616-6caa-47e2-b3ba-1c73caf4041b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f48bafbc-114c-4d68-9add-26482acbe095" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_520cc26e-02de-4e67-b6b8-096c8b3a9dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f48bafbc-114c-4d68-9add-26482acbe095" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_520cc26e-02de-4e67-b6b8-096c8b3a9dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_520cc26e-02de-4e67-b6b8-096c8b3a9dd6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_520cc26e-02de-4e67-b6b8-096c8b3a9dd6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_520cc26e-02de-4e67-b6b8-096c8b3a9dd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_44f6bef7-87b7-4f73-85ca-34a5f30f2f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_520cc26e-02de-4e67-b6b8-096c8b3a9dd6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_44f6bef7-87b7-4f73-85ca-34a5f30f2f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NidMember_88dd04da-ff3f-4710-a8f2-aa49318310e8" xlink:href="dgx-20201231.xsd#dgx_NidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_44f6bef7-87b7-4f73-85ca-34a5f30f2f71" xlink:to="loc_dgx_NidMember_88dd04da-ff3f-4710-a8f2-aa49318310e8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunaudited"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited" xlink:type="extended" id="id72b5c0685e1482b81057ed3d14c016e_QuarterlyOperatingResultsunaudited"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables" xlink:type="extended" id="ib5ddea4f973f4b249e783411934d8e26_QuarterlyOperatingResultsunauditedTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedScheduleDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails" xlink:type="extended" id="i7028b21dd1954fb8970c3afdcc2bfd50_QuarterlyOperatingResultsunauditedScheduleDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails" xlink:type="extended" id="ie89f64ca9a7a4f2f8988529980135087_QuarterlyOperatingResultsunauditedNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:href="dgx-20201231.xsd#dgx_QuarterlyFinancialDataLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_eb6a789b-297b-4eab-b11e-d3f26f4e48a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_eb6a789b-297b-4eab-b11e-d3f26f4e48a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestructuringIntegrationCharges_6a8d9728-1e07-4e95-b095-2b9cf7cef9e9" xlink:href="dgx-20201231.xsd#dgx_RestructuringIntegrationCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_RestructuringIntegrationCharges_6a8d9728-1e07-4e95-b095-2b9cf7cef9e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ChargesDueToCOVID19_5b1fe171-9580-414e-8448-6c052904d9fd" xlink:href="dgx-20201231.xsd#dgx_ChargesDueToCOVID19"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_ChargesDueToCOVID19_5b1fe171-9580-414e-8448-6c052904d9fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_34be06fe-1893-48d2-acf0-d586b530765e" xlink:href="dgx-20201231.xsd#dgx_Sharebasedcompensationexcesstaxbenefitamount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_34be06fe-1893-48d2-acf0-d586b530765e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PreTaxGainLossDueToCOVID19_7fa65e16-7c01-455c-bc2e-27d59da1187b" xlink:href="dgx-20201231.xsd#dgx_PreTaxGainLossDueToCOVID19"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_PreTaxGainLossDueToCOVID19_7fa65e16-7c01-455c-bc2e-27d59da1187b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_ed557d1f-9ff2-451e-a4bb-0124042ab1d0" xlink:href="dgx-20201231.xsd#dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_ed557d1f-9ff2-451e-a4bb-0124042ab1d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_19acb53f-e452-4475-a8f9-f569b4590453" xlink:href="dgx-20201231.xsd#dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_19acb53f-e452-4475-a8f9-f569b4590453" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_6f1ed162-7ffb-4849-b65c-b3dbe449b534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_6f1ed162-7ffb-4849-b65c-b3dbe449b534" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_253b0538-9dca-48fe-93a2-32bf42d4c9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_253b0538-9dca-48fe-93a2-32bf42d4c9e8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt_f77d5e2d-764b-4eac-81d9-1af2cdaefb48" xlink:href="dgx-20201231.xsd#dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt_f77d5e2d-764b-4eac-81d9-1af2cdaefb48" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge_5b10699e-2805-4509-932b-192f51f0900a" xlink:href="dgx-20201231.xsd#dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge_5b10699e-2805-4509-932b-192f51f0900a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_746f33fe-36d1-4f53-b930-254bb85497d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_746f33fe-36d1-4f53-b930-254bb85497d3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_5a390147-7468-4908-b05c-20c85f68b1c1" xlink:href="dgx-20201231.xsd#dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_5a390147-7468-4908-b05c-20c85f68b1c1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident_1c1c5c78-a8ce-48b0-b0d0-48b892ac3c24" xlink:href="dgx-20201231.xsd#dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident_1c1c5c78-a8ce-48b0-b0d0-48b892ac3c24" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_5487df76-7c9e-4bb0-b02a-1a6cd5fe6c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_5487df76-7c9e-4bb0-b02a-1a6cd5fe6c1a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfQuarterlyFinancialDataTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_c804b291-58b0-449b-a2c4-00cf44aa2bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_NatureOfExpenseAxis_c804b291-58b0-449b-a2c4-00cf44aa2bcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_c804b291-58b0-449b-a2c4-00cf44aa2bcd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c804b291-58b0-449b-a2c4-00cf44aa2bcd" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_c804b291-58b0-449b-a2c4-00cf44aa2bcd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_abd154b8-11c5-4744-9ba5-83139e92d4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c804b291-58b0-449b-a2c4-00cf44aa2bcd" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_abd154b8-11c5-4744-9ba5-83139e92d4a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmortizationofIntangibleAssetsMember_47dbc81e-b668-4cbe-be64-012b66087238" xlink:href="dgx-20201231.xsd#dgx_AmortizationofIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_abd154b8-11c5-4744-9ba5-83139e92d4a1" xlink:to="loc_dgx_AmortizationofIntangibleAssetsMember_47dbc81e-b668-4cbe-be64-012b66087238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityinEarningsofEquityMethodInvesteesMember_49f749bd-d736-46c0-9995-140ac7d8bbad" xlink:href="dgx-20201231.xsd#dgx_EquityinEarningsofEquityMethodInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_abd154b8-11c5-4744-9ba5-83139e92d4a1" xlink:to="loc_dgx_EquityinEarningsofEquityMethodInvesteesMember_49f749bd-d736-46c0-9995-140ac7d8bbad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1fc1bda4-2f65-4df3-89f7-c42f5823316a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1fc1bda4-2f65-4df3-89f7-c42f5823316a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1fc1bda4-2f65-4df3-89f7-c42f5823316a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1fc1bda4-2f65-4df3-89f7-c42f5823316a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1fc1bda4-2f65-4df3-89f7-c42f5823316a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1fc1bda4-2f65-4df3-89f7-c42f5823316a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f0ad7c31-4610-4053-8002-0e5a22a2fa48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:to="loc_us-gaap_CostOfSalesMember_f0ad7c31-4610-4053-8002-0e5a22a2fa48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ce15caf0-9601-495b-8c69-b48294aed479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ce15caf0-9601-495b-8c69-b48294aed479" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_60ee0746-d6b1-4e8c-85e4-49c4aab4a883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_60ee0746-d6b1-4e8c-85e4-49c4aab4a883" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_1f540b29-c2e2-4e16-9c8a-376af8f1fe1c" xlink:href="dgx-20201231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:to="loc_dgx_OtherIncomeExpenseMember_1f540b29-c2e2-4e16-9c8a-376af8f1fe1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5318d98f-b7f3-49d5-87a7-d46294e540ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5318d98f-b7f3-49d5-87a7-d46294e540ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5318d98f-b7f3-49d5-87a7-d46294e540ff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5318d98f-b7f3-49d5-87a7-d46294e540ff" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5318d98f-b7f3-49d5-87a7-d46294e540ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5318d98f-b7f3-49d5-87a7-d46294e540ff" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_baac0f26-a78b-4df7-8063-8cc694172164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:to="loc_us-gaap_CostOfSalesMember_baac0f26-a78b-4df7-8063-8cc694172164" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3c571c7e-abb7-4d08-9536-7d65563f7a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3c571c7e-abb7-4d08-9536-7d65563f7a9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_29dc28c0-75f6-4a0e-b744-7eba653fcc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_29dc28c0-75f6-4a0e-b744-7eba653fcc69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48de0976-07c2-479e-9c79-c50b0d0820e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48de0976-07c2-479e-9c79-c50b0d0820e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_2f7acae0-4aff-4058-8112-81f56db50b31" xlink:href="dgx-20201231.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48de0976-07c2-479e-9c79-c50b0d0820e9" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_2f7acae0-4aff-4058-8112-81f56db50b31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c35152cc-e54f-4632-8e0b-70bcdc8c263d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c35152cc-e54f-4632-8e0b-70bcdc8c263d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c35152cc-e54f-4632-8e0b-70bcdc8c263d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c35152cc-e54f-4632-8e0b-70bcdc8c263d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c35152cc-e54f-4632-8e0b-70bcdc8c263d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_806d1c9a-68bc-4fb5-b379-e9fc241db39f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c35152cc-e54f-4632-8e0b-70bcdc8c263d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_806d1c9a-68bc-4fb5-b379-e9fc241db39f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NidMember_6203baa9-b1aa-44f9-9ee4-a5284f81b3e4" xlink:href="dgx-20201231.xsd#dgx_NidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_806d1c9a-68bc-4fb5-b379-e9fc241db39f" xlink:to="loc_dgx_NidMember_6203baa9-b1aa-44f9-9ee4-a5284f81b3e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves" xlink:type="simple" xlink:href="dgx-20201231.xsd#ScheduleIIValuationAccountsandReserves"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves" xlink:type="extended" id="i98e6a2c69653495db476588f0c11d280_ScheduleIIValuationAccountsandReserves"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#ScheduleIIValuationAccountsandReservesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="extended" id="icec8397f9e4a465ea8bab4f54370ef58_ScheduleIIValuationAccountsandReservesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d50ed50c-42ee-457f-a404-94c1c1408c20" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d50ed50c-42ee-457f-a404-94c1c1408c20" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_454b3863-37e5-477f-bf3d-32a96de55d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_454b3863-37e5-477f-bf3d-32a96de55d1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_00d91d39-2955-469b-82d1-6edb46d97371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_00d91d39-2955-469b-82d1-6edb46d97371" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_0b1180d7-2cbb-41ab-be58-f53cc3445906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_0b1180d7-2cbb-41ab-be58-f53cc3445906" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_38af47ce-9b84-4a6c-bc5b-1aca6c71cf7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4e5645c4-f14c-47a3-a3d6-0cef4f201cf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d50ed50c-42ee-457f-a404-94c1c1408c20" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4e5645c4-f14c-47a3-a3d6-0cef4f201cf2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_174e2ffb-4062-4d77-9933-3eeaa60f27f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4e5645c4-f14c-47a3-a3d6-0cef4f201cf2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_174e2ffb-4062-4d77-9933-3eeaa60f27f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_174e2ffb-4062-4d77-9933-3eeaa60f27f2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_174e2ffb-4062-4d77-9933-3eeaa60f27f2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_174e2ffb-4062-4d77-9933-3eeaa60f27f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_9cf26604-9738-4107-944c-9580e9360211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_174e2ffb-4062-4d77-9933-3eeaa60f27f2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_9cf26604-9738-4107-944c-9580e9360211" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_c0821178-4432-477f-bd77-6e3ecb89ccdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9cf26604-9738-4107-944c-9580e9360211" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_c0821178-4432-477f-bd77-6e3ecb89ccdb" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>dgx-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a87d206f-e33b-4d9f-a34a-b74e8733b14f,g:639ddba6-f3fe-4831-960f-76615a38edd9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_aa706624-e2f5-41a7-9e43-3877eccef9fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_d6c658fc-67ab-49f6-9fba-f0a919268438_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reissuance of shares for employee benefit plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_80989171-4af6-4f07-bfc5-aada2c6af4c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, end of year aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_ae7aa8d8-a649-4a10-bdb7-347148d485ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_44f2110e-4b40-480e-8da6-6b5895b5679e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_eb057ff7-54e9-4122-b9df-09abd94fc56e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_a334eb37-3747-446b-9851-51d70fc6c960_totalLabel_en-US" xlink:label="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_label_en-US" xlink:label="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, Estimated amortization expense, total</link:label>
    <link:label id="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_documentation_en-US" xlink:label="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, estimated amortization expense, total.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:to="lab_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_0cb952ef-69b1-4309-bad4-2314dc09c53c_terseLabel_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric (including advanced diagnostics) testing services</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_label_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_documentation_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:href="dgx-20201231.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:to="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_c8473205-15e7-4694-a569-5eb7544676d3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesEquity_ff517497-b69d-42a3-a4ce-5da3fb47e865_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities, equity</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesEquity_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Securities, Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesEquity" xlink:to="lab_us-gaap_TradingSecuritiesEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4c6c0810-fcf5-4382-9ae6-500c56e90fba_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e1fe98ee-810f-4f91-910d-ef8a85cead40_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_44f7b27b-caf3-46b9-a6a8-99ef8d52d26f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a05e50f7-ec28-460e-9167-d31ca4d85b1e_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b8d43743-0b7b-404d-879e-c022f553c666_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of leased assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_cdfb8dd9-fa1a-4acf-aae8-4a9b019bcd8b_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_cce1f1f1-8c46-4692-b10d-75055acb2273_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LeaseRenewalTerm_567df51a-aeee-4fdd-b55c-1a3f95a98ceb_terseLabel_en-US" xlink:label="lab_dgx_LeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_dgx_LeaseRenewalTerm_label_en-US" xlink:label="lab_dgx_LeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Renewal Term</link:label>
    <link:label id="lab_dgx_LeaseRenewalTerm_documentation_en-US" xlink:label="lab_dgx_LeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRenewalTerm" xlink:href="dgx-20201231.xsd#dgx_LeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LeaseRenewalTerm" xlink:to="lab_dgx_LeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4b07d88d-c1a6-470d-a49d-0293d3c65d07_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfQuarterlyFinancialDataTable_39a89ddd-b1ad-464c-a2ab-823a5cd48499_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfQuarterlyFinancialDataTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Quarterly Financial Data [Table]</link:label>
    <link:label id="lab_dgx_ScheduleOfQuarterlyFinancialDataTable_label_en-US" xlink:label="lab_dgx_ScheduleOfQuarterlyFinancialDataTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Quarterly Financial Data [Table]</link:label>
    <link:label id="lab_dgx_ScheduleOfQuarterlyFinancialDataTable_documentation_en-US" xlink:label="lab_dgx_ScheduleOfQuarterlyFinancialDataTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Quarterly Financial Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfQuarterlyFinancialDataTable" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfQuarterlyFinancialDataTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable" xlink:to="lab_dgx_ScheduleOfQuarterlyFinancialDataTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1ce8834e-4bb2-4588-8e5c-ad7090f87cd2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_04a71f10-0246-4703-a8bb-556a3932bc17_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, beginning of year weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b5308841-9f79-410a-b0a3-c0d234e4e71e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, end of year weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_c53b72b1-691c-450e-895f-9bae20b9a862_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment, goodwill</link:label>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_label_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to goodwill acquired in connection with a business combination for which the initial accounting was incomplete.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:to="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_4a869006-b195-4c00-ac8f-b5b315720adc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_334969a2-288e-40bf-b54f-56caca0e8671_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_e3930ffe-484a-4834-9e82-42726b57e9ef_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowances associated with certain net operating losses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_cec6b42e-864f-4005-be46-ba4562cbe762_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79d6efae-6043-489f-bf6f-b5cf012674ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_a56bf237-79f3-456f-8cfb-8c4984566f88_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired from acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_68d09cb6-e6f3-4b5a-92b2-3f8bb7a78059_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_673e06af-c100-42f0-b33e-7b6c566e71ee_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_9bf6715c-7da5-4fc7-91e5-4f68d727a9d5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_ee3e96c6-13e4-44de-8561-89b91d7dcb28_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1aaa13b1-5d51-469e-b744-2af04677b11c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_fbc8c60d-da9e-4674-ad7c-b0b789b106c9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8f52513c-eb06-4ce8-87fa-b215219995c7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_f3046961-9412-4790-8e09-1345a439a77f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_071fe30f-4227-4310-80de-6ea329453d54_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_693eb724-8f55-4c39-8b02-e52ac16f32be_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_0be32818-a0f5-4fe1-b124-aa775ddf5acb_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_704b2ff5-93e6-4645-9877-99477d6d01b9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_606d75aa-d67a-46e5-83ff-957a4a607132_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_59a52b5f-ebae-4a9b-a4cf-a73dcb0860c7_terseLabel_en-US" xlink:label="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual life of stock options and other awards under the shared-based compensation plans</link:label>
    <link:label id="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_label_en-US" xlink:label="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual life of stock options and other awards under the Shared-based compensation plans</link:label>
    <link:label id="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_documentation_en-US" xlink:label="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual life of stock options and other awards under the Shared-based compensation plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:href="dgx-20201231.xsd#dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:to="lab_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_04a8726e-c1bf-4e21-8c32-3e638e782e20_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident_ac738422-7a0a-4356-b916-f7e15edcb89a_terseLabel_en-US" xlink:label="lab_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost incurred do to incident</link:label>
    <link:label id="lab_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident_label_en-US" xlink:label="lab_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain associated with contingent consideration accrual, partially offset by costs incurred related to security incident</link:label>
    <link:label id="lab_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident_documentation_en-US" xlink:label="lab_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain associated with contingent consideration accrual, partially offset by costs incurred related to security incident</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" xlink:href="dgx-20201231.xsd#dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" xlink:to="lab_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_66cf5540-f4cd-4322-8c5e-7733135a2714_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_475bceee-670c-43f0-a02e-e60352008d01_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_a03abdbc-2cbb-4a19-9420-550725338d44_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8b159915-4876-48d8-83f8-e1e39eb7cdc2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current state and local income tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_90f6687c-e50b-4df0-ad6e-24ebc045a42b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_865e1c2b-baf6-48c5-b69d-662f7d0b9adc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_0e04afd0-788b-4ece-9719-5b06c873b061_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7dfea765-2bc3-4de8-924e-f6fa6d7415a7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_64ce665c-e2a8-4393-b04c-0a802e150353_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses and other operating expense (income):</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_face1712-55a8-4aca-870b-3a7c057ba196_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapitatedMember_c721b2e2-6c86-4fde-9f14-5415f4d76838_terseLabel_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated</link:label>
    <link:label id="lab_dgx_CapitatedMember_label_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:label id="lab_dgx_CapitatedMember_documentation_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember" xlink:href="dgx-20201231.xsd#dgx_CapitatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapitatedMember" xlink:to="lab_dgx_CapitatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_7d93e6dc-db35-4345-9331-51d69f7df4fc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_a619b01d-27e3-470c-9ae4-da35e18e145a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_8d0ed89d-48a9-4c90-b215-5dd26a201ab7_terseLabel_en-US" xlink:label="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.45% Senior Notes due June 2026</link:label>
    <link:label id="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_label_en-US" xlink:label="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Four Five Percent Senior Notes due June 2026 [Member]</link:label>
    <link:label id="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_documentation_en-US" xlink:label="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Four Five Percent Senior Notes due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:href="dgx-20201231.xsd#dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:to="lab_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_462e3a4b-85f7-436c-8731-9db6058fe4bd_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_b1465dd2-12d2-4945-bbb3-d50501aecfbc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ChargesDueToCOVID19_06c77ac3-051d-4199-b48f-4989e6844564_terseLabel_en-US" xlink:label="lab_dgx_ChargesDueToCOVID19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charges due to COVID-19</link:label>
    <link:label id="lab_dgx_ChargesDueToCOVID19_label_en-US" xlink:label="lab_dgx_ChargesDueToCOVID19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges due to COVID-19</link:label>
    <link:label id="lab_dgx_ChargesDueToCOVID19_documentation_en-US" xlink:label="lab_dgx_ChargesDueToCOVID19" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges due to COVID-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ChargesDueToCOVID19" xlink:href="dgx-20201231.xsd#dgx_ChargesDueToCOVID19"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ChargesDueToCOVID19" xlink:to="lab_dgx_ChargesDueToCOVID19" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_a1b4d150-4a9b-4ab4-abda-90a4733641a2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_c071ddb5-7712-46e0-babe-2f39058e7b13_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_1cbf40e1-3cdb-4898-94d6-fd9793348ccd_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_82cc9c44-f1af-488f-8366-666cfbbba538_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d5a222b3-5690-4439-a133-509be0adc844_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_c2ab0d32-cbcb-4ccf-86b3-27d2860e4269_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_e9f30151-fd86-4418-acb7-a417f4cb4155_terseLabel_en-US" xlink:label="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_documentation_en-US" xlink:label="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:href="dgx-20201231.xsd#dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:to="lab_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e9c13e42-75df-4eab-a7be-e97105a9df1e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount_cda7d4ab-30da-4084-8556-7d3aec33c1d0_terseLabel_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional authorized amount</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount_label_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Authorized Amount</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount_documentation_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:href="dgx-20201231.xsd#dgx_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:to="lab_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ReproSourceInc.Member_6e61546b-c81c-449a-bd4d-5169a4b647a8_terseLabel_en-US" xlink:label="lab_dgx_ReproSourceInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ReproSource, Inc.</link:label>
    <link:label id="lab_dgx_ReproSourceInc.Member_label_en-US" xlink:label="lab_dgx_ReproSourceInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ReproSource, Inc. [Member]</link:label>
    <link:label id="lab_dgx_ReproSourceInc.Member_documentation_en-US" xlink:label="lab_dgx_ReproSourceInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ReproSource, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReproSourceInc.Member" xlink:href="dgx-20201231.xsd#dgx_ReproSourceInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ReproSourceInc.Member" xlink:to="lab_dgx_ReproSourceInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_e876158a-c6df-4d80-9a79-556e278212c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs of accounts receivable, net of recoveries</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_b8549eb2-dd9c-442f-9fa4-758c9a9d6eff_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_08bcc830-2832-4daf-823f-fe2bb349730d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanMember_2a9a54c8-b9cb-44da-93fc-da21c168eae9_terseLabel_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanMember_label_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan [Member]</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanMember_documentation_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanMember" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalDeferredCompensationPlanMember" xlink:to="lab_dgx_SupplementalDeferredCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_9a3c3c4a-9237-4b41-a012-bd383a767932_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of Hedged Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedge_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedge" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_45cabda2-0d9c-4689-b784-29e9aa4f1d22_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_08e3cfc5-3ba1-48f3-911b-aa540ef3a14f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_483b73df-4f6d-4e2f-acc2-e4216018e66c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fae99136-2edd-4191-9227-b6631eed3613_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_d3428154-2350-4682-980c-8155d594c567_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_9ad56627-8b02-4ec1-9a49-ba3f4bd90663_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_8f213502-21f5-4139-a292-0c67ecbf82eb_terseLabel_en-US" xlink:label="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable reserves</link:label>
    <link:label id="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_label_en-US" xlink:label="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables</link:label>
    <link:label id="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_documentation_en-US" xlink:label="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:to="lab_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_6ce381d7-f13b-4dcf-949b-eba14f304f83_terseLabel_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration payable</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_label_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:label id="lab_dgx_Mergerconsiderationpaidpayablenet_documentation_en-US" xlink:label="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration paid (payable), net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:href="dgx-20201231.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Mergerconsiderationpaidpayablenet" xlink:to="lab_dgx_Mergerconsiderationpaidpayablenet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fa0feac6-dd2c-496f-bc57-5668ed06bbd6_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member_1002f6b7-afa9-4496-9143-47d729f0bab9_terseLabel_en-US" xlink:label="lab_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Senior Notes due January 2020</link:label>
    <link:label id="lab_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member_label_en-US" xlink:label="lab_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Five Percent Senior Notes Due2020 [Member]</link:label>
    <link:label id="lab_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member_documentation_en-US" xlink:label="lab_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Five Percent Senior Notes Due 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenFivePercentSeniorNotesDue2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member" xlink:to="lab_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3e5b98e9-916e-40e0-9f26-3e135277673f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4a00d139-511c-47b0-af2d-6bbc01df5334_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c1801198-13d6-4195-aa58-b1509912b2da_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9d858f2d-7b6d-4eb9-9e30-58241c877f14_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_bd2ee907-c170-478d-b2d4-fa11d5b4f1da_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:href="dgx-20201231.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:to="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_cfa09478-4142-492b-b6a6-a6900577f9f2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_d7606e33-6bec-4bd7-9f2f-cf91716905be_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_258c8c20-650f-496e-8a4d-ece15f09d326_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_d079af9a-a360-4235-9864-1fe9b65abc08_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net accounts receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_label_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_documentation_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetAccountsReceivable" xlink:to="lab_dgx_PercentageofNetAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_24702490-d834-4d35-8f8b-490ace93b026_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_1d9d70a3-c514-442e-8b88-2757cfaa8460_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d95c94b0-3425-40d0-9736-72231e839d3c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_1ab87761-b567-4caf-adbf-99ab1d0596c9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_a6824e4d-5a48-4d05-8e31-ecd7a776538c_terseLabel_en-US" xlink:label="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment and Furniture and Fixtures</link:label>
    <link:label id="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_label_en-US" xlink:label="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment And Furniture And Fixtures [Member]</link:label>
    <link:label id="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_documentation_en-US" xlink:label="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment and furniture and fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:href="dgx-20201231.xsd#dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:to="lab_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_061aef95-24ce-4309-b332-d038f1dc660e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9974e927-6f17-41b3-adb2-fd439fab8a71_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_c36686e6-d1b8-4c66-8542-f13ce9f715ef_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_9fa7d71d-bfd4-485f-aee3-29f3c50da7b2_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_8d2f4e4d-1913-4871-98d7-5d63e98a627e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bcc9f08f-7fac-4519-b790-97e5ea960248_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8de68a37-5236-422c-9cb2-27b94e2c81be_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_36089a05-46e1-45b2-82de-607870cfb9c2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_a16cd7f4-04fe-4295-a50c-f37ab8741a10_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_6b6faae0-9c98-40e6-bfe3-67af49f4a953_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]</link:label>
    <link:label id="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_label_en-US" xlink:label="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:to="lab_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_225f4231-f757-4098-a8c0-110c05ac8316_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_5275d849-221e-4393-ab5b-62c8c720f5d2_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_c0164cdd-6200-46d7-bc5d-19f36a39857b_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses Policy [Policy Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:href="dgx-20201231.xsd#dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:to="lab_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_947525ae-cc93-4c47-9c78-f7004014bd05_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Bonus and Profit Sharing Plan, Type of Deferred Compensation [Axis]</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_c0db4d6d-33c0-4dee-91b6-fc4387133d14_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_ee8e84c5-337a-4779-bf0a-bc3d774ff84b_terseLabel_en-US" xlink:label="lab_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of income recognized due to receipt of initial tranche of funds from the CARES Act</link:label>
    <link:label id="lab_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_label_en-US" xlink:label="lab_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of Income Recognized due to Receipt of Initial Tranche of Funds from the CARES Act</link:label>
    <link:label id="lab_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_documentation_en-US" xlink:label="lab_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of Income Recognized due to Receipt of Initial Tranche of Funds from the CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:href="dgx-20201231.xsd#dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:to="lab_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_5255cb48-0b51-446a-8067-10609ebfbde9_terseLabel_en-US" xlink:label="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.80% Senior Notes due June 2031</link:label>
    <link:label id="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_label_en-US" xlink:label="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Eight Zero Percent Senior Notes due June 2031 [Member]</link:label>
    <link:label id="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_documentation_en-US" xlink:label="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Eight Zero Percent Senior Notes due June 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:href="dgx-20201231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:to="lab_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_26be7dac-6fb7-4344-b1c0-67c18f6a4a87_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_19e52e99-cfbc-4cc1-89a7-28587df4ba3e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DSBusinessesMember_bd3fc694-8059-4b30-9e2e-1520d0ac7597_terseLabel_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_label_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_documentation_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember" xlink:href="dgx-20201231.xsd#dgx_DSBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DSBusinessesMember" xlink:to="lab_dgx_DSBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_1267c78a-40e7-40b0-b298-42f10e988584_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_09fd9d7f-c51d-4600-8b04-9aec9478e6dd_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_e6013f45-0601-40e0-8cd9-4382df650597_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED PARTIES</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PeriodofBillingFullyReserve_7265d903-8d5d-4d17-a39d-8d56bae69791_terseLabel_en-US" xlink:label="lab_dgx_PeriodofBillingFullyReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of billing fully reserve</link:label>
    <link:label id="lab_dgx_PeriodofBillingFullyReserve_label_en-US" xlink:label="lab_dgx_PeriodofBillingFullyReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of Billing Fully Reserve</link:label>
    <link:label id="lab_dgx_PeriodofBillingFullyReserve_documentation_en-US" xlink:label="lab_dgx_PeriodofBillingFullyReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of Billing Fully Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PeriodofBillingFullyReserve" xlink:href="dgx-20201231.xsd#dgx_PeriodofBillingFullyReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PeriodofBillingFullyReserve" xlink:to="lab_dgx_PeriodofBillingFullyReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_3f4ac5ef-af1b-4248-9236-656d4476a80b_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate income (expenses), Net</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d1ae4bce-d197-44ae-bda5-90936ff1f78a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, beginning of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a144a81c-145d-459d-8c5d-f36a687ddb81_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_8a59dc69-36a0-4f14-b4f8-4e350972487b_terseLabel_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long-Term Incentive Plan (DLTIP)</link:label>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_label_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long Term Incentive Plan Dltip [Member]</link:label>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_documentation_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long-Term Incentive Plan (DLTIP) (Member)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:href="dgx-20201231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:to="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member_006fef2d-4e77-4ebb-a0cc-aed1d2d0504c_terseLabel_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70% Senior Notes due April 2021</link:label>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member_label_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Zero Percent Senior Notes due 2021 [Member]</link:label>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member_documentation_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Zero Percent Senior Notes due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member" xlink:to="lab_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_92081045-a432-400e-89f5-d6ff6d01c795_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_f2188871-4b35-4801-bc04-c449cf8bb1a6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_28da17f4-a334-47a2-98dd-2c6542eb90d2_terseLabel_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_label_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022 [Member]</link:label>
    <link:label id="lab_dgx_LoanCommitmentMaturingOctober2022Member_documentation_en-US" xlink:label="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member" xlink:href="dgx-20201231.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LoanCommitmentMaturingOctober2022Member" xlink:to="lab_dgx_LoanCommitmentMaturingOctober2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_c29087e6-b24b-47f9-ae82-980ec504e7a7_terseLabel_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with purchases of treasury stock</link:label>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_label_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchased but Not yet Paid</link:label>
    <link:label id="lab_dgx_TreasuryStockPurchasedbutNotyetPaid_documentation_en-US" xlink:label="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchased but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:href="dgx-20201231.xsd#dgx_TreasuryStockPurchasedbutNotyetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:to="lab_dgx_TreasuryStockPurchasedbutNotyetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_7c799abf-f502-44fc-be2e-da4da622ba42_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_5fd1f0f6-fa45-4c48-a84f-50bded5476a2_terseLabel_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accounting method</link:label>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_label_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Accounting Method</link:label>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_documentation_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Accounting Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" xlink:href="dgx-20201231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" xlink:to="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_86710a61-14ff-4805-9a28-e0e6dce54328_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Subject To Amortization</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_efc74df1-b23c-4afe-b7f2-16122da22d06_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b489075d-f7ed-46c0-a154-1bf9b64c92d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0b844c98-60e6-422e-a59a-7a460aa85b0c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_786f24f1-e04d-4a53-93dd-35ef5cc9d920_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other operating segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_f8910191-4986-4563-b6d5-892109e327ca_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of year weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_985fe30a-e375-4983-9f1a-655ac273ce4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c4333764-6d26-452d-a59a-069b91f91f38_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock_213aaf53-08ac-439c-a778-61466b2beede_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio Covenants</link:label>
    <link:label id="lab_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio Covenants [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio Covenants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock" xlink:to="lab_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_dc018675-c597-4c32-a488-e9d728635409_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ClientPayersMember_136cf0f7-1146-4264-bede-5a032597b727_terseLabel_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client payers</link:label>
    <link:label id="lab_dgx_ClientPayersMember_label_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_dgx_ClientPayersMember_documentation_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember" xlink:href="dgx-20201231.xsd#dgx_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ClientPayersMember" xlink:to="lab_dgx_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e7b6cb96-0289-414d-9db9-60b0e8a3acc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_99bcb1d6-cd63-40af-8413-e6647d2631c6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_cbb89402-4cb1-4041-930a-f51443c53615_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e4c0223c-6c03-4c5d-880e-66bbf893830f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_8ff728c5-aa1e-4156-816c-a924bf5d791b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_11d7f39c-810b-4d5c-8e4d-5d21f608040d_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_84e11dc1-2ff5-4ab8-a1b5-1ec2c349b642_negatedTerseLabel_en-US" xlink:label="lab_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income recognized due to receipt of initial tranche of funds from the CARES Act</link:label>
    <link:label id="lab_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_label_en-US" xlink:label="lab_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Recognized due to Receipt of Initial Tranche of Funds From the CARES Act</link:label>
    <link:label id="lab_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_documentation_en-US" xlink:label="lab_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Recognized due to Receipt of Initial Tranche of Funds From the CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:href="dgx-20201231.xsd#dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:to="lab_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_70cc3fac-b174-4072-84cd-2a8aea4287b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_aa5fd639-a2c8-40db-ad36-0c774df21e4a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_abf63d33-8485-42c7-9638-c85dabb98d82_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_290f35fc-1216-44fd-9f60-dca04478c86c_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_ce57fb37-0781-4047-af09-2bb040631758_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_475be458-a7ae-492c-ba66-77b2b9c20bee_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares, outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_21b66639-5e2f-418a-8003-0194c2d77231_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f92ea21b-1924-4c76-a52d-dac2c7e0e7b7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_be5f0a71-ec5c-4a57-8fdd-be0940d012b6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_0e215251-07a2-42c4-883f-06f53088adcf_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments carrying value</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_747aa1a5-a778-4ae2-8e25-adf4e9c4ea32_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a8c35d2a-7194-4c9d-845e-53eca10a42c6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ContingentConsiderationMember_1d175f29-96af-4ad3-b2fe-cde5284aedf9_terseLabel_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_label_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_dgx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_dgx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember" xlink:href="dgx-20201231.xsd#dgx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ContingentConsiderationMember" xlink:to="lab_dgx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4b8f72b0-7c97-4c7a-b0bd-569bfc50670b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning of year weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c1712f02-4930-464d-b4f4-60e9a8c1657f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, end of year weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_aa393ecd-e891-4ecd-ba8b-4cf837c2d055_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_bd89b9c6-9d7c-41cc-a7fc-a0353be4fd7f_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_cddeeef2-0c3c-4a38-9e20-d3c755d9386b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_4160dd6a-b997-43fd-ba68-1863cf3766a9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_4e2ae12c-257b-4590-884e-f65653b5f813_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_332c6c92-85bc-4abf-b8b7-48ad0287d584_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_37a9421d-55cd-47b4-9c3c-d3a43463ed00_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_f7850246-4d19-4a11-ad33-9d8c6ed2d5bc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defered federal income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankOverdrafts_f333cd0d-4896-41c2-94fa-aadaba758c14_terseLabel_en-US" xlink:label="lab_us-gaap_BankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Overdrafts</link:label>
    <link:label id="lab_us-gaap_BankOverdrafts_label_en-US" xlink:label="lab_us-gaap_BankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Overdrafts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankOverdrafts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankOverdrafts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankOverdrafts" xlink:to="lab_us-gaap_BankOverdrafts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4abd6bed-7398-4a13-8283-c27e9acca412_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_a423812a-8949-4ea7-b3cb-ffe9c06fea4e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_b35d6786-2810-4f32-8a14-49ef744e737a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_af42e1b4-2f95-4d3b-a735-4be187d8c064_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0ba9e1a-7086-4cd6-a160-b7b8721ed3ba_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a675a751-71db-4d78-b040-eea68d4c1d64_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease_cc761d06-6ef1-466e-b9e6-297c510210b0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:to="lab_us-gaap_RestructuringReservePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_af40f6c6-246a-4364-9b77-7cac2ccb8617_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_025ed8c3-b391-450c-8de6-62fd9c8f4cc9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued insurance</link:label>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Insurance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedInsuranceCurrent" xlink:to="lab_us-gaap_AccruedInsuranceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LeaseRemainingLeaseTerm_6d779df6-9d8f-4fe2-a7c9-d4de78b7ea46_terseLabel_en-US" xlink:label="lab_dgx_LeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_dgx_LeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_dgx_LeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Remaining Lease Term</link:label>
    <link:label id="lab_dgx_LeaseRemainingLeaseTerm_documentation_en-US" xlink:label="lab_dgx_LeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRemainingLeaseTerm" xlink:href="dgx-20201231.xsd#dgx_LeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LeaseRemainingLeaseTerm" xlink:to="lab_dgx_LeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_1304941b-ad64-46ba-b464-4f1286df70c3_terseLabel_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund from taxing authorities related to settlement of the uncertain tax benefits</link:label>
    <link:label id="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d2a3138d-0012-4842-a401-e4ac11142bed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a950f005-72c3-4f93-b9b2-438017f1618a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_dc712f1a-2167-44d4-96d1-6ce98aa1930e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge_d72c18e7-21ed-4b65-8668-0ec2d8eaf130_negatedTerseLabel_en-US" xlink:label="lab_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain associated with an insurance claim for hurricane</link:label>
    <link:label id="lab_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge_label_en-US" xlink:label="lab_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain associated with insurance claim, partially offset by non-cash asset impairment charge</link:label>
    <link:label id="lab_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge_documentation_en-US" xlink:label="lab_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain associated with insurance claim, partially offset by non-cash asset impairment charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" xlink:href="dgx-20201231.xsd#dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" xlink:to="lab_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_bcbd325c-18ea-4676-930c-11ff1039438b_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BlueprintGeneticsOyMember_a672b4f0-db92-4c1f-b3a3-36cf78024d97_terseLabel_en-US" xlink:label="lab_dgx_BlueprintGeneticsOyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blueprint Genetics Oy</link:label>
    <link:label id="lab_dgx_BlueprintGeneticsOyMember_label_en-US" xlink:label="lab_dgx_BlueprintGeneticsOyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blueprint Genetics Oy [Member]</link:label>
    <link:label id="lab_dgx_BlueprintGeneticsOyMember_documentation_en-US" xlink:label="lab_dgx_BlueprintGeneticsOyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blueprint Genetics Oy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BlueprintGeneticsOyMember" xlink:href="dgx-20201231.xsd#dgx_BlueprintGeneticsOyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BlueprintGeneticsOyMember" xlink:to="lab_dgx_BlueprintGeneticsOyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_a8b0d9a6-0b9e-4f77-ae1c-088e964b2d91_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_9738bda9-7b58-4a4e-afff-c23a1d426312_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_689ba5b7-a783-4296-a7f7-1bf67f8f2df4_verboseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software Developed or Obtained for Internal Use</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_5045f92e-c0a4-47dd-ae98-a23aab27895e_totalLabel_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_label_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_documentation_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired" xlink:href="dgx-20201231.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired" xlink:to="lab_dgx_FairValueOfNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_5199f336-e160-473b-b178-868d6d1c239d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_1fe5e8a1-aeac-42fe-b531-fb5ae33b8a74_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="lab_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_23b73dd6-4414-4e1e-af0b-33b7b887cab0_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8b7b4c55-091d-4cb8-a379-796e3294bf8c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_373d6416-935c-41cc-806c-71457410523e_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_b5e95805-aff4-48d7-8591-7ef1971dadb3_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataTable_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:href="dgx-20201231.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_dcfd369f-5e1e-478b-bdb2-af1b06b2578a_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_98d00993-d397-43cb-ac40-04ba53aa1feb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_157032b5-deaa-4174-b6b6-34021a189d65_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_ef382f08-0d0c-41ad-a266-d7b6a019f064_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_48c79014-2361-48f9-959e-30ac6c5a8bba_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_772a5aec-9d2c-47b5-a27a-3cfe99406608_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_7967f2f4-381e-4b1f-9fd8-37fab4f4ccc0_terseLabel_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of interest rate swap agreements</link:label>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_label_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Of Interest Rate Swap Agreements</link:label>
    <link:label id="lab_dgx_TerminationOfInterestRateSwapAgreements_documentation_en-US" xlink:label="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Of Interest Rate Swap Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements" xlink:href="dgx-20201231.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TerminationOfInterestRateSwapAgreements" xlink:to="lab_dgx_TerminationOfInterestRateSwapAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_fe1aeba6-f80d-4deb-b3d6-e8929f143eb3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of equity method investees, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_6b266b18-2f4f-476a-9dc4-42a70b80bb39_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of equity earnings from investments in affiliates</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_f33404f0-ad8e-47b0-9ede-d90f677a91e5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes and equity in earnings of equity method investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_460c0a3a-9f65-42ed-8e4c-94c808a682fe_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_8d7439d6-f3d6-4022-a0c2-478bf230a925_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_df58acfc-10fd-4f68-8050-439a6756cb60_terseLabel_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL)</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_label_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL) [Member]</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_documentation_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:href="dgx-20201231.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:to="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_9df6362c-57a3-49a1-b13c-f72cbd2d33c7_terseLabel_en-US" xlink:label="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment, Furniture and Fixtures</link:label>
    <link:label id="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_label_en-US" xlink:label="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment, Furniture and Fixtures [Member]</link:label>
    <link:label id="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_documentation_en-US" xlink:label="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment, Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:href="dgx-20201231.xsd#dgx_LaboratoryEquipmentFurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:to="lab_dgx_LaboratoryEquipmentFurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_51e7b82d-73f4-4a16-a6d8-cd986c3bff2d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_b9abea69-e901-433d-bf32-7698aa71acf5_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_f6e2d987-fe46-49b7-b77b-17234807b2f6_terseLabel_en-US" xlink:label="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.95% Senior Notes due July 2037</link:label>
    <link:label id="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_label_en-US" xlink:label="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Point Nine Five Percent Senior Notes Due2037 [Member]</link:label>
    <link:label id="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_documentation_en-US" xlink:label="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six Point Nine Five Percent Senior Notes Due 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:href="dgx-20201231.xsd#dgx_SixPointNineFivePercentSeniorNotesDue2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:to="lab_dgx_SixPointNineFivePercentSeniorNotesDue2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_02f9ae72-4718-4174-b965-ae77edb846ce_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during the year</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_2ec0225c-06e6-4185-97f0-0fec07fbefbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-Tax Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ReductionsForChangesInJudgment_4e77f674-7f2e-4071-9f67-29f3f9811ba9_negatedTerseLabel_en-US" xlink:label="lab_dgx_ReductionsForChangesInJudgment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for changes in judgment</link:label>
    <link:label id="lab_dgx_ReductionsForChangesInJudgment_label_en-US" xlink:label="lab_dgx_ReductionsForChangesInJudgment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for changes in judgment</link:label>
    <link:label id="lab_dgx_ReductionsForChangesInJudgment_documentation_en-US" xlink:label="lab_dgx_ReductionsForChangesInJudgment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The gross amount of decreases in unrecognized tax benefits resulting from changes in judgment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReductionsForChangesInJudgment" xlink:href="dgx-20201231.xsd#dgx_ReductionsForChangesInJudgment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ReductionsForChangesInJudgment" xlink:to="lab_dgx_ReductionsForChangesInJudgment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_c9e224ba-6424-48af-ae1c-ca0c65416982_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Operating Results (unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_c3325fb9-4730-47c7-9ea1-9e2658f86677_terseLabel_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_label_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_documentation_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember" xlink:href="dgx-20201231.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AnatomicpathologytestingservicesMember" xlink:to="lab_dgx_AnatomicpathologytestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_cf519ed3-76c2-4819-b7ce-f514acfead05_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Excluding Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_0dbd2b94-c8ab-422c-b728-e98b2c1a25ec_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_daa1a7a5-714e-45bc-9699-1be4fdd195ab_negatedTerseLabel_en-US" xlink:label="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit due to release of valuation allowances associated with net operating loss carryforwards</link:label>
    <link:label id="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_label_en-US" xlink:label="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards</link:label>
    <link:label id="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_documentation_en-US" xlink:label="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:href="dgx-20201231.xsd#dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:to="lab_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_6e1006be-4eae-4c4c-a9aa-45c30a5fac95_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_436d3fce-7378-48e4-8477-42a85669d9ea_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale recognized</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_a13d751c-cd3b-4c85-997a-53e548910df8_negatedLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from sale and leaseback of property</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_88ed7387-7639-4595-b557-92c016d681a3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2cc12c94-7cd0-4605-8f48-dbe6fe539cb3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8b78ede7-0ca9-4c14-a7bf-de98c9abcdf9_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_ea004953-7820-467f-9c02-9f08a779609b_terseLabel_en-US" xlink:label="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.20% Senior Notes due June 2029</link:label>
    <link:label id="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_label_en-US" xlink:label="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Two Zero Percent Senior Notes due June 2029 [Member]</link:label>
    <link:label id="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_documentation_en-US" xlink:label="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Two Zero Percent Senior Notes due June 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:href="dgx-20201231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:to="lab_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_d158431b-e327-4657-ab8b-ac8d590e9795_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_2b93a1f8-713f-4d07-bfd8-8dcc1d9f964d_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f37be90b-93b6-4554-a3af-737b6d46e66c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_8a8b4a2b-e9c0-4d9c-91e4-a425f8f4d3ff_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_169aef3f-ef22-4e97-9c13-d3492c2d9ae5_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_25a29086-6e9b-4c33-b318-c95b1886b608_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares forfeited and cancelled weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c1627b5d-89eb-475e-9261-3feb41b3f876_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used in Valuing The Company's Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems_90d633e1-a014-44b5-b43e-609d7b9705af_terseLabel_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies Line Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="dgx-20201231.xsd#dgx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_dgx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1bf6a983-fa10-4395-a8cd-e7ad1f7c4499_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of The Fair Values of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_4113dbc8-fb5c-44ee-bfac-9891de84b1d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_2ff10c61-5f64-43bb-bb1a-41fe42cd4046_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_5e7b2a82-6d59-4864-8a95-df1bb0028735_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_a7ce926b-6d48-4392-ac86-ec92620a21e6_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_ba97256e-752b-44e5-b0cd-6bbd97ccf028_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment, intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock_526bba07-5133-467d-a6e3-6cb8280dd6a5_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments and Hedged Item, Statement of Financial Performance, Location</link:label>
    <link:label id="lab_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments and Hedged Item, Statement of Financial Performance, Location [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments and Hedged Item, Statement of Financial Performance, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" xlink:href="dgx-20201231.xsd#dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" xlink:to="lab_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_4fadc515-e3bf-4609-bb15-7ca6faaf04cb_terseLabel_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_label_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_documentation_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:href="dgx-20201231.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:to="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1e598947-3b60-4efa-b133-c3944b7b8ac4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_436ad3bc-208d-4b8d-a0be-7ee59af9794b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_3ddd8b17-82f5-4a05-96fe-9cac9ba18e23_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_37f51ef0-a4e8-426b-8af7-9f2643f5ad34_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_d7602b57-b7f7-42da-abc1-9e9330e13ef0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_f736fc73-e037-4808-b94f-f6f8b91fd5dc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d1d61b8c-2af6-47ef-8579-98682ce3cb89_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate, Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ShorttermLeaseandVariableLeaseCost_88a8c677-dbce-4984-af19-a090a1adaecf_terseLabel_en-US" xlink:label="lab_dgx_ShorttermLeaseandVariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term leases and variable lease costs</link:label>
    <link:label id="lab_dgx_ShorttermLeaseandVariableLeaseCost_label_en-US" xlink:label="lab_dgx_ShorttermLeaseandVariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease and Variable Lease, Cost</link:label>
    <link:label id="lab_dgx_ShorttermLeaseandVariableLeaseCost_documentation_en-US" xlink:label="lab_dgx_ShorttermLeaseandVariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease and Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ShorttermLeaseandVariableLeaseCost" xlink:href="dgx-20201231.xsd#dgx_ShorttermLeaseandVariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ShorttermLeaseandVariableLeaseCost" xlink:to="lab_dgx_ShorttermLeaseandVariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_77d95ec9-35da-4370-afc0-a5d388556163_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP accrual</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Recorded Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_b44c4a77-cd67-4f46-bf9e-94b3384b7d16_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0e41047f-fa1e-4a83-be3e-d94ca076de28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OtherAccountsReceivableRelatedParties_b6d976ec-81c4-4ad7-a37a-7c8d8fc98892_terseLabel_en-US" xlink:label="lab_dgx_OtherAccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accounts receivable, related parties</link:label>
    <link:label id="lab_dgx_OtherAccountsReceivableRelatedParties_label_en-US" xlink:label="lab_dgx_OtherAccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Receivable, Related Parties</link:label>
    <link:label id="lab_dgx_OtherAccountsReceivableRelatedParties_documentation_en-US" xlink:label="lab_dgx_OtherAccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Receivable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherAccountsReceivableRelatedParties" xlink:href="dgx-20201231.xsd#dgx_OtherAccountsReceivableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OtherAccountsReceivableRelatedParties" xlink:to="lab_dgx_OtherAccountsReceivableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_337b152e-000c-422b-8798-622889a214f3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PatientMember_299cd26e-8097-451a-a3e1-31ae96193bc6_terseLabel_en-US" xlink:label="lab_dgx_PatientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients</link:label>
    <link:label id="lab_dgx_PatientMember_label_en-US" xlink:label="lab_dgx_PatientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient [Member]</link:label>
    <link:label id="lab_dgx_PatientMember_documentation_en-US" xlink:label="lab_dgx_PatientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember" xlink:href="dgx-20201231.xsd#dgx_PatientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PatientMember" xlink:to="lab_dgx_PatientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_ee3019d2-8f6f-4abb-a025-ddd8ae57db4f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fec2ba61-409a-46ee-bf10-7d3cfc521012_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OtherIncomeExpenseMember_b5375078-483c-4e2c-86e5-d7af8490fd93_terseLabel_en-US" xlink:label="lab_dgx_OtherIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_dgx_OtherIncomeExpenseMember_label_en-US" xlink:label="lab_dgx_OtherIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense) [Member]</link:label>
    <link:label id="lab_dgx_OtherIncomeExpenseMember_documentation_en-US" xlink:label="lab_dgx_OtherIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember" xlink:href="dgx-20201231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OtherIncomeExpenseMember" xlink:to="lab_dgx_OtherIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_567da7a1-d7f4-495b-a1ba-30ffd7ec6bbe_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_7c03d005-141f-4003-bd00-84e2541ce734_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_12d81aac-9dab-41f1-8bac-164062820c87_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, long-term growth rate used to determine fair value</link:label>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_label_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value</link:label>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:to="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_110bec53-1d51-44cb-b447-f4e4e06bd480_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_5b638857-4ab7-4bc7-8ceb-3d67b5b69f6f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_e0e8834e-10ac-49be-ba0c-499af5682600_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_761768fb-ffdc-44b3-b7ba-790b0ed54eaa_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_6f39f16d-3ef9-4dc2-a142-153d2cddbf33_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_28e2366c-6436-48bb-8be1-6298d21d6894_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_Goodwill_df6023c8-305f-46d5-92a5-8d82fcd69c36_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, balance at end of year</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_90c2aa2f-05f8-4800-b80e-6eedad329b08_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_44a81585-b1b2-4d51-8b33-2b6b1e8261ed_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_6fe16946-a0cc-4b46-9f07-74a317dd2bbf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_22d6ca42-df22-4cfc-96a4-afc4f1b1b111_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_3445af1d-f5fb-45e3-8085-cd74f28e890b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_f262e337-c54a-4bf1-a03c-e485576cf2e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_a1224b21-c1e6-4909-a1b3-418cb9f5af89_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_3d97af1a-f6dc-4a0b-8e48-6507c49b0b64_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_00962fff-d6db-4705-b09f-dfe3aa9b6cc1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_883c22fb-6dd8-4206-948d-63739556b8fe_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_a302554a-82fe-4cf2-b532-1826dee64ff1_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_d70d0d2a-3b22-4685-a68b-6e31080c1d74_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISCONTINUED OPERATIONS</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_dedbb21c-af0e-4189-b0ed-368f84956097_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a8969c0f-4680-48c0-ad40-6bf85b22a8fa_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision true-ups</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e481e1d2-07a2-4af2-91a6-2975d63f2ded_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, granted weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FinanceLeaseObligationsandOtherMember_7b81a9e2-84ff-4dca-9de2-bb66a5196cc5_verboseLabel_en-US" xlink:label="lab_dgx_FinanceLeaseObligationsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dgx_FinanceLeaseObligationsandOtherMember_label_en-US" xlink:label="lab_dgx_FinanceLeaseObligationsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations and Other [Member]</link:label>
    <link:label id="lab_dgx_FinanceLeaseObligationsandOtherMember_documentation_en-US" xlink:label="lab_dgx_FinanceLeaseObligationsandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceLeaseObligationsandOtherMember" xlink:href="dgx-20201231.xsd#dgx_FinanceLeaseObligationsandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FinanceLeaseObligationsandOtherMember" xlink:to="lab_dgx_FinanceLeaseObligationsandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_31d8929a-475d-4779-ada7-02a0e5b66422_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_15cb1399-f7cf-44d8-be43-da67dc7e1506_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fa71b471-3984-4d80-b923-7c902d63428b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_1a5b9d93-d17f-41e7-8856-e0a35d86417e_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_7846065e-342c-4b8f-b9f2-eefeba37aa60_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_cf058738-8abf-4b03-8f81-90cce544dc0c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares forfeited and cancelled</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EmployeeLongTermIncentivePlanEltipMember_8a770d04-92ba-4424-aba4-c85305470213_terseLabel_en-US" xlink:label="lab_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Long Term Incentive Plan ELTIP</link:label>
    <link:label id="lab_dgx_EmployeeLongTermIncentivePlanEltipMember_label_en-US" xlink:label="lab_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Long Term Incentive Plan Eltip [Member]</link:label>
    <link:label id="lab_dgx_EmployeeLongTermIncentivePlanEltipMember_documentation_en-US" xlink:label="lab_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Long-Term Incentive Plan (ELTIP) (Member)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:href="dgx-20201231.xsd#dgx_EmployeeLongTermIncentivePlanEltipMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:to="lab_dgx_EmployeeLongTermIncentivePlanEltipMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_04026b0d-1bab-462e-91ab-7a1ff256c95e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_a877c6cd-d009-4089-b40b-82b5c1d3ad02_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities not currently deductible</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_88342b8d-65bb-4b3f-b7f1-5f2d5d44c752_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_307313c6-4c7d-456b-9f3b-54ce2a90b93b_terseLabel_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_label_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_documentation_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:href="dgx-20201231.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:to="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e13f83d4-ecea-4ae4-8cdf-dea3d143ea57_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_262c0e23-98b3-4372-a7c1-5e8494753493_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6915893d-9dcc-4d3e-b85a-4bcf6f2cd2de_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2020 and 2019; 217 shares issued as of both December 31, 2020 and 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_f898a6c9-1a8f-4635-a614-8fad8bbac5a6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_12f697fd-f8c0-4236-a58c-2803186933fc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_08cbe31d-ac75-4438-9343-cba127319b9b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_4ddf2408-6fd0-4560-a915-ba51d424c656_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_dad507d2-1690-4514-8f23-c751a5075ba1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_ea2868bd-ebcb-4ab9-a1f8-01b9acd1e7c4_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_51701367-cd9c-4023-af73-fdfad289b835_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9e96cfaf-31b1-46f5-b0c3-5ed176988dc3_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_90825c80-5ded-4224-8635-3c51619e8ea5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (gains)/losses included in earnings - realized/unrealized</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_ac55b4d1-753b-47d2-9142-afcb3f3683d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (gains)/losses included in earnings - realized/unrealized</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_c60bba02-a24a-4760-9473-8b1bcea681de_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_31cb523a-cdce-44a2-9676-5b263da5c889_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8ec8f9b2-c7c9-4173-8e80-8e278f4da585_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6a796c7-b305-41dc-a7d4-54c0cc5a036c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c1578ec6-3ee2-451a-bc5e-3ea807b244ac_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c487d43f-dbce-4ae3-9ef8-27f18e4a551d_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_dd681cc7-c05d-43ef-be20-c28bf6f594e4_terseLabel_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP variable incentive compensation deferral</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_label_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan Variable Incentive Compensation Deferral</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_documentation_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferral percentage of the variable incentive compensation under the Supplemental Deferred Compensation Plan. The plan is an unfunded, non-qualified plan that provides for certain management and highly compensated eligible employees to defer up to this percentage of their variable incentive compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:to="lab_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_213219e8-458e-47a2-90ac-c90d5319ef0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_e7b540f9-809c-4d36-b92f-223b82fd1e2c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_0389ec0a-a2d3-4382-83f3-24af2548f960_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d16e7fd7-8ae8-41c8-a2f0-a7a4ecc67a59_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_7eeaa909-e6f4-4b42-bb4a-99a37d68c141_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Quest Diagnostics stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_a03f2d32-f611-4d35-96dd-25f9956b841f_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_b0cae27d-8e81-44be-87e6-e67be88d11ca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1920fa50-aa51-4561-9345-ba6b7434a60a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_aab2a7f3-221f-4048-9c5b-0e5d7380382e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued wages and benefits (including incentive compensation)</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c31e398-518b-415f-b544-7c0bf6da703e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6dd48aa2-529e-4d71-9891-8559c3e1e9a2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3a5ffdde-b9fa-4f89-95cb-1872e8541e15_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_bfb04d82-5114-47cf-be76-b07d4861c02f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of maximum annual wages witheld for the ESPP</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_b241be8e-1a0f-4aed-b5ea-30edd04f4d5a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_018b63ea-be40-43ee-ac7f-53c6027510a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_028318bb-8882-47ef-bf79-bf750f3fd534_negatedTerseLabel_en-US" xlink:label="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis differences in investments, joint ventures and subsidiaries</link:label>
    <link:label id="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_label_en-US" xlink:label="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments</link:label>
    <link:label id="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_documentation_en-US" xlink:label="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:to="lab_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_0335317b-a23a-4dda-8fb2-ff5fc1396499_terseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Earnings allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_72fbddca-9f6f-474c-901e-a271cf302201_negatedTerseLabel_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dgx-20201231.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MobileMedicalExaminationServicesInc.MedXMMember_1fbe4de0-ca71-4574-b70a-ca55a93b82ee_terseLabel_en-US" xlink:label="lab_dgx_MobileMedicalExaminationServicesInc.MedXMMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobile Medical Examination Services, Inc. (MedXM)</link:label>
    <link:label id="lab_dgx_MobileMedicalExaminationServicesInc.MedXMMember_label_en-US" xlink:label="lab_dgx_MobileMedicalExaminationServicesInc.MedXMMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobile Medical Examination Services, Inc. (MedXM) [Member]</link:label>
    <link:label id="lab_dgx_MobileMedicalExaminationServicesInc.MedXMMember_documentation_en-US" xlink:label="lab_dgx_MobileMedicalExaminationServicesInc.MedXMMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobile Medical Examination Services, Inc. (MedXM) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MobileMedicalExaminationServicesInc.MedXMMember" xlink:href="dgx-20201231.xsd#dgx_MobileMedicalExaminationServicesInc.MedXMMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MobileMedicalExaminationServicesInc.MedXMMember" xlink:to="lab_dgx_MobileMedicalExaminationServicesInc.MedXMMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_d6af4454-5281-4798-8441-c8bfaac49076_terseLabel_en-US" xlink:label="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% Senior Notes due January 2040</link:label>
    <link:label id="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_label_en-US" xlink:label="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Point Seven Five Percent Senior Notes Due2040 [Member]</link:label>
    <link:label id="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_documentation_en-US" xlink:label="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Point Seven Five Percent Senior Notes Due 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:href="dgx-20201231.xsd#dgx_FivePointSevenFivePercentSeniorNotesDue2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:to="lab_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0f9455b5-2c71-487d-baa5-7f2cd043ffdd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses (gains) on sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2e94b1a9-cfd6-4e5d-a436-3b41f86ad6d8_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_b87d16b7-9c12-4bf4-ab24-9ee15c96bad9_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4e1fec4d-dcad-44e4-9d7b-55e6c5081f87_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LongTermDebtMaturitiesGross_073acd2d-8987-4abd-b251-fb626cf1bc05_totalLabel_en-US" xlink:label="lab_dgx_LongTermDebtMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total maturities of long-term debt</link:label>
    <link:label id="lab_dgx_LongTermDebtMaturitiesGross_label_en-US" xlink:label="lab_dgx_LongTermDebtMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities Gross</link:label>
    <link:label id="lab_dgx_LongTermDebtMaturitiesGross_documentation_en-US" xlink:label="lab_dgx_LongTermDebtMaturitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date. May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and before deducting unamortized discount or premiums, if any.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LongTermDebtMaturitiesGross" xlink:href="dgx-20201231.xsd#dgx_LongTermDebtMaturitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LongTermDebtMaturitiesGross" xlink:to="lab_dgx_LongTermDebtMaturitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_925e966f-a0cc-41c3-98c3-b38ff4436fdb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_c0d85673-2d50-493a-8b2a-3ca9976d39eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_11baad54-168a-4f3f-8fc1-9fff54325df1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87febe54-c2d2-4351-8401-f43c6ac06fe0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aeb3467e-a177-4dd2-9851-a106eca94d12_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4f417cf1-8c49-4d66-9790-18a6c16f877b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current period other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_6de294a7-bed8-404f-a56b-4e73d5be8330_terseLabel_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP salary deferral</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_label_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Deferred Compensation Plan Salary Deferral</link:label>
    <link:label id="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_documentation_en-US" xlink:label="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of salary deferral under the Supplemental Deferred Compensation Plan. This plans is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to this percentage of their annual salary in excess of their defined contribution plan limits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanSalaryDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:to="lab_dgx_SupplementalDeferredCompensationPlanSalaryDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_1ff6a440-6c8a-47ac-93f1-a2f4ca3014cb_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_f8a56c4e-3ed7-456f-809a-64b8e92fafd3_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Lease By Asset Type</link:label>
    <link:label id="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Lease By Asset Type [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Lease By Asset Type [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfLeaseByAssetTypeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:to="lab_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1ad06525-2098-49ef-a363-7314beda4db8_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_66fa04d7-d625-4084-b856-79678894171d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3d563d86-88be-412a-be47-098bbd9d317a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_a241d492-e63c-4950-a2ce-978a5c60eccf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_200ce466-a29d-426a-9756-c3159372926f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income statement (income) expense</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_685bf8ce-3d52-4596-ad49-0bbb7bda1dbb_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_81fcae49-a079-4214-a21f-95d90fd74f69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_082ee372-8692-4a66-a82e-91199d3f60dc_terseLabel_en-US" xlink:label="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP</link:label>
    <link:label id="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_label_en-US" xlink:label="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP</link:label>
    <link:label id="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_documentation_en-US" xlink:label="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds in a trust pertaining to all participant deferrals and company matching amounts related to the Supplemental Deferred Compensation Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:href="dgx-20201231.xsd#dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:to="lab_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_d41ac2df-ec2c-451e-ab31-3c0f1b9c0dda_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b92e0962-4276-4d04-8536-e633a82f82a1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b9e1072b-e94a-4a9c-9223-fa3e597805d6_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quest Diagnostics stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e269f6b4-dc8d-4211-aff4-988a82248b3e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4f120d19-a026-4e20-9d49-d691624aef31_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_6de1d528-d133-4961-9800-516cb422e13d_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods_d98f7f56-1f0a-48a2-9929-540365b4b346_terseLabel_en-US" xlink:label="lab_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill adjustment</link:label>
    <link:label id="lab_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods_label_en-US" xlink:label="lab_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill related toprior period acquisitions, including purchase accounting adjustments recorded during subsequent periods</link:label>
    <link:label id="lab_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods_documentation_en-US" xlink:label="lab_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill related toprior period acquisitions, including purchase accounting adjustments recorded during subsequent periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" xlink:href="dgx-20201231.xsd#dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" xlink:to="lab_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NidMember_50facdad-aa98-4ca2-9215-c03d62b9ac63_terseLabel_en-US" xlink:label="lab_dgx_NidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NID</link:label>
    <link:label id="lab_dgx_NidMember_label_en-US" xlink:label="lab_dgx_NidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NID [Member]</link:label>
    <link:label id="lab_dgx_NidMember_documentation_en-US" xlink:label="lab_dgx_NidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NID [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NidMember" xlink:href="dgx-20201231.xsd#dgx_NidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NidMember" xlink:to="lab_dgx_NidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_b253e864-5255-4e22-96d6-e11c3cb38b39_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture</link:label>
    <link:label id="lab_us-gaap_CorporateJointVentureMember_label_en-US" xlink:label="lab_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateJointVentureMember" xlink:to="lab_us-gaap_CorporateJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_229762ea-8c21-45e2-93fa-4bc2da9eda39_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_ad8aba17-bced-433d-ae86-9f6ac3c549bf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_d7d553df-e5c0-44c4-bb8a-81a5010bad9e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_956247d7-2584-4b3e-bf72-3a5bdc1ba127_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RestructuringIntegrationCharges_4efb374b-e07c-43ed-b9b6-cb3a5a6f028e_terseLabel_en-US" xlink:label="lab_dgx_RestructuringIntegrationCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and integration charges</link:label>
    <link:label id="lab_dgx_RestructuringIntegrationCharges_label_en-US" xlink:label="lab_dgx_RestructuringIntegrationCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring &amp; Integration Charges</link:label>
    <link:label id="lab_dgx_RestructuringIntegrationCharges_documentation_en-US" xlink:label="lab_dgx_RestructuringIntegrationCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined restructuring and integration charges, which may include professional fees, incurred in connection with further restructuring and integrating the Company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestructuringIntegrationCharges" xlink:href="dgx-20201231.xsd#dgx_RestructuringIntegrationCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RestructuringIntegrationCharges" xlink:to="lab_dgx_RestructuringIntegrationCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_36f91a11-fb22-4372-898a-da84f7cdd3c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's expense for contributions to its defined contribution plans</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_56a8dac5-632a-4de4-9dce-811365552a86_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate, Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_49ef3c7e-317d-4288-85c0-7a3edacb07e9_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_2ca34dcd-ed60-416d-b21a-32362b69f910_verboseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_e6c04ab3-5112-4bba-8f06-62accdeba49e_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_6289e594-4e94-4ad1-ac37-e41e3d87ad99_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation in 2020</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_99c3229b-a402-4fae-9a85-f8ba45a5975c_verboseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Receivables Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_8bd2d135-a4fa-472e-8b06-b7e89a70d7a8_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_a69259af-396c-40bc-bcf1-ee909b85a7ed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_3976fadc-fef6-44ff-a4dd-19e76b547087_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsIncurred_88a76b96-dc6f-40dc-b581-e2c6e2f0a0fe_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsIncurred_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Obligation Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsIncurred" xlink:to="lab_us-gaap_CapitalLeaseObligationsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_08e5fa77-49ab-42a2-a031-5c1e7394d2ee_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_75acca4f-20e9-4354-a640-25f6673a65f3_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_f85ce2bf-3c84-4fdf-beaf-d7330da1b10f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_8248772e-6fdf-4ab6-8bc4-1453c6795d5b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of equity earnings</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_af8d1c4c-3a8f-42cd-b79f-600eba8323c3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a71e31cd-5400-4a00-842f-dbd989d71578_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_51e72174-437e-42f4-bf7d-d0b7a57a9407_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_d3771589-c7d4-4fc5-9559-dfe69da0e6c5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_991514ba-8aa4-4ae3-bfe1-a8796ba76113_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-operating expenses, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_6899badc-85cd-408f-ba94-d8c7c87a3e1a_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expenses, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_153c6f89-8a65-4163-ba6e-0e6e8cb04739_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items (Long-term debt)</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4ac05005-60aa-4fe2-bb1f-2677ae4d4317_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_a1618103-4a24-486c-9970-2a88153a0467_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_1b1373a8-8d8f-4a9e-9410-931163057021_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II vesting period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d52de553-3643-4c93-bbb3-a50f6c558b27_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred state and local income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_062d277c-4ef3-46b5-a373-f53df897be89_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Separation Costs</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d8018d7d-1375-4e56-b8d1-dc3753597c45_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_341cf2c6-f33e-4d27-9829-508143691bfa_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_9682dcc8-7871-44ec-b313-b0c92dc7a359_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations - domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_143b21dc-371b-41ef-8440-fd8985b6810c_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f19e8f4a-85aa-46e1-af45-7ca33670a484_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without readily determinable fair value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c37294b-413f-482e-834c-652b311002ca_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3da35e23-ab17-4852-9a2f-85df55def190_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_adab3e5a-aa26-4d03-a3c3-0b481683e6dc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_a6673dd0-c802-4fb2-9b2c-8c4e6842615b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c1527e12-7da7-40f3-add5-f391af6d5763_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialDataAbstract_84ce140a-840d-466b-bf9c-82104a842944_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialDataAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_52cf8867-fdf1-4f3d-a828-09dd3c7de2ed_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_ddc2058b-7ccd-4d16-9e4c-0a6c08031713_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e37cf59d-42e1-4ec7-b38c-04e5f90e6166_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember_161f4c3e-0c59-4290-9720-691230ffcfb5_terseLabel_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long-Term Incentive Plan (DLTIP) Amendment</link:label>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember_label_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long Term Incentive Plan Dltip Amendment [Member]</link:label>
    <link:label id="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember_documentation_en-US" xlink:label="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Director Long-Term Incentive Plan (DLTIP) Amendment (Member)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember" xlink:href="dgx-20201231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember" xlink:to="lab_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_0a7325f3-5404-4d92-8e5f-59d0b763cc0c_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6649bc40-2de5-4bb7-8e52-2ce829b05917_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_4a5d0638-aa0a-4e7e-aa5f-582cdd23f94d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete Agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_382cce54-9eb5-45bd-ba77-3046b3efa72b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax Benefits, interest on income taxes expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c2fa2e7c-2d1d-4d21-bfa7-cb7378ccc2e1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_0e9362bd-bf71-4891-892e-82d8d3b4a907_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_3ebc8b22-a62c-4445-92b5-3b1f095ce882_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_764c31e2-df16-423d-b4d8-7a5964cd103d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income recognized from related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_59ca7bfe-fcaa-4f7b-b64b-412cca1fcbac_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Derivatives:</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_b8047564-7e7c-43d6-a848-6c21ff44702f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c9f4c51c-4eb0-4070-ba9e-ddd5e38fe816_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization, intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_2eac3769-9969-4b6f-b576-5e88d5fe87b6_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_87aaf84a-72de-48ca-849b-f880db66aba4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_7e5fcc13-e6ac-48a3-aa76-0906090f2874_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_1a55889f-fbfd-47a0-90ba-738f858bca2c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_b028cceb-4cad-40f5-a1cd-d7d6a30d59a8_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_96be04cf-59e6-4294-bd88-5cb76741a485_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LeaseLiability_d9233e8a-44d4-473d-8fdd-1d98516d1f50_totalLabel_en-US" xlink:label="lab_dgx_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_dgx_LeaseLiability_label_en-US" xlink:label="lab_dgx_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_dgx_LeaseLiability_documentation_en-US" xlink:label="lab_dgx_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseLiability" xlink:href="dgx-20201231.xsd#dgx_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LeaseLiability" xlink:to="lab_dgx_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f4ac10fe-f680-4414-ac70-e5cbeb94977f_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_187f7d6e-f2c3-4c74-80b7-028291bdadb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_0838dcd9-b855-43b8-a2ac-fa88f847a275_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, January 1, 2020</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_6bc7991d-fe08-4cac-a355-370448d482db_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_bf4748c0-a1d6-40ea-8c6b-c8e757a1b9c0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockAwardsMember_c19a93a2-7529-4dd3-9fa1-5ae4d8fdaf91_terseLabel_en-US" xlink:label="lab_dgx_StockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards</link:label>
    <link:label id="lab_dgx_StockAwardsMember_label_en-US" xlink:label="lab_dgx_StockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards [Member]</link:label>
    <link:label id="lab_dgx_StockAwardsMember_documentation_en-US" xlink:label="lab_dgx_StockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement - Equity Instruments Other than Options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockAwardsMember" xlink:href="dgx-20201231.xsd#dgx_StockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockAwardsMember" xlink:to="lab_dgx_StockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_f276b780-1ecc-4b5f-b7ca-190a5439c5a0_terseLabel_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_label_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data [Line Items]</link:label>
    <link:label id="lab_dgx_SupplementalCashFlowAndOtherDataLineItems_documentation_en-US" xlink:label="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Supplemental Cash Flow and Other Data [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:href="dgx-20201231.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:to="lab_dgx_SupplementalCashFlowAndOtherDataLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8471a6f8-d873-400c-bbb6-8b997644b4f4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_89313c0a-0345-4976-83f7-b31833cd4159_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LoancommitmentmaturingOctober2021Member_ec2b4e0e-18e0-44cc-8a30-863c04f08a8f_terseLabel_en-US" xlink:label="lab_dgx_LoancommitmentmaturingOctober2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2021</link:label>
    <link:label id="lab_dgx_LoancommitmentmaturingOctober2021Member_label_en-US" xlink:label="lab_dgx_LoancommitmentmaturingOctober2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2021 [Member]</link:label>
    <link:label id="lab_dgx_LoancommitmentmaturingOctober2021Member_documentation_en-US" xlink:label="lab_dgx_LoancommitmentmaturingOctober2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan commitment maturing October 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoancommitmentmaturingOctober2021Member" xlink:href="dgx-20201231.xsd#dgx_LoancommitmentmaturingOctober2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LoancommitmentmaturingOctober2021Member" xlink:to="lab_dgx_LoancommitmentmaturingOctober2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_192ecafe-ec66-42cd-a334-57c5244d7070_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_687e2bab-0400-47d3-8aeb-7ac158ed85b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations - foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_42358ae7-e523-4125-be92-85e16b302216_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8a065302-c63e-4a35-a14f-6650da49be1d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d9b463c3-1257-49bf-ba59-4af53466e5c3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f646c622-89c4-48c3-b92e-081d614e8559_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_242b4e74-8f7d-4642-9cfe-0f5505590b6c_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_bb1fb546-357b-4f2a-9cdc-513bb2db9f6f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_79b3ecd7-ac90-48e7-ad73-69117eaaa93c_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e096f382-b621-48de-a403-0257f683c842_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_ca3bff08-04aa-44ef-a3e4-5b1fa75194e8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_957a6449-7e7d-4e99-845c-831cc19081b3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_5e6e1d3f-4e0f-4dc8-9518-8c9ff3e1eaa3_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6584b318-9ddb-4646-82a5-2b4f9dd8ea2b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_a4c62869-8957-4432-a4b6-77736e7464e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_3d3fa5c2-188c-4df9-b763-a936ed2fbca1_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_5223ca68-7407-4b18-a8d3-8ffa9850efcd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred gain on cash flow hedges, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_82775491-825d-47cd-93f5-bee134826a0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_bc0d256b-b9e6-4173-81fd-bd1ddad6b04c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_5f55ca5e-010a-4cfe-ba33-bda4f9b6752e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_1b6b57e0-f0b0-40df-ac00-fcef18c53090_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_53565027-83af-43a8-8cf9-91dd3e5ab2ee_terseLabel_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension period</link:label>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_label_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Extension Period</link:label>
    <link:label id="lab_dgx_DebtInstrumentExtensionPeriod_documentation_en-US" xlink:label="lab_dgx_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DebtInstrumentExtensionPeriod" xlink:to="lab_dgx_DebtInstrumentExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OperatingLeaseFixedAndVariableCost_b8b93bac-af8b-44bc-9de0-f42eb9076267_terseLabel_en-US" xlink:label="lab_dgx_OperatingLeaseFixedAndVariableCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_dgx_OperatingLeaseFixedAndVariableCost_label_en-US" xlink:label="lab_dgx_OperatingLeaseFixedAndVariableCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Fixed and Variable Cost</link:label>
    <link:label id="lab_dgx_OperatingLeaseFixedAndVariableCost_documentation_en-US" xlink:label="lab_dgx_OperatingLeaseFixedAndVariableCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Fixed and Variable Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingLeaseFixedAndVariableCost" xlink:href="dgx-20201231.xsd#dgx_OperatingLeaseFixedAndVariableCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OperatingLeaseFixedAndVariableCost" xlink:to="lab_dgx_OperatingLeaseFixedAndVariableCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_c0f669f4-271b-4ace-b4dd-afafb3dc6ed4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityLineItems_4fa53572-19b0-4488-b100-471bf067e22b_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityLineItems_label_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders' Equity [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityLineItems_documentation_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Shareholders' Equity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems" xlink:to="lab_dgx_ScheduleOfShareholdersEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge_1a2b8f04-de70-4ec0-8764-9a7a51dce3e2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged liability, cumulative increase (decrease)</link:label>
    <link:label id="lab_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge_label_en-US" xlink:label="lab_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred (Gain) Loss on Discontinuation of Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge" xlink:to="lab_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapeCodHealthcareInc.Member_772a0c01-73c5-4a24-a5dc-db587dbcb36f_terseLabel_en-US" xlink:label="lab_dgx_CapeCodHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cape Cod Healthcare, Inc.</link:label>
    <link:label id="lab_dgx_CapeCodHealthcareInc.Member_label_en-US" xlink:label="lab_dgx_CapeCodHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cape Cod Healthcare, Inc. [Member]</link:label>
    <link:label id="lab_dgx_CapeCodHealthcareInc.Member_documentation_en-US" xlink:label="lab_dgx_CapeCodHealthcareInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cape Cod Healthcare, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapeCodHealthcareInc.Member" xlink:href="dgx-20201231.xsd#dgx_CapeCodHealthcareInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapeCodHealthcareInc.Member" xlink:to="lab_dgx_CapeCodHealthcareInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_bac3bfe6-3120-47fb-813d-52da686d324a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0dc6ec2c-e076-4ed5-a93c-e88e02ed898f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_e505af85-4d29-4c08-b414-ef0060e440cd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f68f3767-451c-4004-b2cc-5421fda19d1e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_c8010884-8ad9-4ca0-8174-c04afcbec2c0_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_30211af3-35f9-4988-a873-caa34d9e254a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b0134a22-7af0-4ee9-9c5a-c726d28205e7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_75bea217-a495-4b22-8ce6-1ed8fd10ed8e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_acf65879-ee8a-463e-b364-3b16a39d2319_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities_258c0486-c135-4bd4-b209-f9492d0c90c4_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment, other assets and liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities_label_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets and Liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to other assets and liabilities acquired in connection with a business combination for which the initial accounting was incomplete.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" xlink:to="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_fcabcc9b-c5e3-4189-b6f3-dbd95860f39a_verboseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee separation costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_23dcd1ca-1b40-48a0-80d3-5320933f24d9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UMassJointVentureMember_3d1d21a6-b5fb-4a19-9699-d5e16312d2e6_terseLabel_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_label_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_documentation_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember" xlink:href="dgx-20201231.xsd#dgx_UMassJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UMassJointVentureMember" xlink:to="lab_dgx_UMassJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_9c38434e-b9d3-43c1-bf84-1753c30e22f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1c8b9db8-03b3-4356-9865-894827aa1c49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_bd2dfd86-1758-439b-96c6-3b71701f7c1d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d32f3f97-822a-4f5f-a5c7-1948a1273f43_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_bd951239-607a-4434-87a3-99cbe4ec544f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_52591b6e-36f3-472b-87b5-25dee17093de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_d42aa3b4-dea9-4c08-88af-9daa36b4564c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9d76f446-cbb6-4ba2-ae84-90cff9f094b3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum_17ca3986-1044-4605-966c-0d7076ce1989_terseLabel_en-US" xlink:label="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining terms of lease obligations, maximum</link:label>
    <link:label id="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum_label_en-US" xlink:label="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Terms of Contingent Lease Obligations, Maximum</link:label>
    <link:label id="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum_documentation_en-US" xlink:label="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Terms of Contingent Lease Obligations, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:href="dgx-20201231.xsd#dgx_RemainingTermsofContingentLeaseObligationsMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:to="lab_dgx_RemainingTermsofContingentLeaseObligationsMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0c4fc07d-aacb-4171-89f3-9b4212ac2121_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessAcquisitionPostacquisitionRevenue_5d66aac2-0c15-4cff-bb5f-3bac04c571a1_terseLabel_en-US" xlink:label="lab_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_dgx_BusinessAcquisitionPostacquisitionRevenue_label_en-US" xlink:label="lab_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Post-acquisition Revenue</link:label>
    <link:label id="lab_dgx_BusinessAcquisitionPostacquisitionRevenue_documentation_en-US" xlink:label="lab_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Post-acquisition Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:href="dgx-20201231.xsd#dgx_BusinessAcquisitionPostacquisitionRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:to="lab_dgx_BusinessAcquisitionPostacquisitionRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_d1ad37e3-c33d-4416-96db-6e25d844d255_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c89dbffc-f25f-4c24-ba01-fce3b69934c6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9cf60ce8-4ccf-4b6a-89b9-71e63bfb34d9_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_dcf1d06a-97ab-4495-8421-069619fe05a0_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_78f3a900-4e96-4dd5-bd8d-5f72ffa379b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_7cf75c67-f031-4369-b983-fac3c3352356_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4e6add6a-b1b2-410b-9ec2-3dda935c52c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current deferred tax liability - depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DebtInstrumentLeverageRatioRequirement_d3814b30-a185-4dc1-9771-2f0957f40653_terseLabel_en-US" xlink:label="lab_dgx_DebtInstrumentLeverageRatioRequirement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio requirement</link:label>
    <link:label id="lab_dgx_DebtInstrumentLeverageRatioRequirement_label_en-US" xlink:label="lab_dgx_DebtInstrumentLeverageRatioRequirement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio Requirement</link:label>
    <link:label id="lab_dgx_DebtInstrumentLeverageRatioRequirement_documentation_en-US" xlink:label="lab_dgx_DebtInstrumentLeverageRatioRequirement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio Requirement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentLeverageRatioRequirement" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentLeverageRatioRequirement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DebtInstrumentLeverageRatioRequirement" xlink:to="lab_dgx_DebtInstrumentLeverageRatioRequirement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_a1cc31c9-4d37-4dc6-864f-3d9f072db2aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AmortizationofIntangibleAssetsMember_5e5a5f85-7e66-45aa-8edb-94e26738add8_terseLabel_en-US" xlink:label="lab_dgx_AmortizationofIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_dgx_AmortizationofIntangibleAssetsMember_label_en-US" xlink:label="lab_dgx_AmortizationofIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets [Member]</link:label>
    <link:label id="lab_dgx_AmortizationofIntangibleAssetsMember_documentation_en-US" xlink:label="lab_dgx_AmortizationofIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmortizationofIntangibleAssetsMember" xlink:href="dgx-20201231.xsd#dgx_AmortizationofIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AmortizationofIntangibleAssetsMember" xlink:to="lab_dgx_AmortizationofIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_a23d0f73-a31d-46a3-aebe-8b8500a7c4d9_terseLabel_en-US" xlink:label="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance and Operating Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:label id="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance and Operating Lease Liabilities, Payments, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="dgx-20201231.xsd#dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_56db8613-7de1-4d14-a500-c80982db5ba9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7e7c93eb-c575-4119-b0ad-36ab95ee5d99_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ed28551a-88f1-4df0-920f-33956bbdc57a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetRevenues_85a75efe-404b-4fba-b514-27f02e753f21_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_25b031f0-a665-47a6-a6b3-a3f970c7829a_verboseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues from the DIS business</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_label_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_documentation_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetRevenues" xlink:to="lab_dgx_PercentageofNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_6784c687-ebc4-4fb5-aedf-8c15afc74298_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, additions and issuances</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_40dcd5b2-d403-402f-9ebe-a4969f39a2cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_4ad5fc57-493f-43ca-b2be-c1be634606ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes on Income</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_64e3cb2d-1812-4c94-bb57-3377f9d1414e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_62073f2b-a241-46e2-a3be-d5f7d0e1078b_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_f57708e5-4239-4b99-b6c5-ffd5551c1624_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional contributions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a2832c7f-ce6e-4436-8d93-4a0e44469c20_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_70b70426-748e-470e-8b25-bcd0a2d10234_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of year shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e433bf32-f63b-41a4-85bf-59f1da0002f3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase) decrease in investments and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_3f01a0b9-4844-47a9-a597-77fd5d3d8307_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_aa92e5d6-38c0-4572-9a1a-ed2f8279a708_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_98da01cc-4043-4c11-a96d-18bc08f1745b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55eb98af-66bd-413e-87d3-b606b6514047_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aec3c8f0-5434-4dcc-b79b-1cbbe4d53142_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_2493d6c3-3ab0-4952-8c02-8d0938e88e68_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_06b1ba43-b75f-497a-80db-f39f6f1d6ede_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_8ac1cdf9-7627-455e-933e-6fb71c5dae1c_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SdcpIiMember_dff98f6d-a431-4715-a9d2-f46b74c24441_terseLabel_en-US" xlink:label="lab_dgx_SdcpIiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II [Member]</link:label>
    <link:label id="lab_dgx_SdcpIiMember_label_en-US" xlink:label="lab_dgx_SdcpIiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sdcp Ii [Member]</link:label>
    <link:label id="lab_dgx_SdcpIiMember_documentation_en-US" xlink:label="lab_dgx_SdcpIiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiMember" xlink:href="dgx-20201231.xsd#dgx_SdcpIiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SdcpIiMember" xlink:to="lab_dgx_SdcpIiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_86d59007-17ac-4b0d-b34e-499b402ec735_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred foreign income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_5a30b62b-3a10-418b-974d-8b25bb33749d_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_1e59be59-f316-40e5-8d26-c35086d546f6_terseLabel_en-US" xlink:label="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_label_en-US" xlink:label="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities, Noncurrent</link:label>
    <link:label id="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:to="lab_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0f5a98e6-0177-4b62-a923-c64d109acdd7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities_6b13a239-1853-4b92-abd8-a53dc209316b_terseLabel_en-US" xlink:label="lab_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Termination of Derivative Instrument, Operating Activities</link:label>
    <link:label id="lab_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities_label_en-US" xlink:label="lab_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Termination of Derivative Instrument, Operating Activities</link:label>
    <link:label id="lab_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities_documentation_en-US" xlink:label="lab_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Termination of Derivative Instrument, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" xlink:href="dgx-20201231.xsd#dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" xlink:to="lab_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_a3da6a27-5da3-4777-804c-78c9000ca6fa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_bdf83b12-1e11-4631-b456-274ac1d81d21_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_87324fab-3729-48df-b3e0-c338b6b76471_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_34bf0272-45a6-40b6-a709-d9ed346acb64_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_2768e186-0dbc-4c2a-ac5f-7d1343a81e8d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_673b890b-b59f-48e5-8386-9eed272873bb_negatedTerseLabel_en-US" xlink:label="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value basis adjustments attributable to hedged debt</link:label>
    <link:label id="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_label_en-US" xlink:label="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, fair value basis adjustment attributable to hedged debt</link:label>
    <link:label id="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_documentation_en-US" xlink:label="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, fair value basis adjustment attributable to hedged debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:to="lab_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_InterestRateLockAgreementsMember_08295b3f-4a0b-449d-a39e-a2d81526b9ba_terseLabel_en-US" xlink:label="lab_dgx_InterestRateLockAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Lock Agreements</link:label>
    <link:label id="lab_dgx_InterestRateLockAgreementsMember_label_en-US" xlink:label="lab_dgx_InterestRateLockAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Lock Agreements [Member]</link:label>
    <link:label id="lab_dgx_InterestRateLockAgreementsMember_documentation_en-US" xlink:label="lab_dgx_InterestRateLockAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Lock Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InterestRateLockAgreementsMember" xlink:href="dgx-20201231.xsd#dgx_InterestRateLockAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_InterestRateLockAgreementsMember" xlink:to="lab_dgx_InterestRateLockAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_1657a651-2cf5-401f-a3de-1e6d313b9007_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Country</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_0c44ff2e-47b2-446a-bb39-8be15c0c96ac_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment and working capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_64628834-a140-4e7b-bee0-07e64090190c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_4f926ac7-6428-4e30-9916-dfb26e7cefec_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_093cdc10-a7ec-4ec8-8fb4-7ff1061d083e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4dad48ad-3ed1-47b3-9248-30e36621cde0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0274b8a9-6450-4ac8-a4a8-545bc44b2e99_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_be35368c-c96d-42c7-b9a1-9b3c02c655d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_d94af9b8-8ff2-406d-bf90-73423552dafe_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of year weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_7cf83428-82e0-41af-9e3b-94145f71bf2d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_211ca249-f31f-4680-8ab6-ccaacda73027_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_864e2b2e-1778-4dc5-8c6c-d9c9146117d3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c8af510c-d866-4249-913a-a4cca9a16547_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_60aac5c8-74f0-44e9-b13e-1f53d9ad3e7e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_3d61902c-dd2a-441a-863b-62d25b6b852b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5808961c-29be-4fd5-994d-36813e2b97d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_b74253f3-f539-4c06-915d-74d5f1dfd7c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c5338994-b962-4454-b5c1-f2ed62bbde43_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6f86b23f-a329-43e8-8d64-34e907729494_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_9f8bc305-1000-4ecf-8e04-3f8c6a5bb7ea_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_06fb1b71-c477-4cf0-b390-6b604a8be5d7_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Other</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member_18b3248a-f0e8-4ad4-98c8-2452c71c328b_terseLabel_en-US" xlink:label="lab_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.50% Senior Notes due March 2020</link:label>
    <link:label id="lab_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member_label_en-US" xlink:label="lab_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Five Zero Percent Senior Notes due March 2020 [Member]</link:label>
    <link:label id="lab_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member_documentation_en-US" xlink:label="lab_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Five Zero Percent Senior Notes due March 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member" xlink:href="dgx-20201231.xsd#dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member" xlink:to="lab_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_7ce03dfb-4e09-4dfb-8eca-2b9caba8ed55_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_01e24cf8-d3c0-475a-8fde-b2d07ed889d7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f30afe54-ce4b-43cf-be55-73088d2393a8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_d8bf3feb-71ac-4909-af77-954c3842927a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits on stock-based compensation arrangements</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AllotherservicesMember_20fce342-fe37-4a69-8354-d56d2790e253_terseLabel_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_label_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_documentation_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember" xlink:href="dgx-20201231.xsd#dgx_AllotherservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AllotherservicesMember" xlink:to="lab_dgx_AllotherservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_18c2bf91-5020-4658-a911-be8c0bde15ad_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquityinEarningsofEquityMethodInvesteesMember_1645599b-123d-4150-ab7a-a9b32dcb32f8_terseLabel_en-US" xlink:label="lab_dgx_EquityinEarningsofEquityMethodInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in Earnings of Equity Method Investees</link:label>
    <link:label id="lab_dgx_EquityinEarningsofEquityMethodInvesteesMember_label_en-US" xlink:label="lab_dgx_EquityinEarningsofEquityMethodInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in Earnings of Equity Method Investees [Member]</link:label>
    <link:label id="lab_dgx_EquityinEarningsofEquityMethodInvesteesMember_documentation_en-US" xlink:label="lab_dgx_EquityinEarningsofEquityMethodInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in Earnings of Equity Method Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityinEarningsofEquityMethodInvesteesMember" xlink:href="dgx-20201231.xsd#dgx_EquityinEarningsofEquityMethodInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquityinEarningsofEquityMethodInvesteesMember" xlink:to="lab_dgx_EquityinEarningsofEquityMethodInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_ebaf6c08-77ee-430b-89e4-9fd3ba3909a3_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW AND OTHER DATA</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_2fc32a37-8067-40e6-b3d7-4f638e3eae0a_terseLabel_en-US" xlink:label="lab_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="dgx-20201231.xsd#dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_072b2333-c879-470d-963d-4b5934a9ca96_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_174f99a4-02ff-4beb-b6aa-abbf102f09ee_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_36d409d3-09f4-4b71-8fdf-07596656a28a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_93832a1d-21da-4a59-904d-127a83e6b464_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Accounting Basis Adjustment</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_c675e4f9-865c-4311-9fb5-4af023d2fe14_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_73d0f556-f59e-4507-9c93-18d16b92e5b4_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MergerConsiderationPayableCurrent_27705bd4-ee7b-4dab-98e4-599709755abe_terseLabel_en-US" xlink:label="lab_dgx_MergerConsiderationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration payable</link:label>
    <link:label id="lab_dgx_MergerConsiderationPayableCurrent_label_en-US" xlink:label="lab_dgx_MergerConsiderationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Consideration Payable, Current</link:label>
    <link:label id="lab_dgx_MergerConsiderationPayableCurrent_documentation_en-US" xlink:label="lab_dgx_MergerConsiderationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Consideration Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MergerConsiderationPayableCurrent" xlink:href="dgx-20201231.xsd#dgx_MergerConsiderationPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MergerConsiderationPayableCurrent" xlink:to="lab_dgx_MergerConsiderationPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_53e5444c-e2d7-4524-8b63-e080b233dc09_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current federal tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_822a4476-2a38-4622-b2f5-5e6dde50df28_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8aa7e6d3-7b5c-4748-b9e8-51c5343fdcf6_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_06f8c0e9-2b16-4a35-b978-5359766d5bc2_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_90c164e6-faf7-4a7a-ad3a-4b2a0af9477b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_be1decea-c7b8-4cea-b4ac-3e0aa5ad677c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_1db6ece8-e20e-4c54-b1c8-73030c82b5f1_terseLabel_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70% Senior Notes due March 2045</link:label>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_label_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Zero Percent Senior Notes due March 2045 [Member]</link:label>
    <link:label id="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_documentation_en-US" xlink:label="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Seven Zero Percent Senior Notes due March 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:to="lab_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_032e49ae-9234-42f8-83f9-4182147c3ee9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_b0e20ec6-c09a-4dc1-b6b9-e193898db2e9_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5680a7af-443d-403d-bedb-65f827413061_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_586035c5-719a-4e17-9bb7-18d19690ead4_terseLabel_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIS business</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_label_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_documentation_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:href="dgx-20201231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:to="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_923896b0-7580-419d-a089-39b1cc3cba1c_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading equity securities gain or (loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4b6224a0-6a20-4e3c-abca-2df774251200_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at grant date (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_8ee59e49-f51a-46c2-85b5-08b988028f11_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_f27a4a34-c82f-4d86-ad7e-c18a789d4e54_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, related parties</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_dd699502-0535-4520-a6a1-a91097b00ecf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3942c288-a3f2-44b5-ab6f-023797919fce_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_cccdec9c-0663-4200-bda2-4ff50e81f21f_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_f7679dcd-6c04-49d1-8de3-814fa1ad170b_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_589354fa-bb54-466d-b385-27818390abd0_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a5e64fe6-ac26-4951-a3ba-8b0767ca975c_totalLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_752d5417-37a0-4155-8706-2d9f7180f1c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_142ea4f1-303f-4018-85b0-25225d73dcec_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LeaseRightofUseAsset_eb66b33a-8d0d-47c7-969e-3ef67ee2d711_totalLabel_en-US" xlink:label="lab_dgx_LeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease assets</link:label>
    <link:label id="lab_dgx_LeaseRightofUseAsset_label_en-US" xlink:label="lab_dgx_LeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_dgx_LeaseRightofUseAsset_documentation_en-US" xlink:label="lab_dgx_LeaseRightofUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRightofUseAsset" xlink:href="dgx-20201231.xsd#dgx_LeaseRightofUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LeaseRightofUseAsset" xlink:to="lab_dgx_LeaseRightofUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_fac245c6-d24c-4918-a43f-29f9b39f0a2a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DerivativeGainAmortizationPeriod_2e83feb5-f56d-4706-9775-6ee726aa48a5_terseLabel_en-US" xlink:label="lab_dgx_DerivativeGainAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_dgx_DerivativeGainAmortizationPeriod_label_en-US" xlink:label="lab_dgx_DerivativeGainAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Gain, Amortization Period</link:label>
    <link:label id="lab_dgx_DerivativeGainAmortizationPeriod_documentation_en-US" xlink:label="lab_dgx_DerivativeGainAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Gain, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DerivativeGainAmortizationPeriod" xlink:href="dgx-20201231.xsd#dgx_DerivativeGainAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DerivativeGainAmortizationPeriod" xlink:to="lab_dgx_DerivativeGainAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_06723ff4-f006-4b35-b883-759b45949d7a_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f8cceaeb-0a89-476e-9d77-83bb53cf0f20_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation cost weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_385ebab6-f723-412a-8569-6e943d8da7c9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_dc2159c7-fbb2-4769-b7f2-67e48130a6d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_c42b3997-c9b0-4b99-8442-888713254468_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d7e97e18-b6e0-4580-8b97-f78e188696f8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c465883d-e635-4116-9cfe-0852b4c0873f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_f4b48a40-7b33-4da7-81f5-7b1f54fe10a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_7952b345-9afb-4508-a0a1-15b3777af8b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Operating Results</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_3567a21f-23d4-41d6-a1f4-7357c8591261_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_5ee5b93c-1124-4c9c-9377-278dcde13498_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock value acquired cost method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_80b71414-9ce7-4504-837e-1a70cdf10936_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fix-to-variable interest rate swaps</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_5bc04159-235f-4bac-a71c-e5976b641a3b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_53cf109e-fca6-4cb1-a645-85fa5ea88207_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_ce8f8ba0-aeeb-488f-81dc-b7e06ab46d9c_terseLabel_en-US" xlink:label="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units with market-based relative TSR goal</link:label>
    <link:label id="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_label_en-US" xlink:label="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units with market-based relative TSR goal [Member]</link:label>
    <link:label id="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_documentation_en-US" xlink:label="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share units with market-based relative TSR goal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:href="dgx-20201231.xsd#dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:to="lab_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0bab288-a868-4e7f-9391-bdff0d1abb58_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_0a3b12b1-6485-4bd3-b74d-2b6db28ec2c7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_54282acc-03c8-4ee3-8659-6420eba231bb_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RevenueCollectionofConsiderationPeriod_80ffd2db-25c5-413b-8e1b-79df51221093_terseLabel_en-US" xlink:label="lab_dgx_RevenueCollectionofConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collection of consideration</link:label>
    <link:label id="lab_dgx_RevenueCollectionofConsiderationPeriod_label_en-US" xlink:label="lab_dgx_RevenueCollectionofConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Collection of Consideration Period</link:label>
    <link:label id="lab_dgx_RevenueCollectionofConsiderationPeriod_documentation_en-US" xlink:label="lab_dgx_RevenueCollectionofConsiderationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Collection of Consideration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueCollectionofConsiderationPeriod" xlink:href="dgx-20201231.xsd#dgx_RevenueCollectionofConsiderationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RevenueCollectionofConsiderationPeriod" xlink:to="lab_dgx_RevenueCollectionofConsiderationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_7ea792bb-6171-45bc-8126-0142ffeb4067_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Country</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_2cf74ad6-e355-4f03-a5dd-4434cecd14c1_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_9e5e6e5a-729a-4b03-a78b-d01f8b13b515_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FixedtovariableinterestrateswapMember_708e2de8-9e43-4fdc-b77d-644f19089a6f_terseLabel_en-US" xlink:label="lab_dgx_FixedtovariableinterestrateswapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-to-variable interest rate swap</link:label>
    <link:label id="lab_dgx_FixedtovariableinterestrateswapMember_label_en-US" xlink:label="lab_dgx_FixedtovariableinterestrateswapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-to-variable interest rate swap [Member]</link:label>
    <link:label id="lab_dgx_FixedtovariableinterestrateswapMember_documentation_en-US" xlink:label="lab_dgx_FixedtovariableinterestrateswapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed-to-variable interest rate swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FixedtovariableinterestrateswapMember" xlink:href="dgx-20201231.xsd#dgx_FixedtovariableinterestrateswapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FixedtovariableinterestrateswapMember" xlink:to="lab_dgx_FixedtovariableinterestrateswapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_84203f1f-5359-414a-bf7c-ff8f2cbe5522_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_448c0f35-6b73-4704-957c-8db7871e3bc3_terseLabel_en-US" xlink:label="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.50% Senior Notes due March 2025</link:label>
    <link:label id="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_label_en-US" xlink:label="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Five Zero Percent Senior Notes due March 2025 [Member]</link:label>
    <link:label id="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_documentation_en-US" xlink:label="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Point Five Zero Percent Senior Notes due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:href="dgx-20201231.xsd#dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:to="lab_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_InvigorateProgramMember_b22c813b-803b-4741-ac68-87e71cd8d867_terseLabel_en-US" xlink:label="lab_dgx_InvigorateProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invigorate Program</link:label>
    <link:label id="lab_dgx_InvigorateProgramMember_label_en-US" xlink:label="lab_dgx_InvigorateProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invigorate Program [Member]</link:label>
    <link:label id="lab_dgx_InvigorateProgramMember_documentation_en-US" xlink:label="lab_dgx_InvigorateProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invigorate Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvigorateProgramMember" xlink:href="dgx-20201231.xsd#dgx_InvigorateProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_InvigorateProgramMember" xlink:to="lab_dgx_InvigorateProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_d3ddc1f5-87e1-4d9d-942b-9d87d60a0a19_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesTable_becfb418-d754-4a29-85f3-0d5507af98a8_terseLabel_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dgx_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of significant accounting policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:href="dgx-20201231.xsd#dgx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_dgx_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod_a3b27c21-178b-4b5e-a599-53267fb03764_terseLabel_en-US" xlink:label="lab_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit associated with changes in tax return accounting method</link:label>
    <link:label id="lab_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod_label_en-US" xlink:label="lab_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit Associated with Changes in Tax Return Accounting Method</link:label>
    <link:label id="lab_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod_documentation_en-US" xlink:label="lab_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit Associated with Changes in Tax Return Accounting Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" xlink:href="dgx-20201231.xsd#dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" xlink:to="lab_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2a55ced4-d275-4585-8fb2-359849765800_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9a9fda55-076d-422f-936c-943b4107d46e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4cb16302-805d-4345-9fc6-a447ed7dc348_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_297bb922-89d4-403c-a478-a12ef6226cb7_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, rent expense</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense" xlink:to="lab_us-gaap_LeaseAndRentalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_015aff24-f0c4-48c1-903b-7375e1a5d2de_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Term and Discount Rate</link:label>
    <link:label id="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Term and Discount Rate [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Term and Discount Rate [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:href="dgx-20201231.xsd#dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:to="lab_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3a5d0852-b5a1-4e97-9036-f762c6b6483c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_8791b356-8664-4868-be81-741d5c9825f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_6d294d44-5f56-46f2-8dfb-787f580a0da2_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_4a165ffc-5292-4176-aacd-3ad6ba59012d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_13b039e8-fdfc-4e2b-8558-10ce5f5c98d2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_748cc0a8-9c07-48ac-ad39-61da8afc5dd1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ec77973d-46f7-49d2-9c00-1baf56778cff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_b1a1a7b4-225b-4b1a-aca3-ce1c95b4daea_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_6057d116-578d-450d-881c-6eb306b485eb_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_68c44cd0-3b5a-4ddd-bf5e-7336129101ed_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_5b76107e-cf99-48eb-84bf-53699f3bb527_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Federal Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_f5fe5910-1d45-4bb5-b406-50b35ae1b283_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deductions and other</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a3880cb4-6bb0-4f21-a2d2-31aaf29e0989_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_026c6ff3-cd0b-4b70-98b3-cfd332554ba4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b51e339c-9737-4b74-a509-daf162495308_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OtherEquityComponentsMember_06dbf82d-48a9-4e04-8ee8-380f72c04f69_terseLabel_en-US" xlink:label="lab_dgx_OtherEquityComponentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dgx_OtherEquityComponentsMember_label_en-US" xlink:label="lab_dgx_OtherEquityComponentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Equity Components [Member]</link:label>
    <link:label id="lab_dgx_OtherEquityComponentsMember_documentation_en-US" xlink:label="lab_dgx_OtherEquityComponentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Equity Components [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherEquityComponentsMember" xlink:href="dgx-20201231.xsd#dgx_OtherEquityComponentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OtherEquityComponentsMember" xlink:to="lab_dgx_OtherEquityComponentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_b84e7ebe-499a-4486-b910-00cf075723e0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_3a781475-3182-4a56-bc64-f55003d23bdf_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_18ac0072-9c4c-4fc9-982f-0fb61e53dc4d_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_01d09a38-e8f6-417d-b957-a8c389df9e13_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1e8bf87f-d1cf-4dc4-a263-103d192d21b0_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_35064a7b-e91b-4bcf-a3d8-fcdbdf79a2ec_terseLabel_en-US" xlink:label="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryfowards, net of valuation allowance</link:label>
    <link:label id="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_label_en-US" xlink:label="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryfowards, net of valuation allowance</link:label>
    <link:label id="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_documentation_en-US" xlink:label="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:href="dgx-20201231.xsd#dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:to="lab_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OperatingandFinanceLeaseLiability_6f820b0f-541d-4ca7-a2f3-f72c21b2655c_totalLabel_en-US" xlink:label="lab_dgx_OperatingandFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_dgx_OperatingandFinanceLeaseLiability_label_en-US" xlink:label="lab_dgx_OperatingandFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating and Finance Lease, Liability</link:label>
    <link:label id="lab_dgx_OperatingandFinanceLeaseLiability_documentation_en-US" xlink:label="lab_dgx_OperatingandFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lessee's discounted obligation for lease payments from operating and finance leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingandFinanceLeaseLiability" xlink:href="dgx-20201231.xsd#dgx_OperatingandFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OperatingandFinanceLeaseLiability" xlink:to="lab_dgx_OperatingandFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_COVID19TestingServicesMember_f7114a68-fb57-4c81-a0b5-17d60fd82d2a_terseLabel_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 testing services</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_label_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services [Member]</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_documentation_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember" xlink:href="dgx-20201231.xsd#dgx_COVID19TestingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_COVID19TestingServicesMember" xlink:to="lab_dgx_COVID19TestingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_11751bb2-5b6b-4064-a997-43d28aa95c9e_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_5863f640-7119-4739-ac2e-bf61241321d4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_994ddd84-3504-49a0-aa5c-a9a0ce81c755_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_befc52d0-d569-4fd2-a791-7215eaf5a1f2_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_77c05541-3c30-4078-a533-0b3121056cb5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityTable_075cab53-2293-407c-bd98-c14128e869b0_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders' Equity [Table]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityTable_label_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders' Equity [Table]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareholdersEquityTable_documentation_en-US" xlink:label="lab_dgx_ScheduleOfShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shareholders' Equity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable" xlink:to="lab_dgx_ScheduleOfShareholdersEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_5a95a91b-8d3d-4197-85bf-d9edb73de171_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5393b51d-fb8a-4562-8fcd-4003fbab7377_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended company match percentage of employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_dfe4ce2a-57f3-4610-993e-309758464927_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_55c77a95-a6d5-4304-a5a7-edd7bee10b5d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_9a0b3e10-354f-4c3f-8be0-1cac4cb7bb4d_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_9e976756-d982-467b-aab4-d974426847a4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount_05f91494-3fe4-43c3-b454-6c928ae0ccbe_terseLabel_en-US" xlink:label="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:label id="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount_label_en-US" xlink:label="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:label id="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount_documentation_en-US" xlink:label="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, excess tax benefit, amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:href="dgx-20201231.xsd#dgx_Sharebasedcompensationexcesstaxbenefitamount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:to="lab_dgx_Sharebasedcompensationexcesstaxbenefitamount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ContractRelatedMember_ee18266f-dbc4-4efc-948f-342f48d015ac_terseLabel_en-US" xlink:label="lab_dgx_ContractRelatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Related</link:label>
    <link:label id="lab_dgx_ContractRelatedMember_label_en-US" xlink:label="lab_dgx_ContractRelatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Related [Member]</link:label>
    <link:label id="lab_dgx_ContractRelatedMember_documentation_en-US" xlink:label="lab_dgx_ContractRelatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract-Related [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractRelatedMember" xlink:href="dgx-20201231.xsd#dgx_ContractRelatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ContractRelatedMember" xlink:to="lab_dgx_ContractRelatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_986f63a3-ed53-40f0-b58e-d7d34e575c82_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SdcpIiGradedVestingPercentage_227bb675-fb70-459e-9663-f3233bb8d7c7_terseLabel_en-US" xlink:label="lab_dgx_SdcpIiGradedVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II graded vesting percentage</link:label>
    <link:label id="lab_dgx_SdcpIiGradedVestingPercentage_label_en-US" xlink:label="lab_dgx_SdcpIiGradedVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II graded vesting percentage</link:label>
    <link:label id="lab_dgx_SdcpIiGradedVestingPercentage_documentation_en-US" xlink:label="lab_dgx_SdcpIiGradedVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SDCP II graded vesting percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiGradedVestingPercentage" xlink:href="dgx-20201231.xsd#dgx_SdcpIiGradedVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SdcpIiGradedVestingPercentage" xlink:to="lab_dgx_SdcpIiGradedVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_948ff9ad-fcac-4bb0-9f44-0d1f5922ef0e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_3e079b79-4d1f-42d5-af5f-711b5bd603b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_ec10d7dd-b06c-4332-8e2f-be3dcbb69946_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_75163343-426b-4eef-b8b9-a7bd7f10fd9b_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses, net</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2d806fc3-4b37-4857-965b-2f6eff9d15d3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_ca47324e-1e56-41c9-b599-82b83714b8f9_terseLabel_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_label_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services [Member]</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_documentation_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember" xlink:href="dgx-20201231.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RoutineclinicaltestingservicesMember" xlink:to="lab_dgx_RoutineclinicaltestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_428f3d4b-f295-41d9-8543-0d4f1bb1e256_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_91fe6098-af6c-4f06-9fe9-c4e9588bfe7e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_f8678c2d-819c-4228-81e3-845ca920a986_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_c594e3ed-cec4-4b08-8fc9-dd003de0d269_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_20593e0c-c52a-4898-8a47-ea5518bddc63_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance reserves</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_005bc6e9-df5b-43bc-abe3-60be44d6300e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_33be9e52-158a-48e8-92f8-86f228082183_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_37793c5a-c0fb-4b63-ab30-672b8e477257_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxes" xlink:to="lab_us-gaap_AccruedIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_dd33e922-5dde-4243-8140-038d2d6025fa_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3d198e7a-e8b5-4793-baa8-bc1f01c6d095_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0e86a27e-c701-4b9c-8dc5-7392605a77eb_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_cd7b4e58-40a6-4ddb-89a2-9806c9057446_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5e3cf422-6a24-4769-a250-27ef709e0571_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Transactions Under The Company's Stock Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7fafe7e2-7c87-4369-b173-82ef11bf6187_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_1b3933b6-0816-458b-bebd-57db30d0511e_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_ccf1ac78-5277-4c55-b35e-d615be30218f_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_label_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</link:label>
    <link:label id="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:to="lab_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_65f96cd9-53d3-4649-86ad-52c273523049_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current foreign income tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_169897c0-42e7-4564-b7d1-be2b68141858_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_3cfa6ab9-5aae-422d-96df-aa402ad60b4a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_08f93ef7-7d91-467e-861d-f8bd1f0c6b91_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_dd49e5ee-7c9e-4df6-b5ed-a5560f3bf79a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposition of property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3550362c-a228-4636-b02a-04afbb062d8d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross excluding goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b576e081-e191-4412-a590-5db83f1c940e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration arrangements</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_071aa29c-dd3c-4fb5-99c0-2f6eb213ec55_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration arrangements</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_378375b1-0ac8-4325-9170-e6380546433b_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant change in unrecognized tax benefits is reasonably possible, estimated range of change, upper bound</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_428656e3-ec70-4c47-9217-a7ae45611d4f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation arrangement with individual, employer contribution</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e13510eb-fb58-43d3-8c06-d599c8dd26a1_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtfull accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_025ea2d8-7b6f-4812-a410-35e0df0b844a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_d42bdaa3-2d32-4ffc-8fa0-1f951b632dd1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $28 and $15 as of December&#160;31, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d7808fb3-c132-4ae0-b81e-b4d3cedf9862_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_aa84732b-c23e-4ac4-8c12-f88259bc6f94_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, interest on income taxes accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_bbee296a-92d0-47e2-bec7-d6e2670d461c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_769a3145-fcd2-41e5-8186-faf3205c7bdf_terseLabel_en-US" xlink:label="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on settling uncertain tax benefits</link:label>
    <link:label id="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_b0359af5-3015-42f2-9b5f-87482f80ffce_negatedTerseLabel_en-US" xlink:label="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on settling uncertain tax benefits</link:label>
    <link:label id="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_label_en-US" xlink:label="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain on Settling Uncertain Tax Benefits</link:label>
    <link:label id="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_documentation_en-US" xlink:label="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain on Settling Uncertain Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:href="dgx-20201231.xsd#dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:to="lab_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_55867986-eaa0-410a-b02a-40a22990b82c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_bb26953d-5358-4134-b14c-cad4ccf5dee7_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_9af84b80-8baa-473e-87d8-22e250131eda_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3fa2720d-2184-4027-beb2-357e09c898d8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_9e86ef50-3238-4beb-a73e-862fd4bf98a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, related parties</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableRelatedParties" xlink:to="lab_us-gaap_AccountsReceivableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2213e72e-76fd-4962-8fcd-60e86257b54c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GovernmentPayersMember_b40a5e1a-5d3d-4867-a805-f200430d423a_terseLabel_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government payers</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_label_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_documentation_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember" xlink:href="dgx-20201231.xsd#dgx_GovernmentPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GovernmentPayersMember" xlink:to="lab_dgx_GovernmentPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_f14bbec0-e68e-4c3a-bbd2-22c1579c6ef7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_25933fc9-8e6d-4311-9951-ad52623e92f4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c5a4cdc9-45c7-4283-9c6a-dbb219528f23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of year shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_5ab6d953-883a-43b7-8adc-aa22ee0d4288_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_24744be5-4faa-4037-a9e2-e729cb2012d6_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction_ffce8036-04d3-4e0c-9d83-01a83f69c665_terseLabel_en-US" xlink:label="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement to outsource billing and collection function</link:label>
    <link:label id="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction_label_en-US" xlink:label="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement to Outsource Billing and Collection Function</link:label>
    <link:label id="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction_documentation_en-US" xlink:label="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement to Outsource Billing and Collection Function</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:href="dgx-20201231.xsd#dgx_AgreementtoOutsourceBillingandCollectionFunction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:to="lab_dgx_AgreementtoOutsourceBillingandCollectionFunction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_356220f0-d4ca-4c4c-92f3-c1b8fbfec8a6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dae74156-3454-4e2d-bbbd-095559032e30_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected holding period, in years</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c781a9fa-2d1b-42ca-9546-ef1fcc23a871_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_add3e0f2-0220-470b-b0f1-e0db97877d31_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term, Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_120c0e5a-674e-4de0-a482-e85970f971eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from discontinued operations, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d5c88406-1f71-40d7-a907-b35bbd0cb343_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_059e5f01-af77-4d91-8d42-b50dbe566517_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_33cc0955-a85e-458f-b77c-ee36d1219c6c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Changes in Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_28d590ed-6855-4572-929b-f606e2a6cc45_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, discount rate used to determine fair value</link:label>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_label_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value</link:label>
    <link:label id="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:to="lab_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_51efb4f6-5d4f-4d0e-9f30-5eae76481e97_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_72f0a9a3-683b-4ce9-b649-50d6f7753386_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:href="dgx-20201231.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:to="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_8e008801-e905-4cb3-8fd1-79b12c92b24b_terseLabel_en-US" xlink:label="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in quarterly dividends as percent</link:label>
    <link:label id="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_label_en-US" xlink:label="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Common Stock, Dividends, Declared as Percent</link:label>
    <link:label id="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_documentation_en-US" xlink:label="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Common Stock, Dividends, Declared as Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:href="dgx-20201231.xsd#dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:to="lab_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_06880fd0-8416-45a6-a06e-baa7ea4ab454_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ebdffec0-eb30-42b8-9fe0-e923eae3924f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_bb071d1d-bdb1-4a95-aa43-18a6c2d0c02f_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_aeca0fc7-679b-4498-aeb7-d6f8a83652cc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of year aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_08384cae-d75b-4c12-b81a-0338f7526705_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit related to stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_917f6503-f8b9-4230-aadb-295d4ba2bc24_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ForwardStartingInterestRateSwapsMember_69448eaa-85c7-4ddb-a2a7-b643b18c80e1_terseLabel_en-US" xlink:label="lab_dgx_ForwardStartingInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Starting Interest Rate Swaps</link:label>
    <link:label id="lab_dgx_ForwardStartingInterestRateSwapsMember_label_en-US" xlink:label="lab_dgx_ForwardStartingInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Starting Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_dgx_ForwardStartingInterestRateSwapsMember_documentation_en-US" xlink:label="lab_dgx_ForwardStartingInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Starting Interest Rate Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForwardStartingInterestRateSwapsMember" xlink:href="dgx-20201231.xsd#dgx_ForwardStartingInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ForwardStartingInterestRateSwapsMember" xlink:to="lab_dgx_ForwardStartingInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5cf8a8fb-4007-43b3-a6d3-caa3987330d4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans, sharers</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_3f397010-cc06-464a-8a46-b37955811036_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_07389039-2580-4bcb-91c0-c490b342e34f_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Benefits</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_30267b63-e45d-4222-b066-95d658f918c4_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_e9839e6d-80da-416d-9e35-b2e8082481a5_terseLabel_en-US" xlink:label="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation in 2021 through 2022</link:label>
    <link:label id="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_label_en-US" xlink:label="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years</link:label>
    <link:label id="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_documentation_en-US" xlink:label="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:href="dgx-20201231.xsd#dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:to="lab_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fa680340-8af2-4078-93be-68743a9ddbb4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value at grant date (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_54b9435b-98f3-4ce6-a9c2-333609a779f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HealthcareInsurersMember_b5cf4aab-0ee5-4562-a144-bafb290b154b_terseLabel_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare insurers:</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_label_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_documentation_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember" xlink:href="dgx-20201231.xsd#dgx_HealthcareInsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HealthcareInsurersMember" xlink:to="lab_dgx_HealthcareInsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_dffe2835-00fc-4dde-b36a-edd428875dbd_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_ea0b72f1-0736-4fc8-8ad1-98b76b0bb576_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_db0459b0-7b52-4b8b-9fe4-4a035a138ccf_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_299aa690-1270-4857-bcdc-79457a011527_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_QuarterlyFinancialDataLineItems_02c5aa44-6451-48bd-8c5d-2162abc4e332_terseLabel_en-US" xlink:label="lab_dgx_QuarterlyFinancialDataLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Line Items]</link:label>
    <link:label id="lab_dgx_QuarterlyFinancialDataLineItems_label_en-US" xlink:label="lab_dgx_QuarterlyFinancialDataLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Line Items]</link:label>
    <link:label id="lab_dgx_QuarterlyFinancialDataLineItems_documentation_en-US" xlink:label="lab_dgx_QuarterlyFinancialDataLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_QuarterlyFinancialDataLineItems" xlink:href="dgx-20201231.xsd#dgx_QuarterlyFinancialDataLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems" xlink:to="lab_dgx_QuarterlyFinancialDataLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_01e443fe-e2a8-4586-b052-e641657b672f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_e249310b-21a2-4db2-9d40-49d1a1de9c85_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_c60d6dea-a2a6-4c8a-a55a-58a4ed7c8c15_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_ca424dad-9e73-4b16-a2fb-d7259fec1ab5_terseLabel_en-US" xlink:label="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum)</link:label>
    <link:label id="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_label_en-US" xlink:label="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) [Member]</link:label>
    <link:label id="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_documentation_en-US" xlink:label="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:href="dgx-20201231.xsd#dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:to="lab_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ef805114-8e84-40b4-a051-f10805fc56e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_64fb4c2e-1427-4c9b-b89f-fd0f2b459448_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_7c4cc22c-f798-4e5a-820c-170284fd8fbc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3b8e48cc-26f0-47c4-b61f-087821c972cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f8c9c1a9-005b-4e63-9a03-6b725522cdea_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated net loss from designated or qualifying cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16a315ea-9991-4f76-a540-fbeb1b3c3419_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bc93346d-cb47-42e2-8e90-d93a5a42f914_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_af6e07d9-6a90-4791-a743-f5835f4d6099_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAXES ON INCOME</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes_7d92c247-faac-4760-9245-03d84735d051_terseLabel_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes_label_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Taxes</link:label>
    <link:label id="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes_documentation_en-US" xlink:label="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" xlink:to="lab_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_dffe32ba-7d24-41c7-82ad-6ee525cf9ca8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for expirations of statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_eb493d6b-e7f3-48ce-9914-14619c38d555_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_2ca78bc1-577d-4004-8ca0-b28c629f4d39_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility-related costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_50cd4f70-1e5c-4c20-ba4e-bf8f7bd13069_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units not included due to their antidilutive effect</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_3f515404-78d2-4ee7-8431-6a19b4a21e95_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term,Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_406cf2b8-f291-4451-b3f3-c4e92950889e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_f44deb01-fae7-4860-84f9-6d065b51f54b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_91a9fd6a-3899-475e-b5c0-be92b4bb9cba_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e060bc91-248c-4de2-b567-c8633703343a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_35adc224-f1b4-4cf7-a2ad-483c11667d6f_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_02fd912c-1d23-44bb-b710-8ac5425d73ea_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_4088b710-8189-404d-84f0-5abd3836ec30_terseLabel_en-US" xlink:label="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_label_en-US" xlink:label="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment without Readily Determinable Fair Value, Impairment</link:label>
    <link:label id="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_documentation_en-US" xlink:label="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment without Readily Determinable Fair Value, Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:href="dgx-20201231.xsd#dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:to="lab_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c043d27b-8062-4808-a262-6b399e03312c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in available-for-sale debt securities, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_2b99e811-030a-4c66-bbae-6e7f506b5696_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_385503b5-e58f-4fe9-a2b3-5ef6a3a0aa8c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_68a83c78-f674-401a-8286-6e4f24067d36_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_69c3a773-2eca-4c08-ae2d-76b9f0096c2b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_ca975da6-ea30-434b-8f5f-23eef2284250_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ebd6c1e3-df29-468c-a802-8b2b25805929_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_fdde2d61-cf51-49b9-b52f-0350a5de8c12_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK OWNERSHIP AND COMPENSATION PLANS</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8d2120da-b44e-4eaf-ab0a-441e67c75330_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7e14eaff-8646-4314-957e-5c426d818122_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_32d6f99f-67a7-44ea-b318-0238893bf527_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_dfd7f122-34cc-4173-aaef-bd723dae51a9_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f15632a1-0b87-472e-852c-3b4020bc8b12_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2f33c842-caff-4de4-9587-35ac3d0400e3_totalLabel_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_documentation_en-US" xlink:label="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MemorialHermannMember_ae6c206e-b02c-4a8d-8c35-05a8119e217f_terseLabel_en-US" xlink:label="lab_dgx_MemorialHermannMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Memorial Hermann</link:label>
    <link:label id="lab_dgx_MemorialHermannMember_label_en-US" xlink:label="lab_dgx_MemorialHermannMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Memorial Hermann [Member]</link:label>
    <link:label id="lab_dgx_MemorialHermannMember_documentation_en-US" xlink:label="lab_dgx_MemorialHermannMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Memorial Hermann [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MemorialHermannMember" xlink:href="dgx-20201231.xsd#dgx_MemorialHermannMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MemorialHermannMember" xlink:to="lab_dgx_MemorialHermannMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_11c1dd6a-6657-4e50-96f3-adea3323a77b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_5cc8dd33-9bed-4316-8416-5b309eb05ec4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2df8ca5e-c3c0-4247-bf47-2423049403a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_45cd1dab-5a94-446b-8041-e46efbf4855b_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used in Valuing The Company's Performance Share Units</link:label>
    <link:label id="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:to="lab_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a6071a93-6ce4-4cbb-8de9-0631be7f76da_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1379c8a9-73f7-47b0-bd76-f6d517f47274_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FeeforserviceMember_2ecc037d-4953-48d6-9155-a00d3136d7a7_terseLabel_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_label_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_documentation_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember" xlink:href="dgx-20201231.xsd#dgx_FeeforserviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FeeforserviceMember" xlink:to="lab_dgx_FeeforserviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_f4925025-9323-444e-a4d2-8c333b67065b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_029f0341-5cac-4a62-bea9-aeb2ed7ba697_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased by eligible employees under ESPP</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_225cc230-d20f-4b62-bb2c-ecbe56fba7c8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_a0da49bf-4185-4269-85d3-6afc87ef3a08_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_94cf54fb-ee6f-411b-8e82-7d53e9ccf700_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Credit Loss [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossMember" xlink:to="lab_us-gaap_AllowanceForCreditLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_85db6c03-4dc4-4d84-af2b-783ac9bce4e2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_235e2952-0273-4381-9676-9681119f890f_terseLabel_en-US" xlink:label="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% Senior Notes due April 2024</link:label>
    <link:label id="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_label_en-US" xlink:label="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four point two five percent Senior Notes Due 2024 [Member]</link:label>
    <link:label id="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_documentation_en-US" xlink:label="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four point two five percent Senior Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:href="dgx-20201231.xsd#dgx_FourpointtwofivepercentSeniorNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:to="lab_dgx_FourpointtwofivepercentSeniorNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TreasuryStockValueAcquiredCostMethod1_61e02159-866c-4724-b040-a5e22893a458_terseLabel_en-US" xlink:label="lab_dgx_TreasuryStockValueAcquiredCostMethod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual</link:label>
    <link:label id="lab_dgx_TreasuryStockValueAcquiredCostMethod1_label_en-US" xlink:label="lab_dgx_TreasuryStockValueAcquiredCostMethod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method1</link:label>
    <link:label id="lab_dgx_TreasuryStockValueAcquiredCostMethod1_documentation_en-US" xlink:label="lab_dgx_TreasuryStockValueAcquiredCostMethod1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockValueAcquiredCostMethod1" xlink:href="dgx-20201231.xsd#dgx_TreasuryStockValueAcquiredCostMethod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TreasuryStockValueAcquiredCostMethod1" xlink:to="lab_dgx_TreasuryStockValueAcquiredCostMethod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_e7339afe-573f-419d-9bda-2917148e490a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_ee242aaa-04c4-4e42-b8de-9f417897d7d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_576717be-0479-4a38-87c4-77ebbc39ddc0_terseLabel_en-US" xlink:label="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Senior Notes due June 2030</link:label>
    <link:label id="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_label_en-US" xlink:label="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Nine Five Percent Senior Notes due June 2030 [Member]</link:label>
    <link:label id="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_documentation_en-US" xlink:label="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Point Nine Five Percent Senior Notes due June 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:href="dgx-20201231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:to="lab_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_2432d2b3-d777-486a-af2f-f113abebcfba_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_0f1f0d1f-8844-4608-b2ed-7456348a0918_terseLabel_en-US" xlink:label="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</link:label>
    <link:label id="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_b2510d21-e2f5-40dc-86c8-e324be3f3a7b_verboseLabel_en-US" xlink:label="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</link:label>
    <link:label id="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_label_en-US" xlink:label="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Reclassification of Stranded Tax Effects from AOCI to Retained Earnings</link:label>
    <link:label id="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_documentation_en-US" xlink:label="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Reclassification of Stranded Tax Effects from AOCI to Retained Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" xlink:href="dgx-20201231.xsd#dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" xlink:to="lab_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_eb1c0734-1bd3-4cd5-9d86-6a320485ae5c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_7620052e-d496-4f2e-9a62-632e07d9c5f0_terseLabel_en-US" xlink:label="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price of company stock issued at a discount under the ESPP</link:label>
    <link:label id="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_label_en-US" xlink:label="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price of Company stock issued at a discount under the ESPP</link:label>
    <link:label id="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_documentation_en-US" xlink:label="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Element represents the discounted market value of the Company stock on offering date or purchase date that participants pay for shares. Typically, the participant's per share cost is the lower of the prices on the two dates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:href="dgx-20201231.xsd#dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:to="lab_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_8d6e998b-5f10-45e6-a1c9-d1436c13b47b_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_47010151-5b49-4695-9dea-0f8c9b43fbe5_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_ac33dcf8-b559-40d6-a3e0-def1029cc368_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of year aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_de5dfbe3-95f1-4d38-9991-7208db4d1102_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentsAbstract" xlink:to="lab_us-gaap_DebtInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_4d7f0aa6-fac7-4830-b3f6-e7b0ccb55499_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_5b30e160-e414-4325-8b1b-c0f7bd7b40c7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Transactions Under Stock Awards Other than Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_4b6ac32f-3c0e-4844-9a63-eb3287438af6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_6fbb57aa-11e4-4307-8bce-30deeda1baa1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PreTaxGainLossDueToCOVID19_c95624a7-3920-4cf8-a888-8d65d8cc3f24_terseLabel_en-US" xlink:label="lab_dgx_PreTaxGainLossDueToCOVID19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gain (loss) due to COVID-19</link:label>
    <link:label id="lab_dgx_PreTaxGainLossDueToCOVID19_label_en-US" xlink:label="lab_dgx_PreTaxGainLossDueToCOVID19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax Gain (loss) due to COVID-19</link:label>
    <link:label id="lab_dgx_PreTaxGainLossDueToCOVID19_documentation_en-US" xlink:label="lab_dgx_PreTaxGainLossDueToCOVID19" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax Gain (loss) due to COVID-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PreTaxGainLossDueToCOVID19" xlink:href="dgx-20201231.xsd#dgx_PreTaxGainLossDueToCOVID19"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PreTaxGainLossDueToCOVID19" xlink:to="lab_dgx_PreTaxGainLossDueToCOVID19" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_a7dc8feb-3f7d-4b09-8d65-94a2dbd3dce8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c82bc4d3-b01c-49ea-9d37-b4f487489475_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OxfordImmunotecInc.Member_5566fd77-2ec6-42d8-b991-cbe42b28fe4f_terseLabel_en-US" xlink:label="lab_dgx_OxfordImmunotecInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oxford Immunotec, Inc.</link:label>
    <link:label id="lab_dgx_OxfordImmunotecInc.Member_label_en-US" xlink:label="lab_dgx_OxfordImmunotecInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oxford Immunotec, Inc. [Member]</link:label>
    <link:label id="lab_dgx_OxfordImmunotecInc.Member_documentation_en-US" xlink:label="lab_dgx_OxfordImmunotecInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oxford Immunotec, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OxfordImmunotecInc.Member" xlink:href="dgx-20201231.xsd#dgx_OxfordImmunotecInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OxfordImmunotecInc.Member" xlink:to="lab_dgx_OxfordImmunotecInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_96e1e643-a959-4873-bfd6-872d2f277271_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_64a5ac34-0a53-4ae1-8d80-603f7bfe8de8_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_43299752-4495-4349-8191-b7b2f4f8ccf7_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate in excess of LIBOR</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_878e9b9c-1e25-4f81-95ee-5b30fdb23200_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate in excess of LIBOR</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3ef1d2e9-6d5c-47f2-81a2-2ced720dbc94_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_8e3a108c-90a6-415d-a960-416f8a28d0fe_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofReceivablesDueFromPatients_61450999-481b-41c2-a241-3346613dbf9d_terseLabel_en-US" xlink:label="lab_dgx_PercentageofReceivablesDueFromPatients" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of receivables due from patients</link:label>
    <link:label id="lab_dgx_PercentageofReceivablesDueFromPatients_label_en-US" xlink:label="lab_dgx_PercentageofReceivablesDueFromPatients" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Receivables Due From Patients</link:label>
    <link:label id="lab_dgx_PercentageofReceivablesDueFromPatients_documentation_en-US" xlink:label="lab_dgx_PercentageofReceivablesDueFromPatients" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables due from patients as a percentage of consolidated net accounts receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofReceivablesDueFromPatients" xlink:href="dgx-20201231.xsd#dgx_PercentageofReceivablesDueFromPatients"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofReceivablesDueFromPatients" xlink:to="lab_dgx_PercentageofReceivablesDueFromPatients" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_69dc5e8f-85dc-48de-9aea-6207163ee508_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_9496281f-7816-4e8e-9337-8a8b8a90b3ec_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_9acfc623-3098-4db2-ab95-6238b099d129_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_5b558687-db8a-4a13-9874-889fae3f4912_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_d935b8f1-5153-4d6c-9cb0-a843941123fa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_840d3a26-be94-4634-aece-20c4165f3c89_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_635c358a-35e6-4668-ab97-1a17a265e015_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_510ba0e9-0e13-4d24-8b9b-aefcb3b91563_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_40c2beca-e6b9-41d8-8637-296e4e10d75d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fa303f6f-e785-411a-817d-a7331cd2ab2f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_76f8648f-8621-4639-a016-a11140250c38_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_09209599-c80f-4753-aca4-0f521e8299ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cff8d9c9-c512-4ad5-a305-142b2cb9331b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1b382042-f874-40ce-8e63-eb4575337c78_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_0b66db4e-94ac-4fa0-b267-3dae29cc30c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_5333878c-420d-4713-8294-ce9d00fd9f3f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_d95ea273-52ac-48a1-a887-6c33c73be354_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_414f2434-a041-469d-8ec6-b486dd78783c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_5f897117-d970-4a1a-9f54-e916adffd6ea_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_6f95892f-f883-4e83-a61a-00df77dc00eb_netLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for business acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_be23a45f-07b9-4484-b94d-8a91c4dd2914_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_c035e28c-3396-4823-bdc2-f47ef4facfde_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8ab54c2e-78f0-4bde-ab33-741b5bbb4dd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_71c8797c-a669-4608-a399-d052f172aa77_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_6b90375a-ba7b-4790-9e86-40811c9b0290_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Liability Balances Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_d64f654b-a9c1-46e5-b79b-1970d3635f92_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_95ab692d-d7a5-43da-a428-d641e5f33375_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Losses on Cash Flow Hedges, net of tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_30428a11-bb26-4993-bb51-50387dd5a5c5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt_e2c5c41c-fe5b-4d4f-b5f4-79fb134d5f23_negatedTerseLabel_en-US" xlink:label="lab_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain recognized by an equity method investee to adjust certain of its investments to fair value, partially offset by a loss on retirement of debt</link:label>
    <link:label id="lab_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt_label_en-US" xlink:label="lab_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized by equity method investee to adjust certain investments to fair value, partially offset by a loss on retirement of debt</link:label>
    <link:label id="lab_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt_documentation_en-US" xlink:label="lab_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized by equity method investee to adjust certain investments to fair value, partially offset by a loss on retirement of debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" xlink:href="dgx-20201231.xsd#dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" xlink:to="lab_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_81f84da8-f3d8-4b29-b525-d1b1237b8499_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_f82843d7-09a6-42df-b03c-32cdef99009d_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE II - VALUATION ACCOUNTS AND RESERVES</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1cc52b4b-2dea-42bb-9746-dd98a619d296_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, value</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39b34d28-5921-48ce-a3f3-b6eaf4454d1e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_9b418901-d807-44c2-9ca5-c6bcc6f88aad_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_966961cf-6081-48fe-b1cb-0fdfdeca7878_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d0264463-2a18-4b8b-a505-3ac63ddb4d55_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a5a56001-e1ba-4a5e-830b-9a6f77eff49c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4eafac7d-077a-4448-81b2-3550ffbbb262_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c652c3c7-ecc6-4dbc-a879-7ea483710f1a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_f15c8cb5-399e-454d-8d85-979e3d3209cc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_c1abaf65-cc8d-4fae-8f42-ac06149bdce8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New claims filed (in lawsuits)</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f6716f7c-300b-4071-a670-7dcf736efff6_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_aa1e3230-f288-4b90-82f6-2885bfcd9fa5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a4de04e9-b99c-4195-8cea-65a54a665c14_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, end of year weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a42291bc-5653-4ca2-a4f3-f9477dc701a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_dcec9464-0c97-4fca-ba27-da8d9496c3e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity of Restructuring Liability</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_705a91b5-3dfc-4c97-b022-228eb8006576_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable, end of year weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_33b76255-6b5f-4c5c-bc14-89ab40142d85_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d316d089-7ee8-45be-af28-15fdb8eb2de3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_ed5402f0-462d-4ee7-8c6a-f1520840456b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_b2c0df71-3534-412c-b908-dea33c2d8497_terseLabel_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in reserves for uncertain tax positions</link:label>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_label_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change for uncertain tax position</link:label>
    <link:label id="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_documentation_en-US" xlink:label="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change for uncertain tax position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:href="dgx-20201231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:to="lab_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_3b25fc58-b8d5-429d-becd-c6c1a5ec4aa7_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 84 shares as of both December 31, 2020 and 2019</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_8fc4769d-80e1-446c-82b5-d749ac1d7ce1_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility-Related Costs</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b9e64dd3-c7d5-45a1-af73-0b52017aeaae_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DeferredRentAdjustments_d6a1962c-c22c-4d79-913e-87de722360a9_terseLabel_en-US" xlink:label="lab_dgx_DeferredRentAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent adjustments</link:label>
    <link:label id="lab_dgx_DeferredRentAdjustments_label_en-US" xlink:label="lab_dgx_DeferredRentAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Adjustments</link:label>
    <link:label id="lab_dgx_DeferredRentAdjustments_documentation_en-US" xlink:label="lab_dgx_DeferredRentAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredRentAdjustments" xlink:href="dgx-20201231.xsd#dgx_DeferredRentAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DeferredRentAdjustments" xlink:to="lab_dgx_DeferredRentAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_5d5379e8-0b25-4280-a21c-6f19065ea0d1_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_81b751a6-0f29-43c4-88b4-576ee63c5223_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6c1c6665-5a4b-4732-871f-486503ef9970_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, end of year weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_6b5e0849-cd92-4bc2-b7e6-91abca206591_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a3deef46-1f8e-46a1-b97c-5fc8844d0c82_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_742fd484-393a-4659-97ad-7bd50cc610b7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_82368c8e-8546-434a-880f-27525a68b1dd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_89c5ba2f-0c83-4d73-a6b7-e33fc54f216c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>dgx-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a87d206f-e33b-4d9f-a34a-b74e8733b14f,g:639ddba6-f3fe-4831-960f-76615a38edd9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2e407d5b-150e-498c-928f-c87cd28455ea" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_DocumentType_2e407d5b-150e-498c-928f-c87cd28455ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_268e6110-e7ea-482d-8e04-f957b06526bf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_DocumentAnnualReport_268e6110-e7ea-482d-8e04-f957b06526bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a57f3b17-a3d6-494e-bd7c-abcc68b7aebd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_DocumentPeriodEndDate_a57f3b17-a3d6-494e-bd7c-abcc68b7aebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_123843cc-d118-449d-ab3c-3499e787a9b0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_CurrentFiscalYearEndDate_123843cc-d118-449d-ab3c-3499e787a9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_a8dfb639-1560-424e-8360-11fe9d1fc88a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_DocumentTransitionReport_a8dfb639-1560-424e-8360-11fe9d1fc88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_95c8eb56-535f-4f44-af25-57ea2b9593f0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityFileNumber_95c8eb56-535f-4f44-af25-57ea2b9593f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0806080f-158e-46d9-b089-84d2121a81c5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityRegistrantName_0806080f-158e-46d9-b089-84d2121a81c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fd4fa8f1-e06d-49a5-8374-e09c272032d2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fd4fa8f1-e06d-49a5-8374-e09c272032d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_51dc50d8-7c7d-4b06-ab10-5669931f4a9d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityTaxIdentificationNumber_51dc50d8-7c7d-4b06-ab10-5669931f4a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_fcde5f7c-4a6a-40a6-b6ad-beb4a80cf1b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityAddressAddressLine1_fcde5f7c-4a6a-40a6-b6ad-beb4a80cf1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8141feb2-ad3e-48de-b443-a5c5ba40d623" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityAddressCityOrTown_8141feb2-ad3e-48de-b443-a5c5ba40d623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5da28677-f800-4fd1-a058-74aaa4728886" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityAddressStateOrProvince_5da28677-f800-4fd1-a058-74aaa4728886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c584cb46-9467-4853-8680-385d14c32c87" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityAddressPostalZipCode_c584cb46-9467-4853-8680-385d14c32c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0cf39eac-d44f-42b6-996c-8e2fe31feb91" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_CityAreaCode_0cf39eac-d44f-42b6-996c-8e2fe31feb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5aa9b626-4bbb-49af-856a-06578759be14" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_LocalPhoneNumber_5aa9b626-4bbb-49af-856a-06578759be14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e3215d6e-eb07-410c-b58c-a0834e957912" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_Security12bTitle_e3215d6e-eb07-410c-b58c-a0834e957912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2d9b79bc-fc3a-4d25-b8d2-11e4f8c29c76" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_TradingSymbol_2d9b79bc-fc3a-4d25-b8d2-11e4f8c29c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_606258f8-ebbd-44eb-a4b8-e8063a5103a8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_SecurityExchangeName_606258f8-ebbd-44eb-a4b8-e8063a5103a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_fa0a091f-5872-4d53-9e43-914aa6bf26a7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_fa0a091f-5872-4d53-9e43-914aa6bf26a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_ebd74f48-15dc-4909-8578-b20ed1d2a37f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityVoluntaryFilers_ebd74f48-15dc-4909-8578-b20ed1d2a37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_9e9ac1cf-2201-43c0-a768-a65f69dff1eb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityCurrentReportingStatus_9e9ac1cf-2201-43c0-a768-a65f69dff1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_dad2e069-0a2a-4262-97d5-075fe0ff3afd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityInteractiveDataCurrent_dad2e069-0a2a-4262-97d5-075fe0ff3afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e520a15e-9e51-4451-b698-ebe7a313980d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityFilerCategory_e520a15e-9e51-4451-b698-ebe7a313980d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_73789a98-44d0-49f4-8ed6-3424061b960d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntitySmallBusiness_73789a98-44d0-49f4-8ed6-3424061b960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3bae2c0e-845c-487a-aee0-1b0a685b61a6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityEmergingGrowthCompany_3bae2c0e-845c-487a-aee0-1b0a685b61a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_5d8642d2-3017-4e21-8199-c98873b744ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityShellCompany_5d8642d2-3017-4e21-8199-c98873b744ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_d840e917-93e0-4663-ade4-3c99aa8997da" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityPublicFloat_d840e917-93e0-4663-ade4-3c99aa8997da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b51d1ca6-4075-4dbe-8890-108576edc103" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b51d1ca6-4075-4dbe-8890-108576edc103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_af3e4163-0ee4-46dd-9edf-366d064c8c73" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_af3e4163-0ee4-46dd-9edf-366d064c8c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cb2f8a2e-705a-4f4c-948b-2d5089f3421a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_EntityCentralIndexKey_cb2f8a2e-705a-4f4c-948b-2d5089f3421a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b6c97e48-28ab-4761-a600-26ff64f32b57" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_DocumentFiscalYearFocus_b6c97e48-28ab-4761-a600-26ff64f32b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_2b6b6824-add1-40ce-bcd8-3b21e5dd925d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_2b6b6824-add1-40ce-bcd8-3b21e5dd925d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b9213153-ca2a-4c8f-b11a-27c3f98ff526" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_AmendmentFlag_b9213153-ca2a-4c8f-b11a-27c3f98ff526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_1801c0a2-368f-4caf-b345-205027acc8c6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7d849716-8870-4b9f-91ee-7c45679ed48e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_1801c0a2-368f-4caf-b345-205027acc8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_864a8a6a-66bf-48f5-8120-c7f224b4f814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_864a8a6a-66bf-48f5-8120-c7f224b4f814" xlink:to="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9b2ea3b9-e231-42d9-a03b-2c46593256b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9b2ea3b9-e231-42d9-a03b-2c46593256b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_022c6757-5a03-47bb-ba0a-a575cb4be898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_022c6757-5a03-47bb-ba0a-a575cb4be898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2ba0ee58-5ed1-496f-a37c-8ecaae8bf851" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_InventoryNet_2ba0ee58-5ed1-496f-a37c-8ecaae8bf851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d8ea8ca-db74-4c66-935f-669b396cd6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d8ea8ca-db74-4c66-935f-669b396cd6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c416ac43-2fe4-44cf-8170-7a179635859f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_AssetsCurrent_c416ac43-2fe4-44cf-8170-7a179635859f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c4926c98-7c0c-48df-9b47-a97c90d272b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c4926c98-7c0c-48df-9b47-a97c90d272b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e25045d9-7500-4fe2-88ab-db786c8b8b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e25045d9-7500-4fe2-88ab-db786c8b8b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eaa602e6-0016-4cdc-9273-eeb75b905c43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_Goodwill_eaa602e6-0016-4cdc-9273-eeb75b905c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d04ea23c-fe0f-4532-91d3-0c422fb756e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d04ea23c-fe0f-4532-91d3-0c422fb756e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_de585892-175a-46af-8c70-361829d50aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_EquityMethodInvestments_de585892-175a-46af-8c70-361829d50aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7cf00616-2972-435a-a7e9-f0154c61419e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7cf00616-2972-435a-a7e9-f0154c61419e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7d0ab60a-d53d-4a87-9e46-d834a9df0982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_12a5fcf2-a801-46ca-b168-9104a70fa2a9" xlink:to="loc_us-gaap_Assets_7d0ab60a-d53d-4a87-9e46-d834a9df0982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_864a8a6a-66bf-48f5-8120-c7f224b4f814" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ad179add-6270-49f0-a1b1-50c0fbfe0692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ad179add-6270-49f0-a1b1-50c0fbfe0692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_3c63ecc5-2159-4a85-b517-194d3b2e71cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_LongTermDebtCurrent_3c63ecc5-2159-4a85-b517-194d3b2e71cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d3e43276-8d19-4a17-afff-fbc3e732ebde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d3e43276-8d19-4a17-afff-fbc3e732ebde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_595309d7-211c-4e99-bb73-de2d680e59e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_LiabilitiesCurrent_595309d7-211c-4e99-bb73-de2d680e59e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9f9991d6-64b2-4582-b18b-84f6ade1fcc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9f9991d6-64b2-4582-b18b-84f6ade1fcc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f1abf7f0-120e-49e0-8e67-0b2498214f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f1abf7f0-120e-49e0-8e67-0b2498214f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cd18e564-6d02-41ca-9516-1a1e315b3150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cd18e564-6d02-41ca-9516-1a1e315b3150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_26725a84-cf6c-4c15-b6cc-80e693dfce7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_CommitmentsAndContingencies_26725a84-cf6c-4c15-b6cc-80e693dfce7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_1e0365c8-9711-414a-a8df-3583d4a88f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_1e0365c8-9711-414a-a8df-3583d4a88f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_016f07a9-f8cb-4bd0-8fb4-bfd5e8557ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_016f07a9-f8cb-4bd0-8fb4-bfd5e8557ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f9fc93fe-2666-4e7f-ae88-bf364fd22a23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_016f07a9-f8cb-4bd0-8fb4-bfd5e8557ee3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f9fc93fe-2666-4e7f-ae88-bf364fd22a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7f6b4a62-6f5d-4e11-bea4-654366408d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9fc93fe-2666-4e7f-ae88-bf364fd22a23" xlink:to="loc_us-gaap_CommonStockValue_7f6b4a62-6f5d-4e11-bea4-654366408d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_281d56f3-eeaf-4c69-bc98-bab3fd901b6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9fc93fe-2666-4e7f-ae88-bf364fd22a23" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_281d56f3-eeaf-4c69-bc98-bab3fd901b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ee225305-49e9-4034-8ab4-871908c72822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9fc93fe-2666-4e7f-ae88-bf364fd22a23" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ee225305-49e9-4034-8ab4-871908c72822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b40b0a4f-949c-4fbd-909a-a28f2f23b234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9fc93fe-2666-4e7f-ae88-bf364fd22a23" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b40b0a4f-949c-4fbd-909a-a28f2f23b234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ab073ecf-725e-420f-8363-4a2ac6a7e409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9fc93fe-2666-4e7f-ae88-bf364fd22a23" xlink:to="loc_us-gaap_TreasuryStockValue_ab073ecf-725e-420f-8363-4a2ac6a7e409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_266ae168-239c-4fd9-a634-d2611e0879e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9fc93fe-2666-4e7f-ae88-bf364fd22a23" xlink:to="loc_us-gaap_StockholdersEquity_266ae168-239c-4fd9-a634-d2611e0879e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_8c5be0bf-bb9f-47b6-a6e7-972ce4e8accc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_016f07a9-f8cb-4bd0-8fb4-bfd5e8557ee3" xlink:to="loc_us-gaap_MinorityInterest_8c5be0bf-bb9f-47b6-a6e7-972ce4e8accc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4493f797-d9bd-4996-8d45-d53554b2b183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_016f07a9-f8cb-4bd0-8fb4-bfd5e8557ee3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4493f797-d9bd-4996-8d45-d53554b2b183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_43f0ab73-2f80-496d-822c-38d1558938da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_43f0ab73-2f80-496d-822c-38d1558938da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_ad2b6ce9-d9c2-4d70-a0f8-62000a22a033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_62aacc49-43f4-4b35-9722-02344caa5928" xlink:to="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_ad2b6ce9-d9c2-4d70-a0f8-62000a22a033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_392351a1-de5f-4aeb-a6bc-f6207c453368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_ad2b6ce9-d9c2-4d70-a0f8-62000a22a033" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_392351a1-de5f-4aeb-a6bc-f6207c453368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0c5c078a-ee86-4459-9bb6-16723a923f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_392351a1-de5f-4aeb-a6bc-f6207c453368" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0c5c078a-ee86-4459-9bb6-16723a923f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_420e94d1-b5f8-4d2f-adb0-e221a51d11f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_864a8a6a-66bf-48f5-8120-c7f224b4f814" xlink:to="loc_us-gaap_TreasuryStockShares_420e94d1-b5f8-4d2f-adb0-e221a51d11f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3ad6eb17-efb8-4e1f-ae79-71a370b9b4da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_aa7110cc-fa30-40c4-a75c-05d51d2fe55a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3ad6eb17-efb8-4e1f-ae79-71a370b9b4da" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_aa7110cc-fa30-40c4-a75c-05d51d2fe55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_48c94d78-1c08-4da7-b6b4-c89aa5362062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3ad6eb17-efb8-4e1f-ae79-71a370b9b4da" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_48c94d78-1c08-4da7-b6b4-c89aa5362062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b608544d-df4d-47b8-b55d-0b2355619e69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3ad6eb17-efb8-4e1f-ae79-71a370b9b4da" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b608544d-df4d-47b8-b55d-0b2355619e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_379599c5-8fe0-4b7a-91ef-098062b21060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3ad6eb17-efb8-4e1f-ae79-71a370b9b4da" xlink:to="loc_us-gaap_CommonStockSharesIssued_379599c5-8fe0-4b7a-91ef-098062b21060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_045da5e9-a1d2-4da2-ae20-ae80f95f6d6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3ad6eb17-efb8-4e1f-ae79-71a370b9b4da" xlink:to="loc_us-gaap_TreasuryStockShares_045da5e9-a1d2-4da2-ae20-ae80f95f6d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db078ad9-8f74-41cc-9985-f1dcd9591925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db078ad9-8f74-41cc-9985-f1dcd9591925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_5923062d-f626-4c5e-8e56-b099dba48349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_CostOfRevenueAbstract_5923062d-f626-4c5e-8e56-b099dba48349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f6842401-6e1a-4d5c-9e28-f5294cc17cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_5923062d-f626-4c5e-8e56-b099dba48349" xlink:to="loc_us-gaap_CostOfRevenue_f6842401-6e1a-4d5c-9e28-f5294cc17cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3a45020d-7997-433a-ac92-284db74d32ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_5923062d-f626-4c5e-8e56-b099dba48349" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3a45020d-7997-433a-ac92-284db74d32ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b1e7b733-2965-4edd-a466-ecef533c0e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_5923062d-f626-4c5e-8e56-b099dba48349" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b1e7b733-2965-4edd-a466-ecef533c0e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_eae78f90-073b-4820-ab5d-eae8326e3c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_5923062d-f626-4c5e-8e56-b099dba48349" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_eae78f90-073b-4820-ab5d-eae8326e3c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e1e52366-a770-4219-8ff7-96060d08841a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_CostsAndExpenses_e1e52366-a770-4219-8ff7-96060d08841a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6bf4d7ef-0dfb-4508-8785-691345405dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_OperatingIncomeLoss_6bf4d7ef-0dfb-4508-8785-691345405dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8e09e81d-6d6d-4c3f-ad13-4e2582c2c9a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8e09e81d-6d6d-4c3f-ad13-4e2582c2c9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_c4801d21-2f55-4970-acd4-93340aaa3116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8e09e81d-6d6d-4c3f-ad13-4e2582c2c9a6" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_c4801d21-2f55-4970-acd4-93340aaa3116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a3050600-6f47-40a9-b69f-f23776d3497f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8e09e81d-6d6d-4c3f-ad13-4e2582c2c9a6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a3050600-6f47-40a9-b69f-f23776d3497f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a3a9d065-0a5e-4fcb-82a6-1f84e311f14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_8e09e81d-6d6d-4c3f-ad13-4e2582c2c9a6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a3a9d065-0a5e-4fcb-82a6-1f84e311f14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7ae91918-313c-47b7-9c6a-f5da2f156810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7ae91918-313c-47b7-9c6a-f5da2f156810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_eb4a2dc5-bb1d-4baf-98f6-2402230bb83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_eb4a2dc5-bb1d-4baf-98f6-2402230bb83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_92081177-28cc-43d2-a8d7-388c61a9e76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_92081177-28cc-43d2-a8d7-388c61a9e76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d04f234e-5a9f-4cf3-ab4d-131bc8e49b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_d04f234e-5a9f-4cf3-ab4d-131bc8e49b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3389b7d6-4504-4c14-b63d-67d879646832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3389b7d6-4504-4c14-b63d-67d879646832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_22ab8d1f-3dfd-4dc1-b640-22dd563b3142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_ProfitLoss_22ab8d1f-3dfd-4dc1-b640-22dd563b3142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9a0c2e3f-4a97-4257-8c40-1cfabf182280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9a0c2e3f-4a97-4257-8c40-1cfabf182280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dcc29488-92ef-4bb6-80e9-f2b68044f207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_NetIncomeLoss_dcc29488-92ef-4bb6-80e9-f2b68044f207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_058eca13-51c9-41e2-b57d-eae35f456f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_058eca13-51c9-41e2-b57d-eae35f456f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_cc1732d2-0b6e-4f71-97ea-b914c7563fb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_058eca13-51c9-41e2-b57d-eae35f456f97" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_cc1732d2-0b6e-4f71-97ea-b914c7563fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ace2f919-5893-4dce-8059-2139ecd5e58c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_058eca13-51c9-41e2-b57d-eae35f456f97" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_ace2f919-5893-4dce-8059-2139ecd5e58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ea66596f-55ac-404e-936f-3a8a9bfa50eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_058eca13-51c9-41e2-b57d-eae35f456f97" xlink:to="loc_us-gaap_NetIncomeLoss_ea66596f-55ac-404e-936f-3a8a9bfa50eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_67cbf136-a58b-47c2-8bf6-ef41b19b5cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_67cbf136-a58b-47c2-8bf6-ef41b19b5cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d9b62404-0d29-428d-a4a9-b22b49570d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_67cbf136-a58b-47c2-8bf6-ef41b19b5cf8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d9b62404-0d29-428d-a4a9-b22b49570d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_5f300dba-56e1-44ea-b9c9-c7133facff45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_67cbf136-a58b-47c2-8bf6-ef41b19b5cf8" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_5f300dba-56e1-44ea-b9c9-c7133facff45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1145e5f9-bb7f-4078-ae37-8ac941984bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_67cbf136-a58b-47c2-8bf6-ef41b19b5cf8" xlink:to="loc_us-gaap_EarningsPerShareBasic_1145e5f9-bb7f-4078-ae37-8ac941984bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_774d03b7-0388-4cfa-b3f8-abe63b7025aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e9403ca9-8359-4c34-bf31-b8bb566ed5ee" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_774d03b7-0388-4cfa-b3f8-abe63b7025aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2960ba3d-4ebd-48eb-9a21-56539c5bccfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_774d03b7-0388-4cfa-b3f8-abe63b7025aa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2960ba3d-4ebd-48eb-9a21-56539c5bccfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_22ceb9bb-c047-4bda-bbde-995fa8f3480f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_774d03b7-0388-4cfa-b3f8-abe63b7025aa" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_22ceb9bb-c047-4bda-bbde-995fa8f3480f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_428672d8-115a-4053-8631-762fdc36996e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_774d03b7-0388-4cfa-b3f8-abe63b7025aa" xlink:to="loc_us-gaap_EarningsPerShareDiluted_428672d8-115a-4053-8631-762fdc36996e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS_1"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_766f6417-7455-4944-9097-f5fa03c5965c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9c02f055-11cb-4905-8784-4c59e8d79ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_766f6417-7455-4944-9097-f5fa03c5965c" xlink:to="loc_us-gaap_ProfitLoss_9c02f055-11cb-4905-8784-4c59e8d79ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18b0aafe-daad-4e74-9ad7-d9a690a49101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_766f6417-7455-4944-9097-f5fa03c5965c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18b0aafe-daad-4e74-9ad7-d9a690a49101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04d7c5d5-96c2-4875-87ac-8fc3970087f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18b0aafe-daad-4e74-9ad7-d9a690a49101" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04d7c5d5-96c2-4875-87ac-8fc3970087f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_50037097-a92f-41ef-bdeb-d8f9eee90b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18b0aafe-daad-4e74-9ad7-d9a690a49101" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_50037097-a92f-41ef-bdeb-d8f9eee90b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_9f63551c-e03c-4c14-aea0-c1b5f45e23c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18b0aafe-daad-4e74-9ad7-d9a690a49101" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_9f63551c-e03c-4c14-aea0-c1b5f45e23c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_06fa9fc8-29f4-429f-9384-a69166f507f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18b0aafe-daad-4e74-9ad7-d9a690a49101" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_06fa9fc8-29f4-429f-9384-a69166f507f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9e02d733-8903-4936-a0d1-b8c4ccc748f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_766f6417-7455-4944-9097-f5fa03c5965c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9e02d733-8903-4936-a0d1-b8c4ccc748f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_fa09ee63-9f17-4341-b9a5-8ffd68a96fbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_766f6417-7455-4944-9097-f5fa03c5965c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_fa09ee63-9f17-4341-b9a5-8ffd68a96fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f2e014b0-822f-4fba-9872-d92000593df2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_766f6417-7455-4944-9097-f5fa03c5965c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f2e014b0-822f-4fba-9872-d92000593df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6d303545-ce59-42eb-8479-90284402ebad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_2982aac1-b157-4087-bd86-a372e28e81c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d303545-ce59-42eb-8479-90284402ebad" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_2982aac1-b157-4087-bd86-a372e28e81c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a6b1a96d-3018-4108-b26a-3727d27147a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_2982aac1-b157-4087-bd86-a372e28e81c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a6b1a96d-3018-4108-b26a-3727d27147a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aa331dee-0e57-4b4f-92db-ac30508625fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a6b1a96d-3018-4108-b26a-3727d27147a0" xlink:to="loc_us-gaap_ProfitLoss_aa331dee-0e57-4b4f-92db-ac30508625fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a6b1a96d-3018-4108-b26a-3727d27147a0" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_81bcc39c-19ea-4b25-aa7f-b12f42deed8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_81bcc39c-19ea-4b25-aa7f-b12f42deed8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_a6288d04-a1a5-42fb-9f29-dc48bc704c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_a6288d04-a1a5-42fb-9f29-dc48bc704c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_934c5d01-1e3a-4caf-9641-fa52fed4417e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_934c5d01-1e3a-4caf-9641-fa52fed4417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_980ef139-e6b2-4827-91a7-01555a654c3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:to="loc_us-gaap_ShareBasedCompensation_980ef139-e6b2-4827-91a7-01555a654c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_95937193-e60f-4c4b-b109-8d271da711b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_95937193-e60f-4c4b-b109-8d271da711b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_ee70fd73-f6ff-47da-8776-dfe68180052a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_ee70fd73-f6ff-47da-8776-dfe68180052a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8fccf0c9-b42d-4fe8-9c72-b7839e659fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b17e72f0-c6e0-4cc5-9ab1-cc1aa5bfdb72" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8fccf0c9-b42d-4fe8-9c72-b7839e659fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1804922f-1771-4ded-be73-ee98c9ed9dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8fccf0c9-b42d-4fe8-9c72-b7839e659fb3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1804922f-1771-4ded-be73-ee98c9ed9dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ea3e7967-9ec3-42ba-9f96-9a70d9ed46e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8fccf0c9-b42d-4fe8-9c72-b7839e659fb3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ea3e7967-9ec3-42ba-9f96-9a70d9ed46e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5f6c2460-1e5d-4b1f-abf4-2f5b04f5e977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8fccf0c9-b42d-4fe8-9c72-b7839e659fb3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5f6c2460-1e5d-4b1f-abf4-2f5b04f5e977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TerminationOfInterestRateSwapAgreements_cea17d6b-2670-413d-998a-a4b400b59f87" xlink:href="dgx-20201231.xsd#dgx_TerminationOfInterestRateSwapAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8fccf0c9-b42d-4fe8-9c72-b7839e659fb3" xlink:to="loc_dgx_TerminationOfInterestRateSwapAgreements_cea17d6b-2670-413d-998a-a4b400b59f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ccc41270-d1a6-42c8-9bac-efccf0b30138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8fccf0c9-b42d-4fe8-9c72-b7839e659fb3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_ccc41270-d1a6-42c8-9bac-efccf0b30138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5cb2c802-3a4b-433b-bdbc-910d24f5ac3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a6b1a96d-3018-4108-b26a-3727d27147a0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5cb2c802-3a4b-433b-bdbc-910d24f5ac3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dc0d63c0-4373-4304-aee1-bce5f0f03237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_2982aac1-b157-4087-bd86-a372e28e81c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dc0d63c0-4373-4304-aee1-bce5f0f03237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5e9ea2c9-c3f8-448f-a57f-ce3c1b222a54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dc0d63c0-4373-4304-aee1-bce5f0f03237" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5e9ea2c9-c3f8-448f-a57f-ce3c1b222a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_571d3bba-a204-495b-8cca-3d2e48a23115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dc0d63c0-4373-4304-aee1-bce5f0f03237" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_571d3bba-a204-495b-8cca-3d2e48a23115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ecb753f6-d826-474b-80b0-6aeef4b23b21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dc0d63c0-4373-4304-aee1-bce5f0f03237" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ecb753f6-d826-474b-80b0-6aeef4b23b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_dac6dc8f-51c8-4070-bef0-8d65aa9862b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dc0d63c0-4373-4304-aee1-bce5f0f03237" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_dac6dc8f-51c8-4070-bef0-8d65aa9862b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1b91bf77-1ff3-43c7-9e64-aff4acf9387c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dc0d63c0-4373-4304-aee1-bce5f0f03237" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1b91bf77-1ff3-43c7-9e64-aff4acf9387c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_2982aac1-b157-4087-bd86-a372e28e81c3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_3a1b3d11-d4e8-4c54-b383-5b3f0438bbfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_3a1b3d11-d4e8-4c54-b383-5b3f0438bbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_8ae1faf7-fe57-4e7d-b241-1b3043712251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_RepaymentsOfDebt_8ae1faf7-fe57-4e7d-b241-1b3043712251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b6cf9bee-9db8-4299-9328-fe1833b77e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b6cf9bee-9db8-4299-9328-fe1833b77e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_3d6eb22e-1207-44e0-bc22-79c8f54ed2aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_3d6eb22e-1207-44e0-bc22-79c8f54ed2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1db9b717-864b-4824-b2da-f6037697e74b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1db9b717-864b-4824-b2da-f6037697e74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_e8a7d9ee-b03d-4faa-8a9d-52255a8cb8a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_e8a7d9ee-b03d-4faa-8a9d-52255a8cb8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_d647664c-eccf-4549-a080-5502b06226b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_d647664c-eccf-4549-a080-5502b06226b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_76e3237b-bb47-4219-8502-b4a8eba655e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_76e3237b-bb47-4219-8502-b4a8eba655e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a23b117f-be3c-4bc5-9c13-b97f53603a0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a23b117f-be3c-4bc5-9c13-b97f53603a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_963697f7-164f-415a-b766-f089cbcbb04d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_15d1fc27-e159-41a9-b565-5f196eb387ef" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_963697f7-164f-415a-b766-f089cbcbb04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_a47b471b-964e-4b4e-aaa5-f513fd5690a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_2982aac1-b157-4087-bd86-a372e28e81c3" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_a47b471b-964e-4b4e-aaa5-f513fd5690a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_afd1d15c-21ef-436f-bcc8-4dedb44d6b79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d303545-ce59-42eb-8479-90284402ebad" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_afd1d15c-21ef-436f-bcc8-4dedb44d6b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7e2dfb5e-3223-496b-a7f1-1b11339b9dc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d303545-ce59-42eb-8479-90284402ebad" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7e2dfb5e-3223-496b-a7f1-1b11339b9dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20201231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2b439223-ab71-44bc-a520-0ccc641cc522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cabf6934-2d1a-4ae3-889f-e8f061581dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2b439223-ab71-44bc-a520-0ccc641cc522" xlink:to="loc_us-gaap_StatementTable_cabf6934-2d1a-4ae3-889f-e8f061581dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7bd63a78-a7ba-4eb3-9c2e-7a3169414251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cabf6934-2d1a-4ae3-889f-e8f061581dad" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7bd63a78-a7ba-4eb3-9c2e-7a3169414251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7bd63a78-a7ba-4eb3-9c2e-7a3169414251" xlink:to="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5a5add46-2bf9-488f-8426-75eda138e5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_CommonStockMember_5a5add46-2bf9-488f-8426-75eda138e5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_54bde1cf-2b49-45f2-b391-cf042d2e6a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_54bde1cf-2b49-45f2-b391-cf042d2e6a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_449270c2-3a17-4ac0-b264-d8a96808df05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_RetainedEarningsMember_449270c2-3a17-4ac0-b264-d8a96808df05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f587ef36-23eb-4fcb-b7cb-1eaa6d22b2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f587ef36-23eb-4fcb-b7cb-1eaa6d22b2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_39979e2c-1847-4f53-b400-8c1d9b8554b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_TreasuryStockMember_39979e2c-1847-4f53-b400-8c1d9b8554b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_8942de8b-65c3-4f51-b185-209a4db76e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_fe0205af-4971-4f0b-94bd-fac2103eef84" xlink:to="loc_us-gaap_NoncontrollingInterestMember_8942de8b-65c3-4f51-b185-209a4db76e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f4191cea-55e0-43fe-ad7a-8cc0a9cdf21f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cabf6934-2d1a-4ae3-889f-e8f061581dad" xlink:to="loc_us-gaap_StatementLineItems_f4191cea-55e0-43fe-ad7a-8cc0a9cdf21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4191cea-55e0-43fe-ad7a-8cc0a9cdf21f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_154ab640-4083-4a20-a5e6-e84e15aaffb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_154ab640-4083-4a20-a5e6-e84e15aaffb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d2b66550-6015-487c-9c2e-33fff582d130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d2b66550-6015-487c-9c2e-33fff582d130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_94711faf-0977-4d67-b2b0-32003320fd69" xlink:href="dgx-20201231.xsd#dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_94711faf-0977-4d67-b2b0-32003320fd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6af38a9-b318-4d1f-847f-b2bf71bf2dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d6af38a9-b318-4d1f-847f-b2bf71bf2dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_8c56a5bc-1f71-426b-bcbe-e8487a5329a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_DividendsCommonStockCash_8c56a5bc-1f71-426b-bcbe-e8487a5329a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e49c0327-33e3-4ae0-85e9-861643da65c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e49c0327-33e3-4ae0-85e9-861643da65c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e06896df-bc55-4f63-8677-d3fa590e0277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e06896df-bc55-4f63-8677-d3fa590e0277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8ea3ea2a-679b-4fb3-9fb8-e7b706ddd821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8ea3ea2a-679b-4fb3-9fb8-e7b706ddd821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_257727ef-439a-4265-b724-3a33899c5a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_257727ef-439a-4265-b724-3a33899c5a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_01102594-5146-4153-90cd-85cf641a31ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_01102594-5146-4153-90cd-85cf641a31ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_81c00e49-1904-4b7f-bb85-ec7f6b675b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_81c00e49-1904-4b7f-bb85-ec7f6b675b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f637d0b5-db10-4048-b257-9049d6b2e8d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_f637d0b5-db10-4048-b257-9049d6b2e8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_eeb364c9-5c9c-4a88-8e9d-c532d8f1190a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_eeb364c9-5c9c-4a88-8e9d-c532d8f1190a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_d46a4c36-02b8-4cfd-a33d-88d7ed90bc83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_d46a4c36-02b8-4cfd-a33d-88d7ed90bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_26f74b5b-57c2-4cc7-86c2-3942bcecdba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_26f74b5b-57c2-4cc7-86c2-3942bcecdba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_244dd59b-a5b2-4c70-94ba-e4fd2831f9d2" xlink:href="dgx-20201231.xsd#dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_244dd59b-a5b2-4c70-94ba-e4fd2831f9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62181890-74bb-4fa9-b2fd-ff49fe70835b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_62181890-74bb-4fa9-b2fd-ff49fe70835b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_91ff38b1-269a-47db-8202-f198621eaf0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_f0f97196-9c34-4cf0-aca0-04a285b47e40" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_91ff38b1-269a-47db-8202-f198621eaf0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4191cea-55e0-43fe-ad7a-8cc0a9cdf21f" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6e77bb83-e0d0-49c3-8e97-3e54ac07fa01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6e77bb83-e0d0-49c3-8e97-3e54ac07fa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_6e0edbc1-a03b-4d06-a061-7a251ac1b50d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_6e0edbc1-a03b-4d06-a061-7a251ac1b50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_bf924610-1988-4812-bea9-c0786c41585d" xlink:href="dgx-20201231.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_bf924610-1988-4812-bea9-c0786c41585d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4a52d721-8a97-48bf-b481-75a17103a491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a0afd99d-d217-44bf-bdbb-f97b09d892e0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_4a52d721-8a97-48bf-b481-75a17103a491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20201231.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c1f20714-1324-463d-9c43-45ad59964e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_5494bc1f-dff3-4384-8194-937fbf57063c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c1f20714-1324-463d-9c43-45ad59964e2e" xlink:to="loc_us-gaap_NatureOfOperations_5494bc1f-dff3-4384-8194-937fbf57063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3a54f430-5ee7-4e35-a499-82a6ec7e626d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7de207d9-9522-41ca-9597-e3ae2281e281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3a54f430-5ee7-4e35-a499-82a6ec7e626d" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7de207d9-9522-41ca-9597-e3ae2281e281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2a8df77e-3c17-41eb-a606-41ca0d0b0ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2a8df77e-3c17-41eb-a606-41ca0d0b0ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_51033ec4-635b-4c5f-8613-573d88c601a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_51033ec4-635b-4c5f-8613-573d88c601a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1a49a372-72e6-4bd1-8272-8a58d25214bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_1a49a372-72e6-4bd1-8272-8a58d25214bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_d60651cb-9d6c-4ca5-b372-f1d71e252ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_d60651cb-9d6c-4ca5-b372-f1d71e252ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_9cb6c5b7-5f84-4f79-acb4-90980f844daa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_UseOfEstimates_9cb6c5b7-5f84-4f79-acb4-90980f844daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_68438fe4-3259-4ede-9e7b-df7c0fcedf8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_68438fe4-3259-4ede-9e7b-df7c0fcedf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_27c51fa9-2f8c-4e5b-ad22-4d9025c40202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_27c51fa9-2f8c-4e5b-ad22-4d9025c40202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_3e91f3cb-7509-4676-9fd7-ca039d6c25ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_3e91f3cb-7509-4676-9fd7-ca039d6c25ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5f1e35c5-3468-4ccc-9005-d099d5498e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_5f1e35c5-3468-4ccc-9005-d099d5498e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_40188110-50c3-48e7-8f14-ecfca1d5e017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_40188110-50c3-48e7-8f14-ecfca1d5e017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1dd7122c-3989-4ee7-a6db-3e252018a3b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1dd7122c-3989-4ee7-a6db-3e252018a3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_fb0734de-754c-4c58-a543-651d12a4ff3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_fb0734de-754c-4c58-a543-651d12a4ff3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_55741aaf-55f7-42ee-8bdf-34d5195260c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_55741aaf-55f7-42ee-8bdf-34d5195260c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_759eb337-a98e-46e0-bac7-ea173f5f63a7" xlink:href="dgx-20201231.xsd#dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock_759eb337-a98e-46e0-bac7-ea173f5f63a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_bf3be989-9e9a-4599-b95b-a5cdc374d9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_bf3be989-9e9a-4599-b95b-a5cdc374d9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_c17ead7d-b1cb-475f-9a88-b74b73c246f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_c17ead7d-b1cb-475f-9a88-b74b73c246f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_bb000137-8d1d-4890-870b-7a556cecf232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_bb000137-8d1d-4890-870b-7a556cecf232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_6052c6f5-6d0b-499f-9208-613f2c9e26a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_6052c6f5-6d0b-499f-9208-613f2c9e26a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_27088c3b-fe84-45ad-a4a2-ce8546e85bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_27088c3b-fe84-45ad-a4a2-ce8546e85bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_c40ad57c-5982-4acf-b786-8223bdf68a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_c40ad57c-5982-4acf-b786-8223bdf68a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_bbfb3eb0-96c7-4388-b385-48a113563ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_bbfb3eb0-96c7-4388-b385-48a113563ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7548507c-9b2a-4c02-a817-924e179a22e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_7548507c-9b2a-4c02-a817-924e179a22e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_bc6edd1a-a525-4736-a83a-effeb61e350e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_eb9d00d6-6eed-4731-a582-335937f9ce73" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_bc6edd1a-a525-4736-a83a-effeb61e350e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bdb4b6ba-2924-4519-9591-de79de23184b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:href="dgx-20201231.xsd#dgx_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bdb4b6ba-2924-4519-9591-de79de23184b" xlink:to="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_srt_RangeAxis_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7697037-9fd3-4adb-ac37-54b80373a5b7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ca2f1d13-c16b-40a6-b17a-6e2ecaaa7b6b" xlink:to="loc_srt_RangeMember_c7697037-9fd3-4adb-ac37-54b80373a5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e1902732-2b05-4061-85a9-fc53924db54b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c7697037-9fd3-4adb-ac37-54b80373a5b7" xlink:to="loc_srt_MinimumMember_e1902732-2b05-4061-85a9-fc53924db54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_238fea35-6f75-4297-990f-e787749c4f2c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c7697037-9fd3-4adb-ac37-54b80373a5b7" xlink:to="loc_srt_MaximumMember_238fea35-6f75-4297-990f-e787749c4f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_497d9c5a-56a9-4499-a6dd-648109a322f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7aeb5cc3-bec7-4e52-9347-0d8d44bb5a5c" xlink:to="loc_us-gaap_SegmentDomain_497d9c5a-56a9-4499-a6dd-648109a322f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_1737e4d4-26a8-4549-9a17-8d3159bdbb3b" xlink:href="dgx-20201231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_497d9c5a-56a9-4499-a6dd-648109a322f8" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_1737e4d4-26a8-4549-9a17-8d3159bdbb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_b4746f91-e010-46b0-b99e-68164016156b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_SubsegmentsAxis_b4746f91-e010-46b0-b99e-68164016156b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_5751c1db-a902-44db-8078-0ced780fdcf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_b4746f91-e010-46b0-b99e-68164016156b" xlink:to="loc_us-gaap_SubsegmentsDomain_5751c1db-a902-44db-8078-0ced780fdcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_0c168701-47ce-4c9b-b9bc-78324e017a07" xlink:href="dgx-20201231.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_5751c1db-a902-44db-8078-0ced780fdcf0" xlink:to="loc_dgx_GovernmentPayersMember_0c168701-47ce-4c9b-b9bc-78324e017a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember_90d2a33b-7053-41b7-9a1d-6a255a2e022e" xlink:href="dgx-20201231.xsd#dgx_PatientMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_5751c1db-a902-44db-8078-0ced780fdcf0" xlink:to="loc_dgx_PatientMember_90d2a33b-7053-41b7-9a1d-6a255a2e022e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abb6ee46-14c0-4ed3-ac87-bfae898c0856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abb6ee46-14c0-4ed3-ac87-bfae898c0856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_abb6ee46-14c0-4ed3-ac87-bfae898c0856" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_5c13e5ff-3194-410a-9833-ebdba2c5dd85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_5c13e5ff-3194-410a-9833-ebdba2c5dd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_59a8abe6-6900-4780-b1d4-1f56c92dd336" xlink:href="dgx-20201231.xsd#dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:to="loc_dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember_59a8abe6-6900-4780-b1d4-1f56c92dd336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ef9d7f6e-023e-4210-be37-dbb5607255f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2d765573-4e6d-4bf9-bfb0-089eada164e8" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_ef9d7f6e-023e-4210-be37-dbb5607255f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_515d562f-03e3-4f6a-8805-5bbe11d49b7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_515d562f-03e3-4f6a-8805-5bbe11d49b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6bd5d9b5-5840-4c5f-af8d-834344670700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_515d562f-03e3-4f6a-8805-5bbe11d49b7e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6bd5d9b5-5840-4c5f-af8d-834344670700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1f1e54f6-a6e1-4cb2-a35b-c99b696020eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6bd5d9b5-5840-4c5f-af8d-834344670700" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1f1e54f6-a6e1-4cb2-a35b-c99b696020eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_bec650f4-d997-4c2b-b715-5d95eba0982e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_bec650f4-d997-4c2b-b715-5d95eba0982e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d2f86121-10cc-4270-9bc8-36fa5fa80de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_bec650f4-d997-4c2b-b715-5d95eba0982e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d2f86121-10cc-4270-9bc8-36fa5fa80de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_4dd0c783-33b6-4185-8145-91de5c3fc0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d2f86121-10cc-4270-9bc8-36fa5fa80de2" xlink:to="loc_us-gaap_OtherAssetsMember_4dd0c783-33b6-4185-8145-91de5c3fc0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_f1836d24-6122-4657-9a0b-871a850d1676" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_srt_StatementScenarioAxis_f1836d24-6122-4657-9a0b-871a850d1676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5d8436f3-7090-4c3c-bb12-33eec189f9af" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_f1836d24-6122-4657-9a0b-871a850d1676" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5d8436f3-7090-4c3c-bb12-33eec189f9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_bd44e310-2b4a-4b7d-8bd5-a4ea1f1f8a94" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_5d8436f3-7090-4c3c-bb12-33eec189f9af" xlink:to="loc_srt_ScenarioForecastMember_bd44e310-2b4a-4b7d-8bd5-a4ea1f1f8a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f9c5d442-388d-4398-9e6e-aa4a28d53281" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f9c5d442-388d-4398-9e6e-aa4a28d53281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4ba817a2-dcec-4450-8845-848223bae9c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f9c5d442-388d-4398-9e6e-aa4a28d53281" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4ba817a2-dcec-4450-8845-848223bae9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4233b95d-51bd-4b11-ba77-64797fc246cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_4ba817a2-dcec-4450-8845-848223bae9c5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4233b95d-51bd-4b11-ba77-64797fc246cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:href="dgx-20201231.xsd#dgx_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesTable_409a77fb-4fa7-4645-afdd-b964b7b56ba4" xlink:to="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d469a274-8cd0-4751-8d22-7feef28d7a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_d469a274-8cd0-4751-8d22-7feef28d7a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_88304135-31d5-4666-b281-172ca7b7df2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_EquityMethodInvestments_88304135-31d5-4666-b281-172ca7b7df2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_b3f0d0fb-18b3-4204-b8a6-dd143b854f13" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_PercentageofNetRevenues_b3f0d0fb-18b3-4204-b8a6-dd143b854f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7973a43c-e279-4146-925a-0d1ae9fdb3b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7973a43c-e279-4146-925a-0d1ae9fdb3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_e6789717-2b8d-480c-95ba-610be38e533f" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_e6789717-2b8d-480c-95ba-610be38e533f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofReceivablesDueFromPatients_13f2ddfb-bd30-4f8c-bc80-13ea9995b8a6" xlink:href="dgx-20201231.xsd#dgx_PercentageofReceivablesDueFromPatients"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_PercentageofReceivablesDueFromPatients_13f2ddfb-bd30-4f8c-bc80-13ea9995b8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1fa3773-ff19-4ce4-b8eb-d753aa9cda88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1fa3773-ff19-4ce4-b8eb-d753aa9cda88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e555a0a6-9906-4071-9152-336aca4d306c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e555a0a6-9906-4071-9152-336aca4d306c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_13f82472-089d-4434-87bf-33e5d738766d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_OperatingIncomeLoss_13f82472-089d-4434-87bf-33e5d738766d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0ebe4864-f72f-4157-9f16-db5de6647433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_ProfitLoss_0ebe4864-f72f-4157-9f16-db5de6647433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0e85043f-c025-42d5-b46d-9a45b7a71072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_0e85043f-c025-42d5-b46d-9a45b7a71072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesEquity_ec54dd49-5234-40fe-ad7b-166a6261fc50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_TradingSecuritiesEquity_ec54dd49-5234-40fe-ad7b-166a6261fc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_958f7ab5-b399-4d46-905d-6e12e2c562d3" xlink:href="dgx-20201231.xsd#dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment_958f7ab5-b399-4d46-905d-6e12e2c562d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_9a020819-9a15-401a-8401-c577274a74f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_9a020819-9a15-401a-8401-c577274a74f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d20a902e-ac7e-43ef-ba08-62b2c5c72742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d20a902e-ac7e-43ef-ba08-62b2c5c72742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_34c2302a-67a7-4818-9943-b7118e6f0eca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_34c2302a-67a7-4818-9943-b7118e6f0eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_25064f5e-2af0-4a2f-a9cf-f7fe02ed66a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_us-gaap_OperatingLeaseLiability_25064f5e-2af0-4a2f-a9cf-f7fe02ed66a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredRentAdjustments_7f3d6320-4dd2-4768-af63-4b7f5a0d8ec9" xlink:href="dgx-20201231.xsd#dgx_DeferredRentAdjustments"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SummaryOfSignificantAccountingPoliciesLineItems_50dd3aec-38b8-4acc-bcf9-dc882c35d78a" xlink:to="loc_dgx_DeferredRentAdjustments_7f3d6320-4dd2-4768-af63-4b7f5a0d8ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f385b4cd-9fff-44b5-9129-af49ad9297bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_959bbc30-866e-46e0-9b2c-cd4882b45e8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f385b4cd-9fff-44b5-9129-af49ad9297bd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_959bbc30-866e-46e0-9b2c-cd4882b45e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98873e0a-d57c-432c-9349-33e910d85054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_faa5afe5-bb4c-406d-8fcf-690434d9a7cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98873e0a-d57c-432c-9349-33e910d85054" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_faa5afe5-bb4c-406d-8fcf-690434d9a7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_7638467e-f057-4934-85f5-6fa4ab9c4d23" xlink:href="dgx-20201231.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98873e0a-d57c-432c-9349-33e910d85054" xlink:to="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_7638467e-f057-4934-85f5-6fa4ab9c4d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_e0c34d2a-1127-4362-beae-056609e141b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_98873e0a-d57c-432c-9349-33e910d85054" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_e0c34d2a-1127-4362-beae-056609e141b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#REVENUERECOGNITIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0988f935-a21b-4e8e-90f6-0de13046ef30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0988f935-a21b-4e8e-90f6-0de13046ef30" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f2affda1-02a3-4d20-ac19-de48fce530ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f2affda1-02a3-4d20-ac19-de48fce530ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d28092c5-fb47-44d9-b914-c34206aec171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f2affda1-02a3-4d20-ac19-de48fce530ed" xlink:to="loc_us-gaap_SegmentDomain_d28092c5-fb47-44d9-b914-c34206aec171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_934f4d87-c026-43ae-86f6-b61152f5a275" xlink:href="dgx-20201231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d28092c5-fb47-44d9-b914-c34206aec171" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_934f4d87-c026-43ae-86f6-b61152f5a275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_cf6d6d65-e414-4ef4-b7e7-7351c9cc1d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d28092c5-fb47-44d9-b914-c34206aec171" xlink:to="loc_us-gaap_AllOtherSegmentsMember_cf6d6d65-e414-4ef4-b7e7-7351c9cc1d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_c0746ddc-34d8-4476-a545-bd35c48eb753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_us-gaap_SubsegmentsAxis_c0746ddc-34d8-4476-a545-bd35c48eb753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_c0746ddc-34d8-4476-a545-bd35c48eb753" xlink:to="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_34b9b0cf-f450-48a1-b957-b70b609658f6" xlink:href="dgx-20201231.xsd#dgx_HealthcareInsurersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_HealthcareInsurersMember_34b9b0cf-f450-48a1-b957-b70b609658f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_02fd91c9-c952-4beb-8f54-83c9c85b4b14" xlink:href="dgx-20201231.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_GovernmentPayersMember_02fd91c9-c952-4beb-8f54-83c9c85b4b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_b9d1145f-32d5-470a-827c-744c538dd4c4" xlink:href="dgx-20201231.xsd#dgx_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_ClientPayersMember_b9d1145f-32d5-470a-827c-744c538dd4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientMember_2941a7c3-a9cf-49ed-9f76-c1205fd7cba4" xlink:href="dgx-20201231.xsd#dgx_PatientMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_PatientMember_2941a7c3-a9cf-49ed-9f76-c1205fd7cba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_e388976d-4390-4c45-a274-c6a839e54eab" xlink:href="dgx-20201231.xsd#dgx_DSBusinessesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_4a756fa9-437f-4e1b-bb61-347acfb10375" xlink:to="loc_dgx_DSBusinessesMember_e388976d-4390-4c45-a274-c6a839e54eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b7a7d5a9-47f8-4b9e-b749-59dcea267d39" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_srt_ProductOrServiceAxis_b7a7d5a9-47f8-4b9e-b749-59dcea267d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_05a25dd9-d6e8-45ab-b369-f5b16ce9f3f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b7a7d5a9-47f8-4b9e-b749-59dcea267d39" xlink:to="loc_srt_ProductsAndServicesDomain_05a25dd9-d6e8-45ab-b369-f5b16ce9f3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_1002deb2-9cad-4541-ab1a-96dfd0466b31" xlink:href="dgx-20201231.xsd#dgx_FeeforserviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_05a25dd9-d6e8-45ab-b369-f5b16ce9f3f1" xlink:to="loc_dgx_FeeforserviceMember_1002deb2-9cad-4541-ab1a-96dfd0466b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_de4fbb8e-fdc5-4b81-afb0-3464d313adfc" xlink:href="dgx-20201231.xsd#dgx_CapitatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_05a25dd9-d6e8-45ab-b369-f5b16ce9f3f1" xlink:to="loc_dgx_CapitatedMember_de4fbb8e-fdc5-4b81-afb0-3464d313adfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7b98af07-3c9c-4a59-a54a-1a9b3895c341" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_srt_RangeAxis_7b98af07-3c9c-4a59-a54a-1a9b3895c341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3fed11a1-cbdf-4c7f-84d6-894802e7540f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7b98af07-3c9c-4a59-a54a-1a9b3895c341" xlink:to="loc_srt_RangeMember_3fed11a1-cbdf-4c7f-84d6-894802e7540f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d5ff7fa0-984e-4ae1-965b-9f801f220fc2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3fed11a1-cbdf-4c7f-84d6-894802e7540f" xlink:to="loc_srt_MinimumMember_d5ff7fa0-984e-4ae1-965b-9f801f220fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2cea682d-b375-46e1-8853-5b266b07948e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3fed11a1-cbdf-4c7f-84d6-894802e7540f" xlink:to="loc_srt_MaximumMember_2cea682d-b375-46e1-8853-5b266b07948e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f0612f05-4ba4-44ab-aa34-8b2ba3ad92b5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_e8bf06f5-0e1e-4b1f-8852-e508fd9224ba" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_dgx_PercentageofNetRevenues_e8bf06f5-0e1e-4b1f-8852-e508fd9224ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RevenueCollectionofConsiderationPeriod_1d6ed5da-c027-41cb-8933-c1c5d635bf71" xlink:href="dgx-20201231.xsd#dgx_RevenueCollectionofConsiderationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_dgx_RevenueCollectionofConsiderationPeriod_1d6ed5da-c027-41cb-8933-c1c5d635bf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PeriodofBillingFullyReserve_4f117c48-47c1-49d3-95d5-4de0c1404801" xlink:href="dgx-20201231.xsd#dgx_PeriodofBillingFullyReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_dgx_PeriodofBillingFullyReserve_4f117c48-47c1-49d3-95d5-4de0c1404801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_b7f6fbc4-e73a-422e-bf48-f7d5c7a9032e" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_b7f6fbc4-e73a-422e-bf48-f7d5c7a9032e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_589faa48-17dc-46be-af01-c92973bce5eb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4053cf54-593d-4284-8528-00ffc406b7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4053cf54-593d-4284-8528-00ffc406b7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_8097d53c-3b23-49ce-b62d-b7970dbf9a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_8097d53c-3b23-49ce-b62d-b7970dbf9a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_93037c53-16a9-4ecb-8abc-c53a72635ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_93037c53-16a9-4ecb-8abc-c53a72635ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1989d623-faee-49d3-bc8b-12cc0e3fe17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_cc77be28-196e-4642-a996-dfa0e94e5d94" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1989d623-faee-49d3-bc8b-12cc0e3fe17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0b15f5a9-c1c6-44c7-90c4-9e388cf65904" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7cafd305-0002-406c-ba4b-e57cb66da664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0b15f5a9-c1c6-44c7-90c4-9e388cf65904" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7cafd305-0002-406c-ba4b-e57cb66da664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSLOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3a056c9e-a402-462b-b917-3d3c16c60b12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b904d919-9dfb-480c-9512-ff9e07518b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3a056c9e-a402-462b-b917-3d3c16c60b12" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b904d919-9dfb-480c-9512-ff9e07518b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_984f6c2b-2595-4fe3-b39f-708d0af41fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3a056c9e-a402-462b-b917-3d3c16c60b12" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_984f6c2b-2595-4fe3-b39f-708d0af41fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#EARNINGSLOSSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_ada37cb0-3fed-432e-af55-74032e0a8087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_ada37cb0-3fed-432e-af55-74032e0a8087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_f8894c4d-4b0f-42bf-b348-95e1684cb266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_f8894c4d-4b0f-42bf-b348-95e1684cb266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_36855b93-c649-4015-bb2c-74e69f29a3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_NetIncomeLoss_36855b93-c649-4015-bb2c-74e69f29a3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_a1be12da-11a0-49c4-8e3c-ee25d8f40898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic_a1be12da-11a0-49c4-8e3c-ee25d8f40898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2f4c5903-291a-47bf-919d-cebdad815d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2f4c5903-291a-47bf-919d-cebdad815d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_45872c88-172d-4313-b468-11e51f4b613d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_45872c88-172d-4313-b468-11e51f4b613d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5958d056-95ec-4ac1-9ac4-49ae5294347d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5958d056-95ec-4ac1-9ac4-49ae5294347d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f83e8991-bd56-4942-b912-442fa25fe9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f83e8991-bd56-4942-b912-442fa25fe9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b5d5a00f-ce1c-4a15-bd3f-427eb43e72fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_b5d5a00f-ce1c-4a15-bd3f-427eb43e72fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ca9ae8f4-41fd-4d22-ae05-4f561e65cead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ca9ae8f4-41fd-4d22-ae05-4f561e65cead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_99d323fe-67ae-4db1-8380-4ff240a6caf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_EarningsPerShareBasic_99d323fe-67ae-4db1-8380-4ff240a6caf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_89ad0a9a-5139-40dd-9dc9-31c03f405edf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_89ad0a9a-5139-40dd-9dc9-31c03f405edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a085b4f3-3179-48f1-b30c-ad1c2ec5d3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a085b4f3-3179-48f1-b30c-ad1c2ec5d3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_42bd433e-04f7-4041-b6bf-f670d0b8ac59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_EarningsPerShareDiluted_42bd433e-04f7-4041-b6bf-f670d0b8ac59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_de01f29c-2b45-41fd-962d-dbf5512b12a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6dd1b477-847e-4cdb-8092-d9962b504bce" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_de01f29c-2b45-41fd-962d-dbf5512b12a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_578ded3c-43b5-4d84-976c-91d83dd4527b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_a1360ded-9896-4480-9d44-3ee9582a964d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_578ded3c-43b5-4d84-976c-91d83dd4527b" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_a1360ded-9896-4480-9d44-3ee9582a964d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0973ca03-e555-41c0-ba86-5c0ec99b03f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_32330837-3f81-4d84-820c-ab0621fff227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0973ca03-e555-41c0-ba86-5c0ec99b03f7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_32330837-3f81-4d84-820c-ab0621fff227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_025d2a0e-d23b-4428-a4c1-375b24482271" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0973ca03-e555-41c0-ba86-5c0ec99b03f7" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_025d2a0e-d23b-4428-a4c1-375b24482271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8527990c-f0e7-4f05-948f-7de681339c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8527990c-f0e7-4f05-948f-7de681339c55" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e3665934-ef3b-40fc-aca8-5e997ebb2ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:to="loc_us-gaap_RestructuringPlanAxis_e3665934-ef3b-40fc-aca8-5e997ebb2ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1806722f-749f-47c8-af12-359c9f99590e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_e3665934-ef3b-40fc-aca8-5e997ebb2ae6" xlink:to="loc_us-gaap_RestructuringPlanDomain_1806722f-749f-47c8-af12-359c9f99590e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvigorateProgramMember_938c1048-3ad0-4d83-ba74-6620efe14237" xlink:href="dgx-20201231.xsd#dgx_InvigorateProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1806722f-749f-47c8-af12-359c9f99590e" xlink:to="loc_dgx_InvigorateProgramMember_938c1048-3ad0-4d83-ba74-6620efe14237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_cfa692cc-0aa1-4f35-a535-028e0205c730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_cfa692cc-0aa1-4f35-a535-028e0205c730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6fb99f26-f950-4240-a614-0a31af2d8164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_cfa692cc-0aa1-4f35-a535-028e0205c730" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6fb99f26-f950-4240-a614-0a31af2d8164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9d844d92-491c-409d-840f-f8274b36e5ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6fb99f26-f950-4240-a614-0a31af2d8164" xlink:to="loc_us-gaap_CostOfSalesMember_9d844d92-491c-409d-840f-f8274b36e5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_67810eb5-3255-40ce-83bb-f73054ace989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_6fb99f26-f950-4240-a614-0a31af2d8164" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_67810eb5-3255-40ce-83bb-f73054ace989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_49bddaff-958c-42b9-80e5-dfddd5943e31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fe5716ef-c251-4bce-9672-5da2562bd46d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_49bddaff-958c-42b9-80e5-dfddd5943e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5613bb45-560b-4939-9288-490bcacd35e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_49bddaff-958c-42b9-80e5-dfddd5943e31" xlink:to="loc_us-gaap_RestructuringCharges_5613bb45-560b-4939-9288-490bcacd35e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d105263c-8fd4-47f3-8ba8-b023ce771f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c227d590-830c-407c-b260-05cf8d7fa4da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d105263c-8fd4-47f3-8ba8-b023ce771f8e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c227d590-830c-407c-b260-05cf8d7fa4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_db56b8d5-4646-481b-91c6-9d6382b13208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c227d590-830c-407c-b260-05cf8d7fa4da" xlink:to="loc_us-gaap_RestructuringPlanAxis_db56b8d5-4646-481b-91c6-9d6382b13208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0dbed157-e9f4-462c-90aa-f01e6c0228c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_db56b8d5-4646-481b-91c6-9d6382b13208" xlink:to="loc_us-gaap_RestructuringPlanDomain_0dbed157-e9f4-462c-90aa-f01e6c0228c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InvigorateProgramMember_95bd9266-659f-43f3-bbd0-5b2048c6e24d" xlink:href="dgx-20201231.xsd#dgx_InvigorateProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0dbed157-e9f4-462c-90aa-f01e6c0228c0" xlink:to="loc_dgx_InvigorateProgramMember_95bd9266-659f-43f3-bbd0-5b2048c6e24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c227d590-830c-407c-b260-05cf8d7fa4da" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_461195a0-9b44-4b38-a98d-8eaba5a46a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_SeveranceCosts1_461195a0-9b44-4b38-a98d-8eaba5a46a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_5d90eafe-8726-457b-b2bc-afe9eb5f9b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_OtherRestructuringCosts_5d90eafe-8726-457b-b2bc-afe9eb5f9b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_040490ad-1a00-4ca5-bf3e-333094d5f5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_040490ad-1a00-4ca5-bf3e-333094d5f5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_816c95e8-0e9e-451e-b7b8-138623a8eb96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_1652dbf6-9c4f-4379-8aad-f749962b989f" xlink:to="loc_us-gaap_RestructuringCharges_816c95e8-0e9e-451e-b7b8-138623a8eb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e2056c12-fe92-4a5d-8eee-3391c5d472cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0a9e824-dcad-4560-b5ca-557be775b542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e2056c12-fe92-4a5d-8eee-3391c5d472cd" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0a9e824-dcad-4560-b5ca-557be775b542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_524411d8-2a21-429d-9939-54d8fc5573d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0a9e824-dcad-4560-b5ca-557be775b542" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_524411d8-2a21-429d-9939-54d8fc5573d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c9ff81ed-ba7b-45d2-95a5-795cb45a892f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_524411d8-2a21-429d-9939-54d8fc5573d5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c9ff81ed-ba7b-45d2-95a5-795cb45a892f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_87dd4117-b13b-40a1-91e8-cc152fbd7433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c9ff81ed-ba7b-45d2-95a5-795cb45a892f" xlink:to="loc_us-gaap_EmployeeSeveranceMember_87dd4117-b13b-40a1-91e8-cc152fbd7433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_4f0e462a-b5e4-4649-b106-b91965cee0c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c9ff81ed-ba7b-45d2-95a5-795cb45a892f" xlink:to="loc_us-gaap_FacilityClosingMember_4f0e462a-b5e4-4649-b106-b91965cee0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_bca97851-82c4-4302-8cb0-c327c6b12279" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d0a9e824-dcad-4560-b5ca-557be775b542" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_bca97851-82c4-4302-8cb0-c327c6b12279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bca97851-82c4-4302-8cb0-c327c6b12279" xlink:to="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_571ca0b4-cc0b-4994-829c-6920192d245d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_RestructuringReserve_571ca0b4-cc0b-4994-829c-6920192d245d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cd6a02e5-1b71-420b-8306-1130553accc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_RestructuringCharges_cd6a02e5-1b71-420b-8306-1130553accc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_165f2500-7b28-44f1-b650-efb073926920" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_PaymentsForRestructuring_165f2500-7b28-44f1-b650-efb073926920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_89d18d21-8a93-491d-8063-dcf2a7692664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReservePeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_RestructuringReservePeriodIncreaseDecrease_89d18d21-8a93-491d-8063-dcf2a7692664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b92ab4de-e11e-4dba-a3a6-aba5a1957327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_c4afd152-313b-4797-bb84-e62831bc87f6" xlink:to="loc_us-gaap_RestructuringReserve_b92ab4de-e11e-4dba-a3a6-aba5a1957327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_187e959e-c11e-476d-9e6c-541ff64a20f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c16cce4e-004d-47ef-a703-95adf292690e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_187e959e-c11e-476d-9e6c-541ff64a20f8" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_c16cce4e-004d-47ef-a703-95adf292690e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_22b5e790-b3d3-4028-8e48-558111ccb223" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_22b5e790-b3d3-4028-8e48-558111ccb223" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bee437d4-2f7f-4142-a36b-3967f6cbbc1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bee437d4-2f7f-4142-a36b-3967f6cbbc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bee437d4-2f7f-4142-a36b-3967f6cbbc1d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BlueprintGeneticsOyMember_625e1ed5-e16f-4dd5-baa0-364db9dfc1be" xlink:href="dgx-20201231.xsd#dgx_BlueprintGeneticsOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_BlueprintGeneticsOyMember_625e1ed5-e16f-4dd5-baa0-364db9dfc1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MemorialHermannMember_6d524587-8926-4f4a-9eb3-81ce36175cdd" xlink:href="dgx-20201231.xsd#dgx_MemorialHermannMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_MemorialHermannMember_6d524587-8926-4f4a-9eb3-81ce36175cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_e603d49b-b493-404f-a553-4535ece673a7" xlink:href="dgx-20201231.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_e603d49b-b493-404f-a553-4535ece673a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_ef49841d-c8fc-4d8b-ada2-3c17cd4dfef5" xlink:href="dgx-20201231.xsd#dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember_ef49841d-c8fc-4d8b-ada2-3c17cd4dfef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MobileMedicalExaminationServicesInc.MedXMMember_734e2c9a-a1d6-4540-afd4-49fe3677c055" xlink:href="dgx-20201231.xsd#dgx_MobileMedicalExaminationServicesInc.MedXMMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_MobileMedicalExaminationServicesInc.MedXMMember_734e2c9a-a1d6-4540-afd4-49fe3677c055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapeCodHealthcareInc.Member_1b7e91fb-7d7a-46f3-8216-a8ea0ec76259" xlink:href="dgx-20201231.xsd#dgx_CapeCodHealthcareInc.Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_CapeCodHealthcareInc.Member_1b7e91fb-7d7a-46f3-8216-a8ea0ec76259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReproSourceInc.Member_19d55955-2e1d-4b35-892d-6441132cf06d" xlink:href="dgx-20201231.xsd#dgx_ReproSourceInc.Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_ReproSourceInc.Member_19d55955-2e1d-4b35-892d-6441132cf06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OxfordImmunotecInc.Member_0c7b812d-e364-41f5-b0ad-d64c8394d5ad" xlink:href="dgx-20201231.xsd#dgx_OxfordImmunotecInc.Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_af91abe0-9c61-4b6f-91f4-0b0ef966b19e" xlink:to="loc_dgx_OxfordImmunotecInc.Member_0c7b812d-e364-41f5-b0ad-d64c8394d5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6091d5e0-f368-4dd3-8698-3e8a4e54119b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6091d5e0-f368-4dd3-8698-3e8a4e54119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6091d5e0-f368-4dd3-8698-3e8a4e54119b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_452e874c-bbd6-4185-a7f9-8b654d070a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_452e874c-bbd6-4185-a7f9-8b654d070a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7fa7da18-38bc-492f-950c-f35b90412887" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7fa7da18-38bc-492f-950c-f35b90412887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractRelatedMember_f7c40aa4-d555-45a2-8134-8331d65ff31b" xlink:href="dgx-20201231.xsd#dgx_ContractRelatedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7f1fa0e5-c6a4-4d16-a186-8a97feab12e0" xlink:to="loc_dgx_ContractRelatedMember_f7c40aa4-d555-45a2-8134-8331d65ff31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5d18fe3f-954f-419a-a28a-1babd9279b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5d18fe3f-954f-419a-a28a-1babd9279b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6a2875eb-8e3e-431d-8793-3459392c3732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5d18fe3f-954f-419a-a28a-1babd9279b96" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6a2875eb-8e3e-431d-8793-3459392c3732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_092ed17b-5738-44ab-819c-8119cdcaa79b" xlink:href="dgx-20201231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6a2875eb-8e3e-431d-8793-3459392c3732" xlink:to="loc_dgx_OtherIncomeExpenseMember_092ed17b-5738-44ab-819c-8119cdcaa79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_4549c1d8-737c-4e17-a9a2-1d918836b4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6a2875eb-8e3e-431d-8793-3459392c3732" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_4549c1d8-737c-4e17-a9a2-1d918836b4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c83f50e9-cc2f-482b-88f8-4546f64bb9e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c83f50e9-cc2f-482b-88f8-4546f64bb9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40babcc2-f1af-4369-b5b0-0e1a4c97e5b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c83f50e9-cc2f-482b-88f8-4546f64bb9e1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40babcc2-f1af-4369-b5b0-0e1a4c97e5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ec3988eb-fbbe-4e64-8fbd-e7cebfcc4b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_40babcc2-f1af-4369-b5b0-0e1a4c97e5b3" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ec3988eb-fbbe-4e64-8fbd-e7cebfcc4b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d69ff500-dcca-4950-bad9-c01a7c7d0cfe" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_37d3f3dc-4057-4cf8-837a-6a70cc3e9303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_37d3f3dc-4057-4cf8-837a-6a70cc3e9303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a201e8d7-215c-43cf-bd41-6015bfb78462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a201e8d7-215c-43cf-bd41-6015bfb78462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_407820fa-2d97-49fc-85d9-66376909bd81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_407820fa-2d97-49fc-85d9-66376909bd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_3af59375-97fa-4e2a-8176-d790f2d1d8b9" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1_3af59375-97fa-4e2a-8176-d790f2d1d8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessAcquisitionPostacquisitionRevenue_1013becf-7c04-470b-a857-dfe68818d17c" xlink:href="dgx-20201231.xsd#dgx_BusinessAcquisitionPostacquisitionRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessAcquisitionPostacquisitionRevenue_1013becf-7c04-470b-a857-dfe68818d17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_1cb00118-5942-41b4-af19-a41b498bc5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_1cb00118-5942-41b4-af19-a41b498bc5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes_33501d3d-5a72-4029-88a6-68c74a79df6a" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes_33501d3d-5a72-4029-88a6-68c74a79df6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fbd99f61-0a9a-49cf-9bdf-46b817738823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_Goodwill_fbd99f61-0a9a-49cf-9bdf-46b817738823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_67fb85ad-59c7-43be-8aed-8b6f95ed7bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_67fb85ad-59c7-43be-8aed-8b6f95ed7bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_6b0315d4-5c5a-47e6-837d-ba45a36d186a" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital_6b0315d4-5c5a-47e6-837d-ba45a36d186a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55d5b5ba-2042-45a5-8c34-903d1c5da057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55d5b5ba-2042-45a5-8c34-903d1c5da057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2365f661-9f12-4726-a0c6-41d30103bc7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2365f661-9f12-4726-a0c6-41d30103bc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_ad476ec7-6adb-4099-82a4-cce71f181404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_ad476ec7-6adb-4099-82a4-cce71f181404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_3095d1b3-e5ca-43ed-90c1-e84281fda606" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_3095d1b3-e5ca-43ed-90c1-e84281fda606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c55b6ac9-57e6-4a28-92cf-1fdfd8e46340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c55b6ac9-57e6-4a28-92cf-1fdfd8e46340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_8952c323-0d2a-41f2-b811-7ed6416235c4" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue_8952c323-0d2a-41f2-b811-7ed6416235c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_6e427f40-a936-48ac-91c1-a294c6666092" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue_6e427f40-a936-48ac-91c1-a294c6666092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_df4158fd-a0af-402d-8df8-f8aef776d98f" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital_df4158fd-a0af-402d-8df8-f8aef776d98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9ac8de18-2c93-4479-9deb-9d09551b7778" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_9ac8de18-2c93-4479-9deb-9d09551b7778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_e313b354-3bae-48c7-b07a-132323f776a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_e313b354-3bae-48c7-b07a-132323f776a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_12538cad-f330-4fc8-b563-d198579bf426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_12538cad-f330-4fc8-b563-d198579bf426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9bff77b0-71ca-4609-8b76-5b489179b98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9bff77b0-71ca-4609-8b76-5b489179b98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods_e5f41a87-8f1e-409b-b155-49167fce11c3" xlink:href="dgx-20201231.xsd#dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods_e5f41a87-8f1e-409b-b155-49167fce11c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_606143b3-d63f-49a2-b5b6-4f404a090e0b" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_606143b3-d63f-49a2-b5b6-4f404a090e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_36c2c39a-760e-4379-a5f7-ef118495fb3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_36c2c39a-760e-4379-a5f7-ef118495fb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities_141680c5-06f2-4a4d-829b-a77b8d4ad8e0" xlink:href="dgx-20201231.xsd#dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_de1e23b3-811d-4cc9-8e69-0719a3615be6" xlink:to="loc_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities_141680c5-06f2-4a4d-829b-a77b8d4ad8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5be911a0-e5a1-4490-8874-4a207a4220a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_26bbe589-4b16-46d2-b72f-b4d8ec08d461" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5be911a0-e5a1-4490-8874-4a207a4220a7" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_26bbe589-4b16-46d2-b72f-b4d8ec08d461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6b53430b-2c49-4a79-94ac-f7e86d4fb5ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_a530ff1d-44f8-42ac-8a40-2f35c8d66a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6b53430b-2c49-4a79-94ac-f7e86d4fb5ec" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_a530ff1d-44f8-42ac-8a40-2f35c8d66a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_392b1130-f3dc-4613-bf03-918be25924f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6b53430b-2c49-4a79-94ac-f7e86d4fb5ec" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_392b1130-f3dc-4613-bf03-918be25924f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6aa325cf-7d10-4f82-a769-561af6e03dfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6aa325cf-7d10-4f82-a769-561af6e03dfb" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59b21da9-c61f-474b-863c-c0ed0a6a57df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59b21da9-c61f-474b-863c-c0ed0a6a57df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2d29b030-5deb-4780-9c54-9eca3ea9202a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_59b21da9-c61f-474b-863c-c0ed0a6a57df" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2d29b030-5deb-4780-9c54-9eca3ea9202a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_e39f5288-29c1-4702-86d7-bf0c703a4957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2d29b030-5deb-4780-9c54-9eca3ea9202a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_e39f5288-29c1-4702-86d7-bf0c703a4957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9441eb43-ecc7-4d83-b671-6d88b191913c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9441eb43-ecc7-4d83-b671-6d88b191913c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9441eb43-ecc7-4d83-b671-6d88b191913c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_a902472b-cd57-4bd5-afd2-1e140f38d67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_a902472b-cd57-4bd5-afd2-1e140f38d67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8ba3f3eb-15a8-49b5-af4c-bc477891fc3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8ba3f3eb-15a8-49b5-af4c-bc477891fc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7990803b-7f0b-4282-8a12-27053590ffb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c309cd6-2349-470c-8944-9e7a79dc8487" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7990803b-7f0b-4282-8a12-27053590ffb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ec6143df-e244-4896-8276-975a916f1840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ec6143df-e244-4896-8276-975a916f1840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b29b66a1-e9b2-478e-a586-38af38a08989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec6143df-e244-4896-8276-975a916f1840" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b29b66a1-e9b2-478e-a586-38af38a08989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d4c45148-34fc-4ffa-b52e-4e084f95a5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b29b66a1-e9b2-478e-a586-38af38a08989" xlink:to="loc_us-gaap_InterestRateSwapMember_d4c45148-34fc-4ffa-b52e-4e084f95a5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1767c2e3-ad50-4a2c-89d6-8fbdcd4c013f" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_6b2945c7-8a00-489a-80c4-7956c2c92bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_TradingSecurities_6b2945c7-8a00-489a-80c4-7956c2c92bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_82db5d0f-79c8-4f32-8924-6ee7e36f558c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_82db5d0f-79c8-4f32-8924-6ee7e36f558c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_181e6be6-5efd-4427-9844-3057d53f8794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_181e6be6-5efd-4427-9844-3057d53f8794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_34174be5-63c9-4450-8a9b-44aac7e915cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_34174be5-63c9-4450-8a9b-44aac7e915cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_70f6f61a-234f-48c7-a053-0ee21b064a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_70f6f61a-234f-48c7-a053-0ee21b064a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_fd68555c-7997-4f60-9dca-4ba1da584de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_DerivativeLiabilities_fd68555c-7997-4f60-9dca-4ba1da584de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b92ab666-2e8c-457c-9756-d70ddcdc5b67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_b92ab666-2e8c-457c-9756-d70ddcdc5b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6ea78823-ab32-446e-8daf-cb0bc240ac73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6ea78823-ab32-446e-8daf-cb0bc240ac73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_cd4d1f25-c99d-4c29-95ed-48cdad40595b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_1b3173a7-b4d4-4554-a34d-f2a18f2953af" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_cd4d1f25-c99d-4c29-95ed-48cdad40595b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2c708d8b-43d6-4932-8355-706121b0f039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2c708d8b-43d6-4932-8355-706121b0f039" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cdd751b8-3339-486e-8983-024fe754621e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cdd751b8-3339-486e-8983-024fe754621e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_09632371-75f7-4472-a06f-1492aabd13c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_cdd751b8-3339-486e-8983-024fe754621e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_09632371-75f7-4472-a06f-1492aabd13c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_14eed956-dade-4386-b81a-2561ea270c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_09632371-75f7-4472-a06f-1492aabd13c0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_14eed956-dade-4386-b81a-2561ea270c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_22868197-04da-41f9-88b5-474a4b3e2642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_22868197-04da-41f9-88b5-474a4b3e2642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db32c05f-1782-4ce9-9ce0-58f6ac0011e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_22868197-04da-41f9-88b5-474a4b3e2642" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db32c05f-1782-4ce9-9ce0-58f6ac0011e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_7d5e4cab-7795-4952-ba10-a880e4a2c9c4" xlink:href="dgx-20201231.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_db32c05f-1782-4ce9-9ce0-58f6ac0011e2" xlink:to="loc_dgx_ContingentConsiderationMember_7d5e4cab-7795-4952-ba10-a880e4a2c9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_31ded74a-cc2f-4f80-b267-cd5f89b17484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_31ded74a-cc2f-4f80-b267-cd5f89b17484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_12676a7b-bfce-4248-992b-75a02d6aed12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_31ded74a-cc2f-4f80-b267-cd5f89b17484" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_12676a7b-bfce-4248-992b-75a02d6aed12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_1be22bd0-2a3e-4409-a168-810cd319b96c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_12676a7b-bfce-4248-992b-75a02d6aed12" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_1be22bd0-2a3e-4409-a168-810cd319b96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_srt_OwnershipAxis_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e715815f-6961-4d98-833b-47b14b97e284" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_6798bb4b-5f8e-43bf-8fec-6b6643fc4a35" xlink:to="loc_srt_OwnershipDomain_e715815f-6961-4d98-833b-47b14b97e284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_62a841ea-c87d-416f-9a89-fd36998d7591" xlink:href="dgx-20201231.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_e715815f-6961-4d98-833b-47b14b97e284" xlink:to="loc_dgx_UMassJointVentureMember_62a841ea-c87d-416f-9a89-fd36998d7591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_03d74f06-dd4a-4000-bc01-c292b09f1a66" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bd0303f4-b498-40a4-8ab2-944780822729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bd0303f4-b498-40a4-8ab2-944780822729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_eda75055-c906-4f59-9141-1726a4c1f53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_eda75055-c906-4f59-9141-1726a4c1f53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_894e2814-a1ef-4d09-885e-0202b1370cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_894e2814-a1ef-4d09-885e-0202b1370cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d6e38db4-cacb-4472-86b6-7f1fe159d02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_aba530e1-a00c-486b-8399-76d21060a022" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d6e38db4-cacb-4472-86b6-7f1fe159d02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_163252c8-820e-4cac-9063-8b91bb0ddd65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_163252c8-820e-4cac-9063-8b91bb0ddd65" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_24eaa897-6481-4937-a0e6-0504bc93d63f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_24eaa897-6481-4937-a0e6-0504bc93d63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ca4d274-e22d-4461-b085-a01dde2a9cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_24eaa897-6481-4937-a0e6-0504bc93d63f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ca4d274-e22d-4461-b085-a01dde2a9cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c2f7547f-736c-4cf4-8b50-d97af4852e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ca4d274-e22d-4461-b085-a01dde2a9cb4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c2f7547f-736c-4cf4-8b50-d97af4852e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_532da7fb-f606-4ac5-b97b-ae253a468b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_532da7fb-f606-4ac5-b97b-ae253a468b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87cb593e-8bbc-4c1e-82e3-7e03e3039ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_532da7fb-f606-4ac5-b97b-ae253a468b26" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87cb593e-8bbc-4c1e-82e3-7e03e3039ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContingentConsiderationMember_6c76a964-3883-4f7f-a1e8-75ff213081dc" xlink:href="dgx-20201231.xsd#dgx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_87cb593e-8bbc-4c1e-82e3-7e03e3039ce7" xlink:to="loc_dgx_ContingentConsiderationMember_6c76a964-3883-4f7f-a1e8-75ff213081dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_95839cd8-1fc5-4c8b-bdba-905855a7a23c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_e6de92d8-563d-462c-be07-3610f93a6eae" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_95839cd8-1fc5-4c8b-bdba-905855a7a23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_95839cd8-1fc5-4c8b-bdba-905855a7a23c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c5cbbed0-57d9-4d29-a2a6-6f4ea4f1982e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c5cbbed0-57d9-4d29-a2a6-6f4ea4f1982e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_f40d328b-cfd3-4eeb-a469-7d8b935b5b11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_f40d328b-cfd3-4eeb-a469-7d8b935b5b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4cd48e29-4cd1-4f68-8836-ddc780208c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_4cd48e29-4cd1-4f68-8836-ddc780208c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_458ae5c4-7a69-48cb-9cd7-ad1ea42b58a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_458ae5c4-7a69-48cb-9cd7-ad1ea42b58a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a606bc9a-fcf6-4674-827e-5b4f1aa86cee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_2ea2a91d-0644-4a82-81dd-6c45924ac958" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_a606bc9a-fcf6-4674-827e-5b4f1aa86cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_78199c30-fbce-43a3-8c97-40617f3052f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_89e80210-a8ac-4f64-b386-909781d964d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78199c30-fbce-43a3-8c97-40617f3052f9" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_89e80210-a8ac-4f64-b386-909781d964d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMETables" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOMETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1d961186-db4e-4ecb-98b1-ad9d8f329cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4298800b-26f8-4a40-962e-5af7cde7e111" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1d961186-db4e-4ecb-98b1-ad9d8f329cd6" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4298800b-26f8-4a40-962e-5af7cde7e111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_29b0e14c-4116-4e8a-9923-617537b0326c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1d961186-db4e-4ecb-98b1-ad9d8f329cd6" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_29b0e14c-4116-4e8a-9923-617537b0326c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0ab17455-d838-491a-8e84-74f697976ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1d961186-db4e-4ecb-98b1-ad9d8f329cd6" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0ab17455-d838-491a-8e84-74f697976ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_39834957-a77a-4e1a-a2f2-7f3ce66d048d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1d961186-db4e-4ecb-98b1-ad9d8f329cd6" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_39834957-a77a-4e1a-a2f2-7f3ce66d048d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#TAXESONINCOMEDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/TAXESONINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c5b63cb0-fa36-40c0-958c-bdc1310836f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_3135c62e-09a2-45aa-a167-5dec502ef09f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c5b63cb0-fa36-40c0-958c-bdc1310836f7" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_3135c62e-09a2-45aa-a167-5dec502ef09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_37abbf48-c5ad-4b49-a77f-769f545a85a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_3135c62e-09a2-45aa-a167-5dec502ef09f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_37abbf48-c5ad-4b49-a77f-769f545a85a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_37abbf48-c5ad-4b49-a77f-769f545a85a9" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_e43e52be-bceb-404b-aed2-85f52a65b1b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:to="loc_us-gaap_DomesticCountryMember_e43e52be-bceb-404b-aed2-85f52a65b1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_c8ed953c-eece-4639-babb-5378b9dfd93c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_c8ed953c-eece-4639-babb-5378b9dfd93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_60ba2baf-34a2-496d-8b48-9c6c00e45b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_26d85de7-eb02-4b41-a029-c8666c96898a" xlink:to="loc_us-gaap_ForeignCountryMember_60ba2baf-34a2-496d-8b48-9c6c00e45b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_3135c62e-09a2-45aa-a167-5dec502ef09f" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6da42150-7586-464e-beb7-559f623dbf83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6da42150-7586-464e-beb7-559f623dbf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b352f6a5-77cc-4c61-94e7-df62120fcc7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_b352f6a5-77cc-4c61-94e7-df62120fcc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e71e118b-05b1-4eba-8aeb-831fec944da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e71e118b-05b1-4eba-8aeb-831fec944da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_231ae825-29bc-4587-bfd5-d348b10801cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_231ae825-29bc-4587-bfd5-d348b10801cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_480e4817-765a-41ed-b299-e869db237777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_480e4817-765a-41ed-b299-e869db237777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c58a8a39-9e4a-42d7-a342-7dc7e1ed957d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c58a8a39-9e4a-42d7-a342-7dc7e1ed957d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_23033317-6542-4084-815d-e06c551d128a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_23033317-6542-4084-815d-e06c551d128a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0ae5a029-0f45-492a-b40e-9e66965d7e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0ae5a029-0f45-492a-b40e-9e66965d7e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9527f0c1-0f6f-445a-9dd4-fb6520524888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_9527f0c1-0f6f-445a-9dd4-fb6520524888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d2d53896-e972-4c5a-b310-00a401e06246" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d2d53896-e972-4c5a-b310-00a401e06246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9e9fbf4f-5572-41be-b005-7050a47e38e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9e9fbf4f-5572-41be-b005-7050a47e38e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1bc30af1-00e7-461b-8248-721607be336f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1bc30af1-00e7-461b-8248-721607be336f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_62ee95dc-236b-47de-933e-193c86abfe18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_62ee95dc-236b-47de-933e-193c86abfe18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_f33435ba-e62e-4971-8ced-da98ef1cbf61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther_f33435ba-e62e-4971-8ced-da98ef1cbf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a026f1e8-1eca-4936-bc30-19080e9715a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_a026f1e8-1eca-4936-bc30-19080e9715a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_72d5522c-d0d7-4702-858b-6c5948250637" xlink:href="dgx-20201231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod_72d5522c-d0d7-4702-858b-6c5948250637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c357535a-40c1-4d12-8fe8-891bab8e4c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_c357535a-40c1-4d12-8fe8-891bab8e4c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_28022871-1da1-4d01-8d12-84990734cce3" xlink:href="dgx-20201231.xsd#dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition_28022871-1da1-4d01-8d12-84990734cce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_0492d2d8-02f0-48bd-9fe8-d8202d00429d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_0492d2d8-02f0-48bd-9fe8-d8202d00429d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_406191b5-a560-4aad-acd2-df7a6165a689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_406191b5-a560-4aad-acd2-df7a6165a689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_19453a57-18e3-47d6-9b6d-b676e3e85ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_19453a57-18e3-47d6-9b6d-b676e3e85ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod_d8097f0b-3817-44db-b0e8-bbc63050d73b" xlink:href="dgx-20201231.xsd#dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod_d8097f0b-3817-44db-b0e8-bbc63050d73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_cda13aeb-e5ae-4645-8149-46743dabe2ae" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables_cda13aeb-e5ae-4645-8149-46743dabe2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_05b83e92-1bb3-4c86-b78f-547ee0576323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_05b83e92-1bb3-4c86-b78f-547ee0576323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0f74e46b-ca4d-4755-ae1c-f59d5bb50af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0f74e46b-ca4d-4755-ae1c-f59d5bb50af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_624ab7eb-4d17-4277-a293-0001a9bef2c0" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments_624ab7eb-4d17-4277-a293-0001a9bef2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_d7f684fc-94ea-4b92-8ac9-e22a56ee90fd" xlink:href="dgx-20201231.xsd#dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance_d7f684fc-94ea-4b92-8ac9-e22a56ee90fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f766d63d-ddb1-42d3-a594-cb79b9e091eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_f766d63d-ddb1-42d3-a594-cb79b9e091eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_cb40c077-9229-4942-b411-89ef69f70eb9" xlink:href="dgx-20201231.xsd#dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent_cb40c077-9229-4942-b411-89ef69f70eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a886d366-b3a7-406a-a4f7-143f9f06b295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a886d366-b3a7-406a-a4f7-143f9f06b295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_4e2bfb2f-29b3-45ab-bc70-f6c5b3add6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxLiabilities_4e2bfb2f-29b3-45ab-bc70-f6c5b3add6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_8e39897a-8419-4eef-a00b-3fb8a7a94503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_OperatingLossCarryforwards_8e39897a-8419-4eef-a00b-3fb8a7a94503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e22cb768-8925-4590-81c5-de91ad209843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e22cb768-8925-4590-81c5-de91ad209843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d70588a-25b1-4450-ae4a-41cbcf2e2dc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d70588a-25b1-4450-ae4a-41cbcf2e2dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_b0968e7a-38dc-4dc0-b4b1-9db6a506b507" xlink:href="dgx-20201231.xsd#dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards_b0968e7a-38dc-4dc0-b4b1-9db6a506b507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_9a477278-3874-4d7c-b6ca-8de78cf616b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_AccruedIncomeTaxes_9a477278-3874-4d7c-b6ca-8de78cf616b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_3b694bca-7cb4-4a5d-a0f1-06185e89f68d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_PrepaidTaxes_3b694bca-7cb4-4a5d-a0f1-06185e89f68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_69536b3b-7efb-4fe6-adb1-f4483cc5c7d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_69536b3b-7efb-4fe6-adb1-f4483cc5c7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_494e232e-a328-4f79-960b-5f545dca38d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_494e232e-a328-4f79-960b-5f545dca38d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_291be510-bd94-4a07-a375-7a6b5016102a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_291be510-bd94-4a07-a375-7a6b5016102a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReductionsForChangesInJudgment_12a7fc51-91ed-4f4e-a1af-72308a8b3442" xlink:href="dgx-20201231.xsd#dgx_ReductionsForChangesInJudgment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_dgx_ReductionsForChangesInJudgment_12a7fc51-91ed-4f4e-a1af-72308a8b3442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fe3ca0cf-768d-4475-9bc8-a82b447ee43e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fe3ca0cf-768d-4475-9bc8-a82b447ee43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_093f7cb2-eb0c-462b-ba4f-d5de9438f73a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_093f7cb2-eb0c-462b-ba4f-d5de9438f73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6d7d6766-07ee-4bf7-9dcb-6cb84528af21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0ea94fe3-0b25-45f3-899e-88511d346181" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6d7d6766-07ee-4bf7-9dcb-6cb84528af21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_d7cf903d-94f5-4aef-a3a6-9e34457fe88f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_d7cf903d-94f5-4aef-a3a6-9e34457fe88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_57f252d3-a2e2-49f6-a63d-fe2134c5c99a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_57f252d3-a2e2-49f6-a63d-fe2134c5c99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_36bb3400-7188-4b2c-a217-954293534dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_36bb3400-7188-4b2c-a217-954293534dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_97418a2a-52cf-49aa-96d9-c94ed044aa3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_487336c4-1412-4898-acd1-8db8753e0e9d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued_97418a2a-52cf-49aa-96d9-c94ed044aa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATA"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_3a26a521-e17e-43ea-bff4-a8f3371121d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_9ade1cd7-d4b2-4a2d-aa77-59b47e348dfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_3a26a521-e17e-43ea-bff4-a8f3371121d4" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_9ade1cd7-d4b2-4a2d-aa77-59b47e348dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATATables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_955843ee-98a3-4316-9974-e09bb95b7df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bf1388d8-0a99-4811-9a30-9d25b860002f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_955843ee-98a3-4316-9974-e09bb95b7df0" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bf1388d8-0a99-4811-9a30-9d25b860002f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#SUPPLEMENTALCASHFLOWANDOTHERDATADetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataTable_588ae7f0-ec25-4d52-afab-f6317db34008" xlink:href="dgx-20201231.xsd#dgx_SupplementalCashFlowAndOtherDataTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataTable_588ae7f0-ec25-4d52-afab-f6317db34008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_c49a12de-968b-40f5-ac19-aeccd58085b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_588ae7f0-ec25-4d52-afab-f6317db34008" xlink:to="loc_us-gaap_NatureOfExpenseAxis_c49a12de-968b-40f5-ac19-aeccd58085b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8868b558-e60d-4c50-905f-13ab7efc817c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c49a12de-968b-40f5-ac19-aeccd58085b8" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8868b558-e60d-4c50-905f-13ab7efc817c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmortizationofIntangibleAssetsMember_10ab9b99-ff21-4581-89b5-9f06fc6166f3" xlink:href="dgx-20201231.xsd#dgx_AmortizationofIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_8868b558-e60d-4c50-905f-13ab7efc817c" xlink:to="loc_dgx_AmortizationofIntangibleAssetsMember_10ab9b99-ff21-4581-89b5-9f06fc6166f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_6d3a8521-c725-440c-9c02-5d2d61ca902d" xlink:href="dgx-20201231.xsd#dgx_SupplementalCashFlowAndOtherDataLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataTable_588ae7f0-ec25-4d52-afab-f6317db34008" xlink:to="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_6d3a8521-c725-440c-9c02-5d2d61ca902d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d895f15a-b272-40a9-82e8-d8721937181c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_SupplementalCashFlowAndOtherDataLineItems_6d3a8521-c725-440c-9c02-5d2d61ca902d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d895f15a-b272-40a9-82e8-d8721937181c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_46d33633-fa1f-4411-83c5-2dae9bce7a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_Depreciation_46d33633-fa1f-4411-83c5-2dae9bce7a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9e323035-18bf-41ad-8d42-d0665fd9cecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9e323035-18bf-41ad-8d42-d0665fd9cecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_58bdc32c-b66e-4733-aeb2-aca29d107751" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_InterestExpense_58bdc32c-b66e-4733-aeb2-aca29d107751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_1df0b091-b1d8-4bd7-9aea-e0a748a6cc76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_1df0b091-b1d8-4bd7-9aea-e0a748a6cc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_46781127-66d2-4fe7-8d83-aa1862205313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_46781127-66d2-4fe7-8d83-aa1862205313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_a4445361-ee4b-48d8-8f55-76a14bca25c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_InterestPaid_a4445361-ee4b-48d8-8f55-76a14bca25c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_aac19586-97d0-495f-a4ad-61b35f51f365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_IncomeTaxesPaid_aac19586-97d0-495f-a4ad-61b35f51f365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_11179d39-cef1-4b9b-9f83-bb7bf5c6686f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_11179d39-cef1-4b9b-9f83-bb7bf5c6686f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockPurchasedbutNotyetPaid_175e2ff6-72b0-4861-9664-4f2df2523df2" xlink:href="dgx-20201231.xsd#dgx_TreasuryStockPurchasedbutNotyetPaid"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_dgx_TreasuryStockPurchasedbutNotyetPaid_175e2ff6-72b0-4861-9664-4f2df2523df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_41882e46-63d9-4606-9a13-8bd3c8a5da72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_41882e46-63d9-4606-9a13-8bd3c8a5da72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_0ba28af5-edf7-4c55-a30f-94c817721f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_0ba28af5-edf7-4c55-a30f-94c817721f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_0352a91e-16be-4a45-bac9-9a4ceffc9c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_LiabilitiesAssumed1_0352a91e-16be-4a45-bac9-9a4ceffc9c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_0c01fad8-e228-4d1f-ab45-9c333f29c133" xlink:href="dgx-20201231.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_dgx_FairValueOfNetAssetsAcquired_0c01fad8-e228-4d1f-ab45-9c333f29c133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Mergerconsiderationpaidpayablenet_90d5546a-2c32-4f18-9b34-f8ac9c40e3d8" xlink:href="dgx-20201231.xsd#dgx_Mergerconsiderationpaidpayablenet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_dgx_Mergerconsiderationpaidpayablenet_90d5546a-2c32-4f18-9b34-f8ac9c40e3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8dd44407-dbe9-40da-8947-c9bcd236d571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8dd44407-dbe9-40da-8947-c9bcd236d571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_09f7ec72-669c-4cb1-91cd-8f26324f99a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_09f7ec72-669c-4cb1-91cd-8f26324f99a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9c647b17-8bb0-40c9-bc55-f6ea408c0b9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9c647b17-8bb0-40c9-bc55-f6ea408c0b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_c9e63f48-66ea-4c8d-8e48-5de66d3dec49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_4358ee61-20c0-41e5-b032-4f070fb5fd53" xlink:to="loc_us-gaap_LeaseCostAbstract_c9e63f48-66ea-4c8d-8e48-5de66d3dec49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f8300b13-b5d2-4b40-93e5-2c2c1b488e77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_c9e63f48-66ea-4c8d-8e48-5de66d3dec49" xlink:to="loc_us-gaap_OperatingLeasePayments_f8300b13-b5d2-4b40-93e5-2c2c1b488e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_57b2c162-e54c-429b-87e6-689a847fb1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_c9e63f48-66ea-4c8d-8e48-5de66d3dec49" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_57b2c162-e54c-429b-87e6-689a847fb1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_6daf956a-01ec-4ff2-929a-6fd8df0a7c96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_c9e63f48-66ea-4c8d-8e48-5de66d3dec49" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_6daf956a-01ec-4ff2-929a-6fd8df0a7c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3e08df3e-0c77-4cdf-8b52-0168178d26e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_c9e63f48-66ea-4c8d-8e48-5de66d3dec49" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3e08df3e-0c77-4cdf-8b52-0168178d26e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_f25ef731-ea17-4010-821b-030b55fff2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_c9e63f48-66ea-4c8d-8e48-5de66d3dec49" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_f25ef731-ea17-4010-821b-030b55fff2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsIncurred_c8581c76-cf4e-4d2c-9fd1-2c10c140f95d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsIncurred"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_c9e63f48-66ea-4c8d-8e48-5de66d3dec49" xlink:to="loc_us-gaap_CapitalLeaseObligationsIncurred_c8581c76-cf4e-4d2c-9fd1-2c10c140f95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3f3d247d-e839-4bb1-8a1f-1c576e1a1c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d5dd0a8f-8f4f-4b2b-8b6e-a9607a37150e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3f3d247d-e839-4bb1-8a1f-1c576e1a1c8c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d5dd0a8f-8f4f-4b2b-8b6e-a9607a37150e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d75ef9c3-7bbe-4696-99ed-0e67bea79df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6af1194d-be8c-4624-aa28-36491a8747e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d75ef9c3-7bbe-4696-99ed-0e67bea79df3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6af1194d-be8c-4624-aa28-36491a8747e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_60b0f19b-93b5-4cff-8468-6ced5034cd38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_60b0f19b-93b5-4cff-8468-6ced5034cd38" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_57f25992-4b3b-48f7-a4c2-ea39d4c240d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_57f25992-4b3b-48f7-a4c2-ea39d4c240d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_57f25992-4b3b-48f7-a4c2-ea39d4c240d9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_51bb9a8e-954a-4665-9563-3aa597c935b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_LandMember_51bb9a8e-954a-4665-9563-3aa597c935b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_677ab311-cc30-4966-afb2-8cacc0e66b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_677ab311-cc30-4966-afb2-8cacc0e66b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_5cd68385-b949-4c7c-b92b-f7a60bf2f7b0" xlink:href="dgx-20201231.xsd#dgx_LaboratoryEquipmentFurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_dgx_LaboratoryEquipmentFurnitureAndFixturesMember_5cd68385-b949-4c7c-b92b-f7a60bf2f7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_1e6607a1-238f-4b2d-a277-400d6a94d471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_1e6607a1-238f-4b2d-a277-400d6a94d471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_114b20eb-117a-4640-9c3f-f2716c8e7ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_114b20eb-117a-4640-9c3f-f2716c8e7ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_f1d0db34-df78-4b20-a3a1-ae11733d4ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5d70d91b-8ea6-4eaa-b4c6-bdc5d185f9b3" xlink:to="loc_us-gaap_ConstructionInProgressMember_f1d0db34-df78-4b20-a3a1-ae11733d4ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_98edfdf4-0e09-4283-85fb-d17a098a78bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_98edfdf4-0e09-4283-85fb-d17a098a78bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f00ff2f8-0b24-45d4-a679-e6adcec0e744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_98edfdf4-0e09-4283-85fb-d17a098a78bf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f00ff2f8-0b24-45d4-a679-e6adcec0e744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_fd53cdc9-3d5a-4d1c-8bd8-2f429734c039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f00ff2f8-0b24-45d4-a679-e6adcec0e744" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_fd53cdc9-3d5a-4d1c-8bd8-2f429734c039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_69386359-fb36-47c9-81e8-1b9e109d6291" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_cafa0dc5-e42b-4071-b8da-91ccfd1b1993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_cafa0dc5-e42b-4071-b8da-91ccfd1b1993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ac6c8b2e-927a-4163-8b20-19b9cc8a7fe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ac6c8b2e-927a-4163-8b20-19b9cc8a7fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_72e37505-4124-4dd5-9a63-34bc83916d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_72e37505-4124-4dd5-9a63-34bc83916d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_890cde95-f66f-49af-84a6-7b110f640422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f464373b-c112-44e8-97fb-79a300928654" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_890cde95-f66f-49af-84a6-7b110f640422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7c57d35e-1670-40db-994b-ac86b8d0f79f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_51c50f8e-3a69-4df7-8dd3-af4258d0bf3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7c57d35e-1670-40db-994b-ac86b8d0f79f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_51c50f8e-3a69-4df7-8dd3-af4258d0bf3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0d415201-b0ea-4e99-af24-6a6c77699087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_b709da98-0e67-48ff-8112-01d3265b6183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0d415201-b0ea-4e99-af24-6a6c77699087" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_b709da98-0e67-48ff-8112-01d3265b6183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_4b5235b5-d697-40d3-bf2d-a443037db04d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0d415201-b0ea-4e99-af24-6a6c77699087" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_4b5235b5-d697-40d3-bf2d-a443037db04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5720c489-52a7-4a8c-bc0c-4711c946332f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0d415201-b0ea-4e99-af24-6a6c77699087" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5720c489-52a7-4a8c-bc0c-4711c946332f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_48372879-bc4c-4976-a84f-ed0b2fdbe7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_c221a585-d137-42e2-b6e6-feb153ab5e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_48372879-bc4c-4976-a84f-ed0b2fdbe7e7" xlink:to="loc_us-gaap_GoodwillRollForward_c221a585-d137-42e2-b6e6-feb153ab5e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_63acef1f-4758-4277-98a2-999f1b3a0d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c221a585-d137-42e2-b6e6-feb153ab5e5b" xlink:to="loc_us-gaap_Goodwill_63acef1f-4758-4277-98a2-999f1b3a0d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6353fca1-96b6-4756-8fc3-92d31771061c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c221a585-d137-42e2-b6e6-feb153ab5e5b" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6353fca1-96b6-4756-8fc3-92d31771061c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_4fdca561-e7a2-4b87-a2c5-fc6a3b232877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c221a585-d137-42e2-b6e6-feb153ab5e5b" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_4fdca561-e7a2-4b87-a2c5-fc6a3b232877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d7dceee7-23a4-4adb-afd4-07f6a18fadbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_c221a585-d137-42e2-b6e6-feb153ab5e5b" xlink:to="loc_us-gaap_Goodwill_d7dceee7-23a4-4adb-afd4-07f6a18fadbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_48372879-bc4c-4976-a84f-ed0b2fdbe7e7" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29120da4-5b40-4976-a3c1-970ac52d1ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29120da4-5b40-4976-a3c1-970ac52d1ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_29120da4-5b40-4976-a3c1-970ac52d1ce8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9697a02b-8299-4658-af7f-fa7b2ba27a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9697a02b-8299-4658-af7f-fa7b2ba27a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_fd549589-72c1-42dc-836b-a137841a16ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_fd549589-72c1-42dc-836b-a137841a16ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_3cff6446-3229-4dd8-b53e-1fcd6a7b8a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_3cff6446-3229-4dd8-b53e-1fcd6a7b8a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_35002253-deb8-4358-a1ab-bc9105253eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_35002253-deb8-4358-a1ab-bc9105253eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_0cbe13ca-7818-45f7-bf3f-cc8911117de6" xlink:href="dgx-20201231.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_acbcb533-be99-4c9c-8aa3-8fc5a39fe906" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_0cbe13ca-7818-45f7-bf3f-cc8911117de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dd7a872b-f99c-423d-8786-e3d0261ff2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dd7a872b-f99c-423d-8786-e3d0261ff2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89bd0756-a812-40ab-ba70-ce92e76ed28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_dd7a872b-f99c-423d-8786-e3d0261ff2a3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89bd0756-a812-40ab-ba70-ce92e76ed28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_059c0f1a-9832-4ddc-bfbc-06084ce47645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89bd0756-a812-40ab-ba70-ce92e76ed28a" xlink:to="loc_us-gaap_TradeNamesMember_059c0f1a-9832-4ddc-bfbc-06084ce47645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_de2c974d-c374-4e78-ba63-5adf99d93281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_89bd0756-a812-40ab-ba70-ce92e76ed28a" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_de2c974d-c374-4e78-ba63-5adf99d93281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_c4232a9b-dd24-428c-85b6-ffe9ffc2db73" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b5a80b41-2a05-430e-8685-bcfb4fbc8fac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b5a80b41-2a05-430e-8685-bcfb4fbc8fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2eaa1cf8-955b-43f6-8221-e6eb05590037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2eaa1cf8-955b-43f6-8221-e6eb05590037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a9880811-019b-45bd-8713-cc6627525aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a9880811-019b-45bd-8713-cc6627525aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dc34a1c3-8637-48de-9b8b-26f36ea62051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dc34a1c3-8637-48de-9b8b-26f36ea62051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_8688dee4-a398-4444-bba0-79bb930d142f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1d4a439f-7a03-4a7e-9ebd-2c41c4946416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1d4a439f-7a03-4a7e-9ebd-2c41c4946416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_32ebf9b7-87a5-45f4-8220-4f947b2e0213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_32ebf9b7-87a5-45f4-8220-4f947b2e0213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d156870a-94f9-412c-9a44-7d5efa602e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d156870a-94f9-412c-9a44-7d5efa602e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c0095471-235e-4ea5-adfa-563a6af4bcc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c0095471-235e-4ea5-adfa-563a6af4bcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc9f998d-5f29-4b92-8353-f7daa1ed051a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_fc9f998d-5f29-4b92-8353-f7daa1ed051a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9e5b217a-ca32-49d2-b08e-09219e9801c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_9e5b217a-ca32-49d2-b08e-09219e9801c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_e67a6240-7aee-4ba0-ab7a-ae816b57c300" xlink:href="dgx-20201231.xsd#dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_6208c124-4f9e-49a8-a067-4fa393b479d8" xlink:to="loc_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal_e67a6240-7aee-4ba0-ab7a-ae816b57c300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_e817188e-be19-4c16-92a1-2f4ebd63b3d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_98399279-40db-4a3c-907e-3abe85bb69d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_e817188e-be19-4c16-92a1-2f4ebd63b3d2" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_98399279-40db-4a3c-907e-3abe85bb69d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9a8e51be-61ac-4e0e-934f-676798d5ab69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_13e67181-e5d4-4382-9747-85cb75463a14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_9a8e51be-61ac-4e0e-934f-676798d5ab69" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_13e67181-e5d4-4382-9747-85cb75463a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_59f666d8-99f1-4e90-b79d-5a1591d8504f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_59f666d8-99f1-4e90-b79d-5a1591d8504f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_d1f58e11-0089-40e1-9177-aeb2eb73d91c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_d1f58e11-0089-40e1-9177-aeb2eb73d91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_27469f70-d646-4e42-a7b4-47f34c033f72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_27469f70-d646-4e42-a7b4-47f34c033f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankOverdrafts_d6da44f8-aa58-41a1-986e-4e0ee86b0006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BankOverdrafts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_BankOverdrafts_d6da44f8-aa58-41a1-986e-4e0ee86b0006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_53964991-75ec-456a-b0ad-89b0da28e5d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_DividendsPayableCurrent_53964991-75ec-456a-b0ad-89b0da28e5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_38a23965-b727-4b9d-b1f5-baed59d43a63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_38a23965-b727-4b9d-b1f5-baed59d43a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_497e8885-2b4e-4551-b004-97fc8d79abbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_497e8885-2b4e-4551-b004-97fc8d79abbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_9e80109b-2b14-438b-bc55-f432b754a9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_InterestPayableCurrent_9e80109b-2b14-438b-bc55-f432b754a9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MergerConsiderationPayableCurrent_bddcf648-bfeb-4e68-82e2-4bc2e92e8eae" xlink:href="dgx-20201231.xsd#dgx_MergerConsiderationPayableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_dgx_MergerConsiderationPayableCurrent_bddcf648-bfeb-4e68-82e2-4bc2e92e8eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6961d613-c7ba-4ebe-a731-9087e20695a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract_398827f9-5434-45c5-b62c-44891de6f454" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6961d613-c7ba-4ebe-a731-9087e20695a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBT" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_9ceebf20-5e88-4e2f-974b-60071bf1ba32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_efda2d73-f447-459a-82bc-22372b7824e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_9ceebf20-5e88-4e2f-974b-60071bf1ba32" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_efda2d73-f447-459a-82bc-22372b7824e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_6f86b53d-497c-45c6-aeb7-bbdd8fb0a5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_8f0f08bd-8edc-4ccb-8c41-2bac7353683e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_6f86b53d-497c-45c6-aeb7-bbdd8fb0a5a8" xlink:to="loc_us-gaap_LongTermDebtTextBlock_8f0f08bd-8edc-4ccb-8c41-2bac7353683e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock_b83cde09-817e-43ec-8cff-70f3b5773490" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_6f86b53d-497c-45c6-aeb7-bbdd8fb0a5a8" xlink:to="loc_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock_b83cde09-817e-43ec-8cff-70f3b5773490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4d8bfb25-7d66-40f5-b4ef-fbebfde826c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_6f86b53d-497c-45c6-aeb7-bbdd8fb0a5a8" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_4d8bfb25-7d66-40f5-b4ef-fbebfde826c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_6514838b-dd15-4723-ae20-67d939a68cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_6514838b-dd15-4723-ae20-67d939a68cbe" xlink:to="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ee9f11fb-e711-401d-a659-a556bf4d84a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ee9f11fb-e711-401d-a659-a556bf4d84a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72a186e0-cd3f-41ca-938a-ac309e3a6f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ee9f11fb-e711-401d-a659-a556bf4d84a9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72a186e0-cd3f-41ca-938a-ac309e3a6f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_78540ce7-443a-4ec5-aa56-e663f011752a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72a186e0-cd3f-41ca-938a-ac309e3a6f44" xlink:to="loc_us-gaap_SeniorNotesMember_78540ce7-443a-4ec5-aa56-e663f011752a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:to="loc_us-gaap_DebtInstrumentAxis_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce41c455-2ec0-4a89-a3a9-4bf3de2dbaa3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member_4d16755f-46ce-4713-943a-05881a2ee193" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenFivePercentSeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourPointSevenFivePercentSeniorNotesDue2020Member_4d16755f-46ce-4713-943a-05881a2ee193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member_1229fd58-884f-42a4-b1b3-a1d1246b24d1" xlink:href="dgx-20201231.xsd#dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member_1229fd58-884f-42a4-b1b3-a1d1246b24d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member_85c2f546-b24f-4475-9d7b-e40ed3a56094" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member_85c2f546-b24f-4475-9d7b-e40ed3a56094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_4a2f1e39-61fb-48cb-a40d-f2dea03cefb4" xlink:href="dgx-20201231.xsd#dgx_FourpointtwofivepercentSeniorNotesDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourpointtwofivepercentSeniorNotesDue2024Member_4a2f1e39-61fb-48cb-a40d-f2dea03cefb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_789cf00f-f9ed-41be-8a68-3386460b3d1e" xlink:href="dgx-20201231.xsd#dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member_789cf00f-f9ed-41be-8a68-3386460b3d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_c3c0d136-6b0d-4958-8995-87af980eda2e" xlink:href="dgx-20201231.xsd#dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member_c3c0d136-6b0d-4958-8995-87af980eda2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_8962ac13-c304-4f2b-9092-181dac6ff78a" xlink:href="dgx-20201231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_8962ac13-c304-4f2b-9092-181dac6ff78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_8f274e10-f645-4c72-8fda-eb929a096943" xlink:href="dgx-20201231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_8f274e10-f645-4c72-8fda-eb929a096943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_0c312962-a4e1-47ec-a425-ec78cd9ff266" xlink:href="dgx-20201231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_0c312962-a4e1-47ec-a425-ec78cd9ff266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_1d3c3201-648a-4701-8209-fd6969c651a2" xlink:href="dgx-20201231.xsd#dgx_SixPointNineFivePercentSeniorNotesDue2037Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_SixPointNineFivePercentSeniorNotesDue2037Member_1d3c3201-648a-4701-8209-fd6969c651a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_f0fcc686-974d-4e2c-a8d1-d4c9483e23ea" xlink:href="dgx-20201231.xsd#dgx_FivePointSevenFivePercentSeniorNotesDue2040Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FivePointSevenFivePercentSeniorNotesDue2040Member_f0fcc686-974d-4e2c-a8d1-d4c9483e23ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_f4e7cfb8-35cf-4a90-bda4-0f0c07480fa7" xlink:href="dgx-20201231.xsd#dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member_f4e7cfb8-35cf-4a90-bda4-0f0c07480fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceLeaseObligationsandOtherMember_6e8c4b5c-0a99-44ee-84c4-f94124cc5714" xlink:href="dgx-20201231.xsd#dgx_FinanceLeaseObligationsandOtherMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_acde8ca4-5cb5-4c3f-8d52-6735bf1ba2d7" xlink:to="loc_dgx_FinanceLeaseObligationsandOtherMember_6e8c4b5c-0a99-44ee-84c4-f94124cc5714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_57f73232-7ab5-459a-8322-26409497dae1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_121f4e77-c11e-49b9-abaf-4a887210aee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_LongTermDebt_121f4e77-c11e-49b9-abaf-4a887210aee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_b0116ef6-dd22-4057-a60a-f35b4bfdc60b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_OtherLongTermDebt_b0116ef6-dd22-4057-a60a-f35b4bfdc60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_aafabd96-299e-4654-8311-49583d472667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_aafabd96-299e-4654-8311-49583d472667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b3b1a4b8-4696-4f62-89a1-530e4e717979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_LongTermDebtCurrent_b3b1a4b8-4696-4f62-89a1-530e4e717979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_21d038bb-6eaa-4358-9681-0cb741f82bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_21d038bb-6eaa-4358-9681-0cb741f82bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1e26d15-f9b6-4b3a-b43f-171f9b20b9a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_70fc957e-d8aa-4ef6-940c-647e351d4c2d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c1e26d15-f9b6-4b3a-b43f-171f9b20b9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSecuredReceivablesCreditFacilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_f8c708c5-617b-41f5-b601-0309e7359da1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_f8c708c5-617b-41f5-b601-0309e7359da1" xlink:to="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_435c5ece-3cb4-495d-9f15-50ea90eb7a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_435c5ece-3cb4-495d-9f15-50ea90eb7a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_444970fc-447c-4086-acf6-915ff032079d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_435c5ece-3cb4-495d-9f15-50ea90eb7a25" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_444970fc-447c-4086-acf6-915ff032079d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_e3180781-de2c-4bdb-8e52-b85fc1585574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_444970fc-447c-4086-acf6-915ff032079d" xlink:to="loc_us-gaap_SecuredDebtMember_e3180781-de2c-4bdb-8e52-b85fc1585574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_18b8c07a-35d1-4553-8fb5-0bba561d7e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_DebtInstrumentAxis_18b8c07a-35d1-4553-8fb5-0bba561d7e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f897b883-8b25-4016-8b64-b08e236a75c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_18b8c07a-35d1-4553-8fb5-0bba561d7e44" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f897b883-8b25-4016-8b64-b08e236a75c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoancommitmentmaturingOctober2021Member_85be2f01-d59e-40de-af6b-059d737d509b" xlink:href="dgx-20201231.xsd#dgx_LoancommitmentmaturingOctober2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f897b883-8b25-4016-8b64-b08e236a75c0" xlink:to="loc_dgx_LoancommitmentmaturingOctober2021Member_85be2f01-d59e-40de-af6b-059d737d509b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LoanCommitmentMaturingOctober2022Member_2e53c3a1-c9e4-417a-9aa3-22546ea8725a" xlink:href="dgx-20201231.xsd#dgx_LoanCommitmentMaturingOctober2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f897b883-8b25-4016-8b64-b08e236a75c0" xlink:to="loc_dgx_LoanCommitmentMaturingOctober2022Member_2e53c3a1-c9e4-417a-9aa3-22546ea8725a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ae384489-2674-4287-a3e1-db155fbc0acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_CreditFacilityAxis_ae384489-2674-4287-a3e1-db155fbc0acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7a2edb06-cb07-4ddf-832d-dcb277cb958c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ae384489-2674-4287-a3e1-db155fbc0acf" xlink:to="loc_us-gaap_CreditFacilityDomain_7a2edb06-cb07-4ddf-832d-dcb277cb958c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_dd21aff7-7de8-443d-b75f-ff14cdef256c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7a2edb06-cb07-4ddf-832d-dcb277cb958c" xlink:to="loc_us-gaap_LetterOfCreditMember_dd21aff7-7de8-443d-b75f-ff14cdef256c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_78d40cf9-ab0d-4714-9009-5ba2d1c4876b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7a2edb06-cb07-4ddf-832d-dcb277cb958c" xlink:to="loc_us-gaap_LineOfCreditMember_78d40cf9-ab0d-4714-9009-5ba2d1c4876b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_45ae44dd-6cd8-4722-bc2f-b9385ff3938c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_VariableRateAxis_45ae44dd-6cd8-4722-bc2f-b9385ff3938c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_af1008ba-29c0-43c9-aea6-22a25b1450f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_45ae44dd-6cd8-4722-bc2f-b9385ff3938c" xlink:to="loc_us-gaap_VariableRateDomain_af1008ba-29c0-43c9-aea6-22a25b1450f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_1adf6e5f-7872-4ce6-b104-460a4f7dc27e" xlink:href="dgx-20201231.xsd#dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_af1008ba-29c0-43c9-aea6-22a25b1450f8" xlink:to="loc_dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember_1adf6e5f-7872-4ce6-b104-460a4f7dc27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a014b6d7-326f-47b9-a6b5-640fc2a26b76" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_srt_RangeAxis_a014b6d7-326f-47b9-a6b5-640fc2a26b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1e64d1ea-20ab-4704-a59f-53b2a1988a7b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a014b6d7-326f-47b9-a6b5-640fc2a26b76" xlink:to="loc_srt_RangeMember_1e64d1ea-20ab-4704-a59f-53b2a1988a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1bd39944-12f8-44f8-a14d-e9827e83e9bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1e64d1ea-20ab-4704-a59f-53b2a1988a7b" xlink:to="loc_srt_MinimumMember_1bd39944-12f8-44f8-a14d-e9827e83e9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f24c638-43e0-4f7f-9eb2-131b7d7b287a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1e64d1ea-20ab-4704-a59f-53b2a1988a7b" xlink:to="loc_srt_MaximumMember_1f24c638-43e0-4f7f-9eb2-131b7d7b287a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a5609c6e-a47d-450e-ae9b-7000dd26fe4e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f805ff33-74f9-4b28-ab73-e689df6f3bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f805ff33-74f9-4b28-ab73-e689df6f3bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentExtensionPeriod_19114941-c2c2-419e-a510-4afcf5ac5721" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentExtensionPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_dgx_DebtInstrumentExtensionPeriod_19114941-c2c2-419e-a510-4afcf5ac5721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e2e1e78b-a108-432d-a979-d4e8fcc4c46c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e2e1e78b-a108-432d-a979-d4e8fcc4c46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b2c89bb5-b7b6-451d-851d-ca5fb71522e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_67b8651d-53db-4566-aade-6a857bf5c429" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b2c89bb5-b7b6-451d-851d-ca5fb71522e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_431e9bed-8474-449a-abf9-18207c07fc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_431e9bed-8474-449a-abf9-18207c07fc8c" xlink:to="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_522949d7-dcb7-4fec-b6f0-5795273673fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d3bb36f7-f1ac-407b-9c91-5a19bf348ac5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_522949d7-dcb7-4fec-b6f0-5795273673fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_cdd48985-a9ae-4df4-b14c-d108f25010fe" xlink:href="dgx-20201231.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_522949d7-dcb7-4fec-b6f0-5795273673fe" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_cdd48985-a9ae-4df4-b14c-d108f25010fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_ea7ace46-2a80-4d30-8eb7-d623fd38aca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_522949d7-dcb7-4fec-b6f0-5795273673fe" xlink:to="loc_us-gaap_SecuredDebtMember_ea7ace46-2a80-4d30-8eb7-d623fd38aca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e8bf4db3-7bcb-4dde-8d48-192147de159d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_us-gaap_CreditFacilityAxis_e8bf4db3-7bcb-4dde-8d48-192147de159d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5233dda0-58d9-47c4-a468-23b848fe956e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e8bf4db3-7bcb-4dde-8d48-192147de159d" xlink:to="loc_us-gaap_CreditFacilityDomain_5233dda0-58d9-47c4-a468-23b848fe956e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ee890430-75c2-4ea1-b5a8-f115bda5bff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5233dda0-58d9-47c4-a468-23b848fe956e" xlink:to="loc_us-gaap_LetterOfCreditMember_ee890430-75c2-4ea1-b5a8-f115bda5bff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_30675654-178b-4555-8401-78d74a3241e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_us-gaap_VariableRateAxis_30675654-178b-4555-8401-78d74a3241e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_51848653-035e-4b04-b1af-573567b75b73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_30675654-178b-4555-8401-78d74a3241e1" xlink:to="loc_us-gaap_VariableRateDomain_51848653-035e-4b04-b1af-573567b75b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8c4f86a1-c58b-4ab8-992f-1bae41da512d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_51848653-035e-4b04-b1af-573567b75b73" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_8c4f86a1-c58b-4ab8-992f-1bae41da512d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_de98fcb1-3ee5-432a-acc1-8877652cb3ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_srt_RangeAxis_de98fcb1-3ee5-432a-acc1-8877652cb3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1398df59-b4c6-4d16-9b09-67bdf53868b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_de98fcb1-3ee5-432a-acc1-8877652cb3ac" xlink:to="loc_srt_RangeMember_1398df59-b4c6-4d16-9b09-67bdf53868b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e17db0a4-b68d-4b0b-a7ce-c964efa3c58a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1398df59-b4c6-4d16-9b09-67bdf53868b2" xlink:to="loc_srt_MaximumMember_e17db0a4-b68d-4b0b-a7ce-c964efa3c58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_45cd095c-4890-4b35-b218-a909bdf891c2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_srt_StatementScenarioAxis_45cd095c-4890-4b35-b218-a909bdf891c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_84a780cf-285c-4d01-aec4-12f5c9ce1efa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_45cd095c-4890-4b35-b218-a909bdf891c2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_84a780cf-285c-4d01-aec4-12f5c9ce1efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_a1c57fda-1f14-4e29-bae9-b7bf151f2fe5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_84a780cf-285c-4d01-aec4-12f5c9ce1efa" xlink:to="loc_srt_ScenarioForecastMember_a1c57fda-1f14-4e29-bae9-b7bf151f2fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b0337ebb-ecf4-4ac8-bdac-0a66725d1146" xlink:to="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a703501b-3cb4-470f-83ed-89cbe12dfb9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a703501b-3cb4-470f-83ed-89cbe12dfb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0fbee9a6-ff5f-4a6a-a7dd-64c0a26ef0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0fbee9a6-ff5f-4a6a-a7dd-64c0a26ef0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentLeverageRatioRequirement_7b59d084-dc5f-4653-b475-6718eb98b10e" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentLeverageRatioRequirement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_dgx_DebtInstrumentLeverageRatioRequirement_7b59d084-dc5f-4653-b475-6718eb98b10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d15626f2-a84e-4096-a049-b461a95f03af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d15626f2-a84e-4096-a049-b461a95f03af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fc9877e9-f798-4800-8b31-b4873813dfe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_828d92f9-f01f-4a34-b667-9bc29c99082f" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fc9877e9-f798-4800-8b31-b4873813dfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTSeniorNotesOfferingDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_8fec5e64-5dec-474e-b098-fef8a2e45ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_8fec5e64-5dec-474e-b098-fef8a2e45ea6" xlink:to="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_82492fdf-eb4d-49b8-bd9b-907797baa948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a87ef3ca-4858-4bf3-9537-6ac5fc1312c7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_82492fdf-eb4d-49b8-bd9b-907797baa948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_91e0842c-7854-4499-9be6-d7587de4ccae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_82492fdf-eb4d-49b8-bd9b-907797baa948" xlink:to="loc_us-gaap_SeniorNotesMember_91e0842c-7854-4499-9be6-d7587de4ccae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9db33d2d-4768-492b-82e2-7d4c8205758b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_9db33d2d-4768-492b-82e2-7d4c8205758b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9db33d2d-4768-492b-82e2-7d4c8205758b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_4c5d0ebe-21d8-44c0-becb-0872f705d29a" xlink:href="dgx-20201231.xsd#dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:to="loc_dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member_4c5d0ebe-21d8-44c0-becb-0872f705d29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_7169caf7-c547-45df-af6e-de1edbb2702c" xlink:href="dgx-20201231.xsd#dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:to="loc_dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member_7169caf7-c547-45df-af6e-de1edbb2702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_95a35a4f-2a4f-4a40-9f5e-ad536b8a49c0" xlink:href="dgx-20201231.xsd#dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e4273901-cae4-4f7a-931b-d0de808393f2" xlink:to="loc_dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member_95a35a4f-2a4f-4a40-9f5e-ad536b8a49c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e0512496-199e-4485-bfc8-f5a2be6bc4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e0512496-199e-4485-bfc8-f5a2be6bc4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c9eb89a2-9c3c-49c1-ad30-44548da38b32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e0512496-199e-4485-bfc8-f5a2be6bc4ee" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c9eb89a2-9c3c-49c1-ad30-44548da38b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_ce3807ab-1b5b-40fc-9bc9-b127f8078161" xlink:href="dgx-20201231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c9eb89a2-9c3c-49c1-ad30-44548da38b32" xlink:to="loc_dgx_OtherIncomeExpenseMember_ce3807ab-1b5b-40fc-9bc9-b127f8078161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_19824585-ffb5-4a04-9888-a72cfdfac0c3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e6d6d64e-b04f-40e1-be36-a685f47891bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e6d6d64e-b04f-40e1-be36-a685f47891bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5996ff1d-9712-45be-8452-bc7b22cfd747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5996ff1d-9712-45be-8452-bc7b22cfd747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5f756005-dedb-4f04-bfe8-c5aebd1af9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5f756005-dedb-4f04-bfe8-c5aebd1af9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_4e6f9ec0-06e9-4e19-9679-623b0732f4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_4e6f9ec0-06e9-4e19-9679-623b0732f4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bf17964a-aa98-4e9b-8094-c3444f5e539a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fe687355-7ddf-44fe-bfb4-91869ad42db9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bf17964a-aa98-4e9b-8094-c3444f5e539a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DEBTMaturitiesofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_41f41fdc-439d-4e4b-a133-d82139027cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_41f41fdc-439d-4e4b-a133-d82139027cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_2df3f295-29df-4286-93b2-ca0bce738074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_2df3f295-29df-4286-93b2-ca0bce738074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0e976405-7fb3-44e9-b9de-68ea13f1fca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0e976405-7fb3-44e9-b9de-68ea13f1fca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_883f2526-0dcc-4035-b94f-41e5e47141ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_883f2526-0dcc-4035-b94f-41e5e47141ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b9d49ef6-65b7-400c-af22-04ce4465b732" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b9d49ef6-65b7-400c-af22-04ce4465b732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_4c2f97d5-9806-4b26-a536-2b8075319ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_4c2f97d5-9806-4b26-a536-2b8075319ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LongTermDebtMaturitiesGross_e1720111-c534-47aa-8032-332156eaf4d2" xlink:href="dgx-20201231.xsd#dgx_LongTermDebtMaturitiesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_dgx_LongTermDebtMaturitiesGross_e1720111-c534-47aa-8032-332156eaf4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b6600f92-31e9-4017-999e-ff0c7637f287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b6600f92-31e9-4017-999e-ff0c7637f287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_4be89a5c-4971-431e-9c94-8842d91b44a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_4be89a5c-4971-431e-9c94-8842d91b44a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_423b8d0d-b67c-4422-b39f-632c3c6de2d7" xlink:href="dgx-20201231.xsd#dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt_423b8d0d-b67c-4422-b39f-632c3c6de2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_bdb76a66-8b0e-4337-bc6a-8ae7c70ea846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebt_bdb76a66-8b0e-4337-bc6a-8ae7c70ea846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_9f7475a8-90b8-4c10-930e-da7034e7c7af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebtCurrent_9f7475a8-90b8-4c10-930e-da7034e7c7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_393bef98-7f35-4a7c-bf36-8cb98d617325" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentsAbstract_3bfddcfc-1307-46a9-acd6-daf32b5ca593" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_393bef98-7f35-4a7c-bf36-8cb98d617325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASES" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_683ea7e7-9618-4c2d-bf85-c330960a2ef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_46fdcbed-d97b-4edd-8717-51c1e7add9f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_683ea7e7-9618-4c2d-bf85-c330960a2ef9" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_46fdcbed-d97b-4edd-8717-51c1e7add9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_7961e641-a3d8-4821-886f-c8d2db478154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_683ea7e7-9618-4c2d-bf85-c330960a2ef9" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_7961e641-a3d8-4821-886f-c8d2db478154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4f99489c-3107-47ef-bbf7-83724cd017df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_36362261-9f9c-46c2-ba9e-f29d4b5b0290" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfLeaseByAssetTypeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f99489c-3107-47ef-bbf7-83724cd017df" xlink:to="loc_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock_36362261-9f9c-46c2-ba9e-f29d4b5b0290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_e86b2070-caf0-470d-a5f8-d03a1ddcb526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f99489c-3107-47ef-bbf7-83724cd017df" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_e86b2070-caf0-470d-a5f8-d03a1ddcb526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f52e3ab0-5f8f-48c0-8e2a-e8ad8234549b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f99489c-3107-47ef-bbf7-83724cd017df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f52e3ab0-5f8f-48c0-8e2a-e8ad8234549b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_3f3e6325-4a33-4251-82a3-5bd7bd32ccc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f99489c-3107-47ef-bbf7-83724cd017df" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_3f3e6325-4a33-4251-82a3-5bd7bd32ccc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_8ebbe996-d791-4ede-b7f3-8369519f25e0" xlink:href="dgx-20201231.xsd#dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f99489c-3107-47ef-bbf7-83724cd017df" xlink:to="loc_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock_8ebbe996-d791-4ede-b7f3-8369519f25e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_139611b4-6e5a-4737-aebd-ef42c839f519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_bf3a437f-f508-4933-bad6-21e4d62721ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_139611b4-6e5a-4737-aebd-ef42c839f519" xlink:to="loc_us-gaap_LeaseAndRentalExpense_bf3a437f-f508-4933-bad6-21e4d62721ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_2acdd736-422f-47a3-b950-4fef2277f8c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_139611b4-6e5a-4737-aebd-ef42c839f519" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_2acdd736-422f-47a3-b950-4fef2277f8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2acdd736-422f-47a3-b950-4fef2277f8c2" xlink:to="loc_srt_RangeAxis_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1eb355d0-8027-4cb2-a9b6-da3bda1dc0cc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fed41ef6-d1a4-45ab-b5eb-7f8805d7236e" xlink:to="loc_srt_RangeMember_1eb355d0-8027-4cb2-a9b6-da3bda1dc0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c34ecaf4-6094-4da7-8558-74c535c90994" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1eb355d0-8027-4cb2-a9b6-da3bda1dc0cc" xlink:to="loc_srt_MinimumMember_c34ecaf4-6094-4da7-8558-74c535c90994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4ce9efc0-79f1-4c29-8b8d-a5ca271e148d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1eb355d0-8027-4cb2-a9b6-da3bda1dc0cc" xlink:to="loc_srt_MaximumMember_4ce9efc0-79f1-4c29-8b8d-a5ca271e148d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f24b287-454f-4644-adde-3ef74394a7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_2acdd736-422f-47a3-b950-4fef2277f8c2" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f24b287-454f-4644-adde-3ef74394a7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRemainingLeaseTerm_8813f3f9-b4df-46d7-b49e-b1ad8b503f17" xlink:href="dgx-20201231.xsd#dgx_LeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f24b287-454f-4644-adde-3ef74394a7dc" xlink:to="loc_dgx_LeaseRemainingLeaseTerm_8813f3f9-b4df-46d7-b49e-b1ad8b503f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRenewalTerm_f16b99ea-4659-4686-a238-f1649066befc" xlink:href="dgx-20201231.xsd#dgx_LeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f24b287-454f-4644-adde-3ef74394a7dc" xlink:to="loc_dgx_LeaseRenewalTerm_f16b99ea-4659-4686-a238-f1649066befc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e6597397-cb2d-4969-9c86-88b23abdd813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e6597397-cb2d-4969-9c86-88b23abdd813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_ba85836c-14da-4236-bb3e-1ba32ff51d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_ba85836c-14da-4236-bb3e-1ba32ff51d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseRightofUseAsset_b8c02e8f-4fc5-4ab5-85d7-c0b30db59ff9" xlink:href="dgx-20201231.xsd#dgx_LeaseRightofUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_dgx_LeaseRightofUseAsset_b8c02e8f-4fc5-4ab5-85d7-c0b30db59ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_366f6c94-d9f3-4417-a0d3-76e7c906028d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_366f6c94-d9f3-4417-a0d3-76e7c906028d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_50d06a06-5803-4e77-afba-e265c847413c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_50d06a06-5803-4e77-afba-e265c847413c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_29b81b3c-9126-4eff-be48-e6413452e2d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_29b81b3c-9126-4eff-be48-e6413452e2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_90c5983c-4792-4345-b9f6-37a94bdb43bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_90c5983c-4792-4345-b9f6-37a94bdb43bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LeaseLiability_b5b3059b-99ec-43b6-bae2-6189ad18cbc8" xlink:href="dgx-20201231.xsd#dgx_LeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_dgx_LeaseLiability_b5b3059b-99ec-43b6-bae2-6189ad18cbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_34347ab8-15b7-407d-a01a-cd1cc5a9062f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a16263b1-dcb2-4c93-bfab-e32c54b52381" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_34347ab8-15b7-407d-a01a-cd1cc5a9062f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESCostsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_497e0ed5-112b-4086-95bc-6e754bd13b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingLeaseFixedAndVariableCost_683eb9d1-ced4-41ce-b8d1-a32946fab690" xlink:href="dgx-20201231.xsd#dgx_OperatingLeaseFixedAndVariableCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_497e0ed5-112b-4086-95bc-6e754bd13b0d" xlink:to="loc_dgx_OperatingLeaseFixedAndVariableCost_683eb9d1-ced4-41ce-b8d1-a32946fab690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_83d13b7d-2f35-44ee-b4d7-6ddb852b421e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_497e0ed5-112b-4086-95bc-6e754bd13b0d" xlink:to="loc_us-gaap_LeaseCostAbstract_83d13b7d-2f35-44ee-b4d7-6ddb852b421e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_43cc8e7c-ddc0-493a-b314-3fc19e9d2018" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_83d13b7d-2f35-44ee-b4d7-6ddb852b421e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_43cc8e7c-ddc0-493a-b314-3fc19e9d2018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_9afa0b6f-e6d2-41f6-bd80-b978eb076cbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_83d13b7d-2f35-44ee-b4d7-6ddb852b421e" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_9afa0b6f-e6d2-41f6-bd80-b978eb076cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_f0b43620-3d56-4a84-9ed9-cb848483ea7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_497e0ed5-112b-4086-95bc-6e754bd13b0d" xlink:to="loc_us-gaap_LeaseCost_f0b43620-3d56-4a84-9ed9-cb848483ea7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ShorttermLeaseandVariableLeaseCost_14c8d1ce-6c3f-47cf-bd75-7caa24b663d4" xlink:href="dgx-20201231.xsd#dgx_ShorttermLeaseandVariableLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_497e0ed5-112b-4086-95bc-6e754bd13b0d" xlink:to="loc_dgx_ShorttermLeaseandVariableLeaseCost_14c8d1ce-6c3f-47cf-bd75-7caa24b663d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESMaturityDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8fd58a9f-a2f5-4384-b4c1-8dce2a4bd5fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fd58a9f-a2f5-4384-b4c1-8dce2a4bd5fb" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_858957bb-da86-43af-abd9-c3a8681fc9a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_858957bb-da86-43af-abd9-c3a8681fc9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8212b0e8-4be4-489c-b726-e57f691fe03f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8212b0e8-4be4-489c-b726-e57f691fe03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_be305dbe-d31e-4f4f-a356-c05373d26cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_be305dbe-d31e-4f4f-a356-c05373d26cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cb76af11-b38b-445a-8380-bda75ecf3bc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cb76af11-b38b-445a-8380-bda75ecf3bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_94759f2d-6e28-4368-8384-7ff858bb4d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_94759f2d-6e28-4368-8384-7ff858bb4d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f2e4f58e-9fb6-4fdc-b5fa-4fd3e5bbff6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f2e4f58e-9fb6-4fdc-b5fa-4fd3e5bbff6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9804b475-b33d-496f-897b-8b30ce447f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9804b475-b33d-496f-897b-8b30ce447f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_76b82710-43f5-4c71-8a4e-82fb5d6c4948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_76b82710-43f5-4c71-8a4e-82fb5d6c4948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c17fe843-255c-41f4-a703-7d6c2503513b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_987169a1-fb39-4796-b739-5a3804043da7" xlink:to="loc_us-gaap_OperatingLeaseLiability_c17fe843-255c-41f4-a703-7d6c2503513b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fd58a9f-a2f5-4384-b4c1-8dce2a4bd5fb" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_4601b6c6-6c99-429f-9a2b-75cd7314d9ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_4601b6c6-6c99-429f-9a2b-75cd7314d9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9a248ba8-c74c-40d2-9264-b406923a00d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9a248ba8-c74c-40d2-9264-b406923a00d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ed4dd273-d9bd-4cd1-99b3-9f6bdcb4e71e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ed4dd273-d9bd-4cd1-99b3-9f6bdcb4e71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_48d1645e-c259-4d67-9dc9-42d7d4326553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_48d1645e-c259-4d67-9dc9-42d7d4326553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5dc93620-c645-47f0-bd11-1720574c0e1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_5dc93620-c645-47f0-bd11-1720574c0e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_62859d43-c4cf-4635-a7f2-fcae1ecf2b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_62859d43-c4cf-4635-a7f2-fcae1ecf2b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_95adee66-bf35-40b1-90ae-86d2f12ce392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_95adee66-bf35-40b1-90ae-86d2f12ce392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c0da6718-1d5d-41eb-8171-460f91914c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_c0da6718-1d5d-41eb-8171-460f91914c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_289bb297-4a68-4e91-a394-154e2abba580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d30f70d9-9237-4b5a-81bf-dea3a148eede" xlink:to="loc_us-gaap_FinanceLeaseLiability_289bb297-4a68-4e91-a394-154e2abba580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:href="dgx-20201231.xsd#dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fd58a9f-a2f5-4384-b4c1-8dce2a4bd5fb" xlink:to="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2111eae3-add9-4433-bbe1-0f3019e3d99c" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2111eae3-add9-4433-bbe1-0f3019e3d99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_2cd02bef-7249-4ae5-8c0b-b2c9e656e858" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo_2cd02bef-7249-4ae5-8c0b-b2c9e656e858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_d5c7350b-9e3c-4454-b2e4-c542fbeaf8e2" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree_d5c7350b-9e3c-4454-b2e4-c542fbeaf8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_23e178ce-86d6-41a9-82c5-017f224ea67d" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour_23e178ce-86d6-41a9-82c5-017f224ea67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_50d1b4af-128f-42d2-a678-e08ab12adc71" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive_50d1b4af-128f-42d2-a678-e08ab12adc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_6da38b3e-939a-4c83-a3c9-d7062282c015" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive_6da38b3e-939a-4c83-a3c9-d7062282c015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_bfe5ee51-0d14-4987-842d-0c87be3ff021" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue_bfe5ee51-0d14-4987-842d-0c87be3ff021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_6cb2b12c-7e71-4d38-918b-d2ccf901a323" xlink:href="dgx-20201231.xsd#dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount_6cb2b12c-7e71-4d38-918b-d2ccf901a323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OperatingandFinanceLeaseLiability_0b993877-72e6-4c09-92ee-f30dde5782ce" xlink:href="dgx-20201231.xsd#dgx_OperatingandFinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract_5502a210-d02f-4b5a-9a8d-c6d07b1c31a5" xlink:to="loc_dgx_OperatingandFinanceLeaseLiability_0b993877-72e6-4c09-92ee-f30dde5782ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/LEASESTermandRateDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#LEASESTermandRateDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/LEASESTermandRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_530664ae-3ece-4ddb-9270-b9d25afecbe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_3508d021-2972-46d8-bfce-d6259b837fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_530664ae-3ece-4ddb-9270-b9d25afecbe8" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_3508d021-2972-46d8-bfce-d6259b837fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_ece9016b-83a6-45f3-b5ed-b098251dad77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_530664ae-3ece-4ddb-9270-b9d25afecbe8" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_ece9016b-83a6-45f3-b5ed-b098251dad77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5e1d3fe6-3755-4887-866f-cababc5e1f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_530664ae-3ece-4ddb-9270-b9d25afecbe8" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5e1d3fe6-3755-4887-866f-cababc5e1f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_78a81f4d-1a91-4244-89ff-f7225d5b6bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_530664ae-3ece-4ddb-9270-b9d25afecbe8" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_78a81f4d-1a91-4244-89ff-f7225d5b6bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b529a01e-5cfd-47de-bf54-498a037ba071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_05dbdd60-73aa-4f9c-a4da-e588c7c6b6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b529a01e-5cfd-47de-bf54-498a037ba071" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_05dbdd60-73aa-4f9c-a4da-e588c7c6b6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f0c5c47f-3829-438d-8171-8dc20b44e7ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_42135406-4207-4c89-b992-a53f371a79ce" xlink:href="dgx-20201231.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f0c5c47f-3829-438d-8171-8dc20b44e7ea" xlink:to="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_42135406-4207-4c89-b992-a53f371a79ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock_1746e9e0-5086-4b7a-83bb-1bb718277e0f" xlink:href="dgx-20201231.xsd#dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f0c5c47f-3829-438d-8171-8dc20b44e7ea" xlink:to="loc_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock_1746e9e0-5086-4b7a-83bb-1bb718277e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_589d3819-0078-447f-86a9-2775eb06fd49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f0c5c47f-3829-438d-8171-8dc20b44e7ea" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_589d3819-0078-447f-86a9-2775eb06fd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e62f7b04-bb06-4f99-b3c8-86f96baaab20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e62f7b04-bb06-4f99-b3c8-86f96baaab20" xlink:to="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_85b1765b-1627-4250-b57d-f43e1c22777a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_85b1765b-1627-4250-b57d-f43e1c22777a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c5e6f09c-2385-4610-8bdc-b05b7b374551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_85b1765b-1627-4250-b57d-f43e1c22777a" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c5e6f09c-2385-4610-8bdc-b05b7b374551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_f20f0c1e-56fd-499c-939f-2e31938470f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c5e6f09c-2385-4610-8bdc-b05b7b374551" xlink:to="loc_us-gaap_CashFlowHedgingMember_f20f0c1e-56fd-499c-939f-2e31938470f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_7b4384ca-4fef-4872-9237-82a9ef82b823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c5e6f09c-2385-4610-8bdc-b05b7b374551" xlink:to="loc_us-gaap_FairValueHedgingMember_7b4384ca-4fef-4872-9237-82a9ef82b823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0f4ff2b5-7406-450e-8ca9-1535a7fc4eaa" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ForwardStartingInterestRateSwapsMember_b142ea9a-4ee0-497c-a779-bde587084a4d" xlink:href="dgx-20201231.xsd#dgx_ForwardStartingInterestRateSwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:to="loc_dgx_ForwardStartingInterestRateSwapsMember_b142ea9a-4ee0-497c-a779-bde587084a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_InterestRateLockAgreementsMember_4a8ca2f2-2146-4426-8e49-9de5bb6cf60b" xlink:href="dgx-20201231.xsd#dgx_InterestRateLockAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:to="loc_dgx_InterestRateLockAgreementsMember_4a8ca2f2-2146-4426-8e49-9de5bb6cf60b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FixedtovariableinterestrateswapMember_58a4541f-d2cc-4d50-b670-c9f8043849cd" xlink:href="dgx-20201231.xsd#dgx_FixedtovariableinterestrateswapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_59deb603-a681-4ee3-848b-9b8715ced98e" xlink:to="loc_dgx_FixedtovariableinterestrateswapMember_58a4541f-d2cc-4d50-b670-c9f8043849cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7cfc83e2-2cae-4d5f-91f3-ce31126e951e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_srt_StatementScenarioAxis_7cfc83e2-2cae-4d5f-91f3-ce31126e951e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b422d264-3e44-4c3b-962e-6830089b52d7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7cfc83e2-2cae-4d5f-91f3-ce31126e951e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b422d264-3e44-4c3b-962e-6830089b52d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_19c0fee8-1704-4eff-b506-87a46817638c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b422d264-3e44-4c3b-962e-6830089b52d7" xlink:to="loc_srt_ScenarioForecastMember_19c0fee8-1704-4eff-b506-87a46817638c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_3ccb5293-fe28-497b-bf63-b636945d457b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_VariableRateAxis_3ccb5293-fe28-497b-bf63-b636945d457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_72845606-eccb-46ee-b4ad-90b0b940467b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_3ccb5293-fe28-497b-bf63-b636945d457b" xlink:to="loc_us-gaap_VariableRateDomain_72845606-eccb-46ee-b4ad-90b0b940467b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_dc4ab9eb-f16d-487d-a7ef-d7f2f09c5141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_72845606-eccb-46ee-b4ad-90b0b940467b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_dc4ab9eb-f16d-487d-a7ef-d7f2f09c5141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_42f028a0-1d54-4ff7-a18c-223a10c94040" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_srt_RangeAxis_42f028a0-1d54-4ff7-a18c-223a10c94040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cdebca8a-08b9-41f3-acf3-57a1320a172d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_42f028a0-1d54-4ff7-a18c-223a10c94040" xlink:to="loc_srt_RangeMember_cdebca8a-08b9-41f3-acf3-57a1320a172d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ddb64061-fa68-472b-b21b-18b1a7850695" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cdebca8a-08b9-41f3-acf3-57a1320a172d" xlink:to="loc_srt_MinimumMember_ddb64061-fa68-472b-b21b-18b1a7850695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c3cb9de2-7271-46e5-8f99-8f9df449e1a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_cdebca8a-08b9-41f3-acf3-57a1320a172d" xlink:to="loc_srt_MaximumMember_c3cb9de2-7271-46e5-8f99-8f9df449e1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_97ab634d-dc55-496f-88f3-290d93871ace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_97ab634d-dc55-496f-88f3-290d93871ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8438fcab-f0b5-4c2c-a36e-65ff977de02c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_97ab634d-dc55-496f-88f3-290d93871ace" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8438fcab-f0b5-4c2c-a36e-65ff977de02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_4562f2f8-d4a4-4caf-9fce-cb4dba83c671" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_8438fcab-f0b5-4c2c-a36e-65ff977de02c" xlink:to="loc_us-gaap_LongTermDebtMember_4562f2f8-d4a4-4caf-9fce-cb4dba83c671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_15bd42fa-8916-403a-85cb-5af5956f77c2" xlink:to="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_056c588d-7d47-47dc-a87b-f24c277a5392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_DerivativeNotionalAmount_056c588d-7d47-47dc-a87b-f24c277a5392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DerivativeGainAmortizationPeriod_75e7b5c1-a142-4932-887f-31214bf3111a" xlink:href="dgx-20201231.xsd#dgx_DerivativeGainAmortizationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_dgx_DerivativeGainAmortizationPeriod_75e7b5c1-a142-4932-887f-31214bf3111a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_f8fe0574-6237-4217-8284-44d6a16cc579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss_f8fe0574-6237-4217-8284-44d6a16cc579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf4fa415-da03-4453-8c0f-7fbebaf1a31a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf4fa415-da03-4453-8c0f-7fbebaf1a31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b251a0b6-3381-4353-b16d-9f9e1546fa5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b251a0b6-3381-4353-b16d-9f9e1546fa5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge_d722ad6f-d8cb-43fc-8831-398dce19b087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge_d722ad6f-d8cb-43fc-8831-398dce19b087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities_4d1975df-397e-497e-8d7a-c68aa7d9ed39" xlink:href="dgx-20201231.xsd#dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_d9599d76-3a14-4c43-9494-b3b2ab776d66" xlink:to="loc_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities_4d1975df-397e-497e-8d7a-c68aa7d9ed39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a97b156f-29ac-4887-8e5f-1029b8771727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a97b156f-29ac-4887-8e5f-1029b8771727" xlink:to="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_493c5a98-14ab-4baa-a495-5c549d41c67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_493c5a98-14ab-4baa-a495-5c549d41c67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0b162bff-d0de-42db-a925-0f663bb07b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_493c5a98-14ab-4baa-a495-5c549d41c67b" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0b162bff-d0de-42db-a925-0f663bb07b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_ce8f7d13-da5a-4079-8544-9e9699be5d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0b162bff-d0de-42db-a925-0f663bb07b35" xlink:to="loc_us-gaap_LongTermDebtMember_ce8f7d13-da5a-4079-8544-9e9699be5d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0290b789-1e7e-496b-b89b-783259372498" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0290b789-1e7e-496b-b89b-783259372498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_250ad1f3-0cd6-4061-9cec-fa267f6dfaf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0290b789-1e7e-496b-b89b-783259372498" xlink:to="loc_us-gaap_HedgingRelationshipDomain_250ad1f3-0cd6-4061-9cec-fa267f6dfaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_cd6882f5-74b9-4463-bb35-8749dc7673b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_250ad1f3-0cd6-4061-9cec-fa267f6dfaf7" xlink:to="loc_us-gaap_FairValueHedgingMember_cd6882f5-74b9-4463-bb35-8749dc7673b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_653de219-93fa-4a92-b1f7-88eb26269fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d44ce67f-2e63-40c0-aa0f-ed1afc104e9f" xlink:to="loc_us-gaap_DerivativeLineItems_653de219-93fa-4a92-b1f7-88eb26269fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedge_0b7f36b6-a6c7-4d70-a51f-796410059683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedge"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_653de219-93fa-4a92-b1f7-88eb26269fd1" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedge_0b7f36b6-a6c7-4d70-a51f-796410059683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_7231cfa4-30cd-435e-a11d-9d8bca4f0f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_653de219-93fa-4a92-b1f7-88eb26269fd1" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_7231cfa4-30cd-435e-a11d-9d8bca4f0f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cfbdebe9-1998-4c37-ae66-ff6a9000ffb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cfbdebe9-1998-4c37-ae66-ff6a9000ffb4" xlink:to="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d3aa41e3-6936-4a4c-8e76-1336700b62e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d3aa41e3-6936-4a4c-8e76-1336700b62e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a552c7ea-5170-4d5c-af3d-56c26cc98a01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d3aa41e3-6936-4a4c-8e76-1336700b62e1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a552c7ea-5170-4d5c-af3d-56c26cc98a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_aea1b08d-bde3-4ea7-9d6b-51326dfb6553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_a552c7ea-5170-4d5c-af3d-56c26cc98a01" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_aea1b08d-bde3-4ea7-9d6b-51326dfb6553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_90badbaa-ef47-437f-a284-341bf542db6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_90badbaa-ef47-437f-a284-341bf542db6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c5d20f43-43d3-468f-9258-33b1ebb4e4e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_90badbaa-ef47-437f-a284-341bf542db6f" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c5d20f43-43d3-468f-9258-33b1ebb4e4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_210be646-3a14-454d-9647-3ebe5e5b7d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c5d20f43-43d3-468f-9258-33b1ebb4e4e9" xlink:to="loc_us-gaap_FairValueHedgingMember_210be646-3a14-454d-9647-3ebe5e5b7d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_5495cdba-3f50-4bd9-b157-af9a317e946c" xlink:to="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_7dc1b5ed-e82b-4535-94f7-b46939d7872a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_7dc1b5ed-e82b-4535-94f7-b46939d7872a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_bfb1ae71-b08c-4c68-a76e-7e99bdfec0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_bfb1ae71-b08c-4c68-a76e-7e99bdfec0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0b6221e0-e927-4bf9-b1bd-8e72edbecb77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_37b9831a-278d-410a-870f-a81fca843976" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_0b6221e0-e927-4bf9-b1bd-8e72edbecb77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#FINANCIALINSTRUMENTSFairValueofDerivativesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3981fba9-e976-4dae-86f2-72ae86f3d5b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3981fba9-e976-4dae-86f2-72ae86f3d5b7" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_bd814a74-3b68-46e9-8b7c-e37bbec98116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:to="loc_us-gaap_HedgingDesignationAxis_bd814a74-3b68-46e9-8b7c-e37bbec98116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4576b824-694b-411e-9f8a-75afdf7132a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_bd814a74-3b68-46e9-8b7c-e37bbec98116" xlink:to="loc_us-gaap_HedgingDesignationDomain_4576b824-694b-411e-9f8a-75afdf7132a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1ea6bcb6-8e40-4ae9-8158-81dffdd42938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4576b824-694b-411e-9f8a-75afdf7132a3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_1ea6bcb6-8e40-4ae9-8158-81dffdd42938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f8c5a392-2a29-4392-9f42-6d51ac310e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f8c5a392-2a29-4392-9f42-6d51ac310e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b1663e99-1778-41c2-bc32-bdd3ba92f65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8c5a392-2a29-4392-9f42-6d51ac310e64" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b1663e99-1778-41c2-bc32-bdd3ba92f65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_8db479b0-5446-47e9-8daf-5a4cce65d296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b1663e99-1778-41c2-bc32-bdd3ba92f65d" xlink:to="loc_us-gaap_InterestRateSwapMember_8db479b0-5446-47e9-8daf-5a4cce65d296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7c61f6f9-8c66-4963-9a90-d4a901ec57e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7c61f6f9-8c66-4963-9a90-d4a901ec57e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a0fd4f08-ba57-4b81-8f6b-9fd298a142d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7c61f6f9-8c66-4963-9a90-d4a901ec57e2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a0fd4f08-ba57-4b81-8f6b-9fd298a142d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_901f2dcc-37f8-47b1-9669-0109f5f2660b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a0fd4f08-ba57-4b81-8f6b-9fd298a142d7" xlink:to="loc_us-gaap_OtherLiabilitiesMember_901f2dcc-37f8-47b1-9669-0109f5f2660b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_2c00dec2-3bf3-44e2-9328-80bc104d5973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_922bb36b-cec2-4f2f-aebf-fc68a52023ce" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_2c00dec2-3bf3-44e2-9328-80bc104d5973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8bb0d63d-7516-42a3-9277-3d17fa0338c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_2c00dec2-3bf3-44e2-9328-80bc104d5973" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_8bb0d63d-7516-42a3-9277-3d17fa0338c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_94272091-ed02-4962-9687-c21e31bdd77c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8d556bdb-672a-462a-87d5-d70439bd5bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_94272091-ed02-4962-9687-c21e31bdd77c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8d556bdb-672a-462a-87d5-d70439bd5bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_849af3a4-a65f-4975-bab7-1db432be437d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_b58374da-62a8-4a59-9913-f7fe8e6ff708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_849af3a4-a65f-4975-bab7-1db432be437d" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_b58374da-62a8-4a59-9913-f7fe8e6ff708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_94554fde-4256-46ed-a1cc-1962684fda11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_94554fde-4256-46ed-a1cc-1962684fda11" xlink:to="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_630ad11d-916e-44a7-aed7-1ea5bcf5a301" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_srt_RangeAxis_630ad11d-916e-44a7-aed7-1ea5bcf5a301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e27a6018-7a30-47da-9319-01762586d992" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_630ad11d-916e-44a7-aed7-1ea5bcf5a301" xlink:to="loc_srt_RangeMember_e27a6018-7a30-47da-9319-01762586d992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7905e83f-5c7a-4c6e-99a9-80f9af13e0e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e27a6018-7a30-47da-9319-01762586d992" xlink:to="loc_srt_MaximumMember_7905e83f-5c7a-4c6e-99a9-80f9af13e0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5491a930-d6e9-489f-99ea-125cf7eb08b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5491a930-d6e9-489f-99ea-125cf7eb08b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ae345ae0-3367-49e1-9c68-78446db6185a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5491a930-d6e9-489f-99ea-125cf7eb08b9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ae345ae0-3367-49e1-9c68-78446db6185a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_85602cf8-096c-46ef-a1c7-baa990d2d45a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ae345ae0-3367-49e1-9c68-78446db6185a" xlink:to="loc_us-gaap_SubsequentEventMember_85602cf8-096c-46ef-a1c7-baa990d2d45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6442eae1-9d22-4eb5-accd-79c9d91d99df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_srt_StatementScenarioAxis_6442eae1-9d22-4eb5-accd-79c9d91d99df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ddf96881-a211-4654-a3bb-03edaac09f7e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_6442eae1-9d22-4eb5-accd-79c9d91d99df" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ddf96881-a211-4654-a3bb-03edaac09f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_c02f24c7-2aed-421a-8f73-a6ab31b78c9a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_ddf96881-a211-4654-a3bb-03edaac09f7e" xlink:to="loc_srt_ScenarioForecastMember_c02f24c7-2aed-421a-8f73-a6ab31b78c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_66eafc89-50d8-4135-b4d8-ebc803afac89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_66eafc89-50d8-4135-b4d8-ebc803afac89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ce0db203-ed69-448d-bdd8-be57817d711e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_66eafc89-50d8-4135-b4d8-ebc803afac89" xlink:to="loc_us-gaap_EquityComponentDomain_ce0db203-ed69-448d-bdd8-be57817d711e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_d4c2f8e9-4e94-4686-b374-5d9f78d130b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ce0db203-ed69-448d-bdd8-be57817d711e" xlink:to="loc_us-gaap_TreasuryStockMember_d4c2f8e9-4e94-4686-b374-5d9f78d130b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_13339164-cc0d-4a07-a2c2-deaca194debd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f0a3b5d4-66b9-4aa1-8b57-bdec060f27ae" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_13339164-cc0d-4a07-a2c2-deaca194debd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_b42c01ec-3be6-4598-acb5-acd1907a474c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_13339164-cc0d-4a07-a2c2-deaca194debd" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_b42c01ec-3be6-4598-acb5-acd1907a474c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_srt_OwnershipAxis_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_62afd6f4-2572-42db-a15e-1f837eb5c3e3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_7287d597-36a7-4157-ab4c-c5bfb2ce4d4f" xlink:to="loc_srt_OwnershipDomain_62afd6f4-2572-42db-a15e-1f837eb5c3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_969f388c-7944-41d9-afea-3089b164a138" xlink:href="dgx-20201231.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_62afd6f4-2572-42db-a15e-1f837eb5c3e3" xlink:to="loc_dgx_UMassJointVentureMember_969f388c-7944-41d9-afea-3089b164a138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_16f40ab1-0d24-44ea-aabb-15fd800c04be" xlink:to="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2b39b25a-7655-458a-8e91-cc0faebf0168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2b39b25a-7655-458a-8e91-cc0faebf0168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5d1ce16a-51ca-488f-8b62-330195f66625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5d1ce16a-51ca-488f-8b62-330195f66625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7cdf78ae-2728-4ef9-8ed4-df093249efad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7cdf78ae-2728-4ef9-8ed4-df093249efad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_633781e2-7d87-4d54-a6a8-27cd990e8f78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_633781e2-7d87-4d54-a6a8-27cd990e8f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a98c0d0e-ff50-4ac8-9bc1-b1d5fcb6a8b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a98c0d0e-ff50-4ac8-9bc1-b1d5fcb6a8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_5489aab8-971b-4566-946c-79ee17e47d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_5489aab8-971b-4566-946c-79ee17e47d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_ca99e519-1f96-410c-ba37-f0abd56a2da1" xlink:href="dgx-20201231.xsd#dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent_ca99e519-1f96-410c-ba37-f0abd56a2da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount_7dcaa592-9e2b-458b-a69c-8013c2d3d0fe" xlink:href="dgx-20201231.xsd#dgx_StockRepurchaseProgramAdditionalAuthorizedAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount_7dcaa592-9e2b-458b-a69c-8013c2d3d0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0452e0ee-21bb-4ed0-9de5-6a3a92b3bde6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0452e0ee-21bb-4ed0-9de5-6a3a92b3bde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_649e42f7-5605-481b-9d69-28fa379d1290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_649e42f7-5605-481b-9d69-28fa379d1290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e85be5b5-c752-4fa6-8517-6b802cc2b171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e85be5b5-c752-4fa6-8517-6b802cc2b171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TreasuryStockValueAcquiredCostMethod1_8d2a3dcf-f43a-483a-b8f9-537a901660ea" xlink:href="dgx-20201231.xsd#dgx_TreasuryStockValueAcquiredCostMethod1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_dgx_TreasuryStockValueAcquiredCostMethod1_8d2a3dcf-f43a-483a-b8f9-537a901660ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_28d885e0-d449-43ed-b85a-cbbd586dfd20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_28d885e0-d449-43ed-b85a-cbbd586dfd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_bc192f02-362e-48c4-b69c-445e3fd3bcb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_bc192f02-362e-48c4-b69c-445e3fd3bcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_4cb24742-2763-4b3f-a242-533f6aec5989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_4cb24742-2763-4b3f-a242-533f6aec5989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e5c13f3c-c2f5-42ef-a19a-cf904dfd8b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_cc59dcf0-6da1-42e6-b886-419f2eb9f457" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_e5c13f3c-c2f5-42ef-a19a-cf904dfd8b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_93645fcb-247f-4921-8c33-3afb1206241a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityTable_9beef88f-1aef-4b8f-8c22-59835b09f470" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_93645fcb-247f-4921-8c33-3afb1206241a" xlink:to="loc_dgx_ScheduleOfShareholdersEquityTable_9beef88f-1aef-4b8f-8c22-59835b09f470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_889c9bea-aa8b-4d67-b3d4-adf3e293d332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_9beef88f-1aef-4b8f-8c22-59835b09f470" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_889c9bea-aa8b-4d67-b3d4-adf3e293d332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_889c9bea-aa8b-4d67-b3d4-adf3e293d332" xlink:to="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b67ed2b4-3e3a-489b-be8e-2b13cb97ffb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_b67ed2b4-3e3a-489b-be8e-2b13cb97ffb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0a48f42f-92b8-4b82-9c1d-4db1c656a42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_0a48f42f-92b8-4b82-9c1d-4db1c656a42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_50180a46-bed5-4f6f-9706-ec9c3c0aa18d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_50180a46-bed5-4f6f-9706-ec9c3c0aa18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherEquityComponentsMember_e28e5a8b-72dc-4434-86c8-92020564a00b" xlink:href="dgx-20201231.xsd#dgx_OtherEquityComponentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_dgx_OtherEquityComponentsMember_e28e5a8b-72dc-4434-86c8-92020564a00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af61772f-17d1-4987-a550-fce5a5f1eb72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_38b092d1-a4d8-4d18-91cd-aed105befec7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_af61772f-17d1-4987-a550-fce5a5f1eb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareholdersEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityTable_9beef88f-1aef-4b8f-8c22-59835b09f470" xlink:to="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_42278d75-bb1e-4549-bd2b-62372148ea46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_42278d75-bb1e-4549-bd2b-62372148ea46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9aac26ab-b768-4712-b0dd-254622cb555a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9aac26ab-b768-4712-b0dd-254622cb555a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_fc43ef9e-b94d-400c-89db-ffc3f8b37245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_fc43ef9e-b94d-400c-89db-ffc3f8b37245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_473f6939-da6d-4dbf-90bd-e196bf629e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_473f6939-da6d-4dbf-90bd-e196bf629e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_50a4257c-d4b0-4399-9581-50f2168a7a99" xlink:href="dgx-20201231.xsd#dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings_50a4257c-d4b0-4399-9581-50f2168a7a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4e828d60-57e2-46a7-abdd-4969a52ae8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfShareholdersEquityLineItems_32c0b691-3e81-4d76-b726-210eee92f77c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4e828d60-57e2-46a7-abdd-4969a52ae8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d686a8f3-dd75-4d33-8d4a-7f70bd8d56dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7d1a5a56-45b9-4822-8f08-e5ce95815a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d686a8f3-dd75-4d33-8d4a-7f70bd8d56dc" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7d1a5a56-45b9-4822-8f08-e5ce95815a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f04dee82-ffce-4b36-8dd1-3f3c8172c0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_421d8d6c-a574-4800-adf0-ced1bdf9cff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f04dee82-ffce-4b36-8dd1-3f3c8172c0d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_421d8d6c-a574-4800-adf0-ced1bdf9cff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f9f3aaaf-870f-4346-b0cb-a9ada37365c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f04dee82-ffce-4b36-8dd1-3f3c8172c0d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f9f3aaaf-870f-4346-b0cb-a9ada37365c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_c58c6739-a945-4f4e-9428-8fd458a9c9eb" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f04dee82-ffce-4b36-8dd1-3f3c8172c0d2" xlink:to="loc_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock_c58c6739-a945-4f4e-9428-8fd458a9c9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_1e939713-7390-4f4c-8ee2-289ba02fc489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f04dee82-ffce-4b36-8dd1-3f3c8172c0d2" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_1e939713-7390-4f4c-8ee2-289ba02fc489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b577b842-07c4-40ad-b53a-894daea7894f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0ef6e17-e2d2-4893-b095-a92eebe0f125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b577b842-07c4-40ad-b53a-894daea7894f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0ef6e17-e2d2-4893-b095-a92eebe0f125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6b73afb7-f3b9-47f0-8929-d0c1121ed04d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0ef6e17-e2d2-4893-b095-a92eebe0f125" xlink:to="loc_us-gaap_AwardTypeAxis_6b73afb7-f3b9-47f0-8929-d0c1121ed04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6b73afb7-f3b9-47f0-8929-d0c1121ed04d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EmployeeLongTermIncentivePlanEltipMember_033243f4-f63c-4aa1-8db0-12d09182f7b7" xlink:href="dgx-20201231.xsd#dgx_EmployeeLongTermIncentivePlanEltipMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:to="loc_dgx_EmployeeLongTermIncentivePlanEltipMember_033243f4-f63c-4aa1-8db0-12d09182f7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember_2783552d-61f0-4b85-b210-d64ee3fbb8e3" xlink:href="dgx-20201231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:to="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember_2783552d-61f0-4b85-b210-d64ee3fbb8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_acedea87-507a-43dd-8875-10e4086e6ab7" xlink:href="dgx-20201231.xsd#dgx_RestatedDirectorLongTermIncentivePlanDltipMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:to="loc_dgx_RestatedDirectorLongTermIncentivePlanDltipMember_acedea87-507a-43dd-8875-10e4086e6ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_14369b4b-5023-4594-8ec8-1ac82602692e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9ee35211-8d4d-48a6-ae87-645a44b81a40" xlink:to="loc_us-gaap_StockOptionMember_14369b4b-5023-4594-8ec8-1ac82602692e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0ef6e17-e2d2-4893-b095-a92eebe0f125" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_7d9d826b-a841-42ac-b2e7-b9b813220059" xlink:href="dgx-20201231.xsd#dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans_7d9d826b-a841-42ac-b2e7-b9b813220059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5c9d64e0-652f-4cf3-93fe-02b7522d4c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5c9d64e0-652f-4cf3-93fe-02b7522d4c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_72208728-2794-4dc8-a6da-1dc1efe9a99b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_72208728-2794-4dc8-a6da-1dc1efe9a99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7272cc66-18d5-47d4-9730-7fced0407257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7b84ffbd-1b6a-44a6-bf24-c881907287c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7272cc66-18d5-47d4-9730-7fced0407257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cbe319b4-bde8-48bc-9256-792d40f215a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cbe319b4-bde8-48bc-9256-792d40f215a9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2f91982a-a230-42cd-b176-12997121e0ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:to="loc_us-gaap_AwardTypeAxis_2f91982a-a230-42cd-b176-12997121e0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cefa9dda-f530-4831-8768-13eb561caa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2f91982a-a230-42cd-b176-12997121e0ea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cefa9dda-f530-4831-8768-13eb561caa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_6fdd4b47-2a39-4b9a-b947-b5f007c33acd" xlink:href="dgx-20201231.xsd#dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cefa9dda-f530-4831-8768-13eb561caa89" xlink:to="loc_dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember_6fdd4b47-2a39-4b9a-b947-b5f007c33acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_76fdc169-337b-4e2f-8e6e-c15d13b819f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:to="loc_srt_RangeAxis_76fdc169-337b-4e2f-8e6e-c15d13b819f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5153dae7-a794-422a-a162-0f19cf6425aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_76fdc169-337b-4e2f-8e6e-c15d13b819f0" xlink:to="loc_srt_RangeMember_5153dae7-a794-422a-a162-0f19cf6425aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_efd5737c-f8a1-4141-9446-4342d82fde23" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5153dae7-a794-422a-a162-0f19cf6425aa" xlink:to="loc_srt_MinimumMember_efd5737c-f8a1-4141-9446-4342d82fde23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cd0442d5-4412-4c6b-ad1b-9d30bfdad900" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5153dae7-a794-422a-a162-0f19cf6425aa" xlink:to="loc_srt_MaximumMember_cd0442d5-4412-4c6b-ad1b-9d30bfdad900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ee6293b-3abe-43ee-b29b-fe40707e12a9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42ca94ac-7f40-4cd5-9524-76cbc725290c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42ca94ac-7f40-4cd5-9524-76cbc725290c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69c98013-217b-4e7a-beff-3907fa103d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_69c98013-217b-4e7a-beff-3907fa103d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_04227ba7-cdc0-4b1d-bb04-396c9c3d18b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_04227ba7-cdc0-4b1d-bb04-396c9c3d18b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9eb911b0-6343-4c4f-8f66-fe2d41520b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9eb911b0-6343-4c4f-8f66-fe2d41520b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2a9c3dd2-7e64-47ef-9c85-ffdc15b8e6c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2a9c3dd2-7e64-47ef-9c85-ffdc15b8e6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9f8a1536-2b44-4fe3-8ce4-676672e55352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3645cef6-102a-4ac8-abc7-d3535f383e9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9f8a1536-2b44-4fe3-8ce4-676672e55352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ea9739cc-85bb-42fc-8268-24ddb8ad5bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c637c8ef-2649-4737-9ebe-6081dc049d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ea9739cc-85bb-42fc-8268-24ddb8ad5bbc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c637c8ef-2649-4737-9ebe-6081dc049d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6ce7832c-4645-448e-8015-068de0b5c984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c637c8ef-2649-4737-9ebe-6081dc049d21" xlink:to="loc_us-gaap_AwardTypeAxis_6ce7832c-4645-448e-8015-068de0b5c984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4df1e223-e699-49bf-a10e-348a42d029fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6ce7832c-4645-448e-8015-068de0b5c984" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4df1e223-e699-49bf-a10e-348a42d029fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_d0d59769-ba76-4997-8987-1ecd6c8dff45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4df1e223-e699-49bf-a10e-348a42d029fe" xlink:to="loc_us-gaap_StockOptionMember_d0d59769-ba76-4997-8987-1ecd6c8dff45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c637c8ef-2649-4737-9ebe-6081dc049d21" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ec37527c-8810-4cf0-89be-dc246dbc6cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ec37527c-8810-4cf0-89be-dc246dbc6cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_accd85b1-51e7-43ac-b114-c67ad5445363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_accd85b1-51e7-43ac-b114-c67ad5445363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bd32e617-fd5a-45cb-95ad-5038826f613a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bd32e617-fd5a-45cb-95ad-5038826f613a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_83d2c585-6095-4997-81b1-8d568cfa4fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6e3e7a8f-eb6c-465c-9732-63b9dd605f07" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_83d2c585-6095-4997-81b1-8d568cfa4fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_852b8512-c1ef-4a9b-a3ef-58728b637cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_852b8512-c1ef-4a9b-a3ef-58728b637cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_09f428f7-38f8-48bc-bc6c-0e919c32fbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_09f428f7-38f8-48bc-bc6c-0e919c32fbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3c1e200d-7962-478d-b9fe-07dd2c69ac60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3c1e200d-7962-478d-b9fe-07dd2c69ac60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7096fb0f-d520-4646-bd54-fb2d98e86ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f33855c6-1f2d-42ee-9842-027bf8ca763d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7096fb0f-d520-4646-bd54-fb2d98e86ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dfae6665-c5ab-49ea-b9f2-e03eec782481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dfae6665-c5ab-49ea-b9f2-e03eec782481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bc050257-6fe0-40f0-935b-75a30772efe5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_bc050257-6fe0-40f0-935b-75a30772efe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6407199b-7dd6-4f63-b427-fc882239f9ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6407199b-7dd6-4f63-b427-fc882239f9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d9524d2d-99d6-48c5-a97a-404e2171758a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d9524d2d-99d6-48c5-a97a-404e2171758a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f9d83b5e-6eae-4799-9ce5-640d1d6e337a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_f9d83b5e-6eae-4799-9ce5-640d1d6e337a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_876b5b94-0c7a-4c69-8254-af19c761c958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_876b5b94-0c7a-4c69-8254-af19c761c958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3088f6d3-939e-42af-9a8a-1760e2d4de5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3088f6d3-939e-42af-9a8a-1760e2d4de5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e298cb15-6398-4eaf-91b0-bce040344006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e298cb15-6398-4eaf-91b0-bce040344006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_9ff81c2a-8988-4bc9-8337-b758a18c4ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_9ff81c2a-8988-4bc9-8337-b758a18c4ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_710d37e3-c294-4756-9d3a-9f188017cfaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_710d37e3-c294-4756-9d3a-9f188017cfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b357d8ab-149b-483c-a6f4-03f659c4efb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b357d8ab-149b-483c-a6f4-03f659c4efb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8ba41c83-447b-4025-9294-cff39d66d2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8ba41c83-447b-4025-9294-cff39d66d2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ff159f0e-3beb-4703-b601-d831e0deef2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_890fc29a-c8f5-4e04-ae67-834a2a09af67" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ff159f0e-3beb-4703-b601-d831e0deef2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_59207dd5-4745-46da-b628-92891a48d362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bb28baa7-a5e2-415b-97b4-d02e2003a0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_59207dd5-4745-46da-b628-92891a48d362" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bb28baa7-a5e2-415b-97b4-d02e2003a0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8a2304ab-fc23-4260-9714-7032bddf56cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bb28baa7-a5e2-415b-97b4-d02e2003a0a4" xlink:to="loc_us-gaap_AwardTypeAxis_8a2304ab-fc23-4260-9714-7032bddf56cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b00f93e-d7bf-485a-b9c3-78e24ab883d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8a2304ab-fc23-4260-9714-7032bddf56cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b00f93e-d7bf-485a-b9c3-78e24ab883d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockAwardsMember_7dd51e51-8692-43f2-ab6b-c0ae9863acc7" xlink:href="dgx-20201231.xsd#dgx_StockAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b00f93e-d7bf-485a-b9c3-78e24ab883d4" xlink:to="loc_dgx_StockAwardsMember_7dd51e51-8692-43f2-ab6b-c0ae9863acc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bb28baa7-a5e2-415b-97b4-d02e2003a0a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bded95b1-fd5b-47f7-97bd-f423b106fefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bded95b1-fd5b-47f7-97bd-f423b106fefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_294f8f59-a7b5-47cd-96e8-439b34354775" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_294f8f59-a7b5-47cd-96e8-439b34354775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a3d1efac-dc56-468d-a926-2c57010a376c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a3d1efac-dc56-468d-a926-2c57010a376c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8b5d70db-bbaa-4b1f-85bb-4bea845adf69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8b5d70db-bbaa-4b1f-85bb-4bea845adf69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b114da53-1ea2-46cc-805b-85b53e19c1c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9229bcf4-8122-4fc0-80f4-69f289f0b3dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b114da53-1ea2-46cc-805b-85b53e19c1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ca8081bc-e288-44cb-a242-62210f53ed23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ca8081bc-e288-44cb-a242-62210f53ed23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9bbf6d2e-3e9c-40d7-b9e6-45054c05c995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9bbf6d2e-3e9c-40d7-b9e6-45054c05c995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ba0b2b05-f82d-43cb-8bf8-f54cde404216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ba0b2b05-f82d-43cb-8bf8-f54cde404216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d02f1c26-90dc-41ba-921e-0457bfddaa4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d02f1c26-90dc-41ba-921e-0457bfddaa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_42cc852c-bcf0-482d-9162-251c37582a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_374c1a43-58e3-4bfd-b94f-212ab0d3a59c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_42cc852c-bcf0-482d-9162-251c37582a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7e8f7bff-e129-4137-84a4-82fdb868abfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7e8f7bff-e129-4137-84a4-82fdb868abfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c7adb272-bbe5-4d0c-bbc9-9d182b2fa761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c7adb272-bbe5-4d0c-bbc9-9d182b2fa761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_bf6f96e4-fe49-4afa-bdff-57d137f7adcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_bf6f96e4-fe49-4afa-bdff-57d137f7adcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f209d709-93d5-4b34-9001-3b4148336419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_ShareBasedCompensation_f209d709-93d5-4b34-9001-3b4148336419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_5cd15354-6f12-4a0a-8140-6a74ad501311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_5cd15354-6f12-4a0a-8140-6a74ad501311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_041752e7-c688-450b-8298-eb9f49177991" xlink:href="dgx-20201231.xsd#dgx_Sharebasedcompensationexcesstaxbenefitamount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1d86b4e-8864-4f3f-89c6-b171625d4d42" xlink:to="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_041752e7-c688-450b-8298-eb9f49177991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2ce493b9-c2d5-4557-a450-2878b03fe7bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2ce493b9-c2d5-4557-a450-2878b03fe7bf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_dbc93e8a-a2cf-400f-bc3f-26e77797515b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:to="loc_us-gaap_AwardTypeAxis_dbc93e8a-a2cf-400f-bc3f-26e77797515b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be562d0e-712f-4bee-a0e4-d1565916f3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_dbc93e8a-a2cf-400f-bc3f-26e77797515b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be562d0e-712f-4bee-a0e4-d1565916f3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_cffa04ac-0768-438c-b137-2cf6dd1dc69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be562d0e-712f-4bee-a0e4-d1565916f3ec" xlink:to="loc_us-gaap_EmployeeStockMember_cffa04ac-0768-438c-b137-2cf6dd1dc69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_52ae7940-1fa8-40f2-8ecb-f13da7643651" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:to="loc_srt_RangeAxis_52ae7940-1fa8-40f2-8ecb-f13da7643651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f400e3f5-9a6d-4db8-96cc-3ce2773933e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_52ae7940-1fa8-40f2-8ecb-f13da7643651" xlink:to="loc_srt_RangeMember_f400e3f5-9a6d-4db8-96cc-3ce2773933e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_47f8e93a-ed90-4813-bac0-2cc23e0eefd0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f400e3f5-9a6d-4db8-96cc-3ce2773933e1" xlink:to="loc_srt_MaximumMember_47f8e93a-ed90-4813-bac0-2cc23e0eefd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a888e409-206f-454f-a162-d6551e657a0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_4bb50bf9-e6a4-40fc-893b-5effe8726cad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_4bb50bf9-e6a4-40fc-893b-5effe8726cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_8e912da1-d2e9-45e7-8384-f1e4dd7aee2a" xlink:href="dgx-20201231.xsd#dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp_8e912da1-d2e9-45e7-8384-f1e4dd7aee2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_82def2c2-3598-47a1-95d6-20b22b1ff91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_82def2c2-3598-47a1-95d6-20b22b1ff91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9f6a8b4e-ce83-4d9d-a540-79077d978dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9f6a8b4e-ce83-4d9d-a540-79077d978dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2f46e289-0c7c-4437-97e8-09f763301814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2f46e289-0c7c-4437-97e8-09f763301814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_5c50ad46-ef8d-4e4d-bb80-9cc54549d692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e1bcb21-b39f-4605-9e6c-2f9d068d5816" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_5c50ad46-ef8d-4e4d-bb80-9cc54549d692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c398ef46-f527-41cf-820e-9001acea9992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c398ef46-f527-41cf-820e-9001acea9992" xlink:to="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_7751ede0-4f45-47da-89f2-e816e256dc83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis_02d3dc1f-afd6-4479-b3c1-d558ea95c3c7" xlink:to="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_7751ede0-4f45-47da-89f2-e816e256dc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanMember_541bb2ef-64ac-4635-90bf-e5a16008fba1" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_7751ede0-4f45-47da-89f2-e816e256dc83" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanMember_541bb2ef-64ac-4635-90bf-e5a16008fba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiMember_353d099f-3e13-4f62-b382-d5b9f12d5ca5" xlink:href="dgx-20201231.xsd#dgx_SdcpIiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain_7751ede0-4f45-47da-89f2-e816e256dc83" xlink:to="loc_dgx_SdcpIiMember_353d099f-3e13-4f62-b382-d5b9f12d5ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:to="loc_srt_RangeAxis_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e13a9bb4-a00e-49ac-bd00-3063fd6c053e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ab2ab8c7-706e-4e7f-a1dd-5131ce4b48ab" xlink:to="loc_srt_RangeMember_e13a9bb4-a00e-49ac-bd00-3063fd6c053e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08a960c3-895b-4e86-b7bd-67ae02faea50" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e13a9bb4-a00e-49ac-bd00-3063fd6c053e" xlink:to="loc_srt_MaximumMember_08a960c3-895b-4e86-b7bd-67ae02faea50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_c94b5ffc-7c3d-473f-95ec-f5eb945d8c99" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_2d7395b1-0e8a-42b5-8042-7b8424a2b4fa" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanSalaryDeferral"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanSalaryDeferral_2d7395b1-0e8a-42b5-8042-7b8424a2b4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_23e79a23-1425-4c4e-b02c-c706eb0d436b" xlink:href="dgx-20201231.xsd#dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral_23e79a23-1425-4c4e-b02c-c706eb0d436b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_f414eb1d-105e-4a56-bd88-d68f2d4cd530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_f414eb1d-105e-4a56-bd88-d68f2d4cd530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_5e293c5f-cf1e-48fc-8450-aee680a62505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability_5e293c5f-cf1e-48fc-8450-aee680a62505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_e95e4d14-1919-4124-8de3-f7c229d5395e" xlink:href="dgx-20201231.xsd#dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP_e95e4d14-1919-4124-8de3-f7c229d5395e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_3806966f-ea31-4a24-b2fb-cd21a0b6a1de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer_3806966f-ea31-4a24-b2fb-cd21a0b6a1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_11e3c0e3-2bca-4220-9ac2-dcde28406a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1_11e3c0e3-2bca-4220-9ac2-dcde28406a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SdcpIiGradedVestingPercentage_459b89b2-9e16-46f8-93fd-4d96fa2bf7af" xlink:href="dgx-20201231.xsd#dgx_SdcpIiGradedVestingPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_dgx_SdcpIiGradedVestingPercentage_459b89b2-9e16-46f8-93fd-4d96fa2bf7af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_1003ccf0-89ed-428a-9fa7-01f4027f46bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_4e54c6a2-97f1-4027-8dcf-986bb2e42c74" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_1003ccf0-89ed-428a-9fa7-01f4027f46bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f6276494-575c-43fd-9708-f7dfca7a40cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7af5dc88-2fc1-4c91-b1aa-53d1891d2124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f6276494-575c-43fd-9708-f7dfca7a40cc" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7af5dc88-2fc1-4c91-b1aa-53d1891d2124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_06696775-23f2-4b40-8263-bd5ca7cb788d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_06696775-23f2-4b40-8263-bd5ca7cb788d" xlink:to="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ad229736-5846-46fc-89ea-1cf7614ac8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ad229736-5846-46fc-89ea-1cf7614ac8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b91fb481-7f61-4af2-8a94-fd1f59b09e8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ad229736-5846-46fc-89ea-1cf7614ac8e5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b91fb481-7f61-4af2-8a94-fd1f59b09e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_2ffad462-889f-4a70-83f9-55995409706c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b91fb481-7f61-4af2-8a94-fd1f59b09e8d" xlink:to="loc_us-gaap_SecuredDebtMember_2ffad462-889f-4a70-83f9-55995409706c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a434fba5-8efa-4528-a897-ffd9daab7e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:to="loc_us-gaap_CreditFacilityAxis_a434fba5-8efa-4528-a897-ffd9daab7e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_03c4583d-7de2-40b3-a541-51584898ea9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a434fba5-8efa-4528-a897-ffd9daab7e22" xlink:to="loc_us-gaap_CreditFacilityDomain_03c4583d-7de2-40b3-a541-51584898ea9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_c817311d-13e7-443a-add5-f04ab861bbae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_03c4583d-7de2-40b3-a541-51584898ea9a" xlink:to="loc_us-gaap_LetterOfCreditMember_c817311d-13e7-443a-add5-f04ab861bbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:to="loc_us-gaap_DebtInstrumentAxis_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_93607c29-da18-416c-ad18-f75c6feb566b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bfadcbea-4ec7-4028-b57e-2b2c6935ccbc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_93607c29-da18-416c-ad18-f75c6feb566b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d81362bd-c459-43d8-b937-a00305b8675c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_93607c29-da18-416c-ad18-f75c6feb566b" xlink:to="loc_us-gaap_LetterOfCreditMember_d81362bd-c459-43d8-b937-a00305b8675c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_6a6e070d-b76a-48b2-b9bc-aa53d496b493" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41e7f5b3-98cf-4747-852a-d1836d29c422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_41e7f5b3-98cf-4747-852a-d1836d29c422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_651d7aa7-5c5b-40d7-b5cd-554d7a3722dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_651d7aa7-5c5b-40d7-b5cd-554d7a3722dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_e83007d2-179c-4f25-a061-a6bfbde38d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_e83007d2-179c-4f25-a061-a6bfbde38d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_3d4f7041-0095-4018-af43-7e673b619025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_3d4f7041-0095-4018-af43-7e673b619025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_d6289ed6-4ec0-4081-8f27-fad7adc0f76f" xlink:href="dgx-20201231.xsd#dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears_d6289ed6-4ec0-4081-8f27-fad7adc0f76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction_afdce706-0843-491e-9159-6d4e53d6db75" xlink:href="dgx-20201231.xsd#dgx_AgreementtoOutsourceBillingandCollectionFunction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_dgx_AgreementtoOutsourceBillingandCollectionFunction_afdce706-0843-491e-9159-6d4e53d6db75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum_1c0e96bc-d66a-4079-9b6f-0603022b7567" xlink:href="dgx-20201231.xsd#dgx_RemainingTermsofContingentLeaseObligationsMaximum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_dgx_RemainingTermsofContingentLeaseObligationsMaximum_1c0e96bc-d66a-4079-9b6f-0603022b7567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_56e60330-8a01-4fc6-bb46-d0ca8381196e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_56e60330-8a01-4fc6-bb46-d0ca8381196e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_401d0072-ba0d-401a-8df7-0d144c7a1260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_LitigationReserve_401d0072-ba0d-401a-8df7-0d144c7a1260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_b1bafea0-4980-4436-b87c-ec5d1912ebc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d868f5a9-2e49-4ecd-811d-643fc9faa52d" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_b1bafea0-4980-4436-b87c-ec5d1912ebc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_14f9f926-d34e-4702-b684-0e67c1490a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_2f8c77a8-39d9-4e76-8847-d91dab944a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_14f9f926-d34e-4702-b684-0e67c1490a94" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_2f8c77a8-39d9-4e76-8847-d91dab944a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fd05a65e-2c56-4245-bc33-9bfa3c1c1796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8f1ee964-46a1-4c4c-b13d-d18930c4da59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fd05a65e-2c56-4245-bc33-9bfa3c1c1796" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8f1ee964-46a1-4c4c-b13d-d18930c4da59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7073da22-44be-4ad2-8581-f2d0b2882322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7073da22-44be-4ad2-8581-f2d0b2882322" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_df0d8dd8-a79e-4305-9595-bdcc0ecf689d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:to="loc_srt_RangeAxis_df0d8dd8-a79e-4305-9595-bdcc0ecf689d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ff077c09-3803-4dd1-ab95-ab40d8d320a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_df0d8dd8-a79e-4305-9595-bdcc0ecf689d" xlink:to="loc_srt_RangeMember_ff077c09-3803-4dd1-ab95-ab40d8d320a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1fd67cec-e907-495b-b755-5f14baac59a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ff077c09-3803-4dd1-ab95-ab40d8d320a3" xlink:to="loc_srt_MinimumMember_1fd67cec-e907-495b-b755-5f14baac59a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_da02ef2b-a60c-46fd-8cc9-e799ca9ccefb" xlink:to="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_6cdf2a42-ef93-4f97-adb4-3d896fe401c7" xlink:href="dgx-20201231.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_6cdf2a42-ef93-4f97-adb4-3d896fe401c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_917ad02f-71e2-4ff5-86cd-b2f263d5eb04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_917ad02f-71e2-4ff5-86cd-b2f263d5eb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_c4268ca4-6ee0-4c1c-a2a6-bf488f9343e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e559f3f5-dc14-4aa5-b275-71c5907c2f0c" xlink:to="loc_us-gaap_CorporateMember_c4268ca4-6ee0-4c1c-a2a6-bf488f9343e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_03a7a181-de91-40b5-9026-449ef0b940e6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:to="loc_srt_ProductOrServiceAxis_03a7a181-de91-40b5-9026-449ef0b940e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_03a7a181-de91-40b5-9026-449ef0b940e6" xlink:to="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_4aaf4d52-e39c-4fbe-be33-acec0e691533" xlink:href="dgx-20201231.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_4aaf4d52-e39c-4fbe-be33-acec0e691533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_d5a2e809-6475-42e9-9a5c-16d93482c162" xlink:href="dgx-20201231.xsd#dgx_COVID19TestingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_COVID19TestingServicesMember_d5a2e809-6475-42e9-9a5c-16d93482c162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_16b34308-8ea9-4c9e-8ed9-07d2addede17" xlink:href="dgx-20201231.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_16b34308-8ea9-4c9e-8ed9-07d2addede17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_e747cd72-98aa-4f68-8f01-744c2fbc8d65" xlink:href="dgx-20201231.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_e747cd72-98aa-4f68-8f01-744c2fbc8d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_326361a8-59d2-4ea2-a42d-66db29751303" xlink:href="dgx-20201231.xsd#dgx_AllotherservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6663c638-9a7d-4e19-b9f2-cdbc93ddfc8b" xlink:to="loc_dgx_AllotherservicesMember_326361a8-59d2-4ea2-a42d-66db29751303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f643518a-ce6d-422e-a3ca-472bd214bf31" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_eec01598-78c9-46d3-8be7-e90530ed54f5" xlink:href="dgx-20201231.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_dgx_PercentageofNetRevenues_eec01598-78c9-46d3-8be7-e90530ed54f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bb3abe27-556d-4d1a-8e3c-60326dace391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bb3abe27-556d-4d1a-8e3c-60326dace391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c3fe097d-6e0f-4f09-afc9-6c22a66b4916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_OperatingIncomeLoss_c3fe097d-6e0f-4f09-afc9-6c22a66b4916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_f3bcab35-13ff-4726-90db-b4a6f358404c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_f3bcab35-13ff-4726-90db-b4a6f358404c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7ca31df8-71fa-4bed-b0c8-faa01e5c1ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7ca31df8-71fa-4bed-b0c8-faa01e5c1ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_06e707c1-e583-44ce-a290-f7971ae94eea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_06e707c1-e583-44ce-a290-f7971ae94eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5b25f11e-92a4-4240-abe3-fa0710810001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5b25f11e-92a4-4240-abe3-fa0710810001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_eadecec5-b295-4afa-b227-f2afc65256d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_eadecec5-b295-4afa-b227-f2afc65256d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_9b8eaf2f-8961-4c3c-b2a5-4d5d8b4f17f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_9b8eaf2f-8961-4c3c-b2a5-4d5d8b4f17f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_405ededa-4634-41da-9d6f-742e3a8edd40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_ProfitLoss_405ededa-4634-41da-9d6f-742e3a8edd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c74f326e-25fb-462f-9dd2-246234b4d79e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c74f326e-25fb-462f-9dd2-246234b4d79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_62928c8d-62a0-45b1-a138-93aab81e8f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_NetIncomeLoss_62928c8d-62a0-45b1-a138-93aab81e8f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_52ace38b-9a83-4881-bceb-31ff8cd0b50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_52ace38b-9a83-4881-bceb-31ff8cd0b50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2bc5d847-37eb-401a-95d2-42af108d49fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96ad807b-db3e-4b8c-9769-92ac00913900" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2bc5d847-37eb-401a-95d2-42af108d49fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="dgx-20201231.xsd#RELATEDPARTIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b421928a-c88d-41bf-8eb4-54a2a2301687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3724110d-c59b-47c6-a052-ab6acea42ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b421928a-c88d-41bf-8eb4-54a2a2301687" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3724110d-c59b-47c6-a052-ab6acea42ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#RELATEDPARTIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_991a07da-8c69-46ab-877c-38c3783e6aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_991a07da-8c69-46ab-877c-38c3783e6aae" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8aaa5ff8-45e8-433b-8814-0be41acc01e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8aaa5ff8-45e8-433b-8814-0be41acc01e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_81beff05-9274-4baa-b66b-f86ea7070ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8aaa5ff8-45e8-433b-8814-0be41acc01e7" xlink:to="loc_us-gaap_RelatedPartyDomain_81beff05-9274-4baa-b66b-f86ea7070ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_64106da3-0cba-4eab-9fa9-dee80949e7d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_81beff05-9274-4baa-b66b-f86ea7070ac8" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_64106da3-0cba-4eab-9fa9-dee80949e7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateJointVentureMember_904d9f05-a210-48fc-ad81-239e2ef02527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateJointVentureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_81beff05-9274-4baa-b66b-f86ea7070ac8" xlink:to="loc_us-gaap_CorporateJointVentureMember_904d9f05-a210-48fc-ad81-239e2ef02527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d45ff101-942b-40e0-85d3-1c7da686283f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d45ff101-942b-40e0-85d3-1c7da686283f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f7866393-13c3-4bb2-aef2-2e9788bd9ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d45ff101-942b-40e0-85d3-1c7da686283f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f7866393-13c3-4bb2-aef2-2e9788bd9ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a34101d2-20d3-4d0c-965f-fdd54d282e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f7866393-13c3-4bb2-aef2-2e9788bd9ec8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_a34101d2-20d3-4d0c-965f-fdd54d282e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fb69af66-af53-465e-bec8-a23a9c1f0417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fb69af66-af53-465e-bec8-a23a9c1f0417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b23c0860-29ef-4dd2-9c35-5b3df09b3fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fb69af66-af53-465e-bec8-a23a9c1f0417" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b23c0860-29ef-4dd2-9c35-5b3df09b3fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_c8de60d7-4386-4de9-8406-8390507bedd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b23c0860-29ef-4dd2-9c35-5b3df09b3fec" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_c8de60d7-4386-4de9-8406-8390507bedd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8f8ca388-21da-4907-a222-6a2bcb381a05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b23c0860-29ef-4dd2-9c35-5b3df09b3fec" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_8f8ca388-21da-4907-a222-6a2bcb381a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_05c60d42-b79b-48fd-a787-78edbe346437" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_fc7813eb-367c-427e-bc04-2ccd77350168" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_RevenueFromRelatedParties_fc7813eb-367c-427e-bc04-2ccd77350168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_252b14c3-0db1-467a-9448-28f4a4f3fb9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_252b14c3-0db1-467a-9448-28f4a4f3fb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_a093722b-29ee-42f7-8703-35a8841e7b69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_a093722b-29ee-42f7-8703-35a8841e7b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherAccountsReceivableRelatedParties_8127daca-06c7-4945-b996-34fbd4f7fa05" xlink:href="dgx-20201231.xsd#dgx_OtherAccountsReceivableRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_dgx_OtherAccountsReceivableRelatedParties_8127daca-06c7-4945-b996-34fbd4f7fa05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_1a40a1b0-e977-4aac-9534-7ec7e0d350ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_1a40a1b0-e977-4aac-9534-7ec7e0d350ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_2984b8af-bda7-4b23-b050-37018be880d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_2984b8af-bda7-4b23-b050-37018be880d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a647bfe1-acb2-4666-a352-89d799996427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5c69338a-d61b-4a90-a685-5f37c129f348" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a647bfe1-acb2-4666-a352-89d799996427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS" xlink:type="simple" xlink:href="dgx-20201231.xsd#DISCONTINUEDOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6140ff9e-6362-4499-a63d-63c76680bfe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_2802417a-2c8e-46ed-87cd-62194e42c0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_6140ff9e-6362-4499-a63d-63c76680bfe0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_2802417a-2c8e-46ed-87cd-62194e42c0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#DISCONTINUEDOPERATIONSDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_71ece6b0-b0c5-4351-849f-13eb4775befd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f48bafbc-114c-4d68-9add-26482acbe095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_71ece6b0-b0c5-4351-849f-13eb4775befd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f48bafbc-114c-4d68-9add-26482acbe095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_520cc26e-02de-4e67-b6b8-096c8b3a9dd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f48bafbc-114c-4d68-9add-26482acbe095" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_520cc26e-02de-4e67-b6b8-096c8b3a9dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_44f6bef7-87b7-4f73-85ca-34a5f30f2f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_520cc26e-02de-4e67-b6b8-096c8b3a9dd6" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_44f6bef7-87b7-4f73-85ca-34a5f30f2f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NidMember_88dd04da-ff3f-4710-a8f2-aa49318310e8" xlink:href="dgx-20201231.xsd#dgx_NidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_44f6bef7-87b7-4f73-85ca-34a5f30f2f71" xlink:to="loc_dgx_NidMember_88dd04da-ff3f-4710-a8f2-aa49318310e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3695b616-6caa-47e2-b3ba-1c73caf4041b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f48bafbc-114c-4d68-9add-26482acbe095" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3695b616-6caa-47e2-b3ba-1c73caf4041b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_617a2e6b-15a0-49e0-bf58-b409eb15ca8a" xlink:href="dgx-20201231.xsd#dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3695b616-6caa-47e2-b3ba-1c73caf4041b" xlink:to="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_617a2e6b-15a0-49e0-bf58-b409eb15ca8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3d665d69-de3c-46af-bdf5-f233bd12adc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_3695b616-6caa-47e2-b3ba-1c73caf4041b" xlink:to="loc_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_3d665d69-de3c-46af-bdf5-f233bd12adc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunaudited"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_0eb827d5-2e0e-4341-8fbb-091967a7ccba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_aac130d6-74dc-4c30-aa9f-d1e3f97ccbeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_0eb827d5-2e0e-4341-8fbb-091967a7ccba" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_aac130d6-74dc-4c30-aa9f-d1e3f97ccbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_9cfd1f37-7cc1-4a1e-b407-443e000f9558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_d5cd53f7-e0c8-4d62-b791-4fb732198b46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_9cfd1f37-7cc1-4a1e-b407-443e000f9558" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_d5cd53f7-e0c8-4d62-b791-4fb732198b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedScheduleDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_32f0b514-c68e-4304-82ea-1c4ee8573abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_32f0b514-c68e-4304-82ea-1c4ee8573abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e2e5b7b9-0d65-4554-bf66-bd928f65666f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_GrossProfit_e2e5b7b9-0d65-4554-bf66-bd928f65666f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c0132b46-4230-4ac1-b8e4-eaddfee8716c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c0132b46-4230-4ac1-b8e4-eaddfee8716c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_966f6b6b-93b2-4869-b581-9fd47f2e30e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_966f6b6b-93b2-4869-b581-9fd47f2e30e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2ce22ff1-5ec7-4ea1-9551-1f490961a4f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_ProfitLoss_2ce22ff1-5ec7-4ea1-9551-1f490961a4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_23810426-325d-42b7-88df-feb51e949023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_23810426-325d-42b7-88df-feb51e949023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7386d569-420c-40e2-8506-9c82805ea4c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_NetIncomeLoss_7386d569-420c-40e2-8506-9c82805ea4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_6e0277e7-b115-46b5-960e-e51e834544a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_6e0277e7-b115-46b5-960e-e51e834544a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c316a384-d256-4cd8-9d88-c72d41e27043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_6e0277e7-b115-46b5-960e-e51e834544a4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c316a384-d256-4cd8-9d88-c72d41e27043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_785ebee8-c050-4ba8-a29f-f370ec6fec8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_6e0277e7-b115-46b5-960e-e51e834544a4" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_785ebee8-c050-4ba8-a29f-f370ec6fec8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ed23f489-86a8-4fd0-a2be-63bceb5a11c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_6e0277e7-b115-46b5-960e-e51e834544a4" xlink:to="loc_us-gaap_EarningsPerShareBasic_ed23f489-86a8-4fd0-a2be-63bceb5a11c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_2d3da029-f6d6-4699-ac7b-3e8f0240cee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_209693bf-1b66-408c-bbe1-fbe0820560bd" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_2d3da029-f6d6-4699-ac7b-3e8f0240cee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_eb0ea0b7-8f76-476e-8a5e-6093a09d4035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_2d3da029-f6d6-4699-ac7b-3e8f0240cee7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_eb0ea0b7-8f76-476e-8a5e-6093a09d4035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_0606df34-a4fd-4436-80dd-efd12cde61d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_2d3da029-f6d6-4699-ac7b-3e8f0240cee7" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_0606df34-a4fd-4436-80dd-efd12cde61d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e0f075d8-d0b6-4788-9d2a-287806bb8940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_2d3da029-f6d6-4699-ac7b-3e8f0240cee7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e0f075d8-d0b6-4788-9d2a-287806bb8940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#QuarterlyOperatingResultsunauditedNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_814f74de-5284-4247-b578-7c16d2e83028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:href="dgx-20201231.xsd#dgx_ScheduleOfQuarterlyFinancialDataTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_814f74de-5284-4247-b578-7c16d2e83028" xlink:to="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_c804b291-58b0-449b-a2c4-00cf44aa2bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_NatureOfExpenseAxis_c804b291-58b0-449b-a2c4-00cf44aa2bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_abd154b8-11c5-4744-9ba5-83139e92d4a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_c804b291-58b0-449b-a2c4-00cf44aa2bcd" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_abd154b8-11c5-4744-9ba5-83139e92d4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AmortizationofIntangibleAssetsMember_47dbc81e-b668-4cbe-be64-012b66087238" xlink:href="dgx-20201231.xsd#dgx_AmortizationofIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_abd154b8-11c5-4744-9ba5-83139e92d4a1" xlink:to="loc_dgx_AmortizationofIntangibleAssetsMember_47dbc81e-b668-4cbe-be64-012b66087238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityinEarningsofEquityMethodInvesteesMember_49f749bd-d736-46c0-9995-140ac7d8bbad" xlink:href="dgx-20201231.xsd#dgx_EquityinEarningsofEquityMethodInvesteesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_abd154b8-11c5-4744-9ba5-83139e92d4a1" xlink:to="loc_dgx_EquityinEarningsofEquityMethodInvesteesMember_49f749bd-d736-46c0-9995-140ac7d8bbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1fc1bda4-2f65-4df3-89f7-c42f5823316a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1fc1bda4-2f65-4df3-89f7-c42f5823316a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1fc1bda4-2f65-4df3-89f7-c42f5823316a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f0ad7c31-4610-4053-8002-0e5a22a2fa48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:to="loc_us-gaap_CostOfSalesMember_f0ad7c31-4610-4053-8002-0e5a22a2fa48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ce15caf0-9601-495b-8c69-b48294aed479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_ce15caf0-9601-495b-8c69-b48294aed479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_60ee0746-d6b1-4e8c-85e4-49c4aab4a883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_60ee0746-d6b1-4e8c-85e4-49c4aab4a883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherIncomeExpenseMember_1f540b29-c2e2-4e16-9c8a-376af8f1fe1c" xlink:href="dgx-20201231.xsd#dgx_OtherIncomeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d1842f21-7d6c-4f6f-94a8-d022f19f5a9b" xlink:to="loc_dgx_OtherIncomeExpenseMember_1f540b29-c2e2-4e16-9c8a-376af8f1fe1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_5318d98f-b7f3-49d5-87a7-d46294e540ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_5318d98f-b7f3-49d5-87a7-d46294e540ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_5318d98f-b7f3-49d5-87a7-d46294e540ff" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_baac0f26-a78b-4df7-8063-8cc694172164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:to="loc_us-gaap_CostOfSalesMember_baac0f26-a78b-4df7-8063-8cc694172164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3c571c7e-abb7-4d08-9536-7d65563f7a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_3c571c7e-abb7-4d08-9536-7d65563f7a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_29dc28c0-75f6-4a0e-b744-7eba653fcc69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_0226e23a-43da-4480-8c70-bbc2b8d83b09" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_29dc28c0-75f6-4a0e-b744-7eba653fcc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48de0976-07c2-479e-9c79-c50b0d0820e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cb11c2ef-d32c-4736-b4b5-fc63b557c8c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48de0976-07c2-479e-9c79-c50b0d0820e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_2f7acae0-4aff-4058-8112-81f56db50b31" xlink:href="dgx-20201231.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48de0976-07c2-479e-9c79-c50b0d0820e9" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_2f7acae0-4aff-4058-8112-81f56db50b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c35152cc-e54f-4632-8e0b-70bcdc8c263d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c35152cc-e54f-4632-8e0b-70bcdc8c263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_806d1c9a-68bc-4fb5-b379-e9fc241db39f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c35152cc-e54f-4632-8e0b-70bcdc8c263d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_806d1c9a-68bc-4fb5-b379-e9fc241db39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NidMember_6203baa9-b1aa-44f9-9ee4-a5284f81b3e4" xlink:href="dgx-20201231.xsd#dgx_NidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_806d1c9a-68bc-4fb5-b379-e9fc241db39f" xlink:to="loc_dgx_NidMember_6203baa9-b1aa-44f9-9ee4-a5284f81b3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:href="dgx-20201231.xsd#dgx_QuarterlyFinancialDataLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleOfQuarterlyFinancialDataTable_1ab04246-a8b9-45d7-94b7-67fb3da9988c" xlink:to="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_eb6a789b-297b-4eab-b11e-d3f26f4e48a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_eb6a789b-297b-4eab-b11e-d3f26f4e48a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RestructuringIntegrationCharges_6a8d9728-1e07-4e95-b095-2b9cf7cef9e9" xlink:href="dgx-20201231.xsd#dgx_RestructuringIntegrationCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_RestructuringIntegrationCharges_6a8d9728-1e07-4e95-b095-2b9cf7cef9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ChargesDueToCOVID19_5b1fe171-9580-414e-8448-6c052904d9fd" xlink:href="dgx-20201231.xsd#dgx_ChargesDueToCOVID19"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_ChargesDueToCOVID19_5b1fe171-9580-414e-8448-6c052904d9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_34be06fe-1893-48d2-acf0-d586b530765e" xlink:href="dgx-20201231.xsd#dgx_Sharebasedcompensationexcesstaxbenefitamount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_Sharebasedcompensationexcesstaxbenefitamount_34be06fe-1893-48d2-acf0-d586b530765e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PreTaxGainLossDueToCOVID19_7fa65e16-7c01-455c-bc2e-27d59da1187b" xlink:href="dgx-20201231.xsd#dgx_PreTaxGainLossDueToCOVID19"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_PreTaxGainLossDueToCOVID19_7fa65e16-7c01-455c-bc2e-27d59da1187b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_ed557d1f-9ff2-451e-a4bb-0124042ab1d0" xlink:href="dgx-20201231.xsd#dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_ed557d1f-9ff2-451e-a4bb-0124042ab1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_19acb53f-e452-4475-a8f9-f569b4590453" xlink:href="dgx-20201231.xsd#dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct_19acb53f-e452-4475-a8f9-f569b4590453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_6f1ed162-7ffb-4849-b65c-b3dbe449b534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_6f1ed162-7ffb-4849-b65c-b3dbe449b534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_253b0538-9dca-48fe-93a2-32bf42d4c9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_253b0538-9dca-48fe-93a2-32bf42d4c9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt_f77d5e2d-764b-4eac-81d9-1af2cdaefb48" xlink:href="dgx-20201231.xsd#dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt_f77d5e2d-764b-4eac-81d9-1af2cdaefb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge_5b10699e-2805-4509-932b-192f51f0900a" xlink:href="dgx-20201231.xsd#dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge_5b10699e-2805-4509-932b-192f51f0900a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_746f33fe-36d1-4f53-b930-254bb85497d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_746f33fe-36d1-4f53-b930-254bb85497d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_5a390147-7468-4908-b05c-20c85f68b1c1" xlink:href="dgx-20201231.xsd#dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits_5a390147-7468-4908-b05c-20c85f68b1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident_1c1c5c78-a8ce-48b0-b0d0-48b892ac3c24" xlink:href="dgx-20201231.xsd#dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident_1c1c5c78-a8ce-48b0-b0d0-48b892ac3c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_5487df76-7c9e-4bb0-b02a-1a6cd5fe6c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_QuarterlyFinancialDataLineItems_4b10820e-7616-4dce-8d0c-27f70273ee50" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_5487df76-7c9e-4bb0-b02a-1a6cd5fe6c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves" xlink:type="simple" xlink:href="dgx-20201231.xsd#ScheduleIIValuationAccountsandReserves"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_cb4997ca-a0bc-480c-b528-66f5a6bc5460" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_3bd96a5d-2845-4854-8bcc-b4b0d6b8b6cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_cb4997ca-a0bc-480c-b528-66f5a6bc5460" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_3bd96a5d-2845-4854-8bcc-b4b0d6b8b6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="simple" xlink:href="dgx-20201231.xsd#ScheduleIIValuationAccountsandReservesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_a902b87f-57ec-4e46-9a0e-e4ded5b0244b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4e5645c4-f14c-47a3-a3d6-0cef4f201cf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_a902b87f-57ec-4e46-9a0e-e4ded5b0244b" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4e5645c4-f14c-47a3-a3d6-0cef4f201cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_174e2ffb-4062-4d77-9933-3eeaa60f27f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4e5645c4-f14c-47a3-a3d6-0cef4f201cf2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_174e2ffb-4062-4d77-9933-3eeaa60f27f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_9cf26604-9738-4107-944c-9580e9360211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_174e2ffb-4062-4d77-9933-3eeaa60f27f2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_9cf26604-9738-4107-944c-9580e9360211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossMember_c0821178-4432-477f-bd77-6e3ecb89ccdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_9cf26604-9738-4107-944c-9580e9360211" xlink:to="loc_us-gaap_AllowanceForCreditLossMember_c0821178-4432-477f-bd77-6e3ecb89ccdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d50ed50c-42ee-457f-a404-94c1c1408c20" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_4e5645c4-f14c-47a3-a3d6-0cef4f201cf2" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d50ed50c-42ee-457f-a404-94c1c1408c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d50ed50c-42ee-457f-a404-94c1c1408c20" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_454b3863-37e5-477f-bf3d-32a96de55d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_454b3863-37e5-477f-bf3d-32a96de55d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_00d91d39-2955-469b-82d1-6edb46d97371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_00d91d39-2955-469b-82d1-6edb46d97371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_0b1180d7-2cbb-41ab-be58-f53cc3445906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_0b1180d7-2cbb-41ab-be58-f53cc3445906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_38af47ce-9b84-4a6c-bc5b-1aca6c71cf7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_209fa44e-8a76-4e7c-bf4f-880bed1af104" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_38af47ce-9b84-4a6c-bc5b-1aca6c71cf7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>dgx-20201231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dgx-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI8VAO;',L
M(%!A=')I8VEA($<   60 P "    %   $*R0!  "    %   $,"2D0 "
M S$S  "2D@ "     S$S  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZ'KUCX@T];O3Y-R]'1OO(?0BM*@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "HKFYAL[62XNI%BBC4L[L< "I2<#)X%>,^/_&+:W>MI^GR?\2^
M!N2I_P!<P[_0=OS], %7QIXTG\271@MBT6G1GY(\\R'^\W]!VKE:** "BBB@
M J>SLKG4+A8+*WDN)6Z)&I)^OTKL/"WPWO-7V76K[[.S/(3&))![#^$>Y_+O
M7JNE:-8:+:BWTVV2!.Y Y8^I/4F@#S31OA1?7(636;E;1#R8HOG?Z$]!^M=M
MIO@'P[IH!6P6XD Y>Y/F9_ \?D*Z.B@!D<4<,:I$BHBC 51@"GT44 %%%%
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MA44 ?30(901R#R**YGX?ZO\ VMX1MM[9EMOW$G_ >G_CN*Z:@ HHHH ****
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M\U48C 9HP.1G -<?I_P]\9W\WAI?$\TLTBZ)J-G>WKW*2R6QG!$2,V09&52
M6 (R#R1@F6Z\*>+-;^$-A\-[O0'LW4PVEWJYNH6M1!#(&$L8#F5F81IA6C7E
M^< 9H [6P^)NA:AXRUKPS&EW'?Z/&TDAEC4).% +",[N2-RY! ZUO>'==MO$
MWANPUJP26.VOH5FB28 .%/3(!(S]":\HU;X:Z_-+XFUC2[18=9M]9-]HC-,F
M+F%H$CEB)W?*LB@J=V#P.G6O1/AUI-[H7PWT'2]5A\B]M+)(IHMZML8#D94D
M'\#0!TM%%% !1110 4444 <O\0=&&K^$[AD7,]I^_C/?C[P_+/'KBO#:^F2
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MC1D"1!$J%]ZD\J5W##9'RG$;>.M)M(Y&U2=8B=0DL($MXYIWED1=VW:(P=^
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MDZ9!H^E06-HNV*%=H]SW/U)YKF_A_P"$O[!TW[7>QXU"Y7Y@?^6:]E^O<_\
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M>FW=K Q>*"XM(Y$C8]2JD8!.3R*T+:V@L[6*ULX8X+>%!'%%$@5(U P%4#@
M 8 % $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &
M?KT7G:%=+Z)N_+G^E>=UZC-&LT#QORKJ5/T->821M%*\;\,C%3]10 VBBB@#
MJ_!<_P"[NH">A#@?H?Y"NIK@O#%T+;7(PQPLP,9_'I^H%=[0 4444 8NL>+M
M'T.]6SO9;F2Z,1F:"RLIKMXX\XWNL*,44G(!; .#C.#C7AFBN;>.>WD26&50
M\<D;!E=2,@@CJ".]<5'>'PIXW\176J:?J4UOJ[P7%K<V-A-=C"0)$T3")6*$
M,I8;@ =_!R#67/X:OM0U'QWJUEI<EMKTT*#1[FY4!X)&L40^4^2J-N)5F0\[
M0"2%& #TRJFIZK9Z/:I<ZC-Y,3S10*VTMEY'"(, 'JS 9Z#//%>0Z1I4VGZ+
MJUSI.G[BVF)!-I%OX7O=,CE;S%_>R%G/VAD4OE$.Z0$KDY%4U\+O>>%]>6?P
M\L^GPZWIUY;6T/A^6TC:)6B6X:&TDW.N45PP'+?,<?-R >ZT5XKXC\/27?B&
M]98!IUA-;6O]A7*^%+J]ET]%C&/)\IE^RNL@+;60'E<YQA>X^(J2R:-IUN^F
M1ZE;R78%R\^GS7\4($;D.]I$0TP+8 '16*OU4$ '95'<W"6MK+<2B1DA0NPB
MC:1R ,G:B@LQ]  2>@%>0>%O"LVICPG:>)=$DGL;0ZRKV]U9.D"(;A/(5HG)
M 3: 41BP 52,[01T5EIU^OP(U32VL[E;F.PU"UMK5HV\S8&E2%%4\GY @4=Q
MC% '?QN)8ED4, RA@&4J>?4'D'V-.KR'6O"!U*Q\87ESHLUQ?P:#;G2I&@8N
MEREO(08/20.$&5^;.![5J)9>7\5K?4K?3&U*[NVC6[DO=%E5M. MR"]O>,H0
M)PH,0R2SN0>HH ](D<11-(P8A5+$*I8\>@')/L*;;7"75K%<1"14F0.HEC:-
MP",C<C ,I]00".A%>&> M,M[GPYX0GT#0[ZVU&+2IO[6OGM)$%S ULRI&9B,
M39D,+(@9MBIC"[=HZCP;X6$OB32+K7-'=OL/A32HX6NX#MAN4:8M@,,"5,CG
M[R[NVXY /2+.[COK.*Z@698Y5W*L\#PN![HX#*?8@&IZ\C\*>#(]4/AJU\4Z
M"\]I;^&VCDAO;=O+2;SEP&5A@.%+$9Y')%<;JUG=:KI5E8^*-.$[+X5L8)[B
M_L[FYGTF3=*99A'%#)M<JJY\PQEB@Y(!P ?1U%0V8MEL8!8"(6HC40B'&P)C
MY=N.,8QC'&*FH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS_
M ,26OV77)N/EE_>+^/7]<UZ!7.>,+/S+.*Z0<Q-M;Z'_ .O_ #H XZBBB@!4
M=HY%=#AE.01V->EV%VM]817*=)%R1Z'N/SKS.NF\(:D(Y7L)3PYW1Y]>X_S[
MT ==1110 4444 %%%>>^-M$N[KQ5%#:V,T]EXCM$TW4I(58K''','RY'"AHI
M+A0Q[E10!Z%17CW]DZUJ6AWFHZUIM_,;5['2KNV6)EDO+.W;=<.B=721I&RH
M^^J8&X$ K<>'%O?MB:%H5U9^&[O6-*,=BME):C*R8N91"0K1H5* DJN=C'D'
M) /3[;6K>Z\17^C1I*+FP@@GE9@-A64R!0#G.1Y39R!U'7MHUY'KOANYL?'M
MY/:Z&\_A2WM=.2[TJTLR$N45[G!C51B01,RLT(!W!AZ!6HK8VFH:OJXL=%OI
M?$0\3A[/4EM)"EO$)HVD/GX*Q+L$FY"06S]UMPR >M:-K5OK<%U+:)*BVMY-
M9OYH )>)RC$8)XR./;L*T*\?U&QNXM-:VO\ 0!<6LVOZG.\E]HUQJ4: RL8S
M]EB(+;P25D/RJ ?[XJ'2-),>FZ#'X]\.ZEJEI%H0M[:W-A)<FWNEE8,"J[C$
MY3R@LC$ !3\X[@'K>E:79Z)I%KIFEP^19VD2PP1;BVQ%& ,L23^)JW7C=QX?
MOY?'EW+J1:SO6U:&>QO_ /A'+J]G6 &,JBWD<ACB0@,C*P Y<MD-N/LE !6'
MJO@[1=9OI+N^ANA+-&(I_LU]/;K.@SA9$C=5D&&(^8'@XZ5I76J65E_Q\W,:
M'^[G)_(<UDW'C"RCR+>*28]CC:#_ %_2@#>CC2&)8XD5(T4*J*,!0.@ ["G5
MQ\OC.Y;_ %%K$G^^Q;_"JK^*]3<\-&G^ZE '=45P!\3:MVN<?]LU_P *<OBC
M5%ZS*WU04 =[17%1^,;Y<>9%"X^A!/ZU>@\:1EL7-HR#UC?=^AQ0!T]%9EMX
MBTRYP!<K&Q[2#;^IXK25E=05((/0@T +1110 4444 %%%% !1110 4444 %1
M7-NEU:R02C*R*5-2T4 >87-N]I=202_>C8J?>HJZOQ=IF574(5Z867'Z'^GY
M5RE !3HY'AE62-BKH0RD=C3:* /1M(U--4L5F7 D'$B?W3_A5ZO.-)U.32KT
M31_,AXD3/WA_C7H-K=17MLD]NVY&'!]/:@":BBB@ HHHH **** "JEAIEIIG
MVG[##Y7VJX:YF^8G=(V-S<GC.!P.*MT4 %(S*BEG(50,DD]*S=5UVUTM=KGS
M)B.(E//X^E<;J.LW>IL1.^V//$2\+_\ 7H Z?4/%=G;92U'VF0=U.%'X]_PK
MF[SQ!J-Z2&G,:'^"+Y1^?6LVB@ Z]:*** "BBB@ HHHH **** "K%K?W5DV;
M6=X_8'@_ATJO10!U%AXP9<)J,6X?\](^OXBNDM+ZVOH]]K,L@[X/(^H[5YG4
MD%Q+;3"6WD:-QT930!ZA17,Z5XL60K#J0"-T$J]#]1VKI58,H93D$9!'>@!:
M*** "BBB@ HHHH **** &31)/"\4JAD<$,#W%>=ZMIKZ7?-"V2AYC;^\*]'J
MAK&E)JMD8B0LB\QOZ'_"@#SJBGSP26T[PS*5D0X8&F4 %:.D:Q-I,^5^>%C\
M\9/7W'O6=10!Z;9WD%_;+/;.'0_F#Z'WJ>O-+'4+G3I_-M9-I[J>0WU%=II7
MB.UU$+'(1!<=-C'AC['^E &O4<]Q';1>9.P1,@%CT&3@5)69XC7?X?NA[ _D
MP- &G17)>'/$.S;97[_+TBD)Z>Q]JZV@ KF=<\3^4S6VG$,_1INH7V%6_%$E
M]'IV;/B+_ELR_> _P]:X:@!7=I'+NQ9F.22<DTE%% !110 20 ,D] * "BMF
MQ\+W]V TH%O&>\GWOR_QQ6]:^$K"$ W&^X;ON.!^0H XBIH[.ZF&8;::0>JQ
MDUZ/!96ML/\ 1[>./W50*GH \V&E:@?^7&X_[]&FMIM\@RUE< >\3?X5Z710
M!Y8RLC88%3Z$4E>I/$DJE9$5U/9AFLZY\.Z9<Y)MA&Q[Q';C\.E 'GU%=->^
M#I4RUC.)!_<DX/Y]_P!*YZYM)[.7R[J)HF]&'7Z>M $5%%% !6KI&OW&F,$;
M,MN>J$_=^E95% 'IUI=PWMLL]NX=&_3VJ:O.=+U:?2KC?"=R-]^,GAA_C[UW
M]E>0W]JEQ;ME&[=P?0T 3T444 %%%% !1110 4444 8VO:$NIP^;#A;E!P?[
MX]#7#21O#*T<JE'4X*D=*]2K(UK08M43?&1%<*.'QPWL: ."HJ6ZM9K.X:&Y
M0HZ]CW]Q45 !1110!K:=XDOK !"WGQ#^"0\CZ&MFX\26.HZ1<PON@F:(X5QD
M$X[$?UQ7(44 %=3X=\0XV65\_'2*0G]#7+44 >J$!A@\@UQGB'P\;0M=V2Y@
M/+H/X/<>W\JM>'/$.[;97[_-TBD/?V-=20&!!&0: /*Z*Z'Q#X>-H6N[)<P'
MET'\'N/;^5/T+PT;@+=:@I6+JD1ZM[GVH SM*T*ZU0[D_=P9P96'\AWKL=.T
M6STU1Y,>Z3',K\L?\*OJJHH5%"J!@ # %+0 445RGQ-M-6N_AWJC^'+VYL]4
MM8Q=6[VTA1G:,[RG'4, 5QT.: .KHKRG3?'2^)_%\/B"&_FMO#OA_P /#4+^
M.*5E1[BX3<$D7.&V1H2,YP6]\USWPW\;W#^)/L^H>*%U63Q/I4NI);+?B?\
MLVY5WD-NJY)C B=?EXYC/'' ![O17A-]X@UL?L=+K,>K7XU;R(F-\MR_G_\
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M'Y3;=O&TC(P<%3D'TK5HH YC2_AWX:T?3)-,L[.Y;3I8&MVL;G4+BXM]C')
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M'^=>CUY6"001P1TKU"WE$]K%*.CH&_,4 24444 %%%% !1110 4444 %%%%
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M-OI4DV+VYADGBBVGYDC*!SG&!@R)P3GGCH:D-[:B_6Q-S"+MHC,MN9!YAC!
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MHTK8_0?XUR=% &C>:]J%]D23E$/\$?RC_$_C6=110 4444 %%*JEF"J"S$X
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IHHH T$C2)0L:A5'0 8Q3J** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>dgx-20201231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dgx-20201231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI8VAO;',L
M(%!A=')I8VEA($<   60 P "    %   $*R0!  "    %   $,"2D0 "
M S$P  "2D@ "     S$P  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH ]%\$7'G>'_ "B>8967'L>?ZFNBKCOA^^8;Y/1D/YY_PKL: "BBB@ HHHH
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M-OY;2=E:2,@$H21R,]_K5:N^N?LNIZ_JFG36%OE+?S!<;?WA;"\Y_$?E7 T
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M)%X/1E]#7*W%N]K<-%(/F4_G[U/IMZ;*Z#$_NVX<>WK0!U=% ((!!R#T(HH
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M:>=;$AEXDC;JAJ_6=H6E+I&E1VXP9#\TK>K'K_A^%:- !1110 4444 %%%%
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MA[U7KV5XTE0I(JNIZJPR#7DVKVOV+6+JW PJ2D*/;.1^F* *=%%% !1178^
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M^>-1_$P'ZU=UN3?J; ?P*%_K_6H=,C\S4X!Z-N_+F@#K**** "BBB@ HHHH
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M0 4444 %%%% !1110 5Q_B/Q=Y3/9:4WSC*R3C^'V7W]Z["O/O&>C_8M0%[
MN(;@_-C^%^_Y]?SH YHDLQ+$DDY)/>DHJW9:7>ZBV+.VDE_V@,*/Q/% %2BM
M#5-%O=':,7B "095E.1GTSZUGT %%%% !1110 4444 %%%% !1110 4444 %
M%%:&EZ+>ZPT@LT!$8RS,<#/IGUH SZ4$JP*D@@Y!':K5[I=[IS8O+:2+_:(R
MI_$<54H [?PYXN\UDL]5;YSA8YS_ !>S?XUV%>?>#-'^VZ@;V=<PVY^7/\3]
MORZ_E7H- !1110 4CNJ(6<X51DD]J6N>U?4_M#&W@;]T#\S#^(_X4 5-1O3>
MW189$:\(/;UJ*UMVNKE(DZL>3Z#UJ(#)P.373:38?8X-\@_>N.?]D>E %V*)
M8(5CC&%48%/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JKJ5A%J>GRVL_W
M9!P0.5/8BK5% &'8>$=*L<,T)N9!_%,<C\NE;:JJ*%0!5'0 8 I:* *U_80:
ME9/;72[D<=>ZGL1[UYEK.BW.C77ESC=&W^KE X8?X^U>K5!>65O?VK6]W&)(
MVZ@]O<>AH \?HKH=<\)W6F,TUJ&N+7KD#YD^H_K7/4 %%%% !1110 4444 %
M%%% !1170Z'X3NM399KH-;VO7)'S/]!_6@#/T;1;G6;KRX!MC7_62D<*/ZGV
MKTVPL(--LDMK5=J(.O=CW)]Z=9V5O86JV]I&(XUZ =_<^IJ>@!&574JX#*>H
M(R#6)?\ A'2K[++";:0_Q0G _+I6Y10!5TVPBTS3XK6#[L8Y8CECW)JU110
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MP5#;3ZVR7,*R$1%H]PSA@1V^E>BUY?X7G^S^);1L\,Q0_B"/YFO4* "BBB@
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M](JJBA44*HZ # %+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>dgx-20201231_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dgx-20201231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI8VAO;',L
M(%!A=')I8VEA($<   60 P "    %   $*R0!  "    %   $,"2D0 "
M S4S  "2D@ "     S4S  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M$HU?_H1/$'_?_3__ )*H\>?\B[:_]AK2O_3A;UTE '-_\)1J_P#T(GB#_O\
MZ?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R5
M1_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J_
M_0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_
M +_Z?_\ )5=)10!S?_"4:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__
M "57244 <W_PE&K_ /0B>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE%
M '-_\)1J_P#T(GB#_O\ Z?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)10!S?_"4
M:O\ ]")X@_[_ .G_ /R51_PE&K_]")X@_P"_^G__ "57244 <W_PE&K_ /0B
M>(/^_P#I_P#\E4?\)1J__0B>(/\ O_I__P E5TE% '-_\)1J_P#T(GB#_O\
MZ?\ _)5'_"4:O_T(GB#_ +_Z?_\ )5=)7,^,K;:NDZL;F]BCTV_B:>*VNY8D
MEBD81MYBHP#*I99.<\(1T9@0!W_"4:O_ -")X@_[_P"G_P#R51_PE&K_ /0B
M>(/^_P#I_P#\E5RGA^%+ZTO_  V^H:RSC6_,AN9-7N#,]H09582"3>(RB/&
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MY),X)S]T8!)"@&M_PE&K_P#0B>(/^_\ I_\ \E4?\)1J_P#T(GB#_O\ Z?\
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M<AN&ZXW+7Q]+>^.'T.VT*]ELH[E[234$AF*QR(FXECY7E!,C;GS=VXCY,<T
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M.8@@I+Y W X*EE5EP=RLU7U^*J+J&IM/H-__ &/8+= ZA%!,P9[<E7!+1+$
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M091" V,R?*A89 X^;=N.0H% '13>"=#GTV&SDANBL-Q]J2X&H7 N?-VE-YN
M_FD[#LY8_+A>@ #=&\">'?#UY;7.BV#V3VL#6\*17,HC5&;<P\O=L)+<DD$Y
M YX%5K/Q1K-Q;RF70[7[3:SW,=S:P:B7<+$H*E"T2*Q?<F Q0 .ISU YBU\;
MZO\ V<MQ#HXET5?"D.JB :H[7?SH3CS74%B-N-Q<' +<L0H .PUOP-H/B*ZN
MI]6@NI7N[86DX34+B)'ASNV;$<+C/7CG)SU-,_X0#P^8;V.2&^E^W20RS/+J
M=R[EX2#&ZN9"R,I5?F4@\#FLA?B&Z^)K31+#0;Z\@4VT-U<QI<2F!ID5E.X1
M,A50Z%F>1" 2<''.QX4\52^));Z*XT\:?-9[-\+S[I5W%L!XRJNAPH/(VMD[
M"Z@,0!EE\//#6G7%I/8V,T$MI=R7L;I>S@O/(,/))\_[QB.,ONX)'0FJEU\/
M-*M--SH-O.+VUM)[>P2YU:Z\F(2K@K@LX"<#C:0-HP.!B"#Q==7*S6.E:5-'
MJEU?W<"175_]Q8<!Y-Y615ZKM0 KD\X&2.=\-_$J^L?#/ANP&E:EKUXVFV]S
MJ$ZI/-*JRNR*04B=6?Y)"?,:,?*,,>< '3Z/\.=*C\(QZ7K-K(9YK>&&[,.J
M7+@B/E420LK+&#DA%VJ,GBMF#PCHUMK1U6""9+IF#OB[F\N1PNP2/'NV,^T
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MNP1\V0,@DFGW7@O14U&\N+"]NKG2K32H]0:,NJSDR#Y8RVTA>,-G:>"!CG-
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M^1Z/^%^ZG_T*%I_X.6_^1Z\LHH ]3_X7[J?_ $*%I_X.6_\ D>C_ (7[J?\
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MQ!_WW:__ !B@#Q6BO:O^%!:'_P!#%X@_[[M?_C%'_"@M#_Z&+Q!_WW:__&*
M/%:*]J_X4%H?_0Q>(/\ ONU_^,4?\*"T/_H8O$'_ 'W:_P#QB@#Q6BO:O^%!
M:'_T,7B#_ONU_P#C%'_"@M#_ .AB\0?]]VO_ ,8H \5HKVK_ (4%H?\ T,7B
M#_ONU_\ C%'_  H+0_\ H8O$'_?=K_\ &* /%:*]J_X4%H?_ $,7B#_ONU_^
M,4?\*"T/_H8O$'_?=K_\8H \5HKVK_A06A_]#%X@_P"^[7_XQ1_PH+0_^AB\
M0?\ ?=K_ /&* /%:*]J_X4%H?_0Q>(/^^[7_ .,4?\*"T/\ Z&+Q!_WW:_\
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M:_\ QBC_ (4%H?\ T,7B#_ONU_\ C% 'FEYXG.I>-AK^H6S.JS)(MO%+MP$
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M7B#_ +[M?_C% 'BM%>U?\*"T/_H8O$'_ 'W:_P#QBC_A06A_]#%X@_[[M?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M% !1110 4444 %%%% !1110 4444 %<WX#_Y%VZ_[#6J_P#IPN*Z2N;\!_\
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M725S?@/_ )%VZ_[#6J_^G"XH Z2BBB@#F_'G_(NVO_8:TK_TX6]=)7-^//\
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MH **** .T\!?\>][Z;U_D:ZVN6\"Q%=.N9.SR #\!_\ 7KJ: "BBB@ HHHH
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M HHHH **** "BBB@ KF_ ?\ R+MU_P!AK5?_ $X7%=)7-^ _^1=NO^PUJO\
MZ<+B@#I**** .;\>?\B[:_\ 8:TK_P!.%O725S?CS_D7;7_L-:5_Z<+>NDH
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M('R@Y; SM&6P0<<C*WUO;:[HI6&6.:&XC$D,T;!E;(RK C@CH<UYKI>E>)=
M^*@>ZN+QM)\MKB\NG=A:O&8"7)&=@D^T8Q_$(P /E&*ZSX7V]S;?#RP6[5T\
MR2>6!'ZK"\SM$/\ OAEP.PP.U ''SP26UP\,R[9(VVL/0U'7=>*] -[']NLT
MS.@_>*/XQ_B*X6@ HHHH **** "BBB@ HHHH **** "NW\%Z28;=M1G7#RC;
M$#V7N?QK"\.:$^K77F2@BUC/SM_>/]T5Z,JA%"H JJ,  =!0 M%%% !1110
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M- &K1110!Y#:ZY)J>E^*O$_B+Q%JFCC3=5N-.MA8K*\5C'&< O"@8.QW$LS
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M *%?6O\ P73?_$T 8=%;G_"$^*_^A7UK_P %TW_Q-'_"$^*_^A7UK_P73?\
MQ- 'T5^SC_R2Z7_L)3?^@I7K%>8? '3+_2?AO);ZK8W-C.=0E817,+1-@JF#
MA@#CCK7I] !1110 4444 >3:UXD\1V_QK@LM-N-0?31*+>>VDMB+?+6Q9"K!
M3D%\98G@\8P*Y'0/^$FUK6M2NTU'58==D\+_ #7,ML8S#>+/O:!24P5X QSP
M>IKZ'HH \0\8^(?%5IX$TS4M'O-=@U/4(VNDMC;A_+*HG[I@$)7)#';WYY'
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M-LKW_CZM8I3_ 'F7G\^M94W@S29<[%FA_P!R3_'-;]% ',-X&L?X;FX_-?\
M"D_X0RRCY"7$WLTJJ/T%=110!@6VC0V9!BT2%F'\33!S_P"/5I"YNU&!IK8'
M994_QJ[10!2^VW0ZZ9/^$D?_ ,52_;I^^FW0_P"!1G_V:KE% %/[?(.MA=#\
M%/\ 6D_M''6SNA_VRS5VB@"E_::#K;78_P"W=C_2C^U(>\-V/^W63_XFKM%
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MWMQ<+;3RS3% BN5F4)PHP" " .!R30!T6D_$FWU>_P#L4&AZI%<F&VN%CE,
M+PS_ '9!B4Y4=^XZ8S3?$'Q'M_#GBRXTR_L9UL;+2VU&ZO1M(5=VU0%R">>.
M >2.@YI_AO0]5DUZ#5/%-G#]OTZS^QP7T<H)NE<*SLR#A2"",=.XXJYKW@+2
M/$>JSWVHM<EKG3VTZ>)' CEB8[N1C.X$Y!!% &9IWQ6TG59-)CL+"^GDU.XD
M@"HT)$)C=%8EO,PX </^[+D*"2!BL>U^)]SJU_ID@L=0T^WEU.\MUB6*"07:
MP1ME&9I T;;@6R!VQG')Z>3P!97%O80WVJZM>)9S)-BXN%;SF1PR;OEP,;0
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M@#F_'G_(NVO_ &&M*_\ 3A;UTE<I\1[VUT_PI;W%_<PVL*:QIC-)-($50M]
MS$D\8"J2?0 GM4__  L?P1_T.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:
M0?\ Q5'_  L?P1_T.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\ Q5'_
M  L?P1_T.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\ Q5'_  L?P1_T
M.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\ Q5'_  L?P1_T.7A__P &
MD'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\ Q5'_  L?P1_T.7A__P &D'_Q5 '2
M45S?_"Q_!'_0Y>'_ /P:0?\ Q5'_  L?P1_T.7A__P &D'_Q5 '245S?_"Q_
M!'_0Y>'_ /P:0?\ Q5'_  L?P1_T.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_
M /P:0?\ Q5'_  L?P1_T.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\
MQ5'_  L?P1_T.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\ Q5'_  L?
MP1_T.7A__P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\ Q5'_  L?P1_T.7A_
M_P &D'_Q5 '245S?_"Q_!'_0Y>'_ /P:0?\ Q5'_  L?P1_T.7A__P &D'_Q
M5 '245S?_"Q_!'_0Y>'_ /P:0?\ Q5+_ ,+%\$E2P\8:!M! )_M.' )_X%[&
M@#HZ*YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\
MA8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\
M/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_X
MJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^
MAR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2
M#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHK
MF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/
M^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#
M2#_XJC_A8_@C_H<O#_\ X-(/_BJ .DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C
M^"/^AR\/_P#@T@_^*H Z2BN;_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__
M .#2#_XJ@#I**YO_ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJ
M.DHKF_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*H Z2BN;_P"%
MC^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ@#I**YQ?B+X)<X7QAH#'
M!.!J</0<G^*D_P"%C^"/^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_
M .*H_P"%C^"/^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%
MC^"/^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\
M/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_
M^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H Z2BN
M;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H Z2BN;_X6/X(_
MZ'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^
M#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H
M_P"%C^"/^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/
M^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\
M@T@_^*H Z2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H
MZ2BN;_X6/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H Z2BN;_X6
M/X(_Z'+P_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H Z2BN;_X6/X(_Z'+P
M_P#^#2#_ .*H_P"%C^"/^AR\/_\ @T@_^*H Z2BN<;XB^"48J_C#0%93@@ZG
M""#_ -]4G_"Q_!'_ $.7A_\ \&D'_P 50!TE<WX#_P"1=NO^PUJO_IPN*/\
MA8_@C_H<O#__ (-(/_BJ9\/I$G\*27$#K)#/JNI30R(<K)&]].R.I'!5E(((
MX(((H Z>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
8H **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>dgx-20201231_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dgx-20201231_g4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI8VAO;',L
M(%!A=')I8VEA($<   60 P "    %   $*R0!  "    %   $,"2D0 "
M S<U  "2D@ "     S<U  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5L'N,@\C@]LT 9/_  E&K_\ 0B>(/^_^G_\ R51_PE&K_P#0B>(/^_\ I_\
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M6CQ7T,FH2VK7B01G<3"KA"^1P!N8 9ZX.,X.-&@#F_\ A*-7_P"A$\0?]_\
M3_\ Y*H_X2C5_P#H1/$'_?\ T_\ ^2JZ2B@#F_\ A*-7_P"A$\0?]_\ 3_\
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MU:PTRZNXX[[42XM8#DM+L4LY '0 #DGCH.I%7J .;_X2C5_^A$\0?]_]/_\
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M0,/C:3\IR <C@D $9 ,#_A*-7_Z$3Q!_W_T__P"2J/\ A*-7_P"A$\0?]_\
M3_\ Y*KI*9+(L,+RN&*HI8A$+,0/0#))]AS0!SW_  E&K_\ 0B>(/^_^G_\
MR51_PE&K_P#0B>(/^_\ I_\ \E5T4;B6)9%# ,H8!E*GGU!Y!]C5.[UO3K'5
M[#2[J[2.^U$R"U@.2TNQ=SD8Z  =3QT'4B@#)_X2C5_^A$\0?]_]/_\ DJC_
M (2C5_\ H1/$'_?_ $__ .2JZ2F&6,3+"9%$K*65"WS$# ) ]!N'YCUH Y[_
M (2C5_\ H1/$'_?_ $__ .2J/^$HU?\ Z$3Q!_W_ -/_ /DJNDHH YO_ (2C
M5_\ H1/$'_?_ $__ .2J/^$HU?\ Z$3Q!_W_ -/_ /DJNDHH YO_ (2C5_\
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MJW_"ZO G_05N_P#P4WG_ ,:H [RBN#_X75X$_P"@K=_^"F\_^-4?\+J\"?\
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M>VT\TD$#6\J1>>[ L@\R08\TA@I&[[K8V/\ A=7@3_H*W?\ X*;S_P"-4?\
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MVT*Y)7 [GX=MJ(T;4(;[^T)#%=;8)]1$Z^8/*0?*DX\Q5W \,TG)8AV[5/\
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M8:;?7$D=^I4,I02(0N,;=X:# 8<=^]_X75X$_P"@K=_^"F\_^-4?\+J\"?\
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MT)OA_P#\%<'_ ,37244 <W_PKCP1_P!";X?_ /!7!_\ $T?\*X\$?]";X?\
M_!7!_P#$UTE% '-_\*X\$?\ 0F^'_P#P5P?_ !-'_"N/!'_0F^'_ /P5P?\
MQ-=)10!S?_"N/!'_ $)OA_\ \%<'_P 31_PKCP1_T)OA_P#\%<'_ ,37244
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M (FC_A7'@C_H3?#_ /X*X/\ XFMB;5].M_\ 77L"?6055;Q5H:==3M\^S9H
MH_\ "N/!'_0F^'__  5P?_$T?\*X\$?]";X?_P#!7!_\35P>+=")_P"0E#^)
MJ1?$NBLI*ZG;$ 9/SB@#/_X5QX(_Z$WP_P#^"N#_ .)H_P"%<>"/^A-\/_\
M@K@_^)JW;>+_  _>'%OK%H__ &T _G6A#J5C<_\ 'O>6\O\ USE5OY&@#$_X
M5QX(_P"A-\/_ /@K@_\ B:/^%<>"/^A-\/\ _@K@_P#B:Z2B@#F_^%<>"/\
MH3?#_P#X*X/_ (FC_A7'@C_H3?#_ /X*X/\ XFNDHH YO_A7'@C_ *$WP_\
M^"N#_P")H_X5QX(_Z$WP_P#^"N#_ .)KI** .;_X5QX(_P"A-\/_ /@K@_\
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M5QX(_P"A-\/_ /@K@_\ B:/^%<>"/^A-\/\ _@K@_P#B:Z2B@#F_^%<>"/\
MH3?#_P#X*X/_ (FC_A7'@C_H3?#_ /X*X/\ XFNDHH YO_A7'@C_ *$WP_\
M^"N#_P")H_X5QX(_Z$WP_P#^"N#_ .)KI** .;_X5QX(_P"A-\/_ /@K@_\
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M5QX(_P"A-\/_ /@K@_\ B:/^%<>"/^A-\/\ _@K@_P#B:Z2B@#F_^%<>"/\
MH3?#_P#X*X/_ (FC_A7'@C_H3?#_ /X*X/\ XFNDHH YO_A7'@C_ *$WP_\
M^"N#_P")H_X5QX(_Z$WP_P#^"N#_ .)KI** .;_X5QX(_P"A-\/_ /@K@_\
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M2B@#R[4_C'-I6K76GSZ CRVLK1.R7QVD@X.,Q]*J_P#"\C_T+P_\#?\ [77
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MBU]05\O^&/\ D;]&_P"O^#_T8M?0>I>+],L;K[%;F74;_M9V*>;)^..%'NQ
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MD>,L#M\K 7Y>"Y0D]%(%;#^!/#KO$S6,G[JS:Q51=2A?);[RE=V"2>2Q&XD
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ML2S_ "C'8=S_ )]:X*M;Q)?&]UF3:<QP_NT_#J?SK)H **** "BBB@ HHHH
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M4 %%%% !1110 4444 <WXH_Y&+P9_P!AJ3_TWWE=)7-^*/\ D8O!G_8:D_\
M3?>5TE '-^*/^1B\&?\ 8:D_]-]Y725S?BC_ )&+P9_V&I/_ $WWE=)0 444
M4 %<1XQF\S6$C'2.(#'N>?\ "NWKSKQ#)YNOW3>C[?R&/Z4 9M9NO:5+K6EF
MSBO/L>YU9I!$)"<'(&"1W%:54-:U&+2]--Q/-)"#(D:O%%YA!9@!P>,>YZ4
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MHQ//<50G\,M)X@FOQ]GECFD27]\TFZ)E7;PH.TC@=>1S6C)K^E17YLGO8_M
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M **** "BBB@ HHHH ^9?&7_(\:U_U^R_^A&L6ND\7:=/)XTUAUV8:]E(R?\
M:-8_]EW'^Q_WU0!3HJY_9=Q_L?\ ?5']EW'^Q_WU0!3HJY_9=Q_L?]]4?V7<
M?['_ 'U0!3HJY_9=Q_L?]]4?V7<?['_?5 %.BKG]EW'^Q_WU1_9=Q_L?]]4
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M&=H(YX)H [&BN6T_Q%JFI:SI<<=M:Q6TT<YN%\]BP9&V_*=G(].F<\]*ZF@
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M N<YZ$@#IFF>-I]&N%M'TEK=Y69V9H .4(7&_'.[.>O/7- ')T444 :&@?\
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M^J-;ZHEJEO&8;>2:"X57*D)*(R,G[QYZ@8!XYH Z";0X9]%BTV2ZN_)B*;9
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MU*QJ?U/]*X"O7/!MB;'PO;!AAY@96_X%T_3% &[1110 4444 %%%% !1110
M4444 ?*GC?\ Y'[7?^O^;_T(UA5N^-_^1^UW_K_F_P#0C6%0 4444 %%%% !
M1110 4444 %%%% &MX4_Y'31/^PC;_\ HU:^LJ^3?"G_ ".FB?\ 81M__1JU
M]94 %%%% !1110 4444 %%%% !1110 4444 %%%% '-^*/\ D8O!G_8:D_\
M3?>5TE<WXH_Y&+P9_P!AJ3_TWWE=)0!S?BC_ )&+P9_V&I/_ $WWE=)7-^*/
M^1B\&?\ 8:D_]-]Y724 %%%% !45U MU:2P/]V1"I]LBI:* /*Y8FAF>*08=
M&*L/0BJ]U:PWMK);W*;XI!AA_7ZUTOBVP^SZD+E!^[N!S[,.O^?K7/T )&IC
MA2/>[A0!N<Y)^M.R3U-)10 N2#G/-5[>RBMIIYDW-+.P:1W.2<=![ =A4]%
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M#4]+DA'^L'S1GT8?YQ7G)!5BK#!!P0>QKU:N*\5Z5]FNOML*_NIC\^/X6_\
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MR(@Y<?\ +/KDGGWK1E^'YEO+F];Q!J O)+F&Z@G6.$&VECC,6Y1LP0T;,I#
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M _4\_P L5RE:7B&Z^V>(KZ?.09F53Z@<#]!6;0 4444 %%%% !1110 4444
M%%%% !115K3=.N-5OX[2T3=(YZ]E'<F@"[X;T*37=46$96!/FF?T'I]37K\,
M,=O D,*A(T4*JCL*I:+H]OHFG):VXR>KN>KMZUH4 %%%% !1110 4444 %%%
M% !1110 4444 ?*GC?\ Y'[7?^O^;_T(UA5N^-_^1^UW_K_F_P#0C6%0 444
M4 %%%% !1110 4444 %%%% &MX4_Y'31/^PC;_\ HU:^LJ^3?"G_ ".FB?\
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M-]Y725S?BC_D8O!G_8:D_P#3?>5TE !1110 4444 %%%% !1110 5#=6D%[
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M5'_"J?!7_0$7_P ")?\ XJNPHH X_P#X53X*_P"@(O\ X$2__%4?\*I\%?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!S?BC_D8O!G_8:D_P#3?>5TE<WXH_Y&+P9_V&I/_3?>5TE
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>dgx-20201231_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dgx-20201231_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$&17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0UNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $YI8VAO;',L
M(%!A=')I8VEA($<   60 P "    %   $*R0!  "    %   $,"2D0 "
M S<X  "2D@ "     S<X  #J'  '   (#   "*      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M$HU?_H1/$'_?_3__ )*H\>?\B[:_]AK2O_3A;UTE '-_\)1J_P#T(GB#_O\
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M:?J'CX^+-=CL]-T>XB2WN8X%3[+');HX"@AB[Y<==VYNB@$* #;_ .$HU?\
MZ$3Q!_W_ -/_ /DJC_A*-7_Z$3Q!_P!_]/\ _DJH_$?BNST702D>J%;^6R:>
M"=[-Y]BA?]?,L8 1,]6;8@]1BL[0OB!8V?P_\.ZCXIOI9+^_TJ.\F^SV<DSL
M!&IDE*0H=J L,M@*,@4 :O\ PE&K_P#0B>(/^_\ I_\ \E4?\)1J_P#T(GB#
M_O\ Z?\ _)55#\0;&3Q[IOA^TANIX;[3FO5NXK.9XVRT0BVNJD;"KL6<_*IV
M@D$XK4L?&&AZCK"Z7:7K-<R*[P[H)$CN A <Q2,H27;D9V%L=Z *W_"4:O\
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MD:H6==KJVY05PP.<4 )_PE&K_P#0B>(/^_\ I_\ \E4?\)1J_P#T(GB#_O\
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M'TV*_P#M=RMM)??V=N?3[A3'<;@OENI3,?S$#+ #)QFD_P"%C>$O[6DTT:W
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M<$EO) 2H8;HY%5QD$$<?-GC- %?_ (2C5_\ H1/$'_?_ $__ .2J/^$HU?\
MZ$3Q!_W_ -/_ /DJN?TCQY]H\7>+CJ>L"WT/3+&UGC$]DUK)9%_-W>8LHW[C
MM4C< ""N%P<MOR>,]"T?0=/NKW5;F]CN+,74<RV;S32PA03.\<,>47D9;8J@
ML!QD"@!?^$HU?_H1/$'_ '_T_P#^2J/^$HU?_H1/$'_?_3__ )*IVK^/?#>A
MQ0RWVH,T<UK]L5[6VEN0MOQ^]<Q*VQ#GAFP#@X/!PV_^(7A73-7?2[O68?ML
M8A9X8D>4J)FVQYV @9R#[!E)P""0 _X2C5_^A$\0?]_]/_\ DJC_ (2C5_\
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MJ4EE>ZB+B[NO(E3>QD>=TSM'RC>.%YY( Y'_ (2[QG_T.&H?^ EE_P#&*/\
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MH?\ @)9?_&* .CN/"?BK5;KQ'J$^C/9QSZQ::G;6J:KY5Q<I' L;Q;XCB-L
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M5_';1>(6U:ZCFOXIYHP86C+RO+<-ND+MN^1F&T?WN#RO_"7>,_\ H<-0_P#
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M\GASQ,=,\?P1>&]9E;Q#I\<=H][?VLDKRB(Q-YA\[:F6<N GR!1@;3A*Q/\
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M%9O_  D>A_\ 09T__P "D_QH_P"$CT/_ *#.G_\ @4G^- &E16;_ ,)'H?\
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M!U]N>&T3Q_IF@W4TUKJFDRF:$PNLUPI!4D9Z,#V]:TS\7+(ZS;:H;S0OM-M
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M@8XRV\7Z59WJ7=GKEA!-&VY&2[3Y3^)_G6K<_$K2+NZ%Y//H#7VT W7G#<6
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M ,)'H?\ T&=/_P# I/\ &C_A(]#_ .@SI_\ X%)_C0!I45F_\)'H?_09T_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP=6*,&0E64Y!!P17<^&?'3(4L]:;*\*EQZ?[W^- '?T4BLKJ&0AE(R"#UI:
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MS?CS_D7;7_L-:5_Z<+>NDH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHIGGQ>?Y/FIYN,[-PW8]<4 /HHHH **** *.LWPTW1[F[/_+-"1[F
MO%G=I)&DD.68EF/J37HOQ&NI(]*M[9%;;)(6=@.!CIS^-><4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!U7@#4OLFN-:,?W=TN/\ @0Z?UKT^O#+2X:TO(;A#@QN&S7M]M.MS:Q3Q
M_=E0./H1F@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#\:?\ (EZI
M_P!>YK<K#\:?\B7JG_7N: /"Z*** "BBB@ HHHH **** "BBB@ I&^XWTI:1
MON-]* /HJQ_Y!UM_UR7^0J>H+'_D'6W_ %R7^0J>@ HKS+QQ=:CX;\?6/B*S
MU"].G6\ DU.Q:Z8P-$76+S!&3M4INWDCKMI?'NI7NH>,/"NG6&HWEIITFI1Q
MW9LYVA:??%(ZKO4@X'E\C_:% 'IE%<"OQ;T!?&,?A]65@;C[&+G[5$3YV/NF
M+=Y@'^V5V^]9E_XPU#5OB!X0?3QJ%IHMU=7"J^Y/)OU6%B'PIW8R. P /44
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M7B*XTV.WEOD99+;<RJ9.?WC'@A^/:@#W2J6HZO9:6UNMY,$>YD\N&,#+2-[
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M;G!(+1B->>O(X'%=+X3UVUL_AQH5YK^HV]JKV<2B>[G5!)\HP=S$9)&#[YH
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MW0@?GTH KT444 %%%% !1110 4444 %%%% !1110 4444 %=G\-I-NJ7D?\
M>B4C\":XRNL^'C8U^7T,)S0!Z;156;5=/M_^/B^MHO\ ?F5?YFJ$OC#PS <3
M>(M)C/H]]&/_ &:@#8=MJ,P!; S@=Z\^;XD:\-32P7P#J!N9+0WD<1OH%<Q
MX^Z6R&S_  ]:['3_ !%HFKS-#I6L6%]*HW,EM=)(P'KA2:Y&ZU2W3XYVD9CN
M_ETMK8R"SE,8D9PP7S NWIWSCMUH [JVF:>UBE>)H6=0QC?JI]#446I6D^J7
M&GQ2AKFWC225!_ &+!<_]\GBO,/%]E:WGB36(?$&FW4NIO$G_".WD5M)(L;X
M.-KH"(R'V;BV,^^*S+W3+71->\27-[H-S=:Y<:);MYEI#*K7$F,3[9E4@$D#
M/<@< T >I^*_$L'A/P_-JMU;7%TD9"^7;QECDG&3Z#U)X%-\4^()_#GAN;5[
M;2YM3$*[W@AD5&V]R-W7Z#DUXI82PZ=X.\::?:V]UY%RT$MG#::/<Q1<HJLJ
M*R9.&!!8@$XW$#->O^*=8M;7P3]L<7+1RB+8(K261S\P/**I8<#N* +EMXLT
MVZ\%)XHBDS8-;?:,CD@ <K]<\?6F^#O$DOBSPY#J\FES:;'<?-%%-*KLR_WC
MM/'?@\UP%M;RZ0-8TLVMT?"S1?VO;RI;.P =2C6ICQN/SX? &>:YVYBN-5\!
M^$HYS>6^CVHEAU%)M&EN0DQ^X7@(#,!GAE! - 'N6KZDFCZ+>:E-%+,EK"TS
M1PH6=@HS@ =ZIZ-KLFMZ=IE_:Z?(MK?0F5G>108>F 1U)//3IBO(M1LH8M,M
M;3Q+%K&L:>NB.NCW+V,A8W/&QS&@8Q28^Z7Q@<'%6-.;4(KWPFL5OJ]IJ1\/
MW=NL,T,ACBF;:8B2H**S;6Y)[#..,@'MM%>-:1'H=IX3U6ZT?0]8_MXZ3LU>
MWCBFMS/,I.XEV7#N7+D,FXX_"N22*UM]"\06,"ZG!:S7ME<V\.F:7=P1;1L$
MJ@&/<P7!Y(!;&[% 'TE6'XT_Y$O5/^O<UY3XX\,11ZO:6D9FTGP_]AW:>;71
MFO!%<$C)"@[HI#P0Q&.#DBO2]>5X_AE<)-)++(M@H:288=R .6'8GJ: /%J*
M** "BBB@ HHHH **** "BBB@ I&^XWTI:1ON-]* />I] T?7M)LX]<TJRU)(
MXU*+=VZ2A3@<@,#BETKPGX=T.Y:XT30=,TZ9EVM):6<<3$>F5 .*OV/_ "#K
M;_KDO\A4] !7G_BW5_[/^)&AW#:5K-U!9VT_G366F37"*9-FT;D4@GY3D#IQ
MZUZ!5+5]8L="TV2_U2?R;>/ )",[$GH J@LQ]@": ."\::H?$_A:!U\,:E/9
MKJ*(RWFFS.P4+GS?LN-S@$D892O'(KE=-T61O"WAC^V-$U:[T[1M6O?M=N^F
M2+(\+B018MU7YHSN4%5&T#((P*]AT?Q%I>OQNVDW0G\O'F(49&C)[,K %3[$
M ]/6I-3US3-&>T35+R.V>]G6VMD8_-+(QP%4#D]?P[T >66NAR:79Z>^M^';
MC4/"KW5W)'I'V W+6:N5,&8,$X4!QC'R[J@?PO$=5\*VVJ:-JMWIXN[AX[62
MWFF@MH'V[$F7!4<ACAAP,#L*]II&940NY"JHR23P!0!XA?Z6T7Q,@O$\,WEM
M]GU)8W-KH\DPFMMH0,UQM/R[1CRT.T* ".M.T[1(M,T?R#X0N&TZUUN5]9L4
MTEO],@8.(2J;<3JKLC8&<8SQBO7]%US3?$6EIJ.B7:7EG([HDT8.UBC%6QGJ
M,J1GH>U)>Z[IFG:G8:=>WD<5YJ+M':P'):4JI8X [ *>3QVZD4 >.ZMX>B:/
M1"F@:P=%?Q$+BWTV*SG*06OE%7+P 8C!<C"L 0-Q'!-=1K7A+3]+\706>CZ%
M9+I_B2W^Q7\4-NB+&D?._&.<JP7'08KTJL">RTO0]7FUS4M1NG>=A'#%<S&1
M(F/&V&/&06[@9)H H?$:(6WPMUG3]-TZXF::PDM;:UL+5I2&9"J@(@X7D>P%
M9-CX7D@^'NJ3^&)=9CO]3L(D6/4YI3-&R*1@><=R9W$8/ XQ73)XV\/R>)/[
M"2_S?^88@OD2>67 )*>;MV;A@_+NSVQ4^F>*M%UC5KO3=.O?.N[,_O4,3J/0
ME68 . 2,E20,B@#QS3_">HIX-UE?#ZZ_%>36\*W5O-I<=BK%2=XC4(JRR'/+
MX.X 9)XKO/A9H\&E6>HFR_M5;>XF5Q'?Z8NGHC!0#Y<"H@4>I  )R:ZR?Q%I
M5K:&[N+M8[83_9S,RML5^G+8P!GC<> >,UI4 %%%% '-^%_^1B\9_P#8:C_]
M-]G725S?A?\ Y&+QG_V&H_\ TWV==)0!S?CS_D7;7_L-:5_Z<+>NDKF_'G_(
MNVO_ &&M*_\ 3A;UTE !55=+T]+TWB6-LMT229Q"H<D]?FQFK5% %?\ L^S^
MV_;/LD'VK&//\L;\>F[K2+IME'<RW,-K!%<RC#SI$H=OJV,FK-% '":1\/[Z
MSN+>+4K[2+VQM\?,ND".[EV_=+S;R">!N(49YZ9KKQI&FK9O:+I]J+9VW/"(
M%V,?4KC!-7** ,]= T="I32;%2IRN+9!@^HXH3P_HT>/+TFQ7:P8;;9!@CH>
MG6M"B@"M#IMC;W37-O9V\4[KM:5(E5F'H2!G%4M4T,7VIV>I6TYMKRU)7?MW
M+)&?O(P[@X_"M:B@"C!H>DVMR+BVTNSAF7I+';HK#\0,U;2&.-W=(U5G.68+
M@M]?6GT4 8^IZ EWIKV.G2)ID-Q+NNFMH55Y%/W@#T!/<D'C-77TG3I;&&RF
ML;>6UA55BADB#*@ P  ?05;HH RSX8T C!T33O\ P%3_  JI-X&\,S_?T:V'
M^X"O\B*WZ* . \4> O#FF^%M5OM/T\PW,=I)L<7$I X_NEL'\J\*KZB\1P&Y
M\-:C".LENZ_I7RY0 M%%% !1110 4444 %%%7+#1]2U1]NG6-Q<G_IE&6Q0!
M3HKN-,^$OB2_VM<I%8QMWE;+#_@(YKLM,^"^E0;6U2\GNF'5$PB'^OZT >*C
MDX')]!6MIGA;7-7_ .0?IEQ*O=MNT#\Z^@M-\&>'M) ^Q:5;@CHTB^8P_%LF
MMP    8 Z 4 >(:9\&=9N2K:E=V]FAZA<R,/PXKL=+^#_AZRVM?&>_<=1(V$
M/X#G]:[>YOK6S3==7$<*^KL!6%>^.M&M,B*5KEQVC7@_C0!K:;HNFZ/%Y>F6
M<5LO^PO]:O5YU>_$>[D)%A:1PKV:0[F']*Y^\\2ZQ?\ ^OOI0/2,[!^F* /6
M+S6=.T]<W=Y%'[%LUS]Y\0]+@R+6*:Y8=.-JG\:\T)+,68DD]2:2@#K+[XA:
MG<96TCBMD/3C<P_'I^E<]>ZI?:BV;ZZDF]F/'Y54HH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "MSPKH.G^(-4>VU:W,\"IO"B1TP?JI!K#KL_AM&6
MU.\D[+$H_4T ='#\/O"T'W-(B/\ ON[_ ,R:NIX5\/QKA=$T_'^U;(?YBM:B
M@"G::1INGR&2PTZUM788+0P*A(^H%7*** "BBB@ II=58*S*&/0$\FG5YFZ:
MAXFTCQCJUDKRZA!/<:;8Q+(1MCB;#!/[K/SSUH ]&BO;6>-Y(+F&1$.'9) 0
MOU(Z4Z*XAFMQ/#-')"1D2(P*G\:\5M-/37M0U;2/!VEWFA2/HD:W]K/9M:H9
MO,#(2I !+!95+]^Y.*T;22Y\.>%;VRNM/6TA^U&272+212D)?'EV:N/D4N?F
M;&,"0'C.: /6Q(A<('4L1NP#SCUIU><ZAKT-_P"'+3Q=86S:?J.EWZ6,\&_(
M4>>L4T+;>' !)';(!KT56#H&'0C- "T444 %8?C3_D2]4_Z]S6Y6'XT_Y$O5
M/^O<T >%T444 %%%% !1110 4444 %%%% !2-]QOI2TC?<;Z4 ?15C_R#K;_
M *Y+_(5/4%C_ ,@ZV_ZY+_(5/0 5RGQ"AL+G1;."_P!2GTJ62]06=]"H;R)]
MK%68'C;@$'Z]NM=74-U9VU]#Y5[;Q7$?79*@<=".A]B1^- 'E/\ PE.J:7I^
MN0WS:<M_!-;I<Z[IB?NY(I,KYK+R%D4+R,GJ/I2^*[=K?0;"V/BN+5IH_$-G
M]DOKM(VEM=TBD@LNT,><\!>.#7I=IH.CV&FR:=8:58VUC*29+6&V1(GR,'*
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MZEII$U](#=W4%L@D93]YAQ@OZ%@16GI]A;Z7IMO8V,?EV]M&L4:9SA0,#ZT
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M>?$BSCR+&TEF/K(0@_K6!>^/-8NLB%H[9.WEK\P_$T >H2S1PIOFD6-?[SL
M*R+WQ=HMCD/>+(_98@6S^(XKR>XO;J[<O<W$DK'KN:H* .]O?B2.1I]B?]Z9
ML?H*Y^]\8ZU>@J;HPJ>T(V_K6%10 ^2629R\KL['J6.:9110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>A_#:WQ8WEP1]Z0(/
MP /]:\\KUOP7:?9?"UMN&'DR[?B>/TQ0!O4444 %%%% !1110 5RUOX=N++5
M=6M(#+'I6KNURTMM-Y4MO.WWR".?FZY'3%=310!F:+H%CH&GM:Z>K_O&+S3R
M.7EF<C!=W/+-@#D^@J*Y\+Z;>>'Y]'N%E>WG+,\AE/FAB<[P_4,">#U&!6Q1
M0!QTW@]8K.P\.:9;M'HZ7"WMY=2S;I)I%D$@&>K,S@%B>",\YKL1QTHHH **
M** "L/QI_P B7JG_ %[FMRL/QI_R)>J?]>YH \+HHHH **** "BBB@ HHHH
M**** "D;[C?2EI&^XWTH ^BK'_D'6W_7)?Y"IZ@L?^0=;?\ 7)?Y"IZ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YOPO_ ,C%XS_[#4?_ *;[
M.NDKF_"__(Q>,_\ L-1_^F^SKI* .;\>?\B[:_\ 8:TK_P!.%O725S?CS_D7
M;7_L-:5_Z<+>NDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
M![&TDN1</:PM.!@2M&"P_'K4]% !1110 4444 <=\1(9QIMO=02R(B.4D57(
M#9Z<?@:\WKVK6]/74]%N;1NKH=IQT/:O%G1HW9'&&4X8>AH 2BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH EM8&NKN*!!DR.%Q7M]M MM:10)]V) @_ 8KS/P%IOVS7OM+#Y+5=V?]H\
M#^M>HT %%%% !1110 4444 %%%% !1110 4444 %%%% !6'XT_Y$O5/^O<UN
M5A^-/^1+U3_KW- 'A=%%% !1110 4444 %%%% !1110 4C?<;Z4M(WW&^E '
MT58_\@ZV_P"N2_R%3U!8_P#(.MO^N2_R%3T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!S?A?_ )&+QG_V&H__ $WV==)7-^%_^1B\9_\ 8:C_
M /3?9UTE '-^//\ D7;7_L-:5_Z<+>NDKF_'G_(NVO\ V&M*_P#3A;UTE !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>5
M>-]).G:\TT:XANOWBX[-W'Y\UZK6+XKT?^V=#DC1<SQ?/%]1V_&@#R"B@C!P
M>"** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBMWPEHQU?6XPZDV\!\R0]N.@_.@#O?!NDG2M!C\U<33GS']O0
M?Y]:WZ    . .E% !1110 4444 %%%% !1110 4444 %%%% !1110 5A^-/^
M1+U3_KW-;E8/C>1(O ^K/(P55MR23VH \-HJK_:=C_S]1_G1_:=C_P _4?YT
M 6J*J_VG8_\ /U'^=']IV/\ S]1_G0!:HJK_ &G8_P#/U'^=']IV/_/U'^=
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MZY.O<;^QAU*QEM+E=T<BX/MZ&O'=9TF?1=2>UN!TY1^SKZB@"A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #D1I)%2
M-2SL<*HZDUZ]X8T1=#TA8FP9Y/GF;W]/PKF_ GAOE=6O4_ZX(?\ T+_"N]H
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M+ A6_>CN0N#BKGB_P]J<FO6W]B:%)/M%LHGW1/:L$?)\V%V4@J,E74,1D\4
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M1B N,<+G:/KC-:5>4^'_ !3XSUCQ:;PK$FBIJ<UE/%)<VXCC16*)M7;YOFY
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MQ>,_^PU'_P"F^SKI*YOPO_R,7C/_ +#4?_IOLZZ2@#F_'G_(NVO_ &&M*_\
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M4_\ C7>T4 <%_P *8\'?\^MU_P"!3_XT?\*8\'?\^MU_X%/_ (UWM% '!?\
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M_P!AK2O_ $X6]=)7-^//^1=M?^PUI7_IPMZZ2@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#.
MU30M/U>,K>VZLW:1>&'XUQ&J_#R\M]TFF3"Y3_GF_##\>]>D44 >&75G<V4I
MCNX)(7'\+KBH:]TN+:"ZC,=S"DJ'^%U!%<_?>!-'NP3%&ULY[QMP/PZ4 >5T
M5VUW\-KA<FRO4<=A*N"?RK*G\#:[#G;;+*H[I(O\LT <]16G)X;UF(G=IUP<
M?W4+?RJ'^Q=4'73;S_OPW^% %*BKZZ'JK_=TV[_&%O\ "F7FCZI8PI+-I=ZZ
MNVT"&V>0CZA02* *=%65T;7KA UCH%[.3_"X$!_\B8K0M/"/BB?:6T%+9NZW
MEXA7\XF)H QNO2M73/#6JZJ0;:V98_\ GI)\JUT-AX7\6VI'E6_AJS_VT$TS
MC\7%:O\ PC?BR?\ X^?&TL:GK';Z?"!^#$9H ;H_P_L[4K+J;FZD'.P<(/ZF
MNKC6"VC$<0CB1>BK@ 5R_P#P@CSC_B8^)]>G/_3&_>W_ /0"*<OPV\-G_C[M
MY[[U^VW+S9^NXG- &[>:WI>GKNO=0MX!_MR 5B2_$OP;$Q7_ (2&R=^FR.3<
M?TJU9^!?"FGMNLO#FEP-_>2T0$_CBMN&WAMT"6\21*!@!% % '*GXC:?)S8Z
M3KE^O9K33W=3^-'_  F&LW/_ "#O!VHN3T^U.+?^8-==10!R(U7QS<?ZOPWI
M]E_UVO\ SO\ T$"E^R^/[C_6ZIH-HA_YXV4K./Q:0C]*ZVB@#DO^$6\27!S=
M>-]0A_V;2UMU'_CT;&C_ (5]:S\ZGK6M7Q]6OFB_]%;:ZVB@#EXOASX8B.6L
M);C_ *^;R:8'\'<BM"#PAX;M3FWT#3(S_>6SC!/XXK8HH CAMX;:/9;PQQ(/
MX8U"C]*DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH YOPO_P C%XS_ .PU'_Z;[.NDKF_"_P#R,7C/_L-1_P#IOLZZ2@#F_'G_
M "+MK_V&M*_].%O725D>)]&GU[0_L=G=QV=PEU;744TL!F16AG28!D#*2"8\
M'##K5+[#XW_Z&'P__P""&?\ ^3* .DHKF_L/C?\ Z&'P_P#^"&?_ .3*/L/C
M?_H8?#__ ((9_P#Y,H Z2BN;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\
M@AG_ /DR@#I**YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\ ^3*
M.DHKF_L/C?\ Z&'P_P#^"&?_ .3*/L/C?_H8?#__ ((9_P#Y,H Z2BN;^P^-
M_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\ @AG_ /DR@#I**YO[#XW_ .AA\/\
M_@AG_P#DRC[#XW_Z&'P__P""&?\ ^3* .DHKF_L/C?\ Z&'P_P#^"&?_ .3*
M/L/C?_H8?#__ ((9_P#Y,H Z2BN;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\
M/_\ @AG_ /DR@#I**YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\
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M_P#^"&?_ .3*/L/C?_H8?#__ ((9_P#Y,H Z2BN;^P^-_P#H8?#_ /X(9_\
MY,H^P^-_^AA\/_\ @AG_ /DR@#I**YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z
M&'P__P""&?\ ^3* .DHKF_L/C?\ Z&'P_P#^"&?_ .3*/L/C?_H8?#__ ((9
M_P#Y,H Z2BN;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\ @AG_ /DR@#I*
M*YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\ ^3* .DHKF_L/C?\
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M?_H8?#__ ((9_P#Y,H Z2BN;^P^-_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\
M@AG_ /DR@#I**YO[#XW_ .AA\/\ _@AG_P#DRC[#XW_Z&'P__P""&?\ ^3*
M.DHKF_L/C?\ Z&'P_P#^"&?_ .3*/L/C?_H8?#__ ((9_P#Y,H Z2BN;^P^-
M_P#H8?#_ /X(9_\ Y,H^P^-_^AA\/_\ @AG_ /DR@ \+_P#(Q>,_^PU'_P"F
M^SKI*Q/#>B7VD-JMQJM_;WUWJ=Z+N1[:U:WC3$$4(4*TCGI"#G=U-;= !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>dgx-20201231_g6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dgx-20201231_g6.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_
MF_\ 1T5?QA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX
M_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_F_\ 1T5?QA5_9[_P7X_Y0V?M
M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[
M_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]L[]FSQ7^SWJ>GW%Q;2:MXYU.)X+*XB1I/*OE\N-K0N@&QAYB$LHW ,&-/\
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M;<1@' !]CZC<7%GI\]W:6$EW+%"SQ6L3JKS, 2$4N0H)/ +$#GD@5^<OA?\
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MQ7H%8'Q2^*/P]^"7PXUSXO?%GQ=9:#X9\-Z9-J.N:SJ$NR&SMHE+/(QZ\ =
M"2<  D@5^?X_X.#[KQ3^S+XG_P""@'P@_P""?OCOQ)^SSX2UTV&H^/Y/$5C9
M:G>01S+#/?6FDR9>:VCD=5+/-&WWLJOER; #]'Z*\G^$?[<'[+WQL_9(M?VY
MO _Q9TYOAA<>'9]:G\37KF&.QM8 YN/M ;F)X3'(DB'E61AS7R+J7_!>?Q;\
M1OV7_%_[<O[&7_!//Q?\3O@UX):_.J^,[[QKIFB3W$-D-UW<V^GN9KEH8TRY
M,J12%02(^* /T2HKY5_X)1?\%>/V9/\ @KI\']5^(_P'@U31]9\,W4-MXO\
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MWVK^-- BM9S-H.CZ<&UF*]A0,^G/:LXV77S* A8(P='#F-E<@'K'BOXD^ _
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MFKZ9:L?W9O+W4KV&XE Z9*6-LOK^[]Z_0+_@XQT/1-,_X-P8]+B@C6/3M/\
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M"?\ :1TR&XC_ .6?]K>7YYBCW>7YFW<=N_'S4 >\_P#![A_R9=\'/^RH3_\
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M75G/\+_AL8[6YLH+F&W#W]Q=W5V8+F=GMD5X;8B*,;6CWAG\L ^_/V77=_\
M@V7T)G8D_P##']R,D]AX?E K\S_^#'W_ )+Y\??^Q/T7_P!*KFOU2_X)J?LR
M_M<W_P#P1ZL/V*_VTOAWHOPYUK_A5\_@>PL=(UA=3NK>R:P>S6\NFC/DK.V\
MOY$3.JA1F3<Y2/\ -C_@B'_P34_X+=?\$E?VK?B3X&T?]C+PUK.F^.]&CT6'
MXEZIX\M(]%T@PSEX=5\J-FNKR(+(Y^R".&9SM!:+#$ &)_P?%_\ )5/V=O\
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M3?V1?V/_ -BGQ'XDN;;X@6>M7_BJ^\7>'-/T\VMO:W*;85N-32X9VDN%X>%
M C\\KD ^!/\ @VI_X)/_ +,/_!2__@F[\7M$^.NL^.M+O6^(LFF6NI>$_'5_
M8QQ1'3;212]D)397)#N3F:!V(PN<  ?KC_P06_9O\4?L?_\ !-W0_P!EWQE>
M+=:AX#\>^,M%EODB,:WB0>)=22.Y522565 L@!.0'%?+/_!LG^R!_P %"O\
M@F7\(_&W[.?[7?[#7B31X/%/C>#6=,\4Z5XS\-7]I;(]M%;2K<)%JAG4)Y*.
M#''(6!88R &_6Z@#^7'_ (//?^4K_A?_ +(?I'_ISU:OW_\ ^"C7[$N@_P#!
M0[_@G)XS_90U6&W%]XB\)))X9O+@ "RU>!%GLIMW55$\:!\8)C9UZ,:_(3_@
MXO\ ^"17_!5C_@IO_P %"(_CE^S/^PSJTWA30? ]EX;M=3UCQ]X9M6U*2"ZO
M)VN8XFU/>D3?:@%$@5_D)95SBOW?^"'B+Q=XJ^%.AZQX\^%6K^"M7:PC2_\
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M:;1/BFWB*;Q#X1\'3Z@YADU+4%U!(X_M%O&I2*95 8G=M!]37P%X%_X),?\
M!;+_ ((/?\%$[KX\?L ? NX^+W@B>2XT^SGTV:.>+6]$FE5Q9:A;K(D]O.FR
M%C*J^6)(@RLZ[EK]K/V%+[_@HU\?/$D?[27[>OP]TSX0VEKI,EEX3^#'AKQ&
M=0<23,AFU+5KJ,B.:7;&$@MU&V%9)6?=(R^4 ?4]%%4?$FK7^A:#=ZQI?AF^
MUFXMX2\.E:;) EQ=,/X(S<2Q1!C_ +<B+ZD4 ?R,_P#!?O\ 9YTS_@F/_P %
MG]=UG]EG79O#WFWNG>/_  H+!!&=!OIY6G,</\(1+J)WC7 "HR)@A>?Z=?\
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M/2S\8V&E )K'VL7-G<-=.&MGA^VR;9/+>-@B-G)95^GO^#AG_@G1_P %-O\
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MN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\ T^3U^_U !1110 4444 %%%%
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M(?M/_M!_$3X1_LW?%S1?ASH?P=^/7A'P)J);0VU#6-:N[VYA^T7,P:XCC@L
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M^"D/BK]G.X\+?V.!H%K\%[36S>O?&5#OGDU':BPK&'&U%9F9P<J%PW"?!/\
M:]_:S_X*):G\8OB/^Q9X^\(^%/!'PP\9WW@_P(?$'AE]2/CC6;&)'N[BZD%Q
M']FTYI9$@B\C]Z0))6?I$/,O^"8WPA^/7_!-W_@H5\0_^"46G?&'7/&_P<N?
MA'%\1/@Y>>*[G[1=^%%_M$:?+I+2XYC,C>8JA0FV(,JJSRYB_P"#3>SETO\
MX)$Z;H>JP21:S8?$CQ';^(89R?-CO5N_G63/.\+LS0!]>?\ !.+]N/P9_P %
M$_V0O"W[4GA'0)M$FU9)[3Q#X;NIA)-HNJVTK07=F[8&[9*A*L0I>-D;:N[
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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MH I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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M4 %%%% &/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,UL4 %%%% !1110 4444
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M )2F?M=_]O'_ *?)Z_?ZOP!_X--O^4IG[7?_ &\?^GR>OW^H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#P7_@G5_R0_5_^Q[UC_T?7O5>"_\
M!.K_ )(?J_\ V/>L?^CZ]ZH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ K'\2_\A?1_P#K]/\ Z":V*Q_$O_(7T?\ Z_3_
M .@F@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#-\8_\BQ>_]<#5S3O^0?!_UQ7^0JGXQ_Y%B]_ZX&KFG?\ (/@_
MZXK_ "% $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 8]E_P CO>_]>47\S6Q6/9?\CO>_]>47\S6Q0 4444 %%%%
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M110!X+_P3J_Y(?J__8]ZQ_Z/KWJO!?\ @G5_R0_5_P#L>]8_]'U[U0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XE_Y
M"^C_ /7Z?_036Q6/XE_Y"^C_ /7Z?_030!L4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!F^,?^18O?^N!JYIW_ "#X
M/^N*_P A5/QC_P BQ>_]<#5S3O\ D'P?]<5_D* )J*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[+_ )'>]_Z\HOYF
MMBL>R_Y'>]_Z\HOYFMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "L?Q+_P A?1_^OT_^@FMBL?Q+_P A?1_^OT_^@F@#
M8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYF@#8HHHH **** "BBB@#Y
M _X+\?\ *&S]H3_LG\W_ *.BK^,*O[/?^"_'_*&S]H3_ +)_-_Z.BK^,*@#]
M_O\ @TV_Y2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?)Z_?Z@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /!?^"=7_)#]7_['O6/_ $?7
MO5>"_P#!.K_DA^K_ /8]ZQ_Z/KWJ@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "L?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]
M/_H)H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH S?&/_ "+%[_UP-7-._P"0?!_UQ7^0JGXQ_P"18O?^N!JYIW_(
M/@_ZXK_(4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S6Q0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/XE_P"0
MOH__ %^G_P!!-;%8_B7_ )"^C_\ 7Z?_ $$T ;%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_R.][_ ->47\S6
MQ6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444 ?('_  7X_P"4-G[0G_9/YO\
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M^#G#]D:T\&R@7.D_!SQC>ZPPZ16LMCJ,$#2<'*?:3&.1C/Y5;_X--[.72_\
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
M@6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L5C^)?\ D+Z/_P!?
MI_\ 031_P@^D?\_-[_X%M69KGA73K74=-ACGN2)[DJY:X8D#;V]* .KHK'_X
M0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_G
MYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P#
MMJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8H
MK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'
MTC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?
M2/\ GYO?_ MJ/^$'TC_GYO?_  +:@";QC_R+%[_UP-7-._Y!\'_7%?Y"N?\
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M*;JP:>YV1VT;*1<-NR2>IK3_ .$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6/XE_Y"^C_]?I_]!-;%8_B7_D+Z/_U^G_T$T ;%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 9OC'_ )%B]_ZX&KFG
M?\@^#_KBO\A5/QC_ ,BQ>_\ 7 U<T[_D'P?]<5_D* )J*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[+_D=[W_ *\H
MOYFMBL>R_P"1WO?^O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K'\2_P#(7T?_ *_3_P"@FMBL?Q+_ ,A?1_\
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M^"=7_)#]7_['O6/_ $?7O5>"_P#!.K_DA^K_ /8]ZQ_Z/KWJ@ HHHH ****
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M%% !1110 4444 %%%% !1110 45'>7MGIUI+?ZA=Q000H7FFFD"I&H&2S$\
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M^UW_ -O'_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M\%_X)U?\D/U?_L>]8_\ 1]>]5X+_ ,$ZO^2'ZO\ ]CWK'_H^O>J "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_$O_(7T
M?_K]/_H)K8K'\2_\A?1_^OT_^@F@#8HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#-\8_\ (L7O_7 U<T[_ )!\'_7%
M?Y"J?C'_ )%B]_ZX&KFG?\@^#_KBO\A0!-1110 4444 %%%% !1110 4444
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MFW_*4S]KO_MX_P#3Y/7[_4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!X+_P $ZO\ DA^K_P#8]ZQ_Z/KWJO!?^"=7_)#]7_['O6/_ $?7O5 !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8
M_B7_ )"^C_\ 7Z?_ $$UL5C^)?\ D+Z/_P!?I_\ 030!L4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F^,?^18O?\
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M/ ;(98CZUGV*JXVL]W*3C%_<W-_^!_(UH\-89RY\3.527F[+_/\ $\7^&_[
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MW_!IM_RE,_:[_P"WC_T^3U^_U?@#_P &FW_*4S]KO_MX_P#3Y/7[_4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!X+_P $ZO\ DA^K_P#8]ZQ_
MZ/KWJO!?^"=7_)#]7_['O6/_ $?7O5 !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %8_B7_ )"^C_\ 7Z?_ $$UL5C^)?\
MD+Z/_P!?I_\ 030!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!F^,?^18O?\ K@:N:=_R#X/^N*_R%4_&/_(L7O\
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M4 %%%% &;XQ_Y%B]_P"N!JYIW_(/@_ZXK_(53\8_\BQ>_P#7 U<T[_D'P?\
M7%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** ,>R_Y'>]_Z\HOYFMBL>R_Y'>]_P"O*+^9K8H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **Y7XP?&_P"%'P#\(R^./B[X
MXL=#TZ/(22[D^>=@,[(HUR\K_P"R@)]J_-[]KO\ X+/_ !&^(INO!'[,=C<>
M%=&?,;^(;D*=3N5Z9C RML#ZC=)T(9#Q7VO"7 '$G&=:V!I6IIV=26D%\_M/
MRBF^]EJ?$<7^(/#/!5"^/JWJM>[3CK-_+[*\Y-+M=Z'W#^U3^WO^SW^R58/;
M^.O$O]H:^T6ZU\+Z0RRWDF1\I<9VP(?[SD9&=H8C%?FA^T7^WY^U;^W1XE7X
M9>%+&]L-'U&;RK'P5X66222[!Z+.ZC?<GN00(^,[!C-;G[*O_!*S]HG]J+4(
M_B)\6+J[\*>'KZ7[1/JNM1M)J.H[CN+Q0N=QW=?-D(!W!@'Z5^F/[.'[(GP&
M_95\/?V+\(O!<5O<RQA;[6KO$M]>8_YZ3$9QGG8NU >BBOU3ZQX<>%.E!+,,
MQC]K3DIR\MU%KRYIWT;C<_*/JWB5XLN^(;R_+I?95_:5(^>TI)KJ^6%M5&5C
MX$^"_P#P0P^+GC7PBFO_ !@^+-EX,OY\-#HUOI']I2QH1_RU=9XD1O\ 94N/
M4@\5T>I_\$&O[.N[.U_X:JW_ &N8Q[O^$&QLXSG_ (_N:^]_C9\8_"GP*^']
MU\0/%KNT4+"*UM8B/,NIVSMB7/<X))[!2>U?#WCC_@H?^T%XIUY-4T2\T[1;
M:WF+VEG;6"3;1T&YY0Q8XZD;1["OP?CSZ7>=\&8Y4\9C6JD_>5*E1I2<8O9W
MFM%VYIN3\SZ&OX4^%63TH4<1A95)VU;J5.9^;Y9QBK^27H5?^' ?_5V7_EA_
M_=U?HQ7RE^S5_P %&;+Q/>GPK\??L.ER^4SVVO6ZE()"HR4E3)V,0.&7@GC
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M#]7_ .Q[UC_T?7O5>"_\$ZO^2'ZO_P!CWK'_ */KWJ@ HHHH **** "BBB@
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M[+]A!XGU==T<GB2[5AIULW3,2\-<D>ORQ]""XXKX^^+?[3?[9/\ P49\?1>
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MOW^K\ ?^#3;_ )2F?M=_]O'_ *?)Z_?Z@ HHHH **** "BBB@ HHHH ****
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M4 %%%% !1110 4444 %%%% !6/9?\CO>_P#7E%_,UL5CV7_([WO_ %Y1?S-
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M=HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\
M@,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_
M .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-
M_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -B
MBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@ LO\ D=[W_KRB_F:V*Y2UM?%)\4W4
M<>J6PN!;1F20P':5R< "M/[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
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MWBN\7<D/C#XAR-8Z>&'1X[*!C/.AX^_);M_LU^?W[*'_  ;0_P#!8?\ ;_\
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MPG^RQ\"]+FM?#/A#3?LMDUU('GNI&=I9KF9@ &FEF>25R !ND. !@#TJBB@
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M]6\P?\LI(H"4M6]/M#Q#WY%?S;?&[_@KI_P7!_X+$>-IO@]X/\:>-M5M]2)
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M110!X+_P3J_Y(?J__8]ZQ_Z/KWJO!?\ @G5_R0_5_P#L>]8_]'U[U0 4444
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M1K":-X=T@1"\NX[*6581)*D*8C@1G.9)$'RJ<9R< $UTU?.?_!6?_E'YX_\
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M=\3]D?@KXFZ5=328V6<EQY,Y_P"V4NU_TK]/R/C_ (,XCLL!CJ<I/:+?+/\
M\ GRR_ ]C#YG@,7_  JB;[;/[GJ=K1117V!W!1110 4444 %%%% !1110 44
M44 %%%% &/9?\CO>_P#7E%_,UL5CV7_([WO_ %Y1?S-;% !117%?'+]HCX-_
MLX>$V\8_&+QU9Z/:D,+:&1MT]VX'W(8ER\C?08&<D@<UT87"XG'8B-##P<YR
M=E&*;;?9):LY\5B\+@</*OB9J$(J[E)I)+NV]$=K7@O[67_!17]GK]DVWFT?
MQ!K?]N^*%3]SX7T:57G5L<>>_P!VW7I][YL'*HU?#?[6_P#P6,^+_P 8WN/
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P7_ ()U?\D/U?\
M['O6/_1]>]5X+_P3J_Y(?J__ &/>L?\ H^O>J "BBB@ HHHH **** "BBB@
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M!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+:"Q7$V84L)3_ENG)^5VU&_^'G]#\EQ?C:LRKO"\+Y=5Q=3^9IJ*\[).5O\
M%R>I]C_&[_@MU^SEX&\[3?@]X9U;QK>H"([HH;"QST^_*IE./:+![-7R-\6?
M^"K'[;?Q^U'_ (1CP5KQ\-07K^7;Z5X+LG6YE)Z 3'?.6_ZYLH/I7U'\$O\
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MG=?Y_B?G5X<_;)L+@K!\8?V<O 'BZ+(\R:X\/6\-P_N6\MT_\<%=]X;\8_\
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M11726%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^)?^0OH_\
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MM'A_P%=1[_I]N^S_ *XKQ'X@?\'M7[#6F%U^%_[(_P 5M:*YV'7)M-TT,?\
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M/>L?^CZ]ZKP7_@G5_P D/U?_ +'O6/\ T?7O5 !1110 4444 %%%% !1110
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MO:?X?G?P;H7C?Q1;V&G76K,NR F!9+6W$"N1(Z7$LN45P-S%10!^%'_!1_\
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M3PO^PS_P7O\ ^"QGB"V\9^)/ /Q?^(%G<2^9:>)/B-JLUEH\"GJUO)J#QP!
M/X+<'T"Y.*^[OV3O^#);XHZR+;7?VV_VO=)T*([6G\.?#?37OIV4]5-[=B)(
MG'0X@E7/0D<G^B&B@#X6_9._X-OO^"0G[(_V;4M!_98L?&^M6^/^)]\3I_[;
ME=AT;[/*!:(P/.Z.!3GZ#'W!HVBZ-X<TJWT+P]I-M86-I$(K6RLH%BBA0=%1
M% "@>@&*LT4 %%%% &;XQ_Y%B]_ZX&KFG?\ (/@_ZXK_ "%4_&/_ "+%[_UP
M-7-._P"0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#'LO\ D=[W_KRB_F:V*Q[+_D=[W_KRB_F:V* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q
M_$O_ "%]'_Z_3_Z":V*Q_$O_ "%]'_Z_3_Z": -BBBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L>R_Y'>]_P"O*+^9
MK8K'LO\ D=[W_KRB_F: -BBBB@ HHHH **** /D#_@OQ_P H;/VA/^R?S?\
MHZ*OXPJ_L]_X+\?\H;/VA/\ LG\W_HZ*OXPJ /W^_P"#3;_E*9^UW_V\?^GR
M>OW^K\ ?^#3;_E*9^UW_ -O'_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \%_X)U?\D/U?_L>]8_\ 1]>]5X+_ ,$ZO^2'ZO\ ]CWK
M'_H^O>J "BO+?C)^V+\#/@MYMCK?BA=1U2/(_LC1\3S*WHY!"1_1F!] :^4?
MB_\ \%$/C7\2I7T/X?1+X8L)FV(NGL9+V7/ !F(!4],>6JD>IK\TXL\6>#.$
MN:E6K^UK+_EW3M*5^TG?ECZ2:?9,\C&YWE^!TE+FEV6K_P D?9OQ7_:!^$7P
M5M#/\0O&=K:3E-T6GQMYMS+Z;8ERV#_>("^I%?*OQD_X*;^,]>\W2/@QX=31
M;8Y5=4U%5FNF'JJ<QQGZ[_J*X_X4?L'_ !_^,EV/$?C%'\/V5T_F3:AKVYKJ
M;/5A"3O8]\N4!]37OWA+X,_L+?LK;;_XB?$3PN^L08+7OB[6[975QS^[@=@J
MGTPI<?WC7P=#$^-?BC4]GE>'>7867VK2=62\M.?S3C&"_OL\7$8_-<73YYRC
MAZ7\TG9_>[?A;U/FKP+^SC^TW^U)K(\6W]O?2PW."_B+Q)<.L17ML+99UZX"
M*0.G%?3WP;_X)R_!WP#Y6J_$"63Q5J*8)2Z3R[-&]H03O]/G+ _W15?QM_P5
M@_86\$[X$^,!U>>/_EWT/2+F?/TD*+&?^^Z\?\;_ /!>+X*Z=O3X>?!'Q-JS
M+D*VK7EO8JQ_X 9SC\,^U?KW!'T3\9A*JQ5;+:N+Q#U=3$1Y8W[J-1J/G>3F
M^TCYRIQ5X:Y$W/%9A3J3ZVE[37_##F_&[/NC3].T_2+*+3-*L8;6V@0)#;V\
M01(U'0*HP /85-7Y8>-_^"Z_[0^K[X? 7PJ\)Z+&V0KWOVB]E3Z-OC7/U0_2
MO+M7_P""CG_!0_XSWKZ1X?\ BCK;-)PMCX3T6*)USV#01>;^;&OZ2P'@+QG4
MIIXB5*A%?S3O9?\ ;BDOQ2/$QOCYP1AY>SPD*M=].6%D_P#P-Q?_ )*S]GY)
M(XHVEE<*J@EF8X  [FN \;_M7_LR_#?>GC?X^>$M/ECSNMI=>@,W'7]TK%S^
M K\EH_V3_P#@I;^T0ZS>(_A]\1-7$K!A)XPU"6!3[YOI$X]Z[_P1_P $0_VN
M?$6R;Q7KGA+P]$?]9'=:I)<3+]%@C9#_ -]BN_\ XA;P1E6N;Y_336\:?*W_
M .E2?_DAP_\ $5>.<VTRCA^HT]I5.91_])BO_)S[)\;_ /!87]AOPAO33/'>
MJ^(9$SF+0]!FY/H&N!$A^H;'O7CWC?\ X+U^!;7?'\-_V>]6OLY$<VN:S%:8
M]"4B2;/TW#ZU!X(_X()>&(-DWQ(_:)O[K./,M]#T-+?;["2623/UV#Z5[#X(
M_P""-O[#_A+8VL>$]<\1NF/FUO7Y5R?4BV\D'Z8Q1R^ >3;NOC&O\2_^4AS?
M2 SG94,&G_A?_P N9\B^-_\ @N)^U9K^^#P?X3\(Z!$?N21V$US.O_ I9=A_
M[XKSJX_;1_X*2_M SO:>&_B3XYU)I&*B#P;IC0$?[(^PQ*WZYK]7_!'['W[*
M_P .2C^#?V?/"-I+']RZ;0X99Q_VUD5G_6O1;>WM[2!;:U@2*-%PD<:A54>@
M Z4?\10X#RK3*<@IW6TJG*VO_)9O_P G#_B%G'V;:YOQ!4L]XTU))_\ DT%_
MY(?B_IW_  3\_P""BWQRO$U3Q%\+O$UP[G+7GB_6$@=<]21=2B3\@37IO@C_
M ((7?M+:ULG\<?$;PEH<3?>C@FGO)D^JB-$_)S7ZK45Q8SQXXRJPY,)3I4(K
M;E@VU_X$VO\ R5';@O +@NC/VF+J5J\GOS323_\  8I_^3,^"?!'_!!CX36&
MQOB-\>?$.J$<NNC:;!8CZ9D,]>P^"/\ @DA^POX,V2W/PLN=;G3I/K>MW$F?
MJD;I&?Q6OI6BOC,P\2N.\SO[;,*BO_(_9K[H*)]ME_AGP#EEO8Y=3=OYU[1_
M?4<CB_!'[.'[/WPVV-X!^"7A32'3[L]AH%O'+GU+A-Q/N37:445\=B,5BL74
M]I7FYR[R;;^]GV6&PF%P=/V>'IQA'M%)+[D%%%%8'0%8_B7_ )"^C_\ 7Z?_
M $$UL5C^)?\ D+Z/_P!?I_\ 030!L4444 %%%% !116)\0?B7\.?A)X6N/''
MQ6\?Z)X9T6T&;K6/$.JPV5K"/]N69E1>G<T ;=%?G%^UE_P=2?\ !(C]F/[3
MI/A?XP:I\5-;@RHTWX:Z4;J#=T&;V=HK5ESU:.20@<[3P#^8_P"UE_P>G?MA
M_$'[3H?[('[.OA/X<V+EDBUGQ'</KFI =I$&(;>)CU*O',!TR>I /Z4KBXM[
M.WDN[N=(HHD+RRR,%5% R22>  .]?'7[67_!?O\ X),?L<"YT[XD_M@>'M;U
MJVW*?#G@-SKEYY@ZQ/\ 9-\4#^TTD=?S7--_P7R_X+::CM!^-'Q;TF\FZ*)+
M+PS%)GO_ *C38&S_ +IX]!Q]@_LG?\&6?[9'Q#^S:Y^U[^T/X2^&]B^&ET?P
M] ^N:FH[HY#0VT9/0,DLP'7!Z4 >L?M9?\'M\A^U:'^PY^QP!]X6OB7XHZGG
MV!.GV+_CG[5[8K\_/B)_P5G_ ."\W_!5[Q3<?#?P-\5/B;X@CNCM?P7\&]#F
MLK>.)C]R5=-0221=23<.X&,DX''[Q_LG?\&JW_!(G]F3[-J_BSX2:K\5=;@P
MW]H_$G5C<P;^^+*W6&V9,]%ECD('&X\D_H)\._AC\-OA#X6M_ WPF^'NA^%]
M$M!BUT?P[I,-E:PCT2*%51?P% '\N/[*O_!HM_P57_:'GA\1_'2/PO\ "33+
MI_-N)O%NLB^U.16.2ZVMD91O.22LTL3=<X-?IK^R;_P9N_\ !.+X-FVUG]I?
MQ[XQ^+VIQ;3/:7%U_8FDR$=Q;VC&X'/8W3#  QUS^NM% 'F?[.7[&/[)G[(>
MA?\ "._LP_LY>#? MN8A'._AO0(+:>Y _P">TRKYDQX'S2,QX'->F444 %%%
M% !1110 4444 %%%% &;XQ_Y%B]_ZX&KFG?\@^#_ *XK_(53\8_\BQ>_]<#5
MS3O^0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#'LO^1WO?^O*+^9K8K'LO^1WO?^O*+^9K8H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\2_\
MA?1_^OT_^@FMBL?Q+_R%]'_Z_3_Z": -BBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "L>R_P"1WO?^O*+^9K8K'LO^
M1WO?^O*+^9H V**** "BBB@ HHHH ^0/^"_'_*&S]H3_ +)_-_Z.BK^,*O[/
M?^"_'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O\ E*9^UW_V\?\ I\GK]_J_ '_@
MTV_Y2F?M=_\ ;Q_Z?)Z_?Z@ HHHH **** "BBB@#\Z?BE^WI^TA^T_\ M!_$
M3X1_LW?%S1?ASH?P=^/7A'P)J);0VU#6-:N[VYA^T7,P:XCC@L 6>%(0C/<>
M5*3+&/DKZ_\ V2_%W[2NOZ%XN\*_M4Z?X:/B/PEXTFTBSUOPEI]Q:6.NZ?\
M8[2ZM[Y+>XFF>!V6Z,<D?FR*LD+A68 &O@S_ (++_P#!*_7K?XS>'_\ @I7_
M ,$\OB.W@3XZWWCWPYINI:5<R[O#WC&Z^WP16C:C#@A9(Y$B)DVLI\H94/\
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M'?' KN_ _P#P1<_;5\5;'\0:;X;\-JV"PU?75D91]+59@3[9K\CM7_X-6O\
M@N/II(LOV0K#4,$ &S^).@+G(Z_O;Y.G2J'_ !#[?\%_O AWZ;^R1XTM2GS
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M'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (T
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M_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QH V**Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\
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M?@F-LI-*O&_</T[H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!6/XE_Y"^C_]?I_]!-;%8_B7_D+Z/_U^G_T$T ;%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_R.][_P!>47\S
M6Q6/9?\ ([WO_7E%_,T ;%%%% !1110 4444 ?('_!?C_E#9^T)_V3^;_P!'
M15_&%7]GO_!?C_E#9^T)_P!D_F_]'15_&%0!^_W_  :;?\I3/VN_^WC_ -/D
M]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!X+_P3J_Y(?J__8]ZQ_Z/KWJO!?\ @G5_R0_5_P#L>]8_
M]'U[U0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HHHH **** "BBB@ K'LO^1WO?\ KRB_F:V*Q[+_ )'>]_Z\HOYF@#8HHHH
M**** "BBB@#Y _X+\?\ *&S]H3_LG\W_ *.BK^,*O[/?^"_'_*&S]H3_ +)_
M-_Z.BK^,*@#]_O\ @TV_Y2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?
M)Z_?Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /!?^"=7_)#]
M7_['O6/_ $?7O5>"_P#!.K_DA^K_ /8]ZQ_Z/KWJ@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q+_R%]'_Z_3_Z":V*
MQ_$O_(7T?_K]/_H)H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH S?&/_ "+%[_UP-7-._P"0?!_UQ7^0JGXQ_P"1
M8O?^N!JYIW_(/@_ZXK_(4 34444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\
MS6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !6/XE_P"0OH__ %^G_P!!-;%8_B7_ )"^C_\ 7Z?_ $$T ;%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_R
M.][_ ->47\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444 ?('_  7X_P"4
M-G[0G_9/YO\ T=%7\85?V>_\%^/^4-G[0G_9/YO_ $=%7\85 '[_ '_!IM_R
ME,_:[_[>/_3Y/7[_ %?@#_P:;?\ *4S]KO\ [>/_ $^3U^_U !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >"_\$ZO^2'ZO_P!CWK'_ */KWJO!
M?^"=7_)#]7_['O6/_1]>]4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7-._Y!\'_7%?Y"J?C'_D6+W_ *X&KFG?\@^#_KBO\A0!-1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/9?\CO>_P#7
ME%_,UL5CV7_([WO_ %Y1?S-;% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7
MZ?\ T$T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %8]E_R.][_UY1?S-;%8]E_R.][_ ->47\S0!L4444 %%%%
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M HHHH **** "BBB@ HHHH **** "BBB@#'LO^1WO?^O*+^9K8K'LO^1WO?\
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M&HU_J'BS_@E.?BUXBO3=:[XZ^*_B;7_$=Z_WKF^EN5221CDDDB)>3S0!]^_
M7XZ_"G]IOX-^'/C]\#_&%OK_ (3\5Z7'J&AZM:Y"SPOV*L R.K!D=& 9'5E8
M J1775^:'_!K+KVIW/[#GQ5\ LS+HW@K]ICQ;HGA:WS\EOIX6RNA''VV^==3
MGCC+'WK]+Z "BLGQU9^,;_PC?V?P_P!8M-/UJ2 C3KV^MS+##)D89T'WAC/%
M>0_\(#_P4$_Z+_X$_P#"4D_^*H A_P""=7_)#]7_ .Q[UC_T?7O5?&'['_@W
M]L/4?A??S_"KXN>$])T]?%.I)<V^H:$\SO<K.1+(#SA6(!"]J]5_X5]_P4/_
M .C@O G_ (2[T >]45X+_P *^_X*'_\ 1P7@3_PEWH_X5]_P4/\ ^C@O G_A
M+O0![U17@O\ PK[_ (*'_P#1P7@3_P )=Z/^%??\%#_^C@O G_A+O0![U17@
MO_"OO^"A_P#T<%X$_P#"7>C_ (5]_P %#_\ HX+P)_X2[T >]45X+_PK[_@H
M?_T<%X$_\)=Z/^%??\%#_P#HX+P)_P"$N] 'O5%>"_\ "OO^"A__ $<%X$_\
M)=Z/^%??\%#_ /HX+P)_X2[T >]45X+_ ,*^_P""A_\ T<%X$_\ "7>C_A7W
M_!0__HX+P)_X2[T >]45X+_PK[_@H?\ ]'!>!/\ PEWH_P"%??\ !0__ *."
M\"?^$N] 'O5%>"_\*^_X*'_]'!>!/_"7>C_A7W_!0_\ Z."\"?\ A+O0![U1
M7@O_  K[_@H?_P!'!>!/_"7>C_A7W_!0_P#Z."\"?^$N] 'O5%>"_P#"OO\
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MX5]_P4/_ .C@O G_ (2[T?\ "OO^"A__ $<%X$_\)=Z />J*\%_X5]_P4/\
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MHKP7_A7W_!0__HX+P)_X2[T?\*^_X*'_ /1P7@3_ ,)=Z />J*\%_P"%??\
M!0__ *."\"?^$N]'_"OO^"A__1P7@3_PEWH ]ZHKP7_A7W_!0_\ Z."\"?\
MA+O1_P *^_X*'_\ 1P7@3_PEWH ]ZHKP7_A7W_!0_P#Z."\"?^$N]'_"OO\
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M+P)_X2[T >]45X+_ ,*^_P""A_\ T<%X$_\ "7>C_A7W_!0__HX+P)_X2[T
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ME#MSTSQ7K]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7D'@WP+XNL/VT_&GQ O-!GCT74/!^G6MEJ+ >7+-&[%
MT'/4 UZ_10 4444 %%%% !1110!\@?\ !?C_ )0V?M"?]D_F_P#1T5?QA5_9
M[_P7X_Y0V?M"?]D_F_\ 1T5?QA4 ?O\ ?\&FW_*4S]KO_MX_]/D]?O\ 5^ /
M_!IM_P I3/VN_P#MX_\ 3Y/7[_4 %%%% !1110 4444 %%%% !1110 4444
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M/X-?M(>%-<DL]%^(&LOJU[X7UG2;22ZEEM;N0>=]G>,0J8G9@#-(?X%Q^D5
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %?,_[87B'_ (*0?$/X@_\
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M/:MXL^$_PX/B[Q46M[/PSX>-R8(KN_N9X[>'SY@K&&V1Y1)-*%8QPQR,%8J
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MB'\8_%6GIINH>-+W3EM+?2=*1R\>DZ39AY/L%D')<H9)999"7EED.,>\444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?!?Q-_X)J?\
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M=O5HQQ&(I86BZM1VBMSU^BOB7_AZEX__ .B4Z/\ ^!LM'_#U+Q__ -$IT?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'R!_P %^/\ E#9^T)_V3^;_ -'15_&%7]GO_!?C
M_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^WC_T^3U^_P!7X _\&FW_
M "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/^/\
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M0_V;M4\<^(+SQGI.K37,7B/1].L[2"UDDD<.]_>0NSDA  B,/GSG@BOT!HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:P_99_Z.5^'_ /X65C_\=H_X:P_99_Z.5^'_ /X65C_\=K^8'_B$-_X+)?\
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M+_$6G:Q,NK0>%='MDGNX(KS=YT5Q=*/+^U*WFJJ2D,&8,+?_  <"?L@_ ?\
M:3_X)T^.?B=XK\.6T7Q \!:(=8^%/C#3(]FKVFMQNK6-G:3Q_O&-U<&*W$()
M#O.A4>8L;+Y#^VUX+^)_PS_X*[?\$YOVK_C2H8/9:WX%\87Z8\BV\1:AH<L4
M$>1\H:>>>X" =?(/M0!Z'\2?B,W_  30_P""K_P#^ WP^U/4(?A'^TGHVM:'
M>^%+W5KB\M]$\1Z8D,]MJ%I]HD=H#<K<I;RQH1&Y592N\%FS?V+/%%E_P5U_
M:A_:5^)GQHUO7+SX;_"SXC2_#7X6^&-)\1WFG6UK-8Q[M0U@FTEC,MY-++$8
MIV.^"-0L94LY;._X*I^"]5^.W_!:W]@?X5>#+=Y[OP;JGBSQOXF>/D:?IEO%
MI_E2R?W5EF@,()_C91WX7_@W:\':I\ M4_:__9*\90M#XA\(_M5ZSK$T,P(D
METW4[.T:PNL'G9/%:M(I[@T >H_\$4/VNOB=\??AC\5?V<_CUXMG\0^.OV>/
MC!K/P^U7Q->8-QKUC:3,MEJ$Y'!F>,,CMC+M"7/+FN4_X.8;OQ/\._\ @D9\
M3?V@OAA\1O%WA+QEX0DT%M!U[PCXOO\ 2YH/M&NV%K,K?99HUD5H;B5<.&Z@
MCD#',?\ !O=X+U75_B#^V7^U7#;NOAOXG?M4^(V\(W)^[?V5E=SI]KC/1D9Y
MW3()&Z%QVYZ?_@Z._P"4%'QS_P"Y9_\ 4GTF@#ZD_9Q^#?A./]D?PG\/=1U/
MQ%J%KJ7A739]2OM1\6ZC/?W,YMH&:5KQYS<!F90Q(D')/J<_#G_!KY?^,?B?
M^S#\4OBM\6OBSXZ\8Z_I?QXU_P .Z;J'C#QWJ>J_9=,MK>Q,-NB75PZ*%,LA
MW;=Q+<L<#'U'\!_V ?V<M5^!W@S5)M1^)9>Y\*:=*Q@^.?BQ$):VC)VJFIA5
M'/ 4  =!BOSK_P""+][\0/!?_! +]L^_^"\U^GB72O'?Q+?PW+:S/)=1W4>A
M6ODO&Q)=I0P!4DEBP'4T ?IGXF_X*?\ ["G@OQ;I?A/Q;\>K?3H]<U]M#T?Q
M+>:%J$?A^]U-69&LHM:-O_9SSAT=#&+C<&5E(!!%=E\9/VN_@!\!_&.F_#?X
M@>,+V7Q1J^FSZCIWA3PUX;U#7-6FL86"RW?V'38)[A;=694,Q01[B%W;CBOA
M7]GG]G;]D'_@IA_P1 \#Z%\5OVSO%LWP87X;:*OBW2+6?PW8V_AR;28;>6:V
MDN(]*6:V-M-;88F3<R+DLZ29;M?#/B?X7>)?^"GD7PM_8Y\')#\9/#W[.&C6
M?CGXM_$J>^N?[-\,27*3V-@-*6:#[;J$LC":61FMUB&-S2,?)H ^A?&/QB_9
M\_;F_83\8_$3X&?%N7Q!X4U3POJB0:YX2UZ\TVYAN((I-\1D@>&XMI4=</$V
MQNS+@X/PQ^P5_P %$_!7_!.7_@V8^&7[4WQ%M]2UO5H/">KG0=-@LY[E]3U2
M35KX1">1 1#"974RSR$ *3@L[(C:_P#P0OCN+3]@#]L#3KW6QJ$T'[27Q+C:
M]\M$^T$6EKF0(F%4,3NPHVC=QQ7A?_.DM_W3_P#]VV@#U/\ X+?_ !O\!?M4
M?\$L/A]^T!X$\:>(FU"Q^+/@VQU9;>35M)M)9[B6%[B*2SF\J*Z3]XI5V20+
M_"W!K[U^'O\ P4T_8.^*_P"TK)^R#\//VEM U7XB)#<2PZ!;K.!>"#=YXMKE
MHQ;W31[)-Z0R.R^7)D#8V/C#_@OI!INK?\$9?ACI%]'#<13>.OAZES;2 ,'C
M>6($,OH1D<]>:ZW_ (*VZ+HWAC_@HO\ \$\W\-Z3;6']G_%W5].L!9P+$+:T
M?3(D:W0* $C*JJ[!@84#'% 'Z,5^9W[!_P 5_%/_  72^-OQ8_:(^(7C_P 1
M6/[./P[\;S>#OA?\/?#.OW.EP>*+JWC26YUC59K22.:[1EFMS#;%_LZAR&1W
M0LWZ5ZC9)J6GSZ=*[*MQ"T;,O4!@1D>_-?E%_P &I<LG[.GP7^-O_!,[XM%-
M,^*/PA^,-_<:UHDYV27.G7-O:Q07T*MS)"[V\A#KE=DD+9Q*N0#ZP^.?_!/7
M5?"WB+X=>._V,_B+XP\'P>'OBCX?U#QIX#LO&%Y)HGB+1DOXA=J]K<3/'!)%
M&QN T.PR^08Y!)F/9Z9\9?\ @H+^R5\!?%'B'P7\0_B9>-J?@_28M4\96WAW
MPGJFM?\ ".64JL\=QJ3:=;3KI\;(K2!K@Q@QJSCY06KT[QKX_P#"?P\LK*^\
M6:L+9=1U6VTW3XEC:26ZNYW"1Q1H@+.QR6.!\J([MA49A^??A_Q/X%^,GQ=_
M;2/[$7AC1/!-KIFHS:5\>/B+XD>XU2]\1ZY9Z2\3VFGV$DZP6,,$64:[DWH\
MC2!;9P/- !]:_&7_ (*+?L-?L^? ;1OVG/C!^U'X0T;P+XDLDN_#7B!]469-
M9A95<-9QQ;I+H[74E8E8@,,@4GPV_P""BO[$'Q>^)/Q%^$?P\_:6\,ZAKOPE
MMVN/B+;_ &IHH=$A7=YDLEQ*JPLD91A(Z.RQD8<J>*_'KXU2"Y_X,BO#S3OY
MCQZ=I6TN<E0/&BJ,9Z<9 ]N*^W_^#@RQ\+?LX_\ !.2/QYX$\'6^@>'M.^(7
M@:Q^(.H>'-%M_M,?A6SU:!A;_-$PDA1UA18I%>/#E"I5V4@'U%X!_P""BW['
MGQ(^,FE_L_:'\5[BQ\8:_827WAG1O$WA;5-%;7[9!N>;3I-0MH8]00*"VZV:
M0;1N^[S7LNK:79ZWI5SHNH"0V]Y;O!.(IWB<HZE6VNA#(<$X92".H(-?&_[0
M/['W[+7[2J?!/]K'XW?MJ>/?&%AX+\>Z-KOPBUG3+W0HH;O4[NYMTM%B?3],
MB>YBG?R0R;BI0$G 4L/M"@#\I/\ @F#\(;7X]_\ !2']N/X1_&#XO?%C7/#G
MPV^(VBVW@72I?C3XE@BT>WNH]0EFAB$%^GR%HXP V=H0 8YS]O?LX?LU_#[X
M1?M&>-?%_P &/C/XRU/1TTRVT#Q5X.\3_$'6-=ATK68EBOHYX/[3N)S \EG?
MQ>8L;!2/).-VZOA3_@F/^S?\&_C_ /\ !6W_ (*%3?%;PQ<:DVE?$[PZMB;?
M6KRT\L26VH;\_9I8]V=B_>SC'&,FOK-_A#\+_P#@FM\#OC)X!_9=O9[?Q-\0
M$\3^// OA427%]<0WUMH%G%,P::2622+[5;0N7<A5DOHH1C<@(!Z+\4/^"C_
M .QG\'=<UK1?'OQ@DAB\,7JV?BW6]/\ #.IW^D>';DA3Y.I:E:VTEGIT@#H6
M6YFC*AE) !%0^(/^"F/[#_A7X9>"/C5X@^.L%MX/^)%W#:^"?%+Z'J!T_5;B
M61XXH4N!;F-)':-]J.59E4L 5&:^2_\ @FGXO^%7C+_@V877?#6N6-]!)\#_
M !5_PF-S<7"R,^L-#?/J37;.23*\[R2.9.6$@;D,"?EOXRE4_P"#8[]C>>0@
M)%\3? KR.W1!_:-QR3V'O0!^P/C_ /;%_9Q^%?QV\*_LT_$7XB_V-XT\<221
M^#M(O](O$367C3?(EM<&'R)612"ZK(2FY=V-PSY19ZE_P3E\7_\ !5:7QOHO
MQPL]1_:&\-?".\T?4O#>G>*)IH=-T"*_CEF>ZMXR;>"99YT&)2LA#YVG8&7P
M_P#X*W7]B/\ @J]_P3VTPWL/VG_A9?BF7[/Y@W[/[+@&[;UQGC/3-7M=LK2+
M_@Z3T*_C $TW[#=PLN#U"^+#M./^!$9]O:@#V?QY_P %I/\ @EA\-O"_B/QK
MXI_;=\%?V5X3UR'1M:O=,NI;]%OY4=UMX?LL<ANG"1NSB#S/+"DOMKMD_P""
MC'["[?LO6O[:<G[4_@V+X77J,;3QE<:LL5M+(I8- JOB0SAE93!M\T,I&S(Q
M7R#_ ,$@_ '@+5/^"FO_  4 \3:GX0TNYU-/B[8V"WEQ9(\J6D]DSS0@L"5C
ME9%+J.'*+NSM&/EOX2_".R^#O_!.?_@K!\,/AWI(MOA;HOQ \66O@C3H0#96
M5S%8L;N"W7HHA_T2/ ^[Y2CJIH _3C5/^"P'_!-?1/&O@KX?:O\ M9:!;:I\
M0K?3I?"J36MVL,_V^".XLXYIS#Y5G++#+%(L-P\4FV1"5&X5L:!_P5!_8%\4
M?M-P?L=:!^TWH%U\1+N>Y@L=#CCG\N\N+?/GV\%V8_LTT\95@\*2M(K*RE00
M0/SL_P""J'A7PSI?_!J7\*8-,\/6-LEOX,^&-Y;K;VJ((KB5M.,LRX'$CF64
MLXY8R/DG<<^^_P#!;KPAX4\*>./V$8O#'ARQTR/1_P!LSPAINDQ:?;+ EG9O
M#<AK>)4 "1D11#8 !A%&.* /LWXV_M6? W]GN\M](^)/B;4&U2ZL9;Z#0O#?
MAG4-<U(V<9"R79LM-@GN%MT9E5IS&(U) + FN/OO^"FG[ .F?LR6_P"V3J/[
M6?@RW^&EVSQVOBF;50D<TZ'#VRQ$><UPIX-N$\T'@IFODC]F?XA:IXP_X+G?
MM>_ 'QK^TQXE\ ^,)[7P==^!=*TNWT=CK/A^#1\L+<ZC8W+.L-Q<2R,D14![
MN5B"0Q7COV_/V+_V6_V/_P#@DA^W)X!^ 7Q$\3^(;OQ!(WB?XA1:[?V\T%CX
M@NG@N62);:WABMY&0V\KPJORH]N<*K** /M8?\%7?^">#?'7PU^S6/VIM _X
M33Q@\$?A[2?)N=EU/-&DD5J;CRO(BN662,BVDD6;,B#9EE!\Z_:._P""Q?P-
M^ W_  42\%?L(ZG_ &HCW>@:EK7C;7%\+7]S%:1Q0@6MK;^1"[3N\CEY'C5D
MB$:JQ#.0OS9_P6$\*>%_!O\ P2!_97;PEX<L=-_L'XN?#2[T9;&T2);.=E.Z
M2,* %9C(Y)[EV)R37J'[0'R?\','[/[/P'_9Q\3*A/\ $1=N2!ZG'- 'Z%6E
MU!?6L5[;,6CFC5XR5*DJ1D<'D<=C7YZ_\%YOVD]>^!OB_P#9=\!>-O'VJ^%/
M@U\0_C;#H_QBU[2=8ETPO9^4K6]E/>1,CV]I*QE><JZ%HK9P6"[L_H9#-%<1
M+/!*KHZAD=&R&!Y!!'45^._P2^&NB_\ !S_^Q9\>?BO\:_B5>64[>-=1\.?!
M3P?%?2Q:?X ^QQ036-_<VL9'VF^N&E_?SRAF$#R0P>4KR @'TI^QM\?/@5^S
M9\2OC%\7/%GQ\TGX<_LS^)M8T.T^"=S\4O&RZ?8:GJD-I.=8N](;5)E<6$S&
MU\L*?*E>">>$>7)O?[F\*>+?"OCOPY9^,/ _B;3]9TC4(1-8:II5['<6US&>
MCQRQDJZGU!(K\?O^"8G[5_B#_@JW+X*_X)C_ +>VD:7!X]_9>\6'4OBI9ZUJ
MD$\_C6]T:1[72Q;Q[F-PB3$SWLO*E[6 #>EXXC_831?$GA_Q(;O_ (1_6K:]
M^P7LEG>FUF#B"X3&^)B.CKD KU!X/- 'YS?\%C?VO_"7P;_;X_9Q_9Z_:\^(
MVO>!_P!G3QM9ZU<^+-=TG5KK3;75];A$:65AJ-Y:LDL5E&9%D= ZQN94,V8H
MVQ[-HO[#-K\.OVK/@I^T)^R!\7O%X^%POM4/C'P)!X_O-3\.W,=QHMZ++5[>
M*XN)$C*RE(B(3Y<AN8Y-@9"Y]+_:E\"_L@?MA^)IO^"?'[5GPQT?Q9!KWA&3
MQ-9Z/K &9(8+E;66>V=2LL$T+3Q?O8F5U$_##)S^;GA#]EO]H?\ X-_O^"CW
MP*^$G[*_[0OB+QQ^SE^T)X]E\-7GPH\67(N;CPU=.JN;NU88&R-6\UI45"4B
M9)A(2DE 'ZB_'?\ ;3_9P_9NOKG2?BGXVOEOK'2?[5U33?#OA?4M;NM-T_+@
M7MW!IMO/):6Q,<@$\RI&3&X#$J<<W\0O^"G?_!/SX5?LY:-^UMX\_:V\%V/P
M\\20-+X=\1C51,FJ[3M=+:*(--/(C?*\2(SHP(95((KY(_X)O^/=3^*?_!0G
M]M'X#^*_VJ/%?@OXE:=\<9-4B\.:=::(9;_PQ_9ME;:;/&-0T^XFDCCCA (1
M_+03Q-M4S%G\,_X*X_LB_LM_L2?\&\/[1O[/W[*7C7Q!KVB:7\6M*N=8D\0W
M\5U]AU>;5=%>YMK=H88HUB0,FY$7"3/.A(8,J@'Z">*/^"S/_!,GP=XE\=>$
M]<_:ST;[9\,KJ*W\>M9Z7?W,&B/))Y2^=/#;O$%\W$1<,561EC8AV53ZAJ_[
M8G[/&@_LW0_M=ZQXVNX/AU/IB:DGB9_#FH;!8N-RW;1"#S4MRN'$S((RC*^[
M:P)=\3_V1/V?/BI\%/%7P%UGX8Z/::'XP\$-X3U8Z=IL44QTO[.\$4"R!=VV
M%7)B!)$9Y7!K\YO^"7'Q=^(?QQ^#OA+_ ((R_&^Z:X\<?L_?$FZTCXMLRD"\
M\)^')X+C2)AG/[J\GETJV56/[ZVMKPX(S0!]:?'_ ,5_\$V_B_\ MI_L\77Q
M>^-3VOQ@T"^U#4?A#X-CU>]LKZ9KVPS,UYIRJKQH;>'<#=)&!M*Y.]D;VKXT
M?M8? KX ZW9>$_B'XIOY-=U&REO;+PSX9\-:AKNK2VD;*LET+'38)[G[.C,J
MM,8_+5F + D"OC7_ (*I1QG_ (+'_P#!.V4QKO'B_P ? -CD Z-:Y&?P'Y5%
M_P $ZOC7IUU_P7!_;>^#GQ>U5+?Q[)<>$KCP?:7TG[RX\,6^FL$2U!_Y91R7
M*RR*O'F7A8Y.X@ ^T/A9^US^S)\:O@*?VH?AC\<O#FJ?#Z.TGN;KQ:NI)%9V
MD<&?/^T-+M^SM'M.]90K)@[@*YKX;?\ !0[]D+XJ_&>T_9W\-_%*YL?&VIZ8
M^I:)X;\4^%=4T.XUBS4$M<6(U&V@%_$%5FWVYD&U2V=H)KX+_P""LNA?LK_L
M-_L/S:3^R1H+>%/A]I?[9'A+6_VB)?#;O>);F6[M;Z^<K=BXB9PT>EYMRC0*
M6CC,9^:.OI;XZ_L9_LQ?'#QW\!_VO/CC^V-X[\7S^!O'>G:A\']3L;W0XX+^
M^OY[8)$C:;ID3W=O.L49D4,5\A)')559P >N_%[_ (*'_LB? F3Q+)\3/B7?
M6ECX,?R_&&O6/@_5K_2M#E\M)#!>7]K:R6MM,$DC)BDE60>;'E?G7/L]K=07
MMK'>VLF^*:,/&V,94C(//M7Y(?M/^&OVZ/\ @G/I_P >/VD_V>K'PI^TM^R1
M\0/%_BK7?C'\*=:FDL]=\,--<7$'B%;*Z'$MLDL5RKJ0_EJA"Q !YS^I'P'^
M)_@_XV_ [P9\9_AY#<QZ!XN\*:=K6AQWL6R9;.ZMHYX1(I)VN(Y%R,G!SR:
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M9ZG+K*:NWAV+7[T: ;]'\Q)_[,\W[,=K_,L90Q(<%4&!CTOXZ_\ !+C]BO\
M:-_:1TS]K7XF?#/4#X[T[1AI$^L:'XKU'2QJFGABPM+Z.SGC2\AR<&.4,KKA
M'#( H^A** /G3X._\$H?V$/@!9?$C3?@Y\&9_#EO\5KV\N/%\6B^*-2M,_:B
MIN(K,PW"'3HI"B;DM3$"(XU/RQ1A=7P1_P $T_V+?AW^R!JG[!'AGX1W)^$>
MKZ=<6-WX,U3Q9JNH0I;S2-+(D,MW=236X\QVD'E.A5SN7! ->[44 ?+VL_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'R!_P %^/\ E#9^T)_V3^;_ -'15_&%7]GO_!?C
M_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^WC_T^3U^_P!7X _\&FW_
M "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!\@?\ !?C_ )0V?M"?]D_F_P#1T5?QA5_9[_P7X_Y0V?M"?]D_F_\ 1T5?
MQA4 ?O\ ?\&FW_*4S]KO_MX_]/D]?O\ 5^ /_!IM_P I3/VN_P#MX_\ 3Y/7
M[_4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?('_  7X_P"4-G[0
MG_9/YO\ T=%7\85?V>_\%^/^4-G[0G_9/YO_ $=%7\85 '[_ '_!IM_RE,_:
M[_[>/_3Y/7[_ %?@#_P:;?\ *4S]KO\ [>/_ $^3U^_U !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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+1\O0>M?A;0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>dgx-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:dgx="http://questdiagnostics.com/20201231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dgx-20201231.xsd" xlink:type="simple"/>
    <context id="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d73fad95bda4e53aeeeb1bedb9f3590_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i27e80e3d49854295b01b300430151eb4_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i3b2db1a35d1945348b1a626840f7580c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11ae4adedea143f39461ad0909150885_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i79da04d8282d4c8291850645193b2909_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ic2adde92f1a5461aba05c280fca9d09c_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="if187f4fa5af24cc385cdcc159b5ef5cf_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i3ba55df515514c52893c724f25d5e5b2_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i14e2c4e502f24416aea41251e9a7a514_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i930baaff13c549eabbf5ad24d956f10a_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="icab245fbfc314588851b15e6a8b204c7_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ib94226cbc95e4f099933504fa1529358_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ieda80e73180744408f6bbd3ae90626ce_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="idc23a2ce07eb4cab9ac46e9996f1a9da_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic3b3e31d6d274c90b794939c176a7b77_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib6c6477bf68d434b85bfce824998f2ee_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i67fd5ab592cb4dd3942ac4292d19633a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0f0ce225b8594c6a86f10f4f1abe8e39_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i555d3026ca444d259517b679c5239f46_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4f4f32dc2af94a159626591aaf9de348_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibe7163fcb9b04409a8a0d9696060f250_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie567c107fbeb4e04816dbbef6a7bffb2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i115773febea64e13b53405dd26daabf7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1dd09031318c470d8f39dd4c76ee0f42_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice7cb1556ee64aad934a266328c5feb8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie5538d27d3cf4309be1e10b072ade004_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i41a7f39f717a41848294a65ad208374f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1868c09b2e774ccf815153a8ec738276_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3b7931aebebd467eab54c73e0a052b8b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i75af2f2e63234a768a4f963e010f642a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f9ff7ef1303400184e1457d527c79ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3aa95b24c6da4e29ba0be0001d98ee6f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2981e27108c24f95953c617cc7270437_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92ba93e0278a4f689344c35f78cc1de4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71632adeaf9840789ac22fcbe1d4ab41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd49c909bbf34ee8ac8ef91267017389_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i15c1b65002784549a102581ed4f9ec6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i37b30b92632f4bb7b032b7a33f542c34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if93dc28be267444d8934097d07d281a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4536b39c8fa64a308c3b9a68dc9e82ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bf2fc1a93c943d987e412080b37ceb5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bc00e25bfc644b48820a7fd5b03ba76_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd9a84f00e01401a9a6b093b0dc83ae7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3ac9f8df65254c228ccb0893cb2bcae7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i581470f6c29c4d3bbb553be7ce613857_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief7b1c30e21b4abe80d55c1558999325_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id931c5900d5344649f91ba0b0016de0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb24d45e71f14152b0beee33dd6fe7b8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i949923f39e104d6ea10b55d03b6467c2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentAndFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4fa47ff8680e47e186c2a067dad4395c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentAndFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7c9815de6056498884fbf7ad9eb40a7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76c1d7dadde4494c96e7166dd2fa23a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib4e9bac07fa34fa6ac58f793d4697067_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff8b5e5555da40068d37c37923c31be5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe9d4b35706146759a8e29e92296d796_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic81a1f6e1fcc43198cf6c34688f73ef0_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i1b9a18afbf954307bc8e506be81cbe70_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i225797e622964ed59d73033ade33c396_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29c671e617c045bcb06b53c554e033e0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9de3b9dd0a624ae68544d4880991cf82_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if585a3710daf402a97611004eea949c1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6eea2c55b034437ba80ba06e3965157c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i77c9bd2166d847329c826595afad408b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0b01ba3ff27b4ed39eb31b8ed8e1b653_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic4b549cd3a3d4d348d914417e72845c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4019a241c0854daab20a021259e4c9f9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifcb29cd72cb14152805c1b85799d4c7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie8b8bafd84534ecfa78e8dc260538826_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ccba44e5f4a40efb5fa7b5d55920320_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if014b0d6144e489c86cc32ab7f88bc09_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i348dfcaea5c4487f8852b9106d40158f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia52723062e0945b0b050cdad8b6e84ca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b77dcd1e3264ddbbfc39c8cb976394a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id46ed269b0314d81abc231a84b687522_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1ba00c793ebf4cd4aef56d2438bd0c77_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49c3be8da8bb40cfada15e955553b6f3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3716ed1635444a1db24339ff3c1ee6b4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iacb5aef155d741e9acbdddbaa368b0a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib0e0d2b48b134218ab9fe6ae972ccc18_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifae49365342b454dadab2010496cdb33_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i24a36f7ed0c74323a2fa29fbf45031a6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7c506d404ea4b66a4fc8535a8907e45_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iba4d37f590c64c0da8af33c3f247ce79_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9fb51ebe236448f590ad554101a9b9c6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iea687d8906104369b661d038cde542bd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice4829526306498db68da2230ad3f3ff_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5734074de09c4b53a530f4b9f89b68ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45b1a79458e1445fa42674f9f2d678ab_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9ca59367e3f94c41a84556b97c86bdbb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id83f485f0e424cc0b613c7b977010fa5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d87850a80eb4b4babfe02021d7d3c4d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09aa4abe117b4d52b3a8808dab5026d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c2eebecc91f4f99994187f91e6cf8ef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic85598bd2b86456e91558360409ce887_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8246072e29d64600b0af97728d423a90_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icfc7590e98964831a39bf2babda2f26c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9773cd12324249bdad8bba77790feceb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice2731fc599e44eebad216d560288aa5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i76cf32401c784f6282df17d6217338a3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i50637c6aa27f4b9f88abbcb41129c619_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie9e3619ec877416abb976607a2ecb8a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7d5052a7f794e77a5d8ecd713c12c6c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib4c69355f4e54414844cb3cf76a843b9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib030f85555694c49b8643f2d91b9693a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">dgx:InvigorateProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i72f4ed9e9a914e47a81066fd180c145e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1b9ca495276140aebb8a6db9bff67956_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8ac7825e2fb043728473edf6a486a568_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3955951503f44fe3acd85937ac7a0bc4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0f306c25282f4e34bc09d94f5699bb70_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i59d8ddb3ab9d49528f059c8a9bca7418_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie8b59ca556114cfdb36009a1e4663f57_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58ee8ae71172430080535b5a0dd4856b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i280c67ee68804035b46f2faa9dce6680_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a6ab703d4d84efbb36e4f1d64e0fadc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27711a12139e4ecc82c168186cb5ebe9_D20200121-20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-21</endDate>
        </period>
    </context>
    <context id="i9bacdce196024c839a813e482b5f95f0_I20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-21</instant>
        </period>
    </context>
    <context id="idb09fcb6511f47edabcbc8b6c3de97e7_D20200121-20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-21</endDate>
        </period>
    </context>
    <context id="iba3f50b191484f5a975775bb5bcd79c0_D20200121-20200121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BlueprintGeneticsOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-21</startDate>
            <endDate>2020-01-21</endDate>
        </period>
    </context>
    <context id="i9c610e7bc66145a9a5c3d919c604c9d1_D20200406-20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-06</startDate>
            <endDate>2020-04-06</endDate>
        </period>
    </context>
    <context id="if2a967045abe4853ac22eaf7f12d73ce_I20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-06</instant>
        </period>
    </context>
    <context id="i5bc58d2181184b70abf43e0a7797a61f_I20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-06</instant>
        </period>
    </context>
    <context id="i09ff1a062aca4dd091930d26abdc94aa_D20200406-20200406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MemorialHermannMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-06</startDate>
            <endDate>2020-04-06</endDate>
        </period>
    </context>
    <context id="i1be8090c04d8482eb1d5819ad8a4915b_I20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-01</instant>
        </period>
    </context>
    <context id="i0ce66de126184e10bbe6987c714abe61_D20200801-20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-01</endDate>
        </period>
    </context>
    <context id="i4b7731ca50f644dbae4378dcde7faab9_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="iae2b0a12d36246ed98b91815583efc9d_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ibb19efad8ebc48d8bf627a6c143d9f22_D20200801-20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-01</endDate>
        </period>
    </context>
    <context id="i10cf574e9c2e4d21a2695ebf75df7d6c_D20200801-20200801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-01</endDate>
        </period>
    </context>
    <context id="ice7bbcc9e8ed4ad2ade3ad58246561b0_D20190211-20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-11</startDate>
            <endDate>2019-02-11</endDate>
        </period>
    </context>
    <context id="i61272b36e8f248a490bc5be2a3a5cbeb_I20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-11</instant>
        </period>
    </context>
    <context id="i131dd7c4ae56411b91d4494e08f2395b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2baa36a831dc45c59aff0f947d0f6d27_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6895b862b93d4f9db033b2c8960868fe_I20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-11</instant>
        </period>
    </context>
    <context id="id7b3a596687e4a388e56161f877b4099_I20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-11</instant>
        </period>
    </context>
    <context id="ibcbcfd24bcb54356a9bf41706902f795_D20190211-20190211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-11</startDate>
            <endDate>2019-02-11</endDate>
        </period>
    </context>
    <context id="if3dead11eb114dcbb814658459773ee1_D20180201-20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="i05fafb7616b247759bbe4a101ccfe88d_I20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-01</instant>
        </period>
    </context>
    <context id="i7c9edd27d62d479f8d54c3850fa9b9c2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i42b26f40687b440793ed6325db576f39_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7836c791c01346a1b0c5012b1f08c16a_I20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-01</instant>
        </period>
    </context>
    <context id="ib74c4c78b12e4840809c22866c04924d_D20180201-20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MobileMedicalExaminationServicesInc.MedXMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="i2a716478a2894a559df1f5cf678bcbd6_D20180618-20180618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:CapeCodHealthcareInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-18</startDate>
            <endDate>2018-06-18</endDate>
        </period>
    </context>
    <context id="ifac4c7f439bc4a25a8b35842cf0ba6ef_D20180919-20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:ReproSourceInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-19</startDate>
            <endDate>2018-09-19</endDate>
        </period>
    </context>
    <context id="ie9436426b22c4886a5e98f743908762e_I20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:ReproSourceInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-19</instant>
        </period>
    </context>
    <context id="i8da51f5c2e9c490f94945ecf8ac5e9bc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:ReproSourceInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3df733d55ebf4d58bee1631d8ddc6f98_D20181106-20181106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-06</startDate>
            <endDate>2018-11-06</endDate>
        </period>
    </context>
    <context id="ie0e89fc0040e4c588548eaca76b8e386_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5e7f845975ee4548acd03e1afe47b0df_I20181106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-06</instant>
        </period>
    </context>
    <context id="i0a260c8c6a244ff0897322a198ac6525_D20181106-20181106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-06</startDate>
            <endDate>2018-11-06</endDate>
        </period>
    </context>
    <context id="i6a6c9ae6653b48b099eac07be30520ad_D20181106-20181106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:OxfordImmunotecInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:ContractRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-06</startDate>
            <endDate>2018-11-06</endDate>
        </period>
    </context>
    <context id="ib5b80ecba80a4ec3be7640854bdf798a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1da74a1c6cec43718954e17544e09dab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1fc1f28fcd3344fda11bc60c50575b60_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b53551e765e48ada91ce1b2213af833_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic086df6338f745a683de6c79a9de2fcb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id77fd8acee3c4413b86f9d17207eabab_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ae8426bd53a496485b1b374770b199e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5925d31cf3ff45fc9047d3197966b069_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i18d1e7f19b404c199e04abc162106cc4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b50bcaa47814ec28040b26b7160a5ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28ca595e5eb740889d328b33d7ef80c9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib49a85f69283488d9da436dc5543b52e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i92ef5f3f75a64fcea2e40d3c9b3ba138_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie2ea36aabe78463eb75346dd3ac096a6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iac45b37ce14e464c83d493dbb68d08ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i819ba4179ff04a9c8d4de164c0081dc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48245c8eab5c4b8091bfa77ef50e467e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if1e6d68bf2d9484a8f112f2794388931_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i02060ac5ffa04417a6b16a9bd1912233_I20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="i4202ba5a9d04407d83cd7e068541a1d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabd266dd7d024345af367a828d3a1650_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08f2967b216f47cdbe6de707915af4a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57203f1941a34c238bfee31665aa7843_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b179f5a47024b169176a67fc04394a0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i98373f0ec7ac4501bf3c20e192a85ab3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b35a4725d3b4fe88bfb392d476d30ea_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i488c3759446b424087ce0ba119b76f4b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79e00f2d39ae4504bdf0f0d04a7db8be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dgx:LaboratoryEquipmentFurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i17d8a0586d3241db9286ef290dada58c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i963111a2b7bb47c19ef1cb3341f61107_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc60f47f344746ebae9a4d823259060a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i460ce5e8869e4c7ebfa1175c77836f6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b113ac98aea45cf8f7bd27c96d34ba6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb8ced261d56482fb9e20fcf2b809143_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b3427db7dba497ca4f76498d69ffb7b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib7baf33e596b473a946a41c842d5c491_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i08feb83acb194d67a15c42b397b1d300_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide27b07e394e4a51961018b52520f0c9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28c19a374b654a3fa8f26f4bf1cada1b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i621c9dbaf928427c8d032db6c9363c81_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20fc99f28f194d7c887e0338830b8cb3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5f467983b7f945f691b9a39b57df9e3f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if767f2717d3143c6901d055819025e8a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1e2caa4565945f894ecf42eb41689f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7c7dfe44b07a4d7e846ac1bbb305e60e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4534f39f0409446090ba1928a95e44ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8718641f12744c54b79e3f030931340e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if578b84393414e85a55b974226b6eb09_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i610d712018cd496aa9a406ed51db8e20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic84b16b1ff6c4b6e9b65c95661c327fb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia97c59e5c69e47a6a83178a589df2ac9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e856d54e7714c97aec096fbeec1b506_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ide2b357f410944b7bde3dde25e5e073f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f0d7b7e3f6c492db815036cc5c1c97e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc7572c2a2924de4b2ef502d5bbbfa0c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenFivePercentSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9887f5d1e7ec47d794ad4b9c520d77f0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenFivePercentSeniorNotesDue2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i492a760c40d7442ca1a7e0f8594d36e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieace3baae6f84b0e9354cf88139ef2c2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia0dd309e22f4493e85b52fb6f70911e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdue2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie56f70613c89455ab45a405199ac352e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdue2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8eb23b0916d24877a17f2212f4fbd7da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourpointtwofivepercentSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i253f26b0c58e4670a7e5d21e7ed55f38_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourpointtwofivepercentSeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i68618e5aa89c4194adf23217f32a8b41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79c28753e6234d99a6b6e5ecd71a6645_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5e04c7b3917042c0be08e09c6ee19d74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFourFivePercentSeniorNotesdueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i979e993f5cad468e9c420fcb8e10baae_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:ThreePointFourFivePercentSeniorNotesdueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i64c30d8d93c246b9a9045e239918d12b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa89a373573f435bad75aa9ad414d5cf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id3374f07e84740c1b2a1181c5c8ed5fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointNineFivePercentSeniorNotesdueJune2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id253b3ca50134883a39411cabb3236df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointNineFivePercentSeniorNotesdueJune2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a816a93885d4ca989a2e52f8edcd268_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia92ac89bc9464dc4a5bf688a1dc0f2e1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ica3b9d8c23ad48a888fd41a9f78b692e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:SixPointNineFivePercentSeniorNotesDue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6dc40d79750043f0a0c76f967a147ab5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:SixPointNineFivePercentSeniorNotesDue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c0a568fbbe54b32a4d65037b02187d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FivePointSevenFivePercentSeniorNotesDue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie27dd42f03aa4d7da20e94071af99bcc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FivePointSevenFivePercentSeniorNotesDue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4f38dc71c4a4401ba20c8d9d84fd23b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44196df9463840cc83124dd513dea909_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i545c653723ac4b35958b7b601878135c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FinanceLeaseObligationsandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icfbc63685ff840fb973900d155c530e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FinanceLeaseObligationsandOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iecaf492a9ad94a36b60612ba765970e6_I20201022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-22</instant>
        </period>
    </context>
    <context id="ifb648f82ea194e07a192722e1bf31021_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ibce6a4a1e68c4e53a145b95c9e367803_I20201022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoancommitmentmaturingOctober2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-22</instant>
        </period>
    </context>
    <context id="i6f191ea10c984af4842750df37661e22_I20201022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:LoanCommitmentMaturingOctober2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-22</instant>
        </period>
    </context>
    <context id="i462cfe8638814f0f8481f3716a2592c3_I20201022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-22</instant>
        </period>
    </context>
    <context id="i524294a4d8b3418da3d3f916d41a20d1_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6c91c94f07a044d2aa17c4da4b4cf161_D20201231-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dgx:CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i904ef886693341f7b599802cc0a219e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie586bfbfd98b4802b4c74457620ebe91_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b45d450024c47499fbde295edb34e7e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95b81aaa9acb42f1810e4c076150e924_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f895fdee4b5481087569c16292b9b26_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic4e79e85b7c548d0b0dc680c03e2b9e5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d93b15cf2364f2f9c77170f1dcdc9cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ee13471497b4108b33ff83c309a7a45_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i80dc0f5cd5f241689a10b1242a112b9a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i88d8839878a14fa79907f288bf110c47_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i11c5ad757a094b24a5c73f68379fa8f9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie6362246725c44d7844b750f652f23d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0847ec854f1041b091d07bb199a6faaf_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:TwoPointEightZeroPercentSeniorNotesDueJune2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i87fb802f159d45308c5722aab7a51e3f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dgx:FourPointTwoZeroPercentSeniorNotesdueJune2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i752e64558c134adab9652fe39589f9ca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i66ce45540c0b49579be5f2a665d77e65_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dgx:ForwardStartingInterestRateSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7827a00a60bc4aef8604397387c5b8e9_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dgx:InterestRateLockAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i837da46f467741f1a47e6456ab80934a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d52e8506b964853934619358132e916_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i127dea9d515d4af9aad64832390b1702_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dgx:FixedtovariableinterestrateswapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifacb1c5c6dad45498481604994cc9c9b_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dgx:FixedtovariableinterestrateswapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="id141c98d5c21416f95dd9ad86532d5f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb6a84f2be8142b7ad7ceae3cd3f42a7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibb495ec24a01435fbd27a38907a75fca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff2d731644784878a01ffd609e67911a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if16ba469706349e7a5dda9f237173286_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia67a4a0ff8b1447e93f556e763ad297c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7186eb7282e4103827c4b7ee0d01c74_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3219d74c46bf4c0297cf3d070a80cc44_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i73cb452a6ac74285af4a4f642559ad6f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i34c51c66cc164d1da2582f9c600d44f1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i69c7eeb1cf454f3087a541bf615ec3e1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i50dd445f21194164a30af100f410f3e2_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6d1945a14f9f4ce2921e9bbaaa6b9124_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibdffbc0183ce49ee8d6307cd711c32da_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i41c2b4effc544078806b615118dd9278_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5448ffcdebdf4d7ea0f8ffee8b0b8f9b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2ff2b554598b47c6aec52cefb4f6bb51_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7d31347983ac43948ce0a443c75f4aa8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1dab0f39fda445528890429f9f021ab9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib698a53cb2f8426cbe61b6e19fb1a281_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1bd46f02dc1f4473b397c6a576d3bc85_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id24dcfded8274220894b4ec84f289be9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i35228c4a5cbe4bf9a0b8ad2de1992783_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i73cf70b9879644efb91f2116611446a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e0eb38fdc3746ec8e44fcd4afa6a3fe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i192e1f30a76a48d1a4fccda9268bcefa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6fec735f32d545668c9011b3d1ba778b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4e0cd2bf0ce400291395c2d343ce00b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67231146b7644c899681fc68de1cc785_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1bc1b38e887c4144b5780eca80bd204b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifebaca822eff4cc387f98c008d09c38e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ef455113ed841c7b82fbb4ace9b85be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24d73f4e924f4a10a8f521b757db5eb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dgx:OtherEquityComponentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7731e39a610040f98b51c6b6e8764070_D20180101-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i63870adfaa434891bafa374146f885cb_D20180701-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="i696a70381cba476b8c6f79dd4b77fe5b_D20180401-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="ie62d0efe4ae34fd6b32670577a82ac3f_D20181001-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1582bc80466c4a0a99308fa830a6db42_I20210204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-04</instant>
        </period>
    </context>
    <context id="i32de60c551da40599315cbb1e6c3f5ca_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i62130c12d0ec4b10b6bb1bea0f6d8ab3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b5c67810b5d48758c30b695b04494b1_I20210222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-22</instant>
        </period>
    </context>
    <context id="i36c642409ac64921826ebf21bd9b07f1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie95d4b8fec93446cb65b51f7e24e8460_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i163121a462fb460dac48b33c7084fd77_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i98e33a74d2374686abe9f0c57a67eaa5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:EmployeeLongTermIncentivePlanEltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iceca37b233814fac990bb0d43b3d1f18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:EmployeeLongTermIncentivePlanEltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i117f623b34944a4aa09ba43fe0f2b647_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b61e94e7f074f5ab9c3930b140386b5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib33f609e90994e12b073cfeb7263634a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b818bf8df5f410eb2045ec27d80953b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie98b52a6c1794c20a26d3553828e4078_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:RestatedDirectorLongTermIncentivePlanDltipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i727f4b6eb33e4f3c8265b0e2dc2dbd40_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4c1f210e0784a58a5120ccbcaac57c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d1ed33ea86c4c04ba5ce3c4c14d4697_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id1ff65eb76ff475b8f7a4009c8376341_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i33ff90645a634391b6fdea36985a329f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iec25aa9d406c44b6ade6d810256599b6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1ec3b8abba2144858babf9798d912c8a_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iea41724e5f1a4bff83d7d555a0c98b95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dgx:StockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32d8eea035f740d88c4e34d32ac07b50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia85a7d30ffe046e3afb073a1149514cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i362c812a405d45709cb7b160258b8ed1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifec7bf006deb455588ac5eef858ed849_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i43c9eaea209849029715a8175ab5a38f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iefd7e996ee1d4652be0e3370eb259fdb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iba88a90ce070465d896214b27be236f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85260b1da0934bb69e54b6bb7d6ca068_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SupplementalDeferredCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1c5e3bd1735944849b8b66228d6f266b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6f5e7b1b65014971a56d11421ae554a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b09f22a0749457e8f3d51b1f9549c3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib706a5ff02034443bde21ac1c37511c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis">dgx:SdcpIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i739e5869c8ba4c87a0e6a0a88a17f0e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iceca971098f048bb87e4938a5c193612_D20160901-20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2016-09-01</startDate>
            <endDate>2016-09-30</endDate>
        </period>
    </context>
    <context id="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if0b19e4e8df441dd9a3a047864af82a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5bfcea6d4a6f42a28ae201c9acd9e681_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i728b5f186c284cccb74701cceaa73177_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9491ec5cfff349bebd4c36dea5408c17_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i738f18abd516453e9c1b7fdf805a03d8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i18079f917bab424fa56b9c2ca26f0aef_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5c9b10d54f56453ab58e231cabe11e4e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i532b66c76cad4095bab3b1e800197403_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f0ce923b9cb4071b89bf2e5cf956d70_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib5a1e4a3f0744196ae6e420b749b6626_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib82b870198214f2fa9c11cf73b7c2285_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i16009b81f04442439e6d1273e8b3e3d5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8de7c8519348419985b65110c0808877_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i375a264a2ebe483fbbbf773457d0b2fe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4c6fa4c884c0473a8de98fccdb136f8e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0c2eef5ed33d472db8175faea063b824_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i447b9c6561a048c985f4ab898c1121e8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0a7391181b8741db9a1686e9c9b083dc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i944f676d67324e0ba91482f72d96b22c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f3f0dbfc5d747b19835bfdf96c93b85_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic42f8e90bb9742fda4370a7c80d21289_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6c4439a4821541da95311cd6e7ab8e84_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0114534d1d8d4e39aa9cc6b5a35609ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibec3fcd21ae6474f999b20d69d69bd44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b9920e1039a4bbc96cddc20848124d0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i35915c99296f48f3bf58b06369abc86d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:CorporateJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iceeca8e729a74e688a40d2720017ccf7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic4cf653852bc4efabf147c2ab56dcdcf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic9c465a22a3f4e7e8356afdae38c480f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i720a47095d174e48af4858648c214a5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i448e43197d9648fdae5be5f882e40fe0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e9708bf7a3f4fe9bf78754bc3d52636_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:NidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1b4de4e5f21041db87556bf0e720459f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5d7dd6fe1eec401f8fa3bbc7218f34d9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0bbe7f359fb441618dff6db8b09e9693_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i188d6941e8fa42beafe10767321c5eb9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ice1470357afb4f228be84a3f77de9bb4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5034ddf618274bbab61b97eef0228bd8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia853061a347a4f67a24c62ecefdcf9e4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5ac794c54fea41c082189f0a8fed1dd9_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ieb70b878994a44d0a2cea507d2ead6a6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib14b8a10b66a4c97a54f968b44161d88_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idaf490fefc914c45b4456f72c9bdf613_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0f50c4e8562542bc9cb4c710b1f0ce64_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8b9e1c6b12a542709fad464b97f3772e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i299506ac090e48338ffdc86d6e316b6d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iada86b56f45a48b397d3c96f067a7475_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib3c43507276845e68498c4ff71c1ccff_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1db356aed7c84b408e826cf4a5378149_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i55ff501c262847c0851ba168e5b293ff_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8c24be469f644a7d9e205e4e693a21e4_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i36e8ef2ddd684f5c8ee33b7a03675400_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i69b0cda2873944f69a703c9bcbb95cf5_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia72b92b0f0be40e89a72bc54bd0361fc_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3c02f9911b34985a9c3b2cd7600534c_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30b20cba82d2410f8d16e73bbaba47ad_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92f3e38b6a2b49a1a515bcbb581fd02d_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f2e0858b3b740c9ad4cbd585da3c971_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dgx:OtherIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e06c5cb90a9430688ffd3e687ac8d51_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="if8f06c22a7fb411ea90bc48b15e6234c_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="iface07505ab342789068244bb97b89df_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic13cec6030c243db9ed599ac34410b5f_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i97d3ffa754e846359243673a76a4dd3d_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ieb0fe8ee698545d98f72f17ee9b32a59_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i0778872492304f04a882ac24394af772_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i59a64dfb2bb34d24abf433537d03cfb6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icbe11049deab4e0695a9136216555273_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifb52dade7a1942a4a87b386331e3c5fd_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i88fc2768290f406e90452310cc0cc35e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5d23165dad6f4a7c9753adca8283f930_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:NidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4935382cf51a42e5ac2c7f7b75f377d1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id133d541098b460c855ee9ebba789ee6_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ie2cb4ca2313e45f5a150880b15665d99_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0177fd8fa149409d932b66e085fff082_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if0567e595477470982b2e5e34d02c2b2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia64109811371447e8f58f600a7e213ec_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifb2549acbace4796a9c86fd435062b92_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib9aa3e5c40ac445299ed6a675092e9ba_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2e0b27f6e56e4d51946d35cdcfce7aa2_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:AmortizationofIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iebc62645fa31471fbe90700f9465c88a_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">dgx:EquityinEarningsofEquityMethodInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id4cdaf18428f4a29ac09bbda7601b898_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i94e290893fe1450ea0b89d2e52ba32cb_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia8ef0d848be64de88a06475f05c8fc23_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id92fdac500c449b68f3d7a77c241c32a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37650e5ac3af455b982266e74362e4f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5bea947c9da4d009c5112e1fb35819b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib02d0b9ff9814b8c8b499379f5994f66_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia9415c8123544c9387ed93ba012a625f_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia0bc1c3cf41a470d861c0f391ba08410_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>dgx:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF80L2ZyYWc6NGI4NzQxYTVkMjU5NDRkNGE4YWUxZmQ1ZThmY2Q3MzkvdGFibGU6Njk2MjMwNjYwNGYzNDk1YWJhMGY0ZDhkMTY2NTc3NmIvdGFibGVyYW5nZTo2OTYyMzA2NjA0ZjM0OTVhYmEwZjRkOGQxNjY1Nzc2Yl8yLTEtMS0xLTA_0ac17609-b5ae-4fa5-aaa4-2f28a37e52c1">0001022079</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF80L2ZyYWc6NGI4NzQxYTVkMjU5NDRkNGE4YWUxZmQ1ZThmY2Q3MzkvdGFibGU6Njk2MjMwNjYwNGYzNDk1YWJhMGY0ZDhkMTY2NTc3NmIvdGFibGVyYW5nZTo2OTYyMzA2NjA0ZjM0OTVhYmEwZjRkOGQxNjY1Nzc2Yl80LTEtMS0xLTA_b147d0cb-abfb-4a4e-86a4-59c3530360e3">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF80L2ZyYWc6NGI4NzQxYTVkMjU5NDRkNGE4YWUxZmQ1ZThmY2Q3MzkvdGFibGU6Njk2MjMwNjYwNGYzNDk1YWJhMGY0ZDhkMTY2NTc3NmIvdGFibGVyYW5nZTo2OTYyMzA2NjA0ZjM0OTVhYmEwZjRkOGQxNjY1Nzc2Yl81LTEtMS0xLTA_6393fe01-6958-41af-a1dd-2d6e87e478c7">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF80L2ZyYWc6NGI4NzQxYTVkMjU5NDRkNGE4YWUxZmQ1ZThmY2Q3MzkvdGFibGU6Njk2MjMwNjYwNGYzNDk1YWJhMGY0ZDhkMTY2NTc3NmIvdGFibGVyYW5nZTo2OTYyMzA2NjA0ZjM0OTVhYmEwZjRkOGQxNjY1Nzc2Yl82LTEtMS0xLTA_63449a29-f9a7-4207-b7d3-b98dce2d2ecb">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i949923f39e104d6ea10b55d03b6467c2_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDgy_7012da4d-00be-4056-8e53-6cc514ee15da">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i7c9815de6056498884fbf7ad9eb40a7a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njky_056ade57-4241-451a-a1e9-095ca78772c6">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib4e9bac07fa34fa6ac58f793d4697067_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQx_017f65e9-fcca-4642-991b-5a831db9e67f">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i225797e622964ed59d73033ade33c396_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzIvZnJhZzo2MWViMDJiNDYxYjI0ZjdkOTViMDVjZjk4NDlkYzgwOS90YWJsZToyN2FhMjliNzU0MTA0YmJmYmUzZTMzM2IzN2ZlMTdhNC90YWJsZXJhbmdlOjI3YWEyOWI3NTQxMDRiYmZiZTNlMzMzYjM3ZmUxN2E0XzktMS0xLTEtMA_cfee06a9-0540-4b87-b686-9167cb01695e">P31Y6M</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <dgx:DerivativeGainAmortizationPeriod
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1NzI_56514d22-493f-4c97-86ad-19ef10f8afd8">P10Y</dgx:DerivativeGainAmortizationPeriod>
    <dgx:DerivativeGainAmortizationPeriod
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1OTE_2bbebbdb-352e-417a-8de8-f6de9db537f1">P10Y</dgx:DerivativeGainAmortizationPeriod>
    <dgx:AgreementtoOutsourceBillingandCollectionFunction
      contextRef="iceca971098f048bb87e4938a5c193612_D20160901-20160930"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzMzUzMTg_a020698b-1549-440e-9434-fef192bf4df1">P10Y</dgx:AgreementtoOutsourceBillingandCollectionFunction>
    <dei:DocumentType
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODEz_157c68c2-0b12-4798-a22c-59c3e727ea35">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODE0_fef09847-3f70-49cd-abb7-2c819f6f196e">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV80OTQ3ODAyMzI4NzU3_7e784d6f-9d1a-4469-9bd6-c06a1988c5e0">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV80OTQ3ODAyMzI4NzU3_c8362d53-e13b-4397-8240-20c716e51d67">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODA4_cbe2ff35-2ed0-40ee-a2a0-0ff8e54c81d7">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODE1_9ba7d139-8fe2-4c07-9a80-37028e1c8eac">001-12215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODA5_62be1eec-60f3-4f35-a96c-297c0397576a">Quest Diagnostics Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8wLTAtMS0xLTA_7fc5652b-bdc2-428b-a941-aed62b04236b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8wLTUtMS0xLTA_77c88851-0758-4dd1-9105-0889cebd8bcf">16-1387862</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8yLTAtMS0xLTA_99d3414a-2e3e-49eb-a1a0-f5eaf89017f7">500 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8zLTAtMS0xLTA_43a98610-3c46-4f9b-b40e-32df8f5fdd31">Secaucus,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8zLTEtMS0xLTA_aff98956-e4dd-481e-8aba-c69c57cbb769">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl8zLTItMS0xLTA_2cdeefd1-2446-4d0b-b4bb-48fc6609a12d">07094</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl80LTAtMS0xLTA_7e9dfeae-4b91-4b92-a2be-04ab9cfb8cfe">(973)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6NDgwZDQ3ZDJmNTZkNGU3NjlkYTNmNTU2ODFmNWNjYmYvdGFibGVyYW5nZTo0ODBkNDdkMmY1NmQ0ZTc2OWRhM2Y1NTY4MWY1Y2NiZl80LTEtMS0xLTA_d8c2d32c-3ca5-46f1-8339-81e6c296e497">520-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6M2MyNDcwMDY0OGMzNDc0NjhmMjJkMGY2NTkyMjBhNGEvdGFibGVyYW5nZTozYzI0NzAwNjQ4YzM0NzQ2OGYyMmQwZjY1OTIyMGE0YV8yLTAtMS0xLTA_052d766d-cd91-4aa5-bc22-d668e0e655a1">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6M2MyNDcwMDY0OGMzNDc0NjhmMjJkMGY2NTkyMjBhNGEvdGFibGVyYW5nZTozYzI0NzAwNjQ4YzM0NzQ2OGYyMmQwZjY1OTIyMGE0YV8yLTEtMS0xLTA_99620331-133b-4ac8-9e9a-bb248bdfeede">DGX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6M2MyNDcwMDY0OGMzNDc0NjhmMjJkMGY2NTkyMjBhNGEvdGFibGVyYW5nZTozYzI0NzAwNjQ4YzM0NzQ2OGYyMmQwZjY1OTIyMGE0YV8yLTItMS0xLTA_ea48772a-45bc-46a2-860f-eb5ceeb2b11c">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODEw_091464a0-ec58-4fa5-a8c7-b3734425a26f">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODA3_ca61c1c9-59f0-40ef-8c52-b07f90796a9f">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODEx_7508b3ad-7850-4e52-b93a-7c8ce5632618">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yODEy_f4358011-47e0-42c7-bd25-88009679490c">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6OTE1MjBiNTJhZDU0NDg0ODg1M2YxM2NlNDU2ZmY2NzMvdGFibGVyYW5nZTo5MTUyMGI1MmFkNTQ0ODQ4ODUzZjEzY2U0NTZmZjY3M18wLTAtMS0xLTA_950df878-8d19-4fb7-9876-b34fdb6bbe70">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6OTE1MjBiNTJhZDU0NDg0ODg1M2YxM2NlNDU2ZmY2NzMvdGFibGVyYW5nZTo5MTUyMGI1MmFkNTQ0ODQ4ODUzZjEzY2U0NTZmZjY3M18xLTMtMS0xLTA_5a47b25f-c467-4010-8cf8-d8ca40e069ce">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6OTE1MjBiNTJhZDU0NDg0ODg1M2YxM2NlNDU2ZmY2NzMvdGFibGVyYW5nZTo5MTUyMGI1MmFkNTQ0ODQ4ODUzZjEzY2U0NTZmZjY3M18yLTMtMS0xLTA_22a56e4f-61df-4125-93ac-5ca93852ac6b">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV80OTQ3ODAyMzI4Nzgy_8bd40f27-cfb2-4f5d-a299-6c6cb752db12">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV80OTQ3ODAyMzI4ODEx_2efb1ffa-0efa-4ae7-aea5-0e72ec57a5fb">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i7d73fad95bda4e53aeeeb1bedb9f3590_I20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yMTk5MDIzMjU4NDQ4_03f6638e-b3fa-4e9e-b2f6-cef9fbd76d03"
      unitRef="usd">15200000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i27e80e3d49854295b01b300430151eb4_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGV4dHJlZ2lvbjpjMmYzZGRmZTg4NzE0YTBhYWNmOTIwNTg2MGI3ZjFiNV8yNTcy_af3726d8-0b8a-48ed-96b7-d19e049e41a8"
      unitRef="shares">133454761</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xL2ZyYWc6YzJmM2RkZmU4ODcxNGEwYWFjZjkyMDU4NjBiN2YxYjUvdGFibGU6ZDIxYjQ2ZTAyZDJjNDRlMzlhMmM4YzA0ODQ2YmE0MGMvdGFibGVyYW5nZTpkMjFiNDZlMDJkMmM0NGUzOWEyYzhjMDQ4NDZiYTQwY18yLTAtMS0xLTA_e8f594e3-e910-49e7-95d7-2f64b862fc4b">Portions of the registrant's Proxy Statement to be filed by April&#160;30, 2021</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xMjcvZnJhZzpkYmJjZTVkYzRlMWY0NjllYmQwN2I4M2VjNTM1N2ZmNi90ZXh0cmVnaW9uOmRiYmNlNWRjNGUxZjQ2OWViZDA3YjgzZWM1MzU3ZmY2XzIxOTkwMjMyNzE3NzU_99d6bff2-30c7-4b47-8046-a2a6190df74a"
      unitRef="usd">4600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xMjcvZnJhZzpkYmJjZTVkYzRlMWY0NjllYmQwN2I4M2VjNTM1N2ZmNi90ZXh0cmVnaW9uOmRiYmNlNWRjNGUxZjQ2OWViZDA3YjgzZWM1MzU3ZmY2XzIxOTkwMjMyNzE3OTQ_e38628b6-05de-420f-962f-630317d0c154"
      unitRef="usd">5100000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMtMS0xLTEtMA_afd142fa-916b-49d7-b636-b5b1dc0a9ad5"
      unitRef="usd">1158000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMtMy0xLTEtMA_86a8b9c1-8401-4f46-988d-e08c060ec081"
      unitRef="usd">1192000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjUxN2VlMzM4YTYxOTQwZmY4NzU0MGYyOGQ5YWQ5ZjJiXzQ5NDc4MDIzMjUxMDQ_aabfb559-45ce-40bf-83e4-031c4c0ad7ac"
      unitRef="usd">28000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjUxN2VlMzM4YTYxOTQwZmY4NzU0MGYyOGQ5YWQ5ZjJiXzIxOTkwMjMyNTU3MDE_2173ec70-efd5-45bd-964c-da819187da80"
      unitRef="usd">15000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQtMS0xLTEtMA_ded46d82-e6ac-491f-a592-5356664ac154"
      unitRef="usd">1520000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQtMy0xLTEtMA_bf849dfa-2ca2-4d0a-9616-90ce08f09ee8"
      unitRef="usd">1063000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzUtMS0xLTEtMA_a04e4ee7-86a9-4d1d-92d3-4f1f39ec024b"
      unitRef="usd">223000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzUtMy0xLTEtMA_15f9071b-550c-435b-9c58-4fd5aaf130e9"
      unitRef="usd">123000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzYtMS0xLTEtMA_e042caed-9e8c-4579-91e5-ebfea0e42562"
      unitRef="usd">157000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzYtMy0xLTEtMA_388ae5e8-58cd-473c-90f3-0533ff6dd806"
      unitRef="usd">112000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzgtMS0xLTEtMA_89badb56-43e9-4484-86f6-58d0fd860a27"
      unitRef="usd">3058000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzgtMy0xLTEtMA_c56d78a2-bc03-4ca7-82c7-ad3ecfd67fa4"
      unitRef="usd">2490000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzktMS0xLTEtMA_bf3f3669-8d4f-4e4c-8ef7-3004f4ae6aba"
      unitRef="usd">1627000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzktMy0xLTEtMA_164ee54f-4d5c-452e-92dd-13dc8eda53b9"
      unitRef="usd">1453000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEwLTEtMS0xLTA_2ef82887-36e2-4ce3-9e23-2ac94956baf0"
      unitRef="usd">604000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEwLTMtMS0xLTA_6d6b0de9-7f18-4057-90c6-2dc363f1f232"
      unitRef="usd">518000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzExLTEtMS0xLTA_4f89b626-e10a-4b57-9ed8-cf7e0a34ca98"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzExLTMtMS0xLTA_2267c8d0-9912-476b-a168-7b75354fcfeb"
      unitRef="usd">6619000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEyLTEtMS0xLTA_e60e1775-bb48-4959-aa9d-15c9e814c23a"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEyLTMtMS0xLTA_8f6797cd-c158-4f62-a224-73b2f8fdaa5d"
      unitRef="usd">1121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEzLTEtMS0xLTA_ff4e56c3-3f5e-4663-a4bc-e8c4432280a8"
      unitRef="usd">521000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzEzLTMtMS0xLTA_2a0b73f9-63fc-4e87-a5a0-1f377efea30f"
      unitRef="usd">482000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzE0LTEtMS0xLTA_3bef38a0-2ae2-456e-a538-53d0277cf4d8"
      unitRef="usd">176000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzE0LTMtMS0xLTA_5ac4bc0d-5449-435b-8330-e546331bae1a"
      unitRef="usd">160000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzE2LTEtMS0xLTA_72ec415b-4da2-4fd7-8086-f9bf8d3f8d94"
      unitRef="usd">14026000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzE2LTMtMS0xLTA_3d3ac8cb-c744-4538-9f87-977b32aa3424"
      unitRef="usd">12843000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIwLTEtMS0xLTA_3e2fbd51-2488-4804-a2bd-5e0b6149ad34"
      unitRef="usd">1633000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIwLTMtMS0xLTA_d28a69a7-9c61-43cf-8238-6a561ac96d49"
      unitRef="usd">1041000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIxLTEtMS0xLTA_11b78c57-04bb-49b8-a6de-57c43303b80b"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIxLTMtMS0xLTA_05674031-5734-400f-886c-9f1b7caab27a"
      unitRef="usd">804000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIyLTEtMS0xLTA_49e4e2a5-d0f9-429c-b286-22475d084e1b"
      unitRef="usd">141000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIyLTMtMS0xLTA_12f06bc0-dc9c-4042-a742-3aa896bc60f3"
      unitRef="usd">145000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIzLTEtMS0xLTA_2a2ec9e7-5277-444a-b905-c0365b072839"
      unitRef="usd">1776000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzIzLTMtMS0xLTA_ffdc56d4-78dc-4889-ae99-f5f3d2593d39"
      unitRef="usd">1990000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI0LTEtMS0xLTA_be0a796b-65a1-4d6c-a651-34523f85454e"
      unitRef="usd">4013000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI0LTMtMS0xLTA_0f3ead66-d656-4a71-9ddd-9fa607a58cd9"
      unitRef="usd">3966000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI1LTEtMS0xLTA_2524ba60-969b-485a-a364-1fa3aa53e1c7"
      unitRef="usd">499000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI1LTMtMS0xLTA_0b2c7611-037a-407c-b967-6c0fc5281286"
      unitRef="usd">413000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI2LTEtMS0xLTA_71b8c142-38d0-495e-8d27-3f50f1cda574"
      unitRef="usd">847000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI2LTMtMS0xLTA_ec5db944-f175-48a5-bee5-d69807c15052"
      unitRef="usd">711000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI4LTEtMS0xLTA_9c19e824-fa33-4841-bd5a-e173ecedff38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI4LTMtMS0xLTA_47b99332-1278-47f8-9881-02062b9cd25c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI5LTEtMS0xLTA_2b47e4f5-a896-4816-9c38-e7a9817fc719"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzI5LTMtMS0xLTA_4e7a890e-fda6-4464-a26e-e79c3e56be9e"
      unitRef="usd">76000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTYx_82049554-7d71-464e-809c-2340b28dda15"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTYx_89e88483-c50c-4e67-a97d-fab7eecefea9"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTY3_a6b93a48-5ce1-4ad8-b11c-af2c40a94845"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTY3_e497b864-d796-4bda-baa1-4ed79d2bfe5d"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTcz_63ed7796-aa19-4832-b7eb-5ac026362cb9"
      unitRef="shares">217000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTAtMS0xLTAvdGV4dHJlZ2lvbjplZjIxZDI0ZDkxOTA0NjA0YTc1OWQ5MzdkMGM0M2I0MF80OTQ3ODAyMzI1MTcz_c8ab7540-6755-4670-89d6-b55ed482f153"
      unitRef="shares">217000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTEtMS0xLTA_3785e19b-5edb-493c-a308-f578667c2aad"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMyLTMtMS0xLTA_f92e5646-3a56-4f9d-9e33-6e66db713a8f"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMzLTEtMS0xLTA_1f47e9ce-4d93-4d01-bdf6-026140741570"
      unitRef="usd">2841000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzMzLTMtMS0xLTA_877c97ff-c4e1-42e3-81d2-61a46c21fddf"
      unitRef="usd">2722000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM0LTEtMS0xLTA_434806f4-5f61-468a-9176-dcf1eafad93a"
      unitRef="usd">9303000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM0LTMtMS0xLTA_b1e0db34-a043-48df-83c2-a9f73ba6d945"
      unitRef="usd">8174000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM1LTEtMS0xLTA_666ec43a-dc57-4899-80bb-200a25685e1a"
      unitRef="usd">-21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM1LTMtMS0xLTA_445bc6ae-fba5-443b-a089-9bc9c7b2d74f"
      unitRef="usd">-39000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjpjODQwMjU2NmI2YWE0OGVlOTIzODNmMzEyMjQ5MGRiNV80OTQ3ODAyMzI1MTA3_34312f6b-358f-4db0-ac4e-db911672bcdf"
      unitRef="shares">84000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjpjODQwMjU2NmI2YWE0OGVlOTIzODNmMzEyMjQ5MGRiNV80OTQ3ODAyMzI1MTA3_6a6c718a-4611-4baa-9d6b-99d79c10b6f3"
      unitRef="shares">84000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM2LTEtMS0xLTA_91a0c93f-9f7f-462e-ac5c-40f641ff5d39"
      unitRef="usd">5366000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM2LTMtMS0xLTA_6b493d86-cdb3-4e90-8f54-0a1c42ca4d45"
      unitRef="usd">5218000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM3LTEtMS0xLTA_2f37225e-fbe4-4619-971b-e8b90fd2183d"
      unitRef="usd">6759000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM3LTMtMS0xLTA_9059de83-354d-43bd-9f9d-f9b90c2490a2"
      unitRef="usd">5641000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM4LTEtMS0xLTA_5db4a5c9-4d83-4af3-b5a1-860ad94d72da"
      unitRef="usd">50000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM4LTMtMS0xLTA_88725d12-eb9d-4221-a583-b5108c2d52ea"
      unitRef="usd">46000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM5LTEtMS0xLTA_ada9ec69-cf94-4bae-a24c-21fa77e19c30"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzM5LTMtMS0xLTA_08212a82-b8eb-4806-9e5b-c7c9e56acd44"
      unitRef="usd">5687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQwLTEtMS0xLTA_5a42dbc9-7abe-4cae-981f-bb21342473d1"
      unitRef="usd">14026000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNDUvZnJhZzpjN2JiYjhjMWQwZGY0YjUzYTllODFmMzE4ZGVkYTk3NS90YWJsZTpmN2MwZjg5NTQ4OTE0OGQwYThlZTVmYmM2NzJmMWVlYi90YWJsZXJhbmdlOmY3YzBmODk1NDg5MTQ4ZDBhOGVlNWZiYzY3MmYxZWViXzQwLTMtMS0xLTA_0852f1a5-7dfd-4438-b05d-c1a8fb02fd25"
      unitRef="usd">12843000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzItMS0xLTEtMA_17b58273-e5cf-47be-86e8-8733b485968b"
      unitRef="usd">9437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzItMy0xLTEtMA_ae5a0d77-75d5-41bc-b9d3-de49b4dcc828"
      unitRef="usd">7726000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzItNS0xLTEtMA_75e13333-caaa-43df-b226-69deccff8fd6"
      unitRef="usd">7531000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzUtMS0xLTEtMA_5e6940a1-40e4-4a02-bf14-f980e55f2924"
      unitRef="usd">5804000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzUtMy0xLTEtMA_632eee2c-3e90-41ff-9363-308b0755501b"
      unitRef="usd">5037000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzUtNS0xLTEtMA_9eab9018-7681-4a64-bf23-4220044951ee"
      unitRef="usd">4926000000</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzYtMS0xLTEtMA_2f55fd39-03a4-4402-8230-bcd4def8ade7"
      unitRef="usd">1550000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzYtMy0xLTEtMA_3576de12-ced3-416e-bfe8-370138a945ec"
      unitRef="usd">1457000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzYtNS0xLTEtMA_8f56ea1d-7a92-470b-9539-e0567607efb9"
      unitRef="usd">1424000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzctMS0xLTEtMA_9526eb1c-359a-4145-ad03-c701bcf20ea8"
      unitRef="usd">103000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzctMy0xLTEtMA_4c09944e-24c9-469c-a07c-93d490698eb2"
      unitRef="usd">96000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzctNS0xLTEtMA_92aa61ec-2dd5-4681-a52b-4a45d2e2974c"
      unitRef="usd">90000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzgtMS0xLTEtMA_8ad97635-c8b1-47b8-a25d-eaf863382cc0"
      unitRef="usd">-9000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzgtMy0xLTEtMA_1f16af8d-06c6-41e5-a14c-6539dfee1b35"
      unitRef="usd">95000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzgtNS0xLTEtMA_93db7d2b-f1ab-4856-a25a-e53f166004da"
      unitRef="usd">10000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzktMS0xLTEtMA_481f2ca6-ab70-48e4-bd8e-ee321e666f0c"
      unitRef="usd">7466000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzktMy0xLTEtMA_09d408a1-f920-4bf0-89bd-31def512af47"
      unitRef="usd">6495000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzktNS0xLTEtMA_99c0befe-9b8c-420d-9728-5887b11df009"
      unitRef="usd">6430000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzExLTEtMS0xLTA_a7940ae4-d780-49e5-9e9c-677d5a6acda2"
      unitRef="usd">1971000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzExLTMtMS0xLTA_081d0a0c-7803-45bb-adaf-32ed1812b5b8"
      unitRef="usd">1231000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzExLTUtMS0xLTA_cdacca3a-fc15-4b9c-9e7c-300ef513b4bd"
      unitRef="usd">1101000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE0LTEtMS0xLTA_f110f342-95ad-4037-878a-d5177a114644"
      unitRef="usd">-163000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE0LTMtMS0xLTA_4dd771aa-7068-4a04-970e-0014be1352d5"
      unitRef="usd">-175000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE0LTUtMS0xLTA_9c395ed6-c6a9-4359-96b2-37d54c0e6841"
      unitRef="usd">-167000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE1LTEtMS0xLTA_abfaf569-779b-4024-91ee-e1b7e9216558"
      unitRef="usd">76000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE1LTMtMS0xLTA_af25f0d2-462b-4e48-85cd-08530918ee23"
      unitRef="usd">20000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE1LTUtMS0xLTA_2d411edb-5909-446f-b75e-2973c9911c85"
      unitRef="usd">-8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE2LTEtMS0xLTA_a95ac519-ff60-4acc-940f-0ce5cc46bb3f"
      unitRef="usd">-87000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE2LTMtMS0xLTA_870441c3-4a23-4c1e-8f0d-99c7ba0527a2"
      unitRef="usd">-155000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE2LTUtMS0xLTA_f9e1a4fe-8b63-4f22-bccd-03a22033de93"
      unitRef="usd">-175000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE4LTEtMS0xLTA_5057422d-d1ea-4000-a46b-131585f05df6"
      unitRef="usd">1884000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE4LTMtMS0xLTA_a855f93a-9b8c-4b11-a9d4-2b52a1f3dbdc"
      unitRef="usd">1076000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE4LTUtMS0xLTA_127b344e-5b39-477e-8733-eb70d5104738"
      unitRef="usd">926000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE5LTEtMS0xLTA_e6421230-801d-4f27-bf9d-c1603a704e2d"
      unitRef="usd">460000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE5LTMtMS0xLTA_bc6a7fef-8403-4f56-b0a5-4bd023092122"
      unitRef="usd">247000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzE5LTUtMS0xLTA_27a81fcf-faa3-4e47-9908-3b5952187867"
      unitRef="usd">182000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIwLTEtMS0xLTA_ef964fdc-6824-4705-90aa-256aaad90cbe"
      unitRef="usd">75000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIwLTMtMS0xLTA_2175e198-2f0e-4a25-b5f6-92b6d3bf34ea"
      unitRef="usd">57000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIwLTUtMS0xLTA_666a9882-f151-47c8-adec-b6a10871bb1e"
      unitRef="usd">44000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIzLTEtMS0xLTA_302cc3a4-a2b6-43ac-acbd-9ece36acb7ca"
      unitRef="usd">1499000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIzLTMtMS0xLTA_fdca214b-4015-410a-bdd7-e3a43e9d19d4"
      unitRef="usd">886000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzIzLTUtMS0xLTA_c5893705-9122-4525-ac55-1ed04bcc123b"
      unitRef="usd">788000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI0LTEtMS0xLTA_858a69d1-cc53-4643-b018-f89a0d838053"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI0LTMtMS0xLTA_e8731773-ff6f-4cea-839c-1e935aa399df"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI0LTUtMS0xLTA_4785f10c-8d56-4c98-bbc7-f500dcc801b8"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI1LTEtMS0xLTA_998d71d0-1a86-4e93-98a3-339542e11575"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI1LTMtMS0xLTA_314a0b24-be33-4c2f-a77f-2cc23966da3c"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI1LTUtMS0xLTA_daf06ade-71dd-4349-a035-dbafad88baa6"
      unitRef="usd">788000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI2LTEtMS0xLTA_2d816f2e-2f37-40d0-b46d-46c8f89ab645"
      unitRef="usd">68000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI2LTMtMS0xLTA_0fc05eb5-4f17-400a-9bfa-ae4fea75cbcc"
      unitRef="usd">48000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI2LTUtMS0xLTA_de4382f3-5f9c-4c5e-9629-df46920bfcc6"
      unitRef="usd">52000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI3LTEtMS0xLTA_2188af7f-9e66-4bac-90d2-f5f3f1f06c6a"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI3LTMtMS0xLTA_7800c693-cbd0-4c36-abaf-7543e0adfc65"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzI3LTUtMS0xLTA_9903cd66-93ba-4e10-a29e-1a17496ae0d0"
      unitRef="usd">736000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMwLTEtMS0xLTA_78bb0a6b-d1a3-4340-a314-c33e0e91188d"
      unitRef="usd">1431000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMwLTMtMS0xLTA_b2cac41a-7e94-4cd9-bab6-c656618535e5"
      unitRef="usd">838000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMwLTUtMS0xLTA_73ce7356-148d-41fa-8a7d-16c6f2859411"
      unitRef="usd">736000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMxLTEtMS0xLTA_8676d368-dfb5-4ed1-bc50-617482a864ea"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMxLTMtMS0xLTA_6055e6bf-4ae3-4f88-b755-45b9666c0757"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMxLTUtMS0xLTA_c2e2777c-1381-4b01-b52e-4f295e12594e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMyLTEtMS0xLTA_d711e33d-d87f-479b-af45-1c16670ec69e"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMyLTMtMS0xLTA_d42307b6-f384-4ed8-9da1-6abf9c4b23bb"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzMyLTUtMS0xLTA_b35e3d38-4665-4362-9fa1-22355a9d0c26"
      unitRef="usd">736000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM1LTEtMS0xLTA_510a3b88-693a-4cce-970f-cc1a6b7d7f25"
      unitRef="usdPerShare">10.62</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM1LTMtMS0xLTA_1b006825-1829-464c-9cfe-d56907b0b26c"
      unitRef="usdPerShare">6.21</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM1LTUtMS0xLTA_ac12fce7-6a7f-422b-966d-c0311d79a99e"
      unitRef="usdPerShare">5.39</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM2LTEtMS0xLTA_dd9d63a2-ef66-4df4-acd9-5d05200d3483"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM2LTMtMS0xLTA_7b2a5afb-76e5-43f5-b78a-23e33fdb232a"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM2LTUtMS0xLTA_396e7290-400e-4e35-a749-42a53abda969"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM3LTEtMS0xLTA_6266b02f-bf6a-4fa5-aaa7-7fe6d785b08f"
      unitRef="usdPerShare">10.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM3LTMtMS0xLTA_447732e2-1a62-4ccf-916e-c400fc4df42e"
      unitRef="usdPerShare">6.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzM3LTUtMS0xLTA_8b48f3d4-2258-4a33-96f7-02fa64333d87"
      unitRef="usdPerShare">5.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQwLTEtMS0xLTA_b44dbd75-f30f-4df2-a63a-6e08df055cd0"
      unitRef="usdPerShare">10.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQwLTMtMS0xLTA_70e99fdb-039e-4caa-ae1c-8cf56cfe551d"
      unitRef="usdPerShare">6.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQwLTUtMS0xLTA_e890b404-0f64-48e9-8724-3a13d59115a6"
      unitRef="usdPerShare">5.29</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQxLTEtMS0xLTA_11a1cfae-7622-4d8b-89eb-a744299cc677"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQxLTMtMS0xLTA_b4ea33fd-4fb7-462a-84ca-d2ad6b817d60"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQxLTUtMS0xLTA_2f5f781c-24f1-4476-a39c-b2791a00e22b"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQyLTEtMS0xLTA_0d311596-1020-4084-b3fc-8c051901742c"
      unitRef="usdPerShare">10.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQyLTMtMS0xLTA_19d4d753-c152-40a6-a56e-2c75b32eca87"
      unitRef="usdPerShare">6.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTEvZnJhZzo4YWE1NmRiOTE4ZGQ0NjFkYTllMzk0NWFiOWRlYTBlNS90YWJsZTpjOTY1NWU4ODgyMDQ0YjkwYjgzMjFmNDE1MDdlNjRlMC90YWJsZXJhbmdlOmM5NjU1ZTg4ODIwNDRiOTBiODMyMWY0MTUwN2U2NGUwXzQyLTUtMS0xLTA_11bec738-f58a-406f-bd88-c0470e9b5f60"
      unitRef="usdPerShare">5.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzItMS0xLTEtMA_7e99bcd3-1eb5-42a7-a236-e4ac9877b7f1"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzItMy0xLTEtMA_525a0ca2-eaf8-4048-9f39-5e131f2325f6"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzItNS0xLTEtMA_c39fc405-ec71-4f4c-885d-721ef9105e25"
      unitRef="usd">788000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzUtMS0xLTEtMA_8ea84989-ee2e-4486-abf1-a0eef095e956"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzUtMy0xLTEtMA_7f11f3dc-1e66-4c8e-a288-3f70348b7e40"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzUtNS0xLTEtMA_d74e4e27-ee3f-4786-9cdd-f6e2a3abc2ce"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzYtMS0xLTEtMA_09e1500a-2385-4fd6-baba-fa1241c38603"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzYtMy0xLTEtMA_11582426-b312-4380-b2d3-c5880db2859c"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzYtNS0xLTEtMA_ab7ee995-bcb9-415c-af64-7b657a9fc176"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzctMS0xLTEtMA_b864ccbd-2fff-469e-8ede-9c362d312e77"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzctMy0xLTEtMA_ccd88a0c-4c2b-45d8-ad0b-b8c54b63744a"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzctNS0xLTEtMA_7fec155c-2c69-4791-ae10-cf4f36a55ff9"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzktMS0xLTEtMA_a630264c-254d-4d4d-a1fa-9e2eeceba626"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzktMy0xLTEtMA_8f1c198c-3b3e-45b7-a9fc-870bc137199d"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzktNS0xLTEtMA_116c0bb9-00c0-4ff4-a034-d38597f14f34"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzExLTEtMS0xLTA_44b3aded-b134-4f38-b6c4-ff66194a7abb"
      unitRef="usd">1517000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzExLTMtMS0xLTA_3da53301-e30b-4c0f-85e7-8e28a46d02c3"
      unitRef="usd">926000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzExLTUtMS0xLTA_1db0e0ac-d0b8-448c-8cfe-82cca1030c50"
      unitRef="usd">779000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEyLTEtMS0xLTA_39eb6ff3-fc7d-4bda-b950-7d252bd8a4c8"
      unitRef="usd">68000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEyLTMtMS0xLTA_b1f0fee2-8c86-4209-9f53-7291afdb1c69"
      unitRef="usd">48000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEyLTUtMS0xLTA_38ec6eac-c588-41ba-9a9d-5582bf94ce56"
      unitRef="usd">52000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEzLTEtMS0xLTA_d1863028-5ff0-49e1-a64c-24342c147671"
      unitRef="usd">1449000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEzLTMtMS0xLTA_db996a79-ffec-4ad3-b7a3-73dc038c8165"
      unitRef="usd">878000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTQvZnJhZzpiMjc0NTYzOTVkNzM0NmZlYWVhYjM5Y2QxNDllZWYyYy90YWJsZTplYjlkNWZjNmRhM2I0MzdkOGJkZmY4ZjY2MDA3YTk0MS90YWJsZXJhbmdlOmViOWQ1ZmM2ZGEzYjQzN2Q4YmRmZjhmNjYwMDdhOTQxXzEzLTUtMS0xLTA_3569cd25-1acd-41a6-9001-425d285b7b06"
      unitRef="usd">727000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzItMS0xLTEtMA_808abf34-1531-4467-bbcc-c8d2b917da60"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzItMy0xLTEtMA_ac0ad8eb-7b38-4134-b62c-f0cabaf39979"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzItNS0xLTEtMA_01e29f80-4d7f-43d2-8a65-c6ab44d41b9f"
      unitRef="usd">788000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQtMS0xLTEtMA_1de15a3e-0466-42c4-8ef2-bc1bcdf25e50"
      unitRef="usd">361000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQtMy0xLTEtMA_2cb01542-d144-49e6-911b-c134e73affbf"
      unitRef="usd">329000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQtNS0xLTEtMA_c5b50a0a-37db-41db-93fd-ade4670812e7"
      unitRef="usd">309000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUtMS0xLTEtMA_cfcf4264-958d-4044-a5e4-2cd92ec9d37c"
      unitRef="usd">19000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUtMy0xLTEtMA_b52839cc-e643-492b-9cc2-d14990bb0afc"
      unitRef="usd">11000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUtNS0xLTEtMA_dc0f76d3-4128-46a8-bed2-6f5d34e17845"
      unitRef="usd">6000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzYtMS0xLTEtMA_f9671ed6-ceac-4a47-8a55-1e87384ff359"
      unitRef="usd">85000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzYtMy0xLTEtMA_0faaeb2d-dea4-40dc-a3e1-a5cb4740063b"
      unitRef="usd">15000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzYtNS0xLTEtMA_e2226443-5a8c-4d37-b06b-344ee7da0d51"
      unitRef="usd">73000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzctMS0xLTEtMA_499d0c3e-0d12-4344-88bb-7650a8348d0c"
      unitRef="usd">97000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzctMy0xLTEtMA_2a458287-364f-42f5-9008-20a737b7940b"
      unitRef="usd">56000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzctNS0xLTEtMA_9a99ff7d-3e14-47c5-8bcb-7b1ce3538312"
      unitRef="usd">61000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzEzLTEtMS0xLTA_fce79422-605c-46a5-b13c-0c844d669e93"
      unitRef="usd">-3000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzEzLTMtMS0xLTA_7ba16759-dc38-4898-9733-fe35c8da3472"
      unitRef="usd">70000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzEzLTUtMS0xLTA_0e574cfc-9629-4ba0-93e4-b0b385c744d7"
      unitRef="usd">-6000000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE0LTEtMS0xLTA_9ada0ed8-5149-4aac-8506-5e3fd8fceb79"
      unitRef="usd">81000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE0LTMtMS0xLTA_be5725d6-0bd8-4d76-b0e9-cfa5c16142c0"
      unitRef="usd">39000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE0LTUtMS0xLTA_dac0f975-13e7-4e8f-870b-a5808b112951"
      unitRef="usd">-6000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE2LTEtMS0xLTA_bc9ec78e-1a87-4947-b9c5-c8409ac453d0"
      unitRef="usd">455000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE2LTMtMS0xLTA_11b857e4-4d75-49a1-a1c1-38849ff7bf79"
      unitRef="usd">63000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE2LTUtMS0xLTA_1fef0408-149a-47d2-baaf-72ef9626632a"
      unitRef="usd">65000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE3LTEtMS0xLTA_d65c6623-c40f-44e6-8303-27fc85db2742"
      unitRef="usd">452000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE3LTMtMS0xLTA_99d2225a-785e-45d9-8323-66b6445edae4"
      unitRef="usd">73000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE3LTUtMS0xLTA_2e71ecbe-d1e1-406a-90d6-db2c14dc86f8"
      unitRef="usd">-19000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE5LTEtMS0xLTA_a3866d35-f5ab-489a-ac5b-aad020f35147"
      unitRef="usd">22000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE5LTMtMS0xLTA_89d45fe8-6b70-447a-a817-fbd4fcb092dc"
      unitRef="usd">29000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzE5LTUtMS0xLTA_b82d1f5d-2d86-4387-8588-2fac1854bfe2"
      unitRef="usd">4000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIwLTEtMS0xLTA_e4f67e62-63e9-4345-8fec-9dd6457d4baf"
      unitRef="usd">40000000</dgx:TerminationOfInterestRateSwapAgreements>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIwLTMtMS0xLTA_5a61ad74-d5bb-4535-81f0-fb081675b2b9"
      unitRef="usd">0</dgx:TerminationOfInterestRateSwapAgreements>
    <dgx:TerminationOfInterestRateSwapAgreements
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIwLTUtMS0xLTA_d8434bff-84f6-4acd-920e-ed1d4c93f18b"
      unitRef="usd">0</dgx:TerminationOfInterestRateSwapAgreements>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIxLTEtMS0xLTA_84740c80-0caa-4d4a-87cd-0d5d8a27907d"
      unitRef="usd">37000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIxLTMtMS0xLTA_cf104e71-075b-47d8-b7bd-7a31884ee9fe"
      unitRef="usd">4000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIxLTUtMS0xLTA_08cf1b5a-7115-4acd-b1e9-37cd926586bc"
      unitRef="usd">-31000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIyLTEtMS0xLTA_c5397371-ba1e-43b9-9494-4dae3b09d2cb"
      unitRef="usd">2005000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIyLTMtMS0xLTA_a8500b4e-c3e2-443b-b2ed-94847474faa6"
      unitRef="usd">1243000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzIyLTUtMS0xLTA_7b54a957-3a6c-4779-9e13-47235a5661c0"
      unitRef="usd">1200000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI1LTEtMS0xLTA_c293751b-00a3-49be-875a-4f3b8bf7e1c5"
      unitRef="usd">330000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI1LTMtMS0xLTA_28b81394-d6b6-4378-87c5-7b81a1079c55"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI1LTUtMS0xLTA_0f448c16-f8ae-4876-b19a-b072ca518d8e"
      unitRef="usd">421000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI4LTEtMS0xLTA_b79421ab-58aa-4a4a-907b-9cb4a4cafb8e"
      unitRef="usd">3000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI4LTMtMS0xLTA_f5983133-aedf-4c4e-9001-bbfaffd1f390"
      unitRef="usd">91000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI4LTUtMS0xLTA_f7f049c2-f433-40f0-89af-c006c1d47e06"
      unitRef="usd">2000000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI5LTEtMS0xLTA_27d15b09-b962-407e-b02a-f1a370fd1aa9"
      unitRef="usd">418000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI5LTMtMS0xLTA_5a1cc752-1801-4681-aa47-0ebdbcdb6123"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzI5LTUtMS0xLTA_1b6df91b-e7db-47af-b584-e595f568a94d"
      unitRef="usd">383000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMxLTEtMS0xLTA_fc9ec712-24ad-41e0-bd7f-c56833a02729"
      unitRef="usd">27000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMxLTMtMS0xLTA_f76ec52f-09cf-46c6-b9f4-2e587ac29e38"
      unitRef="usd">44000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMxLTUtMS0xLTA_8bd690d5-a7d1-4051-a266-914af831399b"
      unitRef="usd">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMyLTEtMS0xLTA_c3399eb8-9013-4fdf-ba60-c8e80f0c14d4"
      unitRef="usd">-772000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMyLTMtMS0xLTA_db06c409-4c9f-4f91-9703-e08d93453664"
      unitRef="usd">-411000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzMyLTUtMS0xLTA_ae6bff72-56ee-4546-8010-00f17e754466"
      unitRef="usd">-801000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM1LTEtMS0xLTA_82416094-79c2-40bb-8241-2c5f214471f1"
      unitRef="usd">749000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM1LTMtMS0xLTA_85cde062-28f9-42b5-9a8f-edb0d10532ae"
      unitRef="usd">2281000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM1LTUtMS0xLTA_3bdb348e-ee1c-4f69-bb1b-3104d9ff17f7"
      unitRef="usd">2090000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM2LTEtMS0xLTA_955fb804-5523-4c94-a10a-7b51e8c7972f"
      unitRef="usd">1554000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM2LTMtMS0xLTA_61333944-4f64-429f-aa9b-62177c132bd1"
      unitRef="usd">1449000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM2LTUtMS0xLTA_2264b46e-1a25-43c9-bd7c-5d85c085a6ef"
      unitRef="usd">1966000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM3LTEtMS0xLTA_5f890008-4685-46c8-8cc6-f111f0df7bcb"
      unitRef="usd">325000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM3LTMtMS0xLTA_05e97e4b-bdea-4907-9c67-6aad47c6962c"
      unitRef="usd">353000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM3LTUtMS0xLTA_c1c880b7-9813-4b8c-a9cd-1c6ab0d889b3"
      unitRef="usd">322000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM4LTEtMS0xLTA_8ae59104-bfdd-41fb-88d2-464e6f31c8ff"
      unitRef="usd">189000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM4LTMtMS0xLTA_270bc971-853d-488e-9421-ac6d2cdaa76a"
      unitRef="usd">119000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM4LTUtMS0xLTA_63cb7524-ad46-4725-b2d6-6e88d6de6c16"
      unitRef="usd">99000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM5LTEtMS0xLTA_7ad3fe6b-8811-4fca-a7c7-99b2f80a8696"
      unitRef="usd">15000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM5LTMtMS0xLTA_6c66d8e2-0be3-413a-95c3-dbf78e7507ed"
      unitRef="usd">16000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzM5LTUtMS0xLTA_8f2d3d25-f970-4c87-857f-85353091ad69"
      unitRef="usd">21000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQwLTEtMS0xLTA_e2301604-141d-4445-9239-2604fee72fd0"
      unitRef="usd">297000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQwLTMtMS0xLTA_b8eaabbc-4351-4ce0-a546-5c30477edf58"
      unitRef="usd">286000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQwLTUtMS0xLTA_d43c47fb-1a5d-402c-8351-c80cfa65c92e"
      unitRef="usd">266000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQxLTEtMS0xLTA_5192df6f-4961-4a47-bd39-4ecb3ca94676"
      unitRef="usd">58000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQxLTMtMS0xLTA_15d89fc0-9d26-41a6-abd1-be3ce54a9f21"
      unitRef="usd">54000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQxLTUtMS0xLTA_f3fbab91-9575-4159-8dcf-f846bce0ffb9"
      unitRef="usd">54000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQzLTEtMS0xLTA_1865d019-d3ef-4270-b886-6f2089cd4075"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQzLTMtMS0xLTA_6d8b3329-68cc-4410-845b-a4adf07fca80"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQzLTUtMS0xLTA_debe9314-6487-47ec-87ae-c50477a1a1d6"
      unitRef="usd">16000000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ1LTEtMS0xLTA_5beed050-64b3-4b43-a2fd-526bc269b010"
      unitRef="usd">44000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ1LTMtMS0xLTA_0a93a6d0-6f96-41d8-9540-619d18bece7e"
      unitRef="usd">-17000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ1LTUtMS0xLTA_2ccf7bd5-6afb-447e-8f62-6109147b1dcd"
      unitRef="usd">23000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ2LTEtMS0xLTA_c8723eac-3a4a-41e3-8814-abd30ab11ba8"
      unitRef="usd">-1267000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ2LTMtMS0xLTA_4a847de7-9a50-49a8-84af-03b9d72292b2"
      unitRef="usd">225000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ2LTUtMS0xLTA_ebf876a3-4a20-4da8-9b48-3382335e51ae"
      unitRef="usd">-401000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ4LTEtMS0xLTA_1719e6a1-e653-40d3-b601-4c3f4d5dafc7"
      unitRef="usd">-34000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ4LTMtMS0xLTA_73dacfc6-57b0-4e69-8285-c3ca90087598"
      unitRef="usd">1057000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzQ4LTUtMS0xLTA_4c611aab-74bd-4d2e-873a-08657ef66635"
      unitRef="usd">-2000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUwLTEtMS0xLTA_f4783652-88ee-42eb-82dc-352610badbdb"
      unitRef="usd">1192000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUwLTMtMS0xLTA_9852658f-f832-47da-9dac-69899ffe7028"
      unitRef="usd">135000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i79da04d8282d4c8291850645193b2909_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUwLTUtMS0xLTA_00daca45-e3e6-4275-9a53-e64c707792d7"
      unitRef="usd">137000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUxLTEtMS0xLTA_d3e88463-0ab3-4e7d-b848-6445fb200804"
      unitRef="usd">1158000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUxLTMtMS0xLTA_ef611611-45fa-40db-86ad-65672cea9d9c"
      unitRef="usd">1192000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNTcvZnJhZzoxZjJlMWNhZDJhMDQ0NWQ2OTQxN2QyYzRlNjQxNWY3Mi90YWJsZToxNzkxMzBkMDFhODU0MDBkYWUxZjUwMTU0ZTE4YmZjYi90YWJsZXJhbmdlOjE3OTEzMGQwMWE4NTQwMGRhZTFmNTAxNTRlMThiZmNiXzUxLTUtMS0xLTA_a7c1f65e-d7af-47ea-a844-cfa6d3df5ea3"
      unitRef="usd">135000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic2adde92f1a5461aba05c280fca9d09c_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItMS0xLTEtMA_1f8a7596-3e65-4005-8717-58d47f7adab1"
      unitRef="shares">135000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2adde92f1a5461aba05c280fca9d09c_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItMi0xLTEtMA_6ae3a82e-60fb-4a29-bba9-4fd10ab2786d"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if187f4fa5af24cc385cdcc159b5ef5cf_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItMy0xLTEtMA_753eab87-5776-4f30-9271-c0b1809884df"
      unitRef="usd">2612000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ba55df515514c52893c724f25d5e5b2_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItNC0xLTEtMA_54023391-7476-4405-9b87-b76837128fd9"
      unitRef="usd">7138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i14e2c4e502f24416aea41251e9a7a514_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItNS0xLTEtMA_776fc3f8-c72c-4436-86a8-80ed826378f4"
      unitRef="usd">-48000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i930baaff13c549eabbf5ad24d956f10a_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItNi0xLTEtMA_85b23638-8876-45fc-a353-374fee869d7e"
      unitRef="usd">-4783000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icab245fbfc314588851b15e6a8b204c7_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItNy0xLTEtMA_0932a732-3e16-46e6-83fd-b008a44f6061"
      unitRef="usd">34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79da04d8282d4c8291850645193b2909_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItOC0xLTEtMA_30ed5997-037a-4135-b4dd-5b8382fbce9c"
      unitRef="usd">4955000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i79da04d8282d4c8291850645193b2909_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzItMTEtMS0xLTA_720d3688-a6eb-4a30-a5e0-21cc3d49e2a8"
      unitRef="usd">80000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ib94226cbc95e4f099933504fa1529358_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMtNC0xLTEtMA_8d0786c3-2ecf-4f94-b99f-3aa91ac85865"
      unitRef="usd">736000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ieda80e73180744408f6bbd3ae90626ce_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMtNy0xLTEtMA_609d3b96-333f-4973-9831-61cf9f06f445"
      unitRef="usd">45000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMtOC0xLTEtMA_98ae7de7-e3ab-4ecc-997d-2df72dfd4e02"
      unitRef="usd">781000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMtMTEtMS0xLTA_c8c2a344-649a-4d8b-b342-253fb1ed9609"
      unitRef="usd">7000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQtNS0xLTEtMA_ce0fa630-f0b0-4eae-9e3c-d50dfec97617"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQtOC0xLTEtMA_d50b6029-0348-4621-80b1-86cf12ebb7e3"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib94226cbc95e4f099933504fa1529358_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzUtNC0xLTEtMA_07d820eb-fd3a-4e7e-90a7-b0e54ccd1b5f"
      unitRef="usd">274000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzUtOC0xLTEtMA_ba2da02f-1581-4c38-be78-42cce949cdee"
      unitRef="usd">274000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ieda80e73180744408f6bbd3ae90626ce_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzYtNy0xLTEtMA_45ad4a7f-f57e-46f4-9aeb-28810227932f"
      unitRef="usd">44000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzYtOC0xLTEtMA_e54c4ee7-12a4-46be-89a3-20b28c874a49"
      unitRef="usd">44000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzYtMTEtMS0xLTA_ae318129-c5b9-4730-933c-cfb3db3c5085"
      unitRef="usd">10000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzctMy0xLTEtMA_ec0cb450-a74f-4fe3-b1ca-b8b135132366"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzctNi0xLTEtMA_4591ef3a-242d-4c80-b09a-dd48891e0e69"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzctOC0xLTEtMA_78c94679-a699-4dfa-9b38-c24c2666f2e9"
      unitRef="usd">28000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzgtMy0xLTEtMA_576d02ef-e7f4-4859-a4bc-bbe3d7e80ed7"
      unitRef="usd">56000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzgtNi0xLTEtMA_d13148d1-3935-4cfb-a133-e6d5407850b8"
      unitRef="usd">5000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzgtOC0xLTEtMA_fd180d66-40e8-470e-a776-d71b24fd297a"
      unitRef="usd">61000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idc23a2ce07eb4cab9ac46e9996f1a9da_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzktMS0xLTEtMA_bc061d55-d6b5-4596-a629-e40f49d7fe8d"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzktMy0xLTEtMA_134affa4-10ad-4d74-9923-fee39914d5dd"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzktNi0xLTEtMA_43c0f15d-b923-4835-8d7b-07b15053ede3"
      unitRef="usd">93000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzktOC0xLTEtMA_363f6dad-da56-4a73-94f9-76db237fe061"
      unitRef="usd">99000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i33bec573c45c4432aabe045af1c87f71_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEwLTMtMS0xLTA_cfac07fa-141c-4a0c-9524-320f6c0b9028"
      unitRef="usd">21000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEwLTgtMS0xLTA_526c9080-942d-442a-b6c8-d6d4ad7b867b"
      unitRef="usd">21000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="idc23a2ce07eb4cab9ac46e9996f1a9da_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEyLTEtMS0xLTA_fae1ac77-2ee8-45e6-a0c1-3e72b4138e17"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEyLTYtMS0xLTA_d386ecaa-d26a-44cb-b49d-d0826dee35ec"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEyLTgtMS0xLTA_1698dbcc-e8e5-4b43-bc91-5f047dd8b1f6"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ieda80e73180744408f6bbd3ae90626ce_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEzLTctMS0xLTA_36af24b6-f880-4f39-8be0-08f18601fb94"
      unitRef="usd">16000000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzEzLTgtMS0xLTA_575ae474-4fae-4e81-884c-b5a775020089"
      unitRef="usd">16000000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings
      contextRef="ib94226cbc95e4f099933504fa1529358_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE1LTQtMS0xLTA_f050b597-cc8f-4dd6-9c84-01fb35691e80"
      unitRef="usd">2000000</dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings>
    <dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings
      contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE1LTUtMS0xLTA_6ae681fb-f470-4edf-a552-432a19bf7545"
      unitRef="usd">-2000000</dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings>
    <dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE1LTgtMS0xLTA_7e41c3c2-e8e7-4535-875e-a2a34f25403e"
      unitRef="usd">0</dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic3b3e31d6d274c90b794939c176a7b77_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTEtMS0xLTA_767d1fbe-e86e-41fa-ae6c-d7093b7b6247"
      unitRef="shares">135000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic3b3e31d6d274c90b794939c176a7b77_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTItMS0xLTA_ffeda07e-0c96-4af1-afde-a67906197d80"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6c6477bf68d434b85bfce824998f2ee_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTMtMS0xLTA_509198f8-4c18-44b4-977e-9a0ee4b697d4"
      unitRef="usd">2667000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67fd5ab592cb4dd3942ac4292d19633a_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTQtMS0xLTA_d0e30270-005a-45c8-906a-66935a2a6617"
      unitRef="usd">7602000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f0ce225b8594c6a86f10f4f1abe8e39_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTUtMS0xLTA_4e14170a-aa6b-4a7d-879b-abdc848fa616"
      unitRef="usd">-59000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i555d3026ca444d259517b679c5239f46_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTYtMS0xLTA_6d7308ec-858d-4890-b9a4-af34c7bb3e51"
      unitRef="usd">-4996000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f4f32dc2af94a159626591aaf9de348_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTctMS0xLTA_7bfef0e3-8b18-497d-8d8e-3bd340d44dd2"
      unitRef="usd">51000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTgtMS0xLTA_5002fbe4-4dcd-4324-8225-a5963cb9d437"
      unitRef="usd">5267000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE2LTExLTEtMS0w_a4af0758-63fd-4047-97b6-2e7aaea227f9"
      unitRef="usd">77000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ibe7163fcb9b04409a8a0d9696060f250_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE3LTQtMS0xLTA_b2b9f4b2-a229-49b2-ae8c-adc8d0087d32"
      unitRef="usd">858000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ie567c107fbeb4e04816dbbef6a7bffb2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE3LTctMS0xLTA_71bc41cc-980d-41ff-8c30-2ed3a2f48010"
      unitRef="usd">42000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE3LTgtMS0xLTA_9703439a-a86c-472c-bed1-09333973d5a8"
      unitRef="usd">900000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE3LTExLTEtMS0w_2df388ec-c214-4363-8c53-4e6e623bbec9"
      unitRef="usd">6000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE4LTUtMS0xLTA_c39290ba-1196-4018-a2eb-6b1355916389"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE4LTgtMS0xLTA_349702f4-d5c4-43b6-a5c3-90124b593d02"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="ibe7163fcb9b04409a8a0d9696060f250_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE5LTQtMS0xLTA_51286497-4ae5-4dff-9959-acaf502740e6"
      unitRef="usd">286000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzE5LTgtMS0xLTA_4c5fa144-b56a-4d1d-8f5c-e017a05a3202"
      unitRef="usd">286000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie567c107fbeb4e04816dbbef6a7bffb2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIwLTctMS0xLTA_490385df-1f9b-4e00-a099-1312df3761b5"
      unitRef="usd">47000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIwLTgtMS0xLTA_ff77d526-0d32-4c7b-8390-236e11ee9bf5"
      unitRef="usd">47000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIwLTExLTEtMS0w_ecea7580-6613-459d-866a-876a4e31ca31"
      unitRef="usd">7000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIxLTMtMS0xLTA_0777af38-36ba-44c8-91f6-a2d2008cd4b4"
      unitRef="usd">9000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIxLTYtMS0xLTA_1c44dff7-af3b-4a4b-b839-c576c7fbbd16"
      unitRef="usd">15000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIxLTgtMS0xLTA_48a08c61-4be5-4a5f-a081-ba34f359742c"
      unitRef="usd">24000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIyLTMtMS0xLTA_8d9ec04f-0237-4420-b216-f43d9efc3117"
      unitRef="usd">55000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIyLTYtMS0xLTA_0f28d24d-3e17-4980-a53b-62b0fe823763"
      unitRef="usd">1000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIyLTgtMS0xLTA_303d1e90-6dd4-477e-a27a-52d0260d6523"
      unitRef="usd">56000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i115773febea64e13b53405dd26daabf7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIzLTEtMS0xLTA_7753977e-20cb-44f2-9137-3876553478bf"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIzLTMtMS0xLTA_72fa66b9-a3f8-49b9-b78c-1bd3ec648e30"
      unitRef="usd">7000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIzLTYtMS0xLTA_fd538f30-68f0-4909-b005-c905e466995a"
      unitRef="usd">112000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzIzLTgtMS0xLTA_bf3c3293-1dd1-4840-af05-1f3f0a56fe5a"
      unitRef="usd">119000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5b00381bd1f74511aad739f4969b09d2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI0LTMtMS0xLTA_00ffba34-c621-4638-8b21-bb9f9d1abc89"
      unitRef="usd">16000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI0LTgtMS0xLTA_af85f59f-b739-4507-bdb4-db192bb23473"
      unitRef="usd">16000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i115773febea64e13b53405dd26daabf7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI2LTEtMS0xLTA_6aaf6975-213f-46e1-94cd-d9d72652dce0"
      unitRef="shares">4000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI2LTYtMS0xLTA_4d83792f-b4af-4cd7-86c7-861f71dccc7e"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzI2LTgtMS0xLTA_0dfd4c89-cf6b-48d0-af62-184b8791cfda"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1dd09031318c470d8f39dd4c76ee0f42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTEtMS0xLTA_e380a6e4-d63f-44c8-90dc-062cf44f8764"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1dd09031318c470d8f39dd4c76ee0f42_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTItMS0xLTA_aebe07a2-e3ab-48e2-8b3a-65f96cb0d0a7"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice7cb1556ee64aad934a266328c5feb8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTMtMS0xLTA_590bc3dc-b0f0-4551-a1d6-adf5317457a5"
      unitRef="usd">2722000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie5538d27d3cf4309be1e10b072ade004_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTQtMS0xLTA_27259ecc-0561-4f2c-a189-a9e67dac11df"
      unitRef="usd">8174000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i41a7f39f717a41848294a65ad208374f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTUtMS0xLTA_0919b3fb-4867-4443-a9c3-d1ddee8316de"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1868c09b2e774ccf815153a8ec738276_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTYtMS0xLTA_0dee0a04-f9ee-42c5-b710-7154f3298265"
      unitRef="usd">-5218000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b7931aebebd467eab54c73e0a052b8b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTctMS0xLTA_8460e29b-e696-48e3-bc8b-87d35752c41f"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTgtMS0xLTA_da718308-6d2b-4eaf-bdbb-1a80c8d3157c"
      unitRef="usd">5687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMwLTExLTEtMS0w_1f7cb5ba-7524-487b-8a99-abe4939b3cef"
      unitRef="usd">76000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i75af2f2e63234a768a4f963e010f642a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMxLTQtMS0xLTA_25d7b739-1890-4902-87f4-868bf18fa4b3"
      unitRef="usd">1431000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i3f9ff7ef1303400184e1457d527c79ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMxLTctMS0xLTA_d7bf2d03-760f-4afe-87e7-7cb255886922"
      unitRef="usd">53000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMxLTgtMS0xLTA_ed580bec-0e9c-48c4-8b41-1fd646d91ff2"
      unitRef="usd">1484000000</dgx:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMxLTExLTEtMS0w_ddc41542-5a48-4c64-bdd1-762beb0450f1"
      unitRef="usd">15000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMyLTUtMS0xLTA_7f33f288-75c7-4e73-a06b-9562eebea78b"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMyLTgtMS0xLTA_cdcc7646-0e99-4ffa-809c-a273fb71f605"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i75af2f2e63234a768a4f963e010f642a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMzLTQtMS0xLTA_ead438de-bc1e-4c32-b2ac-fe10cc743300"
      unitRef="usd">302000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzMzLTgtMS0xLTA_eb6d3ade-a9e2-4ff9-981c-16527eee213e"
      unitRef="usd">302000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i3f9ff7ef1303400184e1457d527c79ba_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM0LTctMS0xLTA_1b4c120d-9cea-458c-87fc-3f33540c97ba"
      unitRef="usd">49000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM0LTgtMS0xLTA_6aed6852-66b7-4d4a-aba0-553c6d28d7cc"
      unitRef="usd">49000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM0LTExLTEtMS0w_407873fd-cd5e-4024-9674-be417336c15b"
      unitRef="usd">9000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3aa95b24c6da4e29ba0be0001d98ee6f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM1LTEtMS0xLTA_330335d4-afb1-496c-82ec-862b20c62beb"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2981e27108c24f95953c617cc7270437_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM1LTMtMS0xLTA_7a64fc8b-579b-400e-93bd-e212a4af2b05"
      unitRef="usd">11000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM1LTYtMS0xLTA_f0c295dd-8e71-4da4-95ca-add1073f337d"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM1LTgtMS0xLTA_a072b228-7683-4d2f-8720-68d825c96884"
      unitRef="usd">25000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2981e27108c24f95953c617cc7270437_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM2LTMtMS0xLTA_a5a42aeb-c0ad-46e3-a6e5-2dad2b104eab"
      unitRef="usd">97000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM2LTgtMS0xLTA_79571370-7a3e-4f0a-8dac-edd924e9e2be"
      unitRef="usd">97000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3aa95b24c6da4e29ba0be0001d98ee6f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM3LTEtMS0xLTA_e005c163-ded4-453c-9655-3f0ce5707aa6"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2981e27108c24f95953c617cc7270437_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM3LTMtMS0xLTA_57f30262-2e63-4acc-b688-86fd6bba7877"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM3LTYtMS0xLTA_fd6e5635-765c-4a1d-a8ad-09bb9359a07a"
      unitRef="usd">163000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM3LTgtMS0xLTA_35165c82-65e5-47a2-abc5-cd5f42f6e42c"
      unitRef="usd">189000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2981e27108c24f95953c617cc7270437_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM4LTMtMS0xLTA_6e4f218d-d5da-45b2-909f-b5ad5875e369"
      unitRef="usd">15000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM4LTgtMS0xLTA_d7e71f6b-984e-4ea0-b9dc-ea1103c1ffda"
      unitRef="usd">15000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3aa95b24c6da4e29ba0be0001d98ee6f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM5LTEtMS0xLTA_ed497a5f-26c5-4597-a331-6d0983ca8d42"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM5LTYtMS0xLTA_8ffac86d-1221-4345-8506-b29dc95e4615"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzM5LTgtMS0xLTA_6c694a15-9681-44ab-a076-a68958317446"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i92ba93e0278a4f689344c35f78cc1de4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTEtMS0xLTA_f44ce5b0-961c-49d5-8ce9-4c475b3fe2c8"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92ba93e0278a4f689344c35f78cc1de4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTItMS0xLTA_ae9b3dd3-5e11-40ea-8027-f20f7144f582"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71632adeaf9840789ac22fcbe1d4ab41_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTMtMS0xLTA_14bcc337-9b6e-44c4-9f0e-da32960e453f"
      unitRef="usd">2841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd49c909bbf34ee8ac8ef91267017389_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTQtMS0xLTA_84d24b7a-e7b6-4d13-853d-07d3981f2f22"
      unitRef="usd">9303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15c1b65002784549a102581ed4f9ec6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTUtMS0xLTA_2312cf29-2f18-4645-be47-811be6ba70c1"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i37b30b92632f4bb7b032b7a33f542c34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTYtMS0xLTA_593298fa-d5ab-48c8-a2c8-e31ad06cb590"
      unitRef="usd">-5366000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if93dc28be267444d8934097d07d281a0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTctMS0xLTA_e94b45e8-aa51-45ed-8dcf-b535f4bba91b"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTgtMS0xLTA_94751198-8ec3-4f9a-b27e-23bb47491583"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjAvZnJhZzpkNzFjMjVkY2FmMTg0ZWRiYTIxODUzMmI1N2Y3OGMyOC90YWJsZTphNzA3NGE1Y2Q3ZDg0ZjU5YjFjZTI3MTNkYmViZjA3ZS90YWJsZXJhbmdlOmE3MDc0YTVjZDdkODRmNTliMWNlMjcxM2RiZWJmMDdlXzQzLTExLTEtMS0w_c1fd01b0-cd88-4212-97d7-0fb8047dacd7"
      unitRef="usd">82000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NatureOfOperations
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjYvZnJhZzoyZjI3NjBjYjkzMmY0MzA0Yjg3NTI0ZjZmYmU2OTkyYy90ZXh0cmVnaW9uOjJmMjc2MGNiOTMyZjQzMDRiODc1MjRmNmZiZTY5OTJjXzE3NTA_f7ede858-994e-4242-9ff8-ce559fe42cd5">DESCRIPTION OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjk0_c08a70af-42f9-47bd-8477-97daa946fc93">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#x201c;VIEs&#x201d;) in which the Company has a variable interest and for which the Company is the &#x201c;primary beneficiary&#x201d; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 21 for a further discussion of discontinued operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between 20% and 49%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately 11%, 15% and 16% of the Company's consolidated net revenues for the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Taxes on Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#x201c;ELTIP&#x201d;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#x201c;DLTIP&#x201d;).  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating expense (income), net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and is limited to certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of December&#160;31, 2020 and 2019, receivables due from government payers under the Medicare and Medicaid programs represented approximately 6% and 11%, respectively, of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2020 and 2019, receivables due from patients represented approximately 11% and 20%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accounts receivable are reported net of allowances for credit losses.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2020 as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;buildings and improvements, ranging up to thirty-one and a half years; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;laboratory equipment and furniture and fixtures, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDgy_7012da4d-00be-4056-8e53-6cc514ee15da"&gt;five&lt;/span&gt; to twelve years; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;computer software developed or obtained for internal use, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njky_056ade57-4241-451a-a1e9-095ca78772c6"&gt;five&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.  For the year ended December&#160;31, 2019, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQx_017f65e9-fcca-4642-991b-5a831db9e67f"&gt;five&lt;/span&gt; to twenty years.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Based upon the Company&#x2019;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2020 and 2019, the Company concluded that indefinite-lived intangible assets were not impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's investments (except for those accounted for under the equity method of accounting), are included in other assets in the consolidated balance sheet and include:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity investments with readily determinable fair values which are comprised of participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income (expense), net in the consolidated statements of operations.  For the years ended December&#160;31, 2020, 2019 and 2018, gains and (losses) from these equity securities totaled $8&#160;million, $10 million, and $(2) million, respectively.  The carrying value of these investments were $67&#160;million and $59 million at December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; no impairment charges were recognized related to these investments for the years ended December&#160;31, 2020, 2019, and 2018.  The carrying value of these investments was $25 million at both December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $12 million at both December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income (expense), net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16).  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Standards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the Financial Accounting Standards Board ("FASB") which aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.  The adoption of this standard, which the Company elected to do on a prospective basis, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the FASB that changes the impairment model for most financial instruments, including trade receivables, from an incurred loss method to a new forward &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;looking approach, based on expected losses.  The estimate of expected credit losses requires entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts.  The adoption of this new standard, which was done using a modified retrospective transition approach, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.  See "Accounts Receivable and Allowance for Credit Losses" in this footnote for further details on the Company's allowance for credit losses policy.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On January 1, 2019, the Company adopted a new accounting standard issued by the FASB on accounting for leases using the modified retrospective method. This new accounting standard requires a lessee to recognize on its balance sheet an asset and liability for most leases. The Company elected the optional transition method that allowed for a cumulative-effect adjustment to the opening balance of retained earnings recorded on January 1, 2019 and did not restate previously reported results in the comparative periods.  The Company also elected the package of practical expedients, which among other things, allowed it to carry forward its historical lease classification. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As a result of adoption of the new standard, the Company recorded operating lease assets and lease liabilities of approximately $500&#160;million and $550&#160;million, respectively as of January 1, 2019.  The operating lease liability was determined based on the present value of the remaining minimum rental payments and the operating lease asset was determined based on the value of the lease liability, adjusted for the deferred rent balances of approximately $50&#160;million, which were previously included in accounts payable and accrued expenses as well as other liabilities in the consolidated balance sheet.  Accounting for the Company's finance leases remained substantially unchanged.  The adoption of the new standard did not materially impact the Company's consolidated results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:38.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, the adoption of this new accounting standard resulted in increased qualitative and quantitative disclosures regarding the amount, timing, and uncertainty of cash flows arising from leases. For further details, see Note 14.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards To Be Adopted&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;In March 2020, the FASB issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjY0_467ca85a-ba80-44df-b067-487a2c7dd7e7">The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#x201c;VIEs&#x201d;) in which the Company has a variable interest and for which the Company is the &#x201c;primary beneficiary&#x201d; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjIw_2f9899c8-77e8-4349-9034-55240fed6587">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 21 for a further discussion of discontinued operations.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjU5_39438c9f-ef92-4080-9cda-5b923aa93bb4">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjk2_b252adbd-e5fd-48e6-9d2c-0c7e4e4ecc58">Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between 20% and 49%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4536b39c8fa64a308c3b9a68dc9e82ab_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE5OTk_510bbae9-72e4-4e54-affe-66f458ede54e"
      unitRef="number">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3bf2fc1a93c943d987e412080b37ceb5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIwMDY_405360ae-9e12-4993-9918-8dd0215996f4"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:UseOfEstimates
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjIx_ecbbba1c-eaa5-4e17-85d5-8466913de997">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjcy_f185eaaf-d03d-404b-a835-7e266cca383b">The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately 11%, 15% and 16% of the Company's consolidated net revenues for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i9bc00e25bfc644b48820a7fd5b03ba76_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzM1MDA_651646f4-4756-418c-ab54-1dedbedb2571"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ibd9a84f00e01401a9a6b093b0dc83ae7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzM1MDQ_24a01ab2-e642-41c9-b565-521ec092dfbd"
      unitRef="number">0.15</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3ac9f8df65254c228ccb0893cb2bcae7_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzM1MTE_d12a7109-d11f-4661-baa2-7d8ae03a68a1"
      unitRef="number">0.16</dgx:PercentageofNetRevenues>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjMx_a8fdb5e8-8a60-4bf1-b84c-df3b631d25dd">The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjM2_a0ed27e6-c8e1-4850-97b5-32ad6c80e312">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#x201c;ELTIP&#x201d;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#x201c;DLTIP&#x201d;).  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjI2_e34f9139-f836-43ac-847d-2d1160e09b8e">The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNTk5_2f837f8c-a59e-43f8-bd33-278c6a300d9f">The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-72pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjEz_7c36b4b3-0142-41f2-add6-947e01b72fd4">The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating expense (income), net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjc4_6e6f2c03-15d8-40ff-af93-8e87019794a6">Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjA4_e9018092-76a4-47c7-9201-377bd3ac866f">Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and is limited to certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of December&#160;31, 2020 and 2019, receivables due from government payers under the Medicare and Medicaid programs represented approximately 6% and 11%, respectively, of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2020 and 2019, receivables due from patients represented approximately 11% and 20%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i581470f6c29c4d3bbb553be7ce613857_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzExNDA4_fea49c38-8c74-4323-b36d-1f3d3a13341c"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ief7b1c30e21b4abe80d55c1558999325_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzExNDE1_72bdb8ad-4f01-46d9-82a3-645e6a2f2c1a"
      unitRef="number">0.11</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofReceivablesDueFromPatients
      contextRef="id931c5900d5344649f91ba0b0016de0c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzEwNDQ1MzYwNTE5ODM2_2c4c6b64-1bad-43ad-96e0-d5fcd47bfa33"
      unitRef="number">0.11</dgx:PercentageofReceivablesDueFromPatients>
    <dgx:PercentageofReceivablesDueFromPatients
      contextRef="ifb24d45e71f14152b0beee33dd6fe7b8_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzExNjgx_9e147ec7-ae24-43b1-ae8a-e1ee17473bcc"
      unitRef="number">0.20</dgx:PercentageofReceivablesDueFromPatients>
    <dgx:AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjU1_9383d8b6-6b41-48f8-956b-16d834178424">Accounts receivable are reported net of allowances for credit losses.  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.&lt;/span&gt;&lt;/div&gt;</dgx:AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNzIy_5b4671db-47f7-48a7-8566-4bc3e437eebb">Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjM5_9b070949-87d2-4518-b334-1e55839f2959">Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2020 as follows: &lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;buildings and improvements, ranging up to thirty-one and a half years; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;laboratory equipment and furniture and fixtures, ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDgy_7012da4d-00be-4056-8e53-6cc514ee15da"&gt;five&lt;/span&gt; to twelve years; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:63pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;computer software developed or obtained for internal use, &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njky_056ade57-4241-451a-a1e9-095ca78772c6"&gt;five&lt;/span&gt; to ten years.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4fa47ff8680e47e186c2a067dad4395c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDg4_da7548cf-74cc-4eb9-b09e-d6d3c69ea3b1">P12Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i76c1d7dadde4494c96e7166dd2fa23a9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njk4_8bce2674-8995-4194-bdaa-e77e09477b04">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjA5_849b7ae8-c35a-4187-8930-108ec9782fc7">Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.  For the year ended December&#160;31, 2019, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjAz_b26f8f45-0c30-4058-a8c8-fd03e7ea44f3">Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQx_017f65e9-fcca-4642-991b-5a831db9e67f"&gt;five&lt;/span&gt; to twenty years.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  &lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Based upon the Company&#x2019;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2020 and 2019, the Company concluded that indefinite-lived intangible assets were not impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQ3_6128722f-d0b9-4a96-9939-0b1dbe3fd8ab">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNTg3_afcd6c1d-3747-414e-a587-5eb6f9c63f01">The Company's investments (except for those accounted for under the equity method of accounting), are included in other assets in the consolidated balance sheet and include:&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity investments with readily determinable fair values which are comprised of participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income (expense), net in the consolidated statements of operations.  For the years ended December&#160;31, 2020, 2019 and 2018, gains and (losses) from these equity securities totaled $8&#160;million, $10 million, and $(2) million, respectively.  The carrying value of these investments were $67&#160;million and $59 million at December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; no impairment charges were recognized related to these investments for the years ended December&#160;31, 2020, 2019, and 2018.  The carrying value of these investments was $25 million at both December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $12 million at both December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzEwNDQ1MzYwNTE4NTY0_cdff4d87-0159-424d-bb82-1ce53a9b7f3e"
      unitRef="usd">8000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIwNjQ4_1c8e395f-78f6-40bb-bd95-735cbb92b443"
      unitRef="usd">10000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIwNjU2_6351eda7-1e73-4739-9d80-9aa2221b2f65"
      unitRef="usd">-2000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:TradingSecuritiesEquity
      contextRef="iff8b5e5555da40068d37c37923c31be5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzEwNDQ1MzYwNTE4NTQw_08bebd6a-793e-447a-8628-2344b5de966b"
      unitRef="usd">67000000</us-gaap:TradingSecuritiesEquity>
    <us-gaap:TradingSecuritiesEquity
      contextRef="ibe9d4b35706146759a8e29e92296d796_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIwNzI3_03f6b434-dbf6-4acc-809d-14e2367a8e6f"
      unitRef="usd">59000000</us-gaap:TradingSecuritiesEquity>
    <dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMTc3_8c5abe28-a689-4e8d-9858-59d1f677dcc8"
      unitRef="usd">0</dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment>
    <dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMTc3_c9b0b7fe-5837-41ec-b5f1-c1b684441e89"
      unitRef="usd">0</dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment>
    <dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMTc3_e7845de4-a06c-4c64-bbdd-71148090a293"
      unitRef="usd">0</dgx:InvestmentwithoutReadilyDeterminableFairValueImpairment>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMzMz_6aea7c13-362b-4307-814c-e64a84e482b9"
      unitRef="usd">25000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxMzMz_dbb51803-8344-48f8-ae69-0449dc75d941"
      unitRef="usd">25000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxNjAx_15490825-c620-4b88-9f52-dae68182cab3"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxNjAx_b708b957-3fa3-44ac-bfb4-60b1ba43093f"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjQ5_65f8017a-b8a6-4a12-bb42-22a2dc863023">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income (expense), net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNzI0_ee3358f6-cff3-46fd-82b9-dd8bc906cc97">Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities; and &lt;/span&gt;&lt;/div&gt;&#x2022;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16).</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzMwNjg1_1183369c-743a-4091-8ef8-4f21b32ab771">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Standards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the Financial Accounting Standards Board ("FASB") which aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.  The adoption of this standard, which the Company elected to do on a prospective basis, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the FASB that changes the impairment model for most financial instruments, including trade receivables, from an incurred loss method to a new forward &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;looking approach, based on expected losses.  The estimate of expected credit losses requires entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts.  The adoption of this new standard, which was done using a modified retrospective transition approach, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.  See "Accounts Receivable and Allowance for Credit Losses" in this footnote for further details on the Company's allowance for credit losses policy.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On January 1, 2019, the Company adopted a new accounting standard issued by the FASB on accounting for leases using the modified retrospective method. This new accounting standard requires a lessee to recognize on its balance sheet an asset and liability for most leases. The Company elected the optional transition method that allowed for a cumulative-effect adjustment to the opening balance of retained earnings recorded on January 1, 2019 and did not restate previously reported results in the comparative periods.  The Company also elected the package of practical expedients, which among other things, allowed it to carry forward its historical lease classification. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As a result of adoption of the new standard, the Company recorded operating lease assets and lease liabilities of approximately $500&#160;million and $550&#160;million, respectively as of January 1, 2019.  The operating lease liability was determined based on the present value of the remaining minimum rental payments and the operating lease asset was determined based on the value of the lease liability, adjusted for the deferred rent balances of approximately $50&#160;million, which were previously included in accounts payable and accrued expenses as well as other liabilities in the consolidated balance sheet.  Accounting for the Company's finance leases remained substantially unchanged.  The adoption of the new standard did not materially impact the Company's consolidated results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:38.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, the adoption of this new accounting standard resulted in increased qualitative and quantitative disclosures regarding the amount, timing, and uncertainty of cash flows arising from leases. For further details, see Note 14.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards To Be Adopted&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;In March 2020, the FASB issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic81a1f6e1fcc43198cf6c34688f73ef0_I20190101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxOTkwMjMzMTgwNTg_8ad4c698-721c-40a5-a533-bfa67e0a7f39"
      unitRef="usd">500000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic81a1f6e1fcc43198cf6c34688f73ef0_I20190101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxOTkwMjMzMTgwODY_634fb3b1-4918-457b-8d94-0a20354c8e10"
      unitRef="usd">550000000</us-gaap:OperatingLeaseLiability>
    <dgx:DeferredRentAdjustments
      contextRef="i1b9a18afbf954307bc8e506be81cbe70_I20190101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzIxOTkwMjMzMTgxMTM_043204ee-1c4f-4680-9e78-b3b8de2c8b97"
      unitRef="usd">50000000</dgx:DeferredRentAdjustments>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzc3NDc_39b9175c-13dd-4cc7-b6a9-2b6225125426">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DIS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues in the Company&#x2019;s DIS business accounted for greater than 95% of the Company&#x2019;s total net revenues for the years ended December&#160;31, 2020, 2019 and 2018 and are primarily comprised of a high volume of relatively low-dollar transactions.  The DIS business, which provides clinical testing services and other services, satisfies its performance obligation and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions, as discussed below. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers, client payers and patients.  Contracts with customers in the DIS business do not contain significant financing components based on the typical period of time between performance of services and collection of consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The process for estimating revenues and the ultimate collection of accounts receivable involves significant judgment and estimation.  The Company follows a standard process, which considers historical denial and collection experience and other factors (including the period the receivables have been outstanding), to estimate contractual allowances and implicit price concessions, recording adjustments in the current period as changes in estimates.  Further adjustments to the allowances, based on actual receipts, may be recorded upon settlement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following are descriptions of the DIS business&#x2019; portfolios:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Healthcare Insurers &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reimbursements from healthcare insurers are based on negotiated fee-for-service schedules and on capitated payment rates.  Under fee-for-service arrangements, healthcare insurers are billed at the Company's list price.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and the terms of the Company&#x2019;s contractual arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Collection of the Company's net revenues from healthcare insurers is normally a function of providing complete and correct billing information to the healthcare insurers within the various filing deadlines and generally occurs within 30 to 60 days of billing.  Provided the Company has billed healthcare insurers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and if so, it will reserve accordingly for the billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under capitated arrangements with healthcare insurers, the Company recognizes revenue based on a predetermined monthly reimbursement rate for each member of an insurer's health plan regardless of the number or cost of services provided by the Company.  Healthcare insurers typically reimburse the Company under capitated arrangements in the same month services are performed, essentially giving rise to no outstanding accounts receivable at the end of a reporting period.  If any capitated payments are not received on a timely basis, the Company determines the cause and makes a separate determination as to whether or not the collection of the amount from the healthcare insurer is at risk and, if so, would reserve accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Payers&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reimbursements from government payers are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and other factors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Collection of the Company's net revenues from government payers is normally a function of providing the complete and correct billing information within the various filing deadlines and generally occurs within 30 days of billing.  Provided the Company has billed government payers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and, if so, it will reserve for the billing accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Client Payers &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Client payers include physicians, hospitals, ACOs, DCEs, IDNs, employers, other commercial laboratories and institutions for which services are performed on a wholesale basis, and are billed based on negotiated fee schedules.  Credit risk and ability to pay are more of a consideration for these payers than healthcare insurers and government payers.  Collection of consideration the Company expects to receive generally occurs within 60 to 90 days of billing.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company principally estimates the allowance for credit losses for client payers based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding. To the extent that any individual client payers are identified that have deteriorated in credit quality, the Company establishes allowances based on the individual risk characteristics of such customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patients&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients.  Insured patients (includes coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers.  Collection of billings from patients is subject to credit risk and ability of the patients to pay.  Net revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with the Company&#x2019;s policies and implicit price concessions.  Implicit price concessions represent differences between amounts billed and the estimated consideration the Company expects to receive from patients, which considers historical collection experience (including the period the receivables have been outstanding) and other factors including current market conditions. Patient billings are generally fully reserved for when the related billing reaches 210 days outstanding.  Balances are automatically written off when they are sent to collection agencies.  Allowances are further adjusted for estimated recoveries of amounts sent to collection agencies based on historical collection experience, which is regularly monitored.  Collection of consideration the Company expects to receive generally occurs within 30 to 60 days of billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered.  Collection of consideration the Company expects to receive generally occurs within 30 to 60 days of billing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, substantially all of the Company&#x2019;s services were provided within the United States, see Note 19.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2020 and 2019 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table summarizes the activity for the Company's allowance for credit losses during the year ended December&#160;31, 2020, which principally relates to client payers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of accounts receivable, net of recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i29c671e617c045bcb06b53c554e033e0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzEwNA_2a80342c-6593-4f01-9eb7-b27e9cea3064"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9de3b9dd0a624ae68544d4880991cf82_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzEwNA_789f5cd0-709b-4831-a748-eb10be631f11"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="if585a3710daf402a97611004eea949c1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzEwNA_84f3135a-23c8-4c55-8f55-1946a3e9752e"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i6eea2c55b034437ba80ba06e3965157c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzI4Mzg_5bad0566-53d3-49ec-8a15-2fad8b5f645d">P30D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i77c9bd2166d847329c826595afad408b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzI4NDQ_0b761d37-752b-478e-bbba-1f1e39920070">P60D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i0b01ba3ff27b4ed39eb31b8ed8e1b653_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzQ2MzU_baf38a1a-2686-483c-a794-b7f280df9465">P30D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="ic4b549cd3a3d4d348d914417e72845c3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzU0NzI_3c640902-d7c4-4dd8-b0f0-d441c81a69ef">P60D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i4019a241c0854daab20a021259e4c9f9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzU0Nzg_7c6c45c1-cd8b-4a89-a9fd-c4d105092d42">P90D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:PeriodofBillingFullyReserve
      contextRef="ifcb29cd72cb14152805c1b85799d4c7a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzY3NjI_0bbb5214-e2af-40ed-95d0-f3e735f50553">P210D</dgx:PeriodofBillingFullyReserve>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="ie8b8bafd84534ecfa78e8dc260538826_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzcxMjA_8bbadd57-2212-4df2-8d25-58828366245d">P30D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i2ccba44e5f4a40efb5fa7b5d55920320_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzcxMjY_90736009-b6d8-42d9-8c26-4cd1c5a733d5">P60D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="if014b0d6144e489c86cc32ab7f88bc09_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzczOTM_21acb058-5af3-45b5-96d5-0d97eb26b53e">P30D</dgx:RevenueCollectionofConsiderationPeriod>
    <dgx:RevenueCollectionofConsiderationPeriod
      contextRef="i348dfcaea5c4487f8852b9106d40158f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzczOTk_d2df5e37-a2f3-4163-a684-f8a6e3aa7a4b">P60D</dgx:RevenueCollectionofConsiderationPeriod>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzc3NTA_a4c913b3-d4a8-4656-984b-9674d5b547e7">The approximate percentage of net revenue by type of customer was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.026%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="ia52723062e0945b0b050cdad8b6e84ca_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzMtMS0xLTEtMA_84b13c9d-7b70-4e95-acf0-1a6f1848d178"
      unitRef="number">0.34</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i7b77dcd1e3264ddbbfc39c8cb976394a_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzMtMy0xLTEtMA_d6b36cbe-5f95-4878-8a16-23e7e569c8af"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="id46ed269b0314d81abc231a84b687522_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzMtNS0xLTEtMA_bab7f71c-837b-4bc0-a9d8-8c8585ce2590"
      unitRef="number">0.32</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i1ba00c793ebf4cd4aef56d2438bd0c77_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzQtMS0xLTEtMA_339327a0-2922-490a-b893-ed040df961c0"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i49c3be8da8bb40cfada15e955553b6f3_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzQtMy0xLTEtMA_f73071d1-148b-48df-97d1-3f3d5cbec218"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3716ed1635444a1db24339ff3c1ee6b4_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzQtNS0xLTEtMA_46f24fe6-87a3-4033-aaf7-186b627e0a8e"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iacb5aef155d741e9acbdddbaa368b0a8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzUtMS0xLTEtMA_08004e2c-00a1-4fcc-90fb-26a205fb96b6"
      unitRef="number">0.37</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ib0e0d2b48b134218ab9fe6ae972ccc18_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzUtMy0xLTEtMA_abc4fde7-8bd6-414a-a14f-d1e4d576481c"
      unitRef="number">0.36</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ifae49365342b454dadab2010496cdb33_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzUtNS0xLTEtMA_fbb7735b-e8ad-499c-9a8e-ecf98373c648"
      unitRef="number">0.35</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9bc00e25bfc644b48820a7fd5b03ba76_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzYtMS0xLTEtMA_651646f4-4756-418c-ab54-1dedbedb2571"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ibd9a84f00e01401a9a6b093b0dc83ae7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzYtMy0xLTEtMA_24a01ab2-e642-41c9-b565-521ec092dfbd"
      unitRef="number">0.15</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i3ac9f8df65254c228ccb0893cb2bcae7_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzYtNS0xLTEtMA_d12a7109-d11f-4661-baa2-7d8ae03a68a1"
      unitRef="number">0.16</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i24a36f7ed0c74323a2fa29fbf45031a6_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzctMS0xLTEtMA_792ebe09-23c0-4db7-a2b6-38a95a7cb8d7"
      unitRef="number">0.38</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie7c506d404ea4b66a4fc8535a8907e45_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzctMy0xLTEtMA_9fd9aaeb-151a-4933-82e7-79afd69684d3"
      unitRef="number">0.32</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iba4d37f590c64c0da8af33c3f247ce79_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzctNS0xLTEtMA_cc4530b6-59f8-4b15-9bf7-1f147e233005"
      unitRef="number">0.32</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ifcb29cd72cb14152805c1b85799d4c7a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzgtMS0xLTEtMA_12e307e2-2fd7-48d2-b161-ab8c5f0bbcab"
      unitRef="number">0.11</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9fb51ebe236448f590ad554101a9b9c6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzgtMy0xLTEtMA_10fdb7d0-7ecd-4233-9fd3-35e46b1e47ae"
      unitRef="number">0.13</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iea687d8906104369b661d038cde542bd_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzgtNS0xLTEtMA_9e47ba58-def0-4f29-a1b4-13aab814a9e4"
      unitRef="number">0.13</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzktMS0xLTEtMA_c4294434-1ef3-4a24-a0e5-6d5541dd97aa"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzktMy0xLTEtMA_7cffcb0d-2b21-4e98-8bb0-3fcf599a063e"
      unitRef="number">0.96</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzktNS0xLTEtMA_4d88babd-4e4b-4626-adc1-baf94b661358"
      unitRef="number">0.96</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i5734074de09c4b53a530f4b9f89b68ad_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzEwLTEtMS0xLTA_1af7a47f-03dc-41ae-aa4b-466bc05de8cb"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i45b1a79458e1445fa42674f9f2d678ab_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzEwLTMtMS0xLTA_7eb0b0b3-e705-4d29-ae19-52eae9d24651"
      unitRef="number">0.04</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9ca59367e3f94c41a84556b97c86bdbb_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzEwLTUtMS0xLTA_c16b8928-5eff-4873-9971-15ad671b7c3f"
      unitRef="number">0.04</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzExLTEtMS0xLTA_2dfae373-a026-4b40-a928-bfaecf70ce46"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzExLTMtMS0xLTA_2f860d48-b467-4969-b897-c50407fb4667"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTpiNTRiNWMxYzhiMGE0N2EwOWMxMzk1NWQ3ZDkwZDE5MC90YWJsZXJhbmdlOmI1NGI1YzFjOGIwYTQ3YTA5YzEzOTU1ZDdkOTBkMTkwXzExLTUtMS0xLTA_c8cc2af6-6b43-4b5b-bb8a-1cbb4a0a2e6f"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:AccountsReceivableDisaggregationTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzc3NTE_58259dc3-2599-4e9a-8c3c-f57c6f70457a">The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2020 and 2019 was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:AccountsReceivableDisaggregationTableTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="id83f485f0e424cc0b613c7b977010fa5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzItMS0xLTEtMA_cbe8e01a-49d7-4fe0-bab5-699c697d6178"
      unitRef="number">0.34</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i6d87850a80eb4b4babfe02021d7d3c4d_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzItMy0xLTEtMA_b0e9b5ee-f686-42e5-937e-daac94d32580"
      unitRef="number">0.22</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i581470f6c29c4d3bbb553be7ce613857_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzMtMS0xLTEtMA_fea49c38-8c74-4323-b36d-1f3d3a13341c"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ief7b1c30e21b4abe80d55c1558999325_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzMtMy0xLTEtMA_72bdb8ad-4f01-46d9-82a3-645e6a2f2c1a"
      unitRef="number">0.11</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i09aa4abe117b4d52b3a8808dab5026d6_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzQtMS0xLTEtMA_f210a37e-32cc-4a93-8ca1-4640855bcf7c"
      unitRef="number">0.46</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i0c2eebecc91f4f99994187f91e6cf8ef_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzQtMy0xLTEtMA_56a4da26-41ea-4e4a-9a57-16cf87ea87fc"
      unitRef="number">0.42</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="id931c5900d5344649f91ba0b0016de0c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzUtMS0xLTEtMA_97c5549c-c5ab-4e10-9ba4-6d34702b9a7e"
      unitRef="number">0.11</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ifb24d45e71f14152b0beee33dd6fe7b8_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzUtMy0xLTEtMA_4970b3ae-d8ab-4c11-b0e7-de7032cf448a"
      unitRef="number">0.20</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ic85598bd2b86456e91558360409ce887_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzYtMS0xLTEtMA_e51c96be-0f07-454b-9dba-8995759465b4"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i8246072e29d64600b0af97728d423a90_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzYtMy0xLTEtMA_7f35aa87-4857-4983-94ab-f78cbee23427"
      unitRef="number">0.95</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="icfc7590e98964831a39bf2babda2f26c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzctMS0xLTEtMA_61ef8021-5435-4590-9ebb-f877fb7e6adf"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i9773cd12324249bdad8bba77790feceb_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzctMy0xLTEtMA_34f835f6-aa2b-45e4-b6aa-c1002bdc1a77"
      unitRef="number">0.05</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzgtMS0xLTEtMA_8d7d9149-2abc-42c5-8723-14923794a269"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTowNDAyM2Y0ZDQzMWE0ZTQ4YjdlZDU2YTg3ZjZiNTY0NC90YWJsZXJhbmdlOjA0MDIzZjRkNDMxYTRlNDhiN2VkNTZhODdmNmI1NjQ0XzgtMy0xLTEtMA_cd785a47-0c58-45d7-8e9d-e11f1a48acbb"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90ZXh0cmVnaW9uOmE5YmRmODdjZDViMDRlYWQ5MWU5NGQxY2VjYTUzMjAxXzQ5NDc4MDIzMzU4MDA_24ba442b-2c07-4bd0-bfa5-73406e44f198">The following table summarizes the activity for the Company's allowance for credit losses during the year ended December&#160;31, 2020, which principally relates to client payers:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of accounts receivable, net of recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTplYjc3MGU4ZjdhN2Y0NjQwYTAxNzY5MjgxYWJhOTIzZS90YWJsZXJhbmdlOmViNzcwZThmN2E3ZjQ2NDBhMDE3NjkyODFhYmE5MjNlXzItMS0xLTEtMTY5NA_8e9ad984-875e-40fb-951f-f5c925b321d4"
      unitRef="usd">15000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTplYjc3MGU4ZjdhN2Y0NjQwYTAxNzY5MjgxYWJhOTIzZS90YWJsZXJhbmdlOmViNzcwZThmN2E3ZjQ2NDBhMDE3NjkyODFhYmE5MjNlXzMtMS0xLTEtMTY5NA_f2bb301a-69a5-4a3b-b9d9-b6fc56172b7c"
      unitRef="usd">19000000</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTplYjc3MGU4ZjdhN2Y0NjQwYTAxNzY5MjgxYWJhOTIzZS90YWJsZXJhbmdlOmViNzcwZThmN2E3ZjQ2NDBhMDE3NjkyODFhYmE5MjNlXzQtMS0xLTEtMTY5NA_30f5f5f8-343b-4fe3-837d-7a6098f7207a"
      unitRef="usd">6000000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNzUvZnJhZzphOWJkZjg3Y2Q1YjA0ZWFkOTFlOTRkMWNlY2E1MzIwMS90YWJsZTplYjc3MGU4ZjdhN2Y0NjQwYTAxNzY5MjgxYWJhOTIzZS90YWJsZXJhbmdlOmViNzcwZThmN2E3ZjQ2NDBhMDE3NjkyODFhYmE5MjNlXzUtMS0xLTEtMTY5NA_a453af5d-25ab-4772-ba8c-5e786c1fd8da"
      unitRef="usd">28000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90ZXh0cmVnaW9uOjVlNWZmN2FmZjQ4MjQzNDY4ZDQ1ODQzNzlmZjdiMjNjXzI5NQ_3a47bee3-b00f-4404-98b4-c78fd80305a8">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics' common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders - basic:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders - diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90ZXh0cmVnaW9uOjVlNWZmN2FmZjQ4MjQzNDY4ZDQ1ODQzNzlmZjdiMjNjXzI5Mw_880c4288-8d59-4f08-8699-bfdec060bfe3">The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics' common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders - basic:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders - diluted:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzItMS0xLTEtMA_78bb0a6b-d1a3-4340-a314-c33e0e91188d"
      unitRef="usd">1431000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzItMy0xLTEtMA_b2cac41a-7e94-4cd9-bab6-c656618535e5"
      unitRef="usd">838000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzItNS0xLTEtMA_73ce7356-148d-41fa-8a7d-16c6f2859411"
      unitRef="usd">736000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzMtMS0xLTEtMA_8676d368-dfb5-4ed1-bc50-617482a864ea"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzMtMy0xLTEtMA_6055e6bf-4ae3-4f88-b755-45b9666c0757"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzMtNS0xLTEtMA_c2e2777c-1381-4b01-b52e-4f295e12594e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzQtMS0xLTEtMA_d711e33d-d87f-479b-af45-1c16670ec69e"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzQtMy0xLTEtMA_d42307b6-f384-4ed8-9da1-6abf9c4b23bb"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzQtNS0xLTEtMA_b35e3d38-4665-4362-9fa1-22355a9d0c26"
      unitRef="usd">736000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzYtMS0xLTEtMA_b954860e-d87b-4fec-b553-88670e0d701f"
      unitRef="usd">1431000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzYtMy0xLTEtMA_39ff06ce-e322-4c04-9774-63260942f90e"
      unitRef="usd">838000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzYtNS0xLTEtMA_f24b7e7d-6e3e-478b-8ab0-229e0a768a41"
      unitRef="usd">736000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzctMS0xLTEtMA_2ed778be-f599-4acf-bba7-9a3157a4d411"
      unitRef="usd">6000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzctMy0xLTEtMA_71a8af9d-0066-45af-ba8d-1fb860f13fa0"
      unitRef="usd">3000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzctNS0xLTEtMA_7aa248a6-5d6c-493b-9bac-5b4a21caa81d"
      unitRef="usd">3000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzgtMS0xLTEtMA_bf0a3916-bd42-44dd-82b7-add5e0763499"
      unitRef="usd">1425000000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzgtMy0xLTEtMA_3741ef99-f6d0-44bd-bdeb-4a43ca1e1405"
      unitRef="usd">835000000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzgtNS0xLTEtMA_7f87776d-fd88-47c5-9283-c034ca83ae98"
      unitRef="usd">733000000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEwLTEtMS0xLTA_fcdd2d33-759f-4e52-8141-927825c05261"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEwLTMtMS0xLTA_a3be71c8-a83a-4315-80c2-d0515a1e6807"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEwLTUtMS0xLTA_2ee02bd8-f493-41e1-a3b3-011991fde25d"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEyLTEtMS0xLTA_4ad9dfd0-b7dd-4651-bc67-22159cb01c80"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEyLTMtMS0xLTA_bc22b039-362c-4c52-b337-f0652619530c"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEyLTUtMS0xLTA_20a7c574-7cc9-4824-8f37-d051568fa746"
      unitRef="shares">3000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEzLTEtMS0xLTA_126236f8-2634-411e-ab93-80819696cbba"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEzLTMtMS0xLTA_e38fd575-2897-4f38-b364-5751536f62e4"
      unitRef="shares">136000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzEzLTUtMS0xLTA_51d4cb7a-0a7a-4aa9-bf23-381471f20ba4"
      unitRef="shares">139000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE2LTEtMS0xLTA_510a3b88-693a-4cce-970f-cc1a6b7d7f25"
      unitRef="usdPerShare">10.62</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE2LTMtMS0xLTA_1b006825-1829-464c-9cfe-d56907b0b26c"
      unitRef="usdPerShare">6.21</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE2LTUtMS0xLTA_ac12fce7-6a7f-422b-966d-c0311d79a99e"
      unitRef="usdPerShare">5.39</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE3LTEtMS0xLTA_dd9d63a2-ef66-4df4-acd9-5d05200d3483"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE3LTMtMS0xLTA_7b2a5afb-76e5-43f5-b78a-23e33fdb232a"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE3LTUtMS0xLTA_396e7290-400e-4e35-a749-42a53abda969"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE4LTEtMS0xLTA_6266b02f-bf6a-4fa5-aaa7-7fe6d785b08f"
      unitRef="usdPerShare">10.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE4LTMtMS0xLTA_447732e2-1a62-4ccf-916e-c400fc4df42e"
      unitRef="usdPerShare">6.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzE4LTUtMS0xLTA_8b48f3d4-2258-4a33-96f7-02fa64333d87"
      unitRef="usdPerShare">5.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIxLTEtMS0xLTA_b44dbd75-f30f-4df2-a63a-6e08df055cd0"
      unitRef="usdPerShare">10.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIxLTMtMS0xLTA_70e99fdb-039e-4caa-ae1c-8cf56cfe551d"
      unitRef="usdPerShare">6.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIxLTUtMS0xLTA_e890b404-0f64-48e9-8724-3a13d59115a6"
      unitRef="usdPerShare">5.29</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIyLTEtMS0xLTA_11a1cfae-7622-4d8b-89eb-a744299cc677"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIyLTMtMS0xLTA_b4ea33fd-4fb7-462a-84ca-d2ad6b817d60"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIyLTUtMS0xLTA_2f5f781c-24f1-4476-a39c-b2791a00e22b"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIzLTEtMS0xLTA_0d311596-1020-4084-b3fc-8c051901742c"
      unitRef="usdPerShare">10.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIzLTMtMS0xLTA_19d4d753-c152-40a6-a56e-2c75b32eca87"
      unitRef="usdPerShare">6.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZToyZmJiODY0Y2FiZjQ0NTBkYWEwNzU3OWVjNTRhYzUwMy90YWJsZXJhbmdlOjJmYmI4NjRjYWJmNDQ1MGRhYTA3NTc5ZWM1NGFjNTAzXzIzLTUtMS0xLTA_11bec738-f58a-406f-bd88-c0470e9b5f60"
      unitRef="usdPerShare">5.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90ZXh0cmVnaW9uOjVlNWZmN2FmZjQ4MjQzNDY4ZDQ1ODQzNzlmZjdiMjNjXzI4MQ_6870fbf4-1a26-4473-9050-f165f1def7ec">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZTo3NmEzMmJhY2NhNTY0YzQ5OGJiMzU2MmZjMWE0ZTYxZC90YWJsZXJhbmdlOjc2YTMyYmFjY2E1NjRjNDk4YmIzNTYyZmMxYTRlNjFkXzItMS0xLTEtMA_ecdf90bf-42df-4096-a2c0-87fa6848bbd2"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZTo3NmEzMmJhY2NhNTY0YzQ5OGJiMzU2MmZjMWE0ZTYxZC90YWJsZXJhbmdlOjc2YTMyYmFjY2E1NjRjNDk4YmIzNTYyZmMxYTRlNjFkXzItMy0xLTEtMA_c54afd39-f520-45aa-b3a8-455c5902a770"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODEvZnJhZzo1ZTVmZjdhZmY0ODI0MzQ2OGQ0NTg0Mzc5ZmY3YjIzYy90YWJsZTo3NmEzMmJhY2NhNTY0YzQ5OGJiMzU2MmZjMWE0ZTYxZC90YWJsZXJhbmdlOjc2YTMyYmFjY2E1NjRjNDk4YmIzNTYyZmMxYTRlNjFkXzItNS0xLTEtMA_ae25da21-6537-4830-9fcd-60ce4ec4f034"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzI3MTk_92d52f8e-0557-4a09-afb0-d9ed8ddee3de">RESTRUCTURING ACTIVITIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Invigorate Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is committed to a program called Invigorate which is designed to reduce its cost structure and improve performance.  Invigorate consists of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; service excellence; lab excellence; and revenue services excellence.  In addition to these programs, the Company identified key themes to change how it operates including reducing denials and patient price concessions; further digitizing the business; standardization and automation; and optimization initiatives in the areas of lab network and patient service center network. The Invigorate program is intended to partially offset reimbursement pressures and labor and benefit cost increases; free up additional resources to invest in science, innovation and other growth initiatives; and enable the Company to improve service quality and operating profitability. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Restructuring Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the Company's pre-tax restructuring charges for the years ended December&#160;31, 2020, 2019 and 2018: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee separation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The restructuring charges incurred for the year ended December&#160;31, 2020 and 2018 were primarily associated with various workforce reduction initiatives as the Company continued to simplify and restructure its organization.  The restructuring activity incurred for the year ended December&#160;31, 2019 primarily represents a release of the liability relating to restructuring charges recorded in prior periods, which were determined to no longer be required.  Of the total restructuring charges incurred during the year ended December&#160;31, 2020, $9 million and $5&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.  The $(2) million of restructuring charges recognized during the year ended December&#160;31, 2019 were recorded in selling, general and administrative expenses.  Of the total restructuring charges incurred during the year ended December&#160;31, 2018, $22 million and $29 million were recorded in cost of services and selling, general and administrative expenses, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Charges for all periods presented were primarily recorded in the Company's DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity of the restructuring liability during 2020 and 2019, which is included in accrued expenses in Note 12:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Separation Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Facility-Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzI3MjA_a04de1b1-6e2b-4979-a54b-de698cdb7157">The following table provides a summary of the Company's pre-tax restructuring charges for the years ended December&#160;31, 2020, 2019 and 2018: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee separation costs&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility-related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzItMS0xLTEtMA_541d4f5f-ff46-4a03-bb7c-d81b731c5195"
      unitRef="usd">14000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ice2731fc599e44eebad216d560288aa5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzItMy0xLTEtMA_4e709950-0192-4b36-ad59-548d940e7373"
      unitRef="usd">-3000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i76cf32401c784f6282df17d6217338a3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzItNS0xLTEtMA_88690b53-0c10-403d-9e40-5d9ed17a8f7f"
      unitRef="usd">45000000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherRestructuringCosts
      contextRef="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzMtMS0xLTEtMA_2045d0f1-1026-4c3a-9b09-6c99d98e894d"
      unitRef="usd">0</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="ice2731fc599e44eebad216d560288aa5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzMtMy0xLTEtMA_8bda9060-9cb8-42ad-b02a-0049c3ec48ed"
      unitRef="usd">1000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i76cf32401c784f6282df17d6217338a3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzMtNS0xLTEtMA_ced7b285-ac7e-47b8-8a37-38896be9de70"
      unitRef="usd">4000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzQtMS0xLTEtMA_145a3e51-7664-48c3-88a1-0cb0da4cb332"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ice2731fc599e44eebad216d560288aa5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzQtMy0xLTEtMA_36130173-e53a-4c7d-8179-4a8e2fe53991"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i76cf32401c784f6282df17d6217338a3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzQtNS0xLTEtMA_064690e4-4aa7-41e4-99f4-53ae3c38df2a"
      unitRef="usd">2000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzYtMS0xLTEtMA_15e71c11-e1eb-4bd4-ac83-b9e916ce25dd"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ice2731fc599e44eebad216d560288aa5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzYtMy0xLTEtMA_a2097660-d508-49c1-b6a8-b8a4169c306b"
      unitRef="usd">-2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i76cf32401c784f6282df17d6217338a3_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZToxYjE5MGYxMmJiZGM0MmNjODU2NTZkMGY4MTc1NmNmNS90YWJsZXJhbmdlOjFiMTkwZjEyYmJkYzQyY2M4NTY1NmQwZjgxNzU2Y2Y1XzYtNS0xLTEtMA_8252feea-527a-46f0-9552-0df90a904c1f"
      unitRef="usd">51000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i50637c6aa27f4b9f88abbcb41129c619_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzE2OTk_5718f44e-44aa-4184-afcd-a089cef72665"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie9e3619ec877416abb976607a2ecb8a4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzIxOTkwMjMyNTg5NjE_e2c2014c-3544-404f-b482-19190f807e6f"
      unitRef="usd">5000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic7d5052a7f794e77a5d8ecd713c12c6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzE4OTc_02da20fa-7ba5-46d2-9aa0-bbcac91b5846"
      unitRef="usd">-2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib4c69355f4e54414844cb3cf76a843b9_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzIwNzY_e610cd82-a6c3-4463-8031-d29839702327"
      unitRef="usd">22000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib030f85555694c49b8643f2d91b9693a_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzIwODM_6eb65a21-a9c7-48f0-a379-dbd02e173478"
      unitRef="usd">29000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90ZXh0cmVnaW9uOjQ2NDJhMmVmM2JmNjQwNDRiNWY0Njk0ODUwZmY0YTY4XzI3MTU_cba2dc88-b52a-4a92-9fc9-4aac4e817878">The following table summarizes the activity of the restructuring liability during 2020 and 2019, which is included in accrued expenses in Note 12:  &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.049%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Employee Separation Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Facility-Related Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2019&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income statement expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i72f4ed9e9a914e47a81066fd180c145e_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzItMS0xLTEtMA_96aeac33-f034-47c6-a346-173fcb570f56"
      unitRef="usd">37000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i1b9ca495276140aebb8a6db9bff67956_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzItMy0xLTEtMA_fb51fa7a-c8e2-42af-9a21-2ffcc2ead3eb"
      unitRef="usd">1000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzItNS0xLTEtMA_f4acfdbf-6b54-4596-8a75-84b6057d64d2"
      unitRef="usd">38000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i8ac7825e2fb043728473edf6a486a568_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzMtMS0xLTEtMA_b8760546-34a2-40d8-bb16-fde393f3a63d"
      unitRef="usd">-3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3955951503f44fe3acd85937ac7a0bc4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzMtMy0xLTEtMA_d54cbc9d-0d94-4208-97b3-ac23b8e792f3"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzMtNS0xLTEtMA_198fb523-8040-4f1a-bca1-d3c56134caf9"
      unitRef="usd">-3000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i8ac7825e2fb043728473edf6a486a568_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzQtMS0xLTEtMA_7ad9ee78-d9a7-4c58-b255-330b29e2c508"
      unitRef="usd">25000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i3955951503f44fe3acd85937ac7a0bc4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzQtMy0xLTEtMA_95ce0820-e946-4e99-ae5e-e1517b3bcf61"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzQtNS0xLTEtMA_fdadf355-91e7-4ba2-a904-6390b840d26e"
      unitRef="usd">25000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReservePeriodIncreaseDecrease
      contextRef="i8ac7825e2fb043728473edf6a486a568_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzUtMS0xLTEtMzM5Mw_7967d9b6-8053-42fa-833f-9065b22f6bc8"
      unitRef="usd">0</us-gaap:RestructuringReservePeriodIncreaseDecrease>
    <us-gaap:RestructuringReservePeriodIncreaseDecrease
      contextRef="i3955951503f44fe3acd85937ac7a0bc4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzUtMy0xLTEtMzM5Ng_75a5430e-a562-4cc7-829b-53ff47262359"
      unitRef="usd">-1000000</us-gaap:RestructuringReservePeriodIncreaseDecrease>
    <us-gaap:RestructuringReservePeriodIncreaseDecrease
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzUtNS0xLTEtMzM5OQ_a8244495-cd73-4448-ac41-478727080460"
      unitRef="usd">-1000000</us-gaap:RestructuringReservePeriodIncreaseDecrease>
    <us-gaap:RestructuringReserve
      contextRef="i0f306c25282f4e34bc09d94f5699bb70_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzYtMS0xLTEtMA_625b8338-563f-47a9-a170-68b8985685d1"
      unitRef="usd">9000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i59d8ddb3ab9d49528f059c8a9bca7418_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzYtMy0xLTEtMA_038e1ba1-88b3-4436-bcbf-6c815b021746"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzYtNS0xLTEtMA_fba8fd09-9292-4698-b5df-66f9f0900de6"
      unitRef="usd">9000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ie8b59ca556114cfdb36009a1e4663f57_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzctMS0xLTEtMA_b4f623f2-4232-43ba-bff8-41381b93d24c"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i58ee8ae71172430080535b5a0dd4856b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzctMy0xLTEtMA_bca41e18-4049-4e4a-aea0-8cc88a257576"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzctNS0xLTEtMA_ac6f33ae-5662-47fb-901b-e0b6db3bdb6d"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie8b59ca556114cfdb36009a1e4663f57_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzgtMS0xLTEtMA_1beb8aa3-dde1-49ae-91ee-a9f06c08f58a"
      unitRef="usd">16000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i58ee8ae71172430080535b5a0dd4856b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzgtMy0xLTEtMA_25d21b74-d844-4866-a5d7-5d0cbfdd3a75"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzgtNS0xLTEtMA_3d85ff55-3420-4832-9aa6-5db7993f6886"
      unitRef="usd">16000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i280c67ee68804035b46f2faa9dce6680_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzEwLTEtMS0xLTA_ff86b2c7-1fb8-4d21-af98-f9247ee446ee"
      unitRef="usd">7000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6a6ab703d4d84efbb36e4f1d64e0fadc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzEwLTMtMS0xLTA_d2c77ef6-c685-4eae-a477-bb880374001b"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODQvZnJhZzo0NjQyYTJlZjNiZjY0MDQ0YjVmNDY5NDg1MGZmNGE2OC90YWJsZTo5ZjE0YjgzYzBmYzg0ODYwODlkMjdmYmI4NmUyNjAzYS90YWJsZXJhbmdlOjlmMTRiODNjMGZjODQ4NjA4OWQyN2ZiYjg2ZTI2MDNhXzEwLTUtMS0xLTA_75f1c9cf-d8fc-4732-825c-095b211c6f65"
      unitRef="usd">7000000</us-gaap:RestructuringReserve>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEwOTA4_983f7df4-c20a-4ba1-9890-241f4ee28c0b">BUSINESS ACQUISITIONS&#160;&#160;&#160;&#160;2020 Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company completed acquisitions for an aggregate purchase price of $330&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2020 acquisitions resulted in goodwill of $247&#160;million, of which $210&#160;million is deductible for tax purposes.  These acquisitions also resulted in $146&#160;million of intangible assets, principally comprised of customer-related and technology intangible assets.  Net revenues attributable to the 2020 acquisitions were $127&#160;million for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Blueprint Genetics Oy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 21, 2020, the Company completed its acquisition of Blueprint Genetics Oy ("Blueprint Genetics"), in an all cash transaction for $108&#160;million, net of $3&#160;million cash acquired.  Blueprint Genetics is a leading specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing and proprietary bioinformatics.  Through the acquisition, the Company acquired all of Blueprint Genetics' operations.  In the fourth quarter of 2020, the Company made an election to treat the acquisition as a taxable business combination for income tax purposes, which resulted in an adjustment to the preliminary purchase price allocation to reverse the previously recorded $11&#160;million deferred tax liability, with a corresponding decrease to goodwill. Based on the final purchase price allocation, the assets acquired and liabilities assumed primarily consist of $66&#160;million of tax-deductible goodwill, $43&#160;million of intangible assets, and $2&#160;million of property, plant and equipment and working capital.  The intangible assets primarily consist of technology and customer-related assets which are being amortized over a useful life of 10 years and15 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the Outreach Laboratory Services Business of Memorial Hermann Health System&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 6, 2020, the Company completed its acquisition of select assets which constitute substantially all of the operations of Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System ("Memorial Hermann"), in an all cash transaction for $120&#160;million.  Memorial Hermann is a not-for-profit health system in Southeast Texas.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $27&#160;million of customer-related intangible assets and $93&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the Remaining 56% Interest in Mid America Clinical Laboratories, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On August 1, 2020, the Company completed its acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC ("MACL") from its joint venture partners in an all cash transaction for $93&#160;million, net of $18&#160;million cash acquired.  MACL is the largest independent clinical laboratory provider in Indiana.  Prior to the acquisition, the Company accounted for its 44% interest in MACL as an equity method investment, which was remeasured to its fair value of $87&#160;million on the acquisition date, resulting in a gain of $70&#160;million that was recognized in other income (expense), net in the consolidated statements of operations.  The fair value of the previously held equity interest was determined using a discounted cash flow analysis that takes into account, among other items, MACL's expected future cash flows, long-term growth rate (1.5%), and a discount rate commensurate with economic risk (7.5%).  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $84&#160;million of goodwill (of which $47&#160;million is tax-deductible), $74&#160;million of intangible assets, $11&#160;million of working capital and $11&#160;million of property, plant and equipment.  The intangible assets consist of customer-related assets which are being amortized over a useful life of 15 years.  As a result of the acquisition, MACL became a wholly owned subsidiary of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;2019 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During 2019, the Company completed acquisitions for an aggregate purchase price of $63 million, including the acquisition discussed below.  The 2019 acquisitions resulted in goodwill of $43 million, of which $36 million is deductible for tax purposes.  These acquisitions also resulted in $21 million of intangible assets, principally comprised of customer-related intangibles. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the Clinical Laboratory Services Business of Boyce &amp;amp; Bynum Pathology Laboratories, P.C.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On February 11, 2019, the Company completed its acquisition of certain assets of the clinical laboratory services business of Boyce &amp;amp; Bynum Pathology Laboratories, P.C. ("Boyce &amp;amp; Bynum") in an all cash transaction for $61 million, which consisted of cash consideration of $55 million and contingent consideration initially estimated at $6 million.  The contingent consideration arrangement was dependent upon the achievement of certain testing volume benchmarks.  During 2019, the liability was reduced to $0 as a result of updated testing volume forecasts for the earn-out period compared to the testing volume target included in the contingent consideration arrangement, resulting in a $6 million gain recorded in other operating expense (income), net.  Based on the purchase price allocation, the assets acquired principally consist of $41 million of goodwill (of which $35 million is tax deductible) and $20 million of customer-related intangible assets.  The intangible assets are being amortized over a useful life of 15 years.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;2018 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During 2018, the Company completed acquisitions for an aggregate purchase price of $440 million, net of cash acquired, including the acquisitions discussed below.  The 2018 acquisitions resulted in goodwill of $241 million, of which $205 million is deductible for tax purposes.  These acquisitions also resulted in $167 million of intangible assets, principally comprised of customer-related intangibles.  Net revenues attributable to the 2018 acquisitions were $84 million for the year ended December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Mobile Medical Examination Services, LLC.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2018, the Company completed its acquisition of Mobile Medical Examination Services, LLC. ("MedXM"), a leading national provider of home-based health risk assessments and related services, in an all cash transaction for $142 million, net of $5 million cash acquired, which consisted of cash consideration of $130 million and contingent consideration initially estimated at $12 million.  The contingent consideration arrangement was dependent upon the achievement of certain revenue targets.  Subsequent to the acquisition, the estimated fair value of the contingent consideration was reduced to $0 as a result of updated revenue forecasts for 2018 compared to the earn-out revenue target included in the contingent consideration arrangement, resulting in a $12 million net gain recorded in other operating expense (income), net.  Through the acquisition, the Company acquired all of MedXM's operations.  The assets acquired and liabilities assumed consist of $77 million of intangible assets, $57 million of goodwill (of which $45 million is tax deductible), $7 million of working capital and $1 million of property, plant and equipment. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of 15 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the Outreach Laboratory Services Business of Cape Cod Healthcare, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On June 18, 2018, the Company completed the acquisition of the outreach laboratory services business of Cape Cod Healthcare, Inc., in an all cash transaction for $35 million.  The assets acquired principally consist of tax deductible goodwill and customer-related intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of ReproSource, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On September 19, 2018, the Company completed the acquisition of ReproSource, Inc. ("ReproSource"), in an all cash transaction for $35 million, which consisted of cash consideration of $30 million and contingent consideration initially estimated at $5 million.  The contingent consideration arrangement was dependent upon the achievement of certain revenue targets.  During 2019, the liability was reduced to $0 as a result of updated revenue forecasts for 2019 compared to the earn-out revenue target included in the contingent consideration arrangement, resulting in a net gain recorded in other operating expense (income), net. ReproSource is a national leader in specialty fertility diagnostic services.  Through the acquisition, the Company acquired all of ReproSource's operations.  The assets acquired principally consist of goodwill, technology-related intangible assets and customer-related intangible assets.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of the U.S. Laboratory Services Business of Oxford Immunotec, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On November 6, 2018, the Company completed the acquisition of all of the operations of the U.S. laboratory services business of Oxford Immunotec, Inc. ("Oxford"), in an all cash transaction for $170 million, net of $1 million cash acquired.  The acquisition included laboratories in Tennessee and Massachusetts that provide tuberculosis and tick-borne disease testing services.  As part of the transaction, Oxford will sell test kits and related accessories to the Company under a long-term supply agreement.  In September 2019, the Company finalized its purchase price allocation and recorded a $13 million increase to &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;goodwill, an $11 million decrease to intangible assets and a $2 million adjustment to other assets and liabilities.  These adjustments did not have a material impact on the Company's consolidated results of operations.  Based on the final purchase price allocation, the assets acquired and liabilities assumed primarily consist of $43 million of intangible assets, $112 million of tax deductible goodwill, $13 million of working capital and $6 million of property, plant and equipment.  The intangible assets consist primarily of customer-related and contract-related assets which are being amortized over a useful life of 15 years and 5 years, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General Information&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;The acquisitions described above were accounted for under the acquisition method of accounting.  As such, the assets acquired and liabilities assumed are recorded based on their estimated fair values as of the closing date.  Supplemental pro forma combined financial information has not been presented as the impact of the acquisitions is not material to the Company's consolidated financial statements.  The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entities with those of the Company and the value associated with an&#160;assembled workforce and other intangible assets that do not qualify for separate recognition.  All of the goodwill acquired in connection with these acquisitions has been allocated to the Company's DIS business.  For further details regarding business segment information, see Note 19.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDg1Njg_70e2fc6a-8046-4e64-a692-492a81cf66f3"
      unitRef="usd">330000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDg1ODI_ac357e90-319a-497f-95d2-8ec28bb76d3f"
      unitRef="usd">247000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDk1MTY_b7e2bc67-db51-4292-a167-fd4a0662032e"
      unitRef="usd">210000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDg2MTA_5b01b530-3c86-41b5-b804-457e0a5cae14"
      unitRef="usd">146000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1>
    <dgx:BusinessAcquisitionPostacquisitionRevenue
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDc4MDIzNDg2MjQ_872b2471-25a4-4115-8d32-74b11cbe1843"
      unitRef="usd">127000000</dgx:BusinessAcquisitionPostacquisitionRevenue>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i27711a12139e4ecc82c168186cb5ebe9_D20200121-20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI2OTI_14599628-b8a1-4484-b93b-6276b3b2db55"
      unitRef="usd">108000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i27711a12139e4ecc82c168186cb5ebe9_D20200121-20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3MDY_a61da349-74b5-4fa7-8ebc-5190ee4b37d6"
      unitRef="usd">3000000</us-gaap:CashAcquiredFromAcquisition>
    <dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzcyMjk_fa8b59b6-1f8f-4714-a83a-f091f88432e8"
      unitRef="usd">11000000</dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i9bacdce196024c839a813e482b5f95f0_I20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3MTg_019ed159-f77c-404f-989e-7bacaba27261"
      unitRef="usd">66000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:Goodwill
      contextRef="i9bacdce196024c839a813e482b5f95f0_I20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3MTg_36d35e48-1f32-4867-8609-4331d9e80def"
      unitRef="usd">66000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9bacdce196024c839a813e482b5f95f0_I20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3MzE_1f8d4ea4-3464-46cb-9f82-3cdfac9f0259"
      unitRef="usd">43000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital
      contextRef="i9bacdce196024c839a813e482b5f95f0_I20200121"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3NTc_152fc8ea-e967-49cf-befd-00648f6191b2"
      unitRef="usd">2000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idb09fcb6511f47edabcbc8b6c3de97e7_D20200121-20200121"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3Njg_cabd66b9-6de7-498b-9aed-ccb6ee5a9c33">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iba3f50b191484f5a975775bb5bcd79c0_D20200121-20200121"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3Njk_44e3ff0f-760f-4666-8e2b-4a50f5bdeae9">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i9c610e7bc66145a9a5c3d919c604c9d1_D20200406-20200406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3NzE_ad5acf99-9171-4eb9-b09e-27b1c8d36c93"
      unitRef="usd">120000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if2a967045abe4853ac22eaf7f12d73ce_I20200406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3ODU_5694cf95-29a0-4c81-bbce-399a4d971ec3"
      unitRef="usd">27000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i5bc58d2181184b70abf43e0a7797a61f_I20200406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3OTg_6d18e059-6615-409e-8793-d0226b860140"
      unitRef="usd">93000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i5bc58d2181184b70abf43e0a7797a61f_I20200406"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI3OTg_776032f1-1ce4-48d6-82ea-a536106f297c"
      unitRef="usd">93000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i09ff1a062aca4dd091930d26abdc94aa_D20200406-20200406"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4MTI_60a66a3f-968a-4ca7-a078-c1f8b4373c14">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4MTQ_0b8466b4-1f24-4d1a-8ff5-042d907f901d"
      unitRef="number">0.56</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4MTk_3c933b0a-7436-4df0-ac81-31aa8aaf369c"
      unitRef="number">0.56</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0ce66de126184e10bbe6987c714abe61_D20200801-20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4MjQ_21879a28-f9f7-44b9-b020-b1ac20d4c9f7"
      unitRef="usd">93000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i0ce66de126184e10bbe6987c714abe61_D20200801-20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI4Mzc_c8d517b5-c0bc-4138-9887-fa446b684975"
      unitRef="usd">18000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i4b7731ca50f644dbae4378dcde7faab9_I20200731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI5NDU_b34c5082-cd17-46c8-97ea-6a25df90f911"
      unitRef="number">0.44</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="iae2b0a12d36246ed98b91815583efc9d_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI5NTA_298901b7-fb01-449e-a739-93628e9ad27e"
      unitRef="usd">87000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="ibb19efad8ebc48d8bf627a6c143d9f22_D20200801-20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzI5NjQ_95fc7c2f-e180-4852-85fc-6e2267208b5f"
      unitRef="usd">70000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwMzY_361bb109-5756-4827-a7d5-e08d2471aa73"
      unitRef="number">0.015</dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue>
    <dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwNDI_a0329c95-4329-4086-b9d7-ef61153c7655"
      unitRef="number">0.075</dgx:BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue>
    <us-gaap:Goodwill
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwNDg_dbcef9dd-98ae-4745-ace8-d0e20f276786"
      unitRef="usd">84000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwNjE_0bf3e87b-bf12-452b-8afd-f57e9edd6236"
      unitRef="usd">47000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwNzQ_9e7e7f5b-a9dd-4f38-9116-82997f59689d"
      unitRef="usd">74000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMwODc_b9ce39d3-f09a-4b71-9da0-31e5ee42da15"
      unitRef="usd">11000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i1be8090c04d8482eb1d5819ad8a4915b_I20200801"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMxMDA_28643f18-3121-4293-8d46-56e9b63de69e"
      unitRef="usd">11000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i10cf574e9c2e4d21a2695ebf75df7d6c_D20200801-20200801"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzYwNDczMTM5NzMxMTI_02593768-fabd-4095-839e-06f82641154c">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEzNA_47b754e5-4eb9-4c9f-94b9-e8a54e4e0520"
      unitRef="usd">63000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIyOA_36b88cba-8ee8-40e9-80ae-71bb778543e3"
      unitRef="usd">43000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzI0MQ_1e950936-11af-4581-81a7-852d1e2adaf8"
      unitRef="usd">36000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMxMw_81f0afc5-fbd0-46bc-ae75-6de57a593dc7"
      unitRef="usd">21000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ice7bbcc9e8ed4ad2ade3ad58246561b0_D20190211-20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzcxOQ_e270bdbf-2dcd-4d28-83f3-c4d6e6fb68ed"
      unitRef="usd">61000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ice7bbcc9e8ed4ad2ade3ad58246561b0_D20190211-20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzc2NA_13959056-eaef-494e-a25f-3be67e3eb044"
      unitRef="usd">55000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i61272b36e8f248a490bc5be2a3a5cbeb_I20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzgxOQ_ad3a2fc1-8bbd-426c-b2e0-46f5a6fdb062"
      unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i131dd7c4ae56411b91d4494e08f2395b_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzk4MA_dffc7e85-91ae-4f63-8a0b-354daea0f841"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i2baa36a831dc45c59aff0f947d0f6d27_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzExNjI_5395ca58-2df1-4c37-a875-683e263ea756"
      unitRef="usd">6000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:Goodwill
      contextRef="i6895b862b93d4f9db033b2c8960868fe_I20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEzMDU_06a7f334-4ccb-4516-bfcb-a3a8df09533b"
      unitRef="usd">41000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i6895b862b93d4f9db033b2c8960868fe_I20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEzMzA_ab4583c4-8623-495b-85a2-7789264cdff0"
      unitRef="usd">35000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id7b3a596687e4a388e56161f877b4099_I20190211"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzEzNTY_74b7bdf4-da71-46f4-8113-67c3b6bfd2f4"
      unitRef="usd">20000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibcbcfd24bcb54356a9bf41706902f795_D20190211-20190211"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE0NjE_0e6351f7-22ba-45c3-a1bc-899363309b40">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE2NjE_51d63beb-9abc-47e4-96ff-8d24c22e3116"
      unitRef="usd">440000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <dgx:GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE3Nzg_816b7266-921f-4e7b-9a64-dee36f9917a3"
      unitRef="usd">241000000</dgx:GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE3OTE_2c1562de-1c40-4dfe-bf21-79d010d62d37"
      unitRef="usd">205000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzE4NjM_f18f8500-820f-4ea4-b88f-e02c88962e9f"
      unitRef="usd">167000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1>
    <dgx:BusinessAcquisitionPostacquisitionRevenue
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIwMDA_3f56ebbb-fa57-40d7-9fcf-f30e5dab420c"
      unitRef="usd">84000000</dgx:BusinessAcquisitionPostacquisitionRevenue>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if3dead11eb114dcbb814658459773ee1_D20180201-20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIyNDc_f298c2d8-2063-4fbc-b39a-21aeb3bd4bb0"
      unitRef="usd">142000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="if3dead11eb114dcbb814658459773ee1_D20180201-20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIyNTg_8d86e9c2-bd80-4fd5-8a41-c93ac1525eea"
      unitRef="usd">5000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="if3dead11eb114dcbb814658459773ee1_D20180201-20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIzMTc_497c09a2-be2e-454c-a541-bff9890c25d7"
      unitRef="usd">130000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i05fafb7616b247759bbe4a101ccfe88d_I20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzIzNjI_9fe72d2a-dc17-451c-b8a5-58c974b078fa"
      unitRef="usd">12000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7c9edd27d62d479f8d54c3850fa9b9c2_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzI1NzQ_14f32e83-6aa5-4a2e-8456-5a37fb1aea5b"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i42b26f40687b440793ed6325db576f39_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzI3MzY_e6e8f424-4478-4c93-9c35-e00f720cae6f"
      unitRef="usd">12000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMwMjY_906670bb-59e9-4c5e-b430-b1fd1e979e84"
      unitRef="usd">77000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMwNTE_8a5f7d35-3dd8-437b-8d71-25752c3e666b"
      unitRef="usd">57000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMwNzY_0c48103f-26da-4d92-906b-1457070ab468"
      unitRef="usd">45000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital
      contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMwOTk_94d7d909-25a0-4bbb-a25f-03ed5f090e83"
      unitRef="usd">7000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7836c791c01346a1b0c5012b1f08c16a_I20180201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMxMjU_8b6c05b1-61ed-4f82-9cd3-355198fac0fd"
      unitRef="usd">1000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib74c4c78b12e4840809c22866c04924d_D20180201-20180201"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzMyNzc_74e2926f-f135-4476-a4e0-5579c4992539">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2a716478a2894a559df1f5cf678bcbd6_D20180618-20180618"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzM1MzM_910b96f7-7d0b-4144-a82d-e54086dde5f5"
      unitRef="usd">35000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ifac4c7f439bc4a25a8b35842cf0ba6ef_D20180919-20180919"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzM4MTI_a9c4f299-560b-466f-8ccd-f5ef0ce0ab2b"
      unitRef="usd">35000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ifac4c7f439bc4a25a8b35842cf0ba6ef_D20180919-20180919"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzM4NTc_b5234818-527d-44eb-8c38-956774374506"
      unitRef="usd">30000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie9436426b22c4886a5e98f743908762e_I20180919"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzM5MDI_1acda90a-5d68-42a8-8250-42ac5388cc65"
      unitRef="usd">5000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8da51f5c2e9c490f94945ecf8ac5e9bc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQwNTM_cb3523bb-f629-4008-9358-f67c001cf914"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i3df733d55ebf4d58bee1631d8ddc6f98_D20181106-20181106"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5MzA_43c88c9b-1e5e-4bd5-9304-b9b13805621b"
      unitRef="usd">170000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i3df733d55ebf4d58bee1631d8ddc6f98_D20181106-20181106"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzQ5NDE_84b4970a-c956-4a9c-93ff-5d1185dc11c0"
      unitRef="usd">1000000</us-gaap:CashAcquiredFromAcquisition>
    <dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="ie0e89fc0040e4c588548eaca76b8e386_D20190901-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzUzMTQ_25353fac-0e4e-47f8-a197-ca8bc0aecc6b"
      unitRef="usd">13000000</dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="ie0e89fc0040e4c588548eaca76b8e386_D20190901-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzUzNDI_d20166f3-f4e0-41ac-a9ed-4b2d9aa270f0"
      unitRef="usd">-11000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities
      contextRef="ie0e89fc0040e4c588548eaca76b8e386_D20190901-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzUzODE_fa761643-53c9-4f23-9756-5742d96db53a"
      unitRef="usd">2000000</dgx:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU2NDM_fa6d54f7-8fb3-4997-afc3-872eca468b70"
      unitRef="usd">43000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU2Njg_bfce9a2b-a2e5-4c80-add4-83e4065d188b"
      unitRef="usd">112000000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:Goodwill
      contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU2Njg_ef188313-caa1-4172-b5b0-2ac16544a41f"
      unitRef="usd">112000000</us-gaap:Goodwill>
    <dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital
      contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU2OTk_38b3c62f-d2ac-4ae6-abcf-c43fd130d7b2"
      unitRef="usd">13000000</dgx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i5e7f845975ee4548acd03e1afe47b0df_I20181106"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU3MjU_0329661b-73ab-4608-8c7c-e3476782760c"
      unitRef="usd">6000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0a260c8c6a244ff0897322a198ac6525_D20181106-20181106"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU4OTk_dcb841d0-0c05-4b8d-8799-a5c2b87ec076">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6a6c9ae6653b48b099eac07be30520ad_D20181106-20181106"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xODcvZnJhZzoxYWU3NDIwMTNmMjc0ZjhhYjBhNDZiYmI4ZThlODE0My90ZXh0cmVnaW9uOjFhZTc0MjAxM2YyNzRmOGFiMGE0NmJiYjhlOGU4MTQzXzU5MTI_445d482f-05c4-41fe-8d3f-5ab9e6839fc3">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzU2MzQ_9c7211f3-4f80-4e85-ac26-73c2b11693f3">FAIR VALUE MEASUREMENTS &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-to-variable interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:72pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair value measurements of the Company's fixed-to-variable interest rate swaps, which were terminated during April 2020 (see Note 15), were classified within Level 2 of the fair value hierarchy, and were model-derived valuations as of a given date in which all significant inputs were observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with previous business acquisitions, the Company had contingent consideration obligations that were to be paid based on the achievement of certain testing volume or revenue benchmarks.  As of December&#160;31, 2020, no contingent consideration obligations were outstanding.  Contingent consideration liabilities are measured at fair value using an option-pricing method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#x2019;s estimate of volume or revenue and other market inputs including comparable company revenue volatility and a discount rate.    &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, additions and issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (gains)/losses included in earnings - realized/unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (gains)/losses included in earnings - realized/unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The $1 million and $12 million net gains included in earnings associated with the changes in the fair value of contingent consideration for the years ended December&#160;31, 2020 and 2019, respectively, are reported in other operating expense (income), net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long-term growth rates, and a discount rate commensurate with economic risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of December&#160;31, 2020 and 2019, the fair value of the Company&#x2019;s debt was estimated at $4.6 billion and $5.1 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzU2MTU_d6200a72-5549-432e-9cfd-cf606788e650">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-to-variable interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:TradingSecurities
      contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzUtMS0xLTEtMA_15fe5404-2190-4f08-8534-30cc2337781d"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzUtMy0xLTEtMA_5309c50d-cfb0-4490-a5a4-23af1a4012da"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzUtNS0xLTEtMA_ea5d993d-e9c2-402e-acb9-840446c2270c"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzUtNy0xLTEtMA_962e6cad-a9a9-430f-b707-f450163399b6"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzYtMS0xLTEtMA_b3220fd0-bed3-406e-9af3-b184699b619e"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzYtMy0xLTEtMA_03935d1d-d054-4960-80a5-87974db6e1c4"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzYtNS0xLTEtMA_5a68da56-f841-407b-8bcf-3e711cd28ee2"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzYtNy0xLTEtMA_d716a2f4-86cb-43a2-9818-b78d781b45e0"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzgtMS0xLTEtMA_9e747164-be81-42ae-b03f-170497b3a797"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzgtMy0xLTEtMA_0cc04922-e199-4551-a7f6-02e6993c511e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzgtNS0xLTEtMA_1ad3c9ea-b753-4e86-b688-6c44b6ca0a52"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzgtNy0xLTEtMA_d2c97643-9ff4-44b8-80fd-763cae930433"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzExLTEtMS0xLTA_ffbe9aa1-a081-4f45-998d-9243081abee0"
      unitRef="usd">129000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzExLTMtMS0xLTA_73cd8b1f-67fb-4721-a863-3323c166910c"
      unitRef="usd">67000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzExLTUtMS0xLTA_09c6a0b1-82ad-48a2-8417-65327cde4070"
      unitRef="usd">50000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzExLTctMS0xLTA_df4231e3-2155-441d-a1d9-e0047c675477"
      unitRef="usd">12000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzE0LTEtMS0xLTA_7132b5ac-e9a0-437f-8823-c27b94148494"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzE0LTMtMS0xLTA_5ec0f6b2-abc8-4757-a28b-93f3fb278fd2"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i1fc1f28fcd3344fda11bc60c50575b60_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzE0LTUtMS0xLTA_2f7d9ef2-bbf9-4d08-911d-bc91854aa746"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzE0LTctMS0xLTA_db86661c-71af-470e-8f67-ca841e3a2f3d"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ib5b80ecba80a4ec3be7640854bdf798a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzIxLTEtMS0xLTA_fc5ec872-a3ac-4919-aa42-4de08d6a179c"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i1da74a1c6cec43718954e17544e09dab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzIxLTMtMS0xLTA_a0523fb9-8ff0-4189-ac9b-795b8c2f005a"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i1b53551e765e48ada91ce1b2213af833_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzIxLTctMS0xLTA_3c13adeb-02e1-45ed-b854-f7a7799e4150"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:TradingSecurities
      contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI1LTEtMS0xLTA_f3b10071-56f7-4e2b-a431-359eb3721583"
      unitRef="usd">59000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI1LTMtMS0xLTA_2e75eaf1-4af5-41d3-be96-c8af080cc232"
      unitRef="usd">59000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI1LTUtMS0xLTA_789810f0-b497-42dc-807a-7ac9a031ff3e"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI1LTctMS0xLTA_7bb3d987-3319-4830-b4de-0cb43a68dc78"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI2LTEtMS0xLTA_00cca368-2ef0-4c1c-a975-36a9b9dac2e2"
      unitRef="usd">43000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI2LTMtMS0xLTA_5eff49a1-8513-4481-b5f8-5079c952eb5a"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI2LTUtMS0xLTA_6f409cef-bbed-4356-8b78-6447cbb4331f"
      unitRef="usd">43000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI2LTctMS0xLTA_4f0add9d-a7d5-47e9-90d1-c15dda0605e2"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI5LTEtMS0xLTA_92530e57-3966-4d36-bdfe-722e664c0404"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI5LTMtMS0xLTA_3cd243b6-e4fb-4c3b-ad39-1e5e9cc0abcd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI5LTUtMS0xLTA_02be5f29-7551-40b8-81a7-724d7cd6aa45"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzI5LTctMS0xLTA_9d7929cb-2d29-488e-99de-a8d764b0e4d7"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzMxLTEtMS0xLTA_6551c3d2-b04f-42de-84b0-e7a6eb3b289a"
      unitRef="usd">114000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzMxLTMtMS0xLTA_8687b9be-810d-40a7-b6a0-7a2567d6ed8b"
      unitRef="usd">59000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzMxLTUtMS0xLTA_072c9449-1711-4c6b-b5f3-2bf8cd7a9649"
      unitRef="usd">43000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzMxLTctMS0xLTA_120de064-9001-43ed-8484-eb493029f1fe"
      unitRef="usd">12000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM0LTEtMS0xLTA_ea7f6199-5b08-41f9-8d00-b06ca5e6c4b8"
      unitRef="usd">110000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM0LTMtMS0xLTA_a97fb906-99c7-45e7-b25e-719da68d3136"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM0LTUtMS0xLTA_8ee4695b-86c0-4347-910d-bd3662baec64"
      unitRef="usd">110000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM0LTctMS0xLTA_e07ac723-76e7-4af2-9ac2-c205405e3016"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="i5925d31cf3ff45fc9047d3197966b069_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM1LTEtMS0xLTA_2e52bfd7-8c89-4820-943d-79f95a120637"
      unitRef="usd">28000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i18d1e7f19b404c199e04abc162106cc4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM1LTMtMS0xLTA_21f1e154-141f-4034-97d9-e08b3ba4f727"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i6b50bcaa47814ec28040b26b7160a5ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM1LTUtMS0xLTA_75807f04-f291-41b7-9cf7-74c6517af855"
      unitRef="usd">28000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i28ca595e5eb740889d328b33d7ef80c9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM1LTctMS0xLTA_80c67c23-b508-47e1-acb6-deefca21db44"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM2LTEtMS0xLTA_e0a2fd0a-3f64-4c85-b164-18182ec7add2"
      unitRef="usd">7000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM2LTMtMS0xLTA_40eaa75c-b00f-47c3-bfb2-a7fa59a5caad"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM2LTUtMS0xLTA_48ca8d0f-486b-43dd-b7f8-5852e8b52985"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM2LTctMS0xLTA_ec580388-f262-4237-a0ea-f3dcae76ec85"
      unitRef="usd">7000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM5LTEtMS0xLTA_4636f762-3998-4faa-9100-2d6ed198d90d"
      unitRef="usd">145000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM5LTMtMS0xLTA_091d2d40-97a4-4292-ad09-e8d350b98ff7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id77fd8acee3c4413b86f9d17207eabab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM5LTUtMS0xLTA_043a56e7-38cb-455d-ac08-20b929ce5337"
      unitRef="usd">138000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzM5LTctMS0xLTA_1579530f-7f80-4427-b62d-cfb0515b15ea"
      unitRef="usd">7000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ic086df6338f745a683de6c79a9de2fcb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzQxLTEtMS0xLTA_b46db1d0-760a-47c5-811b-b3c0b3deca25"
      unitRef="usd">76000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i24cd7ce59c6e44eeb7a252d32729a2e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzQxLTMtMS0xLTA_19f52077-7e90-4cf5-be26-bf77e14e94a5"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i1ae8426bd53a496485b1b374770b199e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkODg4ZjI0M2Q0ZDQ0MTQwYWY3MWU4OTYzNmM3ZWZlMi90YWJsZXJhbmdlOmQ4ODhmMjQzZDRkNDQxNDBhZjcxZTg5NjM2YzdlZmUyXzQxLTctMS0xLTA_734c908c-5ef8-42cc-9bd7-92814d45d94a"
      unitRef="usd">76000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzEwNDQ1MzYwNDcwMTI0_8ab00fac-c92f-4834-9df3-c8bca25e6e2f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzU2MTg_d72f6a6e-b326-400b-b45e-70ffa669445f">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, additions and issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (gains)/losses included in earnings - realized/unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total (gains)/losses included in earnings - realized/unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib49a85f69283488d9da436dc5543b52e_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzItMS0xLTEtMA_def432e1-c233-433d-ad10-bb51008d6bd9"
      unitRef="usd">14000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
      contextRef="i92ef5f3f75a64fcea2e40d3c9b3ba138_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzMtMS0xLTEtMA_932461f2-8dd3-4193-9efe-f7635396782e"
      unitRef="usd">6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i92ef5f3f75a64fcea2e40d3c9b3ba138_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzQtMS0xLTEtMA_e6a40415-2d34-4332-8525-ba4ad95a3d29"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i92ef5f3f75a64fcea2e40d3c9b3ba138_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzUtMS0xLTEtMA_02279bfb-c0e2-4781-a2a9-066df17f61cc"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie2ea36aabe78463eb75346dd3ac096a6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzktMS0xLTEtMA_b53d9e7c-78c1-4035-ae9b-9e0302efa11e"
      unitRef="usd">7000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="iac45b37ce14e464c83d493dbb68d08ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzExLTEtMS0xLTA_fd6b8879-23e1-4b4b-8601-83b163acc747"
      unitRef="usd">6000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="iac45b37ce14e464c83d493dbb68d08ee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzEyLTEtMS0xLTA_4a805ab8-6587-4ccb-b0fa-c1ea21c6da93"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i819ba4179ff04a9c8d4de164c0081dc2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90YWJsZTpkNzVjYTgyOWZkODY0NjIzYTU4MThhODdjNDIzY2IwOC90YWJsZXJhbmdlOmQ3NWNhODI5ZmQ4NjQ2MjNhNTgxOGE4N2M0MjNjYjA4XzEzLTEtMS0xLTA_db61d9ed-3e96-46b3-a081-d64198dfb83d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i48245c8eab5c4b8091bfa77ef50e467e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzQwMzc_d41e9d30-1092-4a92-a637-3450601c7111"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="if1e6d68bf2d9484a8f112f2794388931_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzIxOTkwMjMyNjEyOTQ_2b0b4800-b6c1-41d9-b4c1-6fec39f9f31f"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i02060ac5ffa04417a6b16a9bd1912233_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzQyOTA_c2c286b3-d4d6-46b4-ae05-e33b604079db"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzIxOTkwMjMyNjE3MTA_99d6bff2-30c7-4b47-8046-a2a6190df74a"
      unitRef="usd">4600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTAvZnJhZzoxZDhiNDhjZjMxZGQ0YmEyOGE2NWNhMTM2ZDg5ZTRjMS90ZXh0cmVnaW9uOjFkOGI0OGNmMzFkZDRiYTI4YTY1Y2ExMzZkODllNGMxXzUyNTc_e38628b6-05de-420f-962f-630317d0c154"
      unitRef="usd">5100000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzcwMDA_7fe45a8f-e465-413d-8038-8755a4b60ff9">TAXES ON INCOME&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's pre-tax income from continuing operations before equity in earnings of equity method investees consisted of approximately $1.9 billion, $1.1 billion and $0.9 billion from U.S. operations and pre-tax (loss) income of $(7) million, $15 million and $(1) million from foreign operations for the years ended December&#160;31, 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As a result of the Tax Cuts and Jobs Act, the Company changed its assertion that it intends to indefinitely reinvest undistributed earnings from certain non-U.S. subsidiaries outside the U.S.  The Company is indefinitely reinvested in the remaining basis difference and it is not practicable to determine the associated amount of unrecognized deferred tax liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The components of income tax expense (benefit) for 2020, 2019 and 2018 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:42.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2020, 2019 and 2018 was as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess tax benefits on stock-based compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision true-ups &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in accounting method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of equity earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in reserves for uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowances associated with certain net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $12 million net income tax benefit due to the release of valuation allowances associated with certain net operating loss carryforwards.   In 2018, the Company filed for a tax return accounting method change, effective for the tax year ending December 31, 2017, to accelerate the deduction of certain expenses on its 2017 tax return at the higher 2017 federal corporate statutory income tax rate, resulting in a $15 million income tax benefit.  The net income tax benefit associated with changes in reserves for uncertain tax positions in 2018 was primarily related to the expiration of the statute of limitations for certain income tax returns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2020 and 2019 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities not currently deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis differences in investments, joint ventures and subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(604)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The non-current deferred tax assets (liabilities) disclosure at December 31, 2019 has been adjusted to separately state the gross deferred tax right-of-use asset and related gross deferred tax lease liability recognized in accordance with the new accounting standard for leases adopted on January 1, 2019.  As of December&#160;31, 2020 and 2019, non-current deferred tax liabilities of $350 million and $264 million, respectively, are included in other liabilities in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2020, the Company had estimated net operating loss carryforwards for federal and state income tax purposes of $60 million and $1.0 billion, respectively, which expire at various dates through 2040.  Estimated net operating loss carryforwards for foreign income tax purposes are $76 million as of December&#160;31, 2020, some of which can be carried forward indefinitely while others expire at various dates through 2040.  As of December&#160;31, 2020 and 2019, deferred tax assets associated with net operating loss carryforwards of $94 million and $101 million, respectively, have each been reduced by valuation allowances of $33 million and $26 million, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Income taxes payable, including those classified as long-term in other liabilities in the consolidated balance sheet as of December&#160;31, 2020 and 2019, were $135 million and $113 million, respectively.  Prepaid income taxes were $2 million and $3 million as of December&#160;31, 2020 and 2019, respectively, and were recorded in prepaid expenses and other current assets in the consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2020, 2019 and 2018 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For tax positions of current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in judgment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expirations of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The contingent liabilities for tax positions primarily relate to uncertainties associated with the realization of tax benefits derived from the allocation of income and expense among state jurisdictions, the characterization and timing of certain tax deductions associated with business combinations, certain tax credits and the deductibility of certain expenses and settlement payments.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of December&#160;31, 2020, that, if recognized, would affect the effective income tax rate is $75 million.  Based upon the expiration of statutes of limitations, settlements and/or the conclusion of tax examinations, the Company believes it is reasonably possible that the total amount of unrecognized tax benefits may decrease by up to $15 million within the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accruals for interest expense on contingent tax liabilities are classified in income tax expense in the consolidated statements of operations.  Accruals for penalties have historically been immaterial.  Interest expense included in income tax expense in each of the years ended December&#160;31, 2020, 2019 and 2018 was approximately $6 million, $5 million and $1 million, respectively.  As of December&#160;31, 2020 and 2019, the Company had approximately $21 million and $17 million, respectively, accrued, net of the benefit of a federal and state deduction, for the payment of interest on uncertain tax positions.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The recognition and measurement of certain tax benefits includes estimates and judgment by management and inherently involves subjectivity.  Changes in estimates may create volatility in the Company's effective tax rate in future periods and may be due to settlements with various tax authorities (either favorable or unfavorable), the expiration of the statute of limitations on certain tax positions and obtaining new information about particular tax positions that may cause management to change its estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the regular course of business, various federal, state, local and foreign tax authorities conduct examinations of the Company's income tax filings and the Company generally remains subject to examination until the statute of limitations expires for the respective jurisdiction.  The Internal Revenue Service has either completed its examinations of the Company's consolidated federal income tax returns or the statute of limitations has expired up through and including the 2016 tax year.  At this time, the Company does not believe that there will be any material additional payments beyond its recorded contingent liability reserves that may be required as a result of these tax audits.  As of December&#160;31, 2020, a summary of the tax years that remain subject to examination, awaiting approval, are under appeal, or are otherwise unresolved for the Company's major jurisdictions are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;United States - federal&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2017 -  2020 &lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;United States - various states&#160;&#160;&#160;&#160;2002 - 2020</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzE2Mg_8d15582d-31c1-45d2-a4d6-ad0f43ded8c7"
      unitRef="usd">1900000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzE2Ng_aa4c5b55-e5e2-4899-9963-a4cd5c78cc47"
      unitRef="usd">1100000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzE3Mw_1cfa4d47-1fb2-4c71-a21e-0f7bedce2239"
      unitRef="usd">900000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzIyNg_4814b3d6-175c-4e7b-b0ed-40c12a0e7e7a"
      unitRef="usd">-7000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzIzMA_e49c1c58-56c3-4691-a84b-3dce8f091d80"
      unitRef="usd">15000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzIzNw_3b96c965-98e4-4363-b3cd-b0f914dd03d2"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzY5ODY_0ca6bbd1-f412-494a-979f-94ae5fb3a32c">The components of income tax expense (benefit) for 2020, 2019 and 2018 were as follows: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzItMS0xLTEtMA_de21fea9-5103-4ea0-9178-188c0d85391e"
      unitRef="usd">300000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzItMy0xLTEtMA_a89c5764-f891-4dcd-b24b-d263d4419858"
      unitRef="usd">176000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzItNS0xLTEtMA_28e9e60a-e8f7-43c6-8e7c-1060e932d343"
      unitRef="usd">82000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzMtMS0xLTEtMA_def4c64a-eaf4-4aeb-bcf6-310171930f80"
      unitRef="usd">74000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzMtMy0xLTEtMA_df854f92-2b34-4ecd-ba55-db5666755a56"
      unitRef="usd">53000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzMtNS0xLTEtMA_e12f9966-fd97-4417-81d1-73b25037ce7e"
      unitRef="usd">26000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzQtMS0xLTEtMA_3f594ff6-4138-4687-aa08-34614624b734"
      unitRef="usd">1000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzQtMy0xLTEtMA_c3a3561f-2875-435c-bddb-ec3dd192402a"
      unitRef="usd">3000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzQtNS0xLTEtMA_59e6a292-1f7f-4a74-8a2f-144df6a3f49d"
      unitRef="usd">1000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzYtMS0xLTEtMA_93a014e4-34cb-48e0-8efa-b6ff4a45dd99"
      unitRef="usd">55000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzYtMy0xLTEtMA_9baffb4f-87d4-488f-93fd-116093adf761"
      unitRef="usd">21000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzYtNS0xLTEtMA_90bbb4fd-e05b-416f-9960-abc6fbadfe64"
      unitRef="usd">66000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzctMS0xLTEtMA_5e8956d7-2fec-41ac-bd30-37499adf9d86"
      unitRef="usd">29000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzctMy0xLTEtMA_f90047cc-230f-4338-a448-544c731805e0"
      unitRef="usd">-4000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzctNS0xLTEtMA_473f2710-37bf-4253-9dd4-f7103adfb3ce"
      unitRef="usd">10000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzgtMS0xLTEtMA_4f0e696e-d614-4a71-9c5e-bf9b30ad9bed"
      unitRef="usd">1000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzgtMy0xLTEtMA_c4529cb6-ebc6-40ed-8bec-d9e925192323"
      unitRef="usd">-2000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzgtNS0xLTEtMA_d26c865f-4428-4246-b6d3-71d641c4e389"
      unitRef="usd">-3000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzktMS0xLTEtMA_76faf29b-6bee-4540-92ec-a9fad3946073"
      unitRef="usd">460000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzktMy0xLTEtMA_4e986900-50c0-421c-a4ae-a20ca842de71"
      unitRef="usd">247000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTo4Y2MxYTgzZTcyYmU0YzI2ODE4MzQxNjgwNmYwZDFiNC90YWJsZXJhbmdlOjhjYzFhODNlNzJiZTRjMjY4MTgzNDE2ODA2ZjBkMWI0XzktNS0xLTEtMA_c36bc224-ef83-48d1-aa9a-b604c870dae3"
      unitRef="usd">182000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzY5OTM_acb73859-3db8-41e6-a02b-4bdd181494f6">A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2020, 2019 and 2018 was as follows: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Excess tax benefits on stock-based compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision true-ups &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in accounting method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impact of equity earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in reserves for uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowances associated with certain net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzItMS0xLTEtMA_6d473874-d29e-44a0-84e6-859b6f2d373d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzItMy0xLTEtMA_9d40b31a-ad4d-45d8-958c-25564d105e58"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzItNS0xLTEtMA_52582a26-01f1-4f1a-8414-270707d7ee51"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzMtMS0xLTEtMA_399bf1db-e971-49d3-b49d-86e3f49da8c6"
      unitRef="number">0.045</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzMtMy0xLTEtMA_790b268e-d74f-4b21-8bfa-7a639fe69ddc"
      unitRef="number">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzMtNS0xLTEtMA_e3ec88eb-4867-4dbd-978c-7679648e1116"
      unitRef="number">0.047</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzgtMS0xLTEtMA_1906b25f-2e86-4547-b85a-3b1d9fd8bf42"
      unitRef="number">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzgtMy0xLTEtMA_907cdd97-9c99-47e5-b04d-5871f325ef3c"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzgtNS0xLTEtMA_f79eeea6-8deb-47bb-a959-924a89eb87e3"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEwLTEtMS0xLTA_99c3eb60-2fb1-446f-9c71-fe7e66e667b3"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEwLTMtMS0xLTA_a0327f11-85c6-46e6-bfe5-56da681ede07"
      unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEwLTUtMS0xLTA_a992cc96-f6ab-4638-8038-4ce279e2357f"
      unitRef="number">0.019</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzExLTEtMS0xLTA_e7a8132f-472a-460e-883d-5ac991aa74c3"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzExLTMtMS0xLTA_72240645-72da-4ab9-8aa9-e9e67af694aa"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzExLTUtMS0xLTA_b817dbca-42aa-427c-a659-741f203ef867"
      unitRef="number">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEzLTEtMS0xLTA_a701cd1d-f815-4e6f-bdd5-b3749b3b2036"
      unitRef="number">0</dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEzLTMtMS0xLTA_f44c7940-e6b6-4dd6-a2a6-a98fbdaaed2d"
      unitRef="number">0</dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzEzLTUtMS0xLTA_aed611a1-5473-48ea-af8c-d6494c248ebf"
      unitRef="number">-0.016</dgx:EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE0LTEtMS0xLTA_b21025f2-5b64-4e9b-bbb2-44337d95a13b"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE0LTMtMS0xLTA_84576556-1608-471b-988e-198e93d4fa33"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE0LTUtMS0xLTA_2a8a0eed-d043-48d1-a6fa-a1dc0d8aaab8"
      unitRef="number">0.010</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE1LTEtMS0xLTA_bfeda372-ac62-47fa-b17d-16c7780acdcf"
      unitRef="number">0.009</dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE1LTMtMS0xLTA_3564819f-e197-4f70-9418-079e51e11919"
      unitRef="number">0.017</dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition>
    <dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE1LTUtMS0xLTA_a3ff9fde-1ce2-435c-98e6-4a26d9bfc0f1"
      unitRef="number">-0.008</dgx:EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE2LTEtMS0xLTA_72b86a6e-4f05-4d08-9a60-d6259ca9a9ea"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE2LTMtMS0xLTA_2bce7748-da88-4498-8e9f-77ef72399d71"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE2LTUtMS0xLTA_abba658d-39ee-4257-9ff6-9d71615ebda2"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE3LTEtMS0xLTA_92337f51-8382-49dd-b121-6153f89b5e70"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE3LTMtMS0xLTA_0bb546f2-69fa-48e7-ab0b-ae739f6b299e"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE3LTUtMS0xLTA_513c808b-3355-4190-887a-61461504ab25"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE4LTEtMS0xLTA_c1994351-1089-4077-ba6c-69c2347b8580"
      unitRef="number">0.245</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE4LTMtMS0xLTA_f03484f7-396e-49a9-8309-f777e579b1f8"
      unitRef="number">0.230</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTplMWNkODk1YmQ5NDQ0MWY3OGJlZGRjMzlhNWQ0MzRiZS90YWJsZXJhbmdlOmUxY2Q4OTViZDk0NDQxZjc4YmVkZGMzOWE1ZDQzNGJlXzE4LTUtMS0xLTA_e9586b42-2aee-4693-8d4d-91a37a76742c"
      unitRef="number">0.197</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <dgx:IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzIyNjU_9c286fa0-7ffc-4187-9627-c81c10d10b9f"
      unitRef="usd">12000000</dgx:IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards>
    <dgx:IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzI2NjM_c7fddc0d-534f-44e5-a67f-0a5f9a06c101"
      unitRef="usd">15000000</dgx:IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzY5OTk_b3b9024c-d933-4ea0-a6d4-da5f0837f100">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2020 and 2019 were as follows: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable reserves&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities not currently deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis differences in investments, joint ventures and subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(604)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current deferred tax liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzItMS0xLTEtMA_ef183d0e-4dbd-4cb3-8fbf-f3bd804846dc"
      unitRef="usd">71000000</dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables>
    <dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzItMy0xLTEtMA_ca4e3903-065d-49f9-83dc-ced079f5e63f"
      unitRef="usd">64000000</dgx:DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzMtMS0xLTEtMA_7f6c5f0b-b82d-4682-b79e-c0d159547b9b"
      unitRef="usd">146000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzMtMy0xLTEtMA_b5935326-883e-4824-a941-0a8b3840fcfd"
      unitRef="usd">126000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzQtMS0xLTEtMA_736ae082-0841-4e87-bba8-dd33f81c14bd"
      unitRef="usd">47000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzQtMy0xLTEtMA_549b7817-3764-4f1b-ba9d-4e43a7548ce9"
      unitRef="usd">35000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzYtMS0xLTEtMA_7939bef5-e616-430c-aa68-7db5aa7e425a"
      unitRef="usd">81000000</dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments>
    <dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzYtMy0xLTEtMA_cdb0f28e-9c56-48b9-b23e-a7f97a731d15"
      unitRef="usd">80000000</dgx:DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments>
    <dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzctMS0xLTEtMA_3766151a-0ff2-4e20-81f2-93706496ce4d"
      unitRef="usd">61000000</dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance>
    <dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzctMy0xLTEtMA_c383896f-315d-4629-b372-aea9285e1593"
      unitRef="usd">75000000</dgx:NetOperatingLossCarryfowardsNetOfValuationAllowance>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzgtMS0xLTEtMTI1MTE_aa8ac901-9aa1-4ccb-b118-49435300c26a"
      unitRef="usd">151000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzgtMy0xLTEtMTI1MDc_cfe25100-ebcd-4cc5-87f0-4bdd2effab7f"
      unitRef="usd">129000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzktMS0xLTEtMTMyMjg_08d11297-b0dc-45a3-8273-59a373ea8502"
      unitRef="usd">161000000</dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent>
    <dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzktMy0xLTEtMTMyMzE_ed9a0ff7-c0ab-42c1-8d3f-ddbbe8a47d47"
      unitRef="usd">139000000</dgx:DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzgtMS0xLTEtMA_39a8f021-7a96-49b4-8de1-e8a31f98585b"
      unitRef="usd">604000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzgtMy0xLTEtMA_81893612-96bd-4f25-ab54-66ccec3054b0"
      unitRef="usd">494000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzktMS0xLTEtMA_d1c352dd-67dd-4fa2-9d42-9d1084ee33fc"
      unitRef="usd">350000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZToyZmRmYzliMmQ5NTc0MGM3YmVjMjNiMzQ1YWNhNWVhNC90YWJsZXJhbmdlOjJmZGZjOWIyZDk1NzQwYzdiZWMyM2IzNDVhY2E1ZWE0XzktMy0xLTEtMA_634f572e-d28e-4fa8-a3c6-79e4ca423025"
      unitRef="usd">264000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzMxMDc_1475740d-8129-4cf6-8182-5281acbedcca"
      unitRef="usd">350000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzMxMTQ_531d8750-2ac3-494c-b6bd-3f8828188412"
      unitRef="usd">264000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i4202ba5a9d04407d83cd7e068541a1d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzMyODU_48360907-d285-42dc-a6f6-c35a89c425e6"
      unitRef="usd">60000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="iabd266dd7d024345af367a828d3a1650_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzMyOTI_60646de9-d180-4a6e-9ba4-07c5992ce826"
      unitRef="usd">1000000000.0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i08f2967b216f47cdbe6de707915af4a3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM0MzI_3a942002-54f3-4da5-8999-47994b6f0b6c"
      unitRef="usd">76000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM2MzQ_db5668c6-3f99-4d57-8e01-689f36fd88c1"
      unitRef="usd">94000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM2NDE_f74c15d5-9812-4b76-a885-9a1b3a096fac"
      unitRef="usd">101000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM3MDk_a02f2a7e-e495-4931-8485-bec27abe9d03"
      unitRef="usd">33000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM3MTY_7092d308-0c35-48e9-8e6d-00b13e4b0107"
      unitRef="usd">26000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:AccruedIncomeTaxes
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM4NDQ_58650287-cee5-46d4-89cc-ad8011904ee4"
      unitRef="usd">135000000</us-gaap:AccruedIncomeTaxes>
    <us-gaap:AccruedIncomeTaxes
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM4NTE_ae824d63-2485-48c3-8926-2346af55471c"
      unitRef="usd">113000000</us-gaap:AccruedIncomeTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM4OTY_b211029f-90b9-4d79-9d10-346d4a25a8dd"
      unitRef="usd">2000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzM5MDM_5de8d78e-0c72-453b-84c7-13b5f6b88d75"
      unitRef="usd">3000000</us-gaap:PrepaidTaxes>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzY5OTU_3cdc469e-6a42-40a6-8638-0c5b65135e4f">The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2020, 2019 and 2018 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For tax positions of current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in judgment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expirations of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzItMS0xLTEtMA_af9c3ba1-9ab3-47d0-a5af-974dfe5cefde"
      unitRef="usd">88000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzItMy0xLTEtMA_e5b5dac3-5c8a-48d1-88ce-e74d80233565"
      unitRef="usd">107000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i79da04d8282d4c8291850645193b2909_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzItNS0xLTEtMA_276ca4c4-e094-4152-b4c2-cc76d44d9a67"
      unitRef="usd">115000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzQtMS0xLTEtMA_5e7ccd16-f92a-46e1-80b8-b8d6c6a06b25"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzQtMy0xLTEtMA_7306f632-1bdb-4f14-a6ca-a081ec40e4ca"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzQtNS0xLTEtMA_5ae3aff7-3210-4bc4-86d2-e7b72aa5fa24"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzUtMS0xLTEtMA_23e997de-48ee-4c96-b46a-34bafe0d18ce"
      unitRef="usd">25000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzUtMy0xLTEtMA_6db5f37b-98b5-44a1-b8e1-9c3a09d0288c"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzUtNS0xLTEtMA_a4030442-9d50-4da7-9785-ebe5ac71a74d"
      unitRef="usd">11000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <dgx:ReductionsForChangesInJudgment
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzctMS0xLTEtMA_e1138bcd-1808-4d01-b643-4244820487cb"
      unitRef="usd">9000000</dgx:ReductionsForChangesInJudgment>
    <dgx:ReductionsForChangesInJudgment
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzctMy0xLTEtMA_c21757b9-1ed3-4d04-b90e-0eb6236c2f2d"
      unitRef="usd">3000000</dgx:ReductionsForChangesInJudgment>
    <dgx:ReductionsForChangesInJudgment
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzctNS0xLTEtMA_30020c2e-9479-4235-844a-c7beed869124"
      unitRef="usd">6000000</dgx:ReductionsForChangesInJudgment>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzgtMS0xLTEtMA_2144e430-0478-410a-82ea-eddec77731d8"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzgtMy0xLTEtMA_06d23d5d-8c43-46e1-88e8-f9d991311a6b"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzgtNS0xLTEtMA_8193fa91-f86a-4d71-ba4e-cc36b5592a3c"
      unitRef="usd">15000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzktMS0xLTEtMA_495c4558-e2c7-4ed2-a0e4-4e2dfa6c7b0a"
      unitRef="usd">9000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzktMy0xLTEtMA_b3063928-699f-4711-933b-7e845a05f4ce"
      unitRef="usd">32000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzktNS0xLTEtMA_0ad4e3d0-5db4-4e83-b8ef-9e20964d0ee7"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzEwLTEtMS0xLTA_93b4ac17-2fe0-425b-85b7-82b8d06ce06b"
      unitRef="usd">93000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzEwLTMtMS0xLTA_99f26cbe-9805-4900-b3b6-3babcfa5d2f2"
      unitRef="usd">88000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90YWJsZTpjZDQxMzNlZTJiMGE0YzE2YjY5YjU5MDI2ZjFlYmRhOC90YWJsZXJhbmdlOmNkNDEzM2VlMmIwYTRjMTZiNjliNTkwMjZmMWViZGE4XzEwLTUtMS0xLTA_c5359e9d-153c-48c9-ad0a-42eebd4cdb83"
      unitRef="usd">107000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzQ3MTA_e7df478b-83ff-46d7-a40f-ce98bcf2b6ba"
      unitRef="usd">75000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzQ5NDQ_48d35ace-43b3-461e-990a-ee1cd2ce30e8"
      unitRef="usd">15000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUyOTA_5ce56185-73af-444a-80f8-10c635bbc42c"
      unitRef="usd">6000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUyOTQ_ae7d3ae1-c9dd-4108-82b0-0af1615cc247"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUzMDE_c0fe53f5-4bde-4d71-b6a4-bf10ff38ef19"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUzNjc_f7e5e107-f66f-4bff-a5d1-3940069047ac"
      unitRef="usd">21000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTMvZnJhZzoyNWMzN2NkMzEyY2E0ZmRmODE1M2JiZDJkNGZiMTFhNS90ZXh0cmVnaW9uOjI1YzM3Y2QzMTJjYTRmZGY4MTUzYmJkMmQ0ZmIxMWE1XzUzNzQ_d655503a-43a6-4a5f-9d16-db68dee51118"
      unitRef="usd">17000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90ZXh0cmVnaW9uOjY4ZWMxOWViMzJiNDQ5MDhhOTE2Y2EwNzZjNTZiOWYzXzQ2Mw_e9e7e38e-abff-4794-89a2-24965cfc3db2">SUPPLEMENTAL CASH FLOW AND OTHER DATA &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the years ended December&#160;31, 2020, 2019 and 2018 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with purchases of treasury stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new finance lease liabilities (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) For the year ended December 31, 2018, leased assets obtained in exchange for new finance lease liabilities reflects information prior to the adoption of the new accounting standard for leases on January 1, 2019.  See Note 14 for further discussion of the Company's accounting for leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90ZXh0cmVnaW9uOjY4ZWMxOWViMzJiNDQ5MDhhOTE2Y2EwNzZjNTZiOWYzXzQ3MQ_f2fd21e8-c64a-4a71-b422-067efd294ffc">Supplemental cash flow and other data for the years ended December&#160;31, 2020, 2019 and 2018 was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with purchases of treasury stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for business acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new finance lease liabilities (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) For the year ended December 31, 2018, leased assets obtained in exchange for new finance lease liabilities reflects information prior to the adoption of the new accounting standard for leases on January 1, 2019.  See Note 14 for further discussion of the Company's accounting for leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:Depreciation
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzItMS0xLTEtMA_5c49c620-90b8-4511-b021-4c086304cba7"
      unitRef="usd">258000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzItMy0xLTEtMA_d1630bed-44de-4168-997c-8301cd4197a7"
      unitRef="usd">233000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzItNS0xLTEtMA_cc5960ac-aef4-485d-b967-ba5c023cae87"
      unitRef="usd">219000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzMtMS0xLTEtMA_77b84477-9e17-4374-9f63-2a4cf97b5f79"
      unitRef="usd">103000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzMtMy0xLTEtMA_ccc5fd09-82ba-4475-8c5e-00dddd5fdf8a"
      unitRef="usd">96000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzMtNS0xLTEtMA_3cb3a249-12ae-4d58-92ec-183f6453dc8f"
      unitRef="usd">90000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzQtMS0xLTEtMA_398e9ce1-a3b8-4ae0-92a7-486d533b345a"
      unitRef="usd">361000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzQtMy0xLTEtMA_e2587a0e-e944-45e8-855e-e090cbb9a6ea"
      unitRef="usd">329000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzQtNS0xLTEtMA_3ebf6dff-7ae5-43f3-84be-a8051c4cf8ce"
      unitRef="usd">309000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzYtMS0xLTEtMA_7028ccf7-52b6-4106-bb09-9d941839873e"
      unitRef="usd">166000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzYtMy0xLTEtMA_1a695da0-f131-46d0-a2d8-ea20192c07f5"
      unitRef="usd">180000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzYtNS0xLTEtMA_e2553e69-2467-4e2e-87c6-d31cfcf8d908"
      unitRef="usd">169000000</us-gaap:InterestExpense>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzctMS0xLTEtMA_0f44b289-df25-49c3-9197-710d4551ce06"
      unitRef="usd">3000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzctMy0xLTEtMA_1659b50f-ab1e-48fd-85b4-0a7895016138"
      unitRef="usd">5000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzctNS0xLTEtMA_eee61bb4-c357-448a-b44d-584f7413fe0d"
      unitRef="usd">2000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzgtMS0xLTEtMA_6e476557-eb0d-43b4-a647-21a2d8f359cb"
      unitRef="usd">-163000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzgtMy0xLTEtMA_a7cf9331-fe71-491b-8b93-6469360b174c"
      unitRef="usd">-175000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzgtNS0xLTEtMA_d37a99c1-3c4f-4606-81b6-9e628a165700"
      unitRef="usd">-167000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestPaid
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEwLTEtMS0xLTA_028b1849-ccbd-4a87-bf89-a159c0773975"
      unitRef="usd">201000000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEwLTMtMS0xLTA_3419c0fb-e26e-486d-b1ea-4e06058429fd"
      unitRef="usd">192000000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEwLTUtMS0xLTA_0de95b57-1f85-4934-a0e1-1dc0953f7915"
      unitRef="usd">174000000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzExLTEtMS0xLTA_b4690eb6-a659-496e-bb85-cf99befda780"
      unitRef="usd">360000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzExLTMtMS0xLTA_bd93fb22-4bb8-493b-a8df-74a4d18932ac"
      unitRef="usd">202000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzExLTUtMS0xLTA_9fbcf859-03fd-4f54-9799-98018422b298"
      unitRef="usd">84000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEzLTEtMS0xLTA_71109283-1d20-448b-a78c-5f80a9d6ffca"
      unitRef="usd">46000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEzLTMtMS0xLTA_838d9044-e460-4710-99eb-2657cfdd5dcb"
      unitRef="usd">26000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzEzLTUtMS0xLTA_55a75b4f-5c31-4976-8a6b-eecc02e727f0"
      unitRef="usd">11000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE0LTEtMS0xLTA_06ca68fc-3e8e-449c-9133-5e1c929f7938"
      unitRef="usd">0</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE0LTMtMS0xLTA_592219d7-a68e-4f6c-91ba-9640b0cfd045"
      unitRef="usd">0</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <dgx:TreasuryStockPurchasedbutNotyetPaid
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE0LTUtMS0xLTA_1d891494-a63d-457c-83a5-9ab3d1dd4b4b"
      unitRef="usd">3000000</dgx:TreasuryStockPurchasedbutNotyetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE1LTEtMS0xLTA_a3aab0f3-4ce9-44ac-ae61-2603a032b50d"
      unitRef="usd">76000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE1LTMtMS0xLTA_fc1fc353-5fcf-49bc-bb1b-2dfe03266165"
      unitRef="usd">71000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE1LTUtMS0xLTA_312e9737-1828-4da1-9dc5-4223b31df4bc"
      unitRef="usd">71000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE4LTEtMS0xLTA_373c5b9d-b212-49c5-bde9-de929c3cacd1"
      unitRef="usd">368000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE4LTMtMS0xLTA_72dcf34a-128a-4e85-9446-d093fc4e9047"
      unitRef="usd">63000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE4LTUtMS0xLTA_e45e9820-89d2-45a2-a283-9d5b7204a29d"
      unitRef="usd">453000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE5LTEtMS0xLTA_e0e62063-4bb0-4aeb-93cf-8632abc16d44"
      unitRef="usd">17000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE5LTMtMS0xLTA_343afc82-2a20-48d6-bfed-507406b55eed"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzE5LTUtMS0xLTA_57647e06-3ba7-4a6b-87ae-132ca279f508"
      unitRef="usd">7000000</us-gaap:LiabilitiesAssumed1>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIwLTEtMS0xLTA_49d7c2bf-b1a1-4dcf-8e35-3e7a7aa9a27a"
      unitRef="usd">351000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIwLTMtMS0xLTA_cff4aad4-f39f-4e73-ab95-dbd92813ece0"
      unitRef="usd">63000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIwLTUtMS0xLTA_ddda369c-bc8b-498c-9ba6-8b6a6e2e3506"
      unitRef="usd">446000000</dgx:FairValueOfNetAssetsAcquired>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIxLTEtMS0xLTA_01e28aee-fac4-43b1-8597-46633213b620"
      unitRef="usd">0</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIxLTMtMS0xLTA_5b648f25-d9d9-4710-914e-8328757a45b8"
      unitRef="usd">-5000000</dgx:Mergerconsiderationpaidpayablenet>
    <dgx:Mergerconsiderationpaidpayablenet
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIxLTUtMS0xLTA_2a2aae37-1ce6-49da-bb94-5e4d7a0ac47c"
      unitRef="usd">-19000000</dgx:Mergerconsiderationpaidpayablenet>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIyLTEtMS0xLTA_aded9d62-1f57-46cf-96f0-48519601f1b4"
      unitRef="usd">351000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIyLTMtMS0xLTA_9f22dfd5-3c56-40c8-8f12-96c3545c24ed"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIyLTUtMS0xLTA_79e19909-3e59-4289-96bd-1852caaf2be8"
      unitRef="usd">427000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIzLTEtMS0xLTA_49c29cf3-78a2-4b4c-978a-f3a3331c3618"
      unitRef="usd">21000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIzLTMtMS0xLTA_30029a77-31c7-4591-967d-1340492119e5"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzIzLTUtMS0xLTA_c74bfc6d-ba6c-4116-ac37-1d054e08ae47"
      unitRef="usd">6000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzI0LTEtMS0xLTA_11ad259c-da25-48fd-97c2-30a205a5de2b"
      unitRef="usd">330000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzI0LTMtMS0xLTA_af398d72-c7f8-4f4f-bb39-df4bd9cbff1b"
      unitRef="usd">58000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTpmNzEyNTZlYzQyYmI0Njk5OWQ3MzA2NDZiNmVjMGE1Yi90YWJsZXJhbmdlOmY3MTI1NmVjNDJiYjQ2OTk5ZDczMDY0NmI2ZWMwYTViXzI0LTUtMS0xLTA_9e6bd023-ff89-41c4-821e-6f739da0644b"
      unitRef="usd">421000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:OperatingLeasePayments
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzMtNC0xLTEtMA_2c3ecd48-1278-414e-9251-b0573172110b"
      unitRef="usd">185000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzMtNi0xLTEtMjI4_03fc32f0-1bb9-44cd-aa92-bab69954cdbe"
      unitRef="usd">180000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzQtNC0xLTEtMA_9051ec6a-8369-46d5-b0f2-1c07de17aaeb"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzQtNi0xLTEtMjM1_c6b53361-48d5-47bf-8962-3ac5706d0050"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzUtNC0xLTEtMA_7591a2a6-6266-45cf-8984-2c6a4f307684"
      unitRef="usd">3000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzUtNi0xLTEtMjM4_c7167e3a-4970-4490-8dcb-8d92417feaeb"
      unitRef="usd">4000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzYtNC0xLTEtMA_5dd32fea-38a7-44cc-ae1b-de7aee999f90"
      unitRef="usd">219000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzYtNi0xLTEtMjQx_a143db4e-d991-45f0-a95b-7eac76c106a5"
      unitRef="usd">164000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzctNC0xLTEtMA_bb2c045a-24c3-404f-ad1c-b3cefc042a89"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzctNi0xLTEtMA_9a45a0d4-71f0-4601-8e05-fc1a0f8aacc1"
      unitRef="usd">1000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:CapitalLeaseObligationsIncurred
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTYvZnJhZzo2OGVjMTllYjMyYjQ0OTA4YTkxNmNhMDc2YzU2YjlmMy90YWJsZTowMDA1ODNmOTkxZDY0YTRjODU5NzljYjEwNzc3ZjFmMy90YWJsZXJhbmdlOjAwMDU4M2Y5OTFkNjRhNGM4NTk3OWNiMTA3NzdmMWYzXzctOC0xLTEtMA_f4a89a85-cfb9-4bdb-86fc-dc1784209a06"
      unitRef="usd">1000000</us-gaap:CapitalLeaseObligationsIncurred>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90ZXh0cmVnaW9uOjEyOGU0ZjFjMjJlYTQ5Njk5NGZjNTA3ZjMwNzdlM2Q5XzI2OA_e0589dbf-fb69-4a76-add9-e6dcd5e15e94">PROPERTY, PLANT AND EQUIPMENT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Property, plant and equipment as of December&#160;31, 2020 and 2019 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment and furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software developed or obtained for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,776)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company recognized a $73 million gain in other operating expense (income), net on the sale and leaseback of a property.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90ZXh0cmVnaW9uOjEyOGU0ZjFjMjJlYTQ5Njk5NGZjNTA3ZjMwNzdlM2Q5XzI3MA_c4db2997-250d-4653-a822-89bfa7c7a77c">Property, plant and equipment as of December&#160;31, 2020 and 2019 consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment and furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software developed or obtained for internal use&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,992)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,776)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i57203f1941a34c238bfee31665aa7843_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzItMS0xLTEtMA_0c4f04ad-da6d-4b3e-9e84-e45a6814e38b"
      unitRef="usd">42000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0b179f5a47024b169176a67fc04394a0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzItMy0xLTEtMA_4354494d-a11b-464f-8665-3d2b2314553b"
      unitRef="usd">25000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i98373f0ec7ac4501bf3c20e192a85ab3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzMtMS0xLTEtMA_d02d4135-a381-4344-a56a-34feb3609c3c"
      unitRef="usd">526000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3b35a4725d3b4fe88bfb392d476d30ea_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzMtMy0xLTEtMA_c0d14c77-ebaa-4b70-b54e-cdc3cebbd6ed"
      unitRef="usd">341000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i488c3759446b424087ce0ba119b76f4b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzQtMS0xLTEtMA_c4a1378f-348e-462d-a7e5-454deee935f7"
      unitRef="usd">1974000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i79e00f2d39ae4504bdf0f0d04a7db8be_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzQtMy0xLTEtMA_35b72cbd-0ce8-4128-aa77-9539673c81d9"
      unitRef="usd">1788000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i17d8a0586d3241db9286ef290dada58c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzUtMS0xLTEtMA_e8c15f9e-f083-4460-9ddb-707c38760020"
      unitRef="usd">666000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i963111a2b7bb47c19ef1cb3341f61107_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzUtMy0xLTEtMA_fa84ab80-ea70-44f0-a8b6-1f2b68275554"
      unitRef="usd">639000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibc60f47f344746ebae9a4d823259060a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzYtMS0xLTEtMA_d81bb237-31e1-469b-9950-c434f211ce30"
      unitRef="usd">1209000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i460ce5e8869e4c7ebfa1175c77836f6a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzYtMy0xLTEtMA_f5478741-649f-4a1f-8256-3b25c62ce894"
      unitRef="usd">1106000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6b113ac98aea45cf8f7bd27c96d34ba6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzctMS0xLTEtMA_8d18eccb-a049-4e58-9b09-a8ec6715108d"
      unitRef="usd">202000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibb8ced261d56482fb9e20fcf2b809143_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzctMy0xLTEtMA_aea0196c-a20f-4c7c-9af5-3669fb606ed8"
      unitRef="usd">330000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzgtMS0xLTEtMA_b93250fd-c639-49ff-b589-b2d0ac071618"
      unitRef="usd">4619000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzgtMy0xLTEtMA_9dd0fd1d-0c8f-48c2-bd73-871b288c8cb0"
      unitRef="usd">4229000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzktMS0xLTEtMA_37f04981-ffd0-47cc-aeec-2497f658e42c"
      unitRef="usd">2992000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzktMy0xLTEtMA_7e3638ba-63a2-48f5-bbad-b08a4d9f438e"
      unitRef="usd">2776000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzEwLTEtMS0xLTA_beb5c776-baa6-46b7-b8bd-1c1be88ff998"
      unitRef="usd">1627000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90YWJsZTpkYjE5MDY1YzdjNGM0YjFmODc1NGE5Y2RiMzkyZjRiOS90YWJsZXJhbmdlOmRiMTkwNjVjN2M0YzRiMWY4NzU0YTljZGIzOTJmNGI5XzEwLTMtMS0xLTA_af0e928b-ee99-4073-b3b0-24fc17d6999f"
      unitRef="usd">1453000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i6b3427db7dba497ca4f76498d69ffb7b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xOTkvZnJhZzoxMjhlNGYxYzIyZWE0OTY5OTRmYzUwN2YzMDc3ZTNkOS90ZXh0cmVnaW9uOjEyOGU0ZjFjMjJlYTQ5Njk5NGZjNTA3ZjMwNzdlM2Q5XzE3MA_4b9a4149-32c0-459f-bfdf-38ce0e6ea003"
      unitRef="usd">73000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90ZXh0cmVnaW9uOjBlYjUwZTAxMmUyZDRmMWVhNGY0NWYyYjczOTk1NmJmXzk2MA_febf017e-3506-4a89-a56d-cc0127d8fcb9">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in goodwill for the years ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Principally all of the Company&#x2019;s goodwill as of December&#160;31, 2020 and 2019 was associated with its DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, goodwill acquired during the period was principally associated with the acquisitions of Blueprint Genetics, Memorial Hermann and MACL (see Note 6). For the year ended December&#160;31, 2020, adjustments to goodwill related to foreign currency translation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, goodwill acquired during the period was principally associated with the acquisition of certain assets of the clinical laboratory services business of Boyce &amp;amp; Bynum and adjustments to goodwill primarily related to the finalization of the purchase price allocation for Oxford (see Note 6).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets as of December&#160;31, 2020 and 2019 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:41.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90ZXh0cmVnaW9uOjBlYjUwZTAxMmUyZDRmMWVhNGY0NWYyYjczOTk1NmJmXzk0OQ_f91d421d-3c99-4d68-a4f7-8d06594944f8">The changes in goodwill for the years ended December&#160;31, 2020 and 2019 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzItMS0xLTEtMA_8703e271-7c00-40b9-977a-64ea62b88573"
      unitRef="usd">6619000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8e7c86051f474a8190d2d494f3dd3a2f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzItMy0xLTEtMA_e19d8440-cee9-4567-b69d-28333ffe2e5b"
      unitRef="usd">6563000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzMtMS0xLTEtMA_f523a6f2-957e-46d1-a12d-e318e17d64d6"
      unitRef="usd">247000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzMtMy0xLTEtMA_c91c71b3-ef70-4b21-800f-e8e6ebdabfbf"
      unitRef="usd">43000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzQtMS0xLTEtMA_62e19ed5-7588-4452-80d3-a8115feaebfa"
      unitRef="usd">7000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzQtMy0xLTEtMA_3fe98de7-8c38-47b1-92b3-9043cd713eb7"
      unitRef="usd">13000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzUtMS0xLTEtMA_ac864493-059c-4e69-8179-32cb2a0970fe"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZToyYmMwNWZlODBkZDY0NTE0YjRjZWJmYzE1OWI4NDg1NS90YWJsZXJhbmdlOjJiYzA1ZmU4MGRkNjQ1MTRiNGNlYmZjMTU5Yjg0ODU1XzUtMy0xLTEtMA_2729e581-16c6-41db-a70b-dd5f55e3cd71"
      unitRef="usd">6619000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90ZXh0cmVnaW9uOjBlYjUwZTAxMmUyZDRmMWVhNGY0NWYyYjczOTk1NmJmXzk0Ng_0e3252cc-25d3-4b92-a46c-47624b0063fe">Intangible assets as of December&#160;31, 2020 and 2019 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:39pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(556)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(699)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib7baf33e596b473a946a41c842d5c491_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtMS0xLTEtMA_ee45e313-c97d-482f-ba51-e245c81999cd">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i08feb83acb194d67a15c42b397b1d300_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtMy0xLTEtMA_26353400-a782-4c58-9478-ee71ae504b23"
      unitRef="usd">1479000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i08feb83acb194d67a15c42b397b1d300_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtNS0xLTEtMA_14e6981c-5cc7-41f9-a491-dbc096f9cd37"
      unitRef="usd">638000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i08feb83acb194d67a15c42b397b1d300_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtNy0xLTEtMA_84272d7b-f2e8-4fb6-922b-6e5d958934f6"
      unitRef="usd">841000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ide27b07e394e4a51961018b52520f0c9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtOS0xLTEtMA_45f9bb6d-3ce9-4c58-98f9-7b22a51228ba"
      unitRef="usd">1367000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ide27b07e394e4a51961018b52520f0c9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtMTEtMS0xLTA_0b7d9db4-34a4-4de9-a54c-675ee4eef55c"
      unitRef="usd">556000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ide27b07e394e4a51961018b52520f0c9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzMtMTMtMS0xLTA_2d828fee-0c5d-4e53-a0f4-23cdf7842480"
      unitRef="usd">811000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i28c19a374b654a3fa8f26f4bf1cada1b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtMS0xLTEtMA_846d05d6-b6d5-4022-8e67-b6f66f6bc88b">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i621c9dbaf928427c8d032db6c9363c81_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtMy0xLTEtMA_3c067f72-94b5-4d86-9706-13c263d88e83"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i621c9dbaf928427c8d032db6c9363c81_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtNS0xLTEtMA_5931ff80-9c70-4352-90c1-31340ba17489"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i621c9dbaf928427c8d032db6c9363c81_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtNy0xLTEtMA_08f2438e-1102-4265-ad8c-82c3b65bb944"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i20fc99f28f194d7c887e0338830b8cb3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtOS0xLTEtMA_204f36fe-0965-48a7-9f74-c12b095ce403"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i20fc99f28f194d7c887e0338830b8cb3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtMTEtMS0xLTA_a67a34d1-e987-4115-b1a2-787662141270"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i20fc99f28f194d7c887e0338830b8cb3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzQtMTMtMS0xLTA_50b24553-26a8-4c4a-9785-30ad91bc9e79"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5f467983b7f945f691b9a39b57df9e3f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtMS0xLTEtMA_24ee5070-d0ef-4b16-b03e-704bf20aadcb">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if767f2717d3143c6901d055819025e8a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtMy0xLTEtMA_f36df7aa-5b7e-48d4-b5dd-8a0f07199b8d"
      unitRef="usd">141000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if767f2717d3143c6901d055819025e8a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtNS0xLTEtMA_c8257609-8774-41a2-85bd-e264b7f9af74"
      unitRef="usd">65000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if767f2717d3143c6901d055819025e8a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtNy0xLTEtMA_c305320d-dccb-4b1e-afb6-74ea8cffc500"
      unitRef="usd">76000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ie1e2caa4565945f894ecf42eb41689f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtOS0xLTEtMA_50a6c931-ff7d-4452-a3fd-2752d100d7f1"
      unitRef="usd">104000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie1e2caa4565945f894ecf42eb41689f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtMTEtMS0xLTA_9b071515-6fab-46b9-bfea-0a8e9921e66f"
      unitRef="usd">56000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie1e2caa4565945f894ecf42eb41689f8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzUtMTMtMS0xLTA_bf12a469-c69c-4eb4-aa8d-b5c8e99c1d78"
      unitRef="usd">48000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7c7dfe44b07a4d7e846ac1bbb305e60e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtMS0xLTEtMA_da36dfb2-aa12-40d0-8024-4b317f02b6ec">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4534f39f0409446090ba1928a95e44ed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtMy0xLTEtMA_bbda1cc2-a814-46c1-87a2-f6fdb3fd9b57"
      unitRef="usd">108000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4534f39f0409446090ba1928a95e44ed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtNS0xLTEtMA_122e3183-ffaf-416f-8d1d-43951a8302f9"
      unitRef="usd">95000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4534f39f0409446090ba1928a95e44ed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtNy0xLTEtMA_442e8d14-a8bd-4f03-823c-02eb94dcdb6b"
      unitRef="usd">13000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8718641f12744c54b79e3f030931340e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtOS0xLTEtMA_0fb5b1e1-73d5-446e-b8d9-d5e0f9d6d5a2"
      unitRef="usd">110000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8718641f12744c54b79e3f030931340e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtMTEtMS0xLTA_de06b70f-d69b-4222-84c4-2f5feb3e2540"
      unitRef="usd">85000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8718641f12744c54b79e3f030931340e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzYtMTMtMS0xLTA_8dc8a9a4-cedc-4721-a473-a640aacd59d3"
      unitRef="usd">25000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if578b84393414e85a55b974226b6eb09_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctMS0xLTEtMA_b8d06ff6-60c7-4f1b-98cf-927621417713">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i610d712018cd496aa9a406ed51db8e20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctMy0xLTEtMA_4bace7d0-3d6c-4e05-afe6-7c2edfe8de68"
      unitRef="usd">1731000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i610d712018cd496aa9a406ed51db8e20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctNS0xLTEtMA_46d4e50a-9165-430b-a916-d4eeba02205f"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i610d712018cd496aa9a406ed51db8e20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctNy0xLTEtMA_ad975155-69ef-4e58-b90c-25c8606139bf"
      unitRef="usd">931000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic84b16b1ff6c4b6e9b65c95661c327fb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctOS0xLTEtMA_0d5dee0d-b50f-44fa-bc73-b625ee5fab4f"
      unitRef="usd">1584000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic84b16b1ff6c4b6e9b65c95661c327fb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctMTEtMS0xLTA_29ea064f-6025-4359-83bf-37dba6abf98e"
      unitRef="usd">699000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic84b16b1ff6c4b6e9b65c95661c327fb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzctMTMtMS0xLTA_dccdc906-47fe-4f90-89c4-50581b484622"
      unitRef="usd">885000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia97c59e5c69e47a6a83178a589df2ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEwLTMtMS0xLTA_8b64f34b-260e-4a57-8c57-ba57f387a121"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia97c59e5c69e47a6a83178a589df2ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEwLTctMS0xLTA_49496316-16bf-43b5-8c06-9f360878be0d"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i0e856d54e7714c97aec096fbeec1b506_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEwLTktMS0xLTA_79c416f2-9066-4299-8f6b-fc44d38c4591"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0e856d54e7714c97aec096fbeec1b506_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEwLTEzLTEtMS0w_6b97b568-380f-4930-9d49-54003faa58ac"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ide2b357f410944b7bde3dde25e5e073f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzExLTMtMS0xLTA_c081b2f5-2413-4c86-a04d-09f31ecb108b"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ide2b357f410944b7bde3dde25e5e073f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzExLTctMS0xLTA_522d506c-d475-4b91-8f33-a0f41a17b74d"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8f0d7b7e3f6c492db815036cc5c1c97e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzExLTktMS0xLTA_db32d125-9f86-4e38-9ad9-755010ef0c62"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8f0d7b7e3f6c492db815036cc5c1c97e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzExLTEzLTEtMS0w_4a4b48e1-73f2-4a96-b8b3-9be91089d081"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTMtMS0xLTA_5f19cecf-2b5a-4adb-9115-67132a89f30c"
      unitRef="usd">1967000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTUtMS0xLTA_26a655a7-474b-4ae6-a238-e72fb1110981"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTctMS0xLTA_59f2f233-f687-42db-8421-dab268a28195"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTktMS0xLTA_7612673f-cd24-4467-8be0-75d3951eb28b"
      unitRef="usd">1820000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTExLTEtMS0w_2e4e249b-c1b0-441d-9b7e-2eb396c65e42"
      unitRef="usd">699000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTo3YmVjYjBhMDViMGM0NjhkYTViZThkN2Q0ZjZhZTZmMy90YWJsZXJhbmdlOjdiZWNiMGEwNWIwYzQ2OGRhNWJlOGQ3ZDRmNmFlNmYzXzEyLTEzLTEtMS0w_7e4261aa-cea1-437c-8ae0-2abde0d82499"
      unitRef="usd">1121000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90ZXh0cmVnaW9uOjBlYjUwZTAxMmUyZDRmMWVhNGY0NWYyYjczOTk1NmJmXzk1OA_29ddfbe3-0843-4bbd-bf00-b40a2e9ca928">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2020 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:41.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.775%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzEtMS0xLTEtMA_508f48bd-205b-4587-8edc-1ff093b473f2"
      unitRef="usd">101000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzItMS0xLTEtMA_d23fcd95-1450-4ae4-9f76-aaa51ea0422f"
      unitRef="usd">98000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzMtMS0xLTEtMA_113f6985-6a95-4ced-8347-f8db6766910b"
      unitRef="usd">96000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzQtMS0xLTEtMA_8c4b5462-d43f-4c05-a327-75afb9bf8146"
      unitRef="usd">93000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzUtMS0xLTEtMA_3495a451-f177-4a38-8d0a-a2d9632e9a72"
      unitRef="usd">92000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzYtMS0xLTEtMA_1216b118-b88b-487d-a242-2acac875f677"
      unitRef="usd">451000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <dgx:FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDIvZnJhZzowZWI1MGUwMTJlMmQ0ZjFlYTRmNDVmMmI3Mzk5NTZiZi90YWJsZTphNTgyY2U2N2U1ZTk0ZmMyYTMwMmRiMGI4NTdkNWIzZS90YWJsZXJhbmdlOmE1ODJjZTY3ZTVlOTRmYzJhMzAyZGIwYjg1N2Q1YjNlXzctMS0xLTEtMA_3ef2ba19-e96e-46c8-a3fd-d8af531deab5"
      unitRef="usd">931000000</dgx:FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90ZXh0cmVnaW9uOjhkNTlkYjk4MTZlMDQ3ZWZiN2Q0OTU3ZWYyYWYxYjUyXzE0Mg_9908ae7d-c6dc-49ef-b8d1-c3e27fbc8a29">ACCOUNTS PAYABLE AND ACCRUED EXPENSES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accounts payable and accrued expenses as of December&#160;31, 2020 and 2019 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages and benefits (including incentive compensation)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Overdrafts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90ZXh0cmVnaW9uOjhkNTlkYjk4MTZlMDQ3ZWZiN2Q0OTU3ZWYyYWYxYjUyXzEzNw_d3ac48b4-3f8f-4581-8172-95e7db107d90">Accounts payable and accrued expenses as of December&#160;31, 2020 and 2019 consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued wages and benefits (including incentive compensation)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Overdrafts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merger consideration payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzItMS0xLTEtMA_c7cd56de-db0a-4ba2-b4a1-4f684d5c0001"
      unitRef="usd">502000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzItMy0xLTEtMA_aa91fe83-2554-4b59-a0f6-49e2beef6d48"
      unitRef="usd">287000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzMtMS0xLTEtODg5Mw_efa37e13-6f84-4fea-bff2-efb37badb4c5"
      unitRef="usd">446000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzMtMy0xLTEtODg5Ng_c60c1ddd-0918-4aff-a018-a32a66151723"
      unitRef="usd">263000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzMtMS0xLTEtMA_2d0feb87-5cd9-4ddc-b031-309db611fdaa"
      unitRef="usd">356000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzMtMy0xLTEtMA_23f84a66-345f-43be-afa2-45ebf2ee0e1a"
      unitRef="usd">223000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:BankOverdrafts
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzUtMS0xLTEtMA_3e416ffa-2804-4869-a538-10ae0d417d40"
      unitRef="usd">153000000</us-gaap:BankOverdrafts>
    <us-gaap:BankOverdrafts
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzUtMy0xLTEtMA_cda62320-44f8-44df-9a54-2191dccafd30"
      unitRef="usd">88000000</us-gaap:BankOverdrafts>
    <us-gaap:DividendsPayableCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzYtMS0xLTEtMA_6c607ce6-7f25-499a-a7da-09b417547e47"
      unitRef="usd">76000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzYtMy0xLTEtMA_984a6136-2223-45b6-bf33-cccfbee53af1"
      unitRef="usd">71000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzgtMS0xLTEtOTc1OA_3b09f4e3-9da4-42b1-82d9-bd6ee3a6baa0"
      unitRef="usd">43000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzgtMy0xLTEtOTc1OA_4678b057-2ad4-4221-8416-a5c45cecf84e"
      unitRef="usd">27000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzktMS0xLTEtODkwOQ_0cf9bb1c-be46-4df6-99e8-2dd61e46cef7"
      unitRef="usd">31000000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzktMy0xLTEtODkwOQ_71e33d15-19b2-4f51-81cf-1fe65b88ceea"
      unitRef="usd">30000000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzctMS0xLTEtMA_24696ec4-2a8d-40b2-bcb7-f10662974767"
      unitRef="usd">26000000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzctMy0xLTEtMA_0870a114-4203-4bab-9ba9-5ae1e9cadf69"
      unitRef="usd">45000000</us-gaap:InterestPayableCurrent>
    <dgx:MergerConsiderationPayableCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzEwLTEtMS0xLTA_ce577a49-8c73-40d8-b414-9a85602addb3"
      unitRef="usd">0</dgx:MergerConsiderationPayableCurrent>
    <dgx:MergerConsiderationPayableCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzEwLTMtMS0xLTA_e463ad69-5eed-4e6d-9519-acaf6faaae95"
      unitRef="usd">7000000</dgx:MergerConsiderationPayableCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzExLTEtMS0xLTA_4a7fb0b3-1de3-427b-960b-6d0d31e13f1f"
      unitRef="usd">1633000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDUvZnJhZzo4ZDU5ZGI5ODE2ZTA0N2VmYjdkNDk1N2VmMmFmMWI1Mi90YWJsZTphMWI2ZjJmMjNlYTk0MzJkOTAwZTM1M2JjNjJlNmMwZC90YWJsZXJhbmdlOmExYjZmMmYyM2VhOTQzMmQ5MDBlMzUzYmM2MmU2YzBkXzExLTMtMS0xLTA_47be40f1-ef87-4d50-babe-92775c27bbea"
      unitRef="usd">1041000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5ODk_1e2d3ae6-b597-4714-a681-c80f4e7cb08a">DEBT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Long-term debt (including finance lease obligations) as of December&#160;31, 2020 and 2019 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Senior Notes due January 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50% Senior Notes due March 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% Senior Notes due April 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25% Senior Notes due April 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50% Senior Notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.45% Senior Notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20% Senior Notes due June 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% Senior Notes due June 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80% Senior Notes due June 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.95% Senior Notes due July 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75% Senior Notes due January 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% Senior Notes due March 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Secured Receivables Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On October 22, 2020, the Company amended the agreement for its $600&#160;million secured receivables credit facility (the &#x201c;Secured Receivables Credit Facility&#x201d;), previously amended in October 2019, to extend the maturity dates for each underlying commitment by one year, while maintaining the borrowing capacity under the facility at $600&#160;million.  Under the Secured Receivables Credit Facility, the Company can borrow against a $250&#160;million loan commitment maturing October 2021 and a $250&#160;million loan commitment maturing October 2022, and can issue up to $100&#160;million of letters of credit (see Note 18) through October 2022.  Borrowings under the Secured Receivables Credit Facility are collateralized by certain domestic receivables.  As of December&#160;31, 2020, interest on the borrowings under the Secured Receivables Credit Facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.825% to 0.95%.  The Secured Receivables Credit Facility is subject to customary affirmative and negative covenants and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility.  As of both December&#160;31, 2020 and 2019, there were no outstanding borrowings under the Secured Receivables Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Unsecured Revolving Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is party to a $750&#160;million senior unsecured revolving credit facility (the &#x201c;Credit Facility&#x201d; or "Senior Unsecured Revolving Credit Facility") which matures in March 2023.  Under the Credit Facility, the Company can issue letters of credit totaling $150&#160;million (see Note 18).  Issued letters of credit reduce the available borrowing capacity under the Credit Facility.  Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings and its leverage ratio.  At the option of the Company, it may elect to lock into LIBOR-based interest rates for periods up to six months.  Interest on any outstanding amounts not covered under LIBOR-based interest rate contracts is based on an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted LIBOR rate.  As of both December&#160;31, 2020 and 2019, the Company's borrowing rate for LIBOR-based loans under the Credit Facility was LIBOR plus 1.125%.  The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness.  In April 2020, the Company amended the Credit Facility to provide increased covenant flexibility.  As amended, the leverage ratio covenant (as defined in the Credit Facility) was increased as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.046%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Covenant:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;no more than 6.5 times EBITDA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;no more than 6.25 times EBITDA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;no more than 4.5 times EBITDA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;                     &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Thereafter, the leverage ratio covenant reverts to no more than 3.5 times EBITDA.  During the period that the increased covenant applies, which period may be terminated early by the Company provided that the Company is in compliance with the historical 3.5 times EBITDA leverage ratio, the amended Credit Facility contains certain additional limitations and restrictions including, but not limited to, repurchases of the Company's common stock, the amount of funds that can be used on business acquisitions, the incurrence of secured indebtedness and the payment of dividends.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of both December&#160;31, 2020 and 2019, there were no outstanding borrowings under the Senior Unsecured Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December 31, 2020, the Company was in compliance with all covenants for its credit facilities.  As of December 31, 2020, the Company had $1.3&#160;billion of borrowing capacity available under the facilities, including $530&#160;million available under the Secured Receivables Credit Facility and $750&#160;million available under the Senior Unsecured Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Notes Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Company completed a senior notes offering, consisting of $550&#160;million aggregate principal amount of 2.80% senior notes due June 2031 (the &#x201c;2031 Senior Notes&#x201d;), which were issued at an original issue discount of $1&#160;million.  The Company incurred $5&#160;million of debt issuance costs associated with the 2031 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During November 2020, the net proceeds from the 2031 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due April 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;In December 2019, the Company completed a senior notes offering, consisting of $800&#160;million&#160;aggregate principal amount of 2.95% senior notes due June 2030 (the "2030 Senior Notes"), which were issued at an original issue discount of&#160;$2&#160;million.  The Company incurred $7&#160;million&#160;of debt issuance costs associated with the 2030 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During January 2020, the net proceeds from the 2030 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due January 2020 and senior notes due March 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2019, the Company completed a senior notes offering, consisting of $500&#160;million&#160;aggregate principal amount of 4.20% senior notes due June 2029 (the "2029 Senior Notes"), which were issued at an original issue discount of&#160;$1&#160;million.  The Company incurred&#160;$5&#160;million&#160;of debt issuance costs associated with the 2029 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The net proceeds from the 2029 Senior Notes were used to repay in full the outstanding indebtedness under the Company's senior notes due April 2019, to repay outstanding indebtedness under the Secured Receivables Credit Facility and for general corporate purposes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, the Company recorded a loss on retirement of debt, principally comprised of premiums paid, of $9&#160;million in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;All of the senior notes are unsecured obligations of the Company and rank equally with the Company's other senior unsecured obligations.  None of the Company's senior notes have a sinking fund requirement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company may redeem its outstanding senior notes prior to scheduled maturity, as a whole or in part, at a redemption price equal to the present value of the remaining scheduled payments of principal and interest, except for certain notes for which the Company also has an option to redeem such instruments at par value on or after dates specified in the indentures governing the notes ("the par value redemption option"). &#160;For notes with the par value redemption option, if such notes are redeemed prior to the specified dates, the redemption price calculations exclude any interest that would have been due after such dates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Maturities of Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2020, long-term debt matures as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:297.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:235.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value basis adjustments attributable to hedged debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LongTermDebtTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5ODU_4033013b-f948-4b8b-be01-1b4c53547c9e">Long-term debt (including finance lease obligations) as of December&#160;31, 2020 and 2019 consisted of the following: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.004%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Senior Notes due January 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50% Senior Notes due March 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% Senior Notes due April 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.25% Senior Notes due April 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50% Senior Notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.45% Senior Notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.20% Senior Notes due June 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% Senior Notes due June 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80% Senior Notes due June 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.95% Senior Notes due July 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.75% Senior Notes due January 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% Senior Notes due March 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifc7572c2a2924de4b2ef502d5bbbfa0c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzQtMC0xLTEtMC90ZXh0cmVnaW9uOjc3YTlkNWI2NmIzNzRkNjg5ZWNjOTk4NTQ3OTJhMDc2XzQ5NDc4MDIzMjUwMzY_cae24bf9-b4f8-4e89-9791-ac1a8ac91830"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ifc7572c2a2924de4b2ef502d5bbbfa0c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzQtMS0xLTEtMA_88da109a-6c1a-4dd1-82e1-2d3664e4d2d6"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9887f5d1e7ec47d794ad4b9c520d77f0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzQtMy0xLTEtMA_07d2757d-68a9-4b0a-b9aa-8f1353f46707"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i492a760c40d7442ca1a7e0f8594d36e4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzUtMC0xLTEtMC90ZXh0cmVnaW9uOjBjYjdiMDE4M2JhYjQ3ODk4NWY3MjM5MWRmOTUwMmNjXzQ5NDc4MDIzMjUwMzQ_24f00cc8-325a-487c-8811-f8a3d1dc53a3"
      unitRef="number">0.0250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i492a760c40d7442ca1a7e0f8594d36e4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzUtMS0xLTEtMA_7e2c7ec4-742d-4773-adda-6d8f6dd0b375"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ieace3baae6f84b0e9354cf88139ef2c2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzUtMy0xLTEtMA_45df75aa-5ef4-4400-8929-27b288d3b7be"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia0dd309e22f4493e85b52fb6f70911e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjk3ODNmNTBkYTg1ZjRlZDI4Mjc4OWMxZmZjNDdkYTAwXzQ5NDc4MDIzMjUwMzQ_d69351db-0b6a-468c-8849-70e3dd840f68"
      unitRef="number">0.0470</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia0dd309e22f4493e85b52fb6f70911e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzYtMS0xLTEtMA_0a273497-ebe3-4870-a4db-ada06ab68a02"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie56f70613c89455ab45a405199ac352e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzYtMy0xLTEtMA_f4744f5a-63b3-4516-9c05-3aeb5ef1b070"
      unitRef="usd">554000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8eb23b0916d24877a17f2212f4fbd7da_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzctMC0xLTEtMC90ZXh0cmVnaW9uOmZiZGU5NDdhZmQ3YzQwMzk5MTYyNTM0OGFjOWVlNjc4XzQ5NDc4MDIzMjUwMzQ_74c5a6a0-c6e3-4c1e-a652-e2ddf0f29f37"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i8eb23b0916d24877a17f2212f4fbd7da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzctMS0xLTEtMA_0585e997-93e0-4b54-ac77-a82926a7c911"
      unitRef="usd">316000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i253f26b0c58e4670a7e5d21e7ed55f38_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzctMy0xLTEtMA_e78df8df-06dc-4783-baeb-76b2c4063a3b"
      unitRef="usd">308000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i68618e5aa89c4194adf23217f32a8b41_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzgtMC0xLTEtMC90ZXh0cmVnaW9uOjlhYjA2MzU3MTNmZTQ1ZWU4MDIzZjFiYmUzMmY3MThmXzQ5NDc4MDIzMjUwMzQ_1dd4733f-7f4e-4d97-aecc-8ecd6f7f9784"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i68618e5aa89c4194adf23217f32a8b41_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzgtMS0xLTEtMA_9d18cb9b-c0a5-42de-a724-b36d3f79e40e"
      unitRef="usd">622000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i79c28753e6234d99a6b6e5ecd71a6645_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzgtMy0xLTEtMA_24d4815d-5847-4c04-bd05-273674e20b69"
      unitRef="usd">593000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5e04c7b3917042c0be08e09c6ee19d74_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzktMC0xLTEtMC90ZXh0cmVnaW9uOmRlYzYxMDU5NDQ0MDRjZDk5MmViMDY2YjNlMTc0NjJhXzQ5NDc4MDIzMjUwMzM_c465d921-716a-4da5-92ac-011140433035"
      unitRef="number">0.0345</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i5e04c7b3917042c0be08e09c6ee19d74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzktMS0xLTEtMA_de592948-c5d9-4353-bf51-7b85ffcde83c"
      unitRef="usd">512000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i979e993f5cad468e9c420fcb8e10baae_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzktMy0xLTEtMA_6622847f-e8fa-4538-afb3-8841cebe17fc"
      unitRef="usd">490000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i64c30d8d93c246b9a9045e239918d12b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjpkYWQ2YTJmNGZjMzE0Mjk0OTQwMjU3ZGZjYzBkNWFkN180OTQ3ODAyMzI1MDMz_381c6dcf-cf8d-4937-8760-a7b707664812"
      unitRef="number">0.0420</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i64c30d8d93c246b9a9045e239918d12b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEwLTEtMS0xLTA_46faadc0-e38a-4826-97a3-da75e2e5497c"
      unitRef="usd">499000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="iaa89a373573f435bad75aa9ad414d5cf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEwLTMtMS0xLTA_55ec2672-3a73-4298-b97a-b33e5255e8ef"
      unitRef="usd">499000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id3374f07e84740c1b2a1181c5c8ed5fe_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzExLTAtMS0xLTAvdGV4dHJlZ2lvbjo5MDFkMDA3MjQxODk0ZjE4OTUxZGM2ODZiN2IxYTQ3Ml80OTQ3ODAyMzI1MDMz_4b922892-dd28-4522-ae17-e6caabd2d596"
      unitRef="number">0.0295</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id3374f07e84740c1b2a1181c5c8ed5fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzExLTEtMS0xLTA_664943e0-b817-4f50-98f6-a216ec4c249c"
      unitRef="usd">798000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="id253b3ca50134883a39411cabb3236df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzExLTMtMS0xLTA_c100eea6-49d6-46ec-a58d-ffd0b94e9f59"
      unitRef="usd">798000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4a816a93885d4ca989a2e52f8edcd268_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTAtMS0xLTI0NzMvdGV4dHJlZ2lvbjo5NjRiMWUxZjVmYmQ0ZjBiYWZjYzQ2YjczNzA4YjlhOV80OTQ3ODAyMzI1MDMx_fb9a7635-e33d-49a4-8ff6-5cee21190649"
      unitRef="number">0.0280</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4a816a93885d4ca989a2e52f8edcd268_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTEtMS0xLTI2OQ_75d9e357-039e-4d9f-b596-c31471ee944e"
      unitRef="usd">549000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia92ac89bc9464dc4a5bf688a1dc0f2e1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTMtMS0xLTI3Mg_159b926e-d615-432b-8a24-594eba3da05a"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ica3b9d8c23ad48a888fd41a9f78b692e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTAtMS0xLTAvdGV4dHJlZ2lvbjowOGUwZjhjNTZkMTA0ZWRkODgwMjQ2NjA4NTA0NjBhZl80OTQ3ODAyMzI1MDMz_b9d83d8d-6ed8-456b-bb03-efec08a49b55"
      unitRef="number">0.0695</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ica3b9d8c23ad48a888fd41a9f78b692e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTEtMS0xLTA_db062e76-ed3f-420a-b41c-54cfce7b8e5c"
      unitRef="usd">175000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6dc40d79750043f0a0c76f967a147ab5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEyLTMtMS0xLTA_d0858768-dbc0-4a9b-9fe1-c9d83c83dfa8"
      unitRef="usd">175000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4c0a568fbbe54b32a4d65037b02187d7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEzLTAtMS0xLTAvdGV4dHJlZ2lvbjpkYjY0OGRkMmJkYmY0ZTMxOGMyMjRjMWYwZTMxN2EzNF80OTQ3ODAyMzI1MDM2_6f54be49-d214-46fb-8ce3-e5f8582005f2"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4c0a568fbbe54b32a4d65037b02187d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEzLTEtMS0xLTA_0a7aebdb-57d4-4774-ae76-789e8cced141"
      unitRef="usd">245000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie27dd42f03aa4d7da20e94071af99bcc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzEzLTMtMS0xLTA_d6589cb1-4bd7-45b7-9148-405d197164c8"
      unitRef="usd">245000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4f38dc71c4a4401ba20c8d9d84fd23b7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE0LTAtMS0xLTAvdGV4dHJlZ2lvbjo5YzhkMGNkOTkwN2E0ODkzODBkMzEzZjEzZDE5ZjRmOF80OTQ3ODAyMzI1MDM0_77159338-a0fd-43ea-88b2-c17ab935fca7"
      unitRef="number">0.0470</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i4f38dc71c4a4401ba20c8d9d84fd23b7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE0LTEtMS0xLTA_1433163a-428b-4bc6-bb4f-21f6db48c7db"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i44196df9463840cc83124dd513dea909_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE0LTMtMS0xLTA_4fb11838-dc23-4779-8c86-cfbf6455e6ea"
      unitRef="usd">300000000</us-gaap:LongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i545c653723ac4b35958b7b601878135c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE1LTEtMS0xLTA_a3104a3a-1ca8-40d4-8230-5851c873b3f8"
      unitRef="usd">27000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="icfbc63685ff840fb973900d155c530e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE1LTMtMS0xLTA_f30f0919-0acb-4823-8e70-3657fa19caa0"
      unitRef="usd">34000000</us-gaap:OtherLongTermDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE2LTEtMS0xLTA_749ce109-58f4-4904-ae99-0d0b01e94e32"
      unitRef="usd">28000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE2LTMtMS0xLTA_0c766802-b8ed-4426-b6a5-5624b09d83e5"
      unitRef="usd">26000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LongTermDebt
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE3LTEtMS0xLTA_8970a93d-6ae5-413c-aecd-e984909079c5"
      unitRef="usd">4015000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE3LTMtMS0xLTA_4ee97d0b-97d7-4dda-b9f7-aae734d39f89"
      unitRef="usd">4770000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE4LTEtMS0xLTA_11b78c57-04bb-49b8-a6de-57c43303b80b"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE4LTMtMS0xLTA_517cf2d9-fc63-4c05-99d6-066e21067c2c"
      unitRef="usd">804000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE5LTEtMS0xLTA_b51cd464-143c-4f9f-aacc-a43c008ca853"
      unitRef="usd">4013000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyOWRlMGNhN2EwYTY0MmVhOGM0ZDZmNGYxYmNjYjQyOC90YWJsZXJhbmdlOjI5ZGUwY2E3YTBhNjQyZWE4YzRkNmY0ZjFiY2NiNDI4XzE5LTMtMS0xLTA_5d1699b7-7d2d-49c4-88f1-fd81ef2df52b"
      unitRef="usd">3966000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iecaf492a9ad94a36b60612ba765970e6_I20201022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MDIx_ebd64165-0fc5-4eb3-8fb2-7d6f2741958f"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dgx:DebtInstrumentExtensionPeriod
      contextRef="ifb648f82ea194e07a192722e1bf31021_D20201001-20201031"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5NDc4MDIzNTU4NTE_0dadb1ec-97d8-4c6c-a069-253026c9738c">P1Y</dgx:DebtInstrumentExtensionPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="iecaf492a9ad94a36b60612ba765970e6_I20201022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MDQ4_f5e5d4a3-855f-4cb8-95c0-e39220f5d51b"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibce6a4a1e68c4e53a145b95c9e367803_I20201022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MDc1_da2ab0fd-70a0-42e8-9c0a-2bc91e00e99f"
      unitRef="usd">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6f191ea10c984af4842750df37661e22_I20201022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MTE4_fead43d9-363f-4889-b0ea-0a01caf5ef0c"
      unitRef="usd">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i462cfe8638814f0f8481f3716a2592c3_I20201022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MTU5_0be67e22-9dc8-48af-80c0-f6005600dedf"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i524294a4d8b3418da3d3f916d41a20d1_D20201231-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MjI1_42be64ec-08cc-4018-8db8-9a793425eb35"
      unitRef="number">0.00825</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6c91c94f07a044d2aa17c4da4b4cf161_D20201231-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDg1MjE4_5f185c35-58eb-4108-be6e-d0344211c36c"
      unitRef="number">0.0095</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i904ef886693341f7b599802cc0a219e7_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0MzIz_3bff1f9f-3cef-412a-a994-6ca3cef7df5a"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie586bfbfd98b4802b4c74457620ebe91_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0MzIz_50c27213-0309-4a77-8143-94230683060d"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1b45d450024c47499fbde295edb34e7e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkxOTgy_400bfc35-2ebb-44bc-8c00-25debf421751"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i95b81aaa9acb42f1810e4c076150e924_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkxNzI5_b3471076-4c1d-4d7e-9c66-9585d649c8f4"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2f895fdee4b5481087569c16292b9b26_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0MzM0_84a856cd-024b-4d27-b933-683cb0e64866"
      unitRef="number">0.01125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic4e79e85b7c548d0b0dc680c03e2b9e5_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0MzM0_9577715f-93bd-4bd3-b1ab-fdda6d9d1fc6"
      unitRef="number">0.01125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <dgx:ScheduleOfLeverageRatioCovenantsTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5NDc4MDIzNTU4NjY_e0ff7034-2c5f-4cbd-9792-b784397ddfdb">As amended, the leverage ratio covenant (as defined in the Credit Facility) was increased as follows:&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.046%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Covenant:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;no more than 6.5 times EBITDA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;no more than 6.25 times EBITDA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;no more than 4.5 times EBITDA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dgx:ScheduleOfLeverageRatioCovenantsTableTextBlock>
    <dgx:DebtInstrumentLeverageRatioRequirement
      contextRef="i6d93b15cf2364f2f9c77170f1dcdc9cc_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyMmUyYjdjMWZiMDY0ZjVmOGNiOTFkMTJlMTg3MDJhMi90YWJsZXJhbmdlOjIyZTJiN2MxZmIwNjRmNWY4Y2I5MWQxMmUxODcwMmEyXzItMi0xLTEtNTQ3MC90ZXh0cmVnaW9uOjUyZjdkMjU2YmFlOTQyNzQ5Y2NiZjgyZGQ0MzczMWYxXzIxOTkwMjMyNTU1ODQ_3463ed49-ecd0-4106-a371-57f0586722cc"
      unitRef="number">6.5</dgx:DebtInstrumentLeverageRatioRequirement>
    <dgx:DebtInstrumentLeverageRatioRequirement
      contextRef="i9ee13471497b4108b33ff83c309a7a45_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyMmUyYjdjMWZiMDY0ZjVmOGNiOTFkMTJlMTg3MDJhMi90YWJsZXJhbmdlOjIyZTJiN2MxZmIwNjRmNWY4Y2I5MWQxMmUxODcwMmEyXzMtMi0xLTEtNTQ3MC90ZXh0cmVnaW9uOjI5MzFlNWJjNTVjYTQ3ZjBhYTFmYTczZmJmMWMzNjlhXzIxOTkwMjMyNTU1ODQ_883bb550-d0d6-48ce-a8ed-8c1f4e4d975f"
      unitRef="number">6.25</dgx:DebtInstrumentLeverageRatioRequirement>
    <dgx:DebtInstrumentLeverageRatioRequirement
      contextRef="i80dc0f5cd5f241689a10b1242a112b9a_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZToyMmUyYjdjMWZiMDY0ZjVmOGNiOTFkMTJlMTg3MDJhMi90YWJsZXJhbmdlOjIyZTJiN2MxZmIwNjRmNWY4Y2I5MWQxMmUxODcwMmEyXzQtMi0xLTEtNTQ3MC90ZXh0cmVnaW9uOmJiNjI5M2VkYmFmMDRjM2FiNTQ0N2Q2ZTMwYjg1NDNlXzIxOTkwMjMyNTU1ODQ_c780f2e4-c32b-44e7-a5e0-9ea37aa48047"
      unitRef="number">4.5</dgx:DebtInstrumentLeverageRatioRequirement>
    <dgx:DebtInstrumentLeverageRatioRequirement
      contextRef="i88d8839878a14fa79907f288bf110c47_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyODcwNjc_8e93bd9e-cb57-4c31-9395-ee5028a2fc45"
      unitRef="number">3.5</dgx:DebtInstrumentLeverageRatioRequirement>
    <dgx:DebtInstrumentLeverageRatioRequirement
      contextRef="i88d8839878a14fa79907f288bf110c47_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyODcwNzc_0329153e-4006-480b-b0e2-9b6c92bc69ca"
      unitRef="number">3.5</dgx:DebtInstrumentLeverageRatioRequirement>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1b45d450024c47499fbde295edb34e7e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkyMjU1_507f6010-fcd6-4aab-9a1f-2c85e59493f9"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i11c5ad757a094b24a5c73f68379fa8f9_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkyMjU1_930eadfd-edb1-42bf-8102-8cc9ea39032e"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkyNjY0_51c51049-0663-46c0-81ed-ff14cfc050c9"
      unitRef="usd">1300000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ie6362246725c44d7844b750f652f23d9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDk0NTk2_223b9f3e-ed9d-462a-a956-ec68eb9d765c"
      unitRef="usd">530000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i1b45d450024c47499fbde295edb34e7e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDkyNzAx_5c0a3384-ba73-4f16-9233-18d85522dc30"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0847ec854f1041b091d07bb199a6faaf_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyNjEwNzY_f0d412d8-3281-4566-9729-4d5773a8d7a1"
      unitRef="usd">550000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0847ec854f1041b091d07bb199a6faaf_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyNjExMTA_e61545fd-481a-4ba1-87a3-73e4a15832b3"
      unitRef="number">0.0280</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i0847ec854f1041b091d07bb199a6faaf_I20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzIxOTkwMjMyNjEyMTM_76410c3a-e5dd-4fca-93ac-ce014a58c0e1"
      unitRef="usd">1000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i0847ec854f1041b091d07bb199a6faaf_I20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDc4NDgy_a2eda081-01fa-40b4-b02b-94f2c51d8408"
      unitRef="usd">5000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id253b3ca50134883a39411cabb3236df_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTQx_6aa2d7c7-21dd-4805-8ba0-e5f2ae577f70"
      unitRef="usd">800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id253b3ca50134883a39411cabb3236df_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTU1_fb2fddd9-c94d-42b6-9f5a-19117b8fa0bf"
      unitRef="number">0.0295</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="id253b3ca50134883a39411cabb3236df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTYy_5e955cbc-8748-48f0-8f6d-4564f84b3ff1"
      unitRef="usd">2000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="id253b3ca50134883a39411cabb3236df_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTc0_79ab940c-75c8-4dc0-bd9c-2b51c312cfe0"
      unitRef="usd">7000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i87fb802f159d45308c5722aab7a51e3f_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNTg2_ed762867-8905-4877-bb38-5e4ce4964811"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i87fb802f159d45308c5722aab7a51e3f_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNjAw_e7110d1e-3c35-4a6e-a13c-1b7680c4fe98"
      unitRef="number">0.0420</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i87fb802f159d45308c5722aab7a51e3f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNjQx_f23e7b2a-b3b7-453c-820f-2f26bb316db3"
      unitRef="usd">1000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i87fb802f159d45308c5722aab7a51e3f_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDgxNjI5_a3a2276b-c3a2-4705-9b1d-3b1d435c0772"
      unitRef="usd">5000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i752e64558c134adab9652fe39589f9ca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzEwNDQ1MzYwNDc4OTc3_7ad05f87-4f68-4737-9910-e63e9d352db6"
      unitRef="usd">-9000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90ZXh0cmVnaW9uOjVlMDM5YzRmNjFlNzQ4ODBhZTA1MDUxM2I4YThiNjljXzQ5ODM_e8ae1d56-593d-478d-bc8e-9a161e831f65">As of December&#160;31, 2020, long-term debt matures as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:297.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:235.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:58.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total maturities of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value basis adjustments attributable to hedged debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzEtMS0xLTEtMA_28826ee6-79d9-4cf3-8066-64ae2f73eee8"
      unitRef="usd">2000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzItMS0xLTEtMA_85548f2c-1b75-4ca7-9d90-c26ed10db745"
      unitRef="usd">1000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzMtMS0xLTEtMA_d234d61e-0a54-4101-854b-320ff318e687"
      unitRef="usd">1000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzQtMS0xLTEtMA_073ee1c3-9e4f-48f5-89ee-b2adb3a6beec"
      unitRef="usd">302000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzUtMS0xLTEtMA_e9543b0b-a6f4-4f9c-9063-ce775acac5fb"
      unitRef="usd">602000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzYtMS0xLTEtMA_2184b35a-c841-42df-a9c7-f60fe844b8bb"
      unitRef="usd">3095000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <dgx:LongTermDebtMaturitiesGross
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzctMS0xLTEtMA_15e999f5-0e08-405a-8599-39e2098e2f0d"
      unitRef="usd">4003000000</dgx:LongTermDebtMaturitiesGross>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzgtMS0xLTEtMA_ef6ef3b9-1001-4931-9726-9553fbbf8c61"
      unitRef="usd">11000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzktMS0xLTEtMA_749ce109-58f4-4904-ae99-0d0b01e94e32"
      unitRef="usd">28000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <dgx:DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzEwLTEtMS0xLTA_80c5510c-1b32-4e63-a7c1-9c1b25b71744"
      unitRef="usd">-51000000</dgx:DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt>
    <us-gaap:LongTermDebt
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzExLTEtMS0xLTA_306f8355-8217-42c2-b517-f7beaa58cce9"
      unitRef="usd">4015000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzEyLTEtMS0xLTA_f73061eb-045e-4aca-bc25-15586a336ca3"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMDgvZnJhZzo1ZTAzOWM0ZjYxZTc0ODgwYWUwNTA1MTNiOGE4YjY5Yy90YWJsZTo1ODkzZWZkODc2Y2U0ZjM5ODc2NzRhZjdhZmJmNjQxOS90YWJsZXJhbmdlOjU4OTNlZmQ4NzZjZTRmMzk4NzY3NGFmN2FmYmY2NDE5XzEzLTEtMS0xLTA_2c09bc24-6421-44e5-a9b4-20c316037148"
      unitRef="usd">4013000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTU_d61045ba-e813-4a48-ae0d-3763deaeb09b">LEASES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A right-of-use asset, representing the underlying asset during the lease term, and a lease liability, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.  For the year ended December&#160;31, 2020 and 2019, lease expense associated with short-term leases was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#x2019;s leases based on tenor.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than 1 year to 16 years, some of which include options to extend the leases for up to 15 years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's assets and liabilities for its lease agreements as of December 31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Finance lease assets as of December 31, 2020 and 2019 were recorded net of accumulated amortization of $14&#160;million and $24&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Components of lease cost for the years ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:364.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $120&#160;million for each of the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Rental expense for real estate, laboratory equipment and vehicles under operating leases amounted to $220 million for the year ended December&#160;31, 2018.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:163.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Lease term and discount rate as of December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:363.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTY_8152b5c2-ea04-4457-b291-1b9ed33e2d84">LEASES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A right-of-use asset, representing the underlying asset during the lease term, and a lease liability, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.  For the year ended December&#160;31, 2020 and 2019, lease expense associated with short-term leases was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#x2019;s leases based on tenor.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than 1 year to 16 years, some of which include options to extend the leases for up to 15 years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's assets and liabilities for its lease agreements as of December 31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Finance lease assets as of December 31, 2020 and 2019 were recorded net of accumulated amortization of $14&#160;million and $24&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Components of lease cost for the years ended December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:364.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $120&#160;million for each of the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Rental expense for real estate, laboratory equipment and vehicles under operating leases amounted to $220 million for the year ended December&#160;31, 2018.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:163.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Lease term and discount rate as of December&#160;31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:363.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTc_7c6b6a70-935c-469f-ac2f-801e47872ef8">The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A right-of-use asset, representing the underlying asset during the lease term, and a lease liability, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <dgx:LeaseRemainingLeaseTerm
      contextRef="ib4e9bac07fa34fa6ac58f793d4697067_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzE5NTA_088c5ac2-92fd-4218-bd0c-32add704a1c1">P1Y</dgx:LeaseRemainingLeaseTerm>
    <dgx:LeaseRemainingLeaseTerm
      contextRef="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzQ5NDc4MDIzMjk3MTE_8b5456dc-c9d6-4c80-8e78-5e5041055656">P16Y</dgx:LeaseRemainingLeaseTerm>
    <dgx:LeaseRenewalTerm
      contextRef="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzIwMjE_935796d6-aa1b-4a33-8c68-b56cd81d0073">P15Y</dgx:LeaseRenewalTerm>
    <dgx:ScheduleOfLeaseByAssetTypeTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTg_38f73790-910c-46c5-9fd9-c8990e8109b0">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's assets and liabilities for its lease agreements as of December 31, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.634%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Finance lease assets as of December 31, 2020 and 2019 were recorded net of accumulated amortization of $14&#160;million and $24&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</dgx:ScheduleOfLeaseByAssetTypeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzItNC0xLTEtMA_2ef82887-36e2-4ce3-9e23-2ac94956baf0"
      unitRef="usd">604000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzItNi0xLTEtMTEwNzI_06548e47-2913-4d91-888f-47dd329d86ff"
      unitRef="usd">518000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzMtNC0xLTEtMA_921f5e89-1cd9-4bd6-9b8f-108c1a4b2b18"
      unitRef="usd">22000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzMtNi0xLTEtMTEwNzI_740ba795-89df-44d8-a093-c822362180c3"
      unitRef="usd">35000000</us-gaap:FinanceLeaseRightOfUseAsset>
    <dgx:LeaseRightofUseAsset
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzQtNC0xLTEtMA_74e86ae5-28d0-4cfd-aa55-fda7aae4c925"
      unitRef="usd">626000000</dgx:LeaseRightofUseAsset>
    <dgx:LeaseRightofUseAsset
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzQtNi0xLTEtMTEwNzI_d7e6325a-b7cb-45a4-9d60-0e9979eccd64"
      unitRef="usd">553000000</dgx:LeaseRightofUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzgtNC0xLTEtMA_49e4e2a5-d0f9-429c-b286-22475d084e1b"
      unitRef="usd">141000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzgtNi0xLTEtMzg5NQ_12f06bc0-dc9c-4042-a742-3aa896bc60f3"
      unitRef="usd">145000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzktNC0xLTEtMA_ff3075e8-5653-4e40-8b29-2416f581e7e1"
      unitRef="usd">2000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzktNi0xLTEtMzg5OA_d8229587-7ac6-461d-b593-542357926294"
      unitRef="usd">3000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzExLTQtMS0xLTA_2524ba60-969b-485a-a364-1fa3aa53e1c7"
      unitRef="usd">499000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzExLTYtMS0xLTM5MDE_0b2c7611-037a-407c-b967-6c0fc5281286"
      unitRef="usd">413000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzEyLTQtMS0xLTA_1526b691-717d-4048-80c5-ad0be9df0726"
      unitRef="usd">25000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzEyLTYtMS0xLTM5MDM_8c9f31ad-3b8e-4351-9884-1ebc1f1ebeb9"
      unitRef="usd">30000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <dgx:LeaseLiability
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzEzLTQtMS0xLTA_d747e486-41bc-4f59-a7e4-f091948018c7"
      unitRef="usd">667000000</dgx:LeaseLiability>
    <dgx:LeaseLiability
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTo4YzIzMjk0M2I4Y2I0MjBjOGY4NTgzNGQ3NmEzZmZmYS90YWJsZXJhbmdlOjhjMjMyOTQzYjhjYjQyMGM4Zjg1ODM0ZDc2YTNmZmZhXzEzLTYtMS0xLTExMDcy_05c0e5d9-517f-4a47-a9d1-06d718a1b39a"
      unitRef="usd">591000000</dgx:LeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzEwNDQ1MzYwNDY4NjE5_9f5b76a2-f9e3-4191-a56b-ef7a1eca5ea0"
      unitRef="usd">14000000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzEwNDQ1MzYwNDY4MDIw_c6756c87-967f-4c43-b980-d666558f6f9b"
      unitRef="usd">24000000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTM_71858773-6b3a-4e3c-a67a-026c4520293c">Components of lease cost for the years ended December&#160;31, 2020 and 2019 were as follows:&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:364.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of leased assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $120&#160;million for each of the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <dgx:OperatingLeaseFixedAndVariableCost
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzItNC0xLTEtMA_e91492bd-9fa9-44b0-a962-29a7f40e8b86"
      unitRef="usd">300000000</dgx:OperatingLeaseFixedAndVariableCost>
    <dgx:OperatingLeaseFixedAndVariableCost
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzItNC0xLTEtMzk0Mw_b9de2764-2f8c-47e7-83c8-98c4b3b66040"
      unitRef="usd">294000000</dgx:OperatingLeaseFixedAndVariableCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzUtNC0xLTEtMA_6abee039-0b95-4fc8-b1a4-48d95b0b1400"
      unitRef="usd">6000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzUtNC0xLTEtMzk0Ng_2de83519-1445-4cd6-9112-a8468be2d723"
      unitRef="usd">7000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzYtNC0xLTEtMA_0bc5572d-cff2-46e2-ad29-5ee8b3e47516"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzYtNC0xLTEtMzk0Ng_38f2c484-1f68-41f8-9933-99092a018b87"
      unitRef="usd">3000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzctNC0xLTEtMA_ffcdeb05-538f-43a9-86f2-a655d8952bdd"
      unitRef="usd">309000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphOGJkM2FmOTgwYTE0OWY5OGQ0NzJhNWNlYTM5MTA3Yi90YWJsZXJhbmdlOmE4YmQzYWY5ODBhMTQ5Zjk4ZDQ3MmE1Y2VhMzkxMDdiXzctNC0xLTEtMTEwNzU_6534aadd-8cb8-45de-b829-23aaaf83da90"
      unitRef="usd">304000000</us-gaap:LeaseCost>
    <dgx:ShorttermLeaseandVariableLeaseCost
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzEwNDQ1MzYwNDY4MTk0_1c03bcb9-c1a0-443d-93e7-11d75e427178"
      unitRef="usd">120000000</dgx:ShorttermLeaseandVariableLeaseCost>
    <dgx:ShorttermLeaseandVariableLeaseCost
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzEwNDQ1MzYwNDY4MTk0_6b476990-0be2-4899-b0f3-c261ca7e7e75"
      unitRef="usd">120000000</dgx:ShorttermLeaseandVariableLeaseCost>
    <us-gaap:LeaseAndRentalExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzI5MjI_1cfd0047-fb6f-46b4-b0f0-b9b4ba1fcdd6"
      unitRef="usd">220000000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTQ_bbbb42dd-3c00-4cc2-ac2f-41a624f356e6">The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:163.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NTk_5b18ad91-dfa8-44f2-8f16-8911619dbce5">The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:163.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:61.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzEtMi0xLTEtMA_a99958db-4035-4e93-974c-6e965be2c202"
      unitRef="usd">160000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzEtNC0xLTEtMA_19ebd94d-8522-4ded-b980-cd3a153f2fc5"
      unitRef="usd">4000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzEtNi0xLTEtMA_67089878-cfab-4096-b087-8907e215f0e5"
      unitRef="usd">164000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzItMi0xLTEtMA_8f9d7242-3d83-4cf2-9a40-75e3fd3518c7"
      unitRef="usd">140000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzItNC0xLTEtMA_6078762b-454a-4bdd-8d0f-e34b5b66a487"
      unitRef="usd">3000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzItNi0xLTEtMA_ba521cdb-6ef0-47ed-9724-50b1fb6ddc53"
      unitRef="usd">143000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzMtMi0xLTEtMA_91c35c31-c0b6-47fc-9ceb-3dca326f9c46"
      unitRef="usd">122000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzMtNC0xLTEtMA_19dbd158-5a25-4b23-91aa-f49cbdd9d03e"
      unitRef="usd">3000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzMtNi0xLTEtMA_e296a7c9-ac94-4fe1-be5f-25b10d5835b3"
      unitRef="usd">125000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzQtMi0xLTEtMA_ac2644ea-1bd6-497f-a0d7-a7be607a3751"
      unitRef="usd">87000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzQtNC0xLTEtMA_cb027041-202f-4540-9129-f01be68ca5b9"
      unitRef="usd">3000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzQtNi0xLTEtMA_bb91a2fe-9e7e-470d-a782-8a31bd4e5cd6"
      unitRef="usd">90000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzUtMi0xLTEtMA_5088a129-3e98-4d9d-bc93-b84e6b047e16"
      unitRef="usd">57000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzUtNC0xLTEtMA_4f155a69-7149-4c2a-b7e2-9b03fc64a513"
      unitRef="usd">3000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzUtNi0xLTEtMA_7a7ccec3-c390-4bdc-964b-a1ea0375b0ea"
      unitRef="usd">60000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzYtMi0xLTEtMA_46d3a2bc-d6a3-4265-b8de-079cd7e61b97"
      unitRef="usd">153000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzYtNC0xLTEtMA_8ad110de-f884-4111-a5b9-4bd253f390b0"
      unitRef="usd">28000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzYtNi0xLTEtMA_c9088951-629b-4933-8b96-c07bc06ccfbf"
      unitRef="usd">181000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzctMi0xLTEtMA_3c0492c4-47b8-47b2-b525-0d7eab4c57d4"
      unitRef="usd">719000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzctNC0xLTEtMA_614126bf-8b8b-4b2f-835b-74bb08aaf60b"
      unitRef="usd">44000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDue
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzctNi0xLTEtMA_eb9696fb-3a9e-4a81-a806-ea6bfc969fb2"
      unitRef="usd">763000000</dgx:LesseeOperatingandFinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzgtMi0xLTEtMA_f93b4304-a9f7-43ac-8361-b0790f88d315"
      unitRef="usd">79000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzgtNC0xLTEtMA_607768c1-f2f4-4ff3-90d3-3d3abd708ac7"
      unitRef="usd">17000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <dgx:LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzgtNi0xLTEtMA_3299ae6b-0637-4017-9d94-36ceaa344626"
      unitRef="usd">96000000</dgx:LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzktMi0xLTEtMA_d171a4d5-b0f4-4a2b-a339-d99b75eea479"
      unitRef="usd">640000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzktNC0xLTEtMA_633a7bb1-6511-4249-80ee-d542c047fe04"
      unitRef="usd">27000000</us-gaap:FinanceLeaseLiability>
    <dgx:OperatingandFinanceLeaseLiability
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTowOGM4MzUwZWEyYzk0MTQ0ODgzYjFkYTlkNWRhY2E0MS90YWJsZXJhbmdlOjA4YzgzNTBlYTJjOTQxNDQ4ODNiMWRhOWQ1ZGFjYTQxXzktNi0xLTEtMA_e2e0def9-4317-4d7a-831d-ea33a55b447f"
      unitRef="usd">667000000</dgx:OperatingandFinanceLeaseLiability>
    <dgx:ScheduleofLeaseTermandDiscountRateTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90ZXh0cmVnaW9uOjEyNDI3NTI0YTQ3ZTQ2ODg4YWJlNzhmZjdhNTQyNGZlXzM4NjE_83a81c73-02aa-463e-946b-5cbe7b5a168d">Lease term and discount rate as of December&#160;31, 2020 and 2019 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:363.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:70.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleofLeaseTermandDiscountRateTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzItMS0xLTEtMA_6c5fdd56-6c44-4d18-ac9f-a1c6b4796800">P6Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzItMi0xLTEtMTEwNzg_ac2540a4-37c4-42ec-b69c-fe2dc6e5cafc">P5Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzMtMS0xLTEtMA_a921889d-8d15-48ac-94cd-e31eef136788">P13Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzMtMi0xLTEtMTEwNzg_db598de3-8e47-4d09-a7df-25d1f8feaef8">P12Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzYtMS0xLTEtMA_4b85ef48-447e-4492-9ee1-593b4cedfdab"
      unitRef="number">0.032</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzYtMi0xLTEtMTEwNzg_c715ce06-ebbb-4fab-97e8-1eb62f3f4367"
      unitRef="number">0.034</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzctMS0xLTEtMA_fad27c89-43ef-4901-b0d8-937ce515cbca"
      unitRef="number">0.081</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTQvZnJhZzoxMjQyNzUyNGE0N2U0Njg4OGFiZTc4ZmY3YTU0MjRmZS90YWJsZTphZjk0ZGVlMTNmMWQ0MGViYWZjZDEyMGE2NGZhNWRkNi90YWJsZXJhbmdlOmFmOTRkZWUxM2YxZDQwZWJhZmNkMTIwYTY0ZmE1ZGQ2XzctMi0xLTEtMTEwNzg_45812a43-e998-4fd1-8e80-1974fef1b17f"
      unitRef="number">0.087</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzM0NjQ_1c2268f8-a4eb-4bd4-be60-11d29e64a29e">FINANCIAL INSTRUMENTS &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest Rate Derivatives &#x2013; Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During March 2020, the Company entered into a forward-starting interest rate swap agreement with a financial institution for a total notional amount of $25&#160;million.  Additionally, during May 2020, the Company entered into interest rate lock agreements with several financial institutions for a total notional amount of $275&#160;million.  The forward-starting interest rate swap agreement and the interest rate lock agreements were entered into in order to hedge a portion of the Company's interest rate exposure associated with variability in future cash flows attributable to changes in interest rates over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1NzI_56514d22-493f-4c97-86ad-19ef10f8afd8"&gt;ten&lt;/span&gt;-year period related to an anticipated issuance of debt and were accounted for as cash flow hedges.  In connection with the issuance of the 2031 Senior Notes (see Note 13), these agreements were settled and the Company received net proceeds of $1&#160;million. The net gain is deferred in stockholders' equity, net of taxes, as a component of accumulated other comprehensive loss, and is being amortized as an adjustment to interest expense, net over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1OTE_2bbebbdb-352e-417a-8de8-f6de9db537f1"&gt;ten&lt;/span&gt;-year period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $1&#160;million and $4&#160;million as of December&#160;31, 2020 and 2019, respectively.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $1&#160;million.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Fair Value Hedges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2019, the Company had various fixed-to-variable interest rate swap agreements outstanding with an aggregate notional amount of $1.2&#160;billion, which were entered into in order to convert a portion of the Company's long-term debt into variable interest rate debt.  In April 2020, the Company terminated these existing fixed-to-variable interest rate swap agreements and received proceeds of $40&#160;million.  Such amount was reflected as a basis adjustment to the hedged debt instruments and is being amortized as a reduction of interest expense, net over their remaining terms.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2020 and 2019, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Amount of Hedged Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Amount of Hedged Long-Term Debt &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships.  As of December&#160;31, 2019, the balance includes $25 million of remaining unamortized hedging adjustments on discontinued relationships. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2020, 2019 and 2018, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A summary of the fair values of derivative instruments in the consolidated balance sheet was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-to-variable interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i66ce45540c0b49579be5f2a665d77e65_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzIxOTkwMjMyNjA2MTc_8e3a5e59-fa2d-4aab-8698-902b61ab95d0"
      unitRef="usd">25000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7827a00a60bc4aef8604397387c5b8e9_I20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzIxOTkwMjMyNjA2MzA_73b9aba1-48c6-4a16-a8cf-5b1a333a37ae"
      unitRef="usd">275000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzIxOTkwMjMyNjA2NDg_0376236e-1280-4e1f-9eb9-cd50e48c0efd"
      unitRef="usd">1000000</us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i837da46f467741f1a47e6456ab80934a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzEwNDQ1MzYwNDcyNDAy_4091f2d3-0898-4bf0-8128-390388a4ef93"
      unitRef="usd">1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4d52e8506b964853934619358132e916_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM2MjQ_c829c3ec-28b3-4707-9bab-d22f23dd61ef"
      unitRef="usd">4000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzEwNDQ1MzYwNDcyNDMy_d102286c-f818-44de-85fe-c3eb2a455bcd"
      unitRef="usd">1000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i127dea9d515d4af9aad64832390b1702_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzEwNDQ1MzYwNDcyMDg5_eb911ad6-000b-4ca7-a9cd-b3ab15d78ff6"
      unitRef="usd">1200000000</us-gaap:DerivativeNotionalAmount>
    <dgx:ProceedsfromTerminationofDerivativeInstrumentOperatingActivities
      contextRef="ifacb1c5c6dad45498481604994cc9c9b_D20200401-20200430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzIxOTkwMjMyNjMzNTI_59fce5ac-d065-4259-b829-35ffe6df3b92"
      unitRef="usd">40000000</dgx:ProceedsfromTerminationofDerivativeInstrumentOperatingActivities>
    <dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzM0OTA_8d61e199-6c2d-43bc-9b61-bdaf2820a830">As of December&#160;31, 2020 and 2019, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Amount of Hedged Long-Term Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Amount of Hedged Long-Term Debt &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;(a) As of December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships.  As of December&#160;31, 2019, the balance includes $25 million of remaining unamortized hedging adjustments on discontinued relationships.</dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="id141c98d5c21416f95dd9ad86532d5f8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo0MDQ2YmM1NmZhZmM0NGZiOTBkNTliYmY4Mjk5YjgyOC90YWJsZXJhbmdlOjQwNDZiYzU2ZmFmYzQ0ZmI5MGQ1OWJiZjgyOTliODI4XzItMy0xLTEtMA_6254ff48-1eea-4172-8025-dc5d84c3bca8"
      unitRef="usd">0</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="id141c98d5c21416f95dd9ad86532d5f8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo0MDQ2YmM1NmZhZmM0NGZiOTBkNTliYmY4Mjk5YjgyOC90YWJsZXJhbmdlOjQwNDZiYzU2ZmFmYzQ0ZmI5MGQ1OWJiZjgyOTliODI4XzItNS0xLTEtMA_35c40673-24c1-4447-b9a3-17bd72e07cb4"
      unitRef="usd">51000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedge
      contextRef="ifb6a84f2be8142b7ad7ceae3cd3f42a7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo0MDQ2YmM1NmZhZmM0NGZiOTBkNTliYmY4Mjk5YjgyOC90YWJsZXJhbmdlOjQwNDZiYzU2ZmFmYzQ0ZmI5MGQ1OWJiZjgyOTliODI4XzItNy0xLTEtMA_1a266eb5-346d-45ce-8826-4b9e025eb37f"
      unitRef="usd">1186000000</us-gaap:HedgedLiabilityFairValueHedge>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="ifb6a84f2be8142b7ad7ceae3cd3f42a7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo0MDQ2YmM1NmZhZmM0NGZiOTBkNTliYmY4Mjk5YjgyOC90YWJsZXJhbmdlOjQwNDZiYzU2ZmFmYzQ0ZmI5MGQ1OWJiZjgyOTliODI4XzItOS0xLTEtMA_31e55f45-9969-43e8-a14b-6c0fa65b06a9"
      unitRef="usd">-3000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:DeferredGainLossOnDiscontinuationOfFairValueHedge
      contextRef="ifb6a84f2be8142b7ad7ceae3cd3f42a7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzMwNjQ_7027f797-3769-417d-81b5-fddf43c9146e"
      unitRef="usd">25000000</us-gaap:DeferredGainLossOnDiscontinuationOfFairValueHedge>
    <dgx:ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzM0ODg_4dde65fb-e760-460f-a9bf-f06be4d1ac6d">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2020, 2019 and 2018, respectively:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.949%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzMtMy0xLTEtMA_abfaf569-779b-4024-91ee-e1b7e9216558"
      unitRef="usd">76000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzMtNS0xLTEtMA_af25f0d2-462b-4e48-85cd-08530918ee23"
      unitRef="usd">20000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzMtNy0xLTEtMA_2d411edb-5909-446f-b75e-2973c9911c85"
      unitRef="usd">-8000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="ibb495ec24a01435fbd27a38907a75fca_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzYtMy0xLTEtMA_40b04cf3-f2e8-476c-b89f-75729dafe03d"
      unitRef="usd">-68000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="iff2d731644784878a01ffd609e67911a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzYtNS0xLTEtMA_13651b75-59de-46a9-bd69-5b74736cbbf2"
      unitRef="usd">-65000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="if16ba469706349e7a5dda9f237173286_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzYtNy0xLTEtMA_c8651f4a-0d63-4339-b8e2-202a7e3e2756"
      unitRef="usd">4000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia67a4a0ff8b1447e93f556e763ad297c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzctMy0xLTEtMA_57610537-b3af-4140-b0ce-5eecf9e17e50"
      unitRef="usd">68000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic7186eb7282e4103827c4b7ee0d01c74_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzctNS0xLTEtMA_8350ad2b-2587-40ca-93b0-1d258f53f9c1"
      unitRef="usd">65000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i3219d74c46bf4c0297cf3d070a80cc44_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo2NTFkMDcxMjM0M2U0MDRlYjYyMGRjNDgwMGJlMjJmMS90YWJsZXJhbmdlOjY1MWQwNzEyMzQzZTQwNGViNjIwZGM0ODAwYmUyMmYxXzctNy0xLTEtMA_cf151baf-76cb-4500-a22d-15b2042c38c6"
      unitRef="usd">-4000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzM0NzE_efce06a7-1dcc-4a22-8ef5-6cadbc12a3a5">A summary of the fair values of derivative instruments in the consolidated balance sheet was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet&lt;br/&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-to-variable interest rate swap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i73cb452a6ac74285af4a4f642559ad6f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90YWJsZTo4M2NkNGYwZDU0ZmE0ZDU1OGQzYWM2NWY0NzUyYjIzYy90YWJsZXJhbmdlOjgzY2Q0ZjBkNTRmYTRkNTU4ZDNhYzY1ZjQ3NTJiMjNjXzgtNy0xLTEtMA_ae94fef2-92e1-4cf1-a0d6-35e5d13f442b"
      unitRef="usd">28000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzc0ODg_ec7f1c84-983d-4dfc-9546-46943ec2c16d">STOCKHOLDERS&#x2019; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Stockholders' Equity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Series Preferred Stock &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Quest Diagnostics is authorized to issue up to 10 million shares of Series Preferred Stock, par value $1.00 per share.  The Company's Board of Directors has the authority to issue such shares without stockholder approval and to determine the designations, preferences, rights and restrictions of such shares.  No shares are currently outstanding.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under the Company's Restated Certificate of Incorporation the number of authorized shares of common stock, par value $0.01 per share, is 600 million shares.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Changes in Accumulated Other Comprehensive Loss by Component&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Comprehensive income (loss) includes:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 15).  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019, and 2018, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in accumulated other comprehensive loss by component for 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Changes in Available-for-Sale Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Losses on Cash Flow Hedges, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, the gross deferred losses on cash flow hedges were reclassified from accumulated other comprehensive loss to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December 31, 2020 and 2018, foreign currency translation adjustment amounts were reclassified from accumulated other comprehensive loss to other operating expense (income), net as a result of the sale of foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share.  During each of the four quarters of 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.53 per common share.  During each of the first three quarters of 2018, the Company's Board of Directors declared a quarterly cash dividend of $0.50 per common share.  During the fourth quarter of 2018, the Company's Board of Directors declared a quarterly cash dividend of $0.53 per common share.  On February 4, 2021, the Company announced that its Board of Directors authorized a 10.7% increase in its quarterly cash dividend from $0.56 to $0.62 per share, or $2.48 per share annually, commencing with the dividend payable in April 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2020, $0.9 billion remained available under the Company&#x2019;s share repurchase authorization.  In February 2021, the Company's Board of Directors authorized the Company to repurchase an additional $1&#160;billion of the Company's common stock.  The share repurchase authorization has no set expiration or termination date.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;For the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020, the Company repurchased 2.7 million shares of its common stock for $325 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company repurchased 3.5 million shares of its common stock for $350 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2018, the Company repurchased 3.4 million shares of its common stock for $325 million, which included an accrual of $3&#160;million recorded in accounts payable and accrued expenses in the consolidated balance sheet for share repurchases not settled until after December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Shares Reissued from Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018 the Company reissued 3 million shares, 2 million shares and 3 million shares, respectively, from treasury stock for shares issued under the Employee Stock Purchase Plan ("ESPP") and stock option plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redeemable Noncontrolling Interest&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  The Company records changes in the fair value of the noncontrolling interest immediately as they occur.  As of December&#160;31, 2020 and 2019, the redeemable noncontrolling interest was $82 million and $76 million, respectively, and was presented at its fair value.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i3bf2fc1a93c943d987e412080b37ceb5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzE2OQ_ed522712-8b0a-4167-9a36-3fbeaabf64c7"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxNg_ba5424ce-110d-4bea-bb44-bdd3340e7cad"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQyMQ_7116e5bb-7a64-44d8-a0be-71025d44cc64"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzYyOQ_848c3d87-ea89-4db3-80dc-a50ce11b1f07"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzY2MQ_05fcecb6-af5d-405e-a82c-898945901a50"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzUyNTY_d103eb45-5473-4f96-b82c-804afbf9ee9a">The changes in accumulated other comprehensive loss by component for 2020, 2019 and 2018 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Changes in Available-for-Sale Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deferred Losses on Cash Flow Hedges, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i34c51c66cc164d1da2582f9c600d44f1_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItMS0xLTEtMA_151c8ddc-bc73-4276-9a76-972dfca4b0d9"
      unitRef="usd">-38000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i69c7eeb1cf454f3087a541bf615ec3e1_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItMy0xLTEtMA_04000e07-6bd6-4654-a128-24be7373f180"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i50dd445f21194164a30af100f410f3e2_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItNS0xLTEtMA_9cb26596-db34-4164-a02a-790bc5589831"
      unitRef="usd">-9000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d1945a14f9f4ce2921e9bbaaa6b9124_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItNy0xLTEtMA_27d9a73d-9fa9-435f-84d6-41aca3249a8d"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i14e2c4e502f24416aea41251e9a7a514_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzItOS0xLTEtMA_c0262c2c-4229-4e3d-b370-0fe6ae539022"
      unitRef="usd">-48000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtMS0xLTEtMA_6ef5ca75-c326-4711-839b-27f2b54342a2"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtMy0xLTEtMA_edde9105-da83-4dc6-8955-1468f88acf99"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtNS0xLTEtMA_1d8f9f7e-0178-4855-a2a7-a3d153b6e4df"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtNy0xLTEtMA_dd97796a-0844-46dd-a5b5-d9b39e7e779f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzMtOS0xLTEtMA_39ba3fae-dcf7-4c71-a7bc-31b63ad8e24c"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtMS0xLTEtMA_e946f36d-1840-4695-bbd2-3bfbd2d9ae2f"
      unitRef="usd">4000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtMy0xLTEtMA_612dcb44-fffa-412c-b6db-822ef3a7db5c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtNS0xLTEtMA_56d099df-3863-451f-b8df-2d0d3f6c8523"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtNy0xLTEtMA_4e389fb2-cda2-4432-8d35-63049f801ffc"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzQtOS0xLTEtMA_eb0938ef-3a97-479f-bde3-678eddfb4a72"
      unitRef="usd">6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtMS0xLTEtMA_b68ecad6-41b9-4282-a9e8-7b7bc3437845"
      unitRef="usd">-11000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtMy0xLTEtMA_50198f78-7128-494f-acd7-dcbf61feea84"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtNS0xLTEtMA_9b569bbc-142f-4d2a-99a8-0dab2bf99f34"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtNy0xLTEtMA_c312f30b-f516-40e7-95b1-6174d5392e0b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzUtOS0xLTEtMA_5f161074-b636-49d5-98b8-ce90b6ae3c3a"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings
      contextRef="i2df8e092d2b3481ab0b75ca5083a88ba_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtMS0xLTEtNDE5NQ_d0d607ae-f7f2-42c6-b565-5ea5048b6359"
      unitRef="usd">0</dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings>
    <dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings
      contextRef="i401fdd69b2954ac5b223db03f757536c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtMy0xLTEtNDE5OQ_6e6913e3-df61-4f27-a9eb-0ba6c4ac6c18"
      unitRef="usd">0</dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings>
    <dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings
      contextRef="ie91cd39bc19348b29697eee127782ef0_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtNS0xLTEtNDE4NQ_8a75e5e7-bba5-406d-91e6-08cee2e1df7e"
      unitRef="usd">-2000000</dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings>
    <dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings
      contextRef="if5779af390b040c493f8a6e76db84d4c_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtNy0xLTEtNDIwMg_fb2427fc-14a5-4211-a349-f04f55c13d02"
      unitRef="usd">0</dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings>
    <dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings
      contextRef="i55c65266fcc843f2ae169e109a1b0756_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtOS0xLTEtNDE4OQ_4a654fe1-c42a-4cc3-81d6-91dca25078b0"
      unitRef="usd">-2000000</dgx:TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibdffbc0183ce49ee8d6307cd711c32da_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtMS0xLTEtMA_a43b4b3b-c04a-41cf-9618-e8341ae96c98"
      unitRef="usd">-49000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i41c2b4effc544078806b615118dd9278_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtMy0xLTEtMA_3b3592f0-1588-4651-9437-bfe1abbdb767"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5448ffcdebdf4d7ea0f8ffee8b0b8f9b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtNS0xLTEtMA_33a6702a-535f-4023-a1da-759889dedfb0"
      unitRef="usd">-9000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2ff2b554598b47c6aec52cefb4f6bb51_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtNy0xLTEtMA_3d2fba2b-faa5-4a3e-a820-467b751bfcc1"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f0ce225b8594c6a86f10f4f1abe8e39_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzYtOS0xLTEtMA_28ebbf89-ecb8-45b2-a581-a0a5742cab20"
      unitRef="usd">-59000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7d31347983ac43948ce0a443c75f4aa8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctMS0xLTEtMA_5bb8e4c8-e1f8-42d5-be0f-cfd5922823a1"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1dab0f39fda445528890429f9f021ab9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctMy0xLTEtMA_80f03945-24b0-49eb-a36a-98c8a55ece85"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib698a53cb2f8426cbe61b6e19fb1a281_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctNS0xLTEtMA_a003f81b-aa59-40f9-b80b-c47e8cba6cb3"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1bd46f02dc1f4473b397c6a576d3bc85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctNy0xLTEtMA_20ae1032-933d-4cd0-b2d1-48129dc9ed24"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzctOS0xLTEtMA_e38ecf9d-d83f-4d2c-b53d-7dac7fd14d10"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7d31347983ac43948ce0a443c75f4aa8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtMS0xLTEtMA_2bbf292a-1819-4e4e-a1ae-97d11cf4ad08"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1dab0f39fda445528890429f9f021ab9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtMy0xLTEtMA_96bfb436-46e6-4f42-b10f-72ed75415e48"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib698a53cb2f8426cbe61b6e19fb1a281_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtNS0xLTEtMA_ac69a9ee-dd53-48dd-a67b-1ed5c75c27dd"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1bd46f02dc1f4473b397c6a576d3bc85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtNy0xLTEtMA_fc7d870a-2ce3-4584-9c0a-dafbb61c5ab6"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzgtOS0xLTEtMA_b25c788c-6752-418e-ab20-ae682e5f2378"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7d31347983ac43948ce0a443c75f4aa8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktMS0xLTEtMA_49a29021-4a18-4ab5-b4f0-1d7f755b30ee"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1dab0f39fda445528890429f9f021ab9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktMy0xLTEtMA_bc7f4c35-fab8-4aa6-a7d2-292f7b274564"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib698a53cb2f8426cbe61b6e19fb1a281_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktNS0xLTEtMA_a785163b-53c3-4e23-b8ec-7ae7fa2d79f6"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1bd46f02dc1f4473b397c6a576d3bc85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktNy0xLTEtMA_a725595c-deb1-4da0-afb1-6f36269e1989"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i12d1c985f3ca4af2a88f2a9be3f1e4ab_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzktOS0xLTEtMA_6d57d8d7-fedf-4989-8f46-82839632af2b"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id24dcfded8274220894b4ec84f289be9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTEtMS0xLTA_08575764-7762-46d6-827f-ad7a19ea2365"
      unitRef="usd">-42000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i35228c4a5cbe4bf9a0b8ad2de1992783_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTMtMS0xLTA_d18c063d-8924-4ada-bd58-cd57340cd97b"
      unitRef="usd">8000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i73cf70b9879644efb91f2116611446a5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTUtMS0xLTA_eb94b09c-762e-409e-a9ed-695669f7069d"
      unitRef="usd">-4000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9e0eb38fdc3746ec8e44fcd4afa6a3fe_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTctMS0xLTA_d69c20de-e336-4b66-832f-a067761c91a9"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i41a7f39f717a41848294a65ad208374f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzExLTktMS0xLTA_220b66f5-2700-4f03-b424-e3aa13c53a2c"
      unitRef="usd">-39000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i192e1f30a76a48d1a4fccda9268bcefa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTEtMS0xLTA_3879ff9a-fd15-46ef-95ba-42a8f8e26478"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6fec735f32d545668c9011b3d1ba778b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTMtMS0xLTA_04f1c77d-f42a-4244-ae35-f5d6da27c561"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia4e0cd2bf0ce400291395c2d343ce00b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTUtMS0xLTA_1e379ce6-83e3-444f-badc-fa8766b75bd0"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i67231146b7644c899681fc68de1cc785_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTctMS0xLTA_8e831620-44cd-41fe-aeb0-bc0061f01dc6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEyLTktMS0xLTA_7c9aab18-c983-4e0f-a5a4-234a39199ab3"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i192e1f30a76a48d1a4fccda9268bcefa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTEtMS0xLTA_212a4350-70ad-464c-8a85-43019c11c3d2"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6fec735f32d545668c9011b3d1ba778b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTMtMS0xLTA_87f0f1e6-a454-424a-b333-7a07b1b65a87"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia4e0cd2bf0ce400291395c2d343ce00b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTUtMS0xLTA_0e807b93-ae8a-4c71-8891-fb29022a387f"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i67231146b7644c899681fc68de1cc785_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTctMS0xLTA_d8d4dbe2-8038-412e-a999-e6062e1da865"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzEzLTktMS0xLTA_21c26f9e-b9e6-41c4-87da-8ffdb3760739"
      unitRef="usd">5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i192e1f30a76a48d1a4fccda9268bcefa_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTEtMS0xLTA_5f90bf9c-d86f-4289-8b61-955f102253c6"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6fec735f32d545668c9011b3d1ba778b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTMtMS0xLTA_37a4c3cf-0487-412b-acdf-1157bb363159"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia4e0cd2bf0ce400291395c2d343ce00b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTUtMS0xLTA_d97ace2c-0c53-424d-8cc1-9b0c095d4cb8"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i67231146b7644c899681fc68de1cc785_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTctMS0xLTA_84117998-585d-4a68-b899-cba8a1063575"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib4c16e4e6d5e4371b6b2fb2f413931d2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE0LTktMS0xLTA_179d89ec-b5bb-46fe-8a66-d2586e31e6bf"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1bc1b38e887c4144b5780eca80bd204b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTEtMS0xLTA_63d25b3a-780d-405e-a876-a9b0ff6cbf70"
      unitRef="usd">-27000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifebaca822eff4cc387f98c008d09c38e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTMtMS0xLTA_1939258f-a694-4afa-b2ab-1aa8fc740a02"
      unitRef="usd">8000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ef455113ed841c7b82fbb4ace9b85be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTUtMS0xLTA_7ac4eddf-6f95-4bb1-b042-2e3d4e32056f"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i24d73f4e924f4a10a8f521b757db5eb7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTctMS0xLTA_a91e7740-afe6-4d5d-a366-935d1c9a79c5"
      unitRef="usd">-1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i15c1b65002784549a102581ed4f9ec6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90YWJsZTpjNmI2ODc0ODZhOWE0MzQ3OTAwNTNiOTE0ZjY5M2Q3Yi90YWJsZXJhbmdlOmM2YjY4NzQ4NmE5YTQzNDc5MDA1M2I5MTRmNjkzZDdiXzE2LTktMS0xLTA_c000cd81-1b33-41b2-9a7a-341648cfad3b"
      unitRef="usd">-21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjIxNzA_47a53e2b-6ee6-4629-88be-be37eb894475"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjIxNzA_7e00b099-5a1b-43bc-a122-89960df62da2"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjIxNzA_a4918063-83d5-4d3e-a00a-2919766486b9"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjIxNzA_e6bc7c7a-1728-43de-b580-197252e6a965"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI3MDE_06d901c9-0c60-42cc-b266-ae067355e87c"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI3MDE_55c6006a-ecff-4215-af53-f4a7b8ae2d6b"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI3MDE_707158b6-567b-4599-a8e9-47c184cf31b6"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI3MDE_ab90ed37-506e-425d-be63-fc8895b2c659"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7731e39a610040f98b51c6b6e8764070_D20180101-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI4NDM_213e1e76-e351-4f9d-8572-b51de3ecf87c"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i63870adfaa434891bafa374146f885cb_D20180701-20180930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI4NDM_43324c5d-6a86-4761-bb9e-22f2c1b640b9"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i696a70381cba476b8c6f79dd4b77fe5b_D20180401-20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI4NDM_88639851-6314-4b35-9a8f-9e8e19c9eeca"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie62d0efe4ae34fd6b32670577a82ac3f_D20181001-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzI5NzE_59a30f65-0c52-4cd4-be65-4b1cb6246c45"
      unitRef="usdPerShare">0.53</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:IncreaseDecreaseinCommonStockDividendsDeclaredasPercent
      contextRef="i1582bc80466c4a0a99308fa830a6db42_I20210204"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzczNzQ_accabc12-5f8f-4840-9676-eddac5849dac"
      unitRef="number">0.107</dgx:IncreaseDecreaseinCommonStockDividendsDeclaredasPercent>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzczODE_f986a4a1-8188-4ca7-a96e-82fc2c95c2c7"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i32de60c551da40599315cbb1e6c3f5ca_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzczODg_f571924f-162e-48b6-9bb3-888f6e63ebba"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i62130c12d0ec4b10b6bb1bea0f6d8ab3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ5NDc4MDIzMzczOTU_6fac60b7-bf42-4405-98da-7f6394c775ab"
      unitRef="usdPerShare">2.48</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzM1MzY_cc93ce54-5b94-4f18-ad34-1c05c59b8709"
      unitRef="usd">900000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <dgx:StockRepurchaseProgramAdditionalAuthorizedAmount
      contextRef="i0b5c67810b5d48758c30b695b04494b1_I20210222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjg0MjM_a7897f24-b648-4e19-b969-0b0e32c00a36"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAuthorizedAmount>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjQ1NzI_a0774e84-142d-4c8e-816e-cf6184083659"
      unitRef="shares">2700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic0979770b28c40ebb3fb7d5525876393_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjQ1OTY_925cf464-4c50-43ae-b502-9a55a324ed41"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzM4NTA_42cd550c-2270-4959-9567-3107b28ffec2"
      unitRef="shares">3500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i97fbbca19e2c480d9777a5207ccfb24d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzM4ODQ_24808727-b1f6-4c3e-8676-e92f6f75d478"
      unitRef="usd">350000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQxMTg_35b385a8-c35d-44a3-b431-f1e78b49a0f0"
      unitRef="shares">3400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iff53d21beabc4272b8a4d25a8e2458bf_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQxNTI_c51e1c4c-23ef-4706-99a4-f172f89bd06b"
      unitRef="usd">325000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <dgx:TreasuryStockValueAcquiredCostMethod1
      contextRef="i36c642409ac64921826ebf21bd9b07f1_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjE1NTU_193de7eb-da26-4602-a769-68582a4b6114"
      unitRef="usd">3000000</dgx:TreasuryStockValueAcquiredCostMethod1>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQyNTQ_0d124fa0-edcd-45bd-9741-e8aa52e9a276"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjQ2MDc_adbc5d5c-e255-41c9-aba5-1b0947ab0f80"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzIxOTkwMjMyNjQ2MTA_3d3fa107-dfd9-4573-b1e7-85e7800cf105"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i02060ac5ffa04417a6b16a9bd1912233_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzQ0ODc_5e91afa1-3041-4ad4-8c10-1660d972ed5a"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ie95d4b8fec93446cb65b51f7e24e8460_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzUxODY_dbb39962-b35e-43a9-9b08-f1a387ed144b"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i163121a462fb460dac48b33c7084fd77_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjMvZnJhZzozMjE5NWM1NDNkMGI0MmYxYjYyMDY2MzBhODUyYTE5MC90ZXh0cmVnaW9uOjMyMTk1YzU0M2QwYjQyZjFiNjIwNjYzMGE4NTJhMTkwXzUxOTM_9b4571b2-0b16-4d8a-b725-97b30b6da02c"
      unitRef="usd">76000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkzNjI_f54866ff-3ca6-44cd-a562-8fef0e868ce1">STOCK OWNERSHIP AND COMPENSATION PLANS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee and Non-employee Directors Stock Ownership Programs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;The ELTIP provides for three types of awards: (a) stock options, (b) stock appreciation rights and (c) stock awards.  The ELTIP provides for the grant to eligible employees of either non-qualified or incentive stock options, or both, to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Grants of stock appreciation rights allow eligible employees to receive a payment based on the appreciation of Company common stock in cash, shares of Company common stock or a combination thereof.  The stock appreciation rights are granted at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Stock options and stock appreciation rights granted under the ELTIP expire on the date designated by the Board of Directors but in no event more than ten years from date of grant.  No stock appreciation rights have been granted under the ELTIP.  Under the ELTIP, awards are subject to forfeiture if employment terminates prior to the end of the vesting period prescribed by the Board of Directors.  For all award types, the vesting period is generally over three years from the date of grant.  For performance share units, the actual amount of shares earned is based on the achievement of the performance goals specified in the awards.  The performance goals for awards granted for 2018 and 2019 were based on the financial performance of the Company.  The performance goals for awards granted in 2020 were based on the financial performance of the Company as well as relative TSR.  The maximum number of shares of Company common stock in respect of which awards may be granted under the ELTIP is approximately 79 million shares.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The DLTIP provides for the grant to non-employee directors of non-qualified stock options to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  The DLTIP also permits awards of restricted stock and restricted stock units to non-employee directors.  Stock options &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;granted under the DLTIP expire on the date designated by the Board of Directors but in no event more than ten years from date of grant.  For all award types, the vesting period is generally over three years from the date of grant, regardless of whether the award recipient remains a director of the Company.  The maximum number of shares that may be issued under the DLTIP is 2.4 million shares.  For the years ended December&#160;31, 2020, 2019 and 2018, grants under the DLTIP totaled 14 thousand shares, 14 thousand shares and 15 thousand shares, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  See Note 16 for further information regarding the Company's share repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160; The fair value of each stock option award granted was estimated on the date of grant using a Black-Scholes option-valuation model.  The expected volatility under the Black-Scholes option-valuation model was based on historical volatilities of the Company's common stock.  The dividend yield was based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the expected holding period of the related award.  The expected holding period was estimated using the historical stock option exercise behavior of employees. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The weighted average assumptions used in valuing stock options granted in the periods presented were:  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$17.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected holding period, in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following summarizes the activity relative to stock option awards for 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company's closing common stock price on the last trading day of 2020 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2020.  This amount changes based on the fair market value of the Company's common stock.  Total intrinsic value of options exercised in 2020, 2019 and 2018 was $113 million, $62 million and $67 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2020, there was $9 million of unrecognized stock-based compensation cost related to nonvested stock options which is expected to be recognized over a weighted average period of 1.6 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair value of restricted stock awards and restricted stock units is the average market price of the Company's common stock at the date of grant.  For performance share units with a goal based on the financial performance of the Company, the fair value is based on the average market price of the Company's common stock at the date of grant, adjusted for the present value of dividends expected to be paid on the Company's common stock during the vesting period.  For performance share units with a market-based relative TSR goal, the fair value is estimated on the date of grant using a Monte Carlo valuation model.  The expected volatility under the Monte Carlo valuation model is based on the historical volatility of the common stock of the Company and the common stock of the companies in the peer index.  The dividend yield is based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the performance period of the related award. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The weighted average assumptions used in valuing performance share units in 2020 with a market-based relative TSR goal were:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$144.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2020, 2019 and 2018: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares forfeited and canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2020, there was $29 million of unrecognized stock-based compensation cost related to nonvested stock awards, which is expected to be recognized over a weighted average period of 1.5 years.  Total fair value of shares vested was $37 million, $40 million and $54 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.  For performance share units with a goal based on financial performance of the Company, the amount of unrecognized stock-based compensation cost is subject to change based on changes, if any, to management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned at the end of the performance periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, stock-based compensation expense totaled $97 million, $56 million and $61 million, respectively.  Income tax benefits recognized in the consolidated statements of operations related to stock-based compensation expense totaled $39 million, $27 million and $33 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively, which includes excess tax benefits associated with stock-based compensation arrangements of $23 million, $13 million and $18 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under the Company's ESPP, substantially all employees can elect to have up to 10% of their annual wages withheld to purchase Quest Diagnostics common stock.  The purchase price of the stock is 95% of the market price of the Company's common stock on the last business day of each calendar month.  Under the ESPP, the maximum number of shares of Quest Diagnostics common stock which may be purchased by eligible employees is 9 million.  Approximately 225 thousand shares, 269 thousand shares and 326 thousand shares of common stock were purchased by eligible employees in 2020, 2019 and 2018, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plans &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company maintains qualified defined contribution plans covering substantially all of its employees.  The maximum Company matching contribution is 5% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions for certain qualified defined contribution plans; matching contributions were reinstated in the third quarter of 2020.  The Company's expense for contributions to its defined contribution plans aggregated $64 million, $84 million and $78 million for 2020, 2019 and 2018, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Deferred Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has a supplemental deferred compensation plan that is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to 50% of their salary in excess of their defined contribution plan limits and for certain eligible employees, up to 95% of their variable incentive compensation.  The maximum Company matching contribution is 5% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions; matching contributions were reinstated in the third quarter of 2020.  The compensation deferred under this plan, together with Company matching amounts, are credited with earnings or losses measured by the mirrored rate of return on investments elected by plan participants.  Each plan participant is fully vested in all deferred compensation, Company match and earnings credited to their account.  The amounts accrued under the Company's deferred compensation plans were $67 million and $59 million as of December&#160;31, 2020 and 2019, respectively.  Although the Company is currently contributing all participant deferrals and matching amounts to a trust, the funds in this trust, totaling $67 million and $59 million as of December&#160;31, 2020 and 2019, respectively, are general assets of the Company and are subject to any claims of the Company's creditors. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company also offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  The Company matches employee contributions equal to 25%, up to a maximum of $5 thousand per plan year.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  Each participant is fully vested in their deferred compensation and vests in Company matching contributions over a period of four years at 25% per year.  This plan was amended effective January 1, 2018 so that future deferrals under the plan may only be made by participants who made deferrals under the plan in 2017.  The amounts accrued under this plan were $59 million and $51 million as of December&#160;31, 2020 and 2019, respectively.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  The cash surrender value of such life insurance policies was $50 million and $43 million as of December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;  For each of the years ended December&#160;31, 2020, 2019 and 2018, the Company's expense for matching contributions to these plans was not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans
      contextRef="i98e33a74d2374686abe9f0c57a67eaa5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzEwODI_de083032-e4e4-492e-a361-690be1c43003">P10Y</dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzEzODc_a230eaec-f87b-4918-9ed6-ace755afbc07">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iceca37b233814fac990bb0d43b3d1f18_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzE2ODI_855af881-0e52-49ff-b5bc-f3cfeee6941b"
      unitRef="shares">79000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans
      contextRef="i117f623b34944a4aa09ba43fe0f2b647_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzIyNDU_83638a05-d698-4f07-9497-579c6af56209">P10Y</dgx:ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9b61e94e7f074f5ab9c3930b140386b5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzIzMjc_8ca5ff10-7d00-457a-9526-3c29569c6eaa">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ib33f609e90994e12b073cfeb7263634a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzI0OTk_d390cf30-4b83-451d-892a-cc6b8389f774"
      unitRef="shares">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9b61e94e7f074f5ab9c3930b140386b5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzI1Nzc_0938cbac-709b-4091-89d9-6c5f92eb2c2e"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8b818bf8df5f410eb2045ec27d80953b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzI1ODg_f1b005c4-79fb-4c21-b5bc-7cd3ffc7fe6b"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie98b52a6c1794c20a26d3553828e4078_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzI2MDI_511077b8-b4f5-47b0-9e91-cd7fa35bf5e2"
      unitRef="shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkzNTg_75f4277d-5441-4ff4-a587-f4c0840514cc">The weighted average assumptions used in valuing stock options granted in the periods presented were:  &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.219%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$17.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$14.30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected holding period, in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzItMS0xLTEtMA_d4ef4403-6de3-47ec-b840-ab3b04ec7e2b"
      unitRef="usdPerShare">17.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzItMy0xLTEtMA_898c1bdd-5cbe-40c7-9118-1ad112b096b0"
      unitRef="usdPerShare">14.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzItNS0xLTEtMA_4aeaf2c0-8713-41bd-9c63-776248a7d3a1"
      unitRef="usdPerShare">18.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzMtMS0xLTEtMA_343d5748-0bbb-42f1-b8a2-4ef0f678ca2d"
      unitRef="number">0.203</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzMtMy0xLTEtMA_65ecba1c-e787-4a52-b60a-062176024587"
      unitRef="number">0.204</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzMtNS0xLTEtMA_29dd81da-fa78-46f4-8cab-16a82a32c720"
      unitRef="number">0.191</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzQtMS0xLTEtMA_3ca6d70b-e5d9-4cb9-a31d-f9f04cc43bf9"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzQtMy0xLTEtMA_3b60e929-c96d-4a5b-9145-4c77eee0e896"
      unitRef="number">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzQtNS0xLTEtMA_403a29d9-dff2-47d0-a975-181689794c90"
      unitRef="number">0.019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzUtMS0xLTEtMA_f26248a0-5de8-4cc8-bc94-961886355773"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzUtMy0xLTEtMA_43ab6e03-2940-4928-87c0-6bddf007e887"
      unitRef="number">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzUtNS0xLTEtMA_a9893ee8-8060-41bd-bbb0-d4dbb8ed1f68"
      unitRef="number">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzYtMS0xLTEtMA_6685b8bc-d488-4cfb-bc68-bbf8b896d520">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzYtMy0xLTEtMA_60e0003e-4fc0-43bf-b8c0-6ad46f7149dc">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTpkMGYwYmM4N2UzYTU0ZDc4YjJjNjZiNjk0N2M4ZDdiOS90YWJsZXJhbmdlOmQwZjBiYzg3ZTNhNTRkNzhiMmM2NmI2OTQ3YzhkN2I5XzYtNS0xLTEtMA_70034805-ff04-45d5-b09b-e9eb8536e90c">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkzNjU_47a600fa-3a46-4dc1-90a0-bdc52c4c59a8">The following summarizes the activity relative to stock option awards for 2020: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i727f4b6eb33e4f3c8265b0e2dc2dbd40_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzItMS0xLTEtMA_7882cdbb-77b2-4085-83ce-b37b97e7e8e7"
      unitRef="shares">8000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i727f4b6eb33e4f3c8265b0e2dc2dbd40_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzItMy0xLTEtMA_9b809d2a-00ad-4e84-b88d-763c579c2edb"
      unitRef="usdPerShare">81.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzMtMS0xLTEtMA_056bbb2c-b269-453b-89d4-855c58aac964"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzMtMy0xLTEtMA_e1ff07fb-ed88-4f23-a7e5-33835572cb3d"
      unitRef="usdPerShare">112.23</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzQtMS0xLTEtMA_102d0f7e-2ec1-4c42-adbc-ca39a06365af"
      unitRef="shares">2600000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzQtMy0xLTEtMA_bc2bdd09-09d0-4452-baee-b4fd94027985"
      unitRef="usdPerShare">72.57</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzYtMS0xLTEtMA_3535e5d2-1c54-4049-a43e-af26967da0ed"
      unitRef="shares">6500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzYtMy0xLTEtMA_b9e52976-194c-4435-9b06-6b37e923f2fb"
      unitRef="usdPerShare">90.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzYtNS0xLTEtMA_de946d47-7ff6-4dd5-b1ed-6d36c86a2bed">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzYtNy0xLTEtMA_1da16758-cf38-4721-bd5f-53590a984333"
      unitRef="usd">187000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzgtMS0xLTEtMA_6dcd46e0-3b16-476d-ae6b-7f7938f6342b"
      unitRef="shares">3900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzgtMy0xLTEtMA_49921dee-8bb2-4bb5-93c5-0dac0584e4fa"
      unitRef="usdPerShare">83.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzgtNS0xLTEtMA_4c2b3bef-b6cc-469a-9d10-67283ef60db0">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzgtNy0xLTEtMA_0cdf33ae-c9ba-4cc5-8a5e-46e833a6af2e"
      unitRef="usd">138000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzktMS0xLTEtMA_a6fe346e-c901-46ac-b237-0829f4b4b72d"
      unitRef="shares">6400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzktMy0xLTEtMA_2acf6a01-3b11-4944-8eb7-e2cd1eaea312"
      unitRef="usdPerShare">90.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzktNS0xLTEtMA_e80d060d-9a2a-4ceb-9342-51743c78ee5b">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTowY2U0NTNkMGJhY2E0YzlmYThjMjI2MGIzZGExMzRjYy90YWJsZXJhbmdlOjBjZTQ1M2QwYmFjYTRjOWZhOGMyMjYwYjNkYTEzNGNjXzktNy0xLTEtMA_10cf2e4b-6768-4111-a284-b4d00cf04482"
      unitRef="usd">185000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ1MzA_f8baa16f-8026-4d9a-a0c2-1bb46b3a44d4"
      unitRef="usd">113000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i6d1ed33ea86c4c04ba5ce3c4c14d4697_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ1MzQ_b2fa1dea-848e-412e-8232-6f234f216506"
      unitRef="usd">62000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="id1ff65eb76ff475b8f7a4009c8376341_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ1NDE_a3ec5149-c037-4c21-81d9-7679c2e4e579"
      unitRef="usd">67000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="id4c1f210e0784a58a5120ccbcaac57c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ1ODM_0357d4eb-b637-4ec0-a4fd-ce83ca34538b"
      unitRef="usd">9000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ3MzY_67c74504-9879-4d4f-9844-2a06ef0bb0e0">P1Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <dgx:ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ5NDc4MDIzMzg4OTg_d6b4e6aa-8d93-4e56-91f9-7535e7618366">The weighted average assumptions used in valuing performance share units in 2020 with a market-based relative TSR goal were:  &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$144.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i33ff90645a634391b6fdea36985a329f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo0YzIwYWQ4NjViNjQ0NjE4YTdjMTRkYTE3YmJhMDYwZC90YWJsZXJhbmdlOjRjMjBhZDg2NWI2NDQ2MThhN2MxNGRhMTdiYmEwNjBkXzAtMS0xLTEtOTI1MQ_a8e17628-e016-4f48-804d-a286f257cf94"
      unitRef="usdPerShare">144.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i33ff90645a634391b6fdea36985a329f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo0YzIwYWQ4NjViNjQ0NjE4YTdjMTRkYTE3YmJhMDYwZC90YWJsZXJhbmdlOjRjMjBhZDg2NWI2NDQ2MThhN2MxNGRhMTdiYmEwNjBkXzEtMS0xLTEtOTI1MQ_b260b574-e085-45fd-a166-b0f5e816a74a"
      unitRef="number">0.201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i33ff90645a634391b6fdea36985a329f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo0YzIwYWQ4NjViNjQ0NjE4YTdjMTRkYTE3YmJhMDYwZC90YWJsZXJhbmdlOjRjMjBhZDg2NWI2NDQ2MThhN2MxNGRhMTdiYmEwNjBkXzItMS0xLTEtOTI1MQ_dc3298c1-b631-4b70-9375-ccca1faf2bb7"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i33ff90645a634391b6fdea36985a329f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo0YzIwYWQ4NjViNjQ0NjE4YTdjMTRkYTE3YmJhMDYwZC90YWJsZXJhbmdlOjRjMjBhZDg2NWI2NDQ2MThhN2MxNGRhMTdiYmEwNjBkXzMtMS0xLTEtOTI1MQ_ac4cebb8-2560-4aa7-b020-f973d1e844a3"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkzNjA_7304a737-757c-4469-8b69-dc585cfc80f6">The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2020, 2019 and 2018: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares forfeited and canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares outstanding, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iec25aa9d406c44b6ade6d810256599b6_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtMS0xLTEtMA_e078b1cb-fcdc-404b-b332-d1de99ed3cfd"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iec25aa9d406c44b6ade6d810256599b6_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtMy0xLTEtMA_bb6330b0-2ced-4303-8350-3051e02198e5"
      unitRef="usdPerShare">93.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtNS0xLTEtMA_9b4cf4de-d670-4611-af46-bb28fbb07a43"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtNy0xLTEtMA_b2114d03-a034-4791-8aef-62d74a1bf696"
      unitRef="usdPerShare">88.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1ec3b8abba2144858babf9798d912c8a_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtOS0xLTEtMA_0e4622d8-4e31-48f5-bb4a-81aafd8316b5"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1ec3b8abba2144858babf9798d912c8a_I20171231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzMtMTEtMS0xLTA_1e0079f7-bb65-4ca2-bdad-df811b8a78aa"
      unitRef="usdPerShare">77.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtMS0xLTEtMA_97d3d714-a61d-4b61-85ae-1fe416e2a221"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtMy0xLTEtMA_d7bca079-4180-4106-b39b-1d344fd0e5c8"
      unitRef="usdPerShare">112.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtNS0xLTEtMA_7afb61aa-bb3d-47e0-8ccc-de92605a474d"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtNy0xLTEtMA_9748f7fc-7697-41b6-bcb0-0b216cdfc5e5"
      unitRef="usdPerShare">86.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtOS0xLTEtMA_d6d09e6b-0d75-4831-964d-454c34f33786"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzQtMTEtMS0xLTA_c6d9b3ef-5254-47f6-ac95-b7b8594101fc"
      unitRef="usdPerShare">103.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtMS0xLTEtMA_82ae25c4-6150-4bf7-b59f-7a009458d0c3"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtMy0xLTEtMA_7aebe5ac-161a-4946-a29a-5086d48a983d"
      unitRef="usdPerShare">96.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtNS0xLTEtMA_e8e86571-2021-491e-9e7b-42fd8d5e010f"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtNy0xLTEtMA_9be428a1-1614-4212-ab3a-0cab0975c605"
      unitRef="usdPerShare">75.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtOS0xLTEtMA_703f9c4a-2798-48a8-a55e-229f6f3d2e1b"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzUtMTEtMS0xLTA_ada3bfbf-4dcf-4acf-a3da-ee0fe239d97c"
      unitRef="usdPerShare">74.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtMS0xLTEtMA_52376257-bc55-4981-ba44-bf65cb133880"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtMy0xLTEtMA_0c0f8ada-ae6a-4033-8e09-d343b40801af"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtNS0xLTEtMA_84be915b-4f2f-4f43-9ad8-618ea9f467d2"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtNy0xLTEtMA_4d247dfb-e0ff-4a1d-83b9-6e39224dec34"
      unitRef="usdPerShare">94.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtOS0xLTEtMA_4b59ea7c-9fbe-4ba9-bc85-d8efd453be41"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzYtMTEtMS0xLTA_03e97e06-d6a3-46d6-92f6-b6018cc9cca7"
      unitRef="usdPerShare">90.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iea41724e5f1a4bff83d7d555a0c98b95_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtMS0xLTEtMA_1bdaa2e0-165d-4bec-92c6-9128efe6fe16"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iea41724e5f1a4bff83d7d555a0c98b95_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtMy0xLTEtMA_67339409-9708-496f-97cb-866bc5daf705"
      unitRef="usdPerShare">100.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iec25aa9d406c44b6ade6d810256599b6_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtNS0xLTEtMA_557d5890-64b9-48ab-a8b1-a6c3c25a3570"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iec25aa9d406c44b6ade6d810256599b6_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtNy0xLTEtMA_a7b0ae3b-740c-41fb-9eb8-95d0c181a325"
      unitRef="usdPerShare">93.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtOS0xLTEtMA_d123ed02-4ba6-48bd-a90c-73de247b1cbb"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i2af39f5d7d6d4ba19d2ada76f5c4c79f_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90YWJsZTo5YWE4ZDk5N2QyNWI0ZGNmOGExNDBmN2EwNzUzYTQ3ZC90YWJsZXJhbmdlOjlhYThkOTk3ZDI1YjRkY2Y4YTE0MGY3YTA3NTNhNDdkXzgtMTEtMS0xLTA_9db15dc1-6323-4c03-92f4-6076d978da87"
      unitRef="usdPerShare">88.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="iea41724e5f1a4bff83d7d555a0c98b95_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzQ5MjE_3bea357b-5fa8-40e3-baf9-a92211597f8d"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzUwNzQ_407dc260-0987-45e0-8585-c28b41ce574a">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ib8496501c8cd49c0ad6e49ee10a49f9e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzUxMjM_98a13e55-765f-4732-8202-b5b612a1c84b"
      unitRef="usd">37000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i59bc1f69a9dc401b817e7f218719d9df_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzUxMjc_b5d5e3e0-4706-44e6-9b20-c4105eee85c1"
      unitRef="usd">40000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8ebc442702004263a438bbfca5d645e5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzUxMzQ_36eaefe7-ec39-4785-a4b8-45bd4ca97585"
      unitRef="usd">54000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU1NjM_32c937fa-6178-47d3-8744-9bcfbd5c75ca"
      unitRef="usd">97000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU1Njc_6771f7e9-76a0-4ec5-adc6-18a5bb7c61e4"
      unitRef="usd">56000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU1NzQ_508cf21c-6a70-48b6-9037-aee047e32412"
      unitRef="usd">61000000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU3MjE_e237b9a1-a759-44e8-9ef3-0c52e4964cd7"
      unitRef="usd">39000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU3MjU_8c8cb011-51f5-4b57-8cad-b320e689e3ca"
      unitRef="usd">27000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU3MzI_2edc2cad-4b2a-451f-983a-e6cfc14343aa"
      unitRef="usd">33000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU4NzY_4b17f3f0-d5b7-4e43-9a30-13fa325a4116"
      unitRef="usd">23000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU4ODA_07a6ce3c-348c-4a5c-bbc5-c53297fd85ae"
      unitRef="usd">13000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzU4ODc_05a633b1-7351-4c97-b0bf-4cd1a724056d"
      unitRef="usd">18000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i32d8eea035f740d88c4e34d32ac07b50_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzYwNTE_ac7aeafc-07a2-4fb1-8eb3-afba481061f0"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <dgx:MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp
      contextRef="ia85a7d30ffe046e3afb073a1149514cb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzYxNjU_11c6c7ee-2e27-4bb5-9f7e-68a51e6d6f7e"
      unitRef="number">0.95</dgx:MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i32d8eea035f740d88c4e34d32ac07b50_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzYzOTU_e25f73eb-8d99-4240-bf02-33268bbab4cb"
      unitRef="shares">9000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia85a7d30ffe046e3afb073a1149514cb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY0MTQ_5b56561a-aa57-4651-b624-3641484b020f"
      unitRef="shares">225000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i362c812a405d45709cb7b160258b8ed1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY0MTg_fb47e3b6-0304-421b-8e6b-5abf65e98266"
      unitRef="shares">269000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ifec7bf006deb455588ac5eef858ed849_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY0MjU_3edd5648-6936-487c-9e59-f818d8f335b9"
      unitRef="shares">326000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY3MDQ_0689be2a-ffa9-4600-b62e-4cab32b65ec9"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY4Mjg_19e42934-15d8-4d23-95e6-fc63a247d1f6"
      unitRef="usd">64000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY4MzI_0e30d364-fc27-4f18-8551-f42e9566b26a"
      unitRef="usd">84000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzY4Mzk_d118c49f-9544-40af-8ff7-85ad4ad047e2"
      unitRef="usd">78000000</us-gaap:DefinedContributionPlanCostRecognized>
    <dgx:SupplementalDeferredCompensationPlanSalaryDeferral
      contextRef="i43c9eaea209849029715a8175ab5a38f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzcxMDQ_7f6723dc-1ac5-4649-850a-3d032ed911d5"
      unitRef="number">0.50</dgx:SupplementalDeferredCompensationPlanSalaryDeferral>
    <dgx:SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral
      contextRef="i43c9eaea209849029715a8175ab5a38f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzcyMTc_50904546-08e5-4448-bfaf-e4278928ffe9"
      unitRef="number">0.95</dgx:SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="iefd7e996ee1d4652be0e3370eb259fdb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzczMDg_fcde0896-17be-4433-87a0-20386a08a7e2"
      unitRef="number">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="iba88a90ce070465d896214b27be236f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzc3NDk_305fdcd2-0072-45ec-ad4d-362d7d861c6a"
      unitRef="usd">67000000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="i85260b1da0934bb69e54b6bb7d6ca068_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzc3NTY_423d0f86-9350-40be-b6ac-38886aa47983"
      unitRef="usd">59000000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP
      contextRef="iba88a90ce070465d896214b27be236f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzc5MzI_9b9f06ff-2e31-4c62-8331-e731740d9754"
      unitRef="usd">67000000</dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP>
    <dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP
      contextRef="i85260b1da0934bb69e54b6bb7d6ca068_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzc5Mzk_93b96757-1238-4f29-8386-706526b5bc35"
      unitRef="usd">59000000</dgx:FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i1c5e3bd1735944849b8b66228d6f266b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzgzMzI_eb1013d9-0e29-4f21-aee2-670c401d30ef"
      unitRef="number">0.25</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer
      contextRef="i6f5e7b1b65014971a56d11421ae554a8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzgzNTU_472fb5a1-c7bf-4a50-98c5-d367c076ba84"
      unitRef="usd">5000</us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer>
    <us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
      contextRef="i1c5e3bd1735944849b8b66228d6f266b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzg2OTc_47954f92-e947-43cc-8719-30216dda9f38">P4Y</us-gaap:DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1>
    <dgx:SdcpIiGradedVestingPercentage
      contextRef="i1c5e3bd1735944849b8b66228d6f266b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzg3MDM_1198deec-fa13-49c5-bd10-ab8e08e6998a"
      unitRef="number">0.25</dgx:SdcpIiGradedVestingPercentage>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="i6b09f22a0749457e8f3d51b1f9549c3c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzg5MjM_6676d330-f9e4-45c7-a00d-995c74087678"
      unitRef="usd">59000000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability
      contextRef="ib706a5ff02034443bde21ac1c37511c0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1Xzg5MzA_4f161eef-4dc7-49fb-84da-9d0debb39d29"
      unitRef="usd">51000000</us-gaap:DeferredCompensationArrangementWithIndividualRecordedLiability>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i6b09f22a0749457e8f3d51b1f9549c3c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkxODE_358e9556-ea32-4278-8e37-060939255c43"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ib706a5ff02034443bde21ac1c37511c0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMjkvZnJhZzozM2VjMzAyYmZhNjc0MTFjODVhMTYyYzc3MTc2MmViNS90ZXh0cmVnaW9uOjMzZWMzMDJiZmE2NzQxMWM4NWExNjJjNzcxNzYyZWI1XzkxODg_bbd55639-4e9c-4cf6-a56f-524b04b58566"
      unitRef="usd">43000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzEwMzE4_db36039d-7bca-4bb0-9956-df1759eafc19">COMMITMENTS AND CONTINGENCIES &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit and Contractual Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company can issue letters of credit under its Secured Receivables Credit Facility and Senior Unsecured Revolving Credit Facility (see Note 13).  In support of its risk management program, to ensure the Company&#x2019;s performance or payment to third parties, $70 million in letters of credit under the Secured Receivables Credit Facility were outstanding as of December&#160;31, 2020.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#x2019; compensation loss payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company has certain noncancelable commitments, primarily under take-or-pay arrangements, to purchase products or services from various suppliers, mainly for consulting and other service agreements, and standing orders to purchase reagents and other laboratory supplies.  As of December&#160;31, 2020, the approximate total future purchase commitments are $334 million, of which $106 million are expected to be incurred in 2021, $103 million are expected to be incurred in 2022 through 2023 and the balance thereafter. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Billing and Collection Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In September 2016, the Company entered into a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzMzUzMTg_a020698b-1549-440e-9434-fef192bf4df1"&gt;ten&lt;/span&gt;-year agreement with a third party to outsource its billing and  related operations for the majority of the Company&#x2019;s revenues.  Services under the agreement commenced during the fourth quarter of 2016.  The agreement includes an annual fee, which is subject to adjustment based on certain changes in the Company's requisition volume and the achievement of various performance metrics.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Lease Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including real estate leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  While over the course of many years, the title to certain properties and interest in the subject leases have been transferred to third parties and the subject leases have been amended several times by such third parties, the lessors have not formally released the subsidiary predecessor companies from their original obligations under the leases and therefore remain contingently liable in the event of default.  The remaining terms of the lease obligations and the Company's corresponding indemnifications range up to 27 years.  The lease payments under certain leases are subject to market value adjustments and contingent rental payments and therefore, the total contingent obligations under the leases cannot be precisely determined but are likely to total several hundred million dollars.  A claim against the Company would be made only upon the current lessee's default and, in certain cases, after a series of claims and corresponding defaults by third parties that precede the Company in the order of liability.  The Company also has certain indemnification rights from other parties to recover losses in the event of default on the lease obligations.  The Company believes that the likelihood of its performance under these contingent obligations is remote and no liability has been recorded for any potential payments under the contingent lease obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for the District of New Jersey against the Company and other defendants with respect to the Company&#x2019;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re: Quest Diagnostics ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and plaintiffs filed a consolidated amended complaint.  The Company plans to vigorously defend this matter and has filed a motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;AMCA Data Security Incident&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#x201c;AMCA&#x201d;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018 and March 30, 2019 (the &#x201c;AMCA Data Security Incident&#x201d;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#x2019;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#x2019;s nor the Company&#x2019;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#x2019; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of December&#160;31, 2020, the Company does not believe that material losses related to legal matters are probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for legal matters totaled $1 million as of both December&#160;31, 2020 and December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reserves for General and Professional Liability Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $138 million and $132 million as of December&#160;31, 2020 and December&#160;31, 2019, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i739e5869c8ba4c87a0e6a0a88a17f0e2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzM0OQ_dc9033d6-b26f-49c8-9962-33c5ecc38879"
      unitRef="usd">70000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzkyNg_24a14f96-f194-46f4-b351-f63d1fe9ea50"
      unitRef="usd">334000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzkzOQ_a1e5a552-3f51-424c-9f67-dd7ac57468e5"
      unitRef="usd">106000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary>
    <dgx:UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzk3Nw_652de087-0cd2-4084-8ce3-87b7c4955a91"
      unitRef="usd">103000000</dgx:UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears>
    <dgx:RemainingTermsofContingentLeaseObligationsMaximum
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzNDc2ODQ_82cfc234-f409-49ea-897b-cbb886eee09d">P27Y</dgx:RemainingTermsofContingentLeaseObligationsMaximum>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzNTg0MjQ_583b82a4-558e-4279-850f-eb2e4edc85c9"
      unitRef="claim">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzNTg0MzI_5f0363be-f5fb-43c2-a4e9-d12cce97592b"
      unitRef="claim">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LitigationReserve
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzkwMzQ_633d6e6d-7c98-41b9-9074-1e04b3858bbb"
      unitRef="usd">1000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzkwMzQ_d5a86d21-6d59-49b6-a4b4-578d9590d7ef"
      unitRef="usd">1000000</us-gaap:LitigationReserve>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i3b2db1a35d1945348b1a626840f7580c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzEwMTM3_6322cc9f-b38f-4616-b4ce-6aebbca7a420"
      unitRef="usd">138000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i11ae4adedea143f39461ad0909150885_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzEwMTQ0_fc01c5f9-fc81-4cf5-b016-c790a94cd706"
      unitRef="usd">132000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzI0NDQ_f8fbe877-32e5-44bb-b543-fd77c1081af5">BUSINESS SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs, and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of December&#160;31, 2020, substantially all of the Company&#x2019;s services were provided within the United States, and substantially all of the Company&#x2019;s assets were located within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table is a summary of segment information for the years ended December&#160;31, 2020, 2019 and 2018. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from continuing operations before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2020, 2019 and 2018 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i29c671e617c045bcb06b53c554e033e0_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzgwMQ_2a80342c-6593-4f01-9eb7-b27e9cea3064"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i9de3b9dd0a624ae68544d4880991cf82_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzgwMQ_789f5cd0-709b-4831-a748-eb10be631f11"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="if585a3710daf402a97611004eea949c1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzgwMQ_84f3135a-23c8-4c55-8f55-1946a3e9752e"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90ZXh0cmVnaW9uOmJjYWE3MjNlODc5MDQ1Zjk4MzZmOGIxYTJlMTUyNzIzXzI0Mzc_45bcb542-aea8-463f-bfc5-da042464b1c9">The following table is a summary of segment information for the years ended December&#160;31, 2020, 2019 and 2018. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating expenses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from continuing operations before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(247)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2020, 2019 and 2018 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzItMS0xLTEtMA_b578c28c-3d40-49ff-beca-ff8d4be9a4f7"
      unitRef="usd">9139000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzItMy0xLTEtMA_8e6fdeaf-7748-4f54-a4c5-0856cc94ec46"
      unitRef="usd">7405000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzItNS0xLTEtMA_c14fa188-38d4-4e75-b64d-efd30b12c9d1"
      unitRef="usd">7204000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzMtMS0xLTEtMA_03a7940c-d8c9-4e98-b1da-d9b5877a7110"
      unitRef="usd">298000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzMtMy0xLTEtMA_b623d87e-a582-40e5-805a-2e803f057fe0"
      unitRef="usd">321000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzMtNS0xLTEtMA_3304ca38-157b-4e30-825a-17cb19655610"
      unitRef="usd">327000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzQtMS0xLTEtMA_43fff1b5-751e-4e2e-b3f3-761e6cd48805"
      unitRef="usd">9437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzQtMy0xLTEtMA_6a823d93-0c6a-45a5-aef4-28e49519ce9d"
      unitRef="usd">7726000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzQtNS0xLTEtMA_e036227e-1238-4c9c-a8f6-626a5e5a0a3a"
      unitRef="usd">7531000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzctMS0xLTEtMA_8cae6930-c965-4e24-a30b-816b3dc2509d"
      unitRef="usd">2201000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzctMy0xLTEtMA_2509aa6a-b224-45b2-b1a6-35932fcf24bc"
      unitRef="usd">1298000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzctNS0xLTEtMA_a1cefed7-cc3e-44e7-9e29-13ddcb7065c5"
      unitRef="usd">1235000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzgtMS0xLTEtMA_bb493708-6beb-4078-9387-efd25538ece9"
      unitRef="usd">39000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzgtMy0xLTEtMA_3b068d4c-5193-4552-b724-9ba382e326b2"
      unitRef="usd">42000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzgtNS0xLTEtMA_86830cd1-a4d4-45b2-aacd-73baef429be3"
      unitRef="usd">47000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if0b19e4e8df441dd9a3a047864af82a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzktMS0xLTEtMA_e76eb7cf-8290-4043-8c89-ff09c6bb1fb6"
      unitRef="usd">-269000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bfcea6d4a6f42a28ae201c9acd9e681_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzktMy0xLTEtMA_ebda9ad5-274b-4ac8-bbf0-293275d5949e"
      unitRef="usd">-109000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i728b5f186c284cccb74701cceaa73177_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzktNS0xLTEtMA_5d296a61-33db-45c2-af91-0325b5e73ff7"
      unitRef="usd">-181000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEwLTEtMS0xLTA_4fc84431-825c-486c-9978-d137ad65783e"
      unitRef="usd">1971000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEwLTMtMS0xLTA_51ed480b-9d80-465f-b1ff-9e29760d0a93"
      unitRef="usd">1231000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEwLTUtMS0xLTA_0b288e83-7c36-4748-8f91-3f61c7b403cf"
      unitRef="usd">1101000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzExLTEtMS0xLTA_a95ac519-ff60-4acc-940f-0ce5cc46bb3f"
      unitRef="usd">-87000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzExLTMtMS0xLTA_870441c3-4a23-4c1e-8f0d-99c7ba0527a2"
      unitRef="usd">-155000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzExLTUtMS0xLTA_f9e1a4fe-8b63-4f22-bccd-03a22033de93"
      unitRef="usd">-175000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEyLTEtMS0xLTA_5057422d-d1ea-4000-a46b-131585f05df6"
      unitRef="usd">1884000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEyLTMtMS0xLTA_a855f93a-9b8c-4b11-a9d4-2b52a1f3dbdc"
      unitRef="usd">1076000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEyLTUtMS0xLTA_127b344e-5b39-477e-8733-eb70d5104738"
      unitRef="usd">926000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEzLTEtMS0xLTA_e6421230-801d-4f27-bf9d-c1603a704e2d"
      unitRef="usd">460000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEzLTMtMS0xLTA_bc6a7fef-8403-4f56-b0a5-4bd023092122"
      unitRef="usd">247000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzEzLTUtMS0xLTA_27a81fcf-faa3-4e47-9908-3b5952187867"
      unitRef="usd">182000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE0LTEtMS0xLTA_ef964fdc-6824-4705-90aa-256aaad90cbe"
      unitRef="usd">75000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE0LTMtMS0xLTA_2175e198-2f0e-4a25-b5f6-92b6d3bf34ea"
      unitRef="usd">57000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE0LTUtMS0xLTA_666a9882-f151-47c8-adec-b6a10871bb1e"
      unitRef="usd">44000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE1LTEtMS0xLTA_302cc3a4-a2b6-43ac-acbd-9ece36acb7ca"
      unitRef="usd">1499000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE1LTMtMS0xLTA_fdca214b-4015-410a-bdd7-e3a43e9d19d4"
      unitRef="usd">886000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE1LTUtMS0xLTA_c5893705-9122-4525-ac55-1ed04bcc123b"
      unitRef="usd">788000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE2LTEtMS0xLTA_858a69d1-cc53-4643-b018-f89a0d838053"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE2LTMtMS0xLTA_e8731773-ff6f-4cea-839c-1e935aa399df"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE2LTUtMS0xLTA_4785f10c-8d56-4c98-bbc7-f500dcc801b8"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE3LTEtMS0xLTA_998d71d0-1a86-4e93-98a3-339542e11575"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE3LTMtMS0xLTA_314a0b24-be33-4c2f-a77f-2cc23966da3c"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE3LTUtMS0xLTA_daf06ade-71dd-4349-a035-dbafad88baa6"
      unitRef="usd">788000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE4LTEtMS0xLTA_2d816f2e-2f37-40d0-b46d-46c8f89ab645"
      unitRef="usd">68000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE4LTMtMS0xLTA_0fc05eb5-4f17-400a-9bfa-ae4fea75cbcc"
      unitRef="usd">48000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE4LTUtMS0xLTA_de4382f3-5f9c-4c5e-9629-df46920bfcc6"
      unitRef="usd">52000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE5LTEtMS0xLTA_2188af7f-9e66-4bac-90d2-f5f3f1f06c6a"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE5LTMtMS0xLTA_7800c693-cbd0-4c36-abaf-7543e0adfc65"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTpiNjdmYTgzNjc4NTA0YWQ3YTA4MmEwNjA3OTZhYjYxOS90YWJsZXJhbmdlOmI2N2ZhODM2Nzg1MDRhZDdhMDgyYTA2MDc5NmFiNjE5XzE5LTUtMS0xLTA_9903cd66-93ba-4e10-a29e-1a17496ae0d0"
      unitRef="usd">736000000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzItMS0xLTEtMA_f1e96ffe-74bb-4fde-a81e-62eb9236e425"
      unitRef="usd">249000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzItMy0xLTEtMA_a0d7d2f2-f6b7-4180-8013-c4a826e6a682"
      unitRef="usd">226000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzItNS0xLTEtMA_c5c6f915-18d3-4cb0-9de3-6400283a8db0"
      unitRef="usd">213000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzMtMS0xLTEtMA_708de140-87e2-41b7-a30e-1850e67f83a5"
      unitRef="usd">8000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzMtMy0xLTEtMA_b97a6b5f-c8f6-4da5-a82a-7777349ba68f"
      unitRef="usd">6000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzMtNS0xLTEtMA_6a52dc4d-16a3-4d23-8cc1-4c42785c2757"
      unitRef="usd">6000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if0b19e4e8df441dd9a3a047864af82a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzQtMS0xLTEtMA_259132c9-da68-48dc-a3aa-ba43d2a4fbc2"
      unitRef="usd">104000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5bfcea6d4a6f42a28ae201c9acd9e681_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzQtMy0xLTEtMA_40b2ae16-f75b-4e8d-bb33-5fe32bbc40c1"
      unitRef="usd">97000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i728b5f186c284cccb74701cceaa73177_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzQtNS0xLTEtMA_26f622f5-1a07-4dbb-8908-d6322a5f6341"
      unitRef="usd">90000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzgtMS0xLTEtMA_a097d522-1a09-4a75-a04a-2922764cbefa"
      unitRef="usd">361000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzgtMy0xLTEtMA_863e21d5-bb36-4b79-9e25-7cee0abd5502"
      unitRef="usd">329000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo5NDI2MTM5OWE2N2M0MGUxOTdkYTBlY2M1YjJhZThkYS90YWJsZXJhbmdlOjk0MjYxMzk5YTY3YzQwZTE5N2RhMGVjYzViMmFlOGRhXzgtNS0xLTEtMA_4dae0a30-7ee6-40d6-94c5-88f86b2a6f40"
      unitRef="usd">309000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ida480c6a5c3341af9733d88aa9f20bf1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzItMS0xLTEtMA_315bd358-1a3e-433f-8d94-bde6e6115254"
      unitRef="usd">394000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ice4829526306498db68da2230ad3f3ff_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzItMy0xLTEtMA_4f5863d7-2092-4512-a8d8-3491fcb618a1"
      unitRef="usd">373000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2bf852f7c44947f3941ee2cba1cd4c26_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzItNS0xLTEtMA_f4944f8b-0111-4a65-ba87-57b5b59b4ec6"
      unitRef="usd">330000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifb0b73d8df2a42cf84aa380e71d78557_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzMtMS0xLTEtMA_8817ef94-bf69-4efb-8840-60327623cb3c"
      unitRef="usd">15000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5dc750b1896142bd9c2a8ba54a38677a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzMtMy0xLTEtMA_3a33b8a1-1bf2-4f1c-b2ab-761b5d544ba8"
      unitRef="usd">20000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0cbd91ab42ed4ac9be210863e2222e2d_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzMtNS0xLTEtMA_7dd9474a-3a6b-4770-9628-31f2703e31c0"
      unitRef="usd">16000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if0b19e4e8df441dd9a3a047864af82a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzQtMS0xLTEtMA_f628fba6-9c1a-4540-bb9b-9481a85c3602"
      unitRef="usd">9000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5bfcea6d4a6f42a28ae201c9acd9e681_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzQtMy0xLTEtMA_e75d31c8-1c98-4989-adf3-0bad7a7d9a9a"
      unitRef="usd">7000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i728b5f186c284cccb74701cceaa73177_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzQtNS0xLTEtMA_931cbcf5-2886-4943-af00-8db2f70161b9"
      unitRef="usd">37000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzgtMS0xLTEtMA_9473d4f4-69ce-427f-b1b9-77d8e56c3b87"
      unitRef="usd">418000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzgtMy0xLTEtMA_203bff9d-4f4c-441d-9922-063bd46ea40c"
      unitRef="usd">400000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTo1YWMwMzA0YzQzZWY0ZjYyYTlhZGEyNGE2YjQ1NTkxYy90YWJsZXJhbmdlOjVhYzAzMDRjNDNlZjRmNjJhOWFkYTI0YTZiNDU1OTFjXzgtNS0xLTEtMA_bf01df69-f484-4696-8dc4-90e13d576a29"
      unitRef="usd">383000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9491ec5cfff349bebd4c36dea5408c17_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzItMS0xLTEtMA_ac1b203d-a6ba-4aa3-b52a-96bc55e3a7f5"
      unitRef="usd">3836000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i738f18abd516453e9c1b7fdf805a03d8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzItMy0xLTEtMA_a73ce273-bee6-4941-b0f0-a9e412c9e804"
      unitRef="usd">4206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18079f917bab424fa56b9c2ca26f0aef_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzItNS0xLTEtMA_1855e68c-fbde-455c-ad73-16dd007c0148"
      unitRef="usd">4217000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c9b10d54f56453ab58e231cabe11e4e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtMS0xLTEtMTMzNTA_f7cea9f5-06b5-42b0-9f37-436fc2b849cb"
      unitRef="usd">2723000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i532b66c76cad4095bab3b1e800197403_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtMy0xLTEtMTMzNTA_d319b68a-8db9-4e8f-b678-1f165a021235"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f0ce923b9cb4071b89bf2e5cf956d70_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtNS0xLTEtMTMzNTA_95dcd562-1877-478d-b2b6-8df27264af4d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5a1e4a3f0744196ae6e420b749b6626_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtMS0xLTEtMA_615dd073-3f1e-464f-91b5-8131fce42e99"
      unitRef="usd">2098000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib82b870198214f2fa9c11cf73b7c2285_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtMy0xLTEtMA_f276d5f1-4f13-496d-bc91-419ec4617337"
      unitRef="usd">2620000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16009b81f04442439e6d1273e8b3e3d5_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzMtNS0xLTEtMA_8ee34fb3-9af0-475b-9c2c-ef8b903b2667"
      unitRef="usd">2409000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8de7c8519348419985b65110c0808877_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzQtMS0xLTEtMA_6f1bbbee-fc02-4c12-b128-cf4d9c0bd9dc"
      unitRef="usd">482000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i375a264a2ebe483fbbbf773457d0b2fe_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzQtMy0xLTEtMA_d674e5b3-2f21-462d-97bc-23ab05c96433"
      unitRef="usd">579000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c6fa4c884c0473a8de98fccdb136f8e_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzQtNS0xLTEtMA_ac9c90ca-d3ab-4daf-8ef3-7c0ce45bf22e"
      unitRef="usd">578000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c2eef5ed33d472db8175faea063b824_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzUtMS0xLTEtMA_21a88fb2-b292-4e98-9a7e-db612d056ae0"
      unitRef="usd">298000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i447b9c6561a048c985f4ab898c1121e8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzUtMy0xLTEtMA_1f083400-3f85-4943-b1a0-81485dd8f5c1"
      unitRef="usd">321000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a7391181b8741db9a1686e9c9b083dc_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzUtNS0xLTEtMA_96613f99-a47d-4234-afac-c4b8c5cd277b"
      unitRef="usd">327000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzYtMS0xLTEtMA_b42c563e-62df-4a66-a333-8842354eda90"
      unitRef="usd">9437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzYtMy0xLTEtMA_a65759c4-aa2d-4867-a995-cf2e23565523"
      unitRef="usd">7726000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzgvZnJhZzpiY2FhNzIzZTg3OTA0NWY5ODM2ZjhiMWEyZTE1MjcyMy90YWJsZTozZThkODE0ZDVjOWE0ODJlODU0NTM5YzQ4Y2Q1YmMxNi90YWJsZXJhbmdlOjNlOGQ4MTRkNWM5YTQ4MmU4NTQ1MzljNDhjZDViYzE2XzYtNS0xLTEtMA_7fa598a6-ad40-48fb-978c-e18785c67b8a"
      unitRef="usd">7531000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE5MDM_9a453c36-9394-4560-9f12-0a15ca5219fb">RELATED PARTIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's equity method investees primarily consist of its clinical trials central laboratory services joint venture and its diagnostic information services joint ventures, which are accounted for under the equity method of accounting.  During the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized net revenues of $34 million, $35 million, and $36 million, respectively, associated with diagnostic information services provided to its equity method investees.  As of December&#160;31, 2020 and 2019, there was $3 million and $4 million, respectively, of accounts receivable from equity method investees related to such services.  During the years ended December&#160;31, 2020 and 2019, the Company recognized net revenues of $3 million and $8 million, respectively, associated with diagnostic information services provided to a noncontrolling interest partner in a joint venture.  As of December&#160;31, 2019, there was $4 million of receivables from the noncontrolling interest partner included in accounts receivable and other assets in the consolidated balance sheet related to such services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized income of $16 million, $15 million and $15 million, respectively, associated with the performance of certain corporate services, including transition services, for its equity method investees, classified within selling, general and administrative expenses.  As of December&#160;31, 2020 and 2019, there was $3 million and $1 million, respectively, of other receivables from equity method investees included in prepaid expenses and other current assets in the consolidated balance sheet related to these service agreements and other transition related items.  In addition, accounts payable and accrued expenses in the consolidated balance sheet as of December&#160;31, 2020 and 2019 included $1 million and $2 million, respectively, due to equity method investees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the years ended December&#160;31, 2020, 2019 and 2018, the Company received dividends from its equity method investees of $54 million, $48 million, and $74 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the year ended December 31, 2018, the Company contributed $10 million to an equity method investee to fund its share of an acquisition made by the equity method investee.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i944f676d67324e0ba91482f72d96b22c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzM0NQ_a01e5b9b-07ad-4197-8e2c-107644a582ff"
      unitRef="usd">34000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i0f3f0dbfc5d747b19835bfdf96c93b85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzM0OQ_fdef9506-0eb7-400c-954e-18005e8ae4f2"
      unitRef="usd">35000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ic42f8e90bb9742fda4370a7c80d21289_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzM1Nw_25c72376-17f1-4985-94cc-670fa098ce60"
      unitRef="usd">36000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="i6c4439a4821541da95311cd6e7ab8e84_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzQ5Mg_8bed2bfd-a375-42ad-bbd8-2bd5d13e629a"
      unitRef="usd">3000000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="i0114534d1d8d4e39aa9cc6b5a35609ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzQ5OQ_453b2673-9514-4952-a9f5-9da89edfa1a3"
      unitRef="usd">4000000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ibec3fcd21ae6474f999b20d69d69bd44_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzY2MA_4edc418f-987d-4e40-981d-d2fa66a2e80a"
      unitRef="usd">3000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i6b9920e1039a4bbc96cddc20848124d0_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzIxOTkwMjMyNTc0NzI_accc62e1-0d39-4ecd-b437-865480980f58"
      unitRef="usd">8000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="i35915c99296f48f3bf58b06369abc86d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzIxOTkwMjMyNTc1MDY_949945bb-cb4f-413a-9f03-4067006af858"
      unitRef="usd">4000000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="iceeca8e729a74e688a40d2720017ccf7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEwMTE_7d6846be-bf94-4939-a39d-5ac1ba321020"
      unitRef="usd">16000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="ic4cf653852bc4efabf147c2ab56dcdcf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEwMTU_d1e25025-1dc2-41f1-aada-7ec6b0753c9a"
      unitRef="usd">15000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="ic9c465a22a3f4e7e8356afdae38c480f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEwMjI_bdb81520-7fa5-43ec-b930-844db822d4f0"
      unitRef="usd">15000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <dgx:OtherAccountsReceivableRelatedParties
      contextRef="i720a47095d174e48af4858648c214a5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEyNTk_7ce6867f-e149-4ce4-8fbd-8832d5934d2c"
      unitRef="usd">3000000</dgx:OtherAccountsReceivableRelatedParties>
    <dgx:OtherAccountsReceivableRelatedParties
      contextRef="i448e43197d9648fdae5be5f882e40fe0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzEyNjY_4a75737d-082e-40fa-bf8c-313a3d836d17"
      unitRef="usd">1000000</dgx:OtherAccountsReceivableRelatedParties>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i6c4439a4821541da95311cd6e7ab8e84_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE1Mzc_ca7c79e9-00d1-4e66-a578-19562f9a097a"
      unitRef="usd">1000000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i0114534d1d8d4e39aa9cc6b5a35609ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE1NDQ_a8afd42f-943f-4800-b648-97137fbe2205"
      unitRef="usd">2000000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="i944f676d67324e0ba91482f72d96b22c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE3MDE_89f6abcb-4a47-48bb-b7bc-d240b9a13135"
      unitRef="usd">54000000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="i0f3f0dbfc5d747b19835bfdf96c93b85_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE3MDU_a0767c16-a919-4891-9c4a-64f0e41a314f"
      unitRef="usd">48000000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="ic42f8e90bb9742fda4370a7c80d21289_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE3MTM_656a86d4-7d27-4153-b1d5-84a0787c7167"
      unitRef="usd">74000000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="iab80bc8d6c034781841021bec4469b4f_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDQvZnJhZzo4OTg1NGQxZWI5ZDg0ZGVhYjdhNGZmMmY1YTEyNTEyYi90ZXh0cmVnaW9uOjg5ODU0ZDFlYjlkODRkZWFiN2E0ZmYyZjVhMTI1MTJiXzE3OTg_240726d5-4164-464c-9a3a-4cd36e4658c4"
      unitRef="usd">10000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDcvZnJhZzo4ZmI3YzZkMWI5ODQ0ZTk4OWMzOTNjMjc4YzdmNzA5OC90ZXh0cmVnaW9uOjhmYjdjNmQxYjk4NDRlOTg5YzM5M2MyNzhjN2Y3MDk4XzQ1Ng_c7b577b4-4d39-4060-b98a-87837881557e">DISCONTINUED OPERATIONS&#160;&#160;&#160;&#160;Discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.  In addition, net cash provided by operating activities in the consolidated statement of cash flows for the year ended December 31, 2019 included a $28 million refund from the taxing authorities related to discontinued operations.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits
      contextRef="i3e9708bf7a3f4fe9bf78754bc3d52636_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDcvZnJhZzo4ZmI3YzZkMWI5ODQ0ZTk4OWMzOTNjMjc4YzdmNzA5OC90ZXh0cmVnaW9uOjhmYjdjNmQxYjk4NDRlOTg5YzM5M2MyNzhjN2Y3MDk4XzE0Ng_6ba2dea4-dd38-43ff-bdeb-45721b031d75"
      unitRef="usd">20000000</dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="i3e9708bf7a3f4fe9bf78754bc3d52636_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNDcvZnJhZzo4ZmI3YzZkMWI5ODQ0ZTk4OWMzOTNjMjc4YzdmNzA5OC90ZXh0cmVnaW9uOjhmYjdjNmQxYjk4NDRlOTg5YzM5M2MyNzhjN2Y3MDk4XzM4Mw_901dbb9d-5285-47c5-8218-98f67ea1b9f1"
      unitRef="usd">28000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4Xzc1MDU_7112d759-9103-4444-89dd-ea7c2c03128f">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;2020 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;First&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Second&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Third&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics' common stockholders - basic:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;2019 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;First&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Second&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Third&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(h)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(j)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics' common stockholders - basic:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  As a result, NID was classified as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved (see Note 21 to the audited consolidated financial statements).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included pre-tax amortization expense of $28&#160;million ($25&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $16&#160;million ($7&#160;million in cost of services and $9&#160;million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; and pre-tax charges of $9&#160;million ($1&#160;million in cost of services, $3&#160;million in selling, general and administrative expenses and $5&#160;million in other operating expense (income), net), associated with certain costs incurred as a result of the COVID-19 pandemic and resulting impact on the economy including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and to transition certain employees to a remote work environment, and certain asset impairment charges; partially offset by excess tax benefits associated with stock-based compensation arrangements of $8 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Included pre-tax amortization expense of $28&#160;million ($25&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $9&#160;million ($3&#160;million in cost of services and $6&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $26&#160;million (charges of $34&#160;million in cost of services and $5&#160;million in selling, general and administrative expenses, offset by a $62&#160;million gain in other operating expense (income), net, and a $3&#160;million gain in equity in earnings of equity method investees, net of taxes), representing certain items resulting from the COVID-19 pandemic, including expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19, incremental costs incurred primarily to protect the health and safety of the Company's employees and customers, and certain impairment charges, which were more than offset by $65&#160;million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"); and excess tax benefits associated with stock-based compensation arrangements of $4 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included net pre-tax charges of $69&#160;million (charges of $3&#160;million in cost of services, $65&#160;million in other operating expense (income), net, and $1&#160;million in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and the reversal of $65&#160;million of income previously recognized during the second quarter of 2020 attributable to the receipt of funds from the government that were appropriated to healthcare providers under the CARES Act; pre-tax amortization expense of $30&#160;million ($27&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $18&#160;million ($11&#160;million in cost of services and $7&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $70&#160;million recognized in other income (expense), net upon the acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC as a result of the remeasurement of the Company's previously held equity interest to fair value; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.    &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Included pre-tax amortization expense of $28&#160;million ($26 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $20 million (charges of $19 million in cost of services, $2 million in selling, general and administrative expenses and $1 million in other operating expense (income), net, partially offset by a $2 million gain in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19 and incremental costs incurred primarily to protect the health and safety of the Company's employees and customers; and pre-tax charges of $15 million ($6 million in cost of services and $9 million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $2&#160;million ($2&#160;million of charges in selling, general and administrative expenses and a $10&#160;million loss in other income (expense), net, offset by a $14&#160;million gain in equity in earnings of equity method investees, net of taxes) related to costs associated with Quest for Health Equity (the Company's recently announced initiative with the Quest &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diagnostics Foundation to reduce health disparities in underserved communities) and a loss on retirement of debt, which were more than offset by a gain recognized by an equity method investee to adjust certain of its investments to fair value; and excess tax benefits associated with stock-based compensation arrangements of $8 million recorded in income tax expense.  In the fourth quarter of 2020, the Company returned the funds received from the government that were appropriated to healthcare providers under the CARES Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(f)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt"&gt;The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the four quarters of 2020 did not equal the totals for the year ended December 31, 2020 due to quarterly fluctuations in the Company's earnings and weighted average common shares outstanding throughout the period primarily due to the impact of the COVID-19 pandemic on the Company's results and the temporary suspension of repurchases under the Company's share repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(g)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included pre-tax amortization expense of $29 million ($24 million in amortization of intangible assets and $5 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $22 million ($11&#160;million in cost of services and $11&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $8 million ($1&#160;million charge in selling, general and administrative expenses offset by a $9&#160;million gain in other operating expense (income), net), due to non-cash asset impairment charges, which were more than offset by a gain associated with proceeds from an insurance claim for hurricane related losses; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(h)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included pre-tax amortization expense of $30 million ($25 million in amortization of intangible assets and $5 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $26 million ($11&#160;million in cost of services and $15&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $6 million in other operating expense (income), net, primarily due to a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $5 million recorded in income tax expense.  Income from discontinued operations, net of taxes includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt"&gt;Included pre-tax amortization expense of $25 million ($23 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $16 million ($7&#160;million in cost of services and $9&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $3 million ($4&#160;million charge in selling, general and administrative expenses, offset by a $7&#160;million gain in other operating expense (income), net), consisting of costs incurred related to the AMCA Data Security Incident, which were more than offset by a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(j)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt"&gt;Includes a pre-tax gain of $72 million ($1&#160;million charge in selling, general and administrative expenses, offset by a $73&#160;million gain in other operating expense (income), net), primarily associated with the sale and leaseback of a property; pre-tax amortization expense of $27 million ($24 million in amortization of intangible assets and $3 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $14 million ($6&#160;million in cost of services and $8&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; and excess tax benefits associated with stock-based compensation arrangements of $2 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4Xzc1MTI_cc1c425d-80e1-4bac-a0a0-9ca7389fd746">&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;2020 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;First&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Second&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Third&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics' common stockholders - basic:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.899%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;2019 (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;First&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Second&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Third&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fourth&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Quarter&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(h)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(j)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations, net of taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics' common stockholders - basic:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  As a result, NID was classified as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved (see Note 21 to the audited consolidated financial statements).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included pre-tax amortization expense of $28&#160;million ($25&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $16&#160;million ($7&#160;million in cost of services and $9&#160;million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; and pre-tax charges of $9&#160;million ($1&#160;million in cost of services, $3&#160;million in selling, general and administrative expenses and $5&#160;million in other operating expense (income), net), associated with certain costs incurred as a result of the COVID-19 pandemic and resulting impact on the economy including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and to transition certain employees to a remote work environment, and certain asset impairment charges; partially offset by excess tax benefits associated with stock-based compensation arrangements of $8 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Included pre-tax amortization expense of $28&#160;million ($25&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $9&#160;million ($3&#160;million in cost of services and $6&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $26&#160;million (charges of $34&#160;million in cost of services and $5&#160;million in selling, general and administrative expenses, offset by a $62&#160;million gain in other operating expense (income), net, and a $3&#160;million gain in equity in earnings of equity method investees, net of taxes), representing certain items resulting from the COVID-19 pandemic, including expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19, incremental costs incurred primarily to protect the health and safety of the Company's employees and customers, and certain impairment charges, which were more than offset by $65&#160;million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"); and excess tax benefits associated with stock-based compensation arrangements of $4 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included net pre-tax charges of $69&#160;million (charges of $3&#160;million in cost of services, $65&#160;million in other operating expense (income), net, and $1&#160;million in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and the reversal of $65&#160;million of income previously recognized during the second quarter of 2020 attributable to the receipt of funds from the government that were appropriated to healthcare providers under the CARES Act; pre-tax amortization expense of $30&#160;million ($27&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $18&#160;million ($11&#160;million in cost of services and $7&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $70&#160;million recognized in other income (expense), net upon the acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC as a result of the remeasurement of the Company's previously held equity interest to fair value; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.    &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Included pre-tax amortization expense of $28&#160;million ($26 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $20 million (charges of $19 million in cost of services, $2 million in selling, general and administrative expenses and $1 million in other operating expense (income), net, partially offset by a $2 million gain in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19 and incremental costs incurred primarily to protect the health and safety of the Company's employees and customers; and pre-tax charges of $15 million ($6 million in cost of services and $9 million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $2&#160;million ($2&#160;million of charges in selling, general and administrative expenses and a $10&#160;million loss in other income (expense), net, offset by a $14&#160;million gain in equity in earnings of equity method investees, net of taxes) related to costs associated with Quest for Health Equity (the Company's recently announced initiative with the Quest &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diagnostics Foundation to reduce health disparities in underserved communities) and a loss on retirement of debt, which were more than offset by a gain recognized by an equity method investee to adjust certain of its investments to fair value; and excess tax benefits associated with stock-based compensation arrangements of $8 million recorded in income tax expense.  In the fourth quarter of 2020, the Company returned the funds received from the government that were appropriated to healthcare providers under the CARES Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(f)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt"&gt;The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the four quarters of 2020 did not equal the totals for the year ended December 31, 2020 due to quarterly fluctuations in the Company's earnings and weighted average common shares outstanding throughout the period primarily due to the impact of the COVID-19 pandemic on the Company's results and the temporary suspension of repurchases under the Company's share repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(g)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included pre-tax amortization expense of $29 million ($24 million in amortization of intangible assets and $5 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $22 million ($11&#160;million in cost of services and $11&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $8 million ($1&#160;million charge in selling, general and administrative expenses offset by a $9&#160;million gain in other operating expense (income), net), due to non-cash asset impairment charges, which were more than offset by a gain associated with proceeds from an insurance claim for hurricane related losses; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(h)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Included pre-tax amortization expense of $30 million ($25 million in amortization of intangible assets and $5 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $26 million ($11&#160;million in cost of services and $15&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $6 million in other operating expense (income), net, primarily due to a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $5 million recorded in income tax expense.  Income from discontinued operations, net of taxes includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt"&gt;Included pre-tax amortization expense of $25 million ($23 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $16 million ($7&#160;million in cost of services and $9&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $3 million ($4&#160;million charge in selling, general and administrative expenses, offset by a $7&#160;million gain in other operating expense (income), net), consisting of costs incurred related to the AMCA Data Security Incident, which were more than offset by a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(j)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt"&gt;Includes a pre-tax gain of $72 million ($1&#160;million charge in selling, general and administrative expenses, offset by a $73&#160;million gain in other operating expense (income), net), primarily associated with the sale and leaseback of a property; pre-tax amortization expense of $27 million ($24 million in amortization of intangible assets and $3 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $14 million ($6&#160;million in cost of services and $8&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; and excess tax benefits associated with stock-based compensation arrangements of $2 million recorded in income tax expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItMS0xLTEtMA_1ce4812f-508c-4cb6-a862-5fc447e9677d"
      unitRef="usd">1822000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItMy0xLTEtMA_57fe195a-3362-47b3-8478-9544d3e0e164"
      unitRef="usd">1827000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItNS0xLTEtMA_aef4980c-f998-49e1-9054-05e87094c664"
      unitRef="usd">2786000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItNy0xLTEtMA_542d7acc-e795-436a-85a7-679b94afe63e"
      unitRef="usd">3002000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzItOS0xLTEtMA_bfada645-1ab9-439d-b60e-00c884f93249"
      unitRef="usd">9437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtMS0xLTEtMA_3fcff5de-f0da-416b-8f92-06d1891f74aa"
      unitRef="usd">552000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtMy0xLTEtMA_3739884d-40c3-4e8e-8812-1fb50dcdd7d5"
      unitRef="usd">606000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtNS0xLTEtMA_af988360-4553-4290-aa03-1eff2b9fc229"
      unitRef="usd">1206000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtNy0xLTEtMA_7b4a0018-5363-45dd-9536-c0b209d4c4fb"
      unitRef="usd">1269000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzMtOS0xLTEtMA_0b943bcf-c2f8-47f1-88ac-fb72d513436d"
      unitRef="usd">3633000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctMS0xLTEtMA_3e1344af-0a6a-4d4c-ab3d-e2c79ffcef1f"
      unitRef="usd">106000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctMy0xLTEtMA_fe6a61b1-1243-4c06-a6dd-640b59aad665"
      unitRef="usd">193000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctNS0xLTEtMA_6cb4234c-2ee9-4a9a-a464-ad28ca0762d0"
      unitRef="usd">591000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctNy0xLTEtMA_718f3a3f-9961-4040-b6c2-d5b771f651bf"
      unitRef="usd">609000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzctOS0xLTEtMA_65774fce-7296-48af-9e8d-0c00b47fc055"
      unitRef="usd">1499000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtMS0xLTEtMA_2062727a-208d-4a12-93a5-8b21cf500780"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtMy0xLTEtMA_2897b411-bc8a-4852-8ffd-ee4772f6c4c7"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtNS0xLTEtMA_0eacf1fb-2538-46e5-a633-cdefac03d505"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtNy0xLTEtMA_fa856f71-90b8-44dd-be6f-a394fcd6b7f1"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzgtOS0xLTEtMA_b5498410-552f-4255-8c59-ac87b231bdc8"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktMS0xLTEtMA_22023a57-beab-46b4-8946-4ec4c576c7bb"
      unitRef="usd">106000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktMy0xLTEtMA_0e87e980-3f00-45f7-80de-d156beca9d4b"
      unitRef="usd">193000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktNS0xLTEtMA_0f575a7a-7a0d-4a91-a5ac-bcf28768cb1d"
      unitRef="usd">591000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktNy0xLTEtMA_0a201576-ce1c-47a4-affc-9a78d3bb41af"
      unitRef="usd">609000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzktOS0xLTEtMA_060c1832-1729-49e5-b9e6-b0428fdc2d9c"
      unitRef="usd">1499000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTEtMS0xLTA_2d21c281-e6c9-4173-9c88-b769ee0e64c4"
      unitRef="usd">7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTMtMS0xLTA_c2cebacd-75a9-4881-838c-4650a5bad430"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTUtMS0xLTA_97313cae-9f80-48fe-a72b-5cbe4bd87b8a"
      unitRef="usd">23000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTctMS0xLTA_4207a196-f4db-4a7a-a8ad-183bc05657e1"
      unitRef="usd">30000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzEwLTktMS0xLTA_1fe4eace-2de1-4a1f-a5c9-1117e01eebaa"
      unitRef="usd">68000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTEtMS0xLTA_fb6f555c-5a27-4421-98c3-1c9262f8fac6"
      unitRef="usd">99000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTMtMS0xLTA_4a46be66-afc6-422c-951b-32ed623cdb8e"
      unitRef="usd">185000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTUtMS0xLTA_456d30c8-9364-4a04-a862-c1f12815e750"
      unitRef="usd">568000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTctMS0xLTA_85b99ee5-f032-47c2-a95a-42fc06d2d31b"
      unitRef="usd">579000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzExLTktMS0xLTA_96a27172-b4a7-4ed4-a5a3-b2897d842b9c"
      unitRef="usd">1431000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTEtMS0xLTA_41b7539f-beed-4725-af10-9b621f7fb426"
      unitRef="usdPerShare">0.74</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTMtMS0xLTA_512b4e06-4dab-4e5b-8cff-8a66b7c070ab"
      unitRef="usdPerShare">1.38</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTUtMS0xLTA_0cf394a3-1b57-463d-8db2-73a3826f21de"
      unitRef="usdPerShare">4.20</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTctMS0xLTA_e112244e-8561-4c59-92c2-5d6410d57ea2"
      unitRef="usdPerShare">4.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzE5LTktMS0xLTA_80a499e9-3797-4642-9bd5-a9e1e1d3ea9b"
      unitRef="usdPerShare">10.62</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTEtMS0xLTA_9ea8e145-d960-4802-8550-8b1f703e2667"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTMtMS0xLTA_4769571b-ef55-4cb5-aa02-f25861d96328"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTUtMS0xLTA_11a5a6ba-f9be-40a6-b73c-b32cce7582b3"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTctMS0xLTA_7af412a6-e51c-48c6-9671-c3f2faaacd3a"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIwLTktMS0xLTA_4397a373-8278-4525-831d-392eefd218ed"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTEtMS0xLTA_6f4696f0-4460-4699-b885-ce8096194b87"
      unitRef="usdPerShare">0.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTMtMS0xLTA_693d597f-61ee-4f1e-af9a-ef77c36b4525"
      unitRef="usdPerShare">1.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTUtMS0xLTA_4c6ebec7-9f64-458d-8e72-680b3431265b"
      unitRef="usdPerShare">4.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTctMS0xLTA_3df7b7ce-70d6-45bf-9480-e2dc18883840"
      unitRef="usdPerShare">4.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzIxLTktMS0xLTA_11d7a953-8dd4-4a8d-85a7-3d489fc852a0"
      unitRef="usdPerShare">10.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTEtMS0xLTA_d8a98ed9-a588-4c01-93c0-b601144f27cf"
      unitRef="usdPerShare">0.73</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTMtMS0xLTA_9abc0660-d43e-43f8-a9f4-fb64a225c71b"
      unitRef="usdPerShare">1.36</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTUtMS0xLTA_889d2f37-4777-42bf-b57a-10fc241433f3"
      unitRef="usdPerShare">4.14</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTctMS0xLTA_ebe79d32-0469-4a3e-9c04-ab3c8e47b943"
      unitRef="usdPerShare">4.21</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI0LTktMS0xLTA_6cc59292-92ca-4cdd-82a2-adbadc6064e1"
      unitRef="usdPerShare">10.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTEtMS0xLTA_3e460e20-fc15-448b-9bdd-87f39db8f5f3"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTMtMS0xLTA_9fa538c3-b343-40aa-a50a-d4825a3eb37a"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTUtMS0xLTA_0d646a71-d3a7-419e-90db-5e389653950a"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTctMS0xLTA_4a7fe9c4-b81f-419c-bd8a-97df0b7a37d6"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI1LTktMS0xLTA_32585858-7305-49b4-bedc-9ccbf32d533e"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTEtMS0xLTA_8c973c32-cf93-4ccc-be7f-9efbdf3f9d03"
      unitRef="usdPerShare">0.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTMtMS0xLTA_c9f68505-41a7-4b34-a4ac-1c23ccf82539"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTUtMS0xLTA_ba241ec9-e87e-43cd-9ac7-41044a03e1cd"
      unitRef="usdPerShare">4.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTctMS0xLTA_33104191-72bc-425a-bbab-25ba07c72c3e"
      unitRef="usdPerShare">4.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTpiMWMyOGI4M2JmZTk0YzUyOTlhOTg1NzNhZTk2NmFhZS90YWJsZXJhbmdlOmIxYzI4YjgzYmZlOTRjNTI5OWE5ODU3M2FlOTY2YWFlXzI2LTktMS0xLTA_eddcf1d5-f850-4919-9a66-3b411757baf1"
      unitRef="usdPerShare">10.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItMS0xLTEtMA_730d95e9-7ce1-4795-bcd3-39c1c458a829"
      unitRef="usd">1891000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItMy0xLTEtMA_6bef34f0-c26c-496a-8519-8aa94f5c3b28"
      unitRef="usd">1953000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItNS0xLTEtMA_6bccac8d-6f4b-49f7-8dec-af7e4f8155b2"
      unitRef="usd">1956000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItNy0xLTEtMA_3edd25a6-0bf5-45e8-8b7e-9dfa11f0e774"
      unitRef="usd">1926000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzItOS0xLTEtMA_c2b0b57a-9ff1-4bdb-b9e1-18c5274a191a"
      unitRef="usd">7726000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtMS0xLTEtMA_0dbddf03-1101-4316-916f-7731212eb344"
      unitRef="usd">647000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtMy0xLTEtMA_cb81c27c-08ff-4e68-b1f1-d889875fa4e2"
      unitRef="usd">688000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtNS0xLTEtMA_5cec8a48-a365-4a71-8a2a-719b98977bf8"
      unitRef="usd">692000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtNy0xLTEtMA_65905cf2-c3c7-477f-9f11-57998ac5d1cc"
      unitRef="usd">662000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzMtOS0xLTEtMA_96d73235-18ae-4e27-9df6-4441ab3cec40"
      unitRef="usd">2689000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtMS0xLTEtMA_0b8cc3dc-5839-4770-b858-091d23ebd6bf"
      unitRef="usd">176000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtMy0xLTEtMA_86f6d886-3b2c-49f9-8c67-103cfcdf689d"
      unitRef="usd">219000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtNS0xLTEtMA_14173663-86dc-456a-ab88-db3d29be36f3"
      unitRef="usd">226000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtNy0xLTEtMA_27b7d675-0dd8-401c-ad78-4d792cac325b"
      unitRef="usd">265000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzUtOS0xLTEtMA_2dab2da1-f770-4ee8-b79e-21c9ad14079a"
      unitRef="usd">886000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtMS0xLTEtMA_98f1a202-d6fd-4ebd-9d57-96ce90cf4876"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtMy0xLTEtMA_c2471b05-a76c-4b19-9fc0-e31296040271"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtNS0xLTEtMA_a84c4bdb-c456-4f95-a704-8b0ac3ed3482"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtNy0xLTEtMA_a4a2af41-90b4-4f9f-a90a-1c9bc4d0141a"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzYtOS0xLTEtMA_a797e6d1-a03e-4283-94a1-2eb23657ebb2"
      unitRef="usd">20000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctMS0xLTEtMA_0ffb4e7c-1295-4ffd-9f31-41643d70d2a4"
      unitRef="usd">176000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctMy0xLTEtMA_5e05a3f6-8d73-482d-98c6-ccf0d0b738c5"
      unitRef="usd">239000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctNS0xLTEtMA_4807472e-7dde-4506-adf0-c20f8664f057"
      unitRef="usd">226000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctNy0xLTEtMA_0337e582-8947-44f3-b0d9-5b0ca9bdb2f1"
      unitRef="usd">265000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzctOS0xLTEtMA_c437b924-0481-4938-869b-16ddb4946be2"
      unitRef="usd">906000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtMS0xLTEtMA_d198447b-34f5-4cac-a8eb-5e4b600a2ef5"
      unitRef="usd">12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtMy0xLTEtMA_aa9a254a-3945-4407-a575-3899d35abb62"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtNS0xLTEtMA_d60c8b10-d33a-4493-bbba-c8a10fe4ab4e"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtNy0xLTEtMA_05a5ee92-9028-468a-8652-ef87348e24e3"
      unitRef="usd">12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzgtOS0xLTEtMA_a767ffa1-950b-4328-aa04-78fa159a9391"
      unitRef="usd">48000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktMS0xLTEtMA_58d2afc4-3b91-459e-8993-19e80d7a126f"
      unitRef="usd">164000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktMy0xLTEtMA_5351ccb2-fd6e-44a8-85ca-d33db45b8e32"
      unitRef="usd">226000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktNS0xLTEtMA_41221634-5c93-417a-8431-27c474f286f7"
      unitRef="usd">215000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktNy0xLTEtMA_559f2f69-908a-4f38-9cb4-0c1c91995213"
      unitRef="usd">253000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzktOS0xLTEtMA_5605537f-524f-495f-a40e-0aea8b64f694"
      unitRef="usd">858000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTEtMS0xLTA_046caf44-ac49-46bf-ab15-a80f244969b8"
      unitRef="usdPerShare">1.22</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTMtMS0xLTA_7e28b23a-baf2-449a-92f9-aa02d71b1a98"
      unitRef="usdPerShare">1.52</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTUtMS0xLTA_a8c6f41e-f235-4b66-843c-43885252e9dc"
      unitRef="usdPerShare">1.59</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTctMS0xLTA_db27425d-7357-42f8-bf34-ba74b24b7eb0"
      unitRef="usdPerShare">1.88</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE3LTktMS0xLTA_97988008-5517-4821-ae87-07d579724536"
      unitRef="usdPerShare">6.21</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTEtMS0xLTA_4b00515d-fcea-4037-a93b-8c93cd9239b4"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTMtMS0xLTA_22c00a83-3332-4ee7-93f9-884fa6e13f13"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTUtMS0xLTA_3178b1d3-84b0-4bbc-96b0-1a7d81bac8ea"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTctMS0xLTA_c07a2410-bf84-40c0-8f73-f6ffd80e163f"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE4LTktMS0xLTA_b449c224-5035-4b91-a0b8-a231aac2e9c0"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTEtMS0xLTA_6e7db102-e477-492b-acf3-4ee7aa515d65"
      unitRef="usdPerShare">1.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTMtMS0xLTA_469e0409-e45a-4c51-a8e3-300634105712"
      unitRef="usdPerShare">1.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTUtMS0xLTA_83f81f60-83da-4ee3-bb7a-df169dcb23c5"
      unitRef="usdPerShare">1.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTctMS0xLTA_3f447451-2da6-4ba9-beda-1f453f2b642d"
      unitRef="usdPerShare">1.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzE5LTktMS0xLTA_0b54c0da-8fb4-4b18-8eb8-b36116249e17"
      unitRef="usdPerShare">6.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTEtMS0xLTA_58b7407b-65e0-4fb9-b0d2-b79cf7bbbc5a"
      unitRef="usdPerShare">1.20</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTMtMS0xLTA_06bb68ac-999c-4079-868b-783c530fbba0"
      unitRef="usdPerShare">1.51</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTUtMS0xLTA_9d442382-ba72-4aab-89e5-5f3a1ae683ec"
      unitRef="usdPerShare">1.56</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTctMS0xLTA_d6f604e5-d01b-483b-ae6a-fddf89536b48"
      unitRef="usdPerShare">1.86</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIyLTktMS0xLTA_31358097-58a3-430b-a2cc-fb037ae1ef3c"
      unitRef="usdPerShare">6.13</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTEtMS0xLTA_7fe6570f-3de2-4d6d-a00d-65ed99662e2a"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTMtMS0xLTA_c82747d2-1deb-4611-bfb2-84bf15155325"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTUtMS0xLTA_0e5adff7-6e52-4f45-864e-bdbf3e352bf1"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTctMS0xLTA_d986693f-24ae-49df-9385-1390a7a34767"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzIzLTktMS0xLTA_587a8a96-40f4-45b0-ba44-e42210043c5b"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTEtMS0xLTA_f6295321-1914-4c3b-9f42-6657a3334d93"
      unitRef="usdPerShare">1.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTMtMS0xLTA_3ffea6aa-2929-4e94-a763-3fc3bac56364"
      unitRef="usdPerShare">1.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTUtMS0xLTA_76d2aa6a-cdde-4852-a5a6-c0a37af9b100"
      unitRef="usdPerShare">1.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTctMS0xLTA_b55aec3c-19bc-4fcc-9030-d44c8c0ef9c2"
      unitRef="usdPerShare">1.86</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia5b01b4a29374dc195d200b11b021354_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90YWJsZTphZTFhYjM5YTMyMTI0YzdiOTI1OWFlYjYzYzkwYjU3NC90YWJsZXJhbmdlOmFlMWFiMzlhMzIxMjRjN2I5MjU5YWViNjNjOTBiNTc0XzI0LTktMS0xLTA_dd70ff6b-cad3-4bf0-8fee-fe800709c328"
      unitRef="usdPerShare">6.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1b4de4e5f21041db87556bf0e720459f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwMjg_f4162294-9e0a-488b-8855-2aaca31ed2ce"
      unitRef="usd">28000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwNDE_79931170-4759-4380-b97b-78bee7b48e99"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5d7dd6fe1eec401f8fa3bbc7218f34d9_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwNzk_c1d8c661-5cf6-46cc-9627-6bda12230f0c"
      unitRef="usd">3000000</us-gaap:AmortizationOfIntangibleAssets>
    <dgx:RestructuringIntegrationCharges
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwNTQ_79b1044d-3c7d-4323-9826-37993b691817"
      unitRef="usd">16000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="i0bbe7f359fb441618dff6db8b09e9693_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwNjc_e97dc3a7-5bbe-4630-a1ac-66ccfacc2886"
      unitRef="usd">7000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="i188d6941e8fa42beafe10767321c5eb9_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgwOTE_170c90f0-31b8-4f8f-bb4b-f809366e6291"
      unitRef="usd">9000000</dgx:RestructuringIntegrationCharges>
    <dgx:ChargesDueToCOVID19
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxMjc_b4c1c7f2-ab46-489e-ba6b-041d247eca13"
      unitRef="usd">9000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="i0bbe7f359fb441618dff6db8b09e9693_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxMDM_97cef5f1-4bdf-471a-a40e-67aec543159e"
      unitRef="usd">1000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="i188d6941e8fa42beafe10767321c5eb9_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxMTU_eafc7f7f-1a68-4d18-a9d0-544207590128"
      unitRef="usd">3000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="ice1470357afb4f228be84a3f77de9bb4_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxMzk_d775a0fa-4e94-411b-be2d-87a4e27df5c5"
      unitRef="usd">5000000</dgx:ChargesDueToCOVID19>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="iffb76e3fd8fe456a94ee4bdffd4b1b1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjg0OTE_d86a1f2e-1fe8-4355-9aae-2fd4638b3dfb"
      unitRef="usd">8000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5034ddf618274bbab61b97eef0228bd8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxNTE_86c04a90-d0e7-4a98-8295-f53fa6beea42"
      unitRef="usd">28000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxNjQ_588ff642-36ea-4c36-92f2-81942474c3c3"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia853061a347a4f67a24c62ecefdcf9e4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxNzc_2a838e1d-0448-4d95-bb27-5740982ba5c0"
      unitRef="usd">3000000</us-gaap:AmortizationOfIntangibleAssets>
    <dgx:RestructuringIntegrationCharges
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgxODk_e878ffa3-c75c-470f-8aec-c9735890da91"
      unitRef="usd">9000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="i5ac794c54fea41c082189f0a8fed1dd9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyMDE_010758eb-cc0c-4ef3-a618-61b35726f237"
      unitRef="usd">3000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="ieb70b878994a44d0a2cea507d2ead6a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNTAxNzc_39fcfadb-61e7-4ca8-8f06-0698970ec527"
      unitRef="usd">6000000</dgx:RestructuringIntegrationCharges>
    <dgx:PreTaxGainLossDueToCOVID19
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyMTM_52ee3ed2-6b22-4efd-9c63-f4b3800dac43"
      unitRef="usd">-26000000</dgx:PreTaxGainLossDueToCOVID19>
    <dgx:PreTaxGainLossDueToCOVID19
      contextRef="i5ac794c54fea41c082189f0a8fed1dd9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwMDQ0_e47b1b35-320d-447f-a6cc-a4ee987717cb"
      unitRef="usd">-34000000</dgx:PreTaxGainLossDueToCOVID19>
    <dgx:PreTaxGainLossDueToCOVID19
      contextRef="ieb70b878994a44d0a2cea507d2ead6a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwMDMy_8afe7685-283a-4dc5-9353-302dbc5f6369"
      unitRef="usd">-5000000</dgx:PreTaxGainLossDueToCOVID19>
    <dgx:PreTaxGainLossDueToCOVID19
      contextRef="ib14b8a10b66a4c97a54f968b44161d88_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyMjY_0e6e709c-269b-4bfe-808d-ec8340a2f7a5"
      unitRef="usd">62000000</dgx:PreTaxGainLossDueToCOVID19>
    <dgx:PreTaxGainLossDueToCOVID19
      contextRef="ia853061a347a4f67a24c62ecefdcf9e4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyNTI_6de7fc22-4698-4c7d-9c87-65dfd43b9457"
      unitRef="usd">3000000</dgx:PreTaxGainLossDueToCOVID19>
    <dgx:IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyNzY_a05e9944-b4f9-4d0c-85ce-a89ad5ea409e"
      unitRef="usd">-65000000</dgx:IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNzAyNDM_49f24dcc-e259-4357-bcf1-a66451fca89b"
      unitRef="usd">4000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <dgx:ChargesDueToCOVID19
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgyODk_955af0f6-2389-4b50-b653-d3f3bf833f17"
      unitRef="usd">69000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="idaf490fefc914c45b4456f72c9bdf613_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwMTA2_5ff5fb36-0278-4e26-b491-02a575e6c52e"
      unitRef="usd">3000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="i0f50c4e8562542bc9cb4c710b1f0ce64_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzMDI_196c417f-0321-4575-8112-a271befd0003"
      unitRef="usd">65000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="i8b9e1c6b12a542709fad464b97f3772e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNTAxNjU_0118f457-6992-4876-b9ab-8baa7cb9f57f"
      unitRef="usd">1000000</dgx:ChargesDueToCOVID19>
    <dgx:ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzMjc_204a165a-0e37-4c87-8fcf-f56b128ae317"
      unitRef="usd">65000000</dgx:ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i299506ac090e48338ffdc86d6e316b6d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzNzg_71a5591e-51c7-42e0-9b85-38f31c9297cd"
      unitRef="usd">30000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzOTE_9fbfdee6-d198-41de-96bb-f1be1e003939"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8b9e1c6b12a542709fad464b97f3772e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzNjY_b7bc4194-9bd2-47b7-bda5-52e9beb1b6ca"
      unitRef="usd">3000000</us-gaap:AmortizationOfIntangibleAssets>
    <dgx:RestructuringIntegrationCharges
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzNDA_ab612703-b3fc-4039-b810-ce30320a303f"
      unitRef="usd">18000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="iada86b56f45a48b397d3c96f067a7475_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDgzNTM_0a1aaf27-71e2-48ae-99e4-6c826f392216"
      unitRef="usd">11000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="ib3c43507276845e68498c4ff71c1ccff_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDg0MDQ_5ffc86e7-2bae-44cd-84de-7df8eee14ace"
      unitRef="usd">7000000</dgx:RestructuringIntegrationCharges>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i1db356aed7c84b408e826cf4a5378149_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNDg0MTY_2317c3a0-fc94-48c3-8979-f38587cda689"
      unitRef="usd">70000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i55ff501c262847c0851ba168e5b293ff_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzQ5NDc4MDIzNTM4MDg_a0d5aa94-40b9-4203-a016-7a49fe46e440"
      unitRef="number">0.56</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="i8e548c1e968643e8b57dda2c5d781a9e_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNzE5ODc_a3f6f777-7229-43a6-a337-8b4af97ce526"
      unitRef="usd">3000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8c24be469f644a7d9e205e4e693a21e4_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTI5Mjc_b93b3aa4-b867-4666-8604-f6b13d8389f9"
      unitRef="usd">28000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTI5MzM_e0f18b58-deb3-41c1-be3c-2ec44d5f892a"
      unitRef="usd">26000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i36e8ef2ddd684f5c8ee33b7a03675400_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTI5ODQ_23f021d3-3af7-458e-a2d6-fdc77e3f6ffc"
      unitRef="usd">2000000</us-gaap:AmortizationOfIntangibleAssets>
    <dgx:ChargesDueToCOVID19
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMxNjg_78591ea4-7d52-442f-85ad-7129e3848365"
      unitRef="usd">20000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="i69b0cda2873944f69a703c9bcbb95cf5_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMwMjE_1c6f7a3a-3dfe-4e69-8bbc-cc57884dd37e"
      unitRef="usd">19000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="ia72b92b0f0be40e89a72bc54bd0361fc_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMwMjQ_232574c0-46e4-4daa-a156-8d88c592f932"
      unitRef="usd">2000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="ia3c02f9911b34985a9c3b2cd7600534c_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMwMjc_7f356054-0542-4d4d-8f72-baa54f78703d"
      unitRef="usd">1000000</dgx:ChargesDueToCOVID19>
    <dgx:ChargesDueToCOVID19
      contextRef="i36e8ef2ddd684f5c8ee33b7a03675400_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMwMzM_e7e52f71-22e2-4715-971f-3ae972bce603"
      unitRef="usd">-2000000</dgx:ChargesDueToCOVID19>
    <dgx:RestructuringIntegrationCharges
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMyMzM_002a40e0-5a05-4a87-84a8-dae29e8dfbed"
      unitRef="usd">15000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="i30b20cba82d2410f8d16e73bbaba47ad_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMyNjE_92fac182-671e-48b1-a55d-236871146c6d"
      unitRef="usd">6000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="i92f3e38b6a2b49a1a515bcbb581fd02d_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTMyODk_6c91e47b-06a2-4d99-982e-15ccfc10728d"
      unitRef="usd">9000000</dgx:RestructuringIntegrationCharges>
    <dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDg5MDg3_74464857-5ca4-4eda-a04f-48b979769939"
      unitRef="usd">-2000000</dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt>
    <dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt
      contextRef="i92f3e38b6a2b49a1a515bcbb581fd02d_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDg5NjY4_b328c69a-6bff-49a4-af5d-5ca580186dc1"
      unitRef="usd">2000000</dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt>
    <dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt
      contextRef="i3f2e0858b3b740c9ad4cbd585da3c971_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDg5Njkz_0dd00390-35cd-488a-a5d0-91c3b2484626"
      unitRef="usd">10000000</dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt>
    <dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt
      contextRef="i36e8ef2ddd684f5c8ee33b7a03675400_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDg5Njgw_83a1c627-e888-4478-93bd-d32060bde207"
      unitRef="usd">-14000000</dgx:GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3NDg3NzkwOTM5MDM_f1f61cf4-57a1-4f28-bc88-e5389558acf3"
      unitRef="usd">8000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7e06c5cb90a9430688ffd3e687ac8d51_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4Xzk1NQ_1cf7a733-b986-400d-9b52-f6f845aba4e0"
      unitRef="usd">29000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4Xzk1OQ_a1781b6e-fc21-4fab-8a27-621a861bc1ba"
      unitRef="usd">24000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if8f06c22a7fb411ea90bc48b15e6234c_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwMDM_426e2e0d-421b-4081-8c63-52a319070395"
      unitRef="usd">5000000</us-gaap:AmortizationOfIntangibleAssets>
    <dgx:RestructuringIntegrationCharges
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwOTA_e1a487a5-591d-4996-9e7f-76e4f29aa6f6"
      unitRef="usd">22000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="iface07505ab342789068244bb97b89df_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwNjMw_9b9e8981-dbf0-4f68-8801-732c5d75bc07"
      unitRef="usd">11000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="ic13cec6030c243db9ed599ac34410b5f_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwNjQz_36eb7340-421a-4c39-ace0-9966db70cf45"
      unitRef="usd">11000000</dgx:RestructuringIntegrationCharges>
    <dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEzMzY_a94647e3-430b-4c4c-b852-ae6b65f4def8"
      unitRef="usd">-8000000</dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge>
    <dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge
      contextRef="i97d3ffa754e846359243673a76a4dd3d_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwNjY4_9b809d6d-eca4-4680-a518-e42f15dbdf50"
      unitRef="usd">1000000</dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge>
    <dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge
      contextRef="ieb0fe8ee698545d98f72f17ee9b32a59_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwNjU2_d58d9f19-7ed3-490c-8db1-1b16664c555f"
      unitRef="usd">-9000000</dgx:Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="id7a099a508d64148ba8a4b3c3aadb403_D20190101-20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjY4OTM_52550710-ba0c-4326-9a3e-73bda2a3449d"
      unitRef="usd">3000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0778872492304f04a882ac24394af772_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzE3NjI_51eddd54-1f96-4597-a261-2fceb2b1c232"
      unitRef="usd">30000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzE3NjY_a5ec0b98-d4a5-4521-ba03-82a834946a52"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i59a64dfb2bb34d24abf433537d03cfb6_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzE4MTA_b288692e-a4de-4331-8ef0-9717c277c596"
      unitRef="usd">5000000</us-gaap:AmortizationOfIntangibleAssets>
    <dgx:RestructuringIntegrationCharges
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzE4OTc_85939bfa-5e09-4d43-9cfa-fdbc2e507b1f"
      unitRef="usd">26000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="icbe11049deab4e0695a9136216555273_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzg2_c6daffb7-6b44-4803-a456-bd9e62c63978"
      unitRef="usd">11000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="ifb52dade7a1942a4a87b386331e3c5fd_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkwODYw_c3f258e0-63c7-419a-ba8d-0a1034e54837"
      unitRef="usd">15000000</dgx:RestructuringIntegrationCharges>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i88fc2768290f406e90452310cc0cc35e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxNDI_a704939f-9f64-46c7-b450-853224692a17"
      unitRef="usd">-6000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="ic7ecfb949f024fa3b4977edc39d72a86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjY4OTk_0b2d5f0b-71a2-4ad4-9e5e-4dee3db5c947"
      unitRef="usd">5000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits
      contextRef="i5d23165dad6f4a7c9753adca8283f930_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI1Mzk_f28612f5-2d7e-409c-8eac-d2200db7bfcc"
      unitRef="usd">-20000000</dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4935382cf51a42e5ac2c7f7b75f377d1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI2NzA_f79eda90-08a1-4688-8040-cdcc44081852"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI2NzQ_cdc76b4e-78f6-473d-a9b8-2d3893881687"
      unitRef="usd">23000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id133d541098b460c855ee9ebba789ee6_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI3MTg_9944a42a-4690-4026-b7ba-567a259e5714"
      unitRef="usd">2000000</us-gaap:AmortizationOfIntangibleAssets>
    <dgx:RestructuringIntegrationCharges
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzI4MDU_e8b937a6-87b9-4d90-b72f-679d9110b5aa"
      unitRef="usd">16000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="ie2cb4ca2313e45f5a150880b15665d99_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzc0_c884efd7-6bfe-45d4-9db1-f1d9a4e18df3"
      unitRef="usd">7000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="i0177fd8fa149409d932b66e085fff082_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzYy_55b87a96-529c-4b70-9d9c-05123ab811d6"
      unitRef="usd">9000000</dgx:RestructuringIntegrationCharges>
    <dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzMwNTE_1612595b-d9a7-419b-9d85-3fe39e0d83d3"
      unitRef="usd">3000000</dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident>
    <dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident
      contextRef="if0567e595477470982b2e5e34d02c2b2_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxOTQ2_51964f1d-4f40-4723-a795-5e770f1ff918"
      unitRef="usd">4000000</dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident>
    <dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident
      contextRef="ia64109811371447e8f58f600a7e213ec_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzUw_5383633a-8d14-4781-acc6-43a04e86534f"
      unitRef="usd">7000000</dgx:Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="icfdcc9cb0df54ad7a470b2a84a7248c1_D20190701-20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjY5MDU_dee1ccf4-76a2-44aa-8d87-8429ccd3411a"
      unitRef="usd">3000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM1NTU_54731377-859c-4f6e-b0f6-a7d3d7a0bc39"
      unitRef="usd">-72000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="ifb2549acbace4796a9c86fd435062b92_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkyMTA4_9d27540c-7a62-45a7-bf75-8a4ec9e6e645"
      unitRef="usd">1000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="ib9aa3e5c40ac445299ed6a675092e9ba_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzEz_8766e196-36df-452f-84d5-5cc19b255b4b"
      unitRef="usd">-73000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2e0b27f6e56e4d51946d35cdcfce7aa2_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM3Nzg_56f111c0-99b0-4a45-b435-912946b604d1"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM3ODI_d46f723a-e8a7-4f89-9f67-dd07c35b91ba"
      unitRef="usd">24000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iebc62645fa31471fbe90700f9465c88a_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM4MjY_76e7f403-7c65-4c32-9727-09cb47b55571"
      unitRef="usd">3000000</us-gaap:AmortizationOfIntangibleAssets>
    <dgx:RestructuringIntegrationCharges
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzM5MTM_bb995f62-1025-43bd-8487-424432b60c91"
      unitRef="usd">14000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="id4cdaf18428f4a29ac09bbda7601b898_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNjg5_5484e5eb-8817-465a-818d-9e43515c7338"
      unitRef="usd">6000000</dgx:RestructuringIntegrationCharges>
    <dgx:RestructuringIntegrationCharges
      contextRef="i94e290893fe1450ea0b89d2e52ba32cb_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzEwNDQ1MzYwNDkxNzAx_09078ebc-5e62-472e-9cd5-d3be3205bcc8"
      unitRef="usd">8000000</dgx:RestructuringIntegrationCharges>
    <dgx:Sharebasedcompensationexcesstaxbenefitamount
      contextRef="ica57331e0f504d8094a49987c8d5212d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTMvZnJhZzplZThlZmMwODJkZGI0ODEwOTg4MDEzZmE3ZWNhMzUzOC90ZXh0cmVnaW9uOmVlOGVmYzA4MmRkYjQ4MTA5ODgwMTNmYTdlY2EzNTM4XzIxOTkwMjMyNjY5MTE_08d7d3cb-af50-4e2d-848e-12003d073797"
      unitRef="usd">2000000</dgx:Sharebasedcompensationexcesstaxbenefitamount>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
      contextRef="ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90ZXh0cmVnaW9uOjMwNTI4ZTZmM2JmMDQ4NmJhMTFjMjRkOWJiODAwYWU5XzIwMQ_93445b47-c167-44dd-a5f9-1302be5309f3">&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE II - VALUATION ACCOUNTS AND RESERVES&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.029%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;Beginning of Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Provision for Credit Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Deductions&lt;br/&gt;and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at&lt;br/&gt;End of Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Doubtful accounts and allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Doubtful accounts and allowances&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)Primarily represents the write-off of accounts receivable, net of recoveries.</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia8ef0d848be64de88a06475f05c8fc23_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzItMS0xLTEtMA_f9f796b3-443e-404b-8653-290bcc3bcfdb"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="id92fdac500c449b68f3d7a77c241c32a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzItMy0xLTEtMA_0b3d9e2e-de2f-4626-9729-e71450ff08ae"
      unitRef="usd">19000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="id92fdac500c449b68f3d7a77c241c32a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzItNS0xLTEtMA_ab7af159-05c0-4dfe-b986-9ea222476451"
      unitRef="usd">6000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i37650e5ac3af455b982266e74362e4f3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzItNy0xLTEtMA_911f46b0-d1f7-476c-89d5-3624dd4b3d08"
      unitRef="usd">28000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib5bea947c9da4d009c5112e1fb35819b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzUtMS0xLTEtMA_d5a13437-6c06-4dfb-9af8-1bd2e147531e"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib02d0b9ff9814b8c8b499379f5994f66_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzUtMy0xLTEtMA_52796007-1e2a-4804-9356-317847c83b0b"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib02d0b9ff9814b8c8b499379f5994f66_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzUtNS0xLTEtMA_586ce88c-2724-4bd4-9e23-7dd4554b4321"
      unitRef="usd">11000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia8ef0d848be64de88a06475f05c8fc23_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzUtNy0xLTEtMA_020b32e1-a3a6-429b-a136-679e9f3e436d"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ia9415c8123544c9387ed93ba012a625f_I20171231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzgtMS0xLTEtMA_a391076b-1a07-4be2-a0e2-d240099fbe3a"
      unitRef="usd">13000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia0bc1c3cf41a470d861c0f391ba08410_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzgtMy0xLTEtMA_05a32cef-3124-4698-9b8a-d0f43dea8c3f"
      unitRef="usd">6000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ia0bc1c3cf41a470d861c0f391ba08410_D20180101-20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzgtNS0xLTEtMA_d215cc58-d63e-4798-9df7-d2ad1fe4a16a"
      unitRef="usd">4000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ib5bea947c9da4d009c5112e1fb35819b_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yNTYvZnJhZzozMDUyOGU2ZjNiZjA0ODZiYTExYzI0ZDliYjgwMGFlOS90YWJsZTo4Njg5MjUxMmQzNjg0ZGRjOGU2ZWU4MjQ1N2JkM2RkNy90YWJsZXJhbmdlOjg2ODkyNTEyZDM2ODRkZGM4ZTZlZTgyNDU3YmQzZGQ3XzgtNy0xLTEtMA_b3845e77-f8e7-4aa4-802e-488a4a7d2442"
      unitRef="usd">15000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480113486728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Quest Diagnostics Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1387862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Secaucus,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,454,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant's Proxy Statement to be filed by April&#160;30, 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480235390376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,158<span></span>
</td>
<td class="nump">$ 1,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $28 and $15 as of December&#160;31, 2020 and 2019, respectively</a></td>
<td class="nump">1,520<span></span>
</td>
<td class="nump">1,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,058<span></span>
</td>
<td class="nump">2,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,627<span></span>
</td>
<td class="nump">1,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,873<span></span>
</td>
<td class="nump">6,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity method investees</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">14,026<span></span>
</td>
<td class="nump">12,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,633<span></span>
</td>
<td class="nump">1,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of long-term operating lease liabilities</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,776<span></span>
</td>
<td class="nump">1,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">4,013<span></span>
</td>
<td class="nump">3,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">499<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">847<span></span>
</td>
<td class="nump">711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Quest Diagnostics stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2020 and 2019; 217 shares issued as of both December 31, 2020 and 2019</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">9,303<span></span>
</td>
<td class="nump">8,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 84 shares as of both December 31, 2020 and 2019</a></td>
<td class="num">(5,366)<span></span>
</td>
<td class="num">(5,218)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Quest Diagnostics stockholders' equity</a></td>
<td class="nump">6,759<span></span>
</td>
<td class="nump">5,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">6,809<span></span>
</td>
<td class="nump">5,687<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 14,026<span></span>
</td>
<td class="nump">$ 12,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480197228648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114241656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 9,437<span></span>
</td>
<td class="nump">$ 7,726<span></span>
</td>
<td class="nump">$ 7,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating costs and expenses and other operating expense (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of services</a></td>
<td class="nump">5,804<span></span>
</td>
<td class="nump">5,037<span></span>
</td>
<td class="nump">4,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">1,457<span></span>
</td>
<td class="nump">1,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense (income), net</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses, net</a></td>
<td class="nump">7,466<span></span>
</td>
<td class="nump">6,495<span></span>
</td>
<td class="nump">6,430<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,971<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(163)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating expenses, net</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from continuing operations before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(460)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income from discontinued operations, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="nump">736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations</a></td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">838<span></span>
</td>
<td class="nump">736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from discontinued operations, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 1,431<span></span>
</td>
<td class="nump">$ 858<span></span>
</td>
<td class="nump">$ 736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="nump">$ 10.62<span></span>
</td>
<td class="nump">$ 6.21<span></span>
</td>
<td class="nump">$ 5.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (in dollars per share)</a></td>
<td class="nump">10.62<span></span>
</td>
<td class="nump">6.36<span></span>
</td>
<td class="nump">5.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="nump">10.47<span></span>
</td>
<td class="nump">6.13<span></span>
</td>
<td class="nump">5.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (in dollars per share)</a></td>
<td class="nump">$ 10.47<span></span>
</td>
<td class="nump">$ 6.28<span></span>
</td>
<td class="nump">$ 5.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114514344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,499<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
<td class="nump">$ 788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in available-for-sale debt securities, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net deferred gain on cash flow hedges, net of taxes</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="nump">779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 1,449<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
<td class="nump">$ 727<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480111721336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 1,499<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
<td class="nump">$ 788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">361<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for credit losses</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Losses (gains) on sale of property, plant and equipment</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(455)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">452<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TerminationOfInterestRateSwapAgreements', window );">Termination of interest rate swap agreements</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities, net</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,005<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="num">(330)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(421)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposition of property, plant, and equipment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(418)<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="num">(383)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">(Increase) decrease in investments and other assets</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(772)<span></span>
</td>
<td class="num">(411)<span></span>
</td>
<td class="num">(801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from borrowings</a></td>
<td class="nump">749<span></span>
</td>
<td class="nump">2,281<span></span>
</td>
<td class="nump">2,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="num">(1,554)<span></span>
</td>
<td class="num">(1,449)<span></span>
</td>
<td class="num">(1,966)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(325)<span></span>
</td>
<td class="num">(353)<span></span>
</td>
<td class="num">(322)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">189<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(297)<span></span>
</td>
<td class="num">(286)<span></span>
</td>
<td class="num">(266)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(58)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Contributions from noncontrolling interest partners</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(1,267)<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="num">(401)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net change in cash and cash equivalents and restricted cash</a></td>
<td class="num">(34)<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">1,192<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of year</a></td>
<td class="nump">$ 1,158<span></span>
</td>
<td class="nump">$ 1,192<span></span>
</td>
<td class="nump">$ 135<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TerminationOfInterestRateSwapAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Termination Of Interest Rate Swap Agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TerminationOfInterestRateSwapAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480112448040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock, at Cost</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2017</a></td>
<td class="nump">$ 4,955<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,612<span></span>
</td>
<td class="nump">$ 7,138<span></span>
</td>
<td class="num">$ (48)<span></span>
</td>
<td class="num">$ (4,783)<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(274)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(274)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options, value</a></td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="num">(325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Contributions from noncontrolling interest partners</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings', window );">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2018</a></td>
<td class="nump">5,267<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,667<span></span>
</td>
<td class="nump">7,602<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">$ (4,996)<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, value at Dec. 31, 2017</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, value at Dec. 31, 2018</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options, value</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="num">(350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2019</a></td>
<td class="nump">5,687<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
<td class="nump">8,174<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">$ (5,218)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, value at Dec. 31, 2019</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">1,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under benefit plans, sharers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options, value</a></td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="num">(325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2020</a></td>
<td class="nump">6,809<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,841<span></span>
</td>
<td class="nump">$ 9,303<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
<td class="num">$ (5,366)<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts and Jobs Act of 2017, Reclassification of Stranded Tax Effects from AOCI to Retained Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108210264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108574696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#8220;VIEs&#8221;) in which the Company has a variable interest and for which the Company is the &#8220;primary beneficiary&#8221; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 21 for a further discussion of discontinued operations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Reclassifications</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between 20% and 49%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately 11%, 15% and 16% of the Company's consolidated net revenues for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxes on Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#8220;ELTIP&#8221;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#8220;DLTIP&#8221;).  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 1: Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating expense (income), net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and is limited to certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of December&#160;31, 2020 and 2019, receivables due from government payers under the Medicare and Medicaid programs represented approximately 6% and 11%, respectively, of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2020 and 2019, receivables due from patients represented approximately 11% and 20%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accounts receivable are reported net of allowances for credit losses.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2020 as follows: </span></div><div><span><br/></span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">buildings and improvements, ranging up to thirty-one and a half years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory equipment and furniture and fixtures, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDgy_7012da4d-00be-4056-8e53-6cc514ee15da">five</span> to twelve years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computer software developed or obtained for internal use, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njky_056ade57-4241-451a-a1e9-095ca78772c6">five</span> to ten years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.  For the year ended December&#160;31, 2019, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQx_017f65e9-fcca-4642-991b-5a831db9e67f">five</span> to twenty years.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  </span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Based upon the Company&#8217;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2020 and 2019, the Company concluded that indefinite-lived intangible assets were not impaired.</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's investments (except for those accounted for under the equity method of accounting), are included in other assets in the consolidated balance sheet and include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments with readily determinable fair values which are comprised of participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income (expense), net in the consolidated statements of operations.  For the years ended December&#160;31, 2020, 2019 and 2018, gains and (losses) from these equity securities totaled $8&#160;million, $10 million, and $(2) million, respectively.  The carrying value of these investments were $67&#160;million and $59 million at December&#160;31, 2020 and 2019, respectively.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; no impairment charges were recognized related to these investments for the years ended December&#160;31, 2020, 2019, and 2018.  The carrying value of these investments was $25 million at both December&#160;31, 2020 and 2019.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $12 million at both December&#160;31, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income (expense), net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income (Loss)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16).  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the Financial Accounting Standards Board ("FASB") which aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.  The adoption of this standard, which the Company elected to do on a prospective basis, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the FASB that changes the impairment model for most financial instruments, including trade receivables, from an incurred loss method to a new forward </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">looking approach, based on expected losses.  The estimate of expected credit losses requires entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts.  The adoption of this new standard, which was done using a modified retrospective transition approach, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.  See "Accounts Receivable and Allowance for Credit Losses" in this footnote for further details on the Company's allowance for credit losses policy.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2019, the Company adopted a new accounting standard issued by the FASB on accounting for leases using the modified retrospective method. This new accounting standard requires a lessee to recognize on its balance sheet an asset and liability for most leases. The Company elected the optional transition method that allowed for a cumulative-effect adjustment to the opening balance of retained earnings recorded on January 1, 2019 and did not restate previously reported results in the comparative periods.  The Company also elected the package of practical expedients, which among other things, allowed it to carry forward its historical lease classification. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a result of adoption of the new standard, the Company recorded operating lease assets and lease liabilities of approximately $500&#160;million and $550&#160;million, respectively as of January 1, 2019.  The operating lease liability was determined based on the present value of the remaining minimum rental payments and the operating lease asset was determined based on the value of the lease liability, adjusted for the deferred rent balances of approximately $50&#160;million, which were previously included in accounts payable and accrued expenses as well as other liabilities in the consolidated balance sheet.  Accounting for the Company's finance leases remained substantially unchanged.  The adoption of the new standard did not materially impact the Company's consolidated results of operations or cash flows.</span></div><div style="text-indent:38.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the adoption of this new accounting standard resulted in increased qualitative and quantitative disclosures regarding the amount, timing, and uncertainty of cash flows arising from leases. For further details, see Note 14.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards To Be Adopted</span></div>&#160;&#160;&#160;&#160;In March 2020, the FASB issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108425336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for greater than 95% of the Company&#8217;s total net revenues for the years ended December&#160;31, 2020, 2019 and 2018 and are primarily comprised of a high volume of relatively low-dollar transactions.  The DIS business, which provides clinical testing services and other services, satisfies its performance obligation and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions, as discussed below. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers, client payers and patients.  Contracts with customers in the DIS business do not contain significant financing components based on the typical period of time between performance of services and collection of consideration.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The process for estimating revenues and the ultimate collection of accounts receivable involves significant judgment and estimation.  The Company follows a standard process, which considers historical denial and collection experience and other factors (including the period the receivables have been outstanding), to estimate contractual allowances and implicit price concessions, recording adjustments in the current period as changes in estimates.  Further adjustments to the allowances, based on actual receipts, may be recorded upon settlement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following are descriptions of the DIS business&#8217; portfolios:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthcare Insurers </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from healthcare insurers are based on negotiated fee-for-service schedules and on capitated payment rates.  Under fee-for-service arrangements, healthcare insurers are billed at the Company's list price.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and the terms of the Company&#8217;s contractual arrangements. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of the Company's net revenues from healthcare insurers is normally a function of providing complete and correct billing information to the healthcare insurers within the various filing deadlines and generally occurs within 30 to 60 days of billing.  Provided the Company has billed healthcare insurers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and if so, it will reserve accordingly for the billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under capitated arrangements with healthcare insurers, the Company recognizes revenue based on a predetermined monthly reimbursement rate for each member of an insurer's health plan regardless of the number or cost of services provided by the Company.  Healthcare insurers typically reimburse the Company under capitated arrangements in the same month services are performed, essentially giving rise to no outstanding accounts receivable at the end of a reporting period.  If any capitated payments are not received on a timely basis, the Company determines the cause and makes a separate determination as to whether or not the collection of the amount from the healthcare insurer is at risk and, if so, would reserve accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Payers</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reimbursements from government payers are based on fee-for-service schedules set by governmental authorities, including traditional Medicare and Medicaid.  Net revenues recognized consist of amounts billed net of contractual allowances for differences between amounts billed and the estimated consideration the Company expects to receive from such payers, which considers historical denial and collection experience and other factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Collection of the Company's net revenues from government payers is normally a function of providing the complete and correct billing information within the various filing deadlines and generally occurs within 30 days of billing.  Provided the Company has billed government payers accurately with complete information prior to the established filing deadline, there has historically been little to no credit risk.  If there has been a delay in billing, the Company determines if the amounts in question will likely go past the filing deadline, and, if so, it will reserve for the billing accordingly.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Client Payers </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Client payers include physicians, hospitals, ACOs, DCEs, IDNs, employers, other commercial laboratories and institutions for which services are performed on a wholesale basis, and are billed based on negotiated fee schedules.  Credit risk and ability to pay are more of a consideration for these payers than healthcare insurers and government payers.  Collection of consideration the Company expects to receive generally occurs within 60 to 90 days of billing.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company principally estimates the allowance for credit losses for client payers based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding. To the extent that any individual client payers are identified that have deteriorated in credit quality, the Company establishes allowances based on the individual risk characteristics of such customers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patients</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Uninsured patients are billed based on established patient fee schedules or fees negotiated with physicians on behalf of their patients.  Insured patients (includes coinsurance and deductible responsibilities) are billed based on fees negotiated with healthcare insurers.  Collection of billings from patients is subject to credit risk and ability of the patients to pay.  Net revenues consist of amounts billed net of discounts provided to uninsured patients in accordance with the Company&#8217;s policies and implicit price concessions.  Implicit price concessions represent differences between amounts billed and the estimated consideration the Company expects to receive from patients, which considers historical collection experience (including the period the receivables have been outstanding) and other factors including current market conditions. Patient billings are generally fully reserved for when the related billing reaches 210 days outstanding.  Balances are automatically written off when they are sent to collection agencies.  Allowances are further adjusted for estimated recoveries of amounts sent to collection agencies based on historical collection experience, which is regularly monitored.  Collection of consideration the Company expects to receive generally occurs within 30 to 60 days of billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered.  Collection of consideration the Company expects to receive generally occurs within 30 to 60 days of billing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.702%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, substantially all of the Company&#8217;s services were provided within the United States, see Note 19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2020 and 2019 was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:74.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the activity for the Company's allowance for credit losses during the year ended December&#160;31, 2020, which principally relates to client payers:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Credit Losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2020</span></div></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108260072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics' common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108425336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING ACTIVITIES</a></td>
<td class="text">RESTRUCTURING ACTIVITIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Invigorate Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is committed to a program called Invigorate which is designed to reduce its cost structure and improve performance.  Invigorate consists of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; service excellence; lab excellence; and revenue services excellence.  In addition to these programs, the Company identified key themes to change how it operates including reducing denials and patient price concessions; further digitizing the business; standardization and automation; and optimization initiatives in the areas of lab network and patient service center network. The Invigorate program is intended to partially offset reimbursement pressures and labor and benefit cost increases; free up additional resources to invest in science, innovation and other growth initiatives; and enable the Company to improve service quality and operating profitability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Restructuring Charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company's pre-tax restructuring charges for the years ended December&#160;31, 2020, 2019 and 2018: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee separation costs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility-related costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charges</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The restructuring charges incurred for the year ended December&#160;31, 2020 and 2018 were primarily associated with various workforce reduction initiatives as the Company continued to simplify and restructure its organization.  The restructuring activity incurred for the year ended December&#160;31, 2019 primarily represents a release of the liability relating to restructuring charges recorded in prior periods, which were determined to no longer be required.  Of the total restructuring charges incurred during the year ended December&#160;31, 2020, $9 million and $5&#160;million were recorded in cost of services and selling, general and administrative expenses, respectively.  The $(2) million of restructuring charges recognized during the year ended December&#160;31, 2019 were recorded in selling, general and administrative expenses.  Of the total restructuring charges incurred during the year ended December&#160;31, 2018, $22 million and $29 million were recorded in cost of services and selling, general and administrative expenses, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Charges for all periods presented were primarily recorded in the Company's DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity of the restructuring liability during 2020 and 2019, which is included in accrued expenses in Note 12:  </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Separation Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Facility-Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2018</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2019</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2020</span></div></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108468808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS&#160;&#160;&#160;&#160;2020 Acquisitions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company completed acquisitions for an aggregate purchase price of $330&#160;million, net of cash acquired, including the acquisitions discussed below.  The 2020 acquisitions resulted in goodwill of $247&#160;million, of which $210&#160;million is deductible for tax purposes.  These acquisitions also resulted in $146&#160;million of intangible assets, principally comprised of customer-related and technology intangible assets.  Net revenues attributable to the 2020 acquisitions were $127&#160;million for the year ended December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Blueprint Genetics Oy</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 21, 2020, the Company completed its acquisition of Blueprint Genetics Oy ("Blueprint Genetics"), in an all cash transaction for $108&#160;million, net of $3&#160;million cash acquired.  Blueprint Genetics is a leading specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing and proprietary bioinformatics.  Through the acquisition, the Company acquired all of Blueprint Genetics' operations.  In the fourth quarter of 2020, the Company made an election to treat the acquisition as a taxable business combination for income tax purposes, which resulted in an adjustment to the preliminary purchase price allocation to reverse the previously recorded $11&#160;million deferred tax liability, with a corresponding decrease to goodwill. Based on the final purchase price allocation, the assets acquired and liabilities assumed primarily consist of $66&#160;million of tax-deductible goodwill, $43&#160;million of intangible assets, and $2&#160;million of property, plant and equipment and working capital.  The intangible assets primarily consist of technology and customer-related assets which are being amortized over a useful life of 10 years and15 years, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Outreach Laboratory Services Business of Memorial Hermann Health System</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 6, 2020, the Company completed its acquisition of select assets which constitute substantially all of the operations of Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System ("Memorial Hermann"), in an all cash transaction for $120&#160;million.  Memorial Hermann is a not-for-profit health system in Southeast Texas.  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired primarily consist of $27&#160;million of customer-related intangible assets and $93&#160;million of tax-deductible goodwill.  The intangible assets are being amortized over a useful life of 15 years.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Remaining 56% Interest in Mid America Clinical Laboratories, LLC</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On August 1, 2020, the Company completed its acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC ("MACL") from its joint venture partners in an all cash transaction for $93&#160;million, net of $18&#160;million cash acquired.  MACL is the largest independent clinical laboratory provider in Indiana.  Prior to the acquisition, the Company accounted for its 44% interest in MACL as an equity method investment, which was remeasured to its fair value of $87&#160;million on the acquisition date, resulting in a gain of $70&#160;million that was recognized in other income (expense), net in the consolidated statements of operations.  The fair value of the previously held equity interest was determined using a discounted cash flow analysis that takes into account, among other items, MACL's expected future cash flows, long-term growth rate (1.5%), and a discount rate commensurate with economic risk (7.5%).  Based on the preliminary purchase price allocation, which may be revised as additional information becomes available during the measurement period, the assets acquired and liabilities assumed consist of $84&#160;million of goodwill (of which $47&#160;million is tax-deductible), $74&#160;million of intangible assets, $11&#160;million of working capital and $11&#160;million of property, plant and equipment.  The intangible assets consist of customer-related assets which are being amortized over a useful life of 15 years.  As a result of the acquisition, MACL became a wholly owned subsidiary of the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2019 Acquisitions</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2019, the Company completed acquisitions for an aggregate purchase price of $63 million, including the acquisition discussed below.  The 2019 acquisitions resulted in goodwill of $43 million, of which $36 million is deductible for tax purposes.  These acquisitions also resulted in $21 million of intangible assets, principally comprised of customer-related intangibles. </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Clinical Laboratory Services Business of Boyce &amp; Bynum Pathology Laboratories, P.C.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On February 11, 2019, the Company completed its acquisition of certain assets of the clinical laboratory services business of Boyce &amp; Bynum Pathology Laboratories, P.C. ("Boyce &amp; Bynum") in an all cash transaction for $61 million, which consisted of cash consideration of $55 million and contingent consideration initially estimated at $6 million.  The contingent consideration arrangement was dependent upon the achievement of certain testing volume benchmarks.  During 2019, the liability was reduced to $0 as a result of updated testing volume forecasts for the earn-out period compared to the testing volume target included in the contingent consideration arrangement, resulting in a $6 million gain recorded in other operating expense (income), net.  Based on the purchase price allocation, the assets acquired principally consist of $41 million of goodwill (of which $35 million is tax deductible) and $20 million of customer-related intangible assets.  The intangible assets are being amortized over a useful life of 15 years.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;2018 Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2018, the Company completed acquisitions for an aggregate purchase price of $440 million, net of cash acquired, including the acquisitions discussed below.  The 2018 acquisitions resulted in goodwill of $241 million, of which $205 million is deductible for tax purposes.  These acquisitions also resulted in $167 million of intangible assets, principally comprised of customer-related intangibles.  Net revenues attributable to the 2018 acquisitions were $84 million for the year ended December 31, 2018.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Mobile Medical Examination Services, LLC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2018, the Company completed its acquisition of Mobile Medical Examination Services, LLC. ("MedXM"), a leading national provider of home-based health risk assessments and related services, in an all cash transaction for $142 million, net of $5 million cash acquired, which consisted of cash consideration of $130 million and contingent consideration initially estimated at $12 million.  The contingent consideration arrangement was dependent upon the achievement of certain revenue targets.  Subsequent to the acquisition, the estimated fair value of the contingent consideration was reduced to $0 as a result of updated revenue forecasts for 2018 compared to the earn-out revenue target included in the contingent consideration arrangement, resulting in a $12 million net gain recorded in other operating expense (income), net.  Through the acquisition, the Company acquired all of MedXM's operations.  The assets acquired and liabilities assumed consist of $77 million of intangible assets, $57 million of goodwill (of which $45 million is tax deductible), $7 million of working capital and $1 million of property, plant and equipment. The intangible assets consist primarily of customer-related assets which are being amortized over a useful life of 15 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the Outreach Laboratory Services Business of Cape Cod Healthcare, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On June 18, 2018, the Company completed the acquisition of the outreach laboratory services business of Cape Cod Healthcare, Inc., in an all cash transaction for $35 million.  The assets acquired principally consist of tax deductible goodwill and customer-related intangible assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of ReproSource, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On September 19, 2018, the Company completed the acquisition of ReproSource, Inc. ("ReproSource"), in an all cash transaction for $35 million, which consisted of cash consideration of $30 million and contingent consideration initially estimated at $5 million.  The contingent consideration arrangement was dependent upon the achievement of certain revenue targets.  During 2019, the liability was reduced to $0 as a result of updated revenue forecasts for 2019 compared to the earn-out revenue target included in the contingent consideration arrangement, resulting in a net gain recorded in other operating expense (income), net. ReproSource is a national leader in specialty fertility diagnostic services.  Through the acquisition, the Company acquired all of ReproSource's operations.  The assets acquired principally consist of goodwill, technology-related intangible assets and customer-related intangible assets.  </span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of the U.S. Laboratory Services Business of Oxford Immunotec, Inc.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On November 6, 2018, the Company completed the acquisition of all of the operations of the U.S. laboratory services business of Oxford Immunotec, Inc. ("Oxford"), in an all cash transaction for $170 million, net of $1 million cash acquired.  The acquisition included laboratories in Tennessee and Massachusetts that provide tuberculosis and tick-borne disease testing services.  As part of the transaction, Oxford will sell test kits and related accessories to the Company under a long-term supply agreement.  In September 2019, the Company finalized its purchase price allocation and recorded a $13 million increase to </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goodwill, an $11 million decrease to intangible assets and a $2 million adjustment to other assets and liabilities.  These adjustments did not have a material impact on the Company's consolidated results of operations.  Based on the final purchase price allocation, the assets acquired and liabilities assumed primarily consist of $43 million of intangible assets, $112 million of tax deductible goodwill, $13 million of working capital and $6 million of property, plant and equipment.  The intangible assets consist primarily of customer-related and contract-related assets which are being amortized over a useful life of 15 years and 5 years, respectively. </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Information</span></div>&#160;&#160;&#160;&#160;The acquisitions described above were accounted for under the acquisition method of accounting.  As such, the assets acquired and liabilities assumed are recorded based on their estimated fair values as of the closing date.  Supplemental pro forma combined financial information has not been presented as the impact of the acquisitions is not material to the Company's consolidated financial statements.  The goodwill recorded primarily includes the expected synergies resulting from combining the operations of the acquired entities with those of the Company and the value associated with an&#160;assembled workforce and other intangible assets that do not qualify for separate recognition.  All of the goodwill acquired in connection with these acquisitions has been allocated to the Company's DIS business.  For further details regarding business segment information, see Note 19.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108296264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-to-variable interest rate swaps</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value using discounted cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable.  Significant inputs include cash flows projections and a discount rate. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value measurements of the Company's fixed-to-variable interest rate swaps, which were terminated during April 2020 (see Note 15), were classified within Level 2 of the fair value hierarchy, and were model-derived valuations as of a given date in which all significant inputs were observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with previous business acquisitions, the Company had contingent consideration obligations that were to be paid based on the achievement of certain testing volume or revenue benchmarks.  As of December&#160;31, 2020, no contingent consideration obligations were outstanding.  Contingent consideration liabilities are measured at fair value using an option-pricing method and are classified within Level 3 of the fair value hierarchy as the fair value is determined based on significant inputs that are not observable.  Significant inputs include management&#8217;s estimate of volume or revenue and other market inputs including comparable company revenue volatility and a discount rate.    </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.912%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (gains)/losses included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (gains)/losses included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The $1 million and $12 million net gains included in earnings associated with the changes in the fair value of contingent consideration for the years ended December&#160;31, 2020 and 2019, respectively, are reported in other operating expense (income), net.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long-term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of December&#160;31, 2020 and 2019, the fair value of the Company&#8217;s debt was estimated at $4.6 billion and $5.1 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109741832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text">TAXES ON INCOME<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's pre-tax income from continuing operations before equity in earnings of equity method investees consisted of approximately $1.9 billion, $1.1 billion and $0.9 billion from U.S. operations and pre-tax (loss) income of $(7) million, $15 million and $(1) million from foreign operations for the years ended December&#160;31, 2020, 2019 and 2018, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a result of the Tax Cuts and Jobs Act, the Company changed its assertion that it intends to indefinitely reinvest undistributed earnings from certain non-U.S. subsidiaries outside the U.S.  The Company is indefinitely reinvested in the remaining basis difference and it is not practicable to determine the associated amount of unrecognized deferred tax liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The components of income tax expense (benefit) for 2020, 2019 and 2018 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:42.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2020, 2019 and 2018 was as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at statutory rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on stock-based compensation arrangements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision true-ups </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accounting method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of equity earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in reserves for uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances associated with certain net operating losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December 31, 2019, the Company recognized a $12 million net income tax benefit due to the release of valuation allowances associated with certain net operating loss carryforwards.   In 2018, the Company filed for a tax return accounting method change, effective for the tax year ending December 31, 2017, to accelerate the deduction of certain expenses on its 2017 tax return at the higher 2017 federal corporate statutory income tax rate, resulting in a $15 million income tax benefit.  The net income tax benefit associated with changes in reserves for uncertain tax positions in 2018 was primarily related to the expiration of the statute of limitations for certain income tax returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2020 and 2019 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities not currently deductible</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis differences in investments, joint ventures and subsidiaries </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards, net of valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current deferred tax liabilities, net</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The non-current deferred tax assets (liabilities) disclosure at December 31, 2019 has been adjusted to separately state the gross deferred tax right-of-use asset and related gross deferred tax lease liability recognized in accordance with the new accounting standard for leases adopted on January 1, 2019.  As of December&#160;31, 2020 and 2019, non-current deferred tax liabilities of $350 million and $264 million, respectively, are included in other liabilities in the consolidated balance sheet. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, the Company had estimated net operating loss carryforwards for federal and state income tax purposes of $60 million and $1.0 billion, respectively, which expire at various dates through 2040.  Estimated net operating loss carryforwards for foreign income tax purposes are $76 million as of December&#160;31, 2020, some of which can be carried forward indefinitely while others expire at various dates through 2040.  As of December&#160;31, 2020 and 2019, deferred tax assets associated with net operating loss carryforwards of $94 million and $101 million, respectively, have each been reduced by valuation allowances of $33 million and $26 million, respectively.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income taxes payable, including those classified as long-term in other liabilities in the consolidated balance sheet as of December&#160;31, 2020 and 2019, were $135 million and $113 million, respectively.  Prepaid income taxes were $2 million and $3 million as of December&#160;31, 2020 and 2019, respectively, and were recorded in prepaid expenses and other current assets in the consolidated balance sheet. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2020, 2019 and 2018 consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in judgment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expirations of statutes of limitations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The contingent liabilities for tax positions primarily relate to uncertainties associated with the realization of tax benefits derived from the allocation of income and expense among state jurisdictions, the characterization and timing of certain tax deductions associated with business combinations, certain tax credits and the deductibility of certain expenses and settlement payments.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total amount of unrecognized tax benefits as of December&#160;31, 2020, that, if recognized, would affect the effective income tax rate is $75 million.  Based upon the expiration of statutes of limitations, settlements and/or the conclusion of tax examinations, the Company believes it is reasonably possible that the total amount of unrecognized tax benefits may decrease by up to $15 million within the next twelve months.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accruals for interest expense on contingent tax liabilities are classified in income tax expense in the consolidated statements of operations.  Accruals for penalties have historically been immaterial.  Interest expense included in income tax expense in each of the years ended December&#160;31, 2020, 2019 and 2018 was approximately $6 million, $5 million and $1 million, respectively.  As of December&#160;31, 2020 and 2019, the Company had approximately $21 million and $17 million, respectively, accrued, net of the benefit of a federal and state deduction, for the payment of interest on uncertain tax positions.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The recognition and measurement of certain tax benefits includes estimates and judgment by management and inherently involves subjectivity.  Changes in estimates may create volatility in the Company's effective tax rate in future periods and may be due to settlements with various tax authorities (either favorable or unfavorable), the expiration of the statute of limitations on certain tax positions and obtaining new information about particular tax positions that may cause management to change its estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the regular course of business, various federal, state, local and foreign tax authorities conduct examinations of the Company's income tax filings and the Company generally remains subject to examination until the statute of limitations expires for the respective jurisdiction.  The Internal Revenue Service has either completed its examinations of the Company's consolidated federal income tax returns or the statute of limitations has expired up through and including the 2016 tax year.  At this time, the Company does not believe that there will be any material additional payments beyond its recorded contingent liability reserves that may be required as a result of these tax audits.  As of December&#160;31, 2020, a summary of the tax years that remain subject to examination, awaiting approval, are under appeal, or are otherwise unresolved for the Company's major jurisdictions are:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;United States - federal&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2017 -  2020 </span></div>&#160;&#160;&#160;&#160;United States - various states&#160;&#160;&#160;&#160;2002 - 2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480115840248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW AND OTHER DATA<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW AND OTHER DATA</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW AND OTHER DATA <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the years ended December&#160;31, 2020, 2019 and 2018 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities (a)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) For the year ended December 31, 2018, leased assets obtained in exchange for new finance lease liabilities reflects information prior to the adoption of the new accounting standard for leases on January 1, 2019.  See Note 14 for further discussion of the Company's accounting for leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109639544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY, PLANT AND EQUIPMENT</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Property, plant and equipment as of December&#160;31, 2020 and 2019 consisted of the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment and furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software developed or obtained for internal use</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,619&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,992)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,776)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company recognized a $73 million gain in other operating expense (income), net on the sale and leaseback of a property.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109801704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in goodwill for the years ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,563&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of December&#160;31, 2020 and 2019 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, goodwill acquired during the period was principally associated with the acquisitions of Blueprint Genetics, Memorial Hermann and MACL (see Note 6). For the year ended December&#160;31, 2020, adjustments to goodwill related to foreign currency translation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, goodwill acquired during the period was principally associated with the acquisition of certain assets of the clinical laboratory services business of Boyce &amp; Bynum and adjustments to goodwill primarily related to the finalization of the purchase price allocation for Oxford (see Note 6).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets as of December&#160;31, 2020 and 2019 consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.436%"/><td style="width:0.1%"/></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2020 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:41.959%"><tr><td style="width:1.0%"/><td style="width:71.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108514472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</a></td>
<td class="text">ACCOUNTS PAYABLE AND ACCRUED EXPENSES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accounts payable and accrued expenses as of December&#160;31, 2020 and 2019 consisted of the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages and benefits (including incentive compensation)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overdrafts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109598632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Long-term debt (including finance lease obligations) as of December&#160;31, 2020 and 2019 consisted of the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:77.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Senior Notes due January 2020</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50% Senior Notes due March 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% Senior Notes due April 2021</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25% Senior Notes due April 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50% Senior Notes due March 2025</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.45% Senior Notes due June 2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20% Senior Notes due June 2029</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% Senior Notes due June 2030</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80% Senior Notes due June 2031</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95% Senior Notes due July 2037</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75% Senior Notes due January 2040</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% Senior Notes due March 2045</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,770&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,966&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Secured Receivables Credit Facility </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On October 22, 2020, the Company amended the agreement for its $600&#160;million secured receivables credit facility (the &#8220;Secured Receivables Credit Facility&#8221;), previously amended in October 2019, to extend the maturity dates for each underlying commitment by one year, while maintaining the borrowing capacity under the facility at $600&#160;million.  Under the Secured Receivables Credit Facility, the Company can borrow against a $250&#160;million loan commitment maturing October 2021 and a $250&#160;million loan commitment maturing October 2022, and can issue up to $100&#160;million of letters of credit (see Note 18) through October 2022.  Borrowings under the Secured Receivables Credit Facility are collateralized by certain domestic receivables.  As of December&#160;31, 2020, interest on the borrowings under the Secured Receivables Credit Facility was based on either commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.825% to 0.95%.  The Secured Receivables Credit Facility is subject to customary affirmative and negative covenants and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility.  As of both December&#160;31, 2020 and 2019, there were no outstanding borrowings under the Secured Receivables Credit Facility. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Unsecured Revolving Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is party to a $750&#160;million senior unsecured revolving credit facility (the &#8220;Credit Facility&#8221; or "Senior Unsecured Revolving Credit Facility") which matures in March 2023.  Under the Credit Facility, the Company can issue letters of credit totaling $150&#160;million (see Note 18).  Issued letters of credit reduce the available borrowing capacity under the Credit Facility.  Interest on the Credit Facility is based on certain published rates plus an applicable margin based on changes in the Company's public debt ratings and its leverage ratio.  At the option of the Company, it may elect to lock into LIBOR-based interest rates for periods up to six months.  Interest on any outstanding amounts not covered under LIBOR-based interest rate contracts is based on an alternate base rate, which is calculated by reference to the prime rate, the federal funds rate or an adjusted LIBOR rate.  As of both December&#160;31, 2020 and 2019, the Company's borrowing rate for LIBOR-based loans under the Credit Facility was LIBOR plus 1.125%.  The Credit Facility contains various covenants, including the maintenance of a financial leverage ratio, which could impact the Company's ability to, among other things, incur additional indebtedness.  In April 2020, the Company amended the Credit Facility to provide increased covenant flexibility.  As amended, the leverage ratio covenant (as defined in the Credit Facility) was increased as follows:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.046%"><tr><td style="width:1.0%"/><td style="width:36.259%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:59.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Covenant:</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 6.5 times EBITDA</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 6.25 times EBITDA</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 4.5 times EBITDA</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                     </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Thereafter, the leverage ratio covenant reverts to no more than 3.5 times EBITDA.  During the period that the increased covenant applies, which period may be terminated early by the Company provided that the Company is in compliance with the historical 3.5 times EBITDA leverage ratio, the amended Credit Facility contains certain additional limitations and restrictions including, but not limited to, repurchases of the Company's common stock, the amount of funds that can be used on business acquisitions, the incurrence of secured indebtedness and the payment of dividends.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of both December&#160;31, 2020 and 2019, there were no outstanding borrowings under the Senior Unsecured Revolving Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December 31, 2020, the Company was in compliance with all covenants for its credit facilities.  As of December 31, 2020, the Company had $1.3&#160;billion of borrowing capacity available under the facilities, including $530&#160;million available under the Secured Receivables Credit Facility and $750&#160;million available under the Senior Unsecured Revolving Credit Facility. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes Offerings</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Company completed a senior notes offering, consisting of $550&#160;million aggregate principal amount of 2.80% senior notes due June 2031 (the &#8220;2031 Senior Notes&#8221;), which were issued at an original issue discount of $1&#160;million.  The Company incurred $5&#160;million of debt issuance costs associated with the 2031 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During November 2020, the net proceeds from the 2031 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due April 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;In December 2019, the Company completed a senior notes offering, consisting of $800&#160;million&#160;aggregate principal amount of 2.95% senior notes due June 2030 (the "2030 Senior Notes"), which were issued at an original issue discount of&#160;$2&#160;million.  The Company incurred $7&#160;million&#160;of debt issuance costs associated with the 2030 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During January 2020, the net proceeds from the 2030 Senior Notes, along with cash on hand, were used to redeem in full the outstanding indebtedness under the Company's senior notes due January 2020 and senior notes due March 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2019, the Company completed a senior notes offering, consisting of $500&#160;million&#160;aggregate principal amount of 4.20% senior notes due June 2029 (the "2029 Senior Notes"), which were issued at an original issue discount of&#160;$1&#160;million.  The Company incurred&#160;$5&#160;million&#160;of debt issuance costs associated with the 2029 Senior Notes, which are included as a reduction to the carrying amount of long-term debt and which are being amortized over the term of the related debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The net proceeds from the 2029 Senior Notes were used to repay in full the outstanding indebtedness under the Company's senior notes due April 2019, to repay outstanding indebtedness under the Secured Receivables Credit Facility and for general corporate purposes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2020, the Company recorded a loss on retirement of debt, principally comprised of premiums paid, of $9&#160;million in other income (expense), net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All of the senior notes are unsecured obligations of the Company and rank equally with the Company's other senior unsecured obligations.  None of the Company's senior notes have a sinking fund requirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may redeem its outstanding senior notes prior to scheduled maturity, as a whole or in part, at a redemption price equal to the present value of the remaining scheduled payments of principal and interest, except for certain notes for which the Company also has an option to redeem such instruments at par value on or after dates specified in the indentures governing the notes ("the par value redemption option"). &#160;For notes with the par value redemption option, if such notes are redeemed prior to the specified dates, the redemption price calculations exclude any interest that would have been due after such dates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maturities of Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, long-term debt matures as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:297.00pt"><tr><td style="width:1.0pt"/><td style="width:235.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities of long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,003&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value basis adjustments attributable to hedged debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109790072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A right-of-use asset, representing the underlying asset during the lease term, and a lease liability, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.  For the year ended December&#160;31, 2020 and 2019, lease expense associated with short-term leases was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#8217;s leases based on tenor.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than 1 year to 16 years, some of which include options to extend the leases for up to 15 years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's assets and liabilities for its lease agreements as of December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"><tr><td style="width:1.0%"/><td style="width:21.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.571%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Finance lease assets as of December 31, 2020 and 2019 were recorded net of accumulated amortization of $14&#160;million and $24&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Components of lease cost for the years ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:364.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $120&#160;million for each of the years ended December&#160;31, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Rental expense for real estate, laboratory equipment and vehicles under operating leases amounted to $220 million for the year ended December&#160;31, 2018.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"><tr><td style="width:1.0pt"/><td style="width:163.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease term and discount rate as of December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:363.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A right-of-use asset, representing the underlying asset during the lease term, and a lease liability, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.  For the year ended December&#160;31, 2020 and 2019, lease expense associated with short-term leases was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company primarily uses its collateralized incremental borrowing rate in determining the present value of lease payments as the Company's leases generally do not provide an implicit rate.  Such incremental borrowing rates, which take into account interest rates offered to companies that have similar credit ratings to the Company, are determined using a portfolio approach which groups the Company&#8217;s leases based on tenor.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has lease agreements with (i) right-of-use asset payments and (ii) non-lease components (i.e., payments related to maintenance fees, utilities, etc.) which have been combined and accounted for as a single lease component. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's leases have remaining terms of less than 1 year to 16 years, some of which include options to extend the leases for up to 15 years. The Company's lease terms may include renewal options that are reasonably certain to be exercised and termination options that are reasonably certain not to be exercised. Certain leases also include options to purchase the leased property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain of the Company's lease agreements include rental payments adjusted periodically for inflation or a market rate which are included in the lease liabilities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's assets and liabilities for its lease agreements as of December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"><tr><td style="width:1.0%"/><td style="width:21.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.571%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Finance lease assets as of December 31, 2020 and 2019 were recorded net of accumulated amortization of $14&#160;million and $24&#160;million, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Components of lease cost for the years ended December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:364.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $120&#160;million for each of the years ended December&#160;31, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Rental expense for real estate, laboratory equipment and vehicles under operating leases amounted to $220 million for the year ended December&#160;31, 2018.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"><tr><td style="width:1.0pt"/><td style="width:163.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease term and discount rate as of December&#160;31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:363.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's discount rates for its operating leases were primarily determined using the Company's incremental borrowing rate.  The Company's weighted-average discount rate for its finance leases principally reflects the implicit interest rate on a lease obligation assumed in a business combination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 9 for cash flow information on cash paid for amounts included in the measurement of lease liabilities, leased assets obtained in exchange for new operating lease liabilities, and leased assets obtained in exchange for new finance lease liabilities for the years ended December&#160;31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480115046312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During March 2020, the Company entered into a forward-starting interest rate swap agreement with a financial institution for a total notional amount of $25&#160;million.  Additionally, during May 2020, the Company entered into interest rate lock agreements with several financial institutions for a total notional amount of $275&#160;million.  The forward-starting interest rate swap agreement and the interest rate lock agreements were entered into in order to hedge a portion of the Company's interest rate exposure associated with variability in future cash flows attributable to changes in interest rates over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1NzI_56514d22-493f-4c97-86ad-19ef10f8afd8">ten</span>-year period related to an anticipated issuance of debt and were accounted for as cash flow hedges.  In connection with the issuance of the 2031 Senior Notes (see Note 13), these agreements were settled and the Company received net proceeds of $1&#160;million. The net gain is deferred in stockholders' equity, net of taxes, as a component of accumulated other comprehensive loss, and is being amortized as an adjustment to interest expense, net over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMTcvZnJhZzpiZjRhMWU5OTA1M2Q0NmFjOTNiY2FiNDFjNGVlYWYxMy90ZXh0cmVnaW9uOmJmNGExZTk5MDUzZDQ2YWM5M2JjYWI0MWM0ZWVhZjEzXzQ5NDc4MDIzMzM1OTE_2bbebbdb-352e-417a-8de8-f6de9db537f1">ten</span>-year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $1&#160;million and $4&#160;million as of December&#160;31, 2020 and 2019, respectively.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $1&#160;million.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2019, the Company had various fixed-to-variable interest rate swap agreements outstanding with an aggregate notional amount of $1.2&#160;billion, which were entered into in order to convert a portion of the Company's long-term debt into variable interest rate debt.  In April 2020, the Company terminated these existing fixed-to-variable interest rate swap agreements and received proceeds of $40&#160;million.  Such amount was reflected as a basis adjustment to the hedged debt instruments and is being amortized as a reduction of interest expense, net over their remaining terms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020 and 2019, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships.  As of December&#160;31, 2019, the balance includes $25 million of remaining unamortized hedging adjustments on discontinued relationships. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2020, 2019 and 2018, respectively:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A summary of the fair values of derivative instruments in the consolidated balance sheet was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.590%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-to-variable interest rate swap agreements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109813800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Series Preferred Stock </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics is authorized to issue up to 10 million shares of Series Preferred Stock, par value $1.00 per share.  The Company's Board of Directors has the authority to issue such shares without stockholder approval and to determine the designations, preferences, rights and restrictions of such shares.  No shares are currently outstanding.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the Company's Restated Certificate of Incorporation the number of authorized shares of common stock, par value $0.01 per share, is 600 million shares.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Changes in Accumulated Other Comprehensive Loss by Component</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Comprehensive income (loss) includes:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 15).  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019, and 2018, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in accumulated other comprehensive loss by component for 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Changes in Available-for-Sale Debt Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Losses on Cash Flow Hedges, net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2017</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, the gross deferred losses on cash flow hedges were reclassified from accumulated other comprehensive loss to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December 31, 2020 and 2018, foreign currency translation adjustment amounts were reclassified from accumulated other comprehensive loss to other operating expense (income), net as a result of the sale of foreign subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share.  During each of the four quarters of 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.53 per common share.  During each of the first three quarters of 2018, the Company's Board of Directors declared a quarterly cash dividend of $0.50 per common share.  During the fourth quarter of 2018, the Company's Board of Directors declared a quarterly cash dividend of $0.53 per common share.  On February 4, 2021, the Company announced that its Board of Directors authorized a 10.7% increase in its quarterly cash dividend from $0.56 to $0.62 per share, or $2.48 per share annually, commencing with the dividend payable in April 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, $0.9 billion remained available under the Company&#8217;s share repurchase authorization.  In February 2021, the Company's Board of Directors authorized the Company to repurchase an additional $1&#160;billion of the Company's common stock.  The share repurchase authorization has no set expiration or termination date.  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">For the year ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, the Company repurchased 2.7 million shares of its common stock for $325 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2019, the Company repurchased 3.5 million shares of its common stock for $350 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the year ended December&#160;31, 2018, the Company repurchased 3.4 million shares of its common stock for $325 million, which included an accrual of $3&#160;million recorded in accounts payable and accrued expenses in the consolidated balance sheet for share repurchases not settled until after December 31, 2018.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Shares Reissued from Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018 the Company reissued 3 million shares, 2 million shares and 3 million shares, respectively, from treasury stock for shares issued under the Employee Stock Purchase Plan ("ESPP") and stock option plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redeemable Noncontrolling Interest</span></div>&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  The Company records changes in the fair value of the noncontrolling interest immediately as they occur.  As of December&#160;31, 2020 and 2019, the redeemable noncontrolling interest was $82 million and $76 million, respectively, and was presented at its fair value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480208524808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK OWNERSHIP AND COMPENSATION PLANS</a></td>
<td class="text">STOCK OWNERSHIP AND COMPENSATION PLANS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee and Non-employee Directors Stock Ownership Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The ELTIP provides for three types of awards: (a) stock options, (b) stock appreciation rights and (c) stock awards.  The ELTIP provides for the grant to eligible employees of either non-qualified or incentive stock options, or both, to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Grants of stock appreciation rights allow eligible employees to receive a payment based on the appreciation of Company common stock in cash, shares of Company common stock or a combination thereof.  The stock appreciation rights are granted at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  Stock options and stock appreciation rights granted under the ELTIP expire on the date designated by the Board of Directors but in no event more than ten years from date of grant.  No stock appreciation rights have been granted under the ELTIP.  Under the ELTIP, awards are subject to forfeiture if employment terminates prior to the end of the vesting period prescribed by the Board of Directors.  For all award types, the vesting period is generally over three years from the date of grant.  For performance share units, the actual amount of shares earned is based on the achievement of the performance goals specified in the awards.  The performance goals for awards granted for 2018 and 2019 were based on the financial performance of the Company.  The performance goals for awards granted in 2020 were based on the financial performance of the Company as well as relative TSR.  The maximum number of shares of Company common stock in respect of which awards may be granted under the ELTIP is approximately 79 million shares.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The DLTIP provides for the grant to non-employee directors of non-qualified stock options to purchase shares of Company common stock at an exercise price no less than the fair market value of the Company's common stock on the date of grant.  The DLTIP also permits awards of restricted stock and restricted stock units to non-employee directors.  Stock options </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">granted under the DLTIP expire on the date designated by the Board of Directors but in no event more than ten years from date of grant.  For all award types, the vesting period is generally over three years from the date of grant, regardless of whether the award recipient remains a director of the Company.  The maximum number of shares that may be issued under the DLTIP is 2.4 million shares.  For the years ended December&#160;31, 2020, 2019 and 2018, grants under the DLTIP totaled 14 thousand shares, 14 thousand shares and 15 thousand shares, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  See Note 16 for further information regarding the Company's share repurchase program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160; The fair value of each stock option award granted was estimated on the date of grant using a Black-Scholes option-valuation model.  The expected volatility under the Black-Scholes option-valuation model was based on historical volatilities of the Company's common stock.  The dividend yield was based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the expected holding period of the related award.  The expected holding period was estimated using the historical stock option exercise behavior of employees. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The weighted average assumptions used in valuing stock options granted in the periods presented were:  </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.219%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.14</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected holding period, in years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following summarizes the activity relative to stock option awards for 2020: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, end of year</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.32&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company's closing common stock price on the last trading day of 2020 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2020.  This amount changes based on the fair market value of the Company's common stock.  Total intrinsic value of options exercised in 2020, 2019 and 2018 was $113 million, $62 million and $67 million, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, there was $9 million of unrecognized stock-based compensation cost related to nonvested stock options which is expected to be recognized over a weighted average period of 1.6 years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of restricted stock awards and restricted stock units is the average market price of the Company's common stock at the date of grant.  For performance share units with a goal based on the financial performance of the Company, the fair value is based on the average market price of the Company's common stock at the date of grant, adjusted for the present value of dividends expected to be paid on the Company's common stock during the vesting period.  For performance share units with a market-based relative TSR goal, the fair value is estimated on the date of grant using a Monte Carlo valuation model.  The expected volatility under the Monte Carlo valuation model is based on the historical volatility of the common stock of the Company and the common stock of the companies in the peer index.  The dividend yield is based on the approved annual dividend rate in effect and current market price of the underlying common stock at the time of grant.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for bonds with maturities consistent with the performance period of the related award. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The weighted average assumptions used in valuing performance share units in 2020 with a market-based relative TSR goal were:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$144.03</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2020, 2019 and 2018: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of year</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.12&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.30&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.13&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, there was $29 million of unrecognized stock-based compensation cost related to nonvested stock awards, which is expected to be recognized over a weighted average period of 1.5 years.  Total fair value of shares vested was $37 million, $40 million and $54 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.  For performance share units with a goal based on financial performance of the Company, the amount of unrecognized stock-based compensation cost is subject to change based on changes, if any, to management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned at the end of the performance periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the years ended December&#160;31, 2020, 2019 and 2018, stock-based compensation expense totaled $97 million, $56 million and $61 million, respectively.  Income tax benefits recognized in the consolidated statements of operations related to stock-based compensation expense totaled $39 million, $27 million and $33 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively, which includes excess tax benefits associated with stock-based compensation arrangements of $23 million, $13 million and $18 million for the years ended December&#160;31, 2020, 2019 and 2018, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under the Company's ESPP, substantially all employees can elect to have up to 10% of their annual wages withheld to purchase Quest Diagnostics common stock.  The purchase price of the stock is 95% of the market price of the Company's common stock on the last business day of each calendar month.  Under the ESPP, the maximum number of shares of Quest Diagnostics common stock which may be purchased by eligible employees is 9 million.  Approximately 225 thousand shares, 269 thousand shares and 326 thousand shares of common stock were purchased by eligible employees in 2020, 2019 and 2018, respectively.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company maintains qualified defined contribution plans covering substantially all of its employees.  The maximum Company matching contribution is 5% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions for certain qualified defined contribution plans; matching contributions were reinstated in the third quarter of 2020.  The Company's expense for contributions to its defined contribution plans aggregated $64 million, $84 million and $78 million for 2020, 2019 and 2018, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Deferred Compensation Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has a supplemental deferred compensation plan that is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to 50% of their salary in excess of their defined contribution plan limits and for certain eligible employees, up to 95% of their variable incentive compensation.  The maximum Company matching contribution is 5% of eligible employee compensation.  During 2020, the Company temporarily suspended matching contributions; matching contributions were reinstated in the third quarter of 2020.  The compensation deferred under this plan, together with Company matching amounts, are credited with earnings or losses measured by the mirrored rate of return on investments elected by plan participants.  Each plan participant is fully vested in all deferred compensation, Company match and earnings credited to their account.  The amounts accrued under the Company's deferred compensation plans were $67 million and $59 million as of December&#160;31, 2020 and 2019, respectively.  Although the Company is currently contributing all participant deferrals and matching amounts to a trust, the funds in this trust, totaling $67 million and $59 million as of December&#160;31, 2020 and 2019, respectively, are general assets of the Company and are subject to any claims of the Company's creditors. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company also offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  The Company matches employee contributions equal to 25%, up to a maximum of $5 thousand per plan year.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  Each participant is fully vested in their deferred compensation and vests in Company matching contributions over a period of four years at 25% per year.  This plan was amended effective January 1, 2018 so that future deferrals under the plan may only be made by participants who made deferrals under the plan in 2017.  The amounts accrued under this plan were $59 million and $51 million as of December&#160;31, 2020 and 2019, respectively.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  The cash surrender value of such life insurance policies was $50 million and $43 million as of December&#160;31, 2020 and 2019, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;  For each of the years ended December&#160;31, 2020, 2019 and 2018, the Company's expense for matching contributions to these plans was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114339608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit and Contractual Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit under its Secured Receivables Credit Facility and Senior Unsecured Revolving Credit Facility (see Note 13).  In support of its risk management program, to ensure the Company&#8217;s performance or payment to third parties, $70 million in letters of credit under the Secured Receivables Credit Facility were outstanding as of December&#160;31, 2020.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company has certain noncancelable commitments, primarily under take-or-pay arrangements, to purchase products or services from various suppliers, mainly for consulting and other service agreements, and standing orders to purchase reagents and other laboratory supplies.  As of December&#160;31, 2020, the approximate total future purchase commitments are $334 million, of which $106 million are expected to be incurred in 2021, $103 million are expected to be incurred in 2022 through 2023 and the balance thereafter. </span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Billing and Collection Agreement</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In September 2016, the Company entered into a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8yMzIvZnJhZzo5NDNhMWIxODMxYmU0ZmRhODRiMjlkNThjNWQ4OWUyMy90ZXh0cmVnaW9uOjk0M2ExYjE4MzFiZTRmZGE4NGIyOWQ1OGM1ZDg5ZTIzXzQ5NDc4MDIzMzUzMTg_a020698b-1549-440e-9434-fef192bf4df1">ten</span>-year agreement with a third party to outsource its billing and  related operations for the majority of the Company&#8217;s revenues.  Services under the agreement commenced during the fourth quarter of 2016.  The agreement includes an annual fee, which is subject to adjustment based on certain changes in the Company's requisition volume and the achievement of various performance metrics.</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div style="padding-right:13.5pt"><span><br/></span></div><div style="padding-right:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including real estate leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  While over the course of many years, the title to certain properties and interest in the subject leases have been transferred to third parties and the subject leases have been amended several times by such third parties, the lessors have not formally released the subsidiary predecessor companies from their original obligations under the leases and therefore remain contingently liable in the event of default.  The remaining terms of the lease obligations and the Company's corresponding indemnifications range up to 27 years.  The lease payments under certain leases are subject to market value adjustments and contingent rental payments and therefore, the total contingent obligations under the leases cannot be precisely determined but are likely to total several hundred million dollars.  A claim against the Company would be made only upon the current lessee's default and, in certain cases, after a series of claims and corresponding defaults by third parties that precede the Company in the order of liability.  The Company also has certain indemnification rights from other parties to recover losses in the event of default on the lease obligations.  The Company believes that the likelihood of its performance under these contingent obligations is remote and no liability has been recorded for any potential payments under the contingent lease obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for the District of New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  The Company plans to vigorously defend this matter and has filed a motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of December&#160;31, 2020, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $1 million as of both December&#160;31, 2020 and December&#160;31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $138 million and $132 million as of December&#160;31, 2020 and December&#160;31, 2019, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480197318424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs, and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2020, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of December&#160;31, 2020, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table is a summary of segment information for the years ended December&#160;31, 2020, 2019 and 2018. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expenses, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations before income taxes and equity in earnings of equity method investees</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2020, 2019 and 2018 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,409&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109743432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text">RELATED PARTIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's equity method investees primarily consist of its clinical trials central laboratory services joint venture and its diagnostic information services joint ventures, which are accounted for under the equity method of accounting.  During the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized net revenues of $34 million, $35 million, and $36 million, respectively, associated with diagnostic information services provided to its equity method investees.  As of December&#160;31, 2020 and 2019, there was $3 million and $4 million, respectively, of accounts receivable from equity method investees related to such services.  During the years ended December&#160;31, 2020 and 2019, the Company recognized net revenues of $3 million and $8 million, respectively, associated with diagnostic information services provided to a noncontrolling interest partner in a joint venture.  As of December&#160;31, 2019, there was $4 million of receivables from the noncontrolling interest partner included in accounts receivable and other assets in the consolidated balance sheet related to such services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the years ended December&#160;31, 2020, 2019 and 2018, the Company recognized income of $16 million, $15 million and $15 million, respectively, associated with the performance of certain corporate services, including transition services, for its equity method investees, classified within selling, general and administrative expenses.  As of December&#160;31, 2020 and 2019, there was $3 million and $1 million, respectively, of other receivables from equity method investees included in prepaid expenses and other current assets in the consolidated balance sheet related to these service agreements and other transition related items.  In addition, accounts payable and accrued expenses in the consolidated balance sheet as of December&#160;31, 2020 and 2019 included $1 million and $2 million, respectively, due to equity method investees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the years ended December&#160;31, 2020, 2019 and 2018, the Company received dividends from its equity method investees of $54 million, $48 million, and $74 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the year ended December 31, 2018, the Company contributed $10 million to an equity method investee to fund its share of an acquisition made by the equity method investee.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109668536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISCONTINUED OPERATIONS</a></td>
<td class="text">DISCONTINUED OPERATIONS&#160;&#160;&#160;&#160;Discontinued operations, net of taxes, for the year ended December 31, 2019 includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.  In addition, net cash provided by operating activities in the consolidated statement of cash flows for the year ended December 31, 2019 included a $28 million refund from the taxing authorities related to discontinued operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108473032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Operating Results (unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Quarterly Operating Results (unaudited)</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.899%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">2020 (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,633&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - basic:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.899%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">2019 (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(j)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - basic:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.59&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  As a result, NID was classified as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved (see Note 21 to the audited consolidated financial statements).</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $28&#160;million ($25&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $16&#160;million ($7&#160;million in cost of services and $9&#160;million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; and pre-tax charges of $9&#160;million ($1&#160;million in cost of services, $3&#160;million in selling, general and administrative expenses and $5&#160;million in other operating expense (income), net), associated with certain costs incurred as a result of the COVID-19 pandemic and resulting impact on the economy including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and to transition certain employees to a remote work environment, and certain asset impairment charges; partially offset by excess tax benefits associated with stock-based compensation arrangements of $8 million recorded in income tax expense.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included pre-tax amortization expense of $28&#160;million ($25&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $9&#160;million ($3&#160;million in cost of services and $6&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $26&#160;million (charges of $34&#160;million in cost of services and $5&#160;million in selling, general and administrative expenses, offset by a $62&#160;million gain in other operating expense (income), net, and a $3&#160;million gain in equity in earnings of equity method investees, net of taxes), representing certain items resulting from the COVID-19 pandemic, including expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19, incremental costs incurred primarily to protect the health and safety of the Company's employees and customers, and certain impairment charges, which were more than offset by $65&#160;million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"); and excess tax benefits associated with stock-based compensation arrangements of $4 million recorded in income tax expense.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included net pre-tax charges of $69&#160;million (charges of $3&#160;million in cost of services, $65&#160;million in other operating expense (income), net, and $1&#160;million in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and the reversal of $65&#160;million of income previously recognized during the second quarter of 2020 attributable to the receipt of funds from the government that were appropriated to healthcare providers under the CARES Act; pre-tax amortization expense of $30&#160;million ($27&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $18&#160;million ($11&#160;million in cost of services and $7&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $70&#160;million recognized in other income (expense), net upon the acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC as a result of the remeasurement of the Company's previously held equity interest to fair value; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.    </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included pre-tax amortization expense of $28&#160;million ($26 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $20 million (charges of $19 million in cost of services, $2 million in selling, general and administrative expenses and $1 million in other operating expense (income), net, partially offset by a $2 million gain in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19 and incremental costs incurred primarily to protect the health and safety of the Company's employees and customers; and pre-tax charges of $15 million ($6 million in cost of services and $9 million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $2&#160;million ($2&#160;million of charges in selling, general and administrative expenses and a $10&#160;million loss in other income (expense), net, offset by a $14&#160;million gain in equity in earnings of equity method investees, net of taxes) related to costs associated with Quest for Health Equity (the Company's recently announced initiative with the Quest </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics Foundation to reduce health disparities in underserved communities) and a loss on retirement of debt, which were more than offset by a gain recognized by an equity method investee to adjust certain of its investments to fair value; and excess tax benefits associated with stock-based compensation arrangements of $8 million recorded in income tax expense.  In the fourth quarter of 2020, the Company returned the funds received from the government that were appropriated to healthcare providers under the CARES Act.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the four quarters of 2020 did not equal the totals for the year ended December 31, 2020 due to quarterly fluctuations in the Company's earnings and weighted average common shares outstanding throughout the period primarily due to the impact of the COVID-19 pandemic on the Company's results and the temporary suspension of repurchases under the Company's share repurchase program.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $29 million ($24 million in amortization of intangible assets and $5 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $22 million ($11&#160;million in cost of services and $11&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $8 million ($1&#160;million charge in selling, general and administrative expenses offset by a $9&#160;million gain in other operating expense (income), net), due to non-cash asset impairment charges, which were more than offset by a gain associated with proceeds from an insurance claim for hurricane related losses; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $30 million ($25 million in amortization of intangible assets and $5 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $26 million ($11&#160;million in cost of services and $15&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $6 million in other operating expense (income), net, primarily due to a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $5 million recorded in income tax expense.  Income from discontinued operations, net of taxes includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Included pre-tax amortization expense of $25 million ($23 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $16 million ($7&#160;million in cost of services and $9&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $3 million ($4&#160;million charge in selling, general and administrative expenses, offset by a $7&#160;million gain in other operating expense (income), net), consisting of costs incurred related to the AMCA Data Security Incident, which were more than offset by a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Includes a pre-tax gain of $72 million ($1&#160;million charge in selling, general and administrative expenses, offset by a $73&#160;million gain in other operating expense (income), net), primarily associated with the sale and leaseback of a property; pre-tax amortization expense of $27 million ($24 million in amortization of intangible assets and $3 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $14 million ($6&#160;million in cost of services and $8&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; and excess tax benefits associated with stock-based compensation arrangements of $2 million recorded in income tax expense.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480197421208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation Accounts and Reserves<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION ACCOUNTS AND RESERVES</a></td>
<td class="text"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II - VALUATION ACCOUNTS AND RESERVES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:51.029%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>Beginning of Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision for Credit Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deductions<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at<br/>End of Year</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts and allowances</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Doubtful accounts and allowances</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)Primarily represents the write-off of accounts receivable, net of recoveries.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480113773304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Principles of Consolidation and Basis of Presentation</a></td>
<td class="text">The consolidated financial statements include the accounts of all entities controlled by the Company through its direct or indirect ownership of a majority voting interest.  Additionally, the consolidated financial statements include the accounts of variable interest entities (&#8220;VIEs&#8221;) in which the Company has a variable interest and for which the Company is the &#8220;primary beneficiary&#8221; as it has both: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of the VIE that potentially could be significant to the VIE or the right to receive benefits from the VIE that potentially could be significant to the VIE.  All significant intercompany accounts and transactions are eliminated in consolidation.&#160;&#160;&#160;&#160;Income attributable to the minority interest in the Company's majority owned and controlled consolidated subsidiaries is recorded as net income attributable to noncontrolling interests in the consolidated statements of operations and the noncontrolling interest is reflected as a separate component of consolidated stockholders' equity in the consolidated balance sheet.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  The accompanying consolidated statements of operations and related disclosures report the results of NID as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved.  See Note 21 for a further discussion of discontinued operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text">Investments in entities which the Company does not control, but in which it has a substantial ownership interest (generally between 20% and 49%) and can exercise significant influence, are accounted for using the equity method of accounting.  These investments are classified as investments in equity method investees in the consolidated balance sheet.  The Company records its pro rata share of the earnings, adjusted for accretion of basis difference, of these investments in equity in earnings of equity method investees, net of taxes in the consolidated statements of operations.  The Company reviews its investments in equity method investees for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">The Company recognizes as revenue the amount that reflects the consideration to which it expects to be entitled in exchange for goods sold or services rendered primarily upon completion of the testing process (when results are reported) or when services have been rendered (see Note 3).  Net revenues from Medicare and Medicaid programs were approximately 11%, 15% and 16% of the Company's consolidated net revenues for the years ended December&#160;31, 2020, 2019 and 2018, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Taxes on Income</a></td>
<td class="text">The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year.  Current and deferred income taxes are measured based on the tax laws that are enacted as of the balance sheet date of the relevant reporting period.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax bases using tax rates in effect for the year in which the differences are expected to reverse.  A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.  Tax benefits from uncertain tax positions are recognized only if the tax position is more likely than not to be sustained upon examination by taxing authorities based on the technical merits of the position.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan (&#8220;ELTIP&#8221;) and its Amended and Restated Non-Employee Director Long-Term Incentive Plan (&#8220;DLTIP&#8221;).  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">The Company measures stock-based compensation for equity awards at fair value on the date of grant and records stock-based compensation as a charge to earnings net of the estimated impact of forfeited awards.  As such, the Company recognizes stock-based compensation cost<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">only for those stock-based awards that are estimated to ultimately vest over their requisite service period, based on the vesting provisions of the individual grants.  The cumulative effect on current and prior periods of a change in the estimated forfeiture rate is recognized as compensation cost in earnings in the period of the change.  The terms of the Company's performance share units allow the recipients of such awards to earn a variable number of shares based on the achievement of the performance goals, which are based on the financial performance of the Company and the total shareholder return of the Company relative to an index of peer companies ("relative TSR"), specified in the awards.  For performance share units with a goal based on the financial performance of the Company, stock-based compensation expense is recognized based on management's best estimates of the achievement of the performance goals specified in such awards and the resulting number of shares that will be earned.  The cumulative effect on current and prior periods of a change in the estimated number of performance share units expected to be earned for these awards is recognized as compensation cost in earnings in the period of the change.  For performance share units with a market-based relative TSR goal, stock-based compensation expense is recognized based on the estimated fair value of the award regardless of the actual number of shares earned.  For further details regarding stock-based compensation, see Note&#160;17.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">The Company determines fair value measurements used in its consolidated financial statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy.  The basis for fair value measurements for each level within the hierarchy is described below with Level 1 having the highest priority and Level 3 having the lowest.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 1: Quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 2: Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Level 3: Valuations derived from valuation techniques in which one or more significant inputs are unobservable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">The Company predominately uses the U.S. dollar as its functional currency.  The functional currency of the Company's foreign operating subsidiaries generally is the applicable local currency.  Assets and liabilities denominated in non-U.S. dollars are translated into U.S. dollars at exchange rates as of the end of the reporting period.  Income and expense items are translated at the average monthly exchange rates during the year.  Resulting translation adjustments are recorded as a component of accumulated other comprehensive loss within stockholders' equity.  Gains and losses from foreign currency transactions, which are denominated in a currency other than the functional currency, are included within other operating expense (income), net in the consolidated statements of operations.  Foreign currency transaction gains and losses have historically not been material.  The Company may be exposed to market risk for changes in foreign exchange rates primarily under certain intercompany receivables and payables.  From time to time, the Company uses foreign exchange forward contracts to mitigate the exposure of the eventual net cash inflows or outflows resulting from these intercompany transactions.  The Company's foreign exchange exposure is not material to the Company's consolidated financial condition.  The Company does not hedge its net investment in non-U.S. subsidiaries because it views those investments as long-term in nature.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash and cash equivalents include all highly-liquid investments with original maturities, at the time acquired by the Company, of three months or less.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text">Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash, cash equivalents, short-term investments, accounts receivable and derivative financial instruments.  The Company's policy is to place its cash, cash equivalents and short-term investments in highly-rated financial instruments and institutions.  Concentration of credit risk with respect to accounts receivable is mitigated by the diversity of the Company's payers and their dispersion across many different geographic regions, and is limited to certain payers who are large buyers of the Company's services.  To reduce risk, the Company routinely assesses the financial strength of these payers and, consequently, believes that its accounts receivable credit risk exposure, with respect to these payers, is limited.  While the Company has receivables due from federal and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by federal and state governments, and payment is primarily dependent on submitting appropriate documentation timely.  As of December&#160;31, 2020 and 2019, receivables due from government payers under the Medicare and Medicaid programs represented approximately 6% and 11%, respectively, of the Company's consolidated net accounts receivable.  The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.  As of December&#160;31, 2020 and 2019, receivables due from patients represented approximately 11% and 20%, respectively, of the Company's consolidated net accounts receivable.  The Company applies assumptions and judgments including historical collection experience (including the period the receivables have been outstanding) for assessing collectability and determining net revenues and accounts receivable from patients.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">Accounts receivable are reported net of allowances for credit losses.  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When estimating its allowance for credit losses, the Company pools its trade receivables based on the following customer types: healthcare insurers, government payers, client payers and patients, which are described in Note 3.&#160; The Company principally estimates the allowance for credit losses by pool based on historical collection experience, the current credit worthiness of the customers, current economic conditions, expectations of future economic conditions and the period that the receivables have been outstanding.&#160; To the extent that any individual payers are identified that have deteriorated in credit quality, the Company removes the customers from their respective pools and establishes allowances based on the individual risk characteristics of such customers.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories, which consist principally of finished goods testing supplies and reagents, are valued at the lower of cost (first in, first out method) or net realizable value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment is recorded at cost.  Major renewals and improvements are capitalized, while maintenance and repairs are expensed as incurred.  Costs incurred for computer software developed or obtained for internal use are capitalized for application development activities and expensed as incurred for preliminary project activities and post-implementation activities.  Capitalized costs include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with the internal-use software project, and interest costs incurred, when material, while developing internal-use software.  Capitalization of such costs ceases when the project is substantially complete and ready for its intended purpose.  Costs for maintenance and training are expensed as incurred.  The Company capitalizes interest on borrowings during the active construction period of major capital projects.  Capitalized interest is added to the cost of the underlying assets and is amortized over the expected useful lives of the assets.  Depreciation and amortization are provided on the straight-line method over expected useful asset lives as of December&#160;31, 2020 as follows: <div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">buildings and improvements, ranging up to thirty-one and a half years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory equipment and furniture and fixtures, ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0NDgy_7012da4d-00be-4056-8e53-6cc514ee15da">five</span> to twelve years; </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">leasehold improvements, the lesser of the useful life of the improvement or the remaining life of the building or lease, as applicable; and </span></div><div style="padding-left:63pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computer software developed or obtained for internal use, <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE0Njky_056ade57-4241-451a-a1e9-095ca78772c6">five</span> to ten years.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">Goodwill represents the excess of the fair value of the acquiree (including the fair value of non-controlling interests) over the recognized bases of the net identifiable assets acquired and includes the future economic benefits from other assets that could not be individually identified and separately recognized.  Goodwill is not amortized, but instead is periodically reviewed for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of goodwill exceeds its fair value.  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On a quarterly basis, the Company performs a review of its business to determine if events or changes in circumstances have occurred which could have a material adverse effect on the fair value of the Company and its goodwill.  If such events or changes in circumstances were deemed to have occurred, the Company would perform an impairment test of goodwill as of the end of the quarter and record any noted impairment loss.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The goodwill test is performed at least annually, or more frequently if events or changes in circumstances indicate that the asset might be impaired.  The annual impairment test includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value; the qualitative test may be performed prior to, or as an alternative to, performing a quantitative goodwill impairment test.  If, after assessing the totality of events or circumstances, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company is required to perform the quantitative goodwill impairment test.  Otherwise, no further analysis is required.  Additionally, the Company's policy is to update the fair value calculation of its reporting units and perform the quantitative goodwill impairment test on a periodic basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The quantitative impairment test involves the comparison of the fair value of the reporting unit to its carrying value.  The Company calculates the fair value of each reporting unit using either (i) a discounted cash flows analysis that converts future cash flow amounts into a single discounted present value amount or (ii) a market approach.  The Company assesses the valuation methodology based upon the relevance and availability of the data at the time that the valuation is performed.  The Company compares the estimate of fair value for the reporting unit to the carrying value of the reporting unit.  If the carrying value is greater than the estimate of fair value, an impairment loss will be recognized in the amount of the excess. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company performs its annual impairment test during the fourth quarter of the fiscal year.  For the year ended December&#160;31, 2020, in accordance with its policy to perform the quantitative test on a periodic basis, the Company updated the fair value calculation of its reporting units, performed the quantitative impairment test and concluded that goodwill was not impaired.  For the year ended December&#160;31, 2019, the Company performed a qualitative impairment test and, based on the totality of information available for the reporting units, the Company concluded that it was more-likely-than-not that the estimated fair values of the reporting units were greater than the carrying values of the reporting units and, as such, no further analysis was required.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text">Intangible assets are recognized at fair value, as an asset apart from goodwill if the asset (i) arises from contractual or other legal rights, or (ii) is separable.  Intangible assets, principally representing the cost of customer-related intangibles, non-competition agreements and technology acquired, are capitalized and amortized on the straight-line method over their expected useful lives, which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE3NTg2ZjVjMTkxODQ2N2Y4NGU5ZDc5YTVhMDhiM2U0L3NlYzoxNzU4NmY1YzE5MTg0NjdmODRlOWQ3OWE1YTA4YjNlNF8xNjkvZnJhZzowMzcxM2ZjMjRmMTU0ODFjOGM1NTYyYWIyMjdhMWUwMS90ZXh0cmVnaW9uOjAzNzEzZmMyNGYxNTQ4MWM4YzU1NjJhYjIyN2ExZTAxXzE4MzQx_017f65e9-fcca-4642-991b-5a831db9e67f">five</span> to twenty years.  Intangible assets with indefinite useful lives, consisting principally of acquired tradenames, are not amortized, but instead are periodically reviewed for impairment.  <div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews indefinite-lived intangible assets periodically for impairment and an impairment charge is recorded in the periods in which the recorded carrying value of an indefinite-lived intangible is more than its estimated fair value.  The indefinite-lived intangible asset impairment test is performed at least annually, or more frequently in the case of other events that indicate a potential impairment.  </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Based upon the Company&#8217;s most recent annual impairment tests completed during the fourth quarters of the years ended December&#160;31, 2020 and 2019, the Company concluded that indefinite-lived intangible assets were not impaired.</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company reviews the recoverability of its long-lived assets (including amortizable intangible assets), other than goodwill and indefinite-lived intangible assets, when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable.  Evaluation of possible impairment is based on the Company's ability to recover the asset from the expected future pre-tax cash flows (undiscounted and without interest charges) of the related operations.  If these cash flows are less than the carrying amount of such asset, an impairment loss is recognized for the difference between the estimated fair value and carrying amount of the asset.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text">The Company's investments (except for those accounted for under the equity method of accounting), are included in other assets in the consolidated balance sheet and include:<div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments with readily determinable fair values which are comprised of participant-directed investments of deferred employee compensation and related Company matching contributions held in trusts pursuant to the Company's supplemental deferred compensation plans (see Note 17).  These investments are measured at fair value with both realized and unrealized gains and losses recorded in current earnings within other income (expense), net in the consolidated statements of operations.  For the years ended December&#160;31, 2020, 2019 and 2018, gains and (losses) from these equity securities totaled $8&#160;million, $10 million, and $(2) million, respectively.  The carrying value of these investments were $67&#160;million and $59 million at December&#160;31, 2020 and 2019, respectively.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments that do not have readily determinable fair values, which consist of investments in preferred and common shares of privately held companies.  These investments are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  The Company regularly evaluates these equity investments to determine if there are any indicators that the investment is impaired; no impairment charges were recognized related to these investments for the years ended December&#160;31, 2020, 2019, and 2018.  The carrying value of these investments was $25 million at both December&#160;31, 2020 and 2019.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Available-for-sale debt securities of privately-held companies.  These investments are measured at fair value with unrealized gains and losses presented in other comprehensive income (loss).  The carrying amount of these investments was $12 million at both December&#160;31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit risk-related contingent features or requirements to post collateral.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div>&#160;&#160;&#160;&#160;The Company accounts for these derivatives as either an asset or liability measured at its fair value.  The fair value is based upon model-derived valuations in which all significant inputs are observable in active markets including certain financial information and certain assumptions regarding past, present and future market conditions.  For a derivative instrument that has been formally designated as a fair value hedge, fair value gains or losses on the derivative instrument along with offsetting fair value gains or losses on the hedged item that are attributable to the risk being hedged are reported in other income (expense), net in the consolidated statements of operations.  For derivatives that have been formally designated as a cash flow hedge, the change in the fair value of the derivatives is recorded in accumulated other comprehensive loss.  Upon maturity or early termination of an effective interest rate swap agreement designated as a cash flow hedge, unrealized gains or losses are deferred in stockholders' equity, as a component of accumulated other comprehensive loss, and are amortized as an adjustment to interest expense over the period during which the hedged forecasted transaction affects earnings, which is when the Company recognizes interest expense on the hedged cash flows.  At inception and quarterly thereafter, the Company formally assesses whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in the fair value or cash flows of the hedged item.  After the initial quantitative assessment, this analysis is initially performed on a qualitative basis and, if it is determined that the hedging relationship was and continues to be highly effective, no further analysis is required.  All components of each derivative financial instrument's gain or loss are included in the assessment of hedge effectiveness.  If it is determined that a derivative ceases to be a highly effective hedge, the Company discontinues hedge accounting and any deferred gains or losses related to a discontinued cash flow hedge shall continue to be reported in accumulated other comprehensive loss, unless it is probable that the forecasted transaction will not occur.  If it is probable that the forecasted transaction will not occur by the originally specified time period, the Company discontinues hedge accounting and any deferred gains or losses reported in accumulated other comprehensive loss are classified into earnings immediately.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text">Comprehensive income (loss) encompasses all changes in stockholders' equity (except those arising from transactions with stockholders) and includes:<div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments; </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax, on available-for-sale debt securities; and </span></div>&#8226;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Notes 15 and 16).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the Financial Accounting Standards Board ("FASB") which aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software.  The adoption of this standard, which the Company elected to do on a prospective basis, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2020, the Company adopted a new accounting standard issued by the FASB that changes the impairment model for most financial instruments, including trade receivables, from an incurred loss method to a new forward </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">looking approach, based on expected losses.  The estimate of expected credit losses requires entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts.  The adoption of this new standard, which was done using a modified retrospective transition approach, did not have a material impact on the Company's consolidated results of operations, financial position or cash flows.  See "Accounts Receivable and Allowance for Credit Losses" in this footnote for further details on the Company's allowance for credit losses policy.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 1, 2019, the Company adopted a new accounting standard issued by the FASB on accounting for leases using the modified retrospective method. This new accounting standard requires a lessee to recognize on its balance sheet an asset and liability for most leases. The Company elected the optional transition method that allowed for a cumulative-effect adjustment to the opening balance of retained earnings recorded on January 1, 2019 and did not restate previously reported results in the comparative periods.  The Company also elected the package of practical expedients, which among other things, allowed it to carry forward its historical lease classification. </span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a result of adoption of the new standard, the Company recorded operating lease assets and lease liabilities of approximately $500&#160;million and $550&#160;million, respectively as of January 1, 2019.  The operating lease liability was determined based on the present value of the remaining minimum rental payments and the operating lease asset was determined based on the value of the lease liability, adjusted for the deferred rent balances of approximately $50&#160;million, which were previously included in accounts payable and accrued expenses as well as other liabilities in the consolidated balance sheet.  Accounting for the Company's finance leases remained substantially unchanged.  The adoption of the new standard did not materially impact the Company's consolidated results of operations or cash flows.</span></div><div style="text-indent:38.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, the adoption of this new accounting standard resulted in increased qualitative and quantitative disclosures regarding the amount, timing, and uncertainty of cash flows arising from leases. For further details, see Note 14.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards To Be Adopted</span></div>&#160;&#160;&#160;&#160;In March 2020, the FASB issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">The Company determines if an arrangement is or contains a lease at contract inception. The Company leases office space, patient service centers, clinical laboratories, warehouses, logistic hubs and equipment primarily through operating leases, with a limited number of finance leases. A right-of-use asset, representing the underlying asset during the lease term, and a lease liability, representing the payment obligation arising from the lease, are recognized on the balance sheet at lease commencement based on the present value of the payment obligation. For operating leases, expense is recognized on a straight-line basis over the lease term. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term.  Short-term leases with an initial term of 12 months or less are not recorded on the balance sheet; the Company recognizes lease expense for these leases on a straight-line basis over the lease term.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable and Allowance for Credit Losses Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21459-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114306584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The approximate percentage of net revenue by type of customer was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:62.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.702%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AccountsReceivableDisaggregationTableTextBlock', window );">Accounts Receivable Disaggregation</a></td>
<td class="text">The approximate percentage of net accounts receivable by type of customer as of December&#160;31, 2020 and 2019 was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:74.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.771%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text">The following table summarizes the activity for the Company's allowance for credit losses during the year ended December&#160;31, 2020, which principally relates to client payers:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Allowance for Credit Losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of accounts receivable, net of recoveries</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2020</span></div></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableDisaggregationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disaggregation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableDisaggregationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109800040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The computation of basic and diluted earnings per common share is as follows (in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics' common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109607208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Pre-Tax Restructuring Charges</a></td>
<td class="text">The following table provides a summary of the Company's pre-tax restructuring charges for the years ended December&#160;31, 2020, 2019 and 2018: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee separation costs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility-related costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment charges</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring charges</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Activity of Restructuring Liability</a></td>
<td class="text">The following table summarizes the activity of the restructuring liability during 2020 and 2019, which is included in accrued expenses in Note 12:  <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:62.049%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee Separation Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Facility-Related Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2018</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2019</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income statement expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December&#160;31, 2020</span></div></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109800040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-to-variable interest rate swaps</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Beginning and Ending Liability Balances Unobservable Inputs</a></td>
<td class="text">The following table provides a reconciliation of the beginning and ending balances of liabilities using significant unobservable inputs (Level 3):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.912%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, additions and issuances</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (gains)/losses included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total (gains)/losses included in earnings - realized/unrealized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114874200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of Income Tax Expense</a></td>
<td class="text">The components of income tax expense (benefit) for 2020, 2019 and 2018 were as follows: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of the Federal Statutory Rate</a></td>
<td class="text">A reconciliation of the federal statutory income tax rate to the Company's effective income tax rate for 2020, 2019 and 2018 was as follows: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at statutory rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excess tax benefits on stock-based compensation arrangements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision true-ups </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accounting method</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of equity earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in reserves for uncertain tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowances associated with certain net operating losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) as of December&#160;31, 2020 and 2019 were as follows: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable reserves</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities not currently deductible</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis differences in investments, joint ventures and subsidiaries </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards, net of valuation allowance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current deferred tax liabilities, net</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Unrecognized Benefits</a></td>
<td class="text">The total amount of unrecognized tax benefits as of and for the years ended December&#160;31, 2020, 2019 and 2018 consisted of the following:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in judgment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expirations of statutes of limitations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108185000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow and Other Data</a></td>
<td class="text">Supplemental cash flow and other data for the years ended December&#160;31, 2020, 2019 and 2018 was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(169)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with purchases of treasury stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for business acquisitions</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new finance lease liabilities (a)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) For the year ended December 31, 2018, leased assets obtained in exchange for new finance lease liabilities reflects information prior to the adoption of the new accounting standard for leases on January 1, 2019.  See Note 14 for further discussion of the Company's accounting for leases.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480110279800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment as of December&#160;31, 2020 and 2019 consisted of the following: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment and furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,974&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">639&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software developed or obtained for internal use</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,619&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,992)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,776)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108559464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill, Net</a></td>
<td class="text">The changes in goodwill for the years ended December&#160;31, 2020 and 2019 were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of year</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,563&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of year</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Excluding Goodwill</a></td>
<td class="text">Intangible assets as of December&#160;31, 2020 and 2019 consisted of the following:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.436%"/><td style="width:0.1%"/></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(556)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(699)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense Intangible Assets</a></td>
<td class="text">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December&#160;31, 2020 is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:41.959%"><tr><td style="width:1.0%"/><td style="width:71.025%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109803976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text">Accounts payable and accrued expenses as of December&#160;31, 2020 and 2019 consisted of the following: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages and benefits (including incentive compensation)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Overdrafts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger consideration payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108559464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt</a></td>
<td class="text">Long-term debt (including finance lease obligations) as of December&#160;31, 2020 and 2019 consisted of the following: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:77.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Senior Notes due January 2020</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50% Senior Notes due March 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% Senior Notes due April 2021</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.25% Senior Notes due April 2024</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50% Senior Notes due March 2025</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.45% Senior Notes due June 2026</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20% Senior Notes due June 2029</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% Senior Notes due June 2030</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80% Senior Notes due June 2031</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.95% Senior Notes due July 2037</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.75% Senior Notes due January 2040</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% Senior Notes due March 2045</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,770&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,966&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock', window );">Schedule of Leverage Ratio Covenants</a></td>
<td class="text">As amended, the leverage ratio covenant (as defined in the Credit Facility) was increased as follows:<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.046%"><tr><td style="width:1.0%"/><td style="width:36.259%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.766%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:59.575%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Covenant:</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 6.5 times EBITDA</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 6.25 times EBITDA</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">no more than 4.5 times EBITDA</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text">As of December&#160;31, 2020, long-term debt matures as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:297.00pt"><tr><td style="width:1.0pt"/><td style="width:235.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:58.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities of long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,003&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value basis adjustments attributable to hedged debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, net of current portion</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Leverage Ratio Covenants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480115154696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock', window );">Schedule Of Lease By Asset Type</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's assets and liabilities for its lease agreements as of December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"><tr><td style="width:1.0%"/><td style="width:21.634%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.571%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.573%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Finance lease assets as of December 31, 2020 and 2019 were recorded net of accumulated amortization of $14&#160;million and $24&#160;million, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text">Components of lease cost for the years ended December&#160;31, 2020 and 2019 were as follows:<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:364.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost (a)</span></td><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of leased assets</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Includes short-term leases and variable lease costs (primarily usage-based maintenance fees and utilities related to real estate leases and certain equipment-related and vehicle-related costs) of $120&#160;million for each of the years ended December&#160;31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease, Liability, Maturity</a></td>
<td class="text">The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"><tr><td style="width:1.0pt"/><td style="width:163.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease, Liability, Maturity</a></td>
<td class="text">The maturity of the Company's lease liabilities as of December&#160;31, 2020 is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:365.25pt"><tr><td style="width:1.0pt"/><td style="width:163.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:61.00pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock', window );">Schedule of Lease Term and Discount Rate</a></td>
<td class="text">Lease term and discount rate as of December&#160;31, 2020 and 2019 were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:363.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfLeaseByAssetTypeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Lease By Asset Type [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfLeaseByAssetTypeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Lease Term and Discount Rate [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109672856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock', window );">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</a></td>
<td class="text">As of December&#160;31, 2020 and 2019, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.380%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Amount of Hedged Long-Term Debt </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>(a) As of December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discounted relationships.  As of December&#160;31, 2019, the balance includes $25 million of remaining unamortized hedging adjustments on discontinued relationships.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock', window );">Schedule of Fair Value Hedging Instruments and Hedged Item, Statement of Financial Performance, Location</a></td>
<td class="text">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the years ended December&#160;31, 2020, 2019 and 2018, respectively:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.246%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of The Fair Values of Derivative Instruments</a></td>
<td class="text">A summary of the fair values of derivative instruments in the consolidated balance sheet was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.590%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet<br/>Classification</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-to-variable interest rate swap agreements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Fair Value Hedging Instruments and Hedged Item, Statement of Financial Performance, Location [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480110276168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">The changes in accumulated other comprehensive loss by component for 2020, 2019 and 2018 were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.379%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Changes in Available-for-Sale Debt Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Deferred Losses on Cash Flow Hedges, net of tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2017</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive (loss) income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2018</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income before reclassifications</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480115379896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Valuing The Company's Stock Options</a></td>
<td class="text">The weighted average assumptions used in valuing stock options granted in the periods presented were:  <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:61.216%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.219%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.30</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.14</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected holding period, in years</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Transactions Under The Company's Stock Option Plans</a></td>
<td class="text">The following summarizes the activity relative to stock option awards for 2020: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:54.471%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Term<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding, end of year</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.32&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, end of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used in Valuing The Company's Performance Share Units</a></td>
<td class="text">The weighted average assumptions used in valuing performance share units in 2020 with a market-based relative TSR goal were:  <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$144.03</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Transactions Under Stock Awards Other than Options</a></td>
<td class="text">The following summarizes the activity relative to stock awards, including restricted stock units and performance share units, for 2020, 2019 and 2018: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:31.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.472%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.478%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, beginning of year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares forfeited and canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.09&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares outstanding, end of year</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.12&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.30&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.13&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480109890648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The following table is a summary of segment information for the years ended December&#160;31, 2020, 2019 and 2018. Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangibles assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2.<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,971&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expenses, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations before income taxes and equity in earnings of equity method investees</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from discontinued operations, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Depreciation and amortization expense for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation and amortization</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Capital expenditures for the years ended December&#160;31, 2020, 2019 and 2018 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service for the years ended December&#160;31, 2020, 2019 and 2018 were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,409&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,531&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480110265928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Operating Results (unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Quarterly Operating Results</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.899%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">2020 (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(f)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,827&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,786&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,633&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - basic:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.62&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.14&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.47&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.899%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">2019 (a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">First</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Second</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Third</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fourth</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Quarter</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(j)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations, net of taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - basic:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.59&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.88&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from continuing operations</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income from discontinued operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.56&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.86&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">During the third quarter of 2006, the Company completed the wind down of Nichols Institute Diagnostics ("NID"), a test kit manufacturing subsidiary.  As a result, NID was classified as discontinued operations through 2019, at which point certain income tax contingencies related to NID were resolved (see Note 21 to the audited consolidated financial statements).</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $28&#160;million ($25&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $16&#160;million ($7&#160;million in cost of services and $9&#160;million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; and pre-tax charges of $9&#160;million ($1&#160;million in cost of services, $3&#160;million in selling, general and administrative expenses and $5&#160;million in other operating expense (income), net), associated with certain costs incurred as a result of the COVID-19 pandemic and resulting impact on the economy including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and to transition certain employees to a remote work environment, and certain asset impairment charges; partially offset by excess tax benefits associated with stock-based compensation arrangements of $8 million recorded in income tax expense.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included pre-tax amortization expense of $28&#160;million ($25&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $9&#160;million ($3&#160;million in cost of services and $6&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $26&#160;million (charges of $34&#160;million in cost of services and $5&#160;million in selling, general and administrative expenses, offset by a $62&#160;million gain in other operating expense (income), net, and a $3&#160;million gain in equity in earnings of equity method investees, net of taxes), representing certain items resulting from the COVID-19 pandemic, including expense associated with a payment to eligible employees to help offset expenses they incurred as a result of COVID-19, incremental costs incurred primarily to protect the health and safety of the Company's employees and customers, and certain impairment charges, which were more than offset by $65&#160;million of income recognized attributable to the receipt of the initial tranche of funds from the government that were appropriated to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"); and excess tax benefits associated with stock-based compensation arrangements of $4 million recorded in income tax expense.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included net pre-tax charges of $69&#160;million (charges of $3&#160;million in cost of services, $65&#160;million in other operating expense (income), net, and $1&#160;million in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, including incremental costs incurred primarily to protect the health and safety of the Company's employees and customers and the reversal of $65&#160;million of income previously recognized during the second quarter of 2020 attributable to the receipt of funds from the government that were appropriated to healthcare providers under the CARES Act; pre-tax amortization expense of $30&#160;million ($27&#160;million in amortization of intangible assets and $3&#160;million in equity in earnings of equity method investees, net of taxes); and pre-tax charges of $18&#160;million ($11&#160;million in cost of services and $7&#160;million in selling, general and administrative expenses), representing costs primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $70&#160;million recognized in other income (expense), net upon the acquisition of the remaining 56% interest in Mid America Clinical Laboratories, LLC as a result of the remeasurement of the Company's previously held equity interest to fair value; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.    </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Included pre-tax amortization expense of $28&#160;million ($26 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $20 million (charges of $19 million in cost of services, $2 million in selling, general and administrative expenses and $1 million in other operating expense (income), net, partially offset by a $2 million gain in equity in earnings of equity method investees, net of taxes), representing the impact of certain items resulting from the COVID-19 pandemic, principally including expense associated with payments to eligible employees to help offset expenses they incurred as a result of COVID-19 and incremental costs incurred primarily to protect the health and safety of the Company's employees and customers; and pre-tax charges of $15 million ($6 million in cost of services and $9 million in selling, general and administrative expenses), primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating the Company; partially offset by a pre-tax gain of $2&#160;million ($2&#160;million of charges in selling, general and administrative expenses and a $10&#160;million loss in other income (expense), net, offset by a $14&#160;million gain in equity in earnings of equity method investees, net of taxes) related to costs associated with Quest for Health Equity (the Company's recently announced initiative with the Quest </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics Foundation to reduce health disparities in underserved communities) and a loss on retirement of debt, which were more than offset by a gain recognized by an equity method investee to adjust certain of its investments to fair value; and excess tax benefits associated with stock-based compensation arrangements of $8 million recorded in income tax expense.  In the fourth quarter of 2020, the Company returned the funds received from the government that were appropriated to healthcare providers under the CARES Act.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.01pt">The sum of basic and diluted earnings per share attributable to Quest Diagnostics' common stockholders for the four quarters of 2020 did not equal the totals for the year ended December 31, 2020 due to quarterly fluctuations in the Company's earnings and weighted average common shares outstanding throughout the period primarily due to the impact of the COVID-19 pandemic on the Company's results and the temporary suspension of repurchases under the Company's share repurchase program.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $29 million ($24 million in amortization of intangible assets and $5 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $22 million ($11&#160;million in cost of services and $11&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $8 million ($1&#160;million charge in selling, general and administrative expenses offset by a $9&#160;million gain in other operating expense (income), net), due to non-cash asset impairment charges, which were more than offset by a gain associated with proceeds from an insurance claim for hurricane related losses; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Included pre-tax amortization expense of $30 million ($25 million in amortization of intangible assets and $5 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $26 million ($11&#160;million in cost of services and $15&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $6 million in other operating expense (income), net, primarily due to a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $5 million recorded in income tax expense.  Income from discontinued operations, net of taxes includes discrete tax benefits of $20 million associated with the favorable resolution of certain tax contingencies related to NID.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Included pre-tax amortization expense of $25 million ($23 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $16 million ($7&#160;million in cost of services and $9&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; a pre-tax gain of $3 million ($4&#160;million charge in selling, general and administrative expenses, offset by a $7&#160;million gain in other operating expense (income), net), consisting of costs incurred related to the AMCA Data Security Incident, which were more than offset by a gain associated with the decrease in the fair value of the contingent consideration accrual associated with a previous acquisition; and excess tax benefits associated with stock-based compensation arrangements of $3 million recorded in income tax expense.</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">Includes a pre-tax gain of $72 million ($1&#160;million charge in selling, general and administrative expenses, offset by a $73&#160;million gain in other operating expense (income), net), primarily associated with the sale and leaseback of a property; pre-tax amortization expense of $27 million ($24 million in amortization of intangible assets and $3 million in equity in earnings of equity method investees, net of taxes); pre-tax charges of $14 million ($6&#160;million in cost of services and $8&#160;million in selling, general and administrative expenses), primarily associated with system conversions and integration incurred in connection with further restructuring and integrating the Company; and excess tax benefits associated with stock-based compensation arrangements of $2 million recorded in income tax expense.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480116841560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments carrying value</a></td>
<td class="nump">$ 521,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 482,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 521,000,000<span></span>
</td>
<td class="nump">$ 482,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of equity earnings from investments in affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 57,000,000<span></span>
</td>
<td class="nump">$ 44,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,971,000,000<span></span>
</td>
<td class="nump">$ 1,231,000,000<span></span>
</td>
<td class="nump">1,101,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 609,000,000<span></span>
</td>
<td class="nump">$ 591,000,000<span></span>
</td>
<td class="nump">$ 193,000,000<span></span>
</td>
<td class="nump">$ 106,000,000<span></span>
</td>
<td class="nump">$ 265,000,000<span></span>
</td>
<td class="nump">$ 226,000,000<span></span>
</td>
<td class="nump">$ 239,000,000<span></span>
</td>
<td class="nump">$ 176,000,000<span></span>
</td>
<td class="nump">1,499,000,000<span></span>
</td>
<td class="nump">906,000,000<span></span>
</td>
<td class="nump">788,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Trading equity securities gain or (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="num">(2,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment', window );">Impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Securities without readily determinable fair value</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">604,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604,000,000<span></span>
</td>
<td class="nump">518,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="nump">640,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">640,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DeferredRentAdjustments', window );">Deferred rent adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesEquity', window );">Trading securities, equity</a></td>
<td class="nump">$ 67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000,000<span></span>
</td>
<td class="nump">$ 59,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,201,000,000<span></span>
</td>
<td class="nump">$ 1,298,000,000<span></span>
</td>
<td class="nump">$ 1,235,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofReceivablesDueFromPatients', window );">Percentage of receivables due from patients</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Laboratory Equipment and Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building and Building Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">31 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Laboratory Equipment and Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DeferredRentAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Rent Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DeferredRentAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment without Readily Determinable Fair Value, Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofReceivablesDueFromPatients">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receivables due from patients as a percentage of consolidated net accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofReceivablesDueFromPatients</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies Line Items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120269885&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investments in trading equity securities and other forms of trading securities that provide ownership interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480111705320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance, January 1, 2020</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease', window );">Provision for credit losses</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs of accounts receivable, net of recoveries</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance, December&#160;31, 2020</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember', window );">Healthcare insurers: | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember', window );">Healthcare insurers: | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember', window );">Government payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember', window );">Client payers | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember', window );">Client payers | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_PatientMember', window );">Patients | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_PatientMember', window );">Patients | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember', window );">DS | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember', window );">DS | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RevenueCollectionofConsiderationPeriod', window );">Collection of consideration</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare insurers:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare insurers: | Fee-for-service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare insurers: | Capitated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Client payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">46.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PeriodofBillingFullyReserve', window );">Period of billing fully reserve</a></td>
<td class="text">210 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments | DS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Percentage of net accounts receivable</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PeriodofBillingFullyReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of Billing Fully Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PeriodofBillingFullyReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_RevenueCollectionofConsiderationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, Collection of Consideration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_RevenueCollectionofConsiderationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_FeeforserviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_FeeforserviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_CapitatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_CapitatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114614408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS (LOSS) PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,431<span></span>
</td>
<td class="nump">$ 838<span></span>
</td>
<td class="nump">$ 736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Income from discontinued operations, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="nump">736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic', window );">Less: Earnings allocated to participating securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,425<span></span>
</td>
<td class="nump">$ 835<span></span>
</td>
<td class="nump">$ 733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="nump">$ 4.28<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="nump">$ 1.52<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 10.62<span></span>
</td>
<td class="nump">$ 6.21<span></span>
</td>
<td class="nump">$ 5.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (in dollars per share)</a></td>
<td class="nump">4.28<span></span>
</td>
<td class="nump">4.20<span></span>
</td>
<td class="nump">1.38<span></span>
</td>
<td class="nump">0.74<span></span>
</td>
<td class="nump">1.88<span></span>
</td>
<td class="nump">1.59<span></span>
</td>
<td class="nump">1.67<span></span>
</td>
<td class="nump">1.22<span></span>
</td>
<td class="nump">10.62<span></span>
</td>
<td class="nump">6.36<span></span>
</td>
<td class="nump">5.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="nump">4.21<span></span>
</td>
<td class="nump">4.14<span></span>
</td>
<td class="nump">1.36<span></span>
</td>
<td class="nump">0.73<span></span>
</td>
<td class="nump">1.86<span></span>
</td>
<td class="nump">1.56<span></span>
</td>
<td class="nump">1.51<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
<td class="nump">10.47<span></span>
</td>
<td class="nump">6.13<span></span>
</td>
<td class="nump">5.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (in dollars per share)</a></td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
<td class="nump">$ 1.86<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 10.47<span></span>
</td>
<td class="nump">$ 6.28<span></span>
</td>
<td class="nump">$ 5.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options and performance share units not included due to their antidilutive effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2740-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480208958792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Income statement (income) expense</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember', window );">Invigorate Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Income statement (income) expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember', window );">Invigorate Program | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Income statement (income) expense</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember', window );">Invigorate Program | Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Income statement (income) expense</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480113879304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES (Pre-Tax Restructuring charges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring charges</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember', window );">Invigorate Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee separation costs</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Facility-related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total restructuring charges</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=dgx_InvigorateProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114162056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING ACTIVITIES (Activities of Restructuring Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Income statement (income) expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReservePeriodIncreaseDecrease', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Separation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Income statement (income) expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReservePeriodIncreaseDecrease', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility-Related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Income statement (income) expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReservePeriodIncreaseDecrease', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReservePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the accrual for restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReservePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480100234712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 01, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Apr. 06, 2020</div></th>
<th class="th"><div>Jan. 21, 2020</div></th>
<th class="th"><div>Feb. 11, 2019</div></th>
<th class="th"><div>Nov. 06, 2018</div></th>
<th class="th"><div>Sep. 19, 2018</div></th>
<th class="th"><div>Jun. 18, 2018</div></th>
<th class="th"><div>Feb. 01, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 330,000,000<span></span>
</td>
<td class="nump">$ 63,000,000<span></span>
</td>
<td class="nump">$ 440,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,000,000<span></span>
</td>
<td class="nump">36,000,000<span></span>
</td>
<td class="nump">205,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,000,000<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="nump">167,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessAcquisitionPostacquisitionRevenue', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,873,000,000<span></span>
</td>
<td class="nump">6,619,000,000<span></span>
</td>
<td class="nump">6,563,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351,000,000<span></span>
</td>
<td class="nump">58,000,000<span></span>
</td>
<td class="nump">427,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods', window );">Goodwill adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">241,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember', window );">Blueprint Genetics Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital', window );">Property, plant, and equipment and working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember', window );">Blueprint Genetics Oy | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember', window );">Blueprint Genetics Oy | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MemorialHermannMember', window );">Memorial Hermann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MemorialHermannMember', window );">Memorial Hermann | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">Mid America Clinical Laboratories, LLC (MACL)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="nump">$ 93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="nump">18,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">84,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="nump">$ 74,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Equity interest in acquiree, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Equity interest in acquiree, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue', window );">Equity interest in acquiree, long-term growth rate used to determine fair value</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue', window );">Equity interest in acquiree, discount rate used to determine fair value</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital', window );">Working capital</a></td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">Mid America Clinical Laboratories, LLC (MACL) | Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="nump">$ 70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">Mid America Clinical Laboratories, LLC (MACL) | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember', window );">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember', window );">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember', window );">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) | Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember', window );">Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MobileMedicalExaminationServicesInc.MedXMMember', window );">Mobile Medical Examination Services, Inc. (MedXM)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MobileMedicalExaminationServicesInc.MedXMMember', window );">Mobile Medical Examination Services, Inc. (MedXM) | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MobileMedicalExaminationServicesInc.MedXMMember', window );">Mobile Medical Examination Services, Inc. (MedXM) | Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MobileMedicalExaminationServicesInc.MedXMMember', window );">Mobile Medical Examination Services, Inc. (MedXM) | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_CapeCodHealthcareInc.Member', window );">Cape Cod Healthcare, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_ReproSourceInc.Member', window );">ReproSource, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_ReproSourceInc.Member', window );">ReproSource, Inc. | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_OxfordImmunotecInc.Member', window );">Oxford Immunotec, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Adjustment, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Adjustment, intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities', window );">Adjustment, other assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_OxfordImmunotecInc.Member', window );">Oxford Immunotec, Inc. | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_OxfordImmunotecInc.Member', window );">Oxford Immunotec, Inc. | Contract Related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessAcquisitionPostacquisitionRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Post-acquisition Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessAcquisitionPostacquisitionRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to goodwill acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to other assets and liabilities acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill related toprior period acquisitions, including purchase accounting adjustments recorded during subsequent periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_BlueprintGeneticsOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MemorialHermannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MemorialHermannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MobileMedicalExaminationServicesInc.MedXMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MobileMedicalExaminationServicesInc.MedXMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_CapeCodHealthcareInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_CapeCodHealthcareInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_ReproSourceInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_ReproSourceInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_OxfordImmunotecInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_OxfordImmunotecInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_ContractRelatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_ContractRelatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480111439784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">67,000,000<span></span>
</td>
<td class="nump">59,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">129,000,000<span></span>
</td>
<td class="nump">114,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">126,000,000<span></span>
</td>
<td class="nump">110,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">82,000,000<span></span>
</td>
<td class="nump">76,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fix-to-variable interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">67,000,000<span></span>
</td>
<td class="nump">59,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">67,000,000<span></span>
</td>
<td class="nump">59,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 1 | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fix-to-variable interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">43,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">126,000,000<span></span>
</td>
<td class="nump">110,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 2 | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fix-to-variable interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">$ 82,000,000<span></span>
</td>
<td class="nump">76,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Level 3 | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fix-to-variable interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480113781368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration, liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt</a></td>
<td class="nump">4,600,000,000<span></span>
</td>
<td class="nump">$ 5,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Total (gains)/losses included in earnings - realized/unrealized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Contingent Consideration | Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Total (gains)/losses included in earnings - realized/unrealized</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480110362568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details) - Level 3 - Contingent Consideration - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Purchases, additions and issuances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Total (gains)/losses included in earnings - realized/unrealized</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480112311304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>TAXES ON INCOME (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Income (loss) from continuing operations - domestic</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income (loss) from continuing operations - foreign</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense (benefit)</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current federal tax expense (benefit)</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current state and local income tax expense</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current foreign income tax expense</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Defered federal income tax expense (benefit)</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred state and local income tax expense (benefit)</a></td>
<td class="nump">29<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred foreign income tax expense (benefit)</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="num">$ (460)<span></span>
</td>
<td class="num">$ (247)<span></span>
</td>
<td class="num">$ (182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax provision at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal benefit</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Impact of noncontrolling interests</a></td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther', window );">Excess tax benefits on stock-based compensation arrangements</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(1.90%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Return to provision true-ups</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod', window );">Change in accounting method</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary', window );">Impact of equity earnings</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition', window );">Changes in reserves for uncertain tax positions</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowances associated with certain net operating losses</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">24.50%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">19.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod', window );">Income tax benefit associated with changes in tax return accounting method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables', window );">Accounts receivable reserves</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Liabilities not currently deductible</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments', window );">Basis differences in investments, joint ventures and subsidiaries</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance', window );">Net operating loss carryfowards, net of valuation allowance</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease right-of-use assets</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Non-current deferred tax liability - depreciation and amortization</a></td>
<td class="num">(604)<span></span>
</td>
<td class="num">(494)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total non-current deferred tax liabilities</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(264)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards', window );">Income tax benefit due to release of valuation allowances associated with net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxes', window );">Income taxes payable</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, beginning balance</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions of current year</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ReductionsForChangesInJudgment', window );">Reductions for changes in judgment</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions for expirations of statutes of limitations</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Reductions for settlements</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, ending balance</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Significant change in unrecognized tax benefits is reasonably possible, estimated range of change, upper bound</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense', window );">Unrecognized tax Benefits, interest on income taxes expense</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued', window );">Unrecognized tax benefits, interest on income taxes accrued</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Country</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change for uncertain tax position</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change in Accounting Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Benefit Associated with Changes in Tax Return Accounting Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ReductionsForChangesInJudgment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross amount of decreases in unrecognized tax benefits resulting from changes in judgment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ReductionsForChangesInJudgment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due.  This amount is the total of current and noncurrent accrued income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense accrued for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480113929864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="num">(180)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable associated with capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TreasuryStockPurchasedbutNotyetPaid', window );">Accounts payable associated with purchases of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividend payable</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FairValueOfNetAssetsAcquired', window );">Fair value of net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Mergerconsiderationpaidpayablenet', window );">Merger consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid for business acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">351<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Leased assets obtained in exchange for new finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsIncurred', window );">Leased assets obtained in exchange for new finance lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=dgx_AmortizationofIntangibleAssetsMember', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalCashFlowAndOtherDataLineItems', window );"><strong>Supplemental Cash Flow and Other Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Mergerconsiderationpaidpayablenet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger consideration paid (payable), net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Mergerconsiderationpaidpayablenet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalCashFlowAndOtherDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Supplemental Cash Flow and Other Data [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalCashFlowAndOtherDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TreasuryStockPurchasedbutNotyetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Purchased but Not yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TreasuryStockPurchasedbutNotyetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in lease obligation from new lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=dgx_AmortizationofIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=dgx_AmortizationofIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480112292824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 4,229<span></span>
</td>
<td class="nump">$ 4,229<span></span>
</td>
<td class="nump">$ 4,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(2,776)<span></span>
</td>
<td class="num">(2,776)<span></span>
</td>
<td class="num">(2,992)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,453<span></span>
</td>
<td class="nump">1,453<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gain on sale recognized</a></td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gain on sale recognized</a></td>
<td class="num">(73)<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentFurnitureAndFixturesMember', window );">Laboratory Equipment, Furniture and Fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,788<span></span>
</td>
<td class="nump">1,788<span></span>
</td>
<td class="nump">1,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">639<span></span>
</td>
<td class="nump">639<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Computer Software Developed or Obtained for Internal Use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">1,106<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 330<span></span>
</td>
<td class="nump">$ 330<span></span>
</td>
<td class="nump">$ 202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121606570&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentFurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dgx_LaboratoryEquipmentFurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480100136568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, balance at beginning of year</a></td>
<td class="nump">$ 6,619<span></span>
</td>
<td class="nump">$ 6,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the year</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Adjustments to goodwill</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, balance at end of year</a></td>
<td class="nump">6,873<span></span>
</td>
<td class="nump">6,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">1,967<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(800)<span></span>
</td>
<td class="num">(699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Future amortization expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal', window );">Total</a></td>
<td class="nump">931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Intangible Assets Not Subject to Amortization - Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Intangible Assets Not Subject to Amortization - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 1,479<span></span>
</td>
<td class="nump">1,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(638)<span></span>
</td>
<td class="num">(556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 841<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets, Subject To Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember', window );">Total Amortizing Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross excluding goodwill</a></td>
<td class="nump">$ 1,731<span></span>
</td>
<td class="nump">1,584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization, intangible assets</a></td>
<td class="num">(800)<span></span>
</td>
<td class="num">(699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, net</a></td>
<td class="nump">$ 931<span></span>
</td>
<td class="nump">$ 885<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived intangible assets, estimated amortization expense, total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114351768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued wages and benefits (including incentive compensation)</a></td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade accounts payable</a></td>
<td class="nump">446<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">356<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BankOverdrafts', window );">Overdrafts</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Accrued insurance</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_MergerConsiderationPayableCurrent', window );">Merger consideration payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,633<span></span>
</td>
<td class="nump">$ 1,041<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_MergerConsiderationPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Consideration Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_MergerConsiderationPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BankOverdrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BankOverdrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480112106200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Long-Term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 4,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Debt issuance costs</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net of current portion</a></td>
<td class="nump">4,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dgx_FinanceLeaseObligationsandOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% Senior Notes due January 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.50% Senior Notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.70% Senior Notes due April 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% Senior Notes due April 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.50% Senior Notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.45% Senior Notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">3.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.20% Senior Notes due June 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.95% Senior Notes due June 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.80% Senior Notes due June 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.95% Senior Notes due July 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">6.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% Senior Notes due January 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.70% Senior Notes due March 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FinanceLeaseObligationsandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FinanceLeaseObligationsandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourPointSevenFivePercentSeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourPointSevenFivePercentSeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourpointtwofivepercentSeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourpointtwofivepercentSeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_SixPointNineFivePercentSeniorNotesDue2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_SixPointNineFivePercentSeniorNotesDue2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FivePointSevenFivePercentSeniorNotesDue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FivePointSevenFivePercentSeniorNotesDue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480112407576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Secured Receivables Credit Facility) (Narrative) (Details) - Secured Receivables Credit Facility - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DebtInstrumentExtensionPeriod', window );">Extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate in excess of LIBOR</a></td>
<td class="nump">0.825%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate in excess of LIBOR</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Loan commitment maturing October 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Loan commitment maturing October 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DebtInstrumentExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DebtInstrumentExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_LoancommitmentmaturingOctober2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_LoancommitmentmaturingOctober2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_LoanCommitmentMaturingOctober2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480100128312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Oct. 22, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior unsecured revolving credit facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior unsecured revolving credit facility [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DebtInstrumentLeverageRatioRequirement', window );">Leverage ratio requirement</a></td>
<td class="nump">650.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior unsecured revolving credit facility [Member] | Maximum | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DebtInstrumentLeverageRatioRequirement', window );">Leverage ratio requirement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350.00%<span></span>
</td>
<td class="nump">450.00%<span></span>
</td>
<td class="nump">625.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior unsecured revolving credit facility [Member] | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate in excess of LIBOR</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior unsecured revolving credit facility [Member] | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="nump">$ 530,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DebtInstrumentLeverageRatioRequirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio Requirement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DebtInstrumentLeverageRatioRequirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480111578888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Senior Notes Offering) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember', window );">Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Losses on extinguishment of debt</a></td>
<td class="nump">$ 9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.80% Senior Notes due June 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 550,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.95% Senior Notes due June 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.20% Senior Notes due June 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480197367560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT (Maturities of Long-Term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentsAbstract', window );"><strong>Debt Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2025</a></td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">3,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LongTermDebtMaturitiesGross', window );">Total maturities of long-term debt</a></td>
<td class="nump">4,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Debt issuance costs</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt', window );">Fair value basis adjustments attributable to hedged debt</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">4,015<span></span>
</td>
<td class="nump">4,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net of current portion</a></td>
<td class="nump">$ 4,013<span></span>
</td>
<td class="nump">$ 3,966<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, fair value basis adjustment attributable to hedged debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LongTermDebtMaturitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date. May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and before deducting unamortized discount or premiums, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LongTermDebtMaturitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480208967960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating leases, rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480115167752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 604<span></span>
</td>
<td class="nump">$ 518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease assets</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseRightofUseAsset', window );">Total lease assets</a></td>
<td class="nump">626<span></span>
</td>
<td class="nump">553<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">141<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current finance lease liabilities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">499<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Noncurrent finance lease liabilities</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">667<span></span>
</td>
<td class="nump">591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Right-of-use asset, accumulated amortization</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LeaseRightofUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LeaseRightofUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108348584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Costs) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_OperatingLeaseFixedAndVariableCost', window );">Operating lease cost</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of leased assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Net lease cost</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ShorttermLeaseandVariableLeaseCost', window );">Short-term leases and variable lease costs</a></td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_OperatingLeaseFixedAndVariableCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Fixed and Variable Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_OperatingLeaseFixedAndVariableCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ShorttermLeaseandVariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term Lease and Variable Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ShorttermLeaseandVariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480309080168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Maturity) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive', window );">Thereafter</a></td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">763<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_OperatingandFinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 667<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance and Operating Lease Liabilities, Payments, Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_OperatingandFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating and finance leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_OperatingandFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480218894664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Term and Rate) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term, Operating leases</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term,Finance leases</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate, Operating leases</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate, Finance leases</a></td>
<td class="nump">8.10%<span></span>
</td>
<td class="nump">8.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480100127352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DerivativeGainAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss', window );">Gain (loss) on derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated net loss from designated or qualifying cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (39,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dgx_ForwardStartingInterestRateSwapsMember', window );">Forward Starting Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dgx_InterestRateLockAgreementsMember', window );">Interest Rate Lock Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dgx_FixedtovariableinterestrateswapMember', window );">Fixed-to-variable interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities', window );">Proceeds from Termination of Derivative Instrument, Operating Activities</a></td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated net loss from designated or qualifying cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge', window );">Hedged liability, cumulative increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DerivativeGainAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Gain, Amortization Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DerivativeGainAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Termination of Derivative Instrument, Operating Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective fair value hedge that is amortized upon discontinuation of the fair value hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 35<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121561968&amp;loc=d3e75592-113984<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dgx_ForwardStartingInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dgx_ForwardStartingInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dgx_InterestRateLockAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dgx_InterestRateLockAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dgx_FixedtovariableinterestrateswapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dgx_FixedtovariableinterestrateswapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108210264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Balance Sheets) (Details) - Long-term Debt - Fair Value Hedging - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedge', window );">Carrying Amount of Hedged Long-Term Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Hedge Accounting Basis Adjustment</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability hedged in fair value hedging relationship.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480106958968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Income Statement) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="num">$ (8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items (Long-term debt)</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108503448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Fair Value of Derivatives) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap Agreements | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability Derivatives:</a></td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480106679544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="13">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Feb. 04, 2021</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock value acquired cost method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325,000,000<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="nump">$ 325,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Reissuance of shares for employee benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Contributions from noncontrolling interest partners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,000,000<span></span>
</td>
<td class="nump">76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,000,000<span></span>
</td>
<td class="nump">$ 76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock value acquired cost method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 325,000,000<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="nump">$ 325,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost | Accounts Payable and Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TreasuryStockValueAcquiredCostMethod1', window );">Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent', window );">Increase in quarterly dividends as percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount', window );">Additional authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Common Stock, Dividends, Declared as Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Shareholders' Equity [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_StockRepurchaseProgramAdditionalAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_StockRepurchaseProgramAdditionalAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TreasuryStockValueAcquiredCostMethod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TreasuryStockValueAcquiredCostMethod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114452920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">$ (39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings', window );">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings', window );">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Net Changes in Available-for-Sale Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings', window );">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Net Deferred Losses on Cash Flow Hedges, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings', window );">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=dgx_OtherEquityComponentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings', window );">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfShareholdersEquityLineItems', window );"><strong>Stockholders&#8217; Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning Balance</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings', window );">Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending Balance</a></td>
<td class="num">$ (21)<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Shareholders' Equity [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts and Jobs Act of 2017, Reclassification of Stranded Tax Effects from AOCI to Retained Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=dgx_OtherEquityComponentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=dgx_OtherEquityComponentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480116510552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_EmployeeLongTermIncentivePlanEltipMember', window );">Employee Long Term Incentive Plan ELTIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans', window );">Contractual life of stock options and other awards under the shared-based compensation plans</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares available for award</a></td>
<td class="nump">79,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember', window );">Restated Director Long-Term Incentive Plan (DLTIP) Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans', window );">Contractual life of stock options and other awards under the shared-based compensation plans</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipMember', window );">Restated Director Long-Term Incentive Plan (DLTIP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares available for award</a></td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual life of stock options and other awards under the Shared-based compensation plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_EmployeeLongTermIncentivePlanEltipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_EmployeeLongTermIncentivePlanEltipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_RestatedDirectorLongTermIncentivePlanDltipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114646200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 17.25<span></span>
</td>
<td class="nump">$ 14.30<span></span>
</td>
<td class="nump">$ 18.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">20.30%<span></span>
</td>
<td class="nump">20.40%<span></span>
</td>
<td class="nump">19.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected holding period, in years</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember', window );">Performance share units with market-based relative TSR goal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 144.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">20.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480238346888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details) - Equity Option - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning of year</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, end of year</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning of year weighted average exercise price</a></td>
<td class="nump">$ 81.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, granted weighted average exercise price</a></td>
<td class="nump">112.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised weighted average exercise price</a></td>
<td class="nump">72.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, end of year weighted average exercise price</a></td>
<td class="nump">$ 90.32<span></span>
</td>
<td class="nump">$ 81.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, end of year weighted average remaining contractual term</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, end of year aggregate intrinsic value</a></td>
<td class="nump">$ 187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, end of year shares</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, end of year weighted average exercise price</a></td>
<td class="nump">$ 83.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, end of year weighted average remaining contractual term</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, end of year aggregate intrinsic value</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest, end of year shares</a></td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest, end of year weighted average exercise price</a></td>
<td class="nump">$ 90.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest, end of year weighted average remaining contractual term</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest, end of year aggregate intrinsic value</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation not yet recognized, stock options</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation cost weighted average period</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480114476776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit related to stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Sharebasedcompensationexcesstaxbenefitamount', window );">Share-based compensation, excess tax benefit, amount</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dgx_StockAwardsMember', window );">Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares outstanding, beginning of year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares forfeited and cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares outstanding, end of year</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Shares outstanding, beginning of year weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88.13<span></span>
</td>
<td class="nump">$ 93.30<span></span>
</td>
<td class="nump">$ 88.13<span></span>
</td>
<td class="nump">$ 77.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Shares granted weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.43<span></span>
</td>
<td class="nump">86.28<span></span>
</td>
<td class="nump">103.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Shares vested weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.36<span></span>
</td>
<td class="nump">75.58<span></span>
</td>
<td class="nump">74.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Shares forfeited and cancelled weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">94.09<span></span>
</td>
<td class="nump">90.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Shares outstanding, end of year weighted average grant date fair value</a></td>
<td class="nump">$ 100.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.12<span></span>
</td>
<td class="nump">$ 93.30<span></span>
</td>
<td class="nump">$ 88.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized stock-based compensation cost</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized stock-based compensation cost weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of shares vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Sharebasedcompensationexcesstaxbenefitamount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation, excess tax benefit, amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Sharebasedcompensationexcesstaxbenefitamount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dgx_StockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dgx_StockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480113765272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Company's expense for contributions to its defined contribution plans</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Amended company match percentage of employee contributions</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Percentage of maximum annual wages witheld for the ESPP</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp', window );">Market price of company stock issued at a discount under the ESPP</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares available for award</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares purchased by eligible employees under ESPP</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Element represents the discounted market value of the Company stock on offering date or purchase date that participants pay for shares. Typically, the participant's per share cost is the lower of the prices on the two dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480106982824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Amended company match percentage of employee contributions</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SupplementalDeferredCompensationPlanMember', window );">Supplemental Deferred Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalDeferredCompensationPlanSalaryDeferral', window );">SDCP salary deferral</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral', window );">SDCP variable incentive compensation deferral</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability', window );">SDCP accrual</a></td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="nump">$ 59,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP', window );">Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP</a></td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="nump">59,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SupplementalDeferredCompensationPlanMember', window );">Supplemental Deferred Compensation Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Amended company match percentage of employee contributions</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SdcpIiMember', window );">SDCP II [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Amended company match percentage of employee contributions</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability', window );">SDCP accrual</a></td>
<td class="nump">$ 59,000<span></span>
</td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1', window );">SDCP II vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_SdcpIiGradedVestingPercentage', window );">SDCP II graded vesting percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 43,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SdcpIiMember', window );">SDCP II [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer', window );">Deferred compensation arrangement with individual, employer contribution</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funds in a trust pertaining to all participant deferrals and company matching amounts related to the Supplemental Deferred Compensation Plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SdcpIiGradedVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>SDCP II graded vesting percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SdcpIiGradedVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalDeferredCompensationPlanSalaryDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of salary deferral under the Supplemental Deferred Compensation Plan. This plans is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to this percentage of their annual salary in excess of their defined contribution plan limits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalDeferredCompensationPlanSalaryDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferral percentage of the variable incentive compensation under the Supplemental Deferred Compensation Plan. The plan is an unfunded, non-qualified plan that provides for certain management and highly compensated eligible employees to defer up to this percentage of their variable incentive compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20015-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6409961&amp;loc=d3e20487-108367<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SupplementalDeferredCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SupplementalDeferredCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SdcpIiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=dgx_SdcpIiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480113914136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount', window );">Purchase obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 334,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary', window );">Purchase obligation in 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears', window );">Purchase obligation in 2021 through 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AgreementtoOutsourceBillingandCollectionFunction', window );">Agreement to outsource billing and collection function</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RemainingTermsofContingentLeaseObligationsMaximum', window );">Remaining terms of lease obligations, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">27 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">New claims filed (in lawsuits) | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted', window );">Self-insurance reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AgreementtoOutsourceBillingandCollectionFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement to Outsource Billing and Collection Function</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AgreementtoOutsourceBillingandCollectionFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_RemainingTermsofContingentLeaseObligationsMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining Terms of Contingent Lease Obligations, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_RemainingTermsofContingentLeaseObligationsMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480116581528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues from the DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 3,002<span></span>
</td>
<td class="nump">$ 2,786<span></span>
</td>
<td class="nump">$ 1,827<span></span>
</td>
<td class="nump">$ 1,822<span></span>
</td>
<td class="nump">$ 1,926<span></span>
</td>
<td class="nump">$ 1,956<span></span>
</td>
<td class="nump">$ 1,953<span></span>
</td>
<td class="nump">$ 1,891<span></span>
</td>
<td class="nump">$ 9,437<span></span>
</td>
<td class="nump">$ 7,726<span></span>
</td>
<td class="nump">$ 7,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,971<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income from continuing operations before income taxes and equity in earnings of equity method investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(460)<span></span>
</td>
<td class="num">(247)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">609<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">609<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net income attributable to noncontrolling interests</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="nump">736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">418<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember', window );">Routine clinical testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,836<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
<td class="nump">4,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember', window );">COVID-19 testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,723<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember', window );">Gene-based and esoteric (including advanced diagnostics) testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,098<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
<td class="nump">2,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember', window );">Anatomic pathology testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="nump">579<span></span>
</td>
<td class="nump">578<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember', window );">All other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
<td class="nump">$ 327<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues from the DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,139<span></span>
</td>
<td class="nump">$ 7,405<span></span>
</td>
<td class="nump">$ 7,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,201<span></span>
</td>
<td class="nump">1,298<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">394<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="nump">327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">General corporate income (expenses), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(269)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Total capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues from the DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AllotherservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480107021272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Additional contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Accounts receivable, related parties</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable, related parties</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDividendsReceived', window );">Dividends paid</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Equity Method Investee | Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_OtherAccountsReceivableRelatedParties', window );">Other accounts receivable, related parties</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Equity Method Investee | Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Income recognized from related party</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember', window );">Corporate Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Accounts receivable, related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_OtherAccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Accounts Receivable, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_OtherAccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables arising from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends received on equity and other investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_CorporateJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480207599736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Details) - NID - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits', window );">Gain on settling uncertain tax benefits</a></td>
<td class="num">$ (20)<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Refund from taxing authorities related to settlement of the uncertain tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Gain on Settling Uncertain Tax Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_NidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_NidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480112380248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Operating Results (unaudited) (Schedule) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 3,002<span></span>
</td>
<td class="nump">$ 2,786<span></span>
</td>
<td class="nump">$ 1,827<span></span>
</td>
<td class="nump">$ 1,822<span></span>
</td>
<td class="nump">$ 1,926<span></span>
</td>
<td class="nump">$ 1,956<span></span>
</td>
<td class="nump">$ 1,953<span></span>
</td>
<td class="nump">$ 1,891<span></span>
</td>
<td class="nump">$ 9,437<span></span>
</td>
<td class="nump">$ 7,726<span></span>
</td>
<td class="nump">$ 7,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,269<span></span>
</td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="nump">552<span></span>
</td>
<td class="nump">662<span></span>
</td>
<td class="nump">692<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="nump">647<span></span>
</td>
<td class="nump">3,633<span></span>
</td>
<td class="nump">2,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">609<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">886<span></span>
</td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income (loss) from discontinued operations, net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">609<span></span>
</td>
<td class="nump">591<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">1,499<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net income attributable to noncontrolling interests</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">$ 1,431<span></span>
</td>
<td class="nump">$ 858<span></span>
</td>
<td class="nump">$ 736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - basic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="nump">$ 4.28<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="nump">$ 1.52<span></span>
</td>
<td class="nump">$ 1.22<span></span>
</td>
<td class="nump">$ 10.62<span></span>
</td>
<td class="nump">$ 6.21<span></span>
</td>
<td class="nump">$ 5.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (in dollars per share)</a></td>
<td class="nump">4.28<span></span>
</td>
<td class="nump">4.20<span></span>
</td>
<td class="nump">1.38<span></span>
</td>
<td class="nump">0.74<span></span>
</td>
<td class="nump">1.88<span></span>
</td>
<td class="nump">1.59<span></span>
</td>
<td class="nump">1.67<span></span>
</td>
<td class="nump">1.22<span></span>
</td>
<td class="nump">10.62<span></span>
</td>
<td class="nump">6.36<span></span>
</td>
<td class="nump">5.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders - diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations (in dollars per share)</a></td>
<td class="nump">4.21<span></span>
</td>
<td class="nump">4.14<span></span>
</td>
<td class="nump">1.36<span></span>
</td>
<td class="nump">0.73<span></span>
</td>
<td class="nump">1.86<span></span>
</td>
<td class="nump">1.56<span></span>
</td>
<td class="nump">1.51<span></span>
</td>
<td class="nump">1.20<span></span>
</td>
<td class="nump">10.47<span></span>
</td>
<td class="nump">6.13<span></span>
</td>
<td class="nump">5.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Income from discontinued operations (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0.15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (in dollars per share)</a></td>
<td class="nump">$ 4.21<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
<td class="nump">$ 1.86<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 10.47<span></span>
</td>
<td class="nump">$ 6.28<span></span>
</td>
<td class="nump">$ 5.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480119426344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Operating Results (unaudited) (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RestructuringIntegrationCharges', window );">Restructuring and integration charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ChargesDueToCOVID19', window );">Pre-tax charges due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Sharebasedcompensationexcesstaxbenefitamount', window );">Share-based compensation, excess tax benefit, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PreTaxGainLossDueToCOVID19', window );">Pre-tax gain (loss) due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct', window );">Income recognized due to receipt of initial tranche of funds from the CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct', window );">Reversal of income recognized due to receipt of initial tranche of funds from the CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt', window );">Gain recognized by an equity method investee to adjust certain of its investments to fair value, partially offset by a loss on retirement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge', window );">Gain associated with an insurance claim for hurricane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident', window );">Cost incurred do to incident</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gain from sale and leaseback of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_NidMember', window );">NID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits', window );">Gain on settling uncertain tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">Mid America Clinical Laboratories, LLC (MACL)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of voting interests acquired</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RestructuringIntegrationCharges', window );">Restructuring and integration charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ChargesDueToCOVID19', window );">Pre-tax charges due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RestructuringIntegrationCharges', window );">Restructuring and integration charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ChargesDueToCOVID19', window );">Pre-tax charges due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ChargesDueToCOVID19', window );">Pre-tax charges due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RestructuringIntegrationCharges', window );">Restructuring and integration charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ChargesDueToCOVID19', window );">Pre-tax charges due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PreTaxGainLossDueToCOVID19', window );">Pre-tax gain (loss) due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_RestructuringIntegrationCharges', window );">Restructuring and integration charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ChargesDueToCOVID19', window );">Pre-tax charges due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PreTaxGainLossDueToCOVID19', window );">Pre-tax gain (loss) due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt', window );">Gain recognized by an equity method investee to adjust certain of its investments to fair value, partially offset by a loss on retirement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge', window );">Gain associated with an insurance claim for hurricane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident', window );">Cost incurred do to incident</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gain from sale and leaseback of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember', window );">Other Operating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ChargesDueToCOVID19', window );">Pre-tax charges due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PreTaxGainLossDueToCOVID19', window );">Pre-tax gain (loss) due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge', window );">Gain associated with an insurance claim for hurricane</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident', window );">Cost incurred do to incident</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gain from sale and leaseback of property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember', window );">Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt', window );">Gain recognized by an equity method investee to adjust certain of its investments to fair value, partially offset by a loss on retirement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember', window );">Other Income (Expense) | Mid America Clinical Laboratories, LLC (MACL)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=dgx_AmortizationofIntangibleAssetsMember', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=dgx_EquityinEarningsofEquityMethodInvesteesMember', window );">Equity in Earnings of Equity Method Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_QuarterlyFinancialDataLineItems', window );"><strong>Quarterly Financial Data [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ChargesDueToCOVID19', window );">Pre-tax charges due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PreTaxGainLossDueToCOVID19', window );">Pre-tax gain (loss) due to COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt', window );">Gain recognized by an equity method investee to adjust certain of its investments to fair value, partially offset by a loss on retirement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ChargesDueToCOVID19">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Charges due to COVID-19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ChargesDueToCOVID19</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Gain on Settling Uncertain Tax Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) recognized by equity method investee to adjust certain investments to fair value, partially offset by a loss on retirement of debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain associated with contingent consideration accrual, partially offset by costs incurred related to security incident</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain associated with insurance claim, partially offset by non-cash asset impairment charge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Recognized due to Receipt of Initial Tranche of Funds From the CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PreTaxGainLossDueToCOVID19">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-tax Gain (loss) due to COVID-19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PreTaxGainLossDueToCOVID19</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_QuarterlyFinancialDataLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Quarterly Financial Data [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_QuarterlyFinancialDataLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_RestructuringIntegrationCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Combined restructuring and integration charges, which may include professional fees, incurred in connection with further restructuring and integrating the Company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_RestructuringIntegrationCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reversal of Income Recognized due to Receipt of Initial Tranche of Funds from the CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_Sharebasedcompensationexcesstaxbenefitamount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation, excess tax benefit, amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_Sharebasedcompensationexcesstaxbenefitamount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121606570&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_NidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_NidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dgx_OtherIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=dgx_AmortizationofIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=dgx_AmortizationofIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=dgx_EquityinEarningsofEquityMethodInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=dgx_EquityinEarningsofEquityMethodInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140480108428456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II - Valuation Accounts and Reserves (Details) - SEC Schedule, 12-09, Allowance, Credit Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning balance</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Provision for doubtfull accounts</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Net deductions and other</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending balance</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>116
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -F!5E('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #9@592%]RN1.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)TEE#Z';B^))07!!\1:2V=U@TX9DI-VW-XV[740?P&-F_GSS
M#4QK@C)CQ.<X!HSD,-W,OA^2,F'+CD1! 21S1*]3G1-#;N['Z#7E9SQ T.9#
M'Q DYQOP2-IJTK  J[ 26==:HTQ$36,\XZU9\>$S]@5F#6"/'@=*(&H!K%LF
MAM/<MW %+##"Z--W >U*+-4_L:4#[)R<DUM3TS354U-R>0<!;T^/+V7=R@V)
M]& P_TI.T2G@EETFOS9W][L'UDDN1<5E)>5.;)2X50U_7UQ_^%V%_6C=WOUC
MXXM@U\*ON^B^ %!+ P04    " #9@592F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M -F!5E(=IOY[ @8   $9   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MI5E;;]LV%'[N?@7A%5L+Q+%(^9)T20#'3CKWDGIQUBX;]D!+M"U$(CV2BI/]
M^AW*LN0&\I& O<2ZG8\?#\GO7'*V4?K!K(2PY"F)I3EOK:Q=O^MT3+ 2"3?'
M:BTDO%DHG7 +MWK9,6LM>)@9)7&'>5Z_D_!(MB[.LF=3?7&F4AM'4DPU,6F2
M</U\*6*U.6_1UN[!;;1<6?>@<W&VYDLQ$_;W]53#7:= ":-$2!,I2;18G+>&
M]-W8'SB#[(NOD=B8O6OBIC)7ZL'=3,+SEN<8B5@$UD%P^'D4(Q''#@EX_).#
MMHHQG>'^]0[].IL\3&;.C1BI^%L4VM5YZZ1%0K'@:6QOU>97D4^HY_ "%9OL
M+]ELO^UV6R1(C55);@P,DDAN?_E3[H@]@T'O@ '+#=@+ WIH!#\W\)L:='.#
M;N:9[50R/XRYY1=G6FV(=E\#FKO(G)E9P_0CZ=9]9C6\C<#.7HS4H]!D"DM,
MVN3WV9B\>?V6O":1))=1',/*F+..A7'<UYT@Q[S<8K(#F)21STK:E2%7,A3A
M]P =(%BP9#N6EPQ%'(O@F/CTB#"/>16$1KCY!RX+<UIA/JXQ3YVY5S7Z=[/Q
M"Y_[&9Z/^OROX=Q8#?O^;P2R6T!V,\CN(0>I((73:,G=\UI4K1AN3KWV1X1%
MKV#1:\9B*&7*8W(KUDK;*CHXCM6I0.CT"SK]9G2F0D<J=+N1P"&I]$\-4K[_
M?GCUJF8/# IN Q1QE&KMJ%U')@!/W0NN47XX6KM-6=NG"*^3@M=)PXVD.8A[
MILV'EQ''6O#88.MX6G Z17&NI(WL,[@J%N0F3>9"5W'!,3R/@H\8[2%\J%>*
MIM>$T:U81NX,@[MN>%*Y;C5 OZ7"6#*.^%(J8Z/ D(D,,(I[NDZ;4 0XI6'Y
MN%O)(S*SL+^(TF2D4FGU,_R&U;QQ]/$51I*5)%D3DG?\B4Q"V'71(@HRIL@Z
MUT#2?IOZ)X.3/L,8EE)-_28,AV&HA3%'NPOR";XC7V2U[W#(GN>1:<S_Y62L
M(>?!:);R3W$!?TESY.Y@F>_41E92Q.%F(N I9!]'&+DR*E!<SE^2*S;A5*O'
M2 ;53L0Q;SY@U,H(07%A?TEM"J<0Y/C/:'WX9."(WL [[6+<R@A!:T)$Q@R2
M^<-4<( WIP/_+4:E# H45_)/R@6IZ4I)3(%K0'K,:[.!AT5/6H8$BNOY760A
M&J@%H>S-_"V!#9MJ\%<E+1QII)($!&=F5?!P1%X?>Y2L(1@_\AA-0E@9+!BN
M\1!)PT@NR>PYF:NXBF$-P/C]'QB1,B0P7+1W3B)73\&*2TCY#T6M&J";^QFF
M_ZS4?]9(_[]!V==^D*!5L)#<P"X+R<28M'J;U6#>"X-Q*Y6?-5+^KRJ&2 DE
M<99_Z,IRJ ;I1F&$2HUGC31^ESENL[)L8X&>IM7$<,0:5Y4"SQH)_$1:H;>%
MO,MC^8YJ)3,<L899J>^LD;YG2T=&$':62E>*1 W.)Z[AN R#0  0P(1;2(QC
MJ?,,E^F<XRSA<4PN4P.O3?5JXCAUZ38KY9[A2ITSNDJ$7KH-]AX0[ K"4++F
MLMI]_Z\28*7NLT:UP&P%DH$2PF'J"/FENON-2H%I.H^C@%S'BE?M]W&.TLM0
M7#/N\8+VCB%'?:P:O91TOU&6_WT,FZTX9#/D2VHAF9$N]E2U3'+D_CXCW^_V
MNH,^/4"KU'4?U^!=%6GVZ@\X,W-7,BT$:$)USE>#.G5ZIZ1Q8=^N!-%%^?6S
M<;GDT_,VM<SJ5ZO(7) %G-)LW.%:1_%//]*^]TO>R<&J97^OE=,H2HQ@2 TI
MTD2&XHE\%)5[L@;*@QK58\P;G&+,RG#A-VP)[;<8KN%AI;;4@-5UOLI0X3=L
M$>6L\M;,85XXW/4]QJH,$SXN[T.@%&YIQ;SJM%S6 -3J21D-?%S%)Z/K6S),
MP\A"@32T5L 9SBKB@\QPO$.]M,Y>S]CI?-9[-R1P?8%M^[AX6O3WAUE7NU-^
MOOWGP&?NPH0AL5B J7?LFN-ZVV_?WEBUSCK0<V6M2K++E>"AT.X#>+]0RNYN
MW #%?STN_@-02P,$%     @ V8%64A'0CFS1!@  -AL  !@   !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6RMF6USFS@0Q[^*QLVTUYFD1@(#SH-GW"1W[4R:
MY.*T]^+F7LA8B9D"<B61-/?I;P4$;"243.?>) 96XJ^5=G]:<?S(Q7>Y9DRA
MGWE6R)/16JG-X7@LDS7+J?S -ZR )W=<Y%3!I;@?RXU@=%4URK,Q\;QPG-.T
M&,V.JWO78G;,2Y6E!;L62)9Y3L731Y;QQY,1'CW?N$GOUTK?&,^.-_2>+9CZ
MNKD6<#5N>UFE.2MDR@LDV-W):(X/3_U0-Z@LOJ7L46[]1GHH2\Z_ZXO/JY.1
MIQ6QC"5*=T'AWP,[95FF>P(=/YI.1^T[=</MW\^]_UX-'@:SI)*=\NRO=*76
M)Z-XA%;LCI:9NN&/GU@SH(GN+^&9K/ZBQ\;6&Z&DE(KG36-0D*=%_9_^;!RQ
MU0 ' PU(TX"\MH'?-/"K@=;*JF&=445GQX(_(J&MH3?]H_)-U1I&DQ9Z&A=*
MP-,4VJG9Z=7EXNKB\]G\]OP,?9Q?S"]/S]'BT_GY[0(=H*^+,_3;WGLDUU0P
MB=("?4FS#-PO]]'>]N7Q6($8W>4X:5[\L7XQ&7CQ&4L^(!_O(^(1S]+\]-7-
M\72W^1A<T/J!M'X@57_^0']S*9F2CH[\MB._ZB@8<BB5:T2+%4KT#_:C3!]H
MQHI^W[6+ZJZBJBL=< \SC"?Q\?AAVQ$VHREIC794!JW*P*ERGB2\!%$0B0D#
MA<N,[:,"L@:_0S2#V*9%PA!D"90(MDH5RC@X2.K'>R2NQK>')XA6=V N6+YD
MXNT;''I'SW-:&>G9V8>7R VKXC5[LKFAUAINCW"B%\6.&RQ&7NC;W3!IW3!Q
MNN%S\0!3PT7*K-,S,5Y)B-^39=I@,J J;%6%3E77@FUHND+L)R1K[77M2:[6
M#&:C% (4@^/-Y5IK#BV^C'J:+39X8$%%K>;(J?F6*YJ]0EYDO-KWC!5O&I%@
MZMD%QJW ^ 6G OJ$>MI'FXQJB>!3'9T;8)*JUKY-;FQZ*B1]=UJ,@LG &IBV
M<J=.N5<@EJJTN$<9 THAH7%TP.\.2K@8=N_4D!)Z04^N:3/!L5TM]CJ,>$Z]
M?W"^>@086$'@F:KBJ!](-JM0YW:KL"V^X1="7-'B/H4$U[AM<*Z;CG;#(NQ/
MMM6*X &9'7XP>3$32:778H59O3+5$\J96O,5W- /F3U)-1WOS.>6GD:U:13$
M R&/.]1A-^NNJIPTO!J;YCN^BL*^-(M1.!#LN.,;=@.NSD<.:1:<!!XQQ%G,
M2!P,!#?NN(,GSNW&14J7:9:JM,GN"\63[VN>K9B0[]!Y-?N.S0CN4(+=+&E!
MOZ%/M H">!M-$E&R#C!6!UD@$?I&T%JLO& H&CJ88#=-+IB4A^BTH<F&BVK+
M#UN-C!?W!XJ)'+;J2WL46^#1%VV:Q%M9<E=SQQ?L!HQ3+>^E\ZR;?^L@;$@Q
M8MK*G8%A=-S!;O#L@OPEG29+<&1&N,5J.L1STB&'N)%S\>):("92 @_WU[#%
MRI^&X8"\#CS$#9Z+7YU\8A(FF$[[HBU&>" MD:TBR$VA.J&_I,]D21ST,6DQ
MBO! 7B =<,@+Q17/\[2A9%5C\4+[E17)D%9G?_J,Y%!N:,).1ALH4IAX8*,9
MLE6C_T-'NV/N2$;<)+MA*\;R*G<7O- C%AR*;EA-:0'+"S8&UH&;X(K[>=!B
M$PTM^XYLQ$VV/TM0A,Y2>E]PJ=)$(KG%MK=O8H*CHV9_<^AR4(<XXD:<7A20
M;ZO7P.Z>"@05=\G0GO?!PPABKSZ^.$*AYSV?9- 2-E8B_1<@6->P2ZBOVD(6
M&37L$0+9[3&(E.5K&UKGQH2F,34NDUT_=5 E;JC.5U#( YD@O>OR\@"VF0G=
MI)#NK2(M'(T-!MFL(C(DM6,I<;/TABD*MV"'0D4!2]T>VR;_IKYG9'?3*L;1
M .U)ATGBQB3LJ\J\S*AB;6G.<PC]M3[A?&#H-WU@\AY"%&XSJWH3B@?&MMUF
MY ^41'X'3M\-SEL!&"K%TW/(4 7BI3I"<=#&QZ^N;=^$Z<'$#_M; JL9&2I#
M_0ZZOANZ]>[%G8/>-=G'*M_$:AA-^O"U6$W"H5VOW]'7=]/WTI[>[2>'EJJO
M?V)FL0D&\KN_=;SI1G#MX5?[TRSNPM@S_&E:3<(X&I#:D=-_30V8]4JM5TL/
MS'-72X5H,QNN$/V.H[Z;HPW5%G6(7I95"$),+JH W4?7P+EO%>?TH.J-VUDJ
M$\@[I8[@O^=+J01-U#^N0^T.LKX;LOV<4><)J]],=,7](RBW32UQO/510W]1
M^D+%?5I(V$/?02/O0P3^$_5'FOI"\4WUG0.REN)Y]7/-*$RS-H#G=YRKYPO]
MZ:3]5#;[#U!+ P04    " #9@592R_RQ[*T"   L!P  &    'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;)65VV[B,!"&7\6*>M%*77+@$+8*D2A0M5(/J&EW
M+U9[81)#K#IQUG:@W:??L9-&@0+;WH =S__/-Q/'#C9<O,B4$(5>,Y;+D94J
M55S8MHQ3DF'9X07)867)18853,7*EH4@.#&BC-F>XPSL#-/<"@/S;"["@)>*
MT9S,!9)EEF'Q=DD8WXPLUWI_\$A7J=(/[# H\(I$1#T7<P$SNW%):$9R27F.
M!%F.K+%[,?%UO GX0<E&ML9(5[+@_$5/;I*1Y6@@PDBLM .&OS69$,:T$6#\
MJ3VM)J46ML?O[E>F=JAE@269</:3)BH=64,+)62)2Z8>^>::U/7TM5_,F32_
M:%/'.A:*2ZEX5HN!(*-Y]8]?ZSZT!&[O@,"K!=YG!=U:T#6%5F2FK"E6. P$
MWR"AH\%-#TQOC!JJH;E^BY$2L$I!I\+)PWWT<'LS'3_-INAR?#N^G\Q0=#V;
M/47H=(X%R55*%(TQ.T/?T',T1:<G9TBFL"(1S=$=90Q>ASQ')^UI8"N TRGL
MN :YK$"\ R!3$G=0USU'GN,Y>^233\O=[]MR&UK2],5K^N(9O^X!OTAA16"W
M*L27Z(KF.(\I9FC.)37;[]=X(96 3?C[2+)NDZQKDO4.)!LS^)@@ T'P6:*$
MEPNU+!EL\9B7N=K;S,K0-X;Z2UV'WC"PU^V&?0QQ^TW(%F>OX>P=Y9SP+(/:
M85/&+^>HP *M,2O)/K[*:-A*[G0<=X?P/T%;C/V&L?\%QGJCXE*E7-"_)-G'
M6AD.6A@#Q]E!/1ZS13IH2 =?)Z52EOLI!Q\(/-??H3P>LT7I-Y3^4<HGN!MD
M*=ZV.?<!^A^2#WL[?$=#*CR[=9;I>^0.BQ7-)6)D"2*GX\.;$-797$T4+\SQ
MMN *#DLS3.$Z(T('P/J2<_4^T2=F<T&&_P!02P,$%     @ V8%64CY3ZCN(
M!@  GQX  !@   !X;"]W;W)K<VAE971S+W-H965T-"YX;6RM66USFS@0_BL:
M7^>FG6EL),#@G..9Q$ZGF6F:7)W>?;BY#]C(-E- KI"3]'[]21@#EA;%??F2
M&'AVT;.KW7V \1/C7XH-I0(]9VE>7/0V0FS/!X-BN:%95/39EN;RRHKQ+!+R
MD*\'Q9;3*"Z-LG1 '&<XR*(D[TW&Y;E[/AFSG4B3G-YS5.RR+.+?KFC*GBYZ
MN'<X\2E9;X0Z,9B,M]&:SJGXO+WG\FA0>XF3C.9%PG+$Z>JB=XG/9ZZO#$K$
M7PE]*EJ_D:*R8.R+.KB)+WJ.6A%-Z5(H%Y'\]TBG-$V5)[F.KY737GU/9=C^
M??#^KB0OR2RB@DY9^G<2B\U%+^RAF*ZB72H^L:?WM")4+G#)TJ+\BYXJK--#
MRUTA6%89RQ5D2;[_'SU7@6@9X&&' :D,B&[@=1BXE8%[JH%7&7AE9/94RCC,
M(A%-QIP](:[0TIOZ40:SM);TDUSE?2ZXO)I(.S&9WGV<WWVXF5T^7,_0_$'^
MN[W^^#!'=^_0W?WUI\N'&PE 9^CS?(9>OWJ#7J$D1[=)FLJD%>.!D$M0C@;+
MZG97^]N1CMMA@FY9+C8%NLYC&A\[&,BUUP3(@< 5L7J<T64?N?@M(@YQ@ 5-
M3S;'(\!\=KIY:&'CUNEP2W]NA[^;?,DRBN8B$E16ET#_7"X*P65U_&OQ[M7>
MO=*[U^']H^PCG#[2?$?!W.VM@]):-8S'R<AS@_'@L1U/$Q0$9'@,F@$@W\4U
MZ&CU?KUZWQJ;NRWED4CR-5JR0A0HRF-$GV4#+.C^@(D-Y8C5L.HB>IV447US
M;@GAL%[$T!K"J;PU8BM44/Z8+.$P[CT,6^3]T/&T, (@1X_US 1YHU:LCQ@$
M-8/ RF N>ZR,SENTIKF,5%J&+HIE;TG43E-M&"(5&$O!ON]HI "0Y^ND(!#Q
M8%)A32JTDKK,&!?)?U$Y2V1ZDEQ$^3I9I!1%14$%F*?07(CC:HQ,S$C?ZP#$
M@=F,:C8C*YN[%S;R6Y13 3$:F4O1^)B(LY&O$0(PN(,1=IHYXU@Y/3 A]QJS
MU' GJ\IS>T&!-]32, 500\_@!J+<+G:M*8KM&:MY[5,$TL#F?AL%6*<!H(B+
M=1H "CL=#1:3A@:QM]ARX^TIH-=58JQ]$S>3#;O6$-WD@G(JNV?EMCO=+K#_
MAGIA@JC 2#?H*^B(4S-'L7V0PG'J9N29&]C8OB:&.#H;$W,6=G!IIBKV3RC,
MG.5G1L.QE*0/K$17"A!(#@V=%(1J)?*85C.GL7U05TIJQ5DF>TTN:>T4LXJC
M%*]H0>5C$SUD443/E8R@7W>)^*9T+HUX+HT*-5&JLQD5&Q;+BX]R*U-X_F-S
M;.,PU 4 A'+T;3$#4)T* #<2 -LUP$W-^9!JD(<YJ<^\H3[S(13Q]*$/H7!(
M.H@T8Q_;Y_[U]^2JW,WJ>IEKD+$YR_66,@4PAL0!,%Z'PL&-*,!V5?#BC@89
MF<,<>R-=%0"H,#2VH@D*PH[V0QI=0.RZH,TJ3HJ*&(U;O%[.&S&GNKY- 8C1
M7ZUNCODURH#8E8%ZYNK6! 28XV9Z -3(T=,#@+K3TR@"0JS+_T"+XAPU)% D
M!$\6.Q$I;2V8&APJ9YR53Q5*>)=3'DX3,<57J',U,5ZH4S4Q?D<K(8T^(79]
M8N'XYT[IEED2K7.I6I,E3,Z4&MC3A=L40(6^P<\$!6Y'TR>-:"&>5=S)9Z1=
MKC3W2^Q^_RTD./A#-IDLDX]3A6#++QN6QI07-BE(&LE![)+CASH9,74"%%\3
M%;I&?$U0=WP;Q4%.5QP_WLG,>6]T,A-B=C*;FV-^C6@@=M'PTP42&"^%H 2:
M**! 3%!W ALQ04)K@5P?)(3,%RHV$3^!J*56T)EZ(YTLK3733'_RD]-?O1U
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M.C<^MC11#J;E1O%-,:JMN,+!KU@F.,Q3H0'X?LVY>MMH ]7?@]%_4$L#!!0
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MZ-_7G*M?7\P#NO]ON/X?4$L#!!0    ( -F!5E+$*K4*U @  ,@P   8
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M;:C22_J:<U$P\RB@A+8=4BI'R<\?7NC.L:%;V_:$A"DM'@WU4R001;0GM^<
MBEF2B2J5HFZ5>O7X0DW!T@O2J1O39:[$BKK%ZGGC"P6TB>C/L*;[4%V*2ISH
MOH/&MTA>0!GH2(\--ZC+7]5\ZJ[YKQU?*/"846OE)P#&TR+_#,)8'J93)2/T
M[8XJ6]4#;]"8 L\*87),"0U[^]-&!@R"6E<S<6.Z9)5&L;<_2F3 !!?JDQ,
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M!^*&NN,C*")?;(#]W-K0+3A ?_^=_PU02P,$%     @ V8%64LQ>KU/G)
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MN3S__ME7.)X&_+VV!Y_\7>!.5LY]P ]7U8\GCQ @V]BRQQD,_'=MG]NFP8D
MC#]ESI.P)#Z8_JVSOZ*]PUY6QMOGKOGWNNJW/YY\>U)4=FV&IG_K#O]B93]/
M<+[2-9[^+0X\]JO')T4Y^-[MY&& 8%>W_+_Y*'A('OCVT9$'+N2!"X*;%R(H
M7YC>_/1#YPY%AZ-A-OR#MDI/ W!UBX?RKN_@UQJ>ZW]Z]_NOOUZ^_8_BMU?%
MNZN?7U^]NGI^^?I]<?G\^6^_OWY_]?KGXLUOOUP]OWKY[H>'/:R'3STL9>YG
M//?%D;G/+XI?7=MO??&RK6R53_ 0  W07BBTSRYNG?&%+9?%X_-%<?'HXM$M
M\ST.NW],\ST^,M]E6;JA[>MV4[QQ35W6UA?_>;GR?0?4\E^W+/!56. K6N"K
M?PAZ_ZJYBS==W9;UOH'MN77QW+4>=EL9XHOW6UN4X1M;%>NZ-3#:-(7OX0O@
MP-X7\'PS5+;H8;1AK-%<IFD*&%#WB#J8IN]<T\ DJQL:^MSM]J;%OSLW;+9%
M#4]5=0<L6;@.)M6_#ZWM_+;>TY1 WW^XKNYOBFM'9U.WO>VL[Y?%9575"#4L
M>[.@%3X?]&O3U6;5V#!]W,B#?_ZG;R\N'CW]^]5+3W^>/SV%8<5A6Y?;;&-;
MXP'@Z52F!6A@B],G:D\?985]5Z,P+%:VM6L@0/A;%BQ@YKJG!5:NWWY?/#@_
MI2?W[F"[HG>*2-X7"#>&'7:&WP#H\+_IBYT#<'R]:6N8W[1] R  )/(@#,/U
MSK]YZ@L+N'2[NBSVMB-QWY:6-O+@@E=VJZ;>,-7 \F;E7;<J&N?]S+)[UR,Z
M\:#@C(8&2,*F8. ,^@#@"?_L4(+B][ M"[):D *GM>[<[K.G!ZH!(DU_HU,J
MY3P"2>!.@?%;;TAAP!>=+6Q3@]0EXH+S+U/.6197+4P"*.K[KEX-/5& K L/
M,0D'BH#'$S+XFX]4CM1?T?() V5T[8>5KRL@#CQ@("! D.LJ?,@7K<6Y9P%I
M7:LSIFSD%99\C<@Q<):@]3LC:$"\P.@CLS$\:U2S#) IO-T;>!H7V.U="W/B
ME*/57/EAZYH*^/YOA?US8%Q-P5J9ANB05-RR>&9\30"^@;5A8J;&%T.'(.'#
M_;;NJN+/P70 '@Y$\V21<2!"U5B<'+\]@!0J*C@#'/P:N!4T*IRL!U$PP!9>
MU&;3 @O5)8B%D]=7+TY.%[#%'G?^ ?@3N&18 \4P!.&@;I8D6)&X:%'\\?[H
M[FQ#@ZK:E\!? ^P5OMN[CID6/H+100\"0(AS'.A0D0WP5#*9RMV+1^?? =B]
MR*.]@],K2MOU8+8I]?3F8\&3;&Q+JE#! %+"=4#LT-JNN;;5LGAG;?$:V+"X
M."=19XKUT %X'4$S>++; ,0CL"V+M[9L# Q#KF1PGPM$9L<L*00!0A+FAR=K
M=T3&;PV)"XN&HD[*@,/2*,N4+_<IV8C,*H>N0QJ]98%E\9))]%?;;V',57L-
M!,!KIW\#P$&)3$5_Y>#KUO7*YXL"F#7J%9'VAJBH-R3>$M48&.X!G ]@$47?
MRO8'W/7%HR^)<+[Z[LM3EB0&(/D(4J[V=B3[ULT YVL7)-]$^EG65H-7-A*.
MW/%V42L'4XDHVZ.NB_O&J1*\H^H:826;CW^T=EX2C5C^?8)!%GR>[(A]!YH"
M;%X8A\O+85K3M0"DA^U5?X#]+#L#\#NKA[XB(5+5ZS4@E%#!#X\V%<'&OV1>
M''ID,PN2Q3B5^7AD:\>X?KS+:_0^:)?WQ"/N$=5ZW>%0("@@D6M@1?B'%NN*
M<FN L6F2LN[*88<D5M(7%3*@9<5*()NN(XFE?+@S-T2W*TLG !.CBED6OWO"
M^TL0C^ @P5SOF<5(_ NRC]ADRIBXFT/=;Q,"0WY7<S62.OQN]Z*'$<C?VQH_
MO>MI8;78?KZ\?!,LM@ZQA;(3A#1XF(09D ,[\P'H),",[ *4.^SV*C,!#09H
MHU1IBX(7J7H7S5ZP><1D:,#RJQMF>?P<9;8H/1:H_=%G>!6D#Z7A692I&IX#
MI\-C'@0 ^Q$\=C3)JJ@5^2'"+0DYL(E 9<$"JDK8AF*64'/+^01-**YI$13;
M#N1)<!Y2WH3O_QO!\ H26Z<$*2-63 4?>*.NA GP:((@Q$W0*(=$1S*UX;.W
M'YF2B>0WSH$T /ZJD,2][:[KDA07.)P=C&?SN@;R&< 04<V?R'[4XTQR#AX$
M.D+."5@Q7<3W:4'F//P:EDFUCBSXP*M6?'RZ+%[;/IX-8?57B\S6L5W-'VH$
MTVTZL_.L8LT>/G\DM /@Y^=?+HKS)RS?S[_^4B&/AF0F8=IL2;&L;T!Z@7V/
M7G@!/K3=K>"4U8]>D'5 T\,?WRYP]XA\L, ;-&-(F '&Q-IE%G?7->EWDCO!
M?F SA56LS[_?XSY1BYL;,D\5-%6^"&*Q;P8A##YB..[* D4B9GF:A*;QB67Q
M7)XGUM.QV<J([9TUR)$517 JW T=/E@\C3DHRZ.YWQHU8P7-F3+*N!2L(WN-
M*G7*7"\2H(_R?6<CRU0!'TSX^,70HPP1J\R#*+,DKLFB4LWE@P4P*[=OEU3P
M2-TEITUK(8*\&@+PN2,9B7S'$C$EJ=PE3J$B7.I.R*,#G>%!8UR"K]P,S.\@
MUMV!D%M[)BFD3V*QFMR*G8-IFOH#L@$<44LZB,[*X_$2UI&5.PI#R+%4,[@_
MU/![4&"F08RSRI5=N7;VN3'6*#H1:3/!CT_/,MK4:L"R94E;2\G;*\$1FXW\
MW:%5 QW7V3M?1[<T6<RUZ-&O T'KP.,())'JP3:"N6$"DHSVHR$_%Q_$V(WY
M2'0T@!;H>.\YY]ARVX+L:H"SNKH/W**+@[VL]M(;$#7OR$)[GTFM@6T7='8\
MN*UE\ KAE[H7GD3UB1@ W_,,*&]M:W9N*53@.0B"9--6C!<P/,!3J_>&V-%;
MD"Z!WLD)!/4#.&';5P)#P:(()AX2)KLD;*CL]@/-%P; >8K5&2WF_N#.R 06
MXXQ]U3)_".;:P:S\+!P08+ <V,D"K--><+Y;?/I_&] %2+S2D:$[W@3SWS&\
M+#10=Z#P-4H^-.Z -MN!E 29,!%F..BA1\.Q(D?@1=T,^-#_WSV"(8AQA U
MC00@5J$C@9/&H"K$!,K0XS,EJDOUQ)N[9TBCEV&(2JUUM@!SC]O'.$(:R!-Z
M)=X"8X-\O@&MEI$U<;EC.P&??VO) *V*EV WN1LP;7YQ[>;LO06'&LP!A!V@
M>0,:,AC@+W]Y?Q4M<)P$%YR=]#4P=9CX!04SX7#O7.%%ND(B:)@8A(2."H(4
MGT&!K!,Q4F$ H6,;X&#AF(T?#P:TU9Y)-B7^R0'?#Z0E^#!P<&?/2,#B08#Y
M;B;FM9@PGH_YC,5QF8XFUF#_T!P,NLD@0=?@$I+.M2J[U88A(I!P$WO51V>F
MJ 0HK6Y#.PD[5G]W&QV%2J/+Z/JQQ$9<$CR@_F&1H=SF\;C$<3@*08E1;%)U
M;("@;Y(.E@U'0RZ  _""+:_6-.J< AW88/T PD!G6;7JY>@6N;Z[CFX"&[Y!
MXZ'W#*2#OA0A5%QY\*]1YJ7,V@9;EU@SB6E-#8L,H8)&M 8IJIH;&\;/8"H-
M6.0VB,:\:"V&%03<SD_=BF/"@\PVL8"!G&N-9N#!AG-@(DE3(U'8BF3+$&S*
M;0TVXDYBQ0)P6'_C3 ."G(U-!"5[./K+Z3/YAH+_W+L>'6N$@>//L W ;3L>
M3\%/LHI!VJ,A4-F/.&9O6<?!($H5G82![]^]Q> PFM,<!A/,*_&_X@.?12J'
M0&B?G[ZWQ7&^D6# B&;""C$P\C=T)3 '%N(BLL9]3B;?<TH(,6J!'C7I_3$=
M$,^2A;YB&TQM\[^2A^*JQTX@=5<"(.KN>#W%OY3Y[D$0.]-]L+V<;$IIA/C/
M/_B1A$F4Q#K2+#RY@?\:#(P$:J"PT>00]=QP2R$-8,%V;[S,$BR4&6AA'QHV
M.?\&)D%P_D[@_,I:CT-@J3J$R4%L@0/C4^AWZ?#!BR_6CV(DL_$UAHJ<(?;#
MP0<% BLE+GK0)*,D)XE./-D'+;N+'-VHZ0?*(V(HS03_D:+(!KU5D#GHC\54
M8W#B^;2CI= 278+!XO'4D<#;_$&D-[2.?<0'6=F@+K9BV4DP%5TUGET<>,H+
MFPHC&" "W.#E=TQK@K\3T4?Z+SCM[/G]B=$E]+Z K@&R> *35$"@.(/)*&O/
M&A F30$RI3-=N94\&4?DD=F.'2;;_2!8^'ED#X$M3(6T7EE?@F&&"V/!$;/1
M+_3(.<;KU$#;@BN XHY$"%E,($]XW.-T',Q!A0<RQ??@F[B> XL<.Y>Z(D&>
M!.(KM%O1.Y8X GR7A!%TMHOQ;/BLKW<UV)_S3T[7>UK\.9DB+I_,5[=@L0XA
M^J[@!H,)(P,\]5/"Q<Y5MCGC\ZWB^?L8\S&3K#J1#>5B5FA-247$"&+=_>/O
MB<5E5EV((A^SU!;6=:W%C5%LX\CZ0QLA()D$GE\KH<+R)I,C>S#U':?X,4KL
M+5O[OR_?+8O*-7P4)$+60UMR[8DHH5*(=^:'J36U%B DYY/FBNLLSR'U(6:_
M;VKV'="'2->\G ].P:F[I%8!0R;)+A@Q)#L:&0+\FP_H8W"=PUHQ# JN48Q[
MCL.=6@<1DP^ ,+N;+"FI#G6_=U@<!CL>+3H)\;X-MH/.13X)101B^C&MB3!Y
MY8$IQ91 242"$7\&^P^+"Z\ME;"H1)DK3%@6/YM:7&HI=R$ZU3,-IYZ6CZ36
MZNAH3$(G(J>-6'M34AK%J@1,?BX2D^+] 8=43A<27_F4%.2K6[93;,88H.3'
M%OQ@D)\E42X'6$F-@2X"]9IG-3&)N**PL/.L/D4A=;7_0((K25$J:D>TD>1S
M*'012QB2BA[6T,@Z$@7AE /ND!);]8[+=.#_W!$E[I^L#%^0,41)>R-)J1WP
MW(:3IK*E(<E!8]*5S"3876G\EK+N[D#BW T]_QU-8BUO\C;?2$I.RU'X= )F
M *+F&@,]!*U\.)(OBK80?%U)\#8SM+1H86LKM*Q[+3G2O'0F;#*AMK*E&4@8
M%)S09K\]*QSP0$_MY@R-%YK(H)^[+)XCUO#PZ \LO@"E0$^$7PBQ-OE%0SNH
MF%"_-S=G#>B.NLI6)(L :'93MV03]2%,*.*)Z,.4E#H>%S)*I0#8,2R]6$&#
M?;S$JDH,5\7$]W-X'';^%JG[5<!RJH<GE6R O3\T[1Q*)ZF&)4Y-;%ORW,0Y
M%/=6(P_+X0 OBPEVP,3>@MA61 =\+&(!7.0;R::!2F9_8ST'_I@B]UA!R_K+
M%?O&E$PL\^#0"O,0(1G(\74C$DV11Z%%*=-B!IF<0(HE.G;)=9%+/[-KS)@(
M7X>#KVK,7%&9WB1 8FYLEZ;2JAJF[SQ7FW>H5';$09(8ZT'+8YYW#WH!G2+6
M$K0/X *PT\3[5*$F\Q^VCLZXH?#;:J O)\!H4AI.!=-MU5!:VO@HU.8PDX&6
M#MJ77JV=U"$"0#?((5H1$W>YB(G('LMOP<+&R(#0,86&9I":'H+*J,7D.-*U
M%@D^EL6_;^O&9IO8&I_)^ I\!=;'%FL)&J8M5'/@),/IM4@P^+74M>4H"?)-
MMB,)1HQAI(N$O#9J[V1+OFY+J_E@(IRM-4V_+9DM):^/']8#A<"!KFZ#4R@"
M,,&R-=5YE=UC&+VE0 C("L 0Z0\J&(!A.%/E2F(0L9]!EC5D,N*!3E+_FO3_
M;C&/T B6DD',&-Q1R1#PA1995M#PM90R8%U#6FJPF!+UI+)AAL!8#"71^7R*
M.9(,^\-8/ D3L@=K90?B-'0.XZ3)D7\V-L-JQW$#2)%9_DKDA! H^A1DUL=J
M)USMCZ':I+7R2%/1LH.%&FVB03,35#N2_(,X-HEP25@X;#Z6R"29JE,NR2,)
MQ(6QM(#&25CY<#A#,X59A=/<F688QO(F&?(V5VJ7H>8 01 5_0M;M)=SBC"I
M -)T1ZA;8'=;2(/-8I17L%D)K5&=M(;,PZK9 [DPVCNL/J;T=V>J')5Y6-CA
ME(0\:A)"IKS96_]]*GY /8*P18$Z8620Y4V=\#7+',9>[KEH/ 44$M<U+4?^
M<[0\8NR8W+SCFT8AB%N->[J+W!99L9!,=H!CV6((,.A#10;N3\:&KH9@W\*/
M'.R-]I04V\R,#1'L0."FOQ^5DR9F]Z"W6OY&'2 Q9:38Q\.BJ V7+>-(FI/8
MH'9=:$#@C?\)SP*GC--H.W<MN ]X"+Y%7NG#=$8.N\>T>^VWUJ>$G1%; C#I
M/,P$8MD*?*"Z>$W^A%675!3=XHE:G_ZMI$6%?QQ^"]3#M:((225U?5J<YP<5
M7)2L1#U.>K+CP&2,+#34&D/Y?*R37M<=A>,7!?\%AR/%&53,QW(%JX&(U6FJ
M9?&F0Y\8D8M99TXTH/^Q)^Z)O^[#KS;\FK5F] 3%LO@5^SRP0M >C""]WF$B
MT<;@16GV=<]U282B!L-EZ NVH0D'JVKK+I96M5X+K8G2*[1_N;>#/S/74>T*
M5JNX=7]@A@9U GN@8CRWDAH@+N.#@>@3H<LV HH%-H>DB#-E&MIUTGR4A( R
MX.AY4'K<3=.AV'#DZ8R>!?.P/ZNQ2#/:,'$(NH41I%*W2TX?,AE!+UU1_"N0
M@OK!XG)H[292(!A*%=<8TF:0U )20HL+S'F&&%$,+I!IL0E&[33\^TR-/UZ6
M@M52V1 ->(:,;6]7UC2>[&#FL9FU%$WB)6@#0)D=](+KRG2?2C_)IF;G3I 9
M'";F8IJ]M%0(&$K6],!JG[8G-+&;1IFSXA0]UZ[W7/:Q'SH,^BB)XN]C\@9]
MQT@_3M^IVHFTZ2->,)/BNH[T8A9'E @TGCGXCZQ;8DJ.&K%T1MWHB-C2;B=3
M5>RH<6S-A[PH&<<-5V#&&"T^L4-+DJKUI/0@IAOA3-9# _[.=9)SI:>QCG2/
M.7;A@[;2B>2+SL:R21'5V+J*54YGV"T:VC>H$V"T(.>L>%ESS*#U8FB 74$5
M-U\_!0>T;BHNN!E),K!83;O!W0][1D\-DO(,X_4$.ZBT9LVUR$_#=(U9H7IS
M(!.B'*7NR:%KN>B!/M4?\>]D#?;X\%C#5$BR&+H=046: 9W=+AR4XGP=8G;)
M(Z$?T>Z$)M.!NG^._,"*E'Z+X7I.GRA,GRN %[RUGT$/4FH\_)'45S,9E8GY
M,Y/'Y3C6Q%S/1V+X;K93\#02["B+'-:D8*#8+FPR"^EK!(U%%TEIB3:,C*V\
M[)4CVS*)%(%BZE7*=Z,M@KF2:#.Q<.>^PR:I*0*Y$7 GD=' C=I_Y7L06^1J
MDTR0<#9WX>C9Q-X:HN4V_48JHU+MG^7]D^258I(&A7KM<! ;!17/U4JC4SRK
M9?$;9@^DNQ'[OS!O.G(AN*  DR"\ YP7IUEAK2H2"^5M)5N,E</WZ!$B8]25
MHLS5AL-CH5],C#:;BBJ]DXJ-><),RW*H)%%V#J:CZ*%[@$7M$I6U.Y;'&90Y
M5CA]+[@9'1_U<J;(GTU[:4MI+)@C8[YU6O,FLZ&'P[HJS->+XI#EV3A$V8'$
MU [<S*XIS76G$;9[GLVT?XM%^X[:J5=6@%,-RBM.]A\X%$L4]MJ/$Q F+@>'
M@]ESUXH@,!&(9>^JV3=)YA!K7/Z656Y@R(^($Y_AN''*'$_U# (0!+7DE")B
MN22H=X1/0[L!=QC%JM1R+70P:6F<$7N+^-=P8"/D($TNI!(X1BU",9D$AY.C
M2L]G%&V,92L2-;T=:5/F&:/Q+LS1^EGO.0LJD<[)(0N&[X./W_#$#S7JJ=:%
M@A\#RNL&"SF2!>;N;#B2,QCVE6;4DBUK^;B8J'7O1PC(2IWOOPFN25&)SY*4
M.21[?,HGU]C_K/UK\"MXP3'P.!5TH]."?4[/:&S;2L&\GYF2:F!&<W(3@M3\
M/*A/85_4=,V-O91ZX91C."!MK@!9394-I)##P*3_&C,E&./>H$<1Y]18.(,E
M_7T.%Z?5);%+L4V =Q2%3#,/L=2#;577N,W-N!9+.JW$4S#7IFXT5JA-/]@'
MG.;O O/$!5(!/$(X':- I$$LBD=$U*^#43@^3B*$B2:?CB7--C.XQGI\B_HS
MU@', [$8*2ZI6^#*R;S_B-2 ',LZL11'P3NU%9B+9A5#XD:M'3)Z>KD")X\\
MANVX5N-5VAYVM.&0BH)0A=*AD@],'=TL#6X32<<X=Y3(WW-4_)-%R2)1)9.U
MQYB1&SND,(,H+@B;@V%;,^K>NS&#B8,92P[-A4SSS< Q*E=/U5+=\M5=Y#$R
MZS3'R-F/+\K(-H<15\/*ZHR5U1D2[%FFK.:*2OT\0XC]-B'^G#^./DS;-MI0
M,*>&#B;50U=MCZXC[EXJJ))OU&G)>^NR_HF%VA-D71DLTM0LF6J8Q'MG.<PY
M)1JEY2,#U^6QF]/8#055L9MM$00HQEC(E:$,S@3*118V#0ZA<JE&)#0:&V)3
M=9@(KRH@EV^WMSUW"QHXAK33' OO6!BK([>8! 63B,1](A <A9X-?&A<.);!
M=5Q[$YS\5&R%^Q& BS!DW",]7F<[U /-/+K_14=..@:.0:<V7[#9YMB&9?6=
MFYR:*)_A:2CG\84.3)QBT#+OJY-A8L%*LC U.Z8J6XXJW"U%U<:8,FG[(XK&
M)_?R'-4Y01C<VM&>)&)O$V=W4P_)IUR,S]&AT@+=BQ'L$CQ6JFWBV67*) ZC
MP3RY."Q?^W21U@9&UY2"*7<!+B'A>SB/Y"V/CGAZ#T@>4F+O\LB5("^CP87-
M%F"A,,''PZY'V:4D5R_(XRO 0N2)%PQW@(T[Y$'\G5&7?+1S'U"'GAJKB#.T
M,=S0)S%T8G4,<(5N?JX/30HBK[0&)C6A.YNX6QF6HKW%'3 (]JS)EO=DJ"J.
M_?-94_]LEP;7OTW6#=A:9K<2O<^PG)9:/4"K<*]=_5B<-[H0*)1[W'(AT.FT
MG3H+XMUYQT\:(HR!YI=Z]\ZH=@]S#%P-PZXTVS.)L1&SUUK600 G715GG(JQ
M>64@MH'J)0":O1GU029W<\6RUK[<RO5>W!-*:>.M;5AY= /*MOW0^2&YERXI
MW,+DII42I;!^MBRF&GURM<CY-Z?'+F$*%UWDK9^$.+Q&,%Q_0'L9VO!Q4M^;
M:L"02]>VIJP*6;JX'TC6YG-KC^^6ZY.;2B+0#QCJT[265D@V:?XENQAF_N+;
M8@?2E#J/OCA_%#_@5%_@=8?AF]%E*,>DXN@H2'%\\?4W.@]/_.2[^+F_HWXH
M7?46CB!973DNT,7PYUW<,<[ DX>0U5Z"/!4B9 <GZV=?H^UYS3%V(O'0"7D?
MBB33%( :?"(3%V@W4VTM7?^"U@F-4)TUJI-.>DNX/4O&C57S!CP]#)%;5DCL
MW4>JR) X"H@C57,*7,LU2LQ0^:@9T^IG'ZR#I^B%3,Q)KQ?G!8F?W*LW)9U/
MN+-G$5CA$R@3G)@O+IZDA$ARX3@U1OJ[5/<1[^(X\X:RS*L^Y;"40,X^G4#&
M(NLV 15KZ((DRMLZ5"[A^-,1AC*=.8>B\XM/0M&+6"P=:[VODG+EE#BIS^"N
M\FIND,#VW$+:4[F\/^^;\./&B6#@='JYV4)D8M;V,&I=D>-!QQ/KI^WF)D_9
M#>P79),7_F#VB=^XT$Z),Q#S779Q[Y'Q^<\-WEXQ<D,G'3;SS1A'T!1*;%*\
MD%#3Z3J^VBP]'*PNCD51%0>E0GT*7A-6T34,B'>NOX_9$*T5H\#G-=9BQ* %
M-]6!U>[(MR%CXU8*R I?F'4"+##]ME[AA9$N)*-K[P>Z9^0NPJ(V0U OVEPM
MU1DC/(2Z:.2QCD/!=]-L>FE/4C.;U,>$^_#6EGH]2.)+E"80/M8!42$@1H:P
MD>A*C^\MD@KU5*3 UC[M*\KIB@[)M:$98;YY1/.0)-#B1<<^65KDB72&8_?M
MT=G0.UHW T9[T&?V8[9DAGT*QW? F[$65"3,ZH *]?ADL",$6R2R+I5^[HRX
M-X=%6>P<Y=D2796E IA4XVT=,U@;M1*-.S[&N$J-BG7]T5;4P$%+Z340_ T]
M>%LKB=R*[:@=AF2YYZ:-K93H:V<N19:PX4>C7EAECUR@170@&324P#"$7FQ"
M1NC&$HO6M'+1)%\SQ7WZ5]*UG8. ]Q K?/FQH C).N.(A;3G\E:AF)#;W,^:
M?DIB4GC%E/: D9=S$WTE]'@E]A\&)$5*L34<JR&=-!Y*\H=O+P12ZAOMD$^O
MFB,GL2.?:GJ9G01*0X=FQI3B)I"7,,H,:0%VO'4A2ARJ4I(<5]IR'_OK4T-B
M7#?Q/L\$U%F__S^LUSFII]>FGE1N)H%Y%")Z^7%2G1^O3M@;WR]"WHT+I"C\
M(<9 K%AF9\JDPCI1*E);[+E<F2"@VZ<L;L^$*[P37)%L6:3?L"F&N)>[W^5B
MH=D%#<; I.MNO49Z(E/^SMEHV8H:B8O0I3YWU3I)JI6EI@5^)BO:_\O=U)0D
M8Z7V[>B,J57!)JV9W54RS1RG"XU"TO?I:%X6OQ-QL^ZX*?CB-*PP8,=08W1&
M[W;D@SLN?>[>U<1<CZ?*I6_A?L[9/NO%9_9NLQ]$]!&R$?<10;&X38I!)>X<
M(_Q"4&B&PF;)9TMZHOF28)_<.2WWUR9ULS.77$W!R"@^*NEE<4E6A]T'(1%+
MO\A)I9J47/D$&@QY=BW0&=-4X"J]Z0,!"&WVZ5L0N!TS(Y.4F1/W8TS)76IS
M"%TGG T[7/<"&D:T42YF.==H7"]8Y:8U)O)$DZ9*73O*EO+5(N0'U6NIMTDN
M2PDNO6Z>C2_8.=ZY?C!>T[QT@;U>2#Q&R'W*8,A($<KVH93C#I,:C"'D)&6D
MV7LK\W(L-@4#9"TE_:^.[3Q3$U+SS5LTTU-/9%>P0./E_EZ63B[RY@S;363\
ML51((B$F?U' 2+9@ (H0R+\+C*F0OY^@&%H*WM?26>E6K$E"J=4\HX?[8RE=
MDJ#S,V?0YF)M0T=#/]R@18ZZWD+WE^+ZTY UOLF'C-=XL=4.N*VF.,^2((P/
MRW4@#["M[G3T6Q:3 ;N8HD.L(/!XHR"9?4&(IBLD50&:/UZ?D,HLLC;2&4ZS
M*N288YB_\F)ZPTBL5T>C. '3W!D24Z40&X@3+:GN.Y^5!K'3%PDL"G>?5?*J
M<P1R1 <A0*Y^:^2M&1"//#P!+#,7@I-_9Y@@-R2FX&BCY2[T8V;O])@HT) :
M\<7Y$^XN_IJN7S\4R2N^WF%C'EWB=EE)B2LL<G30;VWQKZ8=T \-4=>4'0U.
M0L4Y+4R1<**7*2@B8\-- C$N.+O<,X>//#AY=?GNV<EI\#L 3YI@3D(D:[)#
M\8PHS)8W3.7M005?.-.XH4JN,C8=^;;1):CYQ3U\!Z9&UV)[TF3U4 =R-P 4
M.**FA]CR$)H=1CU)Z*>9Y'1ZCDDRDA;%])TJM@FW]E5.*L,Z%QH=I3BLJJN8
M(DFJU37Z,<Y$9^Y \KJ=Z LLTIL9]<KMS-Q9_O44!*0A(3:10!K!D80#.;+<
M7H7AD%GF6R1.Z:3)6&+%5+TBIT>J0-*^I*815@W#-LY]"#<0&*S#"JG]D*;7
MQNCWH[K&,"!O#0XO[;#Z(AWB>/!]]DY>*I6\-().)6D>3ISJV (\]K1!_'K7
MAIYPS,""9M2Z.%+?_@@IXN;'Y(A&8H5=3ER':_ 86%9UMD]HD72+5%L%?/W?
M4":^N^GD,WKD3]CFI+OZ7(^]#WQIW^C&QVEEQRV]X%SU.>66<?G.9W&+:].1
M:^W9\LG%[4=.2V]Q?Z_'/K=B(%;#'696:U?(U=.H\[C804L(DPO<;B+7,H!Y
M9"Q(.30:]Q*H2^A)^9-,>L2UU&^8Y!+5,VG)R7UBGM%2FYO"Z?"-,M*8%@R^
M$'YPDW/B&QN$D#N^WAM#5=>U&SR7*++EJ?0:@BX[?E/0=2BP&P4$&^^RO0-/
M?# 2Z$0%13R/@J3*;R[88<Q)ZZ?8-5>T<-$V)0*#&,-#2H0(G4"1OYR,;OTP
ML@,R3C+18$>28>SZ,^;"=6V\0OJ6"?IB_*Z)[&Z0+YX\>C2J)WCR:+Y003J8
M1L?$N!T#$2GP,+I&-"W2R@O^0\V4-DCB31V[88==[CU?:Y"_M&AVY[<NF"TT
M@G3T.@".:XC!2@)?"'D>B1%E(KYMEU%KZEZ'B+2^MD:N'^E0SH07+24WQ4M9
M;WYEY^W53\O4'M3])!>]U=PD+7*+<6ZK41?VT+))4,WIK9PX Z>JKLG?"/HI
MJF:L5J[0:>(P-+/ K/Z<%Z0XO=5WIZ"&ME7>=,;1KQ@:RE^.J'%R6I7\A@5Z
MTO#50DJ=)+[.Q9E915_B1JKPG;G'.+VD^*M;G(OWKGAFV<68?^GQP^1US3O;
M;>BEU)Y3*OSFYO!MH>^]ON37/<?A_-+L7TVW00>ML6MX]-'RFR<G7$VN'WJW
MIY<_KUS?NQW]N;5@]'4X 'Y'-:X?<('P-O"?_@=02P,$%     @ V8%64K^!
MFSG]"P  Z"4  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL[5IMD]NV
M$?XK&#5NXQGY7J2[L^]J>\8^V\EU&L=CYV4ZG7Z 2%!"3!(,0)ZL_OH^NP!(
M4$==XJ;-IXQO9(D$%OOR[+,+D$^WQGYT&Z5:\:DJ:_=LMFG;YNKXV&4;54EW
M9!I5XTYA;"5;_+3K8]=8)7.>5)7'BY.3B^-*ZGKV_"E?>V>?/S5=6^I:O;/"
M=54E[>ZE*LWVV>QT%B^\U^M-2Q>.GS]MY%I]4.WWS3N+7\>]E%Q7JG;:U,*J
MXMGLQ>G5RS,:SP-^T&KKDN^"+%D9\Y%^W.3/9B>DD"I5UI($B?]NU;4J2Q($
M-7X.,F?]DC0Q_1ZEOV';8<M*.G5MRA]UWFZ>S9[,1*X*V97M>[/]6@5[SDE>
M9DK'GV+KQYX]GHFL<ZVIPF1H4.G:_R\_!3\D$YZ<')BP"!,6K+=?B+5\)5OY
M_*DU6V%I-*31%S:59T,Y75-0/K06=S7FM<_?O_[A]=OO7XOWKZ^__>KMS7<W
MW[Y]>MQ",-T^SH*0EU[(XH"0TX7XQM3MQHG7=:[RL8!C:-2KM8AJO5S<*_&5
MRH[$\G0N%B>+DWOD+7LSERQO><A,=:OJ3HG"FDI<0U<+.,#5[49<LY.5%?]\
ML7)\_5_W+'C6+WC&"Y[]-K_>*X02\LHU,E//9L@XI^RMFDU)%J]N/HBWR&#K
MS71"UZ+=*%A:-;+>_?E/3Q:GC__J>-RJ<UC&.21$9KJZ5;E ;HLU4KJ%%]J-
MK,7E^0-ABDD1K6EE*>IT,9I.0W=*6B<404 @@*I:05X,(GV>7@I9Y_3E"7^1
M5HG&:K"!+G<BPTI6.TS&TE)LD$_BUI1=I>B"5:6D!,9 $,FCW)2EQ+)6UDYR
M@KLC\1V42$V<B^U&9QNL86YU#DTS>%AGT+]5KM7U6I!/=88[I(Z!$;:_-!<.
M"[I"DSM;)QIEF0/K#/JL2KV6GE8PT:K,K&O];XSLG3+8U3481L:5BF<$QT85
MH%Q&X?ARNU'$<PY\XM@U5C7&(CX/!1S,=WMU-_)6B97B"?"W5;FW/D1+D&Q0
M%D;24K*B0-/"&?P$3UBONVZ%^M2 'RFL$(?8M;HM$0'\A%$*_O8ID\4D65O3
M-8PO]2D#5-:*P^\]//(HQ6#-RY,5A2FU$;+!0)EM6%FG$C5UG95=KGB\A@U9
M5)<SLD/(9(FXD_?A*C^:O2=WT"I7M9:E>SCG<#2P#I90"! KR"#_$D)PVXE<
M.UA#,%M12?)^ZU7$?84T --BP'TF>%>Z-H83=R&-Q@<7D?K!:^Y*;)0LVTU&
M8=6UZRPNSL7:W"I;5ZPKV8%+0.CP,[4&\(Z\Y3QQ]=)CMH^R.S>B-BU[$*59
M. V %L ^A!>ZAA])54*EJ4DZES:D@)?4[AI.$V!>&\Y'Q(D UVX)<Z-4*,9)
MA((4*^X^WH*K ]X)-B'^I$J?."2$=$ :,#;V) ;6<@&?<E621\$3MYB;6OE3
MEZ_9M20P+A25B'GBHX9%A6LQ3MH\ZA>Y(UJ G$.TC66_>+SMVTNY9!$K>&6@
MDP(!,W:$60:4]RQ]'0Q)\QH-%*N$"8 U\C'FRJ&DH"61.:7.]"3TB:0LKR_S
MGP"=BL,>H)-UUC+NO%I($Y_</M-CEAZ)-YUEJU(1T(U)IE=E/H IJ,DF-BWN
M5')'1..5H10C<G2J!>N0-!^=(9<H7T#<F<5L,B-F6PKU4)J2'+X27P_I=A/2
M3;Q7NEIUUBFO-O/:1%KRFKT!M5J;5DNNDDH] F@?!;@+:I#SKHS% QPO&]WR
M4*0O0\]ZKWU/%'UGOK267,S:S ]KHDLB9-FFU?@O3I3$/1SFHW'I[XM1GE*4
M+P$NBJ/Z?9A?*35S712H*_P[YOV>D)BI$1_Y7GEITX(TU)E187$=U>= ?K\U
MXWQ9M94[U+R,[$W<3]R:DLS8U>-FYQ!L- 82*98H^5(47=U+&XICZ )4L ,Y
MASI'WJ2;NO9[+':=SZFI=8C[0];>HL$P'732+"#'IHQ:2 _(M:H1"-+&9$CO
M?N+RA*1?G(A<[MA18?TC\<ZW2?DH<!O9QWL2HB0;L<<ROBA%"U-K %-J$4U$
M"[A.8\N2[RL^IP&03FL.L2]WGA%+32Q!8FHC,K0\X#GTBQ^/Q$V13.2Q$C)+
M4 WL#>;-1U;U11YQ*Y(>B?GNYXX0#;VWF(IE/Y)U:P.8.I^%=]1F[D4A-'/J
MJ7A:Z->Y7C'MEKN^4>X][HEAX(T4D]Z?DWU#:LG=WC-A7WA>)?U,19NTDN8D
M3,@DY:LQM365;]N),NJX)'+ ZR&:4E++N4:A+*F(AURI.S\)MAC/-WU/T$10
MK7:IWD<I1?=H"GU'JN+(V.X^?X6D<!*="EN:-"96Q:9%Y7- T%&GRPNM]2VW
M']I%:"65=[+;"%2LZK!1\6TZ-Z-</1F/I.V=>N 5H;8L<&"($C57A'()MCZ(
M4R[3LG.>/"KY47';HAK) 8PCPZZ$F19[!J[6B LMRA+N\%S8'#"O37,.49OT
MN49KSR/4MZ8K\RF@'XFOAL[VG6]EIZKOG?YW7'L/%UPT#(2G83[Q>==N0!AH
MEN'#I-FR$D0!>S'D&W &&T8>]#]T_D?YG&Q8/[<DWHWEKRF('I*_LBC^#RK?
M9]>\"8C^4?%\Q9L?*GE[96[,#-=^@QM8X7JTW8V' ,UFY["-D;1MV1A'+%KB
MZXOK;_'YZOHU/F]>O<6G@NN-![\'+X*!'7%&6"_ERB!.\&C<'-6PL>W\/J+@
M(Q7*E^DBX8EYNS&@&UFJR,WQU"J@X\ V86 JV#N$S<_&5-WN**BPFH55QBI?
M2L8$$/P(Q@_^X;.YR2ZLGD#J?@9_%KL<RJ$+[AXO)S(IW58#_G6F&YZ_=Q05
M:9*M"Y@N#0JRC\GX_*/W;T)ED_PU'^UB@]@MRO+&GX8$ NN/3.;]6-!];2J=
MD7M\H2!<L4-DO^4LNA:.GAK;LWB_H0_MP2_NZN&Q0 ^?6E*$9Y+S-&Z#DZBH
M[)T&4<ASZEP*K<)2+)IS6Q/:%<$\VO\S1 !J8QX8R,BE-6MT_)-HP+C--I+*
M'-9 +#/V"!>>WIW@T7!*A9;6HW(XN)I,F)03XWG=*'.H:<$%EZ86\^U #B1G
MI3:R+$)\M4U.RV[VU0@G,'0,;%A'&0L?^+\#HJBY X<UE"><I6".AY/:3RHV
MD9C[*1B2)93,7C-42M>M?J*ZUXZ(?L08 </]+,\@>^W++_8L=/SIK_>=.01U
M=Z.FZT#<[":V<&I+W1@Z<?K%\R?$X^ ]ZJ"I=@ "OU/;%(V\MV>:;I1^RSG>
MQ+'@("T24B7M1]4F%-,GUP ?PMC T$7G=TQ<??-0VE0=E"K91[$66]KD0<'%
M::3PE)%>RC(<)E*3W"&YL;)O2+9HK5NRIRAZZ;Y\<> (MX._))0C4!R)%\D!
M)<86H_/#H.P026J^;Q57[ 3 ]RSP.17"AUH3W-9=*2V,PC918Q8]/?D_U,K#
M)RVO/J3E<G@\-QQJCIX@^0=1NTAQDP^BW/A)U, ('"STAM#4^M:6M:1<-_;^
M)TJ_JT_((?QPY9,_YH:9&>WLUMP;)1L./DG8-2I]PB*VL$NZ>)Y_)?ZAI/5/
MH^\^BO1/(ODIY,0AQ)5XL[?O7)Z)!V*YI(\%/J[[;?V2_WW'3T2GVK+E8[&\
M$,OS=#L<:OGIJ3@]%Z<7>QWP\@FM@;^^GM+ )?WY9>C@^_*QN+R@/^!E*<[P
M;U0"3D].H&7Z^>:_>$ [IY)$S!#.2?!QZ%2UQ]!6\0/=4%:2[1J: O+7!W(;
M/5A%H7]K$./3RU\3]ZE#F"D,2 ;4W7 'DR[O@&0 P]1AU/+L@5@L'DP$[X*B
M,@[<V84X2Z*65(G/:C8@%RJ-0WWNXWS.49[R!8+\P'^,'YZT?->_;L,'A-R
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M5F+?Q' ?Y-B4+,5I0%^<0?V$P1E@^#5'2%515I9YJZNM<VJC+FO4X2$')>6
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M6]J/8E]_=9Q,DS=B*F;BTG&P 9Q4-D2Z,[43ZGX3<6]\#.,SCG4G)WSRT33
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M\ANG,^.@&_YWR1F/%N#YW  ABR]T0/4*\IO_ 5!+ P04    " #9@5929@U
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M1'F*'-'B7'NJPCB%ML@TSI-X2,:936A8K8!^959$H9R:2<?["^E#'^Y"V$$
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MI2E;.F=+19F!LDO4D%'B -4WT Z>46@#R%$#\CD6,Z+8^)W7<.!8Z:4/*V&
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M NT',K^QJG)#T$Q9&JG<ZY)F6-1,0/=S16:N-RR@F8K'?P%02P,$%     @
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MT,^ 13U221I[.5R3YX:D691#>T#[=*<P%D$[IWF<PIUVE R$D77Z":G(H^@
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MI<RMIE-!.#L8CL=WC[</<Y@-OPU'UU,8WDZ C/>/TPE,O\ZFM_/IO!=:"N4
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M;#<#T-4@JS96K?WP6"A+H\@O5S3[43L'.L^5LL>-"U#_30:_ 5!+ P04
M" #9@592-D <_. +  "*)0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6S-6FF3V[@1_2LH99*=J=)J)$J:PU>5QT?MI.SUEG<VJ50J'R 2DK F"1H
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M:&5E=',O<VAE970R,BYX;6RM6.]3VS@0_5<T.>8.9H#\(-"4 C,!RL%,RW6
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MKX0BHI2F$?G.)V]M9=)0<W33\+WH3V[#0FA]K(14) /7Z&;Y\H+EA^2$9CV
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M3W'C*;92N]JE?_3(9FLJ>%%;R88&1K-(L&'R$V6IY$T8U>W=;LT!<^#S==C
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M45+O]@+\0,0!7N ;FLJ?"Y/@.+EIWYB7+(*;&XD,\8>*,BIE'"%^[6@.8/&
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M8X<^B'.EBP%F(L+;F%U0/YB&O>18?+*BR0#!?AL&IS$Y![4 U%N=ZB\YG=7
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MGU.>1^+P!3  )E42YU&(*<_'C4OI4G>, W/T6(#Q.7B_,.Q,)FWV <H34X_
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M+W=O<FMS:&5E=',O<VAE970S,2YX;6S=7>MOV\:6_U<(W_8V!F3'=IKTD;:
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M B^+XOH>_;6!&W6Y90<)WW]KR=TOBY?@,;I;<.I^<<WZY+UMM^B^X-QA-F_
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M7AMCZ%2#:_K<<9\C_\T:AK!HB#YSJV[/R@LL-JR!<+WN6I"$C B&!S'ZQ93
M8%)L$CGW25I(R-"JDP;=)-.838[>![^"&TY;5)&.HLO!N^"/=R<58LVCSQ@?
M@24F4UKJ<BF\1X5"LY?.8?X6!% 3+1+E*00=Y1X<TY+ARK08%/# E-#N"31/
MD"/*P04J*&P(5;\8_WVBSC8/2\48@2G%D(EGQL&.6U;T/ 4>K$\FQE(V25RF
M'5O+;*,7#$_5=:K\)(N:I)TP,X2HK+&(^M(2HC@@7W7#*I_VD]6QS5-50LG
M%^XTZAC#M>M;S"NJB.+W0_$&V\Y,/RS?J8F-LNDC7[!2Z-J6?( L72T5%MQS
M"-G9CL9"-S4E*T5=Z$#8TLY?4Y8<&G,"UP>T 84A-4.Y8RT W]BBRTZ87P'T
MQ"(^[,FJKR' O$F0#/3V*;CR.T2NQ(L1A)!\T-H(OQ:SA'<T(&;Q!!57Z+>C
MOJW!@%R3Y6%-%C@4,6;PXE2!#T7PN2=/(>2OZI+!<P--!D&!:=:X^G['[*E
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M'TY_>H7\KI3"<896BO'Y=-/WN,L^HNEP:Y-IFCO=20U68CM9XA"J$6+'4 /
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MI[LZ]+71^TG9H/];TR&=EC7KN!-)]<!3?EMN[V@<X3(:-.,(9GJJ-&2( W*
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MV^D:_\3C1^_@AQ%<J=(N#9R7&6:[ &U2MM$XVFA\$GV(>(;I$<3A(41!%'R
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MT0^)*=^$Y<#IW+_#YMK1J\YW5_2,1L,"M+[0VE4#5E _S*_^ 5!+ P04
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M_&="DS$:%J#]I=9N^\,&JEE[]"]02P,$%     @ V8%64K.VJ&#/ P  M D
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M4+$"K4=2FJ<!.R@?:KUO4$L#!!0    ( -F!5E*9:FQG P4  .P,   9
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M!'3]IQ378.[$PKJHC'%EA-(]2A]XXFYN F3<P".X"X_VFF[V <-CN6(.RBU
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M<;3Z2J63LFA?;?RT+-GM]72Y 0W9U!O:[/C.\#))^YPX([*(F<>3ZKT2>WE
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M3H/TXYK@)6&)@/C>I93O+Y(!#F]$7?\?4$L#!!0    ( -F!5E*9Z8?BKP8
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M?(GBZZZZ(N-L';W(8&$4-YU'U0F6+AT.*F+P']HZ@[Y@3!1?C]75%V<[P"G
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M\#5_(_DB.PHZYE+R*'LY9]Z$B?0+ZO,IYW+[)FV@.'[<^P]02P,$%     @
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M4<.3XJUG<<'C;?[FZ3GF/ [SCQM*?)ID@/A^%<?\[2(;H'KW?/D?4$L#!!0
M   ( -F!5E(R9#VD& ,  '@*   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q
M+GAM;+U674_;,!3]*U<1#ZT$Y*OT [652LM8I8&J%MC#M >3W*86B=W9;LND
M_?C93@BE7P.)\=+8SCWG^I[3V+>]XN)1SA 5/&4IDQUGIM3\W'5E-,.,R%,^
M1Z;?3+G(B-)3D;AR+I#$%I2E;N!Y=3<CE#G=MET;B6Z;+U1*&8X$R$66$?'[
M E.^ZCB^\[PPILE,F06WVYZ3!">H[N8CH6=NR1+3#)FDG(' :<?I^><#/S0
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M=,OU5.Q^@Z*@&QLO$5RY7[0K;*, )5NE15HX&P0IR_)_^EHT8L\!MQL<2.%
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MB,R'J'RAQ<;-(7.AS53C+M=F\ 1I#<S]I1#Z?6$3E*/L\%]02P,$%     @
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MN_'3I^CUCA0>&9F^6>0G^?_HM6BKG*'9)DFCH!"F%@1>N/WKOA4CP0E@_8"
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M)4?TL=YPWZEZB_T@5GQR=CXYH$]]LB!QYD[V>/B>^^SYU!MQ!)QZ!/:]J=B
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M+"1K0+]?1#0NQ9OL9XAV/X%V_7]02P,$%     @ V8%64O)6/V[M!0  +",
M !D   !X;"]W;W)K<VAE971S+W-H965T-34N>&ULS9IA;]HX&,>_BH7NQ2:M
M@]@.M!-%ZFA[5ZD[3;#N7ISNA0NF6 LQ9QOH3O?ASPEIG-3)0\AV$GNQDO#8
M_ONQ_?L[)L.=5-_TDG.#GE=1K"\[2V/6'[I=/5OR%=/OY9K']IN%5"MF[*5Z
MZNJUXFR>%EI%7=SK];LK)N+.:)C>^ZQ&0[DQD8CY9X7T9K5BZOM''LG=92?H
MO-R8B*>E26YT1\,U>^)3;A[6GY6]ZN:US,6*QUK(&"F^N.Q<!1_&89@42".^
M"K[3A<\HZ<JCE-^2B[OY9:>7*.(1GYFD"F;_;/F81U%2D]7Q=U9I)V\S*5C\
M_%+[;=IYVYE'IOE81G^(N5E>=LX[:,X7;!.9B=S]QK,.I0)G,M+I_VB7Q?8Z
M:+;11JZRPE;!2L3[O^PY2T2A0$!K"N"L &Y:@&0%2-K1O;*T6]?,L-%0R1U2
M2;2M+?F0YB8M;7LCXF08IT;9;X4M9T:W5W<3]/7J_N$&?;JYFCY,;C[=_/YE
MBMY,^$P^Q>(?/D=76G.C$8OGZ%ZP1Q$)([B]-NB6"86^LFC#WZ(WU]PP$>FW
MZ P]3*_1FU_>#KO&2DP:ZLXR.1_W<G"-G&L^>X](\ [A'NY5%!\W+AY<E(MW
M;6+R[. \.SBMC]1E)^_?._2112R><31-5]>O2F[6(GYZAVY%;.\+%J&I88;;
M*6[0F*V32:K1G_>V1G1G;^N_ #TDUT-2/;1&S]769I@]1OS,+N SS2)NI^RC
M09K/-BH=E:J4[^L<I'4FRWH["NPJ3_X-N]MB<AL$EF337#8%98]E;&RNDLS,
M;%;$G"N6Y*=*[+ZF?D%#3>-AWG@(-CY)<J-L\W8$M=# */3S&OLG,2L&N9X!
MV,,OBLV3_L&S8. EMC^HG 5^8'@!S8+S7.8Y/ N87EJ[4(K'=@*@;9) )!<H
M$@N.1&R_23.YEI&8U?3AW)?6J^R#'T@)U(>+O \7_\,"O/#4U"S !H$EV4'/
M8;X'SQ%I[%QD*<DKL=RK:/KUL&<(K@@-*"BSX$8!*/.:+[B=('/+B97=J>@4
M$W:&Y*Y3J3VHT-ZOUEX1&KR>0F7MSBL"_+,H-\ZJ*NIXO1C+*IQ#!+!%[ <:
MSM@XJZ.4!AJ" ASK QCV$S[G=JMIUPB*96PS892,HH1/(C9<<6TJQ]#G_GGU
M&JF('+P>[+)TYQ3!45:!_D5WF60TL1!'TQU; [P.G($$I^$@@;.0 /:06_%\
M9N39EBF1#MW+6"&5=%S;CE=/)-\L\#DX&,XM M@N_,&XYUL>H0#JK^-X<'$2
M(X =H?$!0C=R<>S#M\;&*R)A'\>.TABF]$]P<NR#V.L %%)67MC/PXQNY]_8
MI[4G%@HIBW4HQTU07N_9V*=XW5SP(P_,!8=[#..^E6-C:)>?26[\(( =WS',
M]V,<.JNJ2?L.^[C_X]Z<U=&D84=W#-.]G2=C'^[>*$$A9;$._+@E^(_U8^S<
M )^&&Q#G!@1V@Y9^3'SHUXP'<;0G,.WKQ@-#'75$)B=RQ%(X8SF W49&3'RD
M>L<I4$A9G,,M.7"4\N/62WRRUCQ%5T3"C]'$H9C *&YYD@5!.=/<F-O$<9LT
MX7:]$1,?V749]2,/9-0QGL",;V7$Q.=WW:-S52C\Z$P<\LF!HZ$CC)GX9SMU
M[3O^$_A8IY$QDXK3&0(^[%"'>PKCOI:QQWH>=5BGP4F ESHKH/#FO*7G47_K
M#3^#4F<%%+:"NF$A4'\+I^+T-$; 49G"5&YF??0PA<&0LCA'80I3^"=8'X7V
MUIGRQMMOZM!,832W,SM:Q>9*-#>)+$MW9*8PF0]9'_5I7">R0619I,,WA?'=
MROJHCW-/,A12_C'*D3Z$27^,U87^;AX\)0X=_$-X3]_(\$+_  9NWI$^A$G?
M[GDTJ[3X^V3-&7%8<;P.GA&'SA+"EI9PK%.'SB?"T_")L/"3*NP3+9TZJW4
MK*=NX56&Y#V23TP]6;:CB"]LF=[[@:U"[5_-V%\8N4[?;GB4QLA5^G')F5U5
M28#]?B&E>;E(7IC(7Y 9_0=02P,$%     @ V8%64E#L2920 P  C L  !D
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M6.&:)<(^JOTG/#C4<GQ+)4SZ#_ML;X<V+Q-C570 DX*(R^S)G@^!. $$[3.
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M7^]0M==9ZY=-K(K39FBA++56Z7!+[3)JMX'>KY6RKQ-G(&_ ^S\ 4$L#!!0
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MVCG0]Z52=K]P!Y3_0/3_ E!+ P04    " #9@592CY=?QR,*  "!,0  &0
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M,CV2JX:;FQFV)0>0(AMD2OX0P/1(0]F16KH0MW0)-8<3W1HU-U>A$4# F"0
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MQ9.BN:(DI"('P/L%Y^JUDP>HK^'&_P%02P,$%     @ V8%64O?)V<2E!@
M)B0  !D   !X;"]W;W)K<VAE971S+W-H965T-C$N>&ULQ5K?<]HX$/Y7-,P]
MM#.AH%\V[B29(4G;8R9-.R&]/G3NP<$"W-H6E45H[Z\_V3B6L621A&;RDF"S
MVOTD[7Z[6G2\X>)'OF1,@E]IDN4GO:64J[>#03Y;LC3,W_ 5R]0W<R[24*I'
ML1CD*\'"J!R4)@,T''J#-(RSWNEQ^>ZS.#WF:YG$&?LL0+Y.TU#\/F,)WYST
M8._^Q76\6,KBQ>#T>!4NV)3)+ZO/0CT-:BU1G+(LCWD&!)N?],;P[3GUBP&E
MQ#\QV^2-SZ"8RBWG/XJ'2732&Q:(6,)FLE 1JG]W[)PE2:%)X?A9*>W5-HN!
MS<_WVM^7DU>3N0US=LZ3KW$DER>]40]$;!ZN$WG--W^S:D*TT#?C25[^!9NM
MK$=[8+;.)4^KP0I!&F?;_^&O:B$: Z#7,0!5 U![ .D8@*L!N)SH%EDYK8M0
MAJ?'@F^ **25MN)#N3;E:#6;."NV<2J%^C96X^3IAT^?+KY.+B_!^.H"3*YN
MQE<?)F>7[\!X.GUW,P6O+I@,XR1_#?K@R_0"O/KK-?@+Q!GX&">)VH;\>" 5
MBD+78%99/-M:1!T6(0(?>2:7.7B712S:53!0\.LYH/LYG"&GQ@LV>P,P/ )H
MB(860.</'@X#!QQ<+RDN]>&N)>4\VJCE =^NN?JKO&T3BNA?AV92:R:E9K)'
M\Y'RW"3,9@R$$MRR19QE<;8 ? Y^LU#8MF2KUR_U%I%]=^IYQ63OFLMD$:(>
MKH5V(-,:,GT09!6O/]>Q8!&(UJ( *Y>L$^U6I=< @HC? FO*D ZH7@W5<T(=
M1]]5O"F*DCF0'"PJY#: GF&\#<^4@!WP_!J>__C-9UGDVG;?0.&-?-R":A%J
M^L8.V%$-=N2,@?=Q%DO6OU04'8%0@9RH6)]O7R;ERTDFPVP1WR8,C/.<J37_
M=JF4@(ED:>X*EJ"&$#C7JV$@+ T<@87@>0[8KUFRC@H?=&UQ8&Y@X+5WV2(T
M*BC(MG1PJ"EYZ';$V6R=KI-0%FN7<B'C_\(BYQTIXFW-R4J_0P-5?S0<MJ#;
MI+R@8]MA(YU )_8;+L/$Q'D$,B:M8*&YA-!89ZL4@AU@D0:+W%ZZEFO!=M98
M>8>JD'+F<$"H$P'$SL50^0A:)XW-Z0R[9J.3 W1G!V4-6:T1PUHPZC"F:1VZ
M>5T9PU9C)B\'7H<Q3<S0S<S*&+$:,UDVZ&!9J&D6NGE6&:-68R9/!JC#F*9)
M.'*'RY*IXGLNF96^J\$[28YV^8GF1>@FQC)$K>9,.@MPASFDV0RYV<PD^BLN
MP71]^UU5\D6B'3?#KP]N1!BQ+$Q9[BH--2$A^%*9"&FB0>@Y<U&E?:<@PK3%
MD7N$=I%K"D-N"GLLGR.3VBQ0W4*[4#7_(3?_/=;1/JD25+BV5Y,AHB_F8YHD
MD9LD#_4Q2\7:WC:7R"YJS;;(S;:/]B_?.*08,$VB[H*I>1JY>?J\/(DS :Y9
M4OI/OHQ73H+2=(R"EW(>K$D:NTGZ:]GN* #<,1$N6C71BHF81[;MV*,6^N71
MQ+506#,Y=I>6!SIXI7W'<XC?/@-C2Z6)&_7H+G:= + [ 1Q8TF.3V_L>'K6Q
M6Z0H[:B^<*.=\6=30*6NN= CT@Y2;*: $>P(4ZQ3 ':G@"N>]6<\73&I0F4A
M&"M/\R[OTQR/7XSCL>9X[.;X)X>I6VVP/THUH6,WH1\:I2:_M_L5V.3WCJ(?
M:W[';GX_-#[-0KV/VK"=,KNX=?+ #ZCE'Q.;P=[TB2U-#3M,HM,+<>>!&S9;
M9CSAB]^N+JC.!.3%:GJB*9VX*?VIL;A'+:1[@Y%HZB9NZCXP&(G)Y-!@<F)K
M9I .CVETNMU,?F! $K/GT??:QQ";4%>Z)#I1$'=GY+$A6:EK+K+OM9%:NMT=
M+1RBDPEQLWYY_C$CY:@^,MWL'IE<'JG3 _%?+'0UVQ,WVS\Y=-UJ]Z=1HHF=
M/&OWFEAX?MBN%XF%Z6%']YIJKJ?/VKVFEKYTT(Y<F]"HHX% =5JA?[9W32TG
MBG:Q0LWS!.H"JE,/=>>(+= J-@M7,&+&X8-49P_J_B'S&6.5ZD1 W8G@J;&Z
M1^T#3J:T\1NGF_(/#%9J9@#HXW:>I68.@'34D6BIS@)TSZ^>!X:KV1.R_-AD
MD^K\L8GJ9$+_;/.(FH>+P%QG4VAD<,N@<>,B96)17D3)P8RO,[F]N%"_K2^[
MC,LK'JWW9_#M^?;*BE:SO4'S,12+.,M!PN9*Y?"-K_9?;"^E;!\D7Y7W.FZY
ME#PM/RY9&#%1"*COYYS+^X?"0'TUZ/1_4$L#!!0    ( -F!5E(!M+B310,
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M5-2J-D1X=)?;A]0]D2M34(C!TJA%5UUS!,GB;5),M-BXZWTAM'DLN.':O.=
M6@'S?2F$?IO8%T/Y0AS^!5!+ P04    " #9@5926;N.>)\%   /(@  &0
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M<+AQOMCKECY204"ELAE3ZB%NGB4-I<QAN\Z=E(;A ;)&51JR3?( LKD7>7<
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M<7TFV.KM1BEL--0;C'4.HCK@5A/%=^8$M^9*GP?-, $:@R@7Z/L;KM563\H
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M Z?K@!F>HXRJ)[[^A(N$(N.7<"KM+UCGL5'D@"23BJ>%6!.DA.5/]%848DL
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M]MT28CFUX'YNP;Y<0BPG%]S/+MC72XCE](*?XQ?L"P;& :03#'X9PV!?,8/
M]PG.,/!<PX!O&!R0.#C#P&L8!GS#0*B4UL+EN&#*QW]L!>2\ OV\ KY7<!9Z
M<\XLT,\LT+5H"<P+<&Z!?FZ!KG7+,$!S=H%^=@'?+I/ ?QAP>H%^>@%?+Z%U
M)CB_P'/\ AT+F#$.,)U@X&4$ QUKF"SPY:3.,.ES#9/ZAIED :PS3/H:AJF3
MMC<76?:_8N+6QLYNDF^(W+!"&<+:1"47(S,G9+7OK 9:[,J]WKW09N=8'F[-
M7IU*>X.YOA9"/PWL]K'9_<__ E!+ P04    " #9@592MR6/A4\"   X!P
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M;*J\I\O R,)==0MI\.)TS34^;:!L HXOI32[P-Z>]6,Y_ U02P,$%     @
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M!F!7_.1LHW:NP:0R$^+)W(RC\X9O(F()"[4Q0?'/FEVR)#&6,(Y?A=%&Z=,
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MK0T7;S)"5/">Q$RVG4BIY8WKREF$"9%7?(E,[\RY2(C24[%PY5(@"2THB=W
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MF;XITLZ:3A1?VEXSY4IW+CN,]-<("A.@]^><J^W$')!_WW3^ 5!+ P04
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M7P+@^8(Q\7@A7[#]PNOT/U!+ P04    " #9@5924/+6M+4#   J#0  &0
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MFY"=[DYGD_Y?,/DV'KY,OXQ"Z(T'T)\\A\/QM#<;3<80/O7&4[@:9GDJ=HC
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MB^N').(^C0 CR]O&"-Y,4$<)Z!7??;+CN6>@7%E0^JX&#^YMHZ40D8 X0JG
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M7+010^F-CJBE-/B$%)QPLO=?XR\)Y\3S#W<(KA&5 '%_0P@_G<@!H@]Y_?\
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M%H(E^@.\GZ%A7-#1)_B^G,'[=Q_@'? $[B*9:9:$>N088F[G=X*"Y<6.I7^
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M<Z^OC^/!@8L?<@N@T,\D3N6PM55J]\GS9+B%A,IKOH-4OUESD5"ENV+CR9T
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M"#- OU]SKHX=,T%YGQS]!U!+ P04    " #9@592\"Z&2O\(   6,@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6R]6^M3V[@6_U<TF=T9.E,:Z^'8
M9H 9:'CD >V%=N^'._>#203QK!^IK4"[LW_\RHZ)8NE8,;3+%XCMWSG2T7E+
M]N%3EO]9+#@7Z'L2I\51;R'$\J#?+V8+GH3%AVS)4_GD/LN34,C+_*%?+',>
MSBNB).X3QQGTDS!*>\>'U;W/^?%AMA)QE/+/.2I621+F/TYYG#T=]7#O^<9-
M]+ 0Y8W^\>$R?."W7'Q=?L[E57_#91XE/"VB+$4YOS_JG>"#J4M+@@KQ1\2?
MBJW?J!3E+LO^+"]&\Z.>4\Z(QWPF2A:A_/?(/_(X+CG)>7RKF?8V8Y:$V[^?
MN9]7PDMA[L*"?\SB_T9SL3CJ^3TTY_?A*A8WV=,EKP5R2WZS+"ZJO^BIQCH]
M-%L5(DMJ8CF#)$K7_\/O]4)L$4@^, &I"8A.P%H(:$U NQ*PFH!U)7!K K<K
MP: F&'0E\&H"KRN!7Q/X70F"FB#0"09MBG.>->=T'0-OE&UHNY7D6=VXTG=_
M;5B550Y#$1X?YMD3RDN\Y%?^J$R[HI?&&*6E%]Z*7#Z-))TX/OUZ.[H^N[U%
MMV<75V?77]#H^OS3S=7)E]&G:[0WY"*,XN(=VD=?;X=H[[=WZ#<4I>@JBF/I
M0\5A7\@YE)SZLWJ\T_5XI&4\BJZR5"P*=);.^1R@']OI,;$PZ$OA-RM GE?@
ME%@Y#OGL Z+X/2(.<8 )?;23W_*E)'=:R8=V\O$JM9*?V<FOPMPZ^?/.LN,
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M3[<'$X*);@X !NO6 &#T9J+#6&, ,_!U2S QS-<-P<2X;86-ZAJQO6V\;K>
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M$K1Q=D7A=371JHU5A1\*"V5IQ/AE1C\!U,Z!SE.E[&;C M2_E>Y?4$L#!!0
M   ( -F!5E) ':N+S 8  .@C   9    >&PO=V]R:W-H965T<R]S:&5E=#@Y
M+GAM;+V:;6_;-A#'OPKA%4,"M+:H9V5.@*9^MK-U#;J]&/9"L>A8J"1Z%)VT
MWWZ4K/CA>)849-B;1))_=R3UOSM2E/K/7'S+UXQ)\CU-LORZLY9R<]7KY<LU
M2\.\RS<L4[^LN$A#J4[%8R_?"!9&I5&:]$S#<'MI&&>=FWYY[;.XZ?.M3.*,
M?18DWZ9I*'[<LH0_7W=HY^7"E_AQ+8L+O9O^)GQD]TQ^W7P6ZJRW]Q+%*<OR
MF&=$L-5UYR.]6E"_,"B)/V+VG!\=DV(H#YQ_*TZFT77'*'K$$K:4A8M0_7MB
MGUB2%)Y4/_ZIG';V;1:&Q\<OWD?EX-5@'L*<?>+)GW$DU]<=OT,BM@JWB?S"
MGR>L&I!3^%OR)"__DN>*-3IDN<TE3RMCU8,TSG;_P^_5C3@R4'YP [,R,*&!
M?<; J@RLM@9V96"W-7 J Z>M@5L9N&T-O,K :VO@5P9^6X.@,@B@@7M...-%
M.:-M&W0OMJ;V69,7N6FI=V\76&54#D(9WO0%?R:BX)6_XJ ,[=)>!6.<%5EX
M+X7Z-59V\N;W;2@D$\D/\MN&B5#&V2/YPG(5PSFYV&;A-HHEBR[)Q;W*_VB;
M,'4X8#*,D_R2?"!?[P?DXMTE>4=Z)%^'@N4DSLC7+);Y>W51'=_%2:+2+>_W
MI.INT6AO677M=M<U\TS7+'+',[G.R3"+6(38S^KMJ5GCH*?NT_YFF2\WZ]:L
M]3A@RRZQZ'MB&J:!=.A3O?D]VRASXZSYH-Y\MLUJS8?UYG>AJ.W\J/78:8"8
MCUN/'36?M!X[:CYM/7;4?/8VW>=ONW6+]N9^311;^Y2W2G]68\J/XBS,EG&8
MD*)VD+\^/N12J'GQ[YI6['TK=MF*?::57]4*0K GEFT9FOL[:Z^T+I8*3S>6
M89C]WM-Q/NF0Z?GN*330(>J;WBDT1"'0W B! A,T-\8@!T 3%+).H2G6IX">
M0C,="FP+C&ZN0YX'.[Y (,<Z-'>BLK-7V:E5>2QXGI.-X*M88BKOK-WC(9IN
M %3&( .JK$,N9(8ZXSA08\2/"Y@QP@2 F2",[P.!$<8&TLUTQG(M$"ES'3)=
M/\"E<_?2N;723;,E3QE9"9Z2I9HGXVQ;3/Y\MPPX,V.[B I03IUQ8%0/=(8&
M8-!#A(&*CW3&=!V@)L+ W)@@# 7CFB+]\8"?&<+8 7 TUR$?%K6%SGA'X74B
MN+<7W&LC^$6B4O9RIWL4YY7T+#I2_CW)5/7F*R+#[WCU]K3N&2 *&HE!(S%L
M)$:-Q+B1F.B$"9!IHY-9(S%O;F91Y^1$<G\ON=\X"<>E[)B(?HMDUAD]F75&
M3V:$T9)99_1D1A@MF1'&@LF,]$=+9H31DUF' CBPA<Z<3>9@KVQ0J^R"Y?E5
MF:8[?4DHI8@?MC)\2!B1G&0\*U);</7XI<IZG*DE'\LEFLV!/@?!=-81$T@\
MT!$P'PYU LR&(YV@<')&$!"0$P2!:Z_FAF8ZXH(!S77$!LA"1XZ6)"?24^/P
MS&ZT3&M-]M_5<EN201P^9CR7\1)_[C:TI:#CP<S'('@#!@A$?9"S0P2":31"
M&!,NF,<81$%K$PR")6**]=NU00!@D&V!8)LCE._ *$ @SW+/Q,'1W@VM?9(;
MAB)3R:T6X$SLME^:X^'GGWR3>K^H)5^:\HSDDB^_K7D2,9&3#\6&9KR\JGG\
MH^:A<^;;UI?D(LY(I.I3*(Y&<(D&[*XI_SC1NJ8/(Q:E8,3J$.U:L%(AE-'U
M;!BTF"_X%#!&*2> 88M2)HQ;C(+/L3.,,KKP,6>.8&[7I#!T=<KI6F<>/NAA
M$X):K</CS#+T-0%B-2Y(FY%!,S)L1D;-R+@9F51(<!*!L-A-FQW-FI%YJ[86
MM8Y.H^"P242;=XFJF>P58MM:=[%J@%)0<1W"JH%.8=4 \Z57 XS2JP%&N1Y4
M'Z/T:H!06#70,;=KP:4L0M54@\,V$G7^YYDLBI.M9%'M7';8*J%OW"MY3?2Z
M6%Q2&+T816T8OCI%-<V&"*7"UX+AB_F"^Q)CE-*V/W&*PO#%*"UZ$<CHPFVT
M.8*Y7;CJ7R"4TS7/1>]A8X6VVEGYK^:RYLV59F30C R;D5$S,FY&)A72-)<U
M[[(T(_-6;2UJ'9U&P6&OA;;=;'F-V#ZV9M6J 4;IU4"GL&J@4U@UP'SIU0"C
M]&J 4:[V2(916C5 (*P:Z)BKK1 6"(54@][1R_64B<?RDY%<30/;3.Y>NNVO
M[C]+^5B^G ?7;^G5E"+79\5G+.7+_(/[W3<P=Z%XC%7M2-A*-:544I.HV'U6
MLCN1?%.^VG_@4O*T/%RS4,V !:!^7W$N7TZ*!O8?]]S\"U!+ P04    " #9
M@592^L52RPH)  #$,P  &0   'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6S5
M6UMOXL@2_BLMM$?*2"'X#JR22!D@"1G8R4ZTNP]'YZ$Q#?B,+VR[G<MJ?_RI
M-H8&=[OM,$$Z^S(!\U6[JJOZJXL]ER\)_9ZN"&'H-0KC]*JU8FS]<Z>3^BL2
MX?0B69,8?EDD-,(,OM)E)UU3@N>Y4!1V+,/P.A$.XM;U97[MD5Y?)AD+@Y@\
M4I1F483IVV<2)B]7+;.UO? M6*X8O]"YOESC)7DB[+?U(X5OG=TJ\R B<1HD
M,:)D<=6Z,7^>>CTND"-^#\A+NO<9<5-F2?*=?QG/KUH&UXB$Q&=\"0Q_GLF
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M9]>>Q=L@QK$?X!#Q0XW^/0$D&C,2I?_1W,?>W<?.[^-4';8HH2SX"^>9,UG
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MHLA:462M*+*N*;*N_Z>LW\=Q_X_CYV?:FW9XS<_F?_K<_ 102P$"% ,4
M" #9@592!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( -F!5E(7W*Y$[@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -F!5E*97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ V8%64AVF_GL"!@   1D  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -F!5E(1T(YL
MT08  #8;   8              " @44.  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    " #9@592R_RQ[*T"   L!P  &
M@(%,%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ V8%6
M4CY3ZCN(!@  GQX  !@              ("!+Q@  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( -F!5E)P8Z!ST@,  "H,   8
M      " @>T>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M" #9@592GFL+,IL'  #K(   &               @('U(@  >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ V8%64L0JM0K4"   R#   !@
M             ("!QBH  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( -F!5E*88M0MV 0   L+   8              " @= S  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #9@592S%ZO4^<D   9
M?   &               @('>.   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ V8%64K^!FSG]"P  Z"4  !D              ("!^UT
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #9@5929IWL
M!=,#  !I"@  &0              @($O:@  >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( -F!5E+IF1;>:08  &D0   9
M  " @3EN  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
MV8%64G73KIWE"P  CBP  !D              ("!V70  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    " #9@5929@U LC *  !R'P  &0
M            @('U@   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( -F!5E+/*BJQE@P  +@C   9              " @5R+  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ V8%64D5HPZ>/!
M(0L  !D              ("!*9@  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    " #9@592072;)E(#  #=!@  &0              @('O
MG   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( -F!5E+Y
M5T/Q$@4  -$+   9              " @7B@  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ V8%64O,CT(KM @  608  !D
M     ("!P:4  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -F!5E+] 3(1H \  #PU   9              "
M@9C-  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ V8%6
M4GW."<=W#P  ]"@  !D              ("!;]T  'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    " #9@592 .70N[P'   K%   &0
M        @($=[0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( -F!5E)&4I]>?P0  $@-   9              " @1#U  !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ V8%64KHN@7[. @  2P8
M !D              ("!QOD  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    " #9@592--E6 [H+  "!-@  &0              @('+_
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( -F!5E*:.=/N
MT0(  !$&   9              " @;P( 0!X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ V8%64B?/I;<D)0  \'\  !D
M ("!Q L! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " #9
M@5926J;2J08$  "Z"0  &0              @($?,0$ >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( -F!5E+%\U4S"P0  &(+   9
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M970S-RYX;6Q02P$"% ,4    " #9@592PU$VE0\#   \!@  &0
M    @($930$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M -F!5E*';(!75@0  #@*   9              " @5]0 0!X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ V8%64ADG\3;X @  2P8  !D
M             ("![%0! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    " #9@592."X9]6\$  "!"P  &0              @($;6 $ >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( -F!5E("83XA,P4
M *0/   9              " @<%< 0!X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ V8%64NRG4Z=W!   =PL  !D              ("!
M*V(! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " #9@592
ML[:H8,\#  "T"0  &0              @('99@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( -F!5E*9:FQG P4  .P,   9
M      " @=]J 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%
M  @ V8%64@I$-;3N!0  RPX  !D              ("!&7 ! 'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #9@592<ISM<\,+  !^-@
M&0              @($^=@$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+
M 0(4 Q0    ( -F!5E+.Q!F]T0@  !TU   9              " @3B" 0!X
M;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ V8%64IGIA^*O
M!@  BBP  !D              ("!0(L! 'AL+W=O<FMS:&5E=',O<VAE970T
M.2YX;6Q02P$"% ,4    " #9@592U4N=T4X&  "''@  &0
M@($FD@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( -F!
M5E(R9#VD& ,  '@*   9              " @:N8 0!X;"]W;W)K<VAE971S
M+W-H965T-3$N>&UL4$L! A0#%     @ V8%64K\2 ^P/ P  @PD  !D
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M=#4V+GAM;%!+ 0(4 Q0    ( -F!5E)E$Q"X-@,  $P(   9
M  " @0.Y 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @
MV8%64H^77\<C"@  @3$  !D              ("!<+P! 'AL+W=O<FMS:&5E
M=',O<VAE970U."YX;6Q02P$"% ,4    " #9@592NRT6K(T&  #J'P  &0
M            @('*Q@$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4
M Q0    ( -F!5E($CKW0?@0  )(3   9              " @8[- 0!X;"]W
M;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ V8%64O?)V<2E!@
M)B0  !D              ("!0](! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX
M;6Q02P$"% ,4    " #9@592 ;2XDT4#   M"@  &0              @($?
MV0$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( -F!5E)9
MNXYXGP4   \B   9              " @9O< 0!X;"]W;W)K<VAE971S+W-H
M965T-C,N>&UL4$L! A0#%     @ V8%64E*^U[20 P  5@X  !D
M     ("!<>(! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -F!5E)@;>(RZ (  *8)   9              "
M@1/U 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @ V8%6
M4A8;^_3& @  U0<  !D              ("!,O@! 'AL+W=O<FMS:&5E=',O
M<VAE970W,"YX;6Q02P$"% ,4    " #9@592*WD/5G\#   )$   &0
M        @($O^P$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0
M   ( -F!5E*W)8^%3P(  #@'   9              " @>7^ 0!X;"]W;W)K
M<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ V8%64MP%3G2)!   PQ
M !D              ("!:P$" 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q0
M2P$"% ,4    " #9@592=B< I%T"  !1!0  &0              @($K!@(
M>&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( -F!5E(H0.[5
M P,  .L(   9              " @;\( @!X;"]W;W)K<VAE971S+W-H965T
M-S4N>&UL4$L! A0#%     @ V8%64F_Y16,Y @  AP0  !D
M ("!^0L" 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " #9
M@592_>L3E_4&  "Q(P  &0              @(%I#@( >&PO=V]R:W-H965T
M<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( -F!5E+"B0"CRP8  .TE   9
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M970X,BYX;6Q02P$"% ,4    " #9@592TJ 67=,#  #'"P  &0
M    @($W, ( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    (
M -F!5E)<IB P<00  /X1   9              " @4$T @!X;"]W;W)K<VAE
M971S+W-H965T.#0N>&UL4$L! A0#%     @ V8%64BX"@XW\ P  6PX  !D
M             ("!Z3@" 'AL+W=O<FMS:&5E=',O<VAE970X-2YX;6Q02P$"
M% ,4    " #9@592\"Z&2O\(   6,@  &0              @($</0( >&PO
M=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( -F!5E(5Q8PKW ,
M &(.   9              " @5)& @!X;"]W;W)K<VAE971S+W-H965T.#<N
M>&UL4$L! A0#%     @ V8%64M KSI/# @  8@8  !D              ("!
M94H" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4    " #9@592
M0!VKB\P&  #H(P  &0              @(%?30( >&PO=V]R:W-H965T<R]S
M:&5E=#@Y+GAM;%!+ 0(4 Q0    ( -F!5E+ZQ5++"@D  ,0S   9
M      " @6)4 @!X;"]W;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%
M  @ V8%64@<*W^#M @  5P@  !D              ("!HUT" 'AL+W=O<FMS
M:&5E=',O<VAE970Y,2YX;6Q02P$"% ,4    " #9@592K8;Q$D4"  !:"P
M#0              @ ''8 ( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -F!
M5E*7BKL<P    !,"   +              "  3=C @!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( -F!5E)HFC?5Z@8  -<[   /              "  2!D @!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #9@5927T[J"J8"  "8-0  &@
M            @ $W:P( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #9@592>S86[3T"  #Q,P  $P              @ $5;@( 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     8P!C "P;  "#< (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>457</ContextCount>
  <ElementCount>616</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>123</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105103 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITION</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108104 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2111105 - Disclosure - RESTRUCTURING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES</Role>
      <ShortName>RESTRUCTURING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2118107 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2123108 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOME</Role>
      <ShortName>TAXES ON INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2126109 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW AND OTHER DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2129110 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2132111 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2135112 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2138113 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2145114 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2152115 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2158116 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2162117 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2170118 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2172119 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2175120 - Disclosure - RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RELATEDPARTIES</Role>
      <ShortName>RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2177121 - Disclosure - DISCONTINUED OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS</Role>
      <ShortName>DISCONTINUED OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2179122 - Disclosure - Quarterly Operating Results (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited</Role>
      <ShortName>Quarterly Operating Results (unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2183123 - Disclosure - Schedule II - Valuation Accounts and Reserves</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves</Role>
      <ShortName>Schedule II - Valuation Accounts and Reserves</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITION</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables</Role>
      <ShortName>EARNINGS (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - RESTRUCTURING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables</Role>
      <ShortName>RESTRUCTURING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2324305 - Disclosure - TAXES ON INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOMETables</Role>
      <ShortName>TAXES ON INCOME (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/TAXESONINCOME</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2327306 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2330307 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2333308 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2336309 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2339310 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBT</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2346311 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASES</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2353312 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2359313 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2363314 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2373315 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2380316 - Disclosure - Quarterly Operating Results (unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables</Role>
      <ShortName>Quarterly Operating Results (unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - REVENUE RECOGNITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONDetails</Role>
      <ShortName>REVENUE RECOGNITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - EARNINGS (LOSS) PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails</Role>
      <ShortName>EARNINGS (LOSS) PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2413404 - Disclosure - RESTRUCTURING ACTIVITIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails</Role>
      <ShortName>RESTRUCTURING ACTIVITIES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - RESTRUCTURING ACTIVITIES (Pre-Tax Restructuring charges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails</Role>
      <ShortName>RESTRUCTURING ACTIVITIES (Pre-Tax Restructuring charges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - RESTRUCTURING ACTIVITIES (Activities of Restructuring Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails</Role>
      <ShortName>RESTRUCTURING ACTIVITIES (Activities of Restructuring Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - BUSINESS ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2420408 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2421409 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2425411 - Disclosure - TAXES ON INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/TAXESONINCOMEDetails</Role>
      <ShortName>TAXES ON INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/TAXESONINCOMETables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2428412 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2431413 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2434414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2437415 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2440416 - Disclosure - DEBT (Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTLongTermDebtDetails</Role>
      <ShortName>DEBT (Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2441417 - Disclosure - DEBT (Secured Receivables Credit Facility) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails</Role>
      <ShortName>DEBT (Secured Receivables Credit Facility) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2442418 - Disclosure - DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails</Role>
      <ShortName>DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2443419 - Disclosure - DEBT (Senior Notes Offering) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails</Role>
      <ShortName>DEBT (Senior Notes Offering) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2444420 - Disclosure - DEBT (Maturities of Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails</Role>
      <ShortName>DEBT (Maturities of Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DEBTTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2447421 - Disclosure - LEASES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2448422 - Disclosure - LEASES (Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESLiabilitiesDetails</Role>
      <ShortName>LEASES (Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2449423 - Disclosure - LEASES (Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESCostsDetails</Role>
      <ShortName>LEASES (Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2450424 - Disclosure - LEASES (Maturity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESMaturityDetails</Role>
      <ShortName>LEASES (Maturity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2451425 - Disclosure - LEASES (Term and Rate) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/LEASESTermandRateDetails</Role>
      <ShortName>LEASES (Term and Rate) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/LEASESTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2454426 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2455427 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2456428 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Income Statement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2457429 - Disclosure - FINANCIAL INSTRUMENTS (Fair Value of Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Fair Value of Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2460430 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2461431 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2464432 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2465433 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2466434 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2467435 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2468436 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2469437 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails</Role>
      <ShortName>STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2471438 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2474439 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2476440 - Disclosure - RELATED PARTIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RELATEDPARTIESDetails</Role>
      <ShortName>RELATED PARTIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/RELATEDPARTIES</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2478441 - Disclosure - DISCONTINUED OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails</Role>
      <ShortName>DISCONTINUED OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2481442 - Disclosure - Quarterly Operating Results (unaudited) (Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails</Role>
      <ShortName>Quarterly Operating Results (unaudited) (Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2482443 - Disclosure - Quarterly Operating Results (unaudited) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails</Role>
      <ShortName>Quarterly Operating Results (unaudited) (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="dgx-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2484444 - Disclosure - Schedule II - Valuation Accounts and Reserves (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails</Role>
      <ShortName>Schedule II - Valuation Accounts and Reserves (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves</ParentRole>
      <Position>91</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="dgx-20201231.htm">dgx-20201231.htm</File>
    <File>dgx-20201231.xsd</File>
    <File>dgx-20201231_cal.xml</File>
    <File>dgx-20201231_def.xml</File>
    <File>dgx-20201231_lab.xml</File>
    <File>dgx-20201231_pre.xml</File>
    <File>dgx12312020ex1017.htm</File>
    <File>dgx12312020ex104.htm</File>
    <File>dgx12312020ex105.htm</File>
    <File>dgx12312020ex211.htm</File>
    <File>dgx12312020ex231.htm</File>
    <File>dgx12312020ex311.htm</File>
    <File>dgx12312020ex312.htm</File>
    <File>dgx12312020ex321.htm</File>
    <File>dgx12312020ex322.htm</File>
    <File>dgx12312020ex997.htm</File>
    <File>dgx12312020exh1015.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dgx-20201231_g1.jpg</File>
    <File>dgx-20201231_g2.jpg</File>
    <File>dgx-20201231_g3.jpg</File>
    <File>dgx-20201231_g4.jpg</File>
    <File>dgx-20201231_g5.jpg</File>
    <File>dgx-20201231_g6.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>122
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dgx-20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 34,
   "contextCount": 457,
   "dts": {
    "calculationLink": {
     "local": [
      "dgx-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dgx-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "dgx-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dgx-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgx-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dgx-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 849,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 4,
    "http://questdiagnostics.com/20201231": 3,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 11
   },
   "keyCustom": 87,
   "keyStandard": 529,
   "memberCustom": 60,
   "memberStandard": 59,
   "nsprefix": "dgx",
   "nsuri": "http://questdiagnostics.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://questdiagnostics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105103 - Disclosure - REVENUE RECOGNITION",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITION",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108104 - Disclosure - EARNINGS PER SHARE",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111105 - Disclosure - RESTRUCTURING ACTIVITIES",
     "role": "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES",
     "shortName": "RESTRUCTURING ACTIVITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - BUSINESS ACQUISITIONS",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118107 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123108 - Disclosure - TAXES ON INCOME",
     "role": "http://questdiagnostics.com/role/TAXESONINCOME",
     "shortName": "TAXES ON INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126109 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA",
     "shortName": "SUPPLEMENTAL CASH FLOW AND OTHER DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129110 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "role": "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132111 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135112 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "role": "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138113 - Disclosure - DEBT",
     "role": "http://questdiagnostics.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145114 - Disclosure - LEASES",
     "role": "http://questdiagnostics.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152115 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158116 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2162117 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2170118 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2172119 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2175120 - Disclosure - RELATED PARTIES",
     "role": "http://questdiagnostics.com/role/RELATEDPARTIES",
     "shortName": "RELATED PARTIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2177121 - Disclosure - DISCONTINUED OPERATIONS",
     "role": "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS",
     "shortName": "DISCONTINUED OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2179122 - Disclosure - Quarterly Operating Results (unaudited)",
     "role": "http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited",
     "shortName": "Quarterly Operating Results (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2183123 - Disclosure - Schedule II - Valuation Accounts and Reserves",
     "role": "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves",
     "shortName": "Schedule II - Valuation Accounts and Reserves",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306301 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - EARNINGS (LOSS) PER SHARE (Tables)",
     "role": "http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables",
     "shortName": "EARNINGS (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - RESTRUCTURING ACTIVITIES (Tables)",
     "role": "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables",
     "shortName": "RESTRUCTURING ACTIVITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324305 - Disclosure - TAXES ON INCOME (Tables)",
     "role": "http://questdiagnostics.com/role/TAXESONINCOMETables",
     "shortName": "TAXES ON INCOME (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327306 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables",
     "shortName": "SUPPLEMENTAL CASH FLOW AND OTHER DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "role": "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333308 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336309 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)",
     "role": "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339310 - Disclosure - DEBT (Tables)",
     "role": "http://questdiagnostics.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleOfLeaseByAssetTypeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346311 - Disclosure - LEASES (Tables)",
     "role": "http://questdiagnostics.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleOfLeaseByAssetTypeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353312 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2359313 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2363314 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2373315 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2380316 - Disclosure - Quarterly Operating Results (unaudited) (Tables)",
     "role": "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables",
     "shortName": "Quarterly Operating Results (unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - REVENUE RECOGNITION (Details)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
     "shortName": "REVENUE RECOGNITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - EARNINGS (LOSS) PER SHARE (Details)",
     "role": "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
     "shortName": "EARNINGS (LOSS) PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413404 - Disclosure - RESTRUCTURING ACTIVITIES (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails",
     "shortName": "RESTRUCTURING ACTIVITIES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i50637c6aa27f4b9f88abbcb41129c619_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414405 - Disclosure - RESTRUCTURING ACTIVITIES (Pre-Tax Restructuring charges) (Details)",
     "role": "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails",
     "shortName": "RESTRUCTURING ACTIVITIES (Pre-Tax Restructuring charges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i7e43b539c2824abb88850270c0d15fd4_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i11ae4adedea143f39461ad0909150885_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - RESTRUCTURING ACTIVITIES (Activities of Restructuring Liabilities) (Details)",
     "role": "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails",
     "shortName": "RESTRUCTURING ACTIVITIES (Activities of Restructuring Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i8e7c86051f474a8190d2d494f3dd3a2f_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - BUSINESS ACQUISITIONS (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420408 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ib5b80ecba80a4ec3be7640854bdf798a_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421409 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ie2ea36aabe78463eb75346dd3ac096a6_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Reconciliation of Beginning and Ending Balances of Liabilities Unobservable Inputs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ib49a85f69283488d9da436dc5543b52e_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425411 - Disclosure - TAXES ON INCOME (Details)",
     "role": "http://questdiagnostics.com/role/TAXESONINCOMEDetails",
     "shortName": "TAXES ON INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428412 - Disclosure - SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails",
     "shortName": "SUPPLEMENTAL CASH FLOW AND OTHER DATA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i11ae4adedea143f39461ad0909150885_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431413 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)",
     "role": "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i11ae4adedea143f39461ad0909150885_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434414 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437415 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)",
     "role": "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440416 - Disclosure - DEBT (Long-Term Debt) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
     "shortName": "DEBT (Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i545c653723ac4b35958b7b601878135c_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "iecaf492a9ad94a36b60612ba765970e6_I20201022",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441417 - Disclosure - DEBT (Secured Receivables Credit Facility) (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
     "shortName": "DEBT (Secured Receivables Credit Facility) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ifb648f82ea194e07a192722e1bf31021_D20201001-20201031",
      "decimals": null,
      "lang": "en-US",
      "name": "dgx:DebtInstrumentExtensionPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442418 - Disclosure - DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
     "shortName": "DEBT (Senior Unsecured Revolving Credit Facility) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443419 - Disclosure - DEBT (Senior Notes Offering) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
     "shortName": "DEBT (Senior Notes Offering) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i752e64558c134adab9652fe39589f9ca_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444420 - Disclosure - DEBT (Maturities of Long-Term Debt) (Details)",
     "role": "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails",
     "shortName": "DEBT (Maturities of Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "iab80bc8d6c034781841021bec4469b4f_D20180101-20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447421 - Disclosure - LEASES (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "iab80bc8d6c034781841021bec4469b4f_D20180101-20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448422 - Disclosure - LEASES (Liabilities) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESLiabilitiesDetails",
     "shortName": "LEASES (Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dgx:ScheduleOfLeaseByAssetTypeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i79da04d8282d4c8291850645193b2909_I20171231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i79da04d8282d4c8291850645193b2909_I20171231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:OperatingLeaseFixedAndVariableCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449423 - Disclosure - LEASES (Costs) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESCostsDetails",
     "shortName": "LEASES (Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:OperatingLeaseFixedAndVariableCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450424 - Disclosure - LEASES (Maturity) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESMaturityDetails",
     "shortName": "LEASES (Maturity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451425 - Disclosure - LEASES (Term and Rate) (Details)",
     "role": "http://questdiagnostics.com/role/LEASESTermandRateDetails",
     "shortName": "LEASES (Term and Rate) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454426 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ib9ba6ffe183a49a6b9354897969c869e_D20200401-20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "id141c98d5c21416f95dd9ad86532d5f8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455427 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "id141c98d5c21416f95dd9ad86532d5f8_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedge",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456428 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ibb495ec24a01435fbd27a38907a75fca_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i73cb452a6ac74285af4a4f642559ad6f_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457429 - Disclosure - FINANCIAL INSTRUMENTS (Fair Value of Derivatives) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Fair Value of Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i73cb452a6ac74285af4a4f642559ad6f_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460430 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i11ae4adedea143f39461ad0909150885_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461431 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Components of Accumulated Other Comprehensive (Loss) Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i34c51c66cc164d1da2582f9c600d44f1_I20171231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464432 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Employee and Non-employee Directors Stock Ownership Programs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465433 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Weighted Average Assumptions Used in Valuing Options Granted) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i727f4b6eb33e4f3c8265b0e2dc2dbd40_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466434 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Transactions Under Stock Option Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i4dab9607bf5a4a4882c8cb0841e51a0c_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467435 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Activities Related to Stock Awards) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468436 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Employee Stock Purchase Plan and Defined Contribution Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i8dc399408d83439f8a45f2e539c668dd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469437 - Disclosure - STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)",
     "role": "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails",
     "shortName": "STOCK OWNERSHIP AND COMPENSATION PLANS (Supplemental Deferred Compensation Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i43c9eaea209849029715a8175ab5a38f_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "dgx:SupplementalDeferredCompensationPlanSalaryDeferral",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471438 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3b2db1a35d1945348b1a626840f7580c_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474439 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i9491ec5cfff349bebd4c36dea5408c17_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "iab80bc8d6c034781841021bec4469b4f_D20180101-20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476440 - Disclosure - RELATED PARTIES (Details)",
     "role": "http://questdiagnostics.com/role/RELATEDPARTIESDetails",
     "shortName": "RELATED PARTIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "iab80bc8d6c034781841021bec4469b4f_D20180101-20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i5d23165dad6f4a7c9753adca8283f930_D20190401-20190630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "dgx:DiscontinuedOperationGainonSettlingUncertainTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478441 - Disclosure - DISCONTINUED OPERATIONS (Details)",
     "role": "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
     "shortName": "DISCONTINUED OPERATIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "i3e9708bf7a3f4fe9bf78754bc3d52636_D20190101-20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2481442 - Disclosure - Quarterly Operating Results (unaudited) (Schedule) (Details)",
     "role": "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails",
     "shortName": "Quarterly Operating Results (unaudited) (Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia47d12fa5d914b40b69fec00a4f80abc_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2482443 - Disclosure - Quarterly Operating Results (unaudited) (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
     "shortName": "Quarterly Operating Results (unaudited) (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ie32b77a26e474585b4b3b48a918c4a53_D20201001-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "dgx:RestructuringIntegrationCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia8ef0d848be64de88a06475f05c8fc23_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2484444 - Disclosure - Schedule II - Valuation Accounts and Reserves (Details)",
     "role": "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails",
     "shortName": "Schedule II - Valuation Accounts and Reserves (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dgx-20201231.htm",
      "contextRef": "ia9415c8123544c9387ed93ba012a625f_I20171231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 123,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r705",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r705",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dgx_AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable and Allowance for Credit Losses Policy",
        "label": "Accounts Receivable and Allowance for Credit Losses Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "AccountsReceivableAndAllowanceForCreditLossesPolicyPolicyTextBlock",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AccountsReceivableDisaggregationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Disaggregation [Table Text Block]",
        "label": "Accounts Receivable Disaggregation [Table Text Block]",
        "terseLabel": "Accounts Receivable Disaggregation"
       }
      }
     },
     "localname": "AccountsReceivableDisaggregationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AgreementtoOutsourceBillingandCollectionFunction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement to Outsource Billing and Collection Function",
        "label": "Agreement to Outsource Billing and Collection Function",
        "terseLabel": "Agreement to outsource billing and collection function"
       }
      }
     },
     "localname": "AgreementtoOutsourceBillingandCollectionFunction",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_AllotherservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other services [Member]",
        "label": "All other services [Member]",
        "terseLabel": "All other services"
       }
      }
     },
     "localname": "AllotherservicesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AmortizationofIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Intangible Assets [Member]",
        "label": "Amortization of Intangible Assets [Member]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "AmortizationofIntangibleAssetsMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AnatomicpathologytestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anatomic pathology testing services [Member]",
        "label": "Anatomic pathology testing services [Member]",
        "terseLabel": "Anatomic pathology testing services"
       }
      }
     },
     "localname": "AnatomicpathologytestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_BlueprintGeneticsOyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blueprint Genetics Oy [Member]",
        "label": "Blueprint Genetics Oy [Member]",
        "terseLabel": "Blueprint Genetics Oy"
       }
      }
     },
     "localname": "BlueprintGeneticsOyMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) [Member]",
        "label": "Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum) [Member]",
        "terseLabel": "Boyce &amp; Bynum Pathology Laboratories, P.C. (Boyce &amp; Bynum)"
       }
      }
     },
     "localname": "BoyceBynumPathologyLaboratoriesP.C.BoyceBynumMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_BusinessAcquisitionPostacquisitionRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Post-acquisition Revenue",
        "label": "Business Acquisition, Post-acquisition Revenue",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionPostacquisitionRevenue",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Taxes",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Taxes",
        "terseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxes",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to goodwill acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "terseLabel": "Adjustment, goodwill"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to other assets and liabilities acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets and Liabilities",
        "terseLabel": "Adjustment, other assets and liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsandLiabilities",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles1",
        "terseLabel": "Finite-lived intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFiniteLivedIntangibles1",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment and Working Capital",
        "terseLabel": "Property, plant, and equipment and working capital"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedPropertyPlantandEquipmentandWorkingCapital",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital",
        "terseLabel": "Working capital"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Dicount Rate used to determine fair value",
        "terseLabel": "Equity interest in acquiree, discount rate used to determine fair value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeDicountRateUsedToDetermineFairValue",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Long-term Growth Rate used to determine fair value",
        "terseLabel": "Equity interest in acquiree, long-term growth rate used to determine fair value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeLongTermGrowthRateUsedToDetermineFairValue",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_COVID19TestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing Services",
        "label": "COVID-19 Testing Services [Member]",
        "terseLabel": "COVID-19 testing services"
       }
      }
     },
     "localname": "COVID19TestingServicesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapeCodHealthcareInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cape Cod Healthcare, Inc. [Member]",
        "label": "Cape Cod Healthcare, Inc. [Member]",
        "terseLabel": "Cape Cod Healthcare, Inc."
       }
      }
     },
     "localname": "CapeCodHealthcareInc.Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapitatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitated [Member]",
        "label": "Capitated [Member]",
        "terseLabel": "Capitated"
       }
      }
     },
     "localname": "CapitatedMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ChargesDueToCOVID19": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charges due to COVID-19",
        "label": "Charges due to COVID-19",
        "terseLabel": "Pre-tax charges due to COVID-19"
       }
      }
     },
     "localname": "ChargesDueToCOVID19",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ClientPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client Payers [Member]",
        "label": "Client Payers [Member]",
        "terseLabel": "Client payers"
       }
      }
     },
     "localname": "ClientPayersMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) [Member]",
        "label": "Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "Commercial Rates for Highly-Rated Issuers or London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "CommercialRatesforHighlyRatedIssuersorLondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration [Member]",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ContractRelatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract-Related [Member]",
        "label": "Contract-Related [Member]",
        "terseLabel": "Contract Related"
       }
      }
     },
     "localname": "ContractRelatedMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual life of stock options and other awards under the Shared-based compensation plans",
        "label": "Contractual life of stock options and other awards under the Shared-based compensation plans",
        "terseLabel": "Contractual life of stock options and other awards under the shared-based compensation plans"
       }
      }
     },
     "localname": "ContractualLifeOfStockOptionsAndOtherAwardsUnderSharedBasedCompensationPlans",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_DSBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Businesses [Member]",
        "label": "DS Businesses [Member]",
        "terseLabel": "DS"
       }
      }
     },
     "localname": "DSBusinessesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DebtInstrumentExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, Extension Period",
        "label": "Debt instrument, Extension Period",
        "terseLabel": "Extension period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriod",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, fair value basis adjustment attributable to hedged debt",
        "label": "Debt Instrument, fair value basis adjustment attributable to hedged debt",
        "negatedTerseLabel": "Fair value basis adjustments attributable to hedged debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DebtInstrumentLeverageRatioRequirement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Leverage Ratio Requirement",
        "label": "Debt Instrument, Leverage Ratio Requirement",
        "terseLabel": "Leverage ratio requirement"
       }
      }
     },
     "localname": "DebtInstrumentLeverageRatioRequirement",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_DeferredRentAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Rent Adjustments",
        "label": "Deferred Rent Adjustments",
        "terseLabel": "Deferred rent adjustments"
       }
      }
     },
     "localname": "DeferredRentAdjustments",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease Liabilities, Noncurrent",
        "label": "Deferred Tax Assets, Operating Lease Liabilities, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilitiesNoncurrent",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Receivables",
        "terseLabel": "Accounts receivable reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesandAccrualsAccountsReceivables",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments",
        "label": "Deferred Tax Liability, Investments, Investments in Subsidiaries and Equity method investments",
        "negatedTerseLabel": "Basis differences in investments, joint ventures and subsidiaries"
       }
      }
     },
     "localname": "DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_DerivativeGainAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Gain, Amortization Period",
        "label": "Derivative Gain, Amortization Period",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "DerivativeGainAmortizationPeriod",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_DiagnosticInformationServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Information Services Business [Member]",
        "label": "Diagnostic Information Services Business [Member]",
        "terseLabel": "DIS business"
       }
      }
     },
     "localname": "DiagnosticInformationServicesBusinessMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DiscontinuedOperationGainonSettlingUncertainTaxBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discontinued Operation, Gain on Settling Uncertain Tax Benefits",
        "label": "Discontinued Operation, Gain on Settling Uncertain Tax Benefits",
        "negatedTerseLabel": "Gain on settling uncertain tax benefits",
        "terseLabel": "Gain on settling uncertain tax benefits"
       }
      }
     },
     "localname": "DiscontinuedOperationGainonSettlingUncertainTaxBenefits",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change for uncertain tax position",
        "label": "Effective Income Tax Rate Reconciliation, Change for uncertain tax position",
        "terseLabel": "Changes in reserves for uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeForUncertainTaxPosition",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change in Accounting Method",
        "label": "Effective Income Tax Rate Reconciliation, Change in Accounting Method",
        "terseLabel": "Change in accounting method"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeinAccountingMethod",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_EmployeeLongTermIncentivePlanEltipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Long-Term Incentive Plan (ELTIP) (Member)",
        "label": "Employee Long Term Incentive Plan Eltip [Member]",
        "terseLabel": "Employee Long Term Incentive Plan ELTIP"
       }
      }
     },
     "localname": "EmployeeLongTermIncentivePlanEltipMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_EquityinEarningsofEquityMethodInvesteesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity in Earnings of Equity Method Investees [Member]",
        "label": "Equity in Earnings of Equity Method Investees [Member]",
        "terseLabel": "Equity in Earnings of Equity Method Investees"
       }
      }
     },
     "localname": "EquityinEarningsofEquityMethodInvesteesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired",
        "label": "Fair value of net assets acquired",
        "totalLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "FairValueOfNetAssetsAcquired",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FeeforserviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee-for-service [Member]",
        "label": "Fee-for-service [Member]",
        "terseLabel": "Fee-for-service"
       }
      }
     },
     "localname": "FeeforserviceMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FinanceLeaseObligationsandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Obligations and Other [Member]",
        "label": "Finance Lease Obligations and Other [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "FinanceLeaseObligationsandOtherMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance and Operating Lease Liabilities, Payments, Due [Abstract]",
        "label": "Finance and Operating Lease Liabilities, Payments, Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FinanceandOperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived intangible assets, estimated amortization expense, total.",
        "label": "Finite-lived intangible assets, Estimated amortization expense, total",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FivePointSevenFivePercentSeniorNotesDue2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Point Seven Five Percent Senior Notes Due 2040 [Member]",
        "label": "Five Point Seven Five Percent Senior Notes Due2040 [Member]",
        "terseLabel": "5.75% Senior Notes due January 2040"
       }
      }
     },
     "localname": "FivePointSevenFivePercentSeniorNotesDue2040Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FixedtovariableinterestrateswapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed-to-variable interest rate swap [Member]",
        "label": "Fixed-to-variable interest rate swap [Member]",
        "terseLabel": "Fixed-to-variable interest rate swap"
       }
      }
     },
     "localname": "FixedtovariableinterestrateswapMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ForwardStartingInterestRateSwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Starting Interest Rate Swaps [Member]",
        "label": "Forward Starting Interest Rate Swaps [Member]",
        "terseLabel": "Forward Starting Interest Rate Swaps"
       }
      }
     },
     "localname": "ForwardStartingInterestRateSwapsMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FourPointSevenFivePercentSeniorNotesDue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Seven Five Percent Senior Notes Due 2020 [Member]",
        "label": "Four Point Seven Five Percent Senior Notes Due2020 [Member]",
        "terseLabel": "4.75% Senior Notes due January 2020"
       }
      }
     },
     "localname": "FourPointSevenFivePercentSeniorNotesDue2020Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FourPointSevenZeroPercentSeniorNotesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Seven Zero Percent Senior Notes due 2021 [Member]",
        "label": "Four Point Seven Zero Percent Senior Notes due 2021 [Member]",
        "terseLabel": "4.70% Senior Notes due April 2021"
       }
      }
     },
     "localname": "FourPointSevenZeroPercentSeniorNotesdue2021Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FourPointSevenZeroPercentSeniorNotesdueMarch2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Seven Zero Percent Senior Notes due March 2045 [Member]",
        "label": "Four Point Seven Zero Percent Senior Notes due March 2045 [Member]",
        "terseLabel": "4.70% Senior Notes due March 2045"
       }
      }
     },
     "localname": "FourPointSevenZeroPercentSeniorNotesdueMarch2045Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FourPointTwoZeroPercentSeniorNotesdueJune2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Two Zero Percent Senior Notes due June 2029 [Member]",
        "label": "Four Point Two Zero Percent Senior Notes due June 2029 [Member]",
        "terseLabel": "4.20% Senior Notes due June 2029"
       }
      }
     },
     "localname": "FourPointTwoZeroPercentSeniorNotesdueJune2029Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FourpointtwofivepercentSeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four point two five percent Senior Notes Due 2024 [Member]",
        "label": "Four point two five percent Senior Notes Due 2024 [Member]",
        "terseLabel": "4.25% Senior Notes due April 2024"
       }
      }
     },
     "localname": "FourpointtwofivepercentSeniorNotesDue2024Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funds in a trust pertaining to all participant deferrals and company matching amounts related to the Supplemental Deferred Compensation Plan.",
        "label": "Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP",
        "terseLabel": "Funds in a trust pertaining to all participant deferrals and company matching amounts related to the SDCP"
       }
      }
     },
     "localname": "FundsinatrustpertainingtoallparticipantdeferralsandcompanymatchingamountsrelatedtotheSDCP",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) recognized by equity method investee to adjust certain investments to fair value, partially offset by a loss on retirement of debt",
        "label": "Gain (loss) recognized by equity method investee to adjust certain investments to fair value, partially offset by a loss on retirement of debt",
        "negatedTerseLabel": "Gain recognized by an equity method investee to adjust certain of its investments to fair value, partially offset by a loss on retirement of debt"
       }
      }
     },
     "localname": "GainLossRecognizedByEquityMethodInvesteeToAdjustCertainInvestmentsToFairValuePartiallyOffsetByALossOnRetirementOfDebt",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain associated with contingent consideration accrual, partially offset by costs incurred related to security incident",
        "label": "Gain associated with contingent consideration accrual, partially offset by costs incurred related to security incident",
        "terseLabel": "Cost incurred do to incident"
       }
      }
     },
     "localname": "Gainassociatedwithcontingentconsiderationaccrualpartiallyoffsetbycostsincurredrelatedtosecurityincident",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain associated with insurance claim, partially offset by non-cash asset impairment charge",
        "label": "Gain associated with insurance claim, partially offset by non-cash asset impairment charge",
        "negatedTerseLabel": "Gain associated with an insurance claim for hurricane"
       }
      }
     },
     "localname": "Gainassociatedwithinsuranceclaimpartiallyoffsetbynoncashassetimpairmentcharge",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_GenebasedandesoterictestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gene-based and esoteric testing services [Member]",
        "label": "Gene-based and esoteric testing services [Member]",
        "terseLabel": "Gene-based and esoteric (including advanced diagnostics) testing services"
       }
      }
     },
     "localname": "GenebasedandesoterictestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill related toprior period acquisitions, including purchase accounting adjustments recorded during subsequent periods",
        "label": "Goodwill related toprior period acquisitions, including purchase accounting adjustments recorded during subsequent periods",
        "terseLabel": "Goodwill adjustment"
       }
      }
     },
     "localname": "GoodwillRelatedTopriorPeriodAcquisitionsIncludingPurchaseAccountingAdjustmentsRecordedDuringSubsequentPeriods",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_GovernmentPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Payers [Member]",
        "label": "Government Payers [Member]",
        "terseLabel": "Government payers"
       }
      }
     },
     "localname": "GovernmentPayersMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HealthcareInsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurers [Member]",
        "label": "Healthcare Insurers [Member]",
        "terseLabel": "Healthcare insurers:"
       }
      }
     },
     "localname": "HealthcareInsurersMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Recognized due to Receipt of Initial Tranche of Funds From the CARES Act",
        "label": "Income Recognized due to Receipt of Initial Tranche of Funds From the CARES Act",
        "negatedTerseLabel": "Income recognized due to receipt of initial tranche of funds from the CARES Act"
       }
      }
     },
     "localname": "IncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Benefit Associated with Changes in Tax Return Accounting Method",
        "label": "Income Tax Benefit Associated with Changes in Tax Return Accounting Method",
        "terseLabel": "Income tax benefit associated with changes in tax return accounting method"
       }
      }
     },
     "localname": "IncomeTaxBenefitAssociatedwithChangesinTaxReturnAccountingMethod",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards",
        "label": "Income Tax Expense (Benefit) Due to Release of Valuation Allowance Associated With Net Operating Loss Carryforwards",
        "negatedTerseLabel": "Income tax benefit due to release of valuation allowances associated with net operating loss carryforwards"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitDuetoReleaseofValuationAllowanceAssociatedWithNetOperatingLossCarryforwards",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_IncreaseDecreaseinCommonStockDividendsDeclaredasPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Common Stock, Dividends, Declared as Percent",
        "label": "Increase (Decrease) in Common Stock, Dividends, Declared as Percent",
        "terseLabel": "Increase in quarterly dividends as percent"
       }
      }
     },
     "localname": "IncreaseDecreaseinCommonStockDividendsDeclaredasPercent",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_InterestRateLockAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Lock Agreements",
        "label": "Interest Rate Lock Agreements [Member]",
        "terseLabel": "Interest Rate Lock Agreements"
       }
      }
     },
     "localname": "InterestRateLockAgreementsMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_InvestmentwithoutReadilyDeterminableFairValueImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment without Readily Determinable Fair Value, Impairment",
        "label": "Investment without Readily Determinable Fair Value, Impairment",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "InvestmentwithoutReadilyDeterminableFairValueImpairment",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_InvigorateProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Invigorate Program [Member]",
        "label": "Invigorate Program [Member]",
        "terseLabel": "Invigorate Program"
       }
      }
     },
     "localname": "InvigorateProgramMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LaboratoryEquipmentAndFurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment and furniture and fixtures [Member]",
        "label": "Laboratory Equipment And Furniture And Fixtures [Member]",
        "terseLabel": "Laboratory Equipment and Furniture and Fixtures"
       }
      }
     },
     "localname": "LaboratoryEquipmentAndFurnitureAndFixturesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LaboratoryEquipmentFurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory Equipment, Furniture and Fixtures [Member]",
        "label": "Laboratory Equipment, Furniture and Fixtures [Member]",
        "terseLabel": "Laboratory Equipment, Furniture and Fixtures"
       }
      }
     },
     "localname": "LaboratoryEquipmentFurnitureAndFixturesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LeaseRemainingLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Remaining Lease Term",
        "label": "Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LeaseRemainingLeaseTerm",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_LeaseRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Renewal Term",
        "label": "Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LeaseRenewalTerm",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_LeaseRightofUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right-of-Use Asset",
        "label": "Lease, Right-of-Use Asset",
        "totalLabel": "Total lease assets"
       }
      }
     },
     "localname": "LeaseRightofUseAsset",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 1.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Next Twelve Months",
        "totalLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 5.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Five",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 4.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Four",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 3.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Three",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due Year Two",
        "totalLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 6.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five",
        "label": "Lessee, Operating and Finance Lease, Liability, Payments, Due after Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityPaymentsDueafterYearFive",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount",
        "label": "Lessee, Operating and Finance Lease, Liability, Undiscounted Excess Amount",
        "totalLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_LoanCommitmentMaturingOctober2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan commitment maturing October 2022",
        "label": "Loan commitment maturing October 2022 [Member]",
        "terseLabel": "Loan commitment maturing October 2022"
       }
      }
     },
     "localname": "LoanCommitmentMaturingOctober2022Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LoancommitmentmaturingOctober2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan commitment maturing October 2021 [Member]",
        "label": "Loan commitment maturing October 2021 [Member]",
        "terseLabel": "Loan commitment maturing October 2021"
       }
      }
     },
     "localname": "LoancommitmentmaturingOctober2021Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_LongTermDebtMaturitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including current and noncurrent portions, aggregate carrying amount of long-term borrowings as of the balance sheet date. May include notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt, which had initial maturities beyond one year or beyond the normal operating cycle, if longer, and before deducting unamortized discount or premiums, if any.",
        "label": "Long-term Debt, Maturities Gross",
        "totalLabel": "Total maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesGross",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Element represents the discounted market value of the Company stock on offering date or purchase date that participants pay for shares. Typically, the participant's per share cost is the lower of the prices on the two dates.",
        "label": "Market price of Company stock issued at a discount under the ESPP",
        "terseLabel": "Market price of company stock issued at a discount under the ESPP"
       }
      }
     },
     "localname": "MarketPriceOfCompanyStockIssuedAtDiscountUnderEspp",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_MemorialHermannMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Memorial Hermann [Member]",
        "label": "Memorial Hermann [Member]",
        "terseLabel": "Memorial Hermann"
       }
      }
     },
     "localname": "MemorialHermannMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MergerConsiderationPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Consideration Payable, Current",
        "label": "Merger Consideration Payable, Current",
        "terseLabel": "Merger consideration payable"
       }
      }
     },
     "localname": "MergerConsiderationPayableCurrent",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_Mergerconsiderationpaidpayablenet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger consideration paid (payable), net",
        "label": "Merger consideration paid (payable), net",
        "terseLabel": "Merger consideration payable"
       }
      }
     },
     "localname": "Mergerconsiderationpaidpayablenet",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_MidAmericaClinicalLaboratoriesLLCMACLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mid America Clinical Laboratories, LLC (MACL)",
        "label": "Mid America Clinical Laboratories, LLC (MACL) [Member]",
        "terseLabel": "Mid America Clinical Laboratories, LLC (MACL)"
       }
      }
     },
     "localname": "MidAmericaClinicalLaboratoriesLLCMACLMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MobileMedicalExaminationServicesInc.MedXMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mobile Medical Examination Services, Inc. (MedXM) [Member]",
        "label": "Mobile Medical Examination Services, Inc. (MedXM) [Member]",
        "terseLabel": "Mobile Medical Examination Services, Inc. (MedXM)"
       }
      }
     },
     "localname": "MobileMedicalExaminationServicesInc.MedXMMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_NetOperatingLossCarryfowardsNetOfValuationAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Net operating loss carryfowards, net of valuation allowance",
        "terseLabel": "Net operating loss carryfowards, net of valuation allowance"
       }
      }
     },
     "localname": "NetOperatingLossCarryfowardsNetOfValuationAllowance",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_NidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NID [Member]",
        "label": "NID [Member]",
        "terseLabel": "NID"
       }
      }
     },
     "localname": "NidMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_OperatingLeaseFixedAndVariableCost": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Fixed and Variable Cost",
        "label": "Operating Lease, Fixed and Variable Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseFixedAndVariableCost",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_OperatingandFinanceLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating and finance leases.",
        "label": "Operating and Finance Lease, Liability",
        "totalLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingandFinanceLeaseLiability",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_OtherAccountsReceivableRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accounts Receivable, Related Parties",
        "label": "Other Accounts Receivable, Related Parties",
        "terseLabel": "Other accounts receivable, related parties"
       }
      }
     },
     "localname": "OtherAccountsReceivableRelatedParties",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_OtherEquityComponentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Equity Components [Member]",
        "label": "Other Equity Components [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherEquityComponentsMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_OtherIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income (Expense)",
        "label": "Other Income (Expense) [Member]",
        "terseLabel": "Other Income (Expense)"
       }
      }
     },
     "localname": "OtherIncomeExpenseMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_OxfordImmunotecInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oxford Immunotec, Inc. [Member]",
        "label": "Oxford Immunotec, Inc. [Member]",
        "terseLabel": "Oxford Immunotec, Inc."
       }
      }
     },
     "localname": "OxfordImmunotecInc.Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PatientMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient [Member]",
        "label": "Patient [Member]",
        "terseLabel": "Patients"
       }
      }
     },
     "localname": "PatientMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PercentageofNetAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Accounts Receivable",
        "label": "Percentage of Net Accounts Receivable",
        "terseLabel": "Percentage of net accounts receivable"
       }
      }
     },
     "localname": "PercentageofNetAccountsReceivable",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Revenues",
        "label": "Percentage of Net Revenues",
        "terseLabel": "Percentage of net revenues",
        "verboseLabel": "Percentage of net revenues from the DIS business"
       }
      }
     },
     "localname": "PercentageofNetRevenues",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofReceivablesDueFromPatients": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables due from patients as a percentage of consolidated net accounts receivable.",
        "label": "Percentage of Receivables Due From Patients",
        "terseLabel": "Percentage of receivables due from patients"
       }
      }
     },
     "localname": "PercentageofReceivablesDueFromPatients",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance share units with market-based relative TSR goal",
        "label": "Performance share units with market-based relative TSR goal [Member]",
        "terseLabel": "Performance share units with market-based relative TSR goal"
       }
      }
     },
     "localname": "PerformanceShareUnitsWithMarketBasedRelativeTSRGoalMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PeriodofBillingFullyReserve": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of Billing Fully Reserve",
        "label": "Period of Billing Fully Reserve",
        "terseLabel": "Period of billing fully reserve"
       }
      }
     },
     "localname": "PeriodofBillingFullyReserve",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_PreTaxGainLossDueToCOVID19": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-tax Gain (loss) due to COVID-19",
        "label": "Pre-tax Gain (loss) due to COVID-19",
        "terseLabel": "Pre-tax gain (loss) due to COVID-19"
       }
      }
     },
     "localname": "PreTaxGainLossDueToCOVID19",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ProceedsfromTerminationofDerivativeInstrumentOperatingActivities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Termination of Derivative Instrument, Operating Activities",
        "label": "Proceeds from Termination of Derivative Instrument, Operating Activities",
        "terseLabel": "Proceeds from Termination of Derivative Instrument, Operating Activities"
       }
      }
     },
     "localname": "ProceedsfromTerminationofDerivativeInstrumentOperatingActivities",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_QuarterlyFinancialDataLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quarterly Financial Data [Line Items]",
        "label": "Quarterly Financial Data [Line Items]",
        "terseLabel": "Quarterly Financial Data [Line Items]"
       }
      }
     },
     "localname": "QuarterlyFinancialDataLineItems",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ReductionsForChangesInJudgment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross amount of decreases in unrecognized tax benefits resulting from changes in judgment.",
        "label": "Reductions for changes in judgment",
        "negatedTerseLabel": "Reductions for changes in judgment"
       }
      }
     },
     "localname": "ReductionsForChangesInJudgment",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_RemainingTermsofContingentLeaseObligationsMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining Terms of Contingent Lease Obligations, Maximum",
        "label": "Remaining Terms of Contingent Lease Obligations, Maximum",
        "terseLabel": "Remaining terms of lease obligations, maximum"
       }
      }
     },
     "localname": "RemainingTermsofContingentLeaseObligationsMaximum",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_ReproSourceInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ReproSource, Inc. [Member]",
        "label": "ReproSource, Inc. [Member]",
        "terseLabel": "ReproSource, Inc."
       }
      }
     },
     "localname": "ReproSourceInc.Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_RestatedDirectorLongTermIncentivePlanDltipAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restated Director Long-Term Incentive Plan (DLTIP) Amendment (Member)",
        "label": "Restated Director Long Term Incentive Plan Dltip Amendment [Member]",
        "terseLabel": "Restated Director Long-Term Incentive Plan (DLTIP) Amendment"
       }
      }
     },
     "localname": "RestatedDirectorLongTermIncentivePlanDltipAmendmentMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_RestatedDirectorLongTermIncentivePlanDltipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restated Director Long-Term Incentive Plan (DLTIP) (Member)",
        "label": "Restated Director Long Term Incentive Plan Dltip [Member]",
        "terseLabel": "Restated Director Long-Term Incentive Plan (DLTIP)"
       }
      }
     },
     "localname": "RestatedDirectorLongTermIncentivePlanDltipMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_RestructuringIntegrationCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combined restructuring and integration charges, which may include professional fees, incurred in connection with further restructuring and integrating the Company.",
        "label": "Restructuring &amp; Integration Charges",
        "terseLabel": "Restructuring and integration charges"
       }
      }
     },
     "localname": "RestructuringIntegrationCharges",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_RevenueCollectionofConsiderationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Collection of Consideration Period",
        "label": "Revenue, Collection of Consideration Period",
        "terseLabel": "Collection of consideration"
       }
      }
     },
     "localname": "RevenueCollectionofConsiderationPeriod",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dgx_ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal of Income Recognized due to Receipt of Initial Tranche of Funds from the CARES Act",
        "label": "Reversal of Income Recognized due to Receipt of Initial Tranche of Funds from the CARES Act",
        "terseLabel": "Reversal of income recognized due to receipt of initial tranche of funds from the CARES Act"
       }
      }
     },
     "localname": "ReversalOfIncomeRecognizedDueToReceiptOfInitialTrancheOfFundsFromTheCARESAct",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_RoutineclinicaltestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Routine clinical testing services",
        "label": "Routine clinical testing services [Member]",
        "terseLabel": "Routine clinical testing services"
       }
      }
     },
     "localname": "RoutineclinicaltestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ScheduleOfLeaseByAssetTypeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Lease By Asset Type [Table Text Block]",
        "label": "Schedule Of Lease By Asset Type [Table Text Block]",
        "terseLabel": "Schedule Of Lease By Asset Type"
       }
      }
     },
     "localname": "ScheduleOfLeaseByAssetTypeTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleOfLeverageRatioCovenantsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Leverage Ratio Covenants",
        "label": "Schedule of Leverage Ratio Covenants [Table Text Block]",
        "terseLabel": "Schedule of Leverage Ratio Covenants"
       }
      }
     },
     "localname": "ScheduleOfLeverageRatioCovenantsTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleOfQuarterlyFinancialDataTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Quarterly Financial Data [Table]",
        "label": "Schedule of Quarterly Financial Data [Table]",
        "terseLabel": "Schedule of Quarterly Financial Data [Table]"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialDataTable",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions",
        "label": "Schedule of Share-based Payment Award, Performance Share Units, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used in Valuing The Company's Performance Share Units"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardPerformanceShareUnitsValuationAssumptionsTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleOfShareholdersEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Shareholders' Equity [Table]",
        "label": "Schedule of Shareholders' Equity [Line Items]",
        "terseLabel": "Stockholders\u2019 Equity and Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfShareholdersEquityLineItems",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleOfShareholdersEquityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Shareholders' Equity [Table]",
        "label": "Schedule of Shareholders' Equity [Table]",
        "terseLabel": "Schedule of Shareholders' Equity [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareholdersEquityTable",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "label": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt"
       }
      }
     },
     "localname": "ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Fair Value Hedging Instruments and Hedged Item, Statement of Financial Performance, Location [Table Text Block]",
        "label": "Schedule of Fair Value Hedging Instruments and Hedged Item, Statement of Financial Performance, Location [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Hedging Instruments and Hedged Item, Statement of Financial Performance, Location"
       }
      }
     },
     "localname": "ScheduleofFairValueHedgingInstrumentsandHedgedItemStatementofFinancialPerformanceLocationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofLeaseTermandDiscountRateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Lease Term and Discount Rate [Table Text Block]",
        "label": "Schedule of Lease Term and Discount Rate [Table Text Block]",
        "terseLabel": "Schedule of Lease Term and Discount Rate"
       }
      }
     },
     "localname": "ScheduleofLeaseTermandDiscountRateTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_SdcpIiGradedVestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SDCP II graded vesting percentage",
        "label": "SDCP II graded vesting percentage",
        "terseLabel": "SDCP II graded vesting percentage"
       }
      }
     },
     "localname": "SdcpIiGradedVestingPercentage",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_SdcpIiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SDCP II [Member]",
        "label": "Sdcp Ii [Member]",
        "terseLabel": "SDCP II [Member]"
       }
      }
     },
     "localname": "SdcpIiMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_SeniorunsecuredrevolvingcreditfacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving credit facility [Member]",
        "label": "Senior unsecured revolving credit facility [Member]",
        "terseLabel": "Senior unsecured revolving credit facility [Member]"
       }
      }
     },
     "localname": "SeniorunsecuredrevolvingcreditfacilityMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_Sharebasedcompensationexcesstaxbenefitamount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation, excess tax benefit, amount",
        "label": "Share-based compensation, excess tax benefit, amount",
        "terseLabel": "Share-based compensation, excess tax benefit, amount"
       }
      }
     },
     "localname": "Sharebasedcompensationexcesstaxbenefitamount",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ShorttermLeaseandVariableLeaseCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term Lease and Variable Lease, Cost",
        "label": "Short-term Lease and Variable Lease, Cost",
        "terseLabel": "Short-term leases and variable lease costs"
       }
      }
     },
     "localname": "ShorttermLeaseandVariableLeaseCost",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_SixPointNineFivePercentSeniorNotesDue2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Six Point Nine Five Percent Senior Notes Due 2037 [Member]",
        "label": "Six Point Nine Five Percent Senior Notes Due2037 [Member]",
        "terseLabel": "6.95% Senior Notes due July 2037"
       }
      }
     },
     "localname": "SixPointNineFivePercentSeniorNotesDue2037Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement - Equity Instruments Other than Options.",
        "label": "Stock Awards [Member]",
        "terseLabel": "Stock Awards"
       }
      }
     },
     "localname": "StockAwardsMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockRepurchaseProgramAdditionalAuthorizedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Authorized Amount",
        "label": "Stock Repurchase Program, Additional Authorized Amount",
        "terseLabel": "Additional authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAuthorizedAmount",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies Line Items",
        "label": "Summary of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies [Table]",
        "label": "Summary of Significant Accounting Policies [Table]",
        "terseLabel": "Summary of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Line Items]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Line Items]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataLineItems",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SupplementalCashFlowAndOtherDataTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Cash Flow and Other Data [Table]",
        "label": "Supplemental Cash Flow and Other Data [Table]",
        "terseLabel": "Supplemental Cash Flow and Other Data [Table]"
       }
      }
     },
     "localname": "SupplementalCashFlowAndOtherDataTable",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SupplementalDeferredCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Deferred Compensation Plan [Member]",
        "label": "Supplemental Deferred Compensation Plan [Member]",
        "terseLabel": "Supplemental Deferred Compensation Plan"
       }
      }
     },
     "localname": "SupplementalDeferredCompensationPlanMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_SupplementalDeferredCompensationPlanSalaryDeferral": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of salary deferral under the Supplemental Deferred Compensation Plan. This plans is an unfunded, non-qualified plan that provides for certain management and highly compensated employees to defer up to this percentage of their annual salary in excess of their defined contribution plan limits.",
        "label": "Supplemental Deferred Compensation Plan Salary Deferral",
        "terseLabel": "SDCP salary deferral"
       }
      }
     },
     "localname": "SupplementalDeferredCompensationPlanSalaryDeferral",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferral percentage of the variable incentive compensation under the Supplemental Deferred Compensation Plan. The plan is an unfunded, non-qualified plan that provides for certain management and highly compensated eligible employees to defer up to this percentage of their variable incentive compensation.",
        "label": "Supplemental Deferred Compensation Plan Variable Incentive Compensation Deferral",
        "terseLabel": "SDCP variable incentive compensation deferral"
       }
      }
     },
     "localname": "SupplementalDeferredCompensationPlanVariableIncentiveCompensationDeferral",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Cuts and Jobs Act of 2017, Reclassification of Stranded Tax Effects from AOCI to Retained Earnings",
        "label": "Tax Cuts and Jobs Act of 2017, Reclassification of Stranded Tax Effects from AOCI to Retained Earnings",
        "terseLabel": "Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act",
        "verboseLabel": "Reclassification of stranded tax effects resulting from enactment of the Tax Cuts and Jobs Act"
       }
      }
     },
     "localname": "TaxCutsandJobsActof2017ReclassificationofStrandedTaxEffectsfromAOCItoRetainedEarnings",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TerminationOfInterestRateSwapAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination Of Interest Rate Swap Agreements",
        "label": "Termination Of Interest Rate Swap Agreements",
        "terseLabel": "Termination of interest rate swap agreements"
       }
      }
     },
     "localname": "TerminationOfInterestRateSwapAgreements",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point Five Zero Percent Senior Notes due March 2025 [Member]",
        "label": "Three Point Five Zero Percent Senior Notes due March 2025 [Member]",
        "terseLabel": "3.50% Senior Notes due March 2025"
       }
      }
     },
     "localname": "ThreePointFiveZeroPercentSeniorNotesdueMarch2025Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ThreePointFourFivePercentSeniorNotesdueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Point Four Five Percent Senior Notes due June 2026 [Member]",
        "label": "Three Point Four Five Percent Senior Notes due June 2026 [Member]",
        "terseLabel": "3.45% Senior Notes due June 2026"
       }
      }
     },
     "localname": "ThreePointFourFivePercentSeniorNotesdueJune2026Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TotalAmortizingIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Amortizing Intangible Assets [Member]",
        "label": "Total Amortizing Intangible Assets [Member]",
        "terseLabel": "Total Amortizing Intangible Assets"
       }
      }
     },
     "localname": "TotalAmortizingIntangibleAssetsMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TreasuryStockPurchasedbutNotyetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Purchased but Not yet Paid",
        "label": "Treasury Stock Purchased but Not yet Paid",
        "terseLabel": "Accounts payable associated with purchases of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockPurchasedbutNotyetPaid",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TreasuryStockValueAcquiredCostMethod1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method1",
        "label": "Treasury Stock, Value, Acquired, Cost Method1",
        "terseLabel": "Accrual"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod1",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TwoPointEightZeroPercentSeniorNotesDueJune2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Eight Zero Percent Senior Notes due June 2031",
        "label": "Two Point Eight Zero Percent Senior Notes due June 2031 [Member]",
        "terseLabel": "2.80% Senior Notes due June 2031"
       }
      }
     },
     "localname": "TwoPointEightZeroPercentSeniorNotesDueJune2031Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Five Zero Percent Senior Notes due March 2020 [Member]",
        "label": "Two Point Five Zero Percent Senior Notes due March 2020 [Member]",
        "terseLabel": "2.50% Senior Notes due March 2020"
       }
      }
     },
     "localname": "TwoPointFiveZeroPercentSeniorNotesdueMarch2020Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_TwoPointNineFivePercentSeniorNotesdueJune2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Point Nine Five Percent Senior Notes due June 2030 [Member]",
        "label": "Two Point Nine Five Percent Senior Notes due June 2030 [Member]",
        "terseLabel": "2.95% Senior Notes due June 2030"
       }
      }
     },
     "localname": "TwoPointNineFivePercentSeniorNotesdueJune2030Member",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UMassJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UMass Joint Venture [Member]",
        "label": "UMass Joint Venture [Member]",
        "terseLabel": "UMass Joint Venture"
       }
      }
     },
     "localname": "UMassJointVentureMember",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years",
        "label": "Unrecorded Unconditional Purchase Obligation, Due within Two and Three Years",
        "terseLabel": "Purchase obligation in 2021 through 2022"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears",
     "nsuri": "http://questdiagnostics.com/20201231",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r178",
      "r183",
      "r271",
      "r422",
      "r423",
      "r424",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r178",
      "r183",
      "r271",
      "r422",
      "r423",
      "r424",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r178",
      "r183",
      "r271",
      "r422",
      "r423",
      "r424",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r383",
      "r386",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r688",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/LEASESNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r383",
      "r386",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r688",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/LEASESNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.",
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r253",
      "r364",
      "r366",
      "r621",
      "r687",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r253",
      "r364",
      "r366",
      "r621",
      "r687",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r371",
      "r383",
      "r386",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r688",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/LEASESNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r371",
      "r383",
      "r386",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r620",
      "r688",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/LEASESNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r384",
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r173",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "SCHEDULE II - VALUATION ACCOUNTS AND RESERVES"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReserves"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r329",
      "r384",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r173",
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities [Abstract]",
        "terseLabel": "Accounts Payable and Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities.",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "terseLabel": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r162",
      "r603",
      "r645",
      "r675"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Accounts payable, related parties"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r31",
      "r60"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Trade accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r25",
      "r44",
      "r258",
      "r259"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $28 and $15 as of December\u00a031, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedParties": {
     "auth_ref": [
      "r43",
      "r157",
      "r603",
      "r605",
      "r672"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.",
        "label": "Accounts Receivable, Related Parties",
        "terseLabel": "Accounts receivable, related parties"
       }
      }
     },
     "localname": "AccountsReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxes": {
     "auth_ref": [
      "r38",
      "r40",
      "r441",
      "r639",
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due.  This amount is the total of current and noncurrent accrued income taxes.",
        "label": "Accrued Income Taxes",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r38",
      "r639",
      "r666"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r30",
      "r31",
      "r64"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "terseLabel": "Accrued insurance"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r58",
      "r305"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r84",
      "r91",
      "r92",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Net Deferred Losses on Cash Flow Hedges, net of tax"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r85",
      "r86",
      "r87",
      "r91",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Net Changes in Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r47",
      "r89",
      "r90",
      "r91",
      "r668",
      "r695",
      "r696"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Accumulated other comprehensive (loss) income",
        "verboseLabel": "Accumulated net loss from designated or qualifying cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r88",
      "r91",
      "r92",
      "r175",
      "r176",
      "r177",
      "r513",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r83",
      "r91",
      "r92",
      "r513",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r422",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r387",
      "r389",
      "r427",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r223",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All other operating segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "SEC Schedule, 12-09, Allowance, Credit Loss [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Credit Loss"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r260",
      "r272",
      "r273",
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance, December\u00a031, 2020",
        "periodStartLabel": "Balance, January 1, 2020"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r51",
      "r260",
      "r272"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs of accounts receivable, net of recoveries"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r140",
      "r290",
      "r298"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options and performance share units not included due to their antidilutive effect"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r155",
      "r235",
      "r242",
      "r249",
      "r270",
      "r506",
      "r514",
      "r565",
      "r637",
      "r663"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r27",
      "r29",
      "r76",
      "r155",
      "r270",
      "r506",
      "r514",
      "r565"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r262",
      "r263",
      "r278",
      "r644"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r391",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r529",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankOverdrafts": {
     "auth_ref": [
      "r64",
      "r332"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of payments made in excess of existing cash balances, which will be honored by the bank but reflected as a loan to the entity. Overdrafts generally have a very short time frame for correction or repayment and are therefore more similar to short-term bank financing than trade financing.",
        "label": "Bank Overdrafts",
        "terseLabel": "Overdrafts"
       }
      }
     },
     "localname": "BankOverdrafts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Building Improvements",
        "verboseLabel": "Building and Improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r382",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r382",
      "r385",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of voting interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible for tax purposes"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r490",
      "r491",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r139",
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Contingent consideration arrangements",
        "terseLabel": "Contingent consideration arrangements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r489",
      "r492",
      "r495"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "netLabel": "Contingent consideration, liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "terseLabel": "Adjustment, intangibles"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r482",
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Finite-lived intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r482",
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Equity interest in acquiree, fair value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Equity interest in acquiree, percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Equity interest in acquiree, remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r145",
      "r146",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable associated with capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsIncurred": {
     "auth_ref": [
      "r145",
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in lease obligation from new lease.",
        "label": "Lease Obligation Incurred",
        "terseLabel": "Leased assets obtained in exchange for new finance lease liabilities"
       }
      }
     },
     "localname": "CapitalLeaseObligationsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash acquired from acquisition",
        "verboseLabel": "Less: cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r23",
      "r54",
      "r142"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r143",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r136",
      "r142",
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r136",
      "r566"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW AND OTHER DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "auth_ref": [
      "r15",
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations",
        "terseLabel": "Refund from taxing authorities related to settlement of the uncertain tax benefits"
       }
      }
     },
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash surrender value of life insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "auth_ref": [
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "terseLabel": "Hedged items (Long-term debt)"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r69",
      "r328",
      "r646",
      "r674"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r324",
      "r326",
      "r327",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r175",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]"
       }
      }
     },
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r42",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares",
        "terseLabel": "Common stock, shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 600 shares authorized as of both December 31, 2020 and 2019; 217 shares issued as of both December 31, 2020 and 2019"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r95",
      "r97",
      "r98",
      "r109",
      "r655",
      "r683"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r95",
      "r97",
      "r108",
      "r503",
      "r504",
      "r518",
      "r654",
      "r682"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r95",
      "r97",
      "r107",
      "r502",
      "r518",
      "r653",
      "r681"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.",
        "label": "Corporate Joint Venture [Member]",
        "terseLabel": "Corporate Joint Venture"
       }
      }
     },
     "localname": "CorporateJointVentureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "General corporate income (expenses), Net"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r116",
      "r155",
      "r270",
      "r565"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Operating costs and expenses and other operating expense (income):"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses, net"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r458",
      "r466"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current federal tax expense (benefit)"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r161",
      "r458"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Current foreign income tax expense"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r458",
      "r466"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current state and local income tax expense"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r638",
      "r641",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rate in excess of LIBOR",
        "verboseLabel": "Interest rate in excess of LIBOR"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r39",
      "r335",
      "r641",
      "r662"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r578",
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r67",
      "r159",
      "r346",
      "r347",
      "r348",
      "r349",
      "r577",
      "r578",
      "r580",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r577",
      "r580"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Unamortized discount",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Abstract]",
        "terseLabel": "Debt Instruments [Abstract]"
       }
      }
     },
     "localname": "DebtInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Significant change in unrecognized tax benefits is reasonably possible, estimated range of change, upper bound"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain]",
        "terseLabel": "Equity-Based Arrangements, Individual Contracts, Type of Deferred Compensation [Domain]"
       }
      }
     },
     "localname": "DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualContributionsByEmployer": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions made by employer into fund established for purposes of making future disbursement to individual in accordance with deferred compensation arrangement.",
        "label": "Deferred Compensation Arrangement with Individual, Contributions by Employer",
        "terseLabel": "Deferred compensation arrangement with individual, employer contribution"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans.",
        "label": "Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]",
        "terseLabel": "Deferred Bonus and Profit Sharing Plan, Type of Deferred Compensation [Axis]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]",
        "terseLabel": "Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRecordedLiability": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the liability as of the balance sheet date to an individual under a deferred compensation arrangement. This amount may be the result of periodic accruals made over the period of active employment, or reflect termination benefits resulting contractual terms or a death benefit.",
        "label": "Deferred Compensation Arrangement with Individual, Recorded Liability",
        "terseLabel": "SDCP accrual"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRecordedLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1": {
     "auth_ref": [
      "r370",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum period the individual is required to perform services to be fully vested under the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Deferred Compensation Arrangement with Individual, Requisite Service Period",
        "terseLabel": "SDCP II vesting period"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r459",
      "r466"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Defered federal income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r59",
      "r579"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r459",
      "r466"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Deferred foreign income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredGainLossOnDiscontinuationOfFairValueHedge": {
     "auth_ref": [
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount as of the balance sheet date of the unamortized adjustment to the carrying value of an interest-bearing hedged item made under an effective fair value hedge that is amortized upon discontinuation of the fair value hedge.",
        "label": "Deferred (Gain) Loss on Discontinuation of Fair Value Hedge",
        "terseLabel": "Hedged liability, cumulative increase (decrease)"
       }
      }
     },
     "localname": "DeferredGainLossOnDiscontinuationOfFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r156",
      "r459",
      "r466",
      "r467",
      "r468"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax provision",
        "verboseLabel": "Deferred income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r459",
      "r466"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "Deferred state and local income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Liabilities not currently deductible"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "verboseLabel": "Deferred tax assets, valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r433",
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTerseLabel": "Total non-current deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r456",
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Non-current deferred tax liability - depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Company's expense for contributions to its defined contribution plans"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Amended company match percentage of employee contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r140",
      "r303"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r140",
      "r230"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r77",
      "r80",
      "r532",
      "r619"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Liability Derivatives:"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r531"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r530",
      "r533",
      "r537",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r527",
      "r530",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r78",
      "r79",
      "r562"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Fix-to-variable interest rate swaps"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r522",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "verboseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r521",
      "r523",
      "r524",
      "r527",
      "r528",
      "r535",
      "r537",
      "r543",
      "r545",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r151",
      "r163",
      "r521",
      "r523",
      "r527",
      "r528",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK OWNERSHIP AND COMPENSATION PLANS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r21",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "verboseLabel": "DISCONTINUED OPERATIONS"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r382",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r31",
      "r64"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividend payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r38",
      "r40",
      "r640",
      "r664"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividend payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Country"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r110",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r189",
      "r192",
      "r200",
      "r201",
      "r202",
      "r206",
      "r207",
      "r656",
      "r684"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Net income (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders - basic:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings Per Share, Basic and Diluted [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r110",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r192",
      "r200",
      "r201",
      "r202",
      "r206",
      "r207",
      "r656",
      "r684"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Net income (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders - diluted:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r151",
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r435",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Tax provision at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r435",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowances associated with certain net operating losses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther": {
     "auth_ref": [
      "r435",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Other, Percent",
        "negatedTerseLabel": "Excess tax benefits on stock-based compensation arrangements"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": {
     "auth_ref": [
      "r435",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent",
        "terseLabel": "Impact of equity earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r435",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "terseLabel": "Impact of noncontrolling interests"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r435",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r435",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "terseLabel": "Return to provision true-ups"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r435",
      "r470"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued wages and benefits (including incentive compensation)"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized stock-based compensation cost weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation not yet recognized, stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit related to stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Separation Costs"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r180",
      "r186",
      "r188",
      "r213",
      "r271",
      "r345",
      "r350",
      "r422",
      "r423",
      "r424",
      "r462",
      "r463",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r691",
      "r692",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r266",
      "r625",
      "r627",
      "r629",
      "r631",
      "r633",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r55",
      "r236",
      "r267"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity method investees",
        "verboseLabel": "Equity method investments carrying value"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r55",
      "r135",
      "r151",
      "r269",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "terseLabel": "Trading equity securities gain or (loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity Securities without readily determinable fair value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility-Related Costs"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r552",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r553",
      "r610",
      "r611",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r552",
      "r553",
      "r554",
      "r555",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r372",
      "r373",
      "r378",
      "r380",
      "r553",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r372",
      "r373",
      "r378",
      "r380",
      "r553",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r553",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r556",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r556",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Liability Balances Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Total (gains)/losses included in earnings - realized/unrealized",
        "terseLabel": "Total (gains)/losses included in earnings - realized/unrealized"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements": {
     "auth_ref": [
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)",
        "terseLabel": "Purchases, additions and issuances"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r558"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r556"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r610",
      "r611",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSReconciliationofBeginningandEndingBalancesofLiabilitiesUnobservableInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r559",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r145",
      "r146",
      "r147"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r529",
      "r535",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r583",
      "r589",
      "r597"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r585",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r582",
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_OperatingandFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "dgx_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease, Liability, Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "dgx_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Noncurrent finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r584",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r581"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "dgx_LeaseRightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [
      "r583",
      "r589"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "terseLabel": "Right-of-use asset, accumulated amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r583",
      "r589",
      "r597"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of leased assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r594",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate, Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTermandRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r593",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term,Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTermandRateDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset, useful life",
        "verboseLabel": "Weighted average amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization, intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 6.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r299"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 1.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r299"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 5.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r299"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 4.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r299"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 3.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r299"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails": {
       "order": 2.0,
       "parentTag": "dgx_FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r291",
      "r293",
      "r297",
      "r301",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Future amortization expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r291",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Country"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r151",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Losses (gains) on sale of property, plant and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r140",
      "r337",
      "r338"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Losses on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r284",
      "r285",
      "r636"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, balance at end of year",
        "periodStartLabel": "Goodwill, balance at beginning of year",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during the year"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r151",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r151",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r114",
      "r155",
      "r235",
      "r241",
      "r245",
      "r248",
      "r251",
      "r270",
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedge": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability hedged in fair value hedging relationship.",
        "label": "Hedged Liability, Fair Value Hedge",
        "terseLabel": "Carrying Amount of Hedged Long-Term Debt"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedge",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Hedge Accounting Basis Adjustment"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r527",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r115",
      "r141",
      "r181",
      "r182",
      "r183",
      "r184",
      "r198",
      "r202",
      "r501"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r160",
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Income (loss) from continuing operations - domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r160",
      "r469"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Income (loss) from continuing operations - foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r160",
      "r235",
      "r241",
      "r245",
      "r248",
      "r251"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from continuing operations before income taxes and equity in earnings of equity method investees"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r155",
      "r179",
      "r235",
      "r241",
      "r245",
      "r248",
      "r251",
      "r270",
      "r502",
      "r565"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from continuing operations",
        "totalLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r101",
      "r110",
      "r179",
      "r181",
      "r182",
      "r183",
      "r184",
      "r192",
      "r200",
      "r201",
      "r648",
      "r650",
      "r656",
      "r677"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income from continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r101",
      "r110",
      "r179",
      "r181",
      "r182",
      "r183",
      "r184",
      "r192",
      "r200",
      "r201",
      "r202",
      "r656",
      "r677",
      "r680",
      "r684"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income from continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r17",
      "r20",
      "r473",
      "r678"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from discontinued operations, net of taxes",
        "verboseLabel": "Income (loss) from discontinued operations, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r14",
      "r17",
      "r502"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Income from discontinued operations, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r104",
      "r110",
      "r196",
      "r200",
      "r201",
      "r656",
      "r678",
      "r680",
      "r684"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Income from discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r196",
      "r200",
      "r201",
      "r519"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Income from discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r103",
      "r140",
      "r232",
      "r267",
      "r649",
      "r676"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in earnings of equity method investees, net of taxes",
        "verboseLabel": "Share of equity earnings from investments in affiliates"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r382",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r16",
      "r18",
      "r19",
      "r20",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DISCONTINUEDOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r441",
      "r448",
      "r450",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r436",
      "r449",
      "r454",
      "r464",
      "r471",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r187",
      "r188",
      "r233",
      "r434",
      "r465",
      "r472",
      "r686"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r99",
      "r151",
      "r431",
      "r432",
      "r449",
      "r450",
      "r453",
      "r460",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Taxes on Income"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r137",
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r202"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r292",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r292",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets Excluding Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible assets, gross excluding goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r289",
      "r295"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Total intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r657"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r102",
      "r229",
      "r576",
      "r579",
      "r659"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r658"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r31",
      "r32",
      "r64"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Interest Rate Swap Agreements"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r24",
      "r74"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r33",
      "r75",
      "r151",
      "r209",
      "r279",
      "r280",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r269",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating leases, rent expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r595",
      "r597"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Net lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESCostsDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r596"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 1.0,
       "parentTag": "dgx_LesseeOperatingandFinanceLeaseLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r50",
      "r155",
      "r270",
      "r565",
      "r643",
      "r671"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r145",
      "r146",
      "r147"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "terseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r65",
      "r155",
      "r270",
      "r507",
      "r514",
      "r515",
      "r565"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r69",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r39",
      "r336",
      "r641",
      "r667"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Less: Current portion of long-term debt",
        "verboseLabel": "Less: current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r165",
      "r333"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r165",
      "r333"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r165",
      "r333"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r165",
      "r333"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r165",
      "r333"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r165",
      "r333"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "dgx_LongTermDebtMaturitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Total long-term debt, net of current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r67",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "New claims filed (in lawsuits)"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "terseLabel": "Self-insurance reserves"
       }
      }
     },
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r73",
      "r155",
      "r270",
      "r565",
      "r642",
      "r670"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]",
        "terseLabel": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r214",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r136",
      "r138",
      "r141"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r20",
      "r93",
      "r96",
      "r105",
      "r141",
      "r155",
      "r179",
      "r181",
      "r182",
      "r183",
      "r184",
      "r187",
      "r188",
      "r198",
      "r235",
      "r241",
      "r245",
      "r248",
      "r251",
      "r270",
      "r565",
      "r651",
      "r679"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r93",
      "r96",
      "r187",
      "r188",
      "r509",
      "r517"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: net income attributable to noncontrolling interests",
        "verboseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "auth_ref": [
      "r190",
      "r202"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic",
        "totalLabel": "Earnings available to Quest Diagnostics\u2019 common stockholders \u2013 basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete Agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r351",
      "r505",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Contributions from noncontrolling interest partners"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r350",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating expenses, net",
        "totalLabel": "Total non-operating expenses, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r235",
      "r241",
      "r245",
      "r248",
      "r251"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating income",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/LEASESMaturityDetails": {
       "order": 1.0,
       "parentTag": "dgx_OperatingandFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease, liability",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESMaturityDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "dgx_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of long-term operating lease liabilities",
        "verboseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "dgx_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Noncurrent operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r586",
      "r591"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r581"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "dgx_LeaseRightofUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/LEASESLiabilitiesDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r594",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate, Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTermandRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r593",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted-average remaining lease term, Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/LEASESTermandRateDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r22",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Principles of Consolidation and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r529",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r85",
      "r86",
      "r89"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net change in available-for-sale debt securities, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r91",
      "r100",
      "r567",
      "r569",
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive (loss) income before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "terseLabel": "Net deferred gain on cash flow hedges, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r94",
      "r97",
      "r100",
      "r106",
      "r345",
      "r567",
      "r572",
      "r573",
      "r652",
      "r680"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Net current period other comprehensive income",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other Intangible Assets, Subject To Amortization"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r529",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSFairValueofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r39",
      "r641",
      "r667"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-term Debt",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r141"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other Operating Income (Expense)"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating expense (income), net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r140",
      "r312",
      "r317",
      "r321"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Facility-related costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic": {
     "auth_ref": [
      "r197",
      "r199"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic",
        "terseLabel": "Less: Earnings allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r122",
      "r125",
      "r164"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "(Increase) decrease in investments and other assets"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r133",
      "r313"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r123",
      "r494"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "netLabel": "Cash paid for business acquisitions",
        "terseLabel": "Cash consideration"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "totalLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Additional contributions"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures",
        "verboseLabel": "Total capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r27",
      "r52",
      "r53"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r26",
      "r28",
      "r282",
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDividendsReceived": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends received on equity and other investments during the current period.",
        "label": "Proceeds from Dividends Received",
        "terseLabel": "Dividends paid"
       }
      }
     },
     "localname": "ProceedsFromDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Contributions from noncontrolling interest partners"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r128",
      "r131",
      "r164"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposition of property, plant, and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r126",
      "r421"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r20",
      "r93",
      "r96",
      "r134",
      "r155",
      "r179",
      "r187",
      "r188",
      "r235",
      "r241",
      "r245",
      "r248",
      "r251",
      "r270",
      "r502",
      "r508",
      "r510",
      "r517",
      "r518",
      "r565",
      "r660"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r58",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r311",
      "r699",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY, PLANT AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r57",
      "r304"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r35",
      "r36",
      "r306",
      "r673"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r56",
      "r151",
      "r306",
      "r699",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r35",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r35",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r111",
      "r274"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_QuarterlyFinancialDataAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Data [Abstract]",
        "terseLabel": "Quarterly Financial Data [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialDataAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Quarterly Operating Results (unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r91",
      "r92",
      "r100",
      "r567",
      "r571",
      "r573"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Amounts reclassified from accumulated other comprehensive loss"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r343"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r343"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r379",
      "r602",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Income recognized from related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r379",
      "r602",
      "r605",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r600",
      "r601",
      "r603",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTIES"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "RESTRUCTURING ACTIVITIES"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r140",
      "r312",
      "r317",
      "r321"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Income statement (income) expense",
        "totalLabel": "Total restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]",
        "verboseLabel": "Restructuring Cost and Reserve [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "terseLabel": "Asset impairment charges"
       }
      }
     },
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r313",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReservePeriodIncreaseDecrease": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the accrual for restructuring costs.",
        "label": "Restructuring Reserve, Period Increase (Decrease)",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReservePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r46",
      "r350",
      "r425",
      "r669",
      "r694",
      "r696"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r180",
      "r186",
      "r188",
      "r271",
      "r422",
      "r423",
      "r424",
      "r462",
      "r463",
      "r691",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r226",
      "r227",
      "r240",
      "r246",
      "r247",
      "r253",
      "r254",
      "r256",
      "r363",
      "r364",
      "r621"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Total net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r113",
      "r697"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r592",
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r592",
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r590",
      "r597",
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "negatedLabel": "Gain from sale and leaseback of property",
        "terseLabel": "Gain on sale recognized"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow and Other Data"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWANDOTHERDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Components of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.",
        "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]",
        "terseLabel": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]"
       }
      }
     },
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSSupplementalDeferredCompensationPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of The Fair Values of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of the Federal Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r552",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill, Net"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Summary of Transactions Under Stock Awards Other than Options"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r58",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Quarterly Operating Results"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r158",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r315",
      "r316",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r315",
      "r316",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Pre-Tax Restructuring Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r313",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Activity of Restructuring Liability"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r235",
      "r238",
      "r244",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r235",
      "r238",
      "r244",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r391",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r396",
      "r408",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Transactions Under The Company's Stock Option Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used in Valuing The Company's Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "verboseLabel": "Secured Receivables Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r223",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r256",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r223",
      "r224",
      "r225",
      "r235",
      "r239",
      "r245",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTSeniorNotesOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r140",
      "r312",
      "r317",
      "r321"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "verboseLabel": "Employee separation costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESPreTaxRestructuringchargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Shares forfeited and cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares forfeited and cancelled weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares granted weighted average grant date fair value (in dollars per share)",
        "verboseLabel": "Fair value at grant date (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Shares outstanding, end of year",
        "periodStartLabel": "Shares outstanding, beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Shares outstanding, end of year weighted average grant date fair value",
        "periodStartLabel": "Shares outstanding, beginning of year weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Shares vested weighted average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Percentage of maximum annual wages witheld for the ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares available for award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable, end of year shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable, end of year weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value at grant date (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options outstanding, end of year aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r398",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, end of year",
        "periodStartLabel": "Options outstanding, beginning of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, end of year weighted average exercise price",
        "periodStartLabel": "Options outstanding, beginning of year weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r411"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest, end of year aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest, end of year shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest, end of year weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r388",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSActivitiesRelatedtoStockAwardsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, granted weighted average exercise price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r151",
      "r391",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r414",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected holding period, in years"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSWeightedAverageAssumptionsUsedinValuingOptionsGrantedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable, end of year aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable, end of year weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options outstanding, end of year weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest, end of year weighted average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software and Software Development Costs",
        "verboseLabel": "Computer Software Developed or Obtained for Internal Use"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r7",
      "r223",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r251",
      "r256",
      "r287",
      "r308",
      "r314",
      "r322",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r72",
      "r175",
      "r176",
      "r177",
      "r180",
      "r186",
      "r188",
      "r213",
      "r271",
      "r345",
      "r350",
      "r422",
      "r423",
      "r424",
      "r462",
      "r463",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r691",
      "r692",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTComponentsofAccumulatedOtherComprehensiveLossIncomeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r213",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r41",
      "r42",
      "r345",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares purchased by eligible employees under ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeStockPurchasePlanandDefinedContributionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r41",
      "r42",
      "r345",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans, sharers"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r41",
      "r42",
      "r345",
      "r350",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercise of stock options, shares",
        "terseLabel": "Exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "auth_ref": [
      "r42",
      "r345",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Reissuance of shares for employee benefit plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r41",
      "r42",
      "r350",
      "r390",
      "r409"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r72",
      "r345",
      "r350"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options, value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Equity Option"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSEmployeeandNonemployeeDirectorsStockOwnershipProgramsDetails",
      "http://questdiagnostics.com/role/STOCKOWNERSHIPANDCOMPENSATIONPLANSTransactionsUnderStockOptionPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r42",
      "r48",
      "r49",
      "r155",
      "r261",
      "r270",
      "r565"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Quest Diagnostics stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Quest Diagnostics stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r155",
      "r175",
      "r176",
      "r177",
      "r180",
      "r186",
      "r270",
      "r271",
      "r350",
      "r422",
      "r423",
      "r424",
      "r462",
      "r463",
      "r499",
      "r500",
      "r516",
      "r565",
      "r567",
      "r568",
      "r573",
      "r692",
      "r693"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r154",
      "r350",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r150",
      "r151",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONDetails",
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r574",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r574",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r574",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r438",
      "r448",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Benefits"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets",
        "verboseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONSDetails",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r70",
      "r155",
      "r270",
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Intangible Assets Not Subject to Amortization - Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r647"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradingSecuritiesEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investments in trading equity securities and other forms of trading securities that provide ownership interests.",
        "label": "Trading Securities, Equity",
        "terseLabel": "Trading securities, equity"
       }
      }
     },
     "localname": "TradingSecuritiesEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r71",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock, at Cost"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r71",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r42",
      "r345",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock, shares",
        "verboseLabel": "Purchases of treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r71",
      "r352",
      "r353"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 84 shares as of both December 31, 2020 and 2019"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r345",
      "r350",
      "r352"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock, value",
        "terseLabel": "Treasury stock value acquired cost method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/QuarterlyOperatingResultsunauditedNarrativeDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESActivitiesofRestructuringLiabilitiesDetails",
      "http://questdiagnostics.com/role/RESTRUCTURINGACTIVITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "negatedTerseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTLongTermDebtDetails",
      "http://questdiagnostics.com/role/DEBTMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-lived Intangible Assets [Member]",
        "terseLabel": "Intangible Assets Not Subject to Amortization - Other"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) related to the increase or decrease in fair value of interest rate derivatives designated as cash flow hedging instruments, which was recorded in accumulated other comprehensive income to the extent that the cash flow hedge was determined to be effective.",
        "label": "Unrealized Gain (Loss) on Interest Rate Cash Flow Hedges, Pretax, Accumulated Other Comprehensive Income (Loss)",
        "terseLabel": "Gain (loss) on derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r430",
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefits, ending balance",
        "periodStartLabel": "Unrecognized tax benefits, beginning balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Reductions for settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions of current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense accrued for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued",
        "terseLabel": "Unrecognized tax benefits, interest on income taxes accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "terseLabel": "Unrecognized tax Benefits, interest on income taxes expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions for expirations of statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/TAXESONINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase obligation in 2020"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).",
        "label": "Unrecorded Unconditional Purchase Obligation",
        "terseLabel": "Purchase obligation"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r166",
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Provision for doubtfull accounts"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Net deductions and other"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r170",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r166",
      "r167",
      "r168",
      "r170",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/ScheduleIIValuationAccountsandReservesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DEBTSecuredReceivablesCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/DEBTSeniorUnsecuredRevolvingCreditFacilityNarrativeDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r191",
      "r202"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r189",
      "r202"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3337-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2740-109256"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e639-108305"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=120269885&loc=SL75117546-209714"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21459-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409961&loc=d3e20487-108367"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613673-111683"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999712-113959"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999712-113959"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121561968&loc=d3e75592-113984"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r702": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r703": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r704": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r705": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r706": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r707": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r708": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r709": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r711": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r712": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e526-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>123
<FILENAME>0001022079-21-000029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001022079-21-000029-xbrl.zip
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M K0<61A\LKD$$)L"@)A2D7:8K6E;T0Y%@!K;YG+CZKVRE8K6$L>^W1-2H#B
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M58A<^@MOZOU&BSO(H_%OANO>DX7^EOOM[)J!R$!PX)1\0<WDP>:*OOK63[^
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M-C]4^)1PSW_ T>3>=#[__O1_I1ZJ\7DHX[,C1L]&QQ]2DYLX?W9G/'UU?N%
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MM>8H! B]_6#BB,+!L32"%HF"'3R:ZXE$5P=0JKZW92FYSYOQ!3*+00#/*31
MS /:]-Q8#[?^#49;D8R2TE85VQ!<SL6 *ZTTXRQ2V6J4UQN)K@5OBB5C\$RN
M97"12:*E*+8TLNBRW7:\U^]-UR\#EBI$U>_*M@$D3[YT!QPT%/7$.6R/#*PK
M$ET+K-5!Y5:E9I= 5SH7T$"'>QU\+B0#Z/BRL7[Z:O:P@W.YSZ97(PS4"FH8
M@]55-<8]$/7;B-<Z(]'5(9<\MV2HY%0B@,8LQ?;]T1BM!5!#NJ7(K=]W7@F:
M18R0SZVR3Q#58 I XW[@$R/Z)H-'<SV1Z J/X18GMGF#*2+D:E'AX8K%Q4PL
M;4C'<S;6PZV_R#HVX>1#ZP<Z(<2862FH)5\M84J9MAKEM4:BZ\$;00Q71\VP
M@#&N6%\"N^K!LQBS]7BOWYNN7P9B4E0M1$K*HSB7$K-M'+-R8.:4A]1=?G-\
M\/IAM<1JN+/DG!B4$E-(V0AC-E2= =K\T_H;ZZ>OYKB\$"HZSDEKP.QS:B6S
M,;F:HL\&, AH ![W2I +TB $:[W4#)839=>( %D*Y4#;BMSZ?>?5#/.!FGR#
M/M*I 5J#N05G*854*0BEP:.YEDATA0!E"9#9BO*4"%ZR.K9:T7&H*5M\V[@N
M7;09NH9^[G^#$*3+M^\IJVG?(]Y12NBB0(*@A@G($V0L=ID ]><C4\TU\KR_
MOF[6K*%MA3)C\:WF)KW/7X$^Z*NV5H&L_O,1/[Z.#J172D _Z +Z60>VA1L5
MZ+O8T%!EK:0DE7VIR6&^F(H&YSM<&]A@LF\A7;+-5K]T10TFN=7>+XU,;0&P
M)H1D2!<,,+EN^,[7+5VLV^;9M[X8E[1O_=(5V;?:IRR4?DJC1@UX,F%&-7'L
M$2N!\1_MJ&Z@GOZU+<N5Z2F&I&LAI@4#-9L^&[X4C1IS5>+CZMFZG?N%Z\G!
M__5UNZQ?6.%6;TJZ:+Y@M+VGH09KU$_#4I2<(JAZ?E1+OHGR]I>*M5<E;U%#
M6X.U(8*'7"RA.H>D&AM;SH'I?-W2Q;IMH'W+E[=O>67V+9:(R?ALF=0E1,H<
M6RI564A*3<+%NL'%NFV@/\V7]Z=Y9?Y4HJM&E+NA>&@UDG<QF:!4.#MDW\[6
M[<*^74NUZU]?MTO;M]4=JK A.V(5J!@U/C!85!%SP^P-1G6H[GQ<EC.PL8'P
M"<WEOR<]$GZI__>)(1L?7G"E ; :6J?BOX( V+LJT7 (MB*8H+A8-9MD):HT
MA_-.B?8B(/D"AC9^;G[>7CX\LJMS@\YZP[;;)M9 TE!4"*D?J(@U(_F/4-S$
MA-. 45R5D304.";U'A0JY!0R>T6R!#( 16&],)+.;1IXFVLDG5N%D8P<P8$I
MJ/\MSF87A9JS5 N9U 9PM.7/^P;=8)Z>3!;S!WC:>Y#?F%1]978B]?*]A"XO
M)I?;(G@\$YR?S$X?+:;\8B"';*2H[E)NPL4#1*88-)1K21Q(AF@V-^/?K>S]
M5Q.9O6N/UK/[/^_C?/YCG^CUB][G9'8%G4BO)+-OH[?.(D372->](D,?1,W)
M9"7N:8,[AF\"$*NLQLSB/2:HKE=CYH@DI2GC3!B3( ZI).1&'ZCUX>32VT?'
MX^FIR$7S]KN3/NYN]%(>J,&]/5Z,KF%ZPQKZIRH'\XF<][E//^92#)&IX'MU
M7[,#F-ZP(5!>C>FSJ46G6"AK! 1$4PC!-S'-480T;(U[*/-.'^JMD48"B^GL
MDW#=ZG#=T-O5;:VN+12M%)#43((6D K[HO&"!>-SI(&;U<N#O(W8*D]I?91!
M,441MDZ##,^M]ZN./@YB+-R&07HUM2.4;::6:PN]=Z*0,]"'CJ2^[Q4\#>C4
MY8;!M?ZCE])WX!Q&MJD .X,N5A^"SRY+;S(SH-Y.FXSM>AIAN]2 HJB5%6B>
ML],8W8BK["I5,)L;&?X.I._2*E-^<?^XYW8&$AO"<IBV2:0$1IEJSHXSDT;H
M5H)%,Z0)(.O 9/U,I0+WD[)&U"8"AHS!.L-,C*@1/@^@P'6]NK1".A*KE:HF
M#7-D8 .$@<7K0PNUCU$:+AVY=EU:4[L'VUKL5>&Q-4B!<DL(QA3./BGKM\/E
M'-</X%J(A49MK9@( 14N7RS%5@5]+#F@=Z4-UYMUTOA 9FTZ.SK;1L*9_#P9
M+>:_CA;/]G'V0A;?XUSJV825E_+XT<,?ICC>1H^G 5Y +,H3U<PJC<0JL6:%
M(,10"@U@]/<GL%TJYO+UH;00<+WQ;@LUU5C5U=E2'594TQG4XZ72-G]+=HTP
MK&Z[TPI[RDB$S@+DD FIE51R517@C)L_?F"-,*QNR !E*#$8J]%3A<(&:USV
M+K8&H;2WQY@&ZGFN%(_U>Y30V\BW6-2I,!A+V29)&E3EI%:MU#9<XGZMX*V'
MM&<AI0$N=?4"%SV"ST2-,50E@A*&2]JO%[SU3'% L,F!A&81J+7LE4^$$-!P
MR53"X+(7U^B]5IBY\*YF$30^M 2FYLP@'JIWR"91V.":J3^)=R\J"JZ\@&V%
M8* &JZEZTYH8B.*Q]=U'M!9*L,!#ZN*S'E363RA\5.IM7:_GKQ"2*4R);-00
M-5.6.J26P.N'<#VTHK=.HV9,K$*@'BEGY"#2-,+JC4'*<&G%.B!<ST@PST50
MT)FB@/5)SS:@<ON %-#G(64#;TF3V4QJ+]36]\ZJQV<SG!PNJ[A[$O#NI(Y>
MCNH)CF^_YO%)'4T.EUG"95KP 9[VZ^8W)O7!=+Z8R6(T6W[R>YE(&RWFWY]V
M ;G?/OE%[YC-R?'Q>/DY''_JRKYKO8WV7%I-4DK4>+Y"#([$B/>I5YR$TNH0
M7'*O:7[8Y>7=B9Y]?#TZ.CE:U9F"G8RNMV0-U445PV*2TL90<XG. KE$XGQL
M<?,Y_!<M0%=3(!=<-&0KFN*!*!8)T$\FIAH93<R;OU6RDXF5MWY6&NNIVN1#
M 5!B1)EB="[7V%R,0_!EFR8<E8_OCK;1I\061 -7ZCL;H/090ZS6@K,H(<#9
MP*H-EY4OA_=LKQ22*<TY- D*A"2Y^1HLV58"%/:\8S9K%I$KX2Z43,30FM[3
M X"Z+%&[PY9]"M;R (J$OQC45SH'1CEJCH4S(7!.:"2BZ:&-3<V(&X*NT^*N
M+L#LI'_PPY3;/5DL9':_W52P+NZQ\8K8CYJJ[S<E-P.9*">!XC.&/GH]6K?,
MA$93SC*A<1,[?,7>MNMRZ<?X.1V^3B:CLT7C,8Z.WJ["T;*+@BRU<?G.Q<<O
MWKAXWC__Z6PT&4J^YMH<@N.6 =%G(\G6E$,8TH'2MZTGOC^9CR8RGS\ZN\7'
MW:G'XV5;XXMWMY'8A,HI:'R>2U123;6P0[5[RJQ]CBGA@+:)-A+5]>P<&58D
M+1(XJ8!<2'F+R=&+T__)>0?.8>P<;2:J:]E,:JJG14#4! /86@MZ-)!R!&S9
M8=D^"WQS.CN>SO32K32]U%@PJH+&!@Y=1E'0N"#7(G&80WLW L[UV-SD,H5F
M<V27@9DI05(X%6),WJ:T?3;WNN!<B[$M4*QPX-::!W6@5(%]K*+4R&2V0Z"[
M/='X8#:M)[RXKXYQ]E+CJ/?.?T]/%@HNCT>3$>-X(7-]>C@_NVPKN6[R6?43
MJ08;(7@I;"FUVK():#2R&8#!W5Q(US3T/.O"MF(3=;(+#4,D#6$876P&I0W
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M+,ZQ\@VNH."N8?[D_HR1<ZR9V_?R%S>'>1<$!-_^A3$C'B_E1\C6<Y_<.50
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MHREX2)9X9UA?A/9Y-@+3F>Y\F9!=C9X#%D+(7ST!3H*5:OE4@Z.=RK>I4B+
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M[;U79S@4K4&TV$72/@]58^B-JME\?G2,O5>'8<JI9;:U!&^##)X#-7E1>Y,
M1=#Q:GRMG:&_-7@6^J@9X;0-_&CMO:J4T$$RGO X:^R?G:+O,]$WC]T^V\2L
MGY9SJ7J2"K2GVME5#+;1*)Q@N=$!T(B%L?8KCSD831B2%I^3[535-<DRI87R
M\.S?JD"\T7&[PBG/1,<U_;M;P(]PH[U72DF1_L'22%!>V8Q&NDAAF8P&\($G
M*')RPC'$<00<##$X41J_;X=XXIDHJ:;U=RL8LHM )F'LA1,PH&K)_M><RS(F
MGEZ&7I-TVR&"/Q,-]-C-P U#/@A#.AA[&H5NF(,!M*2:4COW1MPOHD8%[1#%
MK1_$E]\2%?08';KBG1K]\T#<:)A[KUXG*:9.V_^KG1?C,6LFP.T0;>T[00'T
M&JG<#,H-:EWSOX59GJ0TJG&V@9[:3HN4,E8L;J1V=VAOW\E%::1V,RAG&DU'
M><,?U_-'[T[ AXUD;P;ENCV<UCA)TAP%LY9=!:D]CG.L3B-!QG)][0QH49-O
M\3V@72/%.\,+@T:*-V4M=Z&<4Y?B*K^82V@]GH*U_:YPH]";R06$Z;B1W3D.
M>-W6MI<)C$9Z-V0M=R"<)3KBLB0*?3:+)C<'/:"*"TZ3O(F:[X[D(@,TY^ZF
MK.7VA#/M[MZK13B0%XA>E,*A&TV5JPN'K?)_?RIB5H!?S/V?&PG>$0DF1KA;
MZJL1X0VA'#@]*A&M'1]K;>U/%A5B<K(TE=79"ZN\;([='1):(+U][;C#7W+F
M1ES]?3E1/(YA$DF55_]QTU_F;E?[FGP%R^ST;7C-29)1?/1%2F6DE_SE5>CG
M(YEIKG]1,,8+O?H*<\%>+/+57UFUQ"=,F)NXIG!N<VO_XFI#_[][MZDMV%-?
M&J65< UYVTTY^]IF ;S@"Q9=L6FV]\O,/HS#N#VW[_-;]N0296Z0)KU^+7?
MF=E[=8'2@A$(DJDM?0D,=I+#55<,ZQ"<?_W#Z.DOFW^7Z8]2:%<IW%NJE>[>
M;>]XBP\WA4$N1ESSJP1=&&NB:$ES>91<P>]>5/BPC(R#^<$BS><!W-O70(6.
MLQ?;\.;[!_M@J.T'09+ZI',.6,K!7,NUC5G@&2Y00JZ5*SQ+ARP.O\L.W(U8
MZ<'^.U@ILLQ!$D5\2/I[?\RQ+"/6WK%\! O!&'*V,0M^?W1.M&XCDD(2L\LP
M+3)M/_1I7$S( [+7C[PD3L:AIY5MAAO$'P=OCY&##^ 3*G]YRUP\MI)TJAV/
M)VER*9)PL.)-6?#).:Z7#,F,AO:<<!^6G@JX9O%+6.\JV(AE'QX<P;)%YY5(
M8S+XX0BQIJ<;LL37A\@)'SKG'>UUDOBB52PMAMJ^#Z8KS47:('7Q^H_?#F"Y
MK[F/1T<T%4#=08C57)Q%^4CRR(8L][??SFES-=C=0SYA:2Z2VX%:+>[V;P4\
M9],X]_CP%%9>3^4=@FZ# WL*3\BODO2K]I,XR3&X.$JR29B#(AF)U\JF&1SY
MV<^;\C+O]N=>YMUHFF%S=ZSM9UD"/VP0C[_=_U6>+S6U#&<YSX3F*SO3TQ 1
MZ3=&1[\]O)A9<_L0#+PHF6 W*L\V997O]D_VI<7Q+DUR4,S(P')[\Z0Z5Y $
M(*BF;EC;8)/>TAIG498LFN!D(V8M#7$FO@&]P&;/X7L!F&3)%>[/L A]WED9
M6!JS=!C&;1DFPAB'_$N>3.C79=$@89B6$:845'H;=BMBDXR_4#^\A+5/(C9]
M$<;TSO2E)3%I&51QS,Z@V\.XB@QXR]O+D$N'0BXJ8#KSV<#H6(:S\F.]8ZS\
M[+K;&GI''ZS^ZGUO:W=,??6G];LNC?X[98389=[780IN@M^6G#HP\;\O)4$(
MA\28Y!JEAS7%Q_+35##@JH^1^K4/Y9VO"4H+WE@9EEXB5P']YT'DJK^TX>8-
M<CXJ!HHN5<?S+9J*%O?6H__<;F_OO'G71O37T:ND3!KM79+FH$O"1)O9OOOM
MVO;OBXA3&@^P%S\D?SINU+5JXKJ%2,&[GI6WB2K[$W!\F3?B9 :@01!Q@9*8
M)E?YZ%[4DINT3=L@F-/\D=>]@3D?AO]NI4JW:>/_ET_1(@TX&6JS09E2DYX%
M =P]'F8_HCRV:5<$.W8?45<VZG#IQI>QP=<IB[U1F/'[\=S6JD"K48%/SG-)
MG!5C>!<,XJ6AIQW'81Y2:<(S4WAVH_">>N-/V)<DQ;C06%B ARDA9ZM>0="$
M1]_ )HP$;-ISTH2]1A,^]<9C]_EYGO)XF(^R'_*:M^FM!;OU&]WWY+YOEG%9
M9WK )LP-(SAWGYO!-VC4W%-OO*F;.N83M??\DL?%<[/RG$;3K<VMQ90D9K:.
M8[_(\G3ZO'2=H3?*;AT!O@LPZ?QGIN6,Q\QT-&INZ<Z_YW[AH7H3=494T'"0
M9-+&$S5^^#&6A3XSS=>D-I[^T(43-AG32(QGI?B:M,63[_R[!+MG$+O@-:,Q
M>%AVFX4^09!\''$LM(QDT1?3#D,VC$$MAEY6G\Y9Y=O>H9[T:_6DST-'-KF/
M];C"RXO:E7.LL4S[)\THJJ-UU-UGK?G/BO\\LY.GR1^MQ;U[SX=%)$LV/,HD
M/;.#HTD5/3TB?,UNV;]D84248+E$,%Z<]:M]Y"[VKC\SE;AM:2593+^RN','
M6'=Q0/4#J(^5^[9-.R-Y]B%24C?QT=UY>@&6Y$<[UQO8DH5V'F-V-^K_-@@D
M&PO>T2"0- @D3XQ \GA$6>B'ND%H!<I'1_NUR.#W;%4G\P]"IO3VEIP03Z^U
MEVT.;,'IQ?NSPP\'%\=GI]O<-/I'P;-\+CKJ*5?"U\*,VD.ODC3R_YUI$6?4
M!3Z1P5)4@'[Y72VL.2B9#*QV-/!"-&SLU)CFI06AS:8)*$_9>CJJ\E; ;**?
MO*7Q\22YH@8(;<*3242->3G["OX.C;K%7T,!8*%:T9,B]Y(Q/?&08TFGKP5I
M,IY] 98.\85]!I8-RTB#>ZI0 /PI+17@F2VX6SK[:AGN9@877,+CM!C(PF0H
M#I>"O>9A,*5P7@[G=(ZMN!R>@*VVV21,U3*GFLM'[#),Y)SQV9>@;1B7X/CP
M*L=BE\AVTT;P#?&UJQ#>N/K 0TW^+5^];,1840N1PX+AZ[#,',<'(]DT;/K/
M%CM_MYJ9KUB&/= UAHX1WH!=X3[#SX;CZ"^U$#9HDG)0=J#,DA1V$Z<!8<\]
M!EXUM+N1R(;3ZPMVANWV"R_77*D 82O!+A^.:/N!DO[? I<5'XZP,*SP"N I
M?/W?X:]\*@8UX]61ZOT)L2U[ L*#J 52>C2AXY =R6T2M$^ [JD6,$\6[VF,
MG )BAP]Q*,;4P\(E@Z$LRCE(4>*)<2@H+!FUN\Y_!U[P0QR)=^**K\0CKX"C
M@?__+H")8$GX.2$Y:?_ZQ\ TEVQ_BSXP7M*E\B(Y::G\2/[YBJL_X)KE'V%_
MU%_''-CL!F5%;XN\7@^:9X4++RH@%%8Q]Z;P[X8O#P$&)(."9'%B4D["DB)G
M,&RK_!:"_N?15$NPA7\4ICZJ6*0_\T&Q:I-D4HA)YNKO\QP;%PCW(@1D\98C
M%@4K[RA/E-D[8C0,CAZ04,[;4\Y2.%#2,/&%)&-M&-Y>*$/U].KM9E=0?_I$
M 8L(,:M_I$!2LJ4KZJS"AMH*'7M8T*&,2:P6;M.0QUR(7\QS.AWI3(2=^!^G
M8VEN&$5 &MCL?5_,:(+#,RAAY^L6 XBMQ],8[[XHZ B'PIDW4EN,A,PTQ'CQ
M0:%[?.SR5"RP:[3DZDS=<(@V\,, 31F)AE&B7LPHBFI1V2P6?HP8^'A]RO&D
MCY5V6@F>OPC4K;18B$!G::X='[<$5-Y@-=+&'9%?-XM+,")]&6)[*P@R6AVJ
MLV:8H%C@+EVRB#*=*8I:C@0&BX:  SNWUH]5>(0B6#)2.L#0D?R+C'D-5B"3
MW"(FM>QKX7BH9:GWWSU_^*V-S&:87>.OH='Y,AGN:6#(K?AD+LS5[TV^O5Q$
M5)G'/,$%B(]E.,?L]R??,/;31-=N8E"SB:YMQEJ:Z%H377N>T;6[$05L4A>Q
M12^E29K<?)(2<B,?3C72MQI!]UWQ**(@0>5IPF4)V%9T[F($1RES<)$F.-%+
MN71IB.$6%HY1 *NPQ L9JD#[;$P%2Y'V-V(RYC+J47D'&O^&-C;VSVI7HS!"
MKU%6*0NS*R/ -;SK5L<;CF-I:2X//&!TA;#50&G UN?*=@7O>0*6IPAI(1[N
MV9_'AVVP5>'5?#X.O1;%RT3AXB2\3'(5,H,ON&G"?!YKK,2QBRKTD#+< W\>
M\6BB8F<8MY.D#-$;0J9A ?PD8CXB1"=B>KX&I_U(&\/C//"K9J))Y)+%>>@F
M_A3](P3LG6I@'8LG8@6;M*SEE\2@UO+]%)OXG-#XA \8CL=%O+@IA+4KF!=X
M";T$6!KY<EU=&PNO0FXH?@G7 ._Q*P=;BEP(6,@)2\%A*#T5A+*$>WA1DJ$O
M1Q&T0,"+MH3-3T_#& E*%Q91D$W?JL?FDAJP,L5KIA2>01$"H<4?P4M@P/+X
M(\BE#S>M<"?K\9MZX$=M&T>@Z5R0F<B?:>,"WJ'<P5SV,L$'(+Y9Z$;EAI50
MRH+F@J@$ EA2UJ>)U_'B[4C37)5Q+83H3E;OS43,]Y-A5U;D(WB)/!2P@@HH
ME#A?W&$&S?=0A$7+49]XVW?D-N9"QR'!&1K X41%[+(<[@F[1"2K*".N3<-+
M7!ZP?A[FA:0+L"(U/922-;/DDM?P!O +1T9!%Q5T)K 4*DL^GD3)E,^^$P57
M2?51,*V2NTD-S0>Y8A1QD*)DC&C6N)A4"R(.3D[.V5B\H@?W0GX1,>T\17?1
M3PJ,0V)83O(#"?V5")_+ )?DXCP$JQT>"8Q<RKH*S8C[HUC)\*!0%4I9SU._
MH^U40()8/F-7VBBYTLATHTC.[)9<@3./$7HZ!E,Z42G  T<<(_YW:_LD8NTI
M&P('8<B _UW@T49Z4X7A%T^ UQB398*I85D1*V*<_B.O1%&0R,!'?Q= %F +
M[7_ DU"ZK3V)"M0+"A8%R4RG:)GOP.4S(7C(+RM>%19Y,0I1CT1Y*.)?U4U;
M>#R#?KF"9\*2/'ABHA0(G=!(VY;&(Y]FC%&<*QD3X]7B;O3X*K0L8^%)D2_&
MOEKB45(C848H&;MA7 4$I4)2V2-X-KRR^!B^-$S9& 4*=@CKVP2KUP(WPI#!
MK1*:%'%/^5=21PE>YU/>!GT[.J]\/\4W6=S/SFPE\19*!09@F,2Y$R\/WU%Z
M6=D9V@C.$9>#-9$FB=2UE;V)]*BEX5R>@Q)7FZ42'DMR3>+DF3%BR>H;,814
M&9+T4=@',QAPXS))MV 'P?K@#BX]*=<*)-J0X^'9TL9XLL)?F#1KN<K:3&5Z
M+(J$5BPP]S7)BU3D.C =D#/1-Y(0MRB5 .]>6FE%=D^E>*_BIUOFPYV[Y,/O
M$=3Z@:\]=?;][,-[[?SB_?[%T9M/6RVF("C$XTS+KY+V) GC6E)1^75H4UZ&
M_$H<2RB@OR9,)%;$P(&$C$U0:-Z(9*XFP\KY(V_QCL[6/2*@YLH(J+DL FKV
MC/M%0"U+OTL$M*E,O _3=IO8Z6:LI8F=-K'3YQD[77[\KX9LWMAQ!:#G.KK0
M=7>=5V!V.\XM1P TMUW5C6.8>W,4O6?7S;WPV.<:+6[9ES(.?3_B&V<;E+"%
M9=Z!3,]2)&4-B#8DT<2Z"ZRT]#&R0%Z><-.P),+HO\0X@AH9 &=6637Z()[+
M[=AAH:NFI^-_U\,'R^=BE)RPA-2//A=CR7"'GV374C7VZ5YM</X _WO_-K>[
M#Q%Y"+F@.[[ ^J[0N\7V[7O@']2GP-VEP>OZ'6(>_G?K=PC[J0]&#"?FP2TI
M>MILUDIVRK5][4W$[HM-?*M-NF7#X+;NH0C!_TF)\'=5(OQ.RNP>@WWN9P7
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MC,JJW9LVCU,VO3NTLSN$_X:%$8A=NQ"0(>4U&X0@Q;4\#K&*3"N ^3?67]R
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M,'>"),DG:2C/0RR?8E]%W!CC9]_4Q/C:)I0C[^DM^;>) N&_:?%J:6HDD=S
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M?VD?T^: C=V*@PZK8H66:F[BOE!ZLH)CC$;YNS3Y(E&@J".,V FA4:I.K/*
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M%XPVG+R*)E0ABJ5S\L:IJ$L8+6IV>%53FT@[>#XJK6(P=<Z1M6UCV*5+F4@
M&R5,/5$W(Z/Z\.>6],U$L  LWGB8M31991JF6H:1W<DHB;EHL1I/BESR(=J
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MSBJ3I$>RN;XUE9\;'.^U<UEJZCUFJG/:V--4HKL4JE C9ZI..]JX%*6AKCM
M5EY33T.N4ZGW,F!D=(GDV=QW<2"'Z+R>PNT?]^69IR4A9+LDAL;,ZIZ<.;>(
M^I7*[JOM"JA7+J ^VA50M^-9=@7470%U5T"]?%)^2F<)"@"7'8E=-<.^9*'(
M-_/E5*@L'.7A1)1#\+QSNED)F/ZA?E*5YYQ')W08"[%4RP&X9^^B/7$8T=?0
MRPM+PL+MNT3H*MAWH?,?D8F[RTM0U_:O_^[PE\/)'#2W15#Y$GX+-UA(FF3H
M;CE)!,W%C@A5>@(+@K;OGK95HZUQO:<.SAUW/$+^@K+;4'!R'B/S0HCZEW\'
M]3_XG2%C12F:_IO8AE-U $GX)8B^4$=/,<+K$ND,]WX FT:WN2"SPI#W:N"V
M;B)+VS0J3@DUS/DE)F0/P2U%#[.[#CT%45J[^-TW[%$V"CW1*V:1\;V'[ ]!
MBR>IR-L:\+%8_XO&SBP5LS9J7IO3M$@764."97B:,7<$\& $T0"XOM+%9%W7
MA)0KW&74Q6%8("URDGBC%=!Y"*-7R5N-G\!_'YMB@DU!UP$Y!CG(P0?UV;"-
M/EL_PI9_07+(_=4=\>S(>E<->H(3HAQ9U>F/^H<##'*>K'_,"C)%]*->M%ZN
MQ*-Y]FSOZ0\/X=0TE?O_N5Y>_)T]\G>^;^8#GSW<>_9T\\?W]_8W__2"RSY]
MN/?TP=4N^ST],C^V>WT,[%_O//8)C*G7K)V(J7]\'_\YD*'+TX4ST:MF1([[
M2 \"^;1B"[[I8\Q*_\,5S&%Q\N.#U:>1^_2@YQSW\GLTW<,N\X+^[^LD!>['
M28'17?;#]O?O^06Z<80?WNFLP>Y RH-_[DCA<@,+]NO%%5>'&M&P77[P1&-X
MK:%+9OC/QC5XVT;VXG%TXP;1!)A?C.FX,YH5A?Q>/7,3WKM6FS]GH#FX:;,9
MFWG("1$OVIS]B?VG8_SW,[+BXE[@UM3U+3RASA% N1("1K7)]?BK^I;8-^$Y
M7J;IZ'AVZFZ5IW05IG:A$%/HK'R;VZ*E@HY;)V?IFF4H^9"A]ST8& 1^AR#&
MZB[X8/+@$77.)ZL5Y]#I-=P1M__#7]S;%2VZT?9&G"? ?R%W]N;PI]'AK D#
MAKY/GP-A7A@7]A!GJDP*+CU/W7F"TQ#_\%U-JIA"IN$A[JJ45K(;M7)+HL2$
M-%D^^EOB'L>-TCX&_\$^'Z$BB,L,M773SM>,R<$IBBH!PG)+?R?#9NY( IXT
MPY+488(L,YK\D+PJ\.S"/'-T^/[%,09BS$DV7AUNQIS'17UQ5Z,>JUMBV$N)
M*8$':V#N9FTCR;33!)Z#,QJUK!3& ?DAH6%V__A%1OG!7CSU'IT_M'P/Z[J<
M99*2<L/*:4EZ;2T5UD0HASPALE[.%Z(.P\1MQO.ZS2BM6IUX)(<;0,]FHPMG
M/#KZY7BT2+*</:Z%>ROG<R7 [9Q4O@^7^>1$O,)?!'>G>15&$F,#5LF:^TXT
M=?N!^E[XL4CUFD@O[%[H>IXT=YN"A8@:3]RY 7_;QT]>$C<F4_%XM-"MZ7ZB
MI&K#.M=( $:)OJ]T)LNILTTGQS7/Y%<VA-(HR89'S(;I_O5FSN8_,L(WD;C@
M00UZU6P15#M&N0*B?BNH9A, RM"8*H;+66?ED^G]5C2GQ<[J1H'VK=]D8V$Y
MXQYK/M<U8>[V;$G62,6]AYR('MDD:W\;S>UAG7DE\T@X/V]BZCCW$5W:ZJ#+
MHY!\KC<D72GL+F%Z;:3*W7!-RH7G4*77"2SLBZP0GC<-SSW*(5DB4=-)+6Q,
M(.CNH#?N/YK'MFY*4D@MS5G@E3"?ZD+@OCGAHA"NNWC:\:;\)&/$])QAZ,3Q
MI+W"9U%$OALS:SD_8)%63)DI_8[*.3JF)Y=.0)]DVAX6JOLWRT)U7UBH_I-6
MY62.5()?>JMRQBD09;=A-Z 6 O[^F OOE"PQLF1$#;K!N=<=+R=[K/H8'9%A
MMW8.R0^^4&@0V._\@SE/QPV1$$&ZQ<[&[%P"A!D(=(F>(&S0=,P>CZ!1T'2Y
MXC)%8K>4+GO.7-'BWS(TP!5.2]\8&F]JJCZ3$I5;N\2\M)+6B%JQ8BZL(OBK
M#VU$PI618<Z#*FN.34Z0/2XX1$Z(D%>YKGQ4):(B[B_9W)=TKW!ORH*WU+-+
M^5S:V&-_($TEER>99I P%B7U=[@OM]W9VOE7FU;,49PCWCE15]YK.G*\5"-)
M]I[,^RSZ+K/;:0H9KM-YG)GG++PPU7)01;%NW7#_N_(^R<_#3X')C&XE=FS
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ME:2= E]]PV#\&4&CZEAV>.RM^8 8CT6((&$5I0T,F3[_.ETLX S <"H(/1
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M;AFQT@B)6RP\;Z]/B!#TT,FSTB3>FDP9BK1(1'* .8^F$AF)"N5;C&K=[Z;
M$DNLVE/=;20B?BK2U#A-\H4*^-K>)2_ZZBZBI5:&C=0:QP9^%PPU^EL$K^.N
MM^ >D*@O)O!P>'Y]N03%^$CV9ZIILTK+%:L7II\$UK,BB]-C.]K.*3SB"7+3
M _[%6D>89U59.:ITY48&B2H5MB4>RSEEKW;UBA[Q%S@;)5\_3ZD,Y!9'!AN<
M?+HG)M@MPA4?(4U&>4/R =9>M-H>$61!,07.>+C#>PZ/C#J1QB,O\RPVNF[L
M%((L4??@>#1MG75=<)+*7IZT\ZA 0&:(#B+H %_-0E.>=8AV(>K.LZ8@/E>P
MF=MHX:U(Z@9D<T2!0]R;YNWAOO@18$?*#P(_,]NBZ)Y!R7-3:]<M\6ZT?U-;
M'4$8TX@M9*8F(LFD7D.5X$X,A2,)3@O.4@><6ZR1 '1'4LO(F -A^:]:5*&Y
M#;LH00/%'7DY0Y)PS*<H/ZGJJ*@AT*HX;E>0$'1^EWO&WOCN@J_-I0TISLSJ
M@P#[7A]@9YR!M\I-E5O:Q374/+8E[KHI-R6DWY.S),L%^-,IH#'C:' FB<QP
MF8#'BW_D3OJ$Q42)%,']FJ3=V;B0+7W^Z^&H)I:CT!G<Q/>76\-E4$Y?<,6X
M+;7^CV3MF4714OI&5>3<V0 JMUIFHHB 55#3L,+$FN/,MLBASH-B27@FD>D2
MIN*HH=C9EU6NS;G+<IKED>U\_<%PQ*)$,"\9N&B>%YXW*DO4\6VJH/HZ9=MP
M",1E42JX*0YHN.O[P?T']ZF(%5K+V\8M%.Z]CF=$.7OMK(AL+!Y*@D#_+3<D
M*54]%@DUP7-</EK2H0FV+GJ.J+G9;]:X']\34G7XHGOTMWX 23#&^0W2UN(6
M!%]5IL>L!D^S&64(3*NV-QJT2CSSM:7C'J*Z#L\?'!C]$K/-XJ92 1HBBXU(
MIT?QSO.TH?[I@>3 RVV@%T4'4"-%*%+0$_,70)ATJ;T(-JKP,XC?2>^!CH6E
M,T;,6[&F&87'44&LZ[U$[3=KI  (\(HQXA>1C6%N12M6P3X17\I &$0H6?A4
MC)!'U$R)A6 _(BE.W<$B,NB"T18DO.<=ZA5IQ,=R3YI-GQG",:/+US&, U V
MCU2>PQB5JZ77Z_3Q-48MKC/B9M2<Y:*Y/*6N>Z;0K*MVY?G5S(U-CK'#K3EG
M74*V!)&^8.@9<0ZM\QB5Y'BY+ MG:)$=.>BW"[&5#&U79BIIN..^#7\368M\
M#5HV0YO0DP0P<3-)[N6I6W]"Q7D' XN*+^DMN+=Q)R;$U>XX-R]I2!W9,'=K
M+XOXX1L2A7L&37UU5*)08Z9M(^@TCV2)^5,#.]TX\*LQ71\% 8VHT[M]EJ>"
MS*)53LT:? 2.@\D2KE!O\X2/(Y/#T7TO;TEM+KRLM0+6"G&2QYH._RTV'Y\-
MK?[&O-"C4[?SW)FEVA.*WV>CZ#S3DV15*^_ZSA/]7-TXRK[3T :CZ):VL\[.
M9R-6X3%K@>C6C\#!%\^1!Z2X<VJ:-JFGZG=>A_Q$ KOSOOH<G=Z]1A WVSG\
MP:A685<"_I?)?" 6,._PO0:;=!@[TDOWOQE2:=+Y$OM2/1?B(EY_4>4(6)\
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M(G2STU SNJ!.[:-P0XM!];O-P.QG!*O<L*;XHHQQY/&(.%IC?L#1\R 1;WD
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MAC-J[@Q-\[PVPH!&=4:_QK#7G6..AZ5G=\:!I=4X[663NT+48M([>'VN<,G
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M"(%V*] 2+RF3G<#[''N9K]';V:Q=:6\D[P.V_3P1AZ+0QBDT\F)LRV& &49
M%5^YTR(->>KB5:SRQ!WT,KN(7TQ"/,1*&G[A&=VY15H+(AP6W8IZU3@HH/ *
MK\>-I.!Q<",Y2[$"?463A2.P#.EA<"M*ZD<TU8C&)FZ[%NRBP*OJB-H1A[Q
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M$RW0WGA=F":1W1:YV:DYI40'9^@)\*Y%S-TAL[63]M,:9=#=SKG127A]29(
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ML=[;YV[&I;P5O_4+?U_W92&75D/!6B9SH<B@"53+11P+SE[-N.:EVQXM(DN
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M;:OBK3AUI^*5A-3).C-413!]Z@,M%61+6 DU(7QQ>,,=+!?)A%I"2U C&VM
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M5'=M;6H$:&/&=MU#Z /NQ3!2VEC!BTS*M1"<<+MU@1/#5#U<$B^Z>Z 1827
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M'DO<4\ZA1K,Z0%"-85[S=E9CL'>POX3SM<CV7F  ZY2^J!$"U*]H/D^N#8S
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M E.7CHNNN\E&.3<S17KS.34E8-;V3"YWM%WR2%<S9C-#Z,*W&MMK&$[-6V4
MDU'<-?MR3<=4:4 KE;7F 4Y5KG2?+=-OV!H1YN="]4$=#SF'0,MC]O2(B&C6
M%/W"O"QGK -M:%4+?TM%"*7FB63IP$K)]W3L6J9FIVRJ@EHU-%7KRE=VI3Z\
M0BE2VWK#DBEKW@F3!I&E9 N9]9C#:.Q<#,Q^MGH<2]QI+\*]$C.6,(^?&8Z\
M<[QGG:J5D_$8RT#TKS1_0IGC.6/J)#J1>HEAE\"9C;)9\"+:X^P699@<#J5I
M&BX46=,N1;ASQ"G4JY6%(QWE7*A6=U#6*8HXF96JF3 3ZJEJD[Q*G5[H-M&B
M%3B:.KWU7:^"%Z,]43FL8!R_ 0/+X1QI$.,H1 +Z#%ED@G-9/1"A9,C&>W(E
M2;1:\U=4G_:VP/HBV-1_Q/#NG[/@5P'8O,'3?FZ82K CJNGRL14Q;4S..RZ$
M-NX(I6@O>^?T@.DK#'NHO,/%DCA*P!F_&>'=EH-?:<D5*GH09-(PH=R?0,<1
M%FE/XBRGK$I9RU@B+D<R2'&F1;962LJZG^9;T=1AG- 1?Z>(2_QJ9@1PN@6X
M#OBJPRB4=O" TJKJ^W@![K!AMN,:OKHJ=6N+K,\J.(6FKAFCMYMF1\E!!6:(
M:F9V+R*C$/] <GS5.,LV;Z>W7SGIAH$(W1%!-Z$A=:BP7A%#:$9#LIP7(5K*
MB!DW62A+<NYJKB03K'..+66E-93N+(XMGP3SC RF<G3+.Z24Z%%?X9M1;O>K
M#OH(M-[:JABXR=,D!G<(!+Y8,)G%#.XB1B.#+DW-S[QGF0TH)X0,Q<_*,19N
M[R'(2@JE392^IA<" LXK9R;.TR(S+HP^7*U2Q@X38LI$L<!@4LP<RZXJTJQ@
M]E]-<2O"\YDX%N\I-,GX@RD. YOL5 A6&-)@,_\\/%N-[=*K;O=&?E=M<;\2
M)=0-5."]BE+/4HR@UTKV>$LWE6"$G5X^9X/ /@<_9"'ME(CE\3K,3+@ :?L^
M()>-XP:(#L3U<0*X+3&(:0E-7)*COIKLUTZ@5?O "C=P)22,!*36GTY;&@QC
MO_ E3J[G:H)6.>]T+J8VH;N25K;.CT1VMWG'E!B1M"E=CIUBCPV)G*)Y1N%A
M\U&YRUQ2IFEAW" INC#?IV5'6&%+7RJI]<"+RKU5NJ#,';W^:BLAI5GA.M-
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M6_:@2LFH^BJ=G\S8%PD<E0+12829@KTQ2B:F[<>>;,,HN__0-:.4WG#MP)1
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MMYG;T.&NMNWF5^0>E, %ICT"!9>DMPZL* &&,?!<J3"6$;1,Z3*9B5CQ5NB
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MRT#2%OPT@UVX^/G1"7 YO.,2/O:=\TU?$$O@F$1+,&8SV%AZ[^-N3I"/:&_
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MP\5"I2,I9B@*Y-\XC:A2:. +;T+:VQ@X&O3)0&:N*G07H5I8YDR:RX(I>+=
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M@W??$W)J32"JJD&H<PZ 4OB\O72IM0F,[_LU'*1QH4$!2 _TMQLK?'S$5]W
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M+,--X 6?HS!1G90NN5,T+&CF]B(-[^CSY8=+]#?F#>F,=[K2%S,.L"YXQ+(
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MUP^+2O$ 46P.I\@H#%W,,%SN3"@\^ZRS@NX[:C%^>8!PWF4UB77A,(L$*.6
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M8@'I1MD&\V:\,"Y%H<R/Z5H!<5$]]BZ,D,R&_\IHF:BO!5TF"+$K7 :8@WN
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MLZN>XB FXC$W_F9LL.LAF/@8W3<,?4+,0A _90 9TJ9(P+DJ>53;GV"-$TQ
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M 6^WC)]5A9AL_.QQT66WLN ,.TW6ELUDV)6E.JOL#K"%EQ4OO-R=#EEA<+J
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M V6"QQ4CH 2!GA@+ [G$+P#^#M2!G\.]75!D?O1LR,.DF'E3[8C':<OM\D.
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M^E2XNEO@>"_#>]=Z 4T+UFP&'=%SM$-0I^&9<=6$!^$IN:':ENN*(I^OGP*
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M4K6YJ6WU<4+#R2E68DX-1Y!5G-7"V)PXOY!M;*I)GUQ9DQTDL?.7[,'"G1%
M3X#;<VL_<1@JKQ#->7\</B!8[EC&9.N;*&:->;WM?!VQBU^$7V*WRM-\9GZ)
MFQ)1E_5)>%[#,=F4^*]LH^K9M_B$7LY @+)>6:XQ4]6[_0#M8=W*P_$DBDF-
M%:W;RRK7&$U%UZ\0V_)CPU<:@;DLN@X52E-<[85DVBN_5A6;TKDR@<OYG?7,
M'FX?@R0;\:9B5/9-1:?&N>@X-C7\MEILKO(Y2\%$/88OS:=OAS3B,[IH]?;Y
M_?)?9)\K7_6YZL9>5)^K)V)RJL_56O6Y>GH;^T58*Y^J(HG:6NE*&'LUYLJL
M,I!ES15>7S';8,EFA6UGOI.WH*\;Y-_!NN&)\W6TMIVVW>AK-O/URL!YZEB2
M7X?A$1D0<\2@&58YP5\W_EXVVL?8[83&78].>3/3;_[*M\S)5S7&K?"?H&==
M19X>UJ#UW)GV+';TCW-0L8N>=GF:8DO!5@/M<KQ!2=K<H3Y$1R-OAT^OE:6[
M\IN:$<6?,G3%_%Z<PR2F-?.Q$=KP7(ZP%5=Y.>&?I>T5^7P;,!H'TRM4:\?5
MK!$J!U95;Y5]M^<FZJ@0R2KFZ?Q%LS&F;%3=)P'6&*X7"L6XW^=0;\ZH:$TA
M:LZQX\-,,CZ" OT=S97Y+4\]4<_RD;,G6T--*CPL9Z?T>+1$Z@UR;F ]3D6?
M&*="^]A<572EY\.\,PVT"&QVN3UC/@^B69^-Y&S(Q::US-BNI M,HN1*F1P%
MM(^-:,6F>=;F[*WU1-0'P7]OX%?CL P<539K/-'B_4B%.&6SICLN/\;PYC46
M'\D6#@%Z<#T-B*-"D<:20P HEVM:OQ8J_\00+*2 6Y'WE=/(VZ(G)SA]9L0:
M8]CKN5'V)KQ]!B6/,Z0!,Y"UD1S,$D-[.'%A0$<\,ZMW,S)R_7YWBH87(;\V
M=8MERA;(MZ&T5EH7+60NQV>AK1+XM;JZ'$KC.$9,*Q#NVS3"EKA\SFW9E+F9
MY,;;15\R(&O9-IIOJN'7[S4!C#G<]AWW57.YVV!RTZC"O*FOWX5,-Y>4C6M!
M@Y^&\R8Y5=.;J@2/'-XO)C W)C3A@"8UBNG)_$+;*3HOX)8^Y\.3G [6!'@=
MW9YD,XQ&IR6[3I 6_@NZWXAWAT^D)H&??A@"N?#L&.")$1][$[.HSQ5\6OX&
MYRJA6A27%X4L6M]T7.2R?#XLSC8]A1_5;.Z6]W-5\;[OMV:]_R#3/K$PYYJN
MS34,@TLT'!HP!AD6U\DU,UXN<\OXE#S-T#>]]KCPQD&F-L7U30$6=(/HFZ[)
M]\<WUD/F_<K<M/WZ,SD5M%_.V!5NLRK*6"T,'%\.1FUJD8K_K(K_'/++^,K.
MQZ#$P47/2YGI&O0ZOKV5[BE ;\D"F]IZTC;]-U4& D,(1(8CSWW%N<7(9"Y
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MP#'H6$#YH$P,\^M:2ST; M)K%_#$F(_>PE& *3W)AD"H44NNSON)L$#DOI
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M,&@@@-K#< 48,VF21A1H0WIX<"'I>4?>,8RX^9:M__SYFP,<KXQ-JSD-&UA
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MZ/ +8TI"BK4-##Z(S3!A.%?5U:<KI:99EL FC5;7K-$"^W: 8GFJ;0,#'(3
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M;>WPVX?#77CBZ^[.88?DX.SS?#S8/SSX>W>;[_[P"/ZSM[-_=*@=?-(./N_
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M'#'O]N^5"!Y.!!=?B4 RZ4@HK2E<-B"(,& SMR 3Y30SSF16:^N6S%CLL=)
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M=?S%K3JZ=JY]K,ZU]RXZ>D?3O4I(/TQ(U\IM!Z,93RX =\*A $B\'/D4)>N
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M6WUNI)[27)GS)I4 ED$ '[X2@&0J6&((2K>2T2F8 Z^"@:BB<&A&&:7]ZA'
M4O5;[ Y1A%R4V4K?OWK]Y&I^\DD%SMZ<#\(Q<NJP*?%9SO2=#R[&^OJIAL[N
MWND>)W9V=#G+C4MB;!%MA/^>=P?5(3'K9G;QR]3QR.P2=4%K8*ED LBD !4M
M!9XT\X)RDTK-S/NWB&W%7E;%[*+%[-S]_]?PW3@?K^"]V1^.=M/HN%^!/CO0
MWWT%>N1&I> <1*8<JM;@P0L;(1+#5$R)RQ00Z.QF;EX+H?Z,D#;_0OP5:8M
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MK$\\TR2<GYG[FJ=D<_HAF>@@),+]?.0^5QZ<C0?%=/)=X)99XAU06LX_$6K
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M'$XNJ-_NTF:@(&HK7!7X]D(LX-)W\.[1%-98O#/ V]Q=8X2*&]MK-WO$:5O
M$RH#[SK ^^?CLA[S]4B:"_%N/"LKOU2]&2DTV&'GP$9$NWS-O/Y9]<?F(QJX
M/)5OEU6-Y+*"S:QPU0^/7L*RXAM@A%7O<O?R>FH>V1?7^,+I%LMJ45Z3B1'H
MK!G!4):X9D \P%AA2L!]2?C#/4?H=UAKK-M57<!NXZWNVZE8S"YAM'.QN(##
M>WY=?WW@OG=:S;99/1SU=K>94C-KV 4QDN5,Z%$IIN=^DV$><#[*"G<A^!YQ
M%&.TE0[":,= (P>CBUGE>I*Y2[69&X?^!\=A L>AO(8-7US-RK>XJ$>')]6#
M'P_J0^@@D ]J:&5\%SIBEE/GH!JY'9V5YV(Z_N U!GC"XR?/W1-P]AK.AEHX
M48F^MQ$>I(6GF<,G3^&RP<QGUL)+W$:YV2)9P0MQO\=^_UY-QTB(+]&[X\_T
ME@.SN(#-/+]PU#)UWUW!VM93QH4$(D'RGB$Q']0K6#]@Y-5+?Y[G%Q,C9[C?
MU<*-:'YQ7;E%QI&[USD:Z9UHF/P4%F'\;KRX1F*<+4ME>IL&9VK2>\_E3(XG
MB&-=@H(&NC!</5V657B\/U)A@_"#*S.9.)J @V/A7]>,;GBHQGY98=(3#:.J
MCW\X:R4NQ$>>4G3 E?/2H,<,9XOLQM^)X-M >"9XY6"ERW/<4C<I("0<?*7&
MCKW 2ZN%L+;9Z9I2'PXX1,MF1R_1Y>:.7<T6_-%"OH!'T[USS43+<?5V)/#J
MZK*SUQ6&4/U-8XL#J)8EDGXS%+_\>$:[+*U/ 'A)2WO 5F!HB]YZ+HRZF'I6
M4=43&/@H_S70]#J2\N]:./SK6SC)U[)P7H*]B"=-3!>//1MS\1I0L8#T3^%-
MOTQFZNU7MWK>UE;/U?$'#('\]08ME>/35]'SPV=OGO]Z')^<OKY^_>?1]?$;
M?7'\YZNKXY=#J^?QAY,/3S_\=7E\??+KZ_<GIW_0XS^/Z>L/K^*3-_^^>/WF
MZ/HD>?K^K]/'[__GP_$5O#,Z4V!"%)&P8/%83F@A-6&T*#"F(@2GN54\'9H]
M- 5+J;"%++*",I8(86,)1D@11U05*AF:/2]?'1\_?O$:39Z71[^>'#T[>O+X
MY'3T^,F3YZ_ E#OY=?3[\]^.GCAWS)TMH>V#Z0]>4RKRI& Z$@46+4D)9XHS
MR6(3 =GL+:?[8#G]7H(@'H-&[F"(GP OQH">.U4W>Y\"A'*:-Q#*&UCS;EDX
MGYG%/N\(P]YB/I[JWT'[@25S?SZWS\93$*YC,7G91.H.QY6:S$#JFOO-C%]'
M9R"]E6"9(%*PB%"J+9%17A#*"I&H0B/8^I"?I3IFJ<@IEX6@"D1_4D2IRBU/
M3)0"#Q\R8]2K5+-'H%7;>DLZT=.@IWIE*BC_CE10:6WT^3JY 1XBK[L*<$__
M#N8 *%GHXO6_7TU!Z[T8S]TCP3Q\ WHX*,KO9L[$&H=,"= ]VS[+D^L#]XJ/
M'_L[L-R=!5,_OV.9_)__Q9(D^OD_1T\K]VO\\X^HDEY=C-5%;V87 K2]-8]"
M#1 5R=4[@@X>WC OQY>B1)MY:BRJB^5U>"'HIK!>[@5@;ES\-/HA_M'=Z3T(
MSNIQJ^?GY6R+<<!1AT]@Z-Z>OP0UV95N!*5G<HTFN0@WPF7XOKCXN1H96$MO
MQIK2::JH]N)$?DC\FV=R,CX7M:L"H]VE' &M5FM>.Y]AO&Z,&P5[M)S F3#=
M83C?1[@A*-PN,P(_AVD9M"/\HL!NV7)V^=&/QV,#Q[3[I=NFD$O0G@GOV@!V
MZ]TQ/KD S.-+.%5XNN  J"XW>WBS>K)-6_\Z(F&]UK25:VP4)>@:NX1CTLET
MJM<>ULW3<4,5P:IK[;B&U)$%>-=:AXOT:+OG;@,B*C&FK/&F"@UY)/-U YGV
MDJZ:H3069O\=+=> \SQK8B"-1;_A:7X\=@+DZ <DP)Q$RWUA7#<I,'^G+BUE
M\+8V!?>?(^/RR=8.2WJDNU%U8<SBX1K#<#?.W1V5KDTGZA=1C=WZ=U6%[VN*
M7S.!X3/K?F[WGMN!:7WM?]YOC>[HZ@R,:L:Y8J0H#$/0>$YXE%*290F-K-%Y
MQHJ5**'K/>FXPN)B7.K1?Y>B7'@G%FQ&?M!3+Y#=3 QR#>?I&Z,#%I@K7GP"
MJLAL@M&,"O2<)?"F;HSCAP<G1X?.9^N<UZ.WH'S 85M:D(9^! T'O@Y>P%X^
MWNT9:>D;,F$ (6CZR#WGL]*K)'6L D=\=(C<%"^LE=SNPVJU$DXBAW$O@K8U
MGP%?'BE3+L1X6LL%[ /H'W)NINCJ:88!0@+? TJ5>_=L\LYHF.!+8T8GH&6,
MDMAI<F)DEV5PY%=JZ3RLWF&Z=G"W50YVGTE],P-^8=1$P+Z@DN?V8$=4KJ^_
MP+OH)/B]',]*WU%WN'%M\[9#8(7E>.[;LMU#D?$J.TLY39GBEAC0Q@F-6$2X
MTH)DDB?8%0J+A88BXTG@?>+26S9!J9SCDJ-U!VN^WE:^$,[L,E-4K\.>>!8)
MVX\V8:W;SSNZ66W[J659HIY[PPM6N.+H%C&/8:;V/4K39IO3M/<)U[N:J]PD
M7-=)R]V<Y9U-Q[R_F;+.%Q?'/^.5IT<GKYX>[OSD/CIW=K/9?(M+UKJ.M@;0
M!@YJJZ7B"9=,20723/(T8BI.F$GS%!2)XC,'W+Z#:)6O/!SYSE)@S;TSH=/M
MCCA)=E';]&OFEZRS8MXM<2]5R[?)F4RR1&BIB<FL)I29G'"=*!*IPE#XKU(9
M&ZJ6G<5#M;()F:P&.O0,/I[.%K5']V DEXLVBA)B&\*Y%1;".?,[D:#&M?H#
MV.M@5*.C7YK%%>JF&\M^ITOL S*H_*59FLN4*V9%3@5RFU1RD3.MN&&)V #;
ME]SN!#VO!PR6#$H$4,6:>EZ2W+N#]31[?OKV+(LC*87AI$@,)=1D%!13:TB>
M6YHQH^$#.$G)*FC+/YQ_Z&[;FTJ;6!6#(:3 4M*<P=D%5L,BF1;*R&R_O9]N
M>X^NC@]?G]$(*"H2AG 3@T7*>4HXJ,.$:1TE<<8Y;/.#1W05M.(?/_H(#T@=
M\QX6%'65?EC.3I;&]?1Q=;W>AVQ\)!63^[P7-$1*+KW\PY!QXVSVCDFG K5L
M"I_5,68QKCI@8KT'^B^-61\BZL=B^MF0/B3ED[+GY6P$9@2PMPN7'^A-9"/*
M*0P34VB=CR/,#2: J9/>E)8N_J''F&+H%Z.I9UX_;OPM/!<OW3"; Q<EPT>)
M]QOFMLEKNS+-=V-SY:=YRY7$26+4>5RZ7,NK"^#I[TPY@A_N;>5(76!.LWN(
M&I=J>8DR0;D/O#+KX[YNS %SH7%O7(IK)VBD<5L #T8+;,77<$<_W,[$EKYE
M7?65+T9X6BV \2[,7D7=K*+"4CVWS4+=.]GB(F3OSXP" U+$BA@A,M =XH*P
M#/M;T3SG<:H-YRL1LE/OD'0!]\!$-V0"U6Y,9%(N,;T5'>@=K9, 6Y43"P_F
M(?ECM?2@SA/Z]?'CWYL\H=*X[K]5I\P%O::76.ACZNWU=2-5M;R<U[$LX&ZH
M):DZ"H8!,117EVVV5569D*<R&0LYGGC5VQ=9U+&TD&;@ UV+C??XMR#?KV73
MVB6K$Q_6#0<KA5Q]$%YDWL_-%!.!=!NN]#>YM74N8<S$48LEO*&.\?G4'2_K
MZBR?6=59IU6'\6A'6,AWR:Y?^"T=O0 Q"GK9MY  ^VWLP]=,R0B;VMG3?3;&
MR1MU?69CEH&8L41'J28THI((EF:D,$F>*R52ELIULJ:K[\.*?D 66-7LT.=C
M.BY9%U2ZQ+"JT;>Q JG)HFR<(<A E2_1!#W6^54F7NZ8]UXY=EKT^6P&%@;H
M[!JUYJ9HJ<1ROA*N]PFE<$9'R_EL6J>#=*)T=>$B&"BNINX'5,8;ABS*EM?_
M.'()K*932->-#X87_E#5B1(I5O*=F$4K&!Q'/W:%7J5/)?5_C'&<L_-27%8^
M[T+,X>_WCN7#R._F . 2R,$DF;0JIT BC"61**S.9)1*4>1K*62-)T"?O_^I
M-?-G%F82**>ZSS;_<7Q\^/@LS^*<@EU/:)'EA,9,$2$S2F)MM(3_)5D1/W@4
MK_9)^,?!';=3:BX8M;"E44RC6'"1RXBG,M**I<(4N)TQ#]L9\_UVWGT[_SA+
MJ("EE0DQ.4U@.Q4G,LLSDB4Q"!>>:"LU;&?V:3QT0G'+M,VS)*,J29A2,F(\
M53*1JMY15N\HV^_HG7?T].D9* FBB"-.=!Q; L923*00"2DT$R9*1<X$$N@J
MR/\_:L'0JU9NG4+3'D,/J?K71I35"$6 ;MIO>SVJ[L%]X++RW&G!33U "3-W
M)=# X;_)S/EO0X,_==X]H$F?F/]-+^SG58O] L%Z[;7ADS?'[\\$LUHBU#X3
M>42HM,!!&%5$VU3F::R33.OUGI?9N['+AG5>WB;=UF?U^CRQJO_Y'#5 3$43
MURY7IF8K=089LI?1?+(,.K/7?D$3UL::$I5._YB.JP'O .WS27B <XG4%_=>
M[?!'C$!/B>ZC@F"&\$1<U:X8K/V9BKJ@(_#(GO>_YSTIS<2\PR#&&J?'86?8
M&QTRI6GM"=VLB+<*\(,E G/5:<R5^:\+E%0^ [D.%51-B'2MG_QF%Q+<,BX[
M;-J]"U>HJF,O\'?IG%=HE'A755<@]"ODNJ-RBUG/Q!5XO3-E9= ?-'HG)B&=
M1$PFLRN/M5#54 W:&R!C5V)S.2L1EN$MV@BP25/G]'>[5>$&SSWH,AXLK$L,
M&Z/7+/[5&+YO(@; 63^XE&\\S6%>L^G:&X?KYNH5V_/96:&JNYMM&GJ=B>E3
M)-W<ND>\JL\<C@:7OU<!MYS62>WXHCJ?<>7LS*98XV>;0UU?N'D)G<E9+2M\
M-CS 68[FO7"%;W@CEG.*]^XH+1<76+&%D^]3#P):.$ /Y-:+AF+JEV_+_-P[
MEKY,[E =* 1%>O020Y-[#6%STE!8+%@KMU1[10$4A>1,1$8GA<F)8B8FE&41
MX87,"/8VSQ6+3!JO8'[TX7N6/C",I4#5 G:NJ89TEF20P+B;R.L0BPO$C#5C
M7]19!K R+(!&$3'5G@,B]/=8C1&["8N5#"@3C7!S-5*E@<>$W()0%-[$=9H
M.@HA%=(;O?MLZ9[77 "L.\3TVXR$Q=6,N R#$/D&[HUU<*I_%SSL$J&4W,W
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MT:&[M2@2'N)HOZN?:E<_UB \V(N=AE>]>7M]!G)&:),5A"88_<UB041L.(E
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M1'G\=[/VSS?@VX_P_<^\>OSYO+:US[]M?2;PO.>U\V:^;P-X]_@_YSNB]OF
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M'UA-.>=&(!]4+C_F&EG/">)**ZJPQESBQ^:[UYX);F9G@L\ F(=UU5P_]%D
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MPT)Y2!C9;$PQ8JVV-C%I_!PF:BS,1-G[M?GASXU?*ZG;:154==S).8<_X,S
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M(#7BU&JDJ<#YE1=, ])(<5-VVF,FC*RF$Y<.5F2[@,9LD.=^1X:+Z).&#8B
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M-;QZO;A9.6#^M/QX;Q.\\./2\.-$+! K'W*?,..-05Q%@1SF 0FM2&)4Q,3
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MT77GQB677N=0X)Y]H+L;V/<:3\YW,"Y?ETFF<69[C=,N$$07)&%&@NJ10V
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M/*9"[5&CE>JX8"5>)KI+G ZZIYW>_%C+86C."FL"YARKH)D/*F*I!2>6!+4
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M=@9'QT.$R)B2J3[?#[):5L_-#HVL5^:85[.7 _5Q6GT,'5B3=J<_BIU=!LB
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M'+@G#HR-6V(E;(?%*!%&<K<0C"P-&D6;MX)ZK)( '-#7@Q$%!PH.S(D#B[9
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M5-!B 6A!B(W<AABB);D^L>&2V( --D1@K45&B]EV54&+IT"+L9$E#*7$!(4
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MP7$#KJM!X7VG\/<7N*[3;;S3ZNSO?M@\;;;^[#8^;&81>58GNCH*P)XGS&U
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M[HA$#K.(%.8N46QM\ [(0)0C@?M;QJ2D2E01%1CAS$N#2<!"Y):^5$1MRY'
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M:.^,0QY;@3@-X-@HRI%C,K"D3.0XKJQ*2HO26S(D*>.I5H)%21G0E+'2R2B
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MJ5Q7D:=H=,[PI//X_JFYM@7@QY]A"SQ.L"I;X)D$;>?[0:(L*D<M<LPIL !
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MLGG9V-B"<6[AO>8.VV_N4*!4'&C02>/JZ#33HT83[OUI_^0_5W7>:'XY")*
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MW-HH7N/C5F.]\6%K_<_:;A-^4=]L-'=K1==W\EN^LKG5^+*YL? O]TNK71M
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ML*$O]"[>B/TQ%]</GS96Z>%// VO!XR?FN9<AV96T#L7]/K)$NH^1(<%$@#
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M'-_1O)1&6H69)MX!OI-.>YF4"6!<*I6B&.XG'^YG#=H?9#^UELQH8$W)"$>
MP@0R5B=DHH[$>!.CMZ42P0^K,X:68_]H*.B70DM$20..*7(;&4\ <!F5"@NE
MK*;6LU11X1#*Z!K*W)L*1>,"3 UC&4Y2Y!(,%'$?>(8R.0P2Q(&D7'HN%D"9
M>32VTRX^1M<%TC@O>'F\2*:HJK#M=N>T[8&"^D>V7S3[<\G,GO:/.MWF14EH
M"XFI?9K/,6?".31U'L25A*%;; VH'YVL9MA*L'%H&<Y!,,5\DGS8D'C"X<_W
M6VW?C;:7B:3\M]F>1TI#$K*9J'QL]T>TA.B;(Z9/HK'A^?;&UL7VA;]H7'PZ
ML-Y;YPE%(H%0XYIC9&1&(R%8+S0W\,_*&L&KL_E2?\MEY\J5AU]*$EDD:\K3
MYCM)F]I=_IP$L@-&%!@"TG)+D"9:@^2Q"ED#YI2FR5.?*_=XM<"EFF,'[K+K
MC(8H0= ! K8<@QG.".!51Z($!2-\5:./#!WII+9$'GK7#P^24"3'$2,B*9C.
MV2EBG&-(:YTDV-#1N1+UR-EJVJ6^*17-NZ+3O1,!2#"*, @E0!H>-!QV$G;?
M10L:,&CKV"4"J-G^@0E@[\N!3-9+[!1RB0/@ #9$1@>+5 (XS+U2PN:(O54^
MFW,V)H ,(TYMJW7^K@0@L>TSLCUK J;-8&.D'T[L>0ZDRVID_:3;;)6 9%&
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M*;+!>>0M,Q9+)H5-.7%!SHBYF>.6YY=P+YKO7@,Z&;)D#5 >A6W' ,5YZD+
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M6#P*L+C/^-X6+'X>+!K^'EBBF&)0R'L6$>=1(1.I082%X)W"4GA1P((]0#+
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M<ZNIC-)*G8O,W[3W2PL0+4!<"!#4)2UH4IYSPU5BAI,8J7>6^, ]E3=V)+<
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M,5=:<IL YDU+?!\>)MXTB2\5AC#J#0J@>1'7P0/QM18YRUD XR4Y3U?6"'Z
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M&2AKO,'>H@"BAGBP">F8&%(>^\B%2Y3&+'D/X&MZ2NQYVEOAV7-D[&F,2<3
M6."*!K#*E4@VVEQ'0%/><N2EPXOW38Y,B=4Z.6#&-+=L K 'RUM%%)PD-& A
M;<1@;[>^Z:63/,Z5,UX*22SFVH-UFKAUVFA/""7Q.@'JK>3=N^3-.3))6#/8
M!8@E+:KZE@Z6$FG"M0A!)^%SLS1*6LE;,LG#5C%#@/PZK3@)SE@BM8Q O!PL
M:? M1UY"R6M6EI62L&0,RH7Y$*>,(YNL1YX[[84/5"F7)6_I [8?5RW-0:/
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M7!1):QHY3A'_A$W4KOJU5OW3WD=NE5!,!81AVL'\2198D_:(@4G$@F821!*
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MH@?:5"&9':?M\<6%KE>BSF\_Z!X?Q=YP_/G%E/[;D:"<4FZ4J_NK,]Q_=3S
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ME"PGEG)#0!F'\;#D)&6C!9C$(8GJ8:Z>UBT\O52U[JZU[EP_D](Y.T:LI)Z
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M!FY+[=G^'F=*]$(JEZ(.!CQ0DU !0P8G!5I)L(OTPGXY'G2Z:3# V_&=;O.
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M>G 7&Z7'E;=E-B4OI,UE63%!K5_?2%=/BJY2RLL #$JDHY* *[W&^">)+F&
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M-8J@6$12'&J2T2T'6?H6$EU[R:\I@\Y4NXG:48MA+#51 0/CG7'HG@7A7/1
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ME8 [<:A.\'O0+FR\$F@@VBF$<XDQH\]:$N,@!9M44@UIPXKY^-XZ)Y(,0%T
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M $:*XM2<#05FG@A&/*4N9;YEF<Z46LZ26Z4_^:H,'GKW/67Z,/'V;O,PYC"
M>)Y<->,L01R) TE1I+JS(K^_(((1>PO7[;C1F<"6.CH+!P=V0E6V-/5_4DVQ
M;>K8Q-0B*R]Q;HEN?26&6\25.$Z#0NW8:LB-J\P\#]N6O,8E:#UJ:4C$D9
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M3H7$R7B7FL/\"Z_-GE!NYCN,#Y[R1"SM;40F6Y-B>;F4V['=XZSR$KDIW"=
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MSF*YXKGL=3.' !T+!&S,24M(P38/@E_!^ 9.IU2G62,-UFO:@4(H_R\POB+
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M9( Q&/<Q1:+*CAU&9Z75G-)$V"BMYTXQUV2G:#.X?6@L\,8HN;:6=\E(_.R
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M@H,+Q"5E<=W0#DV\XKC<&VZSM$RI)AU3:GB.)>5Y?YSOPER<W0Y4>:JY)MH
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ME6E49N>9LYXL ;UDW29ZW W9YLT\LC>..X$+(>5SD2#,9",1*0>7H_3>M&D
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MT]%H NGM9%A.?1AV!^GOOC>!J67Z!A>5RI:,^_$TF: #5%NG$VZX4:%YFK5
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M/M,R%#$3[V)&Y["DK4)"HZ[*F;8&SX]"C^T4T&;'MK+^MY!A.(1T@7;9O6;
M'9-%T@+UAH8^)])H2WR95%+Z32M/DX789##@FL<?GH[;DN4*_6X=;&V^]ED=
MO*3.&Y.GW?9P@])2(<Z42' :H0:E@Y<-=+[!1];N%K%/[=>2]$OWEQ@-QYT+
MW_\$TR+HB+L32TR0R#3"+S<(@1D\TX#C\>6]";I)[T%\Z+V# O^V?$@\^-1]
M]XFHJL[!KF)M,6?L%L2\G*0)C U:0S37<OOE.L\W@=A! \LZW$%\-;5IM#-4
ME.!^*E/M4D O!?^J9+#X;>%5:#(C[G5H<4WKA@I*W$!J+2OO/4KJ>G(]!P(,
M'4LC..&!EC"%9L0J[TB.2C@N4T!$;:GOP2?OSSK;2?:#-@378F+V%(C_>@\(
M%S:#%XKH;,H%BC/ENCT3,-88Z:+,O$G^0S,-WO_D[U"#6PNN0E.$VSXP;R8C
MM M'H\N9"37O ^,AJ!C1<8>(ISTH3IR0AJ AGZ0,07E5):OE252':"*UKXX*
M^=AS+(L&3PW U.RM]0#-"_?4VEU;RSS86=0U]HH'H*0SJ8P6)$KC@2.E<\1K
MI+F6EN$;(#BO<S^T![TW[9U56>V;2+CEZIJWM]68I_T\&%Y/IS/,AU".%LN>
MGV#," ,R2<*UMT0J.;UM,L0FP90KG6'%DO&V.G[6_"-?H.'\]HH9U)=JA9*[
MRTD8W6=UD$;J[!@!6B:@Z4#Q/'- M&5:4J:9:A0,V?QM?XCCH,_^'41>H>_-
M/3ASVC<!5/7$7T;T0J?^+GI:K_,=A%SCK'\$3!G%(BM.#KJ<N.F542S46$(C
M)&-I3C%7247;D]:?._.K*GT3V;9\TO\Z^ +#?@'ST7^#X>+XH9%I:U ;TD0@
M,KJ ZPN1&"NXQ#4;3TV#0WWUTU_@_-Y-Y(-6Y=7B<3VMP)K56,V!.)JX%R(0
M0Y4@D@53[ :T33Q7RG.@?+DF?G5)V_V'?L_ZVEXZ%7;5M=5.;[Y=X2.F.XL/
M00-(39B,N+- $L1':TC(I:F,C=2J*O.J&V [9.NK;=54Z$FW%F(!.']-FD"L
M::,UP/@R5EOK^FW*GQV5L\]=Z!Y4GHQ6RN >"3H169HXAXQ&#K4.?/)HY,!^
MBV%K\^<9^^\UT&<3G52@S9M)=SHF'=$MOCR]OAFB/30]IQ=-GB,3H')&Q3J)
M)RSUQ%DA"(04/(\J)5NEG7(C=/LW9%K7ZZ"V4EJV3L]\& S+S[_=+AVQOIL,
M4?*3(92ONU_+5[=8G;?X"$VTHZ77E$7/BB5)6%8Z.IZ2$$UZ,FSZN8=#C>I2
MKQ%N&.3Q'WX*;/'E6_@"O<$4^O%@=$MER"Z9K(%0+M#1XNA]!Q"&I(#V'35H
MQN<JO7<;(SP<(M553K6&47?SL@:SJ=+3PUDQE93FF5 !I7VP]L1:JH@* 1@R
MW053I5?<$Y@.V9UJ2Q45>L&L@;:(,S0 5].!>A+=R[A.K>FR&4=V4$2%D^EI
MD#HDE5Q 5%;BL1E5QE?$)F*%%%)J0PVM-9Y[WRQYQD%Z&9)L(O\*Y)A.KO@P
MZ \>MAHY^7J#4EODB;',0.&BB=? $&/@Q L52'0N:*=1P5#EZK0)N!>9--N6
M/I=KCMI61H5K]3<>;;0(EY\!'KXB :)6-$N27)GU&GD9<L)0#LDI")XZ6Z>5
M[3I AVR;M**$"HW&5N%:W HW0%;3*ED/[65,DG94V( 7.\B_1@AN/<+$L]6,
M,\)HC.AZ&4I<B)8(G;W*WM($50KH]\V,9\R0?1-C$['7,D"F-=>W4]92HM%8
M080(FL@R(<<RW!T=2Z"BR)%"KF9MW$>R?].B+36MLBNVEG'+51>WAM-EA+X?
M=@=3<F=FA4Y<$EPCQ].P=#GS-!!KF+>*)J9-DSOC1M47*Q$<HKG0CKA;["@Y
M!33'\7M_= ,15PUI,7BK :BV"QK7HME_>6,+FAK4$G/+M7/KP:ED)6YI@ACJ
MBOLD(@F!E5:G )%9EYUOLOF_1MT_412Y+]5O(MU**G\W&$+TMS/Q0I(2!*-E
MHJXO31;04T8/FG@)'CW=;+UK<AFRD;X?0MAO^5U+NEFA[1T$V_()?SP;B]K]
M B<Y0QQ_!(27SO-1&MS<6K/91840<7VVM-87SA('&HCWTG.;E."VR0#21HIO
M NA0S__6E=%B4^$F^!:'5@.$;=L&S:#MWU!H7Z4;\&4'?;1\HC1$*H.WS'A.
M4@1TG*2BQ%I\>ZRTG(O@ 5=R"(QYPKQX#8391 U[)LI=^Z>%=\S1+78J$<5"
M235@C 3<?(F6QID<N=2Q27/[=LZF)7#[-5=J*'>3PVD7S:RU:EH?H7QQ\O>3
M#[^?7)P<G__ZX;1,%'Z(H=%XTA4/:6D&Z7/PE@:-6B]\4MIKI;GTD"V:HE$R
M9;W-W"76>1II&^*;FCS;S'A=^ZAJHEP%=7G*;@HTH,FMD;F2%DM-:0I>QT!S
M-C&M$.ACU&V(=?O9N>N?54VP36;BRB"\D0*\H4RR@)(UD@JM<9.@FJ6P0K*[
MS;]=JJ:^@)O!<'91>UL-?7;7G Z=-CP]+6$FQ5)AAX=I+JV+'7=&A BJSK5Y
M$W U!E>"#9GJK @%!F5SSG@**$Y 49N3XQR/B2:%6R\]N+*:DIM,K-Q$B"TG
M.L\Q' ]Z/3R+<96#?#Q ZS)-LQ$&_=GIW&%)0U+)ETD3Z(FR&(AUHK3Q0@-2
M"Q6R80W4W.S3#DSK%43<<C7M#,$@O^GV\,>?WDUZO6\7,(+A%^C(S)B)N&II
M(B/2)4'0%E-$)J"122HM;:+Y)S[BP-3=EC!;S#1N-O@RF*QSB)* $9Y(SH&$
MC%BS22H:[ZAH5H/[>@:+OL2FOJ-@*[3$..KU!G^4*^9W@^';P22,\Z3W&.4%
M;D\HE3_\,'5B-"8 1U$X#27NR(EW3I.4/04G0:5& ?J-C9B-D1X0E?:CK0KU
MO<T =] )$C$K2903Z,5S*PF:.)90](>BI#J85&5X8#-X^R=293UOQ:J-E%0A
M+Z@9RMD!>]J/P]*E_RW,_NQ8ZG _%9&(P 6>K1%W6<T3"<89FD)VWE49I;$+
MZ#]IUY)"*Y1E-</^CV%W#.<YCSI.4&&B$H1-VZM!L=]]B 2_Y0U' _[10(9]
M\N\6YY^4VUYM+V:<=9BS+FE\#;('F#D.(=I &(^1@LC 3)6PTC:GYQ:1M?@9
MTJ2'"GG"O'KS;?[#V=UXIIKQ7-I'!R^)E#X0[\M@W,!#"68['JI4[&^!M?80
MC;W9IK7U]-*3-&[7^62KU,Q]SLDS0KG'<RDA37QDCB20-J/\!(4JENRK:B^]
M-TILU&IZ$]54;S7<!,P/W6IZ(VT]V7-X&U%7UW_B:,'RJ$@.TI3>;XX$QR2)
M0G*J/42V'#/_;O2^4ZOI]M2^B81?L-6T$S++9$V)[&LBA0=B==;HS3"F>%:>
MFR53Y7MO-;V18K9L-;V)5"O4Q*)E/"VQ65![,5XCZX3_5P0DKE="ENBO@B%&
M*!9=C"RY6F&N%7"^1QZT*."Z'89G XVHD3JA)2V0B[A"HXE74I&0A(K20C!*
M5-GD7[;#^(N9?SN(O\9LD4<-7YL ^@&[C6^DIV<;3V\CY+UT&Y?>*)U+'$F8
MC)L3"R3@>80XC8\Y,"J63_KO2NL;=AMO5^F;R+9E8^\W\+WQY^B'<-H?389W
M_;.%#"[0,@FXI+]*BT9M<,K@B42#IDXKFYMT_5OW_-?0P7HCL0]:EEG+R4[K
MNJ#SG!P:#R0ZQ?%4@D!LN02S @T*JX(,K,E8W=?;-7Y;';8@KY;?Q.->=QE-
M<(DQJ3(1O&32&.J)Y282(V54PJ8D8Q/M/7[R]ZRY'>74=N[1@V[VW$GF312S
M&>K202(NX]D0&:<J)Q.;3;%^=;W^M]75]M)I\3YJZGU?+ESLVP:K(*QU1D]K
M@TJ!:JE Y 8=..VM<* D^$93LAX]^7M6V(YR:C$'I]33?!P.TB2.SX?S.,FL
M;XSQ)I61JM)D-+V" SQ?I2/*I0B>:Y-$D\OH1M5,JP <NC_:BN!;?'WOX1F5
MAK?SD-FB#U0#4&T7TJY%L__:V=T5]5CK+4FYY:K']>"H\EREY$C24 ;S(<F#
MT(YD%9B.X++(K97>[UGU3Q3![DGSFPBW98/X'0#N:Z,9GD6W2$IY@L")BSZ5
M(8R,^, \<3KE1*76031)V5_QZ/T6HK8D\$%[TFK9'SWV-]UR59;F4!+('((%
MDE,LQY%%**7=N9!:)L'P+,JQ@>*6'ON]*VT7*;6\OTX'J<_FY09G?::&%)^7
M2*]<B6UYPKP+PCH5A6QM/[W]U!_!JMI.Q"W;U%,0<[HU@=&V\73O\_=O+FVI
M@64=[B"^&F_M(OJ8(3'F&8DAH<\7T?&S,FEBG;24@U&2MM9KK+H6G[!\VE7B
M)E)K67GO45+7D^O%WJ]R-ME3XJP$7 PP/*=5("Y;RC+G-,<F_6(;J>_!)^_W
M$-U:]H,V!-=R:[#W_NL](!QM;&U+&K\P>#B4?N;6*D%4X&AJ48.K:M(RO)D&
M[W_R=ZC!K06W]AULO0W*R='%A],/OUY^/+FX_.WHXN0A@D9])AX]HJ7V$D]#
M6^HJ$9Q <S*E[")(F?%-T9DI;VQFT49J.D^AW%YL9^>7MT_<N@'*$P]K693/
MP5T2*ECM%2]SI:F5!K<:+JBCC@N>/#BJ.\V0MR/>[1NA//6TB@)NT@R%!D\-
MMT%3)J7SR2OF=?21XI$?3!8K);P"^S:=9BZO+GX_OL+?_O#KT?'5Z=]/KTY/
M+K<0[[HGM=9EI@'0);%FZ7$3<#K1#!)XLBPS)J0U#I0(T74:8&Y-I#LT1GKJ
M>77%VV!W*+5<EC/ADA02OT*?,((-2ODLM1-^G9#;Z9.T\M$?_' X;4VV2]>D
M9D^N*_ZG%_*X5Y5*B2O-C):2:VLA>$8U;MHV:IW7*>+1A^R63G6!:QQ.XG@R
M[/8_E?E\1_TT;YQQ=EN^)%U(R>=,G+*E)7YPQ%)0).64DG)2P')LLYT,JR;@
M=LTG>_@9G_WP$XPZJ!41@E1$:1J(=,(1QZW%KVC C3X)56>D\2HP^[^T;9T3
MRWEF.\N\0FKY7;CM ;KITGLE$#H=7CD/LX$R3$,FD2M&9(B ?IWA1"6/+S0/
M2>HZQ6C-,>ZK_+$Z5VKIY;64/3Y851G+.HT?@=!:.2$)9($O \V1^.@M4>"<
M@1"XAR93.G;;@!9H7CX"WK+JG]J.ME)!A3SG1Z#F%SI-8-7,=5^#ZV4RWEO0
MW'-<V$'L>V0%LQ39SC,QTN72Z,P2G\M, ^6BR\XI1ZO,!-PK&Y[)A-\?&3:1
M=LNI!Z?]+]U/95X[?!P./@W](E#IA(V,2DN$3Y3(9$7IURR)UIQ"!B:Y, UN
ML=<\_H5MT&U%/VA7;A6LSB?,IUDU1_;:\1@)]1Z/M2P4\0K_0[D%U)V*1E09
M&OP,KA_*(MA1+14JX*[P]Y9$L"C2:@"LIG6P%MDKL ]VU>.@IA(JV KK >H<
MG,M<D^Q*-1"7E'C-).(5S.<2>=556DWNF1V;V M[(\<FLJ] BK+.\WSI>[=9
M]"[94B/.B70,G7/J$K%H)I%LN9%!:% ^UB##(R3[-S):TM*@31'7"&W!M"GR
MK]"'H>\ARX_2-<H65SV;"#*;>KX JXUE%((B@BN%8/'<M"($DI'N2OH(SE9I
MJ;<1RD/A2CW5["\;8<U%Q<<A7/FO#P069Z'>UN]YGO^HNA<_&RYU.0LBFX3\
MB2(P*5FFUM.(!,+_<1\9K+V2>_Y3]W UQ+3B*61-7)2YU'0Y8KU/2$GI'%K9
MR,@J,Z3W<35T"5_PK>Q'F'H5K"-1*4Z5=*X@)7H4 GU/9W$O!Q^\\E)[6<49
M6\+Q2B^$-F'"XVUP>TE7.#"G+7 >+7K44<E1\!EW75.Z'RD32. A$OR6PVTY
MN^"J1-G6X#E (K0A^=IAURFB<E27.>^GUS>^.RP708M[3"JI=!37RSPM5:E>
MD9 %$"$$=3*IK%*5KK$;8#Q XM324(7HS<K;;S02HU-@"45"(\%9J8\+EC!A
M-1?>0G#U+_Q^%'IL(?,*7:@W"69&SDU2CJ*]3XL':2+N?QH5JF*VR60O4Y4^
M^]]KQL%.QD@EO;SNC(-4)EO;TJ1$2SQA+0O$L8@"3%I8'IC@M'[*T_>4<;"1
MZAME'&RB@CW>+3>!]8-G'&RDN8:7S-N(?8^LH"E 8LH0<!E=-,TC09O*DTP9
MZ$@YM['^S>2KS#BH089-I+VOC ,5DN-:$ZW*3;S(@H20:"F-HB6%&;A<2H+\
M/C,.-A)]DXR##>2V-K:QKR#N41QWO^ 'P&CP\$@\Z_K0[4U_TGHX=Y,/K1O8
MW7KYRZ4M.7'/?50Z:RDA>L/!1^NC83J)N#;$N\GG[R'8&Z)WQBI&+(_X*@C*
MB8V!DBBXB3HPM(BJ7 WMO0Y@_O"+0:_W;C$>2?J,VP!';"6/S#B#KZV5!#2W
M@H5HS7+7T0IK?XSKE?KJFS#ER3-P1TW43ME:S)A5AD5/@R0Q3HL7G,25NTBT
MP^W.\<2EJE(1L K,"U-B5XTU8,-&XJX>#IY'DV+2GG)0A 7#B.0(##U#31@3
M5"GA8XQ[*))Z%1&\FA381MP5@K@?_;=I5TM<WP-X)?*4N:*4F,!+_^W,2-"*
M$LB!&H&&'U*T!@W6 3HL*K0B]@JQW%5K7C=ATR5F$\>CT;LR89,E8JD6),7,
MO='%-:B2?-<<XF%1II)J6FQ^]>11%QSW028@P!@0F8(G7GA-IA?AS"F#%M7+
M6!9U;SP2]0XLERC\:8= 34E0T1.E3 !C5%"R2=.A'^;&8Q>+NY9>7N6-QXI,
M7\6E9"Q9@DYZL25<(J[4'RN9;(ZX,I&J3! Y@"J+C>BP897%)FK9:_Y\$V!_
M5EELI\?&B?3;*&&O+(DN9\L@E8(R-%I4XL0IKXAQ*@:IO'6\2FKD]U5E48<<
MF\B^ BE.KF]Z@V\ MWF-\]B_-2GA:M%ZG=JQU#/B&%B"OJKB.20C197!=6OP
MO*8L^HTT-FA?W!4BA>]\+#'Z;\=HZN!"YZ!DIB U]WA.0KE/D@[A45UF-#JM
M(@"-58+H*]$<"@-V%_7^ZB7>_'YY^N'D\O+H^#]^/[T\O3H]_[!-![>5CVGI
M.NQYB$L77,E3[FDIIW=*"J V<&9MICQ(IZSVG>?0MB/&[:\BGWI:1:$V:C=H
MK4]< U."22.H3R8*B> ],(I[V$K9MG,KN!BY<Q3_9](=+=8]]S@3,. B"&+Q
M_"8R1D<L:$>H8<X+S52HTZ/F*5"[;MF+9Q\/KD.W/VVQ?CQ 0P<WA.E?KO!X
M&648#B&QCC!)9)%*\I<R*(!LB17&$^T-C5& $[3*:;X)R/UO\*UQ9GF/KZ:;
M"D?_KX-!^J/;ZTV%@(#>SK)*IF''CL=]!VPRA#.% $7,)*"=0C3%]>=@+)Y9
M-7CS%*@#XDEKLJ_@&*Q8],?),'[V(_@X++-R>M-GX+<7JR@EH'$,Z<I_?0ME
MR$<W].#H>C#ICSN2&LMI]H0GAR1W.1*KDB-:"Z,==2'9*E>.K:[B@)CW<MIM
M\8:SY*ZMV&HO( X^];O_"^DT07_<S=T2_YM6V(P6;YKOIWN)2?BSR36D=T6?
M<-;]@O^R/_;]3V6)(]RA?5:N=%5W!M<H <UTRXPFR3B:>6+)!O>,T;8GJ ?
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MA%1..!Z%$57F.[T 2YYQ<UZ&))O(OV6S8IH9/4-71OOT1XM1I-1Q2,P$HHQ
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MSW:^+=A@)4</5C*<0+I7+MRA*E@!CA,6@BA] #4)QF:BI &@RFC!JQ2$M;6
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MP6(41F1[G_9W[X-_59>-;\8_,)-?_WIRJ8B+OUGO#WES5=7AC',9D8Y>Z2F
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MZ7^G?"%E=*FVQ:8*_CK9T64MP%BI8^$QB-PD\[Q?-#S@ NP+#'V4/2 (E@T
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M%&%(TI%_<LT.?71_9[-#'\4-?"E^6M %72^&3PDGY!!,+[N@4V9>)U 4NI-
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MX/KG#*K$>X5<TZ..CB=ID0X.I41*(2D5/"=G.F2I^0J,]\B[=6*88O0P69*
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MD$6J RYKY&PL@^2+8]7W]:G3-N_R92=B].$5.Z"C>/?@6IM*<A()BBE@%:B
MYT5"HFB6"X->\\'ZB(]L</?NL<$P:AVPWN/^L;5=A/KMAG;WLE2GR<W;J'G@
M9M:[A8M*B"R, HFJ/@-*.MF,0#!.,N9\U")WJ;LX1MOW'MH]O.G[:+>1R==F
M2W.?6$%TP"VKLZ5+@:@I:G$V*+K@K)%NL#[TXQ[:W<LV#P_M[J/8!FG@?UWZ
M&=7'7()9ID1+\!(*BLJT;R/$8B2Y%])XI;/2MLE0DG5!'O-]/HAR&Y3779?G
M$LU=)&J9U;LMTF%R>;N9ZAZ[[Z#G!EF[#9)9X90V=.)@JD5Z!A&B"AD\BRQZ
MQ91IO^$/F*%K;?@^ZFU!%#:=Y.E%&T,,D_^\+X7"R65;\)O7?[S_>'D)Y:1"
M]!@K?5FN#U$9@D6*+FT1]<U+<]7DV;>3=/L/['<UX^T)= /;8&#&DU_D.W33
M,>$" Y[KD+12+ 3N$@@A V>I+I0-Y>8=G YLJ-!]._4-6/"\3N#218P3I0#K
M98$[V*.V45]#"K"4,:;@ C 7/:@:689$OV@;N!0L<"L&8R Z#@JP(8S81VM-
M*<!RCD8QPZ&$.KK,"O(G!(_ 7>3!.HKUO![*?$=" =9+]W=2@/517%,*L"13
M]+E.FQ.6U[M?@RO>UU]R4<HC#UVJ_A\3!=C6%MQ:<0U\WS_"69@D_/05\>9(
M#F\#>?,J0TY:DXMO"CA'JQ.>92^=K:Q9+=S=NP1ZS [0H,INT,*S2:[5,- .
MDK7,?=PMVF%R(,.8L ,N=M#_GHZ)55V_DJZD0#$9JT/ DD@0I$$PNA1O;<9;
M\Q0?)S(>R)'L&QA]U-XF9W(UNV45$F@C* QWD%4EI4VA@"\)(4658W R&=LJ
M0;(FROZS(4,9ZG969!<M[V_XT2:^K.LZV8'QLO-'-R07>W@IZPR$TF8IK"+'
MKHZYHB- &$5_&9)5J)+:2#"V\5N&)QDS6I)8W(.7Y,:HX 5$3N&C<TA2"N-+
M;K)/&Y",+5OH\XJH]>=::SV+MD@3#023+*AL&03-"UAO%&=,>^.:]&G<*]5Q
M-*OWP<"F=JUAE-[@K?9>X9Y?\,A<T,;,+D8<7/SOR-)QDPJ=J)*E7$D]$ +G
M&7QV%.2IP@IKTLJQI;PGCJ*!#-6TI/\B',Q*)32VMJ092>%@(K@'5@ S#R5Q
MIM"7MH?IP=D.=D'!+NH\%K:#.SU_Y672P3O@BMP_%4. H+P&G;3R6?'4Z-7X
MV%,HO8S<-8721]G[#9"[2/:40NEKPNZ1\C;ZWR]"6.1&Q%(@LXR@1(Y IZ@&
M5HR1,3(;99?GCZ-'QK8IE$; Z*/V_:10$KIB,Y>0@Z:KE%D/3BL%'KWQ/J+.
M;3@ECSR%TLM0#Z=0^FBY08BR)<,&$YYB*^>!XY+FRT2(SD>P3@KMI17*N[:>
MYF-D1]K%U]B#H1HTJ-_-SM!%L"=VI$'-VYGI9AO;[)4=26@6<GWCIK"[OGL:
M#CYA@A($;2^32RA-2$1/@AVI#6;ZF*0!5NX@;"%9G!.E=NS7L@A5RX+I?@9G
MR5=+UE@9FSBSQ\^.T\M>W=AQ^BC[L*]!%T3=5\UAP[X'W?'A#5^$NBQG[4TH
M&"T2BRHS8Q6Z4$=12:\=*B90L\T3?^[XGN%?A:2-WDD>0%B707$6"$3D* 7'
M2PI.26\?R^B9)4O\N^EDNB++O5#BR[^_TRF/(YL3CQHSH!,436K:+EZ5.EG>
M>.FS=58T";+N%^LX,OI]4+!^1 VH]@91U_.OM73O]633!(N+MXBJ@=>3FP\1
M?!1+Y $MA\A< I6,@V -@D4*%7/!Q%*31\0MY7W\,-J'H9H^#%WC?O\UF D7
M(T;GO>#( 'VER(S%0^0Q@T,K,$=,T3:BX7] LL>/F6&5WY0U[B(MH977*<<
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MS3V=J<4S12>JB[;)6(YMA#TU1#4WV :4[92 OD\E%]T4W!3%0N3 LE"54R5
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M37Z@5W7$F($HK0*=Z7)TF4L6FQ <;)!E_TF! :QT7_7S%BK>)V5H8>0,Z:S
MF$C"A<#!16WKD-O$#"O"AB;[_U@H0]L["X.H?L#6T Y<=5TD>V+][&O"[N2.
MV^A_OZR?7$KIN5&5J8>BH, LA5=)D"I#"MRKC+$)O<EC8?UL!(P^:F\ B&<I
MU:+"^8?PLQZ+SR:9_F9VCODV-V54(E5Z4Y 1#2CM'82T3+1D[ID-RJK4 B#=
M13PJ=M!>AIWNQ2H#/TI<E=!?L.(*9^O$/) F6'*KZVSUJ!(D'4L4"556@SU&
MW/CFT_$O=E/J@+0!-P19\59W$&7H)X<U&?;_T+"#-3;9= =5#IQC7A?)B% R
M01:$M@+J('((7"/PXJ3%J)/$+BPSQV/5>YX0VABUCP8'-&8]C?Y\&^;S_YJ2
M-OY%X>[Y;%4QYXTOTKE*3:/H#.+90RAT$$GF?*2K*?#U&6@;:_'O^/C]O@;L
MI.[IL+HZ<N;M7_FN:2&_X?S;^5DE15M2CM>?T7U5=\D/?#.=SU]/Z,OVS?J[
M@X2'Y <>2K%K3,)>F!!3P%QL427;J+G+ 8MAV3KC\W9,PCL(VYIS6)++&HVG
M2P$=!Y6M@6B% <$9(GI1K$T=SJ6]< [?J[H+M54%OL/%^_(Y_#U20EB7K888
M.9(_KCQ%B"*"$=(*KAP&U80.IZ><Q]A)UP<6&R*F9F9JD+R]3\8_L$QG=$^D
M,[JIQF5\$57^$MV'D.J)0<JI$UTM%Q!9SG01*B,$Q7ZZ3<7?#C*?&MKV9;X&
M"9]UP6HS<X?-\_Q\-J.[Y(*BX6HM)2F)Q2-$KS(H"FO!>?+$2DFRN$A;235Y
M91IR$:>&S8,9N$%W1+>CW,IBO/20@R$9<RS@6<R W)M8C/#8!H2_XS4[N$$&
MK)A=TA2%OY^?+^9ADO]K&N?/TF):R&FTZWMB6CXM9J&ZX/0?O"P%TV)>5?GL
M_?/7B^G'Z@9/,+\,L\J?-Q]I%A2%F0FRBJS.'O7@->E.LR*X<<$&[SOXJTV$
M.Q6$'8?U&A1O]?9,T0F7#8,Z1@Y434J%2/Z!\L8'+0(Z;/(.MU, ,5R4>#F3
M,R*6.@""4QQ<1ZL5<$D(T-Y)'9DORK(=(\0C8Y'8=L\,J\M#LTATJ^!RSB=:
M57U1<9%T92Q$F16$7"0*+[.438;B/L*:V%[&[U43V\<(>ZM]["+44TUL7^MU
M*H+<1O5[PX5TA'61.81:Z:DR=^!YRI4 @C,=D7R()B-M'TM-[/!PZ*/Q-G4M
M*V_F,_F*\[.+0I[\?\[GBV^_6CJCL9A%5'3K+@E+?81(#A:(R&6*WI826V=K
M[Q'O6"IG>]GR[L3L4(9HD(^])B4YN'].9AC.*F/ZZ\D/O)#S'Z2(ZO]>RDLQ
MA2M*4&0KHJOWJ@"?^#+:Y<EH0R%'DR1L7T%/#$+#&Z?MV4/RKF2K>;@7.!]_
MF2Q#K-G_.J=5E,KK]SS,O[XZF_[U3\Q?KNJZ-...UD%1 &8-JAA:C64&,/DD
M$PN!N]9AX-;"GQ[H]F#$ =.G-318QO#K=_T5DY)#72]Z*W+EL94*G*FSKRHF
MM%&!K<]TWQA=W_,5CQD!0VJOP3BY#GF:2T%#,=Q:.@:Y)0TH[RP$K1F41/+K
MPC':)F%R9PD?,TK:FN/./&2;"J/W_W[W\N.G?[[^\.S=B^?OWWYX^>[3L\^O
MW[_[\.;9NT_;%@7=_Z%#UO'T$'^M]";7 3<\"XV.*]3*,:13F0R29:TFBZ-^
M*VFA_DVSZ <RPNUI\VU-L6DI:P9AS%H=A+?>!\4T]RDQH4TLSI--O.]@D-NK
M:F&6EV2!Z4_$,,GOZ"RY_-.+\0P3G=_S9:/@+X[YBY%,\QW+[-H)M#<(#*>V
M->"DK+CV7+(LHTK&1Q>R%\X:PI/63G4 SDZR[9COKNG;/\*\CE/Y]ITNCXLH
M>3:K_)<UPOGCYZ]_\B'\K'_U[*\PR[\>$&QTBJ+D##R:4.E-R>LL0D%RKC:"
MD"K:I+AV%WT7-_=Y)4T/:4%^^)MQJ8GPI96^+VMNGDTN[N3EU\W_)+1<C/+,
MM\3]<!8FI,+LLQ,F0G"J,GF'!%&@A4AHXE((QG27=]XA93H H]I^H7C=ZSZ8
M,5NPNFRKQN4O_Z(3]FHB#A_IY+-1R,!H\A]5*A*\+ A,1*N%R"KQ-B1_ R[B
MMT'RP1'0@GMRV[6\.Z\VNGR?O#YZV](.=*1 $+:R)V0*H(/) 7A.G (N'[R/
M1P7INU;RA.N]8J$%!_.V"[K()KR>S!>S\_J7\^4%]?EKF%S>6?^@CUC,7T\N
M=C&MTXJ4C 'N:CK09@7>2@:V),Q,D=[U<;EH/1?XM!6. 3D-<HYK=2;WK7A^
MUY(OZE$RPV*06T"117WGDQ"9UQ"\0(S("A=-BG4'6T'KBK%C0?9!+'XLY6<7
MXJ_8Q$VT,I1HH<C*_&$+ ^>%A\P2YX+7#=CF*>ZZ%/LN+SLP$-:S[%L;Y!#.
M\)V*^+6,2:Y1ZKOP;457WF5-3<<]-%C480K?=L!*W^M]7X9^+"#VB%)73EZ7
M:[N0HQLGH+-@E Y*1<>#:C-,^=& ]X$JO2/';A_[#LQQL4K.OYE.OGS&V;?7
MDSJU=_P#JX@OSQ;C[ZOB'RF%DD5!,3)=\G3ER("+S#QWHMBX%F1M3.)V_;XC
MC'F:6W;:V"P#IF.KC!]Q7HM?\^HE9Z.L+ZJLSTA5^5I5HK!.:BTR&$Y[C]2@
M(0I>Q\HHTE>)T:VSXFS$TM8"_.;@VH_A!CZHN@N]J@NA$!X#J4.S.I%.Y@S.
M60V<H6+.H F=#JR^W_N$K79F:I&D_/44=BD05]+XJ"())&1E_E/@,#G@(3EA
MF# 45[7I@EJ3Y#=&TC#6N3-C=X!JKW_C^,M7VA?/?N L?,%G\_GYMXN4Y)^D
MRO'D7^'L?#SY<CU-29NH85W+3@+MK:YE.+6MU;7(H".JS'3T22F)7B3KT2AK
M4 F)N4-=RTZR';RN1=+^2U@,';2"SMU0'X=BLI"EEKI(1RII0CM[N+J6G278
M^(:PAH+E#U_0#?@JC&<5 3A2(@5/"@9;%#E-*6OP6BBP)I'"A1:>'9>FMUOG
M$5Y7P^Z"P5ZI]H"C8ZJ\Z?DH][ BC$_>,2Y!<!M!(?F-$4L!Z9DM@3.9CZS&
M86@-/&VU1X&]8RH8NEK!-3?EY=_?*4;#_*]I[1X](T5]I+6.6"7QB\%"RJD&
M^3Q#C$S1$DWMK\K<Q2Z<Q?O;7MW7]K1Q#HR78RHSNF^)+\8_QIGBA>4"/4;/
M>61@I**8,ZD"KA@#!46MCA<LFBX4_,>Q(:ZO[&D['!0K+2J*AES@Q_'\/Z]F
MB*\I<)U1#+]<H AU3V<!EJ)E4!8+^.0TE)(3U]&A2<=_.VQ:V=-F."A6&E#$
M+:6/#R\P]MGM-9G-1[ZXP+4T(&*EM2\HP2548*PQ5J F[;>ARFJVI-\3_H='
M1X-Y=</5ECE$([R,(.E;0$E$B,)'NLT4L\PBIQW^5%9Z!%@^B,6/LZQ4%,^]
M(Q4&(2D<$8G"$6Y)K<)[6\M[&+:A$#JMLM)>0+BWK+2/01Y+15Z7-3V5E?8O
M*^V%E7V4YFUCZ,<"8KIM@L\Y0-%U;4YR<'5X I<8M>$I!-?F=G\TX.U55GIT
MV.UCWX&KM3[@K$QGWRZ&>)+8?Y(UYO\>+[Z^#;/_X&*YBH]8TX@_\/.GC_^8
MAK/+ @]3<E9161!!>E#1ASHDP4+4A3&;I QIK2MD8]G6U@(<81S4W/;3?1MN
MX(FI'ZNF+J8.FII:,!ZD7#[/B (.#4+B.G,9'?>E2Z5\IWF+5]_Z>SI[VRM^
MP$> *R$N0=A%C*&GJ5[[_OU/4MW2 NLVW$%] T]0O2Z.YEKF@!;"LH%=U+N5
M&P&L<)^*44*'+J'<<5CQGLFIPQJQC]8&-MY;TM2W\V\K1L>2M94V04V'@>**
M@U?*T/FB1':B9!2##;^]\<W[':&ZM>ZG0RANX*OT;?C[FB I,T5?J4$I+D"E
M2ON3>02?)8LEA^S98-?IC6]^A!;<6G%W[L$#E"DON<1#NJAB77)!_:K 7O(_
MM2Q)[OSE^V-6W$H=:Z7&W.B,R",:C\HA#P712R&2T%II%%VX%[O*<?"R8N=9
M28)\_^0*H1^9@H#&@I,JB,!\*.:XN%C>'$M9\?OSQ7P1)GD\^?)Q>G;V:CJK
M/QP9E&B#*X#1)%!&ITI1(L#(2/&=811='9="[UW.$4;7PV)ZZ"+A 5!Q3+7
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MHUN1_FA\$<X7%F4^+J*@K99YA!?*L'M@?Z/<=T;1,1&E=E_M98U?I,/85^+
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MJ:>!5?L*1C!.^.D+XJ^SIT0;H-13Z&((ES4U:2)YLK@4A"0*UYMQZ_W0YB%
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M'6:S"8EPCOFOX?S+<$PK?0UQ2",8?OVV'L-D,8;X8SP9)YA]@7KR63\>3NM
MTN*LI1ZO<!L">5J>&S*4>: 9*R,3018C"@^<=\F.Z!74^1#S-'K:<I)Y>"&*
M^Z;(Y2)4XC-AI.]FP[R*E[B8TA@_+R;+[/)+_9;,DL7IS55YX*^\&T(<CFC*
MBH'3MBA%^X:R63!=LZUC4)Q)0^Z;-SJXK(YD?[88W\NG]G,FQ!;B'W2&OV^:
MD@$5N-".$7A?TW!]+39/<N7)FV)]%$ET6%2??<I9R^7S&++?PI>#+@SN+_GI
MEM_I+K\AI>D-C.YM 6E"UO1PV=,B3Y=E:^:3&=(/:#+0![6KP7Q 0T@F.<_
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M$1N:F%G8\E,>M710$EL8\U.JL<LRR7X0-3&WD/)P,'GO(:=LY&%EQ&U,*2B
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M]^VINP%'4H_PB(^MWT71Z[7Z*#[%"%ZDM[N'-JK>-$L#;*$R?%61?0.:0O[
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MKC]9NTQP[:HVE5,]>90?;P$1"XHJZ\>O2&&((*.2<(;O+N(&"+FRD8BJ9)X
MN.5+GXTSG_X-V_[Y%M.%!U9MDY#.8<%WDWQOK-DR,&=5)DP;XF]/$4PDTXS%
MC;L^+OSX''AFQ"_KY"+ ?7R95UP057Z60L$"9^)IH8002.@:^L4$M=_OY0WV
M<?XY; V[75BS;$QP<(V!5='R?-UP+567;',4N4:^"AK9YZJ]VB08!^P#!8>]
M6,0L%"^>MO%*ZY5,N$/]R<TD&5GAB_E><_4R?WP-EL^BP)T<-K)ZI)F-F>3Q
M;/<5\RY]L8X6^_!L<"5;(%MSV_1RACUG<EA]G[^!B&*85 \8>[&'UW]=EH-S
MJJ MT::<SN9@VS2>.\GKG3I-+3TV29@"AK I^;HY%^Q%92C=!1+FGN+D_;:6
M_NI:YDOZ#565Q;IX<<1":$))$91GZ);6=ISY%1+<3"_0>=D\$T$0(4UW& ,]
MGC\ IXB#&#*DZ_J"R8V]P&AU<%[O]:_FB,&7 5UBR?*)*FF.4J-0L%#8M*%I
M"8%]ZQ6TA=WEL 1O.K>5XZT\2]L8Z!4/Z ],F\WUG<F;3L?NPX5AJH!UK@76
MLB6:"8EJY!3TR86%87P'E*^:,GSF,1F1IZ2?A%S2,<F(S0H QW:28XREAK6(
MN1]#S#MJ]9)#,8XOE?;%Z1!(5YQ.-_?2 W%C>2=K1V%WQ^57]PXD/#G;ZZ9M
MZ^AE<TTA!W2OQ4H)E<W,W68S6AF\2X[NZ?@Q9R6#KU0:?T[BQ9-5!ZSM?PP0
MB=Z@$^Z,1!I2IJ+$(8/>S@J[-28D;8F^E'XMK4,SKQA@4M5HX=+RCF!#(3_?
MLCIG82#;=N.4"M1L%EC7XDF$HK[H[6\P5I?",*%^2)#JAN@*S_*%N>Z,Y;Z)
M+,#5"6/\VE&R:8)B1G-7:D'/TD&GD\S0)8\&0!;Z/I"90GB1GBDXV;'*UC'V
M)F"+:W]_K87S"3#[W"GZ\N7@_L\B3+X0^KHP8H=\U9F(BCFK2],].:WOR!*X
MNSU6-G,X,&)%!<$HBG%"N&R_Y9?-+*Q#E4JG004?\W5W;$]FP/?7FS:Y5M8U
MPIS+)P!W\<"FWQ83YA+"370U;@EL_;;Q0/LK!EGTT@[1HBHN(*FZ^/8 Y\%J
M>P]/M7W*IOSUD3Q-CT"9_8/5#KE"7(F_7S8 M@0T_].2G1H!8)$BTBQ_4VB$
M=3O8J'R+ VO^8AHC?8EX8O91=^R!Q2*OVT.1ZT[S"5BFO*>"DJMJM<A;W'M$
M:9]T6H=K_DR9O-VD/-#<0/Y"4EY4;5)S4J]@G^QA&^IFNJB"),,1L9CX0A76
MCZM<K8N0^.1=@O:>D5R5&]M>J0RMEDP*I6J2TT_C>(DH.  1!LZCNG\%,0;5
M#:H;TFHXPMM'7G?'GF^/-6VK+V.$B1AQZ39K?!=^/.+ B0RG@%*D*$1(]D6/
M7 _UG>,BQ2X1VB@Y+M=47O06CD:J8*UWK.@6NC+=C47]IZ$T81))&XN5# F"
MUUV82O(V'=+37]H:C5VZ)'8<LBD'!WT>W+CP"3W,&I\QYA,@<^S2@90<4ALE
M96%3Z&;1 !E&/#1IGT/H0NL+YA/CZ$\BR2+71\0M:X>>3>NZ+?BD9SBY$J_%
MO<^6/V7:W."_DO[N9]PZ$J[ M![]JY*@/ORUMC?AP$J=(-C*(RFGR/)[[36C
MZ>-08P 4;3]VZO3B'$X]5'4#@,_@>; .+@JFU[T3;HE0CQY8.G2.0Z/5T%5?
M5VH$^@8*HMTI#=>YOO?(E:.#NLTS$::<EFE'4Z?KW0QGI7@)8H[RSC@Y::\$
M[ -G*U^4:%XS:M<U'F_/*0V,>'- 1A 6E9:5/DL[X[^%CF/O2$)3$>0IY35Q
M30((47*>S8BW1O!FN\OUUC3+O6+.@J4N.O>KO$ AP4?6'_S+GXTT3 )T]M$K
M5%3>;KQ:"-^OE7VQK3IYY*PEHS))[QR#I/E3<TYN>$N+Y>6CVL##&(4"ROO
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MNSL@_E#&;M]E/+R?F#?;4)K\8.10:G1'K7840;S04M7US%)M]LHE24F]K$%
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MJ^833=NQC)#CYH2;M4;-WQ\?>3$^ :3G1*I/P%B4U0S1Q_SE7)O'C;*.OB=
M<^$?<+Z55[7*G-WNM9N?.<0\1NZ$#6VXC/SSE%&4>+5;KAXC-!/%!V,<Y"X+
M+O""%<D]Q6H_>]:!.Y]@0?T7?.G+F:^1PZU.-M>+<=%-V<B2"B<NA59YEHP/
M.;@ZXFN#WBS$JGRANFZ.A,S]S+SX#_OXVY$SLFWW<7L09\AW!/[VE@J,:&Q5
M059#F<@#*#K[0?QX=_+4\[![]ASMW:AB[5_-3K,'-<Y32:$3&1]9-OM&892C
MW6CX:;H]5+/0^^E4,8O)'5K[]N #O@JX-G*MIE%2%H^R@;8@!#\.MB-;47R+
MKD,M)W9Y3(;G0@;", E.>N23JZ VS_P[[&]\KC0G3^3#+LJ)NC6#0^P<<K?5
M@Q?,Z8Q$#.*R!K("!'P9:3FY5^+&#)OWB)!^>>A,:N^D,F29\;;PRMA9QM6P
M.I/[(<L[+I4/&Y@YNMNXVEM -W $1;6.8IM]K(+,8Y\VX>,[HX.VU008I@U/
M>C+K79L3>S(X:IV*W]5?QLTUJ2\[% J:L]!6TD=]+-77#[?S9[=JD2F'DN=$
M(,QR)FQ@"_W^X532JT5.G@S^Z!O7WDZO^Q, -Q+X\!72<?DFXR%_ [/MCMS'
M$342[7KQI^L^5<OQ2*"O$4;B95BA-J2+.I7K36W4.'Z\3! 9*,R4_&+C=@R<
MHN'6VWU[KLE>$-532+NPDZ#'/A)'$)/&BA"(FW 9_WI093XCD+QY(V;M @G6
MYNUZU\QKJYEBB^*V9KQ&,OU!_!:)%3AR(^Y#GR]Y[<?M_L5SHF;%YAXVBV6(
MNE0,]&1Q9$93)7%^<O*DM?3EV35UX3,CV"L-0=#VXF@P4E.(, I<SZM*&$#Z
MOWN3[:\,Z].&E9&CPYAK>]_TF+CMO,LJ42-TTD&SJ_R Y/XQKE:IU:Z+#$-0
M40CIM]?'2H^UGX"69K_,CUQ$.8\BS:DKK<Q.]'5]7?ATWWI\";.*,)9^?[$'
MEJ%Z[8!(M$V+=\[6N)D9)Q6!EKIBB>LLZK J#UW) 60-%1BYLJZ+D]O4$.WI
MCJ9NHG#2CP>KIL0"1U9$UF:ON$0$[[;<K:;Y):M8UJZT%0NS@8/CM4XD^<O7
M8IT4AA]9DO#\P+Y@XAGM1]SV*78B@MT93>TDR/E8]OBAK3(X0*):3.#]1@G'
MFDH*"J\0>1 V<#Y07/P,L?A+M'=9W9GYQH7*:^MU)>$" <*R;V;9HWQJL3NX
MRA"?B%+M'1Z?-8BA,$><W:KG(@NWUI#>4I_&* 0'O5T1>0=$FQ"G/-MYY+[J
M[6YV?#I:V%6^,YLT,W;MHR4%H3!/6LVI37"L4-1FPF\8LC]S !W6JH5?QW1-
MZ%P'7R2!"M5E;:P>@AS:T9O;DN7%(XWZ3U-\!O:(Z>MB"=6X>[ :K\/C^_,L
M9HZ^2!9K];O #(X6#ONB$TML\$+$1-\AZ(/&U4LO%(3 )HH+"Q3E90UH83@D
M(OND4?D.0#\D'('Y'$#S .D*K]K!#Q?'O(2X)8O%>^*)EI7.+VKP"(7:ONY3
M#>L'<?@I8E>!E",/H)U4-9UO[^&FV>IKFK0^[[,C:%FI1K4.^Q=(*2J?^@CY
M2]I'*H!]\<(,-="9$'/\3&C<+\"QWE$\K2&:Q_Y395X&[HZYP_:^L(&V3L6X
ML S)U'8DL"C24!]Q]-*X"*>+DG3U?EAYOUU^9_/V\"!/JXG124.E=H6^C]'.
M;> 5)3RB*'E-$[@H&T4JKEN1+1([2*F;)HG/ ]0OT)EF\R%9M5I;C%PY!:HH
MB2/J&QF9 Q-BX=0KN%_B;F9^M8.>6<AN(MY0HNWU4X837QYGVCVE7VE_FQDJ
MQOD<*9N"2!>*4T]CA-!@OLN'MVK &,864>XHZ7*'$L16M&K5B/S35O$+O5_7
M"^6^[2.&P_EH(7[2D4/>/:Z*;(TD;C6'LF,^!G S%V+A3S]+CU-!>#<6?H5K
MR]D?/ BC%G:K]=%2=C;S@]*MF]],#/Q695 S)<G5\$HU%BV;51)CPME6>1F#
MK/4SUQY'MK:\W\A.I)BB_D!,TRZI\.K",0R,!WT#CT\I<QC.6>MCOB"Q)%.$
M"\%[8;0Y'\T<:81O^.6_?V^_]0GH3NHPF7VSOIE\%7%]\>"HZZ^]'4EW/\A5
M$>OXVL8NYPG8>P)X@/6BY\E)V25:W(G+A!O:A7W'!<O*VP!CP"G.03+G4)#G
MC&>GE:08;M/SI3RRJV26[OK]W1A8Y^^9 6.[G6.<X;!5!9VCGE7>9(U7;-*9
MFD25%M]^B(A!$AZ7F@&=^5!9X7DQI,O_D%!NJ4FPE5=NT7"&IU8]47&0]$:#
MD>Y@WKDKU]DI+M^ZZ&[W,YX_4-X;@GEU$)9CKJ;J@]<RPY9'$#XG;<GRU7!+
M\27\>(Z27WQI1J0[F!QJ\J"NU+,25>_7>'[N5B<<9>)GI" 3%AA@FYOPO1FQ
M,X&G^6S<7CM>4_7)P<9E,][HJHRG#C?#>:D,"]HFQN$'(Q7L6+&ALC$_5UA"
M?\WPGQ!+W/8*.B>M'2\Q/CG"424M:7BM[C=1^0(^\-TMT&FQL5J"S@V(?AXS
M4>5:>Q]T9,SC<R%+LJ:/YD!RV  S-F5D-'\+_%@ET92U[=JD)N0)$,+"K+&Z
M33^BN(RR+Y;P&^AAO50/I6]%4Q4]+0+?K>5,L"40IF7WKB\C[VH6Y&N^:JAO
MX$#33O,L2 Q\4=K8O<F7_949@!'D.@3M>:@FF^5:8#:;)J/$F5F@=4%K15B+
M8T/120N&E3JONQ(2=23W)COLBI<=::D&>^(]+\TE&2K-U$&1)?0;#MAK(E!D
MM "WPQQ2XQT%@!%2<LTK/F.7W](>_$N&S9#Z<=B;OWDDD$L#C5,EUB#TQG]E
MO<!"QS))5>_DS!&7Z'";\A1_1K8WDBZOKR%<.L8H*OL)T)OPX\R+(@DS"L,@
M$X<OR@,)_0+VJ:=[!]=YDYX 12LTW_8?'9TE'>$7G'QL%H^["F!G\0_@;DB#
M5;KO//L3 .]PG:>L6T/KK:  ]A2W5[SNN;'?$D>(R8%^K/- P970PN*(#)SA
M7+S%5P#+BYMJN46\:_J&18M'.('44;Q6FY@XA4$<.!8HA/#O)BQ%[?F"Z;+8
MMRQ?J=\KC0L1&CC:7B8K"3,N185G>80W=V!9I*A,D>A^UK"_)=JY4:,6@N'A
M)L11E?I9FH.8[\(&H8(:KXV299?!2/E CB^5M2BXJE8ZPI8A)TMS+DLT%!+V
M6M#--\H#J7Q*K;Z?O\56 I](WA)(_6/\E:A;)*6:07RZ4!(O2X.;TK8HG:*B
MAOO7N?"1:1;1 256&FHS$F7$>/FWP]/.\SKT+DUG;\A"/YU=WZKA%>UQ>J2A
M\A[$\(FU/H-&73\>;]$?+BYS,HJ7*6!G+L7KJWO:M-83V#P/*8LA<]\ QD\^
MWE8<X0#/Q;^>J95B-ERIRJ9I+ GJNPF&O*T4!YPQ"9E,.BV9;8G.)@0Z0BOB
M)VXAM_R7-72![2ADN[QJ*5.QVC(V3$E+$E&]$N^%"'/$'7G4(C!%JG:%R)S0
M*D4O"$H+5!%S/FV@QDIZ_)<S?QPV:3Y&]!(<_%??KC"V/>I3;W7.1.:HW*,Z
M6FG'=X.K"]Z4&AN2TT4,V?WR[?3CVPWW.I:VX>UB28Q#QL8U 3#R\JU>6[!N
M^KBIWY\DS"YXSCR#MIUZUUB]>;K+$0*4+92<J^*]83IGA P>7XX9V<+F3%%O
M<9=4M= #YU?5?6)8!!S,JS'5CY] E8JC]@2UNL;[J"P@HS'C%>7$E#7VY=6[
MG'V4C6]CL!D8_6Z.W;P<<WH=@Q/4+W?VO4O+LU\T93AV/[YGKT\7%91(*](S
M4+U7I#CW<+&^CGC48GE8$>R::;0$U%SB!ELP3;G)TQ.D_W":\,(/GM:TM_/J
M2I\M6ZO'L_^J@_'DAYWF]=O.5T@]=\%'C2L^(GY<X:F\O,7!!O6IPKO5";HQ
M,(GE54^ 9$.TH+,"C0=P9E!@"7[4MA4\&O]2G^852&_R =PJ^XBQXZ0 3F+Y
MRH&-(?!12:V83YHF,0YCZM(@=:3I^##%,=[FH[5GM\OZ\8X0H;>XTVP[<B++
M#&L8^(I\Y='["7B[76%#69,\V!R6:R=!X)-9"\+X[:#,<@?WH>?S=SR6^<PB
M^<5;595G2\\D?UAZMO0A =[Y97'IB%.;IC?-NA>E ^=R9":V;TR;ZZ5:[#*D
MX$>+"5[#!V\D0/Y?02)'6PY#(4H:,N8F&'RW/C:+1&Z'6(Y?HCBU4DQ .U5*
MICEF./W:RUC\0UY(+]*^.51 ;D%S7>K(:DZ32'1;C*^]XE^:J<]8D]D#7C5D
MO7I\B4+VR\ITO3N))SK.$>$PP#1T5=OX=72WK[8:B3B ,77MVLTU9^)U[Q0N
MXBNJ78<.VOT(B\T7J&T6ZL5G@Z SQZ#/UXRR<D6X/%#^F\?KGST^/$&-XFND
M(PWRAS;&!4Z;:7-.4$*B<JQ:*(; R<+WA.OS-^_/&9'P_!HT Q(C2L0\&IHN
MLQ$/:$6:IY$W'A9POB>&G!+L54_6:O&S2R80[C /50X2'9?NEH1CH-/X^P'?
MT&N?AX5#UFL;=JN.$(^\:X?+K5'END@=K;;:(!P(:VLA@2B@1H!L#E6:VUHH
M>S)QG?7C^#H [Z:\E7?U"4!!$GGD*C"1;&R4_4ZNO5HO\3%R&Z;M3/NJRQ=O
M03!,8+3(+<=9@T^^0*:8XNMRV!-08ZNR)&I;&F_T@E(O.=J(S_X;N&5<][7W
M&I*U3Z],66^I7I167UC4Z4)'UA- %)Y_D[)XY<!SOM8\2K#;'%7X0Q!.ZZ>>
M=I<5?W0Q^;@X+=PF-4 UE+U:)2?,CP1XJ&"LM0.!W3Q'G8+U.[[S)V[!V^\2
M]F_K"\K8+B?[U&.2R'@/K)&Q>QI[MZ>\F&:@$Y9_:0;5-Q7N);WZ-CNC67>F
M6Z%.M/2#V70!+])/)*"5BC<,.*>)]G2SS65>D/A*LM_%3H$.ZMMM1S._DOV"
MMC?5V1MWSK^78D+S0_W5MY4 'K425;F:;-$2DCAFC#Y\ 2X[HT<VT+=QI85Y
M&8L/8PLDTNBG2.)",.;FM[7-*C,7@V(+4IEYLWL:YPK@HBXVUU?Y557&]K'B
M HVC"'M$)HV8[QL.C05)* \;"L>>\<_^KW]]$>'%EYPO\Y8*[FK468>-=X/G
M[#]VVXF:)Z4_\/T2W,Z-:7G.@!W9D9&$YE #ORJV%8_;,K9T4<XMY)V)J&_#
M-X]J\>[0WL6FD!'U$@T)WDZ!,OX6'SJ^(7S"VS!?VWV7G*)%?*ZJKQZ=^U27
M_+/;<X@;&V'H/YW\;+J\O,I&WGAN7!P=Y/^/?7R'>E_$>[+":SW%XX/H6/KS
M<CE1^L565[08YL9'^GF_&\D!. *WC9F*XM4,,HUDN03%KQI$[Y*':VD.B#[-
MNYS41D;B8W"#)^K,LY&-9*Y=5\N)WB6\JZEILN%1QUTLLW5&B(CPCG00"I?&
M>78$P.^^,051\_<2S--FNTQ*Z&>NOR/M=_7D'Y1$N3\3I:T6OT"(7/& _V5)
MZ]GB64U2ETG]48E-"7N!H_=]0"$!W"&O IC3X'BY2]/V,\0Y'6O/T) 906VZ
M8HE<>YLJBAKNFY\H%32A,&QMK3R"!2%!ZJ$WRY*PH\? +"<G)\N"+,-XG:@T
M+>LKL' Z\@=N]LI_6,%T3Y//H[R"2V/,Y^ )R+FL>&%NW)"REO*6!Y\E<WJ7
M??0Z3Q)+=>MRT=?[U<VWQV>,@2J$K_.<Z\!OC^[Y2WPM++J&K$>Q!BD[<NZM
M_,KI7SP!=X*J43_7J 4D;PF? /]L%)'_\&?-%T%;809>,O*V+:,GE0.^<G51
MCBO=W!RN[_@QA;.FU)X[Y^X]A&3E2([V2I.#1NJ7O>),<'L:^U[UXY(O$Y+N
M\1,0 GD(&OY):XTRT+;QC+P5H)R00'6P6%A"Y55\R,'RCW4NOR)PH<7A2Y@
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MU'HV3 G-7QG[RK>T=&W[*MFMWVE[&5GK0XU?9MU5HV"^K@\K^7$2^/44@,4
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MFJ/E50J3PVE%MO$Y5Q_[X$P1H$GO>#Z'L@;M%$%"'/WW5Q6OO_Y8G$O]1OT
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M(O0&R>(>??R]/AYR.OI?4$L#!!0    ( -F!5E)5(<>I3"4  /9%   3
M9&=X+3(P,C Q,C,Q7V<R+FIP9^UZ!5A4Z_KO&H8&000D! <!!>DN*452D>X2
M9NCNDA 4! E!Z2[I9NA22@D)Z5(:!J0[9N[HWF?O?<[9)^[]G_^]]WG^OO.\
MS[QKK6^MM[[XO=]:J''45^"R@HR\#  "@8#'Z!^ FB/!EO:P- , 146 !0
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MXRY@82A@BYL/-,[??OMH2?JTC*R_1C?RQ#,8B<1?6$TG:C?4$YRI?7%!HUZ
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M?3L@)G 4D&;AMS6>3LRW/5(Z>2YM\<Q4X[P-C<E73K7RU1VG[I+:A5(.-FD
M_#?_?+^@- QZ>]X[2*(SKPUY C[5)'?U%:NYG:^G[Q9-GQ::ANRN^Z402YT]
M1 R06#OST1WL+K*F=>>6#2]6C<RW)+FV=4[<F5ZJ[3*T*J['XS"16?T$.E_/
M&]L_H^7K)Z]^RDL72;_QX-8PH^NFD/@^J/^+E;O@4,^R(F?T+H6V[KWN.N%6
M6A;^8<XKQ#<X5K3+(]D4[BVL)0XI$7R1&W@3#28<2'AV%M&A,L9$A1,UF60^
MU]#0<[^65.]>=+EVXYI @M(9 QDHUNZ6M>O3G%?O<YTZM;_AC-&R6!RPKD*U
MYYMJPRDV"[I;B=/[#"NW1Y:6ZA^:5M=<*=>.]11(P-VG%"Z\G?O2'M\JS:KF
MKBO6^[>[Z16[3<0Y@$F'MRO@>*EW,$3\6!YWYN @V[HP>+>FG]63@63IX[A8
M$VOF&)^4^_P-V[=MA+C5/0S)F-(TB\F:WL=F.W;%QO*V2P\R[SO+WK#X2"OC
M*$DU1E&CI8 UTOL9:Y7Q5;6$B%'-K$^ZOD^)G]"E3"6N3?!G,6N9O3:*:DVG
M:='8W1=R5[)5[6"G8:H20:4FY6</*_0Z9U7>2 Z9W,N*=@P%^D.1NYBP@$V/
MD0@=U7L@\5RR<&^76;OUA,B42$$>R"ST[991)YQ^.^>\+,LS]B-?R/+-RIX0
M;1]N[>S+#AY\P)OO8+;AZVK/<>I,\#9K.0IHED/"GQL8^1?W(+0$:;->,,UW
MH8#R=*+=/P+K $G,5&!=6F5D4[P_5YRXC^F#Q/66',#9_<K)$8^"7WA(,82X
MHWY7GOB^OB_3>>+'DB2IP.[/1U&]P>YSD_Y\%O]FW_]7O/+$&F;GPBDLHSN#
M[N>M2CBGD/>-B";B=B0#O*(FMI-?[V4(65;^61[NUM8W0\\?".^*7FW$,I-=
MZ->T3_4IOL@N5<NEFK%E=>X=BQNOK5^)N-&D62WFI1.]'],9>CRD)N,=)+"K
M5Y/D0-ZL@[>*S1O1U"2&R#*P.$U]#<7.\+Y9%2N9@4=E3+_S06@A??U$BU\:
M<-,TI*\6D2["*Y!_V]3RH6UCWHC;VTU(" F_MZ(-3Y,>,18D9ARCP-\Y"0ER
MO>8I1$G+FISI?T=EWAIS[&T4!Y5QX@B4M @6/VU^++=2FG-O\EOM\/YAFE;T
MP8VH5/E+9>%:2W2/0<E[^L_)0(-Z5K&.;?-8G@[V>%R7@E>6FFH1(I\/7C9!
MM*6;O3]"Z_1\ L9E'NF;0P0?PL;0QKESSK_4&;W]6BNQE^VQO%7LN_&:RLN2
M)3?B&V*AL=!H'\NJ7U9(PY=?"QEL,SQ[N<:(C) 80I!A)/^*QJHOY0XM_%NC
M)D_!U+1,!HGLC ..O9\5L/97$U;2Z&;C6?]MI8\4$+79:OBU=^86_>?FSZX?
M?(R69]Q5T@5\&MD=':(XM81*.B[+4F=N%P#DX>FZ/NNYD(W< _Z:_\R[=4<D
MPX[[FW[3',%//!6/)((G?"[6RTK%=U(C#]DE#5MK@[Z>CR,IMDX.SE?!B8R5
M5]JC'\F+K3$7NND:;&:.5U9'&QWZOX]LWY$D9RZ^I";=-#C)[>&/AZWQ9M'\
MLS@\[9\HUPR*RYQ=OT17*7D?RM;KP+N6I@OTYV 68F0'$-VE+1C9C//.%>!D
MSWYYD<F3NT.CH0!\.Q>>W^*/[M>P3YZ#)J, BDJ_<#?RE5G"0>14WK6),:ZI
MM#B)]HL6CI88KU_W)2,0+W0^D<O(B^5;IXX<2%1QUSQM<2'N;3N./%;&4I39
MGYVY2D52BBO69,6JYU9?)_>Z\+I2^D&>_\?6Q3'%['&?B$N[Q+.U*Q=1:Y(4
M)B&/GT/#C-4?JZW^FRCM7W%AOK9T_MKN9/\1C.:RL-IX*%P:,![WD%4H;^.[
MM7SW7(TFLB?'MJ" 61VD[@(\QM=EQH!?/*..>3UEP+'H.%:?VNX]EF MPOXI
MW'7IDZ#,%\02. BR\,VP6-E01^_+)+QIVD1N*D^LJ2LCG1B264_K_-Y=%\HW
MFE'"[K5(G"">=3HF]B>)T9+*.'ZTKF::N,K?5*H?M2<QX(?.S&"57HK9>H^_
M;;C?J((LOD3^8:EB65F@8L4#:XW)%R)'T.DT+]>4F*;G!5.3,@SA7J OTZ>)
MJ?XD,08*M82Y>0QTHS=1P#.7PHV*][;9$AUXK>?UFDMD("W%LI<//\_# S<[
MA4V$H=.)<#0&UW3+\+(IM1U/FZF]T;749S$*>=%\T#*(GCIYU4?.OSZ&2S0@
MF9!'-4/EJ\7%G'+3FM[PA8*,K4T+T*1 0GB-%GB67^)3]7\J2W^'O4NIVVRQ
MJ_-M\3L?WLV>Y(YE/#S5RAR+.\[TJ_*(_5;YONSN,2 1GTX8REQ<2F@)F9RL
M."E,\G#8/85(G_MU^G-;E#Y(>G?*-\,^R;!.$WPZHKE]/=YWX^@!"@"KH8"*
M 9PT%<. 9O!GG-G4M9:O5A*'NG#BP'T+KZFJW%%YXGTT<LFL;E3*]H,A^I8X
MV)=[.E;%M+91 'Y'.M'+=\I32L45^N\K2$@LC@CGGM(VQZS"EY 4:1O(FU4V
MV[W*2+K(9>OAO_DFX,B-:[8@Y%WWQ1 1;B&Z0"&<Q"RO/M,)?+R(_35T'!ZM
M0P>Q".MBG@LV\9%6_.>O4_XK3+Y$#8\Y:-H?^J(G3Q(M8U/V=7&E5,JP5*Z[
M),= ZC8"]P,?:$$A9YPE %V[T/9YI07O1V5;<K^7W$M:>1.QX>U+RVQ$M&:9
M)^M)7M#%9NXP\7YE;:CJMV\FP+SMU'(C^PDW ,^>O78E,]J6ZS%+83F4A1A4
MCW#%PKWYS02#76J&&1MC1V"Q4K5;2\[[:Y+7W;,GC/2-I-C#JZ+C%S6[([")
MO/;)$?NA!:'D9"P1_N@:_K_GJZ?_,$-0$_\+4$L#!!0    ( -F!5E)KO\8W
MW&$  *R8   3    9&=X+3(P,C Q,C,Q7V<S+FIP9^R[!51=VY(VNG9PM^#N
M! VN08*'H GN[NX6++A#@ 2"NP=W=W>7P,:"LTF"A_W([>Y[^YYSWSOI?CW^
M][_QIQ@UF&NMVE6S:M:L^15[ 5V$;@"8+Z1DI0 0" 08//P T$TL>$D/2S,
MD)<'& $ 0 1@08+ HX?1XX>+%Z&6 .S#&/0PUON8_O,WP   F/,') #"PSW4
MAVOA!P9(#O[VV=_TFW[3;_I-O^DW_1]*"I;&%O8VSLP42H8N3I;&EH84T@
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M% 0O]ME1\M1*6VL_?@13 !VAJAQ,7-E;;*DA7!+C7=5QIH2&JSI'UB1/5RB
MN-F4O.R-V.N&/T(EH"N[4XJDJZP1 NL3/%D%"/-R^+M\_NOBIF:BQS/K2B#U
MP3J_CZR)MF^N1A+W\@2,:8M!-3QY-W 9?PPOA.W9"3OMH:C?5'-%F7N8DH"R
MDC^=DRK+9@_[7)I1V)+NS6.3[:JA"_I 4/&O;!2#RM[;V"OI[-GMR;=^^YPK
MJX2L>@2&%H,H'TS#>4Z9V7?#!I035E0KK/2Q.JJY68Q0?M!)Q"H&[$;BO+G9
MLY:*K*?*JJZ1[2GX3M!%&3,)RO\5F\Y5'E][4V/R-Z]L6X63'QVJ)HSOV^N!
ML1A92H>)V'C6="J'/1DZN+R]>"!35Z_Z5*X2M+]4<$$*Q\QK?-B$]]4=;1"B
M2II)&(2BRQ,_-?OW@D3^>CW+Y#'Z]6A:96WMN-HX=!5LI<Z)-3IJ2:G.R[<9
M;C,':;#. X)I:Q(;LC[']IZO7E'6'<JS>K+B$O-0)!LR\DN]["^30<5@+),A
M1%:  Z1_R<O+#ER3D/Z^!_,88\6ZJY)"I_:F-"F4QA&OR'"S(D1UPS;U#4A"
M3*AQ+>_<R\>LP8(M&*B2%[[P:M%]NSE&R;95TJS/:52,MQ/YZ$5<#+"?^UO_
M2I5_+22V53J&-L\U3=WFG19+-W(T/?$TCEG/) K,Y&X*<Q)=<OW,[6LTOY#2
M_L8MBV'MT/%)9126I*'G>UVZ#TFX-'RTHF;;&Q]A_!5 0.PO;,^)R/Z;S(NY
MY'C7[!5Q;^YO\S@!17@Q_'"E.KV#ZVJZA*\#9=1>W3'S%]6RD5N]H6B?*B^[
M$XB/O"5O4!1:V)!&1I*P*W[+?,2!"*=$KBQ*U/$+N\0^LM7/<S/R]LKP['9=
MK'"_8_F53MNR1,'37HXBT/L&$A- 406!J^,LW8I=EED]%55)#K[2LG",?*4!
M-V:#;@B$M='( 0S-!(7:<8!R?VDIQ\#RVAKSK2*.C]+XC>?J2(5MG[$A-31Y
M&+Q_XG[>8^QB$)L"P[\L0Q J!=DMI8O._FRM1;VJM_IE02#B6=(%U3OZE',;
MVUS'=8Q11.6I]XG^Z)F_$-D=UPE"J^7,8#9L;=E:E)29X^^"LK9L>&H>J:*$
M)$?$!"8FK$[$(8?1(_KD<MY;H9/'M4Q+-KE-WK+<L"%&58/AC<G"ZN]PJ.U\
MUE;"KMG' +U_8>//.R?3&\PBX1$CSRDU-:,D)P:C-[@0B!]MZ@2*?A&WHZKY
MGI.> *5Q&S4-@UQ?9W6Q1SB4J&YT.;JEO&TS*5E;VH42%.V.L-1%*S/QXJ>^
M7S#8M-CJ6W&0&AJZ-5/;)HSE6BIKZOVXX4@#KM:R*I;)Q\0@O9I1V%CI-<(J
MRP2$Z&3E!5&I!96O\,FP]1CW<:58@FDT[W$2Z6N)%Z:-YOW3&'RP,/J_<JJ0
M8]=Q-\;;^3REC(&O\EP\8!PCX75"G-R@0_7??H=@![K^ZJ_/UON0@0W<Q-IL
MJ ?X]6Y2NVQUDB0E1!J/DU''"(*5WIFBTM+_#9.L_)*GI1,E5LT=/:3BKS+8
MCK3#OUVSLD3G3Z;*Q/6UR9I%P;WI!3K=C.>K;86\B_=O,'75I4.8BHYL65G6
MMUZ!Z&3U1T8K:Q@VSE4E@JL?I0@IP5_^PHD=:PUAM$X7D6@5H(Q@>:$>8IZQ
MF2-CHGF7GIT7+<:/NJ(_X@0@ERTIK8B$IV@%[V;5Z^'/FC_ ONV551I\V!=G
M]6-E/NE!CK"5R=-5,$EHY[^&$WA#76\K,?<O%JHTEP=09)G=!>W?AE"%PEB\
MWJ,A"5D<%BBR*5K/0K?_A77:9_@M]S\M5RHG.I\+@8]K@&BM:KVYL2!#2<\P
ML7]<B1-4]>'-.2]%?,1TA7VGWSGKFM^BM>I#\@;W 2[OE!\:M#="4"#>;>&^
M1TO]_B/+85Z%_4#F.>LR%%BT?O%3KLWE': L^?@O6=7W>?>*ZHR=R^U5ZZ%V
M42IA+DWT8 ^LB1/?,VENHZ9ROS[>9KML9^L\2X<##@U-EA\'LN[;'-VCFS[9
M54%-YWF;$:#@$>=.^/SZH (M*\NB%:T2W0&S>B;67?I!M=7BH3W8Q,0)NJQ/
M9P6Q!59?K=1XSON$QL\Y4#Z\9#QQ.OF4?#XUX:8*N]-T'>,@LFFPFI83GO?\
M+%IK1?$KW.:J<09-/"VR\>UBW*.W&\Y?B>;/_,+J,'#VIP_P4Y];NJW;Q#^/
M=J-]_W['8\6KY%CO512G.?TD-G#[&<Y"(/HDU]7;FFOZ0'F =/QPJ#Z><-14
M_0VUJ5 I!2RV##]= 1GNM$@U>&8=J2#P2=]P[:7*$),,NCM76=_*#*H,TWEF
M2L0V=VZ1AYH(SH$7>K&W1[( <Z53PX*]0[@7P@?B8)NPLZC1P0!U-/)A>,;O
M27&A.O,^@LZE!_)Y787+^G4C!]CAJNF%F@@9VEY/,',--1W'GZ(SP&2UG67$
M^I5%JWE[JGU%K#A;DT,>Q4S(,**&2[2D)P[H]RB)W,# J$BT+:3A+84KFQ"B
M=16,I^+<\SN52#M;B5'GX]_764NO+W1F#=@<>Z4R&YP$MN*5$UB7Q1WI(2EB
MB<]7(7=/>6J<F%BS.S&F%>?1?S.P29H2?G)D,L<Z5J;([, AN9M,@7\=!I#L
MQ>K! 4H=9W!'1.\<+;!L9G*K0L;7E<%,MYJVRD3/.<(;%1M&AT]<MW8V4#,J
M/G>G2E8TWK2U8N>O)A#JVXX&TL45]- G$(^LJP?>.I_J].WUCD0R6;\WF]0X
MF++J6"HV1ZT>S_N1;L=;(XG2""*&9;8/(77;"<Y$]ZC17? Q8JG@>C?S;7[:
MH.7IZN"^\^.8\R>HT03W#(-=U/[$I;9*:(>GR%]N8LJXF4HMT<;G9%'=L:42
M2Q)>OXCH,@6J.AT6AP:T"EW/H$"/>FK7'*N-J7=E[8]ROQDZK+Q;'L]2 M^(
MJWL*T" "/S!O]K#%3A4R>]EX KM'Q%,%C2F;UKA'JYG-*.*I>(=?Y@J=P"!8
M\BL=TP\0562YS+><;<YL-G4D#(/EBLU#1ZBHJ62)1AYQYH(:F''VMC)J0=-?
M;DA#@G(E\RVK9.J5'Q63S+3V/G*2VD<A<9[A3B+O.47O,[#):6B5X96:8CQ0
MIU@YHBD*;AWMAE?$2B+8(BC3[@@G"DXN-BWD#3%O:;:@;&S3QJC584;BBBK"
M2OZ,VJ54XYFA1 JR<ZC/Q*IC&IE@NL?*MJJ6][6VLZN#0Z.97PF'I>)[3>G8
M0A,4AQM"X,^SM9F'T$=DM*)=?>6U/'SP1/IB;GGUNF8P9G& 5L0]L$ 4X_T
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MG8YKLF8H$*U_+EO'=G-=#06F!ZWWEH'O(E?ZS9D_D/$RK_CM[Z5S[_%/"J'
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MVTT*'K&S+/;JQ3>_JKK*.XII3S2+9"F1JY=L5=O4=C+W>VNO)MV&2)$J["*
M;VARX,.#"[?DA7MT:3E^-0M2(6DA)^J2)+1=9LJA'DPGSZ%Q:S(,HOWY=MF@
M+F?*H EVWCLZWM[L3&%+!',UF@2OO8S6!39)P/7BC?"G*FL8VPU3E,(\QY7^
M=89F%Q1BO#".6@GA;EG=SN,M@L[2U($^F>^W12?<^K!BG/FM]8WZF!-$K1S^
M--%SAJ#9#8?.;X,_H<BA(>3XW=/5_G:4^.B9_G,Y^DA[,B7(CP%-(H[!3L<F
M&;XM/G 9?6_DZQ1%US-FZEM^$PW\>VS!Z,+1H;CF:[YW330U?$:]";+<?<JB
MI/5I$ X6,MQ0A3/+$"Z+"+8[6E[Y*F-^F05VTJK8Z]VG;QU>1ZS]&6V>#S/
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M@VW4YV'TD++F?VZ)T6<Z]2&GWOMM?O$5]4WVCWK5%9H2:P:!GZ!$K_D??Q>
M5)+Y#1[[00$;*/!-:T%0%__A&'+K@ +U?C<LUNG_I!-#X\KR :GD0H&%$2A
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M%"0PV.*.!"PJ]9& .CGI]+_M4@2*O7J@)]&.!ZIM ?^%8W_ D?UZP/V;-@7
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M0_O37?W/NTI)A,"X[::ZP2$,'&*^!:0_^&Z%3BO6WZT7#TI]$^ ?UCZW[DW
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MZX]>:U5W57575_UJL8!-PA: .T]EY&4 ! 0$P 3^ \ 6\5&E/4%6 *"H"+
M ( .(",( XCP'B'\XFDP"$"&]Q'@?:./GW[\!I@ X,[X)B6 !K^'#;]^#&\
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MFBD^("17"PS@\MH@)?V)"F)_,+#V*=-/<SXO[<2VDD_7&3)G6P>L(\L1!F#
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MAO315WY[NG!KL@ZOE;'8@YW+&8<KG-# ;;RL)+/2Y]S"#J:?KH)3$?R1_%$
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MDYI1!%LI9B%0O:J]&9\^,7^_"&=1[R$$:4*5?]_0+!=JSG1FQ/U6/P8T<<.
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M@>/:']#N4(Q,+\F8:#;<U/*^YB7^+>U$H?:G:_F*J6S=683;4I[PE\%T%XG
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MKGH\=I<:VFO=>^97XN"(:$3WA[Y#;=@<KAURZ?%M>D\0S46/G?.!>&MLDL#
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M5]FM:.G?! L." S(.#E#!EBP\G3S"[%)F$LUD5QVD0MEI2*#I[,+,R?:Y6$
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M\!#-^F?7C9P_W?:W2KO0XLSM+JL!/UFLEVK=]B[^F!$<I,]Z>4\:'@ X#4^
MF(5YR!\S<00J71\)78S^AIB$P(>-3!4NM>*]FV4MLIK05Y!G.8%G9ZK;V>H0
M!MZFJV-BDG$>+EZ[5RUE<9G"8+D\1/MM'X<;I)=Q_51=<0/YH+WQ$\-V1!(,
MH8KH>_*Q:<0J^'15^(U'EM\\%0D9]F:E?_JDD9W:<X3,J6A?!G'K2,:MH@W)
M,D*V\4O3O@7W.7R,""!LT^K92'NV#I(^J(<35ZR8\-U'P 4G%[@A,E0N4$UN
M*WW8(GHF>Y=YG/MAFB\1R\%/X(ES76U];WTCD<KK@XN;WX.WEEUKXS@Y;BY,
MUT F".+)AI:QG#[/0E8+C#]T#C[S;:DV])PV4O(L2/,%3N??>3MO0EA^5RE9
M'?H:I>%J19AD*$7);C-V(X:)H)KVAV0JM<)KH4L-SA%OT^!\WN=EB)<=7L6"
M]ZNJ2,]>U'*-4V]WNHDN-],Z-LRX4#BY< 1=6^_& 840U@"\1)AH5J_C?1AQ
M7ZY[U5#Y^UL^J* @F^Y9[I4=D""&JTXV22!EPJU^F9(;QFO9[CWOT[C!K]'X
M4:G1B^5'8DMA9:U9%)E01D7\&L;;FR&W\[:MIV,&XJUJB4.9R;@<=]A\E_X'
M+N=9*4?N".5'[PD&BOPR^7KRLZ>($^0?2)?NYJQ2#R9B60<R-;@'-_7),"64
M$$QMWURV??+K'F@]&[5V* M'=3#(4M? /P+N1K;R4MY]Z9/=9N'\,$RPHCZ^
MH38XJG,8MAO,Q:'2=5=#8NK+9]83#9)Z=_A][ZF]*:OI/(10A'P8+X84Y,,;
M3:;%JZDEHI&7=XN>RE?'&+RY?XFJ:T=G\I!AC4LPC>]B_OO?59?TX.C1,5I3
M8]KA COXXS-^WV(CM$-P*;JQQ"PHG@F*)1[:ZP0<?X6)W4&$XP"4SQA\ PL[
M(QL%.1[-894W7V*;E\]QH6:_+$215 ?(HEX,R/[@@N%38]VFLN*85WBY<&4'
MXP S%O@9<^5^[/\B+!D$&J9PM16@/K201TQQ9J7[2A?I)S)]ND["QIA/+<_7
M.%(@7E4&G<X^RF0T._.I'#RJ:O]Q\JY6[K3>#UE.U;RR870&<-N9!W#-;M$3
MU/:IG R5J3]6401NWI=$BIK,]O#;(A+$1<I+;-GZ5+KE?I":/1[X?3;]PN22
MOP]"H!MKT.VW+]HW9CO_6<RV_*'RR9=;L@1X^YY*%?&WT!36<6CZ;%MT+R/U
M?2H.\-T^XQ_;RH;:2R)\&$0$?'RM&D11MA:V['%N MW3_40V^" E_X#^RD^7
M0C^^9XG"PF7F:0=<45MW8P48XD:K<(!U974@H\?9L'. B2=:(M<FE82,0Y-1
M/X/P)A>!\I>]/0Q?8]]'R@WQN%P83PN%R$#7A6C![*U&":1=M2(@)C'*.RHQ
MS,=+H/V"\./?'0J8:JF#JDY5^4/L"20SHKT6DS_%I1@B>H]1!R!8)7:2I7I1
MN(O,[6FXNI..S#WMWFG!J'D2_QK?E[L$/V:OG#O! 4GGUPP!T"9QO%1/C?$.
M^[AYCTO_/ZX9)H^NM3'4+<=Z>'M;>KSB\HZ2LW1F=1$C$'":\RIIV<^,;&=6
M1/J*&IL0#S,<M/KU;N[LF()-I+XKZZY]B@W/<'_-!IYQ6]-0\Z!O>B;>9)\9
ME6S.ZJ37Q&>^.!KYL*:Z?*APT[&88\=Q:\GMZY+;X@,PT>597REO]86L=*CM
MDEI-?/V#X.>W:=97GRH+<_K*!E?YQ41K6R>B&AXOG$92KW==+PQOH-NR(?U4
M_BHMY)V!.S>-RYW'-QI4O2RS)R<GHPMA+A\(E:-2G!7BQVPER!')5(AB.:VC
MC$X],&^-WW)5R"B_TREG<"C0]WT:M?M%A"#@']8DG1M0G>J!BH/Z^MD>1LYN
MYBT/UF2^G"V5>5V!6>F2P![)OH]Y(@'&RU4,S4W5]R2L7:]MK=3T>5GY2GGR
M1Z0L!@6E-4;/W)V1"-%/B[9Q8.T*Y_1GESFT)F):F4KT>O5@0'?VVQOFT&D3
MF0[G29XTX2"_D,_AF*NO,UULB(K2:_E-@WW =8-;E>S"BQ2J7OI;'6,TQT]M
M,C_K/MP_#IQU1E:+@A"=EX@TO7@K4 WUM0T>YOI7WT@J@,6WGKB%68 9MR%L
ML:#NF5?R0^P/FFOD<B;:*>VV32J#;99U7?PRL.C//R/(9/BFL<(5..!-,$;F
MPG/E7.E'#EFUH<^$Z[)W(U[2W/Y"Q$J;W$^JJOC<\$IPZ"N)(6FY(@EAI"7]
MD,?UPYGW3OGK*BT@)5/&:6213;/U:^@=BJ"ZB!V*7BMH@$W&3 O*?"WY()6J
M+V3!P8=WU5G?\+AL;O8+3Z))0ZZ%WK.;G??")R!+7))G]H_4F<:AL^N:^3.S
MJC!7MG2#=H?=BD+VA"KI)7@/Q>5^XKOO"88&C!J1D7OY2H--0PXY]^H2PC51
M5>.<U@YYD35A8G+S%F&7AQ)+%]CT-$:NCL K#2_?R$:(EGF0Z\C?%-M')8/5
M .5_:I7B_!CY5"(NJ:M&TV)+7@VD*+&O@%:X04\+;LFUDI86ZQ;Q=WKJ310U
M39%CU\UWEXZ@>-V#L&[^JF784\P?=N! -4&ME12Y],T#)91@'2&*JB<&K6NF
M1H@JGN8!['(0JO.K;NHN<5-+=-8"FX4F#0[P8V4?$D7IK*;0.5;9CKJE[G)G
M?3[0C#Q+;-CZ0SPQ>?3D++0^9W/>>/!!J[9GC.:8%_I4OFO3Y/L=AVK2?=@:
MA"TP!J&<9>MDT#[(TRH[*X-<T?N#W[JKO=V,B9S\>0;_=@XU;RN<8\$!G\^*
M\,87,W="6\#W2P3;(!H521U2D6#V!LEITO:%YNH53H@\:@_YX 2JMEWT(<](
M#G:IJ9AR:(G".6/F'LU2QATE>N_GD9['U6TI.U(V*0>TU3A@(-_40(/$L3F]
MLWCMAJ7(X%35?MSUA:O2PM<IBVHO6-!07PWIKD%K5PLKN& YAA5/.@YV9_+D
MF1<9)(5B)RJ5/$% I.%Z3BH5'SQPC0=5-K4Q=C @,U+9 XF"Z-XF#%"\D";1
M%H:*Z12;6^BHZF5 TMLI+G[:F9=\/?6A]LN[E)FEG[=OG2RE$M9[+ESIOB)%
M%9L_N[']+?=&4:%,766FLWQ)6PXC@RV;-L$03UE'&)43P#"UX%IA^'+<L;)1
M?GWFQ6K%T<@@2"A3+7X<!'DIR.8NL2*:YC ?%Z0]^#-[=&O%^\ZWLXG7%U3>
M^!(R"IBS$APZ&S!@91.G.B83FB+6=Y5L"JRJ$V<G-)]E)(M_NVXU/;TDT4>*
M#J-S=;S+@5>T063VNNE3G?A6#U85@9>_"?S4)NML993UT&9E!H*;V*LQ7&.&
MW#Z<PS'J4=(UG%,4W@GBCI.9V=!4IF?OI!Y3MQ>XAYY:"=*8*CLO5[0?,FSN
M5IAHHKH>"7TVFG>CKTZA*Q0Y$VO7:!X0A=I#ES6BOZ%X%9\2EGYMB$G^8=1$
M<,?VV2L/9^F3,#TPN.FR8JYH>&R#%L1DM<!KZD(/_1-^(0'M)SDL22% ,[7_
MC24T*_A*''9=OW!1?['^6,MBW"5,S%>XAJVV6S('A0Z8/O1TF$$&NUXL>G$0
M.ZH42#W+= 5V5=G/;XCQ\)N"PS95SZ%614GYH*MMT;6JZ$4=AO5F*]K>[_>+
M# (-H)(7ZTN9IFM[<4! Y<*F<*_JE9BYAX?KEH]=2KJ%.=ZG"B1H>3!.AGP%
MOK"I 9ROKFD/@=NQ=-X:;2?N0WUFU9_?2CKC ($3U"?O#273H&5H;]+H-DFJ
M('=MX/K%40FYJCB)K]#WSUHOL0B_:PD3ZKID;^-S+<BTN?GU8-\"9VE"JGTP
M^$;1NA-$QV4#!Q#J%-8!B_NF00IZ3=4-*1W,OK4AO ,H(<CWGOL6E.)*;G0=
M%C<)")3EH)_ Z.-^8JPK1>B0M]OA0ZO[8^9BPB2=K$Y2RU7_]#Z:M+JJB)V1
M^8\ON<+8[1)#@%T95?4/:HU>'K7=?'.SX$JMQBN&@UPC!3U.Y=>$FM/V3O12
MU"_$#37<3E.AF?>'T/Y=?$N 6!B_.U ,I>J90BY\\^1Q;J+P=]WO0,'SPWA/
M8LZ[;7K^9CRDNQ?9QCXN<ON^J'Y#M"^-WV:]ZX8F''6GUF^+$7UR";'J.:S4
M_;H.?Q#.ZE;,2"WI-$<,#HC?7RFV9/N22M'$TI\YYJKXQO*)>J+U'CCEL4DS
MI=!4R[NV-"Y%\KP[Y%GIJP<GOR7'52U=RZ]=W]PP_..^DS\U/@=US;P2+:VS
M!:N9Z] U_JC.OVJC$HY2BZ!G? L4,W4MC(<E'VAKD%Z'H4\?57L],[6CIM=0
MN-#?$%RV:8:,7383=ELY>N _S:Q[!$>\KP^&[=-7U= =Z[;=NVYCB8P?^"Y\
ML==[L<51@K NCY<H?+B)>6WR8^5[K?7$9'5;*X$W Q5W4&]O/;EH\YF4CTK[
MIM/M9)U@:2*;775AN\G,VXWCC8'ZJ+>B%5/D=Q!;V[NY'/Z.K&AB5_P'B5K/
MA]ZY9'7IP93&,(.- T\5GXEPF4?QL@K7JX199."\[RT <-8I\ $;VD9-4K#9
MZP>J6MI,6B;>&NHR]>D^%@KOF,^A%/8HJ@L!.H8P0L1!;QU=<P4=?SJNO)7/
M7NKM$ J\4?J ,UH8_K;T['GUG](!=$ZZ2O5IW7GM3=(\/=2QI^*EA9Z\1+W7
M7D-M)YGZ,]\Z:0^[KM8UA<+R%78Q,;S'/$11/[P5G3Z<N'8E.3VM>\B^8#80
ME"-"H/N?&]OF6OL]/%5[/'LYNON=,;O&Q)H#3T[%0NW9%;X'RC[^@G7U]"5_
MC449K(U=N8;5[T >4P[O^RW9%Y>[ZZ*( N,+S+>ES]LG8^@,@F54OO'\"H@(
MRDUW]SDTKIFPJW_Z^/1+TA;B*,4.R$>LC4EE+4(-E"RBFGG F0>@#3 8?=;D
M;UDF+;TEZW6=M70//'(S-&W2QLU'+?U[TIE%X6'R*=X<VO[7H,>>3[]/&'3J
M_RZC^.7@$^99>ORJH7LXH"2\&1MN>-+3I(9&8"(2KYV]<< !>W9CH]I_I'-_
MDK3/25M<]YU)BUEMN(7"^,&)]K &*6V^N^[BT(LJ@T_@>G@PO*N$[.I\&+N"
M2:%!742 9>ZKP>XRT^/59/;N45_I]9"99G369NX-6&A\]Z$[K*>4#7R-G[/L
MUH]V$E\6K2EYQYOI;URCVK#6()"]NQVUK*F_#%=O2@L\@I>H'R!/I0(8Z2OP
M^^,T1U=4"K.THQ;XQD6-(#I.W++O?05W73F*[Y"2HT.L(/=3J9[^[J:53]7+
MHRB3=NK>3BV6WJC_P@M4^/=WW'9]7YU 2BI%Y0^.X'#7*C7%SDQOM_WG6-"T
M[5WP4(4%#E#P]8AOC:TU/^HG94L](K2=L!XMI_2^1^YC=?)IKJ_^U%Y?8'.4
M0C^.]YV9CA*0RS1"7UZBPZ8B05A>)*V8/BD$+33I^HV][9"7^GLB,)A>.]'@
MO1 /M1TQ?W= T[5CC3TFR<#G#,L]<DDW;NLW@DOT2['NJ52)(<O*P?L>W2?4
M;RI)ST??F/L?QZB>I2VQI.PS@U.L<8"I7A;^$!"G4L6%+"M6ASM*).( Y3)P
MB1QW)GSNGH:TS")33=/VBTZOL[@>"?5E50U2M?M].;5NY#(JG<_AZ(""YNWC
MXHT/JC/@'[RRAVTA.FC2("+'Z!Y;Y)EX0R($3N+"2V3B;:]:I37&'%[P!.YI
MR3Y:9GGDMW _Q6S,@6TW/*KI0-8W_WS89%P'HPB;*.,+,YL$S';B: 3O N1=
M5VG.:EX-H:\D\NA1Q1J)@X!H4FF_"+/15P26N)H>WJ:9U_OM@_^^;5!!M!SU
MZ@[1B9ZJ(O#<=-)$* 4K@Y%!0&37?FI=C3P]9-%$N8_"&[W3#:S+IE2=([_%
MB X.0%C'^Z45Q3'>1W46,MA.<WH%]-RR%KR-D0<'1/ZDV1CSJ6W Q_2KL0_6
M;%*I'L$#[]+4U40O;JCL9L>&JG!-]QB,[W-O;>#=>%LN6N^,X H^H, O7<PO
M2?>5P %'.G?)<4 J)PZ8O]>,T6%'Y[T"X0"((@YH"88?Y?W 6RE9+$C]=?,J
M6?,1K2 . "EC^%*(X?VT<#2G*9:OGIR7*!)O%Q[/%Y\0"F(OJ.* 3OR[R!&M
MIGL73#%D'W! 2%%;"+"$ Q:TC_BQOJ'X_(,.!VQKP_^GWZ,[MO#AC4#QU?K*
M@5')^2C+<,SQH]''[SQ@FL8Z?VR:_@1,]J](PV@":EPT%4\GAQT<WM,@E7T^
M?\KDXC![GSI5DKU05@%]NB8>W<O=RVLQF7F3;"5E#5KQ;_ UAV)W66C]R%8Q
M9XADM $%KX$D4<D*:$U$@S1<;:'0CGH_\1D.0(-F,.4Z4-7ARS_'C05'2? [
M?7#"2]0>F.+I:6"4DGD#"^);G4S*Y4<8TY"H;T$Q_%-"BH#[,S'F\!:\T@S^
M1,G.G/*GR1[V$Q;*+1333O/R+YSF]#E7+>IGG"F([Q3;X".LGN[6R4D:RP$1
M-'QM1<,6@J%EJ&,Q9N]TZN */%0H>=0VVOF%/516-M;UO0;I;1Q MMPHYC.R
M1-%&C6ZUIW3'R*_LXQ7VS6\7)>M'*WN3]W6'V;3Q\E,B?E&A02K63-T@S"H]
M:3>M<G:,>GEM5S0-MO"1:I@ EFGPFQ0[APKF<^$#7D*)U$#BJ0LJC'N*1,?:
M[_][<[3^4?HG%A_^#](_\N\^1(CRLW%IH\,/\CU@YK8,%5C+SJ_YK+9)%"7"
M7R%,W-2Y^;+H4@PMWC=\.!]?98LWT"!CGG^=A]"-5CZC,CF?*Y7)?JZI?_']
MQ?<7WU]\?_']_^-KL_,10"\W+LZ13JYZ8C_D&OU6*! .^OCCN51.23WQ6ZU'
MPA!D3=%6""\1;N)? %!+ P04    " #9@592YG'2-^9O  !!K0  $P   &1G
M>"TR,#(P,3(S,5]G-2YJ<&?LO 54G,NZ)OSA[NXNP=TU"1XL$#P0W!U"XP0"
M!+< "4Z  ,&"NP2'X$[C$C2X!NF>WD=G]CYSDSG_77/O^F>_K%I4U5==;[W^
M5'>OALY!5P%<97DE>0 .#@YX ?L#H&MXR'(@6RL 4%4%V   0 40X<0!>%B/
M$#90#K<%$&%].%C?."/SM_\ *P#@SNQ1 BBP.4S86 K6 ,J]O[SV3_J3_J0_
MZ4_ZD_ZD_T=)S=;<QMG!G8-6P]3#S=;<UI16 0"0XA'^CBIP2^,1_]'O2$SX
M2Q]!6 0 $A/_V?\GPD#-^6W7/Q'&G_0G_4E_TI_T)_V_37P\?+QB/+QB?**T
M/")BO")B/'S_<@Z&10!;P!RP 9P!!\ =X !H 0W %/  W/XR;POKTP(P= )
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MZF 7;[37W,D<UZ7GV$4Z.'-ST39'SXN0T-$E5!.."#65%&&:CZ 9?1[!T:T
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M#@+#[*I-IW0A ZY\N8J;\@E?X_5*@PA1I9Q>GY?'SO8:8"UG!OK4ER$:V&*
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M-"M!*2A^N]^.\^,F2E^68;Y*O![\G$$;7W[P^V (2&.!;WXA^HV?[/K79BA
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M,;]4RW3[?HB%.KNXWRAE1<,A>\.Q(C =1P0RN+%ID?9TQ-K*NT]GS':LF[Q
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MD8DF"&J>K<JSFN.>G$_9RS16P,;EU?3Z/8W=(</U9U.'\I2.\EBAFY0;\;_
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M/7$[,G#&W).>/]TYT>=8]J^XZ4[45_^Z;8T"TG"=%>W8:MG_N=MB';!WDM^
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M+U\;@+$<=M&Y&!K3K@;J$[[I:!(3IIK6X <X\<CLB;M+7H5Z1#G*@Y>X\CG
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M?W!+4CYJ=K9W'862*Y=+'J8@((8#>G?$\P\]E?L;#\[WQF5W"1J%L@0>N,&
M1ETUK)D 3G/Q(>*BIL7U/#2O.K:+4(Y:(W48)O&R2&2Q_\8-8V ,@M0-$I<I
MM1=,,<\6O 42XZ,CP))V%1,!#Q8&0J;<A3-/%4A:8.01P/%%(G)ZY5@E\:.R
MV"W@P<H)8S+ZF>_W%#V<49T?I#S#H-*Y9C6+MVO/ORM&/<6Y;QJL;7)/ZBG6
MYC[/<EGXJ4II#0[RS@1<W-1LX"4)F-)>U4B0 B^RI5#OE[+[TLV3E%.7=CF]
M0 D5RX7S2*6)]DN5/9-;P%UU!<8.?!^_8?"R4NJ4S<\=%B%VONP BV[G1 B;
M/2!C9X\"<@!=.N\CYF'Q2#I%2\D*D@\7T]B'L0*1I6$&8N;[ZV6#8'(IQBS.
ML8[4C3@SXT,Q@(/Y5S>2*T9F@3/VAREVY7D,1_\!CP-BKGFH*[Y\M[X8#SAT
M#&"-D<LPA2TDEU_@;1[ZF<&-@O*W.@JJ6!QW];35L=82%;\V(89[B\Q2+/XW
M*CR-0M'(12JAI'O^VYC$;5C7=B,<TU</;<Z,\2$.U-XO]L_3P:_5<4[_]>&)
MR_0-0UW%E+N= D'YMD%C]8"RO5 "5]/^KSZ6C%2$_&M=+5G TKH!.^9]034B
MO>RRAX?_6,3;TH47.G<\%"@B&91=CVY)]5[^?>(;G+"_R3G"]/EW5O@P^EH&
MTTM"#ON=AA2]VP*Q7NF>N$@^I,I'U)!K?WVRTB'>ADKZ$<W.X#"&J1>+^$8C
M::_2_P]57NRXY57Q:X82I5S"U&15)M^N?"9/_OOTX3(<D='TI#JZWZM@9OD<
M]Z:/,/UK $[30G,)9&)&:\S!GJXD"^D\>E9&Y68]']=#HTKM0PLH_0<K]A]7
MOT<@5M[CO(YY2+E_-LI5G:O^9#[\;M68-HVT&3BB! ZKOOWFTO6 (<6)=XUR
M_G89X/\%<?!?M,92-\%K45'4HVE"KBYD]U=DS-!<@-],\31/Q EL/XU(8<Q5
MW%C<6 -UE$G\*#N(U\F+^3_2RE#K]SB'P1@2)?K)$>,GJT3=%E@4./2CRTWC
MD(X=,E01^0E"C<(R#!8S 0 K4/3OE&C^Z[DACEY3:"(N$8^BU)F+5[,%T$CV
MLK.TV*MK^=]CUP5FMP!8XXZU;2-*_OL+S&;V%AB9A*4!!MG%M\"_O(&0'N"?
MIZ!-*:K"XM:_?);_RTBCV,5_==0_-RE[[5^^&)<L,"MO'<_9WI4"*?WKB=?]
M]FB[ILN%X%ELWYN_;ZO_I**_/[WN8)-[9BJAU"*J[$*BTZ\-=L<@I[N?RIQ;
MRT,URQ/'USWEF9<N?6B/YJT4,V0GTZ>7W-9!E65WX>K?6]G_]A$AS8W3%.#<
M<RH6_634O!Q-ZB;!9/J.9NWWAB-,K:.^%=/+,6&J3.NFCND6&&WM:$3^7:MQ
M?#F/NP5848:W0)G.3<+$S/,CEAO%FOH[RH5?/\5:W_EKG/$N8P>U93/Y SQ5
M.SJ*.TMK?/5^[Q;8#8)M,</?0'ENI*E@I^W@$U*=0JPP&(UMBF<W=9-$*>0'
M(LDOBA.QO$"MA/&6/GGUL72/V)+6Z>'#G<1%DI,,@JW$Z7?<9C:( ^X!OXCG
MP5+->E&GJWE6YSF*4WXR_G #U%9MXK@\O2>M0^ZXS'IJF();&Y$AC@6P1O2@
MV+[ *P;TT,OEV)$8.L(LS]\0/54U^EMCB%?=(\2IBWLP7>PH!3C<OY+.F=_Y
MN:W3D/<5&5PW.!TW#.<TN\[#98&['GD=TQV&U=PPCAL,GXUV,M75AZR;6^>]
MOMDKSOA\M% ')U^^@=MY3'L*BM8U50L96TX::^F48^IR?8X"\3Z_AXFW^NBG
MYG8*43-;;9:RYU)&Y8]M'\X4]QU%YP>74L=]/TB(/#D\%FO+A#.)96*[#2Q"
M0_8%C$EV4UZ1S#$4>20Q<:TY*-P?]%YBO([6;SY2?9\_8$>5!;<YJS "I@<$
MOC-]80R6!@L936T8T8V*2V=;!]"D:J#3AB[TMFMIH0N)CVM?L/W2(4-L8U(R
M*:TZ@864(GN-:(ZH"APE\A.6O9>#[%_<7X***I"4Y)8N:!\,/Y#%/2A\E"@^
MBENBLL) NZBCPNVO,RSVFYK9H&F'U9+E$?:P8CM.DM(13BR"IB>R6'\'9[[F
M-5>!OGC-R3M&8LK-!EB( *&,]E%<;.?$%A="OQBUH(J.KZ .^OK;H8ODAT@)
MF/#JN6N>;<\O]7'W$K'<;U05RH5WUJ!C^.[15:PV<+SIBBU1+D4E4$9V/C[3
M[8/(R.O.%(!'?VF1J__YH<H*_.S1DM!W[^V^?.M%2I;6N@F$ ,37'Z38-"&[
MW-18_P;C%R6[2!N-T8-=9/9D$\_#<$F.$7!8$]WC@\2:<$?L_8&78Z$ZEIP/
M!^<_U!$WIHMJGJ?*-=T"?R#I4D$/YHQ__+ ^-D IXDM1TF_B9<V1]N"^5L>U
M;GDZ:G3U@ZW29$;Y?ATO_N<%9E1C %]:H_?(:RVS(]W0=:H>+D<U9X_@_;.Y
MK)^?27++Q*,^"A_(>I\B(DNW;_#0?VRTEU8W0JQ/?/LLW7A855L@O!:<]W6N
MMPY>+JT@_FRU^IIR6GO&%LQZ*5L1_NO562GIL=\L]'-0SF.H#.FG;L!C$46"
M4BGJ+[2E]?-(%.;N,.3'<E!+4>PX[3LKS#VB3#B(M2^T-FA)DFCZI=&6Q"-L
MG3OX7HGCV?H(D_RO<B-_SV6XTXX14X8J>NY;CT"DO>;3=+T:6V8!Y%&42+O9
MR""PK=.DG+M@FZ*:Y%W@1;2!7RAPZ2_31P8I[2.=RHTK9QO\ABU'O2F^$BBV
M=:68K0ROB68L,[U("3+H=Z 8!"_1#)%XI<HT3+)\JYGFM&A,4.[%-&3R5%>*
MIZ#_>)]EAV/ H8J'#-;A;5.HLNR[#><2B$Q>X!"J4?8V2:0A#YAX:L/Z.$0_
MZ"CE0Z<1]725WI4(96W0P=Y0?IFSL]?1@/W@NP"=6P#RJ1T+M'?] F.;\3^M
M?4)'/JSJOON^>,\MP+G]B2)C7C)#:28[4/S%\;@O?CT78O7Y $TGUM5- J'/
M8;B? $ZS75S8P2JH,0F4=5;VK+FB;N)@ 7G,0E'HI'T+/-^7(OEWZPJU91!^
M3;D3-V(2_M5JXOKMR866']>RB'MRXLH6OX>2MP1!>N>5W:1)D)@U&36I630.
MI;83]IUO,),*PRR. L3P#/X=Q5;UL>&@8Y7JD8M3QVVHA"N(#+R6:I=QNK,X
M'BAI]%=K\P-8'+/R\OMOX"TA@9)?:M&<9#_:7?/M?(9C?KZ,9OYA6*0C)F]#
M>G2N@XA<;HQFWB]([4H9+BQM]"OYS61N[%PA(')EIZ9\"WR4R+AV4KN^]Z88
MV'!W#&LA'SVUX1_2U8]8.!,@&*6>^X;;BN<%AW/HE$^?S%83LB\[V%O2*&J3
M$&\.W?GNR-"PU)5)_&6:JO.RD5"K]E8Y"W#+:WL\^:&O+BX21>)6"*_\F2XJ
M4=S@;#T'UO+X8_D0B%=419%&[$()9C)8<)0N_WXFL4KQKU]G#989$J=7 ]C5
M#32/XR[8W\?;]3M>05<OKZ&E)^;5,9NJE4&0/Y0;W8/DWQU:O7AFQB@-9-%_
M&/*4%(WHN6RW$)"0KII*M!8OJ6MSINB1/49]E(9>NJ8_EZ)%"H7SQY)T;UC/
M'$$1\[V6TEASC+)ZD^X0!N9YR\F#G)KH.3DXBYDK8Z#OS)<_>Y%+SFVJC^!Z
M-D-ELG8$&<AIE@>N#^+,R!22Q?1E$C>#,'HI6EY,G/*C_R@JW#U#[G4<(%<Z
M5C:F!>(7/>34$@&D\_%'OAG64=Q2#2/9(J^1+B1WVHHR!NPZR]NF%#DK[<TL
M\R#\28S@$S$/3/R/>>\9^%+*[<J\&F\>+]#/N-^;X#G%WXPR=JQ-7V8B;8K
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M4PH]ATI3CBQZD<LWWNNF@X@<TCF!B3YCK+OIVGNBD<LN[\HT>M^R+V5\KRA
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M!8R;N4 =UE:R*SIRRKL-$=*_F-^W-@=3JK9:,L:SV6\8Z$PQ)+Q>JY)26XU
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MDA&=2<?R$B(=''%+BPUN'Z\^,WJI%SO_0"WJR3:AJS>N&>SF73#6;*50\TB
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M'?#[PQNW7_+7WI,%<]!O?^VZK![R<.5\X*.ZR;-]PJ(H4%.#+8VES;/%46>
MK@1S(V)?CB$#'=UXX18S6'D/4-:7,] 1]J;/OR#I7NP/Q]41PJ5"ZX]])_?Q
M+F5IKM;1T6PE#'!FA&DYQ$7XD<=83"7P T/@1+)JYXB][\LA6R P>O9%_!07
M<?9\%L_MW:L%SOE34CI[IC[VO2'"-3+"$1;8 >(EM;A@KG5R\LP%%^YF).H\
M?].43L?O\+,4'4Z_6YQZ0^MA:86Q=5+J(_[M$5+I T?-,U_&;VA P@E<!-]C
MSE,2-</5.R80%7?W6@U]!04.7Y:)-%<$SZBE.7P-V!U[:G94:]<SV9-*E7UC
M8OE/PE^@W,Z'9&;<#?KG?71>D*(T<'(0:SK(9SUPTN59,@(AI/:'?)]-@I?^
M#BMU%94T)0#N@?\ZSDD)FK[/"+.NU@6QG:H=M1Z[!]J+&05OI[#7Q<I<#3-V
M+XF?P!K(/=VC8X($=::7E6;($23 CAPO3=K9M)W0W^D MM%BXO19%#'0U,V
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MU*.#/3V$2\=V1[;P-YWF)%.NPJ4ZP@KZQ$7(_L'"<+LS.=[43*/]LW=GC@B
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M@DF]CF4#)UU6NLFY0-W]0:*MZG9=A!#GQ OD(YBJK(#:,FWHT2IF+]"UI"X
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M8HLY4HR3]:\G^WL__/U4\>R?^<<V6<= .N4$/'VJ'U1UZL".63"'P,^P*07
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MVPUO1[RN2M05K\/AGYZZ-Z/(0>P:4LL)=CB=D@BW%//1^MC8<Y_5<U)8%J!
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M>&H4CO6'XPYY1KRIDC_?&E&+%^D'P[<VS3M]M",]O]Q^N'JJ%1$4L#I^QOG
M7EW_),9Y6*'"LL09'DDYD6)M-*U[G%J>?2_A6EEN82[_8$KQVNGXM+VU>W!]
MTJXSGY;VLN&@/=36H\B0$X56!R,]&HQ[2*YJ$D.@-Q=Q=RK:6F3TL,=\>DK6
MUK4DTY^\F+I@)?K8W8J#_C2*Q 3]FTOQIJ=>:@H'3B9DCL0.]#X#:GR@1BYB
MP;$0Q6)S$>Q3MQ(7PV*S7783LOOTO;WV3C]>/R(<J[<A==U; +2B;.0B?C[_
MB0458>U_\&)#JA#802^@282G[J+;Q$P520O$Q:GF#B0J9_'=."S5PT7<:ZA!
M+4B%0BO$S3 0!!P7HE0)6>6EG3/&4:Q/:"AZO-G]R2+UCG#(1PKKL!D70=@"
MS'YYL0&@/P&=H%!S@'(6J':BXE>$CG(105;M4],8*!".QDC'\'^[O;,'5OG_
M_9 %',WAPS$_M04XBS:8@D(N8ID1 7$V_.X6D?6[9PS9N]&P^;_H1BU]M8?:
MNKB(L7H4:T'Q=[=K"+][!O6_1;/R^9O(Z7])_T^3_BU!Y#RY[LWX'O%"5YFI
MB UWUDK?0IU'%/W53'])_^\JO3ZM^?#)0)T Y?WOTY7E<_8B].W?O7OOMN7<
MVY?RM1D)6\8B$:&0&&HC\,45R9K @Z:!ZES$T=>8V3>EG.=PI>W1F*6?%G^[
M->?'_.X9#%6=WL!9^X*+J'PSQO0C<!'H?5P$)<WP=_='8!#]VV.O?P>O.80^
M,L &X3 ^. SUMUO$F=\]D_XWX?( 9Q<N8GX$R5G9_+M;'K._Y/_/*'^.LYOK
MD$;%W=QTQ>*XQ&.AB._SD3W_]0SHO[;Y_[>17DFAUKKXO6N9L;Z'5$3YCNH7
M/.%#$3UW5("_VNDOZ?]OI;=JEF;I&?/X.EW/KS?BZ<V\]CN]TSR]1FW+D%WM
M_OKBN#@I.D_3V&:> OW-YCS_ZQ)H1/U]#FRKU:T=?S>N9RXPN_2KK;W!"/CA
M?[T-^'^_X+>7U&*V )?:^R>K>FV2,9^P,:G"#.!>D1?>S_%P)QM#FQ5L]@J@
M'E?-+PL;</,5G]LUG6S:V3H:8(1IF\CK,S_4S@-4'83VL:5!'@;V)*C$.G\T
MC>T.=M%<%F>E Z]6T$6'E"5OO*R6:#!E77;SVKQ),790/M5+>73@LQ'Q[>L7
MR#92Q.H8 @%4EJR>#>\AK M&P3('J-ST6-,Y2(W=KL.T^=(Y(JJIE9\24>DB
M13/TCYO95HB7*XQN^?Y^18 9RGD.!Y@OE!C(3XX*G > !P8)VM0$;Z$O,0WO
MZZYG*'V*(?9-XO;*5<9/**7<;B_<>V>=F.(-C9/-,RNG(Q%SI#N8 @=*#5+2
MC8N0JMP#LB QLP=HE<+"@MX*\S+S=\4A]=V?>\B^85E/]Q06Q(REFL<H=U8D
M-,Z9*'P6:]3"@PJ]]:0^5CU& D.-J-0#@2H9";"#MI6M3QP_OW0OL_LJO>VC
MSZ;(I3.=R4H?S)]6&RK$:>0;'@JXDR_&'^2LCP@@3@6Q%-D[.!&DJ^WKH6;4
MFH72W$!-JI#.5/$I7]F F0QGEZNE3^_P9#YVCK>1Y2D[?F<M8N'-_QH$XH?C
M2%^@"?F5BYBZW8-9"+K]%:?&%LN!3@83N0BGH?=<1/KDT&O$RTC%?_/U%A#E
M(AJQAEP$$5;6%\G?_O4?B&]_ICKXXM6IQ\PI.W(1O;PV6K/+ E5<A+W-\H:L
M$=2RA!HP>3<GV9\=.LQ%Y"FQPQ"G?J>>_Y9KK5X2.W:)M#@J.:_]WI:)G3L\
M!+_H$;:EI^Y/;6T7Q].PRX(_N8C%%6!!S.Z//X](_YFJ_J6Z*UR$W,=93H ^
MN]7=^F]":O&\_X^V\E]= B%PJ4.D[Q$37 13;Q*U@OXX42$)K8<U21YCPT6\
MG[7E(CH69\_^J53ZUI@'P'>U=+@#QKF(+Z?<_]5OA/N?/1X@Y5<Z<H:!9T=)
MDA8_?6T]#!VE [WBT+$[N_^L4LHT0X:W*2MS4<NPBM]66]X^"TQ^5OOA=NG.
M!L67__:K@:'&#EL 5CB8E?6YD;__]4(H\L]4]%ME^5Q$W- 25/$2NEJL]#L)
M_V!SO-^1H%H#.ZV >8^+R =TH-A(4O1>J!WXNR'GU[Q++$AH/Q?Q*#.X%V R
MN(BLIM7M6PA@N,MKV=AYVI^+\$*M!*:2@/\C2/!6 <//L7/'%P&6S"*>@W)<
M=!3D(OA@_8E'Y7 1WY;> C]7EMX@%%]&_ILO)50M:4ZR@XN87. B?NXN_E>_
M[^S_,Y6M7JV_4(ULL '2CZ*L#+O^@)V%+(B9C.0B=AP1^[.Z^(\L6OO]GYL%
M<P*3H&,K&$XP@</74_?[7U_6UOW9*36G/J!Q]C87X6@!:-K] 73^8&S_I',V
M>(9)]-/$Y1TK) [^5@.$)]XB_L)E_3-Q^NHOE>,LVXF+V%DWR[FN[7.:BW@8
MB%JL QZ^6/_Z3ZKC/[3G;W]N1ND]VP26*@@%D<R@$+=+?_AYC??2GYV@>C]%
M^N[_$?;GBJ2G,&;]3L@_6MPR+R0(8X:B.R<-,T5HA<G$2^+(!E(!Y1?P@^!
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MK@H=$5;^P41:>7G#RNN7(9KS]NQ4 89G@^5J2M)W:/&)(7EKJ+V2D^ U3!_
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MB7OUP2_9Y7M@8]6Q#.-R,U0&4(6NU(;:A]1!V.EMU&/,UD#KZ"7U^$WM-!7
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M.HJ$0&TUN] %21]UN @O/2N607.CXLO(9;&IOV9:_YII_<?C]88!MYVSSIL
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M935'R)6K7[CU*K@FC$[827TC4L>(O2AEXFN<4D%)G.J?6MX)(R>^_KVCRMB
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M/M1QQEO9:5Z:-;FU'QP]3;5V63H:-[.Y"-YIX &JN&%JE-[54E+)F#K_:B"
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M ^M6;<]3^\SY_#<IZ\SGSXU<^.=99I_W5#+/$T3J(%EZ.[]Y)3IWHFBF*[8
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M"CF6OFN7Z?/H(]2D$-RG VVSM0"X)ZD*OW&VD"X<]1J,I_H4FQ,N%RMPEGD
MM@^#B&^KC'N*DKZ\H*D\HAV=9O;40"-ZAZ7*W+R:\^F]9M<F753;STR"V%W#
MGJ)IUGEG^/6M1G^<]DD(+"E.>)1<HME_>_'+RK%\MLV(EP!.\O0A4HSNF:QQ
MZYJ,E3#:L8R5-;676<)NP_C[*+HY0#Y,VS9F0O\X77F7KS7_<)!H[\W9U-"6
MH-;RP?T]SF' 93-RR<CCE]H<KR/=.UA'.3]R:<T-,?<7=YI^KJD\%H?%T]@W
MPYT=J#BL2DY4]E";NJ.?L64)6*IG=BG0(,<D0<#X#'"#@Z4XC1,>H.B6V+OH
M3?,JNMO7IM'<7C6><9&,\R(<EW^!JK,(PTG6PC':; -%JN ;3D\Y4,=C!SFD
M&GEH./1;DZP<>N*-V]?@;4"5JBXJ*\"?M)D-^&>?W'>^^>1]NSK"L>G29T%K
MI)8H$5@$>B-;T<H+P3[<Y7[UZ-V [\LEJ"7FJ?:57ATF,G;;E3RGZ'"L/B<2
MV$Z:[AF=\[5)0UG3E &&ZUZ+J1(V9EEN^",OTXV3B[GF8.3+P1[I\>2K@%40
M]W*<9IY5]C26B5W:',EL_RUNU]M-::X "QA2=H^'/X:'K8OA69C/X'NWLI-P
M:X46N92/77- 32U[>EXXT,$FQU=^BA)L2X;B;QRZSM9)Z@S\ZG4P@-3%GKE.
M$,9<!>X"&W1+*R3I(V;A/S#E@ ^*K,JS*&I4FO0S ^DZ\_,ER>'3E5(_JXBS
M^\XZ&0M.5>]5FC&2&WAEG+AEKBO2Y#?Z,JVU02D53&'X4,VJS 1/C>"C"6*!
M>E05"0HGF$CSN"HH: NVMRK/O#ZPJ$U'3EO WOLLS/1E25=)A>/!DF!-3J!E
MC\<<J8\BK&5=>J_$:Z$Y5"A'+<=0_LEV/.).,+X#V]K^6[&\X.XA39U#:E,
M2P4T^]2#+]W9$X@-4BT**BE\L"WXA(@.2W6WQ2QVBRNA$+NZ&%%0)=LLS06M
M!/8RCIM6/&SP?P6>KG?#(!O:U+7\7(0>7;@YJ'IH\<<=3!:%#(=FJ^>IU'.B
M6EL)T_RLJSBU4U]5_-=7Z+UR%3C;W1%!+WK^\/%E>;K@&[QW*+X5#Y= 7N"D
MZ.Y6O8G]-LNT9!A&YR7MD2@9<3BF(M,HTRF_;WG>E#3U/JSR.72(DPA#>RL
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M,,W^.,LF]XJSS1&SGK8VT!Q_F>U1NZ%_20X.#<[\+/6'AWBNB\AB/[R4%N%
M=N()LU_3U'ZMOCQBYO[NGCM5<2C537'#H(L#45"25@LE:-IVFG$)N!D==HE&
M!(4_M6AU3:I%G^U@ 1K=)Q1@<7II',A_$NT3=+>N:%^^6U5KL2%B\8A5@LC:
M,T/'=8.0KPX4[0C;![5)#OOARQ.Y[*0IPJZ?.7$/;J$EC;;F-\>H^NI,+=1.
M6OC@3]A!5R'=D.&</@LWGE]3?$VKA=!(^"&8) @!O$/HRM2KWU*U(_R>'ZRI
MCNVTM1:2RSMP3T<H[8_1052^=UH:Q,1O8!4''L:QS3<G.1#F2\S?P1Z".45
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MS$!'V&F4"<V4\-%NGJ_8$;P,3'\9:_#VR7U#/=></"2Q.]%)*)J^^LP7\87
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M8 3#[WL';:-E67+$Y4--L!&71-<YQ7YG<1> 6*Z."XVT>%[COF"2WO)^'N)
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M/G_HI+L4PW< SO0VV92147MU^G:0CP5KBFD(<B"=,T,$";@7_#GB@/ZXMLD
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MMJX_(LC %Y5=.[WBHBJ[YT6+VD2#\32>5$G#80GD=P@Q/Y4-V ZZ8R+^$B%
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MP^QW6CONTA=T&?(ISDB&J^UO/>\7E6:5/M"6 $>?)+.MWDY2=8+%H%3S'(>
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MI&:SOH^LP[4H+!%91XE"MW$K,BX?/3Q?JY1-S3*M04P" $8/JT Z,Z]*7=[
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MZ_O^U\)_:Z&% ^QWK-TC*#E.N^%^6N(=GWM>2VIL^1=%1:'KYPGC^L>#Z0Y
MPT_9&F2MGL+C7/OB\Z3OC$X+L243FP<:N)N')0K^VM[!VB>0+P(C./(33K)H
MQFU!:DF/=OK"^:9Z2^UBUXVW:7DV??'^RN-(_(M1..O[V$X.-/"QAGLP2KVL
M@\\Z_%V?@_5F^78!1FKN_&$/]+V[#:SQG7\ML+[V^2?%A?V;MQ<DZ"8S^_/7
M<L83- ,RFA24V!':J C.>AHNLD0P#R[L2A;UB6UKMVZVMDK6LA;]\,%*W;!S
MPB1A/8_ICF>/"I5RI6:"%KP&HT9G6FH388J@?H-R8Z8>77SF%>80S>?<=(I=
MCZUTDG34:M[U'COW>QUM0B(?)I4V;D/H8!L!FDW'YM^*>-@&Y' $))CF+)37
MAA\HP0R;;H(R&-28=L+705/AADZFDW/U".W.\2M6IIC"F;+@VU@M-H'H,3<P
MR8#3<"R)V-$6EJ)NYJ:>K,XEHCQF>R=&[Z<OM6.S6\I1.=%!]..X-%U&J[?7
MGI$3C>=&?(TC!);&T#2KN?[8\^Q8%&7 *P: &2#R"34C&T)T&Q%;,(<W[-+M
M75+#B]H,NZ6%!;T-'F"\/FBSPU*),ME/I.3+$"-GB)1O. 4WG7/U6A4$WBG^
MG,+1R[;G6K>1<.=:$W.?P=\"KK@XA)C!=J9:0.PH;KKE)6C=F/XT+7*O;XT4
M1_2077"(X<B&XF2JTI"7>+R*1^YZGJW;6Q>DY.@(FBEN,&K$908BGANF07OF
M.9:3N;:!^:BYL/V,W2&%+W5NB8R*44%1S?V6 C&\MHG22IGN3\'-60$I#43:
M,01O -!\]D-Z4^+TZQS['WG[]9L^!KAI/] )GMN<#BD491BY<F1RF@OCPJY@
MB*L.WD;B1#=@T(LC8$J/8CSM([J@P9V(>RB7ZV1J_M-BM*BGH9:;3$;'WAQ_
MF6\F'BZ\Z=+U=3>^&!2>6)]:$R\^FV!D^(*=KHYR54.&$1!E;'Q)(B\98\+4
M+(OQ-$38#1W-"FRV5DW-\VF^$BL=;V8HJ%'D<>9(8CS1<P[4S6 <96<MQ0.,
M9';Z6)_A%NP7;S<IO=E(^OEZ@C(AP;I7KCAL-LO55LAK>\/6\!,\F/RP8F84
M2U20D0$6,=<J'>AB)2!3D9\6A4N[RZ@WX>_9;K=I:A]_.-,4EZ9O/8X^0 KL
MOZBR@#W#NQ$6HOQ/!)3YXCC]P_KLMS[Y@L:@$U,<1#6D.>K3S3_584Q'(\OU
M$'>+08E3RV5JO$KE:3[WFS87:CQ6.#<63;W?]Q%=9#'3#EGP-O93%.65@@2D
MV&Y W2EU YX1)A##D?U:XA6)$#>4G_+NW]/=;[0LY6?MUU4@8*7R)+Q\T Z9
M;J&[#+R0DI)D^,T[#'U.,A:52K7=JOHB+-G4 ,87M*)/Z:C_ -Q D5YT<P2.
MXOL?TM"AU3L#J4"82(<"X@+S:LQ@3O177QMEFY&2DH[5#XJI&/'R.U\V;&:B
M65?9>40OKV@NK$!W.FLT1*W>#EFG+G@*-X).F-/:_N;B-W>[Y.K2(,N7R!W'
MDEHVG#,U:*\I$Q%]>U5:+1?JQBW.-SORC&LVYCAH37<_WNU#C$%OQ(3X4^'1
MJ7K[? NK4G?M(ETH-I5^F3 X*S*AY/GI>]L.28\PTC@7!FYW2,U^"<W5$13E
M^2KZWH5WK[FPS9OEVTR0JQT%I[S&BIW(EZ/#"5^)--.MOH?.<P3=H3$4H5O=
M?Y<.9^U4$'Y_/XQ9X?6\H,IV7Y#D.83_K0FAI6?PZR""Z<'I&=X+B=<,^4R&
M(%A'16QT-833^NKRO*0" JL/'NKI&>K^YK:%=+>\_.D.ONMBFY,:G[GLQ,4%
MZ\YT,KTP.]AAV(UF])R18NO!N.7TIX1$*E+@>@&_+U+TIZY2_KL,%P5LX,M+
M(0\M']%>$:Z"_ER8FA;K.!=69-2%6MKFM@ '=Z_=:C1AF@%UM>2"Y>D!//C3
MAK8<N0C?""8VZSE/Q(_QXZP2#A*N<SK%"U8*8NW]X 69^Z8_G(V^^7^Q]^;A
M4+___^AH(5N3?8O)GBT54M&\*MD2$A)B*CLQ]19&QDPA:RB*(DU94HDA6Y9,
M]B1D9\0L*H7):]!X919G?,ZYSG7.[_>[SOE\S_F=Z_N[SO7[X^7RQ\S<K_M^
M/N_G\_&X[^<BL):T.%6"FU11K:J&'K+=,-7M9/$_BX*7P8%6CYM](<5""(/W
M8T5'H@WG[B+R+LB2U68%%*SF_LQSIOG D\W*X0^-P[>&\B1Q/?<X>&9I!Q"/
MJDFZ8]*COXI*5NR='V^1&[N1;[NO)&?L]XFYV(+97:]2)F\9V>!O7U^W_+_W
M8,[,G0U^M/0M[(Z\K,]CY-@G]::BZ*UVJC9?FD(MMQ=4[I3>8DMUY8.?%2-6
M&[<(H%(1D^/4EOK-*N;#V .@.4:I;<R0&$(1"*AZG^M>]45=Q;<K],SA#+N?
MS[XN)[>U)9I.:)%E':]Q2_#4-S-R4!#?XK$@%/L25ATT9=6G\,S[:'W:-*'X
MVI3/)^<\Q@85R4JEF?=WZ_8O/V#/G!_=TY@W#U"+[D.9K =0U&M\Z^$6\7D<
M*@6I&QAZ>3;6WUC2FF8H?#$GCL>[/-S_5.)Z2)!$NYU1]6QO?4'V-R)D(-=&
MV(F5@_A$?=LD*!=O[/2"<PP,8,@4!LK*VMBF#L[*.@7=_WUL=,\]L>5(PDW8
MNF$7I;:4L9TMCAM!"2+%>>,(B55#)<AZ]L4KT\0:BFR0MQSO8VX[3W?'6T^/
M1QW+;\:B+C4[;7U<F'6@Q=9U^2&>VH2JEV-L=HU9XM[FV+'/\3XC94'[K^O2
MK/W!IC/Z3W^X&UA.?SV?^L7C5&KVX>C[U1J?BH3V<N'I_ WT*:?Q14,)KYLG
M!5;,C:,W8%?1(LJZ\J0Q69<&I=O*6ZJ[LZ?VC-MNP(0VVY#NQ/&WQH1%.WX=
M7_D,WM!BBNGN\H9!EG1 'GL8-.E.X5C[%)_A*8.,E^W!;M]/3WGF?)0H^N3D
M<5Y5_63_Y]?%F?T V7F6P-E=Q-;&?9[1Y;Y$[L=TLPS2[,"DI.\C?\0-SPR9
M.Q_[^OO9#L:>[0\UGKHKJ)YXIY-EJ52UXC9O@$WC*X+\!BSM+]L*-P!4>I4N
MO6FVGWW!W(!UB%Z+,N2HSR@>\.J6_@C$Q7IX:0'Y<;(G^G?"D/<@A7#FE34J
M,0&-,Y_Z=0^BH\4F>F;E;USP-CO\QZK>XL8]O::W'5K[I(VJR(*V"UZN_\95
M(<J(-^&]>9!_#VL!Q?-)I#./SZ"N4PT%IW[=/.4VLQ?*9:J?;B0E?#TSM.,&
M SDF66CK>F5%.\]*1]%1Y'53]=7U*PT;L%24M#D<1'U0)'0L):^3?ZTCLV%9
M\WB=XDC-.&MIIV>&QD,V/;NO[PG(LCYEZ7]IAU W"3SM".V58Z"8];-17:@)
M0YZ($,AN]W#L@L?)'<7FKJ_%<4:'L)8E%*LA3^]365F#5<?OGM@C<3#]_MNC
MFV5&2'4D1CX[EJ,$$=B^N"ZD!OCT/I6P8V&][C&8W48>2'SZMQEK_.%\2%G3
M\Z,F;TR=]>]-O1%1W-7BFWCUKT4%M)V]E^,PR)%BG^)-J@#@2".J"TX6=<BA
M&6^[[XW:&13I$3+Y,\_65]/^DR5[*O&DR]>+-J^]?-S0AS=@\9Y+-SP=(554
MZZ\<3%&(+<>1^[)C]M-UNH%M"_ZD^E[<HV?PEZ0K U.F;7R*V;WH1D-,B5)E
MT[=:SHH+5UQ=]?)Q"CP_Q#/%A.G_R#M<K/[I7<:%SVE*OEK4=VK-:3QA!!N-
M&R+4>5>S3P42:OJ3:%ZF+I ]<]8%1.8'T':\8.M.N5N*Y*YH^VAT?FU:NO18
M#'FJ:Y!. 8,R"!53_!V!,/9".=7G&)BY0O%T/1)<(Z5&%*C]BSE[N+M@]VS&
M0?$;B,T>L'_U2?6.W*?X5/P#8X&%Q@%& --QMIXCC>\B@(ZD>#[$)0F< ,<_
M*+HE<RS?.!9UX\L6G(,E#V?H[9U#:^D%2O@8G1[\]'GM0&$R*R<LB27,?8/3
MYER'4ICUK"BH-[0$A4FC9F;20 [/$&1D3UT(88W+[I^9ZOG6G!4MY]2]/Q43
M_S;I;&_-X5-_]7@B$6PC%(]" )T"C>&0-K[#MD41-XR 844%R^F(N_N]:B+O
M3:&$I\Z TU]%TEG$&L31R,AS]UK?21/ZEW-'2-0X1,W#S YX'/(P]P%/E3=@
M +;/ JU$&5''="0BZ[=GW6B$)W5E7^.XLWG6M-*2KKMYC\;]C(&',X!!LM#,
M@W^#:UW;@-6@.U (CCYTK Q330/:X^E+,K+UU>! 4GI/G%X3^_%L?=+ (SWY
MT/O?)>WWGC_0OONN3.HM_+$6)&Z* %Z@0)H;L$[')(0L@#YF09WK(,1MP'8U
M7_>CH:7@B8WBOPMBJ>S>ME,'V\(T_!MN1S;T)@8LLQ Z!?*\9^,?^:-3VNW-
M>")&;&M(FWKG?7,47K1%!,,;[R1(U-Y.3#O/U,PZ,%RSPU'MA%A66EG[H/D[
M@[]!6A*P8-PD4$?,:%9ENV.U-YOZ\OI6@LYBK:&2[;SJ,DR2^]N0)K0(YI].
MA=+WA^9_!KQ[:GF(]?."E8;8LI^S3R<;B9O$2Y@?86.A,I[P8[;#@F)8&;T,
MV$*&9FGC=VL8IHOJ'7G2V;7E'5&RM&GUYKH&JW-75#63DR2Z:V__G7*I>C],
MHB[V&9UE7@'NO\1U_Z-]I]COKYW66]Z5+8Y.:8E[+J7/J@MIX@,AXA\\=#2-
MA:GYLL<_5IV%'D?7SJ5G]OKIK]^5D%/>PBT*%&J2^+EWZ\0&+)0RE<9ZPRW
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MXIM-D 6EUJ^].BH'WGB)IN4GY>%U(MMWJ!JL-84]_-1HRA,9YJ,;+K.4([W
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MF5]FJZ$6""*+S;8ON:2.%G&PH$.<QK5:N.6O&#OB;.G__?BY,7R OHQ%&/G
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MF@>?#JF+=$,:@'W-&6MY^M71?6$]ZG^1OE>LW"S#4$J(WF^0/1N'(?)$%<
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MGV&J3W)+\+3 X%R<ZHAVSN$P[2SFL(U58R+]B ;"-]IC1E7MM5:'L <>]-B
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M_W?,'8V;0&T%-B&W,U0*QK,-3PSQ=PJ2@M^ "0L2@(<_?JWM+^T1;V_RMY7
M.-_]1MT2LOH[E?UYO-O!H&_Y$Z0XLG?O^83G6D7G?CGLVS?^>G1QM3&8JP >
M<;O%4<W^\># :LAX>-'A?IU/!?D)#[(BBPLJ:JL=IL\Z6<I #>Q+_VLC.H.=
M*"G(PA7\*O7&\650]91&Q<%=/4I[M)430[X#DQLPEM-F7"3N$Z*:DH3W'TBD
MU"':T4J_9I2_A*Z6R_%IFP1.&27N?"9Q;T(@D77LA/J(K(FKB]B>V-=;>U1[
M$<3-XZ1- M6Z!2? V4SLN@1E\X0GRSCGQ_)=F0%I<\RZ]\QCBVILKZ4TK?R^
M7.>L084KRU-;$-6)\@FZ23/FY&H:&M*J9TPS9UGX--;)S:@VWA1.AKG6+EU9
M7SGVQEP!_+O*".B,! \:V[T,-OKZ256I*/T)N57ZLYM:Q!&#M5!I@;^C;,1F
MQ1 2&I@8^H;KP\-)U%>-!7.+D]O9=J40< [T-:1[*LG>:_H5N?YB [:*>2)9
M;ARL8'$@\;!R?:8MMQ!/?83:C3N\6="_18K_U^9&)KF]75&#(+3:9^? AR[Q
M 9#;,;+7%,4B GV=E?;\S2D/1ZUO=WS33[X5U#VAA_)W.BZ><*:R\*M-^1ZG
M]_</Q<7<$SZL,@EXM$+5-+P\1*&A4\R5P"6Z!F_7^)]0D=\#IYA>=029KWDF
M7^^]M<!4VK,;[CJ</Z'$*:\7BO?:+BVP#+1OP":J6;^@,O#3%#6*(^W#Z@#1
M'8!@VZ!6O0^5E$@LI&#:Y+\>CG=]%]/SG&U^QZVOOK:N?L5%.D@L5 THXDUM
MU@1+(EU%B$-FSL/8\UB]65*B]X$:IEL[2KZS-.UY2?#Y.<$CSR@*[VKR#@[:
MP^Z;%HD=?%L&OUYX"WD#"F%+8:H]N40#((Q(KNX^JIUB?IU&$>ZED6"_5.0'
MOU</-9L$F2TUOSMA/M1[['NK2/J!O:]$DA\B.9F/(]AB6%?H -L.:\TMQE_)
M3'W*QU<4^6?5V=T\96;2G;F1J\YNM>G/T]QK/&/*_LDVMJ_#R#.>%*-;M,10
MO^;W;OU(N@*?&*?5+^J!.X>I4>WE5FR7+'N'I0M,TY2(T!=KJ#%#32.O>;GM
M,-1!6[B(H(3,KFN%#0A(UVWQ!',K3\20C< 06$BPM#O4B,9[/"O/>#YN4D84
MM'US<<?EIL1O^B+U8V4*_K?T9"G+U9>VQB'3^'/6_!=3>D!1)%U%09K]C_E;
M>9CIQKA.Z],RBS6S'*Y%*5[@Z#V>61X_$Q)P2[,L&$JTRIITI_1%J":[>-<.
M\5$6'_9GD.JZDY';,"]66,_ TB1#I C6;KCY'SKBSKBI4XA'0?ZACZR"R^*U
M37K[=1JM>S[>NT$L#WP&3^(=Q+<:X /A8CC*. H\AYA08CT%UVXU!\TBX%.!
M&S!9K,$L7-#^-83OU-FB9A'UK35JV]A*8=>MJ[D:_TM[WQ75U/>M&T5%! R]
M2 E54$"DJR!1D:*(*(HT(2A=!$2J$A(!Z0(" @I"1*0H(-)!0D((18K208*4
M) (* 78L<4L*-_SO&.?E?Q_NO>..>\X8Y_>P\Y"=O?=<:\WYS6^NS#VG^M^I
M4-QM3+TV2\2L%RZ(@G-&81)PWR&2]Q!%FQLA^[G(6,-E0%/M79;E9OJ7OH\Z
M'?UY+<*7<BCX3J7(8NS>YH\:B>',NRD0UBP[CSL'CS#--;3V,B-:)=D6U+C8
MSJ4@XH.57@M+@$TS2Z5IT_.1TZ^6L/";C K",X$1=:]=3^WVN _\QB+JAM*#
MMB#^:9+4YA2<NJ\D;C?@DZ RAI)G&38!UQ_+[?EQ5=CF=73]6E7V17?!V_AO
M?8NG59*E$88>VHTCIV"*:,))] )WXL7P"T5;$&G4P17YW>RR7];<^!$MQ'*-
MH)PT)@LV$U_?I@*-7[[F2D@F7GEB*8,LH!Z];>K\UU_R^";C_[#+TW_2\9_3
M$/-_K^\57(9E P8 _9/\&\DPH5 X]'288CHI(.1:PLC!.[KV%ZJ*DV07KBVB
MO-&$031@C2 1.?NR 3URW@.TEZ"R6=NXB19EH-WLFFN(LXN*HV>C\.MK[A%R
MLQ4\&[:@/W3:AY/N0-Z"<"2NP5GA&?_V#?XI#'QHQ.%7W8*<07!!D'6$>XJB
MO@5),D,OU"%^J;*X=+QS'<91>@ OW_B_OJ'&,@94SV )P_^5*N>*-!W&*7$F
MXPCOPYJ3&WW&?AG+*7?SW8L(4[+PS)Q4N81L<&U[_GA'ELY$/ 3U:AI-Z#>\
MR_44W6\1%!,S1FBN(O!1S:B$!DGN<T6'A[O/9YG0%IR:HAS6YED&B;3Z+8BE
M!K!=FI-? \8Q1G2*1]_CHLOV#HT*9P8.7(4G'ICOFI_60<I4D")#' X$-GM5
M@J6:ZVNJOEV9]6=7,5KCA6]U^2SE+C^ <#K0Y"JX%V;S.()KVJ"3XQ:$3H+_
M^U<<=S1%:![4S&/SH:'<X*V->RJIA*,HR'UJ'WHX[W_*TX(&4R <#/[?KY\!
M+'O@#Q&B@<OOP"#Z%2)*L6A21W7PA'QK4#A=\9A I]K-%T6Z_G^]_Q=+@[_
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MPD+="S+PKFZ#>!3N>,OPZ,I]Y&; P&#MES,C5I-_H (QCD+G^Z3WI\41#PE
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MDU-'^[L7=1OBBYS<+'3U/_5<>_PW?H U\15>&\02-N+PC3'_]99+?"/S..M
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M?_[?WQ]7X"LORC3/_N4O[D_.7P#/:,[2[/Y?_O+;W4<8_^5__^O_^!___/]
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MEA>N)O/.S1)_<8>7"[#B=>R"OKBQOETU0M[X(G5H/,>_,]5%<+3("Z"%AKF
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M<6#,G02Z/@HP\A,<159Y'-.)/K<=81/E?[!(D$[MV&J_ !O]]]TOU-4E7X(
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M1(<+'[O(Z@CW#%GF1@BMS"#?"&UG-9RS+F8VQ41HCTPS6RW "S7 9@6N3Z^
MM>TQ '9#6B;GB#.IW3( ;J^MFB&&[$>=RA78%I#99J&BV">1KR[U1<@@XIZ
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M"PEG,/(3E;3N^C#V8A]2+^()IA0CURIIO:<<<WO]6S7T244M*]AH CJJ+'1
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MI2:'Y2HJ;4!5.GBKT&SK%Y\!K10HM )&+6#T&F^*7.HTCS95H]5S'F/*'"M
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M,.'"@RCV(H@5PE P&2L9A82[-=*S'7AJ[+*5&ZI5!@O+1VB!0;Z5V(U>K"?
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MJUW>:4@RE*H$0<;CW'1:FD#*$A,CIU*GJ51F'(VF5?[9[9HMUV/MNET3^^O
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M:CW3R!'1^;[2V<\ $CRA_5A[PZ>TG_'\8%+[N7LNR\RZ8S^K:8?YH?FW.EW
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M5L?S"Z9"]JE;'/9&/?4F2['6,=#RK%4E:-N95YO.?.4@^,NISO2. GN /60
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M(PZI$@E$4C**4I$F(ND@2.!I1@<F&D*$X.MB#D59?V=M2R>4'I7" TT5A!<
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M#[;ZPZ]L_;0L@^+OZK&.HK_IFV4Q%\4CFUUIP[M6:>]S\:RFE)B)>RR$51-
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MXXY6>+8%@Y[,I?/U-%8IY>;_4*,X@SA2*20RR:! :60#$YSIS'4&U,6 L1'
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MO-&COW--H[O$(J=OY[4^_=VP/,.M(X!MU0P!:_EB*\']*+WQ8*, '7E^7W"
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MCGUR?@NP?Z1[9C#K0%V5JG3!L2P53COH277L!?>=Q/Y[8Z#MQ1Y[Q6OO\3)
M3VQ(=GSP8+N4ESG>WKJ\\$F="W$PX^,7FQK;'*6^J8X??)MODFNG$4H4IDQ!
MFB ,<:())$A3B&.2Q#@72"FO;4VW9L<VSGQ[++>43? F[ %!71X0M*\#T)4_
M8&8=\ISM.G:!6U0<'MB^AY4:N=+BR49= M1&6W'_C=E!"VQXP!2XMH9+RT.7
MU?! XT!%#9^[_7AJM5QO#X#>&C9DRV)1)H+SR,:_(H,BH@QB*6+(,TZABBDB
ME$B>N%'2T1;&QCZ-;5XI]<?Q.\TG05#I>T[M"(@S.YQU^@01F'M;)&#^MDL
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M<@4>;:DX"X(G^PW];K@1ZHA[O.^E,NM671^W[3MH.6^+6K>O:U;@2P0FH,;
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M3TTP-F/YR<Q1U51S:N1P$L#+_NQK8>F9G^H0M%) N%!0BU@Y0*\$QM[)?"U
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M\HM<5<6SS8'J:6$"J\MSKY#BP_OOA2G)L+GUON%:OM+5LK' :< H*[OYDH1
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M&RV> =:.]?S U3.I'4?*8YE/>S1\<M&9V0:EFLM:[S.)Q2^N[_$YS6C 8LT
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MSZOO7_]A_[,_._0P)P@+Y39'!)MGNYT!OBSFB^9*K/+LUO&?F]JHV@HEB)$
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MDD@]. ,,D$JE^F2F.LFD4GTPZ \&Q4>B.8Z5L>2JROWUEY3D1^S8)F524<T
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M*O1V!_6!FF\'BPQ6_NT.D,U*<(=WM7_MJ6UR.2_H]*]"S^N9=?X6%0F+@D3
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M%J"40TQB!''&$TC".(8T"#@*4<)3:E3ENN?^8R-E)6([+Z45TCRP\!9VQT-
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MQE;3$>QE&-O;9-T/NW.05_*?@:4&EJ,2>AC&C/8]P^V9SUOISX )XEY/4DZ
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M[\OD0MHE%\Z7J@&VU@WH-D<]CGX'?H LSGW'^UB,_]!W=:Q[L_E4[:2IKM
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MD$7J#\Q3 DF(!,Q2+M(H0DE B6E ;,\:8R.$I9B@:39.UX*:QTKVH7D\3.4
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MY $%W4#2<-*T)^$.G3DM/,S!K^C&_4\X\)$D*3%JYP$Y<#H2"SR#*.;1L1Y
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MHKO'24S,@M*2Z$1QZ;#HB5-,$^89"*8"_O?,G+.>DJ3/DC3L$?!^ -://AI
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M^$"-@)B)X0J(Y#03*[0@TG,?M3<@:97;:4])&?9\K!*@=I3XYIAQ:\Q,X:*
MN%+@.$))>"C5IERL<%_Z36BTPXEKQH!:XT#50,U34H8]WZJ$FATEWL")_6_C
MZ6Q^,\8$8^&1C2H #9F$TKE+FJ"1?C E>1-!@O4QQAJ(>4Q(:X[Y8(F%G334
MP%[6CRA'4N(B-<Z0Y,J(/^=*5954I21>*1EX8+;A[&UK(4!#:;+J:&C ROXH
M:SZ2(E-?"KMXMJ6H62>"P5$DPB:FE'7X9Y4$R8\(&_AZU;[+[G973@-@>\K!
M>F[V25Z/!?CDYRL']Z;5R[OQ(DYFZ/S"W:4EGWC0$:/VY&(9DFDH\31;HI%@
MZM$GHF)/UG9CV@>^_370 5E=%3?@1MQ+7F[.JW!<*.892:#09?)E/K N\Z.1
MV=*75@A=I>IO%Z);.^NHC+"7#T7JJKLM:#\=W$*CBM183P"L+J,#'7$!77ZF
M#1<>&<WNF9&NO4)WNX$YU:"Y/VB\C,G=]-0 YA[DN];<C"2GX&1B)"A<I3+Q
M3'P*E #GS)?Y02Q7J5E]AI:AXZ7*-V]WE?Z;;'+^:27[SX ?]Y.'G.S6\?SA
M@^NW/W^%D7WV0A<^:0C,$,C!EC*!DK@TCACFA:'!!5DG9MQ++_3)9/8'/AK>
MS^;O9E=AF:\F3UOBWEX)]H8Q&M&*>T'+^!!)O%&14)5PX? ,2M4I+]B$RJ']
MN9X1]>1$KIK&&M@M[^W\N/A/YBMIII6S\0GF*P,^DC:B^3:6L$B+_?:&!!TD
MB=9A,"?0O]"U:Z1>HFWH7'IEZ/6MG;8 MW8/#JZ6GV?S\7]#&@5-K9(RD93Q
MBS0HKZ!4*I>DA%*:.=!53H)?H>D-N&L] 6PG;;0(K./%X@K9$,8IYR+ZL+F,
ME@W&EZD]F5!G<64$SJBNXON_0,_012O[!M066F@ 3,^%,:7_JE?@B,=]O!A:
MCF)!U7NP-#N5==)5\A7;!I$5"U4J@VA7Z;^5(/+L'+_^=O3Q_.SD_<FGH].#
M\V/\VQT#R!<>6B5X[,) 3X'CNO3M%GJW. ,GJ8C>$2M*OYLHRFFM8"38$)36
MD!14N3/Z CV[EP-_A>D5O,=%5VYBED?^8[S\?'BU6.+KYK<-6TO_//Q_*B6
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M*Q:Q--2%=[#^\U9PS ;J?0:2O"_^OD'!^51&3WKMJ)>.458#:+N3WDS?_^H
MW;.:&P?V^]D<QA?3];"-^/U\[J<+9+'H?9I6/TW6*$C_W]7Z5M%M?3N5R425
M%'&ZS&RSIBQO'XG-43A#J36Y2B:_#CO#6NA]@W*#-;$GA#2^3@Z^^O&D%#Z@
M.,[\!,X@7LW7HSN?\JV0.%/LD7<\E[J'3#!X#B39[ # T2"J>%A],3#L9M#P
M6JB&@L;1_P[%_775K'3QOZ[\9)R_KQIP_PW2!=Q=>')9"Z58)$#+]?ARX<F#
MIR2R4*I]@(NX=^^G$^7#YF4:QGO_>F\<Z'=;E\[>Y6@)=V7D,GXE3F#L@O)D
MZ'PJ:O)@GORP+0 ;ANM6VFO@A/D9=FY8V>KFLP/*4VG[:QT5&!Z5PWM:QH7:
M*&.,IDP@K0'>GOEH9E18]9AT2 "TC?].[** T:/2@KC,2N=TB9PZ7T9CY:2M
M=SJ'6H.O=Z&[F<EE0^*[=P4WX&&\PNXH<Z!,!DHL+U%!#IXX:SCN?674O7(B
MY5JS/U^BJ9GA9T/B<"/%O,6CRL.#L[^]_W#RCU[/UVZ?6?]$[7GR^S]#._2+
MS^\GLS_NKK'H)*A04I$(I62-8PQOI7$(.VZEI/BSKU)U]1I1.YLH?&!9:/A'
M:1[UU4]*PZ@?^.W<6>Y]Z5;!5.E%:@T)R:)O(0P';L&R6*5F=AMBFSEQVPU/
M3RQ8;;TUL'VB22[\?9K/OHYQ:?_R_?<%('.W?>(/XG+\=9UUN^'0Z\#0#4A$
M4&:)9-22P+4GR*!)W#!I?*V&(QN2.O"XK.KP>7J-KZ8N&T#KO0-O[X5@"8!0
M*((*,A/'4R ^EB;.5G.5JY2;M5)G4%O9+Y<:;"+Y!C!S=UJP*!$/RNP8MXM%
MN52+X4\<3^#!]=?SV:9B#<R X9F2J,MTZ!@5<3XP$B/S7H6<@JD29=1F;.!&
M\/O%=U,H:6#5O -\<QROU(W?3^#Z$/K^$+2192%&X2)A#CQ: JZ(]R;CWL6S
MY&@BDJU2@MZ%N&&M<UMPFE76;0-X7<EN@82_G\W?S:[",E]-#F)<]5) P\"M
M3502S[S"(" 'XC)W)$5I0S141E.E1N UHH:UKDWCLS==-H#+=]>O?:E-N1,R
MJH3082!PF<72IEQ+1K)7/$.2$N58QX2^2M>PQT%-H[-/C38 T)N[PK!*!",C
M:_/O+(7,A".@0RDGXX8XY@TB22GEM9)1U)E:_"PYPY[>- W''O37  I_]>-I
MD=W)M)1ZG624'LIK^?W3Q$^7)7ORI8A_Y)03ACF!7-'29EP&]$>H([:X]\D;
MQD*5;C[=R!OV;*=IE%;0;SM#.VZFBJUDOA+PS0 H $-S,H)DG9$?DSRQQFB2
M,FC++*6*5VE7\")%P\XD:AJB_6AQ5U3V=:W\07;YGM ._9?QTD_N!I_E&#.-
MC@0,ZHC,8(F+AI-@K'"@E<MU6K-T)W'8D45-0[:2GAOP!YYR=A, HMQA_+54
ML(QPZ4E7"@B8,8Q(%#@)@,L4P-GH(+D4:K5=^R%Q@_?HK0*,'^)O1RTU:CUO
MN/KDOQ>62JHLQOD5OF_LPWBR6M C\ *,T^AG0Q1$\E+3DIW&U6QH0CZEADH#
M@K<A=_!VN\/BLS=-MFHK"T^W&0JXX7>DLHY<:DH8J#(5CV7B0Y9EGG*@,BMP
MIE:S_:XT#MZ$=S!D]J"S >&8+KZ-,*:Z'$]7RBH5ANN*TE.TS&=_^"\'%W.
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MQ*5,2;E O I% (:6TG1/0.;$K6#9I4<':L\6RE0AKAN(W_1I61N*;2"VZJD
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M?OSQUT\G'XX/CX^V,6X=']R;M=N&D9[,WT&,96-<;8F3<;P_4TIX);,4E"B
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M$1E0Y?RD"W%-8FP;+#P>-]*W8AH VR]^4AJPG'T&>+@< T2M:)8DN3+D,_)
M@F$HM^04!$^=K3/!\26"ANE:O<^-L1=5- JIZ]67>+::<488C1%]1T.)"]$2
MH;-7V5N:H$JOB)=)&M96]:/R#CC:0OX-(&EE<->= ZZMJTR)1F,%$2*4L4Q6
M$<MPD3F60$61(X4J3?6?4-(>;K91\7,;W-;R'KA,]G;'/XLP]?/Q;+60,K-"
M)RX)RH2C05;EG(L&8@WS5M'$M.ER*-2I7/99"H9IC[^O2Q2["WUHU%S3_?MT
M\04B2@G2S3EKLA(7C2"&NN(IBDA"8.62)$!DUF7GNYB:;LAYB8KA2NY[T.RL
M;S$W@I72)SCZQ<U1>DA2@F"4\" ]P>622H_,,NP5/$8#V7K7)7.Y$5 >DC @
M2OK1ZS-(V4'( \/D\.KR:K+J,'*4,\3E>@3;23Y(LR^W#EYV42%+* ^+T:<4
MSA('&H@O[6ML4J+;3.5.H.E"T# 3-_:U3?6NDL8A=E.''$H[!\])BH"^H%24
M6(LRLW+5TL8#<KPOD V]G_4/@0WPM84^&D?8W03)FTB!8XC@5"**A7+XQ!@)
MN%:)EL:97/I;=NHUU(]!>T1<NZC;!AB;V+5=M#1P<4*W?>'#> K'Z*@N1NA]
M)N%1?,(&6[IWH<,1LT.16LNC4,G81Z,:=VBC</O:8<8$[6/?K*V#!O)+ST\N
M/?ECBF_X//Z"JZETR/<7,$I2.\^-)#:F4G:A&+%E[)O) !EW!H-^:(V\4V<*
M6^_5L"5&.HV:W55AS2)Q,;)64,F$0EQ@L".UUB2@#T*8X=$;C()RG5.8%^AI
M_59O391MIHRM,?45YF'6Q\6(V[4PRQ]A>3T?=3$*(M-$<2M@-@@B.94D6*])
M2DR*8)7,=Y-,7KLB\?SC6[]/MQM ^I)K P9G?71=QFV\1S&^A'AT"H67(A+@
MQA')I":.*T]H8NB3YA0J#2;K1%WKERKZ,4;]*ZHUT_1T-,P(M+'.,$-X*'&X
MI9$X%3S1C 80%I00>7,C]?1%K5?;]6ZN=I3UT)?][C%SQ\'BW164M7%]P6TQ
M*EWD4T)3')) WZ\,:@[14L($>.>0.;3+&Z+GY;>U7I?2+X1ZDGH#&^"+!=6_
M+R!?33Z,,P81+'MAC" Y,[2J$<J>#H$DHX3W+B9O]WN[ZXZVUH^5^]G\^E92
M [A[/YZ.E_!A_!4>3\NXQQ,HI7SI:N<<U412PXACJAR>:1^]Q 6FJ[1TZD)<
MZR=%_2"O=S4U +V3AW6KQ:<L5MMR:7BY)(*[OQ226!-R.:9%^0AKM*XR(N 9
M6EI/I?8#K%V5,*CW?L\NY_6PQA&% -)J2;+A&2./4A&2&<:]02706AHI1*4]
M\IJ$@<:D#[ 7;B/S!NS..F@]@W@U'Z.SN'C_]>/X5S^>7O-B%94BDTA+SWB>
M% E2)^*\5,%XPZBI4A+\&E$#C3<?)L_9@UX:P-CYW)?[V'?,K)D;050R)>F(
MXFA5)<U ?#*!,*V]YIKEJ*I<PGJ!GH'&EN\;67UH8^!<PUUV[8_Q\O/L:GD*
MR-/D^SO YU^.IR4&?N_'\[_[R14<7W[!;\N'1T[9;'S U2(<AB.I9.*H2D0#
MX\"CTCQUR:]O^?J!1I7O,QVQ#\4T8- >&^=__)C9@\LB[)'S"";+5OT@2VMK
MYHG%KR0J8[B1WL@ZW5NWIGB@:>=#;[=U--H = ^^^O%DQ<=L?N8G<,?R.PC+
MNY]&B=/2Q PW@6B 2 &9!%_F@/* "S(6WJKX?ET)'&@R^KZ!645?#>#P-M1>
M3:LZ'5]\7I[DWQ?K-,Y(R,@%Y9YH4VJB++/$.2G*/3MF06<*T=< WZM4#30D
M?; DR,Z::0YF'\8^C"?%V>6*:ID5$.XS10%AJ.Y=S!BT9\!%E-#GK;(/OT#/
M0&/0AX76=MH8NM'Z]2M/2S>HVPK>Q<ADD;1 G6,,Q8DTVA*?M2BW8;+R-%F(
MKD-H\<+C!QI.OL_0H0_!MCRW\/3H[T<??S\Z/3H\^?7C\?GQR<>'5'<:3OC,
M0WJ;0/@C GL:,WA=E%6.IP]GT]5HN>)L'Z+"9Y<POQTWEX550<9$7,Z92!G*
MQ6;N4/G2^>2X,Z'*X4='^G;=F'[PFKNYG4ZY$**@Q&J-?IV&<F><1Q*3Q 45
MI(+'I?-[D<.&4^W[MDPUT?1XUZJBJK=EJE8W%;:9IOKBHRJ:K>>(W;/Q<M8:
M =23U<AZ*1 $3DA7#@T=PSU+456E8>*>C->[\<)?7,SA8J6SDWS]VI7@[Y9#
M]E[Y#(H$7'EEC%LB-J-7IQV50B;G39T)]YVH>QMF:Q,</39;_2MI8-?[:7WD
M0Q8?<6:TL%(;()DJC%1=.;A7N8R5\]('%V7B79+]F[UUV&ZX-6%560,-Y J>
M<G<PF<S^*,U\WL_FATC0^HC_$9= (RX4[@EC'+D4FI, '@A56E,'3+)09;3!
M=N0.VREW'W9O#VI\6\[;LT/CM_3>>I][WY'</?MO% &8G5#$<Q:(! O$T:P)
M3< $1<\^BRJ5"7ORW\[B9TA7$SC)U[/Q3N'+;+XN?+N=;??+]^N_7%]3SE0S
MGLL\WN E1E ^$.^+10\\>%%BJ%!EML$6M+X-WVX3C#WI"%Y9@0WLQJ\/^<S<
MYYP\(Y1[0=!N4^(C<R2!1/<5E*!0);;8?:YNO<ECM3&QT8S=3134 MH>S A-
MW%+'HR(Y2%/&>#D2'),$/01.M8?(3)<&4)NCZZW,V-U(NZ_.V-U$U$,?_6PP
M 1:]U2R3-:5"4Z,WB8ZDU6C<@V9,\:P\-^H'SM<;GK&[D5*WG+&[B80;,# 8
M@ZPZN-XLHVLN8M8)_Z<(2)2/A"Q),&"($8I%%R-+KLH^]CPY X]3W!E#/0J[
M <@\GB(;J9$ZI4@P3K4H$:.)5U*5.YTJ2@O!J"JW.;89RUP/)/OV<G900EL8
MNFEGYHW2N8P^%R;C(L#8(Z#-1'Z,CSDP*A[O3+VCJ G_9A>]_G!$\R9"'MBK
M^1OXR?)S1*$=3Q=7\[M!PT(&%VBIPBDM[Z1%;R\X9=!DTJ"IT\KF+C?U7WI^
M,^K?1F6SGN77Z)ANGI/#G9%$IS@:3PC$9H5V4^!N6<[3 Y,=$+##F.X]CF[>
M5O\]R&Y@[1].QH^I#RXQ)E4FHMPMDX9Z8KF)Q$@9E; IR=A%\T^?/.SQ0W]:
MWU%F0_=J>3!NG#O)O(EB77,I'90J&=S_(N-4Y63BO0:4O0YF[_W62/]ZWEY2
M0R<KSF[BY=OQI""L=4:O>B>7KN^ET6CIPABUM\*!DN!#!ST_??(PG9KZ5_:.
M,ANX*_2G^2Q=Q>7)_#IALIY59+Q)JHC"9'1K@P/T/\H=3Y<B>*Y-$EV:Q'7J
M_/P< 0/;^ST%B[V(OPWX+,J0V>N,V_5RHLISE9(C20,RH5 B06A'L@I,1W!9
MY-[&(;Q(Q7!MPG=7[%.4["CE@?>6]P"X>A9K^F]&*U+*$P1.7/1H+95DQ ?F
MB=,I)RJU#H)UV%R>>?3@FM]56;/^)#=TI."_C,NY4+HF/8',(5@@.<5B,"V2
M7H9:"ZEE$@RM98X=E/[HL<-$AG44OHO$!MX03OWT8FWL3'#69VI(B5V)],J5
MW)@GS+L@K%-1R-XV@-NW#AQ![-%SV$[0+:#C)M.5 4-?ST@,"?WMB$ZWE4D3
MZZ2E'(R2M+=I;/?>.]S&L*7&'NM\"_$-K/7?QM/QY=7EC3%3.9OL*7%6 C(/
M##<M%3 FMI1ESFF.75H$=-+[@S</K/EM]#;K0XA#:]]_NT<X1T=76YYP(S2E
MXSX2;JT21 6./@LU*(4NXP^Z:?_^FX?S#WK1_M9";.$X\>7-\,/=#6#KLO?2
M$F82VD0= 'V<TA&E7+,3(8*"T $8VU9/O4K<P*FJ?1]>]ZVNH?/6+\QW !M0
M3%D1"@S*Y*Q<5A$GH*C-*"&.LNN2P=YA;D;MRJH>==AA8,8F AT8$]<T'\XF
M$XA%*K-\.)LNQFG5:F(V78]=&S$,W))*OI2+&2)9#&BIA2"1196T4"$_+NE\
M%B+=WM9$'54=Q%00]_!&!2F>Y5_&$_SKB_=7D\GW4R@Y&AC)S)B)*"5I(B/2
M)4&<*J=["6ADDN)6WP4UK[QBX 1Y9>/2BV"'Q\</IG0$DW4.41(PPA/).9"0
MD;=LDHK&.RH>#P*K.!&E7DIDCQO1CD)NP%.^?^?PW>PJ+//5Y"E7IVA&48I_
M^'D:Q6A, (ZB<ZON$9(3[YPF"8-#<!)4ZC2J?)M2X,TH'=B'K@7#_6CNS4!S
M)*D2L90L*2<2+CA;;F\CDY3F'"75P:1:I>D=R!O6*:^,D:T0N9'"MH;AE]6F
M?K;T\^4>P;AV)8ZG<5X:Q[V#]9\C2QU:?Q&)"%R@%Q%Q3] EF6*<H2EDYUV5
MWDB[$#UL;- B<'M0[INQJO^8CY=PDO-BY 05)BI!F"YE!% B)!\BP5]YPS%$
M>M(P<)_8O:5SV/BD1;ANI\+-$>K6")V6WBJ0SO>]_3-G7=*X\K('6$=H(=I
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M1]^^P/1N]+PVEE$(B@A>4G@4S;85(9",2TM)'\'9*H5"&U$Y["Y8!V?UU-0
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ML#4C\E*,P[3B*61<'U$6G@S&.-XGDHU<7:!QUE6Y8]Q;]J&)4Y_>-JP^U-0
M],Z@=->91EC)B(VD9LPI3XD+$E=B$)9X9Q.QX(-77FHOJ^Q;C^AHR$SUHN@G
MN=3MI=Y$E[B3Y6>8/Q'38J22H^ S$&LX[NG*!%Q>(1+\E8.@L@NN2BS[ CT-
MU277@%$?6FC !CWEH)PN+!:P/+[\XL?STG;N)C%')97H&B3"/*5$1J](R *(
M$((ZF516J?[-O==I'#857QUTM;35'!"O>;!,1Z? $HJ+!Q<3 Q),L(0)J[GP
M%H*K7P6Z";2J=278,[2VD']O_0CVEXJ_2]S-'KJO'\8^C"?K>YY])^4W>6GM
M]/S6 MA[HAYX&395YIE!*:[PJCAH4*R98U$E:7@<YG[T$(GZTC$)+)<D15S=
M4F$,%53T1*&W <:HH&25689_PD3])KC:)5&_B<J:VXV?%MLI+B5CR1+N.2.2
MNT1<.:A5,MD<D2F1ZM^1VK("MHGD_49XV+ "=A/E-("UETNFHLO9,DBE6#R@
MD!(G&*DK8IR*02IO':^2=GNC%; ;Z;US!>PF2F@ 34?HF<V^ ]RF>:[3TM:D
MA-(Q)+#5[1;/B&/HV<;(%,\A&2E$#2R]0$^KU;#_/WMOUMQ6KJ2+_I43]QW=
MF(>(\R)/>[M#9?M8=@_WA8$A8;,W17J3E*O<O_XF*%(C)2V2"UR@SZV*L&D-
M:^7P(9$)Y+"3MA]V->M!] T@Z)V/Q?7]]7HR6Z!@UDS(3$%J[M%,0[DFD0[9
MH;JT.7>E(2_06"7W=2LUK>:X'H*>P\7> '8ZA>DA>F>L8L3R,KI!4$YL&0(9
M!3=1!\:YJ0*EW^LVJ9('M9^:6H/>FIG/L\GDW6S^IY^G490^)S2XB(IBA8U#
M>QRL)*"Y%2Q$:W+]L[3'=#7K4NT)A.>0=J!6&@792!D6/0T2-_15PJXK_8!<
M)-IQRAQ/'#>"8R&K(3@=JNT.2-I)]'O#YP?,Q[-TL?3S9;VC_IBTIQP48<&4
MX 79L0(W>L8$54KXB-YB4T?]Q[FZK FB?43?@ U:S\5:H#SNL5.N/S)7E!(3
MN"52EG;<6E$".5 C'"^+H@:$GB*HH<O(GF'4BPIVAY*[AM(4OA5?\$O57>W3
MRNBM1K;Y!;R!Z[]'UB5F$T=?P#M1BCP3L50+=$(S]T:7Q+<J1=G=26SHGO((
M.V /:FK I&W=VX/C/L@$!!A;36[QQ NOR2HMB3EE1)T.F7N[5=6ZG!_=K=I%
M] >Z56^GJ>[=]ZNO%^\_O+VX.'O]?[Z^OWC_Y?W'#_MT*]_ZF-[NIU\FLJ<;
MYU=7"XSK%HO7L\LPGJZ'&V\N YDUX)0#$E=J-SH1!SH2)5G.6GI.<Y5"E.>(
M.M2T;'GVMM;5D>D800*A5"9D'3+QAHIR?)<R+QMWG?Y8W<@;-JKK#3,/;4\%
MW;1<$+MMD>^?7O/<TZK:I9H),<]"C?.@P#A*@DCHU%#TL"U(2Y2RC+$8 ^=5
MKK!JFJ?;$]_-6\[B/Z_&B_'J+:]^W?G7^MA7NYQ+A)%B].C9J=)&.#D2*?,F
MFD1CG5&LNQ+:L,G:!4=/Y[Q4T%<#GO@6KE9WZP% "I,DX=ED(IGDZ!'J0(33
MZ%S&$"*K<L;Y!#VM)+K4 ,$3F^0A&FD46.7C'&!]>>JS8_A[E+BH2W,6G8EC
M61(:*&2G=6!UZC=>I*P-4W:0_CM@:G]E#%S,^FIR!3\P>EV6]E#%??GX:],(
MBBM@D!2&L4B_3/@I>$^)T!C2NI0C"R]Y6<^^H#U@'*#$6=\2'1@62/%L/O:3
MO\/\TD^G&P:2XE)90ZPKY4E9>@Q7@B"611":&153EPKGK0\?]MJD'AP.E^30
M4!BGLTN8CZ-_C=_&OTJY12G=1K9@<7[^^H^SU^=KMD!3D:0+),AR<DHE!IM*
MX2<E%$301O@N[8YW>.6PUR0585-)ZD-O-[-?$5[]FEY=?O++[[/)[-NONWQ]
M^I?7_W+[(QOVLG16LD2BS;'T?P[$)\^)B,S$)%.&K+IL1+N_>MC;D(I;5&4M
M#&VQ9F$\@3\@E67S]B]_N0YB+V#^<QQA\7X:_P6_^Y]_K%DS0@*/SA//4JFZ
M+<TU5YV77$9C;$RD#V>V;+=:N[UVV%N1BI:KHO0'!M9K_P->S]+?P4^6WR/*
M^9J7%1LL&$#Y!&*2P2A5EZ9=G&GB+7@*T:#SYSJ Z)E7= *,/CW ]"75@<'Q
M&;W^V<7L:A[O,>"24DXIP@%MIPQ"%9<O$5VJ+02/F3X<@;05%EL?W@D0YO0
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M8I/8$X6S%O>/' +N'Z Q%LXA$3 10HY1AH<'#3W#[S%-C8"M?R0\A;D#U=(
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M0UTW@)_.M64C>FS3'3I "G<S=(6./ KGB=&T]$7#D-BK; ADQJQT*@>1C^0
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MIKB5P^0!X'\<+3< YU(<?=L-ZC9A.VD0-@5)HH_A.LD#!:B)R2P#4RY1GFJ
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M*0KR&^INPTUFB9:VTR1ELYHP2LMT9D8\('M")!E\%?_L.:*&S92HC;3>U-&
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M=)TWLKO9^(73TCE&C *4@]*>!.H3L2[0Y#E&;*E*DOX3] Q["SXHOOK04 -
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M['3.XX^@@Z%1-IZ63@;GX!?P,4S&WU;:6OAI^KC\#O,U0QJE)X.*A'KGB)0
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M8;Z<5M:O)/F3?>U\EHY[8,PZJ*,:P9G@@1C7&)DI6379H#$P'^/>9QW;/GH
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M85T/AL\HO$N1TX$MO2.55FG5Z88QD7:95(HQ<YHV=WCE%ONW*8X-N5X,](!
M8&=IW1]L^U(<3R+4:0(DN9@H<*  &V)-<KE+BOZ\QQ!S.!%L9[C]U5SV$9..
M!,5>C+BIRWOV^?-BW4]TZTW$<I:E10FD]#KF5)NZZRB +]PYQFTJ6^V*Z_"
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M3\D@#\%<3],=VPKG5O?1.L)_21[E=9@NUA79UQ4MK4H\* G:H20_5NJL6E5
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M\Z8MV]5R.L/E<FL"EYOE$)C (B($P^H$SY+!I>0!K?<I^)2P-*F]>9*JL<Q
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MK%463J!H-*%E#RI'B;I#T/&@SKF5JD: P^W,\\]?$7]=J24:'XHQ$(HF/NI
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MJ6PY\BO> G[28&&#[R7RKL(0704;! ]V+P)!I)A:P!N!N$$ 9GNIL&-QBO^
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MUI/.S)M.80- \>&04%-SMJUUKCO9-_1D 6888=UQ$5LOQ4M8=0I490/%Q.D
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MDHGZ'<<**Y!^,G?,6,5J!)GE&;Z-IJ.Z([2$CDQ-J-TWEL39YZ::'$'1"A6
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M/=8YFP/M+9_A]M*ZJIT;2>W:RR0#N+R1@@.B*JB8+VNE?^B0JL("K0B57@3
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MY7'"_!#_]!/A]*>S()IS+G8<IP?S.C$7:4!/XHL\9&Y"H@2\ DSN '^XQ=7
M% >[)SW]X !Q$207YX;?\S#E (S'\<?NR=NC#BZ<P3 >0#F.HZF3P/XZ223_
MW<(!D)/N[;[_.3=3V3E)?/&X&\6T@^]2 #?&IU[]CHO9'&2O?J?-Z;[?7HXJ
M_#LP9>L:7GB-)[SM>%I\A .*^3B XZ;1X82G OYBB?/@!X%S%]W#F</!1FF8
MZ!]XS!U/S[/UX ,&A_3VE+,0I5# B2&P2T"X&WZW ^?>/3I^W]U!9'I]M,6V
MM[K;VP[M/;U&T.$0[)&- N[,.8L%(#10NQP.  @]AWBO35EX(^^4;,@$ !S-
M 43A ZKC$@DQL[GLU?-[W^.AR^E7'U \I!W#E78<7)L3^%,?=Y\_NGR&/XK.
MAC=DQ('J>7$KY(F-N#HT  4V(3M41<4T-M J#,^):2F.=>4FT0CFW^]()L!H
MPV!U.59 4X11@M,P0#O?)0!A'T7J3LRV;/FA&Z0>PLK"N0/@(]RX7;!54;@M
MSQ.Q6DC^IT^D\]TX'O.\Q*88)"QDEL8SU*@<YW,8< &K1G >? $\\'$&F"("
M1!K<+5_MW@(@'>"HCB\L9)%CAPK'-%;E%H6;Y0+: *(AU$PSPBDH;K$/"YI&
MGC^&K<1U*#[@/(U%-OX<;,.R&GES?I3W%QR".A^D+LUQ<*NMG3,T5DX <#AC
M_1.AHP<;+#&*JSO0F3 \@(#?L0!.>^2'A*121X9S@Y.:,5^R"@7"NO3<W1H1
M/7<4"?%L=&O4!Z Z) O$!WCL'O#L&WE'8T]^.#%GGF-./K'L61PA9X:#M"@_
MY@FP="6LN!$(%K3'\#02;>)P6):/#,G(/#1L-),\/9(8!,.XW)^1!&2SD Z"
M(U(6FL-:X)RPUT,+3F(!*/%(U($OTW"<TC<&5UV;2<WPQ2D(9RB@H:2T*+TQ
M1W"ZC^_B*)WA-[#3H('0JN'Q"6PAH*X9%F\FLUIYAPC)L@5017=K#S!Q'_X%
M+K$O&>^!_-3=QL'[-X/;GD;56!*/7 U_A'$3*<Q=LQA8]1Z,)$<@&3$=D<W(
M^4 X2G\.LB'5%D[9HS]-IS :<4LZ*"'HD+(+CPY;$,CRBACO5&B;FQ/LSP!I
MIGA#*G58,A8Q Z#A5 H(O'B#G<+8P.(#YYR-4/R,8A]9W2!T%Y=:4)Y)G_PA
MRG.!3231[-W^$M-:N2KYS!KX<:TT<.+=S\X@NRNIQ/W'B3\"IM#=W3G\1@Z_
M4:O2L(?Z_-5'Y_3J<MB_'-ZNN(A#&-W"R,.*)24D>AJDCX&9O(:E!6PF^#O]
MQWO/%\!TY^_\D "DE]Z#?)P@,:HA81:%+2='._O= T28!+ D\?3P"I=V")?>
M)%[);\<[N_M'E3_O[G2_\;>C_6][<QFPQP<[1[O'SS[LP<[>WFI;\(:V5VXQ
M')68L?#OK_9?9?3NH5SV;F_VZ'3SQQ_P<5(\/XDW/Q_+B;7T;H:#4\#S;L;'
MU>J7+&P7E_5JI4>;L =G_8^#RP$:]F]W?L3_UMC9DNTB'EZK_>KF%J2(H7#K
M=P\(0YX-CW["HXVDZ@6Y3Y[03O<ED'/YXL] %PE)=!0_A)R?).N]TFW;=6I&
MW!6H@RIZ9N8NW(4%/* E[:Z^H&4,X[!E&)L7 _9>L!AP39LPN"87?\LL5MFR
M@PWYG':ESVDSC*J5;#9X/>V]9,D&[9B^Z\_(&OO<'.K7X57EFW?PL_C%KX!I
M>SM[+Y?,;KA(I]+I$HV='-$Y'Z,@B![0LW7#I>,"/1LM(;6$5$5(^R^7D$XG
M++S#4 /ET20GX&W"DO0[-?.6L'ZP1-M=W,CF2Y3+5=_]%ZSZHHOK9O#A\_/;
MP)M.J>7[==CJO:W>^U,/??\EZ[TR9)(%SBD\&ONC]+F-^TWG4N7;=M@*ZNL0
MV O6>"T=%S1;%7X8?S>Y_9ID==22U3ID]8+U7\J8QI#=:.Q\3$/O1_BC6QIK
MA=SF,8OEJOC!"U;%C1?Z<GC[-Z=W>GKU&?YZN?RA?)>.6P6\Y4T_USC[DA7P
M0>CY][Z7@@K><UW*DGP^">:78%/E^W;<J@KK4-@+UL 56:'ZC5EUUXR<9<]$
M92UQM?=P\[C$<AWA\ 7K"(/+?_9OAUBA2N>G?8OSKNE<H7QOWK::0<N1?JZ;
MY25K!A<L#*6!<Q!B&8@ET7"MZ)(QJ58O6(>^7K!>D%$5EG"052:>D[Y: FMO
MX@9RBN6ZP=$+U@UN!G]\&CK#*^=#_[+_<? ]KH-?B4V4;];)2U 6:L!C&H@P
MY6=V4I=#JQ<KJG#BOV3%:$B%&)G.(NH_E2OT@GAQ2UK/0%HO6"<ZXRR9?#\9
MM:36DMI*I/:"(QB5'U)6]CSC @"BFIT?TR2-N7,&'UJJ:JGJ6ZCJH*6JLY2J
MU;+0^1QBZ5K!.:;*\OB.A^Z\I:>6GM:@I\.72T\]#VN!$TEA\(QE,^\_SF!(
M[)#07E(M4:U/5$<OEZ@^1O&8^R3F@?3W.51%_GO3[PW__#4)J[O;4M8ZE'7\
M<BEKR![YCRU-VM):Z]YM,M-8[MX]?L'NW>O>GSKN4SEX^[=-)_***N/=E^"<
M;1E,C>Z5X[HX+*WF(FJ(U_B\:D2KOHDEY&_UN'[H@<K[[C4^M'ES\0?9$XJZ
M89GR$MA=#SLPR1]=GV$;H:5RBVQQTU#&5B&]_+02Z[\&3=;$T]E4FCQ3/2%-
M*,(%3R:1)TN;KA^1T%)F2YF:,FOB&&TJ9=[@W]2]=CP6_%G3)EI";0G5(M2:
M^%J;2JA:K%6];?OW2L8=LL=O+L7?DF>K/K<+J>U"WE"KS=\KN]I*EE6#KK8_
MD;:I+>I^GG&MVD%W8]UPV^:LU;^US5GK(K@M=WB\K8G#8WGC9HNNZ'-.Q'N[
MO[-WN"#E[1WL'!\6!;VWW9\@Z%5L^$7_\HS\*[W+,V?8O[D87%([N%]#6JMP
MM.RUCI;&R"5-8VP5Z=FMH^4[-=* A4X/E%+O^0IN_!H\KD(CW6L-1NN09^MS
M^<X.<DD<,1=5PHQ*OSWDJZ7,EC(U9;8^E^^_.*W<[/;J; GT>0FT];4\BZ\E
MG44Y0D5_"SI?D(!;DFRUYE]::UYN#CRIB3EP$WLP_-1WAC>?;X?/<W$O8QP-
M91D51K[]ULC7LJN?>N@G=3'R;6+Q?8'N0%],=#ST,$[%<X9X-9U-54@V^RVK
M^*59Q7+)IKO[@D6;B\'M:?_\O'?9O_K\K$VXF\XJ*B2:@U:B:=G4S[V==E^R
M2'/N3_W$V&(H>+WM K82VART%M2UB*PFWL=-K/YVQD,OF<"[B7,=1_=4\;\E
ML9;$GIG$:N)&W,3J/S+7#_QD_JT9D"V-M32V$HW5Q!.XB=6?^<*=L/B.:H==
MC0"@9_2VMP36$A@1V LN>?DQC4-?3 !<9X"U8Z?/2E^_+(4=MA2V%H6]X/J7
M%EDY(YX\8&UF#$#I>5,?2"^)61+%5,V&7#M\>879EIY:>@)Z>L%5+R\C .6G
MU+UL::VE-:"UMR^7UK[$?@*PRF)K_8"[21R%ONN<1M-I"G_0K;8>*;9$U1(5
M$-7)RR6J/R* )D2-ZYP]M#=72V0_SLF\^W*I[!0NIB1.W><U9[24]I,IK6TJ
MV\13JQ>#>")6L/N"8P6OSWN73N_L8G YN!W>4(F2%\X0*X($C0%S$X3=!@F^
MQ"#![DL.$KR.'G@L[0XW7,Q F/-'&&WAPQ0J@S-G0/_E^5(%DARU5_Y:)/6"
M0P)/ ^9/-4G=^S#H=1RYW$OC[[2FMZ35DA:0U@L.!<1B G\3]HV$%7M.(_$L
MD>V_*'T=_QSZ6JC 6UGSM:W..]'5>0\6=F:EZKRX,-_[^RN?'7>/NOO>V_V3
MX[T#[V1_=#C>?>L=,WYX='(\VM_]W^[NJ]_K5=*WNU!K]&C7JBHJ#P7[ _OC
M>;[*R>';G<--E!JED^HA_@?<R:P8/Q^*_+:AE+6/^W'&Q\ .I8NPDM)*#F%Q
MOS>TMY8&M@DBE/QQ\;\;/&@Z&H^[44RNWW<ID$",3^5.>Y.;MN.@6!M&:2B<
M5'!/-UN@@ETLYOKSE DWQ=>=.XZ+<$8I-F9P@]3C],"8XV6>_9Z& 1>"?G(!
M"M@(!^B.Q<$<7O/0%XZJ*?P</_B" QA?X$]^CV\B&/C!#SMRZ"@(H@?T &)+
M)>%,V+V<<\I92/YVP:D%>3)Q1AP>[>C9F>/YXS$,!1NK'G9\80")^;]3/X;9
M1G,;T+_^Y?#M>Z?F)%A^G%MLNWYD@*3Y=F]O]WW/=;&+-7WJ_B2 RO>)L &5
M.X=)F!RN*T< .D02YT=1])7,)\QNI8?0=X_?"Z<_G071'! 6,(^>GZ4Q2#(4
M>Q\CS2./=X#.>1RS ,3;,(E](!LD>1DAH@?(_^0"1OJ)!&/$)RP8+\" 5 EJ
MZ(R[5.3"C:8S'@H9-(G0P*[<8]07=@$4J3O)IL)Y63AWP@@?!K" AJ,I[SC\
M$8> 5[8D52/L+"^@NRB@VP7!8(=BH'A%/6PV"X"NL82_#2KLBDCQ#X#EEI.#
M$9T(^]L=YX[YL%Z -X@$3DT2(RP<N0)/(F *'^%'SF !]H@/D\AY8$C=L_R6
M(!07/+EFP @&H;NC-A]&/+5W"$'OP-OZ45K*;3K2J(!CV^@ 'W$BL_(27%"8
MK2!6B*#V"A@.S>!%;HI93QVGE!P< 4<=&)X:A<"@F.SZ#H.PA+BQIQ?TX,/
MH<T%9;43SL2.<\/O=ARD^N/WW9V#W9/>ZR-@#%O=[6W'2V-BI.R1#FH.C%
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MT A\6"^^+$-?E9E4+;!B'1(5<797S5ZV:[[(LEI5B,7=7:R20TC;6#P!6Z>
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MFG.;L"3==%\+)-)P7A -PL0/4RZT@E]!@&D)11=)A:A1WM5Z6/UT;DX0?OQ
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M5HJ.PE()<ME-7.JQH9S43%Z5KFTJ*VD+SS*I.W)3ZBDE(Y24Z,P?N9MJ^[$
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M-N7CS2CRYO#/))D&O_]_4$L#!!0    ( -F!5E+DC+29\0\  (4^ 0 4
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M42&)58:MYW1S)M\'C#$8X[2%'$_KPZ9DEC^,^P&#]-DTXT$>4CMY1E/J@#_
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M(+,$9 +34POR(]!4_M8#--JJ;ZRXBJ#_<(8GU 7P3KI]!A69GL[O4RX/5DD
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M::&)> X*EUJ60]Z,7'OQ22HII'*+TC2?R@C5EYR:'.=278&*:4K=20/>08U
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M+&@*+W.E+5&2G"N=D:!9^X6HF/R[X,:2,T%'4ADK(D,&,E(:9#'? P ._SX
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MK'VQ -S=.@ .5Z+U:N>@%>P?F1)B)5/!)*+B6,"CB^. 4,T=8@ !(DPY1I9
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M9-[Y<2!38=B5F+$;E?+LQ[)!&"I&:!E[02/_(V 3S'./,V]R&WH2F8F%"XV
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MX]@J4X$.>6YV[T*5<BC8<B1?>U6NH0#Y:RJ-RXJ0$IG30W1^E4_7<[(6"7?
M*XKO"CSE(E]3HT1NA2U&)3)R1P F'QH92:XE.2 ]17!5(B--N:&R[=:I<37>
MY5!E! S"YM]UFG @/LP33JD?;CDC5N4?/3R96.= ^#84)(CLC/Z?EZ+N%;"'
M^P/L(AEOXGKGC/8 WKOGPIU1CI4QE1&!EQN5<4KZW #XQ$P)T5Q'"W0![Y(/
M92+MG C!MF%IK3D@.HSY9;(ANL9L76VY*QR:Y-@Y&42!"$R(?53D#' <=R0R
M\)($4$>+F- :(A'P=P]GK#4Y07K_;@$=[@^@%YE:3'F2NW1&X19Q#)(IIPB4
MV4(6E^QCA_3L'[?S1P=@=$1J-9ZE#E5N'[=@EP+"E]*"*'C\\6T4&R[(O5N3
MQ4S 'D]O,<#WB,%H?S"X2*H^N@]10IO[@OJYEJU0?$(J)0*@PC#7A(6U:KM%
M:ZJ,Q7LZ=X4N$T+1[SF*-50_?Z1+#% CR=V3+@S'%DRX<XEL\S3JA;=JS,V2
MFE!Z=(M 1*YNN/DH<OJ<)?)6),4AQ3WY\B=/T><&_EYM[0[W#OA_;&OG#CB7
M:Z:\RF*45-=QNTIHA+PGD)4'-'AI&@<5MDJ;)3]P+Z R3:6U0GR@9 P5& BU
M1Q+V.27/@6YD:$,5 /^)D"^6I/@]ES#?+;\\"]U9QHO_[^"^'"^@PR?BG!+0
MHUTT[<=#*8"5HK8O=U(SP6^I6'O.Y\JU8ZONS'5Q$/4D!!:;'G^&L27S\0@=
MC5@FOD?16G!<= 'D0$7+GC$8T 63IX '9LDY4Q2<K4=VWS4;V+\M%A7]6".O
ME $#X5(A@.2.S O$E7W-E-E4)5-!A3/CH^+D7Q?94Z231,T%6F=CY5,FW\ S
M\/=96$7UR3_??MJO@5\))Y=BJ,%HYL\.&C_53X*@[&\X?(H;UNU1"_DA5J?0
M%;B3\(D1G<67$Q2Z2<+G'9DYHURGDRG51K"L8GJAL[CH$!Q7@^8QW76PF&,;
M+=07UR"J[AI$S49;V@ZKK?KCS?5JX_&N'U![%.RLMN9,]F;#?3/AV<M2L[3H
M4"R63C"Y8XU%!O'^T_JY/R=^YK\\6IRSK^9+8!1>?^,./3MH(2NXSWO7!38<
M+4*XL*Y0T?1P_^ DU&D*2A^<KV*)T *"+'/GD&SA^E8].R)JA[&_I5A]/#Y_
ML@GIW8DPIR,5]D]L(]A;#7I&Q&.#T_QYIZ<[EB)FE\O2?NUW6P]GIN:*S^>^
M!K0+*;AWJ6^B_*W&CO_A8BH>7/-;Y0QG4GW5A0^1.'+[>)<GT):-3W^#T=VE
M//LO4$L#!!0    ( -F!5E(KH''2KP0  *\3   4    9&=X,3(S,3(P,C!E
M>#,R,2YH=&WM6%ESVS80?N^OV,C3'#,2#QV6=<0S*D6/-4TM5Z*;Y*D#$:"(
M,0FP &A9_?5=D%+2.'8:)TZ3=J('CLC=_?;; TL0XT?3>1"]/@\A-7D&YQ<_
MO9@%T&BY[LM.X+K3: JGT2\OH.MX/D2*",T-EX)DKAN>-:"1&E,,77>SV3B;
MCB/5VHT6KH7JNIF4FCG4T,;QV#[!*R/T^(?QHU8+IC(N<R8,Q(H1PRB4FHLU
MO*1,7T*KM=,*9+%5?)T::'MM'UY*=<FO2"TWW&3L>(\S=NO[L5LY&:\DW1Z/
M*;\"3I\W^("1#F64'?8\VCU,V,KS2;O;[3,_H?[A8/6[CR1=5*]MM-EF['DC
MYZ*5,NM_V&T[_5YA1AM.33KT/>_'1J5Z/$ZD,.A/H7W]MX9Y#\RP:],B&5^+
M8152HS;=BV.9234\\*K?R$I:"<EYMAT^B7C.-)RQ#2QD3L23IL8RM#13/*D5
M-?^3(2>D5]UN:LI]Q,FX8/L0_+8E'5ZG?,4-=-J._R[CV[G&F%RFOCC9[JUD
M@W 1S4YFP22:S<]@?@+!Z2P\@?!5&%Q$L]]"?(32<(%]NUA>3,XBB.;@'\&%
MLW0"!QX?^(?]$?B=GM?\YF.=+&$RG9]'X?2=:)9A4 4_\ YM J+3$):3Q4^3
MLW#9FK]Z$;Z&21!92=OSVO<.\I;&_7O_$[7&);"2QLA\:-M_]\3(PMY^I4R=
METJ7!/T:>4>QP:0,2D&9TA@R3I>8*<,3CAQ,2DS36EJ5%=,&9 +Y%BZ%W&2,
MKEEM/!&B)!DL6"$5J@@XD2H'WVO]#(E4E4J!["4%AFXH3%G,\A53EH4WZOA-
M.[$\B_UK:9U,.5D+J0V/-<Q$+!7BVKG7!**1AIU]"4?_L.$FK>"7+"X5#EOD
M3 2%\#I.B5@SG(EYSK7&(0RQ%*BCL*#9%E*FF#5N0E)F>!_+O,BL]1M$Q?XH
MN6)V7&K+##W868XI>TJ> 4;E]Y[29U9RP_\;WY.X2I<_Z'3AJ=^[D?K^46Y1
M^D<289Y5K&VV*S0N,&TY,3O:AG!;%BYN279"N$+^A6+:,FU:+9)E@-:8<=1#
M08'4=5VIA LB8OL<<6GU=JI<HU:9U8%*+%7E6O]S09S/60V&K#*VUU])A0W8
MPE61D4*SX?[/B')=9&0[Y*+J[<IH=&4[-";9;I4BYMMWC>/5[QN#:]70/?Y.
M[%0BU]#W93W'&_3OE'J.?Z?L0ZA^U^EU.@\.V_:=7O_PX6&/G(%WM_B38;M.
M9]#]*%BW*EM=.NP!71#QO-%I[ T*0BDN_V&[N 8?F^KF/N%F9]3]]^^/WBJ)
M4[M$'A_TCD9OELDN_/M%EK'DVPKLA*U42=06VNUJ=/OWB,^ST37^-ZEX?-#M
MCW1UA:5A1<H$G#JP*'5\*3?ZDG]J:G8+8:^S<]JI)^=#9?AA57<SW$YXU 4M
M,TYA7X+/=?F1@^&K!?]?:MHOT:C?"_, A0E2W,XA2A."E+,$]Y*XKS3\BL$\
M27C,[%[M>YV^?IW.<;_,:762\AG%<*O-[*=_2G[X>_1^7[$?@WCC=*>0]?'6
M4+&,V"9][[SG[8NA"L1[:T)6^'8HS=TF]V#_SK4^RJH.U8[_ E!+ P04
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ME:T!75M, XXI(1T7(#V'L6B,X>#OMD"H!GN9;L!OX,,=OLLX&T9TX(8.@NA
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M:@*) K,(<?8=5YJ*&?85MZ*(P2Y%=BX2XGI=[(E$OF\4BZ,HE/;Y *_ 4_;
MF>;D,V<"L$DOPD=/ @;"XD,3&,8KDVPB[BWXNSI^)M"HAWW ^ .6#H#I0EYI
M;%]G=E1JPHK8#\7+<*6A0E^[)Y32[C YH["AD0]Z07" ?C+^73#4&$H*LX)'
MX9BHF_Z-MG_ZZ4@3<-EQUP4J1:GC=SJ&V16PC3T3SO!TQ;(7ZO'[\HX6V#,!
M81TV=?C(I]@P54;"+2#O@]W4)*=G@+&4A$\H*$BKQ5,=&M6&/*#TK7;=X.M?
M &0PK)V*K*;3! @S6KYR#C8ZW.O[^@P/MBK\>Z54*I3T?R34%1V\-P-H1Q0X
MG(); 8:IXBR\"<50CP-%TDG>LY^.!>N,?ZK:%Z>C0P#(>RM$JNS^;#!>3?+#
M)#,^8L,+,W;\F7::5ACSYR1C3O*![.E8KHEDQL!H0+<P'S_QBRQ%P@ #M;8)
M<4>Y#DLC-"52S'F=2:#-("Q=O_M#X+CQ1O#!<D:PMTO8N%)#&'6$^00C$M.U
MJS,4R_$2/9W7H5@\LEYKE*%VV)^AW8\0(?K=C\^6F>PK<O[0<\7X)]N2D>0G
MDKP#3W/ );\CFR*>K'Z0/Y'&1@A%4ZF+\_1#Q4UZQ.24@0O,>OS=))>@*".C
M[_(H-0%+I29FH<*#6!-G[^AX 1#.CT^%@(5#F= !)WOH3Q!&W]9Y#U@(1YC-
M)I"C-$I*^V"@%3,?TK<&P&:8:T=5$:.>5L(:K7Q=E@!\KB/<WX45TL,R0PVY
M+6@;=3PW&AC,]3MN1:=:NAX)SLCDRD"1")-&G34^P1M"9?HY,$> <(Q@HVT(
M,SLJ8?38-\=C,+5GBC6 [FH<#S*9_TI&C4?RR<;0*<-M#'J13!]L8]#;&/3+
MBD$_H\9=L8(%<#,86$AJ#3RW+U0$9J8B0H-Z@J]&*:;4 J@408EK0F,$60W1
MIHP*$19Q5!N;6A%.@C79C^;VZ,%:5]-(L4>M_<UG, HF7(#:#)_OXF=Y "_2
M=D G+'&XMM9#9#W0U%*$66Q ;)14;KPK5UW.E?OKN=PX]BM$!(%:VGBZE+SO
M>C IRY^(,R%@ I#&33L,\Z:+D764R<^"K=D5GQT7*R9JP1VO[X6IQCH)H  $
MS@'A?-?6K*\&4NIZ;\H^9RIEM6M,4?W4.5!0(: EO&SW@QDJ#T7EGJ-JH8V7
M20&VT488?(^C6\G^K>,4WH(#=ZDV1*O<F:2B7(F_0J ,:!HW'':UY>*8 N8=
MZ8(5$<7WS+[MFA+Y>1LS>U.RN\ R(A5SPJPH-M8U%'3Q<G3$-$Z[X!QH8),_
M(OTSA1.%R9+\>=/0>$+<EY1BTG+T:=A1J,!#$L;4R[!M.CGD"G-]#RPA-'3N
MO( XTC8UYCJ"/8O]-U[Y'2ZG_/QU)_/S&J $PKQY?5H^OQ64-+'ACX/S9SP#
MO\8#T)6-. !=CQ)0I'GB0\68CUC38>>)%Q%F4G;BP8/0+#(%3,%YZMBOEB,J
M[$X6K:N]A4YH^D >'QO^&$,3CY=UYM7]IQP$ FI$3:I/%PH51@HUX[7L1*7J
M74SZ6[X$RHE,RZ%=\!# J-->A'8VQ=R^$]H"V^GN1N?+?F">@ET)D6K"B,<3
MM$.&SR*5]FRS#_3T==L%4LPS&Z/-G'DJ((%XF="V':C0"K1[A4O!1+=NWA3H
M1AN:6O1(*_M$)8 +_$A1^<;44G2 0<RVGMG!C.W% @UEDLH@:PI5]#P^+3[&
MB\DOR!UL!,C=SMC@K_$&KPWG4AD18QK$G)AAPM@IB)JEF;!0=.YN+A8FQD.^
MG( ?:X=0/:'X_ -"43Y9O37#=^=9@_FB?V[EX0$DSA2YY(ND-4P6@3K\K;F>
M-\EE8C3S>DXIL4A!Q=H>8_FA2R5DQCLA;\2ALGK/$0ZY)WC(G\/JXX.5,HH^
M8^&-]E,G]Q/+"I/MO!?S)Z3=W-3XF]>V;[5YX>HV+[S-"[^LO/"TZC^<':Y?
MM9[O;HB>;V3Z':Q1KR=9,41Z&P0&I&@\Z1].54TE?3DF?:U"?(VIL=4YW*3/
M%Y6V3S7CF'#8XO;HB]L()XV"C9U>(%5J,H^9)ZH^=^5_HMX%(UR-MF*21"*Y
MR#P,!IZB#F08$<1DIL#4"U?8+3!JC9 >FGSUZ?#(CRUA%O7QR%?Y^-R?VH7X
M"VJH05]3?P]83M2!)$7Q5+<-1\SJ&X.+HNYK3S]ZEQ,XL#8$#FX\=BEZ/'36
MU<>P.<1.,F#,H010A;LY6&+R&>3FSF3O(&E=H]T ,1SI#A81.[L>:]R9R)!9
M)9J;7URJF88+HP_%=^GK<R\ZOD1_/W<B(B_QF>I&Q&>N$48P:J=!YU+ZW5#Y
M!%UYBLZDVKCJB=(9"]/:9()QDW8F>/9@9N<ES=L\,%U'XK0<,'"^<"-.956+
MASM\U:]+?8R#.\**"!U=?JD2?;@1$OT^/E=TS>_SE4@R9Y[(\BJ8R ,=CS)G
MI[)FBDZFT_$ZM.@<?A_'2]J!J5>[$??L=T]]B[/B^@R>#I*,4^\V2.7DX9D]
M^%VG7V#4Z!R3 WBQ8\Z*#7BJ6N=PKUPME6F^]&LEFD;\]/?"Q=9HK)4R>X'Z
M)BACDOTI"7EZ5Z.<B\C11HA(THLJYE&=HKKE0=P3<5T-I[];8D2A.)-&L\C,
MGW0A'D;DI.I!T:I,V0-ROU1#(W&.$QU,-:W83>T4N3V3Y2I*#/&E,/!O+\1J
M.'0Q=!,XHB=,OJ;[:&:E7R>0_22#7##/[0EJK>8O]>X0JI<S!RRUD,[2['0$
MVK36>'!(TV&CD-R0+I"9_%:'9V=]B@E.\RE&60'#=!P5L[1<Q8U,TX<CS8%S
MTU)O"2]R1MNVKDC3<*ENW%.^Z#RLCFJ=XX>)[QA.]AUJW2BQX$K86 +)]7[B
M[:;B%V N*IL;SZTGG]<M/$'?20%(4L&:Y"\508\W D'KJ2J&?-@8YC1D7 !A
MH"*I-,P47B#_ 3+:LD<"%,0%$EBB+_ T1" R=VATU/*;?#Q'+#F6^U'%O).@
MJGZ'7WH2^N;X/76)W\*Z84"UI9E3",E)<ER]%G<$8@SHF^,5NB^%J?](F3Q@
MY122V!]5]B>42J^'NK#Z(!;DN3.,0<^HML">G )8)5V)(K"9J_)<:0$\X&V^
M!0^AX,%0^@0!.[KV'KTR@YXC.P)4UH-Q=L&,T^1,JHT,KA$%S"JQ#7!Z+;#W
MKNZV&:\I(O_DXK(+>:D8<K(1&!+YMA\$Q_O6&6ZXXTIB%?[ 3&4&SV/,%B10
MJ,"4W(*XW@E7ZN:P+IIH>%HFUI[<Q-4&\6O3XF8AH$F#U-MP,H_QU#)J4DTH
M5Y,Z]E1T].6E<O;I9G!V\A)7W,&:CXB:$ST9:ZPH<4#U[@GO2A>!WZ!N%_S:
MGHR[]DZ\>\MH)ZE2+U])O\!6MX"AM;]4?BR7<L"0U>)!]2&H!66YWEQDTW2P
M3YW?C-\%EL1?E7DKT#0PFA-8!OIT\VUV/^"![^'BD*,'PD&[3^?(X,+03>7!
M3-M*;8)$2.H79CY]TJKS-?G T(D/3&I?F YDSAZ,A&/.6M+2AMF3>^PKE>B+
MJ&O^_'[]V9#U$U3(MJ)G(;\>;BMZMA4]+Z^B9YVOZY[WAN*CTOD%=Z(:$G(X
MT4AV=1T'F-6HXU@7KO@&%U>>^(;&95[U*^U_OI+\L&Q5CNR#0]X[KO;*IR>'
MW>II]?BP?%@Y.3RUJG]47[V8%X0V;]C79N>FT6ZSK_B:T-;5NOKBITQ++-:)
MW?A)O9DMF.U)!<AWKS#B 29LU[L3\_5:QF2JE"I)(;O9DKURL7*X<D/RWU\:
M[0Z[;-;>W[3:G6:]S6X;]4;SM]K%=:/-FC?U95=4+%4F%U0JELKQ@A9W#7XD
M=9YUL%61^F*LSY;E*\,_KW[IS>OJ\;E//UD;.Q^.V&V1?<8*'C;CGR4WHWRT
MD$E6M14W?"C,0;_)Q6W60CHR<.*5,/8;GA3_#-XPO1&(;.\.NBK@4JM<REY^
M!UL?  /HMFX_MVYKG<8EE6]&59@O'HDW<@,C6'_9N+Y*BCY44OMXSBB3M[=I
M2J9\4II8QQHBC6O0,"LS_%>#6]N(%LSS:!O1VD:T-CVB-0$+!\72#%RHKA[(
M:H&#YVHMS/2)( JWF\-([/JZ;OK@8\>74 :Y--<VVO;;/-/O(Q;[T&M:.?P>
MJN%(!-)_E"]?*>5D%U*&UNQE;=J",C;7)^[R/KW;3N(A>6_KR&^Q8'DL^../
MM-3?>M@)]Z,C1B.A_LC\LUEQKY3(9]:T6:O(^E9/%/1J^61C97/3!MM@=V^%
M[M9"GC_>.H);1_!A1_#G,'G>',L?Q9J<FD)U]>9UY>#@W/0WEO \;.ZH1AZ=
M:\"@8=.] ]DBJ<+70^'I)%B7M'4=/7FKU_*O4->AX154>A<[NN;M?O'?[Y47
MCG23O U2)WD8[!=/DS"V]8HW9$&+O>*E-VB#9763!3]?8K]UBW.\B@?<XHV4
M]*D*S=SCPZ8.MO6_%PK7R=;_WOK?6_][(TRGSS=U=E&[^5A@-S4\[E>[9K5V
MNU5OTE^%3;,$9[CXU,:>LM.XUI07'WGXUW76]/WP5RA?_;4351E'_).T!EPX
M[$)Y]^ZLLL2<52;^8,5B3NSN=,%B9@<V:QE9]Z$M7 D^0[9N\9G5W=3[MK:&
MZH\;JJ=;0W5KJ&X-U8TP*=Y[P8 /V56H6WI$J1[@N*=4'BZ-H+^2M98W<RV3
M-A%WTF7_*N+&*]GG;BZ-M,VR8M+IFTGR;M9*LO;8DH98]B!,Z60T^?IN_=G3
M4'^)-Z9N+;@?M^#*I:T)MS7AMB;<1M@9G[Y<O3?!QNO.99'M7)%N_T@_:ZSS
MH4'?LM85Z[0^_M[:^]3LM+]<--L?FNS+U;_T7;M+UO%H>S&7=MUF&XE)PCH?
M9F+*2FPH^8U]E8XC^7 MO0CCG/Z<@.(3VEGDIC8F92W.I/.FK./!U/_C]F<+
M'2O#?8!Z$P7X1:HPM]B>/VS? GM>U[$DL.=2TC<2-IX1UVLV>#_2#Q3YG3G&
M]U71-K><NM5)FZB3MDHIITII6[":ARAR>1M%WD:1<QI%WN]Z]AC^-PB&SKO_
M E!+ P04    " #9@592V.%DQ$P2  #9@@  %@   &1G>#$R,S$R,#(P97AH
M,3 Q-2YH=&WM/6ESVSBRW_=78)W:K+TEZ_05.Y,J19(C)=8QDA)/]LL41$(6
MQA3!!Y!RM+_^=0.\=#FV$]NB)U,U<B020%_H$VR^_6>]6QM^[37(Q)\ZI/?Y
M_46K1G;V"X7+2JU0J _KI#EL7Y"#?+%$AI*ZBOM<N-0I%!J=';(S\7WOM%"X
MN;G)WU3R0EX5AOT"3G50<(10+&_[]LZ[M_@+?#)JO_O'VW_N[Y.ZL((I<WUB
M249]9I- <?>*7-I,79/]_?"NFO#FDE]-?%(NEDOD4LAK/J/FNL]]A[V+YGE;
M,-_?%O0B;T?"GK][:_,9X?9O.[QR?%(\.'IC5:RB=7!T5!I53HKV\0D]LDNC
M8L4J_5D"( MPNQFC_+G#?MN9<G=_PG#]T^.RYY_=<-N?G):*Q7_M+-Y'Y17<
M.A*^+Z:GQ7P);H8[QL+U 1(),YM_KBYPKX$KPWWVS=^G#K]R3S65PJ'194LX
M0IZ^*NK_SO#*_IA.N3,__?>03YDB'79#^F)*W7_G%'!V7S')Q^9&Q?_'3DLE
M0%I_O0FI /,XW&4154IE)$7CVX2/N$]*@,#AO7 ]VX#!_:F6GLD">6#RF8A1
M;3<Z=?A_2#K=/#DFPR[9B,BVP#QL-DBOWSUO#<F@6>VW.A]([Z+:(=WS;/+@
M]\^-P9#46]4/G>Y@V*H-2*M3Z_9[W7YUV*C_')SN(Z++$_T5*)^/YX].G8/U
MW)XPTI-B##MV,*$2U6[/H2X18_)[P)1/ZIQ>N0) M!1IN9:0GI"HHW.$*N))
MIH .SIQ,*7=]^!^5MVLS26 ."KK8UGJ=NC:!6WT8J+^S\9A9/I\QG 26^DC=
M@,HY*>5 MY>.R*X/8+U^=5(N%\\0'/W/TME>CG!%)DRRT=S,#LMQE^#=8^$X
MX@;AAX4\F%WE;E^F7'K]ZO#D[,>X9G[B (CKGU:.O,?7NNO96,J_?E4Z*IZM
M?E8]#^C$OY$J\86FE.8OT#$B8(HY*6K**:%Z*/RH!\*(:L30_,N@6GDSU8@+
M2\2T:VIZV3$M#!%S3T.M9R).51$VX\ BB^'>X3Y20'CH\.'W111SW]$69 ([
MT**!0OHLC$1RC1AAWY@5X(VPLW&I 7.YD.0+MU _,86 &#U2FW V)LT $"1]
MID0@+4"Z.Q[#K9( <)FD]I]__AG!_?3+&S+8S$)F 7]/M0K'NW;>U9G%IB.@
M;/E$:\WB\X&)5+KS7CJ!"3W8LF 1]ATV]D_+I:/G8?A/=4M64;J3"[)QV%-S
M\/U<6UU"R':*^^M7!\=G2G^2&K.XPRGYE"=MZQ-S73:_G[NX-53?9.9>/H:#
M+[WO6XT[XGRTC'"IF-8RTH"C?WM8H)!.+WC")%=.)7,H^K ;$PX11Y(A=*2$
M ]9TXY#'C\W*=W-;U^4TS.=$)KKKBNV/)*/7^W0,L)Y2YX;.U<X39&<>7R">
MT.P<'Z!7U^LU.O76'Z3Z QM]J]'4@M6K]L&FMGK5(>8O&NW>1?=KHS_X2;DW
M_?&T6JY<*4?1.H9O%(-=11I3SQ%S)B&ZA3A$@FM-3412$U./NG-TKK73KGUJ
M3XH95Z @5)X0G,JE"-LNZL>_ LF5S2W4'SI6%O**NOQ_VD#NK4\'X#A<S*P=
MPY);C+:-'@Y#[CAD,EA(=I\8W%@7GXX<EN@^":9['^CO4$^QT^@?9S97GD/G
MI]S55-2#SF9, N#4"274%UZH)]Z<Y,N58U05/O#:MZ/I0RV2UUJDX-NKUPY.
M\L5B>>-ED*2-UVZ=]DW^^,W)G:8M:) -V("^ K[_ME/96?+\3LO>-U):W*&X
ME]?09.=^ EZ#@2/)'\LA:S?:[V'GDNXYP<RD<9MKW<ZPW[VX:-3)AW[W<^\A
M^_II4 .-.X5Q%DA[F]E(:')!1XBGD)S!7EF(DG?KC;VMQ@6VKDO32D CD-]Z
MP-\[ ?,DAP4_,)=%Z8GMASNA-'BM8R9U-F; Y S<UICV[?I6X]#X1J==EY&+
MB]K6TSN"]5)(QR:7W&81D7O5C &.)KCS,0*_\W&KP0>="-#GC(RTNQF %<G;
MG7"1$078YC8)+1&IP>4UEDC3OM79TX[>?TB34<>?U(3K,LL/K]:V>Q-TP,.V
M29LJ1:U)H)CO)SIRNR'O47\"2US-R?N .[8NPU'IN^!.3[BW]2J^!VZ!0!R6
M1*JGI>9RNVF_&MALV""9V.BKV-0%1'GH032%@Y79+-CA52P0>-@6*EL.\W>J
M8ED'?\O5TO? [WS)'/CZ0(,(8%=SQ:ABF=5*+<P.NM2<'\RH3FJY,_@)J]@J
MHQ@8KVZ81:A;%UF$>LO]T%6H%[SIC.+0X19XU[A?X;L?^&SK(YD[X!!I_B]9
MPP0"YQYS735W9M3E-*L&K,\LQF=85\A(+G$5A>'[W :[%54=,EI06(LLDY):
M0'^:45O]!?R,0,:9FBV'O\\\*<PY"W*.(N%P?[ZN<K#EUF3@,8M3!V!?EPS(
MG!DQ63WR^E7EY(Q<,L=QF<J(1'UVN4-'I!8&<'@.==M!UAE7G1>K<=?B+L8[
MD>ATFUD!W6$SYE#7SA[DPE7"X;:.]F'[QMOV?+MCAP2#<U@(X,_&!DW ;@KE
M<1_B^JA4F5%$,I)=20C?<FU.7>J!U&/Z/5_+ZY).-H#_A Z.=3V/J/[I:T8
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M]9J 78[ C[J+'D5(M?$5XS'V_! A<0FC8/3 RBL@3$AOW4\/AA,*YMP\M+I
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M,!+V'/Y,_*GS[O\!4$L! A0#%     @ V8%64I%6H"RM) 4 Q^ V !
M         ( !     &1G>"TR,#(P,3(S,2YH=&U02P$"% ,4    " #9@592
M^4/VB",?   F30$ $               @ ';) 4 9&=X+3(P,C Q,C,Q+GAS
M9%!+ 0(4 Q0    ( -F!5E(U62LDL3D  %AN @ 4              "  2Q$
M!0!D9W@M,C R,#$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( -F!5E+9$$CA0[X
M %=&"  4              "  0]^!0!D9W@M,C R,#$R,S%?9&5F+GAM;%!+
M 0(4 Q0    ( -F!5E(KUM#7.E4  *9S   3              "  80\!@!D
M9W@M,C R,#$R,S%?9S$N:G!G4$L! A0#%     @ V8%64E4AQZE,)0  ]D4
M !,              ( ![Y$& &1G>"TR,#(P,3(S,5]G,BYJ<&=02P$"% ,4
M    " #9@592:[_&-]QA  "LF   $P              @ %LMP8 9&=X+3(P
M,C Q,C,Q7V<S+FIP9U!+ 0(4 Q0    ( -F!5E(2?1#W8E@  .B1   3
M          "  7D9!P!D9W@M,C R,#$R,S%?9S0N:G!G4$L! A0#%     @
MV8%64N9QTC?F;P  0:T  !,              ( !#'(' &1G>"TR,#(P,3(S
M,5]G-2YJ<&=02P$"% ,4    " #9@592#AWQ@K9[ 0!!$P( $P
M    @ $CX@< 9&=X+3(P,C Q,C,Q7V<V+FIP9U!+ 0(4 Q0    ( -F!5E*=
M9+=.:*H! 'QB$0 4              "  0I>"0!D9W@M,C R,#$R,S%?;&%B
M+GAM;%!+ 0(4 Q0    ( -F!5E++<B<5* L! 'PY#  4              "
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M2P$"% ,4    " #9@592Y(RTF?$/  "%/@$ %               @ %[PPP
M9&=X,3(S,3(P,C!E>#(Q,2YH=&U02P$"% ,4    " #9@592"BY^<C8$   *
M#P  %               @ &>TPP 9&=X,3(S,3(P,C!E>#(S,2YH=&U02P$"
M% ,4    " #9@592SDI9"3X(  #Z*0  %               @ $&V P 9&=X
M,3(S,3(P,C!E>#,Q,2YH=&U02P$"% ,4    " #9@592>%<6IC@(  "F*0
M%               @ %VX P 9&=X,3(S,3(P,C!E>#,Q,BYH=&U02P$"% ,4
M    " #9@592*Z!QTJ\$  "O$P  %               @ '@Z P 9&=X,3(S
M,3(P,C!E>#,R,2YH=&U02P$"% ,4    " #9@592?OM#^*L$  "V$P  %
M            @ '![0P 9&=X,3(S,3(P,C!E>#,R,BYH=&U02P$"% ,4
M" #9@592"Q=,_ZP;  #2  $ %               @ &>\@P 9&=X,3(S,3(P
M,C!E>#DY-RYH=&U02P$"% ,4    " #9@592V.%DQ$P2  #9@@  %@
M        @ %\#@T 9&=X,3(S,3(P,C!E>&@Q,#$U+FAT;5!+!08     %P 7
+ .,%  #\( T    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
